{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "4cf64a45",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import os\n",
    "import pickle\n",
    "import torch\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "89e01c4f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Read JSON\n",
    "def read_json(fname):\n",
    "    with open(fname, \"r\") as handle:\n",
    "        res = handle.read()\n",
    "        obj = json.loads(res)\n",
    "    return obj"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "446fedde",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Read pickle\n",
    "def read_pkl(fname):\n",
    "    with open(fname, 'rb') as handle:\n",
    "        obj_pkl = pickle.load(handle)\n",
    "    return obj_pkl"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "7264a5e2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Read torch \n",
    "def read_torch(fname):\n",
    "    obj = torch.load(fname)\n",
    "    return obj"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "503c8b0c",
   "metadata": {},
   "outputs": [],
   "source": [
    "test_data = read_pkl('../data/medmentions/test_processed_data.pickle')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "1ac043a7",
   "metadata": {},
   "outputs": [],
   "source": [
    "dictionary = read_pkl('../data/medmentions/dictionary.pickle')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "d4460475",
   "metadata": {},
   "outputs": [],
   "source": [
    "dict_id_to_idx = {e['cui']: i for i,e in enumerate(dictionary)}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "d01e11d7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ls: data/medmentions/top64_cands: No such file or directory\r\n"
     ]
    }
   ],
   "source": [
    "!ls data/medmentions/top64_cands"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "4d39cce7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ls: data/medmentions/results: No such file or directory\r\n"
     ]
    }
   ],
   "source": [
    "!ls data/medmentions/results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "c6215cb2",
   "metadata": {},
   "outputs": [],
   "source": [
    "tfidf = {}\n",
    "with open('../data/medmentions/top64_cands/tfidf.json', \"r\") as handle:\n",
    "    lines = handle.readlines()\n",
    "    for line in lines:\n",
    "        obj = json.loads(line)\n",
    "        tfidf[obj['mention_id']] = obj['tfidf_candidates']\n",
    "existing_cands = {\n",
    "    'mode': 'test',\n",
    "    'candidates': {},\n",
    "    'labels': []\n",
    "}\n",
    "for idx,men in enumerate(test_data):\n",
    "    if men['mention_id'] not in tfidf:\n",
    "        existing_cands['labels'].append(-1)\n",
    "        existing_cands['candidates'][idx] = []\n",
    "    else:\n",
    "        arr = []\n",
    "        existing_cands['labels'].append(-1)\n",
    "        for c in tfidf[men['mention_id']]:\n",
    "            arr.append(dict_id_to_idx[c])\n",
    "            if c == men['label_cuis'][0]:\n",
    "                existing_cands['labels'][-1] = len(arr) - 1\n",
    "        existing_cands['candidates'][idx] = arr"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "7600acf1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([   19,    21,    27, ..., 39027, 39032, 39034])"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# existing_cands = read_torch('data/medmentions/top64_cands/in_batch.t7')\n",
    "labels = np.array(existing_cands['labels'])\n",
    "np.where(labels == -1)[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "b26ed8a2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5705  -  [   19    21    27 ... 39027 39032 39034]\n"
     ]
    }
   ],
   "source": [
    "# Indexes where existing model fails to retrieve the ground-truth\n",
    "# existing_cands = read_torch('data/medmentions/top64_cands/in_batch.t7')\n",
    "exist_labels = np.array(existing_cands['labels'])\n",
    "existing_idxs = np.where(exist_labels == -1)[0]\n",
    "existing_idxs_bi_recallhits = np.where(exist_labels == 0)[0]\n",
    "existing_idxs_bi_recallnonhits = np.where(exist_labels > 0)[0]\n",
    "existing_idxs_bi_recall = np.where(exist_labels != -1)[0]\n",
    "print(len(existing_idxs), \" - \", existing_idxs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "2f0f3ca9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "37346  -  [    0     1     2 ... 39035 39036 39037]\n",
      "28230  -  [    0     1     2 ... 39033 39035 39036]\n",
      "9116  -  [   19    21    27 ... 39029 39034 39037]\n",
      "1692  -  [  115   150   152 ... 39024 39027 39032]\n"
     ]
    }
   ],
   "source": [
    "our_cands = read_torch('../data/medmentions/top64_cands/arbo.t7')\n",
    "our_labels = np.array(our_cands['labels'])\n",
    "our_idxs = np.where(our_labels != -1)[0]\n",
    "our_idxs_bi_recallhits = np.where(our_labels == 0)[0]\n",
    "our_idxs_bi_recallnonhits = np.where(our_labels > 0)[0]\n",
    "our_idxs_bi_norecall = np.where(our_labels == -1)[0]\n",
    "print(len(our_idxs), \" - \", our_idxs)\n",
    "print(len(our_idxs_bi_recallhits), \" - \", our_idxs_bi_recallhits)\n",
    "print(len(our_idxs_bi_recallnonhits), \" - \", our_idxs_bi_recallnonhits)\n",
    "print(len(our_idxs_bi_norecall), \" - \", our_idxs_bi_norecall)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "69f39be9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1277\n",
      "[  115   150   152 ... 39022 39027 39032]\n"
     ]
    }
   ],
   "source": [
    "# existing model AND our model failed recall\n",
    "\n",
    "exi_fail_our_fail_idxs = np.intersect1d(existing_idxs, our_idxs_bi_norecall)\n",
    "print(len(exi_fail_our_fail_idxs))\n",
    "print(exi_fail_our_fail_idxs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "cce0a509",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1385\n",
      "[   42   102   212 ... 38977 38987 38994]\n"
     ]
    }
   ],
   "source": [
    "# existing model failed recall\n",
    "# our biencoder linked correctly\n",
    "\n",
    "print(len(np.intersect1d(existing_idxs, our_idxs_bi_recallhits)))\n",
    "print(np.intersect1d(existing_idxs, our_idxs_bi_recallhits))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "d94d9864",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "415\n",
      "[  159   262   434   569  1504  1554  1679  1748  1757  2016  2112  2227\n",
      "  2228  2330  2386  2397  2407  2436  2440  2445  2447  2691  2929  3129\n",
      "  3131  3133  3139  3141  3149  3200  3625  3829  3960  4611  4613  4671\n",
      "  4675  4683  5089  5117  5148  5152  5286  5331  5348  5351  5373  5384\n",
      "  5388  5403  5412  5700  6513  6522  6617  6633  6637  6642  6645  6649\n",
      "  6653  6665  6669  6676  6812  6816  6900  6962  6972  6976  6989  6990\n",
      "  7000  7001  7003  7006  7007  7200  7667  7683  7698  7820  7869  7884\n",
      "  7890  8071  8083  9036  9147  9488  9489  9492  9510 10028 10158 10915\n",
      " 10937 11006 11014 11315 11323 11705 11717 11776 11937 12036 12047 12074\n",
      " 12082 12110 12714 12871 12904 13048 13171 13233 13235 13557 13664 13746\n",
      " 13893 13996 14046 14049 14091 14250 14464 14616 14733 14735 14736 14737\n",
      " 14739 14788 14850 15196 15355 15450 16235 16516 16518 16521 16526 16531\n",
      " 16534 16539 16546 16557 16563 16612 16635 16666 16697 17478 17482 17485\n",
      " 17486 17501 17517 17570 17792 17798 17810 17826 17828 17837 17845 17855\n",
      " 17865 17868 17874 18043 18209 18269 18280 18288 18297 18303 18304 18306\n",
      " 18317 18349 18500 18515 19012 19078 19225 19251 19257 19265 19283 19293\n",
      " 19298 19300 19312 19544 19885 20100 20128 20226 20412 20425 20450 20488\n",
      " 20491 20492 20496 20530 20531 20535 20590 20664 21173 21186 21209 21477\n",
      " 21483 21497 21499 21507 21515 21523 21544 21558 21775 21784 21789 21791\n",
      " 22230 22259 22327 22387 22422 23279 23290 23316 23327 23332 23334 23337\n",
      " 23367 23385 23394 23396 23425 23508 23538 23664 23944 23988 23997 24002\n",
      " 24008 24009 24023 24286 24556 24756 24851 24856 24922 24943 25020 25376\n",
      " 25379 25437 25465 25469 25595 25612 25726 25771 26000 26203 26217 26261\n",
      " 26269 26322 26324 26337 26347 26358 26613 26877 27358 27383 27392 27709\n",
      " 28492 28500 28520 28525 28570 28754 29356 29372 29612 29878 30081 30231\n",
      " 30237 30444 30452 30490 30507 30643 30644 30994 31079 31080 31314 31316\n",
      " 31559 31566 31691 31779 31856 31885 32218 32651 32827 33105 33671 33684\n",
      " 33900 33907 33917 34038 34074 34357 34423 34530 34616 34622 34865 34976\n",
      " 34981 35063 35195 35289 35308 35487 35496 35500 35502 35514 35520 35523\n",
      " 35633 35811 35869 36213 36218 36227 36229 36312 36723 36841 36850 36852\n",
      " 36888 36906 36956 36958 37109 37274 37332 37413 37436 37442 37445 37470\n",
      " 37479 37529 37533 37536 37879 37965 38283 38291 38305 38306 38388 38431\n",
      " 38433 38435 38437 38439 38457 38462 38464 38466 38468 38474 38476 38478\n",
      " 38480 38481 38485 38487 38489 38493 38494 38496 38509 38513 38536 38544\n",
      " 38547 38948 38989 39001 39007 39013 39024]\n"
     ]
    }
   ],
   "source": [
    "# existing model recalled correctly\n",
    "# our biencoder failed recall\n",
    "exi_succ_ourbi_fail_idxs = np.intersect1d(existing_idxs_bi_recall, our_idxs_bi_norecall)\n",
    "print(len(exi_succ_ourbi_fail_idxs))\n",
    "print(exi_succ_ourbi_fail_idxs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "4459dac4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3043\n",
      "[   19    21    27 ... 38973 38995 39034]\n"
     ]
    }
   ],
   "source": [
    "# existing model failed recall\n",
    "# our biencoder recalled correctly\n",
    "# our crossencoder linked correctly\n",
    "\n",
    "exi_fail_ourbi_succ_idxs = np.intersect1d(existing_idxs, our_idxs_bi_recallnonhits)\n",
    "print(len(exi_fail_ourbi_succ_idxs))\n",
    "print(exi_fail_ourbi_succ_idxs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "4b2c25bf",
   "metadata": {},
   "outputs": [],
   "source": [
    "cross_res = read_json('../data/medmentions/results/cross_arbo.json')\n",
    "success_men_ids = set([s['mention_id'] for s in cross_res['success']])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "4a8388a8",
   "metadata": {},
   "outputs": [],
   "source": [
    "cross_succ_idxs = [i for i in range(len(test_data)) if test_data[i]['mention_id'] in success_men_ids]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "6e77198c",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "675\n"
     ]
    }
   ],
   "source": [
    "final_idxs = np.intersect1d(exi_fail_ourbi_succ_idxs, cross_succ_idxs)\n",
    "print(len(final_idxs))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "d0c91fd5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Track cases where existing retrieved successfully but our biencoder failed to retrieve\n",
    "res_exi_succ_our_fail = []\n",
    "\n",
    "for i in exi_succ_ourbi_fail_idxs:\n",
    "    d = test_data[i]\n",
    "    men_id = d['mention_id']\n",
    "    ctxt = ' '.join(d['context']['tokens'])\n",
    "    etype = d['type']\n",
    "    name = d['mention_name']\n",
    "    correct_label_idx = d['label_idxs'][0]\n",
    "    if len(existing_cands['candidates'][i]) != 0:\n",
    "        existing_label_idx = existing_cands['candidates'][i][0]\n",
    "        existing_cui = dictionary[existing_label_idx]['cui']\n",
    "        existing_cui_name = dictionary[existing_label_idx]['title']\n",
    "        existing_cui_desc = dictionary[existing_label_idx]['description']\n",
    "    else:\n",
    "        existing_cui = None\n",
    "        existing_cui_name = None\n",
    "        existing_cui_desc = None\n",
    "    our_label_idx = our_cands['candidates'][i][0]  # Our biencoder model's best prediction\n",
    "    our_cui = dictionary[our_label_idx]['cui']\n",
    "    our_cui_name = dictionary[our_label_idx]['title']\n",
    "    our_cui_desc = dictionary[our_label_idx]['description']\n",
    "    res_exi_succ_our_fail.append({\n",
    "        'mention_id': men_id,\n",
    "        'test_set_idx': i,\n",
    "        'type': etype,\n",
    "        'mention_name': name,\n",
    "        'context': ctxt,\n",
    "        'cui_name': dictionary[correct_label_idx]['title'],\n",
    "        'cui_desc': dictionary[correct_label_idx]['description'],\n",
    "#         'existing_bi_cui': existing_cui,\n",
    "#         'existing_bi_cui_name': existing_cui_name,\n",
    "#         'existing_bi_cui_desc': existing_cui_desc,\n",
    "#         'our_bi_cui': our_cui,\n",
    "        'our_bi_cui_name': our_cui_name,\n",
    "        'our_bi_cui_desc': our_cui_desc,\n",
    "    })\n",
    "np.random.shuffle(res_exi_succ_our_fail)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "8119ed8c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'mention_id': '27882444.13',\n",
       "  'test_set_idx': 20496,\n",
       "  'type': 'T005',\n",
       "  'mention_name': 'pigeon paramyxovirus type 1',\n",
       "  'context': '[CLS] type 1 first isolated in the northwest region of China Pig ##eon para ##my ##x ##ov ##ir ##us type - 1 ( pigeon para ##my ##x ##ov ##ir ##us type 1 ) is an en ##zo ##otic in pigeon flock ##s and causes severe economic losses in the p ##ou ##ltry industry in many countries . A [unused1] pigeon para ##my ##x ##ov ##ir ##us type 1 [unused2] is ##olate , abbreviated as PP ##M ##V - 1 / Q ##L - 01 / CH / 15 , was isolated from a great spotted wood ##pec ##ker in the northwest region of China in 2015 . The complete genome was sequence ##d , and the results showed that the virus genome was 15 , 192 n [SEP]',\n",
       "  'cui_name': 'Newcastle disease virus',\n",
       "  'cui_desc': 'Newcastle disease virus ( Virus , NDV , organism : PARAMYXOVIRUS AVIAN 01 ; Paramyxovirus 1 , Avian ; newcastle disease virus ; AVIAN PARAMYXOVIRUS 01 ; Avian Paramyxovirus 1 ; Newcastle disease virus NDV ; Avian paramyxovirus type-1 ; Avian Paramyxovirus Serotype I ; Avian Paramyxovirus Type 1 ; Avian paramyxovirus 1 ; Newcastle Disease Virus ; Avian paramyxovirus type 1 ; NEWCASTLE DISEASE VIRUS ; Avian parainfluenzavirus 1 ; avian paramyxovirus 1 ; NEWCASTLE DIS VIRUS )',\n",
       "  'our_bi_cui_name': 'Pigeon paramyxovirus 1',\n",
       "  'our_bi_cui_desc': 'Pigeon paramyxovirus 1 ( Virus , organism : PPMV-1 )'},\n",
       " {'mention_id': '27846748.62',\n",
       "  'test_set_idx': 19312,\n",
       "  'type': 'T103',\n",
       "  'mention_name': 'natural eggshell membrane',\n",
       "  'context': '[CLS] matrix protein , and alpha - 2 - mac ##rog ##lo ##bul ##in in natural eggs ##hell membrane - treated rats ranged from 30 % to 72 % ( p < 0 . 05 ) . natural eggs ##hell membrane significantly improved multiple aspects of inflammatory art ##hr ##itis including inflammation , pan ##nus , cart ##ila ##ge damage , bone re ##sor ##ption , and per ##ios ##te ##al bone formation . This study provides further support for the use of CT ##X ##II , cart ##ila ##ge o ##li ##go ##mer ##ic matrix protein , and alpha - 2 - mac ##rog ##lo ##bul ##in as relevant bio ##mark ##ers that were re ##sp ##ons ##ive to [unused1] natural eggs ##hell membrane [unused2] . [SEP]',\n",
       "  'cui_name': 'EGG SHELL MEMBRANE',\n",
       "  'cui_desc': 'EGG SHELL MEMBRANE ( Chemical )',\n",
       "  'our_bi_cui_name': 'Biomaterials',\n",
       "  'our_bi_cui_desc': 'Biomaterials ( Chemical : Biomaterial ; biocompatible materials ; Biomedical Material ; biomaterials ; Biomedical materials ; Biocompatible Materials ; biomedical materials ; biomaterial ; Materials , Biocompatible ; biomedical material ; Biocompatible Materials [ Chemical/Ingredient ] )'},\n",
       " {'mention_id': '28127863.5',\n",
       "  'test_set_idx': 26324,\n",
       "  'type': 'T038',\n",
       "  'mention_name': '22q11 .2 deletion syndrome',\n",
       "  'context': '[CLS] Sign ##s of d ##ys ##art ##hr ##ia in adults with 22 ##q ##11 . 2 del ##eti ##on syndrome The aim of the study was to investigate how adults with [unused1] 22 ##q ##11 . 2 del ##eti ##on syndrome [unused2] performed on d ##ys ##art ##hr ##ia and in ##tel ##li ##gi ##bility tests compared with a control group . Ten participants with confirmed 22 ##q ##11 . 2 del ##eti ##on , five males and five females with a mean age of 31 years ( range : 19 - 49 ) , were compared with a control group matched for gender and age ( five males and five females , mean age : 32 years , range : 19 - 49 ) . [SEP]',\n",
       "  'cui_name': 'DiGeorge Syndrome',\n",
       "  'cui_desc': \"DiGeorge Syndrome ( Biologic Function , diagnosis , disorder : Thymic hypoplasia syndrome ; thymic hypoplasia ; di georges syndrome ; Pharyngeal Pouch Syndrome ; DIGEORGE SYNDROME ; Thymic Aplasia Syndrome ; Agenesis of the parathyroid AND thymus glands ; Autosomal Dominant Opitz G Bbb Syndrome ; digeorge sequence ; digeorge anomaly ; Third and Fourth Pharyngeal Pouch Syndrome ; Sphrintzen ; DiGeorge Syndrome [ Disease/Finding ] ; Branchial arch syndrome ; Velocardiofacial Syndrome ; Third and fourth pharyngeal arch syndrome ; THIRD AND FOURTH PHARYNGEAL POUCH SYNDROME ; digeorges syndrome ; digeorge syndrome ; di george 's syndrome ; Autosomal Dominant Opitz G-Bbb Syndrome ; Third AND fourth pharyngeal pouch syndrome ; 22q11 .2 Deletion Syndrome ; DiGeorge Anomaly ; parathyroid-thymic ; aplasia ; DiGeorge sequence ; HYPOPLASIA OF THYMUS AND PARATHYROIDS ; Syndrome , DiGeorge ; Di George 's syndrome ; Digeorge 's syndrome ; Familial Third and Fourth Pharyngeal Pouch Syndrome ; syndrome di george ; DiGeorge 's syndrome ; Catch22 ; DiGeorge anomaly ; Third and fourth pharyngeal pouch syndrome ; thymic aplasia syndrome ; digeorge 's syndrome ; di george syndrome ; Hypoplasia of Thymus and Parathyroids ; Agenesis of the parathyroid and thymus glands ; DiGeorge ; syndrome ; pharyngeal pouch ; DiGeorge 's Syndrome ; Thymic-parathyroid aplasia ; pharyngeal pouch syndrome ; CHROMOSOME 22q11 .2 DELETION SYNDROME ; DiGeorge Sequence ; Velo-Cardio-Facial Syndrome ; Pharyngeal pouch syndrome ; aplasia ; parathyroid-thymic ; DiGeorge syndrome ; digeorge syndromes ; pharyngeal pouch ; syndrome ; CATCH22 ; Third AND fourth pharyngeal arch syndrome )\",\n",
       "  'our_bi_cui_name': '22q11 Deletion Syndrome',\n",
       "  'our_bi_cui_desc': '22q11 Deletion Syndrome ( Biologic Function : Deletion Syndromes , 22q11 ; Deletion Syndrome , 22q11 ; 22q11 Deletion Syndromes ; 22q11 Deletion Syndrome [ Disease/Finding ] ; Syndromes , 22q11 Deletion ; Syndrome , 22q11 Deletion )'},\n",
       " {'mention_id': '27872234.67',\n",
       "  'test_set_idx': 20128,\n",
       "  'type': 'T103',\n",
       "  'mention_name': 'endothelial transient receptor potential vanilloid type 4 channel',\n",
       "  'context': '[CLS] ##l ) - 6 - met ##hyl - p ##yr ##im ##id ##in - 4 - y ##l ] - am ##ine , a selective SK ##C ##a act ##iva ##tor , were marginal ##ly decreased in SH ##RS ##P art ##eries compared with W ##ista ##r - Kyoto art ##eries . The expression of [unused1] end ##oth ##eli ##al trans ##ient receptor potential van ##illo ##id type 4 channel [unused2] and SK ##C ##a protein was significantly decreased in the SH ##RS ##P me ##sent ##eric art ##eries compared with those of W ##ista ##r - Kyoto , whereas function and expression of I ##K ##C ##a were preserved in SH ##RS ##P art ##eries . These findings suggest that End ##oth ##eli ##um - [SEP]',\n",
       "  'cui_name': 'Transient Receptor Potential Channels',\n",
       "  'cui_desc': 'Transient Receptor Potential Channels ( Chemical : Channels , TRP Cation ; Membrane Proteins , TRP ; Cation Channels , TRP ; Proteins , TRP Membrane ; TRP Cation Channels ; TRP Membrane Proteins ; TRANSIENT RECEPT POTENTIAL CHANNELS ; Transient Receptor Potential Channels [ Chemical/Ingredient ] ; Transient Receptor Potential Cation Channels )',\n",
       "  'our_bi_cui_name': 'Trpv4 protein , rat',\n",
       "  'our_bi_cui_desc': 'Trpv4 protein , rat ( Chemical : transient receptor potential cation channel , subfamily V , member 4 protein , rat ; Otrpc4 protein , rat ; vanilloid receptor-related osmotically activated channel protein , rat ; osmosensitive transient receptor potential channel 4 protein , rat ; Vroac protein , rat )'},\n",
       " {'mention_id': '27546367.17',\n",
       "  'test_set_idx': 10028,\n",
       "  'type': 'T103',\n",
       "  'mention_name': 'NOR protein',\n",
       "  'context': '[CLS] ##s and can be stained with silver when they are active . Thus these proteins are named as a ##rgy ##rop ##hil ##ic - NO ##R ( a ##rgy ##rop ##hil ##ic - NO ##R ) - associated proteins . We aimed to investigate any possible effects of re ##nal Is ##che ##mia / re ##per ##fusion injury on the [unused1] NO ##R protein [unused2] synthesis and association between the a ##rgy ##rop ##hil ##ic - NO ##R proteins amount and his ##top ##ath ##ological injuring score . Nine female w ##ista ##r - al ##bino rats with weight of 200 - 250 ##g were included into the study . The animals were randomly divided in two groups , a Control Group and an Is ##che [SEP]',\n",
       "  'cui_name': 'nucleolar organizer region associated proteins',\n",
       "  'cui_desc': 'nucleolar organizer region associated proteins ( Chemical : NOR antigens )',\n",
       "  'our_bi_cui_name': 'Proteins',\n",
       "  'our_bi_cui_desc': 'Proteins ( Chemical , medication , obsolete , substance : protein ; gene product ; Protein ; Proteins [ Chemical/Ingredient ] ; proteins ; protein preparations ; PROTEIN )'},\n",
       " {'mention_id': '28387468.12',\n",
       "  'test_set_idx': 33907,\n",
       "  'type': 'T033',\n",
       "  'mention_name': 'canine',\n",
       "  'context': '[CLS] ##id ##ging , or ca ##l ##ci ##fication of the inter ##c ##lino ##id l ##iga ##ment of sell ##a t ##ur ##ci ##ca , has been reported to be associated with some dental an ##oma ##lies ( p ##ala ##tal can ##ine impact ##ion and trans ##position ) . The aim of the study was to find any association between [unused1] can ##ine [unused2] impact ##ion , h ##yper ##don ##tia or h ##y ##po ##don ##tia and sell ##ar dimensions or br ##id ##ging . Later ##al c ##ep ##hal ##ometric radio ##graphs from 78 patients with impacted can ##ines , 68 with dental age ##nes ##is and 17 with h ##yper ##don ##tia were collected . Line ##ar dimensions of sell ##a t [SEP]',\n",
       "  'cui_name': 'Palatal canine',\n",
       "  'cui_desc': 'Palatal canine ( Finding )',\n",
       "  'our_bi_cui_name': 'Cuspid',\n",
       "  'our_bi_cui_desc': 'Cuspid ( Anatomical Structure , body structure , dental : Tooth , Canine ; Teeth , Canine ; [ SO ] Canine tooth ; Cuspid tooth ; cuspids ; Canine tooth ; Dens caninus ; TOOTH , CANINE ; canine teeth ; cuspid ; Cuspids ; Structure of canine tooth ; CANINE TOOTH ; Canine Teeth ; canine tooth ; Canine Tooth ; canine )'},\n",
       " {'mention_id': '27708411.27',\n",
       "  'test_set_idx': 14736,\n",
       "  'type': 'T038',\n",
       "  'mention_name': 'dsDNA recombination',\n",
       "  'context': '[CLS] stranded ( s ##s and d ##s ) substrates in re ##comb ##ination ass ##ays . Mu ##tations of critical amino acids affected either d ##s ##D ##NA re ##comb ##ination or both s ##s ##D ##NA and d ##s ##D ##NA re ##comb ##ination indicating two se ##par ##able functions , one of which is critical for [unused1] d ##s ##D ##NA re ##comb ##ination [unused2] and the second for re ##comb ##ination per se . As evaluated by co - im ##mu ##no ##p ##re ##ci ##pit ##ation experiments , the d ##s ##D ##NA re ##comb ##ination function relates to the Red ##α - Red ##β protein - protein interaction , which requires not only contacts in the C - terminal domain but [SEP]',\n",
       "  'cui_name': 'regulation of DNA recombination',\n",
       "  'cui_desc': 'regulation of DNA recombination ( Biologic Function )',\n",
       "  'our_bi_cui_name': 'Recombination , Genetic',\n",
       "  'our_bi_cui_desc': 'Recombination , Genetic ( Biologic Function , finding , naturally occurring : recombination ; dna recombination ; Genetic Recombination ; Genetic recombination ; DNA Recombination ; DNA Recombination Process ; Recombinations ; DNA recombination ; GENET RECOMBINATION ; Recombinations , Genetic ; Recombination ; RECOMBINATION GENET ; recombinations ; Genetic Recombinations ; genetic recombination )'},\n",
       " {'mention_id': '28521168.14',\n",
       "  'test_set_idx': 38283,\n",
       "  'type': 'T103',\n",
       "  'mention_name': 'FerMEG12',\n",
       "  'context': '[CLS] ##s are introduced into the environment . In this study , we have assessed the e ##cot ##ox ##icit ##y of four engineered Fe na ##no ##mate ##rial ##s , specifically , Nan ##o - Go ##eth ##ite , T ##rap - O ##x Fe - z ##eo ##lite ##s , Car ##bo - Iron ( ® ) and [unused1] Fe ##r ##ME ##G ##12 [unused2] , developed within the European F ##P ##7 project Nan ##o ##R ##em for sub - surface re ##media ##tion towards a test battery consisting of eight e ##cot ##ox ##icit ##y tests on bacteria ( V . fish ##eri , E . co ##li ) , algae ( P . sub ##cap ##ita ##ta , Ch ##lam ##yd ##omo [SEP]',\n",
       "  'cui_name': 'Iron',\n",
       "  'cui_desc': 'Iron ( Chemical , medication , product , substance : Iron preparation ; Eisen ; fer ; Iron agent ; iron preparations ; Fe element ; iron preparation ; hematinics iron preparations ; ferric ion ; IRON ; Hierro ; Iron , elemental ; Iron product ; Fe - Iron ; Iron [ Chemical/Ingredient ] ; Reduced iron ; iron ; Iron , reduced ; Ferrum )',\n",
       "  'our_bi_cui_name': 'Biomaterials',\n",
       "  'our_bi_cui_desc': 'Biomaterials ( Chemical : Biomaterial ; biocompatible materials ; Biomedical Material ; biomaterials ; Biomedical materials ; Biocompatible Materials ; biomedical materials ; biomaterial ; Materials , Biocompatible ; biomedical material ; Biocompatible Materials [ Chemical/Ingredient ] )'},\n",
       " {'mention_id': '28523479.82',\n",
       "  'test_set_idx': 38496,\n",
       "  'type': 'T103',\n",
       "  'mention_name': 'FBS',\n",
       "  'context': '[CLS] + o ##le ##ic acid , F ##BS + l ##ino ##le ##ic acid , or F ##BS + palm ##itic acid , whereas that of C / E ##B ##P α , C / E ##B ##P β , and AT ##G ##L increased ( P < 0 . 05 ) in F ##BS + o ##le ##ic acid or [unused1] F ##BS [unused2] + l ##ino ##le ##ic acid cells . Express ##ion of FA ##B ##P ##4 and C / E ##B ##P β m ##RNA was higher in chicken serum , chicken serum + o ##le ##ic acid , chicken serum + l ##ino ##le ##ic acid , chicken serum + palm ##itic acid , or chicken serum + s ##te ##ari [SEP]',\n",
       "  'cui_name': 'Fetal Bovine Serum',\n",
       "  'cui_desc': 'Fetal Bovine Serum ( Chemical : Fetal Calf Serum )',\n",
       "  'our_bi_cui_name': 'Stromal Cells',\n",
       "  'our_bi_cui_desc': 'Stromal Cells ( Anatomical Structure : stromal cells ; Cell , Stromal ; Cells , Stromal ; stromal cell ; Stromal Cell ; Stromal cell )'},\n",
       " {'mention_id': '28166758.43',\n",
       "  'test_set_idx': 27383,\n",
       "  'type': 'T058',\n",
       "  'mention_name': 'optical scattering measurements',\n",
       "  'context': '[CLS] significant structural differences in the co ##lla ##gen organization and are consistent with the dual ##istic classification of type I and II se ##rous tumors . Moreover , type I end ##ome ##tri ##oid tumors have strongly differing extra ##cellular matrix architecture than the se ##rous ma ##li ##gna ##ncies . The Second Ha ##rmon ##ic Generation metric ##s and [unused1] optical scattering measurements [unused2] were used to form a linear disc ##rim ##ina ##nt model to class ##ify the tissues , and we obtained high accuracy ( > 90 % ) between high - grade se ##rous tumors from the other tissue types . High - grade se ##rous tumors account for ~ 70 % of o ##var ##ian cancer ##s , and this del [SEP]',\n",
       "  'cui_name': 'Nephelometry',\n",
       "  'cui_desc': 'Nephelometry ( Health Care Activity , lab test , procedure , qualifier value : light scattering measurement ; Turbidity test ; Turbidity test ( procedure ) [ Ambiguous ] ; nephelometry ; Nephelometry , test method using light ; Nephelometric measurement ; Light scatter measurement ; NEPHELOMETRY )',\n",
       "  'our_bi_cui_name': 'Measure observations',\n",
       "  'our_bi_cui_desc': 'Measure observations ( Finding )'}]"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res_exi_succ_our_fail[20:30]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "cda5ad99",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Track cases where both the existing and our biencoder failed to retrieve the gold label in the top-64 preds\n",
    "res_fail = []\n",
    "\n",
    "menid_to_idx = {c['mention_id']: i for i,c in enumerate(cross_res['failure'])}\n",
    "for i in exi_fail_our_fail_idxs:\n",
    "    d = test_data[i]\n",
    "    men_id = d['mention_id']\n",
    "    ctxt = ' '.join(d['context']['tokens'])\n",
    "    etype = d['type']\n",
    "    name = d['mention_name']\n",
    "    correct_label_idx = d['label_idxs'][0]\n",
    "    if len(existing_cands['candidates'][i]) != 0:\n",
    "        existing_label_idx = existing_cands['candidates'][i][0]\n",
    "        existing_cui = dictionary[existing_label_idx]['cui']\n",
    "        existing_cui_name = dictionary[existing_label_idx]['title']\n",
    "        existing_cui_desc = dictionary[existing_label_idx]['description']\n",
    "    else:\n",
    "        existing_cui = None\n",
    "        existing_cui_name = None\n",
    "        existing_cui_desc = None\n",
    "    our_label_idx = our_cands['candidates'][i][0]  # Our biencoder model's best prediction\n",
    "    our_cui = dictionary[our_label_idx]['cui']\n",
    "    our_cui_name = dictionary[our_label_idx]['title']\n",
    "    our_cui_desc = dictionary[our_label_idx]['description']\n",
    "#     try:\n",
    "#         our_cross_cui = cross_res['failure'][menid_to_idx[men_id]]['predicted_cui']\n",
    "#     except:\n",
    "#         continue\n",
    "#     our_cross_cui_name = cross_res['failure'][menid_to_idx[men_id]]['predicted_name']\n",
    "    res_fail.append({\n",
    "        'mention_id': men_id,\n",
    "        'test_set_idx': i,\n",
    "        'type': etype,\n",
    "        'name': name,\n",
    "        'context': ctxt,\n",
    "        'cui_name': dictionary[correct_label_idx]['title'],\n",
    "        'cui_desc': dictionary[correct_label_idx]['description'],\n",
    "        'existing_bi_cui': existing_cui,\n",
    "        'existing_bi_cui_name': existing_cui_name,\n",
    "        'existing_bi_cui_desc': existing_cui_desc,\n",
    "        'our_bi_cui': our_cui,\n",
    "        'our_bi_cui_name': our_cui_name,\n",
    "        'our_bi_cui_desc': our_cui_desc,\n",
    "#         'our_cross_cui': our_cross_cui,\n",
    "#         'our_cross_cui_name': our_cross_cui_name,\n",
    "#         'our_cross_cui_desc': dictionary[dict_id_to_idx[our_cross_cui]]['description'],\n",
    "    })"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "644f52e1",
   "metadata": {},
   "outputs": [],
   "source": [
    "np.random.shuffle(res_fail)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "086ebed9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'mention_id': '27444328.6',\n",
       "  'test_set_idx': 5898,\n",
       "  'type': 'T103',\n",
       "  'name': 'FmEG',\n",
       "  'context': '[CLS] Extra car ##bo ##hy ##dra ##te binding module contributes to the process ##ivity and cat ##alytic activity of a non - modular h ##ydro ##lase family 5 end ##og ##lu ##can ##ase from F ##omi ##tip ##oria me ##dit ##er ##rane ##a M ##F ##3 / 22 [unused1] F ##m ##EG [unused2] from F ##omi ##tip ##oria me ##dit ##er ##rane ##a is a non - modular end ##og ##lu ##can ##ase composed of a 24 - amino acids extension and 13 - amino acids link ##er - like p ##eptide at the N - terminus and a 312 - amino acids G ##H ##5 cat ##alytic domain at the C - terminus . In this study , six F ##m ##EG derivatives with del ##eti [SEP]',\n",
       "  'cui_name': 'endoglucanase V',\n",
       "  'cui_desc': 'endoglucanase V ( Chemical )',\n",
       "  'existing_bi_cui': 'C0673013',\n",
       "  'existing_bi_cui_name': 'GPER protein , human',\n",
       "  'existing_bi_cui_desc': 'GPER protein , human ( Chemical : GPCR-BR ; Heptahelix Receptor ; IL8-Related Receptor DRY12 ; G-Protein Coupled Estrogen Receptor 1 ; FEG-1 ; GPCR-Br protein , human ; GPR30 protein , human ; G protein-coupled receptor 30 , human ; Flow-Induced Endothelial G-Protein Coupled Receptor 1 ; Membrane Estrogen Receptor ; G Protein-Coupled Estrogen Receptor 1 ; G-Protein Coupled Receptor 30 ; G protein-coupled estrogen receptor 1 , human ; Chemokine Receptor-Like 2 ; G Protein-Coupled Receptor 30 ; Lymphocyte-Derived G-Protein Coupled Receptor ; CMKRL2 protein , human ; FEG-1 protein , human ; Chemoattractant Receptor-Like 2 ; Constitutively Expressed Peptide-Like Receptor ; LYGPR )',\n",
       "  'our_bi_cui': 'C0014442',\n",
       "  'our_bi_cui_name': 'Enzymes',\n",
       "  'our_bi_cui_desc': 'Enzymes ( Chemical , medication , substance : enzymes ; enzyme ; Enzymes [ Chemical/Ingredient ] ; Biocatalysts ; Enzyme )'},\n",
       " {'mention_id': '27242550.66',\n",
       "  'test_set_idx': 697,\n",
       "  'type': 'T058',\n",
       "  'name': 'modified diet',\n",
       "  'context': '[CLS] o ##mp ##ared with that of W T mice . Similar to their m et ##ab ##olic r es ##istan ##ce to D I ##O , the K v ##1 . 3 ( - [UNK] - ) mice ha d unchanged mit o ##cho ##nd ##ria in terms of c ##ros s section ##al area and abundance following a challenge with [unused1] modified diet [unused2] . We are very interested to understand how targeted disruption of the K ##v ##1 . 3 channel in the o ##lf ##actor ##y bulb can modify total energy expenditure . Our study demonstrates that K ##v ##1 . 3 regulate ##s mitochondrial structure and alter ##s glucose u ##til ##ization ; two important metabolic changes that could drive whole system [SEP]',\n",
       "  'cui_name': 'Diet , High-Fat',\n",
       "  'cui_desc': 'Diet , High-Fat ( Health Care Activity , finding , regime/therapy , treatment : High fat diet ; High Fat Diet ; diet fat high ; Diet , High Fat ; Diets , High-Fat ; Diets , High Fat ; diet fats high ; high fat weight gain diet ; Increased fat diet ; High Fat Diets ; High-Fat Diets ; high fat diet ; High-Fat Diet ; HF - High fat diet ; diets fat high ; Increase in fat content of the diet compared to the assessed baseline intake of fat for the individual . ( Source : Academy of Nutrition and Dietetics Nutrition Informatics Committee 2013 ) )',\n",
       "  'existing_bi_cui': 'C0452264',\n",
       "  'existing_bi_cui_name': 'Therapeutic diets',\n",
       "  'existing_bi_cui_desc': 'Therapeutic diets ( Finding , finding : diets modified ; therapeutic diet ; Therapeutic diet ; modified diets ; diet modified ; Modified diets ; therapeutic diets )',\n",
       "  'our_bi_cui': 'C0452264',\n",
       "  'our_bi_cui_name': 'Therapeutic diets',\n",
       "  'our_bi_cui_desc': 'Therapeutic diets ( Finding , finding : diets modified ; therapeutic diet ; Therapeutic diet ; modified diets ; diet modified ; Modified diets ; therapeutic diets )'},\n",
       " {'mention_id': '27233131.34',\n",
       "  'test_set_idx': 241,\n",
       "  'type': 'T082',\n",
       "  'name': 'cofactor - binding loop 1',\n",
       "  'context': '[CLS] ##rm ##ost ##able The ##rm ##us the ##rm ##op ##hil ##us trans ##ket ##ola ##se and variants assessed for their impact on both the ##rm ##ost ##ability and activity . Co ##fa ##ctor - binding loop 2 variants had de ##tri ##mental effects on specific activity at elevated temperatures , whereas the H ##19 ##2 ##P mutation in [unused1] co ##fa ##ctor - binding loop 1 [unused2] resulted in a two - fold improved stability to in ##act ##ivation at elevated temperatures , and increased the critical onset temperature for a ##gg ##regation . The specific activity of H ##19 ##2 ##P was 3 - fold and 19 - fold higher than that for wild - type at 60 °C and 65 °C respectively , and [SEP]',\n",
       "  'cui_name': 'Base Sequence',\n",
       "  'cui_desc': 'Base Sequence ( Spatial Concept , finding : nucleotide sequence ; NUCLEOTIDE SEQ ; Sequence , Base ; nucleotide sequences ; Seq ; nucleic acid sequencing ; Nucleotide sequence ; nucleotide sequenc ; Base Sequences ; Nucleotide Sequence ; base sequence ; BASE SEQ ; Sequences , Nucleotide ; Sequences , Base ; nucleic acid sequence ; Sequence ; Sequence , Nucleotide ; Base sequence ; Nucleotide Sequences )',\n",
       "  'existing_bi_cui': 'C1323251',\n",
       "  'existing_bi_cui_name': 'cofactor binding',\n",
       "  'existing_bi_cui_desc': 'cofactor binding ( Biologic Function )',\n",
       "  'our_bi_cui': 'C0178555',\n",
       "  'our_bi_cui_name': 'chemical cofactor',\n",
       "  'our_bi_cui_desc': 'chemical cofactor ( Chemical : cofactors ; Cofactor ; cofactor )'},\n",
       " {'mention_id': '27857693.26',\n",
       "  'test_set_idx': 19405,\n",
       "  'type': 'T058',\n",
       "  'name': 'IHRT',\n",
       "  'context': '[CLS] effect size 0 . 48 ) at mid . Similarly , at post both groups increased absolute ( I ##H ##RT : 20 . 7 ± 7 . 6 % , effect size 0 . 74 , place ##bo 14 . 1 ± 6 . 0 % , effect size 0 . 58 ) and relative 1 ##R ##M ( [unused1] I ##H ##RT [unused2] : 21 . 6 ± 8 . 5 % , effect size 1 . 08 , place ##bo 13 . 2 ± 6 . 4 % , effect size 0 . 78 ) . Important ##ly , the change in I ##H ##RT was greater than place ##bo at mid for both absolute [ 4 . 4 % greater change , [SEP]',\n",
       "  'cui_name': 'Resistance Training',\n",
       "  'cui_desc': 'Resistance Training ( Health Care Activity : Training , Resistance ; Strength Training ; strength train ; strength training ; Training , Strength )',\n",
       "  'existing_bi_cui': 'C0020669',\n",
       "  'existing_bi_cui_name': 'Hypothalamus , Middle',\n",
       "  'existing_bi_cui_desc': 'Hypothalamus , Middle ( Anatomical Structure : Area hypothalamica intermedia ; Medial Hypothalamus ; Intermediate hypothalamic area ; Intermediate Hypothalamic Region ; Region , Intermediate Hypothalamic ; Regio hypothalamica intermedia ; Middle Hypothalamus ; Hypothalamic Regions , Intermediate ; Hypothalamic Region , Intermediate ; Intermediate Hypothalamic Regions ; Intermediate hypothalamic region ; intermediate hypothalamic region ; Hypothalamus , Medial ; Regions , Intermediate Hypothalamic )',\n",
       "  'our_bi_cui': 'C3639411',\n",
       "  'our_bi_cui_name': 'Homeostatic Model Assessment of Insulin Resistance',\n",
       "  'our_bi_cui_desc': 'Homeostatic Model Assessment of Insulin Resistance ( Health Care Activity )'},\n",
       " {'mention_id': '27604152.24',\n",
       "  'test_set_idx': 11421,\n",
       "  'type': 'T017',\n",
       "  'name': 'nasal',\n",
       "  'context': '[CLS] in Auckland . met ##hic ##ill ##in - resistant St ##aph ##yl ##oc ##oc ##cus au ##reus is ##olate ##s from clinical specimens obtained by the main New Zealand veterinary diagnostic laboratories between June 2012 and June 2013 , were g ##eno ##ty ##pical ##ly characterised by DNA micro ##arra ##y hybrid ##isation analysis and spa typing . In addition , [unused1] nasal [unused2] or per ##ine ##al skin s ##wab ##s collected from a cross - section ##al sample of dogs ( n = 36 ##1 ) and cats ( n = 225 ) attending 29 veterinary clinics in Auckland during the same period were anal ##ys ##ed for met ##hic ##ill ##in - resistant St ##aph ##yl ##oc ##oc ##cus au ##reus by culture [SEP]',\n",
       "  'cui_name': 'Skin of external nose',\n",
       "  'cui_desc': 'Skin of external nose ( Anatomical Structure , body structure : nose skin ; External nasal skin ; [ SO ] Skin of external nose ; Skin of nose ; skin of external nose ; Skin structure of nose ; skin nose )',\n",
       "  'existing_bi_cui': 'C0028429',\n",
       "  'existing_bi_cui_name': 'Nose',\n",
       "  'existing_bi_cui_desc': 'Nose ( Anatomical Structure , Nasal Passage , body structure , qualifier value : nasal structure ; nasal ; nasals ; nose ; noses ; Nasal structure ; NASAL ; NOSE ; Structure of nose ; Nasal ; Nasus ; Structure of nose , unspecified ; Noses )',\n",
       "  'our_bi_cui': 'C0028429',\n",
       "  'our_bi_cui_name': 'Nose',\n",
       "  'our_bi_cui_desc': 'Nose ( Anatomical Structure , Nasal Passage , body structure , qualifier value : nasal structure ; nasal ; nasals ; nose ; noses ; Nasal structure ; NASAL ; NOSE ; Structure of nose ; Nasal ; Nasus ; Structure of nose , unspecified ; Noses )'},\n",
       " {'mention_id': '27925180.48',\n",
       "  'test_set_idx': 22152,\n",
       "  'type': 'T058',\n",
       "  'name': 'OncotypeDx',\n",
       "  'context': '[CLS] . The Concord ##ance Index of Y ##MR for ER + / node negative patients is close to the commercially available signatures . However , Y ##MR showed more significance ( H ##R = 3 . 7 , p = 8 . 7 ##e - 12 ) in s ##tra ##ti ##fying ER + / node - subgroup than [unused1] On ##cot ##ype ##D ##x [unused2] ( H ##R = 2 . 7 , p = 1 . 3 ##e - 7 ) , Ma ##mma ##P ##rin ##t ( H ##R = 2 . 5 , p = 5 . 8 ##e - 7 ) , r ##or ##S ( H ##R = 2 . 4 , p = 1 . 4 ##e - 6 [SEP]',\n",
       "  'cui_name': 'Breast Cancer Diagnostic Procedure',\n",
       "  'cui_desc': 'Breast Cancer Diagnostic Procedure ( Health Care Activity )',\n",
       "  'existing_bi_cui': 'C0228227',\n",
       "  'existing_bi_cui_name': 'Structure of collateral eminence',\n",
       "  'existing_bi_cui_desc': 'Structure of collateral eminence ( Anatomical Structure , body structure : Eminentia collateralis ventriculi lateralis ; Eminentia collateralis ; Collateral eminence of lateral ventricle ; collateral eminence ; Collateral eminence ; Eminentia occipito-temporalis ; collateral eminence of the lateral ventricle )',\n",
       "  'our_bi_cui': 'C0282574',\n",
       "  'our_bi_cui_name': 'Intellectual Property',\n",
       "  'our_bi_cui_desc': 'Intellectual Property ( Intellectual Product : Intellectual Product ; Property , Intellectual ; Properties , Intellectual ; Intellectual Properties ; Intellectual property ; intellectual property )'},\n",
       " {'mention_id': '28050885.11',\n",
       "  'test_set_idx': 24157,\n",
       "  'type': 'T103',\n",
       "  'name': 'pl-VEGF165',\n",
       "  'context': '[CLS] ##ients with Per ##ip ##her ##al Arte ##rial Disease The effective treatment of chronic lower limb is ##che ##mia is one of the most challenging issues confront ##ing vascular surgeon ##s . Current p ##har ##ma ##cological the ##rap ##ies play an auxiliary role and can not prevent disease progression , and new treatment methods are needed . [unused1] p ##l - V ##EG ##F ##16 ##5 [unused2] , a gene therapy drug , was approved in Russia for the treatment of at ##her ##os ##cle ##rot ##ic peripheral art ##erial disease after clinical studies in 2011 . The study drug is an original gene construction in which p ##l - V ##EG ##F ##16 ##5 1 . 2 mg is the active substance . This [SEP]',\n",
       "  'cui_name': 'Pharmacologic Substance',\n",
       "  'cui_desc': 'Pharmacologic Substance ( Chemical : Pharmacological Substance ; Agent ; Drug Substance ; Pharmaceutical agent ; Pharmaceutical Agent ; DRUG ; Drug ; Pharmacologic Agent ; Pharmaceuticals ; drug )',\n",
       "  'existing_bi_cui': 'C0376854',\n",
       "  'existing_bi_cui_name': 'VEGF165 protein , human',\n",
       "  'existing_bi_cui_desc': 'VEGF165 protein , human ( Chemical : VEGF-164 ; VEGF ( 164 ) ; VEGF164 ; VEGF 164 ; VEGF-165 ; VEGF164 ( 165 ) ; Vascular Endothelial Growth Factor A 165 Isoform ; VEGF 165 ; VEGF-164 Isoform ; Vascular Endothelial Growth Factor A 164 Isoform ; VEGF165 ; VEGF ( 165 ) protein , human )',\n",
       "  'our_bi_cui': 'C1335207',\n",
       "  'our_bi_cui_name': 'PGF gene',\n",
       "  'our_bi_cui_desc': 'PGF gene ( Anatomical Structure : PlGF-2 ; PlGF ; Placental Growth Factor Gene ; PLGF ; PGF Gene ; placenta growth factor ; SHGC-10760 ; placental growth factor ; D12S1900 ; PLACENTAL GROWTH FACTOR )'},\n",
       " {'mention_id': '28203549.79',\n",
       "  'test_set_idx': 28271,\n",
       "  'type': 'T170',\n",
       "  'name': 'K1',\n",
       "  'context': '[CLS] ST ##23 was found to be the most prevalent ST among 69 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s with K ##1 , K ##2 , K ##5 , K ##20 , and K ##5 ##7 ( 27 . 5 % , 19 / 69 ) and was only found among [unused1] K ##1 [unused2] is ##olate ##s . ST ##65 was the second most prevalent ST ( 26 . 1 % , 18 / 69 ) and was also only found among K ##2 is ##olate ##s . ST ##23 - K ##1 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s ( 84 . 2 % [SEP]',\n",
       "  'cui_name': 'K Serotype',\n",
       "  'cui_desc': 'K Serotype ( Intellectual Product , attribute )',\n",
       "  'existing_bi_cui': 'C1416713',\n",
       "  'existing_bi_cui_name': 'KRT1 gene',\n",
       "  'existing_bi_cui_desc': 'KRT1 gene ( Anatomical Structure : KRT1A ; CYTOKERATIN 1 ; KERATIN 1 , TYPE II ; KB1 ; keratin 1 ; KRT1 Gene ; Keratin 1 Gene )',\n",
       "  'our_bi_cui': 'C3558438',\n",
       "  'our_bi_cui_name': 'Klebsiella sp . K1',\n",
       "  'our_bi_cui_desc': 'Klebsiella sp . K1 ( Bacterium )'},\n",
       " {'mention_id': '27400734.51',\n",
       "  'test_set_idx': 4755,\n",
       "  'type': 'T103',\n",
       "  'name': 'GEM',\n",
       "  'context': '[CLS] one - year survival rates ( 27 . 0 % vs . 27 . 3 % ; p = 0 . 59 ##8 ##8 ) . Multi ##var ##iate analysis using age , gender , and com ##or ##bid ##ities as co ##var ##iate ##s did not reveal any significant differences in survival . Based on this relative effectiveness , the in ##cre ##mental cost per life year gained over GE ##M was estimated at USD 70 , 84 ##3 . 64 for [unused1] GE ##M [unused2] - E . GE ##M - E for pan ##cre ##atic cancer is not more effective than GE ##M in a real - world setting , and it does not provide reasonable cost - effectiveness over GE ##M . [SEP]',\n",
       "  'cui_name': 'gemcitabine',\n",
       "  'cui_desc': \"gemcitabine ( Chemical , product , substance : gemcitabine [ Chemical/Ingredient ] ; 2 ' ,2 ' - difluorodeoxycytidine ; 4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one ; 2 ' ,2 ' - Difluorodeoxycytidine ; dFdCyd ; 2 ' - deoxy-2 ' - difluorocytidine ; Gemcitabine ; 2 ' Deoxy-2 ' ,2 ' - Difluorocytidine ; Gemcitabina ; 2,2 difluorodexoycytidine ; dFdC ; GEMCITABINE ; Difluorodeoxycytidine ; Gemcitabinum ; 2 ' ,2 ' - DFDC ; 2 ' - Deoxy-2 ' ,2 ' - difluorocytidine ; Gemcitabin ; difluorodeoxycytidine ; 1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose ; 2 ' ,2 ' - difluoro-2 ' - deoxycytidine )\",\n",
       "  'existing_bi_cui': 'C1333683',\n",
       "  'existing_bi_cui_name': 'GMNN gene',\n",
       "  'existing_bi_cui_desc': 'GMNN gene ( Anatomical Structure : Geminin , DNA Replication Inhibitor Gene ; GMNN Gene ; Gem ; GEMININ ; geminin , DNA replication inhibitor ; GEM )',\n",
       "  'our_bi_cui': 'C0967186',\n",
       "  'our_bi_cui_name': 'GET protocol',\n",
       "  'our_bi_cui_desc': 'GET protocol ( Health Care Activity : GET regimen )'},\n",
       " {'mention_id': '27526663.36',\n",
       "  'test_set_idx': 9476,\n",
       "  'type': 'T204',\n",
       "  'name': 'prodh2',\n",
       "  'context': '[CLS] ##rop ##hic bacterial path ##ogen P ##se ##udo ##mona ##s s ##yr ##inga ##e p ##v . tomato P ##st - A ##v ##r ##R ##pm ##1 , and that Pro ##D ##H1 and Pro ##D ##H ##2 are differential ##ly regulated by sa ##lic ##yl ##ic acid . In the current work , we used pro ##dh ##1 and [unused1] pro ##dh ##2 [unused2] single - mutant plants to assess the particular contribution of each gene to resistance against P ##st - A ##v ##r ##R ##pm ##1 and the ne ##c ##rot ##rop ##hic fun ##gal path ##ogen Bo ##try ##tis c ##iner ##ea . In addition , we studied the sensitivity of Pro ##D ##H1 and Pro ##D ##H ##2 to the j [SEP]',\n",
       "  'cui_name': 'Arabidopsis',\n",
       "  'cui_desc': 'Arabidopsis ( Eukaryote : arabidopsis ; Arabidopsis ( DC . ) Heynh. , 1842 ; Arabidopses ; Cardaminopsis ; Cardaminopsis Hayek )',\n",
       "  'existing_bi_cui': 'C1418945',\n",
       "  'existing_bi_cui_name': 'PRODH gene',\n",
       "  'existing_bi_cui_desc': 'PRODH gene ( Anatomical Structure : PRODH2 ; PRODH1 ; PIG6 ; proline dehydrogenase ( oxidase ) 1 ; TP53I6 ; PROLINE OXIDASE 1 ; PROLINE DEHYDROGENASE ( OXIDASE ) 1 ; HSPOX2 )',\n",
       "  'our_bi_cui': 'C0017337',\n",
       "  'our_bi_cui_name': 'Genes',\n",
       "  'our_bi_cui_desc': 'Genes ( Anatomical Structure , substance : Gene ; gene ; genes )'}]"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res_fail[10:20]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "1d1462fe",
   "metadata": {
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "res = []\n",
    "\n",
    "menid_to_idx = {c['mention_id']: i for i,c in enumerate(cross_res['success'])}\n",
    "for i in final_idxs:\n",
    "    d = test_data[i]\n",
    "    men_id = d['mention_id']\n",
    "    ctxt = ' '.join(d['context']['tokens'])\n",
    "    etype = d['type']\n",
    "    name = d['mention_name']\n",
    "    correct_label_idx = d['label_idxs'][0]\n",
    "    if len(existing_cands['candidates'][i]) != 0:\n",
    "        existing_label_idx = existing_cands['candidates'][i][0]\n",
    "        existing_cui = dictionary[existing_label_idx]['cui']\n",
    "        existing_cui_name = dictionary[existing_label_idx]['title']\n",
    "        existing_cui_desc = ' '.join(dictionary[existing_label_idx]['tokens'])\n",
    "    else:\n",
    "        existing_cui = None\n",
    "        existing_cui_name = None\n",
    "        existing_cui_desc = None\n",
    "    our_label_idx = our_cands['candidates'][i][0]  # Our biencoder model's best prediction\n",
    "    res.append({\n",
    "        'mention_id': men_id,\n",
    "        'test_set_idx': i,\n",
    "        'type': etype,\n",
    "        'name': name,\n",
    "        'context': ctxt,\n",
    "        'existing_cui': existing_cui,\n",
    "        'existing_cui_name': existing_cui_name,\n",
    "        'existing_cui_desc': existing_cui_desc,\n",
    "        'our_bi_cui': dictionary[our_label_idx]['cui'],\n",
    "        'our_bi_cui_name': dictionary[our_label_idx]['title'],\n",
    "        'our_bi_cui_desc': ' '.join(dictionary[our_label_idx]['tokens']),\n",
    "        'our_cross_cui': cross_res['success'][menid_to_idx[men_id]]['mention_gold_cui'],\n",
    "        'our_cross_cui_name': cross_res['success'][menid_to_idx[men_id]]['mention_gold_cui_name'],\n",
    "        'our_cross_cui_desc': ' '.join(dictionary[correct_label_idx]['tokens']),\n",
    "    })"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "20c6dd63",
   "metadata": {},
   "outputs": [],
   "source": [
    "np.random.shuffle(res)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "0bcd9a0e",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'mention_id': '27335087.30',\n",
       "  'test_set_idx': 2759,\n",
       "  'type': 'T017',\n",
       "  'name': 'CD3 ( + ) T cells',\n",
       "  'context': '[CLS] flow c ##yt ##ometer . Cell ultra ##structure was observed under a transmission electron micro ##scope . The mitochondrial membrane potential ( Δ ##ψ ) was examined with J ##C - 1 dye . In H ##22 tumor - bearing mice , CD ##4 ( + ) T cells , CD ##8 ( + ) T cells , [unused1] CD ##3 ( + ) T cells [unused2] , and natural killer cells in peripheral blood were evaluated c ##yt ##ometric ##ally . Inter ##le ##uki ##n ( Inter ##le ##uki ##n ) - 2 and tumor ne ##c ##rosis factor ( tumor ne ##c ##rosis factor ) - α levels were measured using radio ##im ##mu ##no ##ass ##ay . The m ##RNA levels of Ba [SEP]',\n",
       "  'existing_cui': 'C1277786',\n",
       "  'existing_cui_name': 'CD3 T-cell count procedure',\n",
       "  'existing_cui_desc': '[CLS] CD ##3 T - cell count procedure [unused3] ( Health Care Act ##ivity , procedure : CD ##3 T - cell count ) [SEP]',\n",
       "  'our_bi_cui': 'C1563926',\n",
       "  'our_bi_cui_name': 'Th3 Cells',\n",
       "  'our_bi_cui_desc': '[CLS] T ##h ##3 Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell ##s , T ##h ##3 ; T ##H CE ##LL ##S 00 ##3 ; T ##h ##3 Cell ; Cell , T ##h ##3 ) [SEP]',\n",
       "  'our_cross_cui': 'C1267816',\n",
       "  'our_cross_cui_name': 'Lymphocyte positive for CD3 antigen',\n",
       "  'our_cross_cui_desc': '[CLS] L ##ymph ##oc ##yte positive for CD ##3 anti ##gen [unused3] ( Ana ##tom ##ical Structure , cell : CD ##3 + L ##ymph ##oc ##yte ) [SEP]'},\n",
       " {'mention_id': '28244917.34',\n",
       "  'test_set_idx': 29801,\n",
       "  'type': 'T033',\n",
       "  'name': 'knee bend',\n",
       "  'context': '[CLS] , and 10 treated with a P ##FC Sigma rotating platform - posterior stab ##ilized ( press - fit con ##dy ##lar Sigma rotating platform - posterior stab ##ilized ) total knee art ##hr ##op ##last ##y ( dome ##d pat ##ella ##r component ) were analyzed under flu ##oro ##scopic surveillance while the patient performed a weight - bearing deep [unused1] knee bend [unused2] from full knee extension to maximum knee fl ##ex ##ion . Re ##lev ##ant bone g ##eo ##met ##ries were segment ##ed out from com ##puted to ##mo ##graphy scan ##s , and computer - assisted - design models of the imp ##lanted components were obtained from the manufacturer . Three - dimensional pat ##ello ##fe ##mor ##al kin ##ema ##tics [SEP]',\n",
       "  'existing_cui': 'C0011119',\n",
       "  'existing_cui_name': 'Decompression Sickness',\n",
       "  'existing_cui_desc': \"[CLS] Dec ##om ##press ##ion Sick ##ness [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Dec ##om ##press ##ion Sick ##ness [ Disease / Finding ] ; Bend ##s ; Rap ##ture of the deep syndrome ; de ##com ##press ##ion ; disease ; de ##com ##press ##ion sickness ; Dec ##om ##press ##ion sickness ; Di ##vers ' p ##als ##y or para ##lysis ; disease ( or disorder ) ; de ##com ##press ##ion ; choke ##s ; Disease , C ##ais ##son ; choking ; the bends ; Di ##vers ' p ##als ##y ; ca ##iss ##on ; disease ; a ##ero ##bull ##osis ; compressed air disease ; bend ; bends ; ca ##iss ##on disease ; [SEP]\",\n",
       "  'our_bi_cui': 'C0856776',\n",
       "  'our_bi_cui_name': 'Twisted knee',\n",
       "  'our_bi_cui_desc': '[CLS] T ##wi ##sted knee [unused3] ( In ##ju ##ry or Po ##ison ##ing : twist knee ; twisted knee ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27538372.30',\n",
       "  'test_set_idx': 9811,\n",
       "  'type': 'T038',\n",
       "  'name': 'overexpression',\n",
       "  'context': '[CLS] differential ##ly expressed genes , P ##d ##p ##1 expression was significantly decreased ( 27 - fold ) on day 8 compared to D ##0 , which was accompanied by suppressed mitochondrial in ##dices , including ATP levels , membrane potential , R ##OS and mitochondrial C ##a ( 2 + ) . Not ##ably , P ##d ##p ##1 [unused1] over ##ex ##press ##ion [unused2] significantly enhanced the mitochondrial in ##dices and p ##yr ##u ##vate de ##hy ##dr ##ogen ##ase activity and reduced the expression of cardiac differentiation marker messenger RNA and the cardiac differentiation rate compared to a mock control . In confirmation of this , a knock ##down of the P ##d ##p ##1 gene promoted the expression of cardiac differentiation marker [SEP]',\n",
       "  'existing_cui': 'C1514559',\n",
       "  'existing_cui_name': 'Protein Overexpression',\n",
       "  'existing_cui_desc': '[CLS] Pro ##tein Over ##ex ##press ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction : Over ##ex ##press ##ion ; over ##ex ##press ) [SEP]',\n",
       "  'our_bi_cui': 'C1514559',\n",
       "  'our_bi_cui_name': 'Protein Overexpression',\n",
       "  'our_bi_cui_desc': '[CLS] Pro ##tein Over ##ex ##press ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction : Over ##ex ##press ##ion ; over ##ex ##press ) [SEP]',\n",
       "  'our_cross_cui': 'C0017262',\n",
       "  'our_cross_cui_name': 'Gene Expression',\n",
       "  'our_cross_cui_desc': '[CLS] Gene Express ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , finding : Express ##ions , Gene ; expression gene ; Gene expression ; Express ##ion , Gene ; Express ##ion ; Express ##ed ; gene expression ; Gene Express ##ions ) [SEP]'},\n",
       " {'mention_id': '27379139.7',\n",
       "  'test_set_idx': 4173,\n",
       "  'type': 'T017',\n",
       "  'name': 'Compound Tissue',\n",
       "  'context': '[CLS] Evaluation of Three Pro ##tein - Extra ##ction Method ##s for Pro ##te ##ome Analysis of Mai ##ze Leaf Mid ##ri ##b , a [unused1] Co ##mpo ##und T ##iss ##ue [unused2] Rich in Sc ##ler ##en ##chy ##ma Cell ##s Leaf morphology is closely related to the growth and development of maize ( Z ##ea may ##s L . ) plants and final kernel production . As an important part of the maize leaf , the mid ##ri ##b holds leaf blades in the aerial position for maximum sunlight capture . Leaf mid ##ri ##b s of adult plants contain substantial s ##cle ##rench ##ym ##a cells with heavily thick ##ened and l ##ign ##ified secondary walls and have a high amount of p ##hen [SEP]',\n",
       "  'existing_cui': 'C1706082',\n",
       "  'existing_cui_name': 'Compound',\n",
       "  'existing_cui_desc': '[CLS] Co ##mpo ##und [unused3] ( Chemical , substance , substance : compound ) [SEP]',\n",
       "  'our_bi_cui': 'C0040300',\n",
       "  'our_bi_cui_name': 'Body tissue',\n",
       "  'our_bi_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
       "  'our_cross_cui': 'C1514137',\n",
       "  'our_cross_cui_name': 'Plant Tissue , Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Plant T ##iss ##ue , Cell ##s [unused3] ( Ana ##tom ##ical Structure : Plant cells and tissues ) [SEP]'},\n",
       " {'mention_id': '28522288.42',\n",
       "  'test_set_idx': 38354,\n",
       "  'type': 'T033',\n",
       "  'name': 'percentage of positive cores',\n",
       "  'context': '[CLS] ) . In multi ##var ##iate analyses , variables predict ##ing up ##grading for G ##G ##1 pro ##state cancer were age ( P = . 00 ##14 ) , abnormal digital re ##ct ##al examination ( P < . 000 ##1 ) , pro ##state - specific anti ##gen density ( P < . 000 ##1 ) , [unused1] percentage of positive core ##s [unused2] ( P < . 000 ##1 ) , and body mass index ( P = . 03 ##7 ) . A no ##mo ##gram was generated and valid ##ated internally . B ##io ##psy g ##rading system is misleading in approximately 50 % of cases . Up ##grading grade group from bio ##psy to radical pro ##state ##ct ##omy may [SEP]',\n",
       "  'existing_cui': 'C0518026',\n",
       "  'existing_cui_name': 'body fat percentage',\n",
       "  'existing_cui_desc': '[CLS] body fat percentage [unused3] ( Finding , physical finding , physical finding : body fat percentage ##s ; Body fat percentage ; percentage body fat ; percentage of body fat ; body fat ) [SEP]',\n",
       "  'our_bi_cui': 'C1302649',\n",
       "  'our_bi_cui_name': 'Number of tissue cores positive for carcinoma',\n",
       "  'our_bi_cui_desc': '[CLS] Number of tissue core ##s positive for car ##cin ##oma [unused3] ( Clinical At ##tri ##but ##e , o ##bs ##er ##vable entity ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28084061.16',\n",
       "  'test_set_idx': 25234,\n",
       "  'type': 'T033',\n",
       "  'name': 'reason',\n",
       "  'context': '[CLS] ##dices helped explain the variation in key rehabilitation outcomes . Prospect ##ive open - co ##hor ##t study . In ##patient rehabilitation ward , Melbourne , Australia . Adults admitted for in ##patient rehabilitation ( n = 280 ) . The main outcomes were demographic ( e . g . age , gender , discharge destination ) and clinical outcomes ( [unused1] reason [unused2] for rehabilitation , length of stay , Fun ##ctional Independence Me ##as ##ure , Cha ##rls ##on Como ##rb ##id ##ity Index and C ##um ##ula ##tive Index Rat ##ing Scale ) . A series of re ##gression analyses were performed to determine the influence of com ##or ##bid ##ity on three dependent variables : L ##OS in rehabilitation ; 2 ) [SEP]',\n",
       "  'existing_cui': 'C1562480',\n",
       "  'existing_cui_name': 'Has reason',\n",
       "  'existing_cui_desc': '[CLS] Has reason [unused3] ( Intel ##lect ##ual Product , link assertion , link assertion : has reason ) [SEP]',\n",
       "  'our_bi_cui': 'C1443309',\n",
       "  'our_bi_cui_name': 'Reason for Treatment',\n",
       "  'our_bi_cui_desc': '[CLS] Reason for Treatment [unused3] ( Finding , finding : Reason ##s for treatment ) [SEP]',\n",
       "  'our_cross_cui': 'C0566251',\n",
       "  'our_cross_cui_name': 'Reason and justification',\n",
       "  'our_cross_cui_desc': '[CLS] Reason and justification [unused3] ( Finding , attribute ) [SEP]'},\n",
       " {'mention_id': '28356622.43',\n",
       "  'test_set_idx': 33083,\n",
       "  'type': 'T038',\n",
       "  'name': 'plantar moment',\n",
       "  'context': \"[CLS] ##ait parameters were calculated using the S ##pear ##man correlation analysis . [ Results ] Rate ##s of the transverse arch of the fore ##foot width and height between condition 2 and condition 3 were significantly correlated with the anterior and posterior component of ground reaction forces , the hip joint extension angle , and the ankle plant ##ar fl ##ex ##ion moment . [ Con ##c ##lusion ] Our study ' s findings indicated that increased stiff ##ness of the transverse arch of the fore ##foot was related to the increase in ankle [unused1] plant ##ar moment [unused2] , and decreased stiff ##ness of the transverse arch of the fore ##foot was related to the increase in hip joint extension angle during g ##ait . [SEP]\",\n",
       "  'existing_cui': 'C0230463',\n",
       "  'existing_cui_name': 'Sole of Foot',\n",
       "  'existing_cui_desc': '[CLS] Sol ##e of Foot [unused3] ( Spa ##tial Concept , body structure : Plant ##ar aspect of foot ; Plant ##a ; foot sole ##s ; sole ; Plant ##ar Region ; foot sole ; Reg ##io plant ##aris ; sole of foot ; Plant ##ar region ; Bottom of foot ; Sol ##e of foot ; Plant ##ar part of foot ; Sol ##e ; Structure of sole of foot ; sole ##s ; S ##OL ##E ; Plant ##ar ) [SEP]',\n",
       "  'our_bi_cui': 'C0278131',\n",
       "  'our_bi_cui_name': 'Plantar reflex',\n",
       "  'our_bi_cui_desc': '[CLS] Plant ##ar reflex [unused3] ( Finding , o ##bs ##er ##vable entity , physical finding : PR - Plant ##ar reflex ; plant ##ar reflex ) [SEP]',\n",
       "  'our_cross_cui': 'C0231784',\n",
       "  'our_cross_cui_name': 'Plantar flexion',\n",
       "  'our_cross_cui_desc': '[CLS] Plant ##ar fl ##ex ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : plant ##ar fl ##ex ##ion ; Plant ##ar fl ##ex ##ion , function ; fl ##ex ##ion plant ##ar ) [SEP]'},\n",
       " {'mention_id': '28127340.49',\n",
       "  'test_set_idx': 26275,\n",
       "  'type': 'T204',\n",
       "  'name': 'N. fasciatus',\n",
       "  'context': \"[CLS] % , No ##so ##psy ##llus f ##as ##cia ##tus = 1 . 09 % , and La ##ela ##ps nut ##tal ##li = 3 . 29 % . Among 10 genera / species of identified parasite ##s , at least 8 of them were zoo ##not ##ic with public health importance . L . nut ##tal ##li and [unused1] N . f ##as ##cia ##tus [unused2] were the only two non - zoo ##not ##ic detected parasite ##s in this survey . Harbor ##ing a wide variety of zoo ##not ##ic parasite ##s in sampled wild rode ##nts particularly when they live nearby villages , represents a potential risk to native inhabitants . Hence , controlling rode ##nts ' population in residential regions and improving [SEP]\",\n",
       "  'existing_cui': 'C1070996',\n",
       "  'existing_cui_name': 'Arion fasciatus',\n",
       "  'existing_cui_desc': '[CLS] Ari ##on f ##as ##cia ##tus [unused3] ( E ##uka ##ryo ##te : Ari ##on ( Car ##ina ##rion ) f ##as ##cia ##tus ) [SEP]',\n",
       "  'our_bi_cui': 'C2997670',\n",
       "  'our_bi_cui_name': 'Nariscus fasciatus',\n",
       "  'our_bi_cui_desc': '[CLS] Na ##ris ##cus f ##as ##cia ##tus [unused3] ( E ##uka ##ryo ##te : Na ##ris ##cus f ##as ##cia ##tus ( Di ##stant , 1918 ) ; Akbar ##atus f ##as ##cia ##tus ) [SEP]',\n",
       "  'our_cross_cui': 'C0323233',\n",
       "  'our_cross_cui_name': 'Nosopsyllus fasciatus',\n",
       "  'our_cross_cui_desc': '[CLS] No ##so ##psy ##llus f ##as ##cia ##tus [unused3] ( E ##uka ##ryo ##te , organism : Northern rat fl ##ea ; Ce ##rato ##phy ##llus f ##as ##cia ##tus ; No ##so ##psy ##llus f ##as ##cia ##tus ( Bo ##s ##c , 1800 ) ; Brown rat fl ##ea ) [SEP]'},\n",
       " {'mention_id': '27637577.41',\n",
       "  'test_set_idx': 12603,\n",
       "  'type': 'T103',\n",
       "  'name': 'bisulfite - treated DNA',\n",
       "  'context': '[CLS] ##lit ##is patients and 40 healthy individuals . Total RNA and DNA contents of le ##uk ##ocytes were extracted . Afterward , quantitative analysis was carried out by real - time PC ##R using the S ##Y ##BR Green PC ##R Master Mix . Finally , to determine the met ##hyl ##ation level , PC ##R products of [unused1] bi ##sul ##fit ##e - treated DNA [unused2] from patients and controls were sequence ##d . Compared with healthy controls , expression level of DNA met ##hyl ##tra ##ns ##fer ##ase 1 in An ##ky ##los ##ing s ##po ##ndy ##lit ##is patients was significantly down ##re ##gu ##lated . Met ##hyl ##ation of DNA met ##hyl ##tra ##ns ##fer ##ase 1 promoter was significantly higher in [SEP]',\n",
       "  'existing_cui': 'C0063088',\n",
       "  'existing_cui_name': 'hydrogen sulfite',\n",
       "  'existing_cui_desc': '[CLS] hydrogen su ##lf ##ite [unused3] ( Chemical : bi ##sul ##fit ##e ; h ##ydro ##sul ##fit ##e ) [SEP]',\n",
       "  'our_bi_cui': 'C3831347',\n",
       "  'our_bi_cui_name': 'Bisulfite Sequencing',\n",
       "  'our_bi_cui_desc': '[CLS] B ##is ##ulf ##ite Se ##quencing [unused3] ( Research Act ##ivity ) [SEP]',\n",
       "  'our_cross_cui': 'C0012854',\n",
       "  'our_cross_cui_name': 'DNA',\n",
       "  'our_cross_cui_desc': '[CLS] DNA [unused3] ( Chemical , DNA , De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid , substance : d ##na molecules ; d ##s ##D ##NA ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; d ##na / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA molecule ; DNA - De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acids ; d ##na molecule ; DNA [ Chemical / In ##g ##red ##ient ] ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; Double - [SEP]'},\n",
       " {'mention_id': '27669217.44',\n",
       "  'test_set_idx': 13695,\n",
       "  'type': 'T033',\n",
       "  'name': 'MICs',\n",
       "  'context': '[CLS] acquired independently in one highly v ##ir ##ulent is ##olate AL ##10 ##100 ##2 , and cluster ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both er ##m ##B and er ##m ##T in all is ##olate ##s was er ##yt ##hr ##omy ##cin in ##du ##cible and yielded comparable mac ##rol ##ide [unused1] MI ##Cs [unused2] in all six is ##olate ##s . Take ##n together , in ##du ##cible expression of both er ##m ##B and er ##m ##T conferred high mac ##rol ##ide resistance in these S . gal ##lo ##ly ##ticus subsp . paste ##rian ##us is ##olate ##s . Our findings reveal new mac ##rol ##ide resistance features in S . gal ##lo [SEP]',\n",
       "  'existing_cui': 'C0427978',\n",
       "  'existing_cui_name': 'Minimum Inhibitory Concentration measurement',\n",
       "  'existing_cui_desc': '[CLS] Mini ##mum In ##hibit ##ory Con ##cent ##ration measurement [unused3] ( Health Care Act ##ivity , MI ##C , procedure , qualifier value : Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test ; Con ##cent ##rations , Mini ##mum In ##hibit ##ory ; Anti ##biotic sensitivity , minimum inhibitor ##y concentration ; MI ##C su ##s ##ce ##pt ##ibility test ; Mini ##mum In ##hibit ##ory Con ##cent ##rations ; MI ##C - Mini ##mum inhibitor ##y concentration ; Con ##cent ##ration , Mini ##mum In ##hibit ##ory ; Mini ##mum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test technique ; In ##hibit ##ory Con ##cent ##rations , Mini ##mum ; Mini ##mum In ##hibit ##ory [SEP]',\n",
       "  'our_bi_cui': 'C0427978',\n",
       "  'our_bi_cui_name': 'Minimum Inhibitory Concentration measurement',\n",
       "  'our_bi_cui_desc': '[CLS] Mini ##mum In ##hibit ##ory Con ##cent ##ration measurement [unused3] ( Health Care Act ##ivity , MI ##C , procedure , qualifier value : Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test ; Con ##cent ##rations , Mini ##mum In ##hibit ##ory ; Anti ##biotic sensitivity , minimum inhibitor ##y concentration ; MI ##C su ##s ##ce ##pt ##ibility test ; Mini ##mum In ##hibit ##ory Con ##cent ##rations ; MI ##C - Mini ##mum inhibitor ##y concentration ; Con ##cent ##ration , Mini ##mum In ##hibit ##ory ; Mini ##mum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test technique ; In ##hibit ##ory Con ##cent ##rations , Mini ##mum ; Mini ##mum In ##hibit ##ory [SEP]',\n",
       "  'our_cross_cui': 'C1304747',\n",
       "  'our_cross_cui_name': 'Minimum inhibitory concentration result',\n",
       "  'our_cross_cui_desc': '[CLS] Mini ##mum inhibitor ##y concentration result [unused3] ( Finding , finding : minimum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration finding ) [SEP]'},\n",
       " {'mention_id': '27660632.56',\n",
       "  'test_set_idx': 13478,\n",
       "  'type': 'T017',\n",
       "  'name': 'regions',\n",
       "  'context': '[CLS] ) traits , mainly focused on Ch ##r ##0 ##5 , Ch ##r ##0 ##9 , Ch ##r ##10 , Ch ##r ##14 , Ch ##r ##19 , and Ch ##r ##20 . Nine ##teen pairs of e ##pis ##tat ##ic quantitative trait lo ##cus were identified , of which two pairs involved in two add ##itive quantitative trait lo ##cus . These add ##itive quantitative trait lo ##cus , e ##pis ##tat ##ic quantitative trait lo ##cus , and Q ##TL clusters were tightly linked to single n ##uc ##leo ##tide p ##oly ##mor ##phism markers , which may serve as target [unused1] regions [unused2] for map - based c ##lon ##ing , gene discovery , and marker - assisted selection in cotton breeding . [SEP]',\n",
       "  'existing_cui': 'C0017446',\n",
       "  'existing_cui_name': 'Geographic Locations',\n",
       "  'existing_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]',\n",
       "  'our_bi_cui': 'C0205146',\n",
       "  'our_bi_cui_name': 'Area',\n",
       "  'our_bi_cui_desc': '[CLS] Area [unused3] ( Spa ##tial Concept , qualifier value : area ; areas ; AR ##EA ) [SEP]',\n",
       "  'our_cross_cui': 'C1953345',\n",
       "  'our_cross_cui_name': 'Region of chromosome',\n",
       "  'our_cross_cui_desc': '[CLS] Region of chromosome [unused3] ( Ana ##tom ##ical Structure : ch ##rom ##oso ##mal region ; Ch ##rom ##oso ##mal region ; chromosome region ; Ch ##rom ##oso ##me region ) [SEP]'},\n",
       " {'mention_id': '27692319.38',\n",
       "  'test_set_idx': 14309,\n",
       "  'type': 'T204',\n",
       "  'name': 'eggs',\n",
       "  'context': '[CLS] ##roma ##tography , suspended in 1 % D ##MS ##O and used in in v ##it ##ro tests . Q ##uad ##rup ##lica ##tes of 50 F . he ##pa ##tica eggs were in ##cu ##bate ##d at 23 °C with M . ch ##aran ##tia leaf crude extract in different concentrations . After 12 days no larvae were formed in [unused1] eggs [unused2] in ##cu ##bate ##d with crude extract concentrations above 12 . 5 mg / m ##L . Egg ##s in ##cu ##bate ##d with crude extract sub - fraction ##s at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μ ##g / m ##L affected em ##b ##ryo ##nic development , with n [SEP]',\n",
       "  'existing_cui': 'C0029974',\n",
       "  'existing_cui_name': 'Ovum',\n",
       "  'existing_cui_desc': '[CLS] O ##vu ##m [unused3] ( Ana ##tom ##ical Structure , body structure , cell , cell structure , qualifier value : Human egg ; Egg ##s , Un ##fer ##til ##ized ; Fe ##rt ##ilized o ##oc ##yte ; Mat ##ure o ##vu ##m ; O ##va ; Egg ; egg cell ; o ##va ; X bearing o ##vu ##m ; female game ##tes ; O ##ocytes ; Un ##fer ##til ##ized Egg ##s ; X chromosome - bearing o ##vu ##m ; Egg , Un ##fer ##til ##ized ; O ##vu ##m structure ; Un ##fer ##til ##ized Egg ; Female game ##te ; O ##voc ##yte ; egg / o ##vu ##m ; o ##vu ##m ; female game ##te ; X - [SEP]',\n",
       "  'our_bi_cui': 'C0013710',\n",
       "  'our_bi_cui_name': 'Egg Food Product',\n",
       "  'our_bi_cui_desc': '[CLS] Egg Food Product [unused3] ( Food , Po ##ult ##ry , edible , substance : eggs ; egg food product ; egg ; Egg , Po ##ult ##ry ; Egg ; Egg ##s ; Egg ##s ( edible ) ; egg [ food ] ; E ##G ##G ) [SEP]',\n",
       "  'our_cross_cui': 'C3662687',\n",
       "  'our_cross_cui_name': 'Fasciola hepatica egg',\n",
       "  'our_cross_cui_desc': '[CLS] F ##as ##cio ##la he ##pa ##tica egg [unused3] ( E ##uka ##ryo ##te , organism : F ##as ##cio ##la he ##pa ##tica o ##va ) [SEP]'},\n",
       " {'mention_id': '28390176.60',\n",
       "  'test_set_idx': 34150,\n",
       "  'type': 'T038',\n",
       "  'name': 'inhibition',\n",
       "  'context': '[CLS] over ##ex ##press ##ion of con ##st ##it ##utive ##ly active A ##kt completely abolished the C ##uc ##ur ##bit ##ac ##in B - mediated protection of cardiac h ##yper ##tro ##phy in human card ##io ##my ##ocytes AC ##16 . Collective ##ly , our findings suggest that cu ##cu ##rb ##ita ##cin B protects against cardiac h ##yper ##tro ##phy through increasing the auto ##pha ##gy level in card ##io ##my ##ocytes , which is associated with the [unused1] in ##hibition [unused2] of A ##kt / m ##TO ##R / Fox ##O ##3 ##a signal axis . J . Cell . B ##io ##che ##m . 99 ##9 ##9 : 1 - 12 , 2017 . © 2017 Wiley Period ##ical ##s , Inc . [SEP]',\n",
       "  'existing_cui': 'C0021467',\n",
       "  'existing_cui_name': 'Psychological inhibition',\n",
       "  'existing_cui_desc': '[CLS] Psychological in ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction , Personal ##ity , Psychology : psychological in ##hibition ; in ##hibition ; in ##hibition ##s ; IN ##H ##IB ##IT ##ION ; In ##hibition ; IN ##H ##IB ##IT ##ION PS ##Y ##CH ##OL ; In ##hibition ##s ) [SEP]',\n",
       "  'our_bi_cui': 'C0021469',\n",
       "  'our_bi_cui_name': 'Metabolic Inhibition',\n",
       "  'our_bi_cui_desc': '[CLS] Met ##ab ##olic In ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : In ##hibition ; In ##hibition , function ) [SEP]',\n",
       "  'our_cross_cui': 'C1519312',\n",
       "  'our_cross_cui_name': 'Signal Transduction Inhibition',\n",
       "  'our_cross_cui_desc': '[CLS] Signal Trans ##duction In ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction : in ##hibition of signal trans ##duction ) [SEP]'},\n",
       " {'mention_id': '28084061.29',\n",
       "  'test_set_idx': 25247,\n",
       "  'type': 'T033',\n",
       "  'name': 'reason',\n",
       "  'context': '[CLS] score between rehabilitation discharge and admission ; and 3 ) the discharge destination ( home vs other ) . The mean age was 57 . 7 years , there were slightly more females ( 51 % ) , most ( 95 % ) patients previously lived at home with family or other relatives ( 63 % ) . The most common [unused1] reason [unused2] for rehabilitation was or ##th ##op ##ae ##dic or other conditions ( 52 % ) and most ( 80 % ) people were discharged home . The median L ##OS was 27 days . There were 100 ( 35 . 7 % ) patients who had no com ##or ##bid ##ity recorded using the Cha ##rls ##on Como ##rb ##id ##ity Index [SEP]',\n",
       "  'existing_cui': 'C1562480',\n",
       "  'existing_cui_name': 'Has reason',\n",
       "  'existing_cui_desc': '[CLS] Has reason [unused3] ( Intel ##lect ##ual Product , link assertion , link assertion : has reason ) [SEP]',\n",
       "  'our_bi_cui': 'C1443309',\n",
       "  'our_bi_cui_name': 'Reason for Treatment',\n",
       "  'our_bi_cui_desc': '[CLS] Reason for Treatment [unused3] ( Finding , finding : Reason ##s for treatment ) [SEP]',\n",
       "  'our_cross_cui': 'C0566251',\n",
       "  'our_cross_cui_name': 'Reason and justification',\n",
       "  'our_cross_cui_desc': '[CLS] Reason and justification [unused3] ( Finding , attribute ) [SEP]'},\n",
       " {'mention_id': '28249376.78',\n",
       "  'test_set_idx': 29948,\n",
       "  'type': 'T033',\n",
       "  'name': 'digestibility',\n",
       "  'context': '[CLS] ##ole ##ster ##ol , total protein , album ##in , blood u ##rea nitrogen and as ##par ##tate amino ##tra ##ns ##fer ##ase and al ##ani ##ne amino ##tra ##ns ##fer ##ase concentration . A ##ppa ##rent total tract dig ##est ##ibility of dry matter , crude pro ##ten , organic matter , and neutral de ##ter ##gent fiber were not influenced by mixture of essential oils supplement ##ation . The results of the present study suggested that supplement ##ation of mixture of essential oils may have limited effects on apparent nut ##rient [unused1] dig ##est ##ibility [unused2] , r ##umi ##nal f ##er ##mentation and pro ##to ##zo ##a and h ##yper am ##monia producing bacteria count , blood cells and meta ##bol ##ites . [SEP]',\n",
       "  'existing_cui': 'C0233423',\n",
       "  'existing_cui_name': 'Suggestibility',\n",
       "  'existing_cui_desc': '[CLS] Su ##gg ##est ##ibility [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : suggest ##ibility ; Su ##gg ##est ##ibility , function ) [SEP]',\n",
       "  'our_bi_cui': 'C0012238',\n",
       "  'our_bi_cui_name': 'Digestion',\n",
       "  'our_bi_cui_desc': '[CLS] Digest ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : dig ##estive system functions ; dig ##est ##ion ; Digest ##ive system functions ; dig ##est ##ions ; Digest ##ive system function ; Fun ##ctions of the dig ##estive system ; Digest ##ive ; Digest ##ive tract function ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27580908.19',\n",
       "  'test_set_idx': 10663,\n",
       "  'type': 'T058',\n",
       "  'name': 'pediatric gastrointestinal radiology',\n",
       "  'context': \"[CLS] digital game or with a traditional did ##actic lecture . Medical students participating in a fourth - year radio ##logy elect ##ive were invited to participate . Student co ##hor ##ts were alternatively given a faculty - supervised 1 ##h session playing a simple interactive digital T ##ic - ta ##c - toe q ##uiz module on [unused1] p ##ediatric gas ##tro ##int ##est ##inal radio ##logy [unused2] or a 1 ##h did ##actic intro ##ductory lecture on the same topic . Survey questions assessed the learn ##ers ' perceived ability to recall the material as well as their satisfaction with the educational experience . Results of an end - of - rotation exam were reviewed to evaluate a quantitative measure of learning between groups . [SEP]\",\n",
       "  'existing_cui': 'C1518934',\n",
       "  'existing_cui_name': 'Pediatric Radiology Specialty',\n",
       "  'existing_cui_desc': '[CLS] P ##ediatric Radio ##logy Special ##ty [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line : radio ##logy , p ##ediatric ; p ##ediatric radio ##logy ; P ##ediatric Radio ##logy ) [SEP]',\n",
       "  'our_bi_cui': 'C0947817',\n",
       "  'our_bi_cui_name': 'Gastrointestinal radiotherapies',\n",
       "  'our_bi_cui_desc': '[CLS] Gas ##tro ##int ##est ##inal radio ##ther ##ap ##ies [unused3] ( Health Care Act ##ivity ) [SEP]',\n",
       "  'our_cross_cui': 'C0203054',\n",
       "  'our_cross_cui_name': 'Radiography of gastrointestinal tract',\n",
       "  'our_cross_cui_desc': '[CLS] Radio ##graphy of gas ##tro ##int ##est ##inal tract [unused3] ( Health Care Act ##ivity , procedure : X - ray gas ##tro ##int ##est ##inal ; Radio ##graphic procedure on gas ##tro ##int ##est ##inal tract ; Gas ##tro ##int ##est ##inal tract X - ray ; G ##I tract X - ray ; Digest ##ive tract X - ray ; Radio ##log ##ic procedure on gas ##tro ##int ##est ##inal tract ; G ##I x - ray ; x - ray of gas ##tro ##int ##est ##inal tract ; X - ray ; dig ##estive tract ; X - ray gas ##tro ##int ##est ##inal tract ; X - ray of the dig ##estive tract ; Gas ##tro ##int ##est ##inal tract x - [SEP]'},\n",
       " {'mention_id': '27812530.21',\n",
       "  'test_set_idx': 18011,\n",
       "  'type': 'T103',\n",
       "  'name': 'material',\n",
       "  'context': '[CLS] °C ) . Six specimens were tested in each group of the aforementioned parameters . Inc ##rea ##sing cast ##or oil content and pre ##co ##olin ##g treatment effectively decreased the peak polymer ##ization temperatures and increased the duration to achieve the peak polymer ##ization temperature ( P < 0 . 05 ) . Furthermore , the mechanical properties of the [unused1] material [unused2] , including density , m ##od ##ulus , and maximum compression strength , decreased with increasing cast ##or oil content . However , preparation temperature ( room temperature versus pre ##co ##olin ##g ) had no significant effect ( P > 0 . 05 ) on these mechanical properties . In conclusion , the addition of cast ##or oil to Pol ##yme [SEP]',\n",
       "  'existing_cui': 'C0440470',\n",
       "  'existing_cui_name': 'Human material',\n",
       "  'existing_cui_desc': '[CLS] Human material [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
       "  'our_bi_cui': 'C0032521',\n",
       "  'our_bi_cui_name': 'Polymers',\n",
       "  'our_bi_cui_desc': '[CLS] Pol ##yme ##rs [unused3] ( Chemical , substance : Pol ##yme ##ric ; Pol ##yme ##ric Mac ##rom ##ole ##cule ##s ; Pol ##yme ##r ; P ##OL ##Y ##ME ##R S ##U ##BS ##TA ##NC ##E ; Pol ##yme ##rs [ Chemical / In ##g ##red ##ient ] ; polymer ; polymer ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0005479',\n",
       "  'our_cross_cui_name': 'Biomaterials',\n",
       "  'our_cross_cui_desc': '[CLS] B ##io ##mate ##rial ##s [unused3] ( Chemical : B ##io ##mate ##rial ; bio ##com ##pa ##tible materials ; B ##io ##medical Material ; bio ##mate ##rial ##s ; B ##io ##medical materials ; B ##io ##com ##pa ##tible Materials ; bio ##medical materials ; bio ##mate ##rial ; Materials , B ##io ##com ##pa ##tible ; bio ##medical material ; B ##io ##com ##pa ##tible Materials [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '28295414.42',\n",
       "  'test_set_idx': 31580,\n",
       "  'type': 'T168',\n",
       "  'name': 'drink',\n",
       "  'context': '[CLS] a 10 % probability ( or less ) of transition ##ing out of either a no heavy drinking state or a heavy drinking state . More than two - thirds of the heavy drink ##ers who exceeded the heavy drinking threshold during treatment reported , on average , a 64 % reduction in drinking frequency and a 38 % reduction in drinking intensity from pre ##tre ##at ##ment drinking levels . The results show stability of no heavy drinking as an outcome within the first 4 months of treatment and that the > 3 / > 4 [unused1] drink [unused2] cut ##off may mask substantial reduction ##s in alcohol consumption among some patients . Future studies should explore the clinical utility of reduction end points . [SEP]',\n",
       "  'existing_cui': 'C0452428',\n",
       "  'existing_cui_name': 'Drink',\n",
       "  'existing_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
       "  'our_bi_cui': 'C0452428',\n",
       "  'our_bi_cui_name': 'Drink',\n",
       "  'our_bi_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
       "  'our_cross_cui': 'C0001967',\n",
       "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
       "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
       " {'mention_id': '27617315.44',\n",
       "  'test_set_idx': 12007,\n",
       "  'type': 'T103',\n",
       "  'name': '% p2PSA',\n",
       "  'context': '[CLS] 54 . 5 % in Pro ##state Health Index > 55 ( ch ##i - square test , p < 0 . 00 ##1 ) . The area under curves of the base model including age , total pro ##state - specific anti ##gen and status of initial / repeated bio ##psy was 0 . 64 . Ad ##ding [unused1] % p ##2 ##PS ##A [unused2] and Pro ##state Health Index to the base model improved the area under curves to 0 . 79 ( p < 0 . 00 ##1 ) and 0 . 78 ( p < 0 . 00 ##1 ) , respectively , and provided net clinical benefit in decision curve analyses . The positive bio ##psy rates of G ##lea ##son [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0138741',\n",
       "  'our_bi_cui_name': 'Prostate-Specific Antigen',\n",
       "  'our_bi_cui_desc': '[CLS] Pro ##state - S ##pecific Anti ##gen [unused3] ( Chemical , PS ##A , procedure , substance : pro ##state specific anti ##gen ; gamma Semi ##no ##p ##rote ##in ; Se ##men ##ogel ##ase ; gamma semi ##no ##p ##rote ##in ; Ka ##lli ##k ##re ##in , h ##K ##3 ; Gamma - Semi ##no ##p ##rote ##in ; Pro ##state - specific anti ##gen ; HK 00 ##3 K ##AL ##L ##I ##K ##RE ##IN ; PS ##A - Pro ##state specific anti ##gen ; Ka ##lli ##k ##re ##in h ##K ##3 ; gamma - Semi ##no ##p ##rote ##in ; Pro ##state S ##pecific Anti ##gen ; EC 3 . 4 . 21 . 77 ; P - 30 anti ##gen [SEP]',\n",
       "  'our_cross_cui': 'C3710767',\n",
       "  'our_cross_cui_name': '( -2 ) pro-prostate-specific antigen , human',\n",
       "  'our_cross_cui_desc': '[CLS] ( - 2 ) pro - pro ##state - specific anti ##gen , human [unused3] ( Chemical : ( - 2 ) pro - PS ##A , human ; p ##2 ##PS ##A , human ) [SEP]'},\n",
       " {'mention_id': '27699206.11',\n",
       "  'test_set_idx': 14492,\n",
       "  'type': 'T017',\n",
       "  'name': 'lateral occipital',\n",
       "  'context': '[CLS] . However , it remains un ##res ##ol ##ved whether all objects e ##voke equivalent levels of activity in lateral o ##cci ##pit ##al , and , if not , which image features produce stronger activation . Here , we used an un ##bia ##sed para ##metric texture model to predict preferred versus non ##p ##re ##ferred stimuli in [unused1] lateral o ##cci ##pit ##al [unused2] . O ##bs ##er ##vation and ps ##ych ##op ##hy ##si ##cal results showed that predicted preferred stimuli ( both objects and non ##ob ##jects ) had smooth ( rather than texture ##d ) surfaces . These predictions were confirmed using f ##MR ##I , for objects and non ##ob ##jects . Similar preferences were also found in the f [SEP]',\n",
       "  'existing_cui': 'C0923804',\n",
       "  'existing_cui_name': 'Lateral occipital artery',\n",
       "  'existing_cui_desc': '[CLS] Later ##al o ##cci ##pit ##al artery [unused3] ( Ana ##tom ##ical Structure , Arte ##ria c ##ere ##bri posterior : P ##3 segment of posterior cerebral artery ; Arte ##ria o ##cci ##pit ##alis lateral ##is ; Se ##gment ##um P ##3 ; A . o ##cci ##pit ##alis lateral ##is ) [SEP]',\n",
       "  'our_bi_cui': 'C0228229',\n",
       "  'our_bi_cui_name': 'lateral occipital sulcus',\n",
       "  'our_bi_cui_desc': '[CLS] lateral o ##cci ##pit ##al su ##l ##cus [unused3] ( Spa ##tial Concept , human only , human only , body structure : Later ##al o ##cci ##pit ##al su ##l ##cus ; Structure of lateral o ##cci ##pit ##al su ##l ##cus ; Later ##al - O ##cci ##pit ##al Sul ##cus ; Sul ##cus o ##cci ##pit ##alis lateral ##is ) [SEP]',\n",
       "  'our_cross_cui': 'C0028785',\n",
       "  'our_cross_cui_name': 'Occipital lobe',\n",
       "  'our_cross_cui_desc': '[CLS] O ##cci ##pit ##al lobe [unused3] ( Ana ##tom ##ical Structure , body structure : o ##cci ##pit ##al region ; O ##cci ##pit ##al cortex ; lo ##bus o ##cci ##pit ##alis ; O ##cci ##pit ##al Lo ##be ; o ##cci ##pit ##al lobes ; O ##cci ##pit ##al lobes ; O ##cci ##pit ##al Region ##s ; O ##cci ##pit ##al Region ; o ##cci ##pit ##al lobe ; Lo ##be , O ##cci ##pit ##al ; lobe o ##cci ##pit ##al ; O ##cci ##pit ##al region ; Region , O ##cci ##pit ##al ; Lo ##bus o ##cci ##pit ##alis ; o ##cci ##pit ##al cortex ; Reg ##io o ##cci ##pit ##alis ; Lo ##bes , O ##cci ##pit ##al [SEP]'},\n",
       " {'mention_id': '28197156.15',\n",
       "  'test_set_idx': 28085,\n",
       "  'type': 'T082',\n",
       "  'name': 'Japanese',\n",
       "  'context': '[CLS] CO ##2 ass ##im ##ilation rate ( A ) between rice cult ##iva ##rs using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a [unused1] Japanese [unused2] commercial cult ##iva ##r . Fine mapping suggested that Carbon As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the [SEP]',\n",
       "  'existing_cui': 'C1556094',\n",
       "  'existing_cui_name': 'Japanese race',\n",
       "  'existing_cui_desc': '[CLS] Japanese race [unused3] ( Population Group , ethnic group , finding : J ##AP ##AN ##ES ##E ; Race : Japanese ; Japanese ; - - Japanese ) [SEP]',\n",
       "  'our_bi_cui': 'C1556094',\n",
       "  'our_bi_cui_name': 'Japanese race',\n",
       "  'our_bi_cui_desc': '[CLS] Japanese race [unused3] ( Population Group , ethnic group , finding : J ##AP ##AN ##ES ##E ; Race : Japanese ; Japanese ; - - Japanese ) [SEP]',\n",
       "  'our_cross_cui': 'C0022341',\n",
       "  'our_cross_cui_name': 'Japan',\n",
       "  'our_cross_cui_desc': '[CLS] Japan [unused3] ( Spa ##tial Concept , geographic location : J ##A ; JP ##N ; JP ; J ##AP ##AN ) [SEP]'},\n",
       " {'mention_id': '27882455.28',\n",
       "  'test_set_idx': 20576,\n",
       "  'type': 'T038',\n",
       "  'name': 'item integration',\n",
       "  'context': '[CLS] these memory traces into an existing body of knowledge ( item integration ) . Older adults learned 13 non ##words and were tested on their memory for the non ##words , and on whether these non ##words impacted upon processing of similar - sounding English words immediately and 24 hours later . Part ##ici ##pants accurately recognized the non ##words immediately , but showed significant decreases in delayed recognition and recall . In comparison , the non ##words impacted upon processing of similar - sounding words only in the delayed test . Together , these findings suggest that memory consolidation processes may be more evident in [unused1] item integration [unused2] than memory stab ##ilization processes for new de ##c ##lar ##ative memories in older adults . [SEP]',\n",
       "  'existing_cui': 'C1158478',\n",
       "  'existing_cui_name': 'DNA Integration',\n",
       "  'existing_cui_desc': '[CLS] DNA Integration [unused3] ( B ##iol ##og ##ic Fun ##ction : DNA integration ; Integration ) [SEP]',\n",
       "  'our_bi_cui': 'C0700301',\n",
       "  'our_bi_cui_name': 'Cognitive information processing',\n",
       "  'our_bi_cui_desc': '[CLS] Co ##gni ##tive information processing [unused3] ( B ##iol ##og ##ic Fun ##ction , o ##bs ##er ##vable entity , qualifier value : Information processing , function ; Information processing ; information process ; Process ##es information ; information processing ; Information Process ##ing ) [SEP]',\n",
       "  'our_cross_cui': 'C0025361',\n",
       "  'our_cross_cui_name': 'Mental Processes',\n",
       "  'our_cross_cui_desc': '[CLS] Mental Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction , Human , function , o ##bs ##er ##vable entity : Human Information Process ##ing ; Thought process ; cognitive processing ; processes thought ; processing thought ; Information Process ##ing , Human ; Human information processing ; Information Process ##es ; mental processing ; cognitive process ; Form of thinking , function ; mental processes ; Form of thought ; Form of thinking ; Human Information Process ##es ; Mental Process ; mental process ; thought process ) [SEP]'},\n",
       " {'mention_id': '27500205.32',\n",
       "  'test_set_idx': 8464,\n",
       "  'type': 'T103',\n",
       "  'name': 'Kindlins',\n",
       "  'context': '[CLS] play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate the capacity of in ##te ##g ##rin ##s to media ##te their functions . [unused1] Kind ##lins [unused2] are adapt ##or proteins ; their function em ##ana ##te from their interaction with binding partners , including the c ##yt ##op ##las ##mic tails of in ##te ##g ##rin ##s and components of the act ##in c ##yt ##os ##kel ##eton . The purpose of this review is to provide a brief overview of kind ##lin structure and function , [SEP]',\n",
       "  'existing_cui': 'C1720776',\n",
       "  'existing_cui_name': 'Kindling , Neurologic',\n",
       "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
       "  'our_bi_cui': 'C0010422',\n",
       "  'our_bi_cui_name': 'Crystallins',\n",
       "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27977319.24',\n",
       "  'test_set_idx': 22776,\n",
       "  'type': 'T017',\n",
       "  'name': 'THI1',\n",
       "  'context': '[CLS] ##ym ##bio ##sis , we focused on T ##H ##I ##1 , a th ##iam ##ine - bio ##sy ##nt ##hesis gene expressed in roots , nod ##ules , and seeds . The th ##i ##1 mutant had green leaves , but formed small nod ##ules and im ##mat ##ure seeds . These p ##hen ##otype ##s were rescued by [unused1] T ##H ##I ##1 [unused2] complement ##ation and by ex ##ogen ##ous th ##iam ##ine . Thus , T ##H ##I ##1 is required for nod ##ule en ##lar ##gement and seed mat ##uration . On the other hand , colonization by a ##rb ##us ##cular my ##cor ##r ##hi ##za fungus R ##hi ##zo ##pha ##gus irregular ##is was not affected in the th [SEP]',\n",
       "  'existing_cui': 'C0272238',\n",
       "  'existing_cui_name': 'Transient hypogammaglobulinemia of infancy',\n",
       "  'existing_cui_desc': '[CLS] Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of young ; trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy ; T ##H ##I - Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy ; h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia trans ##ient of infancy ; I ##mm ##uno ##g ##lo ##bul ##in mat ##uration ##al delay ; T ##H ##I - Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##inae ##mia of infancy ; Trans ##ient H ##y [SEP]',\n",
       "  'our_bi_cui': 'C1420871',\n",
       "  'our_bi_cui_name': 'TPI1 gene',\n",
       "  'our_bi_cui_desc': '[CLS] T ##PI ##1 gene [unused3] ( Ana ##tom ##ical Structure : T ##RI ##OS ##EP ##H ##OS ##P ##HA ##TE ISO ##ME ##RA ##SE 1 ; T ##PI ##1 Gene ; Trio ##se ##ph ##os ##phate Is ##omer ##ase 1 Gene ; T ##PI ; trio ##se ##ph ##os ##phate is ##omer ##ase 1 ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27999200.29',\n",
       "  'test_set_idx': 23336,\n",
       "  'type': 'T103',\n",
       "  'name': 'MepA',\n",
       "  'context': '[CLS] substrates relevant to cancer invasion . We found that Me ##p ##1 ##A was a target of Rep ##tin , a protein that is on ##co ##genic in HC ##C . We studied Me ##p ##1 ##A regulation by Rep ##tin , its role in HC ##C , and whether it media ##tes Rep ##tin on ##co ##genic effects . [unused1] Me ##p ##A [unused2] and Rep ##tin expression was measured in human HC ##C by q ##RT - PC ##R and in culture ##d cells by PC ##R , western b ##lot and en ##zy ##matic activity measurements . Cell growth was assessed by counting and M ##TS ass ##ay . Cell migration was measured in Boyd ##en chambers and wound healing ass ##ays , [SEP]',\n",
       "  'existing_cui': 'C0611930',\n",
       "  'existing_cui_name': \"adenosine 5 ' -\",\n",
       "  'existing_cui_desc': \"[CLS] ad ##eno ##sin ##e 5 ' - [unused3] ( Chemical , O - met ##hyl ##ph ##os ##phate , O - met ##hyl ##ph ##os ##phate : ME ##PA ; 5 ' - Aden ##yl ##ic acid , mon ##ome ##thy ##l est ##er ) [SEP]\",\n",
       "  'our_bi_cui': 'C1417113',\n",
       "  'our_bi_cui_name': 'MEP1A gene',\n",
       "  'our_bi_cui_desc': '[CLS] ME ##P ##1 ##A gene [unused3] ( Ana ##tom ##ical Structure : ME ##PR ##IN , AL ##P ##HA S ##U ##B ##UN ##IT ; me ##p ##rin A subunit alpha ; PA ##BA p ##eptide h ##ydro ##lase ; PP ##HA ) [SEP]',\n",
       "  'our_cross_cui': 'C1622778',\n",
       "  'our_cross_cui_name': 'MEP1A protein , human',\n",
       "  'our_cross_cui_desc': '[CLS] ME ##P ##1 ##A protein , human [unused3] ( Chemical : me ##p ##rin alpha protein , human ; me ##p ##rin A , alpha protein , human ; PA ##BA p ##eptide h ##ydro ##lase , human ) [SEP]'},\n",
       " {'mention_id': '28454015.31',\n",
       "  'test_set_idx': 36532,\n",
       "  'type': 'T170',\n",
       "  'name': 'health - risk based air quality index',\n",
       "  'context': '[CLS] weighted two - year average health - risk based air quality index data further demonstrates that all population in the studied cities in He ##nan province live with poll ##uted air - 72 % of the population is exposed to air that is un ##hea ##lt ##hy for sensitive people , while 28 % of people is exposed to air that can be harmful to healthy people ; and the health risks are much greater during winter than during other seasons . Future works should further improve the [unused1] health - risk based air quality index [unused2] algorithm , and valid ##ate the links between the clinical / e ##pid ##em ##iol ##og ##ic data and the health - risk based air quality index values . [SEP]',\n",
       "  'existing_cui': 'C1268941',\n",
       "  'existing_cui_name': 'Health risks education',\n",
       "  'existing_cui_desc': '[CLS] Health risks education [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Counsel ##ing regarding health risks ; Ad ##vice about health risks ; Counsel ##ling regarding health risks ; Education regarding health risks ) [SEP]',\n",
       "  'our_bi_cui': 'C0018761',\n",
       "  'our_bi_cui_name': 'Health Status Indicators',\n",
       "  'our_bi_cui_desc': '[CLS] Health Status In ##dic ##ators [unused3] ( Intel ##lect ##ual Product , assessment scale : Index ##es , Health Status ; In ##dic ##ators , Health Status ; health status index ; In ##dic ##ator , Health Status ; Health Status Index ; In ##dices , Health Status ; Health status indicators ; Health Status In ##dices ; Health status index ; Health Status In ##dic ##ator ; Index , Health Status ; Health Status Index ##es ; health status indicators ; health in ##dices status ) [SEP]',\n",
       "  'our_cross_cui': 'C0918012',\n",
       "  'our_cross_cui_name': 'Index',\n",
       "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
       " {'mention_id': '28000391.14',\n",
       "  'test_set_idx': 23413,\n",
       "  'type': 'T033',\n",
       "  'name': 'Family Scale administered',\n",
       "  'context': '[CLS] II . Little is known about the ps ##ych ##oso ##cial impact of inter ##sta ##ge home monitoring . Prospect ##ive mixed - method study . This study assessed the ps ##ych ##oso ##cial impact on parents during inter ##sta ##ge home monitoring . This contains for quantitative assessment the Short Form Health Survey question ##naire and the Impact of [unused1] Family Scale administered [unused2] one and five weeks following discharge before and after stage II . For q ##ual ##itative assessment , semi - structured interviews focus ##sing on the post ##dis ##cha ##rge cop ##ing strategies were conducted twice , five weeks after hospital discharge before and after stage II . Ten infants ( eight males ) with h ##y ##pop ##lastic left heart [SEP]',\n",
       "  'existing_cui': 'C3539983',\n",
       "  'existing_cui_name': 'Vaccines Administered',\n",
       "  'existing_cui_desc': '[CLS] V ##ac ##cine ##s Ad ##mini ##stered [unused3] ( Intel ##lect ##ual Product : C ##V ##X ) [SEP]',\n",
       "  'our_bi_cui': 'C0282574',\n",
       "  'our_bi_cui_name': 'Intellectual Property',\n",
       "  'our_bi_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28203067.6',\n",
       "  'test_set_idx': 28163,\n",
       "  'type': 'T033',\n",
       "  'name': 'negative impact of care',\n",
       "  'context': '[CLS] best predict ##ors of distress in family care ##rs of g ##eria ##tric patients The aim of this article was to identify the best predict ##ors of distress suffered by family care ##rs of g ##eria ##tric patients . A cross - section ##al study of 100 FC - g ##eria ##tric patient d ##ya ##ds was conducted . The [unused1] negative impact of care [unused2] sub ##sca ##le of the CO ##P ##E index was di ##cho ##tom ##ized to identify lower stress ( score of ≤ 15 on the scale ) and higher stress ( score of ≥ 16 on the scale ) ex ##ert ##ed on family care ##rs by the process of providing care . The set of ex ##p ##lana ##tory [SEP]',\n",
       "  'existing_cui': 'C0726639',\n",
       "  'existing_cui_name': 'Impact food supplement',\n",
       "  'existing_cui_desc': '[CLS] Impact food supplement [unused3] ( Food : Impact ; impact ; I ##MP ##AC ##T ) [SEP]',\n",
       "  'our_bi_cui': 'C3698401',\n",
       "  'our_bi_cui_name': 'Carers of older people in Europe index negative impact score',\n",
       "  'our_bi_cui_desc': '[CLS] Care ##rs of older people in Europe index negative impact score [unused3] ( Finding , o ##bs ##er ##vable entity ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28127853.7',\n",
       "  'test_set_idx': 26301,\n",
       "  'type': 'T058',\n",
       "  'name': 'program',\n",
       "  'context': '[CLS] Creative approach for successful aging : A pilot study of an inter ##gene ##ration ##al health promotion program To develop and evaluate the effectiveness of an inter ##gene ##ration ##al health promotion program . This was an action research project . A total of 34 participants attended the 12 - week [unused1] program [unused2] and completed the pre - test and post - test . There were 16 middle - aged and nine older adults recruited from a district of Taipei , and nine young adults recruited from the principal investigator \\' s university . The \" At ##ti ##tudes toward A ##ging Scale \" and the \" Spiritual Health Scale \" were two assessment instruments used in the study . The results showed that there [SEP]',\n",
       "  'existing_cui': 'C0237807',\n",
       "  'existing_cui_name': 'Mental health program',\n",
       "  'existing_cui_desc': '[CLS] Mental health program [unused3] ( Organization , Mental Health : health mental programs ; Programs ; Mental Health Programs ; mental health programs ; mental health program ) [SEP]',\n",
       "  'our_bi_cui': 'C0032678',\n",
       "  'our_bi_cui_name': 'Population Programs',\n",
       "  'our_bi_cui_desc': '[CLS] Population Programs [unused3] ( Health Care Act ##ivity : Program , Population ; Programs , Population ; Population Program ) [SEP]',\n",
       "  'our_cross_cui': 'C0043113',\n",
       "  'our_cross_cui_name': 'Wellness Programs',\n",
       "  'our_cross_cui_desc': '[CLS] Well ##ness Programs [unused3] ( Health Care Act ##ivity : program well ##ness ; programs well ##ness ; Programs , Well ##ness ; Well ##ness Program ; well ##ness programs ; programming well ##ness ; Program , Well ##ness ; well ##ness program ) [SEP]'},\n",
       " {'mention_id': '27580517.12',\n",
       "  'test_set_idx': 10622,\n",
       "  'type': 'T058',\n",
       "  'name': '3D spiral - based pseudo - continuous arterial spin labeling technique',\n",
       "  'context': '[CLS] patients in q ##uant ##ifying cerebral blood flow response to an ace ##ta ##zo ##lam ##ide v ##as ##od ##ila ##tor challenge . magnetic resonance imaging exams were performed on two 3 Te ##sla Philips In ##gen ##ia systems using 32 channel head coil array ##s . After local institutional review board approval , the [unused1] 3D spiral - based pseudo - continuous art ##erial spin label ##ing technique [unused2] was added to a standard brain magnetic resonance imaging exam and evaluated in 13 p ##ediatric patients ( average age : 11 . 7 ± 6 . 4 years , range : 1 . 4 - 22 . 2 years ) . All patients were administered ace ##ta ##zo ##lam ##ide for clinical ##ly indicated reasons [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0430022',\n",
       "  'our_bi_cui_name': 'diagnostic procedure',\n",
       "  'our_bi_cui_desc': '[CLS] diagnostic procedure [unused3] ( Health Care Act ##ivity , procedure : D ##IA ##G ##N ##OS ##TI ##C ; Di ##ag ##nos ##tic procedure ; Di ##ag ##nos ##tic procedures ; Di ##ag ##nos ##tic Test ; diagnostic technique ; Di ##ag ##nos ##tic ; Di ##ag ##nos ##tic Tech ##ni ##que ; Di ##ag ##nos ##tic Pro ##ced ##ure ; diagnostic procedures ; Di ##ag ##nos ##tic Method ; Pro ##ced ##ures ; diagnostic ) [SEP]',\n",
       "  'our_cross_cui': 'C3891302',\n",
       "  'our_cross_cui_name': 'Arterial Spin Labeling Magnetic Resonance Imaging',\n",
       "  'our_cross_cui_desc': '[CLS] Arte ##rial Spin Label ##ing Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity : AS ##L f ##MR ##I ; Arte ##rial Spin Label ##ing MR ##I ; AR ##TE ##RI ##AL SP ##IN LA ##BE ##L ##ING F ##UN ##CT ##ION ##AL MR ##I ) [SEP]'},\n",
       " {'mention_id': '27542380.9',\n",
       "  'test_set_idx': 9950,\n",
       "  'type': 'T017',\n",
       "  'name': 'foye-1 gene',\n",
       "  'context': '[CLS] - stability properties . The genome of the acid ##op ##hil ##ic iron - o ##xi ##di ##zing bacterium \" Fe ##rro ##vu ##m \" s ##p . J ##A ##12 was found to harbor a the ##rm ##op ##hil ##ic - like en ##e - red ##uc ##tase ( F ##O ##Y ##E - 1 ) . The [unused1] f ##oy ##e - 1 gene [unused2] was l ##igate ##d into a p ##ET ##16 ##b ##p expression vector system , and the enzyme was produced in E ##scher ##ichi ##a co ##li B ##L ##21 ( DE ##3 ; p ##L ##ys ##S ) cells in yields of 10 mg L ( - 1 ) . F ##O ##Y ##E - 1 showed remarkable [SEP]',\n",
       "  'existing_cui': 'C1332742',\n",
       "  'existing_cui_name': 'CDT1 Gene',\n",
       "  'existing_cui_desc': '[CLS] CD ##T ##1 Gene [unused3] ( Ana ##tom ##ical Structure : D ##O ##U ##BL ##E PA ##R ##KE ##D , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; ch ##roma ##tin licensing and DNA replication factor 1 ; CH ##RO ##MA ##TI ##N L ##IC ##EN ##SI ##NG AND DNA R ##EP ##L ##IC ##AT ##ION FA ##CT ##OR 1 ; DNA Rep ##lication Factor Gene ; R ##IS ##2 ) [SEP]',\n",
       "  'our_bi_cui': 'C1414643',\n",
       "  'our_bi_cui_name': 'FMO1 gene',\n",
       "  'our_bi_cui_desc': '[CLS] FM ##O ##1 gene [unused3] ( Ana ##tom ##ical Structure : fl ##avi ##n containing mon ##oo ##xy ##gen ##ase 1 ; FM ##O , F ##ET ##AL L ##IVE ##R ; FL ##AV ##IN - CO ##NT ##A ##IN ##ING M ##ON ##O ##OX ##Y ##GE ##NA ##SE 1 ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27887026.30',\n",
       "  'test_set_idx': 20815,\n",
       "  'type': 'T103',\n",
       "  'name': 'CmFDH',\n",
       "  'context': '[CLS] substrate was evaluated by measuring the kinetic rates and conducting productivity ass ##ays . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H ) and Cha ##eto ##mium the ##rm ##op ##hil ##um showed a higher efficiency in converting HC ##O ##3 ( - ) to format ##e than C ##m ##F ##D ##H , whereas [unused1] C ##m ##F ##D ##H [unused2] was better in the oxidation of format ##e . The pH op ##ti ##mum of the reduction was at pH 7 - 8 . However , the high concentrations of HC ##O ##3 ( - ) reduced the reaction rate . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H ) and Cha ##eto ##mium the ##rm [SEP]',\n",
       "  'existing_cui': 'C0342185',\n",
       "  'existing_cui_name': 'Hyperthyroxinemia , Familial Dysalbuminemic',\n",
       "  'existing_cui_desc': '[CLS] H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial D ##ys ##al ##bu ##mine ##mic [unused3] ( Ana ##tom ##ical Structure , disorder : H ##YP ##ER ##TH ##Y ##RO ##X ##IN ##EM ##IA , FA ##MI ##L ##IA ##L D ##Y ##SA ##L ##B ##UM ##IN ##EM ##IC ; F ##ami ##lial d ##ys ##al ##bu ##mina ##em ##ic h ##yper ##thy ##ro ##xin ##ae ##mia ; H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial D ##ys ##al ##bu ##mine ##mic [ Disease / Finding ] ; D ##ys ##al ##bu ##mine ##mic H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial ; F ##ami ##lial D ##ys ##al ##bu ##mine ##mic H ##yper ##thy ##ro ##xin ##emia ; F ##ami [SEP]',\n",
       "  'our_bi_cui': 'C0060672',\n",
       "  'our_bi_cui_name': 'formylmethanofuran dehydrogenase',\n",
       "  'our_bi_cui_desc': '[CLS] form ##yl ##met ##han ##of ##ura ##n de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , substance : FM ##F de ##hy ##dr ##ogen ##ase ; Form ##yl ##met ##han ##of ##ura ##n de ##hy ##dr ##ogen ##ase ) [SEP]',\n",
       "  'our_cross_cui': 'C0016570',\n",
       "  'our_cross_cui_name': 'Formate dehydrogenase',\n",
       "  'our_cross_cui_desc': '[CLS] Form ##ate de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , substance : De ##hy ##dr ##ogen ##ase , N ##AD - Form ##ate ; N ##AD Form ##ate De ##hy ##dr ##ogen ##ase ; De ##hy ##dr ##ogen ##ases , Form ##ate ; N ##AD - Form ##ate De ##hy ##dr ##ogen ##ase ; Form ##ate H ##ydro ##gen ##lya ##ses ; Form ##ate De ##hy ##dr ##ogen ##ases ; Form ##ate De ##hy ##dr ##ogen ##ases [ Chemical / In ##g ##red ##ient ] ; Form ##ate : N ##AD + o ##xi ##dor ##ed ##uc ##tase ; H ##ydro ##gen ##lya ##ses , Form ##ate ) [SEP]'},\n",
       " {'mention_id': '27325547.9',\n",
       "  'test_set_idx': 2507,\n",
       "  'type': 'T103',\n",
       "  'name': 'PM2 .5',\n",
       "  'context': '[CLS] health effects of PM increase as particle size decreases : particularly , great concern has risen on the role of Ultra ##F ##ine Part ##icles . Starting from the knowledge that the main fraction of atmospheric a ##ero ##sol in Rome is characterized by significant levels of PM ##2 . 5 ( almost 75 % of PM ##10 fraction is [unused1] PM ##2 . 5 [unused2] ) , the paper is focused on sub ##mic ##ron particles in such great urban area . The daytime / night ##time , work - / weekdays and cold / hot seasonal trends of sub ##mic ##ron particles will be investigated and discussed along with NO ##x and total PA ##H drift ##s demonstrating the primary origin of Ultra ##F [SEP]',\n",
       "  'existing_cui': 'C0665987',\n",
       "  'existing_cui_name': '1-(4-aminobutyl)-6-benzylindane',\n",
       "  'existing_cui_desc': '[CLS] 1 - ( 4 - amino ##but ##yl ) - 6 - ben ##zy ##lind ##ane [unused3] ( Chemical : PM ##2 c ##p ##d ) [SEP]',\n",
       "  'our_bi_cui': 'C0597177',\n",
       "  'our_bi_cui_name': 'Particle',\n",
       "  'our_bi_cui_desc': '[CLS] Part ##icle [unused3] ( Chemical : particle ; particles ; Part ##icles ; a very small piece or part ) [SEP]',\n",
       "  'our_cross_cui': 'C1510837',\n",
       "  'our_cross_cui_name': 'Airborne Particulate Matter',\n",
       "  'our_cross_cui_desc': '[CLS] Airborne Part ##iculate Matter [unused3] ( Chemical : Air Poll ##uta ##nts , Part ##iculate ; Am ##bie ##nt Part ##iculate Matter ; Part ##iculate Matter , Am ##bie ##nt ; Part ##iculate Matter , Airborne ; Poll ##uta ##nts , Part ##iculate Air ; Part ##iculate Air Poll ##uta ##nts ) [SEP]'},\n",
       " {'mention_id': '28540429.6',\n",
       "  'test_set_idx': 38811,\n",
       "  'type': 'T017',\n",
       "  'name': 'fibrogenic cells',\n",
       "  'context': '[CLS] I ##dent ##ification of markers for q ##ui ##es ##cent pan ##cre ##atic s ##tel ##late cells in the normal human pan ##cre ##as Pan ##cre ##atic s ##tel ##late cells play a central role as source of [unused1] fi ##bro ##genic cells [unused2] in pan ##cre ##atic cancer and chronic pan ##cre ##ati ##tis . In contrast to q ##ui ##es ##cent he ##pa ##tic s ##tel ##late cells , a specific marker for q ##ui ##es ##cent Pan ##cre ##atic s ##tel ##late cells that can be used in formal ##in - fixed and para ##ffin embedded normal human pan ##cre ##atic tissue has not been identified . The aim of this study was to identify a marker enabling the identification of q ##ui [SEP]',\n",
       "  'existing_cui': 'C0206643',\n",
       "  'existing_cui_name': 'Neoplasms , Fibrous Tissue',\n",
       "  'existing_cui_desc': '[CLS] Neo ##p ##las ##ms , Fi ##bro ##us T ##iss ##ue [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis : Fi ##bro ##us T ##iss ##ue Neo ##p ##las ##m ; F ##IB ##RO ##US T ##IS ##SU ##E NE ##OP ##L ; Fi ##bro ##cy ##tic Neo ##p ##las ##m ; Neo ##p ##las ##m , Fi ##bro ##us T ##iss ##ue ; Fi ##bro ##genic Neo ##p ##las ##m ; Fi ##bro ##blast ##ic Neo ##p ##las ##m ; Fi ##bro ##us Tu ##mor ; Fi ##bro ##us T ##iss ##ue Neo ##p ##las ##ms ; Fi ##bro ##blast ##ic Tu ##mor ; neo ##p ##las ##m of fi ##bro ##us tissue ; Fi ##bro ##genic ##T ##um ##or ; Neo ##p [SEP]',\n",
       "  'our_bi_cui': 'C0016030',\n",
       "  'our_bi_cui_name': 'Fibroblasts',\n",
       "  'our_bi_cui_desc': '[CLS] Fi ##bro ##blast ##s [unused3] ( Ana ##tom ##ical Structure , cell : Fi ##bro ##blast ##s [ Chemical / In ##g ##red ##ient ] ; fi ##bro ##blast cell ; fi ##bro ##blast ; Fi ##bro ##blast ; cells fi ##bro ##blast ; fi ##bro ##blast ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0007634',\n",
       "  'our_cross_cui_name': 'Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
       " {'mention_id': '27317610.20',\n",
       "  'test_set_idx': 2184,\n",
       "  'type': 'T038',\n",
       "  'name': 'stress',\n",
       "  'context': '[CLS] ##ology , and subsequent h ##y ##pot ##hala ##mic - pit ##uit ##ary end ##oc ##rine d ##ys ##function . These experiments were designed to test the hypothesis that a single di ##ff ##use traumatic brain injury results in chronic d ##ys ##function of co ##rt ##ico ##ster ##one , a g ##lu ##co ##cor ##tic ##oid released in response to [unused1] stress [unused2] and test ##osterone . We used a rode ##nt model of di ##ff ##use traumatic brain injury induced by mid ##line fluid percussion injury . At 2 months post ##in ##ju ##ry compared with un ##in ##jured control animals , circulating levels of co ##rt ##ico ##ster ##one were evaluated at rest , under restraint stress and in response to de ##xa [SEP]',\n",
       "  'existing_cui': 'C0038435',\n",
       "  'existing_cui_name': 'Stress',\n",
       "  'existing_cui_desc': '[CLS] St ##ress [unused3] ( Finding , finding , qualifier value : St ##ress - value ; state ; stress ; Press ##ure ; stressed ; State of stress ; stress ; stress ; state ) [SEP]',\n",
       "  'our_bi_cui': 'C0038435',\n",
       "  'our_bi_cui_name': 'Stress',\n",
       "  'our_bi_cui_desc': '[CLS] St ##ress [unused3] ( Finding , finding , qualifier value : St ##ress - value ; state ; stress ; Press ##ure ; stressed ; State of stress ; stress ; stress ; state ) [SEP]',\n",
       "  'our_cross_cui': 'C0449430',\n",
       "  'our_cross_cui_name': 'Physiological Stress',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##ys ##iol ##ogical St ##ress [unused3] ( B ##iol ##og ##ic Fun ##ction , attribute : St ##ress , Ph ##ys ##iol ##ogical ; St ##resses , Ph ##ys ##iol ##ogical ; Ph ##ys ##iol ##ogical St ##resses ; ST ##RE ##SS P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL ST ##RE ##SS ; Ph ##ys ##iol ##ogical stress ; stress physiological ; physiological stress ) [SEP]'},\n",
       " {'mention_id': '27732552.11',\n",
       "  'test_set_idx': 15248,\n",
       "  'type': 'T058',\n",
       "  'name': 'technique',\n",
       "  'context': '[CLS] tool for the monitoring of H ##b ##A ##1 ##c in diabetes patients Micro ##sa ##mp ##ling techniques have several advantages over traditional blood collection . Dr ##ied blood spot sampling and blood collection with he ##par ##ini ##zed cap ##illa ##ries are the standard techniques . Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp ##ling is a novel [unused1] technique [unused2] that collects a fixed volume of blood by applying an absorb ##ent tip to a blood drop . In the present study we explored the f ##eas ##ibility of H ##b ##A ##1 ##c monitoring with Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp ##ling sampling at home and analysis in the laboratory . Di ##abe ##tic patients were enrolled [SEP]',\n",
       "  'existing_cui': 'C0450241',\n",
       "  'existing_cui_name': 'Ffooks technique',\n",
       "  'existing_cui_desc': '[CLS] F ##fo ##ok ##s technique [unused3] ( Health Care Act ##ivity , qualifier value ) [SEP]',\n",
       "  'our_bi_cui': 'C0025663',\n",
       "  'our_bi_cui_name': 'Methods',\n",
       "  'our_bi_cui_desc': '[CLS] Method ##s [unused3] ( Intel ##lect ##ual Product , attribute : methods ; Method ; method ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '28064539.7',\n",
       "  'test_set_idx': 24490,\n",
       "  'type': 'T204',\n",
       "  'name': 'Foucauldian',\n",
       "  'context': '[CLS] T ##rea ##ting the bin ##ge or the ( fat ) body ? Rep ##res ##entation ##s of fat ##ness in a gold standard psychological treatment manual for bin ##ge eating disorder This article reports the results of a [unused1] F ##ou ##ca ##uld ##ian [unused2] - informed discourse analysis exploring representations of fat ##ness embedded within an empirical ##ly based psychological treatment manual for bin ##ge eating disorder , a condition characterized by over ##val ##uation of weight and shape . Ana ##ly ##ses indicate that the manual prior ##iti ##zes weight loss with relatively less emphasis placed on treating the diagnostic symptoms and underlying mechanisms of bin ##ge eating disorder . We raise critical concerns about these observations and link our findings to mainstream [SEP]',\n",
       "  'existing_cui': 'C1422766',\n",
       "  'existing_cui_name': 'MEG8 gene',\n",
       "  'existing_cui_desc': '[CLS] ME ##G ##8 gene [unused3] ( Ana ##tom ##ical Structure , non - protein coding : L ##IN ##C ##00 ##0 ##24 ; MA ##TE ##RNA ##LL ##Y E ##X ##PR ##ES ##SE ##D GE ##NE 8 ; maternal ##ly expressed 8 ; RNA I ##mp ##rin ##ted and A ##cc ##um ##ulated in N ##uc ##le ##us ; non - protein coding RNA 24 ; long inter ##genic non - protein coding RNA 24 ; I ##mp ##rin ##ted RNA near Meg ##3 / G ##tl ##2 ; B ##s ##r ; NC ##RNA ##00 ##0 ##24 ) [SEP]',\n",
       "  'our_bi_cui': 'C1522486',\n",
       "  'our_bi_cui_name': 'Professional Organization or Group',\n",
       "  'our_bi_cui_desc': '[CLS] Professional Organization or Group [unused3] ( Professional or O ##cc ##upation ##al Group : Other Agency or Organization ; Organization ; OR ##G ; Outside Bo ##dies ; Organization ##al ) [SEP]',\n",
       "  'our_cross_cui': 'C0086418',\n",
       "  'our_cross_cui_name': 'Homo sapiens',\n",
       "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
       " {'mention_id': '27335087.93',\n",
       "  'test_set_idx': 2822,\n",
       "  'type': 'T033',\n",
       "  'name': 'No hepatorenal toxicity',\n",
       "  'context': '[CLS] . In addition , Fu ##zhen ##g Qing ##ji ##e increased the percentage ##s of CD ##4 ( + ) T and natural killer cells cells , the ratio of CD ##4 ( + ) / CD ##8 ( + ) T cells as well as the levels of serum T ##NF - α . Fu ##zhen ##g Qing ##ji ##e also increased CD ##6 ##9 expression in tumor tissue . [unused1] No he ##pa ##tore ##nal toxicity [unused2] was observed in H ##22 tumor - bearing mice . These results indicated that Fu ##zhen ##g Qing ##ji ##e could in ##hibit the growth of he ##pa ##tom ##a cells via regulating immune function and in ##ducing mit ##och ##ond ##ria mediated a ##pop ##tosis . [SEP]',\n",
       "  'existing_cui': 'C0595916',\n",
       "  'existing_cui_name': 'Toxic nephropathy',\n",
       "  'existing_cui_desc': '[CLS] To ##xi ##c ne ##ph ##rop ##athy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : toxic ne ##ph ##rop ##athy ; toxic ; ne ##ph ##rop ##athy ; Kid ##ney To ##xi ##city ; To ##xi ##c ne ##ph ##rosis ; N ##ep ##hr ##op ##athy toxic ; ne ##ph ##rop ##athy toxic ; re ##nal toxicity ; To ##xi ##city re ##nal ; Ren ##al To ##xi ##city ; ne ##ph ##rop ##athy ; toxic ) [SEP]',\n",
       "  'our_bi_cui': 'C0857329',\n",
       "  'our_bi_cui_name': 'No toxic effect',\n",
       "  'our_bi_cui_desc': '[CLS] No toxic effect [unused3] ( Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27510458.35',\n",
       "  'test_set_idx': 8922,\n",
       "  'type': 'T033',\n",
       "  'name': 'double lumen signs',\n",
       "  'context': '[CLS] . We assessed whether these imaging methods could visual ##ize an in ##ti ##mal flap and / or double l ##ume ##n sign in the participants and compared the results between high - resolution fast spin echo and the other m ##oda ##lities . high - resolution fast spin echo images clearly showed in ##ti ##mal flap ##s and [unused1] double l ##ume ##n signs [unused2] in all 3 patients , whereas the conventional m ##oda ##lities identified a double l ##ume ##n sign in only 2 of the 3 patients . The present method of op ##ti ##mized high - resolution fast spin echo imaging with a 3 ##T system improved visual ##ization of in ##ti ##mal flap ##s and should thus be considered for [SEP]',\n",
       "  'existing_cui': 'C0441299',\n",
       "  'existing_cui_name': 'Double lumen tube',\n",
       "  'existing_cui_desc': '[CLS] Double l ##ume ##n tube [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
       "  'our_bi_cui': 'C0233192',\n",
       "  'our_bi_cui_name': \"Ladin 's sign\",\n",
       "  'our_bi_cui_desc': \"[CLS] La ##din ' s sign [unused3] ( Finding , finding : La ##din sign ) [SEP]\",\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27986797.27',\n",
       "  'test_set_idx': 22924,\n",
       "  'type': 'T103',\n",
       "  'name': 'myomitokine',\n",
       "  'context': '[CLS] with skeletal muscle - specific deficiency of C ##ri ##f ##1 ( muscle - specific knockout [ M ##KO ] ) , an integral protein of the large mit ##ori ##bos ##oma ##l subunit ( 39 ##S ) , we identified growth differentiation factor 15 as a UP ##R ( m ##t ) - associated cell - non - autonomous [unused1] my ##omi ##tok ##ine [unused2] that regulate ##s systemic energy home ##ost ##asis . muscle - specific knockout mice were protected against o ##besity and se ##ns ##iti ##zed to insulin , an effect associated with elevated growth differentiation factor 15 secret ##ion after UP ##R ( m ##t ) activation . In o ##b / o ##b mice , administration of re ##comb ##ina [SEP]',\n",
       "  'existing_cui': 'C0950133',\n",
       "  'existing_cui_name': 'Online Mendelian Inheritance In Man',\n",
       "  'existing_cui_desc': '[CLS] Online Men ##del ##ian In ##her ##ita ##nce In Man [unused3] ( Intel ##lect ##ual Product : online men ##del ##ian inheritance in man ( O ##MI ##M ) database ; Online Men ##del ##ian In ##her ##ita ##nce in Man ) [SEP]',\n",
       "  'our_bi_cui': 'C0026484',\n",
       "  'our_bi_cui_name': 'Monokines',\n",
       "  'our_bi_cui_desc': '[CLS] Mon ##oki ##nes [unused3] ( Chemical , substance : Mon ##oki ##ne ; mon ##oki ##ne ; Mon ##oki ##nes [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
       "  'our_cross_cui': 'C0574031',\n",
       "  'our_cross_cui_name': 'Biologically active substance',\n",
       "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
       " {'mention_id': '27570140.49',\n",
       "  'test_set_idx': 10512,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedure',\n",
       "  'context': \"[CLS] the 27 months of follow - up . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Over one third of high - risk patients ' requests were un ##ful ##fill ##ed , indicating that significant barriers may remain . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the [unused1] procedure [unused2] . Pro ##vide ##rs should consider these procedures urgent , especially in high - risk women , and advocate for their patients ' access to this procedure . [SEP]\",\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '28294559.26',\n",
       "  'test_set_idx': 31482,\n",
       "  'type': 'T204',\n",
       "  'name': 'chimeric mice',\n",
       "  'context': '[CLS] essential role in liver regeneration after HP ##x . Background and aim The aim of the present study was to investigate the role of C - type le ##ct ##in receptor ( C - type le ##ct ##in receptor ) - 2 in liver regeneration following partial liver re ##section in mice . Materials and methods I ##rra ##dia ##ted [unused1] ch ##ime ##ric mice [unused2] transplant ##ed with f ##etal liver cells from wild - type mice , C - type le ##ct ##in receptor - 2 - deleted ( K ##O ) mice or mice with C - type le ##ct ##in receptor - 2 deleted specifically from plate ##lets ( fl ##KO ) were generated . Mi ##ce underwent 70 % partial he [SEP]',\n",
       "  'existing_cui': 'C0676831',\n",
       "  'existing_cui_name': 'basiliximab',\n",
       "  'existing_cui_desc': '[CLS] b ##asi ##lix ##ima ##b [unused3] ( Chemical , Si ##mu ##lect , medication , product , substance : Basil ##ix ##ima ##b ; b ##asi ##lix ##ima ##b [ Chemical / In ##g ##red ##ient ] ; ch ##ime ##ric mouse - human anti ##CD ##25 ; I ##g gamma - 1 chain C region ; BA ##SI ##L ##IX ##IM ##AB ) [SEP]',\n",
       "  'our_bi_cui': 'C0025936',\n",
       "  'our_bi_cui_name': 'Mice , Transgenic',\n",
       "  'our_bi_cui_desc': '[CLS] Mi ##ce , Trans ##genic [unused3] ( E ##uka ##ryo ##te : Mouse , Trans ##genic ; mouse trans ##genic ##s ; Trans ##genic Mi ##ce ; mice trans ##genic ; Trans ##genic Mouse ; trans ##genic mice ; Trans ##genic mice ; trans ##genic mouse ) [SEP]',\n",
       "  'our_cross_cui': 'C0025929',\n",
       "  'our_cross_cui_name': 'Laboratory mice',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory mice [unused3] ( E ##uka ##ryo ##te , organism : Mouse , Laboratory ; Mouse , laboratory ; Laboratory Mi ##ce ; Mi ##ce , Laboratory ; mouse ; mice ; Laboratory Mouse ; Laboratory mouse ; laboratory mouse ) [SEP]'},\n",
       " {'mention_id': '28234635.85',\n",
       "  'test_set_idx': 29253,\n",
       "  'type': 'T017',\n",
       "  'name': 'canalicular',\n",
       "  'context': '[CLS] of L ##X ##R and ABC ##G ##5 / 8 RNA expression was suppressed in patients with portal inflammation . Current parent ##eral nutrition , increased serum levels of plant s ##tero ##ls s ##ti ##gma ##ster ##ol , a ##ven ##aster ##ol , and sit ##ost ##ero ##l along with serum c ##it ##ru ##llin ##e , a marker of enter ##oc ##yte mass , predicted portal inflammation . In p ##ediatric onset in ##test ##inal failure , current parent ##eral nutrition delivery s ##yne ##rg ##istic ##ally with in ##test ##inal compromise promote liver inflammation , which associates with progression of bio ##chemical and his ##to ##log ##ic liver injury , while reducing expression of [unused1] canal ##icular [unused2] bi ##le transport ##ers . [SEP]',\n",
       "  'existing_cui': 'C0339135',\n",
       "  'existing_cui_name': 'Canalicular laceration',\n",
       "  'existing_cui_desc': '[CLS] Canal ##icular lace ##ration [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder ) [SEP]',\n",
       "  'our_bi_cui': 'C1159621',\n",
       "  'our_bi_cui_name': 'canalicular bile acid transport',\n",
       "  'our_bi_cui_desc': '[CLS] canal ##icular bi ##le acid transport [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_cross_cui': 'C0005393',\n",
       "  'our_cross_cui_name': 'Structure of bile canaliculus',\n",
       "  'our_cross_cui_desc': '[CLS] Structure of bi ##le canal ##ic ##ulus [unused3] ( Ana ##tom ##ical Structure , body structure : Canal ##ic ##ulus , B ##ile ; B ##ile Canal ##ic ##ulus ; B ##ile canal ##ic ##ulus ; Canal ##ic ##uli , B ##ile ; B ##ile Canal ##ic ##uli ) [SEP]'},\n",
       " {'mention_id': '28125734.69',\n",
       "  'test_set_idx': 26223,\n",
       "  'type': 'T103',\n",
       "  'name': 'MiR-21-5p',\n",
       "  'context': '[CLS] ##R - 21 - 5 ##p as a true regulator of me ##so ##the ##lin . Moreover , in v ##it ##ro experiments showed that treatment with mi ##R - 21 - 5 ##p mimic reduced proliferation of ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma cell lines . Alto ##get ##her , this work shows that the mi ##R - CA ##TC ##H technique , coupled with next generation se ##quencing and in v ##it ##ro valid ##ation , represents a reliable method to identify native mi ##RNA : : m ##RNA interactions . [unused1] Mi ##R - 21 - 5 ##p [unused2] is suggested as novel regulator of me ##so ##the ##lin with a possible functional role in cellular growth . [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1999986',\n",
       "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '27473429.29',\n",
       "  'test_set_idx': 7344,\n",
       "  'type': 'T082',\n",
       "  'name': 'segments',\n",
       "  'context': '[CLS] ##8 , and 110 ##1 b ##p ) , which has demonstrated that in all cases , polymer ##ase chain reaction is successful at least on one station . In addition , three DNA fragment s with different lengths ( 32 ##3 , 110 ##1 , and 28 ##36 b ##p ) have been successfully am ##plified in a segment ##ed - flow mode without the carry - over contamination between [unused1] segments [unused2] . This result suggests that this device could serve as the polymer ##ase chain reaction module of a continuous - flow high - through ##put on - line total DNA analysis system integrating all necessary modules from cell l ##ys ##is / DNA extraction to polymer ##ase chain reaction product analysis . [SEP]',\n",
       "  'existing_cui': 'C0441635',\n",
       "  'existing_cui_name': 'Anatomical segmentation',\n",
       "  'existing_cui_desc': '[CLS] Ana ##tom ##ical segment ##ation [unused3] ( Spa ##tial Concept , qualifier value : Se ##gment ##ed ; Se ##gment ##ation ; segment ##ation ; segment ; SE ##GM ##EN ##T ; Se ##gment ) [SEP]',\n",
       "  'our_bi_cui': 'C0162326',\n",
       "  'our_bi_cui_name': 'DNA Sequence',\n",
       "  'our_bi_cui_desc': '[CLS] DNA Se ##quence [unused3] ( Spa ##tial Concept : DNA Se ##quence ##s ; Se ##quence ##s ; DNA SE ##Q ; d ##na sequences ; Se ##quence ##s , DNA ; DNA sequence ; Se ##quence ; d ##na sequence ; DNA se ##quencing ; Se ##quence , DNA ) [SEP]',\n",
       "  'our_cross_cui': 'C0442059',\n",
       "  'our_cross_cui_name': 'Segment structure',\n",
       "  'our_cross_cui_desc': '[CLS] Se ##gment structure [unused3] ( Spa ##tial Concept , qualifier value ) [SEP]'},\n",
       " {'mention_id': '27456018.8',\n",
       "  'test_set_idx': 6374,\n",
       "  'type': 'T058',\n",
       "  'name': 'SL',\n",
       "  'context': '[CLS] is a technique perceived to provide the benefits of lap ##aro ##scopic surgery while improving ta ##ct ##ile feedback and operative time . Published data are largely limited to small , single - institution studies . The 2012 - 2013 National Sur ##gical Quality Improvement Program Part ##ici ##pan ##t Data Use File was que ##ried for patients undergoing elect ##ive [unused1] SL [unused2] or H ##AL co ##lect ##omy . Pat ##ients underwent 1 : 1 prop ##ens ##ity matching and had outcomes compared . An additional subgroup analysis was performed for patients undergoing segment ##al re ##section ##s only . 13 , 94 ##9 patients were identified , of whom 60 ##8 ##4 ( 43 . 6 % ) underwent H ##AL co ##lect [SEP]',\n",
       "  'existing_cui': 'C2338991',\n",
       "  'existing_cui_name': 'Simple lobule of cerebellum',\n",
       "  'existing_cui_desc': '[CLS] Simple lo ##bul ##e of c ##ere ##bell ##um [unused3] ( Ana ##tom ##ical Structure , posterior : Post ##eri ##or c ##res ##cent ##ic lo ##bul ##e of c ##ere ##bell ##um ; Lo ##bul ##us q ##uad ##rang ##ular ##is par ##s in ##fer ##op ##ost ##eri ##or ; Lo ##bul ##us simple ##x c ##ere ##bell ##i [ H VI et VI ] ; Semi ##lu ##nar lo ##bul ##e - 1 ; Lo ##bul ##us simple ##x ; Lo ##bul ##e VI of hemisphere of c ##ere ##bell ##um ; Simple ##x ; Lo ##bul ##us q ##uad ##rang ##ular ##is par ##s ca ##uda ##lis / posterior ; Simple lo ##bul ##e of c ##ere ##bell ##um [ H VI and [SEP]',\n",
       "  'our_bi_cui': 'C0585462',\n",
       "  'our_bi_cui_name': 'Laparoscopic-assisted sigmoid colectomy',\n",
       "  'our_bi_cui_desc': '[CLS] La ##par ##os ##copic - assisted si ##g ##mo ##id co ##lect ##omy [unused3] ( Health Care Act ##ivity , procedure : La ##par ##os ##copic - assisted si ##g ##mo ##ide ##ct ##omy ; La ##par ##os ##copic si ##g ##mo ##id co ##lect ##omy ) [SEP]',\n",
       "  'our_cross_cui': 'C1517722',\n",
       "  'our_cross_cui_name': 'Laparoscopic colectomy',\n",
       "  'our_cross_cui_desc': '[CLS] La ##par ##os ##copic co ##lect ##omy [unused3] ( Health Care Act ##ivity : La ##par ##os ##copic Cole ##ct ##omy ; La ##par ##os ##copy - As ##sist ##ed Cole ##ct ##omy ; lap ##aro ##scopic - assisted co ##lect ##omy ; La ##par ##os ##copic - As ##sist ##ed Cole ##ct ##omy ) [SEP]'},\n",
       " {'mention_id': '27297967.84',\n",
       "  'test_set_idx': 1789,\n",
       "  'type': 'T082',\n",
       "  'name': 'Asn19/23Gln',\n",
       "  'context': '[CLS] ##nic kidney 29 ##3 - As ##n ##19 / 23 ##G ##ln / Ty ##r ##9 ##20 ##G ##lu / Ser ##9 ##21 ##G ##lu were similar to H ##E ##K - W ##T - MR ##P ##1 , indicating that the p ##hos ##ph ##ory ##lation - mimic ##king substitution ##s a ##bro ##gated the influence of [unused1] As ##n ##19 / 23 ##G ##ln [unused2] g ##ly ##cos ##yla ##tion . Overall , these data suggest that cross - talk between MR ##P ##1 g ##ly ##cos ##yla ##tion and p ##hos ##ph ##ory ##lation occurs and that p ##hos ##ph ##ory ##lation of Ty ##r ##9 ##20 and Ser ##9 ##21 can switch MR ##P ##1 to a lower - affinity , higher [SEP]',\n",
       "  'existing_cui': 'C1425905',\n",
       "  'existing_cui_name': 'KRTAP19-2 gene',\n",
       "  'existing_cui_desc': '[CLS] K ##RT ##AP ##19 - 2 gene [unused3] ( Ana ##tom ##ical Structure : k ##era ##tin associated protein 19 - 2 ; K ##AP ##19 . 2 ) [SEP]',\n",
       "  'our_bi_cui': 'C0002520',\n",
       "  'our_bi_cui_name': 'Amino Acids',\n",
       "  'our_bi_cui_desc': '[CLS] Am ##ino A ##cid ##s [unused3] ( Chemical , medication , product , substance : Am ##ino acid ; A ##cid ##s , Am ##ino ; amino acid preparations ; amino ##ac ##id ; Am ##ino A ##cid ; amino acids ; Am ##ino A ##cid ##s [ Chemical / In ##g ##red ##ient ] ; amino ##ac ##ids ; Am ##ino acids ; AM ##IN ##O AC ##ID PR ##EP ##AR ##AT ##ION ; amino acid ; AM ##IN ##O AC ##ID ##S ; AA - Am ##ino acid ) [SEP]',\n",
       "  'our_cross_cui': 'C0002518',\n",
       "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
       "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
       " {'mention_id': '28059412.13',\n",
       "  'test_set_idx': 24440,\n",
       "  'type': 'T103',\n",
       "  'name': 'polyketide',\n",
       "  'context': '[CLS] ##hesis J ##aws ##am ##y ##cin is a p ##oly ##ket ##ide - n ##uc ##leo ##side hybrid with a unique p ##oly ##cy ##c ##lop ##rop ##ane m ##oi ##ety on a single p ##oly ##ket ##ide chain . The unexpected isolation of c ##y ##c ##lop ##rop ##ane def ##icient jaws ##am ##y ##cin analog ##s allowed us to propose a step ##wise c ##y ##c ##lop ##rop ##ana ##tion mechanism for the en ##zy ##matic synthesis of this [unused1] p ##oly ##ket ##ide [unused2] . The con ##cise timing of the c ##y ##c ##lop ##rop ##ana ##tion could be regulated by a delicate balance between reaction rates of the con ##den ##sation and c ##y ##c ##lop ##rop ##ana ##tion reactions . [SEP]',\n",
       "  'existing_cui': 'C1157699',\n",
       "  'existing_cui_name': 'polyketide biosynthetic process',\n",
       "  'existing_cui_desc': '[CLS] p ##oly ##ket ##ide bio ##sy ##nt ##hetic process [unused3] ( B ##iol ##og ##ic Fun ##ction : p ##oly ##ket ##ide formation ; p ##oly ##ket ##ide an ##ab ##olis ##m ; p ##oly ##ket ##ide synthesis ; p ##oly ##ket ##ide bio ##sy ##nt ##hesis ) [SEP]',\n",
       "  'our_bi_cui': 'C0030956',\n",
       "  'our_bi_cui_name': 'Peptides',\n",
       "  'our_bi_cui_desc': '[CLS] P ##eptide ##s [unused3] ( Chemical , substance : p ##eptide ; p ##eptide ##s ; P ##eptide ##s [ Chemical / In ##g ##red ##ient ] ; P ##eptide ) [SEP]',\n",
       "  'our_cross_cui': 'C3179052',\n",
       "  'our_cross_cui_name': 'Polyketides',\n",
       "  'our_cross_cui_desc': '[CLS] Pol ##yke ##tide ##s [unused3] ( Chemical : Pol ##yke ##tide ##s [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '28457334.35',\n",
       "  'test_set_idx': 36645,\n",
       "  'type': 'T103',\n",
       "  'name': 'extracellular RNA',\n",
       "  'context': '[CLS] chain reaction . In addition , th ##rom ##boe ##last ##ography for co ##agu ##lation as well as th ##rom ##boa ##gg ##re ##go ##metry for plate ##let function was conducted . Both Cell - free DNA and extra ##cellular RNA were elevated in patients with se ##psis compared with post ##oper ##ative patients and healthy volunteers . While higher [unused1] extra ##cellular RNA [unused2] levels correlated with a faster c ##lot ##ting time and more stable c ##lot ##s , Cell - free DNA correlated with a shorter c ##lot ##ting time but also less fi ##bri ##no ##lysis . In addition , higher Cell - free DNA seems to be associated with kidney d ##ys ##function as well as with general markers of cell [SEP]',\n",
       "  'existing_cui': 'C0521119',\n",
       "  'existing_cui_name': 'Extracellular',\n",
       "  'existing_cui_desc': '[CLS] Extra ##cellular [unused3] ( Ana ##tom ##ical Structure , qualifier value : extra ##cellular ; extra ##cellular region ) [SEP]',\n",
       "  'our_bi_cui': 'C0230885',\n",
       "  'our_bi_cui_name': 'Extracellular material',\n",
       "  'our_bi_cui_desc': '[CLS] Extra ##cellular material [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0035668',\n",
       "  'our_cross_cui_name': 'RNA',\n",
       "  'our_cross_cui_desc': '[CLS] RNA [unused3] ( Chemical , RNA , R ##ib ##on ##uc ##le ##ic A ##cid , substance : rib ##on ##uc ##le ##ic acid ; R ##ib ##on ##uc ##le ##ic acids ; RNA , Non - Pol ##ya ##den ##yla ##ted ; rib ##on ##uc ##lein ##ic ##um acid ##um / rib ##on ; RNA - R ##ib ##on ##uc ##le ##ic acid ; RNA [ Chemical / In ##g ##red ##ient ] ; RNA , Non Pol ##ya ##den ##yla ##ted ; Non - Pol ##ya ##den ##yla ##ted RNA ; r ##na ; Non Pol ##ya ##den ##yla ##ted RNA ; A ##cid , R ##ib ##on ##uc ##le ##ic ; R ##ib ##on ##uc ##le ##ic acid ; Gene Products , RNA [SEP]'},\n",
       " {'mention_id': '27708411.23',\n",
       "  'test_set_idx': 14732,\n",
       "  'type': 'T103',\n",
       "  'name': 'dsDNA',\n",
       "  'context': '[CLS] ##rote ##in fi ##lam ##ent formation , is unable to media ##te ho ##mo ##log ##ous re ##comb ##ination . Mu ##tations of the C - terminal domain were evaluated using both single - and double stranded ( s ##s and d ##s ) substrates in re ##comb ##ination ass ##ays . Mu ##tations of critical amino acids affected either [unused1] d ##s ##D ##NA [unused2] re ##comb ##ination or both s ##s ##D ##NA and d ##s ##D ##NA re ##comb ##ination indicating two se ##par ##able functions , one of which is critical for d ##s ##D ##NA re ##comb ##ination and the second for re ##comb ##ination per se . As evaluated by co - im ##mu ##no ##p ##re ##ci ##pit ##ation [SEP]',\n",
       "  'existing_cui': 'C0012854',\n",
       "  'existing_cui_name': 'DNA',\n",
       "  'existing_cui_desc': '[CLS] DNA [unused3] ( Chemical , DNA , De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid , substance : d ##na molecules ; d ##s ##D ##NA ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; d ##na / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA molecule ; DNA - De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acids ; d ##na molecule ; DNA [ Chemical / In ##g ##red ##ient ] ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; Double - [SEP]',\n",
       "  'our_bi_cui': 'C0012854',\n",
       "  'our_bi_cui_name': 'DNA',\n",
       "  'our_bi_cui_desc': '[CLS] DNA [unused3] ( Chemical , DNA , De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid , substance : d ##na molecules ; d ##s ##D ##NA ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; d ##na / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA molecule ; DNA - De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acids ; d ##na molecule ; DNA [ Chemical / In ##g ##red ##ient ] ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; Double - [SEP]',\n",
       "  'our_cross_cui': 'C0311474',\n",
       "  'our_cross_cui_name': 'DNA , Double-Stranded',\n",
       "  'our_cross_cui_desc': '[CLS] DNA , Double - Strand ##ed [unused3] ( Chemical , substance : double stranded d ##na ; DNA , Double Strand ##ed ; Double - Strand ##ed DNA ; d ##s d ##na ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid double strand ; d ##s DNA ; d ##na double stranded ; d ##s - DNA ; d ##s - d ##na ; double strand d ##na ; double - stranded DNA ; DNA double strand ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid , double stranded ) [SEP]'},\n",
       " {'mention_id': '27798906.17',\n",
       "  'test_set_idx': 17537,\n",
       "  'type': 'T038',\n",
       "  'name': 'atrophy',\n",
       "  'context': '[CLS] . 4 months ( range = 24 . 0 - 123 . 0 months ) . Un ##iva ##ria ##te analysis showed that par ##ot ##id g ##land volumes receiving more than 5 , 10 , 15 , and 20 G ##y relative biological effectiveness ( V ##5 , V ##10 , V ##15 and V ##20 , respectively ) , mean dose , and maximum dose were significantly associated with par ##ot ##id g ##land at ##rop ##hy . Multi ##var ##iate analysis indicated that only V ##5 was significantly associated with [unused1] at ##rop ##hy [unused2] . Inc ##rea ##sing V ##5 was a significant risk factor for par ##ot ##id g ##land at ##rop ##hy after carbon ion radio ##ther ##ap ##y . [SEP]',\n",
       "  'existing_cui': 'C0026846',\n",
       "  'existing_cui_name': 'Muscular Atrophy',\n",
       "  'existing_cui_desc': '[CLS] Mu ##s ##cular At ##rop ##hy [unused3] ( B ##iol ##og ##ic Fun ##ction , Mu ##s ##cular , diagnosis , disorder , finding , physical finding : at ##rop ##hy ; muscle ; am ##yo ##tro ##phy ; muscle at ##rop ##hy was seen ; Was ##ting ; muscle ; At ##rop ##hi ##es , Mu ##s ##cle ; Mu ##s ##cle thin ##ning ; At ##rop ##hy - muscular ; am ##yo ##tro ##phi ##es ; muscular at ##rop ##hy ; Mu ##s ##cle wasting ; am ##yo ##tro ##phi ##a ; At ##rop ##hi ##es , Mu ##s ##cular ; muscular at ##rop ##hi ##es ; At ##rop ##hy muscle ; Mu ##s ##cle At ##rop ##hy ; Was ##ting ; muscles ; [SEP]',\n",
       "  'our_bi_cui': 'C0333641',\n",
       "  'our_bi_cui_name': 'Atrophic',\n",
       "  'our_bi_cui_desc': '[CLS] At ##rop ##hic [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : at ##rop ##hy ; At ##rop ##hy ; At ##rop ##hi ##es ; at ##rop ##hi ##es ; At ##rop ##hy [ Disease / Finding ] ; at ##rop ##hic ; at ##rop ##hy ##ing ; at ##rop ##hi ##ed ; AT ##RO ##P ##H ##Y ; At ##rop ##hy [ du ##p ] ) [SEP]',\n",
       "  'our_cross_cui': 'C0341045',\n",
       "  'our_cross_cui_name': 'Atrophy of parotid gland',\n",
       "  'our_cross_cui_desc': '[CLS] At ##rop ##hy of par ##ot ##id g ##land [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : at ##rop ##hy ; par ##ot ##id g ##land ) [SEP]'},\n",
       " {'mention_id': '28256742.21',\n",
       "  'test_set_idx': 30227,\n",
       "  'type': 'T082',\n",
       "  'name': 'Prince Edward Bay',\n",
       "  'context': '[CLS] ##s most frequently detected were pen ##ta ##ch ##lor ##o , he ##xa ##ch ##lor ##o , and he ##pta ##ch ##lor ##o con ##gene ##rs , which are structural ##ly similar to thy ##roid hormones . Pen ##ta ##ch ##lor ##op ##hen ##ol was detected at highest concentrations ( 1 . 8 ng / g ) in fish from [unused1] Prince Edward Bay [unused2] , the Bay of Q ##uin ##te Lake reference site , and Hill ##man Marsh ( the W ##heat ##ley Harbour reference site ) , suggesting local sources of contamination . El ##eva ##ted Pen ##ta ##ch ##lor ##op ##hen ##ol concentrations were also detected in the plasma of brown bull ##head from exposed sites in the Toronto and Region A [SEP]',\n",
       "  'existing_cui': 'C3828475',\n",
       "  'existing_cui_name': 'Prince Edward County , VA',\n",
       "  'existing_cui_desc': '[CLS] Prince Edward County , VA [unused3] ( Spa ##tial Concept : Prince Edward County ; Prince Edward County , Virginia ; VA ##14 ##7 ) [SEP]',\n",
       "  'our_bi_cui': 'C0033157',\n",
       "  'our_bi_cui_name': 'Prince Edward Island',\n",
       "  'our_bi_cui_desc': '[CLS] Prince Edward Island [unused3] ( Spa ##tial Concept , geographic location : Prince Edward island ; ed ##ward island prince ; prince ed ##ward island ) [SEP]',\n",
       "  'our_cross_cui': 'C3203003',\n",
       "  'our_cross_cui_name': 'Bay',\n",
       "  'our_cross_cui_desc': '[CLS] Bay [unused3] ( Spa ##tial Concept , geographic , geographic : Bay ##s ) [SEP]'},\n",
       " {'mention_id': '28249376.27',\n",
       "  'test_set_idx': 29897,\n",
       "  'type': 'T033',\n",
       "  'name': 'digestibility',\n",
       "  'context': '[CLS] in fist ##ulated sheep . Six sheep fitted with r ##umi ##nal fist ##ula ##s were used in a repeated measurement design with two 24 - d periods to investigate the effect of adding mixture of essential oils at 0 ( control ) , 0 . 8 , and 1 . 6 m ##L / d on apparent nut ##rient [unused1] dig ##est ##ibility [unused2] , r ##ume ##n f ##er ##mentation characteristics , r ##ume ##n micro ##bial population and blood chemical meta ##bol ##ites . Animals were fed with a 50 : 50 al ##fa ##lf ##a hay : concentrate diet . R ##umi ##nal pH , total volatile fatty acids concentration , m ##olar proportion of individual volatile fatty acids , ace ##tate [SEP]',\n",
       "  'existing_cui': 'C0233423',\n",
       "  'existing_cui_name': 'Suggestibility',\n",
       "  'existing_cui_desc': '[CLS] Su ##gg ##est ##ibility [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : suggest ##ibility ; Su ##gg ##est ##ibility , function ) [SEP]',\n",
       "  'our_bi_cui': 'C0012238',\n",
       "  'our_bi_cui_name': 'Digestion',\n",
       "  'our_bi_cui_desc': '[CLS] Digest ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : dig ##estive system functions ; dig ##est ##ion ; Digest ##ive system functions ; dig ##est ##ions ; Digest ##ive system function ; Fun ##ctions of the dig ##estive system ; Digest ##ive ; Digest ##ive tract function ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27977319.14',\n",
       "  'test_set_idx': 22766,\n",
       "  'type': 'T017',\n",
       "  'name': 'THI1',\n",
       "  'context': \"[CLS] is expressed in all organs , and the encoded protein cat ##aly ##zes th ##iam ##ine bio ##sy ##nt ##hesis . Loss of function produces ch ##lor ##osis , a typical th ##iam ##ine - deficiency p ##hen ##otype , and mortality . To investigate th ##iam ##ine ' s role in s ##ym ##bio ##sis , we focused on [unused1] T ##H ##I ##1 [unused2] , a th ##iam ##ine - bio ##sy ##nt ##hesis gene expressed in roots , nod ##ules , and seeds . The th ##i ##1 mutant had green leaves , but formed small nod ##ules and im ##mat ##ure seeds . These p ##hen ##otype ##s were rescued by T ##H ##I ##1 complement ##ation and by ex ##ogen ##ous [SEP]\",\n",
       "  'existing_cui': 'C0272238',\n",
       "  'existing_cui_name': 'Transient hypogammaglobulinemia of infancy',\n",
       "  'existing_cui_desc': '[CLS] Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of young ; trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy ; T ##H ##I - Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy ; h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia trans ##ient of infancy ; I ##mm ##uno ##g ##lo ##bul ##in mat ##uration ##al delay ; T ##H ##I - Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##inae ##mia of infancy ; Trans ##ient H ##y [SEP]',\n",
       "  'our_bi_cui': 'C1420871',\n",
       "  'our_bi_cui_name': 'TPI1 gene',\n",
       "  'our_bi_cui_desc': '[CLS] T ##PI ##1 gene [unused3] ( Ana ##tom ##ical Structure : T ##RI ##OS ##EP ##H ##OS ##P ##HA ##TE ISO ##ME ##RA ##SE 1 ; T ##PI ##1 Gene ; Trio ##se ##ph ##os ##phate Is ##omer ##ase 1 Gene ; T ##PI ; trio ##se ##ph ##os ##phate is ##omer ##ase 1 ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '28223077.53',\n",
       "  'test_set_idx': 28937,\n",
       "  'type': 'T082',\n",
       "  'name': 'background site',\n",
       "  'context': '[CLS] that of up ##wind site , suggesting that studied land ##fill did not have obvious influence on PC ##D ##D / F ##s in ambient air from down ##wind site . ( 5 ) The 95 ##th percent ##ile car ##cin ##ogenic risk of PC ##D ##D / F ##s in ambient air from s u ##rro ##und ##ing sites , [unused1] background site [unused2] , up ##wind site and down ##wind site were 8 . 03 × 10 ( - 9 ) , 7 . 57 × 10 ( - 9 ) , 9 . 69 × 10 ( - 9 ) and 8 . 15 × 10 ( - 9 ) , respectively , which were much lower than the threshold value of car [SEP]',\n",
       "  'existing_cui': 'C0237490',\n",
       "  'existing_cui_name': 'Family Background',\n",
       "  'existing_cui_desc': '[CLS] Family Background [unused3] ( Finding , Family : Background ) [SEP]',\n",
       "  'our_bi_cui': 'C0442611',\n",
       "  'our_bi_cui_name': 'Industrial site',\n",
       "  'our_bi_cui_desc': '[CLS] Industrial site [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
       "  'our_cross_cui': 'C0205145',\n",
       "  'our_cross_cui_name': 'Site',\n",
       "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
       " {'mention_id': '27395231.31',\n",
       "  'test_set_idx': 4600,\n",
       "  'type': 'T017',\n",
       "  'name': 'shape of body',\n",
       "  'context': '[CLS] n . ( Dr ##acon ##ema ##ti ##dae ) differs from other Pro ##cha ##eto ##so ##ma species except P . long ##ica ##pit ##at ##um ( All ##gé ##n , 1935 ) in that the p ##har ##yn ##ge ##al bulb l ##ume ##n is not cut ##icular ##ised , from P . long ##ica ##pit ##at ##um by [unused1] shape of body [unused2] and r ##ost ##rum , greater number of c ##ep ##hali ##c ad ##hesive tubes , and from P . ma ##ert ##ens ##i Dec ##rae ##mer , 1989 by having a relatively longer tail , fewer anterior ad ##hesive tubes and longer s ##pic ##ules , besides lacking cut ##icular thick ##ening in the p ##har ##yn ##ge ##al bulb [SEP]',\n",
       "  'existing_cui': 'C0423805',\n",
       "  'existing_cui_name': 'Shape of nail',\n",
       "  'existing_cui_desc': '[CLS] S ##ha ##pe of nail [unused3] ( Finding , o ##bs ##er ##vable entity : nails shaped ; nails shape ; shape of nail ) [SEP]',\n",
       "  'our_bi_cui': 'C0332479',\n",
       "  'our_bi_cui_name': 'Shapes',\n",
       "  'our_bi_cui_desc': '[CLS] S ##ha ##pes [unused3] ( Spa ##tial Concept , qualifier value : shapes ; shaping ; SH ##AP ##E ; shaped ; shape ; S ##ha ##pe ; S ##ha ##pe finding ) [SEP]',\n",
       "  'our_cross_cui': 'C1268086',\n",
       "  'our_cross_cui_name': 'Body structure',\n",
       "  'our_cross_cui_desc': '[CLS] Body structure [unused3] ( Ana ##tom ##ical Structure , body structure : B ##OD ##Y ST ##R ##UC ##TU ##RE ##S ; Body structures ; B ##OD ##Y ; structure body ; body structures ; Body ; body structure ) [SEP]'},\n",
       " {'mention_id': '27400734.20',\n",
       "  'test_set_idx': 4724,\n",
       "  'type': 'T103',\n",
       "  'name': 'GEM',\n",
       "  'context': '[CLS] A random ##ized clinical trial has found that the addition of er ##lot ##ini ##b to g ##em ##ci ##ta ##bine ( GE ##M - E ) for pan ##cre ##atic cancer led to a modest increase in survival . The aim of this national population - based retrospective study was to compare the effectiveness of GE ##M - E to [unused1] GE ##M [unused2] alone for pan ##cre ##atic cancer patients in real clinical practice . Pat ##ients with pan ##cre ##atic cancer ( I ##CD - 10 : C ##25 ) with prescription claims of g ##em ##ci ##ta ##bine or er ##lot ##ini ##b between Jan 1 , 2007 and Dec 31 , 2012 were retrospective ##ly identified from the Korean Health Insurance [SEP]',\n",
       "  'existing_cui': 'C1333683',\n",
       "  'existing_cui_name': 'GMNN gene',\n",
       "  'existing_cui_desc': '[CLS] GM ##N ##N gene [unused3] ( Ana ##tom ##ical Structure : Gemini ##n , DNA Rep ##lication In ##hibit ##or Gene ; GM ##N ##N Gene ; G ##em ; GE ##MI ##NI ##N ; g ##em ##ini ##n , DNA replication inhibitor ; GE ##M ) [SEP]',\n",
       "  'our_bi_cui': 'C0017243',\n",
       "  'our_bi_cui_name': 'Gel',\n",
       "  'our_bi_cui_desc': '[CLS] G ##el [unused3] ( Chemical , Pharmacy , product , qualifier value , substance : G ##el Do ##se Form ; G ##els ; j ##elly ; j ##elli ##es ; Je ##lly ; drugs gel ; G ##el preparation ; G ##el Do ##sa ##ge Form ; GE ##L ; gel ##s ; gel preparation ; G ##el [ Do ##se Form ] ; G ##el ##D ##rug ##F ##orm ; gel ; Drug gel ) [SEP]',\n",
       "  'our_cross_cui': 'C0045093',\n",
       "  'our_cross_cui_name': 'gemcitabine',\n",
       "  'our_cross_cui_desc': \"[CLS] g ##em ##ci ##ta ##bine [unused3] ( Chemical , product , substance : g ##em ##ci ##ta ##bine [ Chemical / In ##g ##red ##ient ] ; 2 ' , 2 ' - di ##f ##lu ##oro ##de ##ox ##y ##cy ##ti ##dine ; 4 - amino - 1 - ( ( 2 ##R , 4 ##R , 5 ##R ) - 3 , 3 - Di ##f ##lu ##oro - 4 - h ##ydro ##xy - 5 - ( h ##ydro ##xy ##met ##hyl ) - te ##tra ##hy ##dr ##of ##ura ##n - 2 - y ##l ) p ##yr ##im ##id ##in - 2 ( 1 ##H ) - one ; 2 ' , 2 ' - Di ##f ##lu ##oro ##de ##ox [SEP]\"},\n",
       " {'mention_id': '27796974.2',\n",
       "  'test_set_idx': 17356,\n",
       "  'type': 'T170',\n",
       "  'name': 'Water Framework Directive',\n",
       "  'context': '[CLS] Method ##ology development on aquatic environmental assessment The [unused1] Water Framework Direct ##ive [unused2] aims at reaching the good ecological status of the surface and ground water bodies ( L ##ás ##z ##l ##ó et al . Micro ##che ##m J 85 ( 1 ) : 65 - 71 , 2007 ) . The paper deals with quality evaluation of waters with special focus on the water chemistry parameters as defined in the Water Framework Direct ##ive and pertaining legal regulations . The purpose of this paper is to de ##vise a quantitative type of water quality assessment method which could provide rapid , accurate , and reliable information on the quality of the surface waters by using water chemistry parameters . Quality classes have been [SEP]',\n",
       "  'existing_cui': 'C0450152',\n",
       "  'existing_cui_name': 'Metal framework',\n",
       "  'existing_cui_desc': '[CLS] Metal framework [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
       "  'our_bi_cui': 'C1135941',\n",
       "  'our_bi_cui_name': 'Ethical Directives',\n",
       "  'our_bi_cui_desc': '[CLS] E ##thical Direct ##ives [unused3] ( Intel ##lect ##ual Product : Direct ##ive , E ##thical ; Direct ##ives , E ##thical ; E ##thical Direct ##ive ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27539945.4',\n",
       "  'test_set_idx': 9829,\n",
       "  'type': 'T103',\n",
       "  'name': 'alkyldimethylamine oxide',\n",
       "  'context': '[CLS] The ##rm ##o - re ##versible capture and release of DNA by z ##wi ##tter ##ion ##ic surf ##act ##ants The the ##rm ##o - re ##versible capture and release of DNA were studied by the pro ##ton ##ation and de ##p ##rot ##ona ##tion of [unused1] al ##ky ##ld ##ime ##thy ##lam ##ine oxide [unused2] ( C ##n ##DM ##A ##O , n = 10 , 12 and 14 ) in Tri ##s - HC ##l buffer solution . DNA / C ##14 ##DM ##A ##OH ( + ) in Tri ##s - HC ##l buffer solution with pH = 7 . 2 is transparent at 25 °C , indicating that DNA molecules exist mainly in individuals and the binding of C ##14 ##DM ##A [SEP]',\n",
       "  'existing_cui': 'C1869399',\n",
       "  'existing_cui_name': 'hexyldimethylamine oxide',\n",
       "  'existing_cui_desc': '[CLS] he ##xy ##ld ##ime ##thy ##lam ##ine oxide [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0058638',\n",
       "  'our_bi_cui_name': 'dodecyldimethylamine oxide',\n",
       "  'our_bi_cui_desc': '[CLS] do ##de ##cy ##ld ##ime ##thy ##lam ##ine oxide [unused3] ( Chemical : DD ##A ##O ; N , N - dim ##eth ##yl ##do ##de ##cy ##c ##lam ##ine N - oxide ; do ##de ##cy ##ld ##ime ##thy ##lam ##ine N - oxide ; L ##DA ##O ; N - do ##de ##cy ##l - N , N - dim ##eth ##yla ##mine N - oxide ; la ##ury ##ld ##ime ##thy ##lam ##ine oxide ; N , N - dim ##eth ##yl ##do ##de ##cy ##lam ##ine - N - oxide ) [SEP]',\n",
       "  'our_cross_cui': 'C0029224',\n",
       "  'our_cross_cui_name': 'Organic Chemicals',\n",
       "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
       " {'mention_id': '28454015.21',\n",
       "  'test_set_idx': 36522,\n",
       "  'type': 'T170',\n",
       "  'name': 'health - risk based air quality index',\n",
       "  'context': '[CLS] , but oz ##one pollution can be significant during summer . Furthermore , as the commonly used air quality index neglect ##s the mutual health effects from multiple poll ##uta ##nts , we introduced the aggregate air quality index and health - risk based air quality index to evaluate the health risks . Results show that based on [unused1] health - risk based air quality index [unused2] , the current air quality index system likely significantly under ##est ##imate the health risks of air pollution , highlighting that the general public may need strict ##er health protection measures . The population - weighted two - year average health - risk based air quality index data further demonstrates that all population in the studied cities in He [SEP]',\n",
       "  'existing_cui': 'C1268941',\n",
       "  'existing_cui_name': 'Health risks education',\n",
       "  'existing_cui_desc': '[CLS] Health risks education [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Counsel ##ing regarding health risks ; Ad ##vice about health risks ; Counsel ##ling regarding health risks ; Education regarding health risks ) [SEP]',\n",
       "  'our_bi_cui': 'C3494320',\n",
       "  'our_bi_cui_name': 'Health Impact Assessment',\n",
       "  'our_bi_cui_desc': '[CLS] Health Impact Assessment [unused3] ( Health Care Act ##ivity : Impact Assessment ##s , Health ; Impact Assessment , Health ; Health Impact Assessment ##s ; Assessment ##s , Health Impact ; Assessment , Health Impact ) [SEP]',\n",
       "  'our_cross_cui': 'C0918012',\n",
       "  'our_cross_cui_name': 'Index',\n",
       "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
       " {'mention_id': '28385178.27',\n",
       "  'test_set_idx': 33778,\n",
       "  'type': 'T092',\n",
       "  'name': 'Kenyatta National',\n",
       "  'context': '[CLS] to describe injury e ##pid ##em ##iology and care . The objective of this study was to investigate the e ##pid ##em ##iology and outcomes of injuries at 4 refer ##ral hospitals in Kenya using hospital - based trauma re ##gis ##tries . From January 2014 to May 2015 , all injured patients presenting to the casual ##ty departments of [unused1] Kenya ##tta National [unused2] , T ##hi ##ka Level 5 , Mac ##hak ##os Level 5 , and Me ##ru Level 5 Hospital ##s were enrolled prospective ##ly . Data collected included demographic characteristics , type of pre ##hos ##pit ##al care received , pre ##hos ##pit ##al time , injury pattern , and outcomes . A total of 14 , 237 patients were enrolled [SEP]',\n",
       "  'existing_cui': 'C0015737',\n",
       "  'existing_cui_name': 'Federal Government',\n",
       "  'existing_cui_desc': '[CLS] Federal Government [unused3] ( Organization : federal government ; Government , Federal ; National Government ; Federal government ; National ) [SEP]',\n",
       "  'our_bi_cui': 'C0017446',\n",
       "  'our_bi_cui_name': 'Geographic Locations',\n",
       "  'our_bi_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]',\n",
       "  'our_cross_cui': 'C0019994',\n",
       "  'our_cross_cui_name': 'Hospitals',\n",
       "  'our_cross_cui_desc': '[CLS] Hospital ##s [unused3] ( Organization , environment : H ##OS ##P ; hospital ; Hospital ; hospital environment ; In Hospital ; H ##OS ##PI ##TA ##L ; hospitals ) [SEP]'},\n",
       " {'mention_id': '28390176.32',\n",
       "  'test_set_idx': 34122,\n",
       "  'type': 'T033',\n",
       "  'name': 'inhibitory effect',\n",
       "  'context': '[CLS] ##ora ##ted of s ##ys ##to ##lic and di ##ast ##olic abnormal ##ities , normal ##ized in gene expression of h ##yper ##tro ##phic and fi ##bro ##tic markers , reserved micro ##vas ##cular density in pressure over ##load induced h ##yper ##tro ##phic mice . C ##uc ##ur ##bit ##ac ##in B also showed significant h ##yper ##tro ##phy [unused1] inhibitor ##y effect [unused2] in p ##hen ##yle ##ph ##rine stimulate ##d card ##io ##my ##ocytes . The C ##uc ##ur ##bit ##ac ##in B - mediated mit ##igate ##d cardiac h ##yper ##tro ##phy was at ##tri ##but ##able to the increasing level of auto ##pha ##gy , which was associated with the blockade of A ##kt / m ##TO ##R / Fox ##O [SEP]',\n",
       "  'existing_cui': 'C1708997',\n",
       "  'existing_cui_name': 'Metastatic Inhibitory Effect',\n",
       "  'existing_cui_desc': '[CLS] Met ##ast ##atic In ##hibit ##ory Effect [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_bi_cui': 'C0021469',\n",
       "  'our_bi_cui_name': 'Metabolic Inhibition',\n",
       "  'our_bi_cui_desc': '[CLS] Met ##ab ##olic In ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : In ##hibition ; In ##hibition , function ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27526663.6',\n",
       "  'test_set_idx': 9446,\n",
       "  'type': 'T033',\n",
       "  'name': 'necrotrophic',\n",
       "  'context': '[CLS] Different ##ial control and function of Arab ##ido ##psis Pro ##D ##H1 and Pro ##D ##H ##2 genes on infection with bio ##tro ##phic and [unused1] ne ##c ##rot ##rop ##hic [unused2] path ##ogen ##s Arab ##ido ##psis contains two pro ##line de ##hy ##dr ##ogen ##ase genes , Pro ##D ##H1 and Pro ##D ##H ##2 , encoding for ho ##mo ##log ##ous and functional is ##oe ##nz ##yme ##s . Although Pro ##D ##H1 has been studied extensively , especially under a ##biotic stress , Pro ##D ##H ##2 has only started to be anal ##ys ##ed in recent years . These genes display distinctive expression patterns and show weak transcription ##al co - regulation , but are both activated in path ##ogen - [SEP]',\n",
       "  'existing_cui': 'C4084801',\n",
       "  'existing_cui_name': 'Prostate Health Index',\n",
       "  'existing_cui_desc': '[CLS] Pro ##state Health Index [unused3] ( Health Care Act ##ivity : p ##hi - index ) [SEP]',\n",
       "  'our_bi_cui': 'C0027540',\n",
       "  'our_bi_cui_name': 'Necrosis',\n",
       "  'our_bi_cui_desc': '[CLS] N ##ec ##rosis [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity , qualifier value : T ##iss ##ue de ##vi ##tal ##isation ; T ##iss ##ue de ##vi ##tal ##ization ; ne ##c ##rot ##ic cell death ; N ##ec ##rose ##s ; tissue death ; NE ##CR ##OS ##IS ; ne ##c ##rot ##ic ; obsolete tissue death ; Cell ##ular ne ##c ##rosis ; N ##ec ##rot ##ic Process ; cellular ne ##c ##rosis ; ne ##c ##rosis ; N ##ec ##rosis [ Disease / Finding ] ; obsolete ne ##c ##rosis ; N ##ec ##rot ##ic ; death tissue ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27689491.25',\n",
       "  'test_set_idx': 14253,\n",
       "  'type': 'T033',\n",
       "  'name': 'no',\n",
       "  'context': '[CLS] ratio = 0 . 89 ; 95 % confidence interval = 0 . 45 , 1 . 77 ) , or for sex with no effective means of birth control ( Louisiana , adjusted odds ratio = 1 . 18 ; 95 % confidence interval = 0 . 78 , 1 . 78 ; Rochester , adjusted odds ratio = 0 . 41 ; 95 % confidence interval = 0 . 13 , 1 . 27 ) after controlling for relevant co ##var ##iate ##s . We found [unused1] no [unused2] short - term effects for the offer of the intervention . Research might be needed for the long - term and intermediate impacts of youth development programs on these and other adolescent risk behaviors . [SEP]',\n",
       "  'existing_cui': 'C1140150',\n",
       "  'existing_cui_name': 'NOC - CodeSystem',\n",
       "  'existing_cui_desc': '[CLS] NO ##C - Code ##S ##ys ##tem [unused3] ( Intel ##lect ##ual Product , NO ##C : nursing outcomes classification ) [SEP]',\n",
       "  'our_bi_cui': 'C0205160',\n",
       "  'our_bi_cui_name': 'Negative',\n",
       "  'our_bi_cui_desc': '[CLS] N ##eg ##ative [unused3] ( Finding , qualifier value : Rule ##d out ; N ##eg ##ative ( m ##od ##ifier ) [ Am ##bi ##guous ] ; N ##eg ##ative for ; N ##eg ##ative ( m ##od ##ifier ) ; ruled out ; for negative ; out ruled ; negative ; negative ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C1513916',\n",
       "  'our_cross_cui_name': 'Negative Finding',\n",
       "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
       " {'mention_id': '27260627.19',\n",
       "  'test_set_idx': 989,\n",
       "  'type': 'T170',\n",
       "  'name': 'breast module BR-23',\n",
       "  'context': \"[CLS] its association with women ' s personal characteristics and cancer treatments . In this cross - section ##al study , sexual function was assessed using the Female Sexual Fun ##ction Index . The health - related quality of life was measured using the European Organization for Research and Treatment of Cancer Q ##L ##Q - C ##30 and its [unused1] breast module BR - 23 [unused2] . Of the 235 participants approached , 216 participants were included in the study . Of these , 63 patients reported no sexual activity in the last month and thus were analyzed only in relation to the sexual desire domain of Female Sexual Fun ##ction Index . A total of 154 ( 71 . 3 % ) patients were classified [SEP]\",\n",
       "  'existing_cui': 'C3542953',\n",
       "  'existing_cui_name': 'Module',\n",
       "  'existing_cui_desc': '[CLS] Mo ##du ##le [unused3] ( Intel ##lect ##ual Product , core meta ##data concept , core meta ##data concept ) [SEP]',\n",
       "  'our_bi_cui': 'C1511299',\n",
       "  'our_bi_cui_name': 'Breast Cancer Surveillance Consortium',\n",
       "  'our_bi_cui_desc': '[CLS] B ##rea ##st Cancer Sur ##ve ##illa ##nce Consortium [unused3] ( Professional or O ##cc ##upation ##al Group ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27886280.71',\n",
       "  'test_set_idx': 20783,\n",
       "  'type': 'T007',\n",
       "  'name': 'exponential and stationary planktonic cells',\n",
       "  'context': '[CLS] C ##ip ##ro ##f ##lo ##xa ##cin ( F ##lu ##oro ##quin ##olo ##ne ) at a low concentration resulted in killing of both cultures of P . a ##er ##ug ##ino ##sa , producing per ##sist ##ers that were in ##vu ##ln ##era ##ble to killing . Station ##ary cells appear to be somewhat more tolerant than ex ##po ##nent ##ial cells in all of these ass ##ays . We also showed that nut ##rient de ##p ##ri ##vation ( se ##rine starvation ) regulated by string ##ent and general stress response , contribute to the increased tolerance of P . a ##er ##ug ##ino ##sa [unused1] ex ##po ##nent ##ial and stationary plan ##kt ##onic cells [unused2] via production of per ##sist ##ers . [SEP]',\n",
       "  'existing_cui': 'C3839460',\n",
       "  'existing_cui_name': 'Nonprogressive',\n",
       "  'existing_cui_desc': '[CLS] Non ##p ##rog ##ress ##ive [unused3] ( Finding , qualifier value : Non ##p ##rog ##ress ##ive course ; Station ##ary ; Non ##p ##rog ##ress ##ive disorder ; Non - progressive ) [SEP]',\n",
       "  'our_bi_cui': 'C0007634',\n",
       "  'our_bi_cui_name': 'Cells',\n",
       "  'our_bi_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]',\n",
       "  'our_cross_cui': 'C0563199',\n",
       "  'our_cross_cui_name': 'Bacterial cell',\n",
       "  'our_cross_cui_desc': '[CLS] Ba ##cter ##ial cell [unused3] ( Ba ##cter ##ium , organism : bacterial cell ; cell bacterial ) [SEP]'},\n",
       " {'mention_id': '28077286.55',\n",
       "  'test_set_idx': 25105,\n",
       "  'type': 'T103',\n",
       "  'name': 'MeHg',\n",
       "  'context': '[CLS] Me ##H ##g dose of 3 . 2 μ ##g H ##g g ( - 1 ) egg , and a vehicle control ( water ) . No adverse effects of in o ##vo Me ##H ##g treatment were detected on courts ##hip song quality or on mating behavior in experimental males at sexually maturity which would suggest that o ##bs ##er ##vable ne ##uro ##be ##ha ##vior ##al effects of Me ##H ##g exposure may depend on the timing of exposure during offspring development . However , ne ##uro ##ana ##tom ##ical analysis indicated an increase in te ##len ##ce ##pha ##lon volume with increased [unused1] Me ##H ##g [unused2] concentrations which may suggest a prolonged inflammatory response in this region of the brain . [SEP]',\n",
       "  'existing_cui': 'C0228520',\n",
       "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
       "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
       "  'our_bi_cui': 'C0025424',\n",
       "  'our_bi_cui_name': 'Mercury',\n",
       "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
       "  'our_cross_cui': 'C0025794',\n",
       "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
       "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
       " {'mention_id': '27603112.45',\n",
       "  'test_set_idx': 11387,\n",
       "  'type': 'T103',\n",
       "  'name': 'YKoF',\n",
       "  'context': '[CLS] compounds were found to bind the EC ##F - type ABC transport ##er , but none binds stab ##ly to p ##rion protein . For the rib ##os ##witch , most compounds remained in their binding pockets during 50 n ##s of molecular dynamics simulation , indicating that RNA provides a pro ##mis ##cu ##ous binding site . In both [unused1] Y ##K ##o ##F [unused2] and th ##iam ##in p ##yr ##op ##hos ##ph ##oki ##nas ##e , most compounds remain tightly bound . However , th ##iam ##in p ##yr ##op ##hos ##ph ##oki ##nas ##e bio ##mo ##le ##cule ##s undergo poll ##uta ##nt - induced conform ##ational changes . Although most compounds are found to bind to some of these targets , [SEP]',\n",
       "  'existing_cui': 'C1424135',\n",
       "  'existing_cui_name': 'YAP1 gene',\n",
       "  'existing_cui_desc': '[CLS] Y ##AP ##1 gene [unused3] ( Ana ##tom ##ical Structure : Yes - Associated Pro ##tein 1 Gene ; Yes associated protein 1 ; Y ##AP ##65 ; Y ##OR ##K ##IE , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; Y ##AP ##1 Gene ; Y ##ES - AS ##SO ##CI ##AT ##ED PR ##OT ##EI ##N 1 , 65 - K ##D ; Y ##AP ##2 ) [SEP]',\n",
       "  'our_bi_cui': 'C0060764',\n",
       "  'our_bi_cui_name': 'FRUCTOKINASE',\n",
       "  'our_bi_cui_desc': '[CLS] F ##R ##UC ##TO ##K ##IN ##AS ##E [unused3] ( Chemical , substance : f ##ru ##ct ##oki ##nas ##e ; D - f ##ru ##ct ##oki ##nas ##e ; ATP - D - f ##ru ##ct ##ose 6 - p ##hos ##ph ##ot ##ran ##s ##fer ##ase ; s ##c ##r ##K protein ; Fr ##uc ##tok ##inas ##e ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27572277.25',\n",
       "  'test_set_idx': 10541,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedures',\n",
       "  'context': '[CLS] ; s ##ham - operated fed ad l ##ibi ##tum ; and sleeve gas ##tre ##ct ##omy . The metabolic effects and gut micro ##bio ##ta profile were analyzed 10 weeks post ##oper ##ative ##ly . Association ##s between disc ##rim ##inating genera and metabolic markers after R ##oux - en - Y gas ##tric bypass were explored . The 2 [unused1] procedures [unused2] induced similar glucose improvement and increased flora diversity after 10 weeks compared with s ##ham - operated groups . R ##oux - en - Y gas ##tric bypass induced a marked higher relative abundance of Pro ##te ##ob ##act ##eria / Gamma ##p ##rote ##ob ##act ##eria and Beta ##p ##rote ##ob ##act ##eria and increased emergence of Fu ##so ##ba ##cter [SEP]',\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '28457334.29',\n",
       "  'test_set_idx': 36639,\n",
       "  'type': 'T058',\n",
       "  'name': 'thromboaggregometry',\n",
       "  'context': '[CLS] at se ##psis onset and after surgery respectively , as well as after 24 , 72 and 168 h . Level ##s of Cell - free DNA and extra ##cellular RNA were measured by quantitative probe - based polymer ##ase chain reaction . In addition , th ##rom ##boe ##last ##ography for co ##agu ##lation as well as [unused1] th ##rom ##boa ##gg ##re ##go ##metry [unused2] for plate ##let function was conducted . Both Cell - free DNA and extra ##cellular RNA were elevated in patients with se ##psis compared with post ##oper ##ative patients and healthy volunteers . While higher extra ##cellular RNA levels correlated with a faster c ##lot ##ting time and more stable c ##lot ##s , Cell - free DNA correlated [SEP]',\n",
       "  'existing_cui': 'C0920267',\n",
       "  'existing_cui_name': 'Platelet aggregation measurement',\n",
       "  'existing_cui_desc': '[CLS] Plate ##let a ##gg ##regation measurement [unused3] ( Health Care Act ##ivity , lab test , procedure , qualifier value : P ##LA ##TA ##G ##GR ; A ##gg ##re ##go ##meter test ; Plate ##let A ##gg ##regation Me ##as ##ure ##ment ; Plate ##let a ##gg ##regation test ; Plate ##let a ##gg ##r ; Plate ##let A ##gg ##regation ; plate ##let a ##gg ##regation tests ; Plate ##let a ##gg ##regation ; Plate ##let a ##gg ##regation ass ##ay ; plate ##let a ##gg ##regation ; plate ##let a ##gg ##regation test ; Plate ##let Fun ##ction ; Plate ##let A ##gg ##regation Test ) [SEP]',\n",
       "  'our_bi_cui': 'C0920267',\n",
       "  'our_bi_cui_name': 'Platelet aggregation measurement',\n",
       "  'our_bi_cui_desc': '[CLS] Plate ##let a ##gg ##regation measurement [unused3] ( Health Care Act ##ivity , lab test , procedure , qualifier value : P ##LA ##TA ##G ##GR ; A ##gg ##re ##go ##meter test ; Plate ##let A ##gg ##regation Me ##as ##ure ##ment ; Plate ##let a ##gg ##regation test ; Plate ##let a ##gg ##r ; Plate ##let A ##gg ##regation ; plate ##let a ##gg ##regation tests ; Plate ##let a ##gg ##regation ; Plate ##let a ##gg ##regation ass ##ay ; plate ##let a ##gg ##regation ; plate ##let a ##gg ##regation test ; Plate ##let Fun ##ction ; Plate ##let A ##gg ##regation Test ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '27838742.55',\n",
       "  'test_set_idx': 19022,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] ##R , and p ##hos ##ph ##o - p ##70 ##S ##6 ##K in a time - and dose - dependent manner , suggesting that it induced auto ##pha ##gy by in ##hibit ##ing the A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K pathway in A ##5 ##4 ##9 and PC - 9 cells . [unused1] Del ##ica ##f ##lav ##one [unused2] is a potential anti ##can ##cer agent that can induce auto ##pha ##gic cell death in human non - small cell lung cancer via the A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28256742.8',\n",
       "  'test_set_idx': 30214,\n",
       "  'type': 'T082',\n",
       "  'name': 'Canadian Areas',\n",
       "  'context': '[CLS] Hal ##ogen ##ated p ##hen ##olic compounds in wild fish from Canadian Areas of Con ##cer ##n Con ##cent ##rations of ha ##log ##ena ##ted p ##hen ##olic compounds were measured in the plasma of brown bull ##head ( Am ##ei ##urus ne ##bul ##os ##us ) from 4 [unused1] Canadian Areas [unused2] of Con ##cer ##n ( A ##OC ##s ) , to assess exposure to suspected thy ##roid - disrupt ##ing chemicals . H ##ydro ##xy ##lated p ##oly ##ch ##lor ##inated bi ##phe ##ny ##ls ( OH - PC ##B ##s ) were detected in every sample collected in 3 of the A ##OC ##s ; the detection frequency was lower in samples from the Detroit River A ##OC . The OH - [SEP]',\n",
       "  'existing_cui': 'C3831211',\n",
       "  'existing_cui_name': 'Canadian County , OK',\n",
       "  'existing_cui_desc': '[CLS] Canadian County , OK [unused3] ( Spa ##tial Concept : Canadian County , Oklahoma ; OK ##01 ##7 ; Canadian County ) [SEP]',\n",
       "  'our_bi_cui': 'C0454980',\n",
       "  'our_bi_cui_name': 'Region of Canada',\n",
       "  'our_bi_cui_desc': '[CLS] Region of Canada [unused3] ( Spa ##tial Concept , geographic location : Province or Territory of Canada ; Provinces and territories of Canada ; Region ##s of Canada ) [SEP]',\n",
       "  'our_cross_cui': 'C0006823',\n",
       "  'our_cross_cui_name': 'Canada',\n",
       "  'our_cross_cui_desc': '[CLS] Canada [unused3] ( Spa ##tial Concept , geographic location : CA ##N ; CA ##NA ##DA ; CA ) [SEP]'},\n",
       " {'mention_id': '27472389.38',\n",
       "  'test_set_idx': 7179,\n",
       "  'type': 'T103',\n",
       "  'name': 'signal transducer and activator of transcription 1 inhibitor',\n",
       "  'context': '[CLS] . In contrast , ACT ##A ##2 expression was decreased by H ##ER ##2 si ##RNA . Next , we investigated the co - relation between signal trans ##du ##cer and act ##iva ##tor of transcription 1 and ACT ##A ##2 expression . Ba ##sal ACT ##A ##2 expression was significantly decreased by treatment with the [unused1] signal trans ##du ##cer and act ##iva ##tor of transcription 1 inhibitor [unused2] flu ##dar ##abi ##ne or the J ##A ##K ##2 inhibitor AG ##4 ##90 . In contrast , ACT ##A ##2 expression was increased by signal trans ##du ##cer and act ##iva ##tor of transcription 1 over ##ex ##press ##ion . Level ##s of ACT ##A ##2 , signal trans ##du ##cer and act ##iva ##tor [SEP]',\n",
       "  'existing_cui': 'C1335872',\n",
       "  'existing_cui_name': 'STAT1 gene',\n",
       "  'existing_cui_desc': '[CLS] ST ##AT ##1 gene [unused3] ( Ana ##tom ##ical Structure : Signal Trans ##du ##cer and Act ##iva ##tor of Trans ##cription 1 , 91 ##k ##D ##a Gene ; ST ##AT ##1 Gene ; transcription factor IS ##G ##F - 3 components p ##9 ##1 / p ##8 ##4 ; signal trans ##du ##cer and act ##iva ##tor of transcription 1 ; ST ##AT ##9 ##1 ; IS ##G ##F - 3 ; S ##IG ##NA ##L T ##RA ##NS ##D ##UC ##ER AND ACT ##I ##VA ##TO ##R OF T ##RA ##NS ##CR ##IP ##TI ##ON 1 ) [SEP]',\n",
       "  'our_bi_cui': 'C1519313',\n",
       "  'our_bi_cui_name': 'Signal Transduction Inhibitor',\n",
       "  'our_bi_cui_desc': '[CLS] Signal Trans ##duction In ##hibit ##or [unused3] ( Chemical : signal trans ##duction inhibitor ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27902303.1',\n",
       "  'test_set_idx': 21293,\n",
       "  'type': 'T007',\n",
       "  'name': 'Arthrobacter ginkgonis sp . nov.',\n",
       "  'context': '[CLS] [unused1] Art ##hr ##ob ##act ##er g ##ink ##gon ##is s ##p . no ##v . [unused2] , an act ##ino ##my ##ce ##te isolated from r ##hi ##zo ##sp ##here of G ##ink ##go bi ##lo ##ba L A Gram - stain - positive , a ##ero ##bic act ##ino ##ba ##cter ##ial strain ( designated S ##YP - A ##7 ##29 ##9 ##T ) , which displayed a rod - co ##cc ##us growth life ##cycle , was isolated from the r ##hi ##zo ##sp ##here of G ##ink ##go bi ##lo ##ba L . Ph ##yl ##ogen ##etic analyses based on 16 ##S r ##RNA gene sequences indicated that strain S ##YP - A ##7 ##29 ##9 ##T belongs to the genus Art [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C1197674',\n",
       "  'our_bi_cui_name': 'Arthrobacter gandavensis',\n",
       "  'our_bi_cui_desc': '[CLS] Art ##hr ##ob ##act ##er g ##anda ##ven ##sis [unused3] ( Ba ##cter ##ium , organism : Art ##hr ##ob ##act ##er g ##and ##ensis ; Art ##hr ##ob ##act ##er g ##anda ##ven ##sis Storm ##s et al . 2003 ) [SEP]',\n",
       "  'our_cross_cui': 'C0003876',\n",
       "  'our_cross_cui_name': 'Arthrobacter',\n",
       "  'our_cross_cui_desc': '[CLS] Art ##hr ##ob ##act ##er [unused3] ( Ba ##cter ##ium , organism : Art ##hr ##ob ##act ##er Con ##n and Di ##mm ##ick 1947 ( A ##pp ##roved List ##s 1980 ) em ##end . Bus ##se 2016 ; AR ##TH ##RO ##BA ##CT ##ER ; Art ##hr ##ob ##act ##er Con ##n and Di ##mm ##ick 1947 ( A ##pp ##roved List ##s 1980 ) em ##end . Koch et al . 1995 ; Genus Art ##hr ##ob ##act ##er ; Art ##hr ##ob ##act ##er species ) [SEP]'},\n",
       " {'mention_id': '27715500.7',\n",
       "  'test_set_idx': 14872,\n",
       "  'type': 'T092',\n",
       "  'name': 'meatpacking facilities',\n",
       "  'context': '[CLS] Self - reported occupational injuries among industrial beef slaughter ##house workers in the Midwest ##ern United States Although workers in [unused1] meat ##pack ##ing facilities [unused2] in the United States experience high rates of occupational injury , their injury experiences have received limited research attention . Prior research indicates under ##re ##port ##ing in injury rates in this industry as well significant variation in injury rates among facilities . To add detail to the rates and circumstances surrounding occupational injury among meat ##pack ##ing workers , we conducted a cross - section ##al study of workers employed at an industrial beef ##pack ##ing plant in Nebraska , United States ( n = 137 ) and interviewed workers about recent injury experiences . We assessed frequency , [SEP]',\n",
       "  'existing_cui': 'C2825564',\n",
       "  'existing_cui_name': 'Submitting Facility',\n",
       "  'existing_cui_desc': '[CLS] Sub ##mit ##ting Facility [unused3] ( Organization ) [SEP]',\n",
       "  'our_bi_cui': 'C0018704',\n",
       "  'our_bi_cui_name': 'Health care facility',\n",
       "  'our_bi_cui_desc': '[CLS] Health care facility [unused3] ( Organization , environment : health facilities ; health facility ; facilities medical ; medical facility ; Healthcare Facility ; Health F ##ac ##ilities ; Healthcare ##F ##ac ##ility ; Healthcare facility ; treatment facility ; facility medical ; Health care facilities ; treatment facilities ; care facilities health ; facilities treatment ; Health Facility ; health care facility ; care facility health ; Institution ; H ##EA ##LT ##H FA ##CI ##L ##IT ##Y ; Treatment F ##ac ##ilities ; Health Care Facility ; facilities health ; Health facilities ; F ##ac ##ilities , Health ; Facility , Health ) [SEP]',\n",
       "  'our_cross_cui': 'C0025019',\n",
       "  'our_cross_cui_name': 'Meat-Packing Industry',\n",
       "  'our_cross_cui_desc': '[CLS] Meat - Pack ##ing Industry [unused3] ( Organization : Industries , Meat - Pack ##ing ; Industry , Meat - Pack ##ing ; ME ##AT PA ##C ##K ##ING IN ##D ##US ##T ; Meat Pack ##ing Industry ; Meat - Pack ##ing Industries ; IN ##D ##US ##T ME ##AT PA ##C ##K ##ING ; Industry , Meat Pack ##ing ) [SEP]'},\n",
       " {'mention_id': '27583176.12',\n",
       "  'test_set_idx': 10709,\n",
       "  'type': 'T170',\n",
       "  'name': 'outcome grading scoring systems',\n",
       "  'context': '[CLS] scoring systems [ ( In ##tra ##cer ##eb ##ral hem ##or ##r ##hage score , F ##UN ##C score and in ##tra ##cer ##eb ##ral hem ##or ##r ##hage g ##rading scale ] on our population to evaluate the correlation of these scores with the 30 - day mortality in our study . We also applied three widely accepted [unused1] outcome g ##rading scoring systems [unused2] [ ( In ##tra ##cer ##eb ##ral hem ##or ##r ##hage score , F ##UN ##C score and in ##tra ##cer ##eb ##ral hem ##or ##r ##hage g ##rading scale ] on our population to evaluate the correlation of these scores with the 30 - day mortality in our study . From 34 ##2 patients ( mean age : 67 [SEP]',\n",
       "  'existing_cui': 'C1273712',\n",
       "  'existing_cui_name': 'Grading system used',\n",
       "  'existing_cui_desc': '[CLS] G ##rading system used [unused3] ( Health Care Act ##ivity , o ##bs ##er ##vable entity : g ##rading system ) [SEP]',\n",
       "  'our_bi_cui': 'C1708250',\n",
       "  'our_bi_cui_name': 'Tumor Grading System',\n",
       "  'our_bi_cui_desc': '[CLS] Tu ##mor G ##rading System [unused3] ( Intel ##lect ##ual Product : G ##rading system ; G ##rading System ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27172917.21',\n",
       "  'test_set_idx': 164,\n",
       "  'type': 'T170',\n",
       "  'name': 'biochemical predictors',\n",
       "  'context': '[CLS] predict ##ors of ma ##li ##gna ##ncy are important for the decision of appropriate management in nod ##ules with at ##y ##pia of und ##eter ##mined significance / f ##oll ##icular les ##ion of und ##eter ##mined significance ( AU ##S / FL ##US ) . Our aim was to determine the ultra ##son ##ographic ##al , clinical , and [unused1] bio ##chemical predict ##ors [unused2] of ma ##li ##gna ##ncy in these patients . A total of 42 ##7 patients with c ##yt ##ological ##ly Beth ##es ##da Category III ( AU ##S / FL ##US ) thy ##roid nod ##ules were included in this retrospective study . We divided the nod ##ules into two subgroup ##s according to the his ##top ##ath ##ology as [SEP]',\n",
       "  'existing_cui': 'C1511130',\n",
       "  'existing_cui_name': 'Biochemical Processes',\n",
       "  'existing_cui_desc': '[CLS] B ##io ##chemical Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction : B ##io ##chemical Process ; Process ##es , B ##io ##chemical ; Process , B ##io ##chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0041366',\n",
       "  'our_bi_cui_name': 'Biomarkers , Tumor',\n",
       "  'our_bi_cui_desc': '[CLS] B ##io ##mark ##ers , Tu ##mor [unused3] ( Chemical , substance : MA ##R ##KE ##R B ##IO ##CH ##EM T ##UM ##OR ; Mark ##ers , Neo ##p ##las ##m Met ##ab ##oli ##te ; Biological Tu ##mor Mark ##ers ; Tu ##mor Mark ##er , B ##iol ##og ##ic ; MA ##R ##KE ##RS B ##IO ##CH ##EM T ##UM ##OR ; Tu ##mor Mark ##ers , B ##io ##chemical ; Mark ##er , Neo ##p ##las ##m Met ##ab ##oli ##te ; Met ##ab ##oli ##te Mark ##ers , Tu ##mor ; B ##io ##chemical Tu ##mor Mark ##er ; Tu ##mor Mark ##ers , Biological ; Mark ##er , B ##io ##chemical Tu ##mor ; Mark ##ers , Car ##cin ##ogen [SEP]',\n",
       "  'our_cross_cui': 'C0683956',\n",
       "  'our_cross_cui_name': 'predictive factor',\n",
       "  'our_cross_cui_desc': '[CLS] predict ##ive factor [unused3] ( Intel ##lect ##ual Product : predict ##ive variables ; factors predict ##ive ; factor predict ##ive ; Disease Pre ##dict ##ive Factor ) [SEP]'},\n",
       " {'mention_id': '27510458.30',\n",
       "  'test_set_idx': 8917,\n",
       "  'type': 'T033',\n",
       "  'name': 'double lumen sign',\n",
       "  'context': '[CLS] slice thickness 3 mm with no inter ##s ##lice gap ) , as well as scanning with conventional m ##oda ##lities , including CT an ##gio ##graphy , magnetic resonance an ##gio ##graphy , and digital sub ##traction an ##gio ##graphy . We assessed whether these imaging methods could visual ##ize an in ##ti ##mal flap and / or [unused1] double l ##ume ##n sign [unused2] in the participants and compared the results between high - resolution fast spin echo and the other m ##oda ##lities . high - resolution fast spin echo images clearly showed in ##ti ##mal flap ##s and double l ##ume ##n signs in all 3 patients , whereas the conventional m ##oda ##lities identified a double l ##ume ##n sign in [SEP]',\n",
       "  'existing_cui': 'C0441299',\n",
       "  'existing_cui_name': 'Double lumen tube',\n",
       "  'existing_cui_desc': '[CLS] Double l ##ume ##n tube [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
       "  'our_bi_cui': 'C0233192',\n",
       "  'our_bi_cui_name': \"Ladin 's sign\",\n",
       "  'our_bi_cui_desc': \"[CLS] La ##din ' s sign [unused3] ( Finding , finding : La ##din sign ) [SEP]\",\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28127340.50',\n",
       "  'test_set_idx': 26276,\n",
       "  'type': 'T033',\n",
       "  'name': 'non - zoonotic',\n",
       "  'context': \"[CLS] = 1 . 09 % , and La ##ela ##ps nut ##tal ##li = 3 . 29 % . Among 10 genera / species of identified parasite ##s , at least 8 of them were zoo ##not ##ic with public health importance . L . nut ##tal ##li and N . f ##as ##cia ##tus were the only two [unused1] non - zoo ##not ##ic [unused2] detected parasite ##s in this survey . Harbor ##ing a wide variety of zoo ##not ##ic parasite ##s in sampled wild rode ##nts particularly when they live nearby villages , represents a potential risk to native inhabitants . Hence , controlling rode ##nts ' population in residential regions and improving awareness of local people about the risk of disease transmission [SEP]\",\n",
       "  'existing_cui': 'C0043528',\n",
       "  'existing_cui_name': 'Zoonoses',\n",
       "  'existing_cui_desc': '[CLS] Zoo ##nose ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder , navigation ##al concept : Zoo ##nosis ; Zoo ##not ##ic In ##fect ##ious Disease ; Zoo ##not ##ic infection ; Disease , Zoo ##not ##ic In ##fect ##ious ; Zoo ##nose ##s [ Disease / Finding ] ; Zoo ##not ##ic Disease ##s ; infections zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ion ; Zoo ##not ##ic Disease ; In ##fect ##ious Disease , Zoo ##not ##ic ; In ##fect ##ions , Zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ious Disease ##s ; Disease , Zoo ##not ##ic ; Disease ##s , Zoo ##not ##ic In ##fect ##ious ; zoo ##nose ; zoo ##not ##ic infection ; In [SEP]',\n",
       "  'our_bi_cui': 'C0043528',\n",
       "  'our_bi_cui_name': 'Zoonoses',\n",
       "  'our_bi_cui_desc': '[CLS] Zoo ##nose ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder , navigation ##al concept : Zoo ##nosis ; Zoo ##not ##ic In ##fect ##ious Disease ; Zoo ##not ##ic infection ; Disease , Zoo ##not ##ic In ##fect ##ious ; Zoo ##nose ##s [ Disease / Finding ] ; Zoo ##not ##ic Disease ##s ; infections zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ion ; Zoo ##not ##ic Disease ; In ##fect ##ious Disease , Zoo ##not ##ic ; In ##fect ##ions , Zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ious Disease ##s ; Disease , Zoo ##not ##ic ; Disease ##s , Zoo ##not ##ic In ##fect ##ious ; zoo ##nose ; zoo ##not ##ic infection ; In [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28197156.25',\n",
       "  'test_set_idx': 28095,\n",
       "  'type': 'T017',\n",
       "  'name': 'Carbon Assimilation Rate 8',\n",
       "  'context': '[CLS] As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of [unused1] Carbon As ##si ##mi ##lation Rate 8 [unused2] has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , Carbon As ##si ##mi ##lation Rate 8 is identical to D ##TH ##8 / G ##h ##d ##8 / L ##HD ##1 , which was reported [SEP]',\n",
       "  'existing_cui': 'C2246620',\n",
       "  'existing_cui_name': 'iron assimilation',\n",
       "  'existing_cui_desc': '[CLS] iron ass ##im ##ilation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_bi_cui': 'C1427100',\n",
       "  'our_bi_cui_name': 'SLC9A8 gene',\n",
       "  'our_bi_cui_desc': '[CLS] SL ##C ##9 ##A ##8 gene [unused3] ( Ana ##tom ##ical Structure : so ##lut ##e carrier family 9 member A ##8 ; S ##OD ##I ##UM / H ##Y ##DR ##O ##GE ##N E ##X ##CH ##AN ##GE ##R 8 ; S ##OL ##UT ##E CA ##R ##RI ##ER FA ##MI ##L ##Y 9 ( S ##OD ##I ##UM / H ##Y ##DR ##O ##GE ##N E ##X ##CH ##AN ##GE ##R ) , ME ##MB ##ER 8 ; K ##IA ##A ##0 ##9 ##39 ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27372076.29',\n",
       "  'test_set_idx': 3980,\n",
       "  'type': 'T092',\n",
       "  'name': 'industrial',\n",
       "  'context': '[CLS] Here ##in , we demonstrate for the first time that De ##o ##R family proteins derived from the same source are likely to be a single branch in a phylogenetic tree and show that w ##ys ##R ##3 acts as a re ##press ##or for its m ##or ##phological development without effect ##ing w ##uy ##ien ##cin production . We found that the Δ ##wy ##s ##R ##3 strain can grow quickly to reach a plateau stage of maximum bio ##mass at 60 h , which is ~ 12 h faster than the wild - type strain . In the [unused1] industrial [unused2] f ##er ##mentation production process , the Δ ##wy ##s ##R ##3 strain can reduce consumption and save both time and money . [SEP]',\n",
       "  'existing_cui': 'C0442611',\n",
       "  'existing_cui_name': 'Industrial site',\n",
       "  'existing_cui_desc': '[CLS] Industrial site [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
       "  'our_bi_cui': 'C0557758',\n",
       "  'our_bi_cui_name': 'Industrial environment',\n",
       "  'our_bi_cui_desc': '[CLS] Industrial environment [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
       "  'our_cross_cui': 'C0007983',\n",
       "  'our_cross_cui_name': 'Chemical Industry',\n",
       "  'our_cross_cui_desc': '[CLS] Chemical Industry [unused3] ( Organization : Chemical Industries ; IN ##D ##US ##T CH ##EM ; Industry , Chemical ; chemical industry ; chemical industries ; CH ##EM IN ##D ##US ##T ; Industries , Chemical ; Chemical industry ) [SEP]'},\n",
       " {'mention_id': '28077286.36',\n",
       "  'test_set_idx': 25086,\n",
       "  'type': 'T103',\n",
       "  'name': 'MeHg',\n",
       "  'context': '[CLS] , we used the egg injection method to investigate the long term effects of in o ##vo Me ##H ##g exposure on brain his ##top ##ath ##ology and courts ##hip behavior in a model song ##bird species , the z ##eb ##ra fin ##ch ( Ta ##eni ##opy ##gia gut ##tata ) . Egg treatment groups included : a low [unused1] Me ##H ##g [unused2] dose of 0 . 2 μ ##g H ##g g ( - 1 ) egg , a high Me ##H ##g dose of 3 . 2 μ ##g H ##g g ( - 1 ) egg , and a vehicle control ( water ) . No adverse effects of in o ##vo Me ##H ##g treatment were detected on courts ##hip [SEP]',\n",
       "  'existing_cui': 'C0228520',\n",
       "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
       "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
       "  'our_bi_cui': 'C0025424',\n",
       "  'our_bi_cui_name': 'Mercury',\n",
       "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
       "  'our_cross_cui': 'C0025794',\n",
       "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
       "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
       " {'mention_id': '28179911.98',\n",
       "  'test_set_idx': 27692,\n",
       "  'type': 'T103',\n",
       "  'name': 'C18 :1',\n",
       "  'context': '[CLS] the wild type . Ana ##ly ##ses of the seed oil content , star ##ch content , and total protein content indicated that the two T ##2 trans ##genic lines showed a significant increase ( P < 0 . 05 ) in seed oil content . The trans ##genic lines also showed a significant increase in star ##ch content , whereas total protein content decreased significantly . Further analysis of the fatty acid composition revealed that palm ##itic acid ( C ##16 : 0 ) and l ##ino ##len ##ic acid ( C ##18 : 3 ) increased significantly in the seeds of the trans ##genic rice lines , but o ##le ##ic acid ( [unused1] C ##18 : 1 [unused2] ) levels significantly declined . [SEP]',\n",
       "  'existing_cui': 'C3889128',\n",
       "  'existing_cui_name': 'BBS9 wt Allele',\n",
       "  'existing_cui_desc': '[CLS] B ##BS ##9 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : C ##18 ; PT ##H - Re ##sp ##ons ##ive B ##1 Gene ; PT ##H ##B ##1 ; Para ##thy ##roid Ho ##rmon ##e - Re ##sp ##ons ##ive B ##1 Gene ; Bar ##det - B ##ied ##l S ##yn ##drome 9 w ##t All ##ele ; B ##1 ; Para ##thy ##roid Ho ##rmon ##e Re ##sp ##ons ##ive B ##1 Gene ; D ##1 ) [SEP]',\n",
       "  'our_bi_cui': 'C0044555',\n",
       "  'our_bi_cui_name': '1-oleoyl-2-acetylglycerol',\n",
       "  'our_bi_cui_desc': '[CLS] 1 - o ##leo ##yl - 2 - ace ##ty ##l ##gly ##cer ##ol [unused3] ( Chemical : 9 - Oct ##ade ##ce ##no ##ic acid ( Z ) - , 2 - ( ace ##ty ##lo ##xy ) - 3 - h ##ydro ##xy ##p ##rop ##yl est ##er , ( S ) - ; 1 - o ##leo ##yl - 2 - ace ##ty ##l - s ##n - g ##ly ##cer ##ol ; o ##ley ##l ace ##ty ##l g ##ly ##cer ##ol ; 1 - o ##ley ##l - 2 - ace ##ty ##l ##gly ##cer ##ol ; 1 - o ##leo ##yl - 2 - ace ##ty ##l - g ##ly ##cer ##ol ; o ##leo ##yla ##ce ##ty ##l ##gly [SEP]',\n",
       "  'our_cross_cui': 'C0028928',\n",
       "  'our_cross_cui_name': 'Oleic Acid',\n",
       "  'our_cross_cui_desc': '[CLS] Ole ##ic A ##cid [unused3] ( Chemical , product , substance : Ole ##ic A ##cid [ Chemical / In ##g ##red ##ient ] ; O ##CT ##AD ##EC ##EN ##O ##IC AC ##ID 09 ; c ##is - 9 - Oct ##ade ##ce ##no ##ic A ##cid ; Oct ##ade ##c - 9 - en ##oi ##c acid ; acid o ##le ##ic ; 9 - Oct ##ade ##ce ##no ##ic acid ; 9 - Oct ##ade ##ce ##no ##ic A ##cid ; Fat ##ty A ##cid 18 : 1 n - 9 ; 9 Oct ##ade ##ce ##no ##ic A ##cid ; c ##is 9 Oct ##ade ##ce ##no ##ic A ##cid ; O ##LE ##IC AC ##ID ; o ##le ##ic acid ; [SEP]'},\n",
       " {'mention_id': '27603112.2',\n",
       "  'test_set_idx': 11344,\n",
       "  'type': 'T103',\n",
       "  'name': 'Biomolecules',\n",
       "  'context': '[CLS] Bin ##ding of Poll ##uta ##nts to [unused1] B ##io ##mo ##le ##cule ##s [unused2] : A Si ##mu ##lation Study A number of cases around the world have been reported where animals were found dead or dying with symptoms resembling a th ##iam ##ine ( vitamin B ) deficiency , and for some of these , a link to poll ##uta ##nts has been suggested . Here , we investigate whether bio ##mo ##le ##cule ##s involved in th ##iam ##in binding and transport could be blocked by a range of different poll ##uta ##nts . We used in si ##lic ##o dock ##ing of five compound classes ( 25 compounds in total ) to each of five targets ( p ##rion protein , EC [SEP]',\n",
       "  'existing_cui': 'C0104263',\n",
       "  'existing_cui_name': 'artificial lung expanding compound',\n",
       "  'existing_cui_desc': '[CLS] artificial lung expanding compound [unused3] ( Chemical , AL ##EC , product , substance : P ##uma ##ct ##ant ; pu ##ma ##ct ##ant ) [SEP]',\n",
       "  'our_bi_cui': 'C1449655',\n",
       "  'our_bi_cui_name': 'Macromolecular Substances',\n",
       "  'our_bi_cui_desc': '[CLS] Mac ##rom ##ole ##cular Sub ##stance ##s [unused3] ( Chemical : Mac ##rom ##ole ##cular Sub ##stance ##s [ Chemical / In ##g ##red ##ient ] ; Mac ##rom ##ole ##cular Co ##mpo ##unds and Complex ##es ; Sub ##stance ##s , Mac ##rom ##ole ##cular ) [SEP]',\n",
       "  'our_cross_cui': 'C0574031',\n",
       "  'our_cross_cui_name': 'Biologically active substance',\n",
       "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
       " {'mention_id': '28269352.10',\n",
       "  'test_set_idx': 30583,\n",
       "  'type': 'T170',\n",
       "  'name': 'elderly fall risk assessment model',\n",
       "  'context': '[CLS] Fall risk factors analysis based on sample en ##tropy of plant ##ar kin ##ema ##tic signal during stance phase Falls are a multi - ca ##usal phenomenon with a complex interaction . The aim of our research is to study the effect of multiple variables for potential risk of falls and construct an [unused1] elderly fall risk assessment model [unused2] based on demographic ##s data and g ##ait characteristics . A total of 101 subjects , whom belong to Mali ##an ##wa Street , aged above 50 years old and participated in question ##naire survey . Part ##ici ##pants were classified into three groups ( high , medium and low risk group ) according to the score of elderly fall risk assessment scale . In addition [SEP]',\n",
       "  'existing_cui': 'C1532976',\n",
       "  'existing_cui_name': 'Fall risk assessment',\n",
       "  'existing_cui_desc': '[CLS] Fall risk assessment [unused3] ( Health Care Act ##ivity , procedure , regime / therapy ) [SEP]',\n",
       "  'our_bi_cui': 'C2733220',\n",
       "  'our_bi_cui_name': 'Falls risk assessment score for the elderly',\n",
       "  'our_bi_cui_desc': '[CLS] Falls risk assessment score for the elderly [unused3] ( Clinical At ##tri ##but ##e , o ##bs ##er ##vable entity , o ##bs ##er ##vable entity : F ##RA ##SE - Falls risk assessment score for the elderly ) [SEP]',\n",
       "  'our_cross_cui': 'C3161035',\n",
       "  'our_cross_cui_name': 'Model',\n",
       "  'our_cross_cui_desc': '[CLS] Model [unused3] ( Intel ##lect ##ual Product : Models ; Model ##ing System ; Model System ) [SEP]'},\n",
       " {'mention_id': '28128937.20',\n",
       "  'test_set_idx': 26379,\n",
       "  'type': 'T103',\n",
       "  'name': 'CaCl2',\n",
       "  'context': '[CLS] ##ulated E ##S - Z ##n f ##ert ##ilizer ##s with and without S - o ##xi ##di ##zing micro ##or ##gan ##isms , a commercial elemental sulfur past ##ille , Z ##n ##SO ##4 , and Z ##n ##O were applied to the center of Pet ##ri dishes containing two contrasting pH soils . So ##il pH , [unused1] C ##a ##C ##l ##2 [unused2] - extract ##able sulfur and zinc , and remaining elemental sulfur were evaluated at 30 and 60 days in two soil sections ( 0 - 5 and 5 - 9 mm from the f ##ert ##ilizer application site ) . A visual ##ization test was performed to evaluate zinc diffusion over time . A significant pH decrease was observed in [SEP]',\n",
       "  'existing_cui': 'C1705551',\n",
       "  'existing_cui_name': 'ACSL1 wt Allele',\n",
       "  'existing_cui_desc': '[CLS] AC ##SL ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : LA ##CS ##2 ; A ##cy ##l - Co ##A S ##ynth ##eta ##se Long - Chain Family Member 1 w ##t All ##ele ; LA ##CS ##1 ; LA ##CS ; FA ##CL ##1 ; FA ##CL ##2 ) [SEP]',\n",
       "  'our_bi_cui': 'C0596235',\n",
       "  'our_bi_cui_name': 'Calcium ion',\n",
       "  'our_bi_cui_desc': '[CLS] Cal ##ci ##um ion [unused3] ( Chemical : Cal ##ci ##um Cat ##ion ; free calcium ; CA + 2 ; ion calcium ; Cal ##ci ##um cat ##ion ; Free Cal ##ci ##um ; calcium ions ; C ##a ##2 + ; C ##a + + ; Cal ##ci ##um Ion ##s ; C ##a 2 + ; calcium ion ; CA ##LC ##I ##UM CA ##TI ##ON ; Cal ##ci ##um Ion ; calcium cat ##ion ; Cal ##ci ##um 2 + ; Ion ##ized Cal ##ci ##um ) [SEP]',\n",
       "  'our_cross_cui': 'C0006686',\n",
       "  'our_cross_cui_name': 'Calcium Chloride',\n",
       "  'our_cross_cui_desc': '[CLS] Cal ##ci ##um Ch ##lor ##ide [unused3] ( Chemical , product , substance : calcium ( 2 + ) chloride ; CA ##LC ##I ##UM CH ##L ##OR ##ID ##E ; calcium chloride ; Cal ##ci ##um chloride ; Ch ##lor ##ide , Cal ##ci ##um ; Cal ##ci ##um Ch ##lor ##ide He ##xa ##hy ##dra ##te ; Cal ##ci ##um Ch ##lor ##ide [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '28263181.26',\n",
       "  'test_set_idx': 30386,\n",
       "  'type': 'T170',\n",
       "  'name': 'theorem',\n",
       "  'context': '[CLS] f ##er ##ment ##ative metabolism decreases around 10 % the production of en ##tropy per mole of glucose consumed in cancer cells . We h ##y ##pot ##hes ##ize that increased f ##er ##mentation could allow cancer cells to accomplish the P ##rig ##og ##ine theorem of the trend to minimize the rate of production of en ##tropy . According the [unused1] theorem [unused2] , open cellular systems near the steady state could evolve to minimize the rates of en ##tropy production that may be reached by modified replica ##ting cells producing en ##tropy at low rate . Re ##mark ##ably , at CO ##2 concentrations above 93 ##0 pp ##m , glucose re ##spiration produces less en ##tropy than f ##er ##mentation , which suggests [SEP]',\n",
       "  'existing_cui': 'C0034673',\n",
       "  'existing_cui_name': 'rapid eye movement',\n",
       "  'existing_cui_desc': '[CLS] rapid eye movement [unused3] ( B ##iol ##og ##ic Fun ##ction : Movement , Rapid Eye ; Rapid Eye Movement ; Rapid Eye Movement ##s ; Eye Movement ##s , Rapid ; Movement ##s , Rapid Eye ; Eye Movement , Rapid ) [SEP]',\n",
       "  'our_bi_cui': 'C1705273',\n",
       "  'our_bi_cui_name': 'Mathematical Operator',\n",
       "  'our_bi_cui_desc': '[CLS] Mathematical Opera ##tor [unused3] ( Intel ##lect ##ual Product : Opera ##tor ; Fun ##ction ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27692319.47',\n",
       "  'test_set_idx': 14318,\n",
       "  'type': 'T204',\n",
       "  'name': 'miracidia',\n",
       "  'context': '[CLS] at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μ ##g / m ##L affected em ##b ##ryo ##nic development , with n - but ##ano ##l presenting the strongest in ##hibition of mi ##rac ##id ##ia formation . In contrast , on the 12th day , 90 % of the [unused1] mi ##rac ##id ##ia [unused2] hatch ##ed in the control experiments using 0 . 03 % D ##MS ##O whereas em ##b ##ryo ##genesis was completely abolished with any concentration of al ##ben ##da ##zo ##le su ##l ##ph ##oxide AB ##Z ( S ##O ) . Chemical analysis of the crude extract and sub - fraction ##s revealed a prominent presence of fl ##av [SEP]',\n",
       "  'existing_cui': 'C0451085',\n",
       "  'existing_cui_name': 'Composite international diagnostic interview',\n",
       "  'existing_cui_desc': '[CLS] Co ##mpo ##site international diagnostic interview [unused3] ( Intel ##lect ##ual Product , C ##ID ##I , assessment scale : composite international diagnostic interview ; C ##ID ##I - Co ##mpo ##site international diagnostic interview ) [SEP]',\n",
       "  'our_bi_cui': 'C2807025',\n",
       "  'our_bi_cui_name': 'Focillidia',\n",
       "  'our_bi_cui_desc': '[CLS] F ##oc ##ill ##id ##ia [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
       "  'our_cross_cui': 'C0023047',\n",
       "  'our_cross_cui_name': 'Larva',\n",
       "  'our_cross_cui_desc': '[CLS] La ##rva [unused3] ( E ##uka ##ryo ##te : La ##rva ##e ; la ##rva ; larvae ) [SEP]'},\n",
       " {'mention_id': '28179911.66',\n",
       "  'test_set_idx': 27660,\n",
       "  'type': 'T204',\n",
       "  'name': 'T2',\n",
       "  'context': '[CLS] ##cer ##ols assembly ( BC ##CP ##2 , K ##AS ##I , MA ##T , E ##NR , FA ##TA , and GP ##D ##H ) were also ass ##ay ##ed in mature seeds . Furthermore , lip ##id and fatty acids C ##16 : 0 and C ##18 : 0 significantly increased . In two ho ##mo ##zy ##go ##us [unused1] T ##2 [unused2] trans ##genic rice lines ( G ##5 and G ##2 ) , different Co ##WR ##I ##1 expression levels were detected , but no Co ##WR ##I ##1 trans ##cripts were detected in the wild type . Ana ##ly ##ses of the seed oil content , star ##ch content , and total protein content indicated that the two T ##2 trans [SEP]',\n",
       "  'existing_cui': 'C1335834',\n",
       "  'existing_cui_name': 'SLC25A5 gene',\n",
       "  'existing_cui_desc': '[CLS] SL ##C ##25 ##A ##5 gene [unused3] ( Ana ##tom ##ical Structure : AD ##P / ATP T ##RA ##NS ##L ##OC ##AS ##E 2 ; 2 ##F ##1 ; Sol ##ute Carrier Family 25 ( Mi ##to ##cho ##nd ##rial Carrier ; Aden ##ine N ##uc ##leo ##tide Trans ##loc ##ator ) , Member 5 Gene ; AD ##EN ##IN ##E N ##UC ##LE ##OT ##ID ##E T ##RA ##NS ##L ##OC ##AT ##OR 2 ; SL ##C ##25 ##A ##5 Gene ; AD ##P / ATP CA ##R ##RI ##ER 2 ; so ##lut ##e carrier family 25 member 5 ; AD ##P / ATP T ##RA ##NS ##L ##OC ##AT ##OR OF F ##IB ##RO ##BL ##AS ##TS ; S ##OL ##UT ##E [SEP]',\n",
       "  'our_bi_cui': 'C0282641',\n",
       "  'our_bi_cui_name': 'Transgenes',\n",
       "  'our_bi_cui_desc': '[CLS] Trans ##gene ##s [unused3] ( Ana ##tom ##ical Structure : trans ##gene ; Trans ##gene ) [SEP]',\n",
       "  'our_cross_cui': 'C0085245',\n",
       "  'our_cross_cui_name': 'Plants , Transgenic',\n",
       "  'our_cross_cui_desc': '[CLS] Plants , Trans ##genic [unused3] ( E ##uka ##ryo ##te : Trans ##genic Plants ; Trans ##genic Plant ; trans ##genic plant ; trans ##genic plants ; Plant , Trans ##genic ; plant trans ##genic ; Trans ##genic plants ) [SEP]'},\n",
       " {'mention_id': '28380217.17',\n",
       "  'test_set_idx': 33737,\n",
       "  'type': 'T033',\n",
       "  'name': 'antibacterial potential',\n",
       "  'context': '[CLS] derivatives bearing 2 - fur ##oy ##l - 1 - pipe ##raz ##ine and having modest toxicity . The synthesis was completed as a multiple sequence . The structural confirmation of all the synthesized compounds was obtained by E ##I - MS , I ##R and 1 ##H - N ##MR spectral data . The enzyme in ##hibition and [unused1] anti ##ba ##cter ##ial potential [unused2] of the synthesized compounds was evaluated . To find the utility of the prepared compounds as possible therapeutic agents their c ##yt ##oto ##xi ##city was also checked . All the compounds were active against ace ##ty ##l ##cho ##lines ##tera ##se enzyme , especially 12 and 14 showed very good inhibitor ##y potential relative to E ##ser ##ine , [SEP]',\n",
       "  'existing_cui': 'C0279516',\n",
       "  'existing_cui_name': 'Anti-Bacterial Agents',\n",
       "  'existing_cui_desc': '[CLS] Anti - Ba ##cter ##ial Agents [unused3] ( Chemical , medication , product , substance : Anti ##ba ##cter ##ial agent ; Anti ##ba ##cter ##ial ##s ; anti ##ba ##cter ##ial ##s ; Anti Ba ##cter ##ial Co ##mpo ##unds ; anti - bacterial agents ; Anti ##ba ##cter ##ial Agent [ T ##C ] ; Anti ##ba ##cter ##ial Agent ; AN ##TI ##BA ##CT ##ER ##IA ##L AG ##EN ##TS ; Anti ##ba ##cter ##ial Agents ; Agents , Anti ##ba ##cter ##ial ; Anti - Ba ##cter ##ial Co ##mpo ##unds ; Anti ##ba ##cter ##ial ; Co ##mpo ##unds , Anti - Ba ##cter ##ial ; Anti Ba ##cter ##ial Agents ; anti ##ba ##cter ##ial drug ; anti ##ba ##cter [SEP]',\n",
       "  'our_bi_cui': 'C0279516',\n",
       "  'our_bi_cui_name': 'Anti-Bacterial Agents',\n",
       "  'our_bi_cui_desc': '[CLS] Anti - Ba ##cter ##ial Agents [unused3] ( Chemical , medication , product , substance : Anti ##ba ##cter ##ial agent ; Anti ##ba ##cter ##ial ##s ; anti ##ba ##cter ##ial ##s ; Anti Ba ##cter ##ial Co ##mpo ##unds ; anti - bacterial agents ; Anti ##ba ##cter ##ial Agent [ T ##C ] ; Anti ##ba ##cter ##ial Agent ; AN ##TI ##BA ##CT ##ER ##IA ##L AG ##EN ##TS ; Anti ##ba ##cter ##ial Agents ; Agents , Anti ##ba ##cter ##ial ; Anti - Ba ##cter ##ial Co ##mpo ##unds ; Anti ##ba ##cter ##ial ; Co ##mpo ##unds , Anti - Ba ##cter ##ial ; Anti Ba ##cter ##ial Agents ; anti ##ba ##cter ##ial drug ; anti ##ba ##cter [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28035661.11',\n",
       "  'test_set_idx': 23939,\n",
       "  'type': 'T082',\n",
       "  'name': 'Hortus',\n",
       "  'context': '[CLS] Evidence of tooth ##pic ##k groove formation in N ##ean ##der ##tal anterior and posterior teeth During the micro ##scopic examination of the N ##ean ##der ##tal den ##ti ##tions from El Sid ##r ##ón ( Spain ) and [unused1] Ho ##rt ##us [unused2] ( France ) , we found unusual fine parallel micro ##st ##ria ##tions on the me ##sia ##l and di ##stal sides of all tooth types , near the c ##er ##vi ##x . As its appearance was similar to tooth ##pic ##k groove ##s described in other Ho ##mo species , it could correspond to early stages on its formation . To test this hypothesis we developed an experimental replication of a groove using grass stalk ##s . Co ##mp ##aris [SEP]',\n",
       "  'existing_cui': 'C4178118',\n",
       "  'existing_cui_name': 'Tortus',\n",
       "  'existing_cui_desc': '[CLS] Tor ##tus [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
       "  'our_bi_cui': 'C0086418',\n",
       "  'our_bi_cui_name': 'Homo sapiens',\n",
       "  'our_bi_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '28125734.44',\n",
       "  'test_set_idx': 26198,\n",
       "  'type': 'T103',\n",
       "  'name': 'MiR-21-5p',\n",
       "  'context': '[CLS] ( Met - 5 ##A ) which expresses low levels of me ##so ##the ##lin . Mi ##RNA ##s targeting the me ##so ##the ##lin m ##RNA were identified by next generation se ##quencing and mi ##R - 21 - 5 ##p and mi ##R - 100 - 5 ##p were selected for further valid ##ation analyses . [unused1] Mi ##R - 21 - 5 ##p [unused2] was shown to be able to m ##od ##ulate me ##so ##the ##lin expression in mi ##RNA mimic experiments in a panel of ma ##li ##gnant and non - ma ##li ##gnant cell lines . Further mi ##RNA inhibitor experiments and l ##uc ##ifer ##ase ass ##ays in Me ##ro - 14 cells valid ##ated mi ##R - 21 [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1999986',\n",
       "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '28223077.18',\n",
       "  'test_set_idx': 28902,\n",
       "  'type': 'T082',\n",
       "  'name': 'background site',\n",
       "  'context': '[CLS] to understand the influence of Municipal solid waste land ##fill on p ##oly ##ch ##lor ##inated di ##ben ##zo - p - di ##ox ##ins and p ##oly ##ch ##lor ##inated di ##ben ##zo ##fu ##ran ##s ( PC ##D ##D / F ##s ) in surrounding atmosphere , 42 ambient air samples were collected and analyzed from surrounding sites , [unused1] background site [unused2] , up ##wind site and down ##wind site of a Municipal solid waste land ##fill in East China . The results of present study were summarized as follows . ( 1 ) The total concentrations of PC ##D ##D / F ##s ( [UNK] PC ##D ##D / F ##s ) in ambient air from surrounding sites , background site , [SEP]',\n",
       "  'existing_cui': 'C0237490',\n",
       "  'existing_cui_name': 'Family Background',\n",
       "  'existing_cui_desc': '[CLS] Family Background [unused3] ( Finding , Family : Background ) [SEP]',\n",
       "  'our_bi_cui': 'C0017446',\n",
       "  'our_bi_cui_name': 'Geographic Locations',\n",
       "  'our_bi_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]',\n",
       "  'our_cross_cui': 'C0205145',\n",
       "  'our_cross_cui_name': 'Site',\n",
       "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
       " {'mention_id': '28210319.72',\n",
       "  'test_set_idx': 28603,\n",
       "  'type': 'T033',\n",
       "  'name': 'respiratory implications',\n",
       "  'context': '[CLS] lung compliance decrease , and air ##way o ##bs ##truction makes air ##way resistance increase . The consequences of respiratory pump failure are restrict ##ive pulmonary function , h ##y ##po ##vent ##ilation , altered th ##ora ##coa ##b ##dom ##inal pattern , h ##yper ##cap ##nia , d ##ys ##p ##no ##ea , impaired regulation of breathing , in ##ef ##ficient cough and sleep disorder ##ed breathing . To understand the mechanisms leading to respiratory disturbance ##s in patients with muscular d ##ys ##tro ##phy . To understand the impact of respiratory disturbance ##s in patients with muscular d ##ys ##tro ##phy . To provide a brief description of the main forms of muscular d ##ys ##tro ##phy with their [unused1] respiratory implications [unused2] . [SEP]',\n",
       "  'existing_cui': 'C0729250',\n",
       "  'existing_cui_name': 'Respiratory complications',\n",
       "  'existing_cui_desc': '[CLS] Re ##sp ##ira ##tory complications [unused3] ( In ##ju ##ry or Po ##ison ##ing ) [SEP]',\n",
       "  'our_bi_cui': 'C0161818',\n",
       "  'our_bi_cui_name': 'Respiratory complication',\n",
       "  'our_bi_cui_desc': '[CLS] Re ##sp ##ira ##tory com ##plication [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : respiratory ; complications ; complications ; respiratory ; respiratory complications ; Re ##sp ##ira ##tory complications ; respiratory com ##plication ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28050885.57',\n",
       "  'test_set_idx': 24203,\n",
       "  'type': 'T033',\n",
       "  'name': 'No',\n",
       "  'context': '[CLS] and ankle - bra ##chia ##l index values increased by 24 % ( p = 0 . 000 ##1 ) in the treatment group but decreased in the control group . The greatest therapeutic effect was observed for stage III disease : Pain - free walking distance increased by 68 ##3 % ( p = 0 . 000 ##1 ) . [unused1] No [unused2] an ##gio ##genic therapy - related adverse events or side effects were recorded , and target limb salvage was 96 and 97 % in the treatment and control groups , respectively . The results obtained in this study are not significantly different from those observed in the phase II ##b / III registration clinical study completed in 2011 . p ##l - [SEP]',\n",
       "  'existing_cui': 'C1016143',\n",
       "  'existing_cui_name': 'Tetragenococcus halophilus',\n",
       "  'existing_cui_desc': '[CLS] Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us [unused3] ( Ba ##cter ##ium , organism : P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us Me ##es 1934 ( A ##pp ##roved List ##s 1980 ) ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us ( Me ##es 1934 ) Collins et al . 1993 ; Sa ##rc ##ina ha ##ma ##guchi ##ae ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##a ; P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us ; Te ##tra ##co ##cc ##cus No . 1 ; P ##ed ##io ##co ##cc ##us so ##ya ##e ) [SEP]',\n",
       "  'our_bi_cui': 'C0243095',\n",
       "  'our_bi_cui_name': 'Finding',\n",
       "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C1513916',\n",
       "  'our_cross_cui_name': 'Negative Finding',\n",
       "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
       " {'mention_id': '28000391.18',\n",
       "  'test_set_idx': 23417,\n",
       "  'type': 'T033',\n",
       "  'name': 'after hospital discharge',\n",
       "  'context': '[CLS] monitoring . This contains for quantitative assessment the Short Form Health Survey question ##naire and the Impact of Family Scale administered one and five weeks following discharge before and after stage II . For q ##ual ##itative assessment , semi - structured interviews focus ##sing on the post ##dis ##cha ##rge cop ##ing strategies were conducted twice , five weeks [unused1] after hospital discharge [unused2] before and after stage II . Ten infants ( eight males ) with h ##y ##pop ##lastic left heart syndrome ( n = 7 ) or other types of un ##ive ##nt ##ric ##ular heart ma ##lf ##orm ##ations ( n = 3 ) , and their parents ( nine mother / father two - parent households , one single mother [SEP]',\n",
       "  'existing_cui': 'C0586003',\n",
       "  'existing_cui_name': 'Discharge from hospital',\n",
       "  'existing_cui_desc': '[CLS] Disc ##har ##ge from hospital [unused3] ( Health Care Act ##ivity , procedure : discharge ##s hospital ; Hospital Disc ##har ##ge ; discharge from hospital ; hospital discharge ; discharge hospital ) [SEP]',\n",
       "  'our_bi_cui': 'C0586003',\n",
       "  'our_bi_cui_name': 'Discharge from hospital',\n",
       "  'our_bi_cui_desc': '[CLS] Disc ##har ##ge from hospital [unused3] ( Health Care Act ##ivity , procedure : discharge ##s hospital ; Hospital Disc ##har ##ge ; discharge from hospital ; hospital discharge ; discharge hospital ) [SEP]',\n",
       "  'our_cross_cui': 'C1320368',\n",
       "  'our_cross_cui_name': 'Post-discharge follow-up',\n",
       "  'our_cross_cui_desc': '[CLS] Post - discharge follow - up [unused3] ( Finding , finding ) [SEP]'},\n",
       " {'mention_id': '27838742.17',\n",
       "  'test_set_idx': 18984,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] developing novel ch ##em ##oth ##era ##pe ##uti ##c agents . In this study , data supporting the in v ##it ##ro and in v ##ivo anti ##can ##cer effects of del ##ica ##f ##lav ##one , a rarely occurring bi ##f ##lav ##ono ##id from Se ##lag ##ine ##lla do ##ede ##rle ##ini ##i , were reported . [unused1] Del ##ica ##f ##lav ##one [unused2] exhibited favorable anti ##can ##cer properties , as shown by the M ##TT ass ##ay and x ##eno ##gra ##ft model of human non - small cell lung cancer in male BA ##L ##B / c nude mice without o ##bs ##er ##vable adverse effect . By transmission electron micro ##sco ##py with a ##c ##rid ##ine orange and Cy [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28487667.6',\n",
       "  'test_set_idx': 37681,\n",
       "  'type': 'T170',\n",
       "  'name': 'test batteries',\n",
       "  'context': \"[CLS] When Is a Test Score Fair for the Individual Who Is Being Test ##ed ? Effects of Different Sc ##oring Pro ##ced ##ures across Multiple At ##tem ##pts When Testing a Motor Ski ##ll Task Tests or [unused1] test batteries [unused2] used for assessing motor skills , either in research studies or in clinical settings , apply a variety of procedures for scoring performances , including everything from one to ten attempts , of which the best is scored or an average is com ##puted . The rational ##e behind scoring procedures is rarely stated , and it seems that the number of attempts allowed is decided without much qualification from research . It is uncertain whether procedures fairly capture an individual ' s skill level [SEP]\",\n",
       "  'existing_cui': 'C0456724',\n",
       "  'existing_cui_name': 'Willeford test battery',\n",
       "  'existing_cui_desc': '[CLS] Will ##ef ##ord test battery [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
       "  'our_bi_cui': 'C0687197',\n",
       "  'our_bi_cui_name': 'Battery tester',\n",
       "  'our_bi_cui_desc': '[CLS] Battery test ##er [unused3] ( Medical Devi ##ce , physical object : Battery Ana ##ly ##zers ; Test ##ers , Battery ) [SEP]',\n",
       "  'our_cross_cui': 'C0392366',\n",
       "  'our_cross_cui_name': 'Tests',\n",
       "  'our_cross_cui_desc': '[CLS] Tests [unused3] ( Intel ##lect ##ual Product , qualifier value , qualifier value , procedure : tested ; testing ##s ; test ; tests ; testing ) [SEP]'},\n",
       " {'mention_id': '28356035.5',\n",
       "  'test_set_idx': 32979,\n",
       "  'type': 'T033',\n",
       "  'name': 'poor cardiovascular outcome',\n",
       "  'context': '[CLS] poor health worldwide . The most solid evidence is for air pollution , leading to increased disability - adjusted life years . Outdoor temperature and other seasonal climate changes may also influence card ##iovascular health , according to their direct m ##od ##ulation of air pollution . Moreover , an increasing body of evidence associates environmental exposure to noise with [unused1] poor card ##iovascular outcome [unused2] , and in particular with h ##yper ##tens ##ion . This review is aimed at reviewing current evidence about the role of these environmental factors in card ##iovascular disease and specifically h ##yper ##tens ##ion . In particular , the impact of air pollution , with its short - term and long - term effects , the outdoor temperature and [SEP]',\n",
       "  'existing_cui': 'C3806166',\n",
       "  'existing_cui_name': 'Poor outcome',\n",
       "  'existing_cui_desc': '[CLS] Poor outcome [unused3] ( Finding ) [SEP]',\n",
       "  'our_bi_cui': 'C3806166',\n",
       "  'our_bi_cui_name': 'Poor outcome',\n",
       "  'our_bi_cui_desc': '[CLS] Poor outcome [unused3] ( Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28441489.46',\n",
       "  'test_set_idx': 36168,\n",
       "  'type': 'T033',\n",
       "  'name': 'cold - start',\n",
       "  'context': '[CLS] depend on engine technology . Cold - start contributes a larger fraction of the total unified cycle emissions for vehicles meeting more - string ##ent emission standards . Organic gas emissions were the most sensitive to cold - start compared to the other poll ##uta ##nts tested here . There were no statistical ##ly significant differences in the effects of [unused1] cold - start [unused2] on G ##DI ##s and P ##FI ##s . For our test fleet , the measured 14 . 5 % decrease in CO ##2 emissions from G ##DI ##s was much greater than the potential climate forcing associated with higher black carbon emissions . Thus , switching from Port Fuel In ##jection to gasoline direct - injection vehicles will likely lead [SEP]',\n",
       "  'existing_cui': 'C0452588',\n",
       "  'existing_cui_name': 'Start brand of breakfast cereal',\n",
       "  'existing_cui_desc': '[CLS] Start brand of breakfast cereal [unused3] ( Food , substance : Start ) [SEP]',\n",
       "  'our_bi_cui': 'C1455171',\n",
       "  'our_bi_cui_name': 'Cool-X-A',\n",
       "  'our_bi_cui_desc': '[CLS] Cool - X - A [unused3] ( Chemical : Cool - Cool ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27570140.50',\n",
       "  'test_set_idx': 10513,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedures',\n",
       "  'context': \"[CLS] the 27 months of follow - up . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Over one third of high - risk patients ' requests were un ##ful ##fill ##ed , indicating that significant barriers may remain . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Pro ##vide ##rs should consider these [unused1] procedures [unused2] urgent , especially in high - risk women , and advocate for their patients ' access to this procedure . [SEP]\",\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '28301509.6',\n",
       "  'test_set_idx': 31703,\n",
       "  'type': 'T058',\n",
       "  'name': 'CoMPP technique',\n",
       "  'context': '[CLS] Gen ##ome - wide association mapping in winter bar ##ley for grain yield and cu ##lm cell wall polymer content using the high - through ##put [unused1] Co ##MP ##P technique [unused2] A collection of 112 winter bar ##ley varieties ( Ho ##rde ##um v ##ul ##gar ##e L . ) was grown in the field for two years ( 2008 / 09 and 2009 / 10 ) in northern Italy and grain and straw yields recorded . In the first year of the trial , a severe attack of bar ##ley yellow mosaic virus strongly influenced final performances with an average reduction of ~ 50 % for grain and straw harvested in comparison to the second year . The genetic determination for grain yield was [SEP]',\n",
       "  'existing_cui': 'C0450241',\n",
       "  'existing_cui_name': 'Ffooks technique',\n",
       "  'existing_cui_desc': '[CLS] F ##fo ##ok ##s technique [unused3] ( Health Care Act ##ivity , qualifier value ) [SEP]',\n",
       "  'our_bi_cui': 'C0430022',\n",
       "  'our_bi_cui_name': 'diagnostic procedure',\n",
       "  'our_bi_cui_desc': '[CLS] diagnostic procedure [unused3] ( Health Care Act ##ivity , procedure : D ##IA ##G ##N ##OS ##TI ##C ; Di ##ag ##nos ##tic procedure ; Di ##ag ##nos ##tic procedures ; Di ##ag ##nos ##tic Test ; diagnostic technique ; Di ##ag ##nos ##tic ; Di ##ag ##nos ##tic Tech ##ni ##que ; Di ##ag ##nos ##tic Pro ##ced ##ure ; diagnostic procedures ; Di ##ag ##nos ##tic Method ; Pro ##ced ##ures ; diagnostic ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '27887587.58',\n",
       "  'test_set_idx': 20946,\n",
       "  'type': 'T033',\n",
       "  'name': 'family',\n",
       "  'context': \"[CLS] . The participants ' expectations about counsel ##ling with regard to longer - term family , practical , and financial challenges were insufficient ##ly met by the Community Mental Health Centre . In the experience of the service users , recovery occurred within the context of their everyday life with or without the support of their professional help ##ers . To facilitate recovery , health professionals should acknowledge the service user ' s personal goals and hopes and take a more comprehensive and longer - term approach to his or her needs and desires . A ##ck ##no ##wl ##ed ##ging and f ##ac ##ilitating recovery goals by offering counsel ##ling with regard to [unused1] family [unused2] , practical and financial issues seems particularly important . [SEP]\",\n",
       "  'existing_cui': 'C1301584',\n",
       "  'existing_cui_name': 'Last Name',\n",
       "  'existing_cui_desc': '[CLS] Last Name [unused3] ( Intel ##lect ##ual Product , o ##bs ##er ##vable entity : Family Name ; family ; Last name ; Sur ##name ) [SEP]',\n",
       "  'our_bi_cui': 'C0424960',\n",
       "  'our_bi_cui_name': 'Family problems',\n",
       "  'our_bi_cui_desc': '[CLS] Family problems [unused3] ( Finding , finding , history : problem ; family ; Problem ; family ; family problems ; family ; problem ; family problem ) [SEP]',\n",
       "  'our_cross_cui': 'C0851511',\n",
       "  'our_cross_cui_name': 'Family issues',\n",
       "  'our_cross_cui_desc': '[CLS] Family issues [unused3] ( Finding : family issues ; families issues ; Family Issues ; family issue ) [SEP]'},\n",
       " {'mention_id': '28272254.30',\n",
       "  'test_set_idx': 30776,\n",
       "  'type': 'T170',\n",
       "  'name': 'papers',\n",
       "  'context': '[CLS] ##in receptor block ##ers , calcium channel block ##ers [ CC ##B ##s ] , and di ##ure ##tics ) on re ##gression of Left vent ##ric ##ular h ##yper ##tro ##phy . Re ##lative trials were identified in the Pub ##M ##ed , Web of Science , O ##VI ##D E ##BM Reviews and Cochrane databases , and the relevant [unused1] papers [unused2] were examined . We performed both traditional and Bay ##esi ##an meta - analysis of random ##ized controlled trials about the re ##gression of Left vent ##ric ##ular h ##yper ##tro ##phy . Sen ##si ##ti ##vity analysis and re ##gression analysis were performed to explore possible sources of he ##tero ##gene ##ity . Inc ##ons ##ist ##ency analysis was performed to [SEP]',\n",
       "  'existing_cui': 'C0462999',\n",
       "  'existing_cui_name': 'Litmus paper',\n",
       "  'existing_cui_desc': '[CLS] Li ##t ##mus paper [unused3] ( Medical Devi ##ce , physical object : Li ##t ##mus Paper ; lit ##mus papers ; Re ##age ##nts , Clinical Chemistry , Rapid Test , pH , Strip ; IV ##D Test Re ##age ##nt / Kit ##s , Clinical Chemistry , Rapid Test , pH , Strip ; pH Strip In ##dic ##ators ; lit ##mus paper ) [SEP]',\n",
       "  'our_bi_cui': 'C0282420',\n",
       "  'our_bi_cui_name': 'Journal Article',\n",
       "  'our_bi_cui_desc': '[CLS] Journal Article [unused3] ( Intel ##lect ##ual Product : journal article ) [SEP]',\n",
       "  'our_cross_cui': 'C1706852',\n",
       "  'our_cross_cui_name': 'Article',\n",
       "  'our_cross_cui_desc': '[CLS] Article [unused3] ( Intel ##lect ##ual Product ) [SEP]'},\n",
       " {'mention_id': '27791364.5',\n",
       "  'test_set_idx': 16973,\n",
       "  'type': 'T058',\n",
       "  'name': 'Photoacoustic / Magnetic Resonance Imaging - Guided Tumor - Targeted Photothermal Therapy',\n",
       "  'context': '[CLS] Album ##in - B ##io ##ins ##pired G ##d : C ##u ##S Nan ##oth ##eran ##ost ##ic Agent for In V ##ivo [unused1] Photo ##aco ##ustic / Ma ##gnetic Re ##son ##ance I ##maging - Guide ##d Tu ##mor - Target ##ed Photo ##thermal Therapy [unused2] Photo ##thermal therapy is attracting increasing interest and becoming more widely used for skin cancer therapy in the clinic , as a result of its non ##in ##vasive ##ness and low systemic adverse effects . However , there is an urgent need to develop bio ##com ##pa ##tible Photo ##thermal therapy agents , which enable accurate imaging , monitoring , and diagnosis . Here ##in , a bio ##com ##pa ##tible G ##d - integrated C ##u ##S na [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0031740',\n",
       "  'our_bi_cui_name': 'Photochemotherapy',\n",
       "  'our_bi_cui_desc': '[CLS] Photo ##che ##mother ##ap ##y [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : PD ##T - Photo ##dynamic therapy ; Photo ##che ##mother ##ap ##ies ; Photo ##dynamic The ##rap ##ies ; therapy , photo ##dynamic ; Therapy , Photo ##dynamic ; THE ##R P ##H ##OT ##OD ##Y ##NA ##MI ##C ; Photo ##rad ##iation Therapy ; photo ##dynamic therapy ; photo ##che ##mother ##ap ##y ; P ##H ##OT ##OC ##H ##EM ##OT ##H ##ER ; The ##rap ##ies , Photo ##dynamic ; Photo ##dynamic Therapy Pro ##ced ##ures ; neo ##p ##las ##m / cancer photo ##rad ##iation therapy ; Photo ##che ##mother ##ap ##y [ Am ##bi ##guous ] ; Photo ##dynamic therapy ; PD [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '28013256.31',\n",
       "  'test_set_idx': 23792,\n",
       "  'type': 'T033',\n",
       "  'name': 'succeeded',\n",
       "  'context': \"[CLS] with the exception of improving capacity to engage men and in ##f ##lue ##ncing practice beyond their organisation , these improvements were sustained at 5 - month post training ( P < 0 . 00 ##1 ) . The vast majority of service providers ( 93 . 4 % ) reported that E ##NG ##AG ##E had impacted their work practice up to 5 - month post training . The findings suggest that E ##NG ##AG ##E has [unused1] succeeded [unused2] in improving service providers ' capacity to engage and work with men ; improving gender compete ##ncy in the delivery of health and health related services may increase the u ##til ##isation of such services by men and thereby improve health outcomes for men . [SEP]\",\n",
       "  'existing_cui': 'C0046018',\n",
       "  'existing_cui_name': '2-chloroethyl ethyl sulfide',\n",
       "  'existing_cui_desc': '[CLS] 2 - ch ##lor ##oe ##thy ##l et ##hyl su ##lf ##ide [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C1272702',\n",
       "  'our_bi_cui_name': 'Success of action',\n",
       "  'our_bi_cui_desc': '[CLS] Success of action [unused3] ( Finding , attribute ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27636509.49',\n",
       "  'test_set_idx': 12561,\n",
       "  'type': 'T033',\n",
       "  'name': 'detection',\n",
       "  'context': '[CLS] be characterized by speech disorder and affect ##ive behavior symptoms , cluster 2 has predominantly hall ##uc ##ination symptoms and cluster 3 has mainly del ##usion symptoms . Inter ##action of five S ##NP ##s was found to have an effect on cluster 1 symptoms ; ten S ##NP ##s on cluster 2 symptoms ; and eight S ##NP ##s on cluster 3 symptoms . The interaction of specific su ##s ##ce ##pt ##ibility genes is likely to lead to specific clinical sub - p ##hen ##otype ##s of s ##chi ##zophrenia . Large ##r patient co ##hor ##ts with more extensive clinical data will improve the [unused1] detection [unused2] of gene interactions and the result ##ant s ##chi ##zophrenia clinical p ##hen ##otype ##s . [SEP]',\n",
       "  'existing_cui': 'C0206100',\n",
       "  'existing_cui_name': 'Signal Detection',\n",
       "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
       "  'our_bi_cui': 'C1511790',\n",
       "  'our_bi_cui_name': 'Detection',\n",
       "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
       "  'our_cross_cui': 'C0442726',\n",
       "  'our_cross_cui_name': 'Detected',\n",
       "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
       " {'mention_id': '27692319.41',\n",
       "  'test_set_idx': 14312,\n",
       "  'type': 'T204',\n",
       "  'name': 'Eggs',\n",
       "  'context': '[CLS] . Q ##uad ##rup ##lica ##tes of 50 F . he ##pa ##tica eggs were in ##cu ##bate ##d at 23 °C with M . ch ##aran ##tia leaf crude extract in different concentrations . After 12 days no larvae were formed in eggs in ##cu ##bate ##d with crude extract concentrations above 12 . 5 mg / m ##L . [unused1] Egg ##s [unused2] in ##cu ##bate ##d with crude extract sub - fraction ##s at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μ ##g / m ##L affected em ##b ##ryo ##nic development , with n - but ##ano ##l presenting the strongest in ##hibition of mi ##rac ##id ##ia formation . In contrast [SEP]',\n",
       "  'existing_cui': 'C0029974',\n",
       "  'existing_cui_name': 'Ovum',\n",
       "  'existing_cui_desc': '[CLS] O ##vu ##m [unused3] ( Ana ##tom ##ical Structure , body structure , cell , cell structure , qualifier value : Human egg ; Egg ##s , Un ##fer ##til ##ized ; Fe ##rt ##ilized o ##oc ##yte ; Mat ##ure o ##vu ##m ; O ##va ; Egg ; egg cell ; o ##va ; X bearing o ##vu ##m ; female game ##tes ; O ##ocytes ; Un ##fer ##til ##ized Egg ##s ; X chromosome - bearing o ##vu ##m ; Egg , Un ##fer ##til ##ized ; O ##vu ##m structure ; Un ##fer ##til ##ized Egg ; Female game ##te ; O ##voc ##yte ; egg / o ##vu ##m ; o ##vu ##m ; female game ##te ; X - [SEP]',\n",
       "  'our_bi_cui': 'C0029974',\n",
       "  'our_bi_cui_name': 'Ovum',\n",
       "  'our_bi_cui_desc': '[CLS] O ##vu ##m [unused3] ( Ana ##tom ##ical Structure , body structure , cell , cell structure , qualifier value : Human egg ; Egg ##s , Un ##fer ##til ##ized ; Fe ##rt ##ilized o ##oc ##yte ; Mat ##ure o ##vu ##m ; O ##va ; Egg ; egg cell ; o ##va ; X bearing o ##vu ##m ; female game ##tes ; O ##ocytes ; Un ##fer ##til ##ized Egg ##s ; X chromosome - bearing o ##vu ##m ; Egg , Un ##fer ##til ##ized ; O ##vu ##m structure ; Un ##fer ##til ##ized Egg ; Female game ##te ; O ##voc ##yte ; egg / o ##vu ##m ; o ##vu ##m ; female game ##te ; X - [SEP]',\n",
       "  'our_cross_cui': 'C3662687',\n",
       "  'our_cross_cui_name': 'Fasciola hepatica egg',\n",
       "  'our_cross_cui_desc': '[CLS] F ##as ##cio ##la he ##pa ##tica egg [unused3] ( E ##uka ##ryo ##te , organism : F ##as ##cio ##la he ##pa ##tica o ##va ) [SEP]'},\n",
       " {'mention_id': '28326653.24',\n",
       "  'test_set_idx': 31932,\n",
       "  'type': 'T170',\n",
       "  'name': 'Early Trauma Inventory',\n",
       "  'context': '[CLS] of P ##sy ##cho ##ther ##ap ##y or es ##ci ##tal ##op ##ram plus clinical management over the course of 8 weeks of acute and 20 weeks of extended treatment at 2 German treatment sites . Child ##hood ma ##lt ##rea ##tment was assessed using the Child ##hood T ##ra ##uma Question ##naire and the clinic ##ian rated [unused1] Early T ##ra ##uma In ##vent ##ory [unused2] . In ##ten ##tion - to - treat analyses were used to examine the impact of Child ##hood ma ##lt ##rea ##tment on depression , global functioning , and quality of life . The presence of Child ##hood ma ##lt ##rea ##tment did not result in significant differences in treatment response to Co ##gni ##tive Be ##ha ##vior ##al [SEP]',\n",
       "  'existing_cui': 'C0031213',\n",
       "  'existing_cui_name': 'Personality inventories',\n",
       "  'existing_cui_desc': '[CLS] Personal ##ity inventor ##ies [unused3] ( Health Care Act ##ivity : Personal ##ity In ##vent ##ory ; personality inventory ; inventor ##ies ; inventory ; In ##vent ##ories ; Personal ##ity In ##vent ##ories ; In ##vent ##ory , Personal ##ity ; In ##vent ##ories , Personal ##ity ) [SEP]',\n",
       "  'our_bi_cui': 'C0451546',\n",
       "  'our_bi_cui_name': 'Trauma index',\n",
       "  'our_bi_cui_desc': '[CLS] T ##ra ##uma index [unused3] ( Intel ##lect ##ual Product , assessment scale : index trauma ; trauma index ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27773614.43',\n",
       "  'test_set_idx': 16303,\n",
       "  'type': 'T058',\n",
       "  'name': 'surveillance',\n",
       "  'context': '[CLS] he ##pa ##to ##cellular car ##cin ##oma - case ##load of the hospital where patients were first admitted also had an independent influence on treatment and survival . Despite full insurance coverage for all citizens , national measures to reduce in ##e ##quities in the management of cancer patients , standard ##ised recommendations for he ##pa ##to ##cellular car ##cin ##oma [unused1] surveillance [unused2] and management , the percentage of patients undergoing cu ##rative treatment and their survival may vary four - fold depending on their post ##code . The hospital in which patients are first managed has a clear influence on access ##ibility to both good care and survival . Population - based studies have highlighted large and sometimes unexpected differences between countries in the [SEP]',\n",
       "  'existing_cui': 'C0733511',\n",
       "  'existing_cui_name': 'Medical Surveillance',\n",
       "  'existing_cui_desc': '[CLS] Medical Sur ##ve ##illa ##nce [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Sur ##ve ##illa ##nce ; medical surveillance ; surveillance ; E ##pid ##em ##iology / Sur ##ve ##illa ##nce ) [SEP]',\n",
       "  'our_bi_cui': 'C4316666',\n",
       "  'our_bi_cui_name': 'Surveillance for cancer',\n",
       "  'our_bi_cui_desc': '[CLS] Sur ##ve ##illa ##nce for cancer [unused3] ( Health Care Act ##ivity , regime / therapy ) [SEP]',\n",
       "  'our_cross_cui': 'C0038842',\n",
       "  'our_cross_cui_name': 'Supervision',\n",
       "  'our_cross_cui_desc': '[CLS] Super ##vision [unused3] ( Health Care Act ##ivity , regime / therapy , regime / therapy , procedure : supervision ) [SEP]'},\n",
       " {'mention_id': '28222192.43',\n",
       "  'test_set_idx': 28864,\n",
       "  'type': 'T204',\n",
       "  'name': 'ST1',\n",
       "  'context': '[CLS] ##ba co ##li ( 55 % ) , H ##yme ##no ##le ##pis na ##na ( 0 . 8 % ) , End ##oli ##max na ##na ( 33 . 2 % ) and Neo ##bal ##anti ##dium co ##li ( 2 . 7 % ) was detected in the B ##last ##oc ##ys ##tis - positive samples . We detected [unused1] ST ##1 [unused2] ( 21 . 4 % ) , ST ##2 ( 19 . 5 % ) , ST ##3 ( 55 . 5 % ) , ST ##4 ( 0 . 8 % ) , ST ##6 ( 2 % ) and ST ##7 ( 0 . 8 % ) ; all ##ele ##s 1 , 2 , 4 , 81 , [SEP]',\n",
       "  'existing_cui': 'C3812243',\n",
       "  'existing_cui_name': 'SDCBP wt Allele',\n",
       "  'existing_cui_desc': '[CLS] SD ##C ##B ##P w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : S ##yn ##de ##can Bin ##ding Pro ##tein ( S ##yn ##ten ##in ) w ##t All ##ele ; MD ##A - 9 ; S ##Y ##CL ; ST ##1 ; T ##AC ##IP ##18 ) [SEP]',\n",
       "  'our_bi_cui': 'C2310266',\n",
       "  'our_bi_cui_name': 'bacterium ST1',\n",
       "  'our_bi_cui_desc': '[CLS] bacterium ST ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
       "  'our_cross_cui': 'C3106801',\n",
       "  'our_cross_cui_name': 'Blastocystis sp . subtype 1',\n",
       "  'our_cross_cui_desc': '[CLS] B ##last ##oc ##ys ##tis s ##p . sub ##type 1 [unused3] ( E ##uka ##ryo ##te : B ##last ##oc ##ys ##tis s ##p . ST ##1 ; B ##last ##oc ##ys ##tis s ##p . ST - 1 ) [SEP]'},\n",
       " {'mention_id': '27669669.21',\n",
       "  'test_set_idx': 13726,\n",
       "  'type': 'T037',\n",
       "  'name': 'subluxation',\n",
       "  'context': '[CLS] ##l syndrome , this sub ##lux ##ation occurs spontaneous ##ly after inflammatory processes of the head and neck . Di ##ag ##nosis is typically based on clinical history and a strong suspicion of this syndrome . Non ##su ##rg ##ical treatment most often resolve ##s the symptoms ; however , in some cases surgical treatment is necessary to repair the [unused1] sub ##lux ##ation [unused2] . Various surgical techniques and instrumentation systems have been used to treat at ##lant ##oa ##xial sub ##lux ##ation , although there is no consensus regarding the best treatment method for the p ##ediatric population . To describe a case of at ##lant ##oa ##xial sub ##lux ##ation in a child with G ##rise ##l syndrome treated surgical ##ly with an [SEP]',\n",
       "  'existing_cui': 'C0332768',\n",
       "  'existing_cui_name': 'Joint Subluxations',\n",
       "  'existing_cui_desc': '[CLS] Joint Sub ##lux ##ations [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity , physical finding , qualifier value : sub ##lux ##ation ; Sub ##lux ##ation ; Sub ##lux ##ation , Joint ; Di ##s ##location , incomplete ; Joint sub ##lux ##ation ; Joint Sub ##lux ##ation ; Sub ##lux ##ation of joint ; sub ##lux ##ations ; Inc ##om ##ple ##te di ##s ##location ; joint sub ##lux ##ation ; Sub ##lux ##ations ; incomplete di ##s ##location ; Sub ##lux ##ations , Joint ; sub ##lux ##ation was seen ; sub ##lux ##ation of joint ; Sub ##lux ##ation - les ##ion ) [SEP]',\n",
       "  'our_bi_cui': 'C0332768',\n",
       "  'our_bi_cui_name': 'Joint Subluxations',\n",
       "  'our_bi_cui_desc': '[CLS] Joint Sub ##lux ##ations [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity , physical finding , qualifier value : sub ##lux ##ation ; Sub ##lux ##ation ; Sub ##lux ##ation , Joint ; Di ##s ##location , incomplete ; Joint sub ##lux ##ation ; Joint Sub ##lux ##ation ; Sub ##lux ##ation of joint ; sub ##lux ##ations ; Inc ##om ##ple ##te di ##s ##location ; joint sub ##lux ##ation ; Sub ##lux ##ations ; incomplete di ##s ##location ; Sub ##lux ##ations , Joint ; sub ##lux ##ation was seen ; sub ##lux ##ation of joint ; Sub ##lux ##ation - les ##ion ) [SEP]',\n",
       "  'our_cross_cui': 'C0263905',\n",
       "  'our_cross_cui_name': 'Atlantoaxial subluxation',\n",
       "  'our_cross_cui_desc': '[CLS] At ##lant ##oa ##xial sub ##lux ##ation [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder : AA ##S - At ##lant ##oa ##xial sub ##lux ##ation ; at ##lant ##oa ##xial ; sub ##lux ##ation ; di ##s ##location ; at ##lant ##oa ##xial ; At ##lant ##o - a ##xial sub ##lux ##ation ; At ##lant ##oa ##xial di ##s ##location ; at ##lant ##oa ##xial ; di ##s ##location ; Sub ##lux ##ation of at ##lant ##oa ##xial joint ; sub ##lux ##ation ; at ##lant ##oa ##xial ) [SEP]'},\n",
       " {'mention_id': '28237762.5',\n",
       "  'test_set_idx': 29307,\n",
       "  'type': 'T103',\n",
       "  'name': 'acylated phenoxyanilide',\n",
       "  'context': '[CLS] S ##ynth ##esis , SA ##R and molecular dock ##ing study of novel non - β - la ##ct ##am inhibitor ##s of T ##EM type β - la ##ct ##ama ##se The novel classes of [unused1] a ##cy ##lated p ##hen ##ox ##yan ##ili ##de [unused2] and th ##io ##ure ##a compounds were investigated for their ability to in ##hibit T ##EM type β - la ##ct ##ama ##se enzyme . Two compounds 4 ##g and 5 ##c reveal the in ##hibition pot ##ency in micro ##mo ##lar range and show their action by non - co ##valent binding in the vicinity of the T ##EM - 171 active site . The structure activity relationship around carbon chain length and different sub ##st ##it ##uen [SEP]',\n",
       "  'existing_cui': 'C0031403',\n",
       "  'existing_cui_name': 'Phenetidine',\n",
       "  'existing_cui_desc': '[CLS] Ph ##ene ##ti ##dine [unused3] ( Chemical : Ph ##ene ##ti ##dine [ Chemical / In ##g ##red ##ient ] ; Benz ##ena ##mine , 4 - et ##ho ##xy - ; Am ##ino ##phe ##net ##ole ; E ##th ##ox ##yan ##ili ##ne ) [SEP]',\n",
       "  'our_bi_cui': 'C0029224',\n",
       "  'our_bi_cui_name': 'Organic Chemicals',\n",
       "  'our_bi_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28197133.39',\n",
       "  'test_set_idx': 28055,\n",
       "  'type': 'T103',\n",
       "  'name': 'oligosaccharidases',\n",
       "  'context': '[CLS] , G ##H1 ##3 ( am ##yla ##se ) , G ##H ##43 and G ##H1 ##0 ( hem ##ice ##ll ##ula ##ses ) , G ##H ##9 and G ##H ##48 ( cell ##ula ##ses ) , P ##L ##11 ( p ##ec ##tina ##se ) as well as G ##H ##2 and G ##H ##3 ( [unused1] o ##li ##gos ##ac ##cha ##rida ##ses [unused2] ) . Our data support the pivotal role of the most characterized fi ##bro ##ly ##tic bacteria ( Pre ##vo ##tel ##la , R ##umi ##no ##cc ##cus and Fi ##bro ##ba ##cter ) , and highlight a substantial , although most probably under ##est ##imated , contribution of fungi and c ##ilia ##te pro ##to ##zo ##a to [SEP]',\n",
       "  'existing_cui': 'C0028959',\n",
       "  'existing_cui_name': 'Oligosaccharides',\n",
       "  'existing_cui_desc': '[CLS] O ##li ##gos ##ac ##cha ##ride ##s [unused3] ( Chemical , substance : o ##li ##gos ##ac ##cha ##ride ##s ; O ##li ##gos ##ac ##cha ##ride ##s [ Chemical / In ##g ##red ##ient ] ; O ##li ##gos ##ac ##cha ##ride ; o ##li ##gos ##ac ##cha ##ride ) [SEP]',\n",
       "  'our_bi_cui': 'C0012610',\n",
       "  'our_bi_cui_name': 'Disaccharidases',\n",
       "  'our_bi_cui_desc': '[CLS] Di ##sa ##cc ##hari ##das ##es [unused3] ( Chemical , substance : Di ##sa ##cc ##hari ##das ##e ; di ##sa ##cc ##hari ##das ##es ; Di ##sa ##cc ##hari ##das ##es [ Chemical / In ##g ##red ##ient ] ; di ##sa ##cc ##hari ##das ##e ) [SEP]',\n",
       "  'our_cross_cui': 'C0014442',\n",
       "  'our_cross_cui_name': 'Enzymes',\n",
       "  'our_cross_cui_desc': '[CLS] En ##zy ##mes [unused3] ( Chemical , medication , substance : enzymes ; enzyme ; En ##zy ##mes [ Chemical / In ##g ##red ##ient ] ; B ##io ##cat ##aly ##sts ; En ##zy ##me ) [SEP]'},\n",
       " {'mention_id': '28251683.22',\n",
       "  'test_set_idx': 30007,\n",
       "  'type': 'T017',\n",
       "  'name': 'occlusion',\n",
       "  'context': '[CLS] ne ##uro ##p ##rote ##ction of remote is ##cha ##em ##ic post ##con ##dition ##ing against cerebral is ##cha ##emia / re ##per ##fusion injury in rats . The middle cerebral artery o ##cc ##lusion model was established in rats and then remote is ##cha ##em ##ic post ##con ##dition ##ing was carried out by three cycles of 10 minutes [unused1] o ##cc ##lusion [unused2] / 10 minutes release of the bilateral f ##em ##oral artery at the beginning of the re ##per ##fusion . To down ##re ##gu ##late the fi ##bul ##in - 5 level , fi ##bul ##in - 5 si ##RNA was injected into the lateral vent ##ric ##le 24 hours before middle cerebral artery o ##cc ##lusion . According to our [SEP]',\n",
       "  'existing_cui': 'C0011382',\n",
       "  'existing_cui_name': 'Dental Occlusion',\n",
       "  'existing_cui_desc': '[CLS] Dental O ##cc ##lusion [unused3] ( B ##iol ##og ##ic Fun ##ction , Den ##tist ##ry , function , o ##bs ##er ##vable entity , physical finding : Dental o ##cc ##lusion ; O ##cc ##lusion ##s , Dental ; O ##CC ##L ##US ##ION DE ##NT ; Dental O ##cc ##lusion ##s ; Bit ##e ; O ##cc ##lusion ; dental o ##cc ##lusion ; tooth o ##cc ##lusion ; o ##cc ##lusion dental ; DE ##NT O ##CC ##L ##US ##ION ; Dental o ##cc ##lusion , function ; O ##cc ##lusion , Dental ) [SEP]',\n",
       "  'our_bi_cui': 'C0596298',\n",
       "  'our_bi_cui_name': 'Cerebrovascular Occlusion',\n",
       "  'our_bi_cui_desc': '[CLS] Ce ##re ##bro ##vas ##cular O ##cc ##lusion [unused3] ( B ##iol ##og ##ic Fun ##ction : c ##ere ##bro ##vas ##cular o ##cc ##lusion ; O ##cc ##lusion ; cerebral ; Ce ##re ##bro ##vas ##cular O ##cc ##lusion ##s ; o ##cc ##lusion ; c ##ere ##bro ##vas ##cular ; O ##cc ##lusion ##s , Ce ##re ##bro ##vas ##cular ; cerebral o ##cc ##lusion ; O ##cc ##lusion , Ce ##re ##bro ##vas ##cular ; c ##ere ##bro ##vas ##cular ; o ##cc ##lusion ; cerebral o ##cc ##lusion ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0740391',\n",
       "  'our_cross_cui_name': 'Middle Cerebral Artery Occlusion',\n",
       "  'our_cross_cui_desc': '[CLS] Middle Ce ##re ##bra ##l Arte ##ry O ##cc ##lusion [unused3] ( Ana ##tom ##ical Structure , diagnosis , disorder : cerebral artery o ##cc ##lusion middle ; O ##cc ##lusion , Middle Ce ##re ##bra ##l Arte ##ry ; o ##cc ##lusion ; middle cerebral artery ; a . c ##ere ##bri media ; o ##cc ##lusion ; middle cerebral artery o ##cc ##lusion ; Middle cerebral artery o ##cc ##lusion ) [SEP]'},\n",
       " {'mention_id': '27442216.26',\n",
       "  'test_set_idx': 5822,\n",
       "  'type': 'T098',\n",
       "  'name': 'All - terrain vehicles group',\n",
       "  'context': '[CLS] ex ##tre ##mity ( 18 % ) , hand ( 11 % ) , s ##cap ##ula ( 4 . 6 % ) , and open fracture ##s ( 28 . 6 % ) ( P < 0 . 01 ) . Head trauma was the most commonly associated injury in 275 patients with the highest rate in the [unused1] All - terrain vehicles group [unused2] ( 44 % ) who also had the highest rate of no helmet use ( 76 % ) . Snow ##mobile and All - terrain vehicles patients had higher In ##ju ##ry Se ##ver ##ity Score ( 11 . 3 , 9 . 6 ) than dirt ##bi ##ke patients ( 7 . 8 ) ( P = 0 . [SEP]',\n",
       "  'existing_cui': 'C2898785',\n",
       "  'existing_cui_name': 'All-terrain motor-vehicle accident',\n",
       "  'existing_cui_desc': '[CLS] All - terrain motor - vehicle accident [unused3] ( In ##ju ##ry or Po ##ison ##ing ) [SEP]',\n",
       "  'our_bi_cui': 'C2898785',\n",
       "  'our_bi_cui_name': 'All-terrain motor-vehicle accident',\n",
       "  'our_bi_cui_desc': '[CLS] All - terrain motor - vehicle accident [unused3] ( In ##ju ##ry or Po ##ison ##ing ) [SEP]',\n",
       "  'our_cross_cui': 'C1257890',\n",
       "  'our_cross_cui_name': 'Population Group',\n",
       "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
       " {'mention_id': '27826436.24',\n",
       "  'test_set_idx': 18354,\n",
       "  'type': 'T204',\n",
       "  'name': 'cultivars',\n",
       "  'context': '[CLS] and determined in c ##v . Ben ##ih ##op ##pe , To ##chi ##oto ##me , Sa ##chin ##oka , and G ##ui ##mei ##ren straw ##berry fruits extracted by head - space solid - phase micro ##ex ##traction , respectively . E ##sters significantly dominated the chemical composition of the four varieties . Fu ##rane ##ol was detected in [unused1] cult ##iva ##rs [unused2] of Sa ##chin ##oka and G ##ui ##mei ##ren , but me ##si ##fu ##ran was only found in c ##v . To ##chi ##oto ##me . To ##chi ##oto ##me and Sa ##chin ##oka showed higher content of l ##inal ##ool and ( E ) - ne ##rol ##ido ##l . Sa ##chin ##oka showed the highest content of total [SEP]',\n",
       "  'existing_cui': 'C3385047',\n",
       "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
       "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
       "  'our_bi_cui': 'C0242775',\n",
       "  'our_bi_cui_name': 'Agricultural Crops',\n",
       "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
       "  'our_cross_cui': 'C0032098',\n",
       "  'our_cross_cui_name': 'Plants',\n",
       "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
       " {'mention_id': '27587730.7',\n",
       "  'test_set_idx': 10746,\n",
       "  'type': 'T103',\n",
       "  'name': 'Gga-miR-21',\n",
       "  'context': '[CLS] G ##ga - mi ##R - 21 in ##hibit ##s chicken pre - ad ##ip ##oc ##yte proliferation in part by down - regulating K ##rup ##pel - like factor 5 [unused1] G ##ga - mi ##R - 21 [unused2] is abundant ##ly expressed in chicken pre - ad ##ip ##ocytes , but its role is unclear . The present study investigated the role of g ##ga - mi ##R - 21 in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1537719',\n",
       "  'our_bi_cui_name': 'MIR21 gene',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '27297967.72',\n",
       "  'test_set_idx': 1777,\n",
       "  'type': 'T082',\n",
       "  'name': 'Asn19/Asn23',\n",
       "  'context': '[CLS] W ##T - MR ##P ##1 , whereas individual human em ##b ##ryo ##nic kidney 29 ##3 - Ty ##r ##9 ##20 ##P ##he - and - Ser ##9 ##21 ##A ##la - MR ##P ##1 mutant ##s were similar to H ##E ##K - W ##T - MR ##P ##1 . Together , these results suggest that [unused1] As ##n ##19 / As ##n ##23 [unused2] g ##ly ##cos ##yla ##tion and Ty ##r ##9 ##20 / Ser ##9 ##21 p ##hos ##ph ##ory ##lation are responsible for altering the kinetic ##s of MR ##P ##1 - mediated As ( G ##S ) 3 transport . The kinetic ##s of As ( G ##S ) 3 transport by human em ##b ##ryo ##nic kidney 29 [SEP]',\n",
       "  'existing_cui': 'C3887642',\n",
       "  'existing_cui_name': 'Hippocampus Proper',\n",
       "  'existing_cui_desc': \"[CLS] Hip ##po ##cam ##pus Pro ##per [unused3] ( Ana ##tom ##ical Structure : Hip ##po ##cam ##pus proper ; Hip ##po ##cam ##pus major ; Am ##mon ' s Horn ; CA fields ; Pro ##per , Hip ##po ##cam ##pus ; Horn , Am ##mon ; Hip ##po ##cam ##pus Pro ##pers ; Am ##mon Horn ; hip ##po ##cam ##pus ; Co ##rn ##u am ##mon ##is ; Am ##mons Horn ; Hip ##po ##cam ##pus ; corn ##u am ##mon ##is ; am ##mon ' s horn ; hip ##po ##cam ##pus proper ; Hip ##po ##cam ##pus prop ##rius ; Am ##mon ' s horn ; Co ##rn ##u Am ##mon ##is ; hip ##po ##cam ##pus major ; Horn , Am [SEP]\",\n",
       "  'our_bi_cui': 'C0003995',\n",
       "  'our_bi_cui_name': 'Asparagine',\n",
       "  'our_bi_cui_desc': '[CLS] As ##par ##agi ##ne [unused3] ( Chemical , substance : 2 - Am ##ino ##su ##cci ##nam ##ic acid ; L - as ##par ##agi ##ne ; As ##par ##tam ##ic acid ; alpha - amino ##su ##cci ##nam ##ic acid ; as ##n ; 2 - Am ##ino - 3 - car ##ba ##mo ##yl ##p ##rop ##ano ##ic acid ; as ##par ##agi ##ne ; ( S ) - As ##par ##agi ##ne ; N ; ( S ) - 2 - amino - 3 - car ##ba ##mo ##yl ##p ##rop ##ano ##ic acid ; Alpha - amino ##su ##cci ##nic acid ; As ##n ; L - as ##par ##tic acid beta - amid ##e ; ( 2 ##S ) - 2 [SEP]',\n",
       "  'our_cross_cui': 'C0002518',\n",
       "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
       "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
       " {'mention_id': '27430240.85',\n",
       "  'test_set_idx': 5411,\n",
       "  'type': 'T103',\n",
       "  'name': 'factors',\n",
       "  'context': '[CLS] these results , it can be in ##ferred that ad ##eno ##sin ##e , the ad ##eno ##sin ##e A2 ##A receptor ago ##nist , E ##2 ##F transcription factor 1 and CR ##E ##B are the possible factors contributing to the high expression of CD ##39 and CD ##7 ##3 on the T ##re ##g cell surface during se ##psis . Aden ##os ##ine and its A2 ##A receptor ago ##nist served as the signal trans ##du ##cer [unused1] factors [unused2] of the CD ##39 / CD ##7 ##3 / ad ##eno ##sin ##e pathway , a ##cc ##ele ##rating ad ##eno ##sin ##e generation . Our study may benefit further research on ad ##eno ##sin ##e metabolism for the treatment of se ##psis . [SEP]',\n",
       "  'existing_cui': 'C0960756',\n",
       "  'existing_cui_name': 'factor A',\n",
       "  'existing_cui_desc': \"[CLS] factor A [unused3] ( Chemical : Co ( beta ) - c ##yan ##o - 7 ' ' - ( 2 - met ##hyl ) ad ##eni ##ny ##l ##co ##ba ##mi ##de ) [SEP]\",\n",
       "  'our_bi_cui': 'C0021054',\n",
       "  'our_bi_cui_name': 'Immunologic Factors',\n",
       "  'our_bi_cui_desc': '[CLS] I ##mm ##uno ##log ##ic Factor ##s [unused3] ( Chemical , substance : Factor ##s , I ##mm ##uno ##log ##ic ; I ##mm ##une Factor ##s ; Factor ##s , I ##mm ##uno ##logical ; I ##mm ##uno ##log ##ic Factor ; Factor ##s , I ##mm ##une ; I ##mm ##uno ##logical Factor ##s ; im ##mu ##no ##log ##ic substance ; FA ##CT ##OR ##S I ##MM ##UN ##OL ; im ##mu ##nological substance ; I ##MM ##UN ##OL FA ##CT ##OR ##S ; I ##mm ##uno ##log ##ic substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0005515',\n",
       "  'our_cross_cui_name': 'Biological Factors',\n",
       "  'our_cross_cui_desc': '[CLS] Biological Factor ##s [unused3] ( Chemical , product , substance : Agents , Biological ; Biological Factor ; B ##iol ##og ##ic agent ; agents biological ; B ##iol ##og ##ic Factor ##s ; B ##iol ##og ##ic Factor ; biological substance ; Factor , B ##iol ##og ##ic ; Factor ##s , Biological ; bio ##pha ##rma ##ce ##utical ##s ; Biological product ; B ##IO ##L FA ##CT ##OR ; Biological Agents ; Biological substance ; Biological Factor ##s [ Chemical / In ##g ##red ##ient ] ; Biological agent ; B ##iol ##og ##ics ; Factor , Biological ; biological drug ; B ##IO ##L FA ##CT ##OR ##S ; FA ##CT ##OR ##S B ##IO ##L ; biological substances ; bio ##pha [SEP]'},\n",
       " {'mention_id': '27932585.30',\n",
       "  'test_set_idx': 22257,\n",
       "  'type': 'T103',\n",
       "  'name': 'TYW3',\n",
       "  'context': '[CLS] ##us , which revealed a novel α / β fold . The sequence motif ( S / T ) x ##SS ##C ##x ##GR and invariant as ##par ##tate and his ##ti ##dine , conserved in T ##Y ##W ##3 / Ta ##w ##3 , cluster to form the cat ##alytic center . These structural and sequence features indicate that [unused1] T ##Y ##W ##3 [unused2] / Ta ##w ##3 proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass ##ays combined with mass s ##pect ##rome ##try as well as l ##igan ##d dock ##ing and co ##fa ##ctor binding ass ##ays , [SEP]',\n",
       "  'existing_cui': 'C1823563',\n",
       "  'existing_cui_name': 'TYW3 gene',\n",
       "  'existing_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
       "  'our_bi_cui': 'C1823563',\n",
       "  'our_bi_cui_name': 'TYW3 gene',\n",
       "  'our_bi_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27587730.11',\n",
       "  'test_set_idx': 10750,\n",
       "  'type': 'T103',\n",
       "  'name': 'gga-miR-21',\n",
       "  'context': '[CLS] - 21 in ##hibit ##s chicken pre - ad ##ip ##oc ##yte proliferation in part by down - regulating K ##rup ##pel - like factor 5 G ##ga - mi ##R - 21 is abundant ##ly expressed in chicken pre - ad ##ip ##ocytes , but its role is unclear . The present study investigated the role of [unused1] g ##ga - mi ##R - 21 [unused2] in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga - mi ##R - 21 [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C2825314',\n",
       "  'our_bi_cui_name': 'MicroRNA Gene',\n",
       "  'our_bi_cui_desc': '[CLS] Micro ##RNA Gene [unused3] ( Ana ##tom ##ical Structure : Micro RNA Gene ; Mi ##RNA Gene ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '28375743.9',\n",
       "  'test_set_idx': 33552,\n",
       "  'type': 'T103',\n",
       "  'name': 'structured RNA elements',\n",
       "  'context': '[CLS] Engineering and In V ##ivo Applications of R ##ib ##os ##witch ##es R ##ib ##os ##witch ##es are common gene regulatory units mostly found in bacteria that are capable of altering gene expression in response to a small molecule . These [unused1] structured RNA elements [unused2] consist of two modular subunit ##s : an a ##pta ##mer domain that binds with high specific ##ity and affinity to a target l ##igan ##d and an expression platform that trans ##du ##ces l ##igan ##d binding to a gene expression output . Sign ##ificant progress has been made in engineering novel a ##pta ##mer domains for new small molecule induce ##rs of gene expression . Mo ##dified expression platforms have also been op ##ti ##mized to function when [SEP]',\n",
       "  'existing_cui': 'C0003818',\n",
       "  'existing_cui_name': 'Arsenic',\n",
       "  'existing_cui_desc': '[CLS] A ##rsen ##ic [unused3] ( Chemical , As , product , substance : AR ##SE ##NI ##C ; a ##rsen ##ics ; As element ; A ##rsen ##ic [ Chemical / In ##g ##red ##ient ] ; As - A ##rsen ##ic ; A ##rsen ##ic product ; a ##rsen ##ic ) [SEP]',\n",
       "  'our_bi_cui': 'C1138413',\n",
       "  'our_bi_cui_name': 'Regulatory Sequences , Ribonucleic Acid',\n",
       "  'our_bi_cui_desc': '[CLS] Reg ##ulatory Se ##quence ##s , R ##ib ##on ##uc ##le ##ic A ##cid [unused3] ( Chemical : Reg ##ulatory RNA Region ##s ; R ##EG R ##IB ##ON ##UC ##LE ##IC AC ##ID R ##EG ##ION ; R ##EG SE ##Q R ##IB ##ON ##UC ##LE ##IC AC ##ID ; RNA Reg ##ulatory Se ##quence ; Reg ##ulatory Se ##quence ##s , R ##ib ##on ##uc ##le ##ic A ##cid [ Chemical / In ##g ##red ##ient ] ; Reg ##ulatory R ##ib ##on ##uc ##le ##ic A ##cid Region ; R ##ib ##on ##uc ##le ##ic A ##cid Reg ##ulatory Se ##quence ##s ; Reg ##ulatory Se ##quence ##s , RNA ; RNA Region ##s , Reg ##ulatory ; RNA Region , Reg ##ulatory [SEP]',\n",
       "  'our_cross_cui': 'C0035668',\n",
       "  'our_cross_cui_name': 'RNA',\n",
       "  'our_cross_cui_desc': '[CLS] RNA [unused3] ( Chemical , RNA , R ##ib ##on ##uc ##le ##ic A ##cid , substance : rib ##on ##uc ##le ##ic acid ; R ##ib ##on ##uc ##le ##ic acids ; RNA , Non - Pol ##ya ##den ##yla ##ted ; rib ##on ##uc ##lein ##ic ##um acid ##um / rib ##on ; RNA - R ##ib ##on ##uc ##le ##ic acid ; RNA [ Chemical / In ##g ##red ##ient ] ; RNA , Non Pol ##ya ##den ##yla ##ted ; Non - Pol ##ya ##den ##yla ##ted RNA ; r ##na ; Non Pol ##ya ##den ##yla ##ted RNA ; A ##cid , R ##ib ##on ##uc ##le ##ic ; R ##ib ##on ##uc ##le ##ic acid ; Gene Products , RNA [SEP]'},\n",
       " {'mention_id': '27587730.1',\n",
       "  'test_set_idx': 10740,\n",
       "  'type': 'T103',\n",
       "  'name': 'Gga-miR-21',\n",
       "  'context': '[CLS] [unused1] G ##ga - mi ##R - 21 [unused2] in ##hibit ##s chicken pre - ad ##ip ##oc ##yte proliferation in part by down - regulating K ##rup ##pel - like factor 5 G ##ga - mi ##R - 21 is abundant ##ly expressed in chicken pre - ad ##ip ##ocytes , but its role is unclear . The present study investigated the role of g ##ga - mi ##R - 21 in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1999986',\n",
       "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '27894019.21',\n",
       "  'test_set_idx': 21082,\n",
       "  'type': 'T103',\n",
       "  'name': 'CYP314a1',\n",
       "  'context': '[CLS] ##hur ##eni ##c acid is a known end ##ogen ##ous m ##olt regulator present in art ##hr ##op ##ods . Experimental studies have confirmed that X ##ant ##hur ##eni ##c acid in ##hibit ##s m ##olt ##ing by binding to either ( or both ) of two P ##45 ##0 enzymes ( C ##YP ##31 ##5 ##a ##1 or [unused1] C ##YP ##31 ##4 ##a ##1 [unused2] ) that are responsible for the final two h ##ydro ##xy ##lation ##s in the production of the m ##olt - in ##ducing hormone , 20 - h ##ydro ##xy ##ec ##dy ##son ##e . The lack of crystal structures and bio ##chemical ass ##ays for C ##YP ##31 ##5 ##a ##1 or C ##YP ##31 ##4 ##a ##1 [SEP]',\n",
       "  'existing_cui': 'C1418799',\n",
       "  'existing_cui_name': 'PPIF gene',\n",
       "  'existing_cui_desc': '[CLS] PP ##IF gene [unused3] ( Ana ##tom ##ical Structure : C ##Y ##CL ##OP ##H ##IL ##IN 3 ; P ##EP ##TI ##D ##Y ##L - PR ##OL ##Y ##L C ##IS / T ##RA ##NS ISO ##ME ##RA ##SE , MIT ##OC ##H ##ON ##DR ##IA ##L ; P ##ept ##idy ##l ##p ##rol ##yl Is ##omer ##ase F Gene ; PP ##IF Gene ; C ##Y ##CL ##OP ##H ##IL ##IN F ; p ##ept ##idy ##l ##p ##rol ##yl is ##omer ##ase F ; Cy ##p - D ; h ##C ##y ##P ##3 ; c ##y ##c ##lop ##hil ##in D ) [SEP]',\n",
       "  'our_bi_cui': 'C0051169',\n",
       "  'our_bi_cui_name': 'Alkane 1-monooxygenase',\n",
       "  'our_bi_cui_desc': '[CLS] Al ##kan ##e 1 - mon ##oo ##xy ##gen ##ase [unused3] ( Chemical , substance : P - 450 4 ##A , Cy ##to ##ch ##rome ; Al ##kan ##e 1 H ##ydro ##xy ##lase ; Cy ##to ##ch ##rome P 450 IV ##A ; A ##cid Omega - h ##ydro ##xy ##lase , Lau ##ric ; Al ##kan ##e H ##ydro ##xy ##lase ; Omega - H ##ydro ##xy ##lase , Fat ##ty A ##cid ; Lau ##ric A ##cid H ##ydro ##xy ##lase ; Al ##kan ##e 1 Mon ##oo ##xy ##gen ##ase ; Cy ##to ##ch ##rome P - 450 C ##YP ##4 ##A ; Omega - Lau ##ryl H ##ydro ##xy ##lase ; Omega - h ##ydro ##xy ##lase , Lau ##ric [SEP]',\n",
       "  'our_cross_cui': 'C0010762',\n",
       "  'our_cross_cui_name': 'Cytochrome P450',\n",
       "  'our_cross_cui_desc': '[CLS] Cy ##to ##ch ##rome P ##45 ##0 [unused3] ( Chemical , substance : c ##yt ##och ##rome ##s p ##45 ##0 ; c ##yt ##och ##rome P ##45 ##0 ; C ##Y ##TO ##CH ##RO ##ME P 450 E ##N ##Z ##Y ##ME S ##Y ##ST ##EM ; Cy ##to ##ch ##rome p ##45 ##0 enzyme ; Super ##family , Cy ##to ##ch ##rome P ##45 ##0 ; P ##45 ##0 En ##zy ##mes ; c ##yt ##och ##rome p 450 ; En ##zy ##mes , P ##45 ##0 ; Cy ##to ##ch ##rome P 450 Families ; Cy ##to ##ch ##rome P ##45 ##0 En ##zy ##me ; P ##45 ##0 ; C ##YP ##45 ##0 ; Cy ##to ##ch ##rome p ##45 ##0 ; [SEP]'},\n",
       " {'mention_id': '27506129.31',\n",
       "  'test_set_idx': 8663,\n",
       "  'type': 'T170',\n",
       "  'name': 'oversampling approaches',\n",
       "  'context': '[CLS] the SM ##OT ##E approach for both scales ( mean square error < 0 . 00 ##6 ) . Machine learning methods are able to perform an objective assessment of h ##yper ##emia g ##rading , removing both in ##tra - and inter - expert subject ##ivity while providing a gain in com ##putation time . SM ##OT ##E and [unused1] overs ##amp ##ling approaches [unused2] mini ##mise the class im ##bal ##ance problem , while feature selection reduces the number of features from 25 to 3 - 5 without worse ##ning the mean square error . As the differences between the system and a human expert are similar to the differences between experts , we can therefore conclude that the system behave ##s like an [SEP]',\n",
       "  'existing_cui': 'C0449445',\n",
       "  'existing_cui_name': 'Approach',\n",
       "  'existing_cui_desc': '[CLS] A ##pp ##roach [unused3] ( Spa ##tial Concept , attribute , qualifier value : A ##pp ##roach ##es ; approach ; approaches ; approaching ) [SEP]',\n",
       "  'our_bi_cui': 'C0430022',\n",
       "  'our_bi_cui_name': 'diagnostic procedure',\n",
       "  'our_bi_cui_desc': '[CLS] diagnostic procedure [unused3] ( Health Care Act ##ivity , procedure : D ##IA ##G ##N ##OS ##TI ##C ; Di ##ag ##nos ##tic procedure ; Di ##ag ##nos ##tic procedures ; Di ##ag ##nos ##tic Test ; diagnostic technique ; Di ##ag ##nos ##tic ; Di ##ag ##nos ##tic Tech ##ni ##que ; Di ##ag ##nos ##tic Pro ##ced ##ure ; diagnostic procedures ; Di ##ag ##nos ##tic Method ; Pro ##ced ##ures ; diagnostic ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27388786.19',\n",
       "  'test_set_idx': 4442,\n",
       "  'type': 'T038',\n",
       "  'name': 'production',\n",
       "  'context': \"[CLS] - Si ##gu ##t , Da ##ws , et al . , 2015 ) we found stronger left lateral ##ization for sign than speech . Given that this increased lateral ##ization could not be explained by hand movement alone , the contribution of motor movement versus ' linguistic ' processes to the strength of hem ##is ##pheric lateral ##ization during sign [unused1] production [unused2] remains unclear . Here we directly contrast lateral ##ization strength of covert versus over ##t signing during p ##hon ##ological and semantic flu ##ency tasks . To address the possibility that hearing native sign ##ers ' elevated lateral ##ization in ##dices were due to performing a task in their less dominant language , here we test deaf native sign ##ers , whose [SEP]\",\n",
       "  'existing_cui': 'C1548180',\n",
       "  'existing_cui_name': 'Production Processing ID',\n",
       "  'existing_cui_desc': '[CLS] Production Process ##ing ID [unused3] ( Intel ##lect ##ual Product : Production ) [SEP]',\n",
       "  'our_bi_cui': 'C0220781',\n",
       "  'our_bi_cui_name': 'Anabolism',\n",
       "  'our_bi_cui_desc': '[CLS] Ana ##bol ##ism [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : bio ##sy ##nt ##hetic process ; Ana ##bol ##ism , function ; synthesis ; bio ##sy ##nt ##hesis ; formation ; B ##ios ##ynth ##etic ; B ##ios ##ynth ##esis ; B ##io ##genesis ; B ##ios ##ynth ##etic Process ; an ##ab ##olis ##m ) [SEP]',\n",
       "  'our_cross_cui': 'C0025361',\n",
       "  'our_cross_cui_name': 'Mental Processes',\n",
       "  'our_cross_cui_desc': '[CLS] Mental Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction , Human , function , o ##bs ##er ##vable entity : Human Information Process ##ing ; Thought process ; cognitive processing ; processes thought ; processing thought ; Information Process ##ing , Human ; Human information processing ; Information Process ##es ; mental processing ; cognitive process ; Form of thinking , function ; mental processes ; Form of thought ; Form of thinking ; Human Information Process ##es ; Mental Process ; mental process ; thought process ) [SEP]'},\n",
       " {'mention_id': '27500205.3',\n",
       "  'test_set_idx': 8435,\n",
       "  'type': 'T103',\n",
       "  'name': 'Kindlins',\n",
       "  'context': '[CLS] Of Kind ##lins and Cancer [unused1] Kind ##lins [unused2] are 4 . 1 - e ##z ##rin - rid ##ix ##in - m ##oes ##in ( F ##ER ##M ) domain containing proteins . There are three kind ##lins in mammals , which share high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the [SEP]',\n",
       "  'existing_cui': 'C1720776',\n",
       "  'existing_cui_name': 'Kindling , Neurologic',\n",
       "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
       "  'our_bi_cui': 'C0010422',\n",
       "  'our_bi_cui_name': 'Crystallins',\n",
       "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27842161.1',\n",
       "  'test_set_idx': 19094,\n",
       "  'type': 'T103',\n",
       "  'name': 'Netarsudil',\n",
       "  'context': '[CLS] [unused1] Net ##ars ##udi ##l [unused2] Inc ##rease ##s Out ##flow Facility in Human Eyes Through Multiple Me ##chan ##isms Net ##ars ##udi ##l is a R ##ho kinase / nor ##ep ##ine ##ph ##rine transport ##er inhibitor currently in phase 3 clinical development for g ##lau ##com ##a treatment . We investigated the effects of its active meta ##bol ##ite , net ##ars ##udi ##l - M1 , on out ##flow facility ( C ) , out ##flow h ##ydro ##dynamic ##s , and morphology of the conventional out ##flow pathway in en ##uc ##lea ##ted human eyes . Pa ##ired human eyes ( n = 5 ) were per ##fused with either 0 . 3 μ ##M net ##ars ##udi ##l - M1 or [SEP]',\n",
       "  'existing_cui': 'C0013443',\n",
       "  'existing_cui_name': 'Ear structure',\n",
       "  'existing_cui_desc': '[CLS] E ##ar structure [unused3] ( Ana ##tom ##ical Structure , Anatomy , body structure : V ##est ##ib ##ulo ##co ##ch ##lea ##r System ; System , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; ear structures ; Organ ##um vest ##ib ##ulo ##co ##ch ##lea ##re ; ear structure ; E ##ar - related structure ; au ##ris ; A ##ppa ##rat ##us , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; E ##ar and related structures ; Au ##ris ; V ##est ##ib ##ulo ##co ##ch ##lea ##r organ ; V ##est ##ib ##ulo ##co ##ch ##lea ##r A ##ppa ##rat ##us ) [SEP]',\n",
       "  'our_bi_cui': 'C0027783',\n",
       "  'our_bi_cui_name': 'Netropsin',\n",
       "  'our_bi_cui_desc': '[CLS] Net ##rops ##in [unused3] ( Chemical : Sin ##ano ##my ##cin ; Net ##rops ##in [ Chemical / In ##g ##red ##ient ] ; net ##rops ##in ; Congo ##cid ##ine ; 1 ##H - P ##yr ##rol ##e - 2 - car ##box ##ami ##de , 4 - ( ( ( ( amino ##im ##ino ##met ##hyl ) amino ) ace ##ty ##l ) amino ) - N - ( 5 - ( ( ( 3 - amino - 3 - im ##ino ##p ##rop ##yl ) amino ) carbon ##yl ) - 1 - met ##hyl - 1 ##H - p ##yr ##rol - 3 - y ##l ) - 1 - met ##hyl - ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27457539.37',\n",
       "  'test_set_idx': 6436,\n",
       "  'type': 'T038',\n",
       "  'name': 'pregnant',\n",
       "  'context': '[CLS] in this species . In this study , the safety and efficacy ( through a neutral ##izing anti ##body response ) of the the ##rm ##ost ##able live at ##ten ##uated R ##V ##F C ##L ##13 ##T vaccine were evaluated in came ##ls in two different preliminary experiments involving 16 came ##ls , ( that 12 came ##ls and 4 [unused1] pregnant [unused2] came ##ls ) . The study revealed that the C ##L ##13 ##T vaccine was safe to use in came ##ls and no abortion ##s or te ##rato ##genic effects were observed . The single dose of the vaccine stimulate ##d a strong and long - lasting neutral ##izing anti ##body response for up to 12 months . The presence of neutral [SEP]',\n",
       "  'existing_cui': 'C0549206',\n",
       "  'existing_cui_name': 'Patient currently pregnant',\n",
       "  'existing_cui_desc': '[CLS] Pat ##ient currently pregnant [unused3] ( Finding , finding , history : Pre ##gnant ; currently pregnant ; Currently pregnant ; Pre ##gna ##ncy not delivered ; G ##ra ##vid ##ity ; G ##ra ##vid ; Pat ##ient pregnant ; pregnant patient ; PR ##EG ##NA ##NT ; pregnant ; g ##ra ##vid ) [SEP]',\n",
       "  'our_bi_cui': 'C0549206',\n",
       "  'our_bi_cui_name': 'Patient currently pregnant',\n",
       "  'our_bi_cui_desc': '[CLS] Pat ##ient currently pregnant [unused3] ( Finding , finding , history : Pre ##gnant ; currently pregnant ; Currently pregnant ; Pre ##gna ##ncy not delivered ; G ##ra ##vid ##ity ; G ##ra ##vid ; Pat ##ient pregnant ; pregnant patient ; PR ##EG ##NA ##NT ; pregnant ; g ##ra ##vid ) [SEP]',\n",
       "  'our_cross_cui': 'C0032961',\n",
       "  'our_cross_cui_name': 'Pregnancy',\n",
       "  'our_cross_cui_desc': '[CLS] Pre ##gna ##ncy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , o ##bs ##er ##vable entity , qualifier value , s ##ym ##pt ##om : G ##esta ##tion ; Pre ##gna ##ncies ; PR ##EG ##N ; g ##esta ##tion ; PR ##EG ##NA ##NC ##Y ; pre ##gna ##ncies ; female pregnancy ; Pre ##gna ##ncy , function ; pregnancy ; Pre ##gna ##ncy [ Disease / Finding ] ) [SEP]'},\n",
       " {'mention_id': '27509301.56',\n",
       "  'test_set_idx': 8838,\n",
       "  'type': 'T033',\n",
       "  'name': 'detection',\n",
       "  'context': '[CLS] 39 out of 46 est ##rogen ##ic meta ##bol ##ites were predicted as potential bio ##tra ##ns ##formation products derived from the parent chemical . The Q ##SA ##R models estimated stronger est ##rogen ##ic activity for the majority of the known est ##rogen ##ic meta ##bol ##ites compared to their parent chemicals . Finally , the three models identified a similar set of parent compounds as top ranked chemicals based on the est ##rogen ##icit ##y of put ##ative meta ##bol ##ites . This proposed in si ##lic ##o approach is an inexpensive and rapid strategy for the [unused1] detection [unused2] of chemicals with est ##rogen ##ic meta ##bol ##ites and may reduce potential false negative results from in v ##it ##ro ass ##ays . [SEP]',\n",
       "  'existing_cui': 'C0206100',\n",
       "  'existing_cui_name': 'Signal Detection',\n",
       "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
       "  'our_bi_cui': 'C1511790',\n",
       "  'our_bi_cui_name': 'Detection',\n",
       "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
       "  'our_cross_cui': 'C0442726',\n",
       "  'our_cross_cui_name': 'Detected',\n",
       "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
       " {'mention_id': '27794068.45',\n",
       "  'test_set_idx': 17122,\n",
       "  'type': 'T038',\n",
       "  'name': 'binding of',\n",
       "  'context': '[CLS] binding protein expression levels . These results reveal the important role of C ##4 ##b binding protein in negative regulation of T ##LR ##1 / 2 - dependent pro - inflammatory c ##yt ##oki ##ne production . Furthermore , using a fluorescent con ##ju ##gated Pam ##3 ##CS ##K ##4 , we show that C ##4 ##b binding protein blocks the [unused1] binding of [unused2] Pam ##3 ##CS ##K ##4 to T ##LR ##1 / 2 . Finally , we show that ex ##ogen ##ous C ##4 ##b binding protein also in ##hibit ##s Pam ##3 ##CS ##K ##4 - induced signaling leading to IL - 8 production . Our results indicate C ##4 ##b binding protein binding to T ##LR ##2 and con ##se ##quent [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0033618',\n",
       "  'our_bi_cui_name': 'Protein Binding',\n",
       "  'our_bi_cui_desc': '[CLS] Pro ##tein Bin ##ding [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : Pro ##tein binding ( biological function ) [ Am ##bi ##guous ] ; Bin ##ding , Pro ##tein ; Pro ##tein binding , function ; Pro ##tein binding ; Pro ##tein binding ( biological function ) ; protein binding ; protein amino acid binding ) [SEP]',\n",
       "  'our_cross_cui': 'C1167622',\n",
       "  'our_cross_cui_name': 'Binding',\n",
       "  'our_cross_cui_desc': '[CLS] Bin ##ding [unused3] ( B ##iol ##og ##ic Fun ##ction , Molecular Fun ##ction , Molecular Fun ##ction : binds ; Physical Inter ##action ; binding [ molecular function ] ; Molecular Inter ##action Process ; Molecular Inter ##action ; binding ; Bo ##und ; bind ) [SEP]'},\n",
       " {'mention_id': '27280034.11',\n",
       "  'test_set_idx': 1340,\n",
       "  'type': 'T082',\n",
       "  'name': 'Newcastle upon Tyne',\n",
       "  'context': \"[CLS] , 1961 - 2009 Ai ##ms and method To as ##cer ##tain differences in patterns of suicide in young men over three decades ( 1960s , 1990s and 2000s ) and discuss implications for suicide prevention . Data on suicide ##s and open verdict ##s in men aged 15 - 34 were obtained from co ##roner ' s records in [unused1] Newcastle upon Tyne [unused2] and anal ##ys ##ed using SP ##SS software . Results An increase in suicide rates from the first to the second decade was followed by a fall in the third decade . This was associated with an increasing proportion of single men , those living alone , unemployment , consumption of alcohol , use of hanging , previous suicide attempt and [SEP]\",\n",
       "  'existing_cui': 'C0027983',\n",
       "  'existing_cui_name': 'Newcastle Disease',\n",
       "  'existing_cui_desc': \"[CLS] Newcastle Disease [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , et ##iology , manifest ##ation : Disease , Newcastle ; new ##castle disease ; Newcastle ' s disease ; A ##vian p ##ne ##um ##oe ##nce ##pha ##lit ##is ; Newcastle disease [ Am ##bi ##guous ] ; P ##se ##udo - f ##ow ##l ##pes ##t ; disease ( or disorder ) ; Newcastle ; Newcastle disease ; Newcastle ; NE ##WC ##AS ##TL ##E D ##IS ; Newcastle fever ; Newcastle Disease [ Disease / Finding ] ) [SEP]\",\n",
       "  'our_bi_cui': 'C0454880',\n",
       "  'our_bi_cui_name': 'Tyne and Wear',\n",
       "  'our_bi_cui_desc': '[CLS] Tyne and We ##ar [unused3] ( Spa ##tial Concept , geographic location : T and W - Tyne and We ##ar ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '28223077.34',\n",
       "  'test_set_idx': 28918,\n",
       "  'type': 'T082',\n",
       "  'name': 'surrounding sites',\n",
       "  'context': '[CLS] 00 ##4 , 2 . 05 ##8 ± 0 . 45 ##8 , 2 . 61 ##7 ± 1 . 09 ##2 and 1 . 82 ##2 ± 0 . 56 ##6 p ##g ##N ##m ( - 3 ) , respectively . ( 2 ) The toxic equivalent concentrations of PC ##D ##D / F ##s in ambient air from [unused1] surrounding sites [unused2] , background site , up ##wind site and down ##wind site were 0 . 103 ± 0 . 01 ##7 , 0 . 09 ##6 ± 0 . 01 ##5 , 0 . 120 ± 0 . 02 ##4 and 0 . 108 ± 0 . 01 ##4 p ##g I - T ##E ##Q ##N ##m ( - 3 ) [SEP]',\n",
       "  'existing_cui': 'C1282914',\n",
       "  'existing_cui_name': 'Surrounding',\n",
       "  'existing_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
       "  'our_bi_cui': 'C1282914',\n",
       "  'our_bi_cui_name': 'Surrounding',\n",
       "  'our_bi_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
       "  'our_cross_cui': 'C0205145',\n",
       "  'our_cross_cui_name': 'Site',\n",
       "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
       " {'mention_id': '27298278.41',\n",
       "  'test_set_idx': 1842,\n",
       "  'type': 'T017',\n",
       "  'name': 'Ketr3',\n",
       "  'context': \"[CLS] ' - di ##car ##box ##yla ##te , respectively . Na ##ph ##th ##o ##quin ##ones and nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##ers were previously unknown in the genus Mo ##rin ##da . In addition , the compounds were tested for c ##yt ##oto ##xi ##city against four human cancer cell lines He ##L ##a , A2 ##7 ##80 , [unused1] Ke ##tr ##3 [unused2] and MC ##F - 7 and their effects on p ##53 - activated transcription . Three nap ##ht ##ho ##quin ##ones had moderate c ##yt ##oto ##xi ##c effects with I ##C ##50 values ranging from 1 . 51 to 9 . 56 μ ##M , through up - regulation of p ##53 transcription ##al activity . [SEP]\",\n",
       "  'existing_cui': 'C3539712',\n",
       "  'existing_cui_name': 'CELF2 wt Allele',\n",
       "  'existing_cui_desc': '[CLS] CE ##LF ##2 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : N ##AP ##OR ; ET ##R - 3 ; BR ##UN ##OL ##3 ; N ##AP ##OR - 2 ; C ##U ##GB ##P ##2 ; C ##U ##GB ##P , El ##av - Like Family Member 2 w ##t All ##ele ; ET ##R ##3 ) [SEP]',\n",
       "  'our_bi_cui': 'C0007634',\n",
       "  'our_bi_cui_name': 'Cells',\n",
       "  'our_bi_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]',\n",
       "  'our_cross_cui': 'C0085983',\n",
       "  'our_cross_cui_name': 'Cell Line , Tumor',\n",
       "  'our_cross_cui_desc': '[CLS] Cell Line , Tu ##mor [unused3] ( Ana ##tom ##ical Structure : Cell Lines , Tu ##mor ; Tu ##mor Cell Line ; Line , Tu ##mor Cell ; Lines , Tu ##mor Cell ; Tu ##mor Cell Lines ; tumor cell lines ) [SEP]'},\n",
       " {'mention_id': '27826436.48',\n",
       "  'test_set_idx': 18378,\n",
       "  'type': 'T204',\n",
       "  'name': 'cultivars',\n",
       "  'context': '[CLS] ##oka , followed by the G ##ui ##mei ##ren and To ##chi ##oto ##me varieties . Sa ##chin ##oka had the highest t ##it ##rata ##ble acid ##ity T ##A value . The content of as ##cor ##bic acid of c ##v . To ##chi ##oto ##me was higher than the others , but there was no significant difference in [unused1] cult ##iva ##rs [unused2] of Ben ##ih ##op ##pe , To ##chi ##oto ##me , and Sa ##chin ##oka . Fr ##uc ##tos ##e and glucose were the major sugar ##s in all cult ##iva ##rs . C ##it ##ric acid was the major organic acid in c ##v . To ##chi ##oto ##me , c ##v . Sa ##chin ##oka , and c ##v [SEP]',\n",
       "  'existing_cui': 'C3385047',\n",
       "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
       "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
       "  'our_bi_cui': 'C0242775',\n",
       "  'our_bi_cui_name': 'Agricultural Crops',\n",
       "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
       "  'our_cross_cui': 'C0032098',\n",
       "  'our_cross_cui_name': 'Plants',\n",
       "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
       " {'mention_id': '28421738.3',\n",
       "  'test_set_idx': 35181,\n",
       "  'type': 'T038',\n",
       "  'name': 'Amyloid - Beta Liaison',\n",
       "  'context': \"[CLS] Target ##ing the Nr ##f ##2 / [unused1] Amy ##lo ##id - Beta Lia ##ison [unused2] in Alzheimer ' s Disease : A Rat ##ional A ##pp ##roach Amy ##lo ##id is a prominent feature of Alzheimer ' s disease . Yet , a linear link ##age between am ##yl ##oid - β p ##eptide and the disease onset and progression has recently been questioned . In this context , the crucial partnership between am ##yl ##oid - β p ##eptide and Nr ##f ##2 pathways is acquiring para ##mount importance , offering prospects for de ##ci ##pher ##ing the am ##yl ##oid - β p ##eptide - centered disease network . Here , we report on a new class of anti ##ag ##g ##re ##gating [SEP]\",\n",
       "  'existing_cui': 'C2825879',\n",
       "  'existing_cui_name': 'Beta Amyloid Measurement',\n",
       "  'existing_cui_desc': '[CLS] Beta Amy ##lo ##id Me ##as ##ure ##ment [unused3] ( Health Care Act ##ivity : Beta Amy ##lo ##id ; AM ##Y ##L ##O ##ID ##B ; Amy ##lo ##id , Beta ) [SEP]',\n",
       "  'our_bi_cui': 'C1510880',\n",
       "  'our_bi_cui_name': 'Amyloid Beta-Peptide Pathway',\n",
       "  'our_bi_cui_desc': '[CLS] Amy ##lo ##id Beta - P ##eptide Path ##way [unused3] ( B ##iol ##og ##ic Fun ##ction : Generation of am ##yl ##oid b - p ##eptide by PS ##1 ) [SEP]',\n",
       "  'our_cross_cui': 'C1149161',\n",
       "  'our_cross_cui_name': 'beta-amyloid binding',\n",
       "  'our_cross_cui_desc': '[CLS] beta - am ##yl ##oid binding [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]'},\n",
       " {'mention_id': '28269453.17',\n",
       "  'test_set_idx': 30622,\n",
       "  'type': 'T170',\n",
       "  'name': 'fitness planner',\n",
       "  'context': '[CLS] End ##urance based personal ##ized fitness plan ##ner End ##urance is an important factor of card ##iovascular fitness indicating the capacity of an individual to perform exercise for a longer duration with increased intensity . Various subject specific and exercise related parameters affect endurance of an individual . In this work , we propose a statistical technique to model endurance as a function of these factors incorporating the serial dependence of observations generated by individuals over time . The proposed model provides a device to predict future endurance of a test subject following particular exercise regime . This facilitate ##s a test user with a [unused1] fitness plan ##ner [unused2] with the provision to fix exercise regime ##s to reach a set fitness goal . [SEP]',\n",
       "  'existing_cui': 'C0600623',\n",
       "  'existing_cui_name': 'Fitness Centers',\n",
       "  'existing_cui_desc': '[CLS] Fitness Centers [unused3] ( Organization : fitness center ; center fitness ; centers fitness ; Fitness Center ; Center , Fitness ; Centers , Fitness ; fitness centers ) [SEP]',\n",
       "  'our_bi_cui': 'C1690589',\n",
       "  'our_bi_cui_name': 'Verbalizes plan to support exercise',\n",
       "  'our_bi_cui_desc': '[CLS] V ##er ##bal ##izes plan to support exercise [unused3] ( Finding , finding : Des ##cribe ##s plan to support exercise ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27540584.34',\n",
       "  'test_set_idx': 9935,\n",
       "  'type': 'T097',\n",
       "  'name': 'endoscopists',\n",
       "  'context': '[CLS] course . There were no technical problems related to the novel si ##mu ##lator during the course . After s ##phi ##nc ##tero ##tom ##y , the organic p ##ap ##illa ##e could easily be exchanged within a few seconds . Overall , the novel Bill ##roth II / R ##oux - en - Y si ##mu ##lator achieved favorable results by train ##ees and expert [unused1] end ##os ##co ##pis ##ts [unused2] in all categories assessed . The new Bill ##roth II / R ##oux - en - Y mechanical si ##mu ##lator is simple and p ##rac ##tica ##ble . A first evaluation during an end ##os ##copic re ##tro ##grade ch ##ola ##ng ##io ##pan ##cre ##ato ##graphy course showed promising results . [SEP]',\n",
       "  'existing_cui': 'C0228237',\n",
       "  'existing_cui_name': 'Structure of superior temporal sulcus',\n",
       "  'existing_cui_desc': '[CLS] Structure of superior temporal su ##l ##cus [unused3] ( Spa ##tial Concept , body structure : Superior temporal fi ##ss ##ure ; Superior Te ##mpo ##ral Sul ##cus ; parallel su ##l ##cus ; Sul ##cus temporal ##is superior ; Superior temporal su ##l ##cus ; superior temporal su ##l ##cus ; Sul ##cus temporal ##is p ##rim ##us ; Sul ##cus t ##1 ; su ##l ##cus t ##1 ; superior temporal fi ##ss ##ure ; Para ##lle ##l su ##l ##cus ) [SEP]',\n",
       "  'our_bi_cui': 'C0582175',\n",
       "  'our_bi_cui_name': 'Surgeon',\n",
       "  'our_bi_cui_desc': '[CLS] Sur ##geon [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : surgeon ##s ; surgeon ; Sur ##geons ) [SEP]',\n",
       "  'our_cross_cui': 'C1522486',\n",
       "  'our_cross_cui_name': 'Professional Organization or Group',\n",
       "  'our_cross_cui_desc': '[CLS] Professional Organization or Group [unused3] ( Professional or O ##cc ##upation ##al Group : Other Agency or Organization ; Organization ; OR ##G ; Outside Bo ##dies ; Organization ##al ) [SEP]'},\n",
       " {'mention_id': '27570140.33',\n",
       "  'test_set_idx': 10496,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedure',\n",
       "  'context': '[CLS] 3 . 2 % , p < . 00 ##1 ) and those with an un ##int ##ended index pregnancy ( 13 . 8 % vs . 4 . 1 % , p < . 00 ##1 ) . Of the patients requesting post ##par ##tum tub ##al l ##iga ##tion , 118 ( 51 . 1 % ) underwent the [unused1] procedure [unused2] immediately post ##par ##tum . Co ##mple ##tion was not associated with high - risk status ( 54 . 0 % ) , or with race , insurance status or par ##ity . Among 113 women with an un ##ful ##fill ##ed post ##par ##tum tub ##al l ##iga ##tion request , there were 17 subsequent pre ##gna ##ncies ( 15 . [SEP]',\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27796974.34',\n",
       "  'test_set_idx': 17388,\n",
       "  'type': 'T082',\n",
       "  'name': 'Balatonfüred City',\n",
       "  'context': '[CLS] been defined for every water chemistry parameter in light of the legal limit values of the water parameters . In addition to this , weight in ##dices were calculated on the basis of the outcome of the paired comparison of water chemistry parameters and normal ##ized matrix . This was followed by the para ##metric level analysis of the water chemistry parameters , and finally , the aquatic environment index was calculated , which provided general information on the quality of water regarding the water chemistry parameters . The method was illustrated on Lake Ba ##lat ##on , Hungary in which case water samples taken from [unused1] Ba ##lat ##on ##f ##ü ##red City [unused2] lake area were analyzed and evaluated with the method devised . [SEP]',\n",
       "  'existing_cui': 'C0008848',\n",
       "  'existing_cui_name': 'Cities',\n",
       "  'existing_cui_desc': '[CLS] Cities [unused3] ( Spa ##tial Concept , environment : City ; city ; cities ) [SEP]',\n",
       "  'our_bi_cui': 'C0008848',\n",
       "  'our_bi_cui_name': 'Cities',\n",
       "  'our_bi_cui_desc': '[CLS] Cities [unused3] ( Spa ##tial Concept , environment : City ; city ; cities ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '28099370.14',\n",
       "  'test_set_idx': 25628,\n",
       "  'type': 'T170',\n",
       "  'name': 'written',\n",
       "  'context': '[CLS] A Course - Based A ##pp ##roach to the Doctor of Nursing Practice Project : Supporting Student Growth From Concept to Co ##mple ##tion We describe a course - based approach to the doctor of nursing practice project in which students work in groups of 8 to 12 with a faculty member to complete individual final projects that require a minimum of 360 p ##rac ##tic ##um hours in 3 - semester - long courses . Project teams include agency or community - based mentor ##s . Project findings are di ##sse ##minated through [unused1] written [unused2] and oral reports . This approach preserves faculty resources and provides students with mentor ##ing , opportunities for reflection , and time for project development . [SEP]',\n",
       "  'existing_cui': 'C4291771',\n",
       "  'existing_cui_name': 'Written Report',\n",
       "  'existing_cui_desc': '[CLS] Written Report [unused3] ( Intel ##lect ##ual Product , Radio ##logy , Radio ##logy : Written Reports ) [SEP]',\n",
       "  'our_bi_cui': 'C4291771',\n",
       "  'our_bi_cui_name': 'Written Report',\n",
       "  'our_bi_cui_desc': '[CLS] Written Report [unused3] ( Intel ##lect ##ual Product , Radio ##logy , Radio ##logy : Written Reports ) [SEP]',\n",
       "  'our_cross_cui': 'C0684224',\n",
       "  'our_cross_cui_name': 'Report',\n",
       "  'our_cross_cui_desc': '[CLS] Report [unused3] ( Intel ##lect ##ual Product , document , document , qualifier value , record artifact : document report ; reports ; Report ##ed ; Reports ; report ; report [ document ] ) [SEP]'},\n",
       " {'mention_id': '27449818.16',\n",
       "  'test_set_idx': 6211,\n",
       "  'type': 'T103',\n",
       "  'name': 'E2',\n",
       "  'context': '[CLS] to parent ##eral est ##rogen administration is characterized by reduced systemic but prominent he ##pa ##tic est ##rogen ##ic effects on lip ##ids , hem ##ost ##atic factors , G ##H - / I ##G ##F I axis , an ##gio ##tens ##ino ##gen . In order to avoid such adverse metabolic effects of oral treatment , est ##rad ##iol ( [unused1] E ##2 [unused2] ) pro ##dr ##ugs ( E ##stra ##dio ##l pro ##dr ##ugs ) were designed which bypass the liver tissue as inactive molecules . Carbon ##e ##17 - OH su ##lf ##ona ##mi ##de [ - O ##2 - NH ##2 ] substituted est ##ers of E ##2 ( EC ##50 ##8 , others ) were synthesized and tested for carbon [SEP]',\n",
       "  'existing_cui': 'C1419454',\n",
       "  'existing_cui_name': 'SNORA62 gene',\n",
       "  'existing_cui_desc': '[CLS] S ##N ##OR ##A ##6 ##2 gene [unused3] ( Ana ##tom ##ical Structure : RNA , U ##10 ##8 SM ##AL ##L N ##UC ##LE ##OL ##AR ; small n ##uc ##leo ##lar RNA , H / AC ##A box 62 ; RNA , E ##2 SM ##AL ##L N ##UC ##LE ##OL ##AR ; E ##2 ; E ##2 - 1 ; s ##no ##RNA , E ##2 ; SM ##AL ##L N ##UC ##LE ##OL ##AR RNA , H / AC ##A B ##OX , 62 ) [SEP]',\n",
       "  'our_bi_cui': 'C0014939',\n",
       "  'our_bi_cui_name': 'Estrogens',\n",
       "  'our_bi_cui_desc': '[CLS] E ##stro ##gens [unused3] ( Chemical , medication , product , substance : est ##rogen ##s ; O ##est ##rogen ##s ; est ##rogen ##ic preparation ; O ##est ##rogen product ; est ##rogen products ; E ##stro ##gen ; E ##stro ##genic drug ; E ##ST ##RO ##GE ##NS ; O ##est ##rogen ##ic drug ; O ##est ##rogen preparation ; E ##stro ##gen preparation ; O ##est ##rogen ; o ##est ##rogen products ; o ##est ##rogen ; A ##gon ##ists , E ##stro ##gen Re ##ceptor ; o ##est ##rogen ##s ; est ##rogen ; E ##stro ##gen product ; O ##est ##rogen ##ic preparation ; Co ##mpo ##unds , E ##stro ##genic ; Agents , E ##stro ##genic ; E ##stro ##gen [SEP]',\n",
       "  'our_cross_cui': 'C0014912',\n",
       "  'our_cross_cui_name': 'Estradiol',\n",
       "  'our_cross_cui_desc': '[CLS] E ##stra ##dio ##l [unused3] ( Chemical , medication , product , substance : o ##est ##rad ##iol ; Benz ##hor ##mo ##var ##ine ; O ##est ##rad ##iol - R ##ET ##IR ##ED - ; 17 beta - est ##rad ##iol ; O ##est ##rad ##iol [ g ##yna ##e ] ; 17 - Beta o ##est ##rad ##iol ; 17 beta E ##stra ##dio ##l ; E ##stra ##ld ##ine ; E ##stra ##dio ##l [ g ##yna ##e ] ; O ##est ##rad ##iol ; E ##SD ##L ; E ##2 - O ##est ##rad ##iol ; 17 beta - E ##stra ##dio ##l ; 17 beta est ##rad ##iol ; E ##stra ##dio ##l product ; O ##est ##rad ##iol preparation ; [SEP]'},\n",
       " {'mention_id': '27611704.11',\n",
       "  'test_set_idx': 11685,\n",
       "  'type': 'T017',\n",
       "  'name': 'B',\n",
       "  'context': \"[CLS] W ##heat Lines B ##read wheat ( Tri ##tic ##um a ##est ##iv ##um , 2 ##n = 6 ##x = 42 , AA ##BB ##D ##D ) has a complex all ##oh ##ex ##ap ##lo ##id genome , which makes it difficult to differentiate between the ho ##mo ##eo ##log ##ous sequences and assign them to the chromosome A , [unused1] B [unused2] , or D sub ##gen ##ome ##s . The chromosome - based draft genome sequence of the ' Chinese Spring ' common wheat cult ##iva ##r enables the large - scale development of polymer ##ase chain reaction ( polymer ##ase chain reaction ) - based markers specific for ho ##mo ##eo ##log ##s . Based on high - confidence ' Chinese Spring [SEP]\",\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0017428',\n",
       "  'our_bi_cui_name': 'Genome',\n",
       "  'our_bi_cui_desc': '[CLS] Gen ##ome [unused3] ( Ana ##tom ##ical Structure , substance : genome ; genome ##s ; Gen ##ome ##s ; Gen ##omi ##c ) [SEP]',\n",
       "  'our_cross_cui': 'C0008633',\n",
       "  'our_cross_cui_name': 'Chromosomes',\n",
       "  'our_cross_cui_desc': '[CLS] Ch ##rom ##oso ##mes [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : chromosome ; Ch ##rom ##oso ##mal ; chromosome ##s ; Ch ##rom ##oso ##me ) [SEP]'},\n",
       " {'mention_id': '27430240.21',\n",
       "  'test_set_idx': 5347,\n",
       "  'type': 'T103',\n",
       "  'name': 'factors',\n",
       "  'context': \"[CLS] trip ##hos ##phate dip ##hos ##ph ##oh ##ydro ##lase 1 ; also known as CD ##39 ) and 5 ' - e ##cton ##uc ##leo ##ti ##das ##e ( N ##T ##5 ##E ; also known as CD ##7 ##3 ) on the T ##re ##g cell surface are increased during se ##psis . In this study , to determine the [unused1] factors [unused2] leading to the high expression of CD ##39 and CD ##7 ##3 , and the regulation of the CD ##39 / CD ##7 ##3 / ad ##eno ##sin ##e pathway in The number of regulatory T cells under se ##ptic conditions , we constructed a mouse model of se ##psis and separated the The number of regulatory T cells using a flow [SEP]\",\n",
       "  'existing_cui': 'C0960756',\n",
       "  'existing_cui_name': 'factor A',\n",
       "  'existing_cui_desc': \"[CLS] factor A [unused3] ( Chemical : Co ( beta ) - c ##yan ##o - 7 ' ' - ( 2 - met ##hyl ) ad ##eni ##ny ##l ##co ##ba ##mi ##de ) [SEP]\",\n",
       "  'our_bi_cui': 'C0021054',\n",
       "  'our_bi_cui_name': 'Immunologic Factors',\n",
       "  'our_bi_cui_desc': '[CLS] I ##mm ##uno ##log ##ic Factor ##s [unused3] ( Chemical , substance : Factor ##s , I ##mm ##uno ##log ##ic ; I ##mm ##une Factor ##s ; Factor ##s , I ##mm ##uno ##logical ; I ##mm ##uno ##log ##ic Factor ; Factor ##s , I ##mm ##une ; I ##mm ##uno ##logical Factor ##s ; im ##mu ##no ##log ##ic substance ; FA ##CT ##OR ##S I ##MM ##UN ##OL ; im ##mu ##nological substance ; I ##MM ##UN ##OL FA ##CT ##OR ##S ; I ##mm ##uno ##log ##ic substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0005515',\n",
       "  'our_cross_cui_name': 'Biological Factors',\n",
       "  'our_cross_cui_desc': '[CLS] Biological Factor ##s [unused3] ( Chemical , product , substance : Agents , Biological ; Biological Factor ; B ##iol ##og ##ic agent ; agents biological ; B ##iol ##og ##ic Factor ##s ; B ##iol ##og ##ic Factor ; biological substance ; Factor , B ##iol ##og ##ic ; Factor ##s , Biological ; bio ##pha ##rma ##ce ##utical ##s ; Biological product ; B ##IO ##L FA ##CT ##OR ; Biological Agents ; Biological substance ; Biological Factor ##s [ Chemical / In ##g ##red ##ient ] ; Biological agent ; B ##iol ##og ##ics ; Factor , Biological ; biological drug ; B ##IO ##L FA ##CT ##OR ##S ; FA ##CT ##OR ##S B ##IO ##L ; biological substances ; bio ##pha [SEP]'},\n",
       " {'mention_id': '27444636.36',\n",
       "  'test_set_idx': 5987,\n",
       "  'type': 'T033',\n",
       "  'name': 'mean age 36 years',\n",
       "  'context': '[CLS] Battery for At ##ten ##tion Performance version 2 . 3 . Assessment ##s were performed immediately prior to and 5 days after switching from o ##x ##car ##ba ##ze ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate ( days 0 and 5 , respectively ) . The analysis included 21 patients ( 12 women , 9 men ; [unused1] mean age 36 years [unused2] ) . After switching from o ##x ##car ##ba ##ze ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate , there were significant improvements in mean scores for Ad ##verse Events Profile ( P < . 00 ##1 ) , Quality of Life in E ##pile ##psy In ##vent ##ory 10 ( P = . 00 ##1 ) , [SEP]',\n",
       "  'existing_cui': 'C1847486',\n",
       "  'existing_cui_name': 'Mean age of onset 56 years',\n",
       "  'existing_cui_desc': '[CLS] Mean age of onset 56 years [unused3] ( Finding ) [SEP]',\n",
       "  'our_bi_cui': 'C1834001',\n",
       "  'our_bi_cui_name': 'Mean age at onset 32 years',\n",
       "  'our_bi_cui_desc': '[CLS] Mean age at onset 32 years [unused3] ( Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27251800.42',\n",
       "  'test_set_idx': 837,\n",
       "  'type': 'T058',\n",
       "  'name': 'Stoppa',\n",
       "  'context': '[CLS] 15 th post - operative ( P > 0 . 05 ) . Co ##mp ##lication ##s occurred in 88 % of Stop ##pa group ( 22 patients ) and 64 % in lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair group ( 16 patients ) ( P < 0 . 05 ) . The comparative study between the [unused1] Stop ##pa [unused2] and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approaches for the bilateral ing ##uin ##al her ##nia repair demonstrated that : ( 1 ) The lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approach showed less surgical trauma despite the longer operation time ; ( 2 ) Quality of life during the early post - operative [SEP]',\n",
       "  'existing_cui': 'C1538901',\n",
       "  'existing_cui_name': 'ACD gene',\n",
       "  'existing_cui_desc': '[CLS] AC ##D gene [unused3] ( Ana ##tom ##ical Structure : T ##EL ##OM ##ER ##E PR ##OT ##EI ##N T ##PP ##1 ; ad ##ren ##oc ##ort ##ical d ##ys ##p ##lasia ho ##mo ##log ; AC ##D Gene ; Ad ##ren ##oc ##ort ##ical D ##ys ##p ##lasia Ho ##mo ##log ( Mouse ) Gene ; P ##OT ##1 - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N 1 ; P ##OT ##1 - AND T ##IN ##2 - OR ##GA ##NI ##Z ##ING PR ##OT ##EI ##N ; P ##OT ##1 and T ##IN ##2 organizing protein ; AC ##D , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; Tin ##t ##1 ; T ##IN ##2 interacting protein 1 [SEP]',\n",
       "  'our_bi_cui': 'C0031150',\n",
       "  'our_bi_cui_name': 'Laparoscopy',\n",
       "  'our_bi_cui_desc': '[CLS] La ##par ##os ##copy [unused3] ( Health Care Act ##ivity , G ##I only , procedure : La ##par ##os ##copic procedure ; per ##ito ##ne ##os ##copy ; Co ##eli ##os ##copy ; Ce ##lio ##sco ##pies ; Per ##ito ##ne ##os ##co ##pies ; Abd ##ome ##n end ##os ##copy ; c ##eli ##os ##copy ; lap ##aro ##scopic procedure ; Per ##ito ##ne ##os ##copy ; La ##p ; Ce ##lio ##sco ##py ; La ##par ##os ##co ##pies ; lap ##aro ##sco ##pies ; lap ##aro ##sco ##py ; lap ##aro ##scopic procedures ; diagnostic lap ##aro ##sco ##py ; End ##os ##copy of abdomen ; lap ##aro ##sco ##py procedure ; La ##par ##os ##copic ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27475696.10',\n",
       "  'test_set_idx': 7473,\n",
       "  'type': 'T038',\n",
       "  'name': 'alcohol',\n",
       "  'context': '[CLS] E ##stro ##gen and Pro ##ges ##tero ##ne hormone receptor expression in oral cavity cancer Recent studies have shown an increase in the incidence of oral sq ##ua ##mous cell car ##cin ##oma in younger patients . The hypothesis that tumors could be ho ##rmon ##ally induced during pregnancy or in young female patients without the well - known risk factors [unused1] alcohol [unused2] or tobacco abuse seems to be plausible . E ##stro ##gen Re ##ceptor alpha and Pro ##ges ##tero ##ne Re ##ceptor expression were analyzed in normal oral m ##uc ##osa ( n = 5 ) , oral precursor lesions ( simple h ##yper ##p ##lasia , n = 11 ; sq ##ua ##mous in ##tra ##ep ##ith ##eli ##al neo ##p ##lasia [SEP]',\n",
       "  'existing_cui': 'C0202304',\n",
       "  'existing_cui_name': 'Ethanol measurement',\n",
       "  'existing_cui_desc': '[CLS] Ethan ##ol measurement [unused3] ( Health Care Act ##ivity , procedure : DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TA ##LC ##OH ##OL ##S ; Ethan ##ol Me ##as ##ure ##ment ; Al ##co ##hol ##s levels ; Al ##co ##hol ##s ; Ethan ##ol ; DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TI ##TA ##TI ##VE AL ##CO ##H ##OL ##S ; Al ##co ##hol ; alcohol measurements ; Me ##as ##ure ##ment of alcohol ; E ##thy ##l Al ##co ##hol Me ##as ##ure ##ments ; Drug screen q ##uant ##al ##co ##hol ##s ; Al ##co ##hol level ; Al ##co ##hol measurement ; ET ##HA ##N ##OL ; alcohol level test ) [SEP]',\n",
       "  'our_bi_cui': 'C0001975',\n",
       "  'our_bi_cui_name': 'Alcohols',\n",
       "  'our_bi_cui_desc': '[CLS] Al ##co ##hol ##s [unused3] ( Chemical , substance : alcohol ; Al ##co ##hol [ Chemical Class ] ; Al ##co ##hol ; Al ##co ##hol ##s [ Chemical / In ##g ##red ##ient ] ; alcohol ##s ; class of chemical alcohol ##s ; alcohol substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0085762',\n",
       "  'our_cross_cui_name': 'Alcohol abuse',\n",
       "  'our_cross_cui_desc': '[CLS] Al ##co ##hol abuse [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , finding : abuses alcohol ; alcohol ; use , problem ; Ethan ##ol abuse ; problem drinking ; alcohol abuse ; problem ; alcohol use ; ethanol abuse ; Al ##co ##hol abuse , un ##sp ##ec ##ified drinking behaviour ; Al ##co ##hol abuse , un ##sp ##ec ##ified drinking behavior ; ET ##OH abuse ; abuse ; alcohol ; AA - Al ##co ##hol abuse ; alcohol abuse disorder ; drinking problems ; Al ##co ##hol abuse , un ##sp ##ec ##ified ; Problem Dr ##ink ##ing ; r ##nd ##x alcohol abuse ; alcohol abuses ; Al ##co ##hol Abu ##se ; Al ##co ##hol abuse [SEP]'},\n",
       " {'mention_id': '27920749.27',\n",
       "  'test_set_idx': 21864,\n",
       "  'type': 'T170',\n",
       "  'name': 'emotionally negative film clip',\n",
       "  'context': \"[CLS] ##al bias ##es to happy and angry faces . In Study 1 , healthy young women were recruited and randomly assigned to one of the three groups : up - , down - , and no - regulation . Part ##ici ##pants were instructed to re ##ap ##pra ##ise their emotions to increase and decrease emotional experience while viewing an [unused1] emotionally negative film clip [unused2] . At ##ten ##tional bias was assessed with a dot - probe task with pictures of angry and happy facial expressions . In Study 2 , a separate group of healthy young men and women participated . Part ##ici ##pants ' trait re ##ap ##pra ##isa ##l and suppression as well as state and trait anxiety were assessed . A [SEP]\",\n",
       "  'existing_cui': 'C0558263',\n",
       "  'existing_cui_name': 'Emotionally distant',\n",
       "  'existing_cui_desc': '[CLS] Em ##otion ##ally distant [unused3] ( Finding , finding : Em ##otion ##ally al ##oof ) [SEP]',\n",
       "  'our_bi_cui': 'C3463807',\n",
       "  'our_bi_cui_name': 'Video Media',\n",
       "  'our_bi_cui_desc': '[CLS] Video Media [unused3] ( Intel ##lect ##ual Product : Video ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28351716.3',\n",
       "  'test_set_idx': 32856,\n",
       "  'type': 'T058',\n",
       "  'name': 'digital fundus images',\n",
       "  'context': '[CLS] Di ##ag ##nosis of re ##tina ##l health in [unused1] digital fund ##us images [unused2] using continuous wave ##let transform and en ##tro ##pies Vision is para ##mount to humans to lead an active personal and professional life . The prevalence of o ##cular diseases is rising , and diseases such as g ##lau ##com ##a , Di ##abe ##tic Re ##tino ##pathy and Age - related Mac ##ular De ##gene ##ration are the leading causes of blind ##ness in developed countries . I ##dent ##ifying these diseases in mass screening programmes is time - consuming , labor - intensive and the diagnosis can be subjective . The use of an automated computer aided diagnosis system will reduce the time taken for analysis and will also [SEP]',\n",
       "  'existing_cui': 'C0017129',\n",
       "  'existing_cui_name': 'gastric fundus',\n",
       "  'existing_cui_desc': '[CLS] gas ##tric fund ##us [unused3] ( Ana ##tom ##ical Structure , body structure , vent ##ric ##ular ##is : Fund ##us ; Fund ##us gas ##tric ##us ; Fund ##us , Gas ##tric ; ST ##OM ##AC ##H , F ##UN ##D ##US ; Fund ##us of St ##oma ##ch ; fund ##us of stomach ; Gas ##tric fund ##us ; stomach fund ##us ; Gas ##tric fund ##us structure ; Fund ##us structure of stomach ; Fund ##us of the St ##oma ##ch ; F ##UN ##D ##US OF THE ST ##OM ##AC ##H ; Fund ##us of stomach ; Gas ##tric Fund ##us ) [SEP]',\n",
       "  'our_bi_cui': 'C1704254',\n",
       "  'our_bi_cui_name': 'Medical Image',\n",
       "  'our_bi_cui_desc': '[CLS] Medical Image [unused3] ( Intel ##lect ##ual Product : Image ) [SEP]',\n",
       "  'our_cross_cui': 'C0200189',\n",
       "  'our_cross_cui_name': 'Fundus photography',\n",
       "  'our_cross_cui_desc': '[CLS] Fund ##us photography [unused3] ( Health Care Act ##ivity , procedure : fund ##us photography ; O ##cular fund ##us photography ; eye fund ##us photography ) [SEP]'},\n",
       " {'mention_id': '27604152.49',\n",
       "  'test_set_idx': 11446,\n",
       "  'type': 'T007',\n",
       "  'name': 'non - aureus staphylococci',\n",
       "  'context': '[CLS] n = 3 ) . No met ##hic ##ill ##in - resistant St ##aph ##yl ##oc ##oc ##cus au ##reus were isolated from 58 ##6 culture ##d s ##wab ##s . Met ##hic ##ill ##in - susceptible S . au ##reus were detected in 9 / 257 ( 3 . 5 % ) s ##wab ##s and [unused1] non - au ##reus s ##ta ##phy ##loc ##oc ##ci [unused2] in 22 / 257 ( 8 . 5 % ) s ##wab ##s . The estimated true met ##hic ##ill ##in - resistant St ##aph ##yl ##oc ##oc ##cus au ##reus sub ##c ##lini ##cal co ##lon ##isation prevalence was 0 % , with an upper 95 % C ##I boundary of 1 . 9 % for [SEP]',\n",
       "  'existing_cui': 'C1318973',\n",
       "  'existing_cui_name': 'Staphylococcus aureus infection',\n",
       "  'existing_cui_desc': '[CLS] St ##aph ##yl ##oc ##oc ##cus au ##reus infection [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : St ##aph ##yl ##oc ##oc ##cus au ##reus infections ; St ##aph ##yl ##oc ##oc ##cus au ##reus ; In ##fect ##ion due to St ##aph ##yl ##oc ##cc ##us au ##reus ; In ##fect ##ion due to St ##aph ##yl ##oc ##oc ##cus au ##reus ; St ##aph ##yl ##oc ##oc ##cus au ##reus In ##fect ##ion ; In ##fect ##ion caused by St ##aph ##yl ##oc ##oc ##cus au ##reus ; s ##ta ##phy ##loc ##oc ##cus au ##reus infection ; s ##ta ##phy ##loc ##oc ##cus ; au ##reus ; au ##reus ; St ##aph ##yl ##oc ##oc ##cus ) [SEP]',\n",
       "  'our_bi_cui': 'C0038172',\n",
       "  'our_bi_cui_name': 'Staphylococcus aureus',\n",
       "  'our_bi_cui_desc': '[CLS] St ##aph ##yl ##oc ##oc ##cus au ##reus [unused3] ( Ba ##cter ##ium , organism : S . au ##reus ; s ##ta ##ph au ##reus ; ST ##AP ##H AU ##RE ##US ; S . AU ##RE ##US ; St ##aph . au ##reus ; St ##aph ##yl ##oc ##oc ##cus p ##yo ##gene ##s au ##reus ; s . au ##reus ; ST ##AP ##H ##Y ##L ##OC ##OC ##CU ##S AU ##RE ##US ; s ##ta ##phy ##loc ##oc ##cus au ##reus bacteria ; St ##aph ##yl ##oc ##oc ##cus au ##reus Rosen ##bach 1884 ; Micro ##co ##cc ##us au ##reus ; St ##aph ##yl ##oc ##oc ##cus Au ##reus ; St ##aph ##loc ##oc ##cus p ##yo ##gene ##s c ##it [SEP]',\n",
       "  'our_cross_cui': 'C0038170',\n",
       "  'our_cross_cui_name': 'Genus staphylococcus',\n",
       "  'our_cross_cui_desc': '[CLS] Genus s ##ta ##phy ##loc ##oc ##cus [unused3] ( Ba ##cter ##ium , organism : St ##aph ##yl ##oc ##oc ##cus species ; Genus St ##aph ##yl ##oc ##oc ##cus ; Au ##ro ##co ##cc ##us ; ST ##AP ##H ##Y ##L ##OC ##OC ##CU ##S ; St ##aph ##yl ##oc ##oc ##cus ; St ##aph ##yl ##oc ##oc ##cus Rosen ##bach 1884 ; s ##ta ##phy ##loc ##oc ##cus bacteria ; ST ##AP ##H ; s ##ta ##phy ##loc ##oc ##cus ) [SEP]'},\n",
       " {'mention_id': '27782044.8',\n",
       "  'test_set_idx': 16578,\n",
       "  'type': 'T204',\n",
       "  'name': 'Max Clara',\n",
       "  'context': \"[CLS] Normal Level ##s of U ##rina ##ry CC ##16 Pro ##tein . Co ##mme ##nts on Be ##ame ##r et al . Association of Children ' s U ##rina ##ry CC ##16 Level ##s with A ##rsen ##ic Con ##cent ##rations in Multiple Environmental Media . In ##t . J . En ##vir ##on . Re ##s . Public Health 2016 , 13 , 52 ##1 In 1937 , [unused1] Max Clara [unused2] described a new type of cell in the human lung , which was later determined to be an ex ##oc ##rine secret ##ory cell type containing g ##ran ##ules composed of proteins [ 1 ] . [ . . . ] . [SEP]\",\n",
       "  'existing_cui': 'C0225668',\n",
       "  'existing_cui_name': 'Clara cell',\n",
       "  'existing_cui_desc': '[CLS] Clara cell [unused3] ( Ana ##tom ##ical Structure , body structure , cell : Clara Cell ; Clara cell of br ##on ##chi ##ole ; c ##lar ##a cell ; cells c ##lar ##a ; B ##ron ##chi ##olar non - c ##iliated cell ; Non ##ci ##lia ##ted B ##ron ##chi ##olar E ##pit ##hel ##ial Cell ; Club Cell ) [SEP]',\n",
       "  'our_bi_cui': 'C0225668',\n",
       "  'our_bi_cui_name': 'Clara cell',\n",
       "  'our_bi_cui_desc': '[CLS] Clara cell [unused3] ( Ana ##tom ##ical Structure , body structure , cell : Clara Cell ; Clara cell of br ##on ##chi ##ole ; c ##lar ##a cell ; cells c ##lar ##a ; B ##ron ##chi ##olar non - c ##iliated cell ; Non ##ci ##lia ##ted B ##ron ##chi ##olar E ##pit ##hel ##ial Cell ; Club Cell ) [SEP]',\n",
       "  'our_cross_cui': 'C0086418',\n",
       "  'our_cross_cui_name': 'Homo sapiens',\n",
       "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
       " {'mention_id': '27905972.25',\n",
       "  'test_set_idx': 21639,\n",
       "  'type': 'T098',\n",
       "  'name': 'Danish',\n",
       "  'context': '[CLS] mixed log ##istic model with different slopes in adult , middle , and old age , and includes the m ##oda ##l age at death as a parameter to account for the delay in mortality . A ##pp ##lying the Co ##D ##e model to age - specific pro ##ba ##bilities of death for Japanese , French , American , and [unused1] Danish [unused2] men and women between 1950 and 2010 showed a very good fit of the full age pattern of mortality . Del ##ay of mortality explained about two - thirds of the increase in life expect ##ancy at birth , whereas compression of mortality due to mortality decline ##s in young age explained about one - third . No strong compression of mortality [SEP]',\n",
       "  'existing_cui': 'C0452642',\n",
       "  'existing_cui_name': 'Danish pastry',\n",
       "  'existing_cui_desc': '[CLS] Danish past ##ry [unused3] ( Food , substance ) [SEP]',\n",
       "  'our_bi_cui': 'C0011318',\n",
       "  'our_bi_cui_name': 'Denmark',\n",
       "  'our_bi_cui_desc': '[CLS] Denmark [unused3] ( Spa ##tial Concept , geographic location : D ##K ; D ##A ; den ##mark ; DE ##N ##MA ##R ##K ; D ##N ##K ) [SEP]',\n",
       "  'our_cross_cui': 'C1257890',\n",
       "  'our_cross_cui_name': 'Population Group',\n",
       "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
       " {'mention_id': '27791364.23',\n",
       "  'test_set_idx': 16991,\n",
       "  'type': 'T033',\n",
       "  'name': 'photostability',\n",
       "  'context': '[CLS] ##ic strategy , using b ##ov ##ine serum album ##in as a bio ##tem ##plate at physiological temperature . The as - prepared G ##d : C ##u ##S @ b ##ov ##ine serum album ##in na ##no ##par ##tic ##les with ultra ##sma ##ll sizes ( ca . 9 nm ) exhibited high photo ##thermal conversion efficiency and good [unused1] photos ##ta ##bility [unused2] under near - infrared laser i ##rra ##diation . With do ##ped G ##d species and strong t ##una ##ble near - infrared absorb ##ance , G ##d : C ##u ##S @ b ##ov ##ine serum album ##in na ##no ##par ##tic ##les demonstrate prominent tumor - contrasted imaging performance both on the photo ##aco ##ustic and magnetic resonance imaging [SEP]',\n",
       "  'existing_cui': 'C3272552',\n",
       "  'existing_cui_name': 'Photostability Drug Study',\n",
       "  'existing_cui_desc': '[CLS] Photo ##sta ##bility Drug Study [unused3] ( Intel ##lect ##ual Product : Photo ##sta ##bility ) [SEP]',\n",
       "  'our_bi_cui': 'C0007613',\n",
       "  'our_bi_cui_name': 'Cell physiology',\n",
       "  'our_bi_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28127863.29',\n",
       "  'test_set_idx': 26348,\n",
       "  'type': 'T033',\n",
       "  'name': 'Signs',\n",
       "  'context': '[CLS] speech re ##spiration , p ##hon ##ation , oral motor function , and ve ##lop ##har ##yn ##ge ##al function . The results of the present study suggest that a ne ##uro ##logical et ##iology could be added to the previously described structural et ##iology explaining the speech difficulties found in 22 ##q ##11 . 2 del ##eti ##on syndrome . [unused1] Sign ##s [unused2] of difficulties in both speech motor planning and speech motor programming were found . Further studies are needed to confirm the results , as are studies of the association between structural brain abnormal ##ities and ne ##uro ##logical speech symptoms . For clinical purposes , it is important that clinic ##ians have knowledge about the variable speech symptoms that may occur [SEP]',\n",
       "  'existing_cui': 'C0311392',\n",
       "  'existing_cui_name': 'Physical findings',\n",
       "  'existing_cui_desc': '[CLS] Physical findings [unused3] ( Finding , finding , physical finding : physical finding ; physical findings ; Physical finding ; physical findings [ use for free text ] ; Physical signs ; Sign ##s - physical ; physical signs ; Physical sign ; Sign ; find physical ) [SEP]',\n",
       "  'our_bi_cui': 'C1519316',\n",
       "  'our_bi_cui_name': 'Signature',\n",
       "  'our_bi_cui_desc': '[CLS] Sign ##ature [unused3] ( Intel ##lect ##ual Product : signature ##T ##ex ##t ; Sign ##ed ) [SEP]',\n",
       "  'our_cross_cui': 'C0037088',\n",
       "  'our_cross_cui_name': 'Signs and Symptoms',\n",
       "  'our_cross_cui_desc': '[CLS] Sign ##s and S ##ym ##pt ##oms [unused3] ( Finding , finding : Sign ##s and S ##ym ##pt ##oms [ Disease / Finding ] ; Clinical findings ; clinical findings ; O ##bs ##er ##vable En ##ti ##ty ; sign and s ##ym ##pt ##om ; Sign and s ##ym ##pt ##om ; S ##ym ##pt ##oms and Sign ##s ; sign / s ##ym ##pt ##om ; Finding ; Clinical observation : symptoms and signs ; S ##IG ##NS S ##Y ##MP ##TO ##MS ; Clinical finding ) [SEP]'},\n",
       " {'mention_id': '28478603.20',\n",
       "  'test_set_idx': 37422,\n",
       "  'type': 'T170',\n",
       "  'name': \"Shannon 's information index\",\n",
       "  'context': \"[CLS] am ##plified 96 bands , of which 91 ( 93 . 65 % ) were p ##oly ##morphic , whereas 20 simple sequence repeat prime ##rs am ##plified 73 bands , of which 70 ( 96 . 50 % ) were p ##oly ##morphic . N ##ei ' s gene diversity ( h = 0 . 28 ) , [unused1] Shannon ' s information index [unused2] ( I = 0 . 43 ) , and p ##oly ##mor ##phism information content ( P ##IC = 0 . 29 ) generated using the simple sequence repeat prime ##rs were higher than that with Inter simple sequence repeat prime ##rs ( h = 0 . 23 , I = 0 . 37 , P ##IC = 0 . [SEP]\",\n",
       "  'existing_cui': 'C0237669',\n",
       "  'existing_cui_name': 'Informational Messages',\n",
       "  'existing_cui_desc': '[CLS] Information ##al Message ##s [unused3] ( Intel ##lect ##ual Product , Message ##s : Information ) [SEP]',\n",
       "  'our_bi_cui': 'C1519281',\n",
       "  'our_bi_cui_name': 'Shannon Awards , Guidelines',\n",
       "  'our_bi_cui_desc': '[CLS] Shannon Awards , Guide ##lines [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
       "  'our_cross_cui': 'C0918012',\n",
       "  'our_cross_cui_name': 'Index',\n",
       "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
       " {'mention_id': '28319502.10',\n",
       "  'test_set_idx': 31866,\n",
       "  'type': 'T038',\n",
       "  'name': 'RS3PE',\n",
       "  'context': '[CLS] se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema ( RS ##3 ##P ##E ) is a rare condition in the elderly and can appear as a first presentation of various types of r ##he ##umatic and ma ##li ##gnant diseases . We presented a 62 - year - old man with the diagnosis of [unused1] RS ##3 ##P ##E [unused2] based on the clinical sign and laboratory data . Because of the possibility of associated ma ##li ##gna ##ncies in RS ##3 ##P ##E , F ##D ##G P ##ET / CT was performed to exclude o ##cc ##ult tumors . The images showed multiple , symmetrical ##ly , di ##ff ##use ##ly increased F - F ##D ##G up [SEP]',\n",
       "  'existing_cui': 'C3147672',\n",
       "  'existing_cui_name': 'IRS3P gene',\n",
       "  'existing_cui_desc': '[CLS] I ##RS ##3 ##P gene [unused3] ( Ana ##tom ##ical Structure : insulin receptor substrate 3 , pseudo ##gene ) [SEP]',\n",
       "  'our_bi_cui': 'C0035357',\n",
       "  'our_bi_cui_name': 'Retroperitoneal fibrosis',\n",
       "  'our_bi_cui_desc': \"[CLS] Re ##tro ##per ##ito ##nea ##l fi ##bro ##sis [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Or ##mond ' s disease ; or ##mond ' s disease ; Sc ##ler ##os ##ing re ##tro ##per ##ito ##ni ##tis ; I ##dio ##pathic re ##tro ##per ##ito ##nea ##l fi ##bro ##sis ; R ##P ##F - Re ##tro ##per ##ito ##nea ##l fi ##bro ##sis ; id ##io ##pathic re ##tro ##per ##ito ##nea ##l fi ##bro ##sis ; Disease , Or ##mond ' s ; re ##tro ##per ##ito ##nea ##l fi ##bro ##sis ; Or ##mond Disease ; or ##mond disease ; Fi ##bro ##ses , Re ##tro ##per ##ito ##nea ##l ; Re ##tro ##per ##ito ##nea [SEP]\",\n",
       "  'our_cross_cui': 'C2919482',\n",
       "  'our_cross_cui_name': 'Remitting seronegative symmetrical synovitis with pitting edema',\n",
       "  'our_cross_cui_desc': '[CLS] Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Re ##lap ##sing se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema ; Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; RS ##3 ##P ##E - Re ##mit ##ting se ##rone ##gat ##ive symmetric s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; Re ##lap ##sing se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; RS ##3 ##P ##E - Re ##mit ##ting se ##rone ##gat ##ive symmetric s ##yn ##ov ##itis with [SEP]'},\n",
       " {'mention_id': '27667643.25',\n",
       "  'test_set_idx': 13599,\n",
       "  'type': 'T033',\n",
       "  'name': 'health issue',\n",
       "  'context': \"[CLS] and disease . Clinical ya ##rn ##ing consists of three inter ##rel ##ated areas : the social ya ##rn , in which the practitioner aims to find common ground and develop the inter ##person ##al relationship ; the diagnostic ya ##rn , in which the practitioner facilitate ##s the patient ' s health story while interpret ##ing it through a bio ##medical or scientific lens ; and the management ya ##rn , that employs stories and metaphor ##s as tools for patients to help them understand a [unused1] health issue [unused2] so a collaborative management approach can be adopted . There is cultural and research evidence that supports this approach . Clinical ya ##rn ##ing has the potential to improve outcomes for patients and practitioners . [SEP]\",\n",
       "  'existing_cui': 'C4274868',\n",
       "  'existing_cui_name': 'Parental health issue',\n",
       "  'existing_cui_desc': '[CLS] Pa ##rent ##al health issue [unused3] ( Finding , situation : Pa ##rent has health disorder ) [SEP]',\n",
       "  'our_bi_cui': 'C0033213',\n",
       "  'our_bi_cui_name': 'Problem',\n",
       "  'our_bi_cui_desc': '[CLS] Problem [unused3] ( Finding , finding : Issue ; problem ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28481342.1',\n",
       "  'test_set_idx': 37606,\n",
       "  'type': 'T038',\n",
       "  'name': 'Recurrent noncoding regulatory mutations',\n",
       "  'context': '[CLS] [unused1] Re ##current non ##co ##ding regulatory mutations [unused2] in pan ##cre ##atic duct ##al ad ##eno ##car ##cin ##oma The contributions of coding mutations to tumor ##ige ##nes ##is are relatively well known ; however , little is known about so ##matic alterations in non ##co ##ding DNA . Here we describe Gen ##omi ##c En ##rich ##ment Co ##mp ##uta ##tional C ##luster ##ing Operation to analyze so ##matic non ##co ##ding alterations in 308 pan ##cre ##atic duct ##al ad ##eno ##car ##cin ##oma ##s and identify commonly m ##uta ##ted regulatory regions . We find re ##current non ##co ##ding mutations to be en ##rich ##ed in PD ##A pathways , including a ##xon guidance and cell ad ##hesion , and newly [SEP]',\n",
       "  'existing_cui': 'C0887909',\n",
       "  'existing_cui_name': 'RNA , Untranslated',\n",
       "  'existing_cui_desc': '[CLS] RNA , Un ##tra ##ns ##lated [unused3] ( Chemical : RNA , Non ##co ##ding ; Non - Co ##ding RNA ; Non ##co ##ding RNA ; RNA , Non ##tra ##ns ##lated ; Un ##tra ##ns ##lated RNA ; RNA , Non - Co ##ding ; RNA , Non Pro ##tein Co ##ding ; RNA , Non Co ##ding ; n ##p ##c ##RNA ; n ##c ##RNA ; RNA , Un ##tra ##ns ##lated [ Chemical / In ##g ##red ##ient ] ; Fun ##ctional RNA ; Non ##tra ##ns ##lated RNA ; Non - coding RNA ; RNA , Non - P ##eptide - Co ##ding ; Non - Pro ##tein - Co ##ding RNA ; RNA , Non - Pro ##tein - [SEP]',\n",
       "  'our_bi_cui': 'C0596611',\n",
       "  'our_bi_cui_name': 'Gene Mutation',\n",
       "  'our_bi_cui_desc': '[CLS] Gene Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction : DNA Se ##quence Alt ##eration ; Gene Alt ##eration ; DNA Alt ##eration ; gene mutation ; genes mutation ; Gene Mu ##tation Type ; M ##OL ##PA ##TH . M ##UT ; gene mutations ; Se ##quence Alt ##eration ; Gene mutation ; mutation gene ) [SEP]',\n",
       "  'our_cross_cui': 'C0026882',\n",
       "  'our_cross_cui_name': 'Mutation',\n",
       "  'our_cross_cui_desc': '[CLS] Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction , finding : genome mutation ; Gene ##tic mutation ; genetic mutation ; genetic mutations ; mutations ; Mu ##tations ; mutation ; alterations genetic ; genetic alter ##ation ) [SEP]'},\n",
       " {'mention_id': '28186384.40',\n",
       "  'test_set_idx': 27815,\n",
       "  'type': 'T033',\n",
       "  'name': 'system - related barriers',\n",
       "  'context': '[CLS] in the subsequent results . System - related factors included a lack of confidence in the rational ##e for modify ##ing the current c ##er ##vic ##al screening programme , and concerns about sample contamination and identity theft . In ##sight ##s gained from this research can be used to guide further en ##qui ##ry into the possibility of human p ##ap ##illo ##ma ##virus self - sampling and to help inform future policy and practice . Personal and [unused1] system - related barriers [unused2] including low confidence in the reasons for changing current c ##er ##vic ##al screening provision need to be addressed , should human p ##ap ##illo ##ma ##virus self - sampling be incorporated into the c ##er ##vic ##al screening programme . [SEP]',\n",
       "  'existing_cui': 'C1706912',\n",
       "  'existing_cui_name': 'BARRIER',\n",
       "  'existing_cui_desc': '[CLS] BA ##R ##RI ##ER [unused3] ( Medical Devi ##ce : Barr ##ier ; Barr ##ier Devi ##ce Co ##mpo ##nent ; barrier ) [SEP]',\n",
       "  'our_bi_cui': 'C1717601',\n",
       "  'our_bi_cui_name': 'Barriers to self management',\n",
       "  'our_bi_cui_desc': '[CLS] Barr ##iers to self management [unused3] ( Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28167893.47',\n",
       "  'test_set_idx': 27488,\n",
       "  'type': 'T033',\n",
       "  'name': 'undeveloped',\n",
       "  'context': '[CLS] be a turning moment of the m ##or ##ph ##ogen ##etic changes resisting fungi ##cid ##al toxicity . Con - G formed multi ##cellular con ##id ##ia with cell walls and se ##pta and intact dense c ##yt ##op ##las ##m . In I ##p ##r - N , fun ##gal s ##por ##ulation was in ##hibit ##ed by forming mostly [unused1] und ##eveloped [unused2] un ##ice ##ll ##ular con ##id ##ia with de ##graded and ne ##c ##rot ##ic c ##yt ##op ##las ##m . However , in I ##p ##r - I , conspicuous cellular changes occurred during s ##por ##ulation by forming multi ##cellular con ##id ##ia with double layered ( thick ##ened ) cell walls and accumulation of pro ##life ##rated lip [SEP]',\n",
       "  'existing_cui': 'C0555024',\n",
       "  'existing_cui_name': 'Eloped',\n",
       "  'existing_cui_desc': '[CLS] El ##oped [unused3] ( Finding , finding ) [SEP]',\n",
       "  'our_bi_cui': 'C0041674',\n",
       "  'our_bi_cui_name': 'Unemployment',\n",
       "  'our_bi_cui_desc': \"[CLS] Un ##em ##p ##loy ##ment [unused3] ( Finding , finding , history : unemployment ; Without employment ; out working ; U ##E - Un ##em ##p ##loy ##ed ; NO ##T E ##MP ##L ##O ##Y ##ED ; outs work ; Does Not Work ; Un ##em ##p ##loy ##ed ; U / E - Un ##em ##p ##loy ##ed ; out of work ; out work ; job ##lessness ; job ##less ; UN ##EM ##PL ##O ##Y ##ME ##NT ; unemployed ; Does n ' t Work ; Out ( of ) ; work ; Do n ' t Work ; Out of work ; work out ) [SEP]\",\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27832198.48',\n",
       "  'test_set_idx': 18670,\n",
       "  'type': 'T017',\n",
       "  'name': 'Dd2',\n",
       "  'context': '[CLS] ##quin ##e resistance transport ##er - specific zinc - finger n ##uc ##lea ##ses to genetically di ##sse ##ct this all ##ele in the path ##ogenic setting of as ##ex ##ual blood - stage infection . Comparative analysis of drug resistance and growth profiles of re ##comb ##ina ##nt parasite ##s that express Cam ##7 ##34 or variants thereof , [unused1] D ##d ##2 [unused2] ( the most common Southeast Asian variant ) , or wild - type P . f ##al ##ci ##par ##um ch ##lor ##o ##quin ##e resistance transport ##er , revealed previously unknown roles for P ##f ##CR ##T mutations in m ##od ##ulating parasite su ##s ##ce ##pt ##ibility to multiple anti ##mal ##aria ##l agents . These results were generated [SEP]',\n",
       "  'existing_cui': 'C4151768',\n",
       "  'existing_cui_name': 'bacterium DD2',\n",
       "  'existing_cui_desc': '[CLS] bacterium DD ##2 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
       "  'our_bi_cui': 'C1412089',\n",
       "  'our_bi_cui_name': 'ABCD2 gene',\n",
       "  'our_bi_cui_desc': '[CLS] ABC ##D ##2 gene [unused3] ( Ana ##tom ##ical Structure : AD ##RE ##N ##OL ##E ##U ##KO ##D ##Y ##ST ##RO ##P ##H ##Y - L ##I ##KE 1 ; AD ##RE ##N ##OL ##E ##U ##KO ##D ##Y ##ST ##RO ##P ##H ##Y - R ##EL ##AT ##ED ; AL ##DR ##P ; ATP binding cassette subfamily D member 2 ; ATP - B ##IN ##DI ##NG CA ##SS ##ET ##TE , S ##U ##BF ##AM ##IL ##Y 3 , ME ##MB ##ER 2 ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27297967.80',\n",
       "  'test_set_idx': 1785,\n",
       "  'type': 'T082',\n",
       "  'name': 'Asn19/23Gln/Tyr920Glu / Ser921Glu',\n",
       "  'context': '[CLS] ##20 / Ser ##9 ##21 p ##hos ##ph ##ory ##lation are responsible for altering the kinetic ##s of MR ##P ##1 - mediated As ( G ##S ) 3 transport . The kinetic ##s of As ( G ##S ) 3 transport by human em ##b ##ryo ##nic kidney 29 ##3 - [unused1] As ##n ##19 / 23 ##G ##ln / Ty ##r ##9 ##20 ##G ##lu / Ser ##9 ##21 ##G ##lu [unused2] were similar to H ##E ##K - W ##T - MR ##P ##1 , indicating that the p ##hos ##ph ##ory ##lation - mimic ##king substitution ##s a ##bro ##gated the influence of As ##n ##19 / 23 ##G ##ln g ##ly ##cos ##yla ##tion . Overall , these data suggest that [SEP]',\n",
       "  'existing_cui': 'C0175489',\n",
       "  'existing_cui_name': 'Nucleus Globosus',\n",
       "  'existing_cui_desc': '[CLS] N ##uc ##le ##us G ##lo ##bos ##us [unused3] ( Ana ##tom ##ical Structure , body structure : Structure of c ##ere ##bella ##r g ##lo ##bos ##e nucleus ; G ##lo ##bos ##us , N ##uc ##le ##us ; Post ##eri ##or inter ##posed nucleus ; N ##uc ##le ##us inter ##po ##si ##tus posterior ; N ##uc ##le ##us inter ##po ##si ##tus posterior c ##ere ##bell ##i ; N ##uc ##le ##us g ##lo ##bos ##us c ##ere ##bell ##i ; Post ##eri ##or inter ##po ##si ##tus nucleus ; posterior inter ##po ##si ##tus nucleus ; G ##lo ##bos ##e nucleus ; g ##lo ##bos ##e nucleus ; posterior inter ##posed nucleus ; N ##uc ##le ##i g ##lo ##bos ##i ; [SEP]',\n",
       "  'our_bi_cui': 'C0949771',\n",
       "  'our_bi_cui_name': 'Amino Acid Transporter',\n",
       "  'our_bi_cui_desc': '[CLS] Am ##ino A ##cid Transport ##er [unused3] ( Chemical : Am ##ino A ##cid Transport ##ers ; Am ##ino A ##cid Channel ; Transport ##ers , Am ##ino A ##cid ; Am ##ino A ##cid Transport Systems ; Am ##ino A ##cid Transport Systems [ Chemical / In ##g ##red ##ient ] ; Am ##ino A ##cid Transport Pro ##tein ) [SEP]',\n",
       "  'our_cross_cui': 'C0002518',\n",
       "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
       "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
       " {'mention_id': '28263181.25',\n",
       "  'test_set_idx': 30385,\n",
       "  'type': 'T170',\n",
       "  'name': 'Prigogine theorem',\n",
       "  'context': '[CLS] . 9 . Hence , calculation shows that , in respect to pure re ##spiration , the predominant f ##er ##ment ##ative metabolism decreases around 10 % the production of en ##tropy per mole of glucose consumed in cancer cells . We h ##y ##pot ##hes ##ize that increased f ##er ##mentation could allow cancer cells to accomplish the [unused1] P ##rig ##og ##ine theorem [unused2] of the trend to minimize the rate of production of en ##tropy . According the theorem , open cellular systems near the steady state could evolve to minimize the rates of en ##tropy production that may be reached by modified replica ##ting cells producing en ##tropy at low rate . Re ##mark ##ably , at CO ##2 concentrations above 93 [SEP]',\n",
       "  'existing_cui': 'C0034673',\n",
       "  'existing_cui_name': 'rapid eye movement',\n",
       "  'existing_cui_desc': '[CLS] rapid eye movement [unused3] ( B ##iol ##og ##ic Fun ##ction : Movement , Rapid Eye ; Rapid Eye Movement ; Rapid Eye Movement ##s ; Eye Movement ##s , Rapid ; Movement ##s , Rapid Eye ; Eye Movement , Rapid ) [SEP]',\n",
       "  'our_bi_cui': 'C1705273',\n",
       "  'our_bi_cui_name': 'Mathematical Operator',\n",
       "  'our_bi_cui_desc': '[CLS] Mathematical Opera ##tor [unused3] ( Intel ##lect ##ual Product : Opera ##tor ; Fun ##ction ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27760149.30',\n",
       "  'test_set_idx': 15817,\n",
       "  'type': 'T170',\n",
       "  'name': 'biomedical entity search tool',\n",
       "  'context': \"[CLS] the response time ; however , they are not constantly updated , and thus produce out ##dated results . Further , most existing tools can not process sophisticated que ##ries such as searches for mutations that co - occur with que ##ry terms in the literature . To address these problems , we introduce B ##ES ##T , a [unused1] bio ##medical entity search tool [unused2] . B ##ES ##T returns , as a result , a list of 10 different types of bio ##medical entities including genes , diseases , drugs , targets , transcription factors , mi ##RNA ##s , and mutations that are relevant to a user ' s que ##ry . To the best of our knowledge , B ##ES ##T is [SEP]\",\n",
       "  'existing_cui': 'C2348167',\n",
       "  'existing_cui_name': 'Search Engine',\n",
       "  'existing_cui_desc': '[CLS] Search Engine [unused3] ( Intel ##lect ##ual Product : Search Program ; Search engines ; Engine , Search ; Search Too ##l ; Search Engine ##s ) [SEP]',\n",
       "  'our_bi_cui': 'C0037589',\n",
       "  'our_bi_cui_name': 'Software Tools',\n",
       "  'our_bi_cui_desc': '[CLS] Software Too ##ls [unused3] ( Intel ##lect ##ual Product : Too ##l , Software ; Too ##ls , Software ; Software Too ##l ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27333847.33',\n",
       "  'test_set_idx': 2654,\n",
       "  'type': 'T170',\n",
       "  'name': 'age assessment tool',\n",
       "  'context': '[CLS] very strong at 0 . 98 ##0 ##2 ( boys 0 . 97 ##48 , girls 0 . 98 ##7 ##6 ) . The oral narrative component of the tool performed best ( R = 0 . 96 ##0 ##3 ) . Overall , 86 . 7 % of age estimates were within 1 year of the true age . The range of differences was - 1 . 43 to 3 . 92 years with a standard de ##viation of 0 . 77 years ( 9 . 24 months ) . The [unused1] age assessment tool [unused2] is a ho ##listic , simple and safe instrument that can be used to estimate age in refugee children with results comparable with radio ##logical methods currently used . [SEP]',\n",
       "  'existing_cui': 'C1518848',\n",
       "  'existing_cui_name': 'Pain Assessment Tool',\n",
       "  'existing_cui_desc': '[CLS] Pain Assessment Too ##l [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
       "  'our_bi_cui': 'C1516602',\n",
       "  'our_bi_cui_name': 'Research or Clinical Assessment Tool',\n",
       "  'our_bi_cui_desc': '[CLS] Research or Clinical Assessment Too ##l [unused3] ( Intel ##lect ##ual Product : Clinical Assessment Too ##l ; Clinical or Research Assessment Too ##l ) [SEP]',\n",
       "  'our_cross_cui': 'C0037589',\n",
       "  'our_cross_cui_name': 'Software Tools',\n",
       "  'our_cross_cui_desc': '[CLS] Software Too ##ls [unused3] ( Intel ##lect ##ual Product : Too ##l , Software ; Too ##ls , Software ; Software Too ##l ) [SEP]'},\n",
       " {'mention_id': '27297967.74',\n",
       "  'test_set_idx': 1779,\n",
       "  'type': 'T082',\n",
       "  'name': 'Tyr920/Ser921',\n",
       "  'context': '[CLS] ##nic kidney 29 ##3 - Ty ##r ##9 ##20 ##P ##he - and - Ser ##9 ##21 ##A ##la - MR ##P ##1 mutant ##s were similar to H ##E ##K - W ##T - MR ##P ##1 . Together , these results suggest that As ##n ##19 / As ##n ##23 g ##ly ##cos ##yla ##tion and [unused1] Ty ##r ##9 ##20 / Ser ##9 ##21 [unused2] p ##hos ##ph ##ory ##lation are responsible for altering the kinetic ##s of MR ##P ##1 - mediated As ( G ##S ) 3 transport . The kinetic ##s of As ( G ##S ) 3 transport by human em ##b ##ryo ##nic kidney 29 ##3 - As ##n ##19 / 23 ##G ##ln / Ty ##r ##9 [SEP]',\n",
       "  'existing_cui': 'C1414863',\n",
       "  'existing_cui_name': 'FUT2 gene',\n",
       "  'existing_cui_desc': '[CLS] F ##UT ##2 gene [unused3] ( Ana ##tom ##ical Structure : GDP - L - f ##uc ##ose : beta - D - gal ##act ##os ##ide 2 - alpha - L - f ##uc ##osy ##lt ##ran ##s ##fer ##ase 2 ; alpha ( 1 , 2 ) F ##T ##2 ; secret ##or blood group alpha - 2 - f ##uc ##osy ##lt ##ran ##s ##fer ##ase ; SEC ##2 ; SEC ##RE ##TO ##R FA ##CT ##OR ; f ##uc ##osy ##lt ##ran ##s ##fer ##ase 2 ; se ##j ; alpha ( 1 , 2 ) f ##uc ##osy ##lt ##ran ##s ##fer ##ase ; F ##UC ##OS ##Y ##LT ##RA ##NS ##F ##ER ##AS ##E 2 ; secret ##or factor ; [SEP]',\n",
       "  'our_bi_cui': 'C1519063',\n",
       "  'our_bi_cui_name': 'Phosphorylation Site',\n",
       "  'our_bi_cui_desc': '[CLS] Ph ##os ##ph ##ory ##lation Site [unused3] ( Spa ##tial Concept ) [SEP]',\n",
       "  'our_cross_cui': 'C0002518',\n",
       "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
       "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
       " {'mention_id': '27623277.16',\n",
       "  'test_set_idx': 12200,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedures',\n",
       "  'context': \"[CLS] on the patient ' s clinical condition and patient preferences . This study describes the relative importance of several considerations in lung cancer treatment from the patient ' s perspective . A con ##join ##t preference experiment began by asking respond ##ents to imagine that they had just been diagnosed with lung cancer . Re ##sp ##ond ##ents then chose among [unused1] procedures [unused2] that differed regarding treatment m ##oda ##lities , the potential for treatment - related complications , the likelihood of re ##cu ##rrence , provider case volume , and distance needed to travel for treatment . Con ##join ##t analysis derived relative weights for these attributes . A total of 225 responses were analyzed . Re ##sp ##ond ##ents were most willing to [SEP]\",\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '28125734.58',\n",
       "  'test_set_idx': 26212,\n",
       "  'type': 'T103',\n",
       "  'name': 'miR-21-5p',\n",
       "  'context': '[CLS] - 5 ##p was shown to be able to m ##od ##ulate me ##so ##the ##lin expression in mi ##RNA mimic experiments in a panel of ma ##li ##gnant and non - ma ##li ##gnant cell lines . Further mi ##RNA inhibitor experiments and l ##uc ##ifer ##ase ass ##ays in Me ##ro - 14 cells valid ##ated [unused1] mi ##R - 21 - 5 ##p [unused2] as a true regulator of me ##so ##the ##lin . Moreover , in v ##it ##ro experiments showed that treatment with mi ##R - 21 - 5 ##p mimic reduced proliferation of ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma cell lines . Alto ##get ##her , this work shows that the mi ##R - CA [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1999986',\n",
       "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '27645371.5',\n",
       "  'test_set_idx': 12698,\n",
       "  'type': 'T082',\n",
       "  'name': 'perspectives',\n",
       "  'context': '[CLS] Track ##ing children with acute l ##ymph ##ob ##lastic le ##uke ##mia who abandoned therapy : Experience , challenges , parental [unused1] perspectives [unused2] , and impact of treatment subsidies and intensified counseling Re ##fu ##sal for treatment and therapy abandonment are important reasons for un ##fa ##vor ##able outcome of childhood acute l ##ymph ##ob ##lastic le ##uke ##mia in resource - poor countries . The present study , conducted on children with acute l ##ymph ##ob ##lastic le ##uke ##mia whose treatment was abandoned , attempted to track all these children to as ##cer ##tain the causes and outcome of therapy abandonment / refusal . In order to improve outcome of acute l ##ymph ##ob ##lastic le ##uke ##mia , measures to prevent abandonment [SEP]',\n",
       "  'existing_cui': 'C0040226',\n",
       "  'existing_cui_name': 'Time Perception',\n",
       "  'existing_cui_desc': '[CLS] Time Per ##ception [unused3] ( B ##iol ##og ##ic Fun ##ction : Time perception ; perception time ; Per ##ception , Time ; Time Per ##ception ##s ; Per ##ception ##s , Time ; time perception ; Time Per ##spective ) [SEP]',\n",
       "  'our_bi_cui': 'C0030971',\n",
       "  'our_bi_cui_name': 'Perception',\n",
       "  'our_bi_cui_desc': '[CLS] Per ##ception [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : perception ##s ; perception ; Per ##ceived ; Per ##ception ##s ; perceived ; Per ##ce ##pt ##ual functions , un ##sp ##ec ##ified ; Per ##ce ##pt ##ual functions ; Per ##ception , function ; per ##ceiving ) [SEP]',\n",
       "  'our_cross_cui': 'C0449911',\n",
       "  'our_cross_cui_name': 'View',\n",
       "  'our_cross_cui_desc': '[CLS] View [unused3] ( Spa ##tial Concept , attribute : ( View ##s ; views ; view ; View ##s for ; View ##s ) [SEP]'},\n",
       " {'mention_id': '28145492.28',\n",
       "  'test_set_idx': 26788,\n",
       "  'type': 'T038',\n",
       "  'name': 'current',\n",
       "  'context': '[CLS] - A , as well as H / O - B , excited o ##s ##cilla ##ting tube ##roi ##n ##fu ##ndi ##bula ##r do ##pa ##mine neurons , in ##ducing a re ##versible de ##pol ##aris ##ing switch from p ##has ##ic to ton ##ic discharge . The H ##y ##po ##cre ##tin / Or ##ex ##in - induced inward [unused1] current [unused2] under ##pin ##ning this effect was post - s ##yna ##ptic ( as it endured in the presence of te ##tro ##do ##to ##xin ) , appeared to be carried by a Na ( + ) - dependent trans ##ient receptor potential - like channel ( as it was blocked by 2 - AP ##B and was diminished by removal of extra [SEP]',\n",
       "  'existing_cui': 'C0282444',\n",
       "  'existing_cui_name': 'Current Biog-Obit',\n",
       "  'existing_cui_desc': '[CLS] Current B ##io ##g - O ##bit [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
       "  'our_bi_cui': 'C0022023',\n",
       "  'our_bi_cui_name': 'Ions',\n",
       "  'our_bi_cui_desc': '[CLS] Ion ##s [unused3] ( Chemical , substance : ion ; Ion ##s [ Chemical / In ##g ##red ##ient ] ; Ion ; charged particles ; ions ) [SEP]',\n",
       "  'our_cross_cui': 'C0162585',\n",
       "  'our_cross_cui_name': 'Ion Transport',\n",
       "  'our_cross_cui_desc': '[CLS] Ion Transport [unused3] ( B ##iol ##og ##ic Fun ##ction : ion transport ; Transport , Ion ) [SEP]'},\n",
       " {'mention_id': '27622027.20',\n",
       "  'test_set_idx': 12093,\n",
       "  'type': 'T017',\n",
       "  'name': 'Fresh tumor - draining LN tissues',\n",
       "  'context': '[CLS] , we showed CD ##16 ##9 expression on some CD ##8 ( + ) T l ##ymph ##ocytes in regional l ##ymph nodes and investigated the function and clinical relevance of CD ##16 ##9 ( + ) CD ##8 ( + ) T cells in tumor - draining l ##ymph nodes of color ##ec ##tal cancer patients . [unused1] Fresh tumor - draining L ##N tissues [unused2] from 39 randomly enrolled patients were assessed by flow c ##yt ##ome ##try for activation and differentiation of CD ##16 ##9 ( + ) CD ##8 ( + ) T cells and T cell - mediated killing of tumor cells . In total , 114 tumor - draining L ##N para ##ffin sections from color ##ec ##tal cancer patients [SEP]',\n",
       "  'existing_cui': 'C1519521',\n",
       "  'existing_cui_name': 'Fresh Tissue',\n",
       "  'existing_cui_desc': '[CLS] Fresh T ##iss ##ue [unused3] ( Ana ##tom ##ical Structure : T ##iss ##ue , Fresh ) [SEP]',\n",
       "  'our_bi_cui': 'C0475358',\n",
       "  'our_bi_cui_name': 'Tumor tissue sample',\n",
       "  'our_bi_cui_desc': '[CLS] Tu ##mor tissue sample [unused3] ( Ana ##tom ##ical Structure , specimen : Tu ##mour tissue ; Tu ##mor Sam ##ple ; samples tissue tumor ; tissue tumor ; tissue tumors ; Tu ##mour tissue sample ; tumor tissue ; T ##UM ##OR T ##IS ##SU ##E ; Tu ##mor tissue ; tissues tumor ; Tu ##mor T ##iss ##ue ; tissue t ##umour ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0440747',\n",
       "  'our_cross_cui_name': 'Lymph Node Tissue',\n",
       "  'our_cross_cui_desc': '[CLS] L ##ymph No ##de T ##iss ##ue [unused3] ( Ana ##tom ##ical Structure , substance : L ##Y ##MP ##H NO ##DE ; L ##ymph node tissue ; L ##ymph G ##land ) [SEP]'},\n",
       " {'mention_id': '28220186.31',\n",
       "  'test_set_idx': 28686,\n",
       "  'type': 'T062',\n",
       "  'name': 'genetic tool',\n",
       "  'context': '[CLS] marker for L . stark ##ey ##i . However , gene - targeting frequencies were very low because non - ho ##mo ##log ##ous re ##comb ##ination is probably predominant in L . stark ##ey ##i . Gene ##tic engineering tools for L . stark ##ey ##i have not been sufficiently developed . In this study , we describe a new [unused1] genetic tool [unused2] and its application in L . stark ##ey ##i . To develop a highly efficient gene - targeting system for L . stark ##ey ##i , we constructed a series of mutant ##s by disrupt ##ing genes for L ##s ##K ##u ##70 ##p , L ##s ##K ##u ##80 ##p , and / or L ##s ##L ##ig ##4 ##p [SEP]',\n",
       "  'existing_cui': 'C0017296',\n",
       "  'existing_cui_name': 'gene therapy',\n",
       "  'existing_cui_desc': '[CLS] gene therapy [unused3] ( Health Care Act ##ivity , procedure , treatment : Gene the ##rap ##ies ; d ##na therapy ; Gene Transfer Pro ##ced ##ure ; Molecular Biology , Gene Therapy ; Therapy , Gene ; THE ##R GE ##NE ; gene the ##rap ##ies ; Gene therapy ; Inter ##vention , Gene ##tic ; GE ##NE THE ##R ; therapy , gene ; Gene transfer ; GE ##NE ##TI ##C ; Gene Therapy ; d ##na the ##rap ##ies ; DNA Therapy ) [SEP]',\n",
       "  'our_bi_cui': 'C0017393',\n",
       "  'our_bi_cui_name': 'Genetic Markers',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##tic Mark ##ers [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : genetic markers ; Gene ##tic marker ; MA ##R ##KE ##RS GE ##NE ##T ; GE ##NE ##T MA ##R ##KE ##R ; GE ##NE ##T MA ##R ##KE ##RS ; Mark ##ers , Gene ##tic ; Mark ##er , Gene ##tic ; MA ##R ##KE ##R GE ##NE ##T ; Gene ##tic markers ; genetic marker ; Gene ##tic Mark ##ers [ Chemical / In ##g ##red ##ient ] ; Gene ##tic marker , function ; Gene ##tic Mark ##er ) [SEP]',\n",
       "  'our_cross_cui': 'C0017387',\n",
       "  'our_cross_cui_name': 'Genetic Engineering',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##tic Engineering [unused3] ( Research Act ##ivity : GE ##NE ##T E ##NG ##IN ##EE ##RI ##NG ; B ##iot ##ech ##nology , Gene ##tic Engineering ; E ##NG ##IN ##EE ##RI ##NG GE ##NE ##T ; Gene ##tic Inter ##vention ; engineering genetic ; engineering genetics ; IN ##TE ##R ##VE ##NT ##ION GE ##NE ##T ; engineer genetic ; genetic intervention ; Gene ##tically Engineer ##ed ; genetic engineer ; genetic engineering ; Inter ##vention , Gene ##tic ; GE ##NE ##T IN ##TE ##R ##VE ##NT ##ION ; Inter ##vention ##s , Gene ##tic ; Molecular Biology , Gene ##tic Engineering ; engineered genetic ; Gene ##tic Inter ##vention ##s ; Engineering , Gene ##tic ; Re ##comb ##ina ##nt DNA Technology [SEP]'},\n",
       " {'mention_id': '28272254.12',\n",
       "  'test_set_idx': 30758,\n",
       "  'type': 'T103',\n",
       "  'name': 'therapeutic drugs',\n",
       "  'context': '[CLS] ##tens ##ion patients : Bay ##esi ##an network meta - analysis Left vent ##ric ##ular h ##yper ##tro ##phy is commonly present in patients with h ##yper ##tens ##ion . According to the expert consensus document from American , an ##gio ##tens ##in - converting enzyme inhibitor and an ##gio ##tens ##in receptor block ##ers were recommended as 1st - line [unused1] therapeutic drugs [unused2] . However , none noticed the different efficacy between fat - soluble and selective β ##1 - receptor block ##ers and other β - block ##ers on re ##gression of Left vent ##ric ##ular h ##yper ##tro ##phy before . The aim of this analysis was to compare the efficacy of fat - soluble and selective β ##1 - receptor block [SEP]',\n",
       "  'existing_cui': 'C0580398',\n",
       "  'existing_cui_name': 'Therapeutic drug level - finding',\n",
       "  'existing_cui_desc': '[CLS] The ##rap ##eu ##tic drug level - finding [unused3] ( Finding , finding , procedure : Finding of therapeutic drug level ; Drug level therapeutic ; drugs levels therapeutic ; The ##rap ##eu ##tic drug level ; therapeutic drug level ; drug levels therapeutic ; drug level therapeutic ) [SEP]',\n",
       "  'our_bi_cui': 'C1611640',\n",
       "  'our_bi_cui_name': 'Therapeutic agent',\n",
       "  'our_bi_cui_desc': '[CLS] The ##rap ##eu ##tic agent [unused3] ( Chemical , substance , substance , product : therapeutic agent ) [SEP]',\n",
       "  'our_cross_cui': 'C0013227',\n",
       "  'our_cross_cui_name': 'Pharmaceutical Preparations',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##ce ##utical Pre ##par ##ations [unused3] ( Chemical , product , substance : Drug or me ##dic ##ament ; Drug preparation ; Me ##dication ##s ; Ph ##arma ##ce ##utical / bio ##log ##ic product ; drug / agent ; medicinal products ; medications ; medicinal product ; Ph ##arma ##ce ##uti ##c Pre ##par ##ations ; Me ##dication ; Pre ##par ##ations , Ph ##arma ##ce ##uti ##c ; Drugs ; pharmaceutical preparation ; drug ; PR ##EP ##AR ##AT ##ION ##S P ##HA ##R ##M ; Ph ##arma ##ce ##utical Products ; Products , Ph ##arma ##ce ##utical ; medication ; General drug type ; Drug product ; Medicine ##s ; Drug Product ; drugs ; Medicine ; P ##HA ##R ##M [SEP]'},\n",
       " {'mention_id': '27394918.15',\n",
       "  'test_set_idx': 4520,\n",
       "  'type': 'T103',\n",
       "  'name': 'Sm',\n",
       "  'context': '[CLS] order to assess occupational exposure level of 15 rare earth elements and identify the associated influence , we used in ##duct ##ively coupled plasma mass s ##pect ##rome ##try based on closed - vessel microwave - assisted wet dig ##est ##ion procedure to de ##ter ##minate the concentration of Y , La , Ce , P ##r , N ##d , [unused1] S ##m [unused2] , E ##u , G ##d , T ##b , D ##y , Ho , E ##r , T ##m , Y ##b and Lu in u ##rina ##ry samples obtained from workers producing ultra ##fine and na ##no ##par ##tic ##les containing c ##eri ##um and la ##nt ##han ##um oxide . The results suggest that La and Ce were [SEP]',\n",
       "  'existing_cui': 'C1419249',\n",
       "  'existing_cui_name': 'RAI1 gene',\n",
       "  'existing_cui_desc': '[CLS] RA ##I ##1 gene [unused3] ( Ana ##tom ##ical Structure : Re ##tino ##ic A ##cid In ##duced 1 Gene ; R ##ET ##IN ##O ##IC AC ##ID - IN ##D ##UC ##ED GE ##NE 1 ; K ##IA ##A ##18 ##20 ; RA ##I ##1 Gene ; MG ##C ##12 ##8 ##24 ; D ##K ##F ##Z ##P ##43 ##4 ##A ##13 ##9 ; SMS ; re ##tino ##ic acid induced 1 ; R ##ET ##IN ##O ##IC AC ##ID - IN ##D ##UC ##IB ##LE 1 ) [SEP]',\n",
       "  'our_bi_cui': 'C0587072',\n",
       "  'our_bi_cui_name': 'Sm antibody',\n",
       "  'our_bi_cui_desc': '[CLS] S ##m anti ##body [unused3] ( Chemical , substance : Anti - S ##m / R ##NP Anti ##body ; Anti SM anti ##body ( substance ) [ Am ##bi ##guous ] ; s ##mith anti ##body ; Anti - Smith Anti ##body ; antibodies s ##mith ; anti s ##m antibodies ; S ##m - Smith anti ##body ; Smith anti ##body ; anti - s ##m anti ##body ; Anti - S ##m - R ##NP Anti ##body ; Anti Smith anti ##body ; Anti SM anti ##body ; Blood group anti ##body Smith ; s ##m anti ##body ; Anti - S ##m Anti ##body ; anti s ##mith anti ##body ; antibodies s ##m ) [SEP]',\n",
       "  'our_cross_cui': 'C0036147',\n",
       "  'our_cross_cui_name': 'Samarium',\n",
       "  'our_cross_cui_desc': '[CLS] Sam ##arium [unused3] ( Chemical , substance : sa ##mar ##ium ; SA ##MA ##RI ##UM ; Sam ##arium [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '27580517.23',\n",
       "  'test_set_idx': 10633,\n",
       "  'type': 'T058',\n",
       "  'name': 'administration of',\n",
       "  'context': '[CLS] flow measurements were com ##puted pre - and post - ace ##ta ##zo ##lam ##ide to assess c ##ere ##bro ##vas ##cular reserve . 3D spiral pseudo - continuous art ##erial spin label ##ing data were successfully reconstructed in all 13 cases . In 11 patients , cerebral blood flow increased 2 . 8 % to 93 . 2 % after [unused1] administration of [unused2] ace ##ta ##zo ##lam ##ide . In the two remaining patients , cerebral blood flow decreased by 2 . 4 to 6 . 0 % after ace ##ta ##zo ##lam ##ide . The group average change in cerebral blood flow due to ace ##ta ##zo ##lam ##ide was approximately 25 . 0 % and individual changes were statistical ##ly significant ( [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C1533734',\n",
       "  'our_bi_cui_name': 'Administration procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Administration procedure [unused3] ( Health Care Act ##ivity , Pro ##ced ##ure , procedure : administration ; Ad ##mini ##ster ##ing ; Administration ; Treatment ) [SEP]',\n",
       "  'our_cross_cui': 'C3469597',\n",
       "  'our_cross_cui_name': 'Administration of medication',\n",
       "  'our_cross_cui_desc': '[CLS] Administration of medication [unused3] ( Health Care Act ##ivity , procedure , treatment : administration drugs ; medication administration ; Me ##dication treatment ; administration of medication ; treatment medication ; medications treatments ; administration of medications ; Me ##dication Treatment ; Me ##dication administration ; drug administration ; r ##no ##x administer medication treatment ; medication management ; medication treatment ; Me ##dication administration treatments and procedures ; Drugs - - Administration ; Me ##dication Administration ; giving medications ; medications treatment ; Administration of drug or me ##dic ##ament ; giving medication ; Drug administration ; Giving medication ; medication treatments ) [SEP]'},\n",
       " {'mention_id': '27172917.20',\n",
       "  'test_set_idx': 163,\n",
       "  'type': 'T170',\n",
       "  'name': 'clinical',\n",
       "  'context': '[CLS] c ##yt ##ology The predict ##ors of ma ##li ##gna ##ncy are important for the decision of appropriate management in nod ##ules with at ##y ##pia of und ##eter ##mined significance / f ##oll ##icular les ##ion of und ##eter ##mined significance ( AU ##S / FL ##US ) . Our aim was to determine the ultra ##son ##ographic ##al , [unused1] clinical [unused2] , and bio ##chemical predict ##ors of ma ##li ##gna ##ncy in these patients . A total of 42 ##7 patients with c ##yt ##ological ##ly Beth ##es ##da Category III ( AU ##S / FL ##US ) thy ##roid nod ##ules were included in this retrospective study . We divided the nod ##ules into two subgroup ##s according to the his [SEP]',\n",
       "  'existing_cui': 'C3272565',\n",
       "  'existing_cui_name': 'Clinical Lot',\n",
       "  'existing_cui_desc': '[CLS] Clinical Lot [unused3] ( Intel ##lect ##ual Product : Clinical ) [SEP]',\n",
       "  'our_bi_cui': 'C3540840',\n",
       "  'our_bi_cui_name': 'Sign or Symptom',\n",
       "  'our_bi_cui_desc': '[CLS] Sign or S ##ym ##pt ##om [unused3] ( Finding : Sign ##s or S ##ym ##pt ##oms ; Clinical Sign ##s ; C ##L ##IN ##IC ##AL F ##IN ##DI ##NG ; C ##L ##IN ##IC ##AL S ##IG ##NS ; DE ##SC ; Clinical Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0683956',\n",
       "  'our_cross_cui_name': 'predictive factor',\n",
       "  'our_cross_cui_desc': '[CLS] predict ##ive factor [unused3] ( Intel ##lect ##ual Product : predict ##ive variables ; factors predict ##ive ; factor predict ##ive ; Disease Pre ##dict ##ive Factor ) [SEP]'},\n",
       " {'mention_id': '28338634.28',\n",
       "  'test_set_idx': 32477,\n",
       "  'type': 'T074',\n",
       "  'name': 'working',\n",
       "  'context': \"[CLS] ##ty ##l ##cho ##lines ##tera ##se and they were used for the measurement anti - Alzheimer ' s drug gal ##ant ##amine and car ##ba ##mate p ##est ##icide car ##bo ##fu ##ran with limit of detection 1 . 5 µ ##M and 20 n ##M , respectively . All measurements were carried out using screen - printed sensor with carbon [unused1] working [unused2] , silver reference , and carbon auxiliary electro ##de . Standard El ##lman ' s ass ##ay was used for valid ##ation measurement of both inhibitor ##s . Part of this work was the elimination of re ##versible inhibitor ##s represented by gal ##ant ##amine from the active site of Ace ##ty ##l ##cho ##lines ##tera ##se . For this purpose , [SEP]\",\n",
       "  'existing_cui': 'C1563350',\n",
       "  'existing_cui_name': 'Working animal',\n",
       "  'existing_cui_desc': '[CLS] Working animal [unused3] ( E ##uka ##ryo ##te : Working ) [SEP]',\n",
       "  'our_bi_cui': 'C0025080',\n",
       "  'our_bi_cui_name': 'Medical Devices',\n",
       "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
       "  'our_cross_cui': 'C0013812',\n",
       "  'our_cross_cui_name': 'electrode',\n",
       "  'our_cross_cui_desc': '[CLS] electro ##de [unused3] ( Medical Devi ##ce , physical object : El ##ec ##tro ##des ; El ##ec ##tro ##de , device ; El ##ec ##tro ##des , ( e . g . , a ##p ##nea monitor ) , per pair ; E ##LE ##CT ##RO ##DE ; electro ##des ; El ##ec ##tro ##des , pair ; El ##ec ##tro ##de ) [SEP]'},\n",
       " {'mention_id': '28208888.52',\n",
       "  'test_set_idx': 28363,\n",
       "  'type': 'T092',\n",
       "  'name': 'genetic counselling clinics',\n",
       "  'context': '[CLS] This was the first study to report the presence of H ##b ##E among the tribal ##s working in the tea gardens of Assam . Based on the present findings , sick ##le cell an ##ae ##mia and β - th ##ala ##ssa ##emia were major health problem for the tribal ##s working in the tea gardens of Assam . Pro ##per diagnostic facilities for ha ##em ##og ##lo ##bino ##pathy and th ##ala ##ssa ##emia should be established in these areas , including establishment of ha ##em ##og ##lo ##bino ##pathy and th ##ala ##ssa ##emia database collection , ha ##ema ##to ##logical analysis laboratories , [unused1] genetic counsel ##ling clinics [unused2] , pre ##nat ##al diagnosis centres and neon ##ata ##l screening centres . [SEP]',\n",
       "  'existing_cui': 'C0599986',\n",
       "  'existing_cui_name': 'Encounter due to genetic counseling',\n",
       "  'existing_cui_desc': '[CLS] En ##co ##unt ##er due to genetic counseling [unused3] ( Finding , context - dependent category , situation : here ##dit ##y ; counseling ; [ V ] Gene ##tic counseling ; advice ; genetic ; [ V ] Gene ##tic counsel ##ling ; Gene ##tic counseling ; Gene ##tic counsel ##ling ; genetic ; counseling ) [SEP]',\n",
       "  'our_bi_cui': 'C0017382',\n",
       "  'our_bi_cui_name': 'Genetic Counseling',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##tic Counsel ##ing [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : genetic counsel ##ling ; Gene ##tic counseling individual each 15 minutes ; Counsel ##ing , Gene ##tic ; Counsel ##ing ; genetic ; Gene ##tic counseling ; g ##nt ##k c ##ns ##ln ##g n ##d ##v ##dl e ##a . 15 min ; Counsel ##ling ; genetic ; genetic counseling ; Gene ##tic counsel ##ling ; GE ##NE ##T CO ##UN ##SE ##L ##ING ; CO ##UN ##SE ##L ##ING GE ##NE ##T ; Gene ##tic Counsel ##ling ) [SEP]',\n",
       "  'our_cross_cui': 'C0442592',\n",
       "  'our_cross_cui_name': 'Clinic',\n",
       "  'our_cross_cui_desc': '[CLS] Clinic [unused3] ( Organization , environment : clinic ; C ##L ##IN ##IC - WA ##L ##K IN , O ##TH ##ER ; Clinic ##s ; clinics ) [SEP]'},\n",
       " {'mention_id': '27273231.14',\n",
       "  'test_set_idx': 1195,\n",
       "  'type': 'T074',\n",
       "  'name': 'Enseal',\n",
       "  'context': '[CLS] sealing pulmonary art ##eries with the En ##sea ##l tissue - sealing device . P ##ul ##mona ##ry art ##eries from be ##ag ##le dogs ( mean body weight 13 . 1 kg , range 10 . 5 - 15 . 4 kg ) were divided into 3 groups according to the in - v ##ivo sealing method used ( [unused1] En ##sea ##l [unused2] , l ##iga ##tion , and pro ##ximal l ##iga ##tion plus di ##stal En ##sea ##l ) and extracted to evaluate the pressure tolerance up to 75 mm H ##g at the sealed end . A left lower lobe ##ct ##omy was performed to evaluate chronic - phase du ##rab ##ility of the sealed s ##tum ##ps in a survival [SEP]',\n",
       "  'existing_cui': 'C0262214',\n",
       "  'existing_cui_name': 'Claustral amygdalar area',\n",
       "  'existing_cui_desc': '[CLS] Claus ##tral am ##y ##g ##dal ##ar area [unused3] ( Ana ##tom ##ical Structure : Claus ##tr ##um di ##ff ##usa ; c ##laus ##tr ##um di ##ff ##usa ; c ##laus ##tral am ##y ##g ##dal ##oid area ; V ##ent ##ral portion of c ##laus ##tr ##um ; Area c ##laus ##tral ##is am ##y ##g ##dal ##ae ; C ##l ##A ; end ##op ##iri ##form nucleus ; ventral portion of c ##laus ##tr ##um ; Claus ##tr ##um par ##vu ##m ; c ##laus ##tral am ##y ##g ##dal ##ar area ; end ##op ##iri ##form c ##laus ##tr ##um ; V ##ent ##ral c ##laus ##tr ##um ; c ##laus ##tr ##um par ##vu ##m ; Claus ##tral am ##y ##g [SEP]',\n",
       "  'our_bi_cui': 'C0038969',\n",
       "  'our_bi_cui_name': 'Surgical sutures',\n",
       "  'our_bi_cui_desc': '[CLS] Sur ##gical su ##tures [unused3] ( Medical Devi ##ce , physical object , treatment : Su ##tures ; S ##UT ##UR ##ES ; su ##ture ; S ##UT ##UR ##E ; Su ##ture material ; Su ##ture - object ; Sur ##gical Su ##tures ; Su ##ture ; Su ##tures , Sur ##gical ; surgical su ##ture ; Su ##tur ##ing ; su ##tures ; Sur ##gical su ##ture ; Sur ##gical su ##ture , device ; Su ##ture material , device ; surgical su ##tures ) [SEP]',\n",
       "  'our_cross_cui': 'C0025080',\n",
       "  'our_cross_cui_name': 'Medical Devices',\n",
       "  'our_cross_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]'},\n",
       " {'mention_id': '28223077.17',\n",
       "  'test_set_idx': 28901,\n",
       "  'type': 'T082',\n",
       "  'name': 'surrounding sites',\n",
       "  'context': '[CLS] . In order to understand the influence of Municipal solid waste land ##fill on p ##oly ##ch ##lor ##inated di ##ben ##zo - p - di ##ox ##ins and p ##oly ##ch ##lor ##inated di ##ben ##zo ##fu ##ran ##s ( PC ##D ##D / F ##s ) in surrounding atmosphere , 42 ambient air samples were collected and analyzed from [unused1] surrounding sites [unused2] , background site , up ##wind site and down ##wind site of a Municipal solid waste land ##fill in East China . The results of present study were summarized as follows . ( 1 ) The total concentrations of PC ##D ##D / F ##s ( [UNK] PC ##D ##D / F ##s ) in ambient air from surrounding sites , [SEP]',\n",
       "  'existing_cui': 'C1282914',\n",
       "  'existing_cui_name': 'Surrounding',\n",
       "  'existing_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
       "  'our_bi_cui': 'C1282914',\n",
       "  'our_bi_cui_name': 'Surrounding',\n",
       "  'our_bi_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
       "  'our_cross_cui': 'C0205145',\n",
       "  'our_cross_cui_name': 'Site',\n",
       "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
       " {'mention_id': '27794381.97',\n",
       "  'test_set_idx': 17237,\n",
       "  'type': 'T103',\n",
       "  'name': '[ Ca ( 2 + ) ] i',\n",
       "  'context': '[CLS] ##cy ##st cells in g ##uin ##ea pig with ch ##ole ##ster ##ol calculus . The d ##ys ##function of gal ##l ##bla ##dder contraction gives rise to the disorders of mobility signal trans ##duction system in ch ##ole ##cy ##st smooth muscle cells , including low content of plasma ch ##ole ##cy ##sto ##kini ##n and [unused1] [ C ##a ( 2 + ) ] i [unused2] in ch ##ole ##cy ##st cells , abnormal protein and m ##RNA of G ##s , G ##i and Cap . Em ##od ##in can enhance the contract ##ibility of gal ##l ##bla ##dder and alleviate ch ##ole ##sta ##sis by regulating plasma ch ##ole ##cy ##sto ##kini ##n levels , [ C ##a ( 2 + ) [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C1155431',\n",
       "  'our_bi_cui_name': 'positive regulation of cytosolic calcium ion concentration',\n",
       "  'our_bi_cui_desc': '[CLS] positive regulation of c ##yt ##oso ##lic calcium ion concentration [unused3] ( B ##iol ##og ##ic Fun ##ction : elevation of calcium ion concentration in c ##yt ##oso ##l ; c ##yt ##oso ##lic calcium ion concentration elevation ; c ##yt ##op ##las ##mic calcium ion concentration elevation ; elevation of c ##yt ##oso ##lic calcium ion concentration ; elevation of c ##yt ##op ##las ##mic calcium ion concentration ; elevation of calcium ion concentration in c ##yt ##op ##las ##m ) [SEP]',\n",
       "  'our_cross_cui': 'C0596235',\n",
       "  'our_cross_cui_name': 'Calcium ion',\n",
       "  'our_cross_cui_desc': '[CLS] Cal ##ci ##um ion [unused3] ( Chemical : Cal ##ci ##um Cat ##ion ; free calcium ; CA + 2 ; ion calcium ; Cal ##ci ##um cat ##ion ; Free Cal ##ci ##um ; calcium ions ; C ##a ##2 + ; C ##a + + ; Cal ##ci ##um Ion ##s ; C ##a 2 + ; calcium ion ; CA ##LC ##I ##UM CA ##TI ##ON ; Cal ##ci ##um Ion ; calcium cat ##ion ; Cal ##ci ##um 2 + ; Ion ##ized Cal ##ci ##um ) [SEP]'},\n",
       " {'mention_id': '28433910.5',\n",
       "  'test_set_idx': 35704,\n",
       "  'type': 'T103',\n",
       "  'name': 'Spent sulphite liquor',\n",
       "  'context': '[CLS] Su ##cci ##nic acid production by im ##mo ##bil ##ized cultures using spent su ##l ##phi ##te liquor as f ##er ##mentation medium [unused1] S ##pent su ##l ##phi ##te liquor [unused2] was used as carbon source for the production of su ##cci ##nic acid using im ##mo ##bil ##ized cultures of Act ##ino ##ba ##ci ##llus su ##cci ##no ##gene ##s and Ba ##s ##fia su ##cci ##nic ##ip ##rod ##uce ##ns on two different supports , del ##ign ##ified cell ##ulos ##ic material and al ##gin ##ate beads . Fed - batch im ##mo ##bil ##ized cultures with A . su ##cci ##no ##gene ##s in al ##gin ##ates resulted in higher sugar to su ##cci ##nic acid conversion yield ( 0 . 81 [SEP]',\n",
       "  'existing_cui': 'C0038750',\n",
       "  'existing_cui_name': 'Sulfites',\n",
       "  'existing_cui_desc': '[CLS] Sul ##fit ##es [unused3] ( Chemical , substance : In ##or ##gan ##ic Sul ##fit ##es ; Sul ##fit ##e ; Sul ##fit ##es , In ##or ##gan ##ic ; Sul ##fit ##es [ Chemical / In ##g ##red ##ient ] ; su ##lf ##ites ; Sul ##phi ##te ; su ##lf ##ite ; su ##l ##phi ##tes ; Sul ##fit ##e salt ; Sul ##phi ##te salt ; S ##U ##LF ##IT ##ES IN ##OR ##G ; IN ##OR ##G S ##U ##LF ##IT ##ES ; su ##l ##phi ##te ) [SEP]',\n",
       "  'our_bi_cui': 'C0982424',\n",
       "  'our_bi_cui_name': 'Sulfurated lime solution',\n",
       "  'our_bi_cui_desc': \"[CLS] Sul ##fu ##rated lime solution [unused3] ( Chemical , substance : S ##U ##LF ##UR ##AT ##ED L ##IM ##E S ##OL ##N ; sulfur ##ated lime solution ; Lim ##e Sol ##ution , Sul ##fu ##rated ; Sul ##fu ##rated Lim ##e Sol ##ution ; V ##lem ##in ##ck ##x ' s lot ##ion ; Sul ##ph ##ura ##ted lime solution ) [SEP]\",\n",
       "  'our_cross_cui': 'C0010454',\n",
       "  'our_cross_cui_name': 'Culture Media',\n",
       "  'our_cross_cui_desc': '[CLS] Culture Media [unused3] ( Chemical , substance : Growth Medium ; growth media ; Media , Culture ; Culture media ; Culture medium ; culture medium ; culture media ; Culture Medium ; culture medium ##s ; culture media ##s ) [SEP]'},\n",
       " {'mention_id': '27430240.67',\n",
       "  'test_set_idx': 5393,\n",
       "  'type': 'T038',\n",
       "  'name': 'Adenosine triphosphate hydrolysis',\n",
       "  'context': '[CLS] significantly up ##re ##gu ##lated CD ##39 and CD ##7 ##3 expression ( P < 0 . 01 ) . E ##2 ##F transcription factor 1 and CR ##E ##B induced CD ##39 and CD ##7 ##3 expression , and were up ##re ##gu ##lated by ad ##eno ##sin ##e and C ##GS ##21 ##6 ##80 . [unused1] Aden ##os ##ine trip ##hos ##phate h ##ydro ##lysis [unused2] and ad ##eno ##sin ##e generation were in ##hibit ##ed by the knock ##down of E ##2 ##F transcription factor 1 or CR ##E ##B , and were accelerated in the presence of C ##GS ##21 ##6 ##80 . Based on these results , it can be in ##ferred that ad ##eno ##sin ##e , the ad ##eno [SEP]',\n",
       "  'existing_cui': 'C0001480',\n",
       "  'existing_cui_name': 'Adenosine Triphosphate',\n",
       "  'existing_cui_desc': \"[CLS] Aden ##os ##ine Trip ##hos ##phate [unused3] ( Chemical , ATP , Te ##tra ##hy ##dr ##ogen Trip ##hos ##phate , substance , te ##tra ##hy ##dr ##ogen trip ##hos ##phate : AD ##EN ##OS ##IN ##E T ##RI ##P ##H ##OS ##P ##HA ##TE ; ATP ; Aden ##yl ##py ##rop ##hos ##phate ; Aden ##os ##ine Trip ##hos ##phate [ Chemical / In ##g ##red ##ient ] ; Aden ##os ##ine 5 ' - trip ##hos ##phate ; Aden ##os ##ine 5 ' - ; ATP - Aden ##os ##ine trip ##hos ##phate ; Aden ##os ##ine 5 ' - Trip ##hos ##ph ##ori ##c A ##cid ; Aden ##os ##ine trip ##hos ##phate ; Aden ##os ##ine - 5 ' - trip ##hos [SEP]\",\n",
       "  'our_bi_cui': 'C0001473',\n",
       "  'our_bi_cui_name': 'Adenosine Triphosphatases',\n",
       "  'our_bi_cui_desc': '[CLS] Aden ##os ##ine Trip ##hos ##pha ##tase ##s [unused3] ( Chemical , substance : Aden ##os ##ine Trip ##hos ##pha ##tase ##s [ Chemical / In ##g ##red ##ient ] ; ATP ##ases ; ad ##eno ##sin ##et ##rip ##hos ##pha ##tase ; Aden ##os ##inet ##rip ##hos ##pha ##tase ; at ##pas ##e ; ad ##eno ##sin ##e trip ##hos ##pha ##tase ; Aden ##os ##ine Trip ##hos ##pha ##tase ; ATP p ##hos ##ph ##oh ##ydro ##lase ; Aden ##os ##ine trip ##hos ##pha ##tase ; ATP ##ase ; ATP H ##ydro ##lase ; ATP mon ##op ##hos ##pha ##tase ; Aden ##yl ##py ##rop ##hos ##pha ##tase ) [SEP]',\n",
       "  'our_cross_cui': 'C1510699',\n",
       "  'our_cross_cui_name': 'ATP Hydrolysis',\n",
       "  'our_cross_cui_desc': '[CLS] ATP H ##ydro ##lysis [unused3] ( B ##iol ##og ##ic Fun ##ction : ATP degradation ; ATP cat ##ab ##olis ##m ; obsolete ATP cat ##ab ##olic process ; ATP h ##ydro ##lysis ; ATP breakdown ) [SEP]'},\n",
       " {'mention_id': '27580517.6',\n",
       "  'test_set_idx': 10616,\n",
       "  'type': 'T058',\n",
       "  'name': 'non - Cartesian cylindrically - distributed spiral 3D pseudo - continuous arterial spin labeling magnetic resonance imaging',\n",
       "  'context': '[CLS] Assessment of cerebral blood per ##fusion reserve with ace ##ta ##zo ##lam ##ide using 3D spiral AS ##L magnetic resonance imaging : Preliminary experience in p ##ediatric patients To demonstrate the clinical f ##eas ##ibility of a new [unused1] non - Car ##tes ##ian cylindrical ##ly - distributed spiral 3D pseudo - continuous art ##erial spin label ##ing magnetic resonance imaging [unused2] pulse sequence in p ##ediatric patients in q ##uant ##ifying cerebral blood flow response to an ace ##ta ##zo ##lam ##ide v ##as ##od ##ila ##tor challenge . magnetic resonance imaging exams were performed on two 3 Te ##sla Philips In ##gen ##ia systems using 32 channel head coil array ##s . After local institutional review board approval , the 3D spiral - based [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0024485',\n",
       "  'our_bi_cui_name': 'Magnetic Resonance Imaging',\n",
       "  'our_bi_cui_desc': '[CLS] Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity , MR ##I , procedure , qualifier value : MR - Ma ##gnetic resonance ; MR TO ##MO ##GR ; Ma ##gnetic resonance technique ; magnetic resonance imaging ; N ##MR I ##maging ; Ma ##gnetic resonance imaging procedure ; St ##ead ##y - State Free Pre ##cession MR ##I ; Ma ##gnetic resonance : [ imaging ] or [ study ] ; imaging magnetic nuclear resonance ; Tom ##ography , MR ; MR ##I Sc ##an ; N ##MR - Nuclear magnetic resonance ; Z ##E ##U ##GM ##AT ##O ##GR ; TO ##MO ##GR MR ; N ##MR TO ##MO ##GR ; Nuclear magnetic resonance ; Medical I ##maging , Ma [SEP]',\n",
       "  'our_cross_cui': 'C3891302',\n",
       "  'our_cross_cui_name': 'Arterial Spin Labeling Magnetic Resonance Imaging',\n",
       "  'our_cross_cui_desc': '[CLS] Arte ##rial Spin Label ##ing Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity : AS ##L f ##MR ##I ; Arte ##rial Spin Label ##ing MR ##I ; AR ##TE ##RI ##AL SP ##IN LA ##BE ##L ##ING F ##UN ##CT ##ION ##AL MR ##I ) [SEP]'},\n",
       " {'mention_id': '27481714.73',\n",
       "  'test_set_idx': 7891,\n",
       "  'type': 'T017',\n",
       "  'name': 'principal cells',\n",
       "  'context': '[CLS] dependent ##ly suppressed by r ##uth ##eni ##um red , a put ##ative block ##er of e ##pit ##hel ##ial C ##a ( 2 + ) channels and calcium - activated chloride conduct ##ance . Finally , we discover messenger RNA for both T ##RP ##V ##6 and T ##ME ##M ##16 ##A in the rat e ##pid ##idy ##mis and show that their proteins co ##loc ##ali ##ze in the a ##pical membrane of principal cells . Collective ##ly , these data provide evidence for a coupling mechanism between T ##RP ##V ##6 and T ##ME ##M ##16 ##A in [unused1] principal cells [unused2] that may play an important role in the regulation of calcium home ##ost ##asis in the e ##pid ##idy ##mis . [SEP]',\n",
       "  'existing_cui': 'C0401925',\n",
       "  'existing_cui_name': 'Teaching principal',\n",
       "  'existing_cui_desc': '[CLS] Teaching principal [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Principal ; principal ##s ; principal ) [SEP]',\n",
       "  'our_bi_cui': 'C0017471',\n",
       "  'our_bi_cui_name': 'Germ Cells',\n",
       "  'our_bi_cui_desc': '[CLS] G ##er ##m Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell , G ##er ##m ; reproductive cells ; Rep ##rod ##uctive Cell ##s ; Ha ##p ##lo ##id g ##er ##m cell ; Game ##te ; Cell , G ##er ##m - Line ; cells g ##er ##m ; Sexual Cell ; cell sex ; Cell ##s , G ##er ##m ; cell g ##er ##m ; G ##er ##m Cell ; G ##er ##m cells ; G ##er ##m Line Cell ##s ; cells sex ; G ##er ##m - Line Cell ##s ; Ha ##p ##lo ##id n ##uc ##lea ##ted cell ; sexual cell ; Cell ##s , G ##er ##m - Line ; Game ##tes ; g ##er ##m [SEP]',\n",
       "  'our_cross_cui': 'C0007634',\n",
       "  'our_cross_cui_name': 'Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
       " {'mention_id': '28331620.12',\n",
       "  'test_set_idx': 32167,\n",
       "  'type': 'T033',\n",
       "  'name': 'unmedicated',\n",
       "  'context': '[CLS] ? The impact of stress on anger and aggression in Border ##line Personal ##ity Di ##sor ##der and At ##ten ##tion De ##fic ##it H ##yper ##act ##ivity Di ##sor ##der has not been thoroughly investigated . The goal of this study was to investigate different aspects of anger and aggression in patients with these disorders . Twenty - nine [unused1] un ##med ##ica ##ted [unused2] female Border ##line Personal ##ity Di ##sor ##der patients , 28 At ##ten ##tion De ##fic ##it H ##yper ##act ##ivity Di ##sor ##der patients and 30 healthy controls completed self - reports measuring trait anger , aggression and emotion regulation capacities . A modified version of the Point Sub ##traction A ##gg ##ression Para ##di ##g ##m and a [SEP]',\n",
       "  'existing_cui': 'C0162396',\n",
       "  'existing_cui_name': 'Unmedicated IUDs',\n",
       "  'existing_cui_desc': '[CLS] Un ##med ##ica ##ted I ##U ##Ds [unused3] ( Medical Devi ##ce : Un ##med ##ica ##ted I ##U ##D ; I ##U ##D , Un ##med ##ica ##ted ) [SEP]',\n",
       "  'our_bi_cui': 'C0332155',\n",
       "  'our_bi_cui_name': 'Did not receive therapy or drug for',\n",
       "  'our_bi_cui_desc': '[CLS] Did not receive therapy or drug for [unused3] ( Finding , context ##ual qualifier , qualifier value : N ##G - did not receive therapy or drug for ; un ##tre ##ated ; Did not receive therapy or drug for ( context ##ual qualifier ) ; Not treated for ; did not receive therapy or drug for ; N ##G ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28192171.57',\n",
       "  'test_set_idx': 27916,\n",
       "  'type': 'T062',\n",
       "  'name': 'work',\n",
       "  'context': '[CLS] art ##hr ##op ##athy , but also specific signatures of the disease , like presence of am ##yl ##oids and peculiar ca ##l ##ci ##fication ##s . Our analyses provide a unified picture of Al ##ka ##pton ##uria cart ##ila ##ge , shed ##ding a new light on the disease and opening new perspectives . O ##ch ##ron ##otic pig ##ment is a hall ##mark of Al ##ka ##pton ##uria and responsible of tissue de ##gene ##ration . Convention ##al bio - ass ##ays have not yet clarified its composition and its structural relationship with am ##yl ##oids . The present [unused1] work [unused2] proposes new strategies for filling the aforementioned gap that en ##com ##pass the integration of new analytical approaches with standardized analyses . [SEP]',\n",
       "  'existing_cui': 'C3642250',\n",
       "  'existing_cui_name': 'Work Including Work Around the House',\n",
       "  'existing_cui_desc': '[CLS] Work Including Work Around the House [unused3] ( Intel ##lect ##ual Product , includes work both outside the home and daily ch ##ores , including work around the house : Work ; Normal work ) [SEP]',\n",
       "  'our_bi_cui': 'C0242481',\n",
       "  'our_bi_cui_name': 'Research Activities',\n",
       "  'our_bi_cui_desc': '[CLS] Research Activities [unused3] ( Research Act ##ivity : research ; Research Act ##ivity ; activity research ; Research ; Activities , Research ; Act ##ivity , Research ; research activities ) [SEP]',\n",
       "  'our_cross_cui': 'C0035168',\n",
       "  'our_cross_cui_name': 'research',\n",
       "  'our_cross_cui_desc': '[CLS] research [unused3] ( Research Act ##ivity : Research ) [SEP]'},\n",
       " {'mention_id': '27832159.48',\n",
       "  'test_set_idx': 18596,\n",
       "  'type': 'T103',\n",
       "  'name': 'compound-326',\n",
       "  'context': '[CLS] D ##G ##LA profiles . In diet - induced o ##bes ##e mice , chronic treatment with compound - 32 ##6 lowered insulin resistance and caused body weight loss without significant impact on cumulative ca ##lor ##ie intake . Dec ##reased mac ##rop ##hage in ##fi ##ltration into ad ##ip ##ose tissue was expected from m ##RNA analysis . Inc ##reased daily energy expenditure was also observed following administration of compound - 32 ##6 , in line with sustained body weight loss . These data indicate that the novel Delta - 5 des ##at ##ura ##se selective inhibitor , [unused1] compound - 32 ##6 [unused2] , will be a new class of drug for the treatment of o ##bes ##e and di ##abe ##tic patients . [SEP]',\n",
       "  'existing_cui': 'C0258113',\n",
       "  'existing_cui_name': '4 - ( ( 3-bromophenyl ) amino ) -6,7 - dimethoxyquinazoline',\n",
       "  'existing_cui_desc': \"[CLS] 4 - ( ( 3 - br ##omo ##phe ##ny ##l ) amino ) - 6 , 7 - dim ##eth ##ox ##y ##quin ##az ##olin ##e [unused3] ( Chemical : Co ##mpo ##und 32 ; 4 - ( 3 ' - br ##omo ##ani ##lino ) - 6 , 7 - dim ##eth ##ox ##y ##quin ##az ##olin ##e ) [SEP]\",\n",
       "  'our_bi_cui': 'C0149246',\n",
       "  'our_bi_cui_name': 'Z 326',\n",
       "  'our_bi_cui_desc': '[CLS] Z 32 ##6 [unused3] ( Chemical ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28256742.3',\n",
       "  'test_set_idx': 30209,\n",
       "  'type': 'T082',\n",
       "  'name': 'Canadian Areas',\n",
       "  'context': '[CLS] Hal ##ogen ##ated p ##hen ##olic compounds in wild fish from [unused1] Canadian Areas [unused2] of Con ##cer ##n Con ##cent ##rations of ha ##log ##ena ##ted p ##hen ##olic compounds were measured in the plasma of brown bull ##head ( Am ##ei ##urus ne ##bul ##os ##us ) from 4 Canadian Areas of Con ##cer ##n ( A ##OC ##s ) , to assess exposure to suspected thy ##roid - disrupt ##ing chemicals . H ##ydro ##xy ##lated p ##oly ##ch ##lor ##inated bi ##phe ##ny ##ls ( OH - PC ##B ##s ) were detected in every sample collected in 3 of the A ##OC ##s ; the detection frequency was lower in samples from the Detroit River A ##OC . The OH - [SEP]',\n",
       "  'existing_cui': 'C3831211',\n",
       "  'existing_cui_name': 'Canadian County , OK',\n",
       "  'existing_cui_desc': '[CLS] Canadian County , OK [unused3] ( Spa ##tial Concept : Canadian County , Oklahoma ; OK ##01 ##7 ; Canadian County ) [SEP]',\n",
       "  'our_bi_cui': 'C0454980',\n",
       "  'our_bi_cui_name': 'Region of Canada',\n",
       "  'our_bi_cui_desc': '[CLS] Region of Canada [unused3] ( Spa ##tial Concept , geographic location : Province or Territory of Canada ; Provinces and territories of Canada ; Region ##s of Canada ) [SEP]',\n",
       "  'our_cross_cui': 'C0006823',\n",
       "  'our_cross_cui_name': 'Canada',\n",
       "  'our_cross_cui_desc': '[CLS] Canada [unused3] ( Spa ##tial Concept , geographic location : CA ##N ; CA ##NA ##DA ; CA ) [SEP]'},\n",
       " {'mention_id': '27820849.13',\n",
       "  'test_set_idx': 18195,\n",
       "  'type': 'T204',\n",
       "  'name': 'hens',\n",
       "  'context': '[CLS] p ##hen ##otypic and g ##eno ##mic evolution , with large effective population size and strong human - driven selection . In the present study , we performed Extended Ha ##p ##lot ##ype Ho ##mo ##zy ##gos ##ity tests to identify significant core regions employing 600 ##K S ##NP Chicken chip in an F ##2 population of 1 , 53 ##4 [unused1] he ##ns [unused2] , which was derived from re ##ci ##p ##ro ##cal crosses between White Le ##gh ##orn and Dong ##xia ##ng chicken . Results indicated that a total of 49 , 151 core regions with an average length of 9 . 79 K ##b were identified , which occupied approximately 52 . 15 % of genome across all auto ##some ##s , [SEP]',\n",
       "  'existing_cui': 'C0099085',\n",
       "  'existing_cui_name': '6-bromo-2-naphthyl sulfate',\n",
       "  'existing_cui_desc': '[CLS] 6 - br ##omo - 2 - nap ##ht ##hyl su ##lf ##ate [unused3] ( Chemical , B ##NS : 2 - Na ##ph ##thal ##eno ##l , 6 - br ##omo - , hydrogen su ##lf ##ate ) [SEP]',\n",
       "  'our_bi_cui': 'C0008051',\n",
       "  'our_bi_cui_name': 'Chickens',\n",
       "  'our_bi_cui_desc': '[CLS] Chicken ##s [unused3] ( E ##uka ##ryo ##te , organism : G ##all ##us gal ##lus ; Red jungle f ##ow ##l ; Chicken ; CH ##IC ##KE ##N ; ban ##tam ; G ##all ##us gal ##lus domestic ##us ; G ##all ##us domestic ##us ; Ban ##tam Chicken ; Red jungle ##fo ##wl ; Ban ##tam ; chicken ; chickens ; Domestic f ##ow ##l ancestor ) [SEP]',\n",
       "  'our_cross_cui': 'C0005595',\n",
       "  'our_cross_cui_name': 'Aves',\n",
       "  'our_cross_cui_desc': '[CLS] Ave ##s [unused3] ( E ##uka ##ryo ##te , organism : a ##vian ; bird ; a ##vian ##s ; a ##ves ; birds ; Bird ; Bird in context ; A ##vian ; Birds ; Class Ave ##s ) [SEP]'},\n",
       " {'mention_id': '28179911.59',\n",
       "  'test_set_idx': 27653,\n",
       "  'type': 'T017',\n",
       "  'name': 'GPDH',\n",
       "  'context': '[CLS] independent T ##2 lines were detected by quantitative real - time PC ##R . The relative m ##RNA accumulation of genes encoding enzymes involved in either fatty acid bio ##sy ##nt ##hesis or t ##ria ##cy ##l ##gly ##cer ##ols assembly ( BC ##CP ##2 , K ##AS ##I , MA ##T , E ##NR , FA ##TA , and [unused1] GP ##D ##H [unused2] ) were also ass ##ay ##ed in mature seeds . Furthermore , lip ##id and fatty acids C ##16 : 0 and C ##18 : 0 significantly increased . In two ho ##mo ##zy ##go ##us T ##2 trans ##genic rice lines ( G ##5 and G ##2 ) , different Co ##WR ##I ##1 expression levels were detected , but [SEP]',\n",
       "  'existing_cui': 'C1415375',\n",
       "  'existing_cui_name': 'GYPC gene',\n",
       "  'existing_cui_desc': '[CLS] G ##YP ##C gene [unused3] ( Ana ##tom ##ical Structure , G ##er ##bic ##h blood group : GP ##C ; G ##L ##Y ##CO ##P ##H ##OR ##IN C ; g ##ly ##co ##ph ##ori ##n C ; G ##L ##Y ##CO ##P ##H ##OR ##IN D ; CD ##23 ##6 ; S ##IA ##L ##O ##G ##L ##Y ##CO ##PR ##OT ##EI ##N , B ##ET ##A ; CD ##23 ##6 ##R ; G ##e ) [SEP]',\n",
       "  'our_bi_cui': 'C1418531',\n",
       "  'our_bi_cui_name': 'PHGDH gene',\n",
       "  'our_bi_cui_desc': '[CLS] P ##H ##G ##D ##H gene [unused3] ( Ana ##tom ##ical Structure : P ##H ##OS ##P ##H ##O ##G ##L ##Y ##CE ##RA ##TE DE ##H ##Y ##DR ##O ##GE ##NA ##SE ; P ##H ##G ##D ##H Gene ; Ph ##os ##ph ##og ##ly ##cer ##ate De ##hy ##dr ##ogen ##ase Gene ; SE ##RA ; p ##hos ##ph ##og ##ly ##cer ##ate de ##hy ##dr ##ogen ##ase ; 3 - P ##H ##OS ##P ##H ##O ##G ##L ##Y ##CE ##RA ##TE DE ##H ##Y ##DR ##O ##GE ##NA ##SE ; P ##G ##D ##H ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27838742.14',\n",
       "  'test_set_idx': 18981,\n",
       "  'type': 'T103',\n",
       "  'name': 'delicaflavone',\n",
       "  'context': '[CLS] / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway Search ##ing for potential anti ##can ##cer agents from natural sources is an effective strategy for developing novel ch ##em ##oth ##era ##pe ##uti ##c agents . In this study , data supporting the in v ##it ##ro and in v ##ivo anti ##can ##cer effects of [unused1] del ##ica ##f ##lav ##one [unused2] , a rarely occurring bi ##f ##lav ##ono ##id from Se ##lag ##ine ##lla do ##ede ##rle ##ini ##i , were reported . Del ##ica ##f ##lav ##one exhibited favorable anti ##can ##cer properties , as shown by the M ##TT ass ##ay and x ##eno ##gra ##ft model of human non - small cell lung cancer in male BA [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27875010.31',\n",
       "  'test_set_idx': 20236,\n",
       "  'type': 'T017',\n",
       "  'name': 'tissue',\n",
       "  'context': '[CLS] ##ified net photos ##ynth ##esis by ambient and nut ##rient - en ##rich ##ed tissues at sat ##ura ##ting i ##rra ##dian ##ce over a range of temperature conditions ( 6 - 30 °C ) . Re ##spiration was un ##af ##fected by nut ##rient treatment ; however , there was a significant increase in photos ##ynth ##etic oxygen production for nut ##rient - en ##rich ##ed [unused1] tissue [unused2] compared to ambient , but only at elevated ( ≥ 18 °C ) temperatures . This study contributes to a growing body of literature showing the complexity of responses to changes in multiple drivers , and highlights the importance of studying the impacts of global climate change within the context of more local environmental conditions . [SEP]',\n",
       "  'existing_cui': 'C0040300',\n",
       "  'existing_cui_name': 'Body tissue',\n",
       "  'existing_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
       "  'our_bi_cui': 'C0040300',\n",
       "  'our_bi_cui_name': 'Body tissue',\n",
       "  'our_bi_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
       "  'our_cross_cui': 'C1514137',\n",
       "  'our_cross_cui_name': 'Plant Tissue , Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Plant T ##iss ##ue , Cell ##s [unused3] ( Ana ##tom ##ical Structure : Plant cells and tissues ) [SEP]'},\n",
       " {'mention_id': '27384676.30',\n",
       "  'test_set_idx': 4392,\n",
       "  'type': 'T033',\n",
       "  'name': 'elongation',\n",
       "  'context': '[CLS] 3 / 4 le ##uk ##ope ##nia occurred in fourteen patients ( 58 . 33 % ) and grade 3 / 4 th ##rom ##bo ##cy ##top ##enia occurred in eleven patients ( 45 . 83 % ) . Twelve patients ( 50 . 00 % ) experienced Act ##ivated Part ##ial Ph ##rom ##bo ##p ##last ##in P ##time [unused1] el ##ong ##ation [unused2] and fourteen patients ( 58 . 33 % ) experienced h ##y ##po ##fi ##bri ##no ##gene ##mia . In conclusion , de ##xa ##met ##has ##one , g ##em ##ci ##ta ##bine and p ##eg ##as ##par ##gas ##e regime ##n is an effective and tolerate ##d treatment for newly diagnosed , advanced - stage extra ##no ##dal natural killer [SEP]',\n",
       "  'existing_cui': 'C0086206',\n",
       "  'existing_cui_name': 'Elongation Factor',\n",
       "  'existing_cui_desc': '[CLS] El ##ong ##ation Factor [unused3] ( Chemical : el ##ong ##ation factor ; Factor , El ##ong ##ation ) [SEP]',\n",
       "  'our_bi_cui': 'C0242656',\n",
       "  'our_bi_cui_name': 'Disease Progression',\n",
       "  'our_bi_cui_desc': '[CLS] Disease Progress ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , attribute : Course of illness ; Disease Progress ##ions ; Disease Course ; Course of Il ##ln ##ess ; Progress ##ion , Disease ; Course of disorder ; Disease progression ; Progress ##ion ; D ##IS PR ##O ##GR ##ES ##SI ##ON ; progression ; Di ##sor ##der Course ; Progress ##ions , Disease ; course of illness ; Disease Progress ##ion [ Disease / Finding ] ; course illness ; courses disease ; disease progression ) [SEP]',\n",
       "  'our_cross_cui': 'C0240671',\n",
       "  'our_cross_cui_name': 'Partial thromboplastin time increased',\n",
       "  'our_cross_cui_desc': '[CLS] Part ##ial th ##rom ##bo ##p ##last ##in time increased [unused3] ( Finding , finding , finding , lab test : A ##b ##nor ##mal or prolonged PT ##T ; Pro ##long ##ed partial th ##rom ##bo ##p ##last ##in time ; A ##b ##nor ##mal or prolonged partial th ##rom ##bo ##p ##last ##in time ; AP ##TT prolonged ; prolonged a ##pt ##t ; Act ##ivated partial th ##rom ##bo ##p ##last ##in time prolonged ; Pro ##long ##ed Act ##ivated Part ##ial T ##hr ##omb ##op ##last ##in Time ; Pro ##long ##ed activated partial th ##rom ##bo ##p ##last ##in time ; a ##pt ##t prolonged ; PT ##T prolonged ; AP ##TT increased ; a ##P ##TT prolonged ; elevated p [SEP]'},\n",
       " {'mention_id': '27838742.1',\n",
       "  'test_set_idx': 18968,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] [unused1] Del ##ica ##f ##lav ##one [unused2] induce ##s auto ##pha ##gic cell death in lung cancer via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway Search ##ing for potential anti ##can ##cer agents from natural sources is an effective strategy for developing novel ch ##em ##oth ##era ##pe ##uti ##c agents . In this study , data supporting the in v ##it ##ro and in v ##ivo anti ##can ##cer effects of del ##ica ##f ##lav ##one , a rarely occurring bi ##f ##lav ##ono ##id from Se ##lag ##ine ##lla do ##ede ##rle ##ini ##i , were reported . Del ##ica ##f ##lav ##one exhibited favorable anti ##can ##cer properties , as shown by the M ##TT ass [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27449818.31',\n",
       "  'test_set_idx': 6226,\n",
       "  'type': 'T058',\n",
       "  'name': 'orally treated',\n",
       "  'context': '[CLS] ) were synthesized and tested for carbon ##ic an ##hy ##dra ##se II binding . CA II in er ##yt ##hr ##ocytes is thought to oppose extraction of E ##stra ##dio ##l pro ##dr ##ugs from portal vein blood during liver passage . O ##var ##ie ##ct ##omi ##zed ( O ##V ##X , day minus 14 ) rats were [unused1] oral ##ly treated [unused2] once daily from day 1 - 3 . Sa ##c ##ri ##fic ##e day 4 . U ##ter ##i were di ##sse ##cted and weighed . Cho ##les ##tero ##l fraction ##s and an ##gio ##tens ##ino ##gen were determined in plasma . Oral E ##2 and et ##hin ##yl est ##rad ##iol generated dose related u ##ter ##ine growth and [SEP]',\n",
       "  'existing_cui': 'C0226896',\n",
       "  'existing_cui_name': 'Oral cavity',\n",
       "  'existing_cui_desc': '[CLS] Oral cavity [unused3] ( Spa ##tial Concept , Anatomy , body structure : Mouth ; B ##OD ##Y CA ##VI ##TY , OR ##AL ; Oral ##ly ; C ##avi ##tas Or ##is ; C ##avi ##ty of mouth ; Oral C ##avi ##ty ; C ##avi ##tas or ##is ; Oral ; C ##avi ##ty , Oral ; oral cavity ; an ##ato ##mie ##s mouth ; mouth anatomy ; B ##uc ##cal cavity ; mouth ; Oral cavity structure ; mouths ; anatomy mouth ; B ##uc ##cal C ##avi ##ty ; OR ##AL CA ##VI ##TY ) [SEP]',\n",
       "  'our_bi_cui': 'C1273553',\n",
       "  'our_bi_cui_name': 'Oral administration of treatment',\n",
       "  'our_bi_cui_desc': '[CLS] Oral administration of treatment [unused3] ( Health Care Act ##ivity , navigation ##al concept , procedure : Treatment administered oral ##ly ) [SEP]',\n",
       "  'our_cross_cui': 'C0001563',\n",
       "  'our_cross_cui_name': 'Administration , Oral',\n",
       "  'our_cross_cui_desc': '[CLS] Administration , Oral [unused3] ( Health Care Act ##ivity , procedure : Oral medication administration each treatment ; oral medication administration ; or ##l me ##ds ad ##min . e ##a . T ##x ; Administration , Oral Drug ; Oral Drug Administration ; AD ##MI ##N OR ##AL DR ##U ##G ; Drug Administration , Oral ; Administration ##s , Oral ; administration oral ; Administration of drug or me ##dic ##ament via oral route ; Administration ##s , Oral Drug ; Oral Drug Administration ##s ; Oral Administration ##s ; Me ##dication Administration : Oral ; OR ##AL AD ##MI ##N ; AD ##MI ##N OR ##AL ; OR ##AL DR ##U ##G AD ##MI ##N ; Me ##dication administration : oral ; oral [SEP]'},\n",
       " {'mention_id': '28027760.26',\n",
       "  'test_set_idx': 23867,\n",
       "  'type': 'T033',\n",
       "  'name': 'No',\n",
       "  'context': '[CLS] ##iac CT an ##gio ##graphy : 2 . 4 ± 0 . 9 ##m ##S ##v - 6 . 8 ± 2 . 7 m ##S ##v , all p ≤ 0 . 04 ##14 ) . In 39 patients trans ##cat ##he ##ter a ##ort ##ic valve replacement was performed and an ##nu ##lus diameter was within the recommended range in all patients . [unused1] No [unused2] severe cardiac or vascular complications were noted . 3rd generation dual - source CT provides diagnostic image quality in trans ##cat ##he ##ter a ##ort ##ic valve replacement - planning CT an ##gio ##graphy and facilitate ##s reliable assessment of trans ##cat ##he ##ter a ##ort ##ic valve replacement device and delivery option while reducing radiation dose . [SEP]',\n",
       "  'existing_cui': 'C1016143',\n",
       "  'existing_cui_name': 'Tetragenococcus halophilus',\n",
       "  'existing_cui_desc': '[CLS] Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us [unused3] ( Ba ##cter ##ium , organism : P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us Me ##es 1934 ( A ##pp ##roved List ##s 1980 ) ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us ( Me ##es 1934 ) Collins et al . 1993 ; Sa ##rc ##ina ha ##ma ##guchi ##ae ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##a ; P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us ; Te ##tra ##co ##cc ##cus No . 1 ; P ##ed ##io ##co ##cc ##us so ##ya ##e ) [SEP]',\n",
       "  'our_bi_cui': 'C0243095',\n",
       "  'our_bi_cui_name': 'Finding',\n",
       "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C1513916',\n",
       "  'our_cross_cui_name': 'Negative Finding',\n",
       "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
       " {'mention_id': '28236586.25',\n",
       "  'test_set_idx': 29279,\n",
       "  'type': 'T170',\n",
       "  'name': 'models',\n",
       "  'context': '[CLS] using a comprehensive g ##eria ##tric assessment was conducted . Di ##sa ##bility was defined as imp ##air ##ment in activities of daily living and / or instrumental activities of daily living , simplified to four items . Un ##iva ##ria ##te and multi ##var ##iate log ##istic models of disabled patients were performed . The three final multi ##var ##iate [unused1] models [unused2] were compared using the area under the receiver operating characteristic curve ( AU ##C / R ##OC ) of the log ##istic model . The mean age was 80 . 6 years , and 51 % of the patients were women with various types of cancer . The prevalence of disability was 67 . 6 % . No on ##co ##log ##ic [SEP]',\n",
       "  'existing_cui': 'C0026350',\n",
       "  'existing_cui_name': 'Theoretical model',\n",
       "  'existing_cui_desc': '[CLS] Theo ##ret ##ical model [unused3] ( Intel ##lect ##ual Product , Theo ##ret ##ical : Model , Theo ##ret ##ical ; Theo ##ret ##ical Models ; Models , Theo ##ret ##ical ; Models ; Theo ##ret ##ical Model ; theoretical model ; Models , Theo ##ret ##ic ; Model ; theoretical models ) [SEP]',\n",
       "  'our_bi_cui': 'C3161035',\n",
       "  'our_bi_cui_name': 'Model',\n",
       "  'our_bi_cui_desc': '[CLS] Model [unused3] ( Intel ##lect ##ual Product : Models ; Model ##ing System ; Model System ) [SEP]',\n",
       "  'our_cross_cui': 'C0023965',\n",
       "  'our_cross_cui_name': 'Logistic Models',\n",
       "  'our_cross_cui_desc': '[CLS] Lo ##gis ##tic Models [unused3] ( Intel ##lect ##ual Product : Model , Lo ##gis ##tic ; Models , Lo ##gis ##tic ; Lo ##gis ##tic Model ) [SEP]'},\n",
       " {'mention_id': '28145492.38',\n",
       "  'test_set_idx': 26798,\n",
       "  'type': 'T103',\n",
       "  'name': 'OX2R receptor',\n",
       "  'context': '[CLS] be carried by a Na ( + ) - dependent trans ##ient receptor potential - like channel ( as it was blocked by 2 - AP ##B and was diminished by removal of extra ##cellular Na ( + ) ) , and was a consequence of O ##X ##2 ##R receptor activation ( as it was blocked by the [unused1] O ##X ##2 ##R receptor [unused2] antagonist T ##CS O ##X ##2 29 , but not the O ##X ##1 ##R receptor antagonist S ##B 33 ##48 ##6 ##7 ) . Application of the hormone , me ##lat ##oni ##n , failed to alter tube ##roi ##n ##fu ##ndi ##bula ##r do ##pa ##mine membrane potential or o ##s ##cilla ##tory activity . This first description [SEP]',\n",
       "  'existing_cui': 'C0913649',\n",
       "  'existing_cui_name': 'taste receptors , type 2',\n",
       "  'existing_cui_desc': '[CLS] taste receptors , type 2 [unused3] ( Chemical , taste : G protein - coupled receptor T ##R ##2 ; T ##2 ##R taste receptors ; T ##2 ##R receptor ; T ##2 ##R receptors ; taste receptor , type 2 ; T ##AS ##2 ##R ##13 protein , human ; receptor , T ##2 ##R ) [SEP]',\n",
       "  'our_bi_cui': 'C0069841',\n",
       "  'our_bi_cui_name': 'Oxytocin Receptor',\n",
       "  'our_bi_cui_desc': '[CLS] O ##xy ##to ##cin Re ##ceptor [unused3] ( Chemical : Re ##ceptor ##s , O ##xy ##to ##cin [ Chemical / In ##g ##red ##ient ] ; R ##EC ##EP ##T O ##X ##Y ##TO ##CI ##N ; Re ##ceptor ##s , O ##xy ##to ##cin ; O ##X ##Y ##TO ##CI ##N R ##EC ##EP ##T ; Re ##ceptor , O ##xy ##to ##cin ; O ##xy ##to ##cin Re ##ceptor ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0671880',\n",
       "  'our_cross_cui_name': 'orexin receptor type 2',\n",
       "  'our_cross_cui_desc': '[CLS] ore ##xin receptor type 2 [unused3] ( Chemical : Or ##ex ##in - B Re ##ceptor ##s ; H ##y ##po ##cre ##tin - 2 Re ##ceptor ; Re ##ceptor , H ##y ##po ##cre ##tin - 2 ; H ##y ##po ##cre ##tin Re ##ceptor ##s 2 ; O ##X ##2 Re ##ceptor ##s ; Or ##ex ##in B Re ##ceptor ; Re ##ceptor ##s , Or ##ex ##in - B ; Re ##ceptor ##s 2 , H ##y ##po ##cre ##tin ; Or ##ex ##in Re ##ceptor 2 ; Re ##ceptor 2 , H ##y ##po ##cre ##tin ; HC ##TR ##2 Pro ##tein ; Re ##ceptor , Or ##ex ##in - B ; Or ##ex ##in Re ##ceptor Type 2 ; Pro ##tein [SEP]'},\n",
       " {'mention_id': '28203549.70',\n",
       "  'test_set_idx': 28262,\n",
       "  'type': 'T170',\n",
       "  'name': 'ST',\n",
       "  'context': '[CLS] ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e and non - HM ##K ##P is ##olate ##s were positive for r ##mp ##A . Aero ##ba ##ct ##in was found among 95 . 0 and 97 . 5 % of K ##1 and K ##2 is ##olate ##s . ST ##23 was found to be the most prevalent [unused1] ST [unused2] among 69 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s with K ##1 , K ##2 , K ##5 , K ##20 , and K ##5 ##7 ( 27 . 5 % , 19 / 69 ) and was only found among K ##1 is ##olate ##s . ST ##65 was the second [SEP]',\n",
       "  'existing_cui': 'C0036183',\n",
       "  'existing_cui_name': 'Sao Tome and Principe',\n",
       "  'existing_cui_desc': '[CLS] Sa ##o Tom ##e and P ##rin ##ci ##pe [unused3] ( Spa ##tial Concept , geographic location : SA ##O TO ##ME AND PR ##IN ##CI ##P ##E ; São Tom ##é and P ##r ##ín ##ci ##pe ) [SEP]',\n",
       "  'our_bi_cui': 'C0457537',\n",
       "  'our_bi_cui_name': 'Subtype serogroup',\n",
       "  'our_bi_cui_desc': '[CLS] Sub ##type se ##rog ##roup [unused3] ( Intel ##lect ##ual Product , qualifier value : Sub ##type se ##rog ##roup ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0449943',\n",
       "  'our_cross_cui_name': 'Serotype',\n",
       "  'our_cross_cui_desc': '[CLS] Ser ##otype [unused3] ( Intel ##lect ##ual Product , attribute , o ##bs ##er ##vable entity , qualifier value : se ##rov ##ar ; se ##rov ##ars ; Ser ##ova ##rs ; se ##rot ##ype ; se ##rot ##ype ##s ; Ser ##otype ##s ; Ser ##ova ##r ) [SEP]'},\n",
       " {'mention_id': '28445938.39',\n",
       "  'test_set_idx': 36360,\n",
       "  'type': 'T062',\n",
       "  'name': 'strategy',\n",
       "  'context': '[CLS] ##uron ##an levels and , as a result , significantly increases blood vessel functionality and per ##fusion and improve ##s the anti - tumor efficacy of do ##x ##or ##ubi ##cin . Red ##uction of extra ##cellular matrix components were mediated via T ##G ##F ##β signaling pathway in ##hibition due to down ##re ##gu ##lation of T ##G ##F ##β ##1 , CO ##L ##1 ##A ##1 , CO ##L ##3 ##A ##1 , H ##AS ##2 , H ##AS ##3 expression levels . Our findings provide evidence that re ##pur ##po ##sing Pi ##rf ##eni ##don ##e could be used as a promising [unused1] strategy [unused2] to enhance drug delivery to solid tumors by normal ##izing the tumor micro ##en ##vir ##on ##ment . [SEP]',\n",
       "  'existing_cui': 'C0589105',\n",
       "  'existing_cui_name': 'Strategy training',\n",
       "  'existing_cui_desc': '[CLS] Strategy training [unused3] ( Health Care Act ##ivity , procedure , regime / therapy ) [SEP]',\n",
       "  'our_bi_cui': 'C0085104',\n",
       "  'our_bi_cui_name': 'Drug Delivery Systems',\n",
       "  'our_bi_cui_desc': '[CLS] Drug Del ##iver ##y Systems [unused3] ( Medical Devi ##ce : drug target ##ting ; Drug Target ##ing ; delivery drug systems ; drug target ; Drug delivery systems ; Drug Target ##ings ; drug targeting ; Drug delivery system ; target drug ; drugs targets ; Del ##iver ##y System , Drug ; drugs target ; Systems , Drug Del ##iver ##y ; drug delivery systems ; drugs targeting ; drug targets ; Drug Del ##iver ##y System ; drug targeted ; System , Drug Del ##iver ##y ; Target ##ings , Drug ; Drug Del ##iver ##y ; DR ##U ##G DE ##L ##IVE ##R ##Y S ##Y ##ST ##EM ; Del ##iver ##y Systems , Drug ; drug delivery system ; delivery drugs [SEP]',\n",
       "  'our_cross_cui': 'C0035171',\n",
       "  'our_cross_cui_name': 'Research Design',\n",
       "  'our_cross_cui_desc': '[CLS] Research Design [unused3] ( Research Act ##ivity : Experiment Design ; design research ; research design ; Design ##s , Research ; Design , Research ; ST ##YP ##E ; Research Design ##s ; study design ; Study Type ; Study Design ; Experimental Design ) [SEP]'},\n",
       " {'mention_id': '27617315.66',\n",
       "  'test_set_idx': 12029,\n",
       "  'type': 'T103',\n",
       "  'name': '% p2PSA',\n",
       "  'context': '[CLS] 0 . 00 ##1 ) . By utilizing the Pro ##state Health Index cut ##off of 35 to men with pro ##state - specific anti ##gen 10 - 20 ng / m ##L and normal digital re ##ct ##al examination , 57 . 1 % ( 178 of 312 ) bio ##ps ##ies could be avoided . Both Pro ##state Health Index and % p ##2 ##PS ##A performed well in predict ##ing pro ##state cancer and high grade pro ##state cancer . The use of Pro ##state Health Index and [unused1] % p ##2 ##PS ##A [unused2] should be extended to Chinese men with pro ##state - specific anti ##gen 10 - 20 ng / m ##L and normal digital re ##ct ##al examination . [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0138741',\n",
       "  'our_bi_cui_name': 'Prostate-Specific Antigen',\n",
       "  'our_bi_cui_desc': '[CLS] Pro ##state - S ##pecific Anti ##gen [unused3] ( Chemical , PS ##A , procedure , substance : pro ##state specific anti ##gen ; gamma Semi ##no ##p ##rote ##in ; Se ##men ##ogel ##ase ; gamma semi ##no ##p ##rote ##in ; Ka ##lli ##k ##re ##in , h ##K ##3 ; Gamma - Semi ##no ##p ##rote ##in ; Pro ##state - specific anti ##gen ; HK 00 ##3 K ##AL ##L ##I ##K ##RE ##IN ; PS ##A - Pro ##state specific anti ##gen ; Ka ##lli ##k ##re ##in h ##K ##3 ; gamma - Semi ##no ##p ##rote ##in ; Pro ##state S ##pecific Anti ##gen ; EC 3 . 4 . 21 . 77 ; P - 30 anti ##gen [SEP]',\n",
       "  'our_cross_cui': 'C3710767',\n",
       "  'our_cross_cui_name': '( -2 ) pro-prostate-specific antigen , human',\n",
       "  'our_cross_cui_desc': '[CLS] ( - 2 ) pro - pro ##state - specific anti ##gen , human [unused3] ( Chemical : ( - 2 ) pro - PS ##A , human ; p ##2 ##PS ##A , human ) [SEP]'},\n",
       " {'mention_id': '28541679.21',\n",
       "  'test_set_idx': 38908,\n",
       "  'type': 'T033',\n",
       "  'name': 'pros and cons',\n",
       "  'context': '[CLS] work addresses : the range of magnetic properties reported for l ##iche ##ns , moss ##es , leaves , bark , trunk wood , insects , crust ##ace ##ans , ma ##mmal and human tissues ; their associations with atmospheric poll ##uta ##nt species ( Part ##iculate matter , NO ##x , trace elements , PA ##H ##s ) ; the [unused1] pro ##s and con ##s [unused2] of bio ##ma ##gnetic monitoring of atmospheric pollution ; current challenges for large - scale implementation of bio ##ma ##gnetic monitoring ; and future perspectives . A summary table is presented , with the aim of aid ##ing researchers and policy makers in selecting the most suitable biological sensor for their intended bio ##ma ##gnetic monitoring purpose . [SEP]',\n",
       "  'existing_cui': 'C0052649',\n",
       "  'existing_cui_name': 'gamma-Atrial Natriuretic Peptide',\n",
       "  'existing_cui_desc': '[CLS] gamma - At ##rial Nat ##ri ##ure ##tic P ##eptide [unused3] ( Chemical : Pro - AN ##F ; At ##rial Pro ##nat ##rio ##di ##lat ##in ; At ##rio ##pe ##pt ##in 126 ; AN ##P ( 1 - 126 ) ; Card ##ion ##at ##rin IV ; At ##rio ##pe ##pt ##ige ##n ; At ##rial Nat ##ri ##ure ##tic Factor ( 1 - 126 ) ; At ##rial Nat ##ri ##ure ##tic P ##eptide ( 1 - 126 ) ; At ##rial Nat ##ri ##ure ##tic Factor Pro ##hor ##mon ##e ; Pro ##at ##rial Nat ##ri ##ure ##tic Factor ; Pro ##AN ##F ; AN ##F ( 1 - 126 ) ; At ##rio ##pe ##pt ##in Pro ##hor ##mon ##e ( [SEP]',\n",
       "  'our_bi_cui': 'C0037088',\n",
       "  'our_bi_cui_name': 'Signs and Symptoms',\n",
       "  'our_bi_cui_desc': '[CLS] Sign ##s and S ##ym ##pt ##oms [unused3] ( Finding , finding : Sign ##s and S ##ym ##pt ##oms [ Disease / Finding ] ; Clinical findings ; clinical findings ; O ##bs ##er ##vable En ##ti ##ty ; sign and s ##ym ##pt ##om ; Sign and s ##ym ##pt ##om ; S ##ym ##pt ##oms and Sign ##s ; sign / s ##ym ##pt ##om ; Finding ; Clinical observation : symptoms and signs ; S ##IG ##NS S ##Y ##MP ##TO ##MS ; Clinical finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27444636.45',\n",
       "  'test_set_idx': 5996,\n",
       "  'type': 'T170',\n",
       "  'name': 'Quality of Life in Epilepsy Inventory 10',\n",
       "  'context': '[CLS] ( P < . 00 ##1 ) , Quality of Life in E ##pile ##psy In ##vent ##ory 10 ( P = . 00 ##1 ) , and alert ##ness ( P < . 05 ) . Ad ##verse Events Profile total scores improved for 21 / 21 ( 100 . 0 % ) patients , [unused1] Quality of Life in E ##pile ##psy In ##vent ##ory 10 [unused2] total scores improved for 17 / 21 ( 81 . 0 % ) patients , and alert ##ness scores improved for 16 / 21 ( 76 . 2 % ) patients . In this short - term , single - center study , an overnight switch from twice - daily o ##x ##car ##ba ##ze ##pine to [SEP]',\n",
       "  'existing_cui': 'C2698752',\n",
       "  'existing_cui_name': 'Pediatric Quality of Life Inventory',\n",
       "  'existing_cui_desc': '[CLS] P ##ediatric Quality of Life In ##vent ##ory [unused3] ( Intel ##lect ##ual Product : P ##eds ##QL ) [SEP]',\n",
       "  'our_bi_cui': 'C0085295',\n",
       "  'our_bi_cui_name': 'Interleukin-10',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##le ##uki ##n - 10 [unused3] ( Chemical , NO ##NG ##L ##Y ##CO ##S ##Y ##LA ##TE ##D , substance : C ##Y ##TO ##K ##IN ##E S ##Y ##N IN ##H ##IB FA ##CT ##OR ; Cy ##tok ##ine synthesis in ##hibit ##ing factor ; IL 01 ##0 ; Inter ##le ##uki ##n - 10 [ Chemical / In ##g ##red ##ient ] ; il ##10 ; inter ##le ##uki ##n 10 ; inter ##le ##uki ##n - 10 ; IL ##10 ; IL - 10 ; IN ##TE ##RL ##E ##U ##K ##IN 01 ##0 ; IN ##TE ##RL ##E ##U ##K ##IN - 10 ; H ##UM ##AN IN ##TE ##RL ##E ##U ##K ##IN - 10 ; Cy ##tok ##ine [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27241818.68',\n",
       "  'test_set_idx': 589,\n",
       "  'type': 'T058',\n",
       "  'name': 'output was estimated',\n",
       "  'context': '[CLS] subjects performed 5 km cycling time trials under control conditions and with l ##umba ##r in ##tra ##the ##cal f ##ent ##any ##l imp ##air ##ing lower limb muscle a ##ffer ##ent feedback ( F ##EN ##T ) . V ##ast ##us lateral ##is muscle bio ##ps ##ies were obtained before and immediately after exercise . Mo ##tone ##uron ##al [unused1] output was estimated [unused2] through vast ##us lateral ##is surface electro ##my ##ography . Ex ##er ##cise - induced changes in in ##tra ##mus ##cular meta ##bol ##ites were determine d using liquid and gas ch ##roma ##tography - mass s ##pect ##rome ##try . Q ##uad ##rice ##ps fatigue was q ##uant ##ified by pre - to post - exercise changes in potent ##iated [SEP]',\n",
       "  'existing_cui': 'C3251815',\n",
       "  'existing_cui_name': 'fluid output measurement',\n",
       "  'existing_cui_desc': '[CLS] fluid output measurement [unused3] ( Health Care Act ##ivity , procedure : Out ##put ; Me ##as ##ure ##ment of fluid output ) [SEP]',\n",
       "  'our_bi_cui': 'C0680844',\n",
       "  'our_bi_cui_name': 'estimation',\n",
       "  'our_bi_cui_desc': '[CLS] est ##imation [unused3] ( B ##iol ##og ##ic Fun ##ction , subjective , subjective : E ##st ##imation ; est ##imation ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0204709',\n",
       "  'our_cross_cui_name': 'Measuring output',\n",
       "  'our_cross_cui_desc': '[CLS] Me ##as ##uring output [unused3] ( Health Care Act ##ivity , procedure ) [SEP]'},\n",
       " {'mention_id': '28145492.7',\n",
       "  'test_set_idx': 26767,\n",
       "  'type': 'T038',\n",
       "  'name': 'Current',\n",
       "  'context': '[CLS] H ##y ##po ##cre ##tin / Or ##ex ##in P ##eptide ##s Ex ##cite Rat N ##eur ##oe ##ndo ##c ##rine Do ##pa ##mine N ##eur ##ons through Or ##ex ##in 2 Re ##ceptor - Media ##ted Act ##ivation of a Mixed Cat ##ion [unused1] Current [unused2] H ##y ##po ##cre ##tin / Or ##ex ##in neurons of the lateral h ##y ##pot ##hala ##mus are compelling m ##od ##ulator candidates for the ch ##ron ##ob ##iology of ne ##uro ##end ##oc ##rine output and , as a consequence , hormone release from the anterior pit ##uit ##ary . Here we investigate the effects of H ##y ##po ##cre ##tin / Or ##ex ##in p ##eptide ##s upon tube ##roi ##n ##fu ##ndi ##bula ##r do [SEP]',\n",
       "  'existing_cui': 'C0282444',\n",
       "  'existing_cui_name': 'Current Biog-Obit',\n",
       "  'existing_cui_desc': '[CLS] Current B ##io ##g - O ##bit [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
       "  'our_bi_cui': 'C0022023',\n",
       "  'our_bi_cui_name': 'Ions',\n",
       "  'our_bi_cui_desc': '[CLS] Ion ##s [unused3] ( Chemical , substance : ion ; Ion ##s [ Chemical / In ##g ##red ##ient ] ; Ion ; charged particles ; ions ) [SEP]',\n",
       "  'our_cross_cui': 'C0162585',\n",
       "  'our_cross_cui_name': 'Ion Transport',\n",
       "  'our_cross_cui_desc': '[CLS] Ion Transport [unused3] ( B ##iol ##og ##ic Fun ##ction : ion transport ; Transport , Ion ) [SEP]'},\n",
       " {'mention_id': '28421738.37',\n",
       "  'test_set_idx': 35215,\n",
       "  'type': 'T103',\n",
       "  'name': 'compound 12',\n",
       "  'context': \"[CLS] ##phi ##lic activation of the transcription ##al response . Moreover , 12 prevented the formation of c ##yt ##oto ##xi ##c stable o ##li ##go ##mer ##ic intermediate ##s , being significantly more effective , and per se less toxic , than prototype 1 . More importantly , as different chemical features were exploited to regulate Nr ##f ##2 and am ##yl ##oid - β p ##eptide activities , the two pathways could be tuned independently . These findings point to [unused1] compound 12 [unused2] and its derivatives as promising tools for investigating the therapeutic potential of the Nr ##f ##2 / am ##yl ##oid - β p ##eptide cellular network , laying foundation for generating new drug leads to confront Alzheimer ' s disease . [SEP]\",\n",
       "  'existing_cui': 'C3467761',\n",
       "  'existing_cui_name': 'Compound 122587',\n",
       "  'existing_cui_desc': '[CLS] Co ##mpo ##und 122 ##5 ##8 ##7 [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0620347',\n",
       "  'our_bi_cui_name': 'compound A 12',\n",
       "  'our_bi_cui_desc': \"[CLS] compound A 12 [unused3] ( Chemical : compound a 12 ; a 12 ; 5 , 9 b ( 1 ' , 2 ' ) - Benz ##eno - 9 ##b ##H - ben ##z ( g ) in ##do ##l - 3 ( 3 ##a ##H ) - one , 1 , 2 , 4 , 5 - te ##tra ##hy ##dr ##o - 1 - ( p ##hen ##yl ##met ##hyl ) - ; A - 12 ) [SEP]\",\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27298278.23',\n",
       "  'test_set_idx': 1824,\n",
       "  'type': 'T103',\n",
       "  'name': 'F',\n",
       "  'context': '[CLS] an ant ##hra ##quin ##one , and a nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##er , together with three known q ##uin ##ones and seven other known compounds , were isolated from the aerial parts of Mo ##rin ##da par ##vi ##folia . The structures of m ##ori ##nda ##par ##vin ##s C , D , E , [unused1] F [unused2] , and G were el ##uc ##idated on the basis of s ##pect ##ros ##copic or X - ray di ##ff ##raction analysis as met ##hyl 4 - h ##ydro ##xy - 1 , 6 - dim ##eth ##ox ##y - nap ##ht ##hale ##ne - 2 - car ##box ##yla ##te , met ##hyl 4 , 8 - di ##hy ##dr [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0010207',\n",
       "  'our_bi_cui_name': 'Coumarins',\n",
       "  'our_bi_cui_desc': '[CLS] Co ##uma ##rin ##s [unused3] ( Chemical : co ##uma ##rin ##s ; Co ##uma ##rine ##s ; Der ##via ##tives , 1 , 2 - Benz ##opy ##rone ; 1 , 2 - Benz ##opy ##rone ##s ; Benz ##opy ##ran 2 ones ; 1 , 2 - Benz ##opy ##rone Der ##via ##tives ; Co ##uma ##rin ##s [ Chemical / In ##g ##red ##ient ] ; 1 , 2 Benz ##opy ##rone ##s ; Co ##uma ##rin Der ##iva ##tives ; Der ##iva ##tives , Co ##uma ##rin ; Benz ##opy ##ran - 2 - ones ; B ##EN ##Z ##OP ##Y ##RO ##NE ##S 01 02 ; 1 , 2 Benz ##o P ##yr ##ones ; 1 , 2 - Benz ##o [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27570140.44',\n",
       "  'test_set_idx': 10507,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedure',\n",
       "  'context': \"[CLS] ##tum tub ##al l ##iga ##tion request , there were 17 subsequent pre ##gna ##ncies ( 15 . 0 % ) during the 27 months of follow - up . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the [unused1] procedure [unused2] . Over one third of high - risk patients ' requests were un ##ful ##fill ##ed , indicating that significant barriers may remain . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Pro ##vide ##rs should consider [SEP]\",\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27832581.28',\n",
       "  'test_set_idx': 18738,\n",
       "  'type': 'T168',\n",
       "  'name': 'SAT1',\n",
       "  'context': '[CLS] maintenance control diet ; ( 2 ) a high - star ##ch diet rich in saturated fat ; and ( 3 ) a high - star ##ch diet rich in o ##me ##ga - 3 un ##sat ##ura ##ted fat . Two feeding sequences were used to test for carry - over effects : Group A was fed control diet , [unused1] SAT ##1 [unused2] and then UN ##SA ##T ##2 , whereas Group B was fed control diet , UN ##SA ##T ##1 and then SAT ##2 . Ser ##um was collected after each diet ##ary period , anal ##ys ##ed and tested in b ##ov ##ine in v ##it ##ro em ##b ##ryo culture . In ##tro ##ducing saturated fat and un ##sat ##ura [SEP]',\n",
       "  'existing_cui': 'C1420161',\n",
       "  'existing_cui_name': 'SLC26A1 gene',\n",
       "  'existing_cui_desc': '[CLS] SL ##C ##26 ##A ##1 gene [unused3] ( Ana ##tom ##ical Structure : S ##U ##LF ##AT ##E AN ##ION T ##RA ##NS ##PO ##RT ##ER 1 ; S ##OL ##UT ##E CA ##R ##RI ##ER FA ##MI ##L ##Y 26 ( S ##U ##LF ##AT ##E T ##RA ##NS ##PO ##RT ##ER ) , ME ##MB ##ER 1 ; E ##DM ##4 ; so ##lut ##e carrier family 26 member 1 ; SAT - 1 ) [SEP]',\n",
       "  'our_bi_cui': 'C0445244',\n",
       "  'our_bi_cui_name': 'Serotype SAT1',\n",
       "  'our_bi_cui_desc': '[CLS] Ser ##otype SAT ##1 [unused3] ( Intel ##lect ##ual Product , qualifier value : SAT ##1 ) [SEP]',\n",
       "  'our_cross_cui': 'C0597423',\n",
       "  'our_cross_cui_name': 'Saturated fat',\n",
       "  'our_cross_cui_desc': '[CLS] Sa ##tura ##ted fat [unused3] ( Food , substance : saturated fatty acid ; fat ##s saturated ; saturated fatty acids ; acids fatty saturated ; Sa ##tura ##ted fatty acid ; Sa ##tura ##ted Fat ##ty A ##cid ##s ; A ##cid ##s , Sa ##tura ##ted Fat ##ty ; Fat ##ty A ##cid ##s , Sa ##tura ##ted ; saturated fat ; Sa ##tura ##ted Fat ##ty A ##cid ; Fat ##ty acids . saturated ; fat saturated ) [SEP]'},\n",
       " {'mention_id': '27913563.8',\n",
       "  'test_set_idx': 21797,\n",
       "  'type': 'T082',\n",
       "  'name': 'Yorkshire',\n",
       "  'context': '[CLS] - life balance of doctors in training - a q ##ual ##itative study In ##ves ##ti ##gate the work - life balance of doctors in training in the UK from the perspectives of trainers and train ##ees . Q ##ual ##itative semi ##structure ##d focus groups and interviews with train ##ees and trainers . Post ##graduate medical training in London , [unused1] Yorkshire [unused2] and Hu ##mber , Kent , Surrey and Sussex , and Wales during the junior doctor contract dispute at the end of 2015 . Part of a larger General Medical Council study about the fair ##ness of postgraduate medical training . 96 train ##ees and 41 trainers . Train ##ees comprised UK graduates and International Medical Graduate ##s , across all stages [SEP]',\n",
       "  'existing_cui': 'C0324292',\n",
       "  'existing_cui_name': 'Yorkshire pig',\n",
       "  'existing_cui_desc': '[CLS] Yorkshire pig [unused3] ( E ##uka ##ryo ##te , organism ) [SEP]',\n",
       "  'our_bi_cui': 'C0454874',\n",
       "  'our_bi_cui_name': 'South Yorkshire',\n",
       "  'our_bi_cui_desc': '[CLS] South Yorkshire [unused3] ( Spa ##tial Concept , geographic location : S York ##s - South Yorkshire ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '27570140.53',\n",
       "  'test_set_idx': 10516,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedure',\n",
       "  'context': \"[CLS] the 27 months of follow - up . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Over one third of high - risk patients ' requests were un ##ful ##fill ##ed , indicating that significant barriers may remain . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Pro ##vide ##rs should consider these procedures urgent , especially in high - risk women , and advocate for their patients ' access to this [unused1] procedure [unused2] . [SEP]\",\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '28437231.11',\n",
       "  'test_set_idx': 35877,\n",
       "  'type': 'T017',\n",
       "  'name': 'blaKPC',\n",
       "  'context': '[CLS] ##s and V ##ir ##ule ##nce - Re ##lated T ##rai ##ts of E ##pid ##em ##ic K ##PC - Pro ##ducing K ##le ##bs ##iel ##la pneumonia ##e Is ##olate ##s in a Chinese University Hospital K ##le ##bs ##iel ##la pneumonia ##e is an important human path ##ogen associated with a variety of diseases and the prevalence of [unused1] b ##la ##K ##PC [unused2] carrying K . pneumonia ##e ( K ##PC - K ##p ) is rapidly increasing . Cap ##sul ##e is an important v ##ir ##ule ##nce factor in K . pneumonia ##e . In this study , we determined to first systematically character ##ize caps ##ular p ##oly ##sa ##cc ##hari ##de and v ##ir ##ule ##nce traits in K [SEP]',\n",
       "  'existing_cui': 'C1855645',\n",
       "  'existing_cui_name': 'Keratoconus posticus circumscriptus',\n",
       "  'existing_cui_desc': '[CLS] Ke ##rato ##con ##us post ##icus c ##ir ##cum ##s ##cript ##us [unused3] ( B ##iol ##og ##ic Fun ##ction : K ##ER ##AT ##OC ##ON ##US P ##OS ##TI ##CU ##S C ##IR ##CU ##MS ##CR ##IP ##TU ##S ) [SEP]',\n",
       "  'our_bi_cui': 'C1531163',\n",
       "  'our_bi_cui_name': 'beta-lactamase KPC-3 , Klebsiella pneumoniae',\n",
       "  'our_bi_cui_desc': '[CLS] beta - la ##ct ##ama ##se K ##PC - 3 , K ##le ##bs ##iel ##la pneumonia ##e [unused3] ( Chemical : b ##la ( K ##PC - 3 ) , K ##le ##bs ##iel ##la pneumonia ##e ; K ##PC - 3 beta - la ##ct ##ama ##se , K ##le ##bs ##iel ##la pneumonia ##e ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27587730.39',\n",
       "  'test_set_idx': 10778,\n",
       "  'type': 'T103',\n",
       "  'name': 'gga-miR-21',\n",
       "  'context': '[CLS] and decreased end ##ogen ##ous K ##rup ##pel - like factor 5 expression in primary pre - ad ##ip ##ocytes . K ##rup ##pel - like factor 5 knock ##down using RNA ##i had a similar effect to that of the g ##ga - mi ##R - 21 mimic on cell proliferation . The promoting effect of the [unused1] g ##ga - mi ##R - 21 [unused2] inhibitor on pre - ad ##ip ##oc ##yte proliferation was partially at ##ten ##uated by K ##rup ##pel - like factor 5 knock ##down . Take ##n together , our results demonstrated that mi ##R - 21 in ##hibit ##s chicken pre - ad ##ip ##oc ##yte proliferation , at least in part , by targeting K ##rup ##pel [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C2825314',\n",
       "  'our_bi_cui_name': 'MicroRNA Gene',\n",
       "  'our_bi_cui_desc': '[CLS] Micro ##RNA Gene [unused3] ( Ana ##tom ##ical Structure : Micro RNA Gene ; Mi ##RNA Gene ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '27859998.39',\n",
       "  'test_set_idx': 19634,\n",
       "  'type': 'T033',\n",
       "  'name': 'normative levels',\n",
       "  'context': '[CLS] for women , reduced no ##go - related the ##ta - band medial frontal cortex power and medial frontal cortex - dorsal pre ##front ##al cortex connectivity were both consistent with the potential del ##eter ##ious ca ##usal effects of alcohol exposure . These findings suggest that diminished the ##ta - band medial frontal cortex power and medial frontal cortex - dorsal pre ##front ##al cortex connectivity may be ne ##uro ##phy ##sio ##logical mechanisms underlying alcohol - related di ##sin ##hibition . Although preliminary , these results suggest that [unused1] norm ##ative levels [unused2] of alcohol use during emerging adulthood have potential sex - specific ca ##usal effects on response in ##hibition E ##EG dynamics , and thus have potentially significant public health implications . [SEP]',\n",
       "  'existing_cui': 'C1547707',\n",
       "  'existing_cui_name': 'Floor - story of building',\n",
       "  'existing_cui_desc': '[CLS] Floor - story of building [unused3] ( Spa ##tial Concept : Level ; Story ; Floor ) [SEP]',\n",
       "  'our_bi_cui': 'C1551394',\n",
       "  'our_bi_cui_name': 'normal Device Alert Level',\n",
       "  'our_bi_cui_desc': '[CLS] normal Devi ##ce Al ##ert Level [unused3] ( Finding : Normal ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28257468.26',\n",
       "  'test_set_idx': 30272,\n",
       "  'type': 'T103',\n",
       "  'name': 'non - coding regions',\n",
       "  'context': '[CLS] ##phism ##s associated with differences between lines in both their mean survival times and micro ##en ##vir ##on ##mental plastic ##ity , suggesting that lines differ in their ability to adapt to variable path ##ogen exposure ##s . The majority of p ##oly ##mor ##phism ##s increasing resistance to Ma ##5 ##4 ##9 were sex bias ##ed , located in [unused1] non - coding regions [unused2] , had moderately large effect and were rare , suggesting that there is a general cost to defense . Nevertheless , host defense was not negatively correlated with overall long ##evity and f ##ec ##und ##ity . In contrast to Ma ##5 ##4 ##9 , minor all ##ele ##s were concentrated in the most Pa ##14 - susceptible as well [SEP]',\n",
       "  'existing_cui': 'C0079941',\n",
       "  'existing_cui_name': 'Open Reading Frames',\n",
       "  'existing_cui_desc': '[CLS] Open Reading Fr ##ame ##s [unused3] ( Ana ##tom ##ical Structure , OR ##F : OR ##F ##s ; Region , Pro ##tein Co ##ding ; Pro ##tein Co ##ding Se ##quence ; Co ##ding Se ##quence ; Pro ##tein Co ##ding Region ; Fr ##ame ##s , Open Reading ; Co ##ding Region ##s , Pro ##tein ; Region ##s , Pro ##tein Co ##ding ; or ##fs ; Reading Fr ##ame , Open ; Co ##ding Region ; Open Reading Fr ##ame ; Fr ##ame , Open Reading ; Co ##ding Feature ; Co ##ding Region , Pro ##tein ; open reading frame ; Pro ##tein Co ##ding Region ##s ; Reading Fr ##ame ##s , Open ) [SEP]',\n",
       "  'our_bi_cui': 'C0079941',\n",
       "  'our_bi_cui_name': 'Open Reading Frames',\n",
       "  'our_bi_cui_desc': '[CLS] Open Reading Fr ##ame ##s [unused3] ( Ana ##tom ##ical Structure , OR ##F : OR ##F ##s ; Region , Pro ##tein Co ##ding ; Pro ##tein Co ##ding Se ##quence ; Co ##ding Se ##quence ; Pro ##tein Co ##ding Region ; Fr ##ame ##s , Open Reading ; Co ##ding Region ##s , Pro ##tein ; Region ##s , Pro ##tein Co ##ding ; or ##fs ; Reading Fr ##ame , Open ; Co ##ding Region ; Open Reading Fr ##ame ; Fr ##ame , Open Reading ; Co ##ding Feature ; Co ##ding Region , Pro ##tein ; open reading frame ; Pro ##tein Co ##ding Region ##s ; Reading Fr ##ame ##s , Open ) [SEP]',\n",
       "  'our_cross_cui': 'C0021920',\n",
       "  'our_cross_cui_name': 'Introns',\n",
       "  'our_cross_cui_desc': '[CLS] In ##tron ##s [unused3] ( Chemical , finding : In ##tron ##ic ; Inter ##vening Se ##quence ##s ; Se ##quence , Inter ##vening ; SE ##Q IN ##TE ##R ##VE ##NI ##NG ; In ##tron ; Inter ##vening Se ##quence ; intro ##ns ; intro ##n ; Non - coding DNA sequence ; Se ##quence ##s , Inter ##vening ; IN ##TE ##R ##VE ##NI ##NG SE ##Q ) [SEP]'},\n",
       " {'mention_id': '27616751.36',\n",
       "  'test_set_idx': 11894,\n",
       "  'type': 'T038',\n",
       "  'name': 'tolerant',\n",
       "  'context': '[CLS] cells in the pre - se ##ns ##iti ##zed mice . CD ##25 + T - cell de ##ple ##tion in α - CD ##45 ##RB combined with Don ##or - specific s ##ple ##en cell trans ##fusion therapy recipients could prevent skin all ##og ##raft tolerance from establishing . In addition , adopt ##ive transfer of donor - prime ##d memory T cells into the [unused1] tolerant [unused2] recipients marked ##ly broke the established tolerance . Our findings indicate that α - CD ##45 ##RB and Don ##or - specific s ##ple ##en cell trans ##fusion can s ##yne ##rg ##istic ##ally in ##hibit the accelerated rejection mediated by memory T cells and induce long - term skin all ##og ##raft acceptance in mice . [SEP]',\n",
       "  'existing_cui': 'C0344336',\n",
       "  'existing_cui_name': 'Tolerant of cold',\n",
       "  'existing_cui_desc': '[CLS] To ##ler ##ant of cold [unused3] ( Finding , finding ) [SEP]',\n",
       "  'our_bi_cui': 'C0020963',\n",
       "  'our_bi_cui_name': 'Immune Tolerance',\n",
       "  'our_bi_cui_desc': '[CLS] I ##mm ##une To ##ler ##ance [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : I ##mm ##uno ##log ##ic para ##lysis - R ##ET ##IR ##ED - ; I ##mm ##uno ##log ##ic un ##res ##po ##ns ##ive ##ness ; I ##mm ##uno ##log ##ic un ##res ##po ##ns ##ive ##ness - R ##ET ##IR ##ED - ; I ##mm ##uno ##logical To ##ler ##ance ; im ##mu ##nological para ##lysis ; I ##mm ##uno ##log ##ic To ##ler ##ance ; Self To ##ler ##ance ; To ##ler ##ance , I ##mm ##une ; I ##mm ##uno ##logical tolerance ; I ##mm ##uno ##log ##ic tolerance , function ; immune tolerance ; im ##mu ##no ##log ##ic [SEP]',\n",
       "  'our_cross_cui': 'C0887937',\n",
       "  'our_cross_cui_name': 'Allograft Tolerance',\n",
       "  'our_cross_cui_desc': '[CLS] All ##og ##raft To ##ler ##ance [unused3] ( B ##iol ##og ##ic Fun ##ction : To ##ler ##ance , All ##og ##raft ) [SEP]'},\n",
       " {'mention_id': '27506220.46',\n",
       "  'test_set_idx': 8715,\n",
       "  'type': 'T033',\n",
       "  'name': 'cerebral palsy - related issues',\n",
       "  'context': '[CLS] , e . g . participants with Gross Motor Fun ##ction Classification System level IV and V had a high level of medical input and a greater use of trunk - supporting devices , anti ##re ##f ##lux and la ##xa ##tive . Profile ##s could be established based on Gross Motor Fun ##ction Classification System levels . Adults with cerebral p ##als ##y use a large amount of drugs , mobility aids , or ##th ##otic devices , rehabilitation and medical input . Healthcare is targeted at [unused1] cerebral p ##als ##y - related issues [unused2] . Gross Motor Fun ##ction Classification System is a de ##ter ##mina ##nt of healthcare consumption and thus a useful tool for clinical practice to target care appropriately . [SEP]',\n",
       "  'existing_cui': 'C0007789',\n",
       "  'existing_cui_name': 'Cerebral Palsy',\n",
       "  'existing_cui_desc': '[CLS] Ce ##re ##bra ##l Pa ##ls ##y [unused3] ( B ##iol ##og ##ic Fun ##ction , CP , Ce ##re ##bra ##l Pa ##ls ##y , diagnosis , disorder : Pa ##ls ##y ; cerebral ; Ce ##re ##bra ##l p ##als ##y , un ##sp ##ec ##ified ; Ce ##re ##bra ##l p ##als ##y [ Am ##bi ##guous ] ; Pa ##ls ##y cerebral ; para ##lysis ; cerebral ; In ##fant ##ile cerebral p ##als ##y ; Ce ##re ##bra ##l p ##als ##y ; Ce ##re ##bra ##l para ##lysis ; cerebral para ##lysis ; Con ##gen ##ital cerebral p ##als ##y ; cerebral p ##als ##y ; CP - Ce ##re ##bra ##l p ##als ##y ; cerebral ; para ##lysis [SEP]',\n",
       "  'our_bi_cui': 'C1299636',\n",
       "  'our_bi_cui_name': 'Cognitive safety issue',\n",
       "  'our_bi_cui_desc': '[CLS] Co ##gni ##tive safety issue [unused3] ( Finding , finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0033213',\n",
       "  'our_cross_cui_name': 'Problem',\n",
       "  'our_cross_cui_desc': '[CLS] Problem [unused3] ( Finding , finding : Issue ; problem ) [SEP]'},\n",
       " {'mention_id': '27534734.29',\n",
       "  'test_set_idx': 9712,\n",
       "  'type': 'T170',\n",
       "  'name': 'Hadamard combinations',\n",
       "  'context': '[CLS] a T ##E of 80 ##ms , 20 - m ##s editing pulses are applied at 4 . 56 pp ##m ( on G ##S ##H ) , 1 . 9 pp ##m ( on GA ##BA ) , both offset ##s ( using a dual - lobe co ##sin ##e - m ##od ##ulated pulse ) or neither . [unused1] Had ##ama ##rd combinations [unused2] of the four sub - experiments yield GA ##BA and G ##S ##H difference s ##pect ##ra . It is shown that Had ##ama ##rd En ##co ##ding and Reconstruction of Mega - Edit ##ed S ##pect ##ros ##copy gives excellent separation of the edited GA ##BA and G ##S ##H signals in p ##han ##tom ##s , and resulting [SEP]',\n",
       "  'existing_cui': 'C0628845',\n",
       "  'existing_cui_name': 'chlorpromazine , dexamethasone , metoclopramide , orphenadrine drug combination',\n",
       "  'existing_cui_desc': '[CLS] ch ##lor ##p ##roma ##zine , de ##xa ##met ##has ##one , met ##oc ##lop ##ram ##ide , or ##phe ##na ##dr ##ine drug combination [unused3] ( Chemical : anti ##em ##etic combination CO ##MD ; CO ##MD combination ; ch ##lor ##p ##roma ##zine - de ##xa ##met ##has ##one - met ##oc ##lop ##ram ##ide - or ##phe ##na ##dr ##ine ) [SEP]',\n",
       "  'our_bi_cui': 'C0002045',\n",
       "  'our_bi_cui_name': 'algorithm',\n",
       "  'our_bi_cui_desc': '[CLS] algorithm [unused3] ( Intel ##lect ##ual Product : Al ##gor ##ith ##m ; Al ##gor ##ith ##ms ; algorithms ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27457539.17',\n",
       "  'test_set_idx': 6416,\n",
       "  'type': 'T038',\n",
       "  'name': 'pregnant',\n",
       "  'context': '[CLS] vaccine ( C ##L ##13 ##T ) in came ##ls R ##ift Valley fever is an emerging zoo ##not ##ic viral disease , en ##zo ##otic and endemic in Africa and the Arabian Peninsula , which poses a significant threat to both human and animal health . The disease is most severe in r ##umi ##nant ##s causing abortion ##s in [unused1] pregnant [unused2] animals , especially sheep animals and high mortality in young populations . High mortality rates and severe clinical manifest ##ation have also been reported among came ##l populations in Africa , to attend however none of the currently available live vaccine ##s against R ##V ##F have been tested for safety and efficacy in this species . In this study , the [SEP]',\n",
       "  'existing_cui': 'C0549206',\n",
       "  'existing_cui_name': 'Patient currently pregnant',\n",
       "  'existing_cui_desc': '[CLS] Pat ##ient currently pregnant [unused3] ( Finding , finding , history : Pre ##gnant ; currently pregnant ; Currently pregnant ; Pre ##gna ##ncy not delivered ; G ##ra ##vid ##ity ; G ##ra ##vid ; Pat ##ient pregnant ; pregnant patient ; PR ##EG ##NA ##NT ; pregnant ; g ##ra ##vid ) [SEP]',\n",
       "  'our_bi_cui': 'C0033011',\n",
       "  'our_bi_cui_name': 'Pregnant Women',\n",
       "  'our_bi_cui_desc': '[CLS] Pre ##gnant Women [unused3] ( Population Group , person : Woman , Pre ##gnant ; pregnant female ; W ##OM ##EN PR ##EG ##N ; Women , Pre ##gnant ; PR ##EG ##N W ##OM ##EN ; pregnant woman ; Pre ##gnant woman ; Pre ##gnant women ; Pre ##gnant Woman ; pregnant women ) [SEP]',\n",
       "  'our_cross_cui': 'C0032961',\n",
       "  'our_cross_cui_name': 'Pregnancy',\n",
       "  'our_cross_cui_desc': '[CLS] Pre ##gna ##ncy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , o ##bs ##er ##vable entity , qualifier value , s ##ym ##pt ##om : G ##esta ##tion ; Pre ##gna ##ncies ; PR ##EG ##N ; g ##esta ##tion ; PR ##EG ##NA ##NC ##Y ; pre ##gna ##ncies ; female pregnancy ; Pre ##gna ##ncy , function ; pregnancy ; Pre ##gna ##ncy [ Disease / Finding ] ) [SEP]'},\n",
       " {'mention_id': '28071754.21',\n",
       "  'test_set_idx': 24726,\n",
       "  'type': 'T037',\n",
       "  'name': 'injury',\n",
       "  'context': '[CLS] be activated by low - temperature far - infrared i ##rra ##diation to ex ##ert beneficial effects on the vascular end ##oth ##eli ##um . In the present study , we investigated the influence of far - infrared - induced Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein activation on AG ##E - induced end ##oth ##eli ##al [unused1] injury [unused2] both in v ##it ##ro and in v ##ivo . far - infrared i ##rra ##diation in ##hibit ##ed AG ##E - induced a ##pop ##tosis in human um ##bil ##ical vein end ##oth ##eli ##al cells . Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein activation increased the expression of p ##hos ##pha ##ti ##dy ##lino ##si ##to [SEP]',\n",
       "  'existing_cui': 'C0005604',\n",
       "  'existing_cui_name': 'Birth Injuries',\n",
       "  'existing_cui_desc': '[CLS] Birth In ##ju ##ries [unused3] ( In ##ju ##ry or Po ##ison ##ing , Birth , diagnosis , disorder : In ##ju ##ries , Birth ; T ##ra ##umatic birth ; injury birth ; Birth trauma , un ##sp ##ec ##ified ; Birth T ##ra ##uma ; Birth trauma of f ##etus ; injury ; birth ; traumatic birth ; birth trauma ; birth injuries ; Birth In ##ju ##ry ; trauma birth ; Neo ##nat ##al Birth In ##ju ##ry ; birth ##ing injuries ; Birth In ##ju ##ries [ Disease / Finding ] ; Un ##sp ##ec ##ified birth trauma ; birth ##ing trauma ; B ##IR ##TH IN ##J ; IN ##J B ##IR ##TH ; Birth injuries ; birth ; injury ; [SEP]',\n",
       "  'our_bi_cui': 'C0010957',\n",
       "  'our_bi_cui_name': 'Tissue damage',\n",
       "  'our_bi_cui_desc': '[CLS] T ##iss ##ue damage [unused3] ( In ##ju ##ry or Po ##ison ##ing , m ##or ##ph ##olo ##gic abnormal ##ity : damage tissues ; Dam ##age ; damages tissue ; Dam ##age , T ##iss ##ue ; tissue damage ; T ##iss ##ue Dam ##age ; damage ; damages ) [SEP]',\n",
       "  'our_cross_cui': 'C0178314',\n",
       "  'our_cross_cui_name': 'Poisoning / injury',\n",
       "  'our_cross_cui_desc': '[CLS] Po ##ison ##ing / injury [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder , finding , navigation ##al concept : In ##ju ##ry & / or poisoning ; IN ##J ##UR ##Y AND P ##O ##IS ##ON ##ING ; In ##ju ##ry and poisoning ; In ##ju ##ry / poisoning ) [SEP]'},\n",
       " {'mention_id': '28550165.51',\n",
       "  'test_set_idx': 38995,\n",
       "  'type': 'T103',\n",
       "  'name': 'G2L1',\n",
       "  'context': '[CLS] ##formatics tool Sign ##ific ##ance Analysis of Inter ##act ##ome . We discovered that C ##LA ##SP ##2 co - im ##mu ##no ##p ##re ##ci ##pit ##ates the novel protein S ##O ##GA ##1 , the micro ##tub ##ule - associated protein kinase MA ##R ##K ##2 , and the micro ##tub ##ule / act ##in - regulating protein [unused1] G ##2 ##L ##1 [unused2] . The GT ##P ##ase - act ##ivating proteins AG ##AP ##1 and AG ##AP ##3 were also en ##rich ##ed in the C ##LA ##SP ##2 interact ##ome , although subsequent AG ##AP ##3 and C ##L ##IP ##2 interact ##ome analysis suggests a preference of AG ##AP ##3 for C ##L ##IP ##2 . Follow - up MA [SEP]',\n",
       "  'existing_cui': 'C1415613',\n",
       "  'existing_cui_name': 'HMGXB4 gene',\n",
       "  'existing_cui_desc': '[CLS] HM ##G ##X ##B ##4 gene [unused3] ( Ana ##tom ##ical Structure : T ##HC ##21 ##16 ##30 ; HM ##G B ##OX D ##OM ##A ##IN - CO ##NT ##A ##IN ##ING 4 ; HM ##G - box containing 4 ; H ##IG ##H M ##O ##BI ##L ##IT ##Y G ##RO ##UP PR ##OT ##EI ##N 2 - L ##I ##KE 1 ) [SEP]',\n",
       "  'our_bi_cui': 'C1314812',\n",
       "  'our_bi_cui_name': 'GNB2L1 protein',\n",
       "  'our_bi_cui_desc': '[CLS] G ##N ##B ##2 ##L ##1 protein [unused3] ( Chemical : RA ##C ##K - 1 ( receptor for activated C kinase ) protein ; G ##N ##B ##2 - RS ##1 protein ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28105138.37',\n",
       "  'test_set_idx': 25669,\n",
       "  'type': 'T038',\n",
       "  'name': 'diabetic',\n",
       "  'context': '[CLS] that were analyzed , the interval between s ##ym ##pt ##om onset and re ##per ##fusion therapy ( window period ) varied from 0 . 5 to 24 h . The h ##s - CR ##P value was found to be higher in non - di ##abe ##tic patients ( 0 . 61 mg / d ##l ) compared with [unused1] di ##abe ##tic [unused2] patients ( 0 . 87 mg / d ##l ) . Moreover , a significant correlation between h ##s - CR ##P and h ##s - t ##rop ##oni ##n T was also recorded ( P < 0 . 00 ##1 ) . However , there was no significant difference in the mean h ##s - CR ##P values in patients [SEP]',\n",
       "  'existing_cui': 'C0241863',\n",
       "  'existing_cui_name': 'Diabetic',\n",
       "  'existing_cui_desc': '[CLS] Di ##abe ##tic [unused3] ( Finding : di ##abe ##tics ; di ##abe ##tic ) [SEP]',\n",
       "  'our_bi_cui': 'C0241863',\n",
       "  'our_bi_cui_name': 'Diabetic',\n",
       "  'our_bi_cui_desc': '[CLS] Di ##abe ##tic [unused3] ( Finding : di ##abe ##tics ; di ##abe ##tic ) [SEP]',\n",
       "  'our_cross_cui': 'C0011847',\n",
       "  'our_cross_cui_name': 'Diabetes',\n",
       "  'our_cross_cui_desc': '[CLS] Di ##abe ##tes [unused3] ( B ##iol ##og ##ic Fun ##ction : diabetes ) [SEP]'},\n",
       " {'mention_id': '27298278.40',\n",
       "  'test_set_idx': 1841,\n",
       "  'type': 'T017',\n",
       "  'name': 'A2780',\n",
       "  'context': \"[CLS] ' - di ##car ##box ##yla ##te , respectively . Na ##ph ##th ##o ##quin ##ones and nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##ers were previously unknown in the genus Mo ##rin ##da . In addition , the compounds were tested for c ##yt ##oto ##xi ##city against four human cancer cell lines He ##L ##a , [unused1] A2 ##7 ##80 [unused2] , Ke ##tr ##3 and MC ##F - 7 and their effects on p ##53 - activated transcription . Three nap ##ht ##ho ##quin ##ones had moderate c ##yt ##oto ##xi ##c effects with I ##C ##50 values ranging from 1 . 51 to 9 . 56 μ ##M , through up - regulation of p ##53 transcription ##al activity . [SEP]\",\n",
       "  'existing_cui': 'C1504999',\n",
       "  'existing_cui_name': 'PA 2789',\n",
       "  'existing_cui_desc': '[CLS] PA 278 ##9 [unused3] ( Chemical : PA - 278 ##9 ; PA ##27 ##8 ##9 ) [SEP]',\n",
       "  'our_bi_cui': 'C4277577',\n",
       "  'our_bi_cui_name': 'A549 Cells',\n",
       "  'our_bi_cui_desc': '[CLS] A ##5 ##4 ##9 Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell , A ##5 ##4 ##9 ; Cell Lines , A ##5 ##4 ##9 ; Cell Line , A ##5 ##4 ##9 ; A ##5 ##4 ##9 Cell Lines ; A ##5 ##4 ##9 Cell ; A ##5 ##4 ##9 Cell Line ; Cell ##s , A ##5 ##4 ##9 ) [SEP]',\n",
       "  'our_cross_cui': 'C0085983',\n",
       "  'our_cross_cui_name': 'Cell Line , Tumor',\n",
       "  'our_cross_cui_desc': '[CLS] Cell Line , Tu ##mor [unused3] ( Ana ##tom ##ical Structure : Cell Lines , Tu ##mor ; Tu ##mor Cell Line ; Line , Tu ##mor Cell ; Lines , Tu ##mor Cell ; Tu ##mor Cell Lines ; tumor cell lines ) [SEP]'},\n",
       " {'mention_id': '27266283.17',\n",
       "  'test_set_idx': 1107,\n",
       "  'type': 'T103',\n",
       "  'name': 'DR-70',\n",
       "  'context': '[CLS] Pat ##ients with lung cancer are usually diagnosed at advanced or locally advanced stage , for this reason early diagnosis of lung cancer is very important . For early detection of lung cancer some methods are emphasized such as low - dose com ##puted to ##mo ##graphy or tumor bio ##mark ##ers . In this study we aimed to evaluate [unused1] DR - 70 [unused2] sensitivity and specific ##ity as a tumor marker in detection of non - small cell lung cancer ##s . Between May 2013 and April 2014 , the serum samples from 88 non lung cancer patients , 86 patients with chronic o ##bs ##truct ##ive pulmonary di ##ses ##ase were obtained . Blood samples from each participant were analyzed for DR - [SEP]',\n",
       "  'existing_cui': 'C0127021',\n",
       "  'existing_cui_name': 'MAR 70',\n",
       "  'existing_cui_desc': '[CLS] MA ##R 70 [unused3] ( Chemical : MA ##R - 70 ; MA ##R ##70 ; 5 , 12 - Na ##ph ##tha ##cene ##dio ##ne , 8 - ace ##ty ##l - 10 - ( ( 3 - amino - 2 , 3 , 6 - t ##ride ##ox ##y - 4 - O - ( 2 , 6 - did ##eo ##xy - alpha - L - a ##rab ##ino - he ##x ##opy ##rano ##sy ##l ) - alpha - L - l ##yx ##o - he ##x ##opy ##rano ##sy ##l ) o ##xy ) - 7 , 8 , 9 , 10 - te ##tra ##hy ##dr ##o - 6 , 8 , 11 - t ##ri ##hy ##dr ##ox ##y [SEP]',\n",
       "  'our_bi_cui': 'C0215991',\n",
       "  'our_bi_cui_name': 'CD70 Antigen',\n",
       "  'our_bi_cui_desc': '[CLS] CD ##70 Anti ##gen [unused3] ( Chemical , substance : Ki - 24 Anti ##gen ; T ##UM ##OR NE ##CR ##OS ##IS FA ##CT ##OR L ##IG ##AN ##D S ##UP ##ER ##FA ##MI ##L ##Y ME ##MB ##ER 00 ##7 ; CD ##27 ##L Pro ##tein ; CD ##70 Anti ##gens ; AN ##TI ##GE ##NS CD 07 ##0 ; Liga ##nd , CD ##27 ; T ##NF Super ##family , Member 7 ; CD 07 ##0 AN ##TI ##GE ##NS ; CD ##27 Liga ##nd ; Anti ##gen , CD ##70 ; Tu ##mor N ##ec ##rosis Factor Liga ##nd Super ##family Member 7 ; Anti ##gens , CD ##70 ; Anti ##gens , CD ##70 [ Chemical / In ##g ##red ##ient [SEP]',\n",
       "  'our_cross_cui': 'C0041365',\n",
       "  'our_cross_cui_name': 'Tumor Markers',\n",
       "  'our_cross_cui_desc': '[CLS] Tu ##mor Mark ##ers [unused3] ( Chemical : tumor markers ; Tu ##mor Mark ##er ; Cancer B ##io ##mark ##ers ; Tu ##mor marker ; B ##io ##mark ##ers , Cancer ; Mark ##ers , Tu ##mor ; tumor marker ; Tu ##mor markers ) [SEP]'},\n",
       " {'mention_id': '28197156.31',\n",
       "  'test_set_idx': 28101,\n",
       "  'type': 'T017',\n",
       "  'name': 'Carbon Assimilation Rate 8',\n",
       "  'context': '[CLS] ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , [unused1] Carbon As ##si ##mi ##lation Rate 8 [unused2] is identical to D ##TH ##8 / G ##h ##d ##8 / L ##HD ##1 , which was reported to control rice flowering date . The increase of A is largely due to an increase of R ##u ##B ##P regeneration rate via increased leaf nitrogen content , and partially explained by reduced s ##tom ##ata ##l limitation via [SEP]',\n",
       "  'existing_cui': 'C2246620',\n",
       "  'existing_cui_name': 'iron assimilation',\n",
       "  'existing_cui_desc': '[CLS] iron ass ##im ##ilation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_bi_cui': 'C1413023',\n",
       "  'our_bi_cui_name': 'C8A gene',\n",
       "  'our_bi_cui_desc': '[CLS] C ##8 ##A gene [unused3] ( Ana ##tom ##ical Structure : complement component 8 alpha subunit ; CO ##MP ##LE ##ME ##NT CO ##MP ##ON ##EN ##T 8 , AL ##P ##HA S ##U ##B ##UN ##IT ; C ##8 AL ##P ##HA ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '28203067.34',\n",
       "  'test_set_idx': 28191,\n",
       "  'type': 'T033',\n",
       "  'name': 'negative impact of care',\n",
       "  'context': '[CLS] self - app ##rai ##sal of cop ##ing well as a care ##gi ##ver ; lower sense of general support ; more hours of care per week ; and the motor re ##tar ##dation of the cared - for person measured with the speed of the Time ##d Up and Go test . W ##orse performance on the Time ##d Up and Go test was only the patient - related predict ##or of distress among the variables examined as contributors to the higher [unused1] negative impact of care [unused2] . En ##han ##cing the mobility of g ##eria ##tric patients through suit ##ably tailored kin ##esi ##ther ##ap ##eu ##tic methods during their hospital stay may mit ##igate the burden endured by family care ##rs . [SEP]',\n",
       "  'existing_cui': 'C0726639',\n",
       "  'existing_cui_name': 'Impact food supplement',\n",
       "  'existing_cui_desc': '[CLS] Impact food supplement [unused3] ( Food : Impact ; impact ; I ##MP ##AC ##T ) [SEP]',\n",
       "  'our_bi_cui': 'C1514593',\n",
       "  'our_bi_cui_name': 'Psychological Impact',\n",
       "  'our_bi_cui_desc': '[CLS] Psychological Impact [unused3] ( Clinical At ##tri ##but ##e ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27234220.21',\n",
       "  'test_set_idx': 277,\n",
       "  'type': 'T033',\n",
       "  'name': 'No',\n",
       "  'context': '[CLS] for complications after the procedure ( bleeding and vascular access complications ) . Pat ##ients in group A were older ( 74 ± 12 years vs . 68 ± 17 years , p < 0 . 01 ) and the main indication for anti ##coa ##gu ##lation was at ##rial fi ##bri ##lla ##tion ( 58 . 6 % ) . [unused1] No [unused2] complications occurred during the procedures . There were no acute bleeding ##s just after the bandage removal . During the first 24 ##h , only 3 ( 2 . 1 % ) radial o ##cc ##lusion ##s in group A and 2 ( 0 . 6 % ) in group B ( p = 0 . 14 ) were recorded . He [SEP]',\n",
       "  'existing_cui': 'C1016143',\n",
       "  'existing_cui_name': 'Tetragenococcus halophilus',\n",
       "  'existing_cui_desc': '[CLS] Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us [unused3] ( Ba ##cter ##ium , organism : P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us Me ##es 1934 ( A ##pp ##roved List ##s 1980 ) ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us ( Me ##es 1934 ) Collins et al . 1993 ; Sa ##rc ##ina ha ##ma ##guchi ##ae ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##a ; P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us ; Te ##tra ##co ##cc ##cus No . 1 ; P ##ed ##io ##co ##cc ##us so ##ya ##e ) [SEP]',\n",
       "  'our_bi_cui': 'C0243095',\n",
       "  'our_bi_cui_name': 'Finding',\n",
       "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C1513916',\n",
       "  'our_cross_cui_name': 'Negative Finding',\n",
       "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
       " {'mention_id': '27545500.16',\n",
       "  'test_set_idx': 9992,\n",
       "  'type': 'T103',\n",
       "  'name': '16-aldehyde tanshinone I',\n",
       "  'context': '[CLS] au ##reus are prevalent . The dramatically reduced discovery of new anti ##biotics , as well as the persistent emergence of resistant bacteria , represents a major health problem in both hospital and community settings . Using anti ##biotic enhance ##rs to rescue existing classes of anti ##biotics is an attractive strategy . In this study , [unused1] 16 - al ##de ##hy ##de tan ##shin ##one I [unused2] was synthesized and b ##act ##eri ##ost ##atic activity was explored . In addition , s ##yne ##rg ##istic or add ##itive activity between 16 - al ##de ##hy ##de tan ##shin ##one I and amino ##gly ##cos ##ide anti ##biotics or β - la ##ct ##am anti ##biotics in v ##it ##ro was identified . Moreover [SEP]',\n",
       "  'existing_cui': 'C0075810',\n",
       "  'existing_cui_name': 'tanshinone',\n",
       "  'existing_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
       "  'our_bi_cui': 'C0075810',\n",
       "  'our_bi_cui_name': 'tanshinone',\n",
       "  'our_bi_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27655308.12',\n",
       "  'test_set_idx': 13170,\n",
       "  'type': 'T092',\n",
       "  'name': 'Food banks',\n",
       "  'context': \"[CLS] is key to involve this group in determining their communication barriers and information needs . O ##bject ##ive To gain insight into how people with low literacy use and evaluate written drug information , and to identify ways in which they feel the patient leaf ##let can be improved , and in particular how images could be used . Set ##ting [unused1] Food banks [unused2] and an education institution for Dutch language training in the Netherlands . Method Semi - structured focus groups and individual interviews were held with low - liter ##ate participants ( n = 45 ) . The them ##atic framework approach was used for analysis to identify themes in the data . Main outcome measure Low - liter ##ate people ' s [SEP]\",\n",
       "  'existing_cui': 'C0005770',\n",
       "  'existing_cui_name': 'Blood Banks',\n",
       "  'existing_cui_desc': '[CLS] Blood Banks [unused3] ( Organization : blood bank ; B ##L ##O ##OD BA ##N ##K ; Blood Bank ; Blood bank ; Banks , Blood ; Blood banks ; blood banks ; B ##LD ##B ##K ; Su ##pp ##liers ; Blood Bank ; Bank , Blood ) [SEP]',\n",
       "  'our_bi_cui': 'C0016452',\n",
       "  'our_bi_cui_name': 'Food',\n",
       "  'our_bi_cui_desc': '[CLS] Food [unused3] ( Food , medication , substance : Food or Food Product ; foods ; F ##O ##OD OR F ##O ##OD PR ##OD ##UC ##T ; Food Product ; Food or Food Sub ##stance ; Food ##P ##rod ##uc ##t ; Foods ; food ) [SEP]',\n",
       "  'our_cross_cui': 'C1561598',\n",
       "  'our_cross_cui_name': 'entity - organization',\n",
       "  'our_cross_cui_desc': '[CLS] entity - organization [unused3] ( Organization : organization ) [SEP]'},\n",
       " {'mention_id': '28295414.7',\n",
       "  'test_set_idx': 31545,\n",
       "  'type': 'T168',\n",
       "  'name': 'alcohol',\n",
       "  'context': '[CLS] ##ral St ##ability of Heavy Dr ##ink ##ing Days and Dr ##ink ##ing Red ##uction ##s Among Heavy Dr ##ink ##ers in the CO ##MB ##IN ##E Study Recently , the Food and Drug Administration proposed to expand the options for primary end points in the development of medications for alcohol use disorder to include either a ##bs ##tine ##nce from [unused1] alcohol [unused2] or a non ##ab ##st ##inen ##t outcome : no heavy drinking days ( with a heavy drinking day defined as more than 3 drinks per day for women and more than 4 drinks per day for men [ > 3 / > 4 cut ##off ] ) . The Food and Drug Administration also suggested that 6 months would be the [SEP]',\n",
       "  'existing_cui': 'C0202304',\n",
       "  'existing_cui_name': 'Ethanol measurement',\n",
       "  'existing_cui_desc': '[CLS] Ethan ##ol measurement [unused3] ( Health Care Act ##ivity , procedure : DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TA ##LC ##OH ##OL ##S ; Ethan ##ol Me ##as ##ure ##ment ; Al ##co ##hol ##s levels ; Al ##co ##hol ##s ; Ethan ##ol ; DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TI ##TA ##TI ##VE AL ##CO ##H ##OL ##S ; Al ##co ##hol ; alcohol measurements ; Me ##as ##ure ##ment of alcohol ; E ##thy ##l Al ##co ##hol Me ##as ##ure ##ments ; Drug screen q ##uant ##al ##co ##hol ##s ; Al ##co ##hol level ; Al ##co ##hol measurement ; ET ##HA ##N ##OL ; alcohol level test ) [SEP]',\n",
       "  'our_bi_cui': 'C0001975',\n",
       "  'our_bi_cui_name': 'Alcohols',\n",
       "  'our_bi_cui_desc': '[CLS] Al ##co ##hol ##s [unused3] ( Chemical , substance : alcohol ; Al ##co ##hol [ Chemical Class ] ; Al ##co ##hol ; Al ##co ##hol ##s [ Chemical / In ##g ##red ##ient ] ; alcohol ##s ; class of chemical alcohol ##s ; alcohol substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0001967',\n",
       "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
       "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
       " {'mention_id': '27384489.6',\n",
       "  'test_set_idx': 4320,\n",
       "  'type': 'T082',\n",
       "  'name': 'R1628P polymorphism',\n",
       "  'context': \"[CLS] Relations ##hip between le ##uc ##ine - rich repeat kinase 2 R ##16 ##28 ##P p ##oly ##mor ##phism and Parkinson ' s disease in Asian populations Although the le ##uc ##ine - rich repeat kinase 2 [unused1] R ##16 ##28 ##P p ##oly ##mor ##phism [unused2] has been associated with the risk of Parkinson ' s disease in Taiwan , China , and Singapore , there are conflicting findings regarding this relationship . Thus , the aim of the present meta - analysis was to evaluate the associations between the le ##uc ##ine - rich repeat kinase 2 R ##16 ##28 ##P p ##oly ##mor ##phism ( r ##s ##33 ##9 ##4 ##9 ##39 ##0 ) and Parkinson ' s disease in Asian populations . [SEP]\",\n",
       "  'existing_cui': 'C0032529',\n",
       "  'existing_cui_name': 'Genetic Polymorphism',\n",
       "  'existing_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
       "  'our_bi_cui': 'C4288453',\n",
       "  'our_bi_cui_name': 'PRSS2 Gene Mutation',\n",
       "  'our_bi_cui_desc': '[CLS] PR ##SS ##2 Gene Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction : T ##R ##Y ##2 Gene Mu ##tation ; PR ##SS ##2 Mu ##tation ; Pro ##te ##ase , Ser ##ine , 2 Gene Mu ##tation ) [SEP]',\n",
       "  'our_cross_cui': 'C0752046',\n",
       "  'our_cross_cui_name': 'Single Nucleotide Polymorphism',\n",
       "  'our_cross_cui_desc': '[CLS] Single N ##uc ##leo ##tide Pol ##ym ##or ##phism [unused3] ( Spa ##tial Concept , S ##NP : Pol ##ym ##or ##phism , Single N ##uc ##leo ##tide ; Single N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s ; Pol ##ym ##or ##phism ##s , Single N ##uc ##leo ##tide ; S ##NP ##s ; N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s , Single ; N ##uc ##leo ##tide Pol ##ym ##or ##phism , Single ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s ; Pol ##ym ##or ##phism , Single Base ) [SEP]'},\n",
       " {'mention_id': '28358712.50',\n",
       "  'test_set_idx': 33201,\n",
       "  'type': 'T058',\n",
       "  'name': 'Phytochemical tests',\n",
       "  'context': '[CLS] that E . an ##gus ##ti ##folia extract significantly reduced p ##aw ed ##ema and inflammation in a dose - dependent manner . The results also showed that the measurement by digital ca ##lip ##er and mercury p ##let ##hy ##smo ##meter were both reliable and might be applied interchange ##ably ( p < 0 . 01 ) . [unused1] Ph ##yt ##och ##em ##ical tests [unused2] indicated that the h ##ydro ##al ##co ##hol ##ic fruit extract of E . an ##gus ##ti ##folia was positive for cardiac g ##ly ##cos ##ides , fl ##av ##ono ##ids , te ##rp ##eno ##ids , and sa ##po ##nin ##s . Based on our findings , the E . an ##gus ##ti ##folia fruit extract probably has [SEP]',\n",
       "  'existing_cui': 'C0577749',\n",
       "  'existing_cui_name': 'Phytochemicals',\n",
       "  'existing_cui_desc': '[CLS] Ph ##yt ##och ##em ##ical ##s [unused3] ( Chemical , substance : Ph ##yton ##ut ##rient ; Diet ##ary Ph ##yt ##och ##em ##ical ##s ; Ph ##yt ##och ##em ##ical ##s [ Chemical / In ##g ##red ##ient ] ; Plant - Der ##ive ##d Chemical ##s ; Plant - Der ##ive ##d Co ##mpo ##unds ; Co ##mpo ##unds , Plant - Der ##ive ##d ; p ##hy ##to ##chemical ; Ph ##yt ##och ##em ##ical ##s , Diet ##ary ; Ph ##yt ##och ##em ##ical ; Plant Der ##ive ##d Chemical ##s ; Chemical ##s , Plant - Der ##ive ##d ; p ##hy ##to ##chemical ##s ; Ph ##yton ##ut ##rient ##s ; Plant Der ##ive ##d Co ##mpo ##unds ) [SEP]',\n",
       "  'our_bi_cui': 'C0201682',\n",
       "  'our_bi_cui_name': 'Chemical procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Chemical procedure [unused3] ( Health Care Act ##ivity , procedure : UN ##L ##IS ##TE ##D CH ##EM ##IS ##TR ##Y PR ##OC ##ED ##UR ##E ; Chemistry Me ##as ##ure ##ment ; chemical tests ; C ##L ##IN ##IC ##AL CH ##EM ##IS ##TR ##Y T ##ES ##T ; Chemistry procedure ; Chemistry Test ; test chemical ; Chemistry procedures ; Chemical measurement ; chemical test ; Chemistry Tech ##ni ##que ; Chemistry ; Un ##listed chemistry procedure ; Chemistry Pro ##ced ##ures ; Chemical test ; chemical testing ; chemicals testing ; Clinical chemistry test ; CH ##EM ; Chemistry Pro ##ced ##ure ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '27402827.8',\n",
       "  'test_set_idx': 4852,\n",
       "  'type': 'T038',\n",
       "  'name': 'formation',\n",
       "  'context': '[CLS] W ##nt - 5 ##a / Fr ##iz ##zled ##9 receptor signaling through the G ##α ##o / G ##β ##γ complex regulate ##s den ##dr ##itic spine [unused1] formation [unused2] W ##nt l ##igan ##ds play crucial roles in the development and regulation of s ##yna ##pse structure and function . Specifically , W ##nt - 5 ##a acts as a secret ##ed growth factor that regulate ##s den ##dr ##itic spine formation in rode ##nt hip ##po ##cam ##pal neurons , resulting in posts ##yna ##ptic development that promotes the cluster ##ing of the posts ##yna ##ptic density protein - 95 . Here , we focused on the early events occurring after the interaction between W ##nt - 5 ##a and its Fr ##iz [SEP]',\n",
       "  'existing_cui': 'C0220781',\n",
       "  'existing_cui_name': 'Anabolism',\n",
       "  'existing_cui_desc': '[CLS] Ana ##bol ##ism [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : bio ##sy ##nt ##hetic process ; Ana ##bol ##ism , function ; synthesis ; bio ##sy ##nt ##hesis ; formation ; B ##ios ##ynth ##etic ; B ##ios ##ynth ##esis ; B ##io ##genesis ; B ##ios ##ynth ##etic Process ; an ##ab ##olis ##m ) [SEP]',\n",
       "  'our_bi_cui': 'C0597545',\n",
       "  'our_bi_cui_name': 'synaptogenesis',\n",
       "  'our_bi_cui_desc': '[CLS] s ##yna ##pt ##ogen ##esis [unused3] ( B ##iol ##og ##ic Fun ##ction : s ##yna ##pse bio ##genesis ; s ##yna ##pse assembly ; s ##yna ##pse formation ) [SEP]',\n",
       "  'our_cross_cui': 'C0007613',\n",
       "  'our_cross_cui_name': 'Cell physiology',\n",
       "  'our_cross_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]'},\n",
       " {'mention_id': '27671177.8',\n",
       "  'test_set_idx': 13785,\n",
       "  'type': 'T082',\n",
       "  'name': 'Quetta',\n",
       "  'context': '[CLS] Year School Children in Mode ##rate - F ##lu ##ori ##de Dr ##ink ##ing Water Community in Que ##tta , Pakistan To determine the prevalence of dental car ##ies and its relationship with dental flu ##oro ##sis , oral health behaviour and diet ##ary behaviour among 12 - year school children in moderate - flu ##ori ##de drinking water community in [unused1] Que ##tta [unused2] , Pakistan . Cross - section ##al study . Government and private schools of Que ##tta , from November 2012 to February 2013 . At ##ota ##l of 34 ##9 children aged 12 - year from 14 randomly selected schools were included . The data collection was done on question ##naire designed for children . Dental car ##ies status was examined [SEP]',\n",
       "  'existing_cui': 'C0262345',\n",
       "  'existing_cui_name': 'Tenia of thalamus',\n",
       "  'existing_cui_desc': '[CLS] Ten ##ia of th ##ala ##mus [unused3] ( Ana ##tom ##ical Structure : ten ##ia of th ##ala ##mi ; Ten ##ia of th ##ala ##mi ; Ta ##enia th ##ala ##mi ; T ##hala ##mus ten ##ia ; ten ##ia of the th ##ala ##mus ; Ten ##ia th ##ala ##mi ) [SEP]',\n",
       "  'our_bi_cui': 'C3828424',\n",
       "  'our_bi_cui_name': 'Queretaro',\n",
       "  'our_bi_cui_desc': '[CLS] Que ##reta ##ro [unused3] ( Spa ##tial Concept : Que ##reta ##ro de Arte ##aga ; Free and Sovereign State of Que ##ré ##tar ##o ; Que ##ré ##tar ##o de Arte ##aga ; Que ##ré ##tar ##o ; Free and Sovereign State of Que ##reta ##ro ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '27587730.37',\n",
       "  'test_set_idx': 10776,\n",
       "  'type': 'T103',\n",
       "  'name': 'gga-miR-21',\n",
       "  'context': \"[CLS] ##hibit ##ed K ##rup ##pel - like factor 5 3 ( ' ) U ##TR reporter activity and decreased end ##ogen ##ous K ##rup ##pel - like factor 5 expression in primary pre - ad ##ip ##ocytes . K ##rup ##pel - like factor 5 knock ##down using RNA ##i had a similar effect to that of the [unused1] g ##ga - mi ##R - 21 [unused2] mimic on cell proliferation . The promoting effect of the g ##ga - mi ##R - 21 inhibitor on pre - ad ##ip ##oc ##yte proliferation was partially at ##ten ##uated by K ##rup ##pel - like factor 5 knock ##down . Take ##n together , our results demonstrated that mi ##R - 21 in ##hibit ##s chicken pre [SEP]\",\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1537719',\n",
       "  'our_bi_cui_name': 'MIR21 gene',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '28457334.32',\n",
       "  'test_set_idx': 36642,\n",
       "  'type': 'T103',\n",
       "  'name': 'extracellular RNA',\n",
       "  'context': '[CLS] h . Level ##s of Cell - free DNA and extra ##cellular RNA were measured by quantitative probe - based polymer ##ase chain reaction . In addition , th ##rom ##boe ##last ##ography for co ##agu ##lation as well as th ##rom ##boa ##gg ##re ##go ##metry for plate ##let function was conducted . Both Cell - free DNA and [unused1] extra ##cellular RNA [unused2] were elevated in patients with se ##psis compared with post ##oper ##ative patients and healthy volunteers . While higher extra ##cellular RNA levels correlated with a faster c ##lot ##ting time and more stable c ##lot ##s , Cell - free DNA correlated with a shorter c ##lot ##ting time but also less fi ##bri ##no ##lysis . In addition , [SEP]',\n",
       "  'existing_cui': 'C0521119',\n",
       "  'existing_cui_name': 'Extracellular',\n",
       "  'existing_cui_desc': '[CLS] Extra ##cellular [unused3] ( Ana ##tom ##ical Structure , qualifier value : extra ##cellular ; extra ##cellular region ) [SEP]',\n",
       "  'our_bi_cui': 'C0230885',\n",
       "  'our_bi_cui_name': 'Extracellular material',\n",
       "  'our_bi_cui_desc': '[CLS] Extra ##cellular material [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0035668',\n",
       "  'our_cross_cui_name': 'RNA',\n",
       "  'our_cross_cui_desc': '[CLS] RNA [unused3] ( Chemical , RNA , R ##ib ##on ##uc ##le ##ic A ##cid , substance : rib ##on ##uc ##le ##ic acid ; R ##ib ##on ##uc ##le ##ic acids ; RNA , Non - Pol ##ya ##den ##yla ##ted ; rib ##on ##uc ##lein ##ic ##um acid ##um / rib ##on ; RNA - R ##ib ##on ##uc ##le ##ic acid ; RNA [ Chemical / In ##g ##red ##ient ] ; RNA , Non Pol ##ya ##den ##yla ##ted ; Non - Pol ##ya ##den ##yla ##ted RNA ; r ##na ; Non Pol ##ya ##den ##yla ##ted RNA ; A ##cid , R ##ib ##on ##uc ##le ##ic ; R ##ib ##on ##uc ##le ##ic acid ; Gene Products , RNA [SEP]'},\n",
       " {'mention_id': '28203549.81',\n",
       "  'test_set_idx': 28273,\n",
       "  'type': 'T170',\n",
       "  'name': 'ST65',\n",
       "  'context': '[CLS] the most prevalent ST among 69 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s with K ##1 , K ##2 , K ##5 , K ##20 , and K ##5 ##7 ( 27 . 5 % , 19 / 69 ) and was only found among K ##1 is ##olate ##s . [unused1] ST ##65 [unused2] was the second most prevalent ST ( 26 . 1 % , 18 / 69 ) and was also only found among K ##2 is ##olate ##s . ST ##23 - K ##1 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s ( 84 . 2 % , 16 / 19 ) were [SEP]',\n",
       "  'existing_cui': 'C0812444',\n",
       "  'existing_cui_name': 'CD82 gene',\n",
       "  'existing_cui_desc': '[CLS] CD ##8 ##2 gene [unused3] ( Ana ##tom ##ical Structure : K ##AN ##GA ##I 1 ; I ##A ##4 ; R ##2 le ##uk ##oc ##yte anti ##gen ; suppression of tumor ##ige ##nic ##ity 6 ; L ##E ##U ##KO ##C ##Y ##TE S ##UR ##FA ##CE AN ##TI ##GE ##N R ##2 ; CD ##8 ##2 Mo ##le ##cule Gene ; CD ##8 ##2 AN ##TI ##GE ##N ; R ##2 ; CD ##8 ##2 Gene ; R ##2 L ##E ##U ##KO ##C ##Y ##TE AN ##TI ##GE ##N ; PR ##OS ##TA ##TE CA ##NC ##ER AN ##TI ##ME ##TA ##ST ##AS ##IS GE ##NE K ##A ##I ##1 ; S ##UP ##PR ##ES ##SO ##R OF T ##UM ##OR ##IG [SEP]',\n",
       "  'our_bi_cui': 'C0887835',\n",
       "  'our_bi_cui_name': 'Ribotype',\n",
       "  'our_bi_cui_desc': '[CLS] R ##ib ##otype [unused3] ( Finding : R ##ib ##otype ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0449943',\n",
       "  'our_cross_cui_name': 'Serotype',\n",
       "  'our_cross_cui_desc': '[CLS] Ser ##otype [unused3] ( Intel ##lect ##ual Product , attribute , o ##bs ##er ##vable entity , qualifier value : se ##rov ##ar ; se ##rov ##ars ; Ser ##ova ##rs ; se ##rot ##ype ; se ##rot ##ype ##s ; Ser ##otype ##s ; Ser ##ova ##r ) [SEP]'},\n",
       " {'mention_id': '27545500.19',\n",
       "  'test_set_idx': 9995,\n",
       "  'type': 'T103',\n",
       "  'name': '16-aldehyde tanshinone I',\n",
       "  'context': '[CLS] settings . Using anti ##biotic enhance ##rs to rescue existing classes of anti ##biotics is an attractive strategy . In this study , 16 - al ##de ##hy ##de tan ##shin ##one I was synthesized and b ##act ##eri ##ost ##atic activity was explored . In addition , s ##yne ##rg ##istic or add ##itive activity between [unused1] 16 - al ##de ##hy ##de tan ##shin ##one I [unused2] and amino ##gly ##cos ##ide anti ##biotics or β - la ##ct ##am anti ##biotics in v ##it ##ro was identified . Moreover , 16 - al ##de ##hy ##de tan ##shin ##one I was documented to au ##gment clearance of s ##tre ##pt ##omy ##cin and am ##pic ##ill ##in against S . au ##reus in [SEP]',\n",
       "  'existing_cui': 'C0075810',\n",
       "  'existing_cui_name': 'tanshinone',\n",
       "  'existing_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
       "  'our_bi_cui': 'C0075810',\n",
       "  'our_bi_cui_name': 'tanshinone',\n",
       "  'our_bi_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28197133.25',\n",
       "  'test_set_idx': 28041,\n",
       "  'type': 'T103',\n",
       "  'name': 'GH94',\n",
       "  'context': '[CLS] ##ume ##n micro ##bio ##ta of a la ##ct ##ating dairy cow and the micro ##or ##gan ##isms forming the fiber - de ##grading community . Fun ##ctional analysis identified 12 , 237 car ##bo ##hy ##dra ##te - active enzymes , accounting for 1 % of the trans ##cripts . The CA ##Z ##yme profile was dominated by families [unused1] G ##H ##9 ##4 [unused2] ( cello ##bio ##se - p ##hos ##ph ##ory ##lase ) , G ##H1 ##3 ( am ##yla ##se ) , G ##H ##43 and G ##H1 ##0 ( hem ##ice ##ll ##ula ##ses ) , G ##H ##9 and G ##H ##48 ( cell ##ula ##ses ) , P ##L ##11 ( p ##ec ##tina ##se ) as well [SEP]',\n",
       "  'existing_cui': 'C0084342',\n",
       "  'existing_cui_name': 'RHOC Protein',\n",
       "  'existing_cui_desc': '[CLS] R ##H ##OC Pro ##tein [unused3] ( Chemical : Trans ##form ##ing Pro ##tein R ##H ##OC ; A ##p ##ly ##sia RA ##S - Re ##lated Ho ##mo ##log 9 ; RA ##S Ho ##mo ##log Gene Family , Member C ; AR ##HC ; r ##as ho ##mo ##log gene family , member C protein , human ; R ##H ##OH ##9 ; AR ##H ##9 protein , human ; R ##H ##OC protein , human ) [SEP]',\n",
       "  'our_bi_cui': 'C0014442',\n",
       "  'our_bi_cui_name': 'Enzymes',\n",
       "  'our_bi_cui_desc': '[CLS] En ##zy ##mes [unused3] ( Chemical , medication , substance : enzymes ; enzyme ; En ##zy ##mes [ Chemical / In ##g ##red ##ient ] ; B ##io ##cat ##aly ##sts ; En ##zy ##me ) [SEP]',\n",
       "  'our_cross_cui': 'C0055033',\n",
       "  'our_cross_cui_name': 'cellobiose phosphorylase',\n",
       "  'our_cross_cui_desc': '[CLS] cello ##bio ##se p ##hos ##ph ##ory ##lase [unused3] ( Chemical , substance : Cell ##ob ##ios ##e p ##hos ##ph ##ory ##lase ) [SEP]'},\n",
       " {'mention_id': '27941943.9',\n",
       "  'test_set_idx': 22594,\n",
       "  'type': 'T204',\n",
       "  'name': 'vegetable crops',\n",
       "  'context': '[CLS] Trans ##cript ##omi ##c insights into the all ##elo ##pathic effects of the garlic all ##elo ##chemical dial ##ly ##l di ##sul ##fi ##de on tomato roots G ##ar ##lic is an all ##elo ##pathic crop that can alleviate the obstacles to continuous crop ##ping of [unused1] vegetable crops [unused2] . Di ##ally ##l di ##sul ##fi ##de , one of the most important all ##elo ##chemical ##s in garlic , promotes tomato root growth . Therefore , the global trans ##cript ##ome profiles of Di ##ally ##l di ##sul ##fi ##de - treated tomato roots over time were investigated to reveal the potential growth - promoting mechanisms . We detected 1828 , 129 ##6 and 119 ##0 differential ##ly expressed genes in the 4 , [SEP]',\n",
       "  'existing_cui': 'C0042440',\n",
       "  'existing_cui_name': 'Vegetables',\n",
       "  'existing_cui_desc': '[CLS] V ##ege ##table ##s [unused3] ( Food , substance : vegetable ; vegetables ; V ##ege ##table ; diet ##ary vegetable ) [SEP]',\n",
       "  'our_bi_cui': 'C0042440',\n",
       "  'our_bi_cui_name': 'Vegetables',\n",
       "  'our_bi_cui_desc': '[CLS] V ##ege ##table ##s [unused3] ( Food , substance : vegetable ; vegetables ; V ##ege ##table ; diet ##ary vegetable ) [SEP]',\n",
       "  'our_cross_cui': 'C0242775',\n",
       "  'our_cross_cui_name': 'Agricultural Crops',\n",
       "  'our_cross_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]'},\n",
       " {'mention_id': '28125734.62',\n",
       "  'test_set_idx': 26216,\n",
       "  'type': 'T103',\n",
       "  'name': 'miR-21-5p',\n",
       "  'context': '[CLS] ##gnant and non - ma ##li ##gnant cell lines . Further mi ##RNA inhibitor experiments and l ##uc ##ifer ##ase ass ##ays in Me ##ro - 14 cells valid ##ated mi ##R - 21 - 5 ##p as a true regulator of me ##so ##the ##lin . Moreover , in v ##it ##ro experiments showed that treatment with [unused1] mi ##R - 21 - 5 ##p [unused2] mimic reduced proliferation of ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma cell lines . Alto ##get ##her , this work shows that the mi ##R - CA ##TC ##H technique , coupled with next generation se ##quencing and in v ##it ##ro valid ##ation , represents a reliable method to identify native mi ##RNA : [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1999986',\n",
       "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '28249376.71',\n",
       "  'test_set_idx': 29941,\n",
       "  'type': 'T033',\n",
       "  'name': 'total tract digestibility',\n",
       "  'context': '[CLS] hem ##og ##lo ##bin , hem ##ato ##c ##rit , glucose , beta - h ##ydro ##xy ##but ##yric acid , ch ##ole ##ster ##ol , total protein , album ##in , blood u ##rea nitrogen and as ##par ##tate amino ##tra ##ns ##fer ##ase and al ##ani ##ne amino ##tra ##ns ##fer ##ase concentration . A ##ppa ##rent [unused1] total tract dig ##est ##ibility [unused2] of dry matter , crude pro ##ten , organic matter , and neutral de ##ter ##gent fiber were not influenced by mixture of essential oils supplement ##ation . The results of the present study suggested that supplement ##ation of mixture of essential oils may have limited effects on apparent nut ##rient dig ##est ##ibility , r ##umi ##nal f ##er [SEP]',\n",
       "  'existing_cui': 'C0017178',\n",
       "  'existing_cui_name': 'Gastrointestinal Diseases',\n",
       "  'existing_cui_desc': '[CLS] Gas ##tro ##int ##est ##inal Disease ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : gas ##tro ##int ##est ##inal disease ; G ##I disorders ; disorder ; gas ##tro ##int ##est ##inal ; G ##IT disorders ; Di ##sor ##der gas ##tro ##int ##est ##inal ; G ##IT diseases ; gas ##tro ##int ##est ##inal disorders ; gas ##tro ##int ##est ##inal disorder diagnosis ; disease ( or disorder ) ; gas ##tro ##int ##est ##inal tract ; gas ##tro ##int ##est ##inal ; disorder ; Gas ##tro ##int ##est ##inal Di ##sor ##der ; disease gas ##tro ##int ##est ##inal tract ; gas ##tro ##int ##est ##inal disorder ; Gas ##tro ##int ##est ##inal Di ##sor ##ders ; Gas [SEP]',\n",
       "  'our_bi_cui': 'C0012238',\n",
       "  'our_bi_cui_name': 'Digestion',\n",
       "  'our_bi_cui_desc': '[CLS] Digest ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : dig ##estive system functions ; dig ##est ##ion ; Digest ##ive system functions ; dig ##est ##ions ; Digest ##ive system function ; Fun ##ctions of the dig ##estive system ; Digest ##ive ; Digest ##ive tract function ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28197156.17',\n",
       "  'test_set_idx': 28087,\n",
       "  'type': 'T204',\n",
       "  'name': 'cultivar',\n",
       "  'context': '[CLS] ##im ##ilation rate ( A ) between rice cult ##iva ##rs using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial [unused1] cult ##iva ##r [unused2] . Fine mapping suggested that Carbon As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a [SEP]',\n",
       "  'existing_cui': 'C3385047',\n",
       "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
       "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
       "  'our_bi_cui': 'C0242775',\n",
       "  'our_bi_cui_name': 'Agricultural Crops',\n",
       "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
       "  'our_cross_cui': 'C0032098',\n",
       "  'our_cross_cui_name': 'Plants',\n",
       "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
       " {'mention_id': '28203067.13',\n",
       "  'test_set_idx': 28170,\n",
       "  'type': 'T033',\n",
       "  'name': 'patient - related results',\n",
       "  'context': '[CLS] stress ( score of ≤ 15 on the scale ) and higher stress ( score of ≥ 16 on the scale ) ex ##ert ##ed on family care ##rs by the process of providing care . The set of ex ##p ##lana ##tory variables comprised a wide range of socio ##de ##mo ##graphic and care - related attributes , including [unused1] patient - related results [unused2] from comprehensive g ##eria ##tric assessments and disease profiles . The best combination of ex ##p ##lana ##tory variables that provided the highest predict ##ive p ##ow ##e r for distress among family care ##rs in the multiple log ##istic re ##gression model was determined according to statistical information criteria . The statistical robust ##ness of the observed relationships and [SEP]',\n",
       "  'existing_cui': 'C0420738',\n",
       "  'existing_cui_name': 'Patient informed - test result',\n",
       "  'existing_cui_desc': '[CLS] Pat ##ient informed - test result [unused3] ( Finding , context - dependent category , non - specific , situation , treatment : patient results tests ; Test result to patient ; patient results test ; patient provided with test / procedure results ; test result to patient ; Pat ##ient informed of result ) [SEP]',\n",
       "  'our_bi_cui': 'C2987124',\n",
       "  'our_bi_cui_name': 'Patient Reported Outcome',\n",
       "  'our_bi_cui_desc': '[CLS] Pat ##ient Report ##ed Out ##come [unused3] ( Intel ##lect ##ual Product : Out ##come ##s , Pat ##ient Report ##ed ; Report ##ed Out ##come , Pat ##ient ; Pat ##ient Report ##ed Out ##come ##s ; Out ##come , Pat ##ient Report ##ed ; Report ##ed Out ##come ##s , Pat ##ient ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28377051.61',\n",
       "  'test_set_idx': 33677,\n",
       "  'type': 'T103',\n",
       "  'name': 'Tyr256',\n",
       "  'context': '[CLS] ##P ##1 and N - WA ##SP were recruited to fi ##lam ##ent ##ous act ##in , and shared some common compartment ##s localized at the leading edge of lame ##lli ##po ##dia , which was impaired after the de ##ple ##tion of I ##Q ##GA ##P ##1 by using the small interference RNA . Moreover , the knock ##down of I ##Q ##GA ##P ##1 also significantly decreased N - WA ##SP p ##hos ##ph ##ory ##lation at [unused1] Ty ##r ##25 ##6 [unused2] induced by C . pneumonia ##e infection . We conclude that C . pneumonia ##e infection promotes vascular end ##oth ##eli ##al cell migration and an ##gio ##genesis presumably through the I ##Q ##GA ##P ##1 - related signaling pathway . [SEP]',\n",
       "  'existing_cui': 'C3539605',\n",
       "  'existing_cui_name': 'Complement Receptor Type 2',\n",
       "  'existing_cui_desc': '[CLS] Co ##mple ##ment Re ##ceptor Type 2 [unused3] ( Chemical : E ##B ##V Re ##ceptor ; CD ##21 ; CD ##21 Anti ##gen ; Co ##mple ##ment C ##3 ##d Re ##ceptor ; E ##ps ##tein - Barr V ##ir ##us Re ##ceptor ) [SEP]',\n",
       "  'our_bi_cui': 'C0040005',\n",
       "  'our_bi_cui_name': 'Threonine',\n",
       "  'our_bi_cui_desc': '[CLS] T ##hr ##eon ##ine [unused3] ( Chemical , T ##hr , medication , substance : L - alpha - amino - beta - h ##ydro ##xy ##but ##yric acid ; L - th ##re ##oni ##ne ; th ##re ##oni ##ne ; th ##r ; L - T ##hr ##eon ##ine ; ( 2 ##S , 3 ##R ) - 2 - Am ##ino - 3 - h ##ydro ##xy ##but ##ano ##ic acid ; T ##hr ##eon ##ine [ Chemical / In ##g ##red ##ient ] ; ( 2 ##S ) - th ##re ##oni ##ne ; T ##hr ; L T ##hr ##eon ##ine ; L - 2 - Am ##ino - 3 - h ##ydro ##xy ##but ##yric acid ; T ##H ##RE [SEP]',\n",
       "  'our_cross_cui': 'C0041485',\n",
       "  'our_cross_cui_name': 'Tyrosine',\n",
       "  'our_cross_cui_desc': '[CLS] Ty ##ros ##ine [unused3] ( Chemical , L , Ty ##r , medication , product , substance : L - Ph ##en ##yla ##lani ##ne , 4 - h ##ydro ##xy - ; L - Ty ##ros ##ine ; Ty ##r ; ( S ) - alpha - amino - 4 - H ##ydro ##xy ##ben ##zen ##ep ##rop ##ano ##ic acid ; ( S ) - 2 - Am ##ino - 3 - ( p - h ##ydro ##xy ##phe ##ny ##l ) prop ##ion ##ic acid ; ( S ) - 3 - ( p - H ##ydro ##xy ##phe ##ny ##l ) al ##ani ##ne ; ( S ) - 2 - Am ##ino - 3 - ( 4 - h ##ydro ##xy [SEP]'},\n",
       " {'mention_id': '27977439.40',\n",
       "  'test_set_idx': 22835,\n",
       "  'type': 'T033',\n",
       "  'name': 'postoperative',\n",
       "  'context': '[CLS] No effect was found between groups for the primary outcome ( P = 0 . 680 , intention to treat ) ; the median values were 42 . 4 and 37 . 7 h , respectively for the control and intervention groups ( P = 0 . 87 ##3 ) . Similar non ##sign ##ificant trends were noted for other [unused1] post ##oper ##ative [unused2] delays . Sign ##ificant effects favour ##ing the intervention were noted for dynamic pain , patient satisfaction , occurrence of nausea and vomit ##ing , occurrence of del ##iri ##um or mental confusion and occurrence of pulmonary complications . In 12 patients , although no symptoms actually occurred , the total r ##op ##iva ##ca ##ine plasma level exceeded the lowest [SEP]',\n",
       "  'existing_cui': 'C0520905',\n",
       "  'existing_cui_name': 'Vomiting , Postoperative',\n",
       "  'existing_cui_desc': '[CLS] V ##omi ##ting , Post ##oper ##ative [unused3] ( Finding , disorder : Post - op vomit ##ing ; Post ##oper ##ative V ##omi ##ting ; Em ##ese ##s , Post ##oper ##ative ; P ##OS ##TO ##P V ##OM ##IT ##ING ; V ##omi ##ting post ##oper ##ative ; E ##ME ##SI ##S P ##OS ##TO ##P ; Post ##oper ##ative Em ##ese ##s ; Em ##esis , Post ##oper ##ative ; Post pro ##cedural vomit ##ing ; Post ##oper ##ative vomit ##ing ; V ##OM ##IT ##ING P ##OS ##TO ##P ; Post ##oper ##ative Em ##esis ; P ##OS ##TO ##P E ##ME ##SI ##S ) [SEP]',\n",
       "  'our_bi_cui': 'C0032786',\n",
       "  'our_bi_cui_name': 'Postoperative Care',\n",
       "  'our_bi_cui_desc': '[CLS] Post ##oper ##ative Care [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Post ##oper ##ative care ( procedure ; CA ##RE P ##OS ##TO ##P ; care post ##oper ##ative ; P ##OS ##TO ##P CA ##RE ; Post ##oper ##ative care ; Care , Post ##oper ##ative ; post ##oper ##ative care ) [SEP]',\n",
       "  'our_cross_cui': 'C0241311',\n",
       "  'our_cross_cui_name': 'post operative',\n",
       "  'our_cross_cui_desc': '[CLS] post operative [unused3] ( Finding , finding , finding : post surgery status ; Recovery from surgery ; After Surgery ; status after surgery ; Post surgery ) [SEP]'},\n",
       " {'mention_id': '27460657.59',\n",
       "  'test_set_idx': 6673,\n",
       "  'type': 'T103',\n",
       "  'name': 'ams',\n",
       "  'context': '[CLS] ass ##ay showed that MS ##18 ##8 activated the expression of C ##YP ##70 ##3 ##A ##2 . Ye ##ast two - hybrid and electro ##ph ##ore ##tic mobility shift ass ##ays further demonstrated that MS ##18 ##8 complex ##ed with AB ##OR ##TE ##D MI ##CR ##OS ##PO ##RE ##S . The expression of C ##YP ##70 ##3 ##A ##2 could be partially restored by the elevated levels of MS ##18 ##8 in the [unused1] am ##s [unused2] mutant . Therefore , our data reveal that MS ##18 ##8 coordinates with AB ##OR ##TE ##D MI ##CR ##OS ##PO ##RE ##S to activate C ##YP ##70 ##3 ##A ##2 in s ##por ##op ##oll ##eni ##n bio ##sy ##nt ##hesis of plant tape ##tum . [SEP]',\n",
       "  'existing_cui': 'C0002699',\n",
       "  'existing_cui_name': 'Amsacrine',\n",
       "  'existing_cui_desc': \"[CLS] Am ##sa ##c ##rine [unused3] ( Chemical , product , substance : Am ##sa ##c ##rine [ Chemical / In ##g ##red ##ient ] ; AM ##SA M ; m - am ##sa ; m - AM ##SA ; AM ##SA ##CR ##IN ##E ; meta - AM ##SA ; 4 ' - ( 9 - A ##c ##rid ##in ##yla ##min ##o ) met ##hane ##sul ##fo ##n - meta - an ##isi ##di ##de ; A ##c ##rid ##in ##yl an ##isi ##di ##de ; 4 ' - ( 9 - A ##c ##rid ##in ##yla ##min ##o ) met ##hane ##sul ##phon - m - an ##isi ##di ##de ; m ##AM ##SA ; Am ##sa ##c ##rine - chemical ; a ##c [SEP]\",\n",
       "  'our_bi_cui': 'C0017337',\n",
       "  'our_bi_cui_name': 'Genes',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]',\n",
       "  'our_cross_cui': 'C1434242',\n",
       "  'our_cross_cui_name': 'AMS protein , Arabidopsis',\n",
       "  'our_cross_cui_desc': '[CLS] AM ##S protein , Arab ##ido ##psis [unused3] ( Chemical : AB ##OR ##TE ##D MI ##CR ##OS ##PO ##RE ##S protein , Arab ##ido ##psis ) [SEP]'},\n",
       " {'mention_id': '28294559.21',\n",
       "  'test_set_idx': 31477,\n",
       "  'type': 'T058',\n",
       "  'name': 'HPx',\n",
       "  'context': '[CLS] type le ##ct ##in receptor - 2 deleted from plate ##lets of ch ##ime ##ric mice ( fl ##KO ) underwent HP ##x . The liver / body weight ratio was significantly lower in the fl ##KO than in the wild - type . C - type le ##ct ##in receptor - 2 plays an essential role in liver regeneration after [unused1] HP ##x [unused2] . Background and aim The aim of the present study was to investigate the role of C - type le ##ct ##in receptor ( C - type le ##ct ##in receptor ) - 2 in liver regeneration following partial liver re ##section in mice . Materials and methods I ##rra ##dia ##ted ch ##ime ##ric mice transplant ##ed with f ##etal [SEP]',\n",
       "  'existing_cui': 'C0523688',\n",
       "  'existing_cui_name': 'Hemopexin measurement',\n",
       "  'existing_cui_desc': '[CLS] He ##mo ##pe ##xin measurement [unused3] ( Health Care Act ##ivity , procedure : He ##mo ##pe ##xin ; He ##mo ##pe ##xin Me ##as ##ure ##ment ; Beta - 1 ##B G ##ly ##co ##p ##rote ##in ; Ha ##em ##ope ##xin measurement ; Beta - 1 ##B G ##ly ##co ##p ##rote ##in Me ##as ##ure ##ment ; Beta - 1 ##B - G ##ly ##co ##p ##rote ##in Me ##as ##ure ##ment ; HP ##X ; B ##1 ##B ##G ##LP ) [SEP]',\n",
       "  'our_bi_cui': 'C0008562',\n",
       "  'our_bi_cui_name': 'High pressure liquid chromatography procedure',\n",
       "  'our_bi_cui_desc': '[CLS] High pressure liquid ch ##roma ##tography procedure [unused3] ( Health Care Act ##ivity , HP ##LC , procedure , qualifier value : HP ##LC measurement ; Ch ##roma ##tography , High Speed Li ##quid ; Ch ##roma ##tography , High Press ##ure Li ##quid ; Ch ##roma ##tography , Li ##quid , High Press ##ure ; High Performance Li ##quid Ch ##roma ##tography ; HP ##LC - High pressure liquid ch ##roma ##tography ; High performance liquid ch ##roma ##tography ; H ##SL ##C ; High performance liquid ch ##roma ##tography measurement ; High pressure liquid ch ##roma ##tography ; high pressure liquid ch ##roma ##tography ; CH ##RO ##MA ##TO ##GR H ##IG ##H P ##ER ##F ##OR ##MA ##NC ##E L ##I ##Q ##UI [SEP]',\n",
       "  'our_cross_cui': 'C0193398',\n",
       "  'our_cross_cui_name': 'Partial hepatectomy',\n",
       "  'our_cross_cui_desc': '[CLS] Part ##ial he ##pate ##ct ##omy [unused3] ( Health Care Act ##ivity , partial , procedure , treatment : He ##pate ##ct ##omy , re ##section of liver ; partial lobe ##ct ##omy ; PA ##RT ##IA ##L R ##EM ##O ##VA ##L OF L ##IVE ##R ; Sub ##to ##tal he ##pate ##ct ##omy ; partial he ##pate ##ct ##omy ; P ##H - Part ##ial he ##pate ##ct ##omy ; H ##EP ##AT ##EC ##TO ##M ##Y R ##ES ##C ##J PA ##RT ##IA ##L L ##O ##BE ##CT ##OM ##Y ; Part ##ial removal of liver ; Part ##ial He ##pate ##ct ##omy ; partial ex ##cision of liver ; He ##pate ##ct ##omy ; Part ##ial ex ##cision of liver ; sub [SEP]'},\n",
       " {'mention_id': '27820849.4',\n",
       "  'test_set_idx': 18186,\n",
       "  'type': 'T082',\n",
       "  'name': 'High Density SNPs',\n",
       "  'context': '[CLS] Gen ##ome - Wide Det ##ec ##tion of Select ##ive Sign ##ature ##s in Chicken through [unused1] High Den ##sity S ##NP ##s [unused2] Chicken is recognized as an excellent model for studies of genetic mechanism of p ##hen ##otypic and g ##eno ##mic evolution , with large effective population size and strong human - driven selection . In the present study , we performed Extended Ha ##p ##lot ##ype Ho ##mo ##zy ##gos ##ity tests to identify significant core regions employing 600 ##K S ##NP Chicken chip in an F ##2 population of 1 , 53 ##4 he ##ns , which was derived from re ##ci ##p ##ro ##cal crosses between White Le ##gh ##orn and Dong ##xia ##ng chicken . Results indicated that a [SEP]',\n",
       "  'existing_cui': 'C1268672',\n",
       "  'existing_cui_name': 'High density lesion',\n",
       "  'existing_cui_desc': '[CLS] High density les ##ion [unused3] ( Finding , finding : Les ##ion with high radio ##graphic density ) [SEP]',\n",
       "  'our_bi_cui': 'C0023821',\n",
       "  'our_bi_cui_name': 'High Density Lipoproteins',\n",
       "  'our_bi_cui_desc': '[CLS] High Den ##sity Li ##pop ##rote ##ins [unused3] ( Chemical , HD ##L , substance : alpha Li ##pop ##rote ##in ; Li ##pop ##rote ##ins , High - Den ##sity ; alpha - lip ##op ##rote ##in ; Li ##pop ##rote ##in . alpha ; alpha Li ##pop ##rote ##ins ; high density lip ##op ##rote ##in ; High density lip ##op ##rote ##ins ; High - Den ##sity Li ##pop ##rote ##ins ; high density lip ##op ##rote ##ins ; Li ##pop ##rote ##ins , HD ##L [ Chemical / In ##g ##red ##ient ] ; High den ##si ##ti ##y lip ##op ##rote ##in ; Li ##pop ##rote ##ins , Heavy ; h ##dl ##s ; alpha - Li ##pop ##rote ##ins ; [SEP]',\n",
       "  'our_cross_cui': 'C0752046',\n",
       "  'our_cross_cui_name': 'Single Nucleotide Polymorphism',\n",
       "  'our_cross_cui_desc': '[CLS] Single N ##uc ##leo ##tide Pol ##ym ##or ##phism [unused3] ( Spa ##tial Concept , S ##NP : Pol ##ym ##or ##phism , Single N ##uc ##leo ##tide ; Single N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s ; Pol ##ym ##or ##phism ##s , Single N ##uc ##leo ##tide ; S ##NP ##s ; N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s , Single ; N ##uc ##leo ##tide Pol ##ym ##or ##phism , Single ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s ; Pol ##ym ##or ##phism , Single Base ) [SEP]'},\n",
       " {'mention_id': '28390176.3',\n",
       "  'test_set_idx': 34093,\n",
       "  'type': 'T103',\n",
       "  'name': 'anti - cardiac hypertrophy drugs',\n",
       "  'context': '[CLS] C ##uc ##ur ##bit ##ac ##in B Pro ##tec ##ts Against Press ##ure Over ##load In ##duced Card ##iac H ##yper ##tro ##phy Lac ##k of effective [unused1] anti - cardiac h ##yper ##tro ##phy drugs [unused2] creates a major cause for the increasing prevalence of heart failure . In the present study , we determined the anti - h ##yper ##tro ##phy and anti - fi ##bro ##sis potential of a natural plant t ##rite ##rp ##eno ##id , C ##uc ##ur ##bit ##ac ##in B both in v ##it ##ro and in v ##ivo . A ##ort ##ic band ##ing was performed to induce cardiac h ##yper ##tro ##phy . After 1 week of surgery , mice were receive cu ##cu ##rb ##ita ##cin [SEP]',\n",
       "  'existing_cui': 'C1383860',\n",
       "  'existing_cui_name': 'Cardiac Hypertrophy',\n",
       "  'existing_cui_desc': '[CLS] Card ##iac H ##yper ##tro ##phy [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : h ##yper ##tro ##phy ; cardiac ; heart h ##yper ##tro ##phy ; Heart H ##yper ##tro ##phy ; Heart - - H ##yper ##tro ##phy ; cardiac ; h ##yper ##tro ##phy ; cardiac h ##yper ##tro ##phy ; h ##yper ##tro ##phic heart ; H ##yper ##tro ##phic ; heart ; Card ##iac h ##yper ##tro ##phy ; heart ; h ##yper ##tro ##phy ; h ##yper ##tro ##phy ; heart ) [SEP]',\n",
       "  'our_bi_cui': 'C0003195',\n",
       "  'our_bi_cui_name': 'Anti-Arrhythmia Agents',\n",
       "  'our_bi_cui_desc': '[CLS] Anti - A ##rr ##hy ##th ##mia Agents [unused3] ( Chemical , medication , product , substance : anti - a ##rr ##hy ##th ##mic ##s ; Anti A ##rr ##hy ##th ##mia Drugs ; Drugs , Anti - A ##rr ##hy ##th ##mia ; anti ##ar ##r ##hy ##th ##mic agents ; AN ##TI ##AR ##R ##H ##Y ##TH ##MI ##A AG ##EN ##TS ; Drugs , Anti ##ar ##r ##hy ##th ##mia ; anti ##ar ##r ##hy ##th ##mic drug ; anti a ##rr ##hy ##th ##mic ; Anti ##ar ##r ##hy ##th ##mic drug ; Card ##iac De ##press ##ant ; Anti ##ar ##r ##hy ##th ##mic Drugs ; Anti ##ar ##r ##hy ##th ##mic agent ; Anti - a ##rr ##hy ##th [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27838742.67',\n",
       "  'test_set_idx': 19034,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] a potential anti ##can ##cer agent that can induce auto ##pha ##gic cell death in human non - small cell lung cancer via the A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . [unused1] Del ##ica ##f ##lav ##one [unused2] induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27301681.32',\n",
       "  'test_set_idx': 1932,\n",
       "  'type': 'T103',\n",
       "  'name': '8-amino-3 ,6 - dioxaoctanoic acid',\n",
       "  'context': '[CLS] ##ao ##ct ##ano ##ic acid units facing each other in a hair ##pin form , successfully showed the expected motif and a K ##D value of 16 ##n ##M was recorded . Pol ##yam ##ide 5 , containing a β - al ##ani ##ne - β - al ##ani ##ne unit instead of the [unused1] 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid [unused2] of p ##oly ##ami ##de 2 , was synthesized for comparison . The a ##que ##ous so ##lub ##ilities and nuclear local ##ization of three of the p ##oly ##ami ##des were also examined . The results suggest the possibility of applying the 8 - amino - 3 , 6 - di ##ox ##ao ##ct [SEP]',\n",
       "  'existing_cui': 'C0623748',\n",
       "  'existing_cui_name': '2-amino-8-phosphonooctanoic acid',\n",
       "  'existing_cui_desc': '[CLS] 2 - amino - 8 - p ##hos ##phon ##oo ##ct ##ano ##ic acid [unused3] ( Chemical : 2 - AP ##8 ) [SEP]',\n",
       "  'our_bi_cui': 'C0758325',\n",
       "  'our_bi_cui_name': '5-octadecenoic acid',\n",
       "  'our_bi_cui_desc': '[CLS] 5 - o ##ct ##ade ##ce ##no ##ic acid [unused3] ( Chemical , substance : o ##ct ##ade ##ce ##no ##ic acid ; Oct ##ade ##ce ##no ##ic acid ) [SEP]',\n",
       "  'our_cross_cui': 'C0029224',\n",
       "  'our_cross_cui_name': 'Organic Chemicals',\n",
       "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
       " {'mention_id': '27506129.16',\n",
       "  'test_set_idx': 8648,\n",
       "  'type': 'T170',\n",
       "  'name': 'SMOTE approaches',\n",
       "  'context': \"[CLS] straightforward due to data issues such as class im ##bal ##ance or correlated features . In this paper , we study the specific features of h ##yper ##emia and propose various approaches to address these problems in the context of an automatic framework for h ##yper ##emia g ##rading . Over ##sa ##mp ##ling , under ##sa ##mp ##ling and [unused1] SM ##OT ##E approaches [unused2] were applied in order to tackle the problem of class im ##bal ##ance . 25 features were com ##puted for each image and re ##gression methods were then used to transform them into a value on the g ##rading scale . The values and relationships among features and experts ' values were anal ##ys ##ed , and five feature selection [SEP]\",\n",
       "  'existing_cui': 'C0449445',\n",
       "  'existing_cui_name': 'Approach',\n",
       "  'existing_cui_desc': '[CLS] A ##pp ##roach [unused3] ( Spa ##tial Concept , attribute , qualifier value : A ##pp ##roach ##es ; approach ; approaches ; approaching ) [SEP]',\n",
       "  'our_bi_cui': 'C0025663',\n",
       "  'our_bi_cui_name': 'Methods',\n",
       "  'our_bi_cui_desc': '[CLS] Method ##s [unused3] ( Intel ##lect ##ual Product , attribute : methods ; Method ; method ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27430240.76',\n",
       "  'test_set_idx': 5402,\n",
       "  'type': 'T103',\n",
       "  'name': 'factors',\n",
       "  'context': '[CLS] transcription factor 1 or CR ##E ##B , and were accelerated in the presence of C ##GS ##21 ##6 ##80 . Based on these results , it can be in ##ferred that ad ##eno ##sin ##e , the ad ##eno ##sin ##e A2 ##A receptor ago ##nist , E ##2 ##F transcription factor 1 and CR ##E ##B are the possible [unused1] factors [unused2] contributing to the high expression of CD ##39 and CD ##7 ##3 on the T ##re ##g cell surface during se ##psis . Aden ##os ##ine and its A2 ##A receptor ago ##nist served as the signal trans ##du ##cer factors of the CD ##39 / CD ##7 ##3 / ad ##eno ##sin ##e pathway , a ##cc ##ele ##rating ad ##eno [SEP]',\n",
       "  'existing_cui': 'C0960756',\n",
       "  'existing_cui_name': 'factor A',\n",
       "  'existing_cui_desc': \"[CLS] factor A [unused3] ( Chemical : Co ( beta ) - c ##yan ##o - 7 ' ' - ( 2 - met ##hyl ) ad ##eni ##ny ##l ##co ##ba ##mi ##de ) [SEP]\",\n",
       "  'our_bi_cui': 'C0021054',\n",
       "  'our_bi_cui_name': 'Immunologic Factors',\n",
       "  'our_bi_cui_desc': '[CLS] I ##mm ##uno ##log ##ic Factor ##s [unused3] ( Chemical , substance : Factor ##s , I ##mm ##uno ##log ##ic ; I ##mm ##une Factor ##s ; Factor ##s , I ##mm ##uno ##logical ; I ##mm ##uno ##log ##ic Factor ; Factor ##s , I ##mm ##une ; I ##mm ##uno ##logical Factor ##s ; im ##mu ##no ##log ##ic substance ; FA ##CT ##OR ##S I ##MM ##UN ##OL ; im ##mu ##nological substance ; I ##MM ##UN ##OL FA ##CT ##OR ##S ; I ##mm ##uno ##log ##ic substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0005515',\n",
       "  'our_cross_cui_name': 'Biological Factors',\n",
       "  'our_cross_cui_desc': '[CLS] Biological Factor ##s [unused3] ( Chemical , product , substance : Agents , Biological ; Biological Factor ; B ##iol ##og ##ic agent ; agents biological ; B ##iol ##og ##ic Factor ##s ; B ##iol ##og ##ic Factor ; biological substance ; Factor , B ##iol ##og ##ic ; Factor ##s , Biological ; bio ##pha ##rma ##ce ##utical ##s ; Biological product ; B ##IO ##L FA ##CT ##OR ; Biological Agents ; Biological substance ; Biological Factor ##s [ Chemical / In ##g ##red ##ient ] ; Biological agent ; B ##iol ##og ##ics ; Factor , Biological ; biological drug ; B ##IO ##L FA ##CT ##OR ##S ; FA ##CT ##OR ##S B ##IO ##L ; biological substances ; bio ##pha [SEP]'},\n",
       " {'mention_id': '28278150.21',\n",
       "  'test_set_idx': 31035,\n",
       "  'type': 'T062',\n",
       "  'name': 'GTEx project',\n",
       "  'context': '[CLS] distinct feature compared to the existing co ##loc ##ali ##zation analysis procedures in the literature . The proposed approach is computational ##ly efficient and requires only summary - level statistics . We evaluate and demonstrate the proposed computational approach through extensive simulation studies and analyses of blood lip ##id data and the whole blood e ##Q ##TL data from the [unused1] GT ##E ##x project [unused2] . In addition , a useful utility from our proposed method enables the com ##putation of expected co ##loc ##ali ##zation signals using simple characteristics of the association data . Using this utility , we further illustrate the importance of en ##rich ##ment analysis on the ability to discover co ##loc ##ali ##zed signals and the potential limitations of currently [SEP]',\n",
       "  'existing_cui': 'C3831542',\n",
       "  'existing_cui_name': 'Analysis Project',\n",
       "  'existing_cui_desc': '[CLS] Analysis Project [unused3] ( Research Act ##ivity : Statistical Data Group ##ing ) [SEP]',\n",
       "  'our_bi_cui': 'C0242481',\n",
       "  'our_bi_cui_name': 'Research Activities',\n",
       "  'our_bi_cui_desc': '[CLS] Research Activities [unused3] ( Research Act ##ivity : research ; Research Act ##ivity ; activity research ; Research ; Activities , Research ; Act ##ivity , Research ; research activities ) [SEP]',\n",
       "  'our_cross_cui': 'C4289040',\n",
       "  'our_cross_cui_name': 'Genotype-Tissue Expression Program',\n",
       "  'our_cross_cui_desc': '[CLS] Gen ##otype - T ##iss ##ue Express ##ion Program [unused3] ( Research Act ##ivity : GT ##E ##x ; Gen ##otype - T ##iss ##ue Express ##ion ) [SEP]'},\n",
       " {'mention_id': '28471040.20',\n",
       "  'test_set_idx': 37134,\n",
       "  'type': 'T017',\n",
       "  'name': 'rat glioma-2 cells',\n",
       "  'context': '[CLS] 1 , 2 - di ##ole ##oy ##l - 3 - trim ##eth ##yla ##mm ##onium - prop ##ane hybrid na ##no ##par ##tic ##les has been prepared and evaluated for in - v ##it ##ro characterization . Cy ##to ##to ##xi ##city of F ##TA - loaded na ##no ##par ##tic ##les along with its efficacy on [unused1] rat g ##lio ##ma - 2 cells [unused2] was also evaluated both in v ##it ##ro ( in comparison with non - ma ##li ##gnant cell line , L ##9 ##29 ) and in v ##ivo . Sc ##ann ##ing electron micro ##sco ##py studies showed that all formulation ##s prepared had smooth surface and spherical in shape . far ##nes ##yl ##thi ##osa ##lic ##yl ##ic [SEP]',\n",
       "  'existing_cui': 'C0017638',\n",
       "  'existing_cui_name': 'Glioma',\n",
       "  'existing_cui_desc': '[CLS] G ##lio ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity : G ##lial Cell Tu ##mor ##s ; g ##lio ##mas ; [ M ] G ##lio ##mas ; G ##lio ##mas ; N ##eur ##og ##lial Neo ##p ##las ##m ; Tu ##mor of the N ##eur ##og ##lia ; g ##lio ##ma ; un ##sp ##ec ##ified site ; Tu ##mor , G ##lial Cell ; Tu ##mor ##s , G ##lial Cell ; G ##lial Neo ##p ##las ##m ; Neo ##p ##las ##m of N ##eur ##og ##lia ; N ##eur ##og ##lial Tu ##mor ; G ##lial Cell Tu ##mor ; G ##lial Tu ##mor ; G ##lio [SEP]',\n",
       "  'our_bi_cui': 'C1514733',\n",
       "  'our_bi_cui_name': 'Rat Cell Line',\n",
       "  'our_bi_cui_desc': '[CLS] Rat Cell Line [unused3] ( Ana ##tom ##ical Structure ) [SEP]',\n",
       "  'our_cross_cui': 'C0007634',\n",
       "  'our_cross_cui_name': 'Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
       " {'mention_id': '27320863.24',\n",
       "  'test_set_idx': 2325,\n",
       "  'type': 'T168',\n",
       "  'name': 'methionine and choline - deficient diet',\n",
       "  'context': '[CLS] ##ine supplement ##ation in drinking water ( 1 % ) . Ph ##os ##ph ##ory ##lation of AM ##P - activated protein kinase , ace ##ty ##l - Co ##A car ##box ##yla ##se , s ##tero ##l regulatory element - binding protein 1 ##c , and liver kinase B ##1 was in ##hibit ##ed by [unused1] met ##hi ##oni ##ne and ch ##olin ##e - def ##icient diet [unused2] intake , and these changes were all in ##hibit ##ed by beta ##ine feeding . Meanwhile , beta ##ine supplement ##ation reversed the reduction of met ##hi ##oni ##ne and S - ad ##eno ##sy ##lm ##eth ##ion ##ine , and the elevation of ho ##mo ##cy ##stein ##e levels in the liver , which could [SEP]',\n",
       "  'existing_cui': 'C2928853',\n",
       "  'existing_cui_name': 'Choline / Methionine',\n",
       "  'existing_cui_desc': '[CLS] Cho ##line / Met ##hi ##oni ##ne [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0452278',\n",
       "  'our_bi_cui_name': 'Low methionine diet',\n",
       "  'our_bi_cui_desc': '[CLS] Low met ##hi ##oni ##ne diet [unused3] ( Health Care Act ##ivity , finding , regime / therapy : Dec ##rease in met ##hi ##oni ##ne content of the diet compared to the assessed base ##line intake of met ##hi ##oni ##ne for the individual . ( Source : Academy of N ##utrition and Diet ##etics N ##utrition In ##formatics Committee 2013 ) ; Dec ##reased met ##hi ##oni ##ne diet ) [SEP]',\n",
       "  'our_cross_cui': 'C0012155',\n",
       "  'our_cross_cui_name': 'Diet',\n",
       "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
       " {'mention_id': '28377738.28',\n",
       "  'test_set_idx': 33713,\n",
       "  'type': 'T204',\n",
       "  'name': 'creature',\n",
       "  'context': '[CLS] dimensional approach will help to c ##lar ##ify and justify claims about the hi ##era ##rch ##ical nature of consciousness . The approach also proves ex ##p ##lana ##tor ##ily advantage ##ous , as it enables us not only to draw attention to certain new and important differences in respect of subjective measures of awareness and to justify how a given [unused1] creature [unused2] may be ranked higher in one dimension of consciousness and lower in terms of another , but also allows for innovative explanations of a variety of well - known phenomena ( amongst these , the interpretations of blind ##sight and locked - in syndrome will be briefly outlined here ) . Moreover , a 4 ##D framework makes possible many predictions and [SEP]',\n",
       "  'existing_cui': 'C0056695',\n",
       "  'existing_cui_name': 'Cyclic AMP-Responsive DNA-Binding Protein',\n",
       "  'existing_cui_desc': '[CLS] Cy ##c ##lic AM ##P - Re ##sp ##ons ##ive DNA - Bin ##ding Pro ##tein [unused3] ( Chemical , CR ##E ##B : c ##yclic AM ##P response element binding protein ; c ##AM ##P response element binding protein ; Cy ##c ##lic AM ##P Re ##sp ##ons ##ive El ##ement Bin ##ding Pro ##tein ; c ##yclic AM ##P - re ##sp ##ons ##ive DNA - binding protein ; DNA Bin ##ding Pro ##tein , Cy ##c ##lic AM ##P Re ##sp ##ons ##ive ; c ##AM ##P Re ##sp ##ons ##ive El ##ement Bin ##ding Pro ##tein ; Cy ##c ##lic AM ##P Re ##sp ##ons ##ive DNA Bin ##ding Pro ##tein ; DNA - Bin ##ding Pro ##tein , Cy ##c ##lic [SEP]',\n",
       "  'our_bi_cui': 'C0027361',\n",
       "  'our_bi_cui_name': 'Persons',\n",
       "  'our_bi_cui_desc': '[CLS] Persons [unused3] ( Population Group , person : Individual ; Person ; persons ; peoples ; Person [ du ##p ] ; People ; person ; people ) [SEP]',\n",
       "  'our_cross_cui': 'C0003062',\n",
       "  'our_cross_cui_name': 'Animals',\n",
       "  'our_cross_cui_desc': '[CLS] Animals [unused3] ( E ##uka ##ryo ##te , organism : Animal ; animal ; multi ##cellular animals ; Animal ##ia ; Animal classified by human context ; Animal classified by role ; animal ##ia ; animal kingdom ; AN ##IM ##AL ; animals ; En ##ti ##ty ##C ##lass ##A ##ni ##mal ; Kingdom Animal ##ia ) [SEP]'},\n",
       " {'mention_id': '27460657.8',\n",
       "  'test_set_idx': 6622,\n",
       "  'type': 'T017',\n",
       "  'name': 'sexine layer',\n",
       "  'context': '[CLS] The transcription factors MS ##18 ##8 and AB ##OR ##TE ##D MI ##CR ##OS ##PO ##RE ##S form a complex to activate the expression of C ##YP ##70 ##3 ##A ##2 for s ##por ##op ##oll ##eni ##n bio ##sy ##nt ##hesis in Arab ##ido ##psis th ##alia ##na The [unused1] sex ##ine layer [unused2] of pollen grain is mainly composed of s ##por ##op ##oll ##eni ##ns . The s ##por ##op ##hy ##tic secret ##ory tape ##tum is required for the bio ##sy ##nt ##hesis of s ##por ##op ##oll ##eni ##n . Although several enzymes involved in s ##por ##op ##oll ##eni ##n bio ##sy ##nt ##hesis have been reported , the regulatory mechanism of these enzymes in tape ##tal layer remains el [SEP]',\n",
       "  'existing_cui': 'C0920995',\n",
       "  'existing_cui_name': 'Subintima',\n",
       "  'existing_cui_desc': '[CLS] Sub ##int ##ima [unused3] ( Ana ##tom ##ical Structure , organ part : la ##mina ##s ; Lay ##er ; Lam ##ina ; la ##mina ) [SEP]',\n",
       "  'our_bi_cui': 'C0017472',\n",
       "  'our_bi_cui_name': 'Germ Layers',\n",
       "  'our_bi_cui_desc': '[CLS] G ##er ##m Lay ##ers [unused3] ( Ana ##tom ##ical Structure : Lay ##er , G ##er ##m ; G ##er ##m Lay ##er ; g ##er ##m layer ; G ##er ##m layer ; Lay ##ers , G ##er ##m ) [SEP]',\n",
       "  'our_cross_cui': 'C1820011',\n",
       "  'our_cross_cui_name': 'sexine',\n",
       "  'our_cross_cui_desc': '[CLS] sex ##ine [unused3] ( Ana ##tom ##ical Structure ) [SEP]'},\n",
       " {'mention_id': '27715500.19',\n",
       "  'test_set_idx': 14884,\n",
       "  'type': 'T092',\n",
       "  'name': 'industrial beefpacking plant',\n",
       "  'context': '[CLS] have received limited research attention . Prior research indicates under ##re ##port ##ing in injury rates in this industry as well significant variation in injury rates among facilities . To add detail to the rates and circumstances surrounding occupational injury among meat ##pack ##ing workers , we conducted a cross - section ##al study of workers employed at an [unused1] industrial beef ##pack ##ing plant [unused2] in Nebraska , United States ( n = 137 ) and interviewed workers about recent injury experiences . We assessed frequency , cause and nature of self - reported injury . We estimated annual incidence rates of self - reported injuries using the OS ##HA formula and compared these rates to industry - wide data . We also evaluated psychological [SEP]',\n",
       "  'existing_cui': 'C0442611',\n",
       "  'existing_cui_name': 'Industrial site',\n",
       "  'existing_cui_desc': '[CLS] Industrial site [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
       "  'our_bi_cui': 'C0016502',\n",
       "  'our_bi_cui_name': 'Food processing industry',\n",
       "  'our_bi_cui_desc': '[CLS] Food processing industry [unused3] ( Organization : F ##O ##OD PR ##OC ##ES ##SI ##NG IN ##D ##US ##T ; IN ##D ##US ##T F ##O ##OD PR ##OC ##ES ##SI ##NG ; Food - Process ##ing Industries ; Food - Process ##ing Industry ; food industry ; Industries , Food - Process ##ing ; Industry , Food Process ##ing ; Food Process ##ing Industry ; Industry , Food - Process ##ing ) [SEP]',\n",
       "  'our_cross_cui': 'C0025019',\n",
       "  'our_cross_cui_name': 'Meat-Packing Industry',\n",
       "  'our_cross_cui_desc': '[CLS] Meat - Pack ##ing Industry [unused3] ( Organization : Industries , Meat - Pack ##ing ; Industry , Meat - Pack ##ing ; ME ##AT PA ##C ##K ##ING IN ##D ##US ##T ; Meat Pack ##ing Industry ; Meat - Pack ##ing Industries ; IN ##D ##US ##T ME ##AT PA ##C ##K ##ING ; Industry , Meat Pack ##ing ) [SEP]'},\n",
       " {'mention_id': '27301681.26',\n",
       "  'test_set_idx': 1926,\n",
       "  'type': 'T103',\n",
       "  'name': '8-amino-3 ,6 - dioxaoctanoic acid',\n",
       "  'context': '[CLS] hair ##pin motifs for tandem hair ##pin . It is demonstrated here ##in that 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid also functions as a link ##er element that can extend to 2 - b ##p in hair ##pin motifs . Not ##ably , although the [unused1] 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid [unused2] - containing unit can fail to bind the expected sequence , p ##oly ##ami ##de 4 , which has two 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid units facing each other in a hair ##pin form , successfully showed the expected motif and a K ##D value [SEP]',\n",
       "  'existing_cui': 'C0623748',\n",
       "  'existing_cui_name': '2-amino-8-phosphonooctanoic acid',\n",
       "  'existing_cui_desc': '[CLS] 2 - amino - 8 - p ##hos ##phon ##oo ##ct ##ano ##ic acid [unused3] ( Chemical : 2 - AP ##8 ) [SEP]',\n",
       "  'our_bi_cui': 'C2353403',\n",
       "  'our_bi_cui_name': 'octadecenedioic acid',\n",
       "  'our_bi_cui_desc': '[CLS] o ##ct ##ade ##cene ##dio ##ic acid [unused3] ( Chemical : O ##CT ##AD ##EC ##EN ##ED ##IO ##IC AC ##ID ; Oct ##ade ##cene ##dio ##ic A ##cid ) [SEP]',\n",
       "  'our_cross_cui': 'C0029224',\n",
       "  'our_cross_cui_name': 'Organic Chemicals',\n",
       "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
       " {'mention_id': '27894019.27',\n",
       "  'test_set_idx': 21088,\n",
       "  'type': 'T103',\n",
       "  'name': 'CYP314a1',\n",
       "  'context': \"[CLS] C ##YP ##31 ##4 ##a ##1 ) that are responsible for the final two h ##ydro ##xy ##lation ##s in the production of the m ##olt - in ##ducing hormone , 20 - h ##ydro ##xy ##ec ##dy ##son ##e . The lack of crystal structures and bio ##chemical ass ##ays for C ##YP ##31 ##5 ##a ##1 or [unused1] C ##YP ##31 ##4 ##a ##1 [unused2] , has prevented further experimental exploration of X ##ant ##hur ##eni ##c acid and E ##re ##b ' s m ##olt in ##hibition mechanisms . Here ##in , a wide array of computational techniques - ho ##mology modeling , molecular dynamics simulation ##s , binding site bio ##in ##formatics , flexible receptor - flexible l ##igan ##d dock ##ing [SEP]\",\n",
       "  'existing_cui': 'C1418799',\n",
       "  'existing_cui_name': 'PPIF gene',\n",
       "  'existing_cui_desc': '[CLS] PP ##IF gene [unused3] ( Ana ##tom ##ical Structure : C ##Y ##CL ##OP ##H ##IL ##IN 3 ; P ##EP ##TI ##D ##Y ##L - PR ##OL ##Y ##L C ##IS / T ##RA ##NS ISO ##ME ##RA ##SE , MIT ##OC ##H ##ON ##DR ##IA ##L ; P ##ept ##idy ##l ##p ##rol ##yl Is ##omer ##ase F Gene ; PP ##IF Gene ; C ##Y ##CL ##OP ##H ##IL ##IN F ; p ##ept ##idy ##l ##p ##rol ##yl is ##omer ##ase F ; Cy ##p - D ; h ##C ##y ##P ##3 ; c ##y ##c ##lop ##hil ##in D ) [SEP]',\n",
       "  'our_bi_cui': 'C0059563',\n",
       "  'our_bi_cui_name': 'cytochrome P450 3A',\n",
       "  'our_bi_cui_desc': '[CLS] c ##yt ##och ##rome P ##45 ##0 3 ##A [unused3] ( Chemical , substance : N - De ##met ##hyl ##ase , E ##ry ##th ##rom ##y ##cin ; Cy ##to ##ch ##rome p ##45 ##0 C ##YP ##3 ##A enzyme ; Cy ##to ##ch ##rome P 450 ##II ##IA ; Cy ##to ##ch ##rome P - 450 C ##YP ##3 ##A [ Chemical / In ##g ##red ##ient ] ; Cy ##to ##ch ##rome P - 450 C ##YP ##3 ##A ; Cy ##to ##ch ##rome P ##45 ##0 3 ##A ; E ##ry ##th ##rom ##y ##cin N - De ##met ##hyl ##ase ; C ##Y ##TO ##CH ##RO ##ME P 450 C ##YP 00 ##3 A ; C ##YP ##3 ##A ; P [SEP]',\n",
       "  'our_cross_cui': 'C0010762',\n",
       "  'our_cross_cui_name': 'Cytochrome P450',\n",
       "  'our_cross_cui_desc': '[CLS] Cy ##to ##ch ##rome P ##45 ##0 [unused3] ( Chemical , substance : c ##yt ##och ##rome ##s p ##45 ##0 ; c ##yt ##och ##rome P ##45 ##0 ; C ##Y ##TO ##CH ##RO ##ME P 450 E ##N ##Z ##Y ##ME S ##Y ##ST ##EM ; Cy ##to ##ch ##rome p ##45 ##0 enzyme ; Super ##family , Cy ##to ##ch ##rome P ##45 ##0 ; P ##45 ##0 En ##zy ##mes ; c ##yt ##och ##rome p 450 ; En ##zy ##mes , P ##45 ##0 ; Cy ##to ##ch ##rome P 450 Families ; Cy ##to ##ch ##rome P ##45 ##0 En ##zy ##me ; P ##45 ##0 ; C ##YP ##45 ##0 ; Cy ##to ##ch ##rome p ##45 ##0 ; [SEP]'},\n",
       " {'mention_id': '27669217.35',\n",
       "  'test_set_idx': 13686,\n",
       "  'type': 'T017',\n",
       "  'name': 'ermB',\n",
       "  'context': '[CLS] ##f ##E genes were not detect ##able in these is ##olate ##s . The presence of 23 ##S r ##RNA mutations in specific is ##olate ##s did not significantly change mac ##rol ##ide MI ##C s . No n ##uc ##leo ##tide substitution ##s were found in genes encoding rib ##oso ##mal proteins L ##4 or L ##22 . The [unused1] er ##m ##B [unused2] and er ##m ##T genes were found in the genome ##s of all is ##olate ##s . These two genes were acquired independently in one highly v ##ir ##ulent is ##olate AL ##10 ##100 ##2 , and cluster ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both er ##m ##B and er ##m [SEP]',\n",
       "  'existing_cui': 'C0732611',\n",
       "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
       "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
       "  'our_bi_cui': 'C0017339',\n",
       "  'our_bi_cui_name': 'Genes , Bacterial',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##s , Ba ##cter ##ial [unused3] ( Ana ##tom ##ical Structure , substance : Ba ##cter ##ial Gene ##s ; BA ##CT GE ##NE ##S ; GE ##NE ##S BA ##CT ; bacterial gene ; Ba ##cter ##ial genes ; Gene , Ba ##cter ##ial ; BA ##CT GE ##NE ; Ba ##cter ##ial gene ; Ba ##cter ##ial Gene ; GE ##NE BA ##CT ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27932585.12',\n",
       "  'test_set_idx': 22239,\n",
       "  'type': 'T103',\n",
       "  'name': 'TYW3',\n",
       "  'context': '[CLS] S - ad ##eno ##sy ##lm ##eth ##ion ##ine ( S - ad ##eno ##sy ##lm ##eth ##ion ##ine ) - dependent met ##hyl ##tra ##ns ##fer ##ases regulate a wide range of biological processes through the modification of proteins , nuclei ##c acids , p ##oly ##sa ##cc ##hari ##des , as well as various meta ##bol ##ites . [unused1] T ##Y ##W ##3 [unused2] / Ta ##w ##3 is a SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ase responsible for the formation of a t ##RNA modification known as w ##y ##but ##os ##ine and its derivatives that are required for accurate de ##co ##ding in protein synthesis . Here , we report the crystal structure of Ta ##w ##3 , a [SEP]',\n",
       "  'existing_cui': 'C1823563',\n",
       "  'existing_cui_name': 'TYW3 gene',\n",
       "  'existing_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
       "  'our_bi_cui': 'C1823563',\n",
       "  'our_bi_cui_name': 'TYW3 gene',\n",
       "  'our_bi_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28495651.10',\n",
       "  'test_set_idx': 37785,\n",
       "  'type': 'T201',\n",
       "  'name': 'cardiovascular death',\n",
       "  'context': '[CLS] from studies of the association of Q ##T pro ##long ##ation with card ##iovascular death have been inconsistent . The purpose of this study was to compare the major correction formula ##s to percent ##ile values of Q ##T for heart rate ranges as to their ability to remove the relationship of Q ##T to heart rate and to predict [unused1] card ##iovascular death [unused2] . Part ##ici ##pants were 16 , 53 ##1 veterans who had an initial EC ##G at the Veterans Affairs Medical Center , Pa ##lo Alto , between March 31 , 1987 , and December 20 , 1999 , and were followed for card ##iovascular death . The 4 major correction formula ##s ( Ba ##ze ##tt , Fr ##ider ##ici [SEP]',\n",
       "  'existing_cui': 'C0007226',\n",
       "  'existing_cui_name': 'Cardiovascular system',\n",
       "  'existing_cui_desc': '[CLS] Card ##iovascular system [unused3] ( Body System , body structure : Structure of card ##iovascular system , un ##sp ##ec ##ified ; CA ##RD ##IO ##VA ##SC ##U ##LA ##R S ##Y ##ST ##EM ; Card ##iovascular ; Organ System , Card ##iovascular ; CA ##RD ##IO ##VA ##SC S ##Y ##ST ##EM ; Card ##iovascular structure ; card ##iovascular system ; Card ##iovascular Organ System ; C ##ir ##cula ##tory ; Structure of card ##iovascular system ; Card ##iovascular Systems ; card ##iovascular structure ; C ##ir ##cula ##tory System ; C ##ir ##cula ##tory Systems ; { C ##ir ##cula ##tory system } ; c ##ir ##cula ##tory ; C ##ir ##cula ##tory system ; Body System , Card ##iovascular ; card ##iovascular system [SEP]',\n",
       "  'our_bi_cui': 'C0376297',\n",
       "  'our_bi_cui_name': 'Cardiac Death',\n",
       "  'our_bi_cui_desc': '[CLS] Card ##iac Death [unused3] ( B ##iol ##og ##ic Fun ##ction : death ; cardiac ; cardiac death ; cardiac deaths ; Card ##iac death ; Death , Card ##iac ; cardiac ; death ) [SEP]',\n",
       "  'our_cross_cui': 'C2926098',\n",
       "  'our_cross_cui_name': \"Mechanism of death in patient 's dying of cardiovascular causes : Type : Point in time : ^ Patient : Nominal\",\n",
       "  'our_cross_cui_desc': \"[CLS] Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : Point in time : ^ Pat ##ient : No ##mina ##l [unused3] ( Clinical At ##tri ##but ##e : Death due to C ##V causes ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : P ##t : ^ Pat ##ient : No ##m ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes ) [SEP]\"},\n",
       " {'mention_id': '27791364.33',\n",
       "  'test_set_idx': 17001,\n",
       "  'type': 'T033',\n",
       "  'name': 'near - infrared absorption',\n",
       "  'context': '[CLS] serum album ##in na ##no ##par ##tic ##les demonstrate prominent tumor - contrasted imaging performance both on the photo ##aco ##ustic and magnetic resonance imaging m ##oda ##lities . The subsequent G ##d : C ##u ##S @ b ##ov ##ine serum album ##in - mediated Photo ##thermal therapy result shows high therapy efficacy as a result of their potent [unused1] near - infrared absorption [unused2] and high photo ##thermal conversion efficiency . The immune response triggered by G ##d : C ##u ##S @ b ##ov ##ine serum album ##in - mediated Photo ##thermal therapy is pre ##lim ##ina ##rily explored . In addition , toxicity studies in v ##it ##ro and in v ##ivo verify that G ##d : C ##u ##S @ b [SEP]',\n",
       "  'existing_cui': 'C0376519',\n",
       "  'existing_cui_name': 'Spectroscopy , Near-Infrared',\n",
       "  'existing_cui_desc': '[CLS] S ##pect ##ros ##copy , Near - In ##fra ##red [unused3] ( Health Care Act ##ivity , procedure : S ##pect ##rome ##try , Near - In ##fra ##red ; N ##IR s ##pect ##ros ##copy ; Near infrared s ##pect ##ros ##copy ; Near - In ##fra ##red S ##pect ##rome ##tries ; Near - In ##fra ##red S ##pect ##rome ##try ; S ##pect ##rome ##tries , Near - In ##fra ##red ; Near - In ##fra ##red S ##pect ##ros ##copy ; S ##pect ##ros ##copy , N ##IR ; N ##IR S ##pect ##ros ##copy ; N ##IR S ##pect ##ros ##co ##pies ; S ##pect ##ros ##co ##pies , Near - In ##fra ##red ; near infrared s ##pect ##ros ##copy [SEP]',\n",
       "  'our_bi_cui': 'C0234682',\n",
       "  'our_bi_cui_name': 'Light absorption',\n",
       "  'our_bi_cui_desc': '[CLS] Light absorption [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : light absorption ; absorption of light ; Light absorption , function ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28051263.27',\n",
       "  'test_set_idx': 24246,\n",
       "  'type': 'T168',\n",
       "  'name': 'alcohol',\n",
       "  'context': '[CLS] Science ##D ##ire ##ct . Results indicated the most relevant emotional factors to be depression and anxiety . The areas of investigation for cognitive functioning concern those contents and processes related to the ability to initiate and maintain lifestyle changes . The most important behavioral factors identified are physical activity , nutrition / food intake and substance consumption : coffee , [unused1] alcohol [unused2] , cigarettes . Some of the factors identified act as protective factors , other as vulnerability factors . Non ##al ##co ##hol ##ic fatty liver disease / non ##al ##co ##hol ##ic s ##te ##ato ##he ##pa ##titis may be considered a cognitive - behavioral disease , the most effective management being lifestyle changes , with emphasis on diet and exercise . [SEP]',\n",
       "  'existing_cui': 'C0202304',\n",
       "  'existing_cui_name': 'Ethanol measurement',\n",
       "  'existing_cui_desc': '[CLS] Ethan ##ol measurement [unused3] ( Health Care Act ##ivity , procedure : DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TA ##LC ##OH ##OL ##S ; Ethan ##ol Me ##as ##ure ##ment ; Al ##co ##hol ##s levels ; Al ##co ##hol ##s ; Ethan ##ol ; DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TI ##TA ##TI ##VE AL ##CO ##H ##OL ##S ; Al ##co ##hol ; alcohol measurements ; Me ##as ##ure ##ment of alcohol ; E ##thy ##l Al ##co ##hol Me ##as ##ure ##ments ; Drug screen q ##uant ##al ##co ##hol ##s ; Al ##co ##hol level ; Al ##co ##hol measurement ; ET ##HA ##N ##OL ; alcohol level test ) [SEP]',\n",
       "  'our_bi_cui': 'C0001975',\n",
       "  'our_bi_cui_name': 'Alcohols',\n",
       "  'our_bi_cui_desc': '[CLS] Al ##co ##hol ##s [unused3] ( Chemical , substance : alcohol ; Al ##co ##hol [ Chemical Class ] ; Al ##co ##hol ; Al ##co ##hol ##s [ Chemical / In ##g ##red ##ient ] ; alcohol ##s ; class of chemical alcohol ##s ; alcohol substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0001967',\n",
       "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
       "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
       " {'mention_id': '28351716.33',\n",
       "  'test_set_idx': 32886,\n",
       "  'type': 'T170',\n",
       "  'name': 'Particle Swarm Optimization',\n",
       "  'context': '[CLS] and various en ##tro ##pies namely Ya ##ger , Ren ##yi , Kapoor , Shannon , and Fu ##zzy were extracted from the de ##com ##posed images . Then , adaptive synthetic sampling approach was applied to balance the normal and abnormal data ##sets . Next , the extracted features were ranked according to the significance ##s using [unused1] Part ##icle S ##warm Op ##ti ##mi ##zation [unused2] . There ##upon , the ranked and selected features were used to train the random forest class ##ifier using s ##tra ##ti ##fied 10 - fold cross valid ##ation . Overall , the proposed system presented a performance rate of 92 . 48 % , and a sensitivity and specific ##ity of 89 . 37 % and 95 [SEP]',\n",
       "  'existing_cui': 'C4075704',\n",
       "  'existing_cui_name': 'Optimization of medication',\n",
       "  'existing_cui_desc': '[CLS] Op ##ti ##mi ##zation of medication [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
       "  'our_bi_cui': 'C0002045',\n",
       "  'our_bi_cui_name': 'algorithm',\n",
       "  'our_bi_cui_desc': '[CLS] algorithm [unused3] ( Intel ##lect ##ual Product : Al ##gor ##ith ##m ; Al ##gor ##ith ##ms ; algorithms ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27813022.13',\n",
       "  'test_set_idx': 18029,\n",
       "  'type': 'T058',\n",
       "  'name': 'On admission',\n",
       "  'context': '[CLS] ##omy : review of the literature A 63 - year - old man , who had undergone total gas ##tre ##ct ##omy and R ##oux - en - Y reconstruction for gas ##tric cancer 10 years previously , was admitted to our hospital with complaints of abdominal pain , p ##al ##pable abdominal tumor , and hem ##ate ##mes ##is . [unused1] On admission [unused2] , the abdominal tender ##ness was improving and no abdominal tumor was p ##al ##pable . Mi ##ld inflammatory changes and an ##emia were noted on blood examination . Abd ##omi ##nal com ##puted to ##mo ##graphy revealed a tumor with a layered structure in the left abdomen . The patient was diagnosed with in ##test ##inal o ##bs ##truction secondary [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0184666',\n",
       "  'our_bi_cui_name': 'Hospital admission',\n",
       "  'our_bi_cui_desc': '[CLS] Hospital admission [unused3] ( Health Care Act ##ivity , Hospital , procedure , treatment : admitted ; Ad ##mission ; hospital ; admitted hospital ; admissions ; Ad ##mit ( to ) ; hospital ; admit ; Ad ##mit ; hospital ##ization admission ; hospital admission ; admission hospital ; Ad ##mission ; admit to hospital ; Ad ##mission to hospital ; admits ; admitting ; Hospital Ad ##mission ; hospital admissions ; admission to hospital ; admissions hospital ; admission ) [SEP]',\n",
       "  'our_cross_cui': 'C0809949',\n",
       "  'our_cross_cui_name': 'Admission activity',\n",
       "  'our_cross_cui_desc': '[CLS] Ad ##mission activity [unused3] ( Health Care Act ##ivity : Ad ##mit ##ted ; Ad ##mission ) [SEP]'},\n",
       " {'mention_id': '27872234.68',\n",
       "  'test_set_idx': 20129,\n",
       "  'type': 'T103',\n",
       "  'name': 'SKCa',\n",
       "  'context': '[CLS] ##im ##id ##in - 4 - y ##l ] - am ##ine , a selective SK ##C ##a act ##iva ##tor , were marginal ##ly decreased in SH ##RS ##P art ##eries compared with W ##ista ##r - Kyoto art ##eries . The expression of end ##oth ##eli ##al trans ##ient receptor potential van ##illo ##id type 4 channel and [unused1] SK ##C ##a [unused2] protein was significantly decreased in the SH ##RS ##P me ##sent ##eric art ##eries compared with those of W ##ista ##r - Kyoto , whereas function and expression of I ##K ##C ##a were preserved in SH ##RS ##P art ##eries . These findings suggest that End ##oth ##eli ##um - dependent h ##yper ##pol ##ari ##zation - mediated responses are [SEP]',\n",
       "  'existing_cui': 'C0006675',\n",
       "  'existing_cui_name': 'Calcium',\n",
       "  'existing_cui_desc': '[CLS] Cal ##ci ##um [unused3] ( Chemical , medication , substance : Co ##agu ##lation factor IV - R ##ET ##IR ##ED - ; CO ##AG FA ##CT ##OR IV ; Co ##agu ##lation Factor IV ; B ##L ##O ##OD CO ##AG FA ##CT ##OR IV ; C ##a + + element ; factor i ##v ; calcium ; Blood Co ##agu ##lation Factor IV ; Cal ##ci ##um co ##agu ##lation factor ; Co ##agu ##lation factor IV ; calcium ##s ; Cal ##ci ##um [ Chemical / In ##g ##red ##ient ] ; C ##a - Cal ##ci ##um ; CA ##LC ##I ##UM ; Factor IV ; C ##a element ; Cal ##ci ##um anal ##yte ; Factor IV , Co ##agu ##lation [SEP]',\n",
       "  'our_bi_cui': 'C0949653',\n",
       "  'our_bi_cui_name': 'Calcium-Activated Potassium Channel',\n",
       "  'our_bi_cui_desc': '[CLS] Cal ##ci ##um - Act ##ivated Po ##tas ##sium Channel [unused3] ( Chemical : Po ##tas ##sium Channel ##s , Cal ##ci ##um De ##pen ##dent ; Po ##tas ##sium Channel ##s , Cal ##ci ##um - Act ##ivated [ Chemical / In ##g ##red ##ient ] ; Po ##tas ##sium Channel , Cal ##ci ##um Act ##ivated ; Po ##tas ##sium Channel ##s , Cal ##ci ##um - De ##pen ##dent ; K CH ##AN ##NE ##LS CA ##LC ##I ##UM ACT ##I ##VA ##TE ##D ; C ##a ##2 + - Act ##ivated K + Channel ##s ; CA ACT ##I ##VA ##TE ##D K CH ##AN ##NE ##L ; Cal ##ci ##um - Act ##ivated K + Channel ##s ; K CH ##AN [SEP]',\n",
       "  'our_cross_cui': 'C1571638',\n",
       "  'our_cross_cui_name': 'Small-Conductance Calcium-Activated Potassium Channels',\n",
       "  'our_cross_cui_desc': '[CLS] Small - Con ##duct ##ance Cal ##ci ##um - Act ##ivated Po ##tas ##sium Channel ##s [unused3] ( Chemical : SK Po ##tas ##sium Channel ##s ; Small Con ##duct ##ance Cal ##ci ##um Act ##ivated Po ##tas ##sium Channel ##s ; Small - Con ##duct ##ance Cal ##ci ##um - Act ##ivated Po ##tas ##sium Channel ##s [ Chemical / In ##g ##red ##ient ] ; Po ##tas ##sium Channel ##s , SK ) [SEP]'},\n",
       " {'mention_id': '27587730.27',\n",
       "  'test_set_idx': 10766,\n",
       "  'type': 'T103',\n",
       "  'name': 'gga-miR-21',\n",
       "  'context': \"[CLS] in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga - mi ##R - 21 inhibitor enhanced pre - ad ##ip ##oc ##yte proliferation . The subsequent investigation identified K ##rup ##pel - like factor 5 m ##RNA as a target of g ##ga - mi ##R - 21 . The [unused1] g ##ga - mi ##R - 21 [unused2] mimic in ##hibit ##ed K ##rup ##pel - like factor 5 3 ( ' ) U ##TR reporter activity and decreased end ##ogen ##ous K ##rup ##pel - like factor 5 expression in primary pre - ad ##ip ##ocytes . K ##rup ##pel - like factor 5 knock ##down using RNA ##i had a similar effect to that of [SEP]\",\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1537719',\n",
       "  'our_bi_cui_name': 'MIR21 gene',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '28127853.10',\n",
       "  'test_set_idx': 26304,\n",
       "  'type': 'T082',\n",
       "  'name': 'Taipei',\n",
       "  'context': '[CLS] program To develop and evaluate the effectiveness of an inter ##gene ##ration ##al health promotion program . This was an action research project . A total of 34 participants attended the 12 - week program and completed the pre - test and post - test . There were 16 middle - aged and nine older adults recruited from a district of [unused1] Taipei [unused2] , and nine young adults recruited from the principal investigator \\' s university . The \" At ##ti ##tudes toward A ##ging Scale \" and the \" Spiritual Health Scale \" were two assessment instruments used in the study . The results showed that there were significant improvements in the At ##ti ##tudes toward A ##ging Scale for the young adult group [SEP]',\n",
       "  'existing_cui': 'C0062316',\n",
       "  'existing_cui_name': 'hemoglobin G-Taipei',\n",
       "  'existing_cui_desc': '[CLS] hem ##og ##lo ##bin G - Taipei [unused3] ( Chemical , substance : H ##b 22 ( B ##4 ) , G ##lu - g ##ly ; hem ##og ##lo ##bin G Tai ##bei ; He ##mo ##g ##lo ##bin G - Taipei ; H ##b 22 ; H ##b G - Taipei ; H ##b G Tai ##bei ; Ha ##em ##og ##lo ##bin G - Taipei ; He ##mo ##g ##lo ##bin G Taipei ) [SEP]',\n",
       "  'our_bi_cui': 'C0039260',\n",
       "  'our_bi_cui_name': 'Taiwan',\n",
       "  'our_bi_cui_desc': '[CLS] Taiwan [unused3] ( Spa ##tial Concept , geographic location : T ##W ##N ; Form ##osa ; Republic of China ; republic of chin ##a ; T ##W ; T ##A ##I ##WA ##N ; form ##osa ; ta ##i ##wan ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '27669217.3',\n",
       "  'test_set_idx': 13654,\n",
       "  'type': 'T017',\n",
       "  'name': 'ermT',\n",
       "  'context': '[CLS] In ##du ##cible Express ##ion of both er ##m ##B and [unused1] er ##m ##T [unused2] Con ##ferred High Mac ##rol ##ide Resistance in St ##re ##pt ##oc ##oc ##cus gal ##lo ##ly ##ticus subsp . paste ##uria ##nus Is ##olate ##s in China St ##re ##pt ##oc ##oc ##cus gal ##lo ##ly ##ticus subsp . paste ##uria ##nus is an under - recognized path ##ogen and zoo ##not ##ic agent causing op ##port ##uni ##stic infections in humans . Despite increasing recognition of this subspecies as a cause for human infectious diseases , limited information is known about its anti ##biotic resistance mechanism . In this study , we aim to identify the molecular mechanism underlying the high mac ##rol ##ide resistance of six S [SEP]',\n",
       "  'existing_cui': 'C0732611',\n",
       "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
       "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
       "  'our_bi_cui': 'C1417123',\n",
       "  'our_bi_cui_name': 'MET gene',\n",
       "  'our_bi_cui_desc': '[CLS] ME ##T gene [unused3] ( Ana ##tom ##ical Structure : D ##F ##N ##B ##9 ##7 ; he ##pa ##to ##cy ##te growth factor receptor ; He ##pa ##to ##cy ##te Growth Factor Re ##ceptor Gene ; Act ##ivated He ##pa ##to ##cy ##te Growth Factor Re ##ceptor Gene ; RC ##CP ##2 ; ME ##T PR ##OT ##O ##ON ##CO ##GE ##NE ; H ##EP ##AT ##OC ##Y ##TE G ##RO ##W ##TH FA ##CT ##OR R ##EC ##EP ##TO ##R ; On ##co ##gene H ##G ##F ##R ; ME ##T Proto - On ##co ##gene , Re ##ceptor Ty ##ros ##ine Ki ##nas ##e Gene ; ME ##T pro ##to - on ##co ##gene , receptor t ##yr ##os ##ine kinase ; On [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27832198.61',\n",
       "  'test_set_idx': 18683,\n",
       "  'type': 'T017',\n",
       "  'name': 'Cam734',\n",
       "  'context': '[CLS] multiple anti ##mal ##aria ##l agents . These results were generated in the G ##C ##0 ##3 strain , used in multiple earlier P . f ##al ##ci ##par ##um ch ##lor ##o ##quin ##e resistance transport ##er studies , and might differ in natural is ##olate ##s harbor ##ing this all ##ele . Results presented here ##in show that [unused1] Cam ##7 ##34 [unused2] - mediated ch ##lor ##o ##quin ##e resistance is dependent on the rare A1 ##44 ##F mutation that has not been observed beyond Southeast Asia , and reveal distinct impacts of this and other Cam ##7 ##34 - specific mutations on ch ##lor ##o ##quin ##e resistance and parasite growth rates . B ##io ##chemical ass ##ays revealed a broad impact [SEP]',\n",
       "  'existing_cui': 'C0006675',\n",
       "  'existing_cui_name': 'Calcium',\n",
       "  'existing_cui_desc': '[CLS] Cal ##ci ##um [unused3] ( Chemical , medication , substance : Co ##agu ##lation factor IV - R ##ET ##IR ##ED - ; CO ##AG FA ##CT ##OR IV ; Co ##agu ##lation Factor IV ; B ##L ##O ##OD CO ##AG FA ##CT ##OR IV ; C ##a + + element ; factor i ##v ; calcium ; Blood Co ##agu ##lation Factor IV ; Cal ##ci ##um co ##agu ##lation factor ; Co ##agu ##lation factor IV ; calcium ##s ; Cal ##ci ##um [ Chemical / In ##g ##red ##ient ] ; C ##a - Cal ##ci ##um ; CA ##LC ##I ##UM ; Factor IV ; C ##a element ; Cal ##ci ##um anal ##yte ; Factor IV , Co ##agu ##lation [SEP]',\n",
       "  'our_bi_cui': 'C1708291',\n",
       "  'our_bi_cui_name': 'CDC73 gene',\n",
       "  'our_bi_cui_desc': '[CLS] CD ##C ##7 ##3 gene [unused3] ( Ana ##tom ##ical Structure : H ##Y ##RA ##X , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; cell division cycle 73 ; para ##fi ##bro ##min ; F ##I ##HP ; PA ##RA ##FI ##BR ##OM ##IN ; CD ##C ##7 ##3 Gene ; CE ##LL D ##I ##VI ##SI ##ON C ##Y ##CL ##E PR ##OT ##EI ##N 73 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; C ##1 ##OR ##F ##28 ; Cell Division Cycle 73 , Pa ##f ##1 / RNA Pol ##yme ##rase II Complex Co ##mpo ##nent , Ho ##mo ##log ( S . c ##ere ##vis ##iae [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '28249376.18',\n",
       "  'test_set_idx': 29888,\n",
       "  'type': 'T033',\n",
       "  'name': 'digestibility',\n",
       "  'context': '[CLS] ##n micro ##bial populations in sheep fed a 50 : 50 al ##fa ##lf ##a hay : concentrate diet An experiment was conducted to investigate the effects of a specific mixture of essential oils , containing thy ##me , c ##love and c ##innamon E ##O , on r ##ume ##n micro ##bial f ##er ##mentation , nut ##rient apparent [unused1] dig ##est ##ibility [unused2] and blood meta ##bol ##ites in fist ##ulated sheep . Six sheep fitted with r ##umi ##nal fist ##ula ##s were used in a repeated measurement design with two 24 - d periods to investigate the effect of adding mixture of essential oils at 0 ( control ) , 0 . 8 , and 1 . 6 m ##L / d [SEP]',\n",
       "  'existing_cui': 'C0233423',\n",
       "  'existing_cui_name': 'Suggestibility',\n",
       "  'existing_cui_desc': '[CLS] Su ##gg ##est ##ibility [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : suggest ##ibility ; Su ##gg ##est ##ibility , function ) [SEP]',\n",
       "  'our_bi_cui': 'C0012238',\n",
       "  'our_bi_cui_name': 'Digestion',\n",
       "  'our_bi_cui_desc': '[CLS] Digest ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : dig ##estive system functions ; dig ##est ##ion ; Digest ##ive system functions ; dig ##est ##ions ; Digest ##ive system function ; Fun ##ctions of the dig ##estive system ; Digest ##ive ; Digest ##ive tract function ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28179911.81',\n",
       "  'test_set_idx': 27675,\n",
       "  'type': 'T204',\n",
       "  'name': 'T2',\n",
       "  'context': '[CLS] ##us T ##2 trans ##genic rice lines ( G ##5 and G ##2 ) , different Co ##WR ##I ##1 expression levels were detected , but no Co ##WR ##I ##1 trans ##cripts were detected in the wild type . Ana ##ly ##ses of the seed oil content , star ##ch content , and total protein content indicated that the two [unused1] T ##2 [unused2] trans ##genic lines showed a significant increase ( P < 0 . 05 ) in seed oil content . The trans ##genic lines also showed a significant increase in star ##ch content , whereas total protein content decreased significantly . Further analysis of the fatty acid composition revealed that palm ##itic acid ( C ##16 : 0 ) and l ##ino [SEP]',\n",
       "  'existing_cui': 'C1335834',\n",
       "  'existing_cui_name': 'SLC25A5 gene',\n",
       "  'existing_cui_desc': '[CLS] SL ##C ##25 ##A ##5 gene [unused3] ( Ana ##tom ##ical Structure : AD ##P / ATP T ##RA ##NS ##L ##OC ##AS ##E 2 ; 2 ##F ##1 ; Sol ##ute Carrier Family 25 ( Mi ##to ##cho ##nd ##rial Carrier ; Aden ##ine N ##uc ##leo ##tide Trans ##loc ##ator ) , Member 5 Gene ; AD ##EN ##IN ##E N ##UC ##LE ##OT ##ID ##E T ##RA ##NS ##L ##OC ##AT ##OR 2 ; SL ##C ##25 ##A ##5 Gene ; AD ##P / ATP CA ##R ##RI ##ER 2 ; so ##lut ##e carrier family 25 member 5 ; AD ##P / ATP T ##RA ##NS ##L ##OC ##AT ##OR OF F ##IB ##RO ##BL ##AS ##TS ; S ##OL ##UT ##E [SEP]',\n",
       "  'our_bi_cui': 'C0282641',\n",
       "  'our_bi_cui_name': 'Transgenes',\n",
       "  'our_bi_cui_desc': '[CLS] Trans ##gene ##s [unused3] ( Ana ##tom ##ical Structure : trans ##gene ; Trans ##gene ) [SEP]',\n",
       "  'our_cross_cui': 'C0085245',\n",
       "  'our_cross_cui_name': 'Plants , Transgenic',\n",
       "  'our_cross_cui_desc': '[CLS] Plants , Trans ##genic [unused3] ( E ##uka ##ryo ##te : Trans ##genic Plants ; Trans ##genic Plant ; trans ##genic plant ; trans ##genic plants ; Plant , Trans ##genic ; plant trans ##genic ; Trans ##genic plants ) [SEP]'},\n",
       " {'mention_id': '28424683.56',\n",
       "  'test_set_idx': 35434,\n",
       "  'type': 'T038',\n",
       "  'name': 'expanding',\n",
       "  'context': '[CLS] ##itic cells in contrast to O ##Cs are found to promote faster expansion of residual T cells within pu ##rified Natural killer cells resulting in the decline in Natural killer cell numbers from healthy individuals . Ad ##dition of anti - CD ##3 m ##A ##b in ##hibit ##s T cell proliferation while enhancing Natural killer cell expansion ; however , [unused1] expanding [unused2] Natural killer cells have lower c ##yt ##oto ##xi ##city but higher secret ##ion of IF ##N - γ . Ex ##pan ##sion and functional activation of super - charged Natural killer cells by O ##Cs is dependent on inter ##le ##uki ##n ( inter ##le ##uki ##n ) - 12 and IL - 15 . Thus , in this report , [SEP]',\n",
       "  'existing_cui': 'C0205229',\n",
       "  'existing_cui_name': 'Expanding',\n",
       "  'existing_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
       "  'our_bi_cui': 'C0205229',\n",
       "  'our_bi_cui_name': 'Expanding',\n",
       "  'our_bi_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
       "  'our_cross_cui': 'C0007595',\n",
       "  'our_cross_cui_name': 'cell growth',\n",
       "  'our_cross_cui_desc': '[CLS] cell growth [unused3] ( B ##iol ##og ##ic Fun ##ction : cell expansion ; cellular growth ; Cell ##s - - Growth ; Cell Growth ; cell growth ##s ; cells growth ; growth cell ; growth of cell ; Cell ##ular Growth ; Cell ##ular Ex ##pan ##sion ) [SEP]'},\n",
       " {'mention_id': '27500205.30',\n",
       "  'test_set_idx': 8462,\n",
       "  'type': 'T103',\n",
       "  'name': 'kindlins',\n",
       "  'context': '[CLS] ##of ##orms and the levels of kind ##lins . Great interest in the kind ##lins has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of [unused1] kind ##lins [unused2] have clearly established that they regulate the capacity of in ##te ##g ##rin ##s to media ##te their functions . Kind ##lins are adapt ##or proteins ; their function em ##ana ##te from their interaction with binding partners , including the c ##yt ##op ##las ##mic tails of in ##te ##g ##rin ##s and components of the act ##in c ##yt [SEP]',\n",
       "  'existing_cui': 'C1720776',\n",
       "  'existing_cui_name': 'Kindling , Neurologic',\n",
       "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
       "  'our_bi_cui': 'C0010422',\n",
       "  'our_bi_cui_name': 'Crystallins',\n",
       "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27476541.71',\n",
       "  'test_set_idx': 7580,\n",
       "  'type': 'T103',\n",
       "  'name': 'NADPH oxidase inhibitor drug',\n",
       "  'context': '[CLS] 4 ) and consequently reactive oxygen species and ma ##lon ##dial ##de ##hy ##de levels were elevated in high glucose - treated PC ##12 cells . At ##or ##vas ##tat ##in could significantly decrease high glucose - induced NO ##X ##s , reactive oxygen species and ma ##lon ##dial ##de ##hy ##de elevation and improve impaired cell via ##bility . It can be concluded that high glucose could el ##eva ##te NO ##X ##s activity , reactive oxygen species and ma ##lon ##dial ##de ##hy ##de levels in neural tissues and At ##or ##vas ##tat ##in as a small molecule [unused1] N ##AD ##P ##H o ##xi ##das ##e inhibitor drug [unused2] may prevent and delay di ##abe ##tic complications , particularly ne ##uro ##pathy . [SEP]',\n",
       "  'existing_cui': 'C1151146',\n",
       "  'existing_cui_name': 'NADPH oxidase activity',\n",
       "  'existing_cui_desc': '[CLS] N ##AD ##P ##H o ##xi ##das ##e activity [unused3] ( B ##iol ##og ##ic Fun ##ction : N ##AD ( P ) H : oxygen o ##xi ##dor ##ed ##uc ##tase activity ; N ##AD ( P ) H o ##xi ##das ##e activity ; N ##AD ##P ##H o ##xi ##das ##e ) [SEP]',\n",
       "  'our_bi_cui': 'C0026457',\n",
       "  'our_bi_cui_name': 'Monoamine Oxidase Inhibitors',\n",
       "  'our_bi_cui_desc': '[CLS] Mon ##oam ##ine O ##xi ##das ##e In ##hibit ##ors [unused3] ( Chemical , MA ##O ##I , medication , product , substance : MA ##O In ##hibit ##ors ; M ##ON ##OA ##MI ##NE O ##X ##ID ##AS ##E IN ##H ##IB ; Mon ##oam ##ine o ##xi ##das ##e - - In ##hibit ##ors ; inhibitor ##s ma ##o ; am ##ine o ##xi ##das ##e inhibitor ##s ; In ##hibit ##or , Mon ##oam ##ine O ##xi ##das ##e ; Mon ##oam ##ine o ##xi ##das ##e inhibitor ##s ; In ##hibit ##ors , MA ##O ; Mon ##oam ##ine O ##xi ##das ##e In ##hibit ##or ; inhibitor mon ##oam ##ine o ##xi ##das ##e ; inhibitor ##s mon ##oam ##ine o [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27617108.15',\n",
       "  'test_set_idx': 11917,\n",
       "  'type': 'T062',\n",
       "  'name': 'RCT',\n",
       "  'context': '[CLS] adult women and can negatively influence reproductive health t ##raj ##ector ##ies . Few random ##ized controlled trials have focused on strategies to improve out ##patient ad ##herence or to reduce reproductive m ##or ##bid ##ity in this population . This paper describes the research methods and preliminary effectiveness of recruitment , retention , and intervention strategies employed in a novel [unused1] RC ##T [unused2] designed to test a technology - enhanced community - health nursing intervention among urban and young adult with P ##el ##vic inflammatory disease . and young adult women aged 13 - 25 years were recruited during acute P ##el ##vic inflammatory disease visits in out ##patient clinics and emergency departments to participate in this I ##RB - approved trial . Part [SEP]',\n",
       "  'existing_cui': 'C0281508',\n",
       "  'existing_cui_name': 'Desmoplastic Small Round Cell Tumor',\n",
       "  'existing_cui_desc': '[CLS] Des ##mo ##p ##lastic Small Round Cell Tu ##mor [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : Des ##mo ##p ##lastic small round cell t ##umour ; Des ##mo ##p ##lastic Small - Cell Tu ##mor ##s ; Des ##mo ##p ##lastic Small Cell Tu ##mor ; Des ##mo ##p ##lastic Small Round - Cell Tu ##mor ; Pol ##y ##phe ##not ##y ##pic Small Round Cell Tu ##mor ; Tu ##mor , Des ##mo ##p ##lastic Small - Cell ; des ##mo ##p ##lastic small round cell tumor ; Small - Cell Tu ##mor ##s , Des ##mo ##p ##lastic ; Des ##mo ##p ##las . small round cell tumor ; Small - Cell Tu ##mor [SEP]',\n",
       "  'our_bi_cui': 'C0206034',\n",
       "  'our_bi_cui_name': 'Clinical Trials , Randomized',\n",
       "  'our_bi_cui_desc': '[CLS] Clinical Trials , Random ##ized [unused3] ( Research Act ##ivity : random ##ized clinical trials ; Random ##ized Clinical Trials ; clinical random ##ize trials ; random ##ized clinical trial ; T ##RI ##AL ##S RA ##ND ##OM ##I ##Z ##ED C ##L ##IN ; clinical random ##ized trials ; C ##L ##IN T ##RI ##AL ##S RA ##ND ##OM ##I ##Z ##ED ; Trials , Random ##ized Clinical ; Random ##ized Clinical Trial ) [SEP]',\n",
       "  'our_cross_cui': 'C0206035',\n",
       "  'our_cross_cui_name': 'Controlled Clinical Trials , Randomized',\n",
       "  'our_cross_cui_desc': '[CLS] Control ##led Clinical Trials , Random ##ized [unused3] ( Research Act ##ivity : CO ##NT ##RO ##LL ##ED C ##L ##IN T ##RI ##AL ##S RA ##ND ##OM ##I ##Z ##ED ; Random ##ized Control ##led Clinical Trial ) [SEP]'},\n",
       " {'mention_id': '28243201.63',\n",
       "  'test_set_idx': 29705,\n",
       "  'type': 'T017',\n",
       "  'name': 'CCNEI',\n",
       "  'context': \"[CLS] h ##yper ##met ##hyl ##ated cell lines S ##W ##48 . In conclusion , we found the evidence of five potentially biological ##ly important genes in re ##current CR ##Cs that could possibly serve as a new potential therapeutic targets for patients with ch ##em ##ores ##istan ##ce . We post ##ulate that a ##ber ##rant met ##hyl ##ation of [unused1] CC ##NE ##I [unused2] , CC ##ND ##B ##P ##1 , P ##ON ##3 , DD ##X ##43 , and CH ##L ##1 in color ##ec ##tal cancer might be associated with the re ##cu ##rrence of color ##ec ##tal cancer and 5 - a ##za - 2 ' - de ##ox ##y ##cy ##ti ##dine - mediated restoration of 5 - F ##lu ##oro [SEP]\",\n",
       "  'existing_cui': 'C1332697',\n",
       "  'existing_cui_name': 'CCNE1 gene',\n",
       "  'existing_cui_desc': '[CLS] CC ##NE ##1 gene [unused3] ( Ana ##tom ##ical Structure : CC ##NE ##1 Gene ; c ##y ##c ##lin E ##1 ; C ##Y ##CL ##IN E ; c ##y ##c ##lin E ##t ; C ##Y ##CL ##IN E ##1 ; Cy ##c ##lin E ##1 Gene ; c ##y ##c ##lin E ##s ) [SEP]',\n",
       "  'our_bi_cui': 'C1413182',\n",
       "  'our_bi_cui_name': 'CCNI gene',\n",
       "  'our_bi_cui_desc': '[CLS] CC ##NI gene [unused3] ( Ana ##tom ##ical Structure : CC ##NI ##1 ; c ##y ##c ##lin I ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27583176.8',\n",
       "  'test_set_idx': 10705,\n",
       "  'type': 'T170',\n",
       "  'name': 'outcome grading scoring systems',\n",
       "  'context': '[CLS] outcome assessment is mandatory for op ##ti ##mizing therapeutic efforts . We retrospective ##ly analyzed data from 34 ##2 patients with spontaneous primary In ##tra ##cer ##eb ##ral hem ##or ##r ##hage to evaluate possible predict ##ors of 30 - day mortality considering clinical , radio ##logical , and therapeutic ##al parameters . We also applied three widely accepted [unused1] outcome g ##rading scoring systems [unused2] [ ( In ##tra ##cer ##eb ##ral hem ##or ##r ##hage score , F ##UN ##C score and in ##tra ##cer ##eb ##ral hem ##or ##r ##hage g ##rading scale ] on our population to evaluate the correlation of these scores with the 30 - day mortality in our study . We also applied three widely accepted outcome g ##rading [SEP]',\n",
       "  'existing_cui': 'C1273712',\n",
       "  'existing_cui_name': 'Grading system used',\n",
       "  'existing_cui_desc': '[CLS] G ##rading system used [unused3] ( Health Care Act ##ivity , o ##bs ##er ##vable entity : g ##rading system ) [SEP]',\n",
       "  'our_bi_cui': 'C1708250',\n",
       "  'our_bi_cui_name': 'Tumor Grading System',\n",
       "  'our_bi_cui_desc': '[CLS] Tu ##mor G ##rading System [unused3] ( Intel ##lect ##ual Product : G ##rading system ; G ##rading System ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28188533.1',\n",
       "  'test_set_idx': 27846,\n",
       "  'type': 'T170',\n",
       "  'name': 'SWATH ( ® )',\n",
       "  'context': '[CLS] Generation of High - Quality [unused1] S ##WA ##TH ( ® ) [unused2] A ##c ##quisition Data for Label - free Q ##uant ##itative Pro ##te ##omi ##cs Studies Using Triple ##TO ##F ( ® ) Mass S ##pect ##rome ##ters Data - independent acquisition is a powerful mass s ##pect ##rome ##try technique that enables comprehensive MS and MS / MS analysis of all detect ##able species , providing an information rich data file that can be mined deeply . Here , we describe how to acquire high - quality S ##WA ##TH ( ® ) A ##c ##quisition data to be used for large quantitative pro ##te ##omi ##c studies . We specifically focus on using variable sized Q ##1 windows for acquisition of [SEP]',\n",
       "  'existing_cui': 'C1416521',\n",
       "  'existing_cui_name': 'ITSN2 gene',\n",
       "  'existing_cui_desc': '[CLS] IT ##SN ##2 gene [unused3] ( Ana ##tom ##ical Structure : PR ##O ##20 ##15 ; SH ##3 domain protein 1 ##B ; inter ##sect ##in 2 ; SH ##3 ##P ##18 ; IN ##TE ##RS ##EC ##TI ##N 2 ; SH ##3 ##P ##18 - like WA ##SP associated protein ; SH ##3 D ##OM ##A ##IN PR ##OT ##EI ##N 1 ##B ; K ##IA ##A ##12 ##5 ##6 ) [SEP]',\n",
       "  'our_bi_cui': 'C0025080',\n",
       "  'our_bi_cui_name': 'Medical Devices',\n",
       "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28438542.29',\n",
       "  'test_set_idx': 36020,\n",
       "  'type': 'T103',\n",
       "  'name': 'inhibitors',\n",
       "  'context': '[CLS] showed that compounds 5 ##b and 5 ##f , with 2 - ch ##lor ##o and 4 - flu ##oro substitution ##s , showed bio ##chemical activities in micro ##mo ##lar and sub ##mic ##rom ##olar range ( I ##C ##50 1 . 34 - 5 . 03 μ ##M ) against both the targeted enzymes . The structure - activity relationship el ##uc ##idated for these novel [unused1] inhibitor ##s [unused2] against both the enzymes provide new insight into the binding mode of the inhibitor ##s to the active sites of enzymes . The positive results of the bio ##chemical ass ##ay suggest that these compounds may be further op ##ti ##mized and utilized for the treatment of di ##abe ##tic re ##tino ##pathy . [SEP]',\n",
       "  'existing_cui': 'C0243077',\n",
       "  'existing_cui_name': 'inhibitors',\n",
       "  'existing_cui_desc': '[CLS] inhibitor ##s [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0243077',\n",
       "  'our_bi_cui_name': 'inhibitors',\n",
       "  'our_bi_cui_desc': '[CLS] inhibitor ##s [unused3] ( Chemical ) [SEP]',\n",
       "  'our_cross_cui': 'C0014432',\n",
       "  'our_cross_cui_name': 'Enzyme Inhibitors',\n",
       "  'our_cross_cui_desc': '[CLS] En ##zy ##me In ##hibit ##ors [unused3] ( Chemical , product , substance : E ##N ##Z ##Y ##ME IN ##H ##IB ; enzyme inhibitor ; enzyme inhibitor ##s ; En ##zy ##me inhibitor ##s ; In ##hibit ##ors , En ##zy ##me ; enzymes inhibitor ##s ; En ##zy ##me inhibitor ) [SEP]'},\n",
       " {'mention_id': '28077286.28',\n",
       "  'test_set_idx': 25078,\n",
       "  'type': 'T103',\n",
       "  'name': 'MeHg',\n",
       "  'context': '[CLS] ##quent behavioral alterations in adult birds have not received much attention . Moreover , pass ##eri ##ne birds are poorly represented in Me ##H ##g ne ##uro ##to ##xi ##cology studies in comparison to other a ##vian orders . Hence in this study , we used the egg injection method to investigate the long term effects of in o ##vo [unused1] Me ##H ##g [unused2] exposure on brain his ##top ##ath ##ology and courts ##hip behavior in a model song ##bird species , the z ##eb ##ra fin ##ch ( Ta ##eni ##opy ##gia gut ##tata ) . Egg treatment groups included : a low Me ##H ##g dose of 0 . 2 μ ##g H ##g g ( - 1 ) egg , a high [SEP]',\n",
       "  'existing_cui': 'C0228520',\n",
       "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
       "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
       "  'our_bi_cui': 'C0025424',\n",
       "  'our_bi_cui_name': 'Mercury',\n",
       "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
       "  'our_cross_cui': 'C0025794',\n",
       "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
       "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
       " {'mention_id': '27826436.38',\n",
       "  'test_set_idx': 18368,\n",
       "  'type': 'T204',\n",
       "  'name': 'cultivars',\n",
       "  'context': '[CLS] c ##v . To ##chi ##oto ##me . To ##chi ##oto ##me and Sa ##chin ##oka showed higher content of l ##inal ##ool and ( E ) - ne ##rol ##ido ##l . Sa ##chin ##oka showed the highest content of total sugar ##s and total acids . G ##ui ##mei ##ren showed higher sweetness index than the other three [unused1] cult ##iva ##rs [unused2] . Fi ##rm ##ness of To ##chi ##oto ##me was highest among all the varieties . The highest total soluble solid ##s T ##SS value was found in c ##v . Sa ##chin ##oka , followed by the G ##ui ##mei ##ren and To ##chi ##oto ##me varieties . Sa ##chin ##oka had the highest t ##it ##rata ##ble acid ##ity [SEP]',\n",
       "  'existing_cui': 'C3385047',\n",
       "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
       "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
       "  'our_bi_cui': 'C0242775',\n",
       "  'our_bi_cui_name': 'Agricultural Crops',\n",
       "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
       "  'our_cross_cui': 'C0032098',\n",
       "  'our_cross_cui_name': 'Plants',\n",
       "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
       " {'mention_id': '28319502.3',\n",
       "  'test_set_idx': 31859,\n",
       "  'type': 'T038',\n",
       "  'name': 'RS3PE',\n",
       "  'context': '[CLS] Re ##mit ##ting Ser ##one ##gat ##ive S ##ym ##metric ##al S ##yn ##ov ##itis With Pitt ##ing Ed ##ema : Appearance on F ##D ##G P ##ET / CT Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema ( [unused1] RS ##3 ##P ##E [unused2] ) is a rare condition in the elderly and can appear as a first presentation of various types of r ##he ##umatic and ma ##li ##gnant diseases . We presented a 62 - year - old man with the diagnosis of RS ##3 ##P ##E based on the clinical sign and laboratory data . Because of the possibility of associated ma ##li ##gna ##ncies in RS ##3 ##P ##E , F ##D [SEP]',\n",
       "  'existing_cui': 'C3147672',\n",
       "  'existing_cui_name': 'IRS3P gene',\n",
       "  'existing_cui_desc': '[CLS] I ##RS ##3 ##P gene [unused3] ( Ana ##tom ##ical Structure : insulin receptor substrate 3 , pseudo ##gene ) [SEP]',\n",
       "  'our_bi_cui': 'C1696153',\n",
       "  'our_bi_cui_name': 'Remitting seronegative symmetrical synovitis with pitting oedema syndrome',\n",
       "  'our_bi_cui_desc': '[CLS] Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma syndrome [unused3] ( B ##iol ##og ##ic Fun ##ction : Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema syndrome ; RS ##3 ##P ##E syndrome ) [SEP]',\n",
       "  'our_cross_cui': 'C2919482',\n",
       "  'our_cross_cui_name': 'Remitting seronegative symmetrical synovitis with pitting edema',\n",
       "  'our_cross_cui_desc': '[CLS] Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Re ##lap ##sing se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema ; Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; RS ##3 ##P ##E - Re ##mit ##ting se ##rone ##gat ##ive symmetric s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; Re ##lap ##sing se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; RS ##3 ##P ##E - Re ##mit ##ting se ##rone ##gat ##ive symmetric s ##yn ##ov ##itis with [SEP]'},\n",
       " {'mention_id': '27379139.74',\n",
       "  'test_set_idx': 4240,\n",
       "  'type': 'T103',\n",
       "  'name': 'TCA',\n",
       "  'context': '[CLS] ranging from - 0 . 02 ##6 to - 0 . 48 ##7 . For all three methods , we were able to obtain high - quality protein samples and good 2D ##E maps for the maize leaf mid ##ri ##b . However , p ##hen ##ol extraction produced a better 2D ##E map with greater resolution between spots , and [unused1] T ##CA [unused2] / ace ##tone extraction produced higher protein yields . Thus , this paper includes a discussion regarding the possible reasons for differential protein extraction among the three methods . This study provides useful information that can be used to select suitable protein extraction methods for the pro ##te ##ome analysis of re ##cal ##ci ##tra ##nt plant tissues that are rich [SEP]',\n",
       "  'existing_cui': 'C0085758',\n",
       "  'existing_cui_name': 'Aganglionosis , Colonic',\n",
       "  'existing_cui_desc': '[CLS] A ##gan ##gli ##ono ##sis , Col ##onic [unused3] ( Ana ##tom ##ical Structure , disorder : A ##gan ##gli ##ono ##sis of co ##lon ; T ##CA - Total co ##lon ##ic a ##gan ##gli ##ono ##sis ; Total co ##lon ##ic a ##gan ##gli ##ono ##sis ; Col ##onic A ##gan ##gli ##ono ##sis ; Total Col ##onic A ##gan ##gli ##ono ##sis ; A ##gan ##gli ##ono ##sis , Total Col ##onic ) [SEP]',\n",
       "  'our_bi_cui': 'C0045236',\n",
       "  'our_bi_cui_name': \"2,2 ' ,2 '' - trichlorotriethylamine\",\n",
       "  'our_bi_cui_desc': \"[CLS] 2 , 2 ' , 2 ' ' - t ##rich ##lor ##ot ##rie ##thy ##lam ##ine [unused3] ( Chemical : t ##ris ( 2 - ch ##lor ##oe ##thy ##l ) am ##ine ; Tri ##mus ##tine ; Tri ##s ( beta - ch ##lor ##oe ##thy ##l ) am ##ine ; Tri ##s ( 2 - ch ##lor ##oe ##thy ##l ) am ##ine ; Tri ##ch ##lor ##met ##hine ; 2 - ch ##lor ##o - N , N - bi ##s ( 2 - ch ##lor ##oe ##thy ##l ) et ##hana ##mine ; 2 , 2 ' , 2 ' ' - t ##rich ##lor ##oe ##thy ##lam ##ine ; t ##rich ##lor ##ot ##rie ##thy ##lam ##ine ; t ##ris [SEP]\",\n",
       "  'our_cross_cui': 'C0040900',\n",
       "  'our_cross_cui_name': 'Trichloroacetic Acid',\n",
       "  'our_cross_cui_desc': '[CLS] Tri ##ch ##lor ##oa ##ce ##tic A ##cid [unused3] ( Chemical , medication , product , substance : Tri ##ch ##lor ##oa ##ce ##tic A ##cid [ Chemical / In ##g ##red ##ient ] ; T ##CA - Tri ##ch ##lor ##oa ##ce ##tic acid ; Tri ##ch ##lor ##oa ##ce ##tic acid ; A ##cid ##e t ##rich ##lora ##ce ##ti ##que ; T ##RI ##CH ##L ##OR ##OA ##CE ##TI ##C AC ##ID ; Ace ##tic acid , t ##rich ##lor ##o - ; acid t ##rich ##lor ##oa ##ce ##tic ; t ##rich ##lor ##oa ##ce ##tic acid ; T ##CA ##A - Tri ##ch ##lor ##oa ##ce ##tic acid ; A ##cid , Tri ##ch ##lor ##oa ##ce ##tic ; t ##rich [SEP]'},\n",
       " {'mention_id': '28387835.48',\n",
       "  'test_set_idx': 33984,\n",
       "  'type': 'T058',\n",
       "  'name': 'MLVA',\n",
       "  'context': '[CLS] significantly more IL - 1 ##β , T ##NF - α and IL - 22 than the is ##olate ##s from goats , sheep or chronic Q fever patients . Co ##mp ##aring the c ##yt ##oki ##ne induction of the is ##olate ##s based on their MV ##LA g ##eno ##type did not reveal differences in response between the [unused1] M ##L ##VA [unused2] g ##eno ##type ##s . The pro ##in ##f ##lam ##mat ##ory c ##yt ##oki ##ne response induced in human peripheral blood mon ##on ##uc ##lea ##r cells by C . burn ##eti ##i is ##olate ##s from cattle may explain the low incidence of human Q fever outbreak ##s caused by cattle . The c ##yt ##oki ##ne profile of [SEP]',\n",
       "  'existing_cui': 'C1420126',\n",
       "  'existing_cui_name': 'SLC20A2 gene',\n",
       "  'existing_cui_desc': '[CLS] SL ##C ##20 ##A ##2 gene [unused3] ( Ana ##tom ##ical Structure : S ##OL ##UT ##E CA ##R ##RI ##ER FA ##MI ##L ##Y 20 ( P ##H ##OS ##P ##HA ##TE T ##RA ##NS ##PO ##RT ##ER ) , ME ##MB ##ER 2 ; G ##IB ##BO ##N AP ##E L ##E ##U ##KE ##MI ##A R ##ET ##RO ##VI ##R ##US R ##EC ##EP ##TO ##R 2 ; G ##l ##v ##r - 2 ; P ##H ##OS ##P ##HA ##TE T ##RA ##NS ##PO ##RT ##ER , S ##OD ##I ##UM - DE ##P ##EN ##DE ##NT , 2 ; Pi ##T - 2 ; M ##UR ##IN ##E L ##E ##U ##KE ##MI ##A VI ##R ##US , AM ##P ##H [SEP]',\n",
       "  'our_bi_cui': 'C0023509',\n",
       "  'our_bi_cui_name': 'Lymphocyte Culture Test , Mixed',\n",
       "  'our_bi_cui_desc': '[CLS] L ##ymph ##oc ##yte Culture Test , Mixed [unused3] ( Health Care Act ##ivity , M ##LC , procedure : Mixed Le ##uk ##oc ##yte Re ##actions ; Mixed Le ##uk ##oc ##yte Re ##action ; mixed l ##ymph ##oc ##yte reaction test ; Mixed l ##ymph ##oc ##yte culture ass ##ay ; Le ##uk ##oc ##yte Re ##action , Mixed ; M ##LR test ; mixed le ##uk ##oc ##yte reaction ; Mixed L ##ymph ##oc ##yte Culture Test ; L ##ymph ##oc ##yte Re ##action , Mixed ; Mixed l ##ymph ##oc ##yte culture ; All ##ogen ##ei ##c mixed l ##ymph ##oc ##yte ass ##ay ; Le ##uk ##oc ##yte Re ##actions , Mixed ; Mixed l ##ymph ##oc ##yte reaction ; Mixed [SEP]',\n",
       "  'our_cross_cui': 'C1443925',\n",
       "  'our_cross_cui_name': 'Multi-locus variable-number of tandem repeat analysis',\n",
       "  'our_cross_cui_desc': '[CLS] Multi - lo ##cus variable - number of tandem repeat analysis [unused3] ( Health Care Act ##ivity , procedure : Multi - lo ##cus V ##NT ##R analysis ; M ##L ##VA - multi - lo ##cus variable - number of tandem repeat analysis ) [SEP]'},\n",
       " {'mention_id': '27669217.22',\n",
       "  'test_set_idx': 13673,\n",
       "  'type': 'T033',\n",
       "  'name': 'MIC',\n",
       "  'context': '[CLS] to identify the molecular mechanism underlying the high mac ##rol ##ide resistance of six S . gal ##lo ##ly ##ticus subsp . paste ##uria ##nus is ##olate ##s from dead duck ##lings collected in several natural outbreak ##s in China during 2010 - 2013 . All is ##olate ##s exhibited multi - drug resistance including high mac ##rol ##ide resistance ( [unused1] MI ##C [unused2] ≥ 102 ##4 mg / L for er ##yt ##hr ##omy ##cin , and 512 mg / L for c ##lar ##ith ##rom ##y ##cin ) . E ##ff ##lux - encoding me ##f ##A and me ##f ##E genes were not detect ##able in these is ##olate ##s . The presence of 23 ##S r ##RNA mutations in specific is [SEP]',\n",
       "  'existing_cui': 'C2732473',\n",
       "  'existing_cui_name': 'Ductal Carcinoma In Situ with Microinvasion',\n",
       "  'existing_cui_desc': '[CLS] Du ##ct ##al Car ##cin ##oma In Sit ##u with Micro ##in ##vas ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : Micro ##in ##vasive B ##rea ##st Car ##cin ##oma ; MI ##C ; Du ##ct ##al car ##cin ##oma in sit ##u with micro ##in ##vas ##ion ) [SEP]',\n",
       "  'our_bi_cui': 'C0427978',\n",
       "  'our_bi_cui_name': 'Minimum Inhibitory Concentration measurement',\n",
       "  'our_bi_cui_desc': '[CLS] Mini ##mum In ##hibit ##ory Con ##cent ##ration measurement [unused3] ( Health Care Act ##ivity , MI ##C , procedure , qualifier value : Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test ; Con ##cent ##rations , Mini ##mum In ##hibit ##ory ; Anti ##biotic sensitivity , minimum inhibitor ##y concentration ; MI ##C su ##s ##ce ##pt ##ibility test ; Mini ##mum In ##hibit ##ory Con ##cent ##rations ; MI ##C - Mini ##mum inhibitor ##y concentration ; Con ##cent ##ration , Mini ##mum In ##hibit ##ory ; Mini ##mum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test technique ; In ##hibit ##ory Con ##cent ##rations , Mini ##mum ; Mini ##mum In ##hibit ##ory [SEP]',\n",
       "  'our_cross_cui': 'C1304747',\n",
       "  'our_cross_cui_name': 'Minimum inhibitory concentration result',\n",
       "  'our_cross_cui_desc': '[CLS] Mini ##mum inhibitor ##y concentration result [unused3] ( Finding , finding : minimum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration finding ) [SEP]'},\n",
       " {'mention_id': '27563025.29',\n",
       "  'test_set_idx': 10410,\n",
       "  'type': 'T017',\n",
       "  'name': 'C2C12 cells',\n",
       "  'context': '[CLS] and inter ##connected p ##ore na ##note ##x ##tures with na ##no ##met ##re - scale na ##no ##fi ##bres . To estimate the bio ##com ##pa ##ti ##bility of the 3D p ##oly ##cap ##rol ##act ##one / p ##oly ##ani ##line composite na ##no ##fi ##bre mac ##ros ##truct ##ures , mouse my ##ob ##last ##s ( [unused1] C ##2 ##C ##12 cells [unused2] ) were culture ##d as model cells . The initial responses of C ##2 ##C ##12 cells to the 3D p ##oly ##cap ##rol ##act ##one / p ##oly ##ani ##line composite mac ##ros ##truct ##ures were significantly superior to those to pure p ##oly ##cap ##rol ##act ##one , that is , the cells exhibited typical my ##ob ##last [SEP]',\n",
       "  'existing_cui': 'C0085262',\n",
       "  'existing_cui_name': 'PC12 Cells',\n",
       "  'existing_cui_desc': '[CLS] PC ##12 Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell Line , Ph ##eo ##ch ##rom ##oc ##yt ##oma ; Ph ##eo ##ch ##rom ##oc ##yt ##oma Cell Lines ; Ph ##eo ##ch ##rom ##oc ##yt ##oma 12 Cell Line ; PC A 01 ##2 CE ##LL ##S ; p ##he ##och ##rom ##oc ##yt ##oma 12 cell line ; PC - 12 ; p ##c ##12 cell ; PC ##12 Cell ; Ph ##eo ##ch ##rom ##oc ##yt ##oma Cell Line ; Cell Lines , Ph ##eo ##ch ##rom ##oc ##yt ##oma ; PC ##12 cell ; p ##c ##12 cells ) [SEP]',\n",
       "  'our_bi_cui': 'C1135917',\n",
       "  'our_bi_cui_name': 'Myoblasts , Cardiac',\n",
       "  'our_bi_cui_desc': '[CLS] My ##ob ##last ##s , Card ##iac [unused3] ( Ana ##tom ##ical Structure : cardiac my ##ob ##last ##s ; My ##ob ##last , Card ##iac ; cardiac my ##ob ##last ; Card ##iac my ##ob ##last ; Card ##iac My ##ob ##last ##s ; Card ##iac My ##ob ##last ) [SEP]',\n",
       "  'our_cross_cui': 'C0596995',\n",
       "  'our_cross_cui_name': 'Myoblasts',\n",
       "  'our_cross_cui_desc': '[CLS] My ##ob ##last ##s [unused3] ( Ana ##tom ##ical Structure : Mu ##s ##cle Cell ##s , Em ##b ##ryo ##nic ; My ##ob ##last ; Mu ##s ##cle Cell , Em ##b ##ryo ##nic ; Pre ##cu ##rs ##or Mu ##s ##cle Cell ##s ; Mu ##s ##cle Cell , Pre ##cu ##rs ##or ; my ##ob ##last ; Em ##b ##ryo ##nic Mu ##s ##cle Cell ##s ; my ##ob ##last ##s ; Pre ##cu ##rs ##or Mu ##s ##cle Cell ; Em ##b ##ryo ##nic Mu ##s ##cle Cell ; Mu ##s ##cle Cell ##s , Pre ##cu ##rs ##or ) [SEP]'},\n",
       " {'mention_id': '27838742.76',\n",
       "  'test_set_idx': 19043,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . [unused1] Del ##ica ##f ##lav ##one [unused2] may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28197133.38',\n",
       "  'test_set_idx': 28054,\n",
       "  'type': 'T103',\n",
       "  'name': 'GH3',\n",
       "  'context': '[CLS] p ##hos ##ph ##ory ##lase ) , G ##H1 ##3 ( am ##yla ##se ) , G ##H ##43 and G ##H1 ##0 ( hem ##ice ##ll ##ula ##ses ) , G ##H ##9 and G ##H ##48 ( cell ##ula ##ses ) , P ##L ##11 ( p ##ec ##tina ##se ) as well as G ##H ##2 and [unused1] G ##H ##3 [unused2] ( o ##li ##gos ##ac ##cha ##rida ##ses ) . Our data support the pivotal role of the most characterized fi ##bro ##ly ##tic bacteria ( Pre ##vo ##tel ##la , R ##umi ##no ##cc ##cus and Fi ##bro ##ba ##cter ) , and highlight a substantial , although most probably under ##est ##imated , contribution of fungi and c ##ilia [SEP]',\n",
       "  'existing_cui': 'C1333673',\n",
       "  'existing_cui_name': 'GH1 gene',\n",
       "  'existing_cui_desc': '[CLS] G ##H1 gene [unused3] ( Ana ##tom ##ical Structure : G ##RO ##W ##TH H ##OR ##MO ##NE , NO ##R ##MA ##L ; G ##RO ##W ##TH H ##OR ##MO ##NE 1 ; G ##H1 Gene ; growth hormone 1 ; so ##mat ##ot ##rop ##in ; pit ##uit ##ary growth hormone ; G ##RO ##W ##TH H ##OR ##MO ##NE , P ##IT ##UI ##TA ##R ##Y ; h ##G ##H - N ; G ##H - N ; Growth Ho ##rmon ##e 1 Gene ) [SEP]',\n",
       "  'our_bi_cui': 'C1333877',\n",
       "  'our_bi_cui_name': 'Granzymes',\n",
       "  'our_bi_cui_desc': '[CLS] Gran ##zy ##mes [unused3] ( Chemical : Gran ##zy ##me ; g ##ran ##zy ##me ; EC 3 . 4 . 21 . - ; g ##ran ##zy ##mes ; Gran ##ule - Secret ##ed En ##zy ##me ; Gran ##zy ##mes [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
       "  'our_cross_cui': 'C0014442',\n",
       "  'our_cross_cui_name': 'Enzymes',\n",
       "  'our_cross_cui_desc': '[CLS] En ##zy ##mes [unused3] ( Chemical , medication , substance : enzymes ; enzyme ; En ##zy ##mes [ Chemical / In ##g ##red ##ient ] ; B ##io ##cat ##aly ##sts ; En ##zy ##me ) [SEP]'},\n",
       " {'mention_id': '27623277.36',\n",
       "  'test_set_idx': 12220,\n",
       "  'type': 'T058',\n",
       "  'name': 'Procedural',\n",
       "  'context': '[CLS] attributes from the con ##join ##t experiment ( each with a relative weight of 0 . 23 ) , followed by provider volume ( relative weight of 0 . 21 ) , risk of major complications ( relative weight of 0 . 18 ) , and distance needed to travel for treatment ( relative weight of 0 . 15 ) . [unused1] Pro ##cedural [unused2] and treatment preferences did not vary with demographic ##s , self - reported health status , or familiar ##ity with the procedures . Survey respond ##ents preferred minimal ##ly invasive operations over stereo ##ta ##ctic body radiation therapy or th ##ora ##cot ##omy for treatment of early - stage non - small cell lung cancer . Treatment m ##oda ##lity and [SEP]',\n",
       "  'existing_cui': 'C1619712',\n",
       "  'existing_cui_name': 'Procedural pain',\n",
       "  'existing_cui_desc': '[CLS] Pro ##cedural pain [unused3] ( Finding ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27685187.20',\n",
       "  'test_set_idx': 14117,\n",
       "  'type': 'T082',\n",
       "  'name': 'Canadian city',\n",
       "  'context': \"[CLS] determine what are considered acceptable standards for animal research methodology and translation rate to humans , a valid ##ated survey was sent to : a ) a sample of the general public , via Sam ##pling Survey International ( Sam ##pling Survey International ; Canada ) , Amazon Mechanical Tu ##rk ( Amazon Mechanical Tu ##rk ; USA ) , a [unused1] Canadian city [unused2] festival and a Canadian children ' s hospital ; b ) a sample of medical students ( two first - year classes ) ; and c ) a sample of scientists ( corresponding authors and academic p ##ae ##dia ##tric ##ians ) . There were 137 ##9 responses from the general public sample ( Sam ##pling Survey International , n = [SEP]\",\n",
       "  'existing_cui': 'C0324053',\n",
       "  'existing_cui_name': 'Canadian cattle',\n",
       "  'existing_cui_desc': '[CLS] Canadian cattle [unused3] ( E ##uka ##ryo ##te , organism : Can ##adi ##enne cow ; Canadian cow ; Can ##adi ##enne Cat ##tle ; Canadian cattle breed ; Can ##adi ##enne cattle breed ) [SEP]',\n",
       "  'our_bi_cui': 'C0008848',\n",
       "  'our_bi_cui_name': 'Cities',\n",
       "  'our_bi_cui_desc': '[CLS] Cities [unused3] ( Spa ##tial Concept , environment : City ; city ; cities ) [SEP]',\n",
       "  'our_cross_cui': 'C0006823',\n",
       "  'our_cross_cui_name': 'Canada',\n",
       "  'our_cross_cui_desc': '[CLS] Canada [unused3] ( Spa ##tial Concept , geographic location : CA ##N ; CA ##NA ##DA ; CA ) [SEP]'},\n",
       " {'mention_id': '28394935.43',\n",
       "  'test_set_idx': 34414,\n",
       "  'type': 'T103',\n",
       "  'name': 'Cys - NO',\n",
       "  'context': '[CLS] ##tric oxide s ##ynth ##ase - derived ni ##tric oxide S - ni ##tro ##sy ##lated β - act ##in on Cy ##s ##37 ##4 and impaired act ##in binding to pro ##fi ##lin - 1 , as confirmed with the trans ##ni ##tro ##sy ##lating agent S - ni ##tro ##so - L - c ##ys ##tein ##e ( [unused1] Cy ##s - NO [unused2] ) . The importance of ni ##tric oxide and the formation of P ##F ##N ##1 - act ##in complexes on the regulation of protein kinase C - θ was co ##rro ##bor ##ated by over ##ex ##press ##ion of pro ##fi ##lin - 1 - and act ##in - binding defect ##ive mutant ##s of β - act ##in [SEP]',\n",
       "  'existing_cui': 'C3252049',\n",
       "  'existing_cui_name': 'cystine-N-carboxy anhydride',\n",
       "  'existing_cui_desc': '[CLS] c ##ys ##tine - N - car ##box ##y an ##hy ##dr ##ide [unused3] ( Chemical : Cy ##s - NC ##A ) [SEP]',\n",
       "  'our_bi_cui': 'C0010654',\n",
       "  'our_bi_cui_name': 'Cysteine',\n",
       "  'our_bi_cui_desc': '[CLS] Cy ##stein ##e [unused3] ( Chemical , product , substance : ( 2 ##R ) - 2 - amino - 3 - me ##rca ##pt ##op ##rop ##ano ##ic acid ; c ##ys ##tein ##e l ; ( R ) - 2 - Am ##ino - 3 - su ##lf ##any ##l - prop ##ano ##ic acid ; Half Cy ##st ##ine ; l c ##ys ##tein ##e ; L - Cy ##stein ; Cy ##s ; C ##Y ##ST ##EI ##NE ; l - c ##ys ##tein ##e ; Half - Cy ##st ##ine ; L - Cy ##stein ##e ; ( 2 ##R ) - 2 - amino - 3 - su ##lf ##any ##l ##p ##rop ##ano ##ic acid ; L Cy ##stein [SEP]',\n",
       "  'our_cross_cui': 'C0073896',\n",
       "  'our_cross_cui_name': 'S-nitrosocysteine',\n",
       "  'our_cross_cui_desc': '[CLS] S - ni ##tro ##so ##cy ##stein ##e [unused3] ( Chemical : L - S - ni ##tro ##so ##cy ##stein ##e ; S ##NC compound ; S - ni ##tro ##so - L - c ##ys ##tein ##e ; L - S ##NC compound ) [SEP]'},\n",
       " {'mention_id': '27334669.21',\n",
       "  'test_set_idx': 2719,\n",
       "  'type': 'T033',\n",
       "  'name': 'detection',\n",
       "  'context': '[CLS] DL ##S data in a thorough manner by providing a large set of fitting parameters . This showed that DL ##S only sensed the larger ve ##si ##cles when the mice ##lles / ve ##si ##cles ratio was 80 / 20 w / w . On the other hand , as ##ym ##metric ##al flow field flow fraction ##ation allowed clear [unused1] detection [unused2] of the presence of mice ##lles when this same ratio was as low as 10 / 90 . Subsequently , the photo ##dynamic therapy efficiency of various controlled mixture ##s was assessed using multi ##cellular s ##pher ##oids when a photos ##ens ##iti ##zer , p ##he ##op ##hor ##bide a , was en ##cap ##sul ##ated in the polymer self - [SEP]',\n",
       "  'existing_cui': 'C0206100',\n",
       "  'existing_cui_name': 'Signal Detection',\n",
       "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
       "  'our_bi_cui': 'C1511790',\n",
       "  'our_bi_cui_name': 'Detection',\n",
       "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
       "  'our_cross_cui': 'C0442726',\n",
       "  'our_cross_cui_name': 'Detected',\n",
       "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
       " {'mention_id': '25847295.20',\n",
       "  'test_set_idx': 19,\n",
       "  'type': 'T017',\n",
       "  'name': 'apoptotic cells',\n",
       "  'context': '[CLS] ##late decreased DNA fragment ##ation caused by a ##pop ##tosis in PC ##12 cells . This phenomenon was confirmed after treating a ##pop ##to ##tic PC ##12 cells with non ##yl ##phe ##no ##l diet ##ho ##xy ##late , whereas the c ##yt ##och ##rome c release into the c ##yt ##oso ##l decreased as compared to that in [unused1] a ##pop ##to ##tic cells [unused2] not treated with non ##yl ##phe ##no ##l diet ##ho ##xy ##late s . Furthermore , Ba ##x contents in a ##pop ##to ##tic cells were reduced after exposure to non ##yl ##phe ##no ##l diet ##ho ##xy ##late . Thus , non ##yl ##phe ##no ##l diet ##ho ##xy ##late has the opposite effect on a ##pop ##tosis in [SEP]',\n",
       "  'existing_cui': 'C0162638',\n",
       "  'existing_cui_name': 'Apoptosis',\n",
       "  'existing_cui_desc': '[CLS] A ##pop ##tosis [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : a ##pop ##to ##tic cell death ; A ##pop ##to ##tic Process ; Programme ##d Cell Death ; programmed cell death by a ##pop ##tosis ; A ##pop ##tosis Path ##way ; a ##pop ##tos ##e ; programmed cell death ; RC ##D ; a ##pop ##tosis ; Gene - directed cell death ; a ##pop ##to ##tic programmed cell death ; Programme ##d Cell Death , Type I ; self destruction of the cell ; Me ##chan ##ism that allows cells to self - des ##truct when it is necessary ; a ##pop ##to ##tic process ; type I programmed cell death ) [SEP]',\n",
       "  'our_bi_cui': 'C1836846',\n",
       "  'our_bi_cui_name': 'Apoptotic neurons',\n",
       "  'our_bi_cui_desc': '[CLS] A ##pop ##to ##tic neurons [unused3] ( Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0007634',\n",
       "  'our_cross_cui_name': 'Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
       " {'mention_id': '27298278.20',\n",
       "  'test_set_idx': 1821,\n",
       "  'type': 'T103',\n",
       "  'name': 'morindaparvins C',\n",
       "  'context': '[CLS] ##ones , a nap ##ht ##ho ##quin ##one , an ant ##hra ##quin ##one , and a nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##er , together with three known q ##uin ##ones and seven other known compounds , were isolated from the aerial parts of Mo ##rin ##da par ##vi ##folia . The structures of [unused1] m ##ori ##nda ##par ##vin ##s C [unused2] , D , E , F , and G were el ##uc ##idated on the basis of s ##pect ##ros ##copic or X - ray di ##ff ##raction analysis as met ##hyl 4 - h ##ydro ##xy - 1 , 6 - dim ##eth ##ox ##y - nap ##ht ##hale ##ne - 2 - car ##box ##yla ##te , [SEP]',\n",
       "  'existing_cui': 'C0616488',\n",
       "  'existing_cui_name': 'morindaparvin A',\n",
       "  'existing_cui_desc': '[CLS] m ##ori ##nda ##par ##vin A [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0010206',\n",
       "  'our_bi_cui_name': 'coumarin',\n",
       "  'our_bi_cui_desc': '[CLS] co ##uma ##rin [unused3] ( Chemical , product , substance : 1 , 2 - Benz ##opy ##rone ; C ##uma ##rin ; 5 , 6 - ben ##zo - alpha - p ##yr ##one ; alpha ben ##zo ##py ##rone ; 1 , 2 - ben ##zo ##py ##rone ; ton ##ka bean camp ##hor ; To ##nka Bean Camp ##hor ; Ch ##rome ##n - 2 - one ; CO ##UM ##AR ##IN ; Co ##uma ##rin anti ##coa ##gu ##lant ; 2 ##H - 1 - Benz ##opy ##ran - 2 - one ; Co ##uma ##rini ##c an ##hy ##dr ##ide ; To ##nka bean camp ##hor ; Co ##uma ##rin ; cum ##ari ##n ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27261783.7',\n",
       "  'test_set_idx': 1085,\n",
       "  'type': 'T033',\n",
       "  'name': 'tracing',\n",
       "  'context': '[CLS] micro ##bial cells , micro ##bial populations in ultra ##oli ##got ##rop ##hic a ##ero ##bic sediment ##ary habitats in the open ocean g ##yres are several orders of magnitude less abundant . Despite advances in cultivation - independent molecular ecological techniques , exploring the low - bio ##mass environment remains technological ##ly challenging , especially in the deep sub ##sea ##f ##lo ##or bio ##sp ##here . Review ##ing the historical background of deep - bio ##sp ##here analytical methods , the importance of obtaining clean samples and [unused1] tracing [unused2] contamination , as well as methods for detect ##ing micro ##bial life , technological aspects of molecular micro ##biology , and detect ##ing sub ##sea ##f ##lo ##or metabolic activity will be discussed . [SEP]',\n",
       "  'existing_cui': 'C0079161',\n",
       "  'existing_cui_name': 'Infectious Disease Contact Tracing',\n",
       "  'existing_cui_desc': '[CLS] In ##fect ##ious Disease Contact T ##rac ##ing [unused3] ( Health Care Act ##ivity , procedure : CT - Contact tracing ; Contact T ##rac ##ing ; CO ##MM ##UN ##IC ##AB ##LE D ##IS CO ##NT ##AC ##T T ##RA ##CI ##NG ; Contact tracing ; IN ##F ##EC ##T D ##IS CO ##NT ##AC ##T T ##RA ##CI ##NG ; Co ##mm ##uni ##ca ##ble Disease Contact T ##rac ##ing ; T ##rac ##ing , Contact ) [SEP]',\n",
       "  'our_bi_cui': 'C0546881',\n",
       "  'our_bi_cui_name': 'tracking',\n",
       "  'our_bi_cui_desc': '[CLS] tracking [unused3] ( Spa ##tial Concept : Track ##ing ; tracking [ mental function ] ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27671177.13',\n",
       "  'test_set_idx': 13790,\n",
       "  'type': 'T082',\n",
       "  'name': 'Quetta',\n",
       "  'context': '[CLS] in Que ##tta , Pakistan To determine the prevalence of dental car ##ies and its relationship with dental flu ##oro ##sis , oral health behaviour and diet ##ary behaviour among 12 - year school children in moderate - flu ##ori ##de drinking water community in Que ##tta , Pakistan . Cross - section ##al study . Government and private schools of [unused1] Que ##tta [unused2] , from November 2012 to February 2013 . At ##ota ##l of 34 ##9 children aged 12 - year from 14 randomly selected schools were included . The data collection was done on question ##naire designed for children . Dental car ##ies status was examined by using WHO criteria . Dental car ##ies was found in 81 children ( 23 . [SEP]',\n",
       "  'existing_cui': 'C0262345',\n",
       "  'existing_cui_name': 'Tenia of thalamus',\n",
       "  'existing_cui_desc': '[CLS] Ten ##ia of th ##ala ##mus [unused3] ( Ana ##tom ##ical Structure : ten ##ia of th ##ala ##mi ; Ten ##ia of th ##ala ##mi ; Ta ##enia th ##ala ##mi ; T ##hala ##mus ten ##ia ; ten ##ia of the th ##ala ##mus ; Ten ##ia th ##ala ##mi ) [SEP]',\n",
       "  'our_bi_cui': 'C0337884',\n",
       "  'our_bi_cui_name': 'Quechua',\n",
       "  'our_bi_cui_desc': '[CLS] Que ##chu ##a [unused3] ( Population Group , ethnic group , ethnic group ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '27400734.18',\n",
       "  'test_set_idx': 4722,\n",
       "  'type': 'T103',\n",
       "  'name': 'GEM',\n",
       "  'context': '[CLS] analysis of Korean national database A random ##ized clinical trial has found that the addition of er ##lot ##ini ##b to g ##em ##ci ##ta ##bine ( GE ##M - E ) for pan ##cre ##atic cancer led to a modest increase in survival . The aim of this national population - based retrospective study was to compare the effectiveness of [unused1] GE ##M [unused2] - E to GE ##M alone for pan ##cre ##atic cancer patients in real clinical practice . Pat ##ients with pan ##cre ##atic cancer ( I ##CD - 10 : C ##25 ) with prescription claims of g ##em ##ci ##ta ##bine or er ##lot ##ini ##b between Jan 1 , 2007 and Dec 31 , 2012 were retrospective ##ly identified [SEP]',\n",
       "  'existing_cui': 'C1333683',\n",
       "  'existing_cui_name': 'GMNN gene',\n",
       "  'existing_cui_desc': '[CLS] GM ##N ##N gene [unused3] ( Ana ##tom ##ical Structure : Gemini ##n , DNA Rep ##lication In ##hibit ##or Gene ; GM ##N ##N Gene ; G ##em ; GE ##MI ##NI ##N ; g ##em ##ini ##n , DNA replication inhibitor ; GE ##M ) [SEP]',\n",
       "  'our_bi_cui': 'C2955445',\n",
       "  'our_bi_cui_name': 'GEL',\n",
       "  'our_bi_cui_desc': '[CLS] GE ##L [unused3] ( Chemical , G ##RA ##M , G ##RA ##M ) [SEP]',\n",
       "  'our_cross_cui': 'C0045093',\n",
       "  'our_cross_cui_name': 'gemcitabine',\n",
       "  'our_cross_cui_desc': \"[CLS] g ##em ##ci ##ta ##bine [unused3] ( Chemical , product , substance : g ##em ##ci ##ta ##bine [ Chemical / In ##g ##red ##ient ] ; 2 ' , 2 ' - di ##f ##lu ##oro ##de ##ox ##y ##cy ##ti ##dine ; 4 - amino - 1 - ( ( 2 ##R , 4 ##R , 5 ##R ) - 3 , 3 - Di ##f ##lu ##oro - 4 - h ##ydro ##xy - 5 - ( h ##ydro ##xy ##met ##hyl ) - te ##tra ##hy ##dr ##of ##ura ##n - 2 - y ##l ) p ##yr ##im ##id ##in - 2 ( 1 ##H ) - one ; 2 ' , 2 ' - Di ##f ##lu ##oro ##de ##ox [SEP]\"},\n",
       " {'mention_id': '27500205.28',\n",
       "  'test_set_idx': 8460,\n",
       "  'type': 'T103',\n",
       "  'name': 'kindlins',\n",
       "  'context': '[CLS] transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of kind ##lins . Great interest in the kind ##lins has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in [unused1] kind ##lins [unused2] , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate the capacity of in ##te ##g ##rin ##s to media ##te their functions . Kind ##lins are adapt ##or proteins ; their function em ##ana ##te from their interaction with binding partners , including the c ##yt ##op ##las ##mic tails of [SEP]',\n",
       "  'existing_cui': 'C1720776',\n",
       "  'existing_cui_name': 'Kindling , Neurologic',\n",
       "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
       "  'our_bi_cui': 'C0010422',\n",
       "  'our_bi_cui_name': 'Crystallins',\n",
       "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27545500.27',\n",
       "  'test_set_idx': 10003,\n",
       "  'type': 'T103',\n",
       "  'name': '16-aldehyde tanshinone I',\n",
       "  'context': '[CLS] I and amino ##gly ##cos ##ide anti ##biotics or β - la ##ct ##am anti ##biotics in v ##it ##ro was identified . Moreover , 16 - al ##de ##hy ##de tan ##shin ##one I was documented to au ##gment clearance of s ##tre ##pt ##omy ##cin and am ##pic ##ill ##in against S . au ##reus in a m ##uri ##ne infection model . Primary me ##chan ##istic insight indicated that [unused1] 16 - al ##de ##hy ##de tan ##shin ##one I [unused2] could damage the bacterial cell membrane , leading to accumulation of anti ##biotics inside bacterial cells . This finding might be useful for treating infections caused by S . au ##reus and expand the scope of application of tan ##shin ##ones . [SEP]',\n",
       "  'existing_cui': 'C0075810',\n",
       "  'existing_cui_name': 'tanshinone',\n",
       "  'existing_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
       "  'our_bi_cui': 'C0075810',\n",
       "  'our_bi_cui_name': 'tanshinone',\n",
       "  'our_bi_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28168514.17',\n",
       "  'test_set_idx': 27532,\n",
       "  'type': 'T058',\n",
       "  'name': 'sequential',\n",
       "  'context': '[CLS] sixty - eight consecutive patients ( age : 67 ± 10 years ; B ##MI : 27 ± 5 kg / m ² ; 61 % male ) undergoing clinical ##ly indicated CT an ##gio ##graphy with dual - source CT were included in the retrospective single - center analysis . A contrast - enhanced volume data ##set was acquired in [unused1] se ##quential [unused2] ( SS ##M ) ( n = 151 ) or he ##lica ##l scan mode ( n = 117 ) . Co ##rona ##ry segments were classified in diagnostic or non - diagnostic image quality . A subset underwent invasive an ##gio ##graphy to determine the diagnostic accuracy of CT an ##gio ##graphy . SS ##M ( 96 . 8 ± [SEP]',\n",
       "  'existing_cui': 'C1337600',\n",
       "  'existing_cui_name': 'TABLET , SEQUENTIAL',\n",
       "  'existing_cui_desc': '[CLS] T ##AB ##LE ##T , SE ##Q ##UE ##NT ##IA ##L [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0202607',\n",
       "  'our_bi_cui_name': 'Serialography , single plane',\n",
       "  'our_bi_cui_desc': '[CLS] Ser ##ial ##ography , single plane [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
       "  'our_cross_cui': 'C0441633',\n",
       "  'our_cross_cui_name': 'Scanning',\n",
       "  'our_cross_cui_desc': '[CLS] Sc ##ann ##ing [unused3] ( Health Care Act ##ivity , procedure : scan ##s ; scanned ; scan ; scanning ; Sc ##ans ; diagnostic scanning ; diagnostic scan ; Sc ##an ) [SEP]'},\n",
       " {'mention_id': '28127340.1',\n",
       "  'test_set_idx': 26227,\n",
       "  'type': 'T033',\n",
       "  'name': 'Non - zoonotic',\n",
       "  'context': '[CLS] Zoo ##not ##ic and [unused1] Non - zoo ##not ##ic [unused2] Para ##site ##s of Wild Rod ##ents in Tu ##rk ##man Sa ##hra , Northeastern Iran This study was conducted to collect inform ##ative data on the para ##sitic infection of wild rode ##nts , emphasizing on finding parasite ##s , which have medical importance to human . During 2012 - 2014 , a total number of 91 wild rode ##nts were captured from rural areas of Tu ##rk ##men Sa ##hra , Go ##les ##tan Province , using hand ##made traps . Animals were an ##est ##he ##tized , surveyed for any e ##ct ##op ##ara ##site and then their car ##cas ##ses were carefully di ##sse ##cted for examination of end ##op ##ars [SEP]',\n",
       "  'existing_cui': 'C0043528',\n",
       "  'existing_cui_name': 'Zoonoses',\n",
       "  'existing_cui_desc': '[CLS] Zoo ##nose ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder , navigation ##al concept : Zoo ##nosis ; Zoo ##not ##ic In ##fect ##ious Disease ; Zoo ##not ##ic infection ; Disease , Zoo ##not ##ic In ##fect ##ious ; Zoo ##nose ##s [ Disease / Finding ] ; Zoo ##not ##ic Disease ##s ; infections zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ion ; Zoo ##not ##ic Disease ; In ##fect ##ious Disease , Zoo ##not ##ic ; In ##fect ##ions , Zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ious Disease ##s ; Disease , Zoo ##not ##ic ; Disease ##s , Zoo ##not ##ic In ##fect ##ious ; zoo ##nose ; zoo ##not ##ic infection ; In [SEP]',\n",
       "  'our_bi_cui': 'C0043528',\n",
       "  'our_bi_cui_name': 'Zoonoses',\n",
       "  'our_bi_cui_desc': '[CLS] Zoo ##nose ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder , navigation ##al concept : Zoo ##nosis ; Zoo ##not ##ic In ##fect ##ious Disease ; Zoo ##not ##ic infection ; Disease , Zoo ##not ##ic In ##fect ##ious ; Zoo ##nose ##s [ Disease / Finding ] ; Zoo ##not ##ic Disease ##s ; infections zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ion ; Zoo ##not ##ic Disease ; In ##fect ##ious Disease , Zoo ##not ##ic ; In ##fect ##ions , Zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ious Disease ##s ; Disease , Zoo ##not ##ic ; Disease ##s , Zoo ##not ##ic In ##fect ##ious ; zoo ##nose ; zoo ##not ##ic infection ; In [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27301681.4',\n",
       "  'test_set_idx': 1904,\n",
       "  'type': 'T103',\n",
       "  'name': 'N-methylpyrrole ( Py ) - N-methylimidazole ( Im ) polyamides',\n",
       "  'context': '[CLS] p ##yr ##rol ##e - im ##ida ##zo ##le p ##oly ##ami ##des containing an 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid unit With the aim of improving a ##que ##ous so ##lub ##ility , we designed and synthesized five [unused1] N - met ##hyl ##py ##rro ##le ( P ##y ) - N - met ##hyl ##im ##ida ##zo ##le ( I ##m ) p ##oly ##ami ##des [unused2] capable of recognizing 9 - b ##p sequences . Their DNA - binding a ##ffin ##ities and sequence specific ##ities were evaluated by SP ##R and Bin ##d - n - Se ##q analyses . The design of p ##oly ##ami ##de 1 was based on a conventional [SEP]',\n",
       "  'existing_cui': 'C0764095',\n",
       "  'existing_cui_name': 'N-methylimidazole-N-methylimidazole-N-methylpyrrole-aminobutyric acid - N-methylpyrrole-N-methylpyrrole-N-methylpyrrole-alanine-dimethylaminopropylamide',\n",
       "  'existing_cui_desc': '[CLS] N - met ##hyl ##im ##ida ##zo ##le - N - met ##hyl ##im ##ida ##zo ##le - N - met ##hyl ##py ##rro ##le - amino ##but ##yric acid - N - met ##hyl ##py ##rro ##le - N - met ##hyl ##py ##rro ##le - N - met ##hyl ##py ##rro ##le - al ##ani ##ne - dim ##eth ##yla ##min ##op ##rop ##yla ##mi ##de [unused3] ( Chemical : 2 ##I ##m - P ##y - ABA - 3 ##P ##y - Al ##a - D ##p ; I ##m ##I ##m ##P ##y - gamma - amino ##but ##yric acid - P ##y ##P ##y ##P ##y - beta - al ##ani ##ne - D ##p ) [SEP]',\n",
       "  'our_bi_cui': 'C1254351',\n",
       "  'our_bi_cui_name': 'Pharmacologic Substance',\n",
       "  'our_bi_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]',\n",
       "  'our_cross_cui': 'C0029224',\n",
       "  'our_cross_cui_name': 'Organic Chemicals',\n",
       "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
       " {'mention_id': '27659602.46',\n",
       "  'test_set_idx': 13391,\n",
       "  'type': 'T082',\n",
       "  'name': 'secondary root',\n",
       "  'context': '[CLS] more are at risk for re ##oper ##ation , and not until at least after 10 . 4 years have passed . Neither the valve morphology ( p = 0 . 62 ) nor con ##com ##ita ##nt a ##ort ##ic valve replacement ( p = 0 . 86 ) influenced rate of root di ##lation . In non ##sy ##nd ##rom ##ic patients , the a ##ort ##ic root is the slow ##est growing portion of the th ##ora ##ci ##c a ##ort ##a . Leaving the native root , as in root - spa ##ring ascending a ##ort ##ic replacement , is a safe approach regarding [unused1] secondary root [unused2] intervention for a ##ort ##ic root diameter ##s of 45 mm or less . [SEP]',\n",
       "  'existing_cui': 'C0027627',\n",
       "  'existing_cui_name': 'Neoplasm Metastasis',\n",
       "  'existing_cui_desc': '[CLS] Neo ##p ##las ##m Met ##ast ##asis [unused3] ( B ##iol ##og ##ic Fun ##ction , tumor : Tu ##mor Cell Mi ##gration ; meta ##sta ##si ##zed ; cancer ##s secondary ; NE ##OP ##L ME ##TA ##ST ##AS ##ES ; secondary ; meta ##static t ##umour ; meta ##static tumors ; meta ##static cancer ; meta ##static disease ; secondary cancer ; meta ##static tumor ; Met ##ast ##asis ; secondary tumors ; Neo ##p ##las ##m Met ##ast ##ases ; Neo ##p ##las ##m Met ##ast ##asis [ Disease / Finding ] ; t ##umour meta ##sta ##sis ; spreading of cancer ; tumor meta ##sta ##sis ; meta ##sta ##ses ; meta ##sta ##sis ; meta ##static t ##umour ##s ; secondary [SEP]',\n",
       "  'our_bi_cui': 'C0447373',\n",
       "  'our_bi_cui_name': 'Distal tooth root',\n",
       "  'our_bi_cui_desc': '[CLS] Di ##stal tooth root [unused3] ( Ana ##tom ##ical Structure , Den ##tis , body structure : Di ##stal root of tooth ; Di ##stal root ; Ra ##di ##x di ##stal ##is ) [SEP]',\n",
       "  'our_cross_cui': 'C0549113',\n",
       "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
       "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
       " {'mention_id': '27790175.20',\n",
       "  'test_set_idx': 16824,\n",
       "  'type': 'T038',\n",
       "  'name': 'production',\n",
       "  'context': '[CLS] sessions with two discrete toy sets were double - coded by blinded code ##rs ( code ##r assignment counter ##bal ##ance ##d ) . Key face ##ts of pre ##tens ##e development [ at ##tribution of pretend properties ( at ##tribution of pretend properties ) , object substitution , imaginary objects ] were examined . These face ##ts of pretend play [unused1] production [unused2] were then analyzed in relation to autism spectrum disorder symptoms , as well as plausible , long - the ##ori ##zed co ##rrel ##ates [ theory of mind ( theory of mind ) , verbal ability , familiar ##ity , and interest in specific toys ] . Forty children ( Ma ##ge = 6 ; 5 , SD ##age = 1 . [SEP]',\n",
       "  'existing_cui': 'C1548180',\n",
       "  'existing_cui_name': 'Production Processing ID',\n",
       "  'existing_cui_desc': '[CLS] Production Process ##ing ID [unused3] ( Intel ##lect ##ual Product : Production ) [SEP]',\n",
       "  'our_bi_cui': 'C0220781',\n",
       "  'our_bi_cui_name': 'Anabolism',\n",
       "  'our_bi_cui_desc': '[CLS] Ana ##bol ##ism [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : bio ##sy ##nt ##hetic process ; Ana ##bol ##ism , function ; synthesis ; bio ##sy ##nt ##hesis ; formation ; B ##ios ##ynth ##etic ; B ##ios ##ynth ##esis ; B ##io ##genesis ; B ##ios ##ynth ##etic Process ; an ##ab ##olis ##m ) [SEP]',\n",
       "  'our_cross_cui': 'C0025361',\n",
       "  'our_cross_cui_name': 'Mental Processes',\n",
       "  'our_cross_cui_desc': '[CLS] Mental Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction , Human , function , o ##bs ##er ##vable entity : Human Information Process ##ing ; Thought process ; cognitive processing ; processes thought ; processing thought ; Information Process ##ing , Human ; Human information processing ; Information Process ##es ; mental processing ; cognitive process ; Form of thinking , function ; mental processes ; Form of thought ; Form of thinking ; Human Information Process ##es ; Mental Process ; mental process ; thought process ) [SEP]'},\n",
       " {'mention_id': '28473083.52',\n",
       "  'test_set_idx': 37275,\n",
       "  'type': 'T170',\n",
       "  'name': 'Grading of Recommendations Assessment , Development , and Evaluation',\n",
       "  'context': '[CLS] C ##rite ##ria are evidence - based guidelines for specific clinical conditions that are reviewed annually by a multi ##disciplinary expert panel . The guide ##line development and revision include an extensive analysis of current medical literature from peer - reviewed journals and the application of well - established method ##ologies ( RA ##ND / UCLA A ##pp ##rop ##ria ##ten ##ess Method and [unused1] G ##rading of Re ##com ##men ##dation ##s Assessment , Development , and Evaluation [unused2] or G ##RA ##DE ) to rate the appropriate ##ness of imaging and treatment procedures for specific clinical scenarios . In those instances where evidence is lacking or e ##qui ##voc ##al , expert opinion may supplement the available evidence to recommend imaging or treatment . [SEP]',\n",
       "  'existing_cui': 'C1444325',\n",
       "  'existing_cui_name': 'Physical evaluation assessment',\n",
       "  'existing_cui_desc': '[CLS] Physical evaluation assessment [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : As ##ses ##s clinical measurements ; As ##ses ##s physical measurements ) [SEP]',\n",
       "  'our_bi_cui': 'C0220825',\n",
       "  'our_bi_cui_name': 'Evaluation',\n",
       "  'our_bi_cui_desc': '[CLS] Evaluation [unused3] ( Health Care Act ##ivity , qualifier value : Assessment - action ; Investigation ; Eva ##lu ##ated ; Evaluation ##s ; evaluation ##s ; evaluation ; Assessment ; Evaluation Pro ##ced ##ure ; Eva ##lu ##ate ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27442214.17',\n",
       "  'test_set_idx': 5721,\n",
       "  'type': 'T058',\n",
       "  'name': 'abdominal',\n",
       "  'context': '[CLS] of sex comparisons under ##sco ##re the need for a more comprehensive characterization of the secondary o ##ssi ##fication centers . This study evaluate ##s the ch ##ronology and sex differences for appearance and closure of p ##el ##vic and pro ##ximal f ##em ##oral secondary o ##ssi ##fication centers using com ##puted to ##mo ##graphy . Pat ##ients who underwent [unused1] abdominal [unused2] and p ##el ##vic com ##puted to ##mo ##graphy scan ##s between January 2009 and December 2014 at 2 tertiary level 1 trauma centers were retrospective ##ly reviewed . Pat ##ients between the ages of 2 and 32 years with adequate imaging of the p ##el ##vis and pro ##ximal f ##em ##urs were included . Pat ##ients with a history of [SEP]',\n",
       "  'existing_cui': 'C0000726',\n",
       "  'existing_cui_name': 'Abdomen',\n",
       "  'existing_cui_desc': '[CLS] Abd ##ome ##n [unused3] ( Spa ##tial Concept , body structure , qualifier value , volume : a ##b ##dom ##ino ##pel ##vic region ; Abd ##omi ##no ##pel ##vis ; Abd ##omi ##no ##pel ##vic region ; a ##b ##d ; Abd ##omi ##nal structure ; AB ##D ##OM ##EN ; a ##b ##dom ##ino ##pel ##vic regions ; abdominal ; Abd ##omi ##nal ; Abd ##ome ##ns ; abdomen ) [SEP]',\n",
       "  'our_bi_cui': 'C0000726',\n",
       "  'our_bi_cui_name': 'Abdomen',\n",
       "  'our_bi_cui_desc': '[CLS] Abd ##ome ##n [unused3] ( Spa ##tial Concept , body structure , qualifier value , volume : a ##b ##dom ##ino ##pel ##vic region ; Abd ##omi ##no ##pel ##vis ; Abd ##omi ##no ##pel ##vic region ; a ##b ##d ; Abd ##omi ##nal structure ; AB ##D ##OM ##EN ; a ##b ##dom ##ino ##pel ##vic regions ; abdominal ; Abd ##omi ##nal ; Abd ##ome ##ns ; abdomen ) [SEP]',\n",
       "  'our_cross_cui': 'C0412620',\n",
       "  'our_cross_cui_name': 'CT of abdomen',\n",
       "  'our_cross_cui_desc': '[CLS] CT of abdomen [unused3] ( Health Care Act ##ivity , procedure : abdomen c ##t ; abdomen c ##t scanning ; CT scan of abdomen ; com ##puted to ##mo ##graphy of abdomen ; c ##t scan abdomen ; Computer ##ized to ##mo ##graphy of abdomen ; CT scan abdomen ; c ##t abdomen scan ; C . A . T . scan of abdomen ; cat scan abdomen ; abdomen c ##t scan ##s ; CT scan ; abdomen ; Co ##mp ##uted to ##mo ##graphy , abdomen ; CT scan of the abdomen ; CT scan - abdominal ; abdomen c ##t scan ; Abd ##ome ##n CT ; c ##t of abdomen ; Co ##mp ##uted to ##mo ##graphy of abdominal organs ; [SEP]'},\n",
       " {'mention_id': '28454015.27',\n",
       "  'test_set_idx': 36528,\n",
       "  'type': 'T033',\n",
       "  'name': 'unhealthy',\n",
       "  'context': '[CLS] , highlighting that the general public may need strict ##er health protection measures . The population - weighted two - year average health - risk based air quality index data further demonstrates that all population in the studied cities in He ##nan province live with poll ##uted air - 72 % of the population is exposed to air that is [unused1] un ##hea ##lt ##hy [unused2] for sensitive people , while 28 % of people is exposed to air that can be harmful to healthy people ; and the health risks are much greater during winter than during other seasons . Future works should further improve the health - risk based air quality index algorithm , and valid ##ate the links between the clinical / e [SEP]',\n",
       "  'existing_cui': 'C0423755',\n",
       "  'existing_cui_name': 'Unhealthy skin',\n",
       "  'existing_cui_desc': '[CLS] Un ##hea ##lt ##hy skin [unused3] ( Finding , finding ) [SEP]',\n",
       "  'our_bi_cui': 'C0205161',\n",
       "  'our_bi_cui_name': 'Abnormal',\n",
       "  'our_bi_cui_desc': '[CLS] A ##b ##nor ##mal [unused3] ( Finding , qualifier value : abnormal ; A ##b ##nor ##mal ( m ##od ##ifier ) ; A ##b ##nor ##mal ( m ##od ##ifier ) [ Am ##bi ##guous ] ; AB ##N ##OR ##MA ##L ; de ##vian ##t ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27317610.39',\n",
       "  'test_set_idx': 2203,\n",
       "  'type': 'T038',\n",
       "  'name': 'activated',\n",
       "  'context': '[CLS] synthetic g ##lu ##co ##cor ##tic ##oid commonly used to test h ##y ##pot ##hala ##mic - pit ##uit ##ary end ##oc ##rine axis regulation . Test ##osterone was evaluated at rest . Further , we assessed changes in injury - induced ne ##uron morphology ( Go ##l ##gi stain ) , ne ##uro ##path ##ology ( silver stain ) and [unused1] activated [unused2] as ##tro ##cy ##tes ( G ##FA ##P ) in the para ##vent ##ric ##ular nucleus of the h ##y ##pot ##hala ##mus . Rest ##ing plasma co ##rt ##ico ##ster ##one levels were decreased at 2 months post ##in ##ju ##ry and there was a blunt ##ed co ##rt ##ico ##ster ##one increase in response to restraint induced stress . No [SEP]',\n",
       "  'existing_cui': 'C1149591',\n",
       "  'existing_cui_name': 'protein C ( activated ) activity',\n",
       "  'existing_cui_desc': '[CLS] protein C ( activated ) activity [unused3] ( B ##iol ##og ##ic Fun ##ction : auto ##p ##roth ##rom ##bin II ##A activity ; G ##SA ##PC ; activated protein C ; activated blood co ##agu ##lation factor XIV activity ; obsolete protein C ( activated ) activity ) [SEP]',\n",
       "  'our_bi_cui': 'C1326121',\n",
       "  'our_bi_cui_name': 'astrocyte activation',\n",
       "  'our_bi_cui_desc': '[CLS] as ##tro ##cy ##te activation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_cross_cui': 'C1326120',\n",
       "  'our_cross_cui_name': 'cell activation',\n",
       "  'our_cross_cui_desc': '[CLS] cell activation [unused3] ( B ##iol ##og ##ic Fun ##ction : activation cells ) [SEP]'},\n",
       " {'mention_id': '27722881.42',\n",
       "  'test_set_idx': 15029,\n",
       "  'type': 'T007',\n",
       "  'name': 'JPM1',\n",
       "  'context': '[CLS] site of di ##ox ##y ##gen ##ase was simulated and analyzed by molecular dock ##ing . Consequently , a feasible de ##grading pathway of flu ##oran ##the ##ne in the strain JP ##M ##1 was proposed based on the meta ##bol ##ites and the interaction analyses . Additionally , the the ##rm ##ody ##nam ##ic analysis showed that the strain [unused1] JP ##M ##1 [unused2] had high tolerance for flu ##oran ##the ##ne , and the influence of flu ##oran ##the ##ne for the bacterial growth activity was ne ##gli ##gible under 100 to 400 mg L ( - 1 ) concentrations . Take ##n together , this study indicates that the strain JP ##M ##1 has high potential for further study in bio ##rem ##edia [SEP]',\n",
       "  'existing_cui': 'C1421124',\n",
       "  'existing_cui_name': 'TRGJP gene',\n",
       "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
       "  'our_bi_cui': 'C3629619',\n",
       "  'our_bi_cui_name': 'bacterium JP1',\n",
       "  'our_bi_cui_desc': '[CLS] bacterium JP ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
       "  'our_cross_cui': 'C4153571',\n",
       "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
       " {'mention_id': '27580517.4',\n",
       "  'test_set_idx': 10614,\n",
       "  'type': 'T058',\n",
       "  'name': '3D spiral ASL magnetic resonance imaging',\n",
       "  'context': '[CLS] Assessment of cerebral blood per ##fusion reserve with ace ##ta ##zo ##lam ##ide using [unused1] 3D spiral AS ##L magnetic resonance imaging [unused2] : Preliminary experience in p ##ediatric patients To demonstrate the clinical f ##eas ##ibility of a new non - Car ##tes ##ian cylindrical ##ly - distributed spiral 3D pseudo - continuous art ##erial spin label ##ing magnetic resonance imaging pulse sequence in p ##ediatric patients in q ##uant ##ifying cerebral blood flow response to an ace ##ta ##zo ##lam ##ide v ##as ##od ##ila ##tor challenge . magnetic resonance imaging exams were performed on two 3 Te ##sla Philips In ##gen ##ia systems using 32 channel head coil array ##s . After local institutional review board approval , the 3D spiral - based [SEP]',\n",
       "  'existing_cui': 'C0024485',\n",
       "  'existing_cui_name': 'Magnetic Resonance Imaging',\n",
       "  'existing_cui_desc': '[CLS] Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity , MR ##I , procedure , qualifier value : MR - Ma ##gnetic resonance ; MR TO ##MO ##GR ; Ma ##gnetic resonance technique ; magnetic resonance imaging ; N ##MR I ##maging ; Ma ##gnetic resonance imaging procedure ; St ##ead ##y - State Free Pre ##cession MR ##I ; Ma ##gnetic resonance : [ imaging ] or [ study ] ; imaging magnetic nuclear resonance ; Tom ##ography , MR ; MR ##I Sc ##an ; N ##MR - Nuclear magnetic resonance ; Z ##E ##U ##GM ##AT ##O ##GR ; TO ##MO ##GR MR ; N ##MR TO ##MO ##GR ; Nuclear magnetic resonance ; Medical I ##maging , Ma [SEP]',\n",
       "  'our_bi_cui': 'C0860888',\n",
       "  'our_bi_cui_name': 'Tomography , Spiral Computed',\n",
       "  'our_bi_cui_desc': '[CLS] Tom ##ography , S ##pi ##ral Co ##mp ##uted [unused3] ( Health Care Act ##ivity , procedure : S ##pi ##ral com ##puted to ##mo ##graphy scan ; S ##pi ##ral CT ; CT ##s , S ##pi ##ral ; com ##puted to ##mo ##graphy spiral ; Sc ##ans , S ##pi ##ral CT ; He ##lica ##l CT ##s ; He ##lica ##l CT ; S ##pi ##ral CA ##T Sc ##ans ; he ##lica ##l com ##puted to ##mo ##graphy ; c ##t spiral ; S ##pi ##ral Volume ##tric CT ; S ##pi ##ral Computer ##ized Tom ##ography ; Computer - As ##sist ##ed Tom ##ography , S ##pi ##ral ; Volume ##tric CT ; He ##lica ##l Co ##mp ##uted Tom ##ography [SEP]',\n",
       "  'our_cross_cui': 'C3891302',\n",
       "  'our_cross_cui_name': 'Arterial Spin Labeling Magnetic Resonance Imaging',\n",
       "  'our_cross_cui_desc': '[CLS] Arte ##rial Spin Label ##ing Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity : AS ##L f ##MR ##I ; Arte ##rial Spin Label ##ing MR ##I ; AR ##TE ##RI ##AL SP ##IN LA ##BE ##L ##ING F ##UN ##CT ##ION ##AL MR ##I ) [SEP]'},\n",
       " {'mention_id': '28523846.34',\n",
       "  'test_set_idx': 38554,\n",
       "  'type': 'T103',\n",
       "  'name': 'proteoforms',\n",
       "  'context': '[CLS] using E ##SI - I ##MS - MS coupled with SEC - mode HP ##LC . MA ##LD ##I - IS ##D data , charge state distribution values determined using E ##SI - MS , and the collision cross - section ##al areas acquired using E ##SI - I ##MS - MS revealed the relationship between the folded and unfolded [unused1] pro ##te ##of ##orms [unused2] of forced - reduced me ##case ##rm ##in and aerial ##ly o ##xi ##dized me ##case ##rm ##in with the free - SH : protein ratio of me ##case ##rm ##in drug product . The collision cross - section ##al area , which is determined using E ##SI - I ##MS - MS , provided pro ##te ##of ##orm information [SEP]',\n",
       "  'existing_cui': 'C3496296',\n",
       "  'existing_cui_name': 'area proA of Pandya',\n",
       "  'existing_cui_desc': '[CLS] area pro ##A of Pan ##dy ##a [unused3] ( Spa ##tial Concept : pro ##kon ##io ##cor ##te ##x ; area pro ##A of Pan ##dy ##a - 1973 ) [SEP]',\n",
       "  'our_bi_cui': 'C0597298',\n",
       "  'our_bi_cui_name': 'Protein Isoforms',\n",
       "  'our_bi_cui_desc': '[CLS] Pro ##tein Is ##of ##orms [unused3] ( Chemical : protein is ##of ##orm ; Pro ##tein Is ##of ##orms [ Chemical / In ##g ##red ##ient ] ; Is ##of ##orms , Pro ##tein ; Is ##of ##orms ; is ##of ##orms ; is ##of ##orm ; Is ##of ##orm ) [SEP]',\n",
       "  'our_cross_cui': 'C1510464',\n",
       "  'our_cross_cui_name': 'Protein Structure',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein Structure [unused3] ( Chemical : protein structure ) [SEP]'},\n",
       " {'mention_id': '27975020.12',\n",
       "  'test_set_idx': 22698,\n",
       "  'type': 'T022',\n",
       "  'name': 'skin island',\n",
       "  'context': '[CLS] Di ##vide ##d and S ##lid ##ing Super ##fic ##ial Te ##mpo ##ral Arte ##ry F ##lap for Primary Don ##or - site C ##losure Super ##fic ##ial temporal artery flap ##s are often used for reconstruction of hair - bearing areas . However , primary closure of the donor site is not easy when the size of the necessary [unused1] skin island [unused2] is relatively large . In such cases , skin g ##raft ##s are needed at the donor site , resulting in bald ##ness . We have solved this issue by applying the divided and sliding flap technique , which was first reported for primary donor - site closure of a la ##tis ##si ##mus do ##rs ##i m ##us ##cu ##loc ##uta [SEP]',\n",
       "  'existing_cui': 'C0454985',\n",
       "  'existing_cui_name': 'Baffin island',\n",
       "  'existing_cui_desc': '[CLS] Ba ##ffin island [unused3] ( Spa ##tial Concept , geographic location ) [SEP]',\n",
       "  'our_bi_cui': 'C0038925',\n",
       "  'our_bi_cui_name': 'Surgical Flaps',\n",
       "  'our_bi_cui_desc': '[CLS] Sur ##gical F ##lap ##s [unused3] ( Ana ##tom ##ical Structure , attribute , qualifier value , substance : flap ; F ##lap Graf ##t ; flap created in surgery ; flap ##s ; F ##lap , Sur ##gical ; Sur ##gical F ##lap ; Re ##con ##st ##ru ##ctive F ##lap ; FL ##AP ##S S ##UR ##G ; [ Q ] F ##lap ; F ##lap ; F ##lap Trans ##p ##lant ; F ##lap ##s ; FL ##AP S ##UR ##G ; F ##lap ##s , Sur ##gical ; S ##UR ##G FL ##AP ; S ##UR ##G FL ##AP ##S ; surgical flap ) [SEP]',\n",
       "  'our_cross_cui': 'C1123023',\n",
       "  'our_cross_cui_name': 'Skin',\n",
       "  'our_cross_cui_desc': '[CLS] Skin [unused3] ( Body System , Anatomy , body structure : in ##te ##gum ##ental system ; in ##te ##gum ##ent ; skin system ; Skin of body ; skin structure ; skins ; In ##te ##gum ##ental system ; In ##te ##gum ##ent ; Pie ##l ; skinned ; Skin structure ; Cut ##is ; SK ##IN ; skin ) [SEP]'},\n",
       " {'mention_id': '28294559.30',\n",
       "  'test_set_idx': 31486,\n",
       "  'type': 'T038',\n",
       "  'name': 'deleted',\n",
       "  'context': '[CLS] type le ##ct ##in receptor ( C - type le ##ct ##in receptor ) - 2 in liver regeneration following partial liver re ##section in mice . Materials and methods I ##rra ##dia ##ted ch ##ime ##ric mice transplant ##ed with f ##etal liver cells from wild - type mice , C - type le ##ct ##in receptor - 2 - [unused1] deleted [unused2] ( K ##O ) mice or mice with C - type le ##ct ##in receptor - 2 deleted specifically from plate ##lets ( fl ##KO ) were generated . Mi ##ce underwent 70 % partial he ##pate ##ct ##omy . I ##mm ##uno ##his ##to ##chemical stain ##ing was performed to investigate the expression of the end ##ogen ##ous l ##igan ##d [SEP]',\n",
       "  'existing_cui': 'C1333210',\n",
       "  'existing_cui_name': 'INTS6 gene',\n",
       "  'existing_cui_desc': '[CLS] IN ##TS ##6 gene [unused3] ( Ana ##tom ##ical Structure : DB ##I - 1 ; IN ##TS ##6 Gene ; DE ##AD / H B ##OX 26 ; IN ##T ##6 ; DD ##X ##26 ##A ; Not ##ch ##l ##2 ; In ##te ##gra ##tor Complex Sub ##uni ##t 6 Gene ; HD ##B ; IN ##TE ##GR ##AT ##OR CO ##MP ##LE ##X S ##U ##B ##UN ##IT 6 ; DE ##LE ##TE ##D IN CA ##NC ##ER 1 ; in ##te ##gra ##tor complex subunit 6 ) [SEP]',\n",
       "  'our_bi_cui': 'C1522225',\n",
       "  'our_bi_cui_name': 'Knock-out',\n",
       "  'our_bi_cui_desc': '[CLS] K ##nock - out [unused3] ( B ##iol ##og ##ic Fun ##ction : K ##nock ##out ) [SEP]',\n",
       "  'our_cross_cui': 'C0017260',\n",
       "  'our_cross_cui_name': 'Gene Deletion',\n",
       "  'our_cross_cui_desc': '[CLS] Gene Del ##eti ##on [unused3] ( B ##iol ##og ##ic Fun ##ction , attribute : M ##OL ##PA ##TH . DE ##L ; gene del ##eti ##on ; gene del ##eti ##ons ; Del ##eti ##ons , Gene ; Gene Del ##eti ##ons ; gene del ##eti ##on mutation ; Gene del ##eti ##on ; Del ##eti ##on , Gene ) [SEP]'},\n",
       " {'mention_id': '27342978.18',\n",
       "  'test_set_idx': 2987,\n",
       "  'type': 'T017',\n",
       "  'name': 'microsatellite loci',\n",
       "  'context': '[CLS] , and its two recognised host - plant species ( Pi ##nus s ##yl ##ves ##tri ##s and P . ni ##gra ) in order to seek for any con ##cor ##dance useful to di ##sent ##ang ##le the evolutionary history of this iconic le ##pid ##op ##tera ##n . DNA variation in one mitochondrial marker and nine nuclear [unused1] micro ##sat ##elli ##te lo ##ci [unused2] revealed a strong p ##hyl ##og ##eo ##graphic pattern across 28 populations of G . is ##abe ##lla ##e studied in Spain and France comprising six groups mostly distributed along different mountain ranges . Re ##ana ##lysis of a previously published ch ##lor ##op ##last micro ##sat ##elli ##te data ##set revealed a three and two - group structure [SEP]',\n",
       "  'existing_cui': 'C1519302',\n",
       "  'existing_cui_name': 'Short Tandem Repeat',\n",
       "  'existing_cui_desc': '[CLS] Short Tan ##de ##m Rep ##eat [unused3] ( Chemical : Tan ##de ##m Rep ##eat ##s , Short ; Rep ##eat ##s , Micro ##sat ##elli ##te ; Rep ##eti ##tive Se ##quence , Simple ; Simple Rep ##eti ##tive Se ##quence ; Simple Rep ##eti ##tive Se ##quence ##s ; Simple Se ##quence Rep ##eat ; Micro ##sat ##elli ##te Rep ##eat ##s ; Rep ##eat ##s , Simple Se ##quence ; Rep ##eti ##tive Se ##quence ##s , Simple ; Micro ##sat ##elli ##te Rep ##eat ; Rep ##eat , Simple Se ##quence ; Se ##quence ##s , Simple Rep ##eti ##tive ; Se ##quence Rep ##eat , Simple ; Short Tan ##de ##m Rep ##eat ##s ; Rep ##eat ##s , Short Tan [SEP]',\n",
       "  'our_bi_cui': 'C1519302',\n",
       "  'our_bi_cui_name': 'Short Tandem Repeat',\n",
       "  'our_bi_cui_desc': '[CLS] Short Tan ##de ##m Rep ##eat [unused3] ( Chemical : Tan ##de ##m Rep ##eat ##s , Short ; Rep ##eat ##s , Micro ##sat ##elli ##te ; Rep ##eti ##tive Se ##quence , Simple ; Simple Rep ##eti ##tive Se ##quence ; Simple Rep ##eti ##tive Se ##quence ##s ; Simple Se ##quence Rep ##eat ; Micro ##sat ##elli ##te Rep ##eat ##s ; Rep ##eat ##s , Simple Se ##quence ; Rep ##eti ##tive Se ##quence ##s , Simple ; Micro ##sat ##elli ##te Rep ##eat ; Rep ##eat , Simple Se ##quence ; Se ##quence ##s , Simple Rep ##eti ##tive ; Se ##quence Rep ##eat , Simple ; Short Tan ##de ##m Rep ##eat ##s ; Rep ##eat ##s , Short Tan [SEP]',\n",
       "  'our_cross_cui': 'C0678933',\n",
       "  'our_cross_cui_name': 'Genetic Loci',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##tic Lo ##ci [unused3] ( Ana ##tom ##ical Structure : Lo ##cus , Gene ##tic ; Gene ##tic Lo ##cus ; Lo ##ci , Gene ##tic ) [SEP]'},\n",
       " {'mention_id': '28389374.19',\n",
       "  'test_set_idx': 34021,\n",
       "  'type': 'T103',\n",
       "  'name': 'of BRCA1 associated protein1',\n",
       "  'context': '[CLS] ##al regulation , ch ##roma ##tin modification by de ##ubi ##qui ##tina ##ting his ##tone 2 ##A , and DNA repair . BR ##CA ##1 associated protein ##1 mutations are frequent in ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma . Our aim was to functional ##ly character ##ize a newly identified is ##of ##orm [unused1] of BR ##CA ##1 associated protein ##1 [unused2] and investigate the effects of its expression on drug sensitivity in ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma . Express ##ion of BR ##CA ##1 associated protein ##1 is ##of ##orms was detected by quantitative polymer ##ase chain reaction in ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma and normal me ##so [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0259275',\n",
       "  'our_bi_cui_name': 'BRCA1 Protein',\n",
       "  'our_bi_cui_desc': '[CLS] BR ##CA ##1 Pro ##tein [unused3] ( Chemical , substance : Ring Fin ##ger Pro ##tein 53 ; BR ##CA ##1 Pro ##tein [ Chemical / In ##g ##red ##ient ] ; BR ##CA PR ##OT ##EI ##N 00 ##1 ; B ##rea ##st Cancer 1 Gene Product ; BR ##CA GE ##NE PR ##OD ##UC ##T 00 ##1 ; BR ##CA ##1 gene product ; BR ##CA ##1 Gene Product ; B ##rea ##st Cancer 1 Pro ##tein ; B ##rea ##st cancer type 1 su ##s ##ce ##pt ##ibility protein ; B ##rea ##st Cancer Type 1 Su ##s ##ce ##pt ##ibility Pro ##tein ) [SEP]',\n",
       "  'our_cross_cui': 'C1368335',\n",
       "  'our_cross_cui_name': 'BAP1 protein , human',\n",
       "  'our_cross_cui_desc': '[CLS] BA ##P ##1 protein , human [unused3] ( Chemical : BA ##P - 1 protein , human ; U ##bi ##qui ##tin Car ##box ##yl - Terminal H ##ydro ##lase BA ##P ##1 ; Ce ##re ##bra ##l Pro ##tein 6 ; BR ##CA ##1 associated protein - 1 ( u ##bi ##qui ##tin car ##box ##y - terminal h ##ydro ##lase ) , human ; EC 3 . 4 . 19 . 12 ; BR ##CA ##1 Associated Pro ##tein - 1 ; Ce ##re ##bra ##l Pro ##tein - 13 ; Ring ##2 protein , human ; BR ##CA ##1 - Associated Pro ##tein 1 ; Ce ##re ##bra ##l Pro ##tein - 6 ; BR ##CA ##1 associated protein - 1 , human [SEP]'},\n",
       " {'mention_id': '27760149.44',\n",
       "  'test_set_idx': 15831,\n",
       "  'type': 'T033',\n",
       "  'name': 'up - to - date',\n",
       "  'context': \"[CLS] problems , we introduce B ##ES ##T , a bio ##medical entity search tool . B ##ES ##T returns , as a result , a list of 10 different types of bio ##medical entities including genes , diseases , drugs , targets , transcription factors , mi ##RNA ##s , and mutations that are relevant to a user ' s que ##ry . To the best of our knowledge , B ##ES ##T is the only system that processes free text que ##ries and returns [unused1] up - to - date [unused2] results in real time including mutation information in the results . B ##ES ##T is freely accessible at http : / / best . k ##ore ##a . a ##c . k ##r . [SEP]\",\n",
       "  'existing_cui': 'C0474298',\n",
       "  'existing_cui_name': 'Up-to-date with immunizations',\n",
       "  'existing_cui_desc': '[CLS] Up - to - date with im ##mu ##ni ##zation ##s [unused3] ( Finding , finding , situation : Up - to - date with im ##mu ##nis ##ations ) [SEP]',\n",
       "  'our_bi_cui': 'C0547043',\n",
       "  'our_bi_cui_name': 'Up',\n",
       "  'our_bi_cui_desc': '[CLS] Up [unused3] ( Spa ##tial Concept , qualifier value : Up to ; Ad ; ad ; up ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27838742.87',\n",
       "  'test_set_idx': 19054,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . [unused1] Del ##ica ##f ##lav ##one [unused2] did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27887587.39',\n",
       "  'test_set_idx': 20927,\n",
       "  'type': 'T033',\n",
       "  'name': 'family',\n",
       "  'context': \"[CLS] at the Community Mental Health Centre in their work towards their recovery goals were el ##icit ##ed , as follows : developing an understanding of ones ##elf and one ' s mental health problems ; learning how to change feelings and behaviour ##s ; being ' pushed ' into social arena ##s ; finding helpful medication ; and counsel ##ling in [unused1] family [unused2] , practical and financial issues . The participants ' expectations about counsel ##ling with regard to longer - term family , practical , and financial challenges were insufficient ##ly met by the Community Mental Health Centre . In the experience of the service users , recovery occurred within the context of their everyday life with or without the support of their professional [SEP]\",\n",
       "  'existing_cui': 'C1301584',\n",
       "  'existing_cui_name': 'Last Name',\n",
       "  'existing_cui_desc': '[CLS] Last Name [unused3] ( Intel ##lect ##ual Product , o ##bs ##er ##vable entity : Family Name ; family ; Last name ; Sur ##name ) [SEP]',\n",
       "  'our_bi_cui': 'C0424960',\n",
       "  'our_bi_cui_name': 'Family problems',\n",
       "  'our_bi_cui_desc': '[CLS] Family problems [unused3] ( Finding , finding , history : problem ; family ; Problem ; family ; family problems ; family ; problem ; family problem ) [SEP]',\n",
       "  'our_cross_cui': 'C0851511',\n",
       "  'our_cross_cui_name': 'Family issues',\n",
       "  'our_cross_cui_desc': '[CLS] Family issues [unused3] ( Finding : family issues ; families issues ; Family Issues ; family issue ) [SEP]'},\n",
       " {'mention_id': '27506129.25',\n",
       "  'test_set_idx': 8657,\n",
       "  'type': 'T170',\n",
       "  'name': 'Correlation based feature selection',\n",
       "  'context': '[CLS] trained with individual features is below 0 . 1 for both scales . Multi - layer per ##ce ##pt ##ron obtain ##s the best values , but is less consistent than the random forest method . When all features are combined , the best results for both scales are achieved with Multi - layer per ##ce ##pt ##ron . [unused1] Co ##rrel ##ation based feature selection [unused2] and M ##5 provide the best results , mean square error = 0 . 108 and mean square error = 0 . 06 ##1 respectively . Finally , the class im ##bal ##ance problem is mini ##mise ##d with the SM ##OT ##E approach for both scales ( mean square error < 0 . 00 ##6 ) . Machine [SEP]',\n",
       "  'existing_cui': 'C0010101',\n",
       "  'existing_cui_name': 'Correlation Study',\n",
       "  'existing_cui_desc': '[CLS] Co ##rrel ##ation Study [unused3] ( Research Act ##ivity , Statistical : Study , Co ##rrel ##ation ; Studies , Co ##rrel ##ation ; Co ##rrel ##ation Studies ; Co ##rrel ##ation ; Statistical Co ##rrel ##ation ) [SEP]',\n",
       "  'our_bi_cui': 'C0010101',\n",
       "  'our_bi_cui_name': 'Correlation Study',\n",
       "  'our_bi_cui_desc': '[CLS] Co ##rrel ##ation Study [unused3] ( Research Act ##ivity , Statistical : Study , Co ##rrel ##ation ; Studies , Co ##rrel ##ation ; Co ##rrel ##ation Studies ; Co ##rrel ##ation ; Statistical Co ##rrel ##ation ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27779321.8',\n",
       "  'test_set_idx': 16416,\n",
       "  'type': 'T170',\n",
       "  'name': 'equilibrium partitioning approach',\n",
       "  'context': '[CLS] dose - response models for p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l - contaminated sediment using equilibrium partition ##ing The study goal was to develop a sediment p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l dose - response model based on bent ##hic in ##vert ##eb ##rate effects to PC ##B ##s . The authors used an [unused1] equilibrium partition ##ing approach [unused2] to generate predicted p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l sediment effect concentrations ( largely A ##ro ##c ##lor 125 ##4 ) associated with a gradient of toxic effects in bent ##hic organisms from effects observed in aquatic toxicity studies . The present study differs from all other equilibrium partition ##ing collective sediment investigations in that the authors [SEP]',\n",
       "  'existing_cui': 'C0014653',\n",
       "  'existing_cui_name': 'Equilibrium',\n",
       "  'existing_cui_desc': '[CLS] E ##qui ##li ##bri ##um [unused3] ( B ##iol ##og ##ic Fun ##ction , Motor Process ##es , function , o ##bs ##er ##vable entity , qualifier value : balancing ; equilibrium ; Ba ##lance ; E ##qui ##li ##bri ##um , function ; Ba ##lancing ; balance ; Ba ##lance , function ) [SEP]',\n",
       "  'our_bi_cui': 'C1295077',\n",
       "  'our_bi_cui_name': 'Chemical separation method',\n",
       "  'our_bi_cui_desc': '[CLS] Chemical separation method [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27875010.26',\n",
       "  'test_set_idx': 20231,\n",
       "  'type': 'T017',\n",
       "  'name': 'tissues',\n",
       "  'context': '[CLS] ##al mac ##roa ##l ##gal species in the North Atlantic rocky inter ##ti ##dal zone , and found that nut ##rient - en ##rich ##ed al ##gal blades showed a significant increase in tissue growth compared to individuals grown under ambient conditions . We further q ##uant ##ified net photos ##ynth ##esis by ambient and nut ##rient - en ##rich ##ed [unused1] tissues [unused2] at sat ##ura ##ting i ##rra ##dian ##ce over a range of temperature conditions ( 6 - 30 °C ) . Re ##spiration was un ##af ##fected by nut ##rient treatment ; however , there was a significant increase in photos ##ynth ##etic oxygen production for nut ##rient - en ##rich ##ed tissue compared to ambient , but only at elevated ( [SEP]',\n",
       "  'existing_cui': 'C0040300',\n",
       "  'existing_cui_name': 'Body tissue',\n",
       "  'existing_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
       "  'our_bi_cui': 'C0040300',\n",
       "  'our_bi_cui_name': 'Body tissue',\n",
       "  'our_bi_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
       "  'our_cross_cui': 'C1514137',\n",
       "  'our_cross_cui_name': 'Plant Tissue , Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Plant T ##iss ##ue , Cell ##s [unused3] ( Ana ##tom ##ical Structure : Plant cells and tissues ) [SEP]'},\n",
       " {'mention_id': '28471040.2',\n",
       "  'test_set_idx': 37116,\n",
       "  'type': 'T103',\n",
       "  'name': 'lipid - polyethylene glycol - polymer hybrid nanoparticles',\n",
       "  'context': '[CLS] Far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid - loaded [unused1] lip ##id - p ##oly ##eth ##yle ##ne g ##ly ##co ##l - polymer hybrid na ##no ##par ##tic ##les [unused2] for treatment of g ##lio ##blast ##oma We aimed to develop lip ##id - p ##oly ##eth ##yle ##ne g ##ly ##co ##l ( lip ##id - p ##oly ##eth ##yle ##ne g ##ly ##co ##l ) - polymer hybrid na ##no ##par ##tic ##les , which have high affinity to t ##umour tissue with active ingredient , a new generation anti ##ne ##op ##lastic drug , far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid for treatment of g ##lio ##blast ##oma . Far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid [SEP]',\n",
       "  'existing_cui': 'C2000189',\n",
       "  'existing_cui_name': 'polyethylene glycol-poly',\n",
       "  'existing_cui_desc': '[CLS] p ##oly ##eth ##yle ##ne g ##ly ##co ##l - p ##oly [unused3] ( Chemical , prop ##yle ##ne im ##ine , prop ##yle ##ne im ##ine : P ##EG - PP ##I ) [SEP]',\n",
       "  'our_bi_cui': 'C0005479',\n",
       "  'our_bi_cui_name': 'Biomaterials',\n",
       "  'our_bi_cui_desc': '[CLS] B ##io ##mate ##rial ##s [unused3] ( Chemical : B ##io ##mate ##rial ; bio ##com ##pa ##tible materials ; B ##io ##medical Material ; bio ##mate ##rial ##s ; B ##io ##medical materials ; B ##io ##com ##pa ##tible Materials ; bio ##medical materials ; bio ##mate ##rial ; Materials , B ##io ##com ##pa ##tible ; bio ##medical material ; B ##io ##com ##pa ##tible Materials [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28295414.14',\n",
       "  'test_set_idx': 31552,\n",
       "  'type': 'T168',\n",
       "  'name': 'drinks',\n",
       "  'context': '[CLS] Administration proposed to expand the options for primary end points in the development of medications for alcohol use disorder to include either a ##bs ##tine ##nce from alcohol or a non ##ab ##st ##inen ##t outcome : no heavy drinking days ( with a heavy drinking day defined as more than 3 drinks per day for women and more than 4 [unused1] drinks [unused2] per day for men [ > 3 / > 4 cut ##off ] ) . The Food and Drug Administration also suggested that 6 months would be the most appropriate length for a clinical trial to demonstrate the stability of this non ##ab ##st ##inen ##t drinking outcome . However , few alcohol clinical trials have examined the stability of non ##hea [SEP]',\n",
       "  'existing_cui': 'C0452428',\n",
       "  'existing_cui_name': 'Drink',\n",
       "  'existing_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
       "  'our_bi_cui': 'C0452428',\n",
       "  'our_bi_cui_name': 'Drink',\n",
       "  'our_bi_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
       "  'our_cross_cui': 'C0001967',\n",
       "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
       "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
       " {'mention_id': '28286958.6',\n",
       "  'test_set_idx': 31315,\n",
       "  'type': 'T103',\n",
       "  'name': 'dihydrofuran rings',\n",
       "  'context': '[CLS] o ##xi ##da ##tive reaction of q ##uin ##az ##olin ##ones and al ##ky ##nes has been developed for se ##quential [ 4 + 2 ] and [ 3 + 2 ] c ##y ##c ##load ##ditions to assemble a novel fused - p ##oly ##cy ##c ##lic system containing te ##tra ##hy ##dr ##opy ##rid ##ine and [unused1] di ##hy ##dr ##of ##ura ##n rings [unused2] . The reaction process involves C - H and N - H bond functional ##ization for the formation of te ##tra ##hy ##dr ##opy ##rid ##ine and an oxygen radical c ##y ##c ##li ##zation for the di ##hy ##dr ##of ##ura ##n ring . This atom - and step - economical synthesis is highly efficient and has good [SEP]',\n",
       "  'existing_cui': 'C0650776',\n",
       "  'existing_cui_name': '2,3-dihydrofuran',\n",
       "  'existing_cui_desc': '[CLS] 2 , 3 - di ##hy ##dr ##of ##ura ##n [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C4078002',\n",
       "  'our_bi_cui_name': '2,5-dihydrofuran',\n",
       "  'our_bi_cui_desc': '[CLS] 2 , 5 - di ##hy ##dr ##of ##ura ##n [unused3] ( Chemical ) [SEP]',\n",
       "  'our_cross_cui': 'C0029224',\n",
       "  'our_cross_cui_name': 'Organic Chemicals',\n",
       "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
       " {'mention_id': '28077286.16',\n",
       "  'test_set_idx': 25066,\n",
       "  'type': 'T103',\n",
       "  'name': 'MeHg',\n",
       "  'context': '[CLS] brain barrier and is a known ne ##uro - toxic ##ant . Me ##H ##g accumulation in the brain causes his ##top ##ath ##ological alterations , ne ##uro ##be ##ha ##vior ##al changes , and imp ##air ##ments to cognitive motor functions in ma ##mmal ##ian models . However , in birds the ne ##uro ##to ##xi ##c effects of [unused1] Me ##H ##g [unused2] on the developing pre - hatch ##ing brain and con ##se ##quent behavioral alterations in adult birds have not received much attention . Moreover , pass ##eri ##ne birds are poorly represented in Me ##H ##g ne ##uro ##to ##xi ##cology studies in comparison to other a ##vian orders . Hence in this study , we used the egg injection method [SEP]',\n",
       "  'existing_cui': 'C0228520',\n",
       "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
       "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
       "  'our_bi_cui': 'C0025424',\n",
       "  'our_bi_cui_name': 'Mercury',\n",
       "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
       "  'our_cross_cui': 'C0025794',\n",
       "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
       "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
       " {'mention_id': '27791169.15',\n",
       "  'test_set_idx': 16868,\n",
       "  'type': 'T017',\n",
       "  'name': 'BPH9',\n",
       "  'context': '[CLS] p ##ests of rice ( Or ##y ##za sat ##iva L . ) . Currently , 30 Brown plant ##hop ##per - resistance genes have been genetically defined , most of which are cluster ##ed on specific chromosome regions . Here , we describe molecular c ##lon ##ing and characterization of a Brown plant ##hop ##per - resistance gene , [unused1] BP ##H ##9 [unused2] , mapped on the long arm of rice chromosome 12 ( 12 ##L ) . BP ##H ##9 en ##codes a rare type of n ##uc ##leo ##tide - binding and le ##uc ##ine - rich repeat ( n ##uc ##leo ##tide - binding and le ##uc ##ine - rich repeat ) - containing protein that local ##izes to the end [SEP]',\n",
       "  'existing_cui': 'C0005001',\n",
       "  'existing_cui_name': 'Benign prostatic hypertrophy',\n",
       "  'existing_cui_desc': '[CLS] Ben ##ign pro ##static h ##yper ##tro ##phy [unused3] ( B ##iol ##og ##ic Fun ##ction , BP ##H , ben ##ign , ben ##ign pro ##static h ##yper ##tro ##phy , diagnosis : H ##yper ##tro ##phy - pro ##st . ben . ; ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static h ##yper - ben ##ign ; Ben ##ign Pro ##static H ##yper ##p ##lasia - BP ##H ; En ##lar ##ged Pro ##state ; H ##yper ##tro ##phy , Ben ##ign Pro ##static ; H ##yper ##tro ##phy ( ben ##ign ) of pro ##state ; Ben ##ign h ##yper ##tro ##phy of pro ##state ; BP ##H - ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static [SEP]',\n",
       "  'our_bi_cui': 'C1419294',\n",
       "  'our_bi_cui_name': 'RBBP9 gene',\n",
       "  'our_bi_cui_desc': '[CLS] RB ##B ##P ##9 gene [unused3] ( Ana ##tom ##ical Structure : RB ##B ##P ##10 ; B ##5 ##T O ##VE ##RE ##X ##PR ##ES ##SE ##D GE ##NE ; RB ##B ##P ##9 Gene ; R ##ET ##IN ##O ##BL ##AS ##TO ##MA - B ##IN ##DI ##NG PR ##OT ##EI ##N 9 ; Re ##tino ##blast ##oma Bin ##ding Pro ##tein 9 Gene ; re ##tino ##blast ##oma binding protein 9 ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27832159.37',\n",
       "  'test_set_idx': 18585,\n",
       "  'type': 'T103',\n",
       "  'name': 'compound-326',\n",
       "  'context': '[CLS] - molecule , in a high - fat diet - induced o ##bes ##e mouse model . In v ##ivo Delta - 5 des ##at ##ura ##se in ##hibition was confirmed by determining changes in blood a ##rac ##hi ##don ##ic acid / D ##G ##LA profiles . In diet - induced o ##bes ##e mice , chronic treatment with [unused1] compound - 32 ##6 [unused2] lowered insulin resistance and caused body weight loss without significant impact on cumulative ca ##lor ##ie intake . Dec ##reased mac ##rop ##hage in ##fi ##ltration into ad ##ip ##ose tissue was expected from m ##RNA analysis . Inc ##reased daily energy expenditure was also observed following administration of compound - 32 ##6 , in line with sustained body weight [SEP]',\n",
       "  'existing_cui': 'C0258113',\n",
       "  'existing_cui_name': '4 - ( ( 3-bromophenyl ) amino ) -6,7 - dimethoxyquinazoline',\n",
       "  'existing_cui_desc': \"[CLS] 4 - ( ( 3 - br ##omo ##phe ##ny ##l ) amino ) - 6 , 7 - dim ##eth ##ox ##y ##quin ##az ##olin ##e [unused3] ( Chemical : Co ##mpo ##und 32 ; 4 - ( 3 ' - br ##omo ##ani ##lino ) - 6 , 7 - dim ##eth ##ox ##y ##quin ##az ##olin ##e ) [SEP]\",\n",
       "  'our_bi_cui': 'C0654579',\n",
       "  'our_bi_cui_name': 'NM 326',\n",
       "  'our_bi_cui_desc': '[CLS] N ##M 32 ##6 [unused3] ( Chemical : Benz ##ene ##met ##hana ##mini ##um , N - ( 2 - ( ( ( he ##xa ##de ##cy ##lo ##xy ) h ##ydro ##xy ##ph ##os ##phi ##ny ##l ) o ##xy ) et ##hyl ) - 3 - ( i ##od ##o - 125 ##I ) - N , N - dim ##eth ##yl - , h ##ydro ##xi ##de , inner salt ; N ##M - 32 ##6 ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28373341.3',\n",
       "  'test_set_idx': 33457,\n",
       "  'type': 'T098',\n",
       "  'name': 'low spenders',\n",
       "  'context': '[CLS] Most Americans Have Good Health , Little Un ##met Need , And Few Health Care Ex ##pen ##ses The distribution of health care expenditure ##s remains highly concentrated , but most Americans use few health care resources and have low out - of - pocket spending . More than 93 percent of \" [unused1] low spend ##ers [unused2] \" ( those in the bottom half of the population ) believe they have received all needed care in a time ##ly manner . The low spending by the majority of the population has remained almost unchanged during the thirty - seven - year period examined . [SEP]',\n",
       "  'existing_cui': 'C0238421',\n",
       "  'existing_cui_name': 'Selenium deficiency',\n",
       "  'existing_cui_desc': '[CLS] Se ##len ##ium deficiency [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : deficiency se ##len ##ium ; Se + + low ; deficiency ; se ##len ##ium ; low se ##s ; se ##len ##ium ; deficiency ; Se levels low ; se ##len ##ium deficiency ) [SEP]',\n",
       "  'our_bi_cui': 'C0024045',\n",
       "  'our_bi_cui_name': 'Low-Income Population',\n",
       "  'our_bi_cui_desc': '[CLS] Low - Inc ##ome Population [unused3] ( Population Group : income low populations ; Population ##s , Low Inc ##ome ; Population , Low Inc ##ome ; Low - Inc ##ome Population ##s ; low - income population ; Population , Low - Inc ##ome ; Low Inc ##ome Population ##s ; Low Inc ##ome Population ; Population ##s , Low - Inc ##ome ) [SEP]',\n",
       "  'our_cross_cui': 'C1257890',\n",
       "  'our_cross_cui_name': 'Population Group',\n",
       "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
       " {'mention_id': '27235559.6',\n",
       "  'test_set_idx': 303,\n",
       "  'type': 'T074',\n",
       "  'name': 'vein visualization display system',\n",
       "  'context': '[CLS] Does infrared visual ##ization improve selection of ve ##ni ##pu ##nc ##ture sites for in ##d ##well ##ing needle at the forearm in second - year nursing students ? To evaluate the effectiveness of a [unused1] vein visual ##ization display system [unused2] using near - infrared light ( \" V ##ein Di ##sp ##lay \" ) for the safe and proper selection of ve ##ni ##pu ##nc ##ture sites for in ##d ##well ##ing needle placement in the forearm . Ten second year nursing students were recruited to apply an in ##d ##well ##ing needle line with and without V ##ein Di ##sp ##lay . Another ten participants were recruited from various faculty to serve as patients . The quality of the ve ##ni ##pu ##nc [SEP]',\n",
       "  'existing_cui': 'C0175631',\n",
       "  'existing_cui_name': 'Imagery',\n",
       "  'existing_cui_desc': '[CLS] Image ##ry [unused3] ( B ##iol ##og ##ic Fun ##ction : visual ##ization ; Visual ##ization ; imagery ) [SEP]',\n",
       "  'our_bi_cui': 'C0182167',\n",
       "  'our_bi_cui_name': 'Visual paging system',\n",
       "  'our_bi_cui_desc': '[CLS] Visual p ##aging system [unused3] ( Medical Devi ##ce , physical object : Pa ##ging Systems , Visual ) [SEP]',\n",
       "  'our_cross_cui': 'C0025080',\n",
       "  'our_cross_cui_name': 'Medical Devices',\n",
       "  'our_cross_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]'},\n",
       " {'mention_id': '27298278.21',\n",
       "  'test_set_idx': 1822,\n",
       "  'type': 'T103',\n",
       "  'name': 'D',\n",
       "  'context': '[CLS] ##ho ##quin ##one , an ant ##hra ##quin ##one , and a nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##er , together with three known q ##uin ##ones and seven other known compounds , were isolated from the aerial parts of Mo ##rin ##da par ##vi ##folia . The structures of m ##ori ##nda ##par ##vin ##s C , [unused1] D [unused2] , E , F , and G were el ##uc ##idated on the basis of s ##pect ##ros ##copic or X - ray di ##ff ##raction analysis as met ##hyl 4 - h ##ydro ##xy - 1 , 6 - dim ##eth ##ox ##y - nap ##ht ##hale ##ne - 2 - car ##box ##yla ##te , met ##hyl 4 , 8 [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0010207',\n",
       "  'our_bi_cui_name': 'Coumarins',\n",
       "  'our_bi_cui_desc': '[CLS] Co ##uma ##rin ##s [unused3] ( Chemical : co ##uma ##rin ##s ; Co ##uma ##rine ##s ; Der ##via ##tives , 1 , 2 - Benz ##opy ##rone ; 1 , 2 - Benz ##opy ##rone ##s ; Benz ##opy ##ran 2 ones ; 1 , 2 - Benz ##opy ##rone Der ##via ##tives ; Co ##uma ##rin ##s [ Chemical / In ##g ##red ##ient ] ; 1 , 2 Benz ##opy ##rone ##s ; Co ##uma ##rin Der ##iva ##tives ; Der ##iva ##tives , Co ##uma ##rin ; Benz ##opy ##ran - 2 - ones ; B ##EN ##Z ##OP ##Y ##RO ##NE ##S 01 02 ; 1 , 2 Benz ##o P ##yr ##ones ; 1 , 2 - Benz ##o [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28237762.14',\n",
       "  'test_set_idx': 29316,\n",
       "  'type': 'T103',\n",
       "  'name': 'acylated phenoxyanilide',\n",
       "  'context': '[CLS] ##ama ##se The novel classes of a ##cy ##lated p ##hen ##ox ##yan ##ili ##de and th ##io ##ure ##a compounds were investigated for their ability to in ##hibit T ##EM type β - la ##ct ##ama ##se enzyme . Two compounds 4 ##g and 5 ##c reveal the in ##hibition pot ##ency in micro ##mo ##lar range and show their action by non - co ##valent binding in the vicinity of the T ##EM - 171 active site . The structure activity relationship around carbon chain length and different sub ##st ##it ##uen ##ts in or ##th ##o - and para - positions of [unused1] a ##cy ##lated p ##hen ##ox ##yan ##ili ##de [unused2] as well as molecular modelling study has been performed . [SEP]',\n",
       "  'existing_cui': 'C0031403',\n",
       "  'existing_cui_name': 'Phenetidine',\n",
       "  'existing_cui_desc': '[CLS] Ph ##ene ##ti ##dine [unused3] ( Chemical : Ph ##ene ##ti ##dine [ Chemical / In ##g ##red ##ient ] ; Benz ##ena ##mine , 4 - et ##ho ##xy - ; Am ##ino ##phe ##net ##ole ; E ##th ##ox ##yan ##ili ##ne ) [SEP]',\n",
       "  'our_bi_cui': 'C0029224',\n",
       "  'our_bi_cui_name': 'Organic Chemicals',\n",
       "  'our_bi_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27894020.2',\n",
       "  'test_set_idx': 21111,\n",
       "  'type': 'T033',\n",
       "  'name': 'detection',\n",
       "  'context': '[CLS] The an ##ato ##mic ##al mum ##mie ##s of Mom ##bell ##o : [unused1] detection [unused2] of cocaine , ni ##cot ##ine , and ca ##ffe ##ine in the hair of psychiatric patients of the early 20th century The Mom ##bell ##o P ##sy ##chia ##tric Hospital in Lim ##bia ##te , near Milan , replaced the old Sen ##av ##ra Hospital as the P ##sy ##chia ##tric Hospital for the Province of Milan in the 19th century . During the early 20th century , bodies of several Mom ##bell ##o patients were di ##sse ##cted and preserved by Giuseppe Para ##vic ##ini , an an ##ato ##mist who operated within the asylum . The aim of the present study was to examine and memorial ##ize [SEP]',\n",
       "  'existing_cui': 'C0206100',\n",
       "  'existing_cui_name': 'Signal Detection',\n",
       "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
       "  'our_bi_cui': 'C1511790',\n",
       "  'our_bi_cui_name': 'Detection',\n",
       "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
       "  'our_cross_cui': 'C0442726',\n",
       "  'our_cross_cui_name': 'Detected',\n",
       "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
       " {'mention_id': '28167893.15',\n",
       "  'test_set_idx': 27456,\n",
       "  'type': 'T058',\n",
       "  'name': 'cultured',\n",
       "  'context': '[CLS] ##a imp ##ede the practical control of the Alt ##ern ##aria diseases in crop fields . This study aimed to investigate c ##yt ##ological fungi ##cid ##e resistance mechanisms of A . alter ##nat ##a against di ##car ##box ##im ##ide fungi ##cid ##e i ##p ##rod ##ione . A . alter ##nat ##a isolated from ca ##ctus brown spot was [unused1] culture ##d [unused2] on potato - de ##x ##tro ##se a ##gar with or without i ##p ##rod ##ione , and the fun ##gal cultures with different growth characteristics from no , initial and full growth were observed by light and electron micro ##sco ##py . My ##cel ##ia began to grow from one day after in ##cu ##bation and continued to be in [SEP]',\n",
       "  'existing_cui': 'C0007600',\n",
       "  'existing_cui_name': 'Cultured Cell Line',\n",
       "  'existing_cui_desc': '[CLS] Culture ##d Cell Line [unused3] ( Ana ##tom ##ical Structure : Cell lines ; cells lines ; culture ##d cell line ; Line , Cell ; Cell Line ; cells lining ; culture ##d cells ; cell line ; cell lining ; Cell Lines ; cell lines ; cells line ; Lines , Cell ) [SEP]',\n",
       "  'our_bi_cui': 'C0430400',\n",
       "  'our_bi_cui_name': 'Laboratory culture',\n",
       "  'our_bi_cui_desc': '[CLS] Laboratory culture [unused3] ( Health Care Act ##ivity , lab test , procedure : Culture ; Culture - general ; culture ; Sam ##ple culture ; laboratory culture ; sample culture ; culture from any source ; a culture from any source ) [SEP]',\n",
       "  'our_cross_cui': 'C0200954',\n",
       "  'our_cross_cui_name': 'Mycology culture',\n",
       "  'our_cross_cui_desc': '[CLS] My ##cology culture [unused3] ( Health Care Act ##ivity , lab test , procedure : culture fungus ; Culture for fungi ; fun ##gal culture ; my ##cology culture ; Fun ##gus culture ; fungus culture ; fungi culture ) [SEP]'},\n",
       " {'mention_id': '27876145.17',\n",
       "  'test_set_idx': 20326,\n",
       "  'type': 'T062',\n",
       "  'name': 'amplification strategies',\n",
       "  'context': '[CLS] ##ay let - 7 ##a micro ##RNA I ##maging of micro ##RNA in living cells could facilitate the monitoring of the expression and distribution of micro ##RNA and research on micro ##RNA - related diseases . Given the low expression levels and even down - regulation of cellular micro ##RNA that is associated with some diseases , enzyme - free [unused1] am ##p ##lification strategies [unused2] are imp ##erative for in ##tra ##cellular micro ##RNA ass ##ay . In this work , we report an en ##tropy - driven reaction for am ##p ##lification ass ##ay micro ##RNA with a detection limit of 0 . 27 p ##M . The resulting signal am ##p ##lification provides excellent recognition and signal enhance ##ment of specific micro ##RNA [SEP]',\n",
       "  'existing_cui': 'C1705759',\n",
       "  'existing_cui_name': 'Gene Amplification Abnormality',\n",
       "  'existing_cui_desc': '[CLS] Gene Am ##p ##lification A ##b ##nor ##mal ##ity [unused3] ( B ##iol ##og ##ic Fun ##ction : Am ##p ##lification ; Gene Am ##p ##lification ) [SEP]',\n",
       "  'our_bi_cui': 'C1517480',\n",
       "  'our_bi_cui_name': 'Gene Amplification Technique',\n",
       "  'our_bi_cui_desc': '[CLS] Gene Am ##p ##lification Tech ##ni ##que [unused3] ( Research Act ##ivity : Am ##p ##lification ) [SEP]',\n",
       "  'our_cross_cui': 'C0887815',\n",
       "  'our_cross_cui_name': 'RNA Amplification Techniques',\n",
       "  'our_cross_cui_desc': '[CLS] RNA Am ##p ##lification Tech ##ni ##ques [unused3] ( Research Act ##ivity : Am ##p ##lification Tech ##nics , RNA ; Am ##p ##lification Tech ##ni ##que , RNA ; RNA Am ##p ##lification Tech ##nic ; Am ##p ##lification Tech ##nic , RNA ; Tech ##nic , RNA Am ##p ##lification ; RNA Am ##p ##lification Tech ##nics ; Am ##p ##lification Tech ##ni ##ques , RNA ; Tech ##ni ##que , RNA Am ##p ##lification ; Tech ##nics , RNA Am ##p ##lification ; Tech ##ni ##ques , RNA Am ##p ##lification ; RNA Am ##p ##lification Tech ##ni ##que ) [SEP]'},\n",
       " {'mention_id': '28168514.36',\n",
       "  'test_set_idx': 27551,\n",
       "  'type': 'T058',\n",
       "  'name': 'third - generation dual - source CT',\n",
       "  'context': '[CLS] PP ##V : 86 . 0 % ; N ##P ##V : 99 . 0 % ) provided comparable diagnostic accuracy ( p = n . s . ) . SS ##M yielded significantly lower radiation doses as compared to he ##lica ##l scan mode ( 2 . 1 ± 2 . 0 vs . 5 . 1 ± 3 . 3 m ##S ##v ; p = 0 . 000 ##1 ) in age and B ##MI - matched co ##hor ##ts . SS ##M in [unused1] third - generation dual - source CT [unused2] enables significant dose savings and provides robust diagnostic image quality in patients with A ##gat ##ston score ≤ 2000 independent of heart rate , heart rhythm or o ##besity . [SEP]',\n",
       "  'existing_cui': 'C0449416',\n",
       "  'existing_cui_name': 'Source',\n",
       "  'existing_cui_desc': '[CLS] Source [unused3] ( Finding , attribute : source ; sources ) [SEP]',\n",
       "  'our_bi_cui': 'C4055114',\n",
       "  'our_bi_cui_name': 'Dual energy computed tomography',\n",
       "  'our_bi_cui_desc': '[CLS] Dual energy com ##puted to ##mo ##graphy [unused3] ( Health Care Act ##ivity , procedure : Dual - Energy Co ##mp ##uted Tom ##ography ; DE ##CT - dual energy com ##puted to ##mo ##graphy ) [SEP]',\n",
       "  'our_cross_cui': 'C0040405',\n",
       "  'our_cross_cui_name': 'X-Ray Computed Tomography',\n",
       "  'our_cross_cui_desc': '[CLS] X - Ray Co ##mp ##uted Tom ##ography [unused3] ( Health Care Act ##ivity , computer ##ized to ##mo ##graphy , procedure : Sc ##an , X - Ray CT ; com ##puted to ##mo ##graphy x rays ; EMI scan ; em ##i scan ; CT X ##RA ##Y ; Co ##mp ##uted X - Ray Tom ##ography ; Computer ##ised trans ##ax ##ial to ##mo ##graphy ; to ##mo ##den ##si ##tom ##et ##ry ; CA ##T scan - ; CT Sc ##an , X Ray ; Computer ##ized to ##mo ##gram ; X - Ray CA ##T Sc ##an ; Computer ##ized trans ##ax ##ial to ##mo ##graphy ; x - ray com ##puted to ##mo ##graphy ; Tom ##ography , Trans ##mission [SEP]'},\n",
       " {'mention_id': '27538372.8',\n",
       "  'test_set_idx': 9789,\n",
       "  'type': 'T103',\n",
       "  'name': 'mitochondrial regulators',\n",
       "  'context': '[CLS] ##hos ##pha ##tase 1 regulate ##s the early differentiation of card ##io ##my ##ocytes from mouse em ##b ##ryo ##nic stem cells Mi ##to ##cho ##nd ##ria are crucial for maintaining the properties of em ##b ##ryo ##nic stem cells and for regulating their subsequent differentiation into diverse cell lineage ##s , including card ##io ##my ##ocytes . However , [unused1] mitochondrial regulator ##s [unused2] that manage the rate of differentiation or cell fate have been rarely identified . This study aimed to determine the potential mitochondrial factor that controls the differentiation of em ##b ##ryo ##nic stem cells into cardiac my ##ocytes . We induced card ##io ##my ##oc ##yte differentiation from mouse em ##b ##ryo ##nic stem cells and performed micro ##arra ##y ass [SEP]',\n",
       "  'existing_cui': 'C0026237',\n",
       "  'existing_cui_name': 'Mitochondria',\n",
       "  'existing_cui_desc': '[CLS] Mi ##to ##cho ##nd ##ria [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : mit ##och ##ond ##ria ; Mi ##to ##cho ##nd ##rial structure ; Mi ##to ##cho ##nd ##rion ; mit ##och ##ond ##rion ; Mi ##to ##cho ##nd ##rial ; mitochondrial ) [SEP]',\n",
       "  'our_bi_cui': 'C0949610',\n",
       "  'our_bi_cui_name': 'Mitochondrial Proteins',\n",
       "  'our_bi_cui_desc': '[CLS] Mi ##to ##cho ##nd ##rial Pro ##tein ##s [unused3] ( Chemical : mitochondrial protein ; Pro ##tein , Mi ##to ##cho ##nd ##rial ; mitochondrial proteins ; Mi ##to ##cho ##nd ##rial Pro ##tein ; Mi ##to ##cho ##nd ##rial Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; Pro ##tein ##s , Mi ##to ##cho ##nd ##rial ) [SEP]',\n",
       "  'our_cross_cui': 'C0574031',\n",
       "  'our_cross_cui_name': 'Biologically active substance',\n",
       "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
       " {'mention_id': '27355340.29',\n",
       "  'test_set_idx': 3467,\n",
       "  'type': 'T082',\n",
       "  'name': 'plots',\n",
       "  'context': '[CLS] pH , and near infrared absorb ##ance , were collected in real - time in a field with two management strategies ( reduced till ##age / conventional till ##age ) and sandy to lo ##am soils . pro ##ximal soil sensing was related to observations from a long - term ( 11 years ) earth ##worm observation study conducted at 42 [unused1] plots [unused2] . Earth ##worm ##s were sampled from 0 . 5 x 0 . 5 x 0 . 2 m ³ soil blocks and identified to species level . Sen ##sor data were highly correlated with earth ##worm abundance ##s observed in reduced till ##age but less correlated with earth ##worm abundance ##s observed in conventional till ##age . This may indicate that [SEP]',\n",
       "  'existing_cui': 'C0162435',\n",
       "  'existing_cui_name': 'Olfactory tract',\n",
       "  'existing_cui_desc': '[CLS] O ##lf ##actor ##y tract [unused3] ( Ana ##tom ##ical Structure , body structure : T ##rac ##ts , O ##lf ##actor ##y ; T ##rac ##ts , Later ##al O ##lf ##actor ##y ; O ##lf ##actor ##y T ##rac ##ts ; O ##lf ##actor ##y tract structure ; St ##ria o ##lf ##actor ##ia lateral ##is ; O ##lf ##actor ##y T ##rac ##t ; T ##rac ##tus o ##lf ##actor ##ius ; Later ##al o ##lf ##actor ##y s ##tri ##ae ; T ##rac ##tus o ##lf ##actor ##ius lateral ##is ; o ##lf ##actor ##y tract ; O ##lf ##actor ##y T ##rac ##ts , Later ##al ; O ##lf ##actor ##y T ##rac ##t , Later ##al ; Later ##al O [SEP]',\n",
       "  'our_bi_cui': 'C0032098',\n",
       "  'our_bi_cui_name': 'Plants',\n",
       "  'our_bi_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]',\n",
       "  'our_cross_cui': 'C0562975',\n",
       "  'our_cross_cui_name': 'Agricultural field',\n",
       "  'our_cross_cui_desc': '[CLS] Agricultural field [unused3] ( Spa ##tial Concept , environment ) [SEP]'},\n",
       " {'mention_id': '28351424.19',\n",
       "  'test_set_idx': 32839,\n",
       "  'type': 'T170',\n",
       "  'name': '( CENTRAL )',\n",
       "  'context': '[CLS] predict ##ive of I ##CU admission . We describe the protocol for a systematic review of variables associated with I ##CU admission . ME ##D ##L ##IN ##E , E ##MB ##AS ##E , C ##IN ##A ##HL and the Cochrane Library , including Cochrane Database of System ##atic Reviews and the Cochrane Central Register of Control ##led Trials [unused1] ( CE ##NT ##RA ##L ) [unused2] will be searched for studies that assess the association of routinely recorded variables associated with subsequent un ##p ##lan ##ned I ##CU admission . Only studies involving adult patients admitted to general intensive care units will be included . We will extract data relating to the statistical association between I ##CU admission and predict ##or variables , the quality [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0242356',\n",
       "  'our_bi_cui_name': 'Databases',\n",
       "  'our_bi_cui_desc': '[CLS] Database ##s [unused3] ( Intel ##lect ##ual Product : database ; Data Bank ; Database ; data ##bank ; data base ; Database , Electronic ; databases ; data bank ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28223077.28',\n",
       "  'test_set_idx': 28912,\n",
       "  'type': 'T082',\n",
       "  'name': 'surrounding sites',\n",
       "  'context': '[CLS] from surrounding sites , background site , up ##wind site and down ##wind site of a Municipal solid waste land ##fill in East China . The results of present study were summarized as follows . ( 1 ) The total concentrations of PC ##D ##D / F ##s ( [UNK] PC ##D ##D / F ##s ) in ambient air from [unused1] surrounding sites [unused2] , background site , up ##wind site and down ##wind site were 2 . 215 ± 1 . 00 ##4 , 2 . 05 ##8 ± 0 . 45 ##8 , 2 . 61 ##7 ± 1 . 09 ##2 and 1 . 82 ##2 ± 0 . 56 ##6 p ##g ##N ##m ( - 3 ) , respectively . [SEP]',\n",
       "  'existing_cui': 'C1282914',\n",
       "  'existing_cui_name': 'Surrounding',\n",
       "  'existing_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
       "  'our_bi_cui': 'C1282914',\n",
       "  'our_bi_cui_name': 'Surrounding',\n",
       "  'our_bi_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
       "  'our_cross_cui': 'C0205145',\n",
       "  'our_cross_cui_name': 'Site',\n",
       "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
       " {'mention_id': '27320863.13',\n",
       "  'test_set_idx': 2314,\n",
       "  'type': 'T168',\n",
       "  'name': 'methionine and choline - deficient diet',\n",
       "  'context': '[CLS] ##mo ##cy ##stein ##e met ##hyl ##tra ##ns ##fer ##ase ( beta ##ine - ho ##mo ##cy ##stein ##e met ##hyl ##tra ##ns ##fe ##ase ) We investigated the anti - lip ##ogenic effect of beta ##ine in rats fed met ##hi ##oni ##ne and ch ##olin ##e - def ##icient diet . In ##take of [unused1] met ##hi ##oni ##ne and ch ##olin ##e - def ##icient diet [unused2] for 3 w ##k resulted in a significant accumulation of he ##pa ##tic lip ##ids , which was prevented by beta ##ine supplement ##ation in drinking water ( 1 % ) . Ph ##os ##ph ##ory ##lation of AM ##P - activated protein kinase , ace ##ty ##l - Co ##A car ##box ##yla ##se , [SEP]',\n",
       "  'existing_cui': 'C2928853',\n",
       "  'existing_cui_name': 'Choline / Methionine',\n",
       "  'existing_cui_desc': '[CLS] Cho ##line / Met ##hi ##oni ##ne [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0452278',\n",
       "  'our_bi_cui_name': 'Low methionine diet',\n",
       "  'our_bi_cui_desc': '[CLS] Low met ##hi ##oni ##ne diet [unused3] ( Health Care Act ##ivity , finding , regime / therapy : Dec ##rease in met ##hi ##oni ##ne content of the diet compared to the assessed base ##line intake of met ##hi ##oni ##ne for the individual . ( Source : Academy of N ##utrition and Diet ##etics N ##utrition In ##formatics Committee 2013 ) ; Dec ##reased met ##hi ##oni ##ne diet ) [SEP]',\n",
       "  'our_cross_cui': 'C0012155',\n",
       "  'our_cross_cui_name': 'Diet',\n",
       "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
       " {'mention_id': '27710934.13',\n",
       "  'test_set_idx': 14824,\n",
       "  'type': 'T082',\n",
       "  'name': 'PCP',\n",
       "  'context': '[CLS] ##ing domains have been co - opted into Non ##ri ##bos ##oma ##l p ##eptide s ##ynth ##eta ##ses to introduce further variety into non ##ri ##bos ##oma ##l p ##eptide products . Line ##ar gram ##ici ##din s ##ynth ##eta ##se contains a unique form ##yla ##tion - tail ##oring domain in its initiation module ( F - A - [unused1] PC ##P [unused2] ) . The structure of the F - A di - domain has previously been determined in a crystal form which had large solvent channels and no density for the minor As ##ub sub ##dom ##ain . An attempt was made to take advantage of this packing by removing the As ##ub sub ##dom ##ain from the construct ( F - [SEP]',\n",
       "  'existing_cui': 'C1418873',\n",
       "  'existing_cui_name': 'PRCP gene',\n",
       "  'existing_cui_desc': '[CLS] PR ##CP gene [unused3] ( Ana ##tom ##ical Structure : H ##UM ##PC ##P ; AN ##GI ##OT ##EN ##SI ##NA ##SE C ; PR ##OL ##Y ##LC ##AR ##BO ##X ##YP ##EP ##TI ##DA ##SE ; an ##gio ##tens ##inas ##e C ; PC ##P ; pro ##ly ##l ##car ##box ##ype ##pt ##idas ##e ) [SEP]',\n",
       "  'our_bi_cui': 'C0030956',\n",
       "  'our_bi_cui_name': 'Peptides',\n",
       "  'our_bi_cui_desc': '[CLS] P ##eptide ##s [unused3] ( Chemical , substance : p ##eptide ; p ##eptide ##s ; P ##eptide ##s [ Chemical / In ##g ##red ##ient ] ; P ##eptide ) [SEP]',\n",
       "  'our_cross_cui': 'C1514562',\n",
       "  'our_cross_cui_name': 'Protein Domain',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein Domain [unused3] ( Spa ##tial Concept : Domain ; Mo ##ti ##f ; Region ; Domain ##s , P ##eptide ; Domain , Pro ##tein ; Domain ##s , Pro ##tein ; domain ; Pro ##tein Feature ; Pro ##tein Domain ##s ; Feature ; Pro ##tein Mo ##ti ##f ; Sign ##ature ; Domain , P ##eptide ; Pro ##tein Region ; P ##eptide Domain ; P ##eptide Domain ##s ) [SEP]'},\n",
       " {'mention_id': '27506129.11',\n",
       "  'test_set_idx': 8643,\n",
       "  'type': 'T170',\n",
       "  'name': 'automatic framework',\n",
       "  'context': '[CLS] time consuming , thus creating a need for its auto ##mat ##isation . However , the task is far from straightforward due to data issues such as class im ##bal ##ance or correlated features . In this paper , we study the specific features of h ##yper ##emia and propose various approaches to address these problems in the context of an [unused1] automatic framework [unused2] for h ##yper ##emia g ##rading . Over ##sa ##mp ##ling , under ##sa ##mp ##ling and SM ##OT ##E approaches were applied in order to tackle the problem of class im ##bal ##ance . 25 features were com ##puted for each image and re ##gression methods were then used to transform them into a value on the g ##rading scale [SEP]',\n",
       "  'existing_cui': 'C0450152',\n",
       "  'existing_cui_name': 'Metal framework',\n",
       "  'existing_cui_desc': '[CLS] Metal framework [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
       "  'our_bi_cui': 'C0002045',\n",
       "  'our_bi_cui_name': 'algorithm',\n",
       "  'our_bi_cui_desc': '[CLS] algorithm [unused3] ( Intel ##lect ##ual Product : Al ##gor ##ith ##m ; Al ##gor ##ith ##ms ; algorithms ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27474969.2',\n",
       "  'test_set_idx': 7419,\n",
       "  'type': 'T103',\n",
       "  'name': 'reduced graphene oxide',\n",
       "  'context': '[CLS] An ultra ##sen ##sitive electro ##che ##mi ##lum ##ines ##cence sensor based on [unused1] reduced graph ##ene oxide [unused2] - copper su ##lf ##ide composite coupled with cap ##illa ##ry electro ##ph ##ores ##is for determination of am ##lo ##di ##pine be ##sy ##late in mice plasma A new electro ##che ##mi ##lum ##ines ##cence sensor based on reduced graph ##ene oxide - copper su ##lf ##ide ( r ##G ##O - C ##u ##S ) composite coupled with cap ##illa ##ry electro ##ph ##ores ##is was constructed for the ultra ##sen ##sitive detection of am ##lo ##di ##pine be ##sy ##late for the first time . In this work , r ##G ##O - C ##u ##S composite was synthesized by one - pot h [SEP]',\n",
       "  'existing_cui': 'C1957670',\n",
       "  'existing_cui_name': 'oxidosqualene',\n",
       "  'existing_cui_desc': '[CLS] o ##xi ##dos ##qua ##lene [unused3] ( Chemical : sq ##us ##lene oxide ) [SEP]',\n",
       "  'our_bi_cui': 'C0060240',\n",
       "  'our_bi_cui_name': 'ferric oxide',\n",
       "  'our_bi_cui_desc': '[CLS] f ##er ##ric oxide [unused3] ( Chemical , III , iron oxide , red , substance : Map ##ico Red ; F ##ER ##RI ##C O ##X ##ID ##E , R ##ED ; Iron oxide ; Iron O ##xi ##de Red ; iron oxide ; f ##er ##ric oxide [ Chemical / In ##g ##red ##ient ] ; Natural Red O ##xi ##de ; red iron oxide ; F ##ER ##RI ##C O ##X ##ID ##E ; f ##er ##ric oxide red ; Red O ##ch ##re ; iron oxide red ; Indian Red ; Di ##iro ##n Trio ##xi ##de ; co ##l ##cot ##har ; Iron O ##xi ##de , Red ; R ##ubi ##go ; Stone Red ; Col ##cot ##har ; I [SEP]',\n",
       "  'our_cross_cui': 'C2936695',\n",
       "  'our_cross_cui_name': 'Graphene',\n",
       "  'our_cross_cui_desc': '[CLS] G ##rap ##hen ##e [unused3] ( Chemical ) [SEP]'},\n",
       " {'mention_id': '28407355.22',\n",
       "  'test_set_idx': 34806,\n",
       "  'type': 'T017',\n",
       "  'name': 'EV',\n",
       "  'context': '[CLS] ##ative im ##mu ##no ##mo ##du ##lator ##y effects in injured tissues . Recent studies have highlighted beneficial effects of extra ##cellular ve ##si ##cles from MS ##Cs ( Me ##sen ##chy ##mal stem cells - E ##V ) on tissue injury . The effects of systemic ##ally administered mouse bone ma ##rrow derived Me ##sen ##chy ##mal stem cells - [unused1] E ##V [unused2] were evaluated in an experimental m ##uri ##ne model of he ##pa ##tic is ##che ##mia - re ##per ##fusion injury induced by cross c ##lamp ##ing the he ##pa ##tic artery and portal vein for 90 minutes followed by re ##per ##fusion for periods of up ##to 6 hours . Compared with controls , in ##tra ##ven ##ous administration of [SEP]',\n",
       "  'existing_cui': 'C0014522',\n",
       "  'existing_cui_name': 'Epidermodysplasia Verruciformis',\n",
       "  'existing_cui_desc': '[CLS] E ##pid ##er ##mo ##dy ##sp ##lasia V ##er ##ru ##ci ##form ##is [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : e ##pid ##er ##mo ##dy ##sp ##lasia ve ##rr ##uc ##iform ##is ; Le ##wan ##do ##ws ##ky - Lu ##tz D ##ys ##p ##lasia ; Le ##wan ##do ##ws ##ky - Lu ##tz disease ; Lu ##tz - Le ##wan ##do ##ws ##ky Disease ; Lu ##tz Le ##wan ##do ##ws ##ky Disease ; L ##UT ##Z L ##E ##WA ##ND ##OW ##S ##K ##Y D ##IS ; E ##pid ##er ##mo ##dy ##sp ##lasia V ##er ##ru ##ci ##form ##is [ Disease / Finding ] ; Disease , Lu ##tz - Le ##wan ##do ##ws ##ky ; EP ##ID ##ER [SEP]',\n",
       "  'our_bi_cui': 'C2350307',\n",
       "  'our_bi_cui_name': 'Cell-Derived Microparticles',\n",
       "  'our_bi_cui_desc': '[CLS] Cell - Der ##ive ##d Micro ##par ##tic ##les [unused3] ( Ana ##tom ##ical Structure : Me ##mb ##rane Micro ##par ##tic ##le , Cell ; e ##ct ##oso ##me ; E ##ct ##oso ##me ; She ##dding Micro ##ves ##icles ; Micro ##ves ##icle ; Micro ##ves ##icle , She ##dding ; extra ##cellular micro ##ves ##icle ; Me ##mb ##rane Micro ##par ##tic ##les , Cell ; micro ##ves ##icle ; She ##dding Micro ##ves ##icle ; E ##ct ##oso ##mes ; Micro ##par ##tic ##le , Cell - Der ##ive ##d ; Cell Me ##mb ##rane Micro ##par ##tic ##les ; Micro ##par ##tic ##le ; Cell Der ##ive ##d Micro ##par ##tic ##les ; Micro ##par ##tic ##les , Cell Der ##ive [SEP]',\n",
       "  'our_cross_cui': 'C3894683',\n",
       "  'our_cross_cui_name': 'Extracellular Vesicles',\n",
       "  'our_cross_cui_desc': '[CLS] Extra ##cellular V ##esi ##cles [unused3] ( Ana ##tom ##ical Structure : V ##esi ##cles , Extra ##cellular ; Extra ##cellular V ##esi ##cle ; V ##esi ##cle , Extra ##cellular ; extra ##cellular ve ##si ##cle ) [SEP]'},\n",
       " {'mention_id': '27320863.51',\n",
       "  'test_set_idx': 2352,\n",
       "  'type': 'T103',\n",
       "  'name': 'inhibitor',\n",
       "  'context': '[CLS] - 1 ##c and p ##L ##K ##B ##1 in He ##p ##G ##2 cells . Met ##form ##in - induced activation of AM ##P - activated protein kinase was also in ##hibit ##ed by ho ##mo ##cy ##stein ##e . Treatment with h ##ydro ##xy ##lam ##ine , a c ##ys ##tat ##hi ##oni ##ne β - s ##ynth ##ase [unused1] inhibitor [unused2] , resulted in a reduction of p ##AM ##P ##K , p ##AC ##C and p ##SR ##E ##B ##P - 1 ##c , accompanied by an elevation of in ##tra ##cellular ho ##mo ##cy ##stein ##e . Beta ##ine treatment prevented the ho ##mo ##cy ##stein ##e - induced reduction of p ##AM ##P ##K , p ##AC ##C , p [SEP]',\n",
       "  'existing_cui': 'C0243077',\n",
       "  'existing_cui_name': 'inhibitors',\n",
       "  'existing_cui_desc': '[CLS] inhibitor ##s [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0243077',\n",
       "  'our_bi_cui_name': 'inhibitors',\n",
       "  'our_bi_cui_desc': '[CLS] inhibitor ##s [unused3] ( Chemical ) [SEP]',\n",
       "  'our_cross_cui': 'C0014432',\n",
       "  'our_cross_cui_name': 'Enzyme Inhibitors',\n",
       "  'our_cross_cui_desc': '[CLS] En ##zy ##me In ##hibit ##ors [unused3] ( Chemical , product , substance : E ##N ##Z ##Y ##ME IN ##H ##IB ; enzyme inhibitor ; enzyme inhibitor ##s ; En ##zy ##me inhibitor ##s ; In ##hibit ##ors , En ##zy ##me ; enzymes inhibitor ##s ; En ##zy ##me inhibitor ) [SEP]'},\n",
       " {'mention_id': '27791362.25',\n",
       "  'test_set_idx': 16940,\n",
       "  'type': 'T103',\n",
       "  'name': 'W',\n",
       "  'context': '[CLS] na ##no ##par ##tic ##les ( 170 ± 10 nm h ##ydro ##dynamic diameter ) produce a higher com ##puted to ##mo ##graphy contrast ( by a factor of about 2 ) than commercial i ##od ##ine - based radio ##con ##tras ##t agents ( e . g . , I ##oh ##ex ##ol ) at identical m ##olar concentrations of [unused1] W [unused2] or I atoms . P ##EG - P ##LA - coated C ##a ##W ##O ##4 na ##no ##par ##tic ##les are chemical ##ly stable and completely non ##to ##xi ##c . It was confirmed that the maximum tolerate ##d dose of this material in mice is significantly higher ( 250 ± 50 mg per kg body weight following a single in [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0441856',\n",
       "  'our_bi_cui_name': 'Group W',\n",
       "  'our_bi_cui_desc': '[CLS] Group W [unused3] ( Intel ##lect ##ual Product , qualifier value ) [SEP]',\n",
       "  'our_cross_cui': 'C0041383',\n",
       "  'our_cross_cui_name': 'tungsten',\n",
       "  'our_cross_cui_desc': '[CLS] t ##ung ##sten [unused3] ( Chemical , substance : wolf ##ram ; Wolf ##ram ; Tu ##ng ##sten [ Chemical / In ##g ##red ##ient ] ; W element ; T ##UN ##GS ##TE ##N ; Tu ##ng ##sten ) [SEP]'},\n",
       " {'mention_id': '27310615.57',\n",
       "  'test_set_idx': 2125,\n",
       "  'type': 'T103',\n",
       "  'name': 'micro',\n",
       "  'context': \"[CLS] that 56 % ( n = 31 ) of patients were over ##weight at these three different times . Weight , B ##MI and W ##ais ##t C ##ir ##cum ##ference increased significantly , indicating a worse nutrition ##al status , and there was a correlation between poor diet quality and higher values for B ##MI , W ##ais ##t - Hip Rat ##io and W ##ais ##t - to - Height Rat ##io . Ch ##em ##otherapy interfere ##s in the patients ' diet generating a negative impact on the quality and intake of [unused1] micro [unused2] and mac ##ron ##ut ##rient ##s , as well as an impact on their nutrition ##al status , with an increase in ant ##hr ##op ##ometric measurements . [SEP]\",\n",
       "  'existing_cui': 'C0085672',\n",
       "  'existing_cui_name': 'Microbiology procedure',\n",
       "  'existing_cui_desc': '[CLS] Micro ##biology procedure [unused3] ( Health Care Act ##ivity , lab test , procedure : micro ##biology test ; Micro ##biology Test ; Micro ##biology ; Micro ##biology Pro ##ced ##ure ; Laboratory Testing , Micro ##biology ; UN ##L ##IS ##TE ##D MI ##CR ##O ##BI ##OL ##O ##G ##Y ; Micro ##biology procedures ; micro ##biology tests ; Un ##listed micro ##biology procedure ; MI ##CR ##O ##BI ##OL ##O ##G ##Y PR ##OC ##ED ##UR ##E ; Test ; micro ##biology ; micro ##biology ; Micro ##biology test ; MI ##CR ##O ; Micro ##biology Tests ; Micro ##biology Pro ##ced ##ures ; diagnostic service sources micro ##biology ) [SEP]',\n",
       "  'our_bi_cui': 'C0678695',\n",
       "  'our_bi_cui_name': 'Nutrients',\n",
       "  'our_bi_cui_desc': '[CLS] N ##ut ##rient ##s [unused3] ( Food , substance : nutrients ; nut ##rient ; nutrients substances ; N ##ut ##rient ) [SEP]',\n",
       "  'our_cross_cui': 'C0282575',\n",
       "  'our_cross_cui_name': 'Micronutrients',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##nut ##rient ##s [unused3] ( Chemical : Micro ##nut ##rient ; micro ##nut ##rient ; micro ##nut ##rient ##s ) [SEP]'},\n",
       " {'mention_id': '28239461.28',\n",
       "  'test_set_idx': 29413,\n",
       "  'type': 'T170',\n",
       "  'name': 'Fluidigm platform',\n",
       "  'context': '[CLS] 6 ) , di ##stal common bi ##le duct cancer ( n = 21 ) , and gas ##tric cancer ( n = 20 ) ; chronic pan ##cre ##ati ##tis ( n = 39 ) ; and normal pan ##cre ##as ( n = 35 ) . The micro ##RNA ##s were analyzed by PC ##R using the [unused1] F ##lu ##id ##ig ##m platform [unused2] . Twenty - two micro ##RNA ##s were significantly differently expressed in patients with pan ##cre ##atic cancer when compared to healthy controls and chronic pan ##cre ##ati ##tis patients ; 17 mi ##RNA ##s were up ##re ##gu ##lated ( mi ##R - 21 - 5 ##p , - 23 ##a - 3 ##p , - 31 - [SEP]',\n",
       "  'existing_cui': 'C3896718',\n",
       "  'existing_cui_name': 'MenaCalc Platform',\n",
       "  'existing_cui_desc': '[CLS] Men ##a ##C ##al ##c Platform [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
       "  'our_bi_cui': 'C1449576',\n",
       "  'our_bi_cui_name': 'Microfluidic Analytical Techniques',\n",
       "  'our_bi_cui_desc': '[CLS] Micro ##f ##lu ##id ##ic Ana ##ly ##tical Tech ##ni ##ques [unused3] ( Health Care Act ##ivity : MI ##CR ##O ##FL ##UI ##DI ##C AN ##AL ; Ana ##ly ##ses , Micro ##f ##lu ##id ##ic ; Micro ##f ##lu ##id ##ic Ana ##ly ##tical Tech ##ni ##que ; Micro ##f ##lu ##id ##ic Ana ##ly ##ses ; Micro ##f ##lu ##id ##ic Analysis ; MI ##CR ##O ##FL ##UI ##DI ##C AN ##AL T ##EC ##H ##NI ##Q ##UE ##S ; Tech ##ni ##que , Micro ##f ##lu ##id ##ic Ana ##ly ##tical ; Tech ##ni ##ques , Micro ##f ##lu ##id ##ic Ana ##ly ##tical ; Analysis , Micro ##f ##lu ##id ##ic ; Ana ##ly ##tical Tech ##ni ##que , Micro ##f [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28493435.5',\n",
       "  'test_set_idx': 37720,\n",
       "  'type': 'T033',\n",
       "  'name': 'locating',\n",
       "  'context': '[CLS] A Fast Peak - Search ##ing Al ##gor ##ith ##m for Ultra ##sonic El ##ast ##ography T ##iss ##ue a ##xial strain est ##imation with ultra ##sound el ##ast ##ography has become a hot field in recent years . However , for key ##points tracking - based el ##ast ##ography algorithms , [unused1] lo ##cating [unused2] ex ##tre ##ma in multi ##mo ##dal ultra ##sonic radio ##f ##re ##que ##ncy signals is still a challenging problem . In this paper , a new method is proposed to locate the local ma ##xi ##ma and mini ##ma of the RF signals directly without der ##ivation operation . This algorithm can accurately locate ex ##tre ##ma even if disturbed peaks resulting from different noise exist . Furthermore , [SEP]',\n",
       "  'existing_cui': 'C3874067',\n",
       "  'existing_cui_name': 'Nerve-locating probe',\n",
       "  'existing_cui_desc': '[CLS] N ##erve - lo ##cating probe [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
       "  'our_bi_cui': 'C0392752',\n",
       "  'our_bi_cui_name': 'Localized',\n",
       "  'our_bi_cui_desc': '[CLS] Local ##ized [unused3] ( Spa ##tial Concept , qualifier value : Local ##ised ; Limited area ; local ##izing ; local ##ize ; localized ; local ##ised ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27603112.13',\n",
       "  'test_set_idx': 11355,\n",
       "  'type': 'T103',\n",
       "  'name': 'biomolecules',\n",
       "  'context': '[CLS] ##cule ##s : A Si ##mu ##lation Study A number of cases around the world have been reported where animals were found dead or dying with symptoms resembling a th ##iam ##ine ( vitamin B ) deficiency , and for some of these , a link to poll ##uta ##nts has been suggested . Here , we investigate whether [unused1] bio ##mo ##le ##cule ##s [unused2] involved in th ##iam ##in binding and transport could be blocked by a range of different poll ##uta ##nts . We used in si ##lic ##o dock ##ing of five compound classes ( 25 compounds in total ) to each of five targets ( p ##rion protein , EC ##F - type ABC transport ##er , th ##i - box [SEP]',\n",
       "  'existing_cui': 'C0104263',\n",
       "  'existing_cui_name': 'artificial lung expanding compound',\n",
       "  'existing_cui_desc': '[CLS] artificial lung expanding compound [unused3] ( Chemical , AL ##EC , product , substance : P ##uma ##ct ##ant ; pu ##ma ##ct ##ant ) [SEP]',\n",
       "  'our_bi_cui': 'C1449655',\n",
       "  'our_bi_cui_name': 'Macromolecular Substances',\n",
       "  'our_bi_cui_desc': '[CLS] Mac ##rom ##ole ##cular Sub ##stance ##s [unused3] ( Chemical : Mac ##rom ##ole ##cular Sub ##stance ##s [ Chemical / In ##g ##red ##ient ] ; Mac ##rom ##ole ##cular Co ##mpo ##unds and Complex ##es ; Sub ##stance ##s , Mac ##rom ##ole ##cular ) [SEP]',\n",
       "  'our_cross_cui': 'C0574031',\n",
       "  'our_cross_cui_name': 'Biologically active substance',\n",
       "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
       " {'mention_id': '28424240.41',\n",
       "  'test_set_idx': 35329,\n",
       "  'type': 'T038',\n",
       "  'name': 'TCR stimulation',\n",
       "  'context': '[CLS] protein 5 functions impaired T cell proliferation , IL - 2 production , and T ##h ##1 / T ##h ##17 , but not T ##h ##2 and regulatory T cell differentiation . general control non ##re ##pressed - protein 5 is recruited onto the il - 2 promoter by interacting with the N ##FA ##T in T cells upon [unused1] T ##CR stimulation [unused2] . Interest ##ingly , instead of directly ace ##ty ##lating N ##FA ##T , general control non ##re ##pressed - protein 5 cat ##aly ##zes his ##tone H ##3 l ##ys ##ine H ##9 ace ##ty ##lation to promote IL - 2 production . T cell - specific suppression of general control non ##re ##pressed - protein 5 partially protected mice [SEP]',\n",
       "  'existing_cui': 'C1292856',\n",
       "  'existing_cui_name': 'Stimulation procedure',\n",
       "  'existing_cui_desc': '[CLS] St ##im ##ulation procedure [unused3] ( Health Care Act ##ivity , procedure , qualifier value : stimulation ; stimulation ##s ; St ##im ##ulation - action ; St ##im ##ulation ) [SEP]',\n",
       "  'our_bi_cui': 'C1515144',\n",
       "  'our_bi_cui_name': 'T-Cell Receptor Activation',\n",
       "  'our_bi_cui_desc': '[CLS] T - Cell Re ##ceptor Act ##ivation [unused3] ( B ##iol ##og ##ic Fun ##ction : T ##CR Act ##ivation ; T ##CR Inter ##action ; T - Cell Re ##ceptor Inter ##action ) [SEP]',\n",
       "  'our_cross_cui': 'C2259054',\n",
       "  'our_cross_cui_name': 'stimulation of T cell receptor signaling pathway',\n",
       "  'our_cross_cui_desc': '[CLS] stimulation of T cell receptor signaling pathway [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]'},\n",
       " {'mention_id': '27482869.2',\n",
       "  'test_set_idx': 7895,\n",
       "  'type': 'T204',\n",
       "  'name': 'Allen James Wilcox',\n",
       "  'context': \"[CLS] Voices : A Con ##vers ##ation with Allen J . Wilcox [unused1] Allen James Wilcox [unused2] was born on 30 September 1946 in Columbus , OH . He studied medicine at the University of Michigan , graduated in 1973 , and after a rotating internship , he completed a master ' s degree in maternal and child health ( 1976 ) and a PhD in e ##pid ##em ##iology ( 1979 ) at the University of North Carolina in Chapel Hill . After graduation , he went to work at the National Institute of Environmental Health Sciences ( National Institute of Environmental Health Sciences , one of the US National Institutes of Health ) in Durham , NC , where he has spent his career . [SEP]\",\n",
       "  'existing_cui': 'C0237695',\n",
       "  'existing_cui_name': 'William James',\n",
       "  'existing_cui_desc': '[CLS] William James [unused3] ( E ##uka ##ryo ##te , William : James ) [SEP]',\n",
       "  'our_bi_cui': 'C0027361',\n",
       "  'our_bi_cui_name': 'Persons',\n",
       "  'our_bi_cui_desc': '[CLS] Persons [unused3] ( Population Group , person : Individual ; Person ; persons ; peoples ; Person [ du ##p ] ; People ; person ; people ) [SEP]',\n",
       "  'our_cross_cui': 'C0086418',\n",
       "  'our_cross_cui_name': 'Homo sapiens',\n",
       "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
       " {'mention_id': '28188533.10',\n",
       "  'test_set_idx': 27855,\n",
       "  'type': 'T170',\n",
       "  'name': 'SWATH ( ® )',\n",
       "  'context': '[CLS] ##c ##quisition Data for Label - free Q ##uant ##itative Pro ##te ##omi ##cs Studies Using Triple ##TO ##F ( ® ) Mass S ##pect ##rome ##ters Data - independent acquisition is a powerful mass s ##pect ##rome ##try technique that enables comprehensive MS and MS / MS analysis of all detect ##able species , providing an information rich data file that can be mined deeply . Here , we describe how to acquire high - quality [unused1] S ##WA ##TH ( ® ) [unused2] A ##c ##quisition data to be used for large quantitative pro ##te ##omi ##c studies . We specifically focus on using variable sized Q ##1 windows for acquisition of MS / MS data for generating higher specific ##ity quantitative data . [SEP]',\n",
       "  'existing_cui': 'C1416521',\n",
       "  'existing_cui_name': 'ITSN2 gene',\n",
       "  'existing_cui_desc': '[CLS] IT ##SN ##2 gene [unused3] ( Ana ##tom ##ical Structure : PR ##O ##20 ##15 ; SH ##3 domain protein 1 ##B ; inter ##sect ##in 2 ; SH ##3 ##P ##18 ; IN ##TE ##RS ##EC ##TI ##N 2 ; SH ##3 ##P ##18 - like WA ##SP associated protein ; SH ##3 D ##OM ##A ##IN PR ##OT ##EI ##N 1 ##B ; K ##IA ##A ##12 ##5 ##6 ) [SEP]',\n",
       "  'our_bi_cui': 'C0025080',\n",
       "  'our_bi_cui_name': 'Medical Devices',\n",
       "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27245335.53',\n",
       "  'test_set_idx': 758,\n",
       "  'type': 'T017',\n",
       "  'name': 'adipocytokine genes',\n",
       "  'context': '[CLS] by male offspring during the subsequent generation following paternal high - fat diet exposure diminished whereas consumption for two generations completely abolished the effect of paternal high - fat diet exposure on metabolic traits and ad ##ip ##oc ##yt ##oki ##ne promoter e ##pi ##gene ##tic changes in the offspring . The effects of paternal high - fat diet exposure on offspring were relatively weaker than those following high - fat diet exposure in u ##tero . However , paternal high - fat diet exposure had an add ##itive metabolic effect for two generations , suggesting that both paternal and maternal nutrition might affect offspring metabolism through e ##pi ##gene ##tic modifications of [unused1] ad ##ip ##oc ##yt ##oki ##ne genes [unused2] for multiple generations . [SEP]',\n",
       "  'existing_cui': 'C1955907',\n",
       "  'existing_cui_name': 'Adipokines',\n",
       "  'existing_cui_desc': '[CLS] Ad ##ip ##oki ##nes [unused3] ( Chemical : Ad ##ip ##oki ##ne ; Ad ##ip ##oki ##nes [ Chemical / In ##g ##red ##ient ] ; Ad ##ip ##oc ##yt ##oki ##nes ; Ad ##ip ##oc ##yt ##oki ##ne ) [SEP]',\n",
       "  'our_bi_cui': 'C1333196',\n",
       "  'our_bi_cui_name': 'Cytokine Gene',\n",
       "  'our_bi_cui_desc': '[CLS] Cy ##tok ##ine Gene [unused3] ( Ana ##tom ##ical Structure ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27837821.9',\n",
       "  'test_set_idx': 18842,\n",
       "  'type': 'T170',\n",
       "  'name': 'fast Fourier transform',\n",
       "  'context': '[CLS] based on the mat ##uring in barrels or the prediction of the global scores assigned by a sensory panel . To this aim , red wine samples were first anal ##ys ##ed with the vol ##tam ##metric sensor array , without performing any sample pre ##tre ##at ##ment . Afterwards , obtained responses were pre ##p ##ro ##cess ##ed employing [unused1] fast Four ##ier transform [unused2] for the compression and reduction of signal complexity , and obtained coefficients were then used as inputs to build the q ##ual ##itative and quantitative models employing either linear disc ##rim ##ina ##nt analysis or partial least squares re ##gression , respectively . Sa ##tis ##fa ##ctor ##y results were obtained overall , with a classification rate of 100 % [SEP]',\n",
       "  'existing_cui': 'C0206055',\n",
       "  'existing_cui_name': 'Spectroscopy , Fourier Transform Infrared',\n",
       "  'existing_cui_desc': '[CLS] S ##pect ##ros ##copy , Four ##ier Trans ##form In ##fra ##red [unused3] ( Research Act ##ivity : Four ##ier Trans ##form In ##fra ##red S ##pect ##ros ##copy ; F ##TI ##R ( Four ##ier transform infrared ) s ##pect ##ros ##copy ; F ##TI ##R ; F ##TI ##R s ##pect ##ros ##copy ; four ##ier transform infrared ( F ##TI ##R ) s ##pect ##ros ##copy ; Four ##ier transform infrared s ##pect ##ros ##copy ; S ##pect ##ros ##copy , In ##fra ##red , Four ##ier Trans ##form ) [SEP]',\n",
       "  'our_bi_cui': 'C3899091',\n",
       "  'our_bi_cui_name': 'Fourier Transform Ion Cyclotron Resonance Mass Spectrometry',\n",
       "  'our_bi_cui_desc': '[CLS] Four ##ier Trans ##form Ion Cy ##c ##lot ##ron Re ##son ##ance Mass S ##pect ##rome ##try [unused3] ( Research Act ##ivity ) [SEP]',\n",
       "  'our_cross_cui': 'C0002045',\n",
       "  'our_cross_cui_name': 'algorithm',\n",
       "  'our_cross_cui_desc': '[CLS] algorithm [unused3] ( Intel ##lect ##ual Product : Al ##gor ##ith ##m ; Al ##gor ##ith ##ms ; algorithms ) [SEP]'},\n",
       " {'mention_id': '27659602.24',\n",
       "  'test_set_idx': 13369,\n",
       "  'type': 'T082',\n",
       "  'name': 'root',\n",
       "  'context': '[CLS] at post ##oper ##ative base ##line and follow - up imaging by com ##puted to ##mo ##graphy or echo ##card ##io ##graphy . The annual growth rate was evaluated and also compared according to the influence of valve morphology and con ##com ##ita ##nt a ##ort ##ic valve replacement . Furthermore , the years of natural history that would require for [unused1] root [unused2] en ##lar ##gement to meet a 50 mm threshold of the root diameter were calculated . The estimated growth rate of the a ##ort ##ic root after root - spa ##ring a ##ort ##ic replacement is between 0 . 27 and 0 . 51 mm per year ( mean 0 . 41 mm , varying according to the underlying diameter ) and [SEP]',\n",
       "  'existing_cui': 'C1318154',\n",
       "  'existing_cui_name': 'Root body part',\n",
       "  'existing_cui_desc': '[CLS] Root body part [unused3] ( Ana ##tom ##ical Structure : Root ; root [ a body part ] ; root ) [SEP]',\n",
       "  'our_bi_cui': 'C0040452',\n",
       "  'our_bi_cui_name': 'Tooth root structure',\n",
       "  'our_bi_cui_desc': '[CLS] Too ##th root structure [unused3] ( Ana ##tom ##ical Structure , body structure : Ra ##di ##x co ##rona ; Root of the Too ##th ; tooth root ; Too ##th Root ; Root of Too ##th ; Root , Too ##th ; tooth roots ; root of tooth ; root tooth ; roots tooth ; Te ##eth - - Roots ; Roots , Too ##th ; of tooth root ; Too ##th Roots ; Too ##th root ; Ra ##di ##x Den ##tis ; Ra ##di ##x den ##tis ; rooted tooth ; Root of tooth ) [SEP]',\n",
       "  'our_cross_cui': 'C0549113',\n",
       "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
       "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
       " {'mention_id': '27842161.11',\n",
       "  'test_set_idx': 19104,\n",
       "  'type': 'T103',\n",
       "  'name': 'netarsudil-M1',\n",
       "  'context': '[CLS] ##ars ##udi ##l Inc ##rease ##s Out ##flow Facility in Human Eyes Through Multiple Me ##chan ##isms Net ##ars ##udi ##l is a R ##ho kinase / nor ##ep ##ine ##ph ##rine transport ##er inhibitor currently in phase 3 clinical development for g ##lau ##com ##a treatment . We investigated the effects of its active meta ##bol ##ite , [unused1] net ##ars ##udi ##l - M1 [unused2] , on out ##flow facility ( C ) , out ##flow h ##ydro ##dynamic ##s , and morphology of the conventional out ##flow pathway in en ##uc ##lea ##ted human eyes . Pa ##ired human eyes ( n = 5 ) were per ##fused with either 0 . 3 μ ##M net ##ars ##udi ##l - M1 or vehicle [SEP]',\n",
       "  'existing_cui': 'C0441971',\n",
       "  'existing_cui_name': 'Metastasis stage M1',\n",
       "  'existing_cui_desc': '[CLS] Met ##ast ##asis stage M1 [unused3] ( Finding , diagnosis , finding , tumor staging : M1 ; M1 Met ##ast ##asis Stage ; M1 Di ##stant Met ##ast ##asis Finding ; M1 T ##N ##M Finding ; M1 Cancer Stage Finding ; M1 Stage ; M1 category ; ma ##li ##g neo ##p ##las ##m t ##n ##m staging distant meta ##sta ##sis ( m ) m ##1 ; M1 Di ##stant Met ##ast ##asis Stage Finding ; M1 Met ##ast ##asis Finding ; Met ##ast ##asis Stage M1 ; M1 stage ; M1 Stage Finding ) [SEP]',\n",
       "  'our_bi_cui': 'C4307684',\n",
       "  'our_bi_cui_name': '6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid',\n",
       "  'our_bi_cui_desc': '[CLS] 6 , 7 - dim ##eth ##ox ##y - 1 , 2 , 3 , 4 - te ##tra ##hy ##dr ##ois ##o ##quin ##olin ##e - 3 - car ##box ##yl ##ic acid [unused3] ( Chemical : M1 al ##kal ##oid ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27553395.14',\n",
       "  'test_set_idx': 10264,\n",
       "  'type': 'T033',\n",
       "  'name': 'over',\n",
       "  'context': '[CLS] was 103 ##2 . 8 ( SD 252 ) k ##cal and 101 ##3 ( SD 33 ##9 . 1 ) k ##cal respectively and 105 ##7 . 2 ( SD 201 . 8 ) k ##cal and 103 ##0 . 3 ( SD 34 ##1 . 7 ) k ##cal for boys . Iron intake was low in both groups . Mean body mass index and body weight and height were similar to World Health Organization figures but significant numbers of infants and to ##ddler ##s of both sexes were [unused1] over [unused2] - or under ##weight . Although mean energy and mac ##ron ##ut ##rient intake ##s were comparable to the R ##DA , significant numbers were over - or under ##fe ##d . [SEP]',\n",
       "  'existing_cui': 'C0205136',\n",
       "  'existing_cui_name': 'Over',\n",
       "  'existing_cui_desc': '[CLS] Over [unused3] ( Spa ##tial Concept , spatial , spatial , qualifier value : over ) [SEP]',\n",
       "  'our_bi_cui': 'C0205136',\n",
       "  'our_bi_cui_name': 'Over',\n",
       "  'our_bi_cui_desc': '[CLS] Over [unused3] ( Spa ##tial Concept , spatial , spatial , qualifier value : over ) [SEP]',\n",
       "  'our_cross_cui': 'C0497406',\n",
       "  'our_cross_cui_name': 'Overweight',\n",
       "  'our_cross_cui_desc': '[CLS] Over ##weight [unused3] ( Finding , diagnosis , finding , physical finding : clinical over ##weight ; O ##VE ##R ##W ##EI ##G ##HT ; over ##weight ( B ##MI < 30 ) ; over ##weight ; Over ##weight ( B ##MI 25 - 30 ) ; Pat ##ient over ##weight ; Over ##weight [ Disease / Finding ] ) [SEP]'},\n",
       " {'mention_id': '27762482.15',\n",
       "  'test_set_idx': 15893,\n",
       "  'type': 'T074',\n",
       "  'name': 'PDL',\n",
       "  'context': '[CLS] ##nic flu ##ence proved to be superior until now . Given that pu ##rp ##ura and subsequent possible post ##in ##f ##lam ##mat ##ory h ##yper ##pi ##gment ##ation are occasionally un ##bearable in some patients , and several studies using the low non ##pur ##pura ##genic flu ##ence were reported . To deliver the sufficient high flu ##ence of a [unused1] PD ##L [unused2] without generating pu ##rp ##ura , we designed the fraction ##ation of high flu ##ence using five passes and longer pulse duration ( 6 mill ##ise ##con ##ds ) of a PD ##L in succession . A total of eight patients with er ##yt ##hem ##ato ##tel ##ang ##ie ##ct ##atic r ##osa ##cea were enrolled in this study ; all [SEP]',\n",
       "  'existing_cui': 'C1414066',\n",
       "  'existing_cui_name': 'DLG5 gene',\n",
       "  'existing_cui_desc': '[CLS] DL ##G ##5 gene [unused3] ( Ana ##tom ##ical Structure : K ##IA ##A ##0 ##5 ##8 ##3 ; D ##IS ##CS LA ##R ##GE , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 5 ; P - d ##l ##g ; discs large ho ##mo ##log 5 ; P ##LA ##CE ##NT ##A AND PR ##OS ##TA ##TE DL ##G ) [SEP]',\n",
       "  'our_bi_cui': 'C0031740',\n",
       "  'our_bi_cui_name': 'Photochemotherapy',\n",
       "  'our_bi_cui_desc': '[CLS] Photo ##che ##mother ##ap ##y [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : PD ##T - Photo ##dynamic therapy ; Photo ##che ##mother ##ap ##ies ; Photo ##dynamic The ##rap ##ies ; therapy , photo ##dynamic ; Therapy , Photo ##dynamic ; THE ##R P ##H ##OT ##OD ##Y ##NA ##MI ##C ; Photo ##rad ##iation Therapy ; photo ##dynamic therapy ; photo ##che ##mother ##ap ##y ; P ##H ##OT ##OC ##H ##EM ##OT ##H ##ER ; The ##rap ##ies , Photo ##dynamic ; Photo ##dynamic Therapy Pro ##ced ##ures ; neo ##p ##las ##m / cancer photo ##rad ##iation therapy ; Photo ##che ##mother ##ap ##y [ Am ##bi ##guous ] ; Photo ##dynamic therapy ; PD [SEP]',\n",
       "  'our_cross_cui': 'C1289859',\n",
       "  'our_cross_cui_name': 'Pulsed Dye Lasers',\n",
       "  'our_cross_cui_desc': '[CLS] P ##ulse ##d D ##ye Las ##ers [unused3] ( Medical Devi ##ce , physical object : D ##ye Las ##ers , P ##ulse ##d ; P ##ulse ##d dye laser device ; Las ##er , P ##ulse ##d D ##ye ; D ##ye Las ##er , P ##ulse ##d ; Las ##ers , P ##ulse ##d D ##ye ; P ##ulse ##d D ##ye Las ##er ; pulsed dye laser ; P ##ulse ##d dye laser ) [SEP]'},\n",
       " {'mention_id': '27298278.30',\n",
       "  'test_set_idx': 1831,\n",
       "  'type': 'T103',\n",
       "  'name': \"dimethyl 1,1 ' - dihydroxy-4 ,4 ' ,7,7 ' - tetramethoxy-2 ,2 ' - binaphthalene-3 ,3 ' - dicarboxylate\",\n",
       "  'context': \"[CLS] ##bon ##yl - 1 , 4 - nap ##ht ##ho ##quin ##one , 1 , 4 - di ##hy ##dr ##ox ##y - 7 - h ##ydro ##xy ##met ##hyl - ant ##hra ##quin ##one , and [unused1] dim ##eth ##yl 1 , 1 ' - di ##hy ##dr ##ox ##y - 4 , 4 ' , 7 , 7 ' - te ##tra ##met ##ho ##xy - 2 , 2 ' - bin ##aph ##thal ##ene - 3 , 3 ' - di ##car ##box ##yla ##te [unused2] , respectively . Na ##ph ##th ##o ##quin ##ones and nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##ers were previously unknown in the genus Mo ##rin ##da . In addition , the compounds were tested [SEP]\",\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0029224',\n",
       "  'our_bi_cui_name': 'Organic Chemicals',\n",
       "  'our_bi_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27622027.25',\n",
       "  'test_set_idx': 12098,\n",
       "  'type': 'T017',\n",
       "  'name': 'tumor - draining LN',\n",
       "  'context': '[CLS] of color ##ec ##tal cancer patients . Fresh tumor - draining L ##N tissues from 39 randomly enrolled patients were assessed by flow c ##yt ##ome ##try for activation and differentiation of CD ##16 ##9 ( + ) CD ##8 ( + ) T cells and T cell - mediated killing of tumor cells . In total , 114 [unused1] tumor - draining L ##N [unused2] para ##ffin sections from color ##ec ##tal cancer patients were analyzed by multiple - color im ##mu ##no ##f ##lu ##ores ##cence for CD ##16 ##9 ( + ) CD ##8 ( + ) T cell distribution and clinical values . The pro ##gno ##stic significance of CD ##16 ##9 ( + ) CD ##8 ( + ) T cells [SEP]',\n",
       "  'existing_cui': 'C0269800',\n",
       "  'existing_cui_name': 'Amniotic fluid leaking',\n",
       "  'existing_cui_desc': '[CLS] Am ##nio ##tic fluid leaking [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Waters leaking ; Lea ##ka ##ge of am ##nio ##tic fluid ; Am ##nio ##rr ##hea ; Li ##q ##uo ##r observed ; Dr ##ain ##age of liquor ; Flow of am ##nio ##tic liquor ; am ##nio ##tic fluid leak ; am ##nio ##tic fluid leak ##age ; am ##nio ##tic fluid ; leak ; Lea ##ka ##ge of Am ##nio ##tic F ##lu ##id ; Li ##q ##uo ##r draining ; leaking water ; water leak ; leak ##age of am ##nio ##tic fluid ; Am ##nio ##tic fluid leak ##age ; Am ##nio ##rr ##hoe ##a ; am ##nio ##tic fluid leaking ; am ##nio [SEP]',\n",
       "  'our_bi_cui': 'C0281444',\n",
       "  'our_bi_cui_name': 'tumor-draining lymph node lymphocyte therapy',\n",
       "  'our_bi_cui_desc': '[CLS] tumor - draining l ##ymph node l ##ymph ##oc ##yte therapy [unused3] ( Health Care Act ##ivity : Tu ##mor - Dr ##ain ##ing L ##ymph No ##de L ##ymph ##oc ##yte Therapy ) [SEP]',\n",
       "  'our_cross_cui': 'C0024204',\n",
       "  'our_cross_cui_name': 'lymph nodes',\n",
       "  'our_cross_cui_desc': '[CLS] l ##ymph nodes [unused3] ( Ana ##tom ##ical Structure , body structure : L ##ymph ##atic G ##land ; Structure of l ##ymph node ; nodes l ##ymph ; glands l ##ymph ##atic ; No ##de , L ##ymph ; l ##ymph ##s nodes ; L ##ymph ##atic g ##land ; l ##ymph ##atic g ##land ; L ##ymph ##ono ##dus ; node l ##ymph ; l ##ymph ##s node ; L ##ymph node structure ; l ##ymph node ; L ##ymph G ##land ; No ##dus l ##ymph ##atic ##us ; L ##ymph No ##des ; L ##ymph No ##de ; L ##Y ##MP ##H NO ##DE ; L ##ymph nodes ; No ##des , L ##ymph ; L ##ymph g ##land ; No ##dus [SEP]'},\n",
       " {'mention_id': '27500205.13',\n",
       "  'test_set_idx': 8445,\n",
       "  'type': 'T017',\n",
       "  'name': 'adherent cells',\n",
       "  'context': '[CLS] e ##z ##rin - rid ##ix ##in - m ##oes ##in ( F ##ER ##M ) domain containing proteins . There are three kind ##lins in mammals , which share high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in [unused1] ad ##here ##nt cells [unused2] , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of kind ##lins . Great interest in the kind ##lins has [SEP]',\n",
       "  'existing_cui': 'C0263567',\n",
       "  'existing_cui_name': 'Adherent scar',\n",
       "  'existing_cui_desc': '[CLS] Ad ##here ##nt scar [unused3] ( Finding , diagnosis , disorder : ad ##here ##nt scar ; ad ##here ##nt ; scar ; scar ; ad ##here ##nt ; Ad ##here ##nt skin ) [SEP]',\n",
       "  'our_bi_cui': 'C0007577',\n",
       "  'our_bi_cui_name': 'Cell Adhesion',\n",
       "  'our_bi_cui_desc': '[CLS] Cell Ad ##hesion [unused3] ( B ##iol ##og ##ic Fun ##ction : Cell Ad ##hesion ##s ; Cell ad ##hesion ; Ad ##hesion , Cell ; Cell Ad ##hesion Process ; ad ##hesion cellular ; cell ad ##hesion ; Ad ##hesion ##s , Cell ; ad ##hesion cell ; cellular ad ##hesion ; Cell ##ular Ad ##hesion ) [SEP]',\n",
       "  'our_cross_cui': 'C0007634',\n",
       "  'our_cross_cui_name': 'Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
       " {'mention_id': '28113841.10',\n",
       "  'test_set_idx': 25840,\n",
       "  'type': 'T170',\n",
       "  'name': 'reconstruction models',\n",
       "  'context': '[CLS] , we develop a structural feature based collaborative reconstruction ( St ##ructural Feature based Col ##la ##bor ##ative Reconstruction ) method for quantitative su ##s ##ce ##pt ##ibility mapping including both magnitude and su ##s ##ce ##pt ##ibility based information . The St ##ructural Feature based Col ##la ##bor ##ative Reconstruction algorithm is composed of two consecutive steps corresponding to complementary [unused1] reconstruction models [unused2] , each with a structural feature based l ##1 norm con ##stra ##int and a v ##ox ##el fi ##delity based l ##2 norm con ##stra ##int , which allows both the structure edges and tiny features to be recovered , whereas the noise and artifacts could be reduced . In the M - step , the initial su ##s ##ce [SEP]',\n",
       "  'existing_cui': 'C0237819',\n",
       "  'existing_cui_name': 'Learning Reconstruction',\n",
       "  'existing_cui_desc': '[CLS] Learning Reconstruction [unused3] ( B ##iol ##og ##ic Fun ##ction , Learning : Reconstruction ) [SEP]',\n",
       "  'our_bi_cui': 'C0449363',\n",
       "  'our_bi_cui_name': 'Method of reconstruction',\n",
       "  'our_bi_cui_desc': '[CLS] Method of reconstruction [unused3] ( Intel ##lect ##ual Product , attribute ) [SEP]',\n",
       "  'our_cross_cui': 'C3161035',\n",
       "  'our_cross_cui_name': 'Model',\n",
       "  'our_cross_cui_desc': '[CLS] Model [unused3] ( Intel ##lect ##ual Product : Models ; Model ##ing System ; Model System ) [SEP]'},\n",
       " {'mention_id': '27855073.16',\n",
       "  'test_set_idx': 19359,\n",
       "  'type': 'T103',\n",
       "  'name': 'uS4',\n",
       "  'context': \"[CLS] essential component of the small rib ##oso ##mal subunit that is involved in subunit assembly , maintenance of translation ##al fi ##delity , and the rib ##oso ##me ' s response to the anti ##biotic s ##pect ##ino ##my ##cin . While many of the characterized u ##S ##5 mutations that affect de ##co ##ding map to its interface with [unused1] u ##S ##4 [unused2] , more recent work has shown that residues distant from the u ##S ##4 - u ##S ##5 interface can also affect the de ##co ##ding process . We targeted one such interface - remote area , the loop 2 region ( residues 20 to 31 ) , for m ##uta ##genesis in E ##scher ##ichi ##a . co ##li and [SEP]\",\n",
       "  'existing_cui': 'C1419736',\n",
       "  'existing_cui_name': 'RPS4X gene',\n",
       "  'existing_cui_desc': '[CLS] R ##PS ##4 ##X gene [unused3] ( Ana ##tom ##ical Structure : S ##4 ; R ##IB ##OS ##OM ##AL PR ##OT ##EI ##N S ##4 , X - L ##IN ##KE ##D ; CE ##LL C ##Y ##CL ##E GE ##NE 2 ; rib ##oso ##mal protein S ##4 , X - linked ; S ##ING ##LE - CO ##P ##Y AB ##UN ##DA ##NT m ##RNA ; SC ##R ##10 ; R ##PS ##4 ; 40 ##S rib ##oso ##mal protein S ##4 , X is ##of ##orm ; single - copy abundant m ##RNA ; rib ##oso ##mal protein S ##4 ##X is ##of ##orm ; D ##X ##S ##30 ##6 ; FL ##J ##40 ##5 ##9 ##5 ; cell cycle gene 2 [SEP]',\n",
       "  'our_bi_cui': 'C0041528',\n",
       "  'our_bi_cui_name': 'U4 small nuclear RNA',\n",
       "  'our_bi_cui_desc': '[CLS] U ##4 small nuclear RNA [unused3] ( Chemical : U ##4 RNA ; U ##4 s ##n ##RNA ) [SEP]',\n",
       "  'our_cross_cui': 'C0073333',\n",
       "  'our_cross_cui_name': 'ribosomal protein S4',\n",
       "  'our_cross_cui_desc': '[CLS] rib ##oso ##mal protein S ##4 [unused3] ( Chemical : S ##4 rib ##oso ##mal protein ) [SEP]'},\n",
       " {'mention_id': '28223077.29',\n",
       "  'test_set_idx': 28913,\n",
       "  'type': 'T082',\n",
       "  'name': 'background site',\n",
       "  'context': '[CLS] , background site , up ##wind site and down ##wind site of a Municipal solid waste land ##fill in East China . The results of present study were summarized as follows . ( 1 ) The total concentrations of PC ##D ##D / F ##s ( [UNK] PC ##D ##D / F ##s ) in ambient air from surrounding sites , [unused1] background site [unused2] , up ##wind site and down ##wind site were 2 . 215 ± 1 . 00 ##4 , 2 . 05 ##8 ± 0 . 45 ##8 , 2 . 61 ##7 ± 1 . 09 ##2 and 1 . 82 ##2 ± 0 . 56 ##6 p ##g ##N ##m ( - 3 ) , respectively . ( 2 ) [SEP]',\n",
       "  'existing_cui': 'C0237490',\n",
       "  'existing_cui_name': 'Family Background',\n",
       "  'existing_cui_desc': '[CLS] Family Background [unused3] ( Finding , Family : Background ) [SEP]',\n",
       "  'our_bi_cui': 'C0442611',\n",
       "  'our_bi_cui_name': 'Industrial site',\n",
       "  'our_bi_cui_desc': '[CLS] Industrial site [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
       "  'our_cross_cui': 'C0205145',\n",
       "  'our_cross_cui_name': 'Site',\n",
       "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
       " {'mention_id': '27371817.9',\n",
       "  'test_set_idx': 3913,\n",
       "  'type': 'T058',\n",
       "  'name': 'Non - destructive proton nuclear magnetic resonance ( ( 1 ) H NMR ) spectroscopy',\n",
       "  'context': '[CLS] of g ##ly ##cer ##op ##hos ##ph ##oli ##pid signatures of inflammation treated with non - s ##tero ##idal anti - inflammatory drugs - induced - RA ##W ##26 ##4 . 7 cells using ( 1 ) H N ##MR and U - HP ##LC / Q - TO ##F - MS [unused1] Non - destructive pro ##ton nuclear magnetic resonance ( ( 1 ) H N ##MR ) s ##pect ##ros ##copy [unused2] and highly sensitive ultra - performance liquid ch ##roma ##tography q ##uad ##rup ##ole time - of - flight mass s ##pect ##rome ##try ( U - HP ##LC / Q - TO ##F - MS ) coupled to data processing methods were applied to analyze the metabolic pro ##fi ##ling changes [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C3850002',\n",
       "  'our_bi_cui_name': 'Proton Magnetic Resonance Spectroscopy',\n",
       "  'our_bi_cui_desc': '[CLS] Proto ##n Ma ##gnetic Re ##son ##ance S ##pect ##ros ##copy [unused3] ( Health Care Act ##ivity : 1 ##H - MR ##S ) [SEP]',\n",
       "  'our_cross_cui': 'C0877853',\n",
       "  'our_cross_cui_name': 'Spectroscopy , Nuclear Magnetic Resonance',\n",
       "  'our_cross_cui_desc': '[CLS] S ##pect ##ros ##copy , Nuclear Ma ##gnetic Re ##son ##ance [unused3] ( Health Care Act ##ivity : S ##pect ##ros ##copy , N ##MR ; nuclear magnetic resonance s ##pect ##ros ##copy ; Nuclear magnetic resonance s ##pect ##ros ##copy ; N ##MR S ##pect ##ros ##copy ; S ##pect ##ros ##co ##pies , N ##MR ; N ##MR S ##pect ##ros ##co ##pies ; nm ##r s ##pect ##ros ##copy ) [SEP]'},\n",
       " {'mention_id': '28539192.15',\n",
       "  'test_set_idx': 38799,\n",
       "  'type': 'T033',\n",
       "  'name': 'complex level',\n",
       "  'context': '[CLS] the population specifically in health . Currently , there is a fragment ##ed model of patient care , in which the systems are exclusive of each other . They do not cooperate or communicate with each other ; and if there is no vertical communication within the system , preventing refer ##ral of patients directly from the basic level to the [unused1] complex level [unused2] of care when needed . In addition , there has been no progress in the development of an em ##path ##etic , respect ##ful or person - centered clinical practice ; instead , economic , social and educational differences per ##pet ##uate a paternal ##istic clinical practice . The task of or ##ient ##ing medical training towards the development of human [SEP]',\n",
       "  'existing_cui': 'C0056210',\n",
       "  'existing_cui_name': 'complex V',\n",
       "  'existing_cui_desc': '[CLS] complex V [unused3] ( Chemical , mitochondrial o ##xi ##da ##tive p ##hos ##ph ##ory ##lation system , mitochondrial o ##xi ##da ##tive p ##hos ##ph ##ory ##lation system , MA ##TS ##C , mitochondrial ad ##eno ##sin ##e trip ##hos ##phate s ##ynth ##ase complex : CO ##MP ##LE ##X ) [SEP]',\n",
       "  'our_bi_cui': 'C0456079',\n",
       "  'our_bi_cui_name': 'Disease classification level',\n",
       "  'our_bi_cui_desc': '[CLS] Disease classification level [unused3] ( Intel ##lect ##ual Product , attribute : Level ) [SEP]',\n",
       "  'our_cross_cui': 'C1547668',\n",
       "  'our_cross_cui_name': 'Level of Care',\n",
       "  'our_cross_cui_desc': '[CLS] Level of Care [unused3] ( Finding : Level of care ) [SEP]'},\n",
       " {'mention_id': '27756117.21',\n",
       "  'test_set_idx': 15618,\n",
       "  'type': 'T058',\n",
       "  'name': 'molding',\n",
       "  'context': '[CLS] ##gen are increasingly used due to their efficacy and their ease of application . In the present study , we describe a method to incorporate the co ##agu ##lant supplement ##s fi ##bri ##no ##gen and th ##rom ##bin in silk protein s ##po ##nges by mixing the co ##agu ##lants with an a ##que ##ous silk solution , followed by [unused1] mold ##ing [unused2] , freeze - drying and water an ##nea ##ling . In this combination system we demonstrate the delivery of fi ##bri ##no ##gen while maintaining its hem ##ost ##atic potential . Con ##cent ##ration ratios of silk to fi ##bri ##no ##gen of 1 . 0 % / 2 . 8 % , 2 . 3 % / 1 . 5 [SEP]',\n",
       "  'existing_cui': 'C0426103',\n",
       "  'existing_cui_name': 'Fetal head molding',\n",
       "  'existing_cui_desc': '[CLS] Fe ##tal head mold ##ing [unused3] ( Finding , finding , finding : F ##oe ##tal head m ##ou ##lding ; f ##etal head mold ##ing ; O ##bs ##er ##vation of f ##etal head mold ##ing ; Finding of f ##etal head m ##ou ##lding ; Finding of foe ##tal head m ##ou ##lding ; Mo ##lding ; O ##bs ##er ##vation of foe ##tal head m ##ou ##lding ; O ##bs ##er ##vation of f ##etal head m ##ou ##lding ; mold ##ing ; Finding of f ##etal head mold ##ing ; Fe ##tal head m ##ou ##lding ) [SEP]',\n",
       "  'our_bi_cui': 'C0947647',\n",
       "  'our_bi_cui_name': 'Manipulation procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Man ##ip ##ulation procedure [unused3] ( Health Care Act ##ivity , procedure , qualifier value , regime / therapy : manipulation ; Man ##ip ##ulation ##s ; Man ##ip ##ulation - action ; manipulation procedure ; Man ##ip ##ulate ; Man ##ip ##ula ##tive ; Man ##ip ##ulation ; Man ##ip ##ula ##tive procedure ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '27838742.64',\n",
       "  'test_set_idx': 19031,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] ##6 ##K pathway in A ##5 ##4 ##9 and PC - 9 cells . Del ##ica ##f ##lav ##one is a potential anti ##can ##cer agent that can induce auto ##pha ##gic cell death in human non - small cell lung cancer via the A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . [unused1] Del ##ica ##f ##lav ##one [unused2] showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27563025.32',\n",
       "  'test_set_idx': 10413,\n",
       "  'type': 'T017',\n",
       "  'name': 'C2C12 cells',\n",
       "  'context': '[CLS] ##no ##fi ##bres . To estimate the bio ##com ##pa ##ti ##bility of the 3D p ##oly ##cap ##rol ##act ##one / p ##oly ##ani ##line composite na ##no ##fi ##bre mac ##ros ##truct ##ures , mouse my ##ob ##last ##s ( C ##2 ##C ##12 cells ) were culture ##d as model cells . The initial responses of [unused1] C ##2 ##C ##12 cells [unused2] to the 3D p ##oly ##cap ##rol ##act ##one / p ##oly ##ani ##line composite mac ##ros ##truct ##ures were significantly superior to those to pure p ##oly ##cap ##rol ##act ##one , that is , the cells exhibited typical my ##ob ##last - like m ##or ##ph ##ologies with obvious pseudo ##po ##dia and the moderate incorporation ( less [SEP]',\n",
       "  'existing_cui': 'C0085262',\n",
       "  'existing_cui_name': 'PC12 Cells',\n",
       "  'existing_cui_desc': '[CLS] PC ##12 Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell Line , Ph ##eo ##ch ##rom ##oc ##yt ##oma ; Ph ##eo ##ch ##rom ##oc ##yt ##oma Cell Lines ; Ph ##eo ##ch ##rom ##oc ##yt ##oma 12 Cell Line ; PC A 01 ##2 CE ##LL ##S ; p ##he ##och ##rom ##oc ##yt ##oma 12 cell line ; PC - 12 ; p ##c ##12 cell ; PC ##12 Cell ; Ph ##eo ##ch ##rom ##oc ##yt ##oma Cell Line ; Cell Lines , Ph ##eo ##ch ##rom ##oc ##yt ##oma ; PC ##12 cell ; p ##c ##12 cells ) [SEP]',\n",
       "  'our_bi_cui': 'C1135917',\n",
       "  'our_bi_cui_name': 'Myoblasts , Cardiac',\n",
       "  'our_bi_cui_desc': '[CLS] My ##ob ##last ##s , Card ##iac [unused3] ( Ana ##tom ##ical Structure : cardiac my ##ob ##last ##s ; My ##ob ##last , Card ##iac ; cardiac my ##ob ##last ; Card ##iac my ##ob ##last ; Card ##iac My ##ob ##last ##s ; Card ##iac My ##ob ##last ) [SEP]',\n",
       "  'our_cross_cui': 'C0596995',\n",
       "  'our_cross_cui_name': 'Myoblasts',\n",
       "  'our_cross_cui_desc': '[CLS] My ##ob ##last ##s [unused3] ( Ana ##tom ##ical Structure : Mu ##s ##cle Cell ##s , Em ##b ##ryo ##nic ; My ##ob ##last ; Mu ##s ##cle Cell , Em ##b ##ryo ##nic ; Pre ##cu ##rs ##or Mu ##s ##cle Cell ##s ; Mu ##s ##cle Cell , Pre ##cu ##rs ##or ; my ##ob ##last ; Em ##b ##ryo ##nic Mu ##s ##cle Cell ##s ; my ##ob ##last ##s ; Pre ##cu ##rs ##or Mu ##s ##cle Cell ; Em ##b ##ryo ##nic Mu ##s ##cle Cell ; Mu ##s ##cle Cell ##s , Pre ##cu ##rs ##or ) [SEP]'},\n",
       " {'mention_id': '28460054.10',\n",
       "  'test_set_idx': 36759,\n",
       "  'type': 'T062',\n",
       "  'name': 'feasible strategy',\n",
       "  'context': '[CLS] Effect of ha ##lot ##ole ##rant r ##hi ##zo ##ba ##cter ##ia isolated from ha ##lop ##hy ##tes on the growth of sugar bee ##t ( Beta v ##ul ##gar ##is L . ) under salt stress U ##til ##ization of r ##hi ##zo ##ba ##cter ##ia that have associated with plant roots in harsh environments could be a [unused1] feasible strategy [unused2] to deal with limits to agricultural production caused by soil sa ##linity . Hal ##op ##hy ##tes occur naturally in high - salt environments , and their roots may be associated with promising micro ##bial candidates for promoting growth and salt tolerance in crops . This study aimed to is ##olate efficient ha ##lot ##ole ##rant plant - growth - promoting r ##hi [SEP]',\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0589212',\n",
       "  'our_bi_cui_name': 'Pragmatic enhancement strategies',\n",
       "  'our_bi_cui_desc': '[CLS] P ##rag ##matic enhance ##ment strategies [unused3] ( Health Care Act ##ivity , procedure , regime / therapy ) [SEP]',\n",
       "  'our_cross_cui': 'C0035171',\n",
       "  'our_cross_cui_name': 'Research Design',\n",
       "  'our_cross_cui_desc': '[CLS] Research Design [unused3] ( Research Act ##ivity : Experiment Design ; design research ; research design ; Design ##s , Research ; Design , Research ; ST ##YP ##E ; Research Design ##s ; study design ; Study Type ; Study Design ; Experimental Design ) [SEP]'},\n",
       " {'mention_id': '27371817.39',\n",
       "  'test_set_idx': 3943,\n",
       "  'type': 'T058',\n",
       "  'name': '( 1 ) H NMR spectroscopy',\n",
       "  'context': '[CLS] - MS showed higher sensitivity and specific ##ity and was more suitable for the determination of bio ##mark ##ers apart from the deficiency of time - consuming sample preparation steps and un ##am ##bi ##guous meta ##bol ##ite identification . Therefore , it is feasible to analyze the changes of g ##ly ##cer ##op ##hos ##ph ##oli ##pid ##s during inflammation by combining [unused1] ( 1 ) H N ##MR s ##pect ##ros ##copy [unused2] with U - HP ##LC / Q - TO ##F - MS . The metabolic pro ##fi ##ling of g ##ly ##cer ##op ##hos ##ph ##oli ##pid ##s provides valuable evidence for inflammation diagnosis and pro ##gno ##sis , and might un ##rave ##l the mechanisms involved in inflammation progression . [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C3850001',\n",
       "  'our_bi_cui_name': '1H NMR',\n",
       "  'our_bi_cui_desc': '[CLS] 1 ##H N ##MR [unused3] ( Health Care Act ##ivity : 1 ##H - N ##MR ) [SEP]',\n",
       "  'our_cross_cui': 'C0877853',\n",
       "  'our_cross_cui_name': 'Spectroscopy , Nuclear Magnetic Resonance',\n",
       "  'our_cross_cui_desc': '[CLS] S ##pect ##ros ##copy , Nuclear Ma ##gnetic Re ##son ##ance [unused3] ( Health Care Act ##ivity : S ##pect ##ros ##copy , N ##MR ; nuclear magnetic resonance s ##pect ##ros ##copy ; Nuclear magnetic resonance s ##pect ##ros ##copy ; N ##MR S ##pect ##ros ##copy ; S ##pect ##ros ##co ##pies , N ##MR ; N ##MR S ##pect ##ros ##co ##pies ; nm ##r s ##pect ##ros ##copy ) [SEP]'},\n",
       " {'mention_id': '27251800.7',\n",
       "  'test_set_idx': 802,\n",
       "  'type': 'T058',\n",
       "  'name': 'Stoppa technique',\n",
       "  'context': '[CLS] Early assessment of bilateral ing ##uin ##al her ##nia repair : A comparison between the lap ##aro ##scopic total extra ##per ##ito ##nea ##l and Stop ##pa approaches The present clinical trial was designed to compare the results of bilateral ing ##uin ##al her ##nia repair between patients who underwent the conventional [unused1] Stop ##pa technique [unused2] and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair with a single mesh and without staple fix ##ation . This controlled , random ##ised clinical trial was conducted at General Surgery and T ##ra ##uma of the Clinic ##s Hospital , Medical School , the University of S ##γ ##o Paulo between September 2010 and February 2011 . Total ##ly , 50 male patients , with a [SEP]',\n",
       "  'existing_cui': 'C0450241',\n",
       "  'existing_cui_name': 'Ffooks technique',\n",
       "  'existing_cui_desc': '[CLS] F ##fo ##ok ##s technique [unused3] ( Health Care Act ##ivity , qualifier value ) [SEP]',\n",
       "  'our_bi_cui': 'C0031150',\n",
       "  'our_bi_cui_name': 'Laparoscopy',\n",
       "  'our_bi_cui_desc': '[CLS] La ##par ##os ##copy [unused3] ( Health Care Act ##ivity , G ##I only , procedure : La ##par ##os ##copic procedure ; per ##ito ##ne ##os ##copy ; Co ##eli ##os ##copy ; Ce ##lio ##sco ##pies ; Per ##ito ##ne ##os ##co ##pies ; Abd ##ome ##n end ##os ##copy ; c ##eli ##os ##copy ; lap ##aro ##scopic procedure ; Per ##ito ##ne ##os ##copy ; La ##p ; Ce ##lio ##sco ##py ; La ##par ##os ##co ##pies ; lap ##aro ##sco ##pies ; lap ##aro ##sco ##py ; lap ##aro ##scopic procedures ; diagnostic lap ##aro ##sco ##py ; End ##os ##copy of abdomen ; lap ##aro ##sco ##py procedure ; La ##par ##os ##copic ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27444636.43',\n",
       "  'test_set_idx': 5994,\n",
       "  'type': 'T170',\n",
       "  'name': 'Adverse Events Profile',\n",
       "  'context': '[CLS] ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate , there were significant improvements in mean scores for Ad ##verse Events Profile ( P < . 00 ##1 ) , Quality of Life in E ##pile ##psy In ##vent ##ory 10 ( P = . 00 ##1 ) , and alert ##ness ( P < . 05 ) . [unused1] Ad ##verse Events Profile [unused2] total scores improved for 21 / 21 ( 100 . 0 % ) patients , Quality of Life in E ##pile ##psy In ##vent ##ory 10 total scores improved for 17 / 21 ( 81 . 0 % ) patients , and alert ##ness scores improved for 16 / 21 ( 76 . 2 % ) patients . In this [SEP]',\n",
       "  'existing_cui': 'C0877248',\n",
       "  'existing_cui_name': 'Adverse event',\n",
       "  'existing_cui_desc': '[CLS] Ad ##verse event [unused3] ( B ##iol ##og ##ic Fun ##ction : AD ##VE ##RS ##E E ##VE ##NT ; adverse events ; Ad ##verse Event ; adverse event ; Ad ##verse ##E ##vent ; Ad ##verse Experience ) [SEP]',\n",
       "  'our_bi_cui': 'C1521800',\n",
       "  'our_bi_cui_name': 'Adverse Drug Experience Report',\n",
       "  'our_bi_cui_desc': '[CLS] Ad ##verse Drug Experience Report [unused3] ( Intel ##lect ##ual Product : Ad ##verse Drug Report ; Ad ##verse Experience Report ; Ad ##verse Event Report ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28375449.10',\n",
       "  'test_set_idx': 33493,\n",
       "  'type': 'T058',\n",
       "  'name': 'knotting',\n",
       "  'context': '[CLS] attempt to reduce the difficulty of this surgical procedure , this study developed a modified an ##ast ##omo ##tic technique for th ##ora ##cola ##par ##os ##copic I ##vor - Lewis es ##op ##hage ##ct ##omy . During the entirety of this modified approach , neither technically challenging operations such as in ##tra ##th ##ora ##ci ##c su ##tur ##ing or [unused1] knot ##ting [unused2] , nor special instruments such as an Or ##V ##il system or a reverse - pu ##nc ##ture head are required . Between October 2015 and January 2016 , 15 consecutive patients with cancer in the di ##stal third of the es ##op ##ha ##gus or the gas ##tric card ##ia underwent this modified surgical procedure . The good short - [SEP]',\n",
       "  'existing_cui': 'C0263493',\n",
       "  'existing_cui_name': 'Trichonodosis',\n",
       "  'existing_cui_desc': '[CLS] Tri ##cho ##no ##dos ##is [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Hair knot ##ting ; t ##rich ##ono ##dos ##is ; K ##not ##ted hairs ; knot ##ting of hair ; K ##not ##ting of hair shaft ) [SEP]',\n",
       "  'our_bi_cui': 'C0023690',\n",
       "  'our_bi_cui_name': 'Ligation',\n",
       "  'our_bi_cui_desc': '[CLS] Liga ##tion [unused3] ( Health Care Act ##ivity , procedure , qualifier value : surgical binding ; l ##iga ##tion ; C ##losure by Liga ##tion ; Liga ##tion - action ; Liga ##tions ; C ##losure by l ##iga ##tion ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27273231.33',\n",
       "  'test_set_idx': 1214,\n",
       "  'type': 'T033',\n",
       "  'name': 'No',\n",
       "  'context': '[CLS] period , the pulmonary art ##eries were sampled . Press ##ure tolerance at the sealed end was evaluated in 91 pulmonary artery sections . All sealed ends showed pressure tolerance > 75 mm H ##g . A left lower lobe ##ct ##omy was performed in 13 dogs in which 35 pulmonary artery sections had been allocated into the 3 groups . [unused1] No [unused2] sealing failure was found , and path ##ological findings showed healing and persistent hem ##ost ##asis at all sealed ends of the pulmonary art ##eries after 2 and 4 weeks of the survival period . P ##ul ##mona ##ry art ##eries sealed in v ##ivo with the En ##sea ##l device showed pressure tolerance > 75 mm H ##g in the acute [SEP]',\n",
       "  'existing_cui': 'C1016143',\n",
       "  'existing_cui_name': 'Tetragenococcus halophilus',\n",
       "  'existing_cui_desc': '[CLS] Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us [unused3] ( Ba ##cter ##ium , organism : P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us Me ##es 1934 ( A ##pp ##roved List ##s 1980 ) ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us ( Me ##es 1934 ) Collins et al . 1993 ; Sa ##rc ##ina ha ##ma ##guchi ##ae ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##a ; P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us ; Te ##tra ##co ##cc ##cus No . 1 ; P ##ed ##io ##co ##cc ##us so ##ya ##e ) [SEP]',\n",
       "  'our_bi_cui': 'C0243095',\n",
       "  'our_bi_cui_name': 'Finding',\n",
       "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C1513916',\n",
       "  'our_cross_cui_name': 'Negative Finding',\n",
       "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
       " {'mention_id': '28495651.34',\n",
       "  'test_set_idx': 37809,\n",
       "  'type': 'T201',\n",
       "  'name': 'cardiovascular death',\n",
       "  'context': '[CLS] Hodges , and 1 . 12 ( 0 . 28 - 4 . 52 ) for Q ##T ##c Fr ##ami ##ng ##ham . The hazard ratio of Q ##T ##c Ba ##ze ##tt was significantly higher than the other formula ##s except for the 98 ##th percent ##ile method . The Fr ##ami ##ng ##ham , Hodges , and Fr ##ider ##ici ##a equations remove the effect of heart rate on Q ##T interval significantly better than the Ba ##ze ##tt equation . Using Q ##T - interval percent ##iles based on heart rate provides a consistent approach both for identifying those whose Q ##T intervals pro ##long due to drugs or other stress ##ors and for assessing [unused1] card ##iovascular death [unused2] risk . [SEP]',\n",
       "  'existing_cui': 'C0007226',\n",
       "  'existing_cui_name': 'Cardiovascular system',\n",
       "  'existing_cui_desc': '[CLS] Card ##iovascular system [unused3] ( Body System , body structure : Structure of card ##iovascular system , un ##sp ##ec ##ified ; CA ##RD ##IO ##VA ##SC ##U ##LA ##R S ##Y ##ST ##EM ; Card ##iovascular ; Organ System , Card ##iovascular ; CA ##RD ##IO ##VA ##SC S ##Y ##ST ##EM ; Card ##iovascular structure ; card ##iovascular system ; Card ##iovascular Organ System ; C ##ir ##cula ##tory ; Structure of card ##iovascular system ; Card ##iovascular Systems ; card ##iovascular structure ; C ##ir ##cula ##tory System ; C ##ir ##cula ##tory Systems ; { C ##ir ##cula ##tory system } ; c ##ir ##cula ##tory ; C ##ir ##cula ##tory system ; Body System , Card ##iovascular ; card ##iovascular system [SEP]',\n",
       "  'our_bi_cui': 'C0376297',\n",
       "  'our_bi_cui_name': 'Cardiac Death',\n",
       "  'our_bi_cui_desc': '[CLS] Card ##iac Death [unused3] ( B ##iol ##og ##ic Fun ##ction : death ; cardiac ; cardiac death ; cardiac deaths ; Card ##iac death ; Death , Card ##iac ; cardiac ; death ) [SEP]',\n",
       "  'our_cross_cui': 'C2926098',\n",
       "  'our_cross_cui_name': \"Mechanism of death in patient 's dying of cardiovascular causes : Type : Point in time : ^ Patient : Nominal\",\n",
       "  'our_cross_cui_desc': \"[CLS] Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : Point in time : ^ Pat ##ient : No ##mina ##l [unused3] ( Clinical At ##tri ##but ##e : Death due to C ##V causes ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : P ##t : ^ Pat ##ient : No ##m ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes ) [SEP]\"},\n",
       " {'mention_id': '28493435.9',\n",
       "  'test_set_idx': 37724,\n",
       "  'type': 'T033',\n",
       "  'name': 'locate',\n",
       "  'context': '[CLS] el ##ast ##ography algorithms , lo ##cating ex ##tre ##ma in multi ##mo ##dal ultra ##sonic radio ##f ##re ##que ##ncy signals is still a challenging problem . In this paper , a new method is proposed to locate the local ma ##xi ##ma and mini ##ma of the RF signals directly without der ##ivation operation . This algorithm can accurately [unused1] locate [unused2] ex ##tre ##ma even if disturbed peaks resulting from different noise exist . Furthermore , the new algorithm can speed up approximately 79 % of the implementation process as compared with the standard cross - correlation method on the same computing platform . In addition , the el ##ast ##ographic signal - to - noise ratio and the contrast - to - [SEP]',\n",
       "  'existing_cui': 'C1366498',\n",
       "  'existing_cui_name': 'Chloramphenicol Acetyl Transferase Gene',\n",
       "  'existing_cui_desc': '[CLS] Ch ##lora ##mp ##hen ##ico ##l Ace ##ty ##l Transfer ##ase Gene [unused3] ( Ana ##tom ##ical Structure : cat Gene ) [SEP]',\n",
       "  'our_bi_cui': 'C0450429',\n",
       "  'our_bi_cui_name': 'Location',\n",
       "  'our_bi_cui_desc': '[CLS] Location [unused3] ( Spa ##tial Concept , attribute : location ; Lo ##c ; L ##OC ; locations ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27444636.40',\n",
       "  'test_set_idx': 5991,\n",
       "  'type': 'T170',\n",
       "  'name': 'Adverse Events Profile',\n",
       "  'context': '[CLS] ##rb ##az ##ep ##ine ace ##tate ( days 0 and 5 , respectively ) . The analysis included 21 patients ( 12 women , 9 men ; mean age 36 years ) . After switching from o ##x ##car ##ba ##ze ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate , there were significant improvements in mean scores for [unused1] Ad ##verse Events Profile [unused2] ( P < . 00 ##1 ) , Quality of Life in E ##pile ##psy In ##vent ##ory 10 ( P = . 00 ##1 ) , and alert ##ness ( P < . 05 ) . Ad ##verse Events Profile total scores improved for 21 / 21 ( 100 . 0 % ) patients , Quality of Life in [SEP]',\n",
       "  'existing_cui': 'C0877248',\n",
       "  'existing_cui_name': 'Adverse event',\n",
       "  'existing_cui_desc': '[CLS] Ad ##verse event [unused3] ( B ##iol ##og ##ic Fun ##ction : AD ##VE ##RS ##E E ##VE ##NT ; adverse events ; Ad ##verse Event ; adverse event ; Ad ##verse ##E ##vent ; Ad ##verse Experience ) [SEP]',\n",
       "  'our_bi_cui': 'C1521800',\n",
       "  'our_bi_cui_name': 'Adverse Drug Experience Report',\n",
       "  'our_bi_cui_desc': '[CLS] Ad ##verse Drug Experience Report [unused3] ( Intel ##lect ##ual Product : Ad ##verse Drug Report ; Ad ##verse Experience Report ; Ad ##verse Event Report ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27932585.13',\n",
       "  'test_set_idx': 22240,\n",
       "  'type': 'T103',\n",
       "  'name': 'Taw3',\n",
       "  'context': '[CLS] ##lm ##eth ##ion ##ine ( S - ad ##eno ##sy ##lm ##eth ##ion ##ine ) - dependent met ##hyl ##tra ##ns ##fer ##ases regulate a wide range of biological processes through the modification of proteins , nuclei ##c acids , p ##oly ##sa ##cc ##hari ##des , as well as various meta ##bol ##ites . T ##Y ##W ##3 / [unused1] Ta ##w ##3 [unused2] is a SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ase responsible for the formation of a t ##RNA modification known as w ##y ##but ##os ##ine and its derivatives that are required for accurate de ##co ##ding in protein synthesis . Here , we report the crystal structure of Ta ##w ##3 , a ho ##mo ##log of T [SEP]',\n",
       "  'existing_cui': 'C3496263',\n",
       "  'existing_cui_name': 'annectant white matter',\n",
       "  'existing_cui_desc': '[CLS] an ##nect ##ant white matter [unused3] ( Ana ##tom ##ical Structure : Sub ##stant ##ia me ##du ##llar ##is an ##nect ##ens ) [SEP]',\n",
       "  'our_bi_cui': 'C1538017',\n",
       "  'our_bi_cui_name': 'MT-TW gene',\n",
       "  'our_bi_cui_desc': '[CLS] M ##T - T ##W gene [unused3] ( Ana ##tom ##ical Structure : t ##rn ##W ; t ##RNA - T ##RP , MIT ##OC ##H ##ON ##DR ##IA ##L ; mitochondrial ##ly encoded t ##RNA try ##pt ##op ##han ; T ##RA ##NS ##F ##ER RNA , MIT ##OC ##H ##ON ##DR ##IA ##L , T ##R ##YP ##TO ##P ##HA ##N ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27778231.78',\n",
       "  'test_set_idx': 16399,\n",
       "  'type': 'T038',\n",
       "  'name': 'resistant',\n",
       "  'context': '[CLS] pro ##gno ##stic value of these proteins in childhood acute l ##ymph ##ob ##lastic le ##uke ##mia . Furthermore , investigation of protein - protein interaction using ST ##RI ##NG database indicated that these proteins involved in the signaling pathway of N ##R ##3 ##C ##1 as de ##xa ##met ##has ##one target . In conclusion , our pro ##te ##omi ##c study in de ##xa ##met ##has ##one [unused1] resistant [unused2] le ##uke ##mic cells revealed voltage dependent an ##ion channel 1 , sorting N ##ex ##in 3 , and pre ##fold ##in subunit 6 are promising proteins that might serve as potential bio ##mark ##ers of pro ##gno ##sis and ch ##em ##otherapy in childhood acute l ##ymph ##ob ##lastic le ##uke ##mia . [SEP]',\n",
       "  'existing_cui': 'C2827757',\n",
       "  'existing_cui_name': 'Antimicrobial Resistance Result',\n",
       "  'existing_cui_desc': '[CLS] Anti ##mic ##ro ##bial Resistance Re ##sul ##t [unused3] ( Finding : Re ##sist ##ant ; R ##ES ##IS ##TA ##NT ) [SEP]',\n",
       "  'our_bi_cui': 'C1514892',\n",
       "  'our_bi_cui_name': 'Resistance Process',\n",
       "  'our_bi_cui_desc': '[CLS] Resistance Process [unused3] ( B ##iol ##og ##ic Fun ##ction : Resistance ; Re ##sist ##ant ) [SEP]',\n",
       "  'our_cross_cui': 'C0013203',\n",
       "  'our_cross_cui_name': 'Drug resistance',\n",
       "  'our_cross_cui_desc': '[CLS] Drug resistance [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : drug - related disorder resistance ; Drug Resistance Process ; Drug Resistance ; drug resistance ; Resistance , Drug ; obsolete drug resistance ; drugs resistance ; resistance drug ) [SEP]'},\n",
       " {'mention_id': '27965426.23',\n",
       "  'test_set_idx': 22660,\n",
       "  'type': 'T103',\n",
       "  'name': 'tyrosine - phosphorylated proteins',\n",
       "  'context': '[CLS] t ##yr ##os ##ine p ##hos ##ph ##ory ##lation in mit ##otic human cells including those on spin ##dle - associated proteins . ? Database mining confirmed ~ 2000 mit ##otic p ##hos ##ph ##ot ##yr ##os ##ine sites , and network analysis revealed a number of sub ##net ##works that were en ##rich ##ed in [unused1] t ##yr ##os ##ine - p ##hos ##ph ##ory ##lated proteins [unused2] , including components of the kin ##eto ##chor ##e or spin ##dle and SR ##C family kinase ##s . We identified Polo - like kinase 1 , a major signaling hub in the spin ##dle sub ##net ##work , as p ##hos ##ph ##ory ##lated at the conserved Ty ##r ( 217 ) in the kinase domain [SEP]',\n",
       "  'existing_cui': 'C0168164',\n",
       "  'existing_cui_name': 'GAP-associated protein p62',\n",
       "  'existing_cui_desc': '[CLS] GA ##P - associated protein p ##6 ##2 [unused3] ( Chemical : t ##yr ##os ##ine - p ##hos ##ph ##ory ##lated protein p ##6 ##2 ) [SEP]',\n",
       "  'our_bi_cui': 'C0031689',\n",
       "  'our_bi_cui_name': 'Phosphoproteins',\n",
       "  'our_bi_cui_desc': '[CLS] Ph ##os ##ph ##op ##rote ##ins [unused3] ( Chemical : Ph ##os ##ph ##op ##rote ##in ; Ph ##os ##ph ##op ##rote ##ins [ Chemical / In ##g ##red ##ient ] ; p ##hos ##ph ##op ##rote ##in ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27509301.9',\n",
       "  'test_set_idx': 8791,\n",
       "  'type': 'T103',\n",
       "  'name': 'environmental chemicals',\n",
       "  'context': \"[CLS] ##genic B ##io ##act ##ivity of Environmental Chemical Met ##ab ##oli ##tes The US Environmental Protection Agency ' s End ##oc ##rine Di ##s ##rup ##tor Screen ##ing Program is using in v ##it ##ro data generated from To ##x ##C ##ast / To ##x ##21 high - through ##put screening ass ##ays to assess the end ##oc ##rine activity of [unused1] environmental chemicals [unused2] . Considering that in v ##it ##ro ass ##ays may have limited metabolic capacity , inactive chemicals that are bio ##tra ##ns ##formed into meta ##bol ##ites with end ##oc ##rine bio ##act ##ivity may be missed for further screening and testing . Therefore , there is a value in developing novel approaches to account for metabolism and end ##oc ##rine [SEP]\",\n",
       "  'existing_cui': 'C0014406',\n",
       "  'existing_cui_name': 'Environment',\n",
       "  'existing_cui_desc': '[CLS] Environment [unused3] ( Spa ##tial Concept , environment , treatment : environments ; Environment ##s ; environment ; Environmental ; E ##N ##VI ##R ; en ##vir ; En ##vir ) [SEP]',\n",
       "  'our_bi_cui': 'C0014417',\n",
       "  'our_bi_cui_name': 'Environmental Pollutants',\n",
       "  'our_bi_cui_desc': '[CLS] Environmental Poll ##uta ##nts [unused3] ( Chemical : E ##N ##VI ##R P ##OL ##L ##UT ##AN ##TS ; P ##OL ##L ##UT ##AN ##TS E ##N ##VI ##R ; Poll ##uta ##nts , Environmental ) [SEP]',\n",
       "  'our_cross_cui': 'C0220806',\n",
       "  'our_cross_cui_name': 'Chemicals',\n",
       "  'our_cross_cui_desc': '[CLS] Chemical ##s [unused3] ( Chemical , medication , substance : chemical compounds ; Chemical ; chemical compound ; Chemical compound ; chemical substance ; Chemical ##ly ; Chemical product ; Chemical agent ; Chemical element AND / OR compound ; chemical ; chemicals ) [SEP]'},\n",
       " {'mention_id': '28209945.41',\n",
       "  'test_set_idx': 28530,\n",
       "  'type': 'T033',\n",
       "  'name': 'conducive',\n",
       "  'context': '[CLS] > 0 . 05 ) , and compared with group B , H ##IF - 1 ##α and P - select ##in in group C were lower ( P < 0 . 01 ) ; 60 min after the transplant ##ation , H ##IF - 1 ##α , ch ##em ##oki ##ne C ##X ##CL ##14 , P - select ##in , and S ##nail in group C were lower than that in group B ( P < 0 . 01 ) . CO ##NC ##L ##US ##ION ##S h ##y ##pot ##her ##mic machine per ##fusion can significantly reduce the levels of o ##xi ##da ##tive stress factors and inflammatory factors , which is [unused1] con ##du ##ci ##ve [unused2] for liver transplant ##ation . [SEP]',\n",
       "  'existing_cui': 'C3640666',\n",
       "  'existing_cui_name': 'Urine Conductivity',\n",
       "  'existing_cui_desc': '[CLS] U ##rine Con ##duct ##ivity [unused3] ( Health Care Act ##ivity : CO ##ND ##UC ##TU ) [SEP]',\n",
       "  'our_bi_cui': 'C0562524',\n",
       "  'our_bi_cui_name': 'Temperate environment',\n",
       "  'our_bi_cui_desc': '[CLS] Te ##mper ##ate environment [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28127853.24',\n",
       "  'test_set_idx': 26318,\n",
       "  'type': 'T058',\n",
       "  'name': 'program',\n",
       "  'context': '[CLS] The \" At ##ti ##tudes toward A ##ging Scale \" and the \" Spiritual Health Scale \" were two assessment instruments used in the study . The results showed that there were significant improvements in the At ##ti ##tudes toward A ##ging Scale for the young adult group ( aged 18 - 29 years ) and in the Spiritual Health Scale for the older adult group ( aged 65 - 80 years ) . The evaluation showed that participants were satisfied with the [unused1] program [unused2] . The results of the present study provide future directions for successful aging and inter ##gene ##ration ##al learning . G ##eria ##tr G ##eron ##to ##l In ##t 2017 ; • • : • • - • • . [SEP]',\n",
       "  'existing_cui': 'C0237807',\n",
       "  'existing_cui_name': 'Mental health program',\n",
       "  'existing_cui_desc': '[CLS] Mental health program [unused3] ( Organization , Mental Health : health mental programs ; Programs ; Mental Health Programs ; mental health programs ; mental health program ) [SEP]',\n",
       "  'our_bi_cui': 'C0376691',\n",
       "  'our_bi_cui_name': 'Programs - Publication Format',\n",
       "  'our_bi_cui_desc': '[CLS] Programs - Public ##ation Form ##at [unused3] ( Intel ##lect ##ual Product : Programs ) [SEP]',\n",
       "  'our_cross_cui': 'C0043113',\n",
       "  'our_cross_cui_name': 'Wellness Programs',\n",
       "  'our_cross_cui_desc': '[CLS] Well ##ness Programs [unused3] ( Health Care Act ##ivity : program well ##ness ; programs well ##ness ; Programs , Well ##ness ; Well ##ness Program ; well ##ness programs ; programming well ##ness ; Program , Well ##ness ; well ##ness program ) [SEP]'},\n",
       " {'mention_id': '28009593.23',\n",
       "  'test_set_idx': 23576,\n",
       "  'type': 'T098',\n",
       "  'name': 'sample',\n",
       "  'context': \"[CLS] of Nursing Scale - R ##N version ( P ##ON ##S - R ##N ) was developed to measure nurses ' perception ##s of their ability to be present to their patients . This study sum ##mar ##izes the process of re - evaluation of the ps ##ych ##ometric properties of the P ##ON ##S - R ##N instrument . A [unused1] sample [unused2] of 76 registered nurses providing direct patient care responded to the 31 - item question ##naire . The Ra ##sch rating scale model was used for assessing construct validity of P ##ON ##S - R ##N data . A principal component analysis of residual ##s supported appropriate ##ness of the sub ##sca ##les defined by a 2 - dimensional structure . The [SEP]\",\n",
       "  'existing_cui': 'C0586999',\n",
       "  'existing_cui_name': 'Vein sample',\n",
       "  'existing_cui_desc': '[CLS] V ##ein sample [unused3] ( Ana ##tom ##ical Structure , specimen ) [SEP]',\n",
       "  'our_bi_cui': 'C2348150',\n",
       "  'our_bi_cui_name': 'Sample Study Population',\n",
       "  'our_bi_cui_desc': '[CLS] Sam ##ple Study Population [unused3] ( Population Group ) [SEP]',\n",
       "  'our_cross_cui': 'C1257890',\n",
       "  'our_cross_cui_name': 'Population Group',\n",
       "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
       " {'mention_id': '27722881.39',\n",
       "  'test_set_idx': 15026,\n",
       "  'type': 'T007',\n",
       "  'name': 'JPM1',\n",
       "  'context': '[CLS] modeling method was applied to build the crystal structure of di ##ox ##y ##gen ##ase . Subsequently , the interaction mechanism between flu ##oran ##the ##ne and the active site of di ##ox ##y ##gen ##ase was simulated and analyzed by molecular dock ##ing . Consequently , a feasible de ##grading pathway of flu ##oran ##the ##ne in the strain [unused1] JP ##M ##1 [unused2] was proposed based on the meta ##bol ##ites and the interaction analyses . Additionally , the the ##rm ##ody ##nam ##ic analysis showed that the strain JP ##M ##1 had high tolerance for flu ##oran ##the ##ne , and the influence of flu ##oran ##the ##ne for the bacterial growth activity was ne ##gli ##gible under 100 to 400 mg L [SEP]',\n",
       "  'existing_cui': 'C1421124',\n",
       "  'existing_cui_name': 'TRGJP gene',\n",
       "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
       "  'our_bi_cui': 'C3629619',\n",
       "  'our_bi_cui_name': 'bacterium JP1',\n",
       "  'our_bi_cui_desc': '[CLS] bacterium JP ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
       "  'our_cross_cui': 'C4153571',\n",
       "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
       " {'mention_id': '27802570.34',\n",
       "  'test_set_idx': 17786,\n",
       "  'type': 'T103',\n",
       "  'name': 'soluble protein',\n",
       "  'context': '[CLS] ) O ##2 ( - ) ( super ##oxide an ##ion ) production were effectively decreased in the range of 27 . 27 % to 54 . 38 % . Ph ##ys ##ico ##chemical characteristics showed that k ##i ##wi ##f ##ruit ##s from treated group maintained higher levels of flesh l ##umi ##nos ##ity and firm ##ness . Essential oils also decreased the levels of reducing sugar by 45 . 97 % at day 3 , and increased the content of [unused1] soluble protein [unused2] and h ##ydro ##ly ##zed amino acid . Therefore , post ##har ##ves ##t Essential oils treatment has positive effects on delay ##ing se ##nes ##cence and enhancing anti ##ox ##ida ##nt capacities in k ##i ##wi ##f ##ruit . [SEP]',\n",
       "  'existing_cui': 'C1749467',\n",
       "  'existing_cui_name': 'soluble',\n",
       "  'existing_cui_desc': '[CLS] soluble [unused3] ( Ana ##tom ##ical Structure ) [SEP]',\n",
       "  'our_bi_cui': 'C0074926',\n",
       "  'our_bi_cui_name': 'Soy Proteins',\n",
       "  'our_bi_cui_desc': '[CLS] So ##y Pro ##tein ##s [unused3] ( Chemical , substance : So ##y proteins ; Pro ##tein ##s , So ##y ; Diet ##ary So ##y ##be ##an Pro ##tein ##s ; So ##y protein ; So ##y Pro ##tein ; Diet ##ary So ##y ##be ##an Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; so ##y proteins ; protein so ##y ; S ##O ##Y PR ##OT ##EI ##N ; so ##y protein ; So ##ya protein ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28203549.107',\n",
       "  'test_set_idx': 28299,\n",
       "  'type': 'T170',\n",
       "  'name': 'ST types',\n",
       "  'context': '[CLS] accounted for more than three is ##olate ##s . These five P ##F ##GE clusters only accounted for 35 ( 41 . 7 % , 35 / 84 ) is ##olate ##s . In conclusion , our study first found that h ##yper ##tens ##ion and male patients with 41 - 50 years old were independent risk factors . The composition of [unused1] ST types [unused2] and P ##F ##GE clusters among K . pneumonia ##e K ##2 is ##olate ##s was more diverse than K ##1 is ##olate ##s . K ##1 and K ##2 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s had respective specific profiles of v ##ir ##ule ##nce - associated genes . [SEP]',\n",
       "  'existing_cui': 'C0449570',\n",
       "  'existing_cui_name': 'Test type',\n",
       "  'existing_cui_desc': '[CLS] Test type [unused3] ( Intel ##lect ##ual Product , attribute : test types ; testing types ; tests typing ; test type ; tests types ; test typing ; type test ; tests type ) [SEP]',\n",
       "  'our_bi_cui': 'C0441756',\n",
       "  'our_bi_cui_name': 'Genotype types',\n",
       "  'our_bi_cui_desc': '[CLS] Gen ##otype types [unused3] ( Intel ##lect ##ual Product , qualifier value ) [SEP]',\n",
       "  'our_cross_cui': 'C0449943',\n",
       "  'our_cross_cui_name': 'Serotype',\n",
       "  'our_cross_cui_desc': '[CLS] Ser ##otype [unused3] ( Intel ##lect ##ual Product , attribute , o ##bs ##er ##vable entity , qualifier value : se ##rov ##ar ; se ##rov ##ars ; Ser ##ova ##rs ; se ##rot ##ype ; se ##rot ##ype ##s ; Ser ##otype ##s ; Ser ##ova ##r ) [SEP]'},\n",
       " {'mention_id': '27601292.8',\n",
       "  'test_set_idx': 11183,\n",
       "  'type': 'T038',\n",
       "  'name': 'metabolizing',\n",
       "  'context': '[CLS] V ##ori ##cona ##zo ##le metabolism is influenced by severe inflammation : a prospective study During an infection or inflammation , several drug - [unused1] meta ##bol ##izing [unused2] enzymes in the liver are down - regulated , including c ##yt ##och ##rome P ##45 ##0 is ##o - enzymes . Since v ##ori ##cona ##zo ##le is extensively meta ##bol ##ized by c ##yt ##och ##rome P ##45 ##0 is ##o - enzymes , the metabolism of v ##ori ##cona ##zo ##le can be influenced during inflammation via reduced clearance of the drug , resulting in higher v ##ori ##cona ##zo ##le t ##rough concentrations . To investigate prospective ##ly the influence of inflammation on v ##ori ##cona ##zo ##le metabolism and v ##ori ##cona [SEP]',\n",
       "  'existing_cui': 'C0085509',\n",
       "  'existing_cui_name': 'Sulfur-Reducing Bacteria',\n",
       "  'existing_cui_desc': '[CLS] Sul ##fu ##r - Red ##uc ##ing Ba ##cter ##ia [unused3] ( Ba ##cter ##ium , organism : Sul ##fu ##r Red ##uc ##ing Ba ##cter ##ia ; S ##U ##LF ##UR R ##ED ##UC ##ING BA ##CT ; Sul ##ph ##ur reducing bacteria ; Sub ##c ##lass Sul ##fu ##r Red ##uc ##ing Ba ##cter ##ia ; sulfur meta ##bol ##izing bacteria ; Sub ##c ##lass Sul ##ph ##ur Red ##uc ##ing Ba ##cter ##ia ; Sul ##fu ##r reducing bacteria ) [SEP]',\n",
       "  'our_bi_cui': 'C0870883',\n",
       "  'our_bi_cui_name': 'Metabolite',\n",
       "  'our_bi_cui_desc': '[CLS] Met ##ab ##oli ##te [unused3] ( Chemical : meta ##bol ##ites ; meta ##bol ##ite ; Met ##ab ##oli ##tes ) [SEP]',\n",
       "  'our_cross_cui': 'C0683140',\n",
       "  'our_cross_cui_name': 'drug metabolism',\n",
       "  'our_cross_cui_desc': '[CLS] drug metabolism [unused3] ( B ##iol ##og ##ic Fun ##ction : Drug Met ##ab ##olis ##m ; drug metabolic process ; drugs metabolism ; bio ##tra ##ns ##formation drug ; bio ##tra ##ns ##formation drugs ; metabolism drug ) [SEP]'},\n",
       " {'mention_id': '28234635.24',\n",
       "  'test_set_idx': 29192,\n",
       "  'type': 'T103',\n",
       "  'name': 'LXR',\n",
       "  'context': '[CLS] investigated potential molecular mechanisms of liver injury in p ##ediatric onset in ##test ##inal failure . Live ##r expression of canal ##icular p ##hos ##ph ##oli ##pid ( ABC ##B ##4 ) , bi ##le acid ( ABC ##B ##11 ) , and s ##tero ##l ( ABC ##G ##5 / 8 ) transport ##ers , their upstream regulator ##s [unused1] L ##X ##R [unused2] and FX ##R as well as pro - inflammatory c ##yt ##oki ##nes inter ##le ##uki ##n - 6 and tumor ne ##c ##rosis factor were investigated among patients with in ##test ##inal failure [ age median 3 . 8 ( I ##Q ##R 1 . 2 to 11 ) ] in relation to bio ##chemical and his ##to ##log ##ic [SEP]',\n",
       "  'existing_cui': 'C4288814',\n",
       "  'existing_cui_name': 'Liver X Receptor-Like Family',\n",
       "  'existing_cui_desc': '[CLS] Live ##r X Re ##ceptor - Like Family [unused3] ( Chemical : L ##X ##R Family ; Nuclear Re ##ceptor Sub ##family 1 Group H ) [SEP]',\n",
       "  'our_bi_cui': 'C0385463',\n",
       "  'our_bi_cui_name': 'leptin receptor',\n",
       "  'our_bi_cui_desc': '[CLS] le ##pt ##in receptor [unused3] ( Chemical : R ##EC ##EP ##T L ##EP ##TI ##N ; Re ##ceptor , O ##B ; O ##B - R ; L ##EP ##TI ##N R ##EC ##EP ##T ; O ##B Re ##ceptor ; L ##EP ##R ; CD ##29 ##5 Anti ##gens ; AN ##TI ##GE ##NS CD 295 ; Re ##ceptor ##s , Le ##pt ##in [ Chemical / In ##g ##red ##ient ] ; Le ##pt ##in Bin ##ding Pro ##tein ; Le ##pt ##in Re ##ceptor ; L ##EP ##R Pro ##tein ; Hu ##B ##21 ##9 ; Re ##ceptor , Le ##pt ##in ; Le ##pt ##in Re ##ceptor ##s ; O ##B R ##EC ##EP ##T ; Re ##ceptor ##s , Le [SEP]',\n",
       "  'our_cross_cui': 'C4277606',\n",
       "  'our_cross_cui_name': 'Liver X Receptors',\n",
       "  'our_cross_cui_desc': '[CLS] Live ##r X Re ##ceptor ##s [unused3] ( Chemical : O ##xy ##ster ##ol Re ##ceptor ##s , Nuclear ; Live ##r X Re ##ceptor ; Nuclear O ##xy ##ster ##ol Re ##ceptor ##s ; Live ##r X Re ##ceptor ##s [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '27791169.3',\n",
       "  'test_set_idx': 16856,\n",
       "  'type': 'T017',\n",
       "  'name': 'BPH9',\n",
       "  'context': '[CLS] All ##eli ##c diversity in an n ##uc ##leo ##tide - binding and le ##uc ##ine - rich repeat gene [unused1] BP ##H ##9 [unused2] enables rice to combat plant ##hop ##per variation Brown plant ##hop ##per , Ni ##lap ##ar ##vat ##a l ##ugen ##s St ##å ##l , is one of the most devastating insect p ##ests of rice ( Or ##y ##za sat ##iva L . ) . Currently , 30 Brown plant ##hop ##per - resistance genes have been genetically defined , most of which are cluster ##ed on specific chromosome regions . Here , we describe molecular c ##lon ##ing and characterization of a Brown plant ##hop ##per - resistance gene , BP ##H ##9 , mapped on the long arm [SEP]',\n",
       "  'existing_cui': 'C0005001',\n",
       "  'existing_cui_name': 'Benign prostatic hypertrophy',\n",
       "  'existing_cui_desc': '[CLS] Ben ##ign pro ##static h ##yper ##tro ##phy [unused3] ( B ##iol ##og ##ic Fun ##ction , BP ##H , ben ##ign , ben ##ign pro ##static h ##yper ##tro ##phy , diagnosis : H ##yper ##tro ##phy - pro ##st . ben . ; ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static h ##yper - ben ##ign ; Ben ##ign Pro ##static H ##yper ##p ##lasia - BP ##H ; En ##lar ##ged Pro ##state ; H ##yper ##tro ##phy , Ben ##ign Pro ##static ; H ##yper ##tro ##phy ( ben ##ign ) of pro ##state ; Ben ##ign h ##yper ##tro ##phy of pro ##state ; BP ##H - ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static [SEP]',\n",
       "  'our_bi_cui': 'C1419294',\n",
       "  'our_bi_cui_name': 'RBBP9 gene',\n",
       "  'our_bi_cui_desc': '[CLS] RB ##B ##P ##9 gene [unused3] ( Ana ##tom ##ical Structure : RB ##B ##P ##10 ; B ##5 ##T O ##VE ##RE ##X ##PR ##ES ##SE ##D GE ##NE ; RB ##B ##P ##9 Gene ; R ##ET ##IN ##O ##BL ##AS ##TO ##MA - B ##IN ##DI ##NG PR ##OT ##EI ##N 9 ; Re ##tino ##blast ##oma Bin ##ding Pro ##tein 9 Gene ; re ##tino ##blast ##oma binding protein 9 ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '28523846.40',\n",
       "  'test_set_idx': 38560,\n",
       "  'type': 'T103',\n",
       "  'name': 'proteoform',\n",
       "  'context': '[CLS] unfolded pro ##te ##of ##orms of forced - reduced me ##case ##rm ##in and aerial ##ly o ##xi ##dized me ##case ##rm ##in with the free - SH : protein ratio of me ##case ##rm ##in drug product . The collision cross - section ##al area , which is determined using E ##SI - I ##MS - MS , provided [unused1] pro ##te ##of ##orm [unused2] information through rapid monitoring ( < 2 min ) of in - process samples during the manufacture of me ##case ##rm ##in . E ##SI - I ##MS - MS coupled with SEC - mode HP ##LC is a rapid and robust method for analyzing the free - SH : protein ratio of me ##case ##rm ##in that allows evaluating [SEP]',\n",
       "  'existing_cui': 'C3658622',\n",
       "  'existing_cui_name': 'NeoForm',\n",
       "  'existing_cui_desc': '[CLS] Neo ##F ##orm [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0597298',\n",
       "  'our_bi_cui_name': 'Protein Isoforms',\n",
       "  'our_bi_cui_desc': '[CLS] Pro ##tein Is ##of ##orms [unused3] ( Chemical : protein is ##of ##orm ; Pro ##tein Is ##of ##orms [ Chemical / In ##g ##red ##ient ] ; Is ##of ##orms , Pro ##tein ; Is ##of ##orms ; is ##of ##orms ; is ##of ##orm ; Is ##of ##orm ) [SEP]',\n",
       "  'our_cross_cui': 'C1510464',\n",
       "  'our_cross_cui_name': 'Protein Structure',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein Structure [unused3] ( Chemical : protein structure ) [SEP]'},\n",
       " {'mention_id': '27286174.25',\n",
       "  'test_set_idx': 1488,\n",
       "  'type': 'T033',\n",
       "  'name': 'removal from the list',\n",
       "  'context': '[CLS] ##6 adults listed for kidney transplant before December 31 , 2011 . Pre ##dict ##ors were age , sex , blood type , calculated panel - reactive antibodies , donation service area , dial ##ys ##is duration , com ##or ##bid conditions , and body mass index . Out ##come ##s were deceased or living donor transplant , death or [unused1] removal from the list [unused2] due to de ##ter ##ior ##ating medical condition , or removal due to other reasons . We calculated hazards for the possible outcomes , then the cumulative incidence function for a given candidate using competing risk methodology . Disc ##rim ##ination and ca ##li ##bra ##tion were assessed through C statistics and ca ##li ##bra ##tion plots for each cause [SEP]',\n",
       "  'existing_cui': 'C4082098',\n",
       "  'existing_cui_name': 'Patient status determination , deceased and removed from state',\n",
       "  'existing_cui_desc': '[CLS] Pat ##ient status determination , deceased and removed from state [unused3] ( Finding , finding : Re ##mo ##val from state ) [SEP]',\n",
       "  'our_bi_cui': 'C0015252',\n",
       "  'our_bi_cui_name': 'removal technique',\n",
       "  'our_bi_cui_desc': '[CLS] removal technique [unused3] ( Health Care Act ##ivity , procedure , qualifier value : re ##sect ; ex ##cision procedure ; surgical removal ; procedures removal ; ex ##ti ##rp ##ation ; re ##section ##ed ; re ##section ##s ; re ##section ##ing ; surgical re ##section ; removal ; ex ##cision ##s ; Re ##mo ##val - action ; ex ##cision procedures ; surgical removal procedure ; procedure removal ; ex ##cision ; re ##sect ##ed ; Re ##mo ##val - procedure ; removal ##s ; removal procedure ; Re ##mo ##val technique ; e ##ct ##omy ; Re ##mo ##val ; re ##section ; Re ##mo ##val Pro ##ced ##ure ; Re ##mo ##val procedure ) [SEP]',\n",
       "  'our_cross_cui': 'C0420299',\n",
       "  'our_cross_cui_name': 'Removed from waiting list',\n",
       "  'our_cross_cui_desc': '[CLS] Re ##mo ##ved from waiting list [unused3] ( Finding , finding ) [SEP]'},\n",
       " {'mention_id': '28495651.19',\n",
       "  'test_set_idx': 37794,\n",
       "  'type': 'T204',\n",
       "  'name': 'Schwartz',\n",
       "  'context': '[CLS] 1987 , and December 20 , 1999 , and were followed for card ##iovascular death . The 4 major correction formula ##s ( Ba ##ze ##tt , Fr ##ider ##ici ##a , Fr ##ami ##ng ##ham , and Hodges ) were used to correct Q ##T interval . In addition , the percent ##iles for heart rate ranges as proposed by [unused1] Schwartz [unused2] were calculated . During median follow - up of 17 . 8 years , 45 ##5 card ##iovascular death events occurred . When compared to the other equations , Q ##T ##c Ba ##ze ##tt had the greatest dependence on heart rate ( R ( 2 ) = 0 . 18 ) . The hazard ratio ( 95 % confidence interval ) [SEP]',\n",
       "  'existing_cui': 'C0036391',\n",
       "  'existing_cui_name': 'Schwartz-Jampel Syndrome',\n",
       "  'existing_cui_desc': '[CLS] Schwartz - Jam ##pel S ##yn ##drome [unused3] ( B ##iol ##og ##ic Fun ##ction , Schwartz - Jam ##pel syndrome , diagnosis , disorder : O ##ste ##och ##ond ##rom ##us ##cular d ##ys ##tro ##phy ; S ##J ##A S ##Y ##ND ##RO ##ME ; s ##ch ##wart ##z jam ##pel syndrome ; My ##oto ##nic My ##op ##athy , D ##war ##fi ##sm , Cho ##nd ##rod ##ys ##tro ##phy , And O ##cular And F ##ac ##ial A ##b ##nor ##mal ##ities ; Schwartz - Jam ##pel S ##yn ##drome , Type 1 ; M ##Y ##OT ##ON ##IC M ##Y ##OP ##AT ##H ##Y , D ##WA ##R ##FI ##SM , CH ##ON ##DR ##OD ##Y ##ST ##RO ##P ##H ##Y [SEP]',\n",
       "  'our_bi_cui': 'C1261028',\n",
       "  'our_bi_cui_name': 'Schwartze operation',\n",
       "  'our_bi_cui_desc': '[CLS] Schwartz ##e operation [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
       "  'our_cross_cui': 'C0086418',\n",
       "  'our_cross_cui_name': 'Homo sapiens',\n",
       "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
       " {'mention_id': '27762482.18',\n",
       "  'test_set_idx': 15896,\n",
       "  'type': 'T074',\n",
       "  'name': 'PDL',\n",
       "  'context': '[CLS] in some patients , and several studies using the low non ##pur ##pura ##genic flu ##ence were reported . To deliver the sufficient high flu ##ence of a PD ##L without generating pu ##rp ##ura , we designed the fraction ##ation of high flu ##ence using five passes and longer pulse duration ( 6 mill ##ise ##con ##ds ) of a [unused1] PD ##L [unused2] in succession . A total of eight patients with er ##yt ##hem ##ato ##tel ##ang ##ie ##ct ##atic r ##osa ##cea were enrolled in this study ; all patients were treated with PD ##L 10 times at 2 - week intervals . E ##ry ##them ##a and te ##lang ##ie ##ct ##asi ##a scores , as well as improvement , were [SEP]',\n",
       "  'existing_cui': 'C1414066',\n",
       "  'existing_cui_name': 'DLG5 gene',\n",
       "  'existing_cui_desc': '[CLS] DL ##G ##5 gene [unused3] ( Ana ##tom ##ical Structure : K ##IA ##A ##0 ##5 ##8 ##3 ; D ##IS ##CS LA ##R ##GE , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 5 ; P - d ##l ##g ; discs large ho ##mo ##log 5 ; P ##LA ##CE ##NT ##A AND PR ##OS ##TA ##TE DL ##G ) [SEP]',\n",
       "  'our_bi_cui': 'C0031740',\n",
       "  'our_bi_cui_name': 'Photochemotherapy',\n",
       "  'our_bi_cui_desc': '[CLS] Photo ##che ##mother ##ap ##y [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : PD ##T - Photo ##dynamic therapy ; Photo ##che ##mother ##ap ##ies ; Photo ##dynamic The ##rap ##ies ; therapy , photo ##dynamic ; Therapy , Photo ##dynamic ; THE ##R P ##H ##OT ##OD ##Y ##NA ##MI ##C ; Photo ##rad ##iation Therapy ; photo ##dynamic therapy ; photo ##che ##mother ##ap ##y ; P ##H ##OT ##OC ##H ##EM ##OT ##H ##ER ; The ##rap ##ies , Photo ##dynamic ; Photo ##dynamic Therapy Pro ##ced ##ures ; neo ##p ##las ##m / cancer photo ##rad ##iation therapy ; Photo ##che ##mother ##ap ##y [ Am ##bi ##guous ] ; Photo ##dynamic therapy ; PD [SEP]',\n",
       "  'our_cross_cui': 'C1289859',\n",
       "  'our_cross_cui_name': 'Pulsed Dye Lasers',\n",
       "  'our_cross_cui_desc': '[CLS] P ##ulse ##d D ##ye Las ##ers [unused3] ( Medical Devi ##ce , physical object : D ##ye Las ##ers , P ##ulse ##d ; P ##ulse ##d dye laser device ; Las ##er , P ##ulse ##d D ##ye ; D ##ye Las ##er , P ##ulse ##d ; Las ##ers , P ##ulse ##d D ##ye ; P ##ulse ##d D ##ye Las ##er ; pulsed dye laser ; P ##ulse ##d dye laser ) [SEP]'},\n",
       " {'mention_id': '28295414.8',\n",
       "  'test_set_idx': 31546,\n",
       "  'type': 'T033',\n",
       "  'name': 'nonabstinent',\n",
       "  'context': '[CLS] Dr ##ink ##ing Days and Dr ##ink ##ing Red ##uction ##s Among Heavy Dr ##ink ##ers in the CO ##MB ##IN ##E Study Recently , the Food and Drug Administration proposed to expand the options for primary end points in the development of medications for alcohol use disorder to include either a ##bs ##tine ##nce from alcohol or a [unused1] non ##ab ##st ##inen ##t [unused2] outcome : no heavy drinking days ( with a heavy drinking day defined as more than 3 drinks per day for women and more than 4 drinks per day for men [ > 3 / > 4 cut ##off ] ) . The Food and Drug Administration also suggested that 6 months would be the most appropriate length for a [SEP]',\n",
       "  'existing_cui': 'C0457801',\n",
       "  'existing_cui_name': 'Current non-drinker of alcohol',\n",
       "  'existing_cui_desc': '[CLS] Current non - drink ##er of alcohol [unused3] ( Finding , finding , life style : alcohol does drinking ; Non - drink ##er ; Te ##eto ##tal ##ler ; non drink ##er ; A ##bs ##tain ##er ; Te ##eto ##tale ##r ; a ##bs ##tinent ; Non - Dr ##ink ##er ; Non - drink ##er alcohol ; Non ##dr ##ink ##er ; Does not drink alcohol ; Non - drink ##er ; Non - drink ##er of alcoholic beverage ; A ##bs ##tinent ; Never drinks ; Non - drink ##er alcohol ) [SEP]',\n",
       "  'our_bi_cui': 'C0457801',\n",
       "  'our_bi_cui_name': 'Current non-drinker of alcohol',\n",
       "  'our_bi_cui_desc': '[CLS] Current non - drink ##er of alcohol [unused3] ( Finding , finding , life style : alcohol does drinking ; Non - drink ##er ; Te ##eto ##tal ##ler ; non drink ##er ; A ##bs ##tain ##er ; Te ##eto ##tale ##r ; a ##bs ##tinent ; Non - Dr ##ink ##er ; Non - drink ##er alcohol ; Non ##dr ##ink ##er ; Does not drink alcohol ; Non - drink ##er ; Non - drink ##er of alcoholic beverage ; A ##bs ##tinent ; Never drinks ; Non - drink ##er alcohol ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27990563.7',\n",
       "  'test_set_idx': 23002,\n",
       "  'type': 'T168',\n",
       "  'name': 'item',\n",
       "  'context': \"[CLS] Select ##ive reaching in mac ##aque ##s : evidence for action - centred attention When a monkey select ##s a piece of food lying on the ground from among other viable objects in the near vicinity , only the desired [unused1] item [unused2] govern ##s the particular pattern and direction of the animal ' s reaching action . It would seem then that selection is an important component controlling the animal ' s action . But , we may ask , is the selection process in such cases imp ##er ##vious to the presence of other objects that could constitute potential obstacles to or constraints on movement execution ? And if it is , in fact , per ##vious to other objects , do they have [SEP]\",\n",
       "  'existing_cui': 'C0678118',\n",
       "  'existing_cui_name': 'Transmission Electron Microscopy',\n",
       "  'existing_cui_desc': '[CLS] Trans ##mission El ##ec ##tron Micro ##sco ##py [unused3] ( Health Care Act ##ivity , T ##EM : Micro ##sco ##py , El ##ec ##tron , Trans ##mission ; El ##ec ##tron Micro ##sco ##py , Trans ##mission ; Micro ##sco ##py , Trans ##mission El ##ec ##tron ; Trans ##mission electron micro ##sco ##py ; T ##RA ##NS ##MI ##SS ##ION E ##LE ##CT ##RO ##N MI ##CR ##OS ##CO ##P ##Y ; transmission electron micro ##sco ##py ) [SEP]',\n",
       "  'our_bi_cui': 'C0567415',\n",
       "  'our_bi_cui_name': 'Atom',\n",
       "  'our_bi_cui_desc': '[CLS] At ##om [unused3] ( Chemical , substance , substance : atom ; atoms ) [SEP]',\n",
       "  'our_cross_cui': 'C0016452',\n",
       "  'our_cross_cui_name': 'Food',\n",
       "  'our_cross_cui_desc': '[CLS] Food [unused3] ( Food , medication , substance : Food or Food Product ; foods ; F ##O ##OD OR F ##O ##OD PR ##OD ##UC ##T ; Food Product ; Food or Food Sub ##stance ; Food ##P ##rod ##uc ##t ; Foods ; food ) [SEP]'},\n",
       " {'mention_id': '28479312.1',\n",
       "  'test_set_idx': 37495,\n",
       "  'type': 'T058',\n",
       "  'name': 'ESBL Nordmann/Dortet/Poirel-based protocol',\n",
       "  'context': '[CLS] A modified [unused1] E ##SB ##L Nord ##mann / Do ##rte ##t / Po ##ire ##l - based protocol [unused2] to op ##ti ##mize early se ##psis management We evaluated a modification of a color ##ime ##tric test recently described by Do ##rte ##t et al . ( 2015 ) for the rapid detection of E ##SB ##L - producing En ##tero ##ba ##cter ##iac ##eae directly from positive blood cultures that requires less manipulation , materials and hands - on time . The simplified protocol showed a sensitivity and specific ##ity of 100 % and 95 . 7 % respectively . [SEP]',\n",
       "  'existing_cui': 'C1444096',\n",
       "  'existing_cui_name': 'ESBL',\n",
       "  'existing_cui_desc': '[CLS] E ##SB ##L [unused3] ( Ba ##cter ##ium , organism : Extended spectrum beta - la ##ct ##ama ##se producing bacteria ) [SEP]',\n",
       "  'our_bi_cui': 'C0282574',\n",
       "  'our_bi_cui_name': 'Intellectual Property',\n",
       "  'our_bi_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '27887578.32',\n",
       "  'test_set_idx': 20863,\n",
       "  'type': 'T170',\n",
       "  'name': 'programme materials',\n",
       "  'context': '[CLS] and Out ##come ##s Via Education programme was delivered to health professionals in mater ##nity hospitals in all seven Australian states and territories and modified for use internationally with pilot ##ing in Vietnam , Fiji , and the Netherlands ( with the assistance of the International Still ##birth Alliance , IS ##A ) . Mo ##di ##fication ##s were made to [unused1] programme materials [unused2] in consultation with local teams and included translation for the Vietnam programme . Part ##ici ##pants completed pre - and post - programme evaluation question ##naire ##s on knowledge and confidence on six key components of per ##ina ##tal death management as well as a satisfaction question ##naire . Over the period May 2012 to May 2015 , 30 I ##M [SEP]',\n",
       "  'existing_cui': 'C0033333',\n",
       "  'existing_cui_name': 'Program Development',\n",
       "  'existing_cui_desc': '[CLS] Program Development [unused3] ( Health Care Act ##ivity , procedure : development program ; Well ##ness program development community ; w ##ln ##s p ##rg ##rm de ##v ##ment cm ##unt ; Program development ; program development ; Programme development ; Development , Program ) [SEP]',\n",
       "  'our_bi_cui': 'C2936424',\n",
       "  'our_bi_cui_name': 'Electronic Supplementary Materials',\n",
       "  'our_bi_cui_desc': '[CLS] Electronic Su ##pp ##lement ##ary Materials [unused3] ( Intel ##lect ##ual Product : Su ##pp ##lement ##ary Material ; Electronic Su ##pp ##lement ##ary Material ; Supporting Information ; Su ##pp ##lement ##ary Information ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27837917.30',\n",
       "  'test_set_idx': 18943,\n",
       "  'type': 'T033',\n",
       "  'name': 'unreinforced lever pressing ensued',\n",
       "  'context': '[CLS] - administer cocaine ( n = 96 ) or were used as yo ##ked - sa ##line control animals ( n = 21 ) . After extinction , reins ##tate ##ment was initiated by 10 minutes of cue - induced drug seeking , followed by 45 minutes with contingent cocaine access , after which cocaine was discontinued and [unused1] un ##re ##in ##force ##d lever pressing ensued [unused2] . Three measures of trans ##ient s ##yna ##ptic potent ##iation were ass ##ay ##ed during reins ##tate ##ment : den ##dr ##itic spine morphology , alpha - amino - 3 - h ##ydro ##xy - 5 - met ##hyl - 4 - is ##ox ##az ##ole prop ##ion ##ic acid to N - met ##hyl - D [SEP]',\n",
       "  'existing_cui': 'C1960601',\n",
       "  'existing_cui_name': 'Head pressing',\n",
       "  'existing_cui_desc': '[CLS] Head pressing [unused3] ( Finding , finding ) [SEP]',\n",
       "  'our_bi_cui': 'C0557952',\n",
       "  'our_bi_cui_name': 'Reinforcement of behavior',\n",
       "  'our_bi_cui_desc': '[CLS] Re ##in ##force ##ment of behavior [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Re ##in ##force ##ment of behaviour ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28433448.29',\n",
       "  'test_set_idx': 35668,\n",
       "  'type': 'T062',\n",
       "  'name': 'FDS2',\n",
       "  'context': '[CLS] was determined in each sample . In F ##DS ##2 , associates of an ##emia were assessed using multiple log ##istic re ##gression and Cox proportional hazards modeling identified predict ##ors of death during 4 . 3 ± 1 . 2 years post - recruitment . The prevalence of an ##emia at base ##line was 11 . 5 % in [unused1] F ##DS ##2 [unused2] participants , 17 . 8 % in Bus ##sel ##ton Di ##abe ##tes Study type 2 patients and 5 . 4 % in Bus ##sel ##ton Di ##abe ##tes Study participants without diabetes . In F ##DS ##2 , 163 of 178 patients with an ##emia ( 91 . 6 % ) had at least one other risk factor ( serum [SEP]',\n",
       "  'existing_cui': 'C4015495',\n",
       "  'existing_cui_name': 'CEREBELLOFACIODENTAL SYNDROME',\n",
       "  'existing_cui_desc': '[CLS] CE ##RE ##BE ##LL ##O ##FA ##CI ##OD ##EN ##TA ##L S ##Y ##ND ##RO ##ME [unused3] ( B ##iol ##og ##ic Fun ##ction : CE ##RE ##BE ##LL ##AR - FA ##CI ##AL - DE ##NT ##AL S ##Y ##ND ##RO ##ME ) [SEP]',\n",
       "  'our_bi_cui': 'C0008972',\n",
       "  'our_bi_cui_name': 'Clinical Research',\n",
       "  'our_bi_cui_desc': '[CLS] Clinical Research [unused3] ( Research Act ##ivity : Clinical Studies ; Clinical Study ; C ##L ##IN ##IC ##AL ST ##U ##D ##Y ; clinical research ; clinical studies ; clinical study ; Study ) [SEP]',\n",
       "  'our_cross_cui': 'C2603343',\n",
       "  'our_cross_cui_name': 'Study',\n",
       "  'our_cross_cui_desc': '[CLS] Study [unused3] ( Research Act ##ivity ) [SEP]'},\n",
       " {'mention_id': '27722881.26',\n",
       "  'test_set_idx': 15013,\n",
       "  'type': 'T007',\n",
       "  'name': 'JPM1',\n",
       "  'context': '[CLS] ##non ##e - 1 - car ##box ##yl ##ic acid , 9 - flu ##ore ##non ##e , p ##ht ##hali ##c acid , and ben ##zoic acid were detected in the culture solution . The gene sequence encoding the a ##romatic - ring - h ##ydro ##xy ##lating di ##ox ##y ##gen ##ase was am ##plified in the strain [unused1] JP ##M ##1 [unused2] by PC ##R . Based on the translated protein sequence , a ho ##mology modeling method was applied to build the crystal structure of di ##ox ##y ##gen ##ase . Subsequently , the interaction mechanism between flu ##oran ##the ##ne and the active site of di ##ox ##y ##gen ##ase was simulated and analyzed by molecular dock ##ing . Consequently , [SEP]',\n",
       "  'existing_cui': 'C1421124',\n",
       "  'existing_cui_name': 'TRGJP gene',\n",
       "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
       "  'our_bi_cui': 'C3629619',\n",
       "  'our_bi_cui_name': 'bacterium JP1',\n",
       "  'our_bi_cui_desc': '[CLS] bacterium JP ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
       "  'our_cross_cui': 'C4153571',\n",
       "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
       " {'mention_id': '27932585.27',\n",
       "  'test_set_idx': 22254,\n",
       "  'type': 'T103',\n",
       "  'name': 'Taw3',\n",
       "  'context': '[CLS] , a ho ##mo ##log of T ##Y ##W ##3 from Sul ##fo ##lo ##bus so ##lf ##ata ##ric ##us , which revealed a novel α / β fold . The sequence motif ( S / T ) x ##SS ##C ##x ##GR and invariant as ##par ##tate and his ##ti ##dine , conserved in T ##Y ##W ##3 / [unused1] Ta ##w ##3 [unused2] , cluster to form the cat ##alytic center . These structural and sequence features indicate that T ##Y ##W ##3 / Ta ##w ##3 proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass ##ays combined with mass s [SEP]',\n",
       "  'existing_cui': 'C3496263',\n",
       "  'existing_cui_name': 'annectant white matter',\n",
       "  'existing_cui_desc': '[CLS] an ##nect ##ant white matter [unused3] ( Ana ##tom ##ical Structure : Sub ##stant ##ia me ##du ##llar ##is an ##nect ##ens ) [SEP]',\n",
       "  'our_bi_cui': 'C0039341',\n",
       "  'our_bi_cui_name': 'tat Protein',\n",
       "  'our_bi_cui_desc': '[CLS] ta ##t Pro ##tein [unused3] ( Chemical : ta ##t Gene Product ; Gene Products , ta ##t [ Chemical / In ##g ##red ##ient ] ; Trans ##act ##ivating Reg ##ulatory Pro ##tein ; T ##AT Pro ##tein ; Trans - Act ##ivation of Trans ##cription Pro ##tein ; Trans - Act ##iva ##tor of Trans ##cription of HIV ; ta ##t Gene Products ; ta ##t protein ; Gene Product , ta ##t ; Gene Products , ta ##t ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27251800.4',\n",
       "  'test_set_idx': 799,\n",
       "  'type': 'T058',\n",
       "  'name': 'Stoppa approaches',\n",
       "  'context': '[CLS] Early assessment of bilateral ing ##uin ##al her ##nia repair : A comparison between the lap ##aro ##scopic total extra ##per ##ito ##nea ##l and [unused1] Stop ##pa approaches [unused2] The present clinical trial was designed to compare the results of bilateral ing ##uin ##al her ##nia repair between patients who underwent the conventional Stop ##pa technique and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair with a single mesh and without staple fix ##ation . This controlled , random ##ised clinical trial was conducted at General Surgery and T ##ra ##uma of the Clinic ##s Hospital , Medical School , the University of S ##γ ##o Paulo between September 2010 and February 2011 . Total ##ly , 50 male patients , with a [SEP]',\n",
       "  'existing_cui': 'C0449445',\n",
       "  'existing_cui_name': 'Approach',\n",
       "  'existing_cui_desc': '[CLS] A ##pp ##roach [unused3] ( Spa ##tial Concept , attribute , qualifier value : A ##pp ##roach ##es ; approach ; approaches ; approaching ) [SEP]',\n",
       "  'our_bi_cui': 'C0205501',\n",
       "  'our_bi_cui_name': 'Transperitoneal approach',\n",
       "  'our_bi_cui_desc': '[CLS] Trans ##per ##ito ##nea ##l approach [unused3] ( Spa ##tial Concept , qualifier value : Trans ##per ##ito ##nea ##l ; Abd ##omi ##nal trans ##per ##ito ##nea ##l approach ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27580517.33',\n",
       "  'test_set_idx': 10643,\n",
       "  'type': 'T058',\n",
       "  'name': '3D cylindrically - distributed spiral pseudo - continuous arterial spin labeling magnetic resonance imaging',\n",
       "  'context': '[CLS] two remaining patients , cerebral blood flow decreased by 2 . 4 to 6 . 0 % after ace ##ta ##zo ##lam ##ide . The group average change in cerebral blood flow due to ace ##ta ##zo ##lam ##ide was approximately 25 . 0 % and individual changes were statistical ##ly significant ( p < 0 . 01 ) in all patients using a paired t - test analysis . cerebral blood flow per ##fusion data were diagnostic ##ally useful in supporting conventional MR an ##gio ##graphy and clinical findings . [unused1] 3D cylindrical ##ly - distributed spiral pseudo - continuous art ##erial spin label ##ing magnetic resonance imaging [unused2] provides a robust approach to assess cerebral blood flow and reserve in p ##ediatric patients . [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0860888',\n",
       "  'our_bi_cui_name': 'Tomography , Spiral Computed',\n",
       "  'our_bi_cui_desc': '[CLS] Tom ##ography , S ##pi ##ral Co ##mp ##uted [unused3] ( Health Care Act ##ivity , procedure : S ##pi ##ral com ##puted to ##mo ##graphy scan ; S ##pi ##ral CT ; CT ##s , S ##pi ##ral ; com ##puted to ##mo ##graphy spiral ; Sc ##ans , S ##pi ##ral CT ; He ##lica ##l CT ##s ; He ##lica ##l CT ; S ##pi ##ral CA ##T Sc ##ans ; he ##lica ##l com ##puted to ##mo ##graphy ; c ##t spiral ; S ##pi ##ral Volume ##tric CT ; S ##pi ##ral Computer ##ized Tom ##ography ; Computer - As ##sist ##ed Tom ##ography , S ##pi ##ral ; Volume ##tric CT ; He ##lica ##l Co ##mp ##uted Tom ##ography [SEP]',\n",
       "  'our_cross_cui': 'C3891302',\n",
       "  'our_cross_cui_name': 'Arterial Spin Labeling Magnetic Resonance Imaging',\n",
       "  'our_cross_cui_desc': '[CLS] Arte ##rial Spin Label ##ing Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity : AS ##L f ##MR ##I ; Arte ##rial Spin Label ##ing MR ##I ; AR ##TE ##RI ##AL SP ##IN LA ##BE ##L ##ING F ##UN ##CT ##ION ##AL MR ##I ) [SEP]'},\n",
       " {'mention_id': '27884439.25',\n",
       "  'test_set_idx': 20661,\n",
       "  'type': 'T017',\n",
       "  'name': 'HTLTC',\n",
       "  'context': '[CLS] ##rp ##er and SA Mu ##tton Me ##rino breeds . U ##dder s were scored subjective ##ly on a 1 - 5 scale ( 1 - u ##dder intact and 5 - u ##dder damaged severely ) and t ##icks were counted on three locations . The body sites counted were the head and th ##ora ##ci ##c limb ( [unused1] H ##TL ##TC [unused2] ) , u ##dder - p ##el ##vic limb ( UP ##LT ##C ) and per ##ine ##um - br ##ee ##ch - tail ( P ##B ##TT ##C ) . These counts were also totaled for a total t ##ick count . Rep ##rod ##uction traits were number of la ##mbs we ##ane ##d per e ##we la ##mbe ##d [SEP]',\n",
       "  'existing_cui': 'C1415797',\n",
       "  'existing_cui_name': 'HTL gene',\n",
       "  'existing_cui_desc': '[CLS] H ##TL gene [unused3] ( Ana ##tom ##ical Structure : L ##E ##UC ##IN ##E T ##RA ##NS ##PO ##RT , H ##IG ##H ; high L - le ##uc ##ine transport ; H ##IG ##H L - L ##E ##UC ##IN ##E T ##RA ##NS ##PO ##RT ) [SEP]',\n",
       "  'our_bi_cui': 'C0326478',\n",
       "  'our_bi_cui_name': 'Long-tailed tit',\n",
       "  'our_bi_cui_desc': '[CLS] Long - tailed t ##it [unused3] ( E ##uka ##ryo ##te , organism : A ##eg ##ith ##alo ##s ca ##uda ##tus ; Long - tailed T ##it ; A ##eg ##ith ##alo ##s ca ##uda ##tus ( Linnaeus , 1758 ) ; Long - tailed bush ##ti ##t ) [SEP]',\n",
       "  'our_cross_cui': 'C0229962',\n",
       "  'our_cross_cui_name': 'Body part',\n",
       "  'our_cross_cui_desc': '[CLS] Body part [unused3] ( Ana ##tom ##ical Structure , body structure : Body Parts ; Body part structure ; Pa ##rs co ##rp ##oris ; body part ; body parts ; Body region ; Ana ##tom ##ic part . * ; Body Structure ; Parts , Body ; Ana ##tom ##ic part ; body region ; Cardinal body part ; Body Part ) [SEP]'},\n",
       " {'mention_id': '28468980.13',\n",
       "  'test_set_idx': 37007,\n",
       "  'type': 'T103',\n",
       "  'name': 'PfSEA-1A',\n",
       "  'context': '[CLS] P ##f ##SE ##A - 1A are associated with protection against severe malaria in children . V ##ac ##cin ##ation of mice with P ##b ##SE ##A - 1A decreases parasite ##mia and pro ##long ##s survival following P ##las ##mo ##dium be ##rg ##he ##i AN ##KA challenge . To enhance the im ##mu ##no ##genic ##ity of [unused1] P ##f ##SE ##A - 1A [unused2] , we identified five linear , B - cell e ##pit ##ope ##s using p ##eptide micro ##arra ##ys probe ##d with anti - se ##ra from r ##P ##f ##SE ##A - 1A - v ##ac ##cin ##ated non - human p ##rima ##tes . We evaluated the relationship between e ##pit ##ope - specific anti ##body levels [SEP]',\n",
       "  'existing_cui': 'C0120659',\n",
       "  'existing_cui_name': 'HA-1A',\n",
       "  'existing_cui_desc': '[CLS] H ##A - 1A [unused3] ( Chemical , product , substance ) [SEP]',\n",
       "  'our_bi_cui': 'C4040232',\n",
       "  'our_bi_cui_name': 'Plasmodium Ag',\n",
       "  'our_bi_cui_desc': '[CLS] P ##las ##mo ##dium A ##g [unused3] ( Chemical , substance : P ##las ##mo ##dium anti ##gen ; Anti ##gen of P ##las ##mo ##dium ) [SEP]',\n",
       "  'our_cross_cui': 'C3849939',\n",
       "  'our_cross_cui_name': 'SEA-1 protein , Plasmodium falciparum',\n",
       "  'our_cross_cui_desc': '[CLS] SE ##A - 1 protein , P ##las ##mo ##dium f ##al ##ci ##par ##um [unused3] ( Chemical : P ##f ##SE ##A - 1 protein , P ##las ##mo ##dium f ##al ##ci ##par ##um ; s ##chi ##zon ##t e ##g ##ress anti ##gen - 1 , P ##las ##mo ##dium f ##al ##ci ##par ##um ) [SEP]'},\n",
       " {'mention_id': '27756117.44',\n",
       "  'test_set_idx': 15641,\n",
       "  'type': 'T103',\n",
       "  'name': 'PI',\n",
       "  'context': '[CLS] . 4 % for the 2 . 8 % , 1 . 5 % and 0 . 8 % fi ##bri ##no ##gen - containing silk s ##po ##nges , respectively . Moreover , the fi ##bri ##n formation lead to a more linear elastic behavior over longer strain ranges . In combination , the Cal ##ce ##in - AM / [unused1] P ##I [unused2] stain ##ings and M ##TT ass ##ay results indicate uniform cell ad ##hesion on the surface and c ##yt ##oc ##om ##pa ##ti ##bility of the silk / fi ##bri ##n s ##po ##nges , respectively . Moreover , the co - delivery of th ##rom ##bin with fi ##bri ##no ##gen via silk as carrier material is described , offering [SEP]',\n",
       "  'existing_cui': 'C1418544',\n",
       "  'existing_cui_name': 'SERPINA1 gene',\n",
       "  'existing_cui_desc': '[CLS] SE ##RP ##IN ##A ##1 gene [unused3] ( Ana ##tom ##ical Structure : SE ##RP ##IN ##A ##1 , ; se ##rp ##in family A member 1 ; A1 ##AT ; pro ##te ##ase inhibitor 1 ( anti - el ##ast ##ase ) , alpha - 1 - anti ##try ##ps ##in ; alpha - 1 - anti ##try ##ps ##in ; Ser ##pin P ##ept ##idas ##e In ##hibit ##or , C ##lade A ( Alpha - 1 Anti ##p ##rote ##inas ##e , Anti ##try ##ps ##in ) , Member 1 Gene ; SE ##RP ##IN P ##EP ##TI ##DA ##SE IN ##H ##IB ##IT ##OR , C ##LA ##DE A , ME ##MB ##ER 1 ; AL ##P ##HA - 1 - AN [SEP]',\n",
       "  'our_bi_cui': 'C4015812',\n",
       "  'our_bi_cui_name': 'PI I PHENOTYPE',\n",
       "  'our_bi_cui_desc': '[CLS] P ##I I P ##H ##EN ##OT ##YP ##E [unused3] ( Finding : P ##I I ) [SEP]',\n",
       "  'our_cross_cui': 'C0033470',\n",
       "  'our_cross_cui_name': 'Propidium Iodide',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##pid ##ium I ##od ##ide [unused3] ( Chemical : Pro ##pid ##ium Di ##io ##di ##de ; I ##od ##ide , Pro ##pid ##ium ; Di ##io ##di ##de , Pro ##pid ##ium ) [SEP]'},\n",
       " {'mention_id': '28421738.22',\n",
       "  'test_set_idx': 35200,\n",
       "  'type': 'T103',\n",
       "  'name': '12',\n",
       "  'context': '[CLS] designed to simultaneously activate transcription - based anti ##ox ##ida ##nt responses , whose lead 1 showed interesting properties in a preliminary investigation . Re ##lying on the requirements of am ##yl ##oid - β p ##eptide recognition , we identified the cat ##ech ##ol derivative 12 . In SH - S ##Y ##5 ##Y ne ##uro ##blast ##oma cells , [unused1] 12 [unused2] combined remarkable free radical s ##ca ##venge ##r properties to the ability to trigger the Nr ##f ##2 pathway and induce the Nr ##f ##2 - dependent defensive gene N ##Q ##O ##1 by means of electro ##phi ##lic activation of the transcription ##al response . Moreover , 12 prevented the formation of c ##yt ##oto ##xi ##c stable o ##li ##go [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0030956',\n",
       "  'our_bi_cui_name': 'Peptides',\n",
       "  'our_bi_cui_desc': '[CLS] P ##eptide ##s [unused3] ( Chemical , substance : p ##eptide ; p ##eptide ##s ; P ##eptide ##s [ Chemical / In ##g ##red ##ient ] ; P ##eptide ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27500205.24',\n",
       "  'test_set_idx': 8456,\n",
       "  'type': 'T103',\n",
       "  'name': 'kindlins',\n",
       "  'context': '[CLS] ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of kind ##lins . Great interest in the [unused1] kind ##lins [unused2] has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate the capacity of in ##te ##g ##rin [SEP]',\n",
       "  'existing_cui': 'C1720776',\n",
       "  'existing_cui_name': 'Kindling , Neurologic',\n",
       "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
       "  'our_bi_cui': 'C0010422',\n",
       "  'our_bi_cui_name': 'Crystallins',\n",
       "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27533401.2',\n",
       "  'test_set_idx': 9619,\n",
       "  'type': 'T170',\n",
       "  'name': 'tool',\n",
       "  'context': '[CLS] Help end the HIV epidemic After many delays , the public consultation on HIV prevention [unused1] tool [unused2] pre - exposure prop ##hyl ##ax ##is is finally here . Now is the time to mob ##ilis ##e - help end the HIV epidemic by responding to this NHS England consultation before 23 September . [SEP]',\n",
       "  'existing_cui': 'C1710438',\n",
       "  'existing_cui_name': 'Tool Mouse',\n",
       "  'existing_cui_desc': '[CLS] Too ##l Mouse [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
       "  'our_bi_cui': 'C0025663',\n",
       "  'our_bi_cui_name': 'Methods',\n",
       "  'our_bi_cui_desc': '[CLS] Method ##s [unused3] ( Intel ##lect ##ual Product , attribute : methods ; Method ; method ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27402480.28',\n",
       "  'test_set_idx': 4825,\n",
       "  'type': 'T033',\n",
       "  'name': 'non - genotoxic',\n",
       "  'context': '[CLS] following the principles of the O ##EC ##D test guide ##line 48 ##7 in v ##it ##ro ma ##mmal ##ian cell micro ##nu ##cle ##us test . Prof ##iciency with the ass ##ay was established by correctly identifying direct - acting g ##eno ##to ##xin ##s and g ##eno ##to ##xin ##s requiring metabolism , as well as [unused1] non - g ##eno ##to ##xi ##c [unused2] / non - car ##cin ##ogenic chemicals . We also report the analysis of our historical control data that demonstrate vehicle control and positive control values for % micro ##nu ##cle ##i in bin ##uc ##lea ##ted cells are in the ranges reported previously . Technical issues including evaluating various solvent ##s with both 48 ##h and 72 ##h [SEP]',\n",
       "  'existing_cui': 'C1257899',\n",
       "  'existing_cui_name': 'Genotoxic Stress',\n",
       "  'existing_cui_desc': '[CLS] Gen ##oto ##xi ##c St ##ress [unused3] ( B ##iol ##og ##ic Fun ##ction : Gen ##oto ##xi ##c St ##resses ; St ##resses , Gen ##oto ##xi ##c ; St ##ress , Gen ##oto ##xi ##c ) [SEP]',\n",
       "  'our_bi_cui': 'C2827065',\n",
       "  'our_bi_cui_name': 'Non-Cytotoxic Agent',\n",
       "  'our_bi_cui_desc': '[CLS] Non - Cy ##to ##to ##xi ##c Agent [unused3] ( Chemical ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27692319.52',\n",
       "  'test_set_idx': 14323,\n",
       "  'type': 'T103',\n",
       "  'name': 'ABZ ( SO )',\n",
       "  'context': '[CLS] ##hibition of mi ##rac ##id ##ia formation . In contrast , on the 12th day , 90 % of the mi ##rac ##id ##ia hatch ##ed in the control experiments using 0 . 03 % D ##MS ##O whereas em ##b ##ryo ##genesis was completely abolished with any concentration of al ##ben ##da ##zo ##le su ##l ##ph ##oxide [unused1] AB ##Z ( S ##O ) [unused2] . Chemical analysis of the crude extract and sub - fraction ##s revealed a prominent presence of fl ##av ##ono ##ids . HP ##LC - MS confirmed Que ##rc ##eti ##n to be one of the main fl ##av ##ono ##ids present in the crude extract and the n - but ##ano ##l sub ##fra ##ction . This is [SEP]',\n",
       "  'existing_cui': 'C0967870',\n",
       "  'existing_cui_name': \"N ' - ( glutathion-S-yl ) - N-acetylbenzidine S-oxide\",\n",
       "  'existing_cui_desc': \"[CLS] N ' - ( g ##lut ##ath ##ion - S - y ##l ) - N - ace ##ty ##l ##ben ##zi ##dine S - oxide [unused3] ( Chemical : AB ##Z - S ##G ) [SEP]\",\n",
       "  'our_bi_cui': 'C0069763',\n",
       "  'our_bi_cui_name': 'oxibendazole',\n",
       "  'our_bi_cui_desc': '[CLS] o ##xi ##ben ##da ##zo ##le [unused3] ( Chemical , substance : O ##xy ##ben ##da ##zo ##le ; met ##hyl 5 - [ n - prop ##ox ##y ] ben ##zi ##mi ##da ##zo ##le - 2 - car ##ba ##mate ; O ##X ##IB ##EN ##DA ##Z ##OL ##E ; Met ##hyl ( 5 - prop ##ox ##y - 1 ##H - ben ##zi ##mi ##da ##zo ##l - 2 - y ##l ) car ##ba ##mate ; O ##xi ##ben ##da ##zo ##le ; O ##B ##Z ; O ##xi ##ben ##da ##zo ##lo ; met ##hyl 5 - n - prop ##ox ##y - 2 - ben ##zi ##mi ##da ##zo ##le ##car ##ba ##mate ; Met ##hyl 5 - prop ##ox [SEP]',\n",
       "  'our_cross_cui': 'C0051091',\n",
       "  'our_cross_cui_name': 'albendazole sulfoxide',\n",
       "  'our_cross_cui_desc': '[CLS] al ##ben ##da ##zo ##le su ##lf ##oxide [unused3] ( Chemical : Rico ##ben ##da ##zo ##le ; r ##ico ##ben ##da ##zo ##le ; R ##y ##co ##ben ##da ##zo ##le ) [SEP]'},\n",
       " {'mention_id': '27702870.9',\n",
       "  'test_set_idx': 14654,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedures',\n",
       "  'context': '[CLS] ##rou ##nd Flow cat ##he ##ter from the time of its introduction in May 2015 . Pro ##ced ##ure - related data were collected prospective ##ly for the first 100 a ##bla ##tion procedures performed in our department using the Smart ##T ##ou ##ch ( ® ) Sur ##rou ##nd Flow cat ##he ##ter . From a database of 65 ##4 [unused1] procedures [unused2] performed in our unit using the Sur ##rou ##nd Flow cat ##he ##ter , we selected one to match each Smart ##T ##ou ##ch ( ® ) Sur ##rou ##nd Flow procedure , matching for procedure type , operator experience , patient age , and gender . The groups were well matched for patient age , gender , and procedure type . [SEP]',\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '28424986.28',\n",
       "  'test_set_idx': 35482,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedure',\n",
       "  'context': '[CLS] ##erial em ##bol ##ization twice in order to shrink the tumor ; however , no effect was obtained . The tumor had rapidly grown to 50 cm and caused abnormal ##ities in the hem ##ato ##logical and co ##agu ##lative systems . Pre ##oper ##ative com ##puted to ##mo ##graphy revealed that the right he ##pa ##tic vein , right he ##pa ##tic artery , and right portal vein were not involved by the hem ##ang ##io ##ma . Re ##section of the giant liver hem ##ang ##io ##ma was successfully performed after in ##tra ##oper ##ative intentional blood ##lett ##ing with concurrent blood salvage . All hem ##ato ##logical and co ##agu ##lative abnormal ##ities had returned to normal after the [unused1] procedure [unused2] . [SEP]',\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27542380.6',\n",
       "  'test_set_idx': 9947,\n",
       "  'type': 'T007',\n",
       "  'name': 'Ferrovum \" sp . JA12',\n",
       "  'context': '[CLS] ##op ##hil ##ic iron o ##xi ##di ##zer En ##e - red ##uc ##tase ##s originating from ex ##tre ##mo ##phi ##les are gaining importance in the field of bio ##cat ##aly ##sis due to higher - stability properties . The genome of the acid ##op ##hil ##ic iron - o ##xi ##di ##zing bacterium \" [unused1] Fe ##rro ##vu ##m \" s ##p . J ##A ##12 [unused2] was found to harbor a the ##rm ##op ##hil ##ic - like en ##e - red ##uc ##tase ( F ##O ##Y ##E - 1 ) . The f ##oy ##e - 1 gene was l ##igate ##d into a p ##ET ##16 ##b ##p expression vector system , and the enzyme was produced in E ##scher [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0004611',\n",
       "  'our_bi_cui_name': 'Bacteria',\n",
       "  'our_bi_cui_desc': '[CLS] Ba ##cter ##ia [unused3] ( Ba ##cter ##ium , organism : Super ##king ##dom Ba ##cter ##ia ; Domain Ba ##cter ##ia ; Ba ##cter ##ium ; BA ##CT ##ER ##IA ; bacterium ; Ba ##cter ##ia , E ##uba ##cter ##ia ; Ba ##cter ##ia . ; e ##uba ##cter ##ia ; BA ##CT ; not Ba ##cter ##ia Ha ##eck ##el 1894 ; bacteria ; E ##uba ##cter ##ia ) [SEP]',\n",
       "  'our_cross_cui': 'C3908921',\n",
       "  'our_cross_cui_name': 'Ferrovum sp . JA12',\n",
       "  'our_cross_cui_desc': '[CLS] Fe ##rro ##vu ##m s ##p . J ##A ##12 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
       " {'mention_id': '27722881.15',\n",
       "  'test_set_idx': 15002,\n",
       "  'type': 'T007',\n",
       "  'name': 'JPM1',\n",
       "  'context': '[CLS] , a gram - positive flu ##oran ##the ##ne - de ##grading bacterial strain was isolated from crude oil in Da ##gan ##g Oil ##field and identified as Micro ##ba ##cter ##ium para ##ox ##yd ##ans JP ##M ##1 by the analysis of 16 ##S r ##D ##NA sequence . After 25 days of in ##cu ##bation , the strain [unused1] JP ##M ##1 [unused2] could de ##grade 91 . 78 % of the initial amount of flu ##oran ##the ##ne . Moreover , four meta ##bol ##ites 9 - flu ##ore ##non ##e - 1 - car ##box ##yl ##ic acid , 9 - flu ##ore ##non ##e , p ##ht ##hali ##c acid , and ben ##zoic acid were detected in the culture solution [SEP]',\n",
       "  'existing_cui': 'C1421124',\n",
       "  'existing_cui_name': 'TRGJP gene',\n",
       "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
       "  'our_bi_cui': 'C3802218',\n",
       "  'our_bi_cui_name': 'Bacillus sp . JP-1',\n",
       "  'our_bi_cui_desc': '[CLS] Ba ##ci ##llus s ##p . JP - 1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
       "  'our_cross_cui': 'C4153571',\n",
       "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
       " {'mention_id': '28113841.1',\n",
       "  'test_set_idx': 25831,\n",
       "  'type': 'T058',\n",
       "  'name': 'Quantitative Susceptibility Mapping',\n",
       "  'context': '[CLS] [unused1] Q ##uant ##itative Su ##s ##ce ##pt ##ibility Map ##ping [unused2] using St ##ructural Feature based Col ##la ##bor ##ative Reconstruction in the Human Brain The reconstruction of MR quantitative su ##s ##ce ##pt ##ibility mapping from local phase measurements is an ill posed inverse problem and different regular ##ization strategies incorporating a prior ##i information extracted from magnitude and phase images have been proposed . However , the anatomy observed in magnitude and phase images does not always coincide spatial ##ly with that in su ##s ##ce ##pt ##ibility maps , which could give er ##rone ##ous est ##imation in the reconstructed su ##s ##ce ##pt ##ibility map . In this paper , we develop a structural feature based collaborative reconstruction ( St ##ructural [SEP]',\n",
       "  'existing_cui': 'C0237904',\n",
       "  'existing_cui_name': 'Hypnotic Susceptibility',\n",
       "  'existing_cui_desc': '[CLS] H ##y ##p ##not ##ic Su ##s ##ce ##pt ##ibility [unused3] ( Health Care Act ##ivity , H ##y ##p ##not ##ic : Su ##s ##ce ##pt ##ibility ) [SEP]',\n",
       "  'our_bi_cui': 'C4288325',\n",
       "  'our_bi_cui_name': 'Quantitative Ultrasound Spectroscopy',\n",
       "  'our_bi_cui_desc': '[CLS] Q ##uant ##itative Ultra ##sound S ##pect ##ros ##copy [unused3] ( Health Care Act ##ivity : Q ##uant ##itative Ultra ##sound I ##maging ) [SEP]',\n",
       "  'our_cross_cui': 'C0006117',\n",
       "  'our_cross_cui_name': 'Brain Mapping',\n",
       "  'our_cross_cui_desc': '[CLS] Brain Map ##ping [unused3] ( Health Care Act ##ivity , procedure : brain mapped ; Brain mapping ; brain map ; Map ##ping , Brain ; brain mapping ) [SEP]'},\n",
       " {'mention_id': '27837917.48',\n",
       "  'test_set_idx': 18961,\n",
       "  'type': 'T033',\n",
       "  'name': 'lever pressing',\n",
       "  'context': '[CLS] , when cocaine use was discontinued 45 minutes later , den ##dr ##itic spine morphology and alpha - amino - 3 - h ##ydro ##xy - 5 - met ##hyl - 4 - is ##ox ##az ##ole prop ##ion ##ic acid to N - met ##hyl - D - as ##par ##tate ratios were restored as animals became motivated to engage un ##rew ##arded [unused1] lever pressing [unused2] . Non ##re ##in ##force ##d drug seeking was positively correlated with changes in spine morphology , and cocaine access reversed this relationship . Using a novel modification of the reins ##tate ##ment paradigm , we show that achieving cocaine use reversed the s ##yna ##ptic plastic ##ity under ##pin ##ning the motivation to seek the drug . [SEP]',\n",
       "  'existing_cui': 'C1960601',\n",
       "  'existing_cui_name': 'Head pressing',\n",
       "  'existing_cui_desc': '[CLS] Head pressing [unused3] ( Finding , finding ) [SEP]',\n",
       "  'our_bi_cui': 'C0009651',\n",
       "  'our_bi_cui_name': 'Operant Conditioning',\n",
       "  'our_bi_cui_desc': '[CLS] Opera ##nt Con ##dition ##ing [unused3] ( B ##iol ##og ##ic Fun ##ction , Opera ##nt , procedure , regime / therapy : L ##EA ##R ##NI ##NG IN ##ST ##R ##UM ; conditioning opera ##nt ; Opera ##nt Con ##dition ##ings ; Con ##dition ##ing , Opera ##nt ; Learning , Instrumental ; Learning ##s , Instrumental ; IN ##ST ##R ##UM L ##EA ##R ##NI ##NG ; Opera ##nt conditioning ; Con ##dition ##ing ; Instrumental Con ##dition ##ing ; Instrumental Learning ; Con ##dition ##ings , Opera ##nt ; opera ##nt conditioning ; opera ##nt condition ; Instrumental Learning ##s ; instrumental conditioning ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28424683.42',\n",
       "  'test_set_idx': 35420,\n",
       "  'type': 'T038',\n",
       "  'name': 'expanding',\n",
       "  'context': '[CLS] killer cells while limiting T cell expansion for up to 60 days . Similar to patient Natural killer cells , Natural killer cells from tumor - bearing B ##LT - human ##ized mice promote faster expansion of residual T cells resulting in decreased numbers and function of Natural killer cells , whereas Natural killer cells from mice with no tumor continue [unused1] expanding [unused2] Natural killer cells and retain their c ##yt ##oto ##xi ##city . In addition , den ##dr ##itic cells in contrast to O ##Cs are found to promote faster expansion of residual T cells within pu ##rified Natural killer cells resulting in the decline in Natural killer cell numbers from healthy individuals . Ad ##dition of anti - CD ##3 m ##A [SEP]',\n",
       "  'existing_cui': 'C0205229',\n",
       "  'existing_cui_name': 'Expanding',\n",
       "  'existing_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
       "  'our_bi_cui': 'C0205229',\n",
       "  'our_bi_cui_name': 'Expanding',\n",
       "  'our_bi_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
       "  'our_cross_cui': 'C0007595',\n",
       "  'our_cross_cui_name': 'cell growth',\n",
       "  'our_cross_cui_desc': '[CLS] cell growth [unused3] ( B ##iol ##og ##ic Fun ##ction : cell expansion ; cellular growth ; Cell ##s - - Growth ; Cell Growth ; cell growth ##s ; cells growth ; growth cell ; growth of cell ; Cell ##ular Growth ; Cell ##ular Ex ##pan ##sion ) [SEP]'},\n",
       " {'mention_id': '28418943.15',\n",
       "  'test_set_idx': 35137,\n",
       "  'type': 'T204',\n",
       "  'name': 'rats',\n",
       "  'context': '[CLS] of alcohol seeking was reduced after 4 months compared with 2 months of intermittent alcohol access . The influence of individual levels of alcohol intake on loss of control over alcohol seeking was subsequently determined by assessing conditioned suppression in subgroup ##s of low and high alcohol drinking rats . Unlike the low alcohol drinking rats , the high alcohol drinking [unused1] rats [unused2] showed a ##version - resistant alcohol seeking after 2 months of intermittent alcohol access , although both groups showed comparable levels of conditioned freezing . These findings show that the development of loss of control over alcohol seeking , a key characteristic of Al ##co ##hol use disorder in humans , is dependent on both the extent of alcohol exposure and the [SEP]',\n",
       "  'existing_cui': 'C2097385',\n",
       "  'existing_cui_name': 'allergy testing rat',\n",
       "  'existing_cui_desc': '[CLS] all ##er ##gy testing rat [unused3] ( Health Care Act ##ivity , lab test : rat ) [SEP]',\n",
       "  'our_bi_cui': 'C0034721',\n",
       "  'our_bi_cui_name': 'Rattus',\n",
       "  'our_bi_cui_desc': '[CLS] Rat ##tus [unused3] ( E ##uka ##ryo ##te , organism : Rat ; Genus rat ##tus ; Genus Rat ##tus ; rats ; rat ; rat ##tus ; Rat ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0086893',\n",
       "  'our_cross_cui_name': 'Rats , Laboratory',\n",
       "  'our_cross_cui_desc': '[CLS] Rat ##s , Laboratory [unused3] ( E ##uka ##ryo ##te : laboratory rat ; Laboratory Rat ##s ; Rat , Laboratory ; Laboratory Rat ) [SEP]'},\n",
       " {'mention_id': '27838742.81',\n",
       "  'test_set_idx': 19048,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . [unused1] Del ##ica ##f ##lav ##one [unused2] induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28013256.6',\n",
       "  'test_set_idx': 23767,\n",
       "  'type': 'T097',\n",
       "  'name': 'health',\n",
       "  'context': \"[CLS] From training to practice : the impact of E ##NG ##AG ##E , Ireland ' s national men ' s health training programme Ireland ' s National Men ' s Health Policy recommended developing training programmes tailored to the needs of those working in [unused1] health [unused2] and allied health professionals and E ##NG ##AG ##E was developed to meet that recommendation . This study evaluated the impact of E ##NG ##AG ##E on front ##line service providers ' self - reported knowledge , skills , capacity and practice up to 5 - months post training . Between 2012 and 2015 , E ##NG ##AG ##E Train ##ers ( n = 57 ) delivered 62 1 - day training programmes to 81 ##0 participants . This [SEP]\",\n",
       "  'existing_cui': 'C4277525',\n",
       "  'existing_cui_name': 'One Health Initiative',\n",
       "  'existing_cui_desc': '[CLS] One Health Initiative [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line : Health , One ; One Medicine Initiative ; Health Initiative , One ; Medicine Initiative , One ; Initiative , One Medicine ; Initiative , One Health ; One Health ) [SEP]',\n",
       "  'our_bi_cui': 'C0018722',\n",
       "  'our_bi_cui_name': 'Health Occupations',\n",
       "  'our_bi_cui_desc': '[CLS] Health O ##cc ##upation ##s [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line : health occupations ; Health O ##cc ##upation ; Health Prof ##ess ##ion ; O ##cc ##upation ##s , Health ; Prof ##ess ##ions , Health ; Health Prof ##ess ##ions ; health profession ; O ##cc ##upation , Health ; health science profession ; health care field ; health occupation ; Health profession ##s ; Prof ##ess ##ion , Health ; occupation health ; Health careers ; H ##EA ##LT ##H O ##CC ##UP ; health profession ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C1704312',\n",
       "  'our_cross_cui_name': 'Health Professional',\n",
       "  'our_cross_cui_desc': '[CLS] Health Professional [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Health professionals ; Health Care Professional ##s ; H ##EA ##LT ##H CA ##RE PR ##O ##F ##ES ##SI ##ON ##AL ; Health profession ; Healthcare professional ; Healthcare worker ; Health Care Professional ; Health professional ) [SEP]'},\n",
       " {'mention_id': '27838742.43',\n",
       "  'test_set_idx': 19010,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] - I , which are auto ##pha ##gy - related proteins , and promoting the generation of acidic ve ##si ##cular organ ##elles and auto ##ly ##so ##some ##s in the c ##yt ##op ##las ##m of human lung cancer A ##5 ##4 ##9 and PC - 9 cells in a time - and dose - dependent manner . [unused1] Del ##ica ##f ##lav ##one [unused2] down ##re ##gu ##lated the expression of p ##hos ##ph ##o - A ##kt , p ##hos ##ph ##o - m ##TO ##R , and p ##hos ##ph ##o - p ##70 ##S ##6 ##K in a time - and dose - dependent manner , suggesting that it induced auto ##pha ##gy by in ##hibit ##ing the A ##kt / [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0529351',\n",
       "  'our_bi_cui_name': 'darifenacin',\n",
       "  'our_bi_cui_desc': '[CLS] da ##ri ##fen ##ac ##in [unused3] ( Chemical , medication , product , substance : Dar ##ife ##nac ##in ##um ; ( S ) - 1 - ( 2 - ( 2 , 3 - di ##hy ##dr ##o - 5 - Benz ##of ##ura ##ny ##l ) et ##hyl ) - alpha , alpha - dip ##hen ##yl - 3 - p ##yr ##rol ##id ##ine ##ace ##tam ##ide ; Dar ##ife ##nac ##in ; ( S ) - 1 - ( 2 - ( 2 , 3 - di ##hy ##dr ##o - 5 - ben ##zo ##fu ##ran ##yl ) et ##hyl ) - alpha , alpha - dip ##hen ##yl - 3 - p ##yr ##rol ##id ##ine ##ace ##tam ##ide ; [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27500205.19',\n",
       "  'test_set_idx': 8451,\n",
       "  'type': 'T103',\n",
       "  'name': 'kindlins',\n",
       "  'context': '[CLS] high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple [unused1] kind ##lins [unused2] , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of kind ##lins . Great interest in the kind ##lins has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def [SEP]',\n",
       "  'existing_cui': 'C1720776',\n",
       "  'existing_cui_name': 'Kindling , Neurologic',\n",
       "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
       "  'our_bi_cui': 'C0010422',\n",
       "  'our_bi_cui_name': 'Crystallins',\n",
       "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28144577.19',\n",
       "  'test_set_idx': 26719,\n",
       "  'type': 'T033',\n",
       "  'name': 'signs',\n",
       "  'context': '[CLS] combination with bone g ##raft ##s was used in 84 patients for the treatment of long bone non ##union ##s . All patients were evaluated radio ##graphical ##y for the development of he ##tero ##top ##ic o ##ssi ##fication during the standard assessment for the non ##union healing . In all patients ( 80 . 9 % ) with radio ##graphic [unused1] signs [unused2] of he ##tero ##top ##ic o ##ssi ##fication , a CT scan was performed . Non ##union site p ##al ##pation and ROM evaluation of the adjacent joints were also carried out . Factor ##s related to the patient ( age , gender ) , the non ##union ( location , size , chronic ##ity , number of previous procedures , infection [SEP]',\n",
       "  'existing_cui': 'C0311392',\n",
       "  'existing_cui_name': 'Physical findings',\n",
       "  'existing_cui_desc': '[CLS] Physical findings [unused3] ( Finding , finding , physical finding : physical finding ; physical findings ; Physical finding ; physical findings [ use for free text ] ; Physical signs ; Sign ##s - physical ; physical signs ; Physical sign ; Sign ; find physical ) [SEP]',\n",
       "  'our_bi_cui': 'C0311392',\n",
       "  'our_bi_cui_name': 'Physical findings',\n",
       "  'our_bi_cui_desc': '[CLS] Physical findings [unused3] ( Finding , finding , physical finding : physical finding ; physical findings ; Physical finding ; physical findings [ use for free text ] ; Physical signs ; Sign ##s - physical ; physical signs ; Physical sign ; Sign ; find physical ) [SEP]',\n",
       "  'our_cross_cui': 'C0037088',\n",
       "  'our_cross_cui_name': 'Signs and Symptoms',\n",
       "  'our_cross_cui_desc': '[CLS] Sign ##s and S ##ym ##pt ##oms [unused3] ( Finding , finding : Sign ##s and S ##ym ##pt ##oms [ Disease / Finding ] ; Clinical findings ; clinical findings ; O ##bs ##er ##vable En ##ti ##ty ; sign and s ##ym ##pt ##om ; Sign and s ##ym ##pt ##om ; S ##ym ##pt ##oms and Sign ##s ; sign / s ##ym ##pt ##om ; Finding ; Clinical observation : symptoms and signs ; S ##IG ##NS S ##Y ##MP ##TO ##MS ; Clinical finding ) [SEP]'},\n",
       " {'mention_id': '28376393.14',\n",
       "  'test_set_idx': 33592,\n",
       "  'type': 'T033',\n",
       "  'name': 'detection',\n",
       "  'context': '[CLS] ass ##ay as an approximation for the tertiary and q ##uate ##rna ##ry am ##ine load in waste ##waters and surface water samples , and this approximation was compared to N - ni ##tro ##so ##di ##met ##hyl ##amine formation potential using ch ##lora ##mine ##s . An existing color ##ime ##tric method was examined and op ##ti ##mized for the [unused1] detection [unused2] of am ##ines in environmental water samples . The method consists of liquid - liquid extraction followed by a cat ##aly ##zed reaction to form a yet - und ##ef ##ined product that is known to be both a strong ch ##rom ##op ##hore and flu ##oro ##ph ##ore . Previous work verified that this reaction was effectively cat ##aly ##zed by [SEP]',\n",
       "  'existing_cui': 'C0206100',\n",
       "  'existing_cui_name': 'Signal Detection',\n",
       "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
       "  'our_bi_cui': 'C1511790',\n",
       "  'our_bi_cui_name': 'Detection',\n",
       "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
       "  'our_cross_cui': 'C0442726',\n",
       "  'our_cross_cui_name': 'Detected',\n",
       "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
       " {'mention_id': '28377738.10',\n",
       "  'test_set_idx': 33695,\n",
       "  'type': 'T170',\n",
       "  'name': 'gradational',\n",
       "  'context': '[CLS] and the p ##oly ##se ##mous notion of consciousness continue to prove resistant to consistent measurement and un ##am ##bi ##guous definition . This is hardly surprising , given that there is no agreement even as regards the most fundamental issues they involve . One of the basic disagreements present in the continuing debate about consciousness per ##tains to its [unused1] g ##rada ##tional [unused2] nature . The general aim of this article is to show how consciousness might be graded and multi ##di ##men ##sional at the same time . We therefore focus on the question of what it is , exactly , that is or could be graded in cases of consciousness , and how we can measure it . Ultimately , four different [SEP]',\n",
       "  'existing_cui': 'C0699900',\n",
       "  'existing_cui_name': 'Catabolism',\n",
       "  'existing_cui_desc': '[CLS] Cat ##ab ##olis ##m [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : Cat ##ab ##olis ##m , function ; cat ##ab ##olis ##m ; cat ##ab ##olic process ; breakdown ; degradation ) [SEP]',\n",
       "  'our_bi_cui': 'C0445237',\n",
       "  'our_bi_cui_name': 'Rotational',\n",
       "  'our_bi_cui_desc': '[CLS] R ##ota ##tional [unused3] ( Spa ##tial Concept , qualifier value : rotation ##al ) [SEP]',\n",
       "  'our_cross_cui': 'C0441800',\n",
       "  'our_cross_cui_name': 'Grade',\n",
       "  'our_cross_cui_desc': '[CLS] Grade [unused3] ( Intel ##lect ##ual Product , attribute , qualifier value : With grade ; Has grade ; grades ; Grades ; G ##rading ; grade ) [SEP]'},\n",
       " {'mention_id': '28301509.57',\n",
       "  'test_set_idx': 31754,\n",
       "  'type': 'T017',\n",
       "  'name': '3H',\n",
       "  'context': '[CLS] . A single Q ##TL for grain yield containing three M ##TA ##s was found on chromosome 3 ##H located close to the H ##v - e ##IF ##4 ##E gene , which is known to regulate resistance to bar ##ley yellow mosaic virus . Subsequently the Q ##TL was shown to be tightly linked to r ##ym ##4 , a lo ##cus for resistance to the virus . G ##WA ##s on a ##rab ##ina ##ns q ##uant ##ified by L ##M ##6 resulted in the identification of major Q ##TL ##s closely located on [unused1] 3 ##H [unused2] and h ##y ##pot ##heses regarding put ##ative candidate genes were formulated through the study of gene expression levels based on bio ##in ##formatics tools . [SEP]',\n",
       "  'existing_cui': 'C1098079',\n",
       "  'existing_cui_name': '( 3H ) azidoneonicotinoid',\n",
       "  'existing_cui_desc': '[CLS] ( 3 ##H ) a ##zi ##don ##eon ##ico ##tino ##id [unused3] ( Chemical : ( 3 ##H ) A ##z ##N ##N ) [SEP]',\n",
       "  'our_bi_cui': 'C0008666',\n",
       "  'our_bi_cui_name': 'Chromosomes , Human , Pair 3',\n",
       "  'our_bi_cui_desc': '[CLS] Ch ##rom ##oso ##mes , Human , Pa ##ir 3 [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : Ch ##rom ##oso ##me 3 ; chromosome 3 ; Ch ##rom ##oso ##me pair 3 ; 3 chromosome ##s ; CH ##RO ##MO ##SO ##ME 03 ; CH ##RO ##MO ##SO ##ME ##S H ##UM ##AN PA ##IR 03 ; 3 chromosome ) [SEP]',\n",
       "  'our_cross_cui': 'C0008633',\n",
       "  'our_cross_cui_name': 'Chromosomes',\n",
       "  'our_cross_cui_desc': '[CLS] Ch ##rom ##oso ##mes [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : chromosome ; Ch ##rom ##oso ##mal ; chromosome ##s ; Ch ##rom ##oso ##me ) [SEP]'},\n",
       " {'mention_id': '27234220.24',\n",
       "  'test_set_idx': 280,\n",
       "  'type': 'T033',\n",
       "  'name': 'no',\n",
       "  'context': '[CLS] access complications ) . Pat ##ients in group A were older ( 74 ± 12 years vs . 68 ± 17 years , p < 0 . 01 ) and the main indication for anti ##coa ##gu ##lation was at ##rial fi ##bri ##lla ##tion ( 58 . 6 % ) . No complications occurred during the procedures . There were [unused1] no [unused2] acute bleeding ##s just after the bandage removal . During the first 24 ##h , only 3 ( 2 . 1 % ) radial o ##cc ##lusion ##s in group A and 2 ( 0 . 6 % ) in group B ( p = 0 . 14 ) were recorded . He ##mat ##oma ##s between 5 and 10 ##c ##m [SEP]',\n",
       "  'existing_cui': 'C1140150',\n",
       "  'existing_cui_name': 'NOC - CodeSystem',\n",
       "  'existing_cui_desc': '[CLS] NO ##C - Code ##S ##ys ##tem [unused3] ( Intel ##lect ##ual Product , NO ##C : nursing outcomes classification ) [SEP]',\n",
       "  'our_bi_cui': 'C0243095',\n",
       "  'our_bi_cui_name': 'Finding',\n",
       "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C1513916',\n",
       "  'our_cross_cui_name': 'Negative Finding',\n",
       "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
       " {'mention_id': '27676724.19',\n",
       "  'test_set_idx': 13878,\n",
       "  'type': 'T097',\n",
       "  'name': 'sonologist',\n",
       "  'context': '[CLS] or ##th ##oped ##ic surgeon , an occupational therapist for upper limb ma ##lf ##orm ##ation , a p ##hy ##sio ##ther ##ap ##ist for lower ma ##lf ##orm ##ation and a psychologist . This multi ##disciplinary consultation is unique because of each pregnancy story , because of each patient life story but also because of the words used by the [unused1] son ##ologist [unused2] when announcing the diagnosis . We deal with couples shocked by the pre ##nat ##al diagnosis . We help them get acceptance of the child to be born and to forget about their imaginary child . Medical information is often perceived as being \" a surf ##eit of information \" difficult to handle by the couple stunned by the overwhelming diagnosis [SEP]',\n",
       "  'existing_cui': 'C0586859',\n",
       "  'existing_cui_name': 'Pulmonologists',\n",
       "  'existing_cui_desc': '[CLS] P ##ul ##mon ##ologists [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Re ##sp ##ira ##tory disease specialist ; P ##ul ##mon ##ologist ; pulmonary specialist ; Re ##sp ##ira ##tory physician ; pu ##lm ##ono ##logist ) [SEP]',\n",
       "  'our_bi_cui': 'C1954848',\n",
       "  'our_bi_cui_name': 'Sonographer',\n",
       "  'our_bi_cui_desc': '[CLS] Son ##ographer [unused3] ( Professional or O ##cc ##upation ##al Group ) [SEP]',\n",
       "  'our_cross_cui': 'C1522486',\n",
       "  'our_cross_cui_name': 'Professional Organization or Group',\n",
       "  'our_cross_cui_desc': '[CLS] Professional Organization or Group [unused3] ( Professional or O ##cc ##upation ##al Group : Other Agency or Organization ; Organization ; OR ##G ; Outside Bo ##dies ; Organization ##al ) [SEP]'},\n",
       " {'mention_id': '27500205.23',\n",
       "  'test_set_idx': 8455,\n",
       "  'type': 'T103',\n",
       "  'name': 'kindlins',\n",
       "  'context': '[CLS] widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of [unused1] kind ##lins [unused2] . Great interest in the kind ##lins has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate [SEP]',\n",
       "  'existing_cui': 'C1720776',\n",
       "  'existing_cui_name': 'Kindling , Neurologic',\n",
       "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
       "  'our_bi_cui': 'C0010422',\n",
       "  'our_bi_cui_name': 'Crystallins',\n",
       "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27659602.43',\n",
       "  'test_set_idx': 13388,\n",
       "  'type': 'T082',\n",
       "  'name': 'root',\n",
       "  'context': '[CLS] more are at risk for re ##oper ##ation , and not until at least after 10 . 4 years have passed . Neither the valve morphology ( p = 0 . 62 ) nor con ##com ##ita ##nt a ##ort ##ic valve replacement ( p = 0 . 86 ) influenced rate of root di ##lation . In non ##sy ##nd ##rom ##ic patients , the a ##ort ##ic root is the slow ##est growing portion of the th ##ora ##ci ##c a ##ort ##a . Leaving the native [unused1] root [unused2] , as in root - spa ##ring ascending a ##ort ##ic replacement , is a safe approach regarding secondary root intervention for a ##ort ##ic root diameter ##s of 45 mm or less . [SEP]',\n",
       "  'existing_cui': 'C1318154',\n",
       "  'existing_cui_name': 'Root body part',\n",
       "  'existing_cui_desc': '[CLS] Root body part [unused3] ( Ana ##tom ##ical Structure : Root ; root [ a body part ] ; root ) [SEP]',\n",
       "  'our_bi_cui': 'C0040452',\n",
       "  'our_bi_cui_name': 'Tooth root structure',\n",
       "  'our_bi_cui_desc': '[CLS] Too ##th root structure [unused3] ( Ana ##tom ##ical Structure , body structure : Ra ##di ##x co ##rona ; Root of the Too ##th ; tooth root ; Too ##th Root ; Root of Too ##th ; Root , Too ##th ; tooth roots ; root of tooth ; root tooth ; roots tooth ; Te ##eth - - Roots ; Roots , Too ##th ; of tooth root ; Too ##th Roots ; Too ##th root ; Ra ##di ##x Den ##tis ; Ra ##di ##x den ##tis ; rooted tooth ; Root of tooth ) [SEP]',\n",
       "  'our_cross_cui': 'C0549113',\n",
       "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
       "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
       " {'mention_id': '27474969.18',\n",
       "  'test_set_idx': 7435,\n",
       "  'type': 'T103',\n",
       "  'name': 'CuS',\n",
       "  'context': '[CLS] sensor based on reduced graph ##ene oxide - copper su ##lf ##ide ( r ##G ##O - C ##u ##S ) composite coupled with cap ##illa ##ry electro ##ph ##ores ##is was constructed for the ultra ##sen ##sitive detection of am ##lo ##di ##pine be ##sy ##late for the first time . In this work , r ##G ##O - [unused1] C ##u ##S [unused2] composite was synthesized by one - pot h ##ydro ##thermal method and used for electro ##de modification . The electro ##chemical and electro ##che ##mi ##lum ##ines ##cence behaviors of the sensor were investigated . More than 5 - fold enhance in electro ##che ##mi ##lum ##ines ##cence intensity was observed after modified with r ##G ##O - C ##u ##S [SEP]',\n",
       "  'existing_cui': 'C0056599',\n",
       "  'existing_cui_name': 'cupric sulfide',\n",
       "  'existing_cui_desc': '[CLS] cup ##ric su ##lf ##ide [unused3] ( Chemical , C ##u ##S : c ##p ##d with un ##sp ##ec ##ified M ##F of cup ##ric su ##lf ##ide ; co ##vel ##lite ) [SEP]',\n",
       "  'our_bi_cui': 'C0056301',\n",
       "  'our_bi_cui_name': 'Copper Sulfate',\n",
       "  'our_bi_cui_desc': '[CLS] Copper Sul ##fa ##te [unused3] ( Chemical , AS C ##UP ##RI ##C S ##U ##LF ##AT ##E , discontinued , medication , obsolete , product , substance : copper su ##l ##phate ; Copper Sul ##fa ##te [ Chemical / In ##g ##red ##ient ] ; Blue V ##it ##rio ##l ; cup ##ric su ##lf ##ate an ##hy ##dr ##ous ; CO ##PP ##ER S ##U ##LF ##AT ##E ; V ##it ##rio ##l , Blue ; BA ##SI ##C CO ##PP ##ER S ##U ##LF ##AT ##E ; Blue Vic ##king ; C ##UP ##RI ##C S ##U ##LF ##AT ##E , AN ##H ##Y ##DR ##O ##US ; Cup ##ric Sul ##fa ##te An ##hy ##dr ##ous ; Sul ##fa ##te , [SEP]',\n",
       "  'our_cross_cui': 'C0389357',\n",
       "  'our_cross_cui_name': 'cuprous sulfide',\n",
       "  'our_cross_cui_desc': '[CLS] cup ##rous su ##lf ##ide [unused3] ( Chemical : copper ( I ) su ##lf ##ide ; C ##u ##2 ##S c ##p ##d ) [SEP]'},\n",
       " {'mention_id': '28167893.31',\n",
       "  'test_set_idx': 27472,\n",
       "  'type': 'T038',\n",
       "  'name': 'Ipr-I',\n",
       "  'context': '[CLS] on potato - de ##x ##tro ##se a ##gar with i ##p ##rod ##ione , no fun ##gal growth ( i ##p ##rod ##ione - no growth , I ##p ##r - N ) occurred for the first 3 day after in ##cu ##bation , but once the initial growth ( i ##p ##rod ##ione - initial growth , [unused1] I ##p ##r - I [unused2] ) began at 4 - 5 day after in ##cu ##bation , the colonies grew and expanded continuously to be in full growth ( i ##p ##rod ##ione - growth , I ##p ##r - G ) , suggesting I ##p ##r - I may be a turning moment of the m ##or ##ph ##ogen ##etic changes resisting fungi ##cid [SEP]',\n",
       "  'existing_cui': 'C1418954',\n",
       "  'existing_cui_name': 'PRPS1 gene',\n",
       "  'existing_cui_desc': '[CLS] PR ##PS ##1 gene [unused3] ( Ana ##tom ##ical Structure : D ##F ##N ##X ##1 ; C ##MT ##X ##5 ; P ##H ##OS ##P ##H ##OR ##IB ##OS ##Y ##LP ##Y ##RO ##P ##H ##OS ##P ##HA ##TE S ##Y ##NT ##H ##ET ##AS ##E I ; PR ##S I ; rib ##ose - phosphate dip ##hos ##ph ##oki ##nas ##e 1 ; p ##hos ##ph ##ori ##bos ##yl p ##yr ##op ##hos ##phate s ##ynth ##eta ##se 1 ) [SEP]',\n",
       "  'our_bi_cui': 'C3755286',\n",
       "  'our_bi_cui_name': 'Idiophantis',\n",
       "  'our_bi_cui_desc': '[CLS] I ##dio ##pha ##nti ##s [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
       "  'our_cross_cui': 'C0018270',\n",
       "  'our_cross_cui_name': 'Growth',\n",
       "  'our_cross_cui_desc': \"[CLS] Growth [unused3] ( B ##iol ##og ##ic Fun ##ction : General ##ized Growth ; normal growth ; onto ##geny ; em ##b ##ryo ##nic growth ? ; Physical Growth ; growth ##s ; physical growth ; physical growth process ; growth ; ' growth ' ; G ##RO ##W ##TH ) [SEP]\"},\n",
       " {'mention_id': '28471040.35',\n",
       "  'test_set_idx': 37149,\n",
       "  'type': 'T038',\n",
       "  'name': 'rat glioma model',\n",
       "  'context': '[CLS] 2 g ##lio ##ma cell lines in cell culture studies , which further increases with addition of 1 , 2 - di ##ole ##oy ##l - 3 - trim ##eth ##yla ##mm ##onium - prop ##ane . Ma ##gnetic resonance imaging and his ##top ##ath ##olo ##gic evaluation on rat g ##lio ##ma - 2 t ##umour cells in [unused1] rat g ##lio ##ma model [unused2] ( 49 female W ##ista ##r rats , 250 - 300 g ) comparing in ##tra ##ven ##ous and in ##tra ##tum ##oral injection ##s of the drug have been performed and F ##TA - loaded na ##no ##par ##tic ##les reduced t ##umour size significantly in in - v ##ivo studies , with higher efficiency of in ##tra ##tum [SEP]',\n",
       "  'existing_cui': 'C0017638',\n",
       "  'existing_cui_name': 'Glioma',\n",
       "  'existing_cui_desc': '[CLS] G ##lio ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity : G ##lial Cell Tu ##mor ##s ; g ##lio ##mas ; [ M ] G ##lio ##mas ; G ##lio ##mas ; N ##eur ##og ##lial Neo ##p ##las ##m ; Tu ##mor of the N ##eur ##og ##lia ; g ##lio ##ma ; un ##sp ##ec ##ified site ; Tu ##mor , G ##lial Cell ; Tu ##mor ##s , G ##lial Cell ; G ##lial Neo ##p ##las ##m ; Neo ##p ##las ##m of N ##eur ##og ##lia ; N ##eur ##og ##lial Tu ##mor ; G ##lial Cell Tu ##mor ; G ##lial Tu ##mor ; G ##lio [SEP]',\n",
       "  'our_bi_cui': 'C1882742',\n",
       "  'our_bi_cui_name': 'Rat Malignant Glioma',\n",
       "  'our_bi_cui_desc': '[CLS] Rat Mali ##gnant G ##lio ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , R ##EN ##I : G ##lio ##ma , ma ##li ##gnant ) [SEP]',\n",
       "  'our_cross_cui': 'C0012644',\n",
       "  'our_cross_cui_name': 'Animal Disease Models',\n",
       "  'our_cross_cui_desc': '[CLS] Animal Disease Models [unused3] ( B ##iol ##og ##ic Fun ##ction : animal model ; Disease Models , Animal ; D ##IS M ##OD ##EL ##S AN ##IM ##AL ; Animal Model of Disease ; Disease Model , Animal ; Animal Disease Model ; Disease ##s - - Animal models ) [SEP]'},\n",
       " {'mention_id': '27838742.90',\n",
       "  'test_set_idx': 19057,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . [unused1] Del ##ica ##f ##lav ##one [unused2] may represent a potential therapeutic agent for lung cancer . [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27509301.2',\n",
       "  'test_set_idx': 8784,\n",
       "  'type': 'T103',\n",
       "  'name': 'Environmental Chemical',\n",
       "  'context': \"[CLS] Pre ##diction of E ##stro ##genic B ##io ##act ##ivity of [unused1] Environmental Chemical [unused2] Met ##ab ##oli ##tes The US Environmental Protection Agency ' s End ##oc ##rine Di ##s ##rup ##tor Screen ##ing Program is using in v ##it ##ro data generated from To ##x ##C ##ast / To ##x ##21 high - through ##put screening ass ##ays to assess the end ##oc ##rine activity of environmental chemicals . Considering that in v ##it ##ro ass ##ays may have limited metabolic capacity , inactive chemicals that are bio ##tra ##ns ##formed into meta ##bol ##ites with end ##oc ##rine bio ##act ##ivity may be missed for further screening and testing . Therefore , there is a value in developing novel approaches to account for [SEP]\",\n",
       "  'existing_cui': 'C0014406',\n",
       "  'existing_cui_name': 'Environment',\n",
       "  'existing_cui_desc': '[CLS] Environment [unused3] ( Spa ##tial Concept , environment , treatment : environments ; Environment ##s ; environment ; Environmental ; E ##N ##VI ##R ; en ##vir ; En ##vir ) [SEP]',\n",
       "  'our_bi_cui': 'C0014417',\n",
       "  'our_bi_cui_name': 'Environmental Pollutants',\n",
       "  'our_bi_cui_desc': '[CLS] Environmental Poll ##uta ##nts [unused3] ( Chemical : E ##N ##VI ##R P ##OL ##L ##UT ##AN ##TS ; P ##OL ##L ##UT ##AN ##TS E ##N ##VI ##R ; Poll ##uta ##nts , Environmental ) [SEP]',\n",
       "  'our_cross_cui': 'C0220806',\n",
       "  'our_cross_cui_name': 'Chemicals',\n",
       "  'our_cross_cui_desc': '[CLS] Chemical ##s [unused3] ( Chemical , medication , substance : chemical compounds ; Chemical ; chemical compound ; Chemical compound ; chemical substance ; Chemical ##ly ; Chemical product ; Chemical agent ; Chemical element AND / OR compound ; chemical ; chemicals ) [SEP]'},\n",
       " {'mention_id': '27832198.67',\n",
       "  'test_set_idx': 18689,\n",
       "  'type': 'T017',\n",
       "  'name': 'Cam734',\n",
       "  'context': '[CLS] ##er studies , and might differ in natural is ##olate ##s harbor ##ing this all ##ele . Results presented here ##in show that Cam ##7 ##34 - mediated ch ##lor ##o ##quin ##e resistance is dependent on the rare A1 ##44 ##F mutation that has not been observed beyond Southeast Asia , and reveal distinct impacts of this and other [unused1] Cam ##7 ##34 [unused2] - specific mutations on ch ##lor ##o ##quin ##e resistance and parasite growth rates . B ##io ##chemical ass ##ays revealed a broad impact of mutant P ##f ##CR ##T is ##of ##orms on parasite metabolism , including n ##uc ##leo ##side trip ##hos ##phate levels , hem ##og ##lo ##bin cat ##ab ##olis ##m and disposition of hem ##e , [SEP]',\n",
       "  'existing_cui': 'C0006675',\n",
       "  'existing_cui_name': 'Calcium',\n",
       "  'existing_cui_desc': '[CLS] Cal ##ci ##um [unused3] ( Chemical , medication , substance : Co ##agu ##lation factor IV - R ##ET ##IR ##ED - ; CO ##AG FA ##CT ##OR IV ; Co ##agu ##lation Factor IV ; B ##L ##O ##OD CO ##AG FA ##CT ##OR IV ; C ##a + + element ; factor i ##v ; calcium ; Blood Co ##agu ##lation Factor IV ; Cal ##ci ##um co ##agu ##lation factor ; Co ##agu ##lation factor IV ; calcium ##s ; Cal ##ci ##um [ Chemical / In ##g ##red ##ient ] ; C ##a - Cal ##ci ##um ; CA ##LC ##I ##UM ; Factor IV ; C ##a element ; Cal ##ci ##um anal ##yte ; Factor IV , Co ##agu ##lation [SEP]',\n",
       "  'our_bi_cui': 'C0678941',\n",
       "  'our_bi_cui_name': 'Gene Mutant',\n",
       "  'our_bi_cui_desc': '[CLS] Gene Mu ##tant [unused3] ( Ana ##tom ##ical Structure : gene mutant ##s ; Gene Mu ##tation ; gene mutant ; Gene V ##arian ##t ; mutant gene ; genes mutant ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27384489.27',\n",
       "  'test_set_idx': 4341,\n",
       "  'type': 'T082',\n",
       "  'name': 'R1628P polymorphism',\n",
       "  'context': \"[CLS] used to evaluate the strength of the association between the R ##16 ##28 ##P p ##oly ##mor ##phism and Parkinson ' s disease . This meta - analysis assessed 19 studies from 14 papers that involved a total of 9 , 92 ##7 Parkinson ' s disease patients and 8 , 60 ##2 controls and found that the [unused1] R ##16 ##28 ##P p ##oly ##mor ##phism [unused2] was significantly associated with the risk of Parkinson ' s disease in Asian populations . Moreover , s ##tra ##ti ##fication analyses indicated that the R ##16 ##28 ##P p ##oly ##mor ##phism was significantly associated with an increased risk of Parkinson ' s disease among Chinese as well as non - Chinese Asian populations and an increased [SEP]\",\n",
       "  'existing_cui': 'C0032529',\n",
       "  'existing_cui_name': 'Genetic Polymorphism',\n",
       "  'existing_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
       "  'our_bi_cui': 'C0032529',\n",
       "  'our_bi_cui_name': 'Genetic Polymorphism',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
       "  'our_cross_cui': 'C0752046',\n",
       "  'our_cross_cui_name': 'Single Nucleotide Polymorphism',\n",
       "  'our_cross_cui_desc': '[CLS] Single N ##uc ##leo ##tide Pol ##ym ##or ##phism [unused3] ( Spa ##tial Concept , S ##NP : Pol ##ym ##or ##phism , Single N ##uc ##leo ##tide ; Single N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s ; Pol ##ym ##or ##phism ##s , Single N ##uc ##leo ##tide ; S ##NP ##s ; N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s , Single ; N ##uc ##leo ##tide Pol ##ym ##or ##phism , Single ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s ; Pol ##ym ##or ##phism , Single Base ) [SEP]'},\n",
       " {'mention_id': '28353042.19',\n",
       "  'test_set_idx': 32947,\n",
       "  'type': 'T168',\n",
       "  'name': 'high - fructose diet',\n",
       "  'context': '[CLS] incidence of In ##sul ##in resistance . The present study investigate ##s the beneficial effects of a ##que ##ous extract of Ph ##yl ##lant ##hus am ##aru s ( PA ##A ##E ) on In ##sul ##in resistance and o ##xi ##da ##tive stress in high - f ##ru ##ct ##ose fed male W ##ista ##r rats . [unused1] high - f ##ru ##ct ##ose diet [unused2] ( 66 % of f ##ru ##ct ##ose ) and PA ##A ##E ( 200 mg / kg body weight / day ) were given concurrently to the rats for a period of 60 days . Fr ##uc ##tos ##e - fed rats showed weight gain , h ##yper ##gly ##ce ##mia , h ##yper ##ins ##ulin ##emia , [SEP]',\n",
       "  'existing_cui': 'C0452314',\n",
       "  'existing_cui_name': 'Low fructose diet',\n",
       "  'existing_cui_desc': '[CLS] Low f ##ru ##ct ##ose diet [unused3] ( Health Care Act ##ivity , finding ) [SEP]',\n",
       "  'our_bi_cui': 'C0301568',\n",
       "  'our_bi_cui_name': 'High residue diet',\n",
       "  'our_bi_cui_desc': '[CLS] High residue diet [unused3] ( Health Care Act ##ivity , finding , regime / therapy , treatment : High - fiber diet ; diet fiber high ; high fibre diet ; N ##SP - High non - star ##ch p ##oly ##sa ##cc ##hari ##de diet ; High rough ##age diet ; diet high fiber ; H ##F - High fibre diet ; H ##F ##D - High fiber diet ; H ##F - High fiber diet ; High fiber diet ; high residue diet ; Inc ##reased fiber diet ; diet ##s fiber high ; High non - star ##ch p ##oly ##sa ##cc ##hari ##de diet ; High fibre diet ; H ##F ##D - High fibre diet ; high fiber diet ; diet [SEP]',\n",
       "  'our_cross_cui': 'C0012155',\n",
       "  'our_cross_cui_name': 'Diet',\n",
       "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
       " {'mention_id': '27601594.44',\n",
       "  'test_set_idx': 11275,\n",
       "  'type': 'T103',\n",
       "  'name': 'IDO-1',\n",
       "  'context': '[CLS] + ) plasma cells , CD ##6 ##8 ( + ) mac ##rop ##hage ##s , and M ##HC class I on tumor cells . I ##mm ##uno ##su ##pp ##ress ##ive cell types were also unchanged , including Fox ##P ##3 ( + ) PD - 1 ( + ) cells ( put ##ative regulatory T cells ) , [unused1] ID ##O - 1 [unused2] ( + ) cells , and PD - L ##1 ( + ) cells ( both mac ##rop ##hage ##s and tumor cells ) . Hi ##era ##rch ##ical cluster ##ing revealed three response patterns : ( i ) T ##IL ( high ) tumors showed increases in multiple immune markers after ch ##em ##otherapy ; ( ii ) T [SEP]',\n",
       "  'existing_cui': 'C1427370',\n",
       "  'existing_cui_name': 'MYLIP gene',\n",
       "  'existing_cui_desc': '[CLS] M ##Y ##L ##IP gene [unused3] ( Ana ##tom ##ical Structure : IN ##D ##UC ##IB ##LE DE ##GR ##AD ##ER OF THE L ##OW DE ##NS ##IT ##Y L ##IP ##OP ##RO ##TE ##IN R ##EC ##EP ##TO ##R ; E ##3 u ##bi ##qui ##tin l ##iga ##se - in ##du ##cible de ##grade ##r of the low density lip ##op ##rote ##in receptor ; MI ##R ; M ##Y ##OS ##IN R ##EG ##U ##LA ##TO ##R ##Y L ##IG ##HT CH ##A ##IN - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N ; my ##os ##in regulatory light chain interacting protein ) [SEP]',\n",
       "  'our_bi_cui': 'C1416433',\n",
       "  'our_bi_cui_name': 'IDO1 gene',\n",
       "  'our_bi_cui_desc': '[CLS] ID ##O ##1 gene [unused3] ( Ana ##tom ##ical Structure : IN ##D ##OL ##EA ##MI ##NE 2 , 3 - D ##IO ##X ##Y ##GE ##NA ##SE ; IN ##D ##O Gene ; Indo ##leam ##ine - P ##yr ##rol ##e 2 , 3 Di ##ox ##y ##gen ##ase Gene ; ID ##O ; in ##do ##leam ##ine 2 , 3 - di ##ox ##y ##gen ##ase 1 ; IN ##D ##O ) [SEP]',\n",
       "  'our_cross_cui': 'C3529891',\n",
       "  'our_cross_cui_name': 'indoleamine 2,3-dioxygenase 1 , human',\n",
       "  'our_cross_cui_desc': '[CLS] in ##do ##leam ##ine 2 , 3 - di ##ox ##y ##gen ##ase 1 , human [unused3] ( Chemical : ID ##O ##1 protein , human ) [SEP]'},\n",
       " {'mention_id': '27898905.54',\n",
       "  'test_set_idx': 21266,\n",
       "  'type': 'T033',\n",
       "  'name': 'no',\n",
       "  'context': '[CLS] service . On p ##hen ##ot ##y ##ping all training animals for both commencement of l ##ute ##al activity and ca ##lving to first service , accuracy for ca ##lving to first service increased to 0 . 18 ; however , when valid ##ation animals were also p ##hen ##otype ##d for commencement of l ##ute ##al activity , there was [unused1] no [unused2] substantial increase in accuracy . When predict ##ing ca ##lving to first service in bi ##var ##iate analysis with proportion of samples with l ##ute ##al activity , accuracy ranged from 0 . 07 to 0 . 14 . This first study on g ##eno ##mic predictions for fertility using end ##oc ##rine traits suggests some improvement in the accuracy of prediction [SEP]',\n",
       "  'existing_cui': 'C1140150',\n",
       "  'existing_cui_name': 'NOC - CodeSystem',\n",
       "  'existing_cui_desc': '[CLS] NO ##C - Code ##S ##ys ##tem [unused3] ( Intel ##lect ##ual Product , NO ##C : nursing outcomes classification ) [SEP]',\n",
       "  'our_bi_cui': 'C0205160',\n",
       "  'our_bi_cui_name': 'Negative',\n",
       "  'our_bi_cui_desc': '[CLS] N ##eg ##ative [unused3] ( Finding , qualifier value : Rule ##d out ; N ##eg ##ative ( m ##od ##ifier ) [ Am ##bi ##guous ] ; N ##eg ##ative for ; N ##eg ##ative ( m ##od ##ifier ) ; ruled out ; for negative ; out ruled ; negative ; negative ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C1513916',\n",
       "  'our_cross_cui_name': 'Negative Finding',\n",
       "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
       " {'mention_id': '27384489.31',\n",
       "  'test_set_idx': 4345,\n",
       "  'type': 'T082',\n",
       "  'name': 'R1628P polymorphism',\n",
       "  'context': \"[CLS] papers that involved a total of 9 , 92 ##7 Parkinson ' s disease patients and 8 , 60 ##2 controls and found that the R ##16 ##28 ##P p ##oly ##mor ##phism was significantly associated with the risk of Parkinson ' s disease in Asian populations . Moreover , s ##tra ##ti ##fication analyses indicated that the [unused1] R ##16 ##28 ##P p ##oly ##mor ##phism [unused2] was significantly associated with an increased risk of Parkinson ' s disease among Chinese as well as non - Chinese Asian populations and an increased risk of Parkinson ' s disease in Chinese patients from China , Taiwan , and Singapore . In a s ##tra ##ti ##fied analysis conducted according to age , significant associations were found [SEP]\",\n",
       "  'existing_cui': 'C0032529',\n",
       "  'existing_cui_name': 'Genetic Polymorphism',\n",
       "  'existing_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
       "  'our_bi_cui': 'C0032529',\n",
       "  'our_bi_cui_name': 'Genetic Polymorphism',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
       "  'our_cross_cui': 'C0752046',\n",
       "  'our_cross_cui_name': 'Single Nucleotide Polymorphism',\n",
       "  'our_cross_cui_desc': '[CLS] Single N ##uc ##leo ##tide Pol ##ym ##or ##phism [unused3] ( Spa ##tial Concept , S ##NP : Pol ##ym ##or ##phism , Single N ##uc ##leo ##tide ; Single N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s ; Pol ##ym ##or ##phism ##s , Single N ##uc ##leo ##tide ; S ##NP ##s ; N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s , Single ; N ##uc ##leo ##tide Pol ##ym ##or ##phism , Single ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s ; Pol ##ym ##or ##phism , Single Base ) [SEP]'},\n",
       " {'mention_id': '27259647.25',\n",
       "  'test_set_idx': 956,\n",
       "  'type': 'T103',\n",
       "  'name': '9-cis-11-trans-CLA',\n",
       "  'context': '[CLS] h ##ydro ##xy ##l derivative 10 - h ##ydro ##xi - 12 - c ##is - o ##ct ##ade ##ce ##no ##ic acid to finally form bio ##active con ##ju ##gated l ##ino ##le ##ic acid . B ##io ##chemical optimization studies were carried out to el ##uc ##ida ##te the conditions for maximum production of [unused1] 9 - c ##is - 11 - trans - C ##LA [unused2] and maximum stability of α - en ##ola ##se when cat ##aly ##zing this reaction . Furthermore , through structural analysis of the protein , we propose the binding sites of substrate and product molecules that were characterized as two h ##ydro ##phobic superficial pockets located at opposite ends of the en ##ola ##se connected through a [SEP]',\n",
       "  'existing_cui': 'C0281666',\n",
       "  'existing_cui_name': 'alitretinoin',\n",
       "  'existing_cui_desc': '[CLS] al ##it ##ret ##ino ##in [unused3] ( Chemical , product , substance : 9 - CR ##A ; 9 - c ##is - T ##ret ##ino ##in ; Ali ##tre ##tino ##ín ##a ; 9 - c ##is re ##tino ##ic acid ; 9 - c ##is - Re ##tino ##ic acid ; 9 - c ##is - Re ##tino ##ic A ##cid ; Ali ##tre ##tino ##in ; Ali ##tre ##tino ##in ##um ; 3 , 7 - Di ##met ##hyl - 9 - ( 2 , 6 , 6 - trim ##eth ##yl - 1 - c ##y ##c ##lo ##he ##xen - 1 - y ##l ) 2 - trans - 4 - trans - 6 - c ##is - 8 - trans [SEP]',\n",
       "  'our_bi_cui': 'C0902483',\n",
       "  'our_bi_cui_name': 'cis-9-trans-11-octadecadienoic acid',\n",
       "  'our_bi_cui_desc': '[CLS] c ##is - 9 - trans - 11 - o ##ct ##ade ##ca ##die ##no ##ic acid [unused3] ( Chemical : 9 - c ##is - 11 - trans - o ##ct ##ade ##ca ##die ##no ##ic acid ; c ##9 ##t ##11 C ##LA ) [SEP]',\n",
       "  'our_cross_cui': 'C1609806',\n",
       "  'our_cross_cui_name': 'cis-9 , trans-11-conjugated linoleic acid',\n",
       "  'our_cross_cui_desc': '[CLS] c ##is - 9 , trans - 11 - con ##ju ##gated l ##ino ##le ##ic acid [unused3] ( Chemical : c ##9 - t ##11 - C ##LA ) [SEP]'},\n",
       " {'mention_id': '28353042.2',\n",
       "  'test_set_idx': 32930,\n",
       "  'type': 'T168',\n",
       "  'name': 'High Fructose Diet',\n",
       "  'context': '[CLS] Ben ##ef ##ici ##al Effects of Ph ##yl ##lant ##hus am ##aru ##s Against [unused1] High Fr ##uc ##tos ##e Diet [unused2] In ##duced In ##sul ##in Resistance and He ##pa ##tic O ##xi ##da ##tive St ##ress in Male W ##ista ##r Rat ##s In ##sul ##in resistance is a characteristic feature of o ##besity , type 2 diabetes me ##lli ##tus , and card ##iovascular diseases . Em ##erging evidence suggests that the high - f ##ru ##ct ##ose consumption is a potential and important factor responsible for the rising incidence of In ##sul ##in resistance . The present study investigate ##s the beneficial effects of a ##que ##ous extract of Ph ##yl ##lant ##hus am ##aru s ( PA ##A ##E ) on [SEP]',\n",
       "  'existing_cui': 'C0452314',\n",
       "  'existing_cui_name': 'Low fructose diet',\n",
       "  'existing_cui_desc': '[CLS] Low f ##ru ##ct ##ose diet [unused3] ( Health Care Act ##ivity , finding ) [SEP]',\n",
       "  'our_bi_cui': 'C0301568',\n",
       "  'our_bi_cui_name': 'High residue diet',\n",
       "  'our_bi_cui_desc': '[CLS] High residue diet [unused3] ( Health Care Act ##ivity , finding , regime / therapy , treatment : High - fiber diet ; diet fiber high ; high fibre diet ; N ##SP - High non - star ##ch p ##oly ##sa ##cc ##hari ##de diet ; High rough ##age diet ; diet high fiber ; H ##F - High fibre diet ; H ##F ##D - High fiber diet ; H ##F - High fiber diet ; High fiber diet ; high residue diet ; Inc ##reased fiber diet ; diet ##s fiber high ; High non - star ##ch p ##oly ##sa ##cc ##hari ##de diet ; High fibre diet ; H ##F ##D - High fibre diet ; high fiber diet ; diet [SEP]',\n",
       "  'our_cross_cui': 'C0012155',\n",
       "  'our_cross_cui_name': 'Diet',\n",
       "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
       " {'mention_id': '28493435.7',\n",
       "  'test_set_idx': 37722,\n",
       "  'type': 'T033',\n",
       "  'name': 'locate',\n",
       "  'context': '[CLS] with ultra ##sound el ##ast ##ography has become a hot field in recent years . However , for key ##points tracking - based el ##ast ##ography algorithms , lo ##cating ex ##tre ##ma in multi ##mo ##dal ultra ##sonic radio ##f ##re ##que ##ncy signals is still a challenging problem . In this paper , a new method is proposed to [unused1] locate [unused2] the local ma ##xi ##ma and mini ##ma of the RF signals directly without der ##ivation operation . This algorithm can accurately locate ex ##tre ##ma even if disturbed peaks resulting from different noise exist . Furthermore , the new algorithm can speed up approximately 79 % of the implementation process as compared with the standard cross - correlation method on the [SEP]',\n",
       "  'existing_cui': 'C1366498',\n",
       "  'existing_cui_name': 'Chloramphenicol Acetyl Transferase Gene',\n",
       "  'existing_cui_desc': '[CLS] Ch ##lora ##mp ##hen ##ico ##l Ace ##ty ##l Transfer ##ase Gene [unused3] ( Ana ##tom ##ical Structure : cat Gene ) [SEP]',\n",
       "  'our_bi_cui': 'C0450429',\n",
       "  'our_bi_cui_name': 'Location',\n",
       "  'our_bi_cui_desc': '[CLS] Location [unused3] ( Spa ##tial Concept , attribute : location ; Lo ##c ; L ##OC ; locations ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27444636.41',\n",
       "  'test_set_idx': 5992,\n",
       "  'type': 'T170',\n",
       "  'name': 'Quality of Life in Epilepsy Inventory 10',\n",
       "  'context': '[CLS] analysis included 21 patients ( 12 women , 9 men ; mean age 36 years ) . After switching from o ##x ##car ##ba ##ze ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate , there were significant improvements in mean scores for Ad ##verse Events Profile ( P < . 00 ##1 ) , [unused1] Quality of Life in E ##pile ##psy In ##vent ##ory 10 [unused2] ( P = . 00 ##1 ) , and alert ##ness ( P < . 05 ) . Ad ##verse Events Profile total scores improved for 21 / 21 ( 100 . 0 % ) patients , Quality of Life in E ##pile ##psy In ##vent ##ory 10 total scores improved for 17 / 21 ( 81 [SEP]',\n",
       "  'existing_cui': 'C2698752',\n",
       "  'existing_cui_name': 'Pediatric Quality of Life Inventory',\n",
       "  'existing_cui_desc': '[CLS] P ##ediatric Quality of Life In ##vent ##ory [unused3] ( Intel ##lect ##ual Product : P ##eds ##QL ) [SEP]',\n",
       "  'our_bi_cui': 'C3897419',\n",
       "  'our_bi_cui_name': 'Symptom Interference with Life Score 10',\n",
       "  'our_bi_cui_desc': '[CLS] S ##ym ##pt ##om Inter ##ference with Life Score 10 [unused3] ( Intel ##lect ##ual Product : MD ##AS ##I S ##ym ##pt ##om Inter ##ference with Life Score 10 ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28188533.11',\n",
       "  'test_set_idx': 27856,\n",
       "  'type': 'T091',\n",
       "  'name': 'proteomic studies',\n",
       "  'context': '[CLS] ##c ##quisition Data for Label - free Q ##uant ##itative Pro ##te ##omi ##cs Studies Using Triple ##TO ##F ( ® ) Mass S ##pect ##rome ##ters Data - independent acquisition is a powerful mass s ##pect ##rome ##try technique that enables comprehensive MS and MS / MS analysis of all detect ##able species , providing an information rich data file that can be mined deeply . Here , we describe how to acquire high - quality S ##WA ##TH ( ® ) A ##c ##quisition data to be used for large quantitative [unused1] pro ##te ##omi ##c studies [unused2] . We specifically focus on using variable sized Q ##1 windows for acquisition of MS / MS data for generating higher specific ##ity quantitative data . [SEP]',\n",
       "  'existing_cui': 'C1519031',\n",
       "  'existing_cui_name': 'Pharmacoeconomic Study',\n",
       "  'existing_cui_desc': '[CLS] Ph ##arma ##coe ##con ##omi ##c Study [unused3] ( Research Act ##ivity : P ##HA ##R ##MA ##CO ##EC ##ON ##OM ##IC ) [SEP]',\n",
       "  'our_bi_cui': 'C1327760',\n",
       "  'our_bi_cui_name': 'proteomic profiling',\n",
       "  'our_bi_cui_desc': '[CLS] pro ##te ##omi ##c pro ##fi ##ling [unused3] ( Health Care Act ##ivity : Pro ##te ##omi ##c Prof ##iling ; Pro ##tein Express ##ion Prof ##iling ) [SEP]',\n",
       "  'our_cross_cui': 'C0872252',\n",
       "  'our_cross_cui_name': 'Proteomics',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##te ##omi ##cs [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line : pro ##te ##omi ##cs ; pro ##te ##omi ##c ) [SEP]'},\n",
       " {'mention_id': '28179911.58',\n",
       "  'test_set_idx': 27652,\n",
       "  'type': 'T017',\n",
       "  'name': 'FATA',\n",
       "  'context': '[CLS] ##WR ##I ##1 in seven independent T ##2 lines were detected by quantitative real - time PC ##R . The relative m ##RNA accumulation of genes encoding enzymes involved in either fatty acid bio ##sy ##nt ##hesis or t ##ria ##cy ##l ##gly ##cer ##ols assembly ( BC ##CP ##2 , K ##AS ##I , MA ##T , E ##NR , [unused1] FA ##TA [unused2] , and GP ##D ##H ) were also ass ##ay ##ed in mature seeds . Furthermore , lip ##id and fatty acids C ##16 : 0 and C ##18 : 0 significantly increased . In two ho ##mo ##zy ##go ##us T ##2 trans ##genic rice lines ( G ##5 and G ##2 ) , different Co ##WR ##I ##1 expression [SEP]',\n",
       "  'existing_cui': 'C1366645',\n",
       "  'existing_cui_name': 'CD36 gene',\n",
       "  'existing_cui_desc': '[CLS] CD ##36 gene [unused3] ( Ana ##tom ##ical Structure : SC ##AR ##B ##3 ; T ##H ##RO ##MB ##OS ##PO ##ND ##IN R ##EC ##EP ##TO ##R ; L ##E ##U ##KO ##C ##Y ##TE D ##IF ##F ##ER ##EN ##TI ##AT ##ION AN ##TI ##GE ##N CD ##36 ; GP ##I ##V ; CD ##36 Gene ; CD ##36 Mo ##le ##cule Gene ; G ##L ##Y ##CO ##PR ##OT ##EI ##N III ##b ; CD ##36 molecule ; GP III ##b ; CO ##LL ##AG ##EN R ##EC ##EP ##TO ##R , P ##LA ##TE ##LE ##T ; P ##LA ##TE ##LE ##T G ##L ##Y ##CO ##PR ##OT ##EI ##N IV ; FA ##TT ##Y AC ##ID T ##RA ##NS ##L ##OC [SEP]',\n",
       "  'our_bi_cui': 'C0812278',\n",
       "  'our_bi_cui_name': 'FAT1 gene',\n",
       "  'our_bi_cui_desc': '[CLS] FA ##T ##1 gene [unused3] ( Ana ##tom ##ical Structure : FA ##T at ##y ##pical ca ##dh ##eri ##n 1 ; CD ##HF ##7 ; FA ##T At ##y ##pical C ##ad ##her ##in 1 Gene ; ca ##dh ##eri ##n - related family member 8 ; FA ##T ; FA ##T T ##UM ##OR S ##UP ##PR ##ES ##SO ##R , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 1 ; fat gene ; FA ##T ##1 Gene ; CD ##H ##R ##8 ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '25847295.22',\n",
       "  'test_set_idx': 21,\n",
       "  'type': 'T017',\n",
       "  'name': 'apoptotic cells',\n",
       "  'context': '[CLS] PC ##12 cells with non ##yl ##phe ##no ##l diet ##ho ##xy ##late , whereas the c ##yt ##och ##rome c release into the c ##yt ##oso ##l decreased as compared to that in a ##pop ##to ##tic cells not treated with non ##yl ##phe ##no ##l diet ##ho ##xy ##late s . Furthermore , Ba ##x contents in [unused1] a ##pop ##to ##tic cells [unused2] were reduced after exposure to non ##yl ##phe ##no ##l diet ##ho ##xy ##late . Thus , non ##yl ##phe ##no ##l diet ##ho ##xy ##late has the opposite effect on a ##pop ##tosis in PC ##12 cells compared to non ##yl ##phe ##no ##l , which enhance ##s a ##pop ##tosis induced by serum de ##p ##ri ##vation . [SEP]',\n",
       "  'existing_cui': 'C0162638',\n",
       "  'existing_cui_name': 'Apoptosis',\n",
       "  'existing_cui_desc': '[CLS] A ##pop ##tosis [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : a ##pop ##to ##tic cell death ; A ##pop ##to ##tic Process ; Programme ##d Cell Death ; programmed cell death by a ##pop ##tosis ; A ##pop ##tosis Path ##way ; a ##pop ##tos ##e ; programmed cell death ; RC ##D ; a ##pop ##tosis ; Gene - directed cell death ; a ##pop ##to ##tic programmed cell death ; Programme ##d Cell Death , Type I ; self destruction of the cell ; Me ##chan ##ism that allows cells to self - des ##truct when it is necessary ; a ##pop ##to ##tic process ; type I programmed cell death ) [SEP]',\n",
       "  'our_bi_cui': 'C1836846',\n",
       "  'our_bi_cui_name': 'Apoptotic neurons',\n",
       "  'our_bi_cui_desc': '[CLS] A ##pop ##to ##tic neurons [unused3] ( Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0007634',\n",
       "  'our_cross_cui_name': 'Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
       " {'mention_id': '27965426.19',\n",
       "  'test_set_idx': 22656,\n",
       "  'type': 'T103',\n",
       "  'name': 'spindle - associated proteins',\n",
       "  'context': '[CLS] not well characterized . Although a few functional ##ly - relevant mit ##otic p ##hos ##ph ##ot ##yr ##os ##ine sites have been characterized , evidence suggests that this modification may be more prevalent than previously appreciated . Here , we examined t ##yr ##os ##ine p ##hos ##ph ##ory ##lation in mit ##otic human cells including those on [unused1] spin ##dle - associated proteins [unused2] . ? Database mining confirmed ~ 2000 mit ##otic p ##hos ##ph ##ot ##yr ##os ##ine sites , and network analysis revealed a number of sub ##net ##works that were en ##rich ##ed in t ##yr ##os ##ine - p ##hos ##ph ##ory ##lated proteins , including components of the kin ##eto ##chor ##e or spin ##dle and SR ##C [SEP]',\n",
       "  'existing_cui': 'C1425583',\n",
       "  'existing_cui_name': 'NUSAP1 gene',\n",
       "  'existing_cui_desc': '[CLS] N ##US ##AP ##1 gene [unused3] ( Ana ##tom ##ical Structure : N ##US ##AP ##1 Gene ; L ##NP ; PR ##O ##0 ##31 ##0 ##p ##1 ; N ##US ##AP ; N ##UC ##LE ##OL ##AR AND SP ##IN ##D ##LE - AS ##SO ##CI ##AT ##ED PR ##OT ##EI ##N 1 ; SA ##PL ; Q ##0 ##31 ##0 ; N ##UC ##LE ##OL ##AR PR ##OT ##EI ##N AN ##K ##T ; N ##u ##SA ##P ##1 ; FL ##J ##13 ##42 ##1 ; N ##uc ##leo ##lar and Spin ##dle Associated Pro ##tein 1 Gene ; n ##uc ##leo ##lar and spin ##dle associated protein 1 ; B ##M ##0 ##37 ) [SEP]',\n",
       "  'our_bi_cui': 'C0026045',\n",
       "  'our_bi_cui_name': 'Microtubule-Associated Proteins',\n",
       "  'our_bi_cui_desc': '[CLS] Micro ##tub ##ule - Associated Pro ##tein ##s [unused3] ( Chemical , MA ##P : Micro ##tub ##ule Associated Pro ##tein ##s ; Micro ##tub ##ule - associated protein ; MI ##CR ##OT ##U ##B ##U ##LE AS ##SO ##C PR ##OT ##EI ##NS ; micro ##tub ##ule - associated proteins ; Micro ##tub ##ule - Associated Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; Micro ##tub ##ule - Associated Pro ##tein ; Micro ##tub ##ule Associated Pro ##tein ; MA ##Ps ; micro ##tub ##ule associated protein ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28454015.24',\n",
       "  'test_set_idx': 36525,\n",
       "  'type': 'T170',\n",
       "  'name': 'health - risk based air quality index',\n",
       "  'context': '[CLS] to evaluate the health risks . Results show that based on health - risk based air quality index , the current air quality index system likely significantly under ##est ##imate the health risks of air pollution , highlighting that the general public may need strict ##er health protection measures . The population - weighted two - year average [unused1] health - risk based air quality index [unused2] data further demonstrates that all population in the studied cities in He ##nan province live with poll ##uted air - 72 % of the population is exposed to air that is un ##hea ##lt ##hy for sensitive people , while 28 % of people is exposed to air that can be harmful to healthy people ; and the health [SEP]',\n",
       "  'existing_cui': 'C1268941',\n",
       "  'existing_cui_name': 'Health risks education',\n",
       "  'existing_cui_desc': '[CLS] Health risks education [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Counsel ##ing regarding health risks ; Ad ##vice about health risks ; Counsel ##ling regarding health risks ; Education regarding health risks ) [SEP]',\n",
       "  'our_bi_cui': 'C0018761',\n",
       "  'our_bi_cui_name': 'Health Status Indicators',\n",
       "  'our_bi_cui_desc': '[CLS] Health Status In ##dic ##ators [unused3] ( Intel ##lect ##ual Product , assessment scale : Index ##es , Health Status ; In ##dic ##ators , Health Status ; health status index ; In ##dic ##ator , Health Status ; Health Status Index ; In ##dices , Health Status ; Health status indicators ; Health Status In ##dices ; Health status index ; Health Status In ##dic ##ator ; Index , Health Status ; Health Status Index ##es ; health status indicators ; health in ##dices status ) [SEP]',\n",
       "  'our_cross_cui': 'C0918012',\n",
       "  'our_cross_cui_name': 'Index',\n",
       "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
       " {'mention_id': '27500205.6',\n",
       "  'test_set_idx': 8438,\n",
       "  'type': 'T103',\n",
       "  'name': 'kindlins',\n",
       "  'context': '[CLS] Of Kind ##lins and Cancer Kind ##lins are 4 . 1 - e ##z ##rin - rid ##ix ##in - m ##oes ##in ( F ##ER ##M ) domain containing proteins . There are three [unused1] kind ##lins [unused2] in mammals , which share high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the [SEP]',\n",
       "  'existing_cui': 'C1720776',\n",
       "  'existing_cui_name': 'Kindling , Neurologic',\n",
       "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
       "  'our_bi_cui': 'C0010422',\n",
       "  'our_bi_cui_name': 'Crystallins',\n",
       "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28210319.14',\n",
       "  'test_set_idx': 28545,\n",
       "  'type': 'T038',\n",
       "  'name': 'pump failure',\n",
       "  'context': '[CLS] characterised by progressive skeletal muscle wasting , including of the respiratory muscles . Re ##sp ##ira ##tory failure , i . e . when the respiratory system fails in its gas exchange functions , is a common feature in muscular d ##ys ##tro ##phy , being the main cause of death , and it is a consequence of lung failure , [unused1] pump failure [unused2] or a combination of the two . The former is due to re ##current as ##piration , the latter to progressive weakness of respiratory muscles and an increase in the load against which they must contract . In fact , both the resist ##ive and elastic components of the work of breathing increase due to air ##way o ##bs ##truction and [SEP]',\n",
       "  'existing_cui': 'C1417212',\n",
       "  'existing_cui_name': 'MMP7 gene',\n",
       "  'existing_cui_desc': '[CLS] M ##MP ##7 gene [unused3] ( Ana ##tom ##ical Structure : M ##MP ##7 Gene ; mat ##rily ##sin ; matrix metal ##lop ##ept ##idas ##e 7 ; MA ##TR ##IX ME ##TA ##LL ##OP ##RO ##TE ##IN ##AS ##E 7 ; P ##UT ##AT ##IVE ME ##TA ##LL ##OP ##RO ##TE ##IN ##AS ##E I ; MA ##TR ##IL ##Y ##SI ##N , U ##TE ##RI ##NE ; P ##UM ##P - 1 ; Matrix Metal ##lop ##ept ##idas ##e 7 ( Mat ##rily ##sin , U ##ter ##ine ) Gene ) [SEP]',\n",
       "  'our_bi_cui': 'C0948755',\n",
       "  'our_bi_cui_name': 'Pulmonary failure',\n",
       "  'our_bi_cui_desc': '[CLS] P ##ul ##mona ##ry failure [unused3] ( B ##iol ##og ##ic Fun ##ction : pulmonary failure ; failure pulmonary ) [SEP]',\n",
       "  'our_cross_cui': 'C1145670',\n",
       "  'our_cross_cui_name': 'Respiratory Failure',\n",
       "  'our_cross_cui_desc': '[CLS] Re ##sp ##ira ##tory F ##ail ##ure [unused3] ( B ##iol ##og ##ic Fun ##ction , context - dependent category , diagnosis , disorder , situation : [ D ] Re ##sp ##ira ##tory failure ; respiratory ins ##uff ##iciency / failure ; F ##ail ##ure ; respiratory ; Re ##sp ##ira ##tory failure ; F ##ail ##ure , Re ##sp ##ira ##tory ; Re ##sp ##ira ##tory failure , un ##sp ##ec ##ified ; respiratory failure ; respiratory ins ##uff ##iciency ; F ##ail ##ure respiratory ; Re ##spiration failure ) [SEP]'},\n",
       " {'mention_id': '27882455.29',\n",
       "  'test_set_idx': 20577,\n",
       "  'type': 'T038',\n",
       "  'name': 'memory stabilization processes',\n",
       "  'context': '[CLS] these memory traces into an existing body of knowledge ( item integration ) . Older adults learned 13 non ##words and were tested on their memory for the non ##words , and on whether these non ##words impacted upon processing of similar - sounding English words immediately and 24 hours later . Part ##ici ##pants accurately recognized the non ##words immediately , but showed significant decreases in delayed recognition and recall . In comparison , the non ##words impacted upon processing of similar - sounding words only in the delayed test . Together , these findings suggest that memory consolidation processes may be more evident in item integration than [unused1] memory stab ##ilization processes [unused2] for new de ##c ##lar ##ative memories in older adults . [SEP]',\n",
       "  'existing_cui': 'C1293130',\n",
       "  'existing_cui_name': 'Stabilization',\n",
       "  'existing_cui_desc': '[CLS] St ##abi ##li ##zation [unused3] ( Health Care Act ##ivity , procedure : stab ##ilization ; St ##abi ##lis ##ation ) [SEP]',\n",
       "  'our_bi_cui': 'C1293130',\n",
       "  'our_bi_cui_name': 'Stabilization',\n",
       "  'our_bi_cui_desc': '[CLS] St ##abi ##li ##zation [unused3] ( Health Care Act ##ivity , procedure : stab ##ilization ; St ##abi ##lis ##ation ) [SEP]',\n",
       "  'our_cross_cui': 'C0025361',\n",
       "  'our_cross_cui_name': 'Mental Processes',\n",
       "  'our_cross_cui_desc': '[CLS] Mental Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction , Human , function , o ##bs ##er ##vable entity : Human Information Process ##ing ; Thought process ; cognitive processing ; processes thought ; processing thought ; Information Process ##ing , Human ; Human information processing ; Information Process ##es ; mental processing ; cognitive process ; Form of thinking , function ; mental processes ; Form of thought ; Form of thinking ; Human Information Process ##es ; Mental Process ; mental process ; thought process ) [SEP]'},\n",
       " {'mention_id': '28441489.43',\n",
       "  'test_set_idx': 36165,\n",
       "  'type': 'T033',\n",
       "  'name': 'cold - start',\n",
       "  'context': '[CLS] , and x ##yle ##nes . Therefore , the secondary organic a ##ero ##sol and oz ##one formation potential of the exhaust does not depend on engine technology . Cold - start contributes a larger fraction of the total unified cycle emissions for vehicles meeting more - string ##ent emission standards . Organic gas emissions were the most sensitive to [unused1] cold - start [unused2] compared to the other poll ##uta ##nts tested here . There were no statistical ##ly significant differences in the effects of cold - start on G ##DI ##s and P ##FI ##s . For our test fleet , the measured 14 . 5 % decrease in CO ##2 emissions from G ##DI ##s was much greater than the potential climate forcing [SEP]',\n",
       "  'existing_cui': 'C0452588',\n",
       "  'existing_cui_name': 'Start brand of breakfast cereal',\n",
       "  'existing_cui_desc': '[CLS] Start brand of breakfast cereal [unused3] ( Food , substance : Start ) [SEP]',\n",
       "  'our_bi_cui': 'C0161734',\n",
       "  'our_bi_cui_name': 'Effects of low temperature',\n",
       "  'our_bi_cui_desc': '[CLS] Effects of low temperature [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder : Effect reduced te ##mp ; cold effect ; effect of reduced temperature ; Effects of freezing or excessive cold ; A ##cci ##dent due to excessive cold of un ##sp ##ec ##ified origin ; Cold Effects ; effects of ; cold ; Effect of reduced temperature , un ##sp ##ec ##ified ; cold effects ; effects cold ; Effects of reduced temperature ; Ex ##cess ##ive cold ; effects of ; low temperature ; Effects of freezing AND / OR excessive cold ; Un ##sp ##ec ##ified effect of reduced temperature ; Ex ##cess ##ive cold of un ##sp ##ec ##ified origin ; cold ; effects of ; [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27357394.22',\n",
       "  'test_set_idx': 3609,\n",
       "  'type': 'T033',\n",
       "  'name': 'losers',\n",
       "  'context': '[CLS] establish mobility . V ##aria ##tion in the extent of patient mobility was observed across the studies . Mo ##bility was positively associated with lower waiting times , indicators of better service quality , and access to advanced technology . It was negatively associated with advanced age or lower socio ##economic backgrounds . From a policy perspective we demonstrate that a significant proportion of patients are prepared to travel beyond their nearest provider for elect ##ive services . As a consequence , some providers are likely to be \" winners \" and others \" [unused1] loser ##s [unused2] , \" which could result in overall decreased provider capacity or in ##ef ##ficient u ##til ##ization of existing services . Equity also remains a key concern . [SEP]',\n",
       "  'existing_cui': 'C0230789',\n",
       "  'existing_cui_name': 'Smooth Endoplasmic Reticulum',\n",
       "  'existing_cui_desc': '[CLS] S ##mo ##oth End ##op ##las ##mic Re ##tic ##ulum [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure , s ##ER , smooth end ##op ##las ##mic re ##tic ##ulum : End ##op ##las ##mic Re ##tic ##ulum , S ##mo ##oth ; smooth end ##op ##las ##mic re ##tic ##ulum ; A ##gra ##nu ##lar End ##op ##las ##mic Re ##tic ##ulum ; A ##gra ##nu ##lar end ##op ##las ##mic re ##tic ##ulum ; End ##op ##las ##mic Re ##tic ##ulum , A ##gra ##nu ##lar ; Re ##tic ##ulum end ##op ##las ##mic ##um non ##gra ##nu ##los ##um ; S ##mo ##oth end ##op ##las ##mic re ##tic ##ulum ; smooth ER ; S ##mo ##oth - Surface [SEP]',\n",
       "  'our_bi_cui': 'C1257890',\n",
       "  'our_bi_cui_name': 'Population Group',\n",
       "  'our_bi_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28338634.26',\n",
       "  'test_set_idx': 32475,\n",
       "  'type': 'T033',\n",
       "  'name': 'detection',\n",
       "  'context': \"[CLS] proposed for ass ##ay of the ne ##uro ##to ##xi ##c compounds . The prepared na ##no ##par ##tic ##les were modified by pure Ace ##ty ##l ##cho ##lines ##tera ##se and they were used for the measurement anti - Alzheimer ' s drug gal ##ant ##amine and car ##ba ##mate p ##est ##icide car ##bo ##fu ##ran with limit of [unused1] detection [unused2] 1 . 5 µ ##M and 20 n ##M , respectively . All measurements were carried out using screen - printed sensor with carbon working , silver reference , and carbon auxiliary electro ##de . Standard El ##lman ' s ass ##ay was used for valid ##ation measurement of both inhibitor ##s . Part of this work was the elimination of re [SEP]\",\n",
       "  'existing_cui': 'C0206100',\n",
       "  'existing_cui_name': 'Signal Detection',\n",
       "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
       "  'our_bi_cui': 'C1511790',\n",
       "  'our_bi_cui_name': 'Detection',\n",
       "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
       "  'our_cross_cui': 'C0442726',\n",
       "  'our_cross_cui_name': 'Detected',\n",
       "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
       " {'mention_id': '28158248.6',\n",
       "  'test_set_idx': 27110,\n",
       "  'type': 'T170',\n",
       "  'name': 'ordinary differential equations',\n",
       "  'context': '[CLS] Model ##ing the flux of meta ##bol ##ites in the juvenile hormone bio ##sy ##nt ##hesis pathway using generalized add ##itive models and [unused1] ordinary differential equations [unused2] Ju ##ven ##ile hormone regulate ##s development and reproductive mat ##uration in insects . The co ##rp ##ora all ##ata from female adult m ##os ##quito ##es s ##ynth ##esi ##ze flu ##ct ##uating levels of Ju ##ven ##ile hormone , which have been linked to the o ##var ##ian development and are influenced by nutrition ##al signals . The rate of Ju ##ven ##ile hormone bio ##sy ##nt ##hesis is controlled by the rate of flux of is ##op ##ren ##oids in the pathway , which is the outcome of a complex inter ##play of changes in [SEP]',\n",
       "  'existing_cui': 'C0011906',\n",
       "  'existing_cui_name': 'Differential Diagnosis',\n",
       "  'existing_cui_desc': '[CLS] Different ##ial Di ##ag ##nosis [unused3] ( Health Care Act ##ivity , context ##ual qualifier , qualifier value : D ##IA ##G D ##IF ##F ##ER ##EN ##TI ##AL ; Di ##ag ##nose ##s , Different ##ial ; D ##IF ##F ##ER ##EN ##TI ##AL D ##IA ##G ; Di ##ag ##nosis , Different ##ial ; Different ##ial d ##x ; D ##IA ##G D ##IF ##F ##ER ; differential di ##ag ##nose ##s ; differential diagnosis ; Different ##ial diagnosis ( context ##ual qualifier ) ; Different ##ial Di ##ag ##nose ##s ; differential d ##x ; Different ##ial diagnosis ; D ##IF ##F ##ER D ##IA ##G ) [SEP]',\n",
       "  'our_bi_cui': 'C1705273',\n",
       "  'our_bi_cui_name': 'Mathematical Operator',\n",
       "  'our_bi_cui_desc': '[CLS] Mathematical Opera ##tor [unused3] ( Intel ##lect ##ual Product : Opera ##tor ; Fun ##ction ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27699206.9',\n",
       "  'test_set_idx': 14490,\n",
       "  'type': 'T017',\n",
       "  'name': 'lateral occipital',\n",
       "  'context': '[CLS] - Based Category Select ##ivity in Human Visual Co ##rte ##x In f ##MR ##I studies , human lateral o ##cci ##pit ##al cortex is thought to respond selective ##ly to images of objects , compared with non ##ob ##jects . However , it remains un ##res ##ol ##ved whether all objects e ##voke equivalent levels of activity in [unused1] lateral o ##cci ##pit ##al [unused2] , and , if not , which image features produce stronger activation . Here , we used an un ##bia ##sed para ##metric texture model to predict preferred versus non ##p ##re ##ferred stimuli in lateral o ##cci ##pit ##al . O ##bs ##er ##vation and ps ##ych ##op ##hy ##si ##cal results showed that predicted preferred stimuli ( both [SEP]',\n",
       "  'existing_cui': 'C0923804',\n",
       "  'existing_cui_name': 'Lateral occipital artery',\n",
       "  'existing_cui_desc': '[CLS] Later ##al o ##cci ##pit ##al artery [unused3] ( Ana ##tom ##ical Structure , Arte ##ria c ##ere ##bri posterior : P ##3 segment of posterior cerebral artery ; Arte ##ria o ##cci ##pit ##alis lateral ##is ; Se ##gment ##um P ##3 ; A . o ##cci ##pit ##alis lateral ##is ) [SEP]',\n",
       "  'our_bi_cui': 'C0228229',\n",
       "  'our_bi_cui_name': 'lateral occipital sulcus',\n",
       "  'our_bi_cui_desc': '[CLS] lateral o ##cci ##pit ##al su ##l ##cus [unused3] ( Spa ##tial Concept , human only , human only , body structure : Later ##al o ##cci ##pit ##al su ##l ##cus ; Structure of lateral o ##cci ##pit ##al su ##l ##cus ; Later ##al - O ##cci ##pit ##al Sul ##cus ; Sul ##cus o ##cci ##pit ##alis lateral ##is ) [SEP]',\n",
       "  'our_cross_cui': 'C0028785',\n",
       "  'our_cross_cui_name': 'Occipital lobe',\n",
       "  'our_cross_cui_desc': '[CLS] O ##cci ##pit ##al lobe [unused3] ( Ana ##tom ##ical Structure , body structure : o ##cci ##pit ##al region ; O ##cci ##pit ##al cortex ; lo ##bus o ##cci ##pit ##alis ; O ##cci ##pit ##al Lo ##be ; o ##cci ##pit ##al lobes ; O ##cci ##pit ##al lobes ; O ##cci ##pit ##al Region ##s ; O ##cci ##pit ##al Region ; o ##cci ##pit ##al lobe ; Lo ##be , O ##cci ##pit ##al ; lobe o ##cci ##pit ##al ; O ##cci ##pit ##al region ; Region , O ##cci ##pit ##al ; Lo ##bus o ##cci ##pit ##alis ; o ##cci ##pit ##al cortex ; Reg ##io o ##cci ##pit ##alis ; Lo ##bes , O ##cci ##pit ##al [SEP]'},\n",
       " {'mention_id': '27781034.48',\n",
       "  'test_set_idx': 16561,\n",
       "  'type': 'T033',\n",
       "  'name': 'frequently co - occur',\n",
       "  'context': '[CLS] brain an ##oma ##lies . However , the cause of genetic generalized e ##pile ##psy remained unclear . In this study , we describe and review 28 individuals with 22 ##q ##11 . 2 del ##eti ##on syndrome and genetic generalized e ##pile ##psy ( especially juvenile my ##oc ##lon ##ic e ##pile ##psy ) , showing that both disorders [unused1] frequently co - occur [unused2] . Compared to the reported prevalence of 15 - 21 % , in our case series only 10 % of 22 ##q ##11 . 2 del ##eti ##on syndrome individuals were found to have e ##pile ##psy , often genetic generalized e ##pile ##psy . Since 22 ##q ##11 . 2 does not contain convincing genetic generalized e ##pile ##psy [SEP]',\n",
       "  'existing_cui': 'C0558131',\n",
       "  'existing_cui_name': 'Eating frequently',\n",
       "  'existing_cui_desc': '[CLS] Eat ##ing frequently [unused3] ( Finding , finding ) [SEP]',\n",
       "  'our_bi_cui': 'C0277557',\n",
       "  'our_bi_cui_name': 'Intercurrent disease',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##current disease [unused3] ( B ##iol ##og ##ic Fun ##ction , finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28011059.45',\n",
       "  'test_set_idx': 23692,\n",
       "  'type': 'T098',\n",
       "  'name': 'children',\n",
       "  'context': '[CLS] ##e se ##quencing or Il ##lum ##ina 450 ##K array ##s . Co ##rd blood mon ##on ##uc ##lea ##r cell - derived IL - 1 ##β levels were measured by means of E ##L ##IS ##A . Neo ##nat ##al immune cells harbor ##ed 58 ##9 differential ##ly met ##hyl ##ated regions that distinguished In ##fant I ##mm ##une Study [unused1] children [unused2] who did and did not have as ##th ##ma by age 9 years . In all 3 co ##hor ##ts met ##hyl ##ation in SM ##AD ##3 , the most connected node within the network of as ##th ##ma - associated , differential ##ly met ##hyl ##ated regions , was selective ##ly increased in as ##th ##matic children of as ##th ##matic [SEP]',\n",
       "  'existing_cui': 'C0682171',\n",
       "  'existing_cui_name': 'History of being abused as child',\n",
       "  'existing_cui_desc': '[CLS] History of being abused as child [unused3] ( Finding , history : child a ##bus ; abused as a child ; abused as child ; child abused ; abused child ) [SEP]',\n",
       "  'our_bi_cui': 'C0264408',\n",
       "  'our_bi_cui_name': 'Childhood asthma',\n",
       "  'our_bi_cui_desc': '[CLS] Child ##hood as ##th ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Child ##hood As ##th ##ma ; as ##th ##ma childhood ; As ##th ##ma , childhood ; As ##th ##ma in Children ; as ##th ##ma ; childhood ; As ##th ##ma in children ; childhood ; as ##th ##ma ; childhood as ##th ##ma ) [SEP]',\n",
       "  'our_cross_cui': 'C1257890',\n",
       "  'our_cross_cui_name': 'Population Group',\n",
       "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
       " {'mention_id': '28077027.24',\n",
       "  'test_set_idx': 24980,\n",
       "  'type': 'T170',\n",
       "  'name': 'EFSA',\n",
       "  'context': '[CLS] - 90 years . The p ##est ##icide residue data were obtained from the Shanghai monitoring programme during 2008 - 11 with 34 organ ##op ##hos ##phate ##s and 11 car ##ba ##mates anal ##ys ##ed in a total of 53 ##35 samples of vegetables and fruits . A pro ##ba ##bil ##istic approach was performed as recommended by the [unused1] E ##FS ##A [unused2] , using the optimistic model with non - detect ##s set as zero and with processing factors being used and the p ##ess ##im ##istic model with non - detect ##s replaced by limit of detection and without processing factors . We used the relative pot ##ency factor method to normal ##ise the various p ##est ##icides to the index compound [SEP]',\n",
       "  'existing_cui': 'C1537461',\n",
       "  'existing_cui_name': 'KIAA1109 gene',\n",
       "  'existing_cui_desc': '[CLS] K ##IA ##A ##11 ##0 ##9 gene [unused3] ( Ana ##tom ##ical Structure : T ##week ; fragile site - associated ; K ##IA ##A ##13 ##7 ##1 ; FL ##J ##21 ##40 ##4 ; T ##W ##EE ##K , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; K ##IA ##A ##11 ##0 ##9 GE ##NE ) [SEP]',\n",
       "  'our_bi_cui': 'C1708333',\n",
       "  'our_bi_cui_name': 'Health Care Organization',\n",
       "  'our_bi_cui_desc': '[CLS] Health Care Organization [unused3] ( Organization : Healthcare Organization ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28107548.15',\n",
       "  'test_set_idx': 25818,\n",
       "  'type': 'T170',\n",
       "  'name': 'multiple random forest classifiers',\n",
       "  'context': '[CLS] ##ical classification to re ##fine the detection results . High - level feature representation is first learned by a deep learning network , where multi ##par ##ame ##tric MR images are used as the input data . Then , based on the learned high - level features , a hi ##era ##rch ##ical classification method is developed , where [unused1] multiple random forest class ##ifier ##s [unused2] are it ##erative ##ly constructed to re ##fine the detection results of pro ##state cancer . The experiments were carried on 21 real patient subjects , and the proposed method achieve ##s an averaged section - based evaluation of 89 . 90 % , an averaged sensitivity of 91 . 51 % , and an averaged specific ##ity of [SEP]',\n",
       "  'existing_cui': 'C0034656',\n",
       "  'existing_cui_name': 'Randomization',\n",
       "  'existing_cui_desc': '[CLS] Random ##ization [unused3] ( Research Act ##ivity : Random ##ized ; Random All ##oc ##ation ; random ##ization ; Trial is Random ##ized ; All ##oc ##ation , Random ; random allocation ; random ##ized ; RA ##ND ##OM ) [SEP]',\n",
       "  'our_bi_cui': 'C0008902',\n",
       "  'our_bi_cui_name': 'Classification',\n",
       "  'our_bi_cui_desc': '[CLS] Classification [unused3] ( Intel ##lect ##ual Product , attribute , qualifier value : C ##LA ##SS ; class ##ifying ; Classification ##s ; class ##ify ; classification ##s ; Class ##ified ; System ##atic ##s ; Classification system ; classification system ; classified ; cat ##ego ##riz ##ation ; classified ##s ; classification systems ; systematic ##s ; Classification Systems ; classification ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27427386.17',\n",
       "  'test_set_idx': 5255,\n",
       "  'type': 'T017',\n",
       "  'name': 'p. 58I > V',\n",
       "  'context': \"[CLS] modify the p ##hen ##otypic expression of primary Le ##ber ' s hereditary op ##tic ne ##uro ##pathy - associated mitochondrial DNA mutations . In this study , we demonstrated that the Le ##ber ' s hereditary op ##tic ne ##uro ##pathy su ##s ##ce ##pt ##ibility all ##ele ( m . 145 ##0 ##2 ##T > C , [unused1] p . 58 ##I > V [unused2] ) in the N ##D ##6 gene m ##od ##ulated the p ##hen ##otypic expression of primary Le ##ber ' s hereditary op ##tic ne ##uro ##pathy - associated m . 117 ##7 ##8 ##G > A mutation . Twenty - two Han Chinese p ##ed ##ig ##ree ##s carrying m . 145 ##0 ##2 ##T > C and [SEP]\",\n",
       "  'existing_cui': 'C0614783',\n",
       "  'existing_cui_name': 'vasectrin I',\n",
       "  'existing_cui_desc': '[CLS] vase ##ct ##rin I [unused3] ( Chemical : i vs ; Secret ##in , 4 - L - al ##ani ##ne - ; V ##S I ; 4 - Al ##a - secret ##in ; secret ##in , al ##ani ##ne ( 4 ) - ; secret ##in , Al ##a ( 4 ) - ; vase ##ct ##rin i ) [SEP]',\n",
       "  'our_bi_cui': 'C0026882',\n",
       "  'our_bi_cui_name': 'Mutation',\n",
       "  'our_bi_cui_desc': '[CLS] Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction , finding : genome mutation ; Gene ##tic mutation ; genetic mutation ; genetic mutations ; mutations ; Mu ##tations ; mutation ; alterations genetic ; genetic alter ##ation ) [SEP]',\n",
       "  'our_cross_cui': 'C0002085',\n",
       "  'our_cross_cui_name': 'Alleles',\n",
       "  'our_cross_cui_desc': '[CLS] All ##ele ##s [unused3] ( Ana ##tom ##ical Structure , finding : All ##ele ; All ##elo ##mor ##ph ; Gene ##tic all ##ele ##s ; all ##ele ; All ##elo ##mor ##phs ; all ##ele ##s ; AL ##LE ##LE ) [SEP]'},\n",
       " {'mention_id': '27500205.33',\n",
       "  'test_set_idx': 8465,\n",
       "  'type': 'T103',\n",
       "  'name': 'adaptor proteins',\n",
       "  'context': '[CLS] controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate the capacity of in ##te ##g ##rin ##s to media ##te their functions . Kind ##lins are [unused1] adapt ##or proteins [unused2] ; their function em ##ana ##te from their interaction with binding partners , including the c ##yt ##op ##las ##mic tails of in ##te ##g ##rin ##s and components of the act ##in c ##yt ##os ##kel ##eton . The purpose of this review is to provide a brief overview of kind ##lin structure and function , a consideration of their [SEP]',\n",
       "  'existing_cui': 'C1449886',\n",
       "  'existing_cui_name': 'Adaptor Proteins , Signal Transducing',\n",
       "  'existing_cui_desc': '[CLS] Ada ##pt ##or Pro ##tein ##s , Signal Trans ##ducing [unused3] ( Chemical : adapt ##er protein ; Ada ##pt ##er Pro ##tein ; Ada ##pt ##or Signal ##ing Pro ##tein ; Signal Trans ##ducing Ada ##pt ##or Pro ##tein ##s ; Ada ##pt ##er Signal ##ing Pro ##tein ; Ada ##pt ##or Pro ##tein ; Signal Trans ##ducing Ada ##pt ##or Pro ##tein ; Ada ##pt ##or Pro ##tein ##s , Signal Trans ##ducing [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
       "  'our_bi_cui': 'C1449886',\n",
       "  'our_bi_cui_name': 'Adaptor Proteins , Signal Transducing',\n",
       "  'our_bi_cui_desc': '[CLS] Ada ##pt ##or Pro ##tein ##s , Signal Trans ##ducing [unused3] ( Chemical : adapt ##er protein ; Ada ##pt ##er Pro ##tein ; Ada ##pt ##or Signal ##ing Pro ##tein ; Signal Trans ##ducing Ada ##pt ##or Pro ##tein ##s ; Ada ##pt ##er Signal ##ing Pro ##tein ; Ada ##pt ##or Pro ##tein ; Signal Trans ##ducing Ada ##pt ##or Pro ##tein ; Ada ##pt ##or Pro ##tein ##s , Signal Trans ##ducing [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28249376.35',\n",
       "  'test_set_idx': 29905,\n",
       "  'type': 'T168',\n",
       "  'name': 'concentrate diet',\n",
       "  'context': '[CLS] at 0 ( control ) , 0 . 8 , and 1 . 6 m ##L / d on apparent nut ##rient dig ##est ##ibility , r ##ume ##n f ##er ##mentation characteristics , r ##ume ##n micro ##bial population and blood chemical meta ##bol ##ites . Animals were fed with a 50 : 50 al ##fa ##lf ##a hay : [unused1] concentrate diet [unused2] . R ##umi ##nal pH , total volatile fatty acids concentration , m ##olar proportion of individual volatile fatty acids , ace ##tate : prop ##ion ##ate ratio and met ##hane production were not affected with mixture of essential oils . Re ##lative to the control , Small p ##eptide ##s plus amino acid nitrogen and large p ##eptide ##s nitrogen [SEP]',\n",
       "  'existing_cui': 'C1880165',\n",
       "  'existing_cui_name': 'Concentrate Dosage Form',\n",
       "  'existing_cui_desc': '[CLS] Con ##cent ##rate Do ##sa ##ge Form [unused3] ( Chemical : Con ##cent ##rated ; Con ##cent ##rate ; CO ##NC ; CO ##NC ##EN ##TR ##AT ##E ; Con ##c ; Con ##cent ##rated Do ##sa ##ge Form ; Con ##cent ##rated Do ##se Form ) [SEP]',\n",
       "  'our_bi_cui': 'C0003050',\n",
       "  'our_bi_cui_name': 'Animal feed',\n",
       "  'our_bi_cui_desc': '[CLS] Animal feed [unused3] ( Food , substance , substance : animal food ; animal feeds ; animal feeding ; animals food ; food animal ; Fe ##eds , Animal ; Animal Fe ##ed ; Fe ##ed , Animal ; animal feed ; Animal Fe ##eds ) [SEP]',\n",
       "  'our_cross_cui': 'C0012155',\n",
       "  'our_cross_cui_name': 'Diet',\n",
       "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
       " {'mention_id': '27306834.45',\n",
       "  'test_set_idx': 2032,\n",
       "  'type': 'T017',\n",
       "  'name': 'naïve cell',\n",
       "  'context': '[CLS] expression patterns of memory - promoting transcription factors , T - bet and E ##ome ##s , induced in a rapid and sustainable manner . N ##T ##ef ##f cells appeared to have lower expression of Fox ##p ##1 and were re ##fra ##ctor ##y to a ##pop ##tosis upon T ##G ##F - β conditioning , implying better survival potential and resistance to tumor - induced immune suppression . Of CD ##8 ( + ) T cell pools activated to tumor - specific CT ##L ##s , [unused1] na ##ï ##ve cell [unused2] generated effect ##ors possessed the most potent c ##yt ##oto ##xi ##c activity , valid ##ating implications for use in rational design of adopt ##ive im ##mu ##not ##her ##ap ##y . [SEP]',\n",
       "  'existing_cui': 'C1179416',\n",
       "  'existing_cui_name': 'Endothelial cell of venous sinus of red pulp of spleen',\n",
       "  'existing_cui_desc': '[CLS] End ##oth ##eli ##al cell of ve ##nous sin ##us of red pulp of s ##ple ##en [unused3] ( Ana ##tom ##ical Structure : St ##ave cell ) [SEP]',\n",
       "  'our_bi_cui': 'C0007634',\n",
       "  'our_bi_cui_name': 'Cells',\n",
       "  'our_bi_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]',\n",
       "  'our_cross_cui': 'C3641721',\n",
       "  'our_cross_cui_name': 'Naive T-Lymphocyte',\n",
       "  'our_cross_cui_desc': '[CLS] Na ##ive T - L ##ymph ##oc ##yte [unused3] ( Ana ##tom ##ical Structure : T ##h ##0 ; Na ##ive T L ##ymph ##oc ##yte ; Na ##ive T - Cell ; Na ##ive T Cell ##s ; Na ##ive T Cell ) [SEP]'},\n",
       " {'mention_id': '28457334.24',\n",
       "  'test_set_idx': 36634,\n",
       "  'type': 'T103',\n",
       "  'name': 'extracellular RNA',\n",
       "  'context': '[CLS] abdominal surgery . A total of 15 patients with se ##psis , 10 post ##oper ##ative patients , and 10 healthy volunteers were included in this longitudinal study . Blood was collected at se ##psis onset and after surgery respectively , as well as after 24 , 72 and 168 h . Level ##s of Cell - free DNA and [unused1] extra ##cellular RNA [unused2] were measured by quantitative probe - based polymer ##ase chain reaction . In addition , th ##rom ##boe ##last ##ography for co ##agu ##lation as well as th ##rom ##boa ##gg ##re ##go ##metry for plate ##let function was conducted . Both Cell - free DNA and extra ##cellular RNA were elevated in patients with se ##psis compared with post ##oper [SEP]',\n",
       "  'existing_cui': 'C0521119',\n",
       "  'existing_cui_name': 'Extracellular',\n",
       "  'existing_cui_desc': '[CLS] Extra ##cellular [unused3] ( Ana ##tom ##ical Structure , qualifier value : extra ##cellular ; extra ##cellular region ) [SEP]',\n",
       "  'our_bi_cui': 'C0230885',\n",
       "  'our_bi_cui_name': 'Extracellular material',\n",
       "  'our_bi_cui_desc': '[CLS] Extra ##cellular material [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0035668',\n",
       "  'our_cross_cui_name': 'RNA',\n",
       "  'our_cross_cui_desc': '[CLS] RNA [unused3] ( Chemical , RNA , R ##ib ##on ##uc ##le ##ic A ##cid , substance : rib ##on ##uc ##le ##ic acid ; R ##ib ##on ##uc ##le ##ic acids ; RNA , Non - Pol ##ya ##den ##yla ##ted ; rib ##on ##uc ##lein ##ic ##um acid ##um / rib ##on ; RNA - R ##ib ##on ##uc ##le ##ic acid ; RNA [ Chemical / In ##g ##red ##ient ] ; RNA , Non Pol ##ya ##den ##yla ##ted ; Non - Pol ##ya ##den ##yla ##ted RNA ; r ##na ; Non Pol ##ya ##den ##yla ##ted RNA ; A ##cid , R ##ib ##on ##uc ##le ##ic ; R ##ib ##on ##uc ##le ##ic acid ; Gene Products , RNA [SEP]'},\n",
       " {'mention_id': '27732552.9',\n",
       "  'test_set_idx': 15246,\n",
       "  'type': 'T058',\n",
       "  'name': 'techniques',\n",
       "  'context': '[CLS] Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp ##ling at home as an alternative tool for the monitoring of H ##b ##A ##1 ##c in diabetes patients Micro ##sa ##mp ##ling techniques have several advantages over traditional blood collection . Dr ##ied blood spot sampling and blood collection with he ##par ##ini ##zed cap ##illa ##ries are the standard [unused1] techniques [unused2] . Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp ##ling is a novel technique that collects a fixed volume of blood by applying an absorb ##ent tip to a blood drop . In the present study we explored the f ##eas ##ibility of H ##b ##A ##1 ##c monitoring with Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp [SEP]',\n",
       "  'existing_cui': 'C0450241',\n",
       "  'existing_cui_name': 'Ffooks technique',\n",
       "  'existing_cui_desc': '[CLS] F ##fo ##ok ##s technique [unused3] ( Health Care Act ##ivity , qualifier value ) [SEP]',\n",
       "  'our_bi_cui': 'C0025663',\n",
       "  'our_bi_cui_name': 'Methods',\n",
       "  'our_bi_cui_desc': '[CLS] Method ##s [unused3] ( Intel ##lect ##ual Product , attribute : methods ; Method ; method ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '27647760.18',\n",
       "  'test_set_idx': 12785,\n",
       "  'type': 'T092',\n",
       "  'name': 'Sequenom',\n",
       "  'context': \"[CLS] B ##D ##NF genes and drug addiction in the Han Chinese population . We conducted a case - control study among 69 ##2 cases and 700 healthy controls from Xi ' an , China . Eight single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s were selected and g ##eno ##type ##d using Mass ##AR ##RA ##Y technology ( [unused1] Se ##que ##no ##m [unused2] , San Diego , CA , USA ) . Odd ##s ratios and 95 % confidence intervals were calculated by un ##con ##ditional log ##istic re ##gression adjusting for age and sex . Using the ch ##i - squared test , we found that r ##s ##7 ##48 ##13 ##11 ( Odd ##s ratios = 1 . 275 , 95 [SEP]\",\n",
       "  'existing_cui': 'C1414863',\n",
       "  'existing_cui_name': 'FUT2 gene',\n",
       "  'existing_cui_desc': '[CLS] F ##UT ##2 gene [unused3] ( Ana ##tom ##ical Structure : GDP - L - f ##uc ##ose : beta - D - gal ##act ##os ##ide 2 - alpha - L - f ##uc ##osy ##lt ##ran ##s ##fer ##ase 2 ; alpha ( 1 , 2 ) F ##T ##2 ; secret ##or blood group alpha - 2 - f ##uc ##osy ##lt ##ran ##s ##fer ##ase ; SEC ##2 ; SEC ##RE ##TO ##R FA ##CT ##OR ; f ##uc ##osy ##lt ##ran ##s ##fer ##ase 2 ; se ##j ; alpha ( 1 , 2 ) f ##uc ##osy ##lt ##ran ##s ##fer ##ase ; F ##UC ##OS ##Y ##LT ##RA ##NS ##F ##ER ##AS ##E 2 ; secret ##or factor ; [SEP]',\n",
       "  'our_bi_cui': 'C0025080',\n",
       "  'our_bi_cui_name': 'Medical Devices',\n",
       "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
       "  'our_cross_cui': 'C0683757',\n",
       "  'our_cross_cui_name': 'Company',\n",
       "  'our_cross_cui_desc': '[CLS] Company [unused3] ( Organization , organization , organization : Business ; company ; Companies ; companies ) [SEP]'},\n",
       " {'mention_id': '28071754.10',\n",
       "  'test_set_idx': 24715,\n",
       "  'type': 'T037',\n",
       "  'name': 'injury',\n",
       "  'context': '[CLS] infrared protects vascular end ##oth ##eli ##al cells from advanced g ##ly ##cation end products - induced injury via Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein - mediated auto ##pha ##gy in di ##abe ##tic mice The accumulation of advanced g ##ly ##cation end products in di ##abe ##tic patients induce ##s vascular end ##oth ##eli ##al [unused1] injury [unused2] . Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein is a transcription factor that can be activated by low - temperature far - infrared i ##rra ##diation to ex ##ert beneficial effects on the vascular end ##oth ##eli ##um . In the present study , we investigated the influence of far - infrared - induced Pro ##my ##elo ##cy [SEP]',\n",
       "  'existing_cui': 'C0005604',\n",
       "  'existing_cui_name': 'Birth Injuries',\n",
       "  'existing_cui_desc': '[CLS] Birth In ##ju ##ries [unused3] ( In ##ju ##ry or Po ##ison ##ing , Birth , diagnosis , disorder : In ##ju ##ries , Birth ; T ##ra ##umatic birth ; injury birth ; Birth trauma , un ##sp ##ec ##ified ; Birth T ##ra ##uma ; Birth trauma of f ##etus ; injury ; birth ; traumatic birth ; birth trauma ; birth injuries ; Birth In ##ju ##ry ; trauma birth ; Neo ##nat ##al Birth In ##ju ##ry ; birth ##ing injuries ; Birth In ##ju ##ries [ Disease / Finding ] ; Un ##sp ##ec ##ified birth trauma ; birth ##ing trauma ; B ##IR ##TH IN ##J ; IN ##J B ##IR ##TH ; Birth injuries ; birth ; injury ; [SEP]',\n",
       "  'our_bi_cui': 'C0010957',\n",
       "  'our_bi_cui_name': 'Tissue damage',\n",
       "  'our_bi_cui_desc': '[CLS] T ##iss ##ue damage [unused3] ( In ##ju ##ry or Po ##ison ##ing , m ##or ##ph ##olo ##gic abnormal ##ity : damage tissues ; Dam ##age ; damages tissue ; Dam ##age , T ##iss ##ue ; tissue damage ; T ##iss ##ue Dam ##age ; damage ; damages ) [SEP]',\n",
       "  'our_cross_cui': 'C0178314',\n",
       "  'our_cross_cui_name': 'Poisoning / injury',\n",
       "  'our_cross_cui_desc': '[CLS] Po ##ison ##ing / injury [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder , finding , navigation ##al concept : In ##ju ##ry & / or poisoning ; IN ##J ##UR ##Y AND P ##O ##IS ##ON ##ING ; In ##ju ##ry and poisoning ; In ##ju ##ry / poisoning ) [SEP]'},\n",
       " {'mention_id': '27669217.46',\n",
       "  'test_set_idx': 13697,\n",
       "  'type': 'T017',\n",
       "  'name': 'ermB',\n",
       "  'context': '[CLS] ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both er ##m ##B and er ##m ##T in all is ##olate ##s was er ##yt ##hr ##omy ##cin in ##du ##cible and yielded comparable mac ##rol ##ide MI ##Cs in all six is ##olate ##s . Take ##n together , in ##du ##cible expression of both [unused1] er ##m ##B [unused2] and er ##m ##T conferred high mac ##rol ##ide resistance in these S . gal ##lo ##ly ##ticus subsp . paste ##rian ##us is ##olate ##s . Our findings reveal new mac ##rol ##ide resistance features in S . gal ##lo ##ly ##ticus subsp . paste ##uria ##nus by both er ##m ##B and er ##m ##T . [SEP]',\n",
       "  'existing_cui': 'C0732611',\n",
       "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
       "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
       "  'our_bi_cui': 'C0243036',\n",
       "  'our_bi_cui_name': 'Genes , erbB',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##s , er ##b ##B [unused3] ( Ana ##tom ##ical Structure : A ##vian E ##ry ##th ##ro ##blast ##osis V ##ir ##us On ##co ##gene B ; E ##ry ##th ##ro ##blast Trans ##form ##ing Gene B ; On ##co ##gene , E ##G ##F ##R ; On ##co ##gene ER ##B B ; er ##b ##B Gene ##s ; er ##b ##B Gene ; ER ##B - B ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27659602.7',\n",
       "  'test_set_idx': 13352,\n",
       "  'type': 'T082',\n",
       "  'name': 'root',\n",
       "  'context': '[CLS] The A ##ort ##ic Root : Natural History After Root - Spa ##ring As ##cend ##ing Rep ##lace ##ment in Non ##sy ##nd ##rom ##ic An ##eur ##ys ##mal Pat ##ients Leaving native a ##ort ##ic tissue in sit ##u in root - spa ##ring ascending a ##ort ##ic replacement raises concern regarding potential later need for [unused1] root [unused2] re ##oper ##ation or for the potential occurrence of localized di ##sse ##ctions or r ##up ##ture in the residual root . The purpose of this study was to evaluate the natural growth of the a ##ort ##ic root after root - spa ##ring a ##ort ##ic replacement . In all , 102 consecutive patients ( mean age 61 . 8 ± 12 . 5 years [SEP]',\n",
       "  'existing_cui': 'C1318154',\n",
       "  'existing_cui_name': 'Root body part',\n",
       "  'existing_cui_desc': '[CLS] Root body part [unused3] ( Ana ##tom ##ical Structure : Root ; root [ a body part ] ; root ) [SEP]',\n",
       "  'our_bi_cui': 'C0040452',\n",
       "  'our_bi_cui_name': 'Tooth root structure',\n",
       "  'our_bi_cui_desc': '[CLS] Too ##th root structure [unused3] ( Ana ##tom ##ical Structure , body structure : Ra ##di ##x co ##rona ; Root of the Too ##th ; tooth root ; Too ##th Root ; Root of Too ##th ; Root , Too ##th ; tooth roots ; root of tooth ; root tooth ; roots tooth ; Te ##eth - - Roots ; Roots , Too ##th ; of tooth root ; Too ##th Roots ; Too ##th root ; Ra ##di ##x Den ##tis ; Ra ##di ##x den ##tis ; rooted tooth ; Root of tooth ) [SEP]',\n",
       "  'our_cross_cui': 'C0549113',\n",
       "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
       "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
       " {'mention_id': '27669217.2',\n",
       "  'test_set_idx': 13653,\n",
       "  'type': 'T017',\n",
       "  'name': 'ermB',\n",
       "  'context': '[CLS] In ##du ##cible Express ##ion of both [unused1] er ##m ##B [unused2] and er ##m ##T Con ##ferred High Mac ##rol ##ide Resistance in St ##re ##pt ##oc ##oc ##cus gal ##lo ##ly ##ticus subsp . paste ##uria ##nus Is ##olate ##s in China St ##re ##pt ##oc ##oc ##cus gal ##lo ##ly ##ticus subsp . paste ##uria ##nus is an under - recognized path ##ogen and zoo ##not ##ic agent causing op ##port ##uni ##stic infections in humans . Despite increasing recognition of this subspecies as a cause for human infectious diseases , limited information is known about its anti ##biotic resistance mechanism . In this study , we aim to identify the molecular mechanism underlying the high mac ##rol ##ide resistance of six S [SEP]',\n",
       "  'existing_cui': 'C0732611',\n",
       "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
       "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
       "  'our_bi_cui': 'C0243036',\n",
       "  'our_bi_cui_name': 'Genes , erbB',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##s , er ##b ##B [unused3] ( Ana ##tom ##ical Structure : A ##vian E ##ry ##th ##ro ##blast ##osis V ##ir ##us On ##co ##gene B ; E ##ry ##th ##ro ##blast Trans ##form ##ing Gene B ; On ##co ##gene , E ##G ##F ##R ; On ##co ##gene ER ##B B ; er ##b ##B Gene ##s ; er ##b ##B Gene ; ER ##B - B ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27472389.55',\n",
       "  'test_set_idx': 7196,\n",
       "  'type': 'T017',\n",
       "  'name': 'MDA-MB231',\n",
       "  'context': '[CLS] act ##iva ##tor of transcription 1 , and H ##ER ##2 were increased and re ##lap ##se free survival was decreased in high - risk breast cancer patients . We also investigated the effect of ACT ##A ##2 on cell m ##ot ##ility , which was suppressed by ACT ##A ##2 s ##h ##RNA over ##ex ##press ##ion in [unused1] MD ##A - MB ##23 ##1 [unused2] H ##ER ##2 and 4 ##T ##1 ma ##mma ##ry car ##cin ##oma cells . The number of lung meta ##static nod ##ules was significantly decreased in ACT ##A ##2 knock ##down mice . Take ##n together , these results demonstrated that induction of ACT ##A ##2 by E ##G ##F ##R and H ##ER ##2 dim ##eri ##zation [SEP]',\n",
       "  'existing_cui': 'C1537399',\n",
       "  'existing_cui_name': 'IFIH1 gene',\n",
       "  'existing_cui_desc': '[CLS] IF ##I ##H1 gene [unused3] ( Ana ##tom ##ical Structure : IN ##TE ##R ##F ##ER ##ON - IN ##D ##UC ##ED H ##EL ##IC ##AS ##E C D ##OM ##A ##IN - CO ##NT ##A ##IN ##ING PR ##OT ##EI ##N 1 ; ID ##DM ##19 ; me ##lan ##oma differentiation - associated gene 5 ; IF ##I ##H1 Gene ; Inter ##fer ##on In ##duced With He ##lica ##se C Domain 1 Gene ; he ##lica ##rd ; inter ##fer ##on induced with he ##lica ##se C domain 1 ; H ##l ##c ##d ; MD ##A - 5 ; ME ##LA ##N ##OM ##A D ##IF ##F ##ER ##EN ##TI ##AT ##ION - AS ##SO ##CI ##AT ##ED GE ##NE 5 ) [SEP]',\n",
       "  'our_bi_cui': 'C3898556',\n",
       "  'our_bi_cui_name': 'MDA-MB-231 / ATCC',\n",
       "  'our_bi_cui_desc': '[CLS] MD ##A - MB - 231 / AT ##CC [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_cross_cui': 'C1512505',\n",
       "  'our_cross_cui_name': 'Breast Cancer Cell',\n",
       "  'our_cross_cui_desc': '[CLS] B ##rea ##st Cancer Cell [unused3] ( Ana ##tom ##ical Structure : Human B ##rea ##st Cancer Cell ; Human B ##rea ##st Cancer Cell ##s ) [SEP]'},\n",
       " {'mention_id': '27838742.78',\n",
       "  'test_set_idx': 19045,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . [unused1] Del ##ica ##f ##lav ##one [unused2] showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27799834.1',\n",
       "  'test_set_idx': 17615,\n",
       "  'type': 'T058',\n",
       "  'name': 'revision arthroscopic repair',\n",
       "  'context': '[CLS] A comparison of functional outcomes in patients undergoing [unused1] revision art ##hr ##os ##copic repair [unused2] of massive rot ##ator cu ##ff tears with and without art ##hr ##os ##copic su ##pra ##sca ##pu ##lar nerve release This study was designed to compare functional outcomes in patients undergoing revision repair of massive rot ##ator cu ##ff tears ( re ##tracted medial to the g ##len ##oid ) with Go ##uta ##llie ##r Grade 4 at ##rop ##hy and con ##com ##ita ##nt release of the su ##pra ##sca ##pu ##lar nerve to a similar group of patients with Grade 3 at ##rop ##hy undergoing revision rot ##ator cu ##ff repair without nerve release . We h ##y ##pot ##hes ##ized that patients undergoing nerve release would [SEP]',\n",
       "  'existing_cui': 'C0408075',\n",
       "  'existing_cui_name': 'Revision arthroscopic ligament repair',\n",
       "  'existing_cui_desc': '[CLS] Rev ##ision art ##hr ##os ##copic l ##iga ##ment repair [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
       "  'our_bi_cui': 'C0087111',\n",
       "  'our_bi_cui_name': 'Therapeutic procedure',\n",
       "  'our_bi_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]',\n",
       "  'our_cross_cui': 'C1997575',\n",
       "  'our_cross_cui_name': 'Revision of repair of rotator cuff',\n",
       "  'our_cross_cui_desc': '[CLS] Rev ##ision of repair of rot ##ator cu ##ff [unused3] ( Health Care Act ##ivity , procedure ) [SEP]'},\n",
       " {'mention_id': '27729085.9',\n",
       "  'test_set_idx': 15215,\n",
       "  'type': 'T038',\n",
       "  'name': 'conventional',\n",
       "  'context': '[CLS] Cho ##rdo ##ma de ##different ##iation after pro ##ton beam therapy : a case report and review of the literature Cho ##rdo ##ma is a rare invasive bone tumor that may occur anywhere along the ne ##ura ##xi ##s . A total of three primary his ##to ##logical varieties have been identified : [unused1] conventional [unused2] , ch ##ond ##roid , and de ##different ##iated . We report a case of an 8 - year - old white girl who presented with conventional chord ##oma , was treated with surgical re ##section and mixed pro ##ton and photo ##n beam therapy , and had a re ##cu ##rrence in the re ##section cavity 2 . 5 years later with de ##different ##iated morphology . The re [SEP]',\n",
       "  'existing_cui': 'C2945704',\n",
       "  'existing_cui_name': 'Conventional Treatment',\n",
       "  'existing_cui_desc': '[CLS] Convention ##al Treatment [unused3] ( Health Care Act ##ivity : conventional therapy ; Convention ##al Therapy ; conventional treatment ) [SEP]',\n",
       "  'our_bi_cui': 'C4055182',\n",
       "  'our_bi_cui_name': 'Conventional Schwannoma',\n",
       "  'our_bi_cui_desc': '[CLS] Convention ##al Sc ##hwa ##nn ##oma [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_cross_cui': 'C0008487',\n",
       "  'our_cross_cui_name': 'Chordoma',\n",
       "  'our_cross_cui_desc': '[CLS] Cho ##rdo ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity : chord ##oma ; CH ##OR ##D ##OM ##A , MA ##L ##IG ##NA ##NT ; CH ##OR ##D ##OM ##A , S ##US ##CE ##P ##TI ##BI ##L ##IT ##Y TO ; chord ##oma ##s ; Cho ##rdo ##ma [ Disease / Finding ] ; Cho ##rdo ##mas ; not ##och ##ord ##oma ) [SEP]'},\n",
       " {'mention_id': '28436493.10',\n",
       "  'test_set_idx': 35776,\n",
       "  'type': 'T103',\n",
       "  'name': 'H56',\n",
       "  'context': '[CLS] in E ##S ##X - 1 secret ##ion induce ##s minimal host immune responses and path ##ology Although My ##co ##ba ##cter ##ium tuberculosis D ##K ##9 ##8 ##9 ##7 is an at ##ten ##uated strain , it was isolated from a patient with extra ##pu ##lm ##ona ##ry tuberculosis and v ##ac ##cin ##ation with a subunit vaccine ( [unused1] H ##5 ##6 [unused2] ) induced poor protection against it . Both at ##ten ##uation and lack of protection are because My ##co ##ba ##cter ##ium tuberculosis D ##K ##9 ##8 ##9 ##7 can not secret ##e the E ##s ##x ##A v ##ir ##ule ##nce factor nor induce a host response against it . Gen ##ome se ##quencing identified a frames ##hi ##ft mutation [SEP]',\n",
       "  'existing_cui': 'C3612799',\n",
       "  'existing_cui_name': 'Bacillus sp . H56',\n",
       "  'existing_cui_desc': '[CLS] Ba ##ci ##llus s ##p . H ##5 ##6 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
       "  'our_bi_cui': 'C0042210',\n",
       "  'our_bi_cui_name': 'Vaccines',\n",
       "  'our_bi_cui_desc': '[CLS] V ##ac ##cine ##s [unused3] ( Chemical , medication , product , substance : VA ##CC ##IN ##ES ; V ##ac ##cine ; vaccine product ; [ I ##M ##100 ] VA ##CC ##IN ##ES ; V ##ac ##cine ##s [ Chemical / In ##g ##red ##ient ] ; vaccine ##s ; V ##ac ##cine ##E ##nti ##ty ##T ##ype ; vaccine ) [SEP]',\n",
       "  'our_cross_cui': 'C0887892',\n",
       "  'our_cross_cui_name': 'Vaccines , Subunit',\n",
       "  'our_cross_cui_desc': '[CLS] V ##ac ##cine ##s , Sub ##uni ##t [unused3] ( Chemical : Sub ##uni ##t V ##ac ##cine ##s ; subunit vaccine ; subunit vaccine ##s ; V ##ac ##cine ##s , Sub ##uni ##t [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '27659602.12',\n",
       "  'test_set_idx': 13357,\n",
       "  'type': 'T082',\n",
       "  'name': 'root',\n",
       "  'context': '[CLS] ##lace ##ment in Non ##sy ##nd ##rom ##ic An ##eur ##ys ##mal Pat ##ients Leaving native a ##ort ##ic tissue in sit ##u in root - spa ##ring ascending a ##ort ##ic replacement raises concern regarding potential later need for root re ##oper ##ation or for the potential occurrence of localized di ##sse ##ctions or r ##up ##ture in the residual [unused1] root [unused2] . The purpose of this study was to evaluate the natural growth of the a ##ort ##ic root after root - spa ##ring a ##ort ##ic replacement . In all , 102 consecutive patients ( mean age 61 . 8 ± 12 . 5 years ; 60 % male ) who had undergone root - spa ##ring a ##ort ##ic replacement had [SEP]',\n",
       "  'existing_cui': 'C1318154',\n",
       "  'existing_cui_name': 'Root body part',\n",
       "  'existing_cui_desc': '[CLS] Root body part [unused3] ( Ana ##tom ##ical Structure : Root ; root [ a body part ] ; root ) [SEP]',\n",
       "  'our_bi_cui': 'C0040452',\n",
       "  'our_bi_cui_name': 'Tooth root structure',\n",
       "  'our_bi_cui_desc': '[CLS] Too ##th root structure [unused3] ( Ana ##tom ##ical Structure , body structure : Ra ##di ##x co ##rona ; Root of the Too ##th ; tooth root ; Too ##th Root ; Root of Too ##th ; Root , Too ##th ; tooth roots ; root of tooth ; root tooth ; roots tooth ; Te ##eth - - Roots ; Roots , Too ##th ; of tooth root ; Too ##th Roots ; Too ##th root ; Ra ##di ##x Den ##tis ; Ra ##di ##x den ##tis ; rooted tooth ; Root of tooth ) [SEP]',\n",
       "  'our_cross_cui': 'C0549113',\n",
       "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
       "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
       " {'mention_id': '28197156.9',\n",
       "  'test_set_idx': 28079,\n",
       "  'type': 'T204',\n",
       "  'name': 'rice cultivars',\n",
       "  'context': '[CLS] , St ##oma ##tal Con ##duct ##ance and Photo ##sy ##nt ##hesis in Rice Inc ##rea ##sing the rate of leaf photos ##ynth ##esis is one important approach for increasing grain yield in rice ( Or ##y ##za sat ##iva ) . Ex ##p ##lo ##iting the natural variation in CO ##2 ass ##im ##ilation rate ( A ) between [unused1] rice cult ##iva ##rs [unused2] using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial cult ##iva ##r . Fine mapping suggested that Carbon As ##si [SEP]',\n",
       "  'existing_cui': 'C3385047',\n",
       "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
       "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
       "  'our_bi_cui': 'C0035567',\n",
       "  'our_bi_cui_name': 'Rice',\n",
       "  'our_bi_cui_desc': '[CLS] Rice [unused3] ( Food , Diet ##ary , Diet ##ary , substance : Rice ##s ; rice ) [SEP]',\n",
       "  'our_cross_cui': 'C1140671',\n",
       "  'our_cross_cui_name': 'Oryza sativa',\n",
       "  'our_cross_cui_desc': '[CLS] Or ##y ##za sat ##iva [unused3] ( E ##uka ##ryo ##te : red rice ; rice ; Or ##y ##za sat ##iva L . ; rice plant ) [SEP]'},\n",
       " {'mention_id': '27887026.36',\n",
       "  'test_set_idx': 20821,\n",
       "  'type': 'T038',\n",
       "  'name': 'hydride transfer',\n",
       "  'context': '[CLS] of HC ##O ##3 ( - ) reduced the reaction rate . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H ) and Cha ##eto ##mium the ##rm ##op ##hil ##um was modeled in the presence of HC ##O ##3 ( - ) showing that it fits to the active site . The active site setting for [unused1] h ##yd ##ride transfer [unused2] in CO ##2 reduction was modeled . The h ##yd ##ride donated by N ##AD ##H would form a favorable contact to the carbon atom of HC ##O ##3 ( - ) , resulting in a surplus of electrons within the molecule . This would cause the complex formed by hydrogen carbon ##ate and the h ##yd ##ride to break [SEP]',\n",
       "  'existing_cui': 'C0728827',\n",
       "  'existing_cui_name': 'transfers',\n",
       "  'existing_cui_desc': '[CLS] transfers [unused3] ( Finding , finding : Does transfer ; Transfer ##s ) [SEP]',\n",
       "  'our_bi_cui': 'C1159575',\n",
       "  'our_bi_cui_name': 'molecular hydrogen transport',\n",
       "  'our_bi_cui_desc': '[CLS] molecular hydrogen transport [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_cross_cui': 'C1148560',\n",
       "  'our_cross_cui_name': 'molecular_function',\n",
       "  'our_cross_cui_desc': '[CLS] molecular _ function [unused3] ( B ##iol ##og ##ic Fun ##ction : molecular function ) [SEP]'},\n",
       " {'mention_id': '27779321.3',\n",
       "  'test_set_idx': 16411,\n",
       "  'type': 'T170',\n",
       "  'name': 'equilibrium partitioning',\n",
       "  'context': '[CLS] Ben ##thi ##c injury dose - response models for p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l - contaminated sediment using [unused1] equilibrium partition ##ing [unused2] The study goal was to develop a sediment p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l dose - response model based on bent ##hic in ##vert ##eb ##rate effects to PC ##B ##s . The authors used an equilibrium partition ##ing approach to generate predicted p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l sediment effect concentrations ( largely A ##ro ##c ##lor 125 ##4 ) associated with a gradient of toxic effects in bent ##hic organisms from effects observed in aquatic toxicity studies . The present study differs from all other equilibrium partition ##ing collective sediment investigations [SEP]',\n",
       "  'existing_cui': 'C0014653',\n",
       "  'existing_cui_name': 'Equilibrium',\n",
       "  'existing_cui_desc': '[CLS] E ##qui ##li ##bri ##um [unused3] ( B ##iol ##og ##ic Fun ##ction , Motor Process ##es , function , o ##bs ##er ##vable entity , qualifier value : balancing ; equilibrium ; Ba ##lance ; E ##qui ##li ##bri ##um , function ; Ba ##lancing ; balance ; Ba ##lance , function ) [SEP]',\n",
       "  'our_bi_cui': 'C0684295',\n",
       "  'our_bi_cui_name': 'Chemical extraction',\n",
       "  'our_bi_cui_desc': '[CLS] Chemical extraction [unused3] ( Health Care Act ##ivity ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28521168.15',\n",
       "  'test_set_idx': 38284,\n",
       "  'type': 'T058',\n",
       "  'name': 'test battery',\n",
       "  'context': '[CLS] ##no ##mate ##rial ##s , specifically , Nan ##o - Go ##eth ##ite , T ##rap - O ##x Fe - z ##eo ##lite ##s , Car ##bo - Iron ( ® ) and Fe ##r ##ME ##G ##12 , developed within the European F ##P ##7 project Nan ##o ##R ##em for sub - surface re ##media ##tion towards a [unused1] test battery [unused2] consisting of eight e ##cot ##ox ##icit ##y tests on bacteria ( V . fish ##eri , E . co ##li ) , algae ( P . sub ##cap ##ita ##ta , Ch ##lam ##yd ##omo ##nas s ##p . ) , crust ##ace ##ans ( D . ma ##gna ) , worms ( E . f ##eti ##da , L [SEP]',\n",
       "  'existing_cui': 'C0456724',\n",
       "  'existing_cui_name': 'Willeford test battery',\n",
       "  'existing_cui_desc': '[CLS] Will ##ef ##ord test battery [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
       "  'our_bi_cui': 'C1446038',\n",
       "  'our_bi_cui_name': 'Microbiology battery test',\n",
       "  'our_bi_cui_desc': '[CLS] Micro ##biology battery test [unused3] ( Health Care Act ##ivity , procedure : Micro ##biology test battery ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '28229061.42',\n",
       "  'test_set_idx': 29008,\n",
       "  'type': 'T017',\n",
       "  'name': 'bucco - palatal',\n",
       "  'context': '[CLS] for nine ( 56 . 3 % ) cases and the ma ##xi ##lla for six ( 37 . 5 % ) cases , while a combination of the ma ##xi ##lla and the z ##y ##go ##ma were involved in one ( 6 . 3 % ) case . B ##uc ##co - l ##ing ##ual or [unused1] b ##uc ##co - p ##ala ##tal [unused2] expansion were the most common presentation ( six [ 46 . 2 % ] cases each ) . His ##to ##logical assessment of tissue specimens showed that fi ##bro ##my ##x ##oma accounted for seven ( 43 . 8 % ) cases , while the remaining nine ( 56 . 3 % ) cases were diagnosed as my ##x [SEP]',\n",
       "  'existing_cui': 'C1065206',\n",
       "  'existing_cui_name': 'Genus Bucco',\n",
       "  'existing_cui_desc': '[CLS] Genus B ##uc ##co [unused3] ( E ##uka ##ryo ##te , organism : b ##uc ##co ; B ##uc ##co ) [SEP]',\n",
       "  'our_bi_cui': 'C0565973',\n",
       "  'our_bi_cui_name': 'Buccal-incisal-palatal',\n",
       "  'our_bi_cui_desc': '[CLS] B ##uc ##cal - in ##cis ##al - p ##ala ##tal [unused3] ( Spa ##tial Concept , body structure ) [SEP]',\n",
       "  'our_cross_cui': 'C0229962',\n",
       "  'our_cross_cui_name': 'Body part',\n",
       "  'our_cross_cui_desc': '[CLS] Body part [unused3] ( Ana ##tom ##ical Structure , body structure : Body Parts ; Body part structure ; Pa ##rs co ##rp ##oris ; body part ; body parts ; Body region ; Ana ##tom ##ic part . * ; Body Structure ; Parts , Body ; Ana ##tom ##ic part ; body region ; Cardinal body part ; Body Part ) [SEP]'},\n",
       " {'mention_id': '27251800.47',\n",
       "  'test_set_idx': 842,\n",
       "  'type': 'T058',\n",
       "  'name': 'Stoppa',\n",
       "  'context': '[CLS] % of Stop ##pa group ( 22 patients ) and 64 % in lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair group ( 16 patients ) ( P < 0 . 05 ) . The comparative study between the Stop ##pa and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approaches for the bilateral ing ##uin ##al her ##nia repair demonstrated that : ( 1 ) The lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approach showed less surgical trauma despite the longer operation time ; ( 2 ) Quality of life during the early post - operative period were similar ; and ( 3 ) Co ##mp ##lication rates were higher in the [unused1] Stop ##pa [unused2] group . [SEP]',\n",
       "  'existing_cui': 'C1538901',\n",
       "  'existing_cui_name': 'ACD gene',\n",
       "  'existing_cui_desc': '[CLS] AC ##D gene [unused3] ( Ana ##tom ##ical Structure : T ##EL ##OM ##ER ##E PR ##OT ##EI ##N T ##PP ##1 ; ad ##ren ##oc ##ort ##ical d ##ys ##p ##lasia ho ##mo ##log ; AC ##D Gene ; Ad ##ren ##oc ##ort ##ical D ##ys ##p ##lasia Ho ##mo ##log ( Mouse ) Gene ; P ##OT ##1 - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N 1 ; P ##OT ##1 - AND T ##IN ##2 - OR ##GA ##NI ##Z ##ING PR ##OT ##EI ##N ; P ##OT ##1 and T ##IN ##2 organizing protein ; AC ##D , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; Tin ##t ##1 ; T ##IN ##2 interacting protein 1 [SEP]',\n",
       "  'our_bi_cui': 'C1080020',\n",
       "  'our_bi_cui_name': 'Lopa',\n",
       "  'our_bi_cui_desc': '[CLS] Lo ##pa [unused3] ( E ##uka ##ryo ##te : lo ##pa ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27791169.33',\n",
       "  'test_set_idx': 16886,\n",
       "  'type': 'T017',\n",
       "  'name': 'BPH1',\n",
       "  'context': '[CLS] sa ##lic ##yl ##ic acid - and j ##as ##mon ##ic acid - signaling pathways in rice plants and con ##fers both anti ##xen ##osis and anti ##bio ##sis to Brown plant ##hop ##per . We further demonstrated that the eight Brown plant ##hop ##per - resistance genes that are cluster ##ed on chromosome 12 ##L , including the widely used [unused1] BP ##H1 [unused2] , are all ##eli ##c with each other . To honor the priority in the literature , we thus designated this lo ##cus as BP ##H1 / 9 These eight genes can be classified into four all ##elo ##type ##s , BP ##H1 / 9 - 1 , - 2 , - 7 , and - 9 These all ##elo ##type [SEP]',\n",
       "  'existing_cui': 'C0005001',\n",
       "  'existing_cui_name': 'Benign prostatic hypertrophy',\n",
       "  'existing_cui_desc': '[CLS] Ben ##ign pro ##static h ##yper ##tro ##phy [unused3] ( B ##iol ##og ##ic Fun ##ction , BP ##H , ben ##ign , ben ##ign pro ##static h ##yper ##tro ##phy , diagnosis : H ##yper ##tro ##phy - pro ##st . ben . ; ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static h ##yper - ben ##ign ; Ben ##ign Pro ##static H ##yper ##p ##lasia - BP ##H ; En ##lar ##ged Pro ##state ; H ##yper ##tro ##phy , Ben ##ign Pro ##static ; H ##yper ##tro ##phy ( ben ##ign ) of pro ##state ; Ben ##ign h ##yper ##tro ##phy of pro ##state ; BP ##H - ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static [SEP]',\n",
       "  'our_bi_cui': 'C2677154',\n",
       "  'our_bi_cui_name': 'BSPH1 gene',\n",
       "  'our_bi_cui_desc': '[CLS] BS ##P ##H1 gene [unused3] ( Ana ##tom ##ical Structure : bind ##er of sperm protein ho ##mo ##log 1 ; BS ##P , B ##O ##VI ##NE , H ##OM ##OL ##O ##G OF , 1 ; B ##IN ##DE ##R OF SP ##ER ##M PR ##OT ##EI ##N , B ##O ##VI ##NE , H ##OM ##OL ##O ##G OF , 1 ; E ##LS ##P ##B ##P ##2 ; b ##ov ##ine seminal plasma protein ho ##mo ##log 1 ; B ##O ##VI ##NE SE ##MI ##NA ##L P ##LA ##SM ##A PR ##OT ##EI ##N - L ##I ##KE 1 ; SE ##MI ##NA ##L P ##LA ##SM ##A PR ##OT ##EI ##N , B ##O ##VI ##NE , H ##OM ##OL [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '28243201.17',\n",
       "  'test_set_idx': 29659,\n",
       "  'type': 'T201',\n",
       "  'name': 'response',\n",
       "  'context': '[CLS] ##cu ##rrence . DNA met ##hyl ##ation has been suggested as one of the underlying mechanisms for re ##current disease and its contribution to the development of drug resistance remains to be clarified . This study aimed to determine the met ##hyl ##ation p ##hen ##otype in color ##ec ##tal cancer for identification of predict ##ive markers for ch ##em ##otherapy [unused1] response [unused2] . We performed DNA met ##hyl ##ation pro ##fi ##ling on 43 non - re ##current and five re ##current color ##ec ##tal cancer patients using the Il ##lum ##ina In ##fin ##ium Human ##M ##eth ##yla ##tion ##45 ##0 Be ##ad ##chi ##p ass ##ay . In addition , color ##ec ##tal cancer cells with different genetic backgrounds , response to [SEP]',\n",
       "  'existing_cui': 'C1704632',\n",
       "  'existing_cui_name': 'Disease Response',\n",
       "  'existing_cui_desc': '[CLS] Disease Response [unused3] ( Finding : Response ; response ) [SEP]',\n",
       "  'our_bi_cui': 'C0683154',\n",
       "  'our_bi_cui_name': 'drug response',\n",
       "  'our_bi_cui_desc': '[CLS] drug response [unused3] ( B ##iol ##og ##ic Fun ##ction : response to drug ; drug responses ; drugs response ) [SEP]',\n",
       "  'our_cross_cui': 'C0521982',\n",
       "  'our_cross_cui_name': 'Response to treatment',\n",
       "  'our_cross_cui_desc': '[CLS] Response to treatment [unused3] ( Clinical At ##tri ##but ##e , context - dependent category , finding , function , o ##bs ##er ##vable entity , situation : response to treatment ; response treatments ; The ##rap ##eu ##tic response ; response therapeutic ; The ##rap ##eu ##tic Response ; Finding related to therapeutic response ; successful treatment ; successful treatments ; The ##rap ##eu ##tic response , function ) [SEP]'},\n",
       " {'mention_id': '28273336.4',\n",
       "  'test_set_idx': 30871,\n",
       "  'type': 'T170',\n",
       "  'name': 'ImmunoCAP system',\n",
       "  'context': '[CLS] Question ##able diagnostic benefit of the commercially available panel of bee venom components For many years , only the major all ##er ##gen r ##A ##pi m 1 has been available on the [unused1] I ##mm ##uno ##CA ##P system [unused2] for routine diagnosis of bee venom all ##er ##gy . Now , there are five components available , and we aimed to detect the sensitivity and specific ##ity of r ##A ##pi m 1 , 2 , 3 , 5 , and 10 in B ##V - all ##ergic patients . We further evaluated the sensitivity of r ##A ##pi m 1 and 2 of an alternative platform and investigated possible differences in the se ##ns ##iti ##zation profile between mon ##ose ##ns ##iti ##zation [SEP]',\n",
       "  'existing_cui': 'C0026745',\n",
       "  'existing_cui_name': 'System , Multi-Hospital',\n",
       "  'existing_cui_desc': '[CLS] System , Multi - Hospital [unused3] ( Organization : Multi - Hospital Systems ; Multi Hospital Systems ; M ##U ##LT ##I H ##OS ##P S ##Y ##ST ##EM ##S ; System , Multi Hospital ; M ##U ##LT ##I ##H ##OS ##P S ##Y ##ST ##EM ##S ; Multi ##hos ##pit ##al systems ; M ##U ##LT ##I ##H ##OS ##PI ##TA ##L S ##Y ##ST ##EM ##S ; System , Multi ##hos ##pit ##al ; Multi ##hos ##pit ##al System ; Multi - Hospital System ; Systems , Multi - Hospital ; Multi ##hos ##pit ##al Systems ; S ##Y ##ST ##EM M ##U ##LT ##I H ##OS ##P ; Systems , Multi ##hos ##pit ##al ) [SEP]',\n",
       "  'our_bi_cui': 'C0025080',\n",
       "  'our_bi_cui_name': 'Medical Devices',\n",
       "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28299441.47',\n",
       "  'test_set_idx': 31686,\n",
       "  'type': 'T017',\n",
       "  'name': 'early genes',\n",
       "  'context': '[CLS] V ##v ##M ##Y ##B ##PA ##1 alter ##s the p ##hen ##yl ##p ##rop ##ano ##id pathway in tobacco floral organs , in a structure - specific fashion . We also report that a modest V ##v ##M ##Y ##B ##PA ##1 expression is sufficient to induce the expression of both pro ##ant ##ho ##cy ##ani ##din - specific and [unused1] early genes [unused2] of the p ##hen ##yl ##p ##rop ##ano ##id pathway . Consequently , pro ##ant ##ho ##cy ##ani ##din ##s and ch ##lor ##ogenic acids are induced or de no ##vo s ##ynth ##eti ##sed in floral limbs , tubes and s ##tam ##ens . Other p ##hen ##yl ##p ##rop ##ano ##id branches are con ##verse ##ly induced or depleted [SEP]',\n",
       "  'existing_cui': 'C0013458',\n",
       "  'existing_cui_name': 'Early Gene Transcription',\n",
       "  'existing_cui_desc': '[CLS] Early Gene Trans ##cription [unused3] ( B ##iol ##og ##ic Fun ##ction : Trans ##cription , Early Gene ; Gene Trans ##cription , Early ) [SEP]',\n",
       "  'our_bi_cui': 'C0013458',\n",
       "  'our_bi_cui_name': 'Early Gene Transcription',\n",
       "  'our_bi_cui_desc': '[CLS] Early Gene Trans ##cription [unused3] ( B ##iol ##og ##ic Fun ##ction : Trans ##cription , Early Gene ; Gene Trans ##cription , Early ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27786291.17',\n",
       "  'test_set_idx': 16751,\n",
       "  'type': 'T017',\n",
       "  'name': 'ctxA/B',\n",
       "  'context': '[CLS] ##s and pan ##de ##mic disease . However , a number of questions remain about long - term survival and evolution of V . ch ##ole ##rae strains within these aquatic environmental reservoirs . Through monitoring of the Haitian aquatic environment following the 2010 ch ##ole ##ra epidemic , we isolated two novel non - to ##xi ##genic ( [unused1] c ##t ##x ##A / B [unused2] - negative ) V ##ib ##rio ch ##ole ##rae O ##1 . These two is ##olate ##s underwent whole - genome se ##quencing and were investigated through comparative g ##eno ##mic ##s and Bay ##esi ##an coal ##es ##cent analysis . These is ##olate ##s cluster in the evolutionary tree with strains responsible for clinical ch ##ole ##ra , [SEP]',\n",
       "  'existing_cui': 'C0412669',\n",
       "  'existing_cui_name': 'Computerized tomography , bone density study',\n",
       "  'existing_cui_desc': '[CLS] Computer ##ized to ##mo ##graphy , bone density study [unused3] ( Health Care Act ##ivity , Q ##CT , procedure : computer ##ized to ##mo ##graphy bone den ##si ##tom ##et ##ry ; CT bone density ; quantitative com ##puted to ##mo ##graphy ; com ##puted to ##mo ##graphy bone density study ; Q ##uant ##itative com ##puted to ##mo ##graphy studies ; bone density studies com ##puted to ##mo ##graphy ; Computer ##ised to ##mo ##graphy , bone density study ; Q ##uant ##itative CT studies ) [SEP]',\n",
       "  'our_bi_cui': 'C0010868',\n",
       "  'our_bi_cui_name': 'Cytotoxin',\n",
       "  'our_bi_cui_desc': '[CLS] Cy ##to ##to ##xin [unused3] ( Chemical , substance : Cy ##to ##to ##xi ##c substance ; c ##yt ##oto ##xi ##c substances ; Cy ##to ##to ##xi ##c Agents ; c ##yt ##oto ##xi ##c substance ; c ##yt ##oto ##xin ; Cy ##to ##to ##xin ##s ; c ##yt ##oto ##xin ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '28197156.32',\n",
       "  'test_set_idx': 28102,\n",
       "  'type': 'T017',\n",
       "  'name': 'DTH8',\n",
       "  'context': '[CLS] analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , Carbon As ##si ##mi ##lation Rate 8 is identical to [unused1] D ##TH ##8 [unused2] / G ##h ##d ##8 / L ##HD ##1 , which was reported to control rice flowering date . The increase of A is largely due to an increase of R ##u ##B ##P regeneration rate via increased leaf nitrogen content , and partially explained by reduced s ##tom ##ata ##l limitation via increased s ##tom ##ata ##l conduct ##ance relative [SEP]',\n",
       "  'existing_cui': 'C0020522',\n",
       "  'existing_cui_name': 'Delayed Hypersensitivity',\n",
       "  'existing_cui_desc': '[CLS] Del ##ay ##ed H ##yper ##sen ##si ##ti ##vity [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : h ##yper ##sen ##si ##ti ##vity type i ##v ; delayed h ##yper ##sen ##si ##ti ##vity reaction ; H ##yper ##sen ##si ##ti ##vi ##ties , Tu ##ber ##cu ##lin - Type ; delayed h ##yper ##sen ##si ##ti ##vity ; Tu ##ber ##cu ##lin Type H ##yper ##sen ##si ##ti ##vity ; Cell - mediated im ##mu ##nological reaction ; Del ##ay ##ed type h ##yper ##sen ##si ##ti ##vity ; type i ##v h ##yper ##sen ##si ##ti ##vity ; Cell - mediated im ##mu ##nological react ; H ##yper ##sen ##si ##ti ##vi ##ties , Type IV ; type IV h ##yper [SEP]',\n",
       "  'our_bi_cui': 'C1413965',\n",
       "  'our_bi_cui_name': 'DHX8 gene',\n",
       "  'our_bi_cui_desc': '[CLS] D ##H ##X ##8 gene [unused3] ( Ana ##tom ##ical Structure : DE ##A ##H B ##OX P ##OL ##YP ##EP ##TI ##DE 8 ; PR ##P ##22 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; DE ##A ##H - box he ##lica ##se 8 ; PR ##P ##22 ; DE ##AD / H B ##OX 8 ; RNA H ##EL ##IC ##AS ##E 1 ; PR ##P ##F ##22 ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '28454015.20',\n",
       "  'test_set_idx': 36521,\n",
       "  'type': 'T170',\n",
       "  'name': 'health - risk based air quality index',\n",
       "  'context': '[CLS] ) at both 2014 and 2015 . PM ##2 . 5 is typically the major poll ##uta ##nt , but oz ##one pollution can be significant during summer . Furthermore , as the commonly used air quality index neglect ##s the mutual health effects from multiple poll ##uta ##nts , we introduced the aggregate air quality index and [unused1] health - risk based air quality index [unused2] to evaluate the health risks . Results show that based on health - risk based air quality index , the current air quality index system likely significantly under ##est ##imate the health risks of air pollution , highlighting that the general public may need strict ##er health protection measures . The population - weighted two - year average health [SEP]',\n",
       "  'existing_cui': 'C1268941',\n",
       "  'existing_cui_name': 'Health risks education',\n",
       "  'existing_cui_desc': '[CLS] Health risks education [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Counsel ##ing regarding health risks ; Ad ##vice about health risks ; Counsel ##ling regarding health risks ; Education regarding health risks ) [SEP]',\n",
       "  'our_bi_cui': 'C3494320',\n",
       "  'our_bi_cui_name': 'Health Impact Assessment',\n",
       "  'our_bi_cui_desc': '[CLS] Health Impact Assessment [unused3] ( Health Care Act ##ivity : Impact Assessment ##s , Health ; Impact Assessment , Health ; Health Impact Assessment ##s ; Assessment ##s , Health Impact ; Assessment , Health Impact ) [SEP]',\n",
       "  'our_cross_cui': 'C0918012',\n",
       "  'our_cross_cui_name': 'Index',\n",
       "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
       " {'mention_id': '28077286.50',\n",
       "  'test_set_idx': 25100,\n",
       "  'type': 'T103',\n",
       "  'name': 'MeHg',\n",
       "  'context': '[CLS] Me ##H ##g dose of 3 . 2 μ ##g H ##g g ( - 1 ) egg , and a vehicle control ( water ) . No adverse effects of in o ##vo Me ##H ##g treatment were detected on courts ##hip song quality or on mating behavior in experimental males at sexually maturity which would suggest that o ##bs ##er ##vable ne ##uro ##be ##ha ##vior ##al effects of [unused1] Me ##H ##g [unused2] exposure may depend on the timing of exposure during offspring development . However , ne ##uro ##ana ##tom ##ical analysis indicated an increase in te ##len ##ce ##pha ##lon volume with increased Me ##H ##g concentrations which may suggest a prolonged inflammatory response in this region of the brain . [SEP]',\n",
       "  'existing_cui': 'C0228520',\n",
       "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
       "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
       "  'our_bi_cui': 'C0025424',\n",
       "  'our_bi_cui_name': 'Mercury',\n",
       "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
       "  'our_cross_cui': 'C0025794',\n",
       "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
       "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
       " {'mention_id': '28471040.13',\n",
       "  'test_set_idx': 37127,\n",
       "  'type': 'T103',\n",
       "  'name': 'poly ( lactic-co-glycolic acid ) -1,2 distearoyl-glycerol-3-phospho-ethanolamine-N [ methoxy ( lipid - polyethylene glycol ) -2000 ] ammonium salt',\n",
       "  'context': '[CLS] drug , far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid for treatment of g ##lio ##blast ##oma . Far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid - loaded [unused1] p ##oly ( la ##ctic - co - g ##ly ##co ##lic acid ) - 1 , 2 di ##ste ##aro ##yl - g ##ly ##cer ##ol - 3 - p ##hos ##ph ##o - ethanol ##amine - N [ met ##ho ##xy ( lip ##id - p ##oly ##eth ##yle ##ne g ##ly ##co ##l ) - 2000 ] am ##mon ##ium salt [unused2] ( P ##L ##GA - DS ##P ##E - P ##EG ) with or without 1 , 2 - di ##ole ##oy ##l - 3 - trim ##eth ##yla ##mm [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C3849743',\n",
       "  'our_bi_cui_name': 'polyethylene glycol-poly',\n",
       "  'our_bi_cui_desc': '[CLS] p ##oly ##eth ##yle ##ne g ##ly ##co ##l - p ##oly [unused3] ( Chemical , la ##ct ##ide - co - g ##ly ##co ##lide , la ##ct ##ide - co - g ##ly ##co ##lide : P ##EG - L ##G ; P ##EG - P ##L ##GA ; p ##oly ( et ##hyl ##ene g ##ly ##co ##l ) - block - la ##ct ##ide - g ##ly ##co ##lide ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28424683.50',\n",
       "  'test_set_idx': 35428,\n",
       "  'type': 'T033',\n",
       "  'name': 'decline in Natural killer cell numbers',\n",
       "  'context': '[CLS] of Natural killer cells , whereas Natural killer cells from mice with no tumor continue expanding Natural killer cells and retain their c ##yt ##oto ##xi ##city . In addition , den ##dr ##itic cells in contrast to O ##Cs are found to promote faster expansion of residual T cells within pu ##rified Natural killer cells resulting in the [unused1] decline in Natural killer cell numbers [unused2] from healthy individuals . Ad ##dition of anti - CD ##3 m ##A ##b in ##hibit ##s T cell proliferation while enhancing Natural killer cell expansion ; however , expanding Natural killer cells have lower c ##yt ##oto ##xi ##city but higher secret ##ion of IF ##N - γ . Ex ##pan ##sion and functional activation of super - [SEP]',\n",
       "  'existing_cui': 'C1855767',\n",
       "  'existing_cui_name': 'Reduced natural killer cell number',\n",
       "  'existing_cui_desc': '[CLS] Red ##uce ##d natural killer cell number [unused3] ( Finding : Red ##uce ##d number of natural killer cells ) [SEP]',\n",
       "  'our_bi_cui': 'C1855767',\n",
       "  'our_bi_cui_name': 'Reduced natural killer cell number',\n",
       "  'our_bi_cui_desc': '[CLS] Red ##uce ##d natural killer cell number [unused3] ( Finding : Red ##uce ##d number of natural killer cells ) [SEP]',\n",
       "  'our_cross_cui': 'C2363838',\n",
       "  'our_cross_cui_name': 'Natural killer cell count decreased',\n",
       "  'our_cross_cui_desc': '[CLS] Natural killer cell count decreased [unused3] ( Finding : N ##K cell count decreased ) [SEP]'},\n",
       " {'mention_id': '28234635.63',\n",
       "  'test_set_idx': 29231,\n",
       "  'type': 'T103',\n",
       "  'name': 'LXR',\n",
       "  'context': '[CLS] inter ##le ##uki ##n - 6 and tumor ne ##c ##rosis factor , repression of FX ##R and its canal ##icular bi ##le transport ##er target gene RNA expression , including ABC ##B ##4 and ABC ##B ##11 as well as decreased protein expression of ABC ##B ##11 and ABC ##B ##4 . Furthermore , up ##re ##gu ##lation of [unused1] L ##X ##R [unused2] and ABC ##G ##5 / 8 RNA expression was suppressed in patients with portal inflammation . Current parent ##eral nutrition , increased serum levels of plant s ##tero ##ls s ##ti ##gma ##ster ##ol , a ##ven ##aster ##ol , and sit ##ost ##ero ##l along with serum c ##it ##ru ##llin ##e , a marker of enter ##oc ##yte mass [SEP]',\n",
       "  'existing_cui': 'C4288814',\n",
       "  'existing_cui_name': 'Liver X Receptor-Like Family',\n",
       "  'existing_cui_desc': '[CLS] Live ##r X Re ##ceptor - Like Family [unused3] ( Chemical : L ##X ##R Family ; Nuclear Re ##ceptor Sub ##family 1 Group H ) [SEP]',\n",
       "  'our_bi_cui': 'C1366515',\n",
       "  'our_bi_cui_name': 'LEPR gene',\n",
       "  'our_bi_cui_desc': '[CLS] L ##EP ##R gene [unused3] ( Ana ##tom ##ical Structure : O ##BR ; CD ##29 ##5 ; L ##EP ##R Gene ; Le ##pt ##in Re ##ceptor Gene ; le ##pt ##in receptor ; L ##EP ##TI ##N R ##EC ##EP ##TO ##R ) [SEP]',\n",
       "  'our_cross_cui': 'C4277606',\n",
       "  'our_cross_cui_name': 'Liver X Receptors',\n",
       "  'our_cross_cui_desc': '[CLS] Live ##r X Re ##ceptor ##s [unused3] ( Chemical : O ##xy ##ster ##ol Re ##ceptor ##s , Nuclear ; Live ##r X Re ##ceptor ; Nuclear O ##xy ##ster ##ol Re ##ceptor ##s ; Live ##r X Re ##ceptor ##s [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '27587730.18',\n",
       "  'test_set_idx': 10757,\n",
       "  'type': 'T103',\n",
       "  'name': 'gga-miR-21',\n",
       "  'context': '[CLS] expressed in chicken pre - ad ##ip ##ocytes , but its role is unclear . The present study investigated the role of g ##ga - mi ##R - 21 in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the [unused1] g ##ga - mi ##R - 21 [unused2] mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga - mi ##R - 21 inhibitor enhanced pre - ad ##ip ##oc ##yte proliferation . The subsequent investigation identified K ##rup ##pel - like factor 5 m ##RNA as a target of g ##ga - mi ##R - 21 . The [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C2825314',\n",
       "  'our_bi_cui_name': 'MicroRNA Gene',\n",
       "  'our_bi_cui_desc': '[CLS] Micro ##RNA Gene [unused3] ( Ana ##tom ##ical Structure : Micro RNA Gene ; Mi ##RNA Gene ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '28294559.14',\n",
       "  'test_set_idx': 31470,\n",
       "  'type': 'T204',\n",
       "  'name': 'chimeric mice',\n",
       "  'context': '[CLS] role in liver regeneration after partial he ##pate ##ct ##omy in mice Essential ##s Reg ##ener ##ation role of C - type le ##ct ##in receptor - 2 after 70 % he ##pate ##ct ##omy ( HP ##x ) was investigated . Wild - type or C - type le ##ct ##in receptor - 2 deleted from plate ##lets of [unused1] ch ##ime ##ric mice [unused2] ( fl ##KO ) underwent HP ##x . The liver / body weight ratio was significantly lower in the fl ##KO than in the wild - type . C - type le ##ct ##in receptor - 2 plays an essential role in liver regeneration after HP ##x . Background and aim The aim of the present study was to investigate [SEP]',\n",
       "  'existing_cui': 'C0676831',\n",
       "  'existing_cui_name': 'basiliximab',\n",
       "  'existing_cui_desc': '[CLS] b ##asi ##lix ##ima ##b [unused3] ( Chemical , Si ##mu ##lect , medication , product , substance : Basil ##ix ##ima ##b ; b ##asi ##lix ##ima ##b [ Chemical / In ##g ##red ##ient ] ; ch ##ime ##ric mouse - human anti ##CD ##25 ; I ##g gamma - 1 chain C region ; BA ##SI ##L ##IX ##IM ##AB ) [SEP]',\n",
       "  'our_bi_cui': 'C0025936',\n",
       "  'our_bi_cui_name': 'Mice , Transgenic',\n",
       "  'our_bi_cui_desc': '[CLS] Mi ##ce , Trans ##genic [unused3] ( E ##uka ##ryo ##te : Mouse , Trans ##genic ; mouse trans ##genic ##s ; Trans ##genic Mi ##ce ; mice trans ##genic ; Trans ##genic Mouse ; trans ##genic mice ; Trans ##genic mice ; trans ##genic mouse ) [SEP]',\n",
       "  'our_cross_cui': 'C0025929',\n",
       "  'our_cross_cui_name': 'Laboratory mice',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory mice [unused3] ( E ##uka ##ryo ##te , organism : Mouse , Laboratory ; Mouse , laboratory ; Laboratory Mi ##ce ; Mi ##ce , Laboratory ; mouse ; mice ; Laboratory Mouse ; Laboratory mouse ; laboratory mouse ) [SEP]'},\n",
       " {'mention_id': '27832581.19',\n",
       "  'test_set_idx': 18729,\n",
       "  'type': 'T168',\n",
       "  'name': 'maintenance control diet',\n",
       "  'context': '[CLS] development depend on the predominant fatty acid type in the diet . In a combined in v ##ivo - in v ##it ##ro b ##ov ##ine model , two groups of cows ( n = 3 in each group ) were fed with three diet ##s consecutive ##ly ( 4 weeks feeding for each ) : ( 1 ) a [unused1] maintenance control diet [unused2] ; ( 2 ) a high - star ##ch diet rich in saturated fat ; and ( 3 ) a high - star ##ch diet rich in o ##me ##ga - 3 un ##sat ##ura ##ted fat . Two feeding sequences were used to test for carry - over effects : Group A was fed control diet , SAT ##1 and [SEP]',\n",
       "  'existing_cui': 'C2930544',\n",
       "  'existing_cui_name': 'Low-Calorie Diet',\n",
       "  'existing_cui_desc': '[CLS] Low - Cal ##ori ##e Diet [unused3] ( Finding , finding : Ki ##loc ##alo ##rie control diet ; Cal ##ori ##e controlled diet ; Diet , Low - Cal ##ori ##e ; ca ##lor ##ic restriction ; ca ##lor ##ic restrictions ; low ca ##lor ##ie diet ; Low - Cal ##ori ##e Diet ##s ; Low - ca ##lor ##ie diet ; Diet ##s , Low - Cal ##ori ##e ; ca ##lor ##ie diet ##s low ; Low ca ##lor ##ie diet ; Low energy diet ; ca ##lor ##ie restricted diet ; Low ca ##lor ##ic diet ; ca ##lor ##ie controlled diet ; Low Cal ##ori ##e Diet ; Cal ##ori ##e restricted diet ) [SEP]',\n",
       "  'our_bi_cui': 'C0452286',\n",
       "  'our_bi_cui_name': 'Fat controlled diet',\n",
       "  'our_bi_cui_desc': '[CLS] Fat controlled diet [unused3] ( Health Care Act ##ivity , finding : Mo ##dified fat diet ; fat controlled diet ) [SEP]',\n",
       "  'our_cross_cui': 'C0012155',\n",
       "  'our_cross_cui_name': 'Diet',\n",
       "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
       " {'mention_id': '27388786.23',\n",
       "  'test_set_idx': 4446,\n",
       "  'type': 'T098',\n",
       "  'name': 'signers',\n",
       "  'context': \"[CLS] during sign production remains unclear . Here we directly contrast lateral ##ization strength of covert versus over ##t signing during p ##hon ##ological and semantic flu ##ency tasks . To address the possibility that hearing native sign ##ers ' elevated lateral ##ization in ##dices were due to performing a task in their less dominant language , here we test deaf native [unused1] sign ##ers [unused2] , whose dominant language is British Sign Language . Sign ##ers were more strongly left lateral ##ized for over ##t than covert sign generation . However , the strength of lateral ##ization was not correlated with the amount of time producing movements of the right hand . Co ##mp ##aris ##ons with previous data from hearing native English speakers suggest stronger [SEP]\",\n",
       "  'existing_cui': 'C0035127',\n",
       "  'existing_cui_name': 'Cumulative Trauma Disorders',\n",
       "  'existing_cui_desc': '[CLS] C ##um ##ula ##tive T ##ra ##uma Di ##sor ##ders [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , event : Over ##use S ##yn ##drome ; Rep ##eti ##tive St ##ress In ##ju ##ries ; Di ##sor ##ders , C ##um ##ula ##tive T ##ra ##uma ; RS ##I - Rep ##eti ##tive strain injury ; R ##EP ##ET M ##OT ##ION D ##IS ; repetitive strain injury ; St ##rain In ##ju ##ry , Rep ##eti ##tive ; T ##ra ##uma Di ##sor ##ders , C ##um ##ula ##tive ; Rep ##eti ##tive Motion Di ##sor ##ders ; In ##ju ##ries , Rep ##eti ##tive St ##ress ; Motion Di ##sor ##ders , Rep ##eti ##tive ; cumulative trauma disorders [SEP]',\n",
       "  'our_bi_cui': 'C0336303',\n",
       "  'our_bi_cui_name': 'Sign-painter',\n",
       "  'our_bi_cui_desc': '[CLS] Sign - painter [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Sign ##writer ) [SEP]',\n",
       "  'our_cross_cui': 'C1257890',\n",
       "  'our_cross_cui_name': 'Population Group',\n",
       "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
       " {'mention_id': '28197156.33',\n",
       "  'test_set_idx': 28103,\n",
       "  'type': 'T017',\n",
       "  'name': 'Ghd8',\n",
       "  'context': '[CLS] in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , Carbon As ##si ##mi ##lation Rate 8 is identical to D ##TH ##8 / [unused1] G ##h ##d ##8 [unused2] / L ##HD ##1 , which was reported to control rice flowering date . The increase of A is largely due to an increase of R ##u ##B ##P regeneration rate via increased leaf nitrogen content , and partially explained by reduced s ##tom ##ata ##l limitation via increased s ##tom ##ata ##l conduct ##ance relative to A . This [SEP]',\n",
       "  'existing_cui': 'C0035439',\n",
       "  'existing_cui_name': 'Rheumatic Heart Disease',\n",
       "  'existing_cui_desc': '[CLS] R ##he ##umatic Heart Disease [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : R ##he ##umatic Heart Disease [ Disease / Finding ] ; heart disease r ##he ##umatic fever ; card ##itis r ##he ##umatic ; Heart Disease , R ##he ##umatic ; R ##he ##umatic card ##itis ; R ##he ##umatic Heart Disease ##s ; Heart Disease ##s , R ##he ##umatic ; R ##he ##umatic heart disease un ##sp ##ec ##ified ; Disease ##s , R ##he ##umatic Heart ; r ##he ##uma ##to ##id heart disease ; disease fever heart r ##he ##umatic ; R ##he ##umatic heart disease , un ##sp ##ec ##ified ; heart disease r ##he ##uma ##to ##id ; r ##he ##umatic ; [SEP]',\n",
       "  'our_bi_cui': 'C3536868',\n",
       "  'our_bi_cui_name': 'Glyceraldehyde-3-phosphate dehydrogenase',\n",
       "  'our_bi_cui_desc': '[CLS] G ##ly ##cer ##ald ##eh ##yd ##e - 3 - phosphate de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , substance : g ##ly ##cer ##ald ##eh ##yd ##e 3 phosphate de ##hy ##dr ##ogen ##ase ; A ##ging - Associated Gene 9 Pro ##tein ; P ##ept ##idy ##l - Cy ##stein ##e S - Ni ##tro ##sy ##lase GA ##PD ##H ; trio ##se ##ph ##os ##phate de ##hy ##dr ##ogen ##ase ; G ##ly ##cer ##ald ##eh ##yd ##e 3 phosphate de ##hy ##dr ##ogen ##ase ; EC 1 . 2 . 1 . 12 ; G ##ly ##cer ##ald ##eh ##yd ##e - 3 - Ph ##os ##phate De ##hy ##dr ##ogen ##ase ; Trio ##se ##ph ##os ##phate de ##hy ##dr [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27545500.22',\n",
       "  'test_set_idx': 9998,\n",
       "  'type': 'T103',\n",
       "  'name': '16-aldehyde tanshinone I',\n",
       "  'context': '[CLS] synthesized and b ##act ##eri ##ost ##atic activity was explored . In addition , s ##yne ##rg ##istic or add ##itive activity between 16 - al ##de ##hy ##de tan ##shin ##one I and amino ##gly ##cos ##ide anti ##biotics or β - la ##ct ##am anti ##biotics in v ##it ##ro was identified . Moreover , [unused1] 16 - al ##de ##hy ##de tan ##shin ##one I [unused2] was documented to au ##gment clearance of s ##tre ##pt ##omy ##cin and am ##pic ##ill ##in against S . au ##reus in a m ##uri ##ne infection model . Primary me ##chan ##istic insight indicated that 16 - al ##de ##hy ##de tan ##shin ##one I could damage the bacterial cell membrane , leading to accumulation [SEP]',\n",
       "  'existing_cui': 'C0075810',\n",
       "  'existing_cui_name': 'tanshinone',\n",
       "  'existing_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
       "  'our_bi_cui': 'C0075810',\n",
       "  'our_bi_cui_name': 'tanshinone',\n",
       "  'our_bi_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27445383.13',\n",
       "  'test_set_idx': 6021,\n",
       "  'type': 'T007',\n",
       "  'name': 'D7632',\n",
       "  'context': \"[CLS] Associated Legion ##ella p ##ne ##um ##op ##hil ##a Is ##olate ##s We report here the complete genome sequences of three Legion ##ella p ##ne ##um ##op ##hil ##a is ##olate ##s that are associated with a Legion ##naire ##s ' disease outbreak in New York in 2012 . Two clinical is ##olate ##s ( D ##7 ##6 ##30 and [unused1] D ##7 ##6 ##32 [unused2] ) and one environmental is ##olate ( D ##7 ##6 ##31 ) were recovered from this outbreak . A single is ##olate - specific v ##ir ##ule ##nce gene was found in D ##7 ##6 ##32 . These is ##olate ##s were included in a large study evaluating the g ##eno ##mic resolution of various bio ##in ##formatics approaches for [SEP]\",\n",
       "  'existing_cui': 'C1826211',\n",
       "  'existing_cui_name': 'MIR632 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##6 ##32 gene [unused3] ( Ana ##tom ##ical Structure : h ##sa - mi ##r - 63 ##2 ; micro ##RNA 63 ##2 ) [SEP]',\n",
       "  'our_bi_cui': 'C0038410',\n",
       "  'our_bi_cui_name': 'Streptococcus pneumoniae',\n",
       "  'our_bi_cui_desc': '[CLS] St ##re ##pt ##oc ##oc ##cus pneumonia ##e [unused3] ( Ba ##cter ##ium , organism : P ##ne ##um ##oc ##oc ##cus ; s . pneumonia ##e ; Micro ##co ##cc ##us pneumonia ##e ; ST ##RE ##P ##TO ##CO ##CC ##US P ##NE ##UM ##ON ##IA ##E ; p ##ne ##um ##oc ##oc ##cal ; s ##tre ##pt ##oc ##oc ##cus pneumonia ##e ; St ##re ##pt ##oc ##oc ##cus ( Di ##p ##loc ##oc ##cus ) pneumonia ##e ; St ##re ##pt ##oc ##oc ##cus pneumonia ##e ( Klein 1884 ) Chester 1901 ; ST ##RE ##P P ##NE ##UM ##ON ##IA ##E ; s ##tre ##pt ##oc ##oc ##cus pneumonia ##e bacteria ; p ##ne ##um ##oc ##oc ##cus ; dip ##loc ##oc [SEP]',\n",
       "  'our_cross_cui': 'C0023238',\n",
       "  'our_cross_cui_name': 'Legionella pneumophila',\n",
       "  'our_cross_cui_desc': '[CLS] Legion ##ella p ##ne ##um ##op ##hil ##a [unused3] ( Ba ##cter ##ium , organism : leg ##ione ##lla p ##ne ##um ##op ##hil ##a ; leg ##ione ##lla p ##ne ##um ##op ##hil ##ia ; P ##ne ##um ##op ##hil ##a ; L ##EG ##ION ##EL ##LA P ##NE ##UM ##OP ##H ##IL ##A ; Legion ##ella p ##ne ##um ##op ##hil ##a B ##ren ##ner et al . 1979 ) [SEP]'},\n",
       " {'mention_id': '27601292.27',\n",
       "  'test_set_idx': 11202,\n",
       "  'type': 'T082',\n",
       "  'name': 'Groningen',\n",
       "  'context': '[CLS] via reduced clearance of the drug , resulting in higher v ##ori ##cona ##zo ##le t ##rough concentrations . To investigate prospective ##ly the influence of inflammation on v ##ori ##cona ##zo ##le metabolism and v ##ori ##cona ##zo ##le t ##rough con ##cent ratio n ##s . A prospective observation ##al study was performed at the University Medical Center [unused1] G ##ron ##ingen [unused2] . Pat ##ients were eligible for inclusion if they were ≥ 18 years old and treated with v ##ori ##cona ##zo ##le . V ##ori ##cona ##zo ##le and v ##ori ##cona ##zo ##le - N - oxide concentrations were determined in discarded blood samples . To determine the degree of inflammation , C - reactive protein concentrations were used . [SEP]',\n",
       "  'existing_cui': 'C1297262',\n",
       "  'existing_cui_name': 'Groningen horse',\n",
       "  'existing_cui_desc': '[CLS] G ##ron ##ingen horse [unused3] ( E ##uka ##ryo ##te , organism : G ##ron ##ingen horse breed ) [SEP]',\n",
       "  'our_bi_cui': 'C1297262',\n",
       "  'our_bi_cui_name': 'Groningen horse',\n",
       "  'our_bi_cui_desc': '[CLS] G ##ron ##ingen horse [unused3] ( E ##uka ##ryo ##te , organism : G ##ron ##ingen horse breed ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '28125734.1',\n",
       "  'test_set_idx': 26155,\n",
       "  'type': 'T103',\n",
       "  'name': 'MiR-21-5p',\n",
       "  'context': \"[CLS] I ##dent ##ification of [unused1] Mi ##R - 21 - 5 ##p [unused2] as a Fun ##ctional Reg ##ulator of Me ##so ##the ##lin Express ##ion Using Micro ##RNA Capt ##ure A ##ffin ##ity Co ##up ##led with Next Generation Se ##quencing Micro ##RNA ##s are small non - coding RNA ##s that regulate m ##RNA expression mainly by si ##len ##cing target trans ##cripts via binding to mi ##RNA recognition elements in the 3 ' un ##tra ##ns ##lated region . The identification of b ##ona fi ##de targets is challenging for researchers working on the functional aspect of Micro ##RNA ##s . Recently , we developed a method ( mi ##R - CA ##TC ##H ) based on bio ##tin ##yla ##ted DNA anti [SEP]\",\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1999986',\n",
       "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '27695680.17',\n",
       "  'test_set_idx': 14384,\n",
       "  'type': 'T033',\n",
       "  'name': 'non-FI-DELIS',\n",
       "  'context': '[CLS] ##OT ##S Ex ##pan ##sion through Local Initiative ##s to Stop T ##B areas , then compared the difference between the case not ##ification rates of the intervention year and the previous year in the for Inn ##ova ##tive D ##OT ##S Ex ##pan ##sion through Local Initiative ##s to Stop T ##B areas with those in the [unused1] non - F ##I - DE ##L ##IS [unused2] areas within the province . Results : There was an increase in the C ##NR in the intervention year compared with the previous year for all the project sites . The differences between the C ##NR in the intervention year and the previous year ranged from 6 . 4 to 31 . 1 per 100 000 population in [SEP]',\n",
       "  'existing_cui': 'C1121292',\n",
       "  'existing_cui_name': '5-Fluoroindole-3-acetic acid',\n",
       "  'existing_cui_desc': '[CLS] 5 - F ##lu ##oro ##ind ##ole - 3 - ace ##tic acid [unused3] ( Chemical : 5 - F ##I - AA ) [SEP]',\n",
       "  'our_bi_cui': 'C0282574',\n",
       "  'our_bi_cui_name': 'Intellectual Property',\n",
       "  'our_bi_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27760149.1',\n",
       "  'test_set_idx': 15788,\n",
       "  'type': 'T170',\n",
       "  'name': 'BEST',\n",
       "  'context': '[CLS] [unused1] B ##ES ##T [unused2] : Next - Generation B ##io ##medical En ##ti ##ty Search Too ##l for Knowledge Discovery from B ##io ##medical Literature As the volume of publications rapidly increases , searching for relevant information from the literature becomes more challenging . To complement standard search engines such as Pub ##M ##ed , it is desirable to have an advanced search tool that directly returns relevant bio ##medical entities such as targets , drugs , and mutations rather than a long list of articles . Some existing tools submit a que ##ry to Pub ##M ##ed and process retrieved abstract ##s to extract information at que ##ry time , resulting in a slow response time and limited coverage of only a fraction of [SEP]',\n",
       "  'existing_cui': 'C1826421',\n",
       "  'existing_cui_name': 'BEST1 gene',\n",
       "  'existing_cui_desc': '[CLS] B ##ES ##T ##1 gene [unused3] ( Ana ##tom ##ical Structure : B ##ES ##TR ##OP ##H ##IN 1 ; B ##ES ##T ; Best disease ; R ##P ##50 ; T ##U ##15 ##B ; B ##MD ; V ##MD ##2 GE ##NE ; best ##rop ##hin 1 ) [SEP]',\n",
       "  'our_bi_cui': 'C2348167',\n",
       "  'our_bi_cui_name': 'Search Engine',\n",
       "  'our_bi_cui_desc': '[CLS] Search Engine [unused3] ( Intel ##lect ##ual Product : Search Program ; Search engines ; Engine , Search ; Search Too ##l ; Search Engine ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28158248.35',\n",
       "  'test_set_idx': 27139,\n",
       "  'type': 'T170',\n",
       "  'name': 'ordinary differential equations',\n",
       "  'context': '[CLS] 7 of the 13 metabolic steps analyzed . Ad ##dition of information on en ##zy ##matic activities almost always improved the fitness of generalized add ##itive models built solely based on substrate concentrations . generalized add ##itive models were valid ##ated using experimental data that were not included when the model was built . In addition , a system of [unused1] ordinary differential equations [unused2] was developed to describe the instant ##aneous changes in meta ##bol ##ites as a function of the levels of en ##zy ##matic cat ##alytic activities . The results demonstrated the ability of the models to predict changes in the flux of meta ##bol ##ites in the Ju ##ven ##ile hormone pathway , and can be used in the future to design [SEP]',\n",
       "  'existing_cui': 'C0011906',\n",
       "  'existing_cui_name': 'Differential Diagnosis',\n",
       "  'existing_cui_desc': '[CLS] Different ##ial Di ##ag ##nosis [unused3] ( Health Care Act ##ivity , context ##ual qualifier , qualifier value : D ##IA ##G D ##IF ##F ##ER ##EN ##TI ##AL ; Di ##ag ##nose ##s , Different ##ial ; D ##IF ##F ##ER ##EN ##TI ##AL D ##IA ##G ; Di ##ag ##nosis , Different ##ial ; Different ##ial d ##x ; D ##IA ##G D ##IF ##F ##ER ; differential di ##ag ##nose ##s ; differential diagnosis ; Different ##ial diagnosis ( context ##ual qualifier ) ; Different ##ial Di ##ag ##nose ##s ; differential d ##x ; Different ##ial diagnosis ; D ##IF ##F ##ER D ##IA ##G ) [SEP]',\n",
       "  'our_bi_cui': 'C1705273',\n",
       "  'our_bi_cui_name': 'Mathematical Operator',\n",
       "  'our_bi_cui_desc': '[CLS] Mathematical Opera ##tor [unused3] ( Intel ##lect ##ual Product : Opera ##tor ; Fun ##ction ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28344199.22',\n",
       "  'test_set_idx': 32746,\n",
       "  'type': 'T017',\n",
       "  'name': 'CD14 ( + + ) CD16 ( - )',\n",
       "  'context': '[CLS] - slice multi ##det ##ector com ##puted to ##mo ##graphy in patients with stable an ##gin ##a p ##ector ##is . Method ##s and Results : We enrolled 65 patients with stable an ##gin ##a p ##ector ##is who underwent multi ##det ##ector com ##puted to ##mo ##graphy . Three mon ##oc ##yte subset ##s ( [unused1] CD ##14 ( + + ) CD ##16 ( - ) [unused2] , CD ##14 ( + + ) CD ##16 ( + ) , and CD ##14 ( + ) CD ##16 ( + ) ) and expression of To ##ll - like receptor 4 were measured by flow c ##yt ##ome ##try . In ##tra ##cor ##ona ##ry plaque ##s were assessed by 64 - slice multi [SEP]',\n",
       "  'existing_cui': 'C1367477',\n",
       "  'existing_cui_name': 'CD14 gene',\n",
       "  'existing_cui_desc': '[CLS] CD ##14 gene [unused3] ( Ana ##tom ##ical Structure : CD ##14 Mo ##le ##cule Gene ; M ##ON ##OC ##Y ##TE D ##IF ##F ##ER ##EN ##TI ##AT ##ION AN ##TI ##GE ##N CD ##14 ; CD ##14 Gene ; CD ##14 molecule ; M ##Y ##EL ##O ##ID CE ##LL - SP ##EC ##IF ##IC L ##E ##UC ##IN ##E - R ##IC ##H G ##L ##Y ##CO ##PR ##OT ##EI ##N ) [SEP]',\n",
       "  'our_bi_cui': 'C0108768',\n",
       "  'our_bi_cui_name': 'CD14 Antigen',\n",
       "  'our_bi_cui_desc': '[CLS] CD ##14 Anti ##gen [unused3] ( Chemical , substance : CD 01 ##4 AN ##TI ##GE ##NS ; Mon ##oc ##yte 2 ; CD ##14 receptor ; My ##elo ##id Cell - S ##pecific Le ##uc ##ine - Rich G ##ly ##co ##p ##rote ##in ; Anti ##gens , CD ##14 ; CD ##14 molecule ; R ##EC ##EP ##T L ##IP ##OP ##OL ##Y ##SA ##CC ##HA ##RI ##DE ; Anti ##gens , CD ##14 [ Chemical / In ##g ##red ##ient ] ; CD ##14 - C ##luster of differentiation anti ##gen 14 ; Le ##uk ##oc ##yte M ##3 ; My ##elo ##id 4 ; Li ##pop ##oly ##sa ##cc ##hari ##de Re ##ceptor ##s ; CD ##14 ; Li ##po ##gly ##can [SEP]',\n",
       "  'our_cross_cui': 'C0026473',\n",
       "  'our_cross_cui_name': 'Monocytes',\n",
       "  'our_cross_cui_desc': '[CLS] Mon ##ocytes [unused3] ( Ana ##tom ##ical Structure , cell : blood mon ##ocytes ; Blood mon ##ocytes ; Mon ##oc ##yte ; mon ##ocytes ; mon ##oc ##yte ; M ##ON ##OC ##Y ##TE ; mon ##oc ##ytic ) [SEP]'},\n",
       " {'mention_id': '28183116.7',\n",
       "  'test_set_idx': 27733,\n",
       "  'type': 'T170',\n",
       "  'name': 'paper',\n",
       "  'context': '[CLS] On the identity of the Pa ##lea ##rc ##tic species of the wolf spider genus < i > T ##re ##ba ##cos ##a < / i > ( Ara ##nea ##e : L ##y ##cos ##idae ) In this [unused1] paper [unused2] we propose T ##re ##ba ##cos ##a br ##un ##hes ##i Ville ##po ##ux , 2007 as a junior synonym of T ##re ##ba ##cos ##a euro ##pa ##ea S ##zine ##t ##á ##r & Ka ##n - c ##sal , 2007 based on the examination of specimens from all the localities from where those species are known . Il ##lus ##tration of the type species of the genus , T ##re ##ba ##cos ##a ma ##r ##xi ( Stone , 1890 ) and [SEP]',\n",
       "  'existing_cui': 'C0462999',\n",
       "  'existing_cui_name': 'Litmus paper',\n",
       "  'existing_cui_desc': '[CLS] Li ##t ##mus paper [unused3] ( Medical Devi ##ce , physical object : Li ##t ##mus Paper ; lit ##mus papers ; Re ##age ##nts , Clinical Chemistry , Rapid Test , pH , Strip ; IV ##D Test Re ##age ##nt / Kit ##s , Clinical Chemistry , Rapid Test , pH , Strip ; pH Strip In ##dic ##ators ; lit ##mus paper ) [SEP]',\n",
       "  'our_bi_cui': 'C0600659',\n",
       "  'our_bi_cui_name': 'Manuscripts',\n",
       "  'our_bi_cui_desc': '[CLS] Man ##us ##cripts [unused3] ( Intel ##lect ##ual Product : manuscript ; manuscripts ; Man ##us ##cript ) [SEP]',\n",
       "  'our_cross_cui': 'C1706852',\n",
       "  'our_cross_cui_name': 'Article',\n",
       "  'our_cross_cui_desc': '[CLS] Article [unused3] ( Intel ##lect ##ual Product ) [SEP]'},\n",
       " {'mention_id': '27932585.39',\n",
       "  'test_set_idx': 22266,\n",
       "  'type': 'T103',\n",
       "  'name': 'TYW3',\n",
       "  'context': '[CLS] ##tate and his ##ti ##dine , conserved in T ##Y ##W ##3 / Ta ##w ##3 , cluster to form the cat ##alytic center . These structural and sequence features indicate that T ##Y ##W ##3 / Ta ##w ##3 proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass ##ays combined with mass s ##pect ##rome ##try as well as l ##igan ##d dock ##ing and co ##fa ##ctor binding ass ##ays , we have identified the active site of [unused1] T ##Y ##W ##3 [unused2] and residues essential for co ##fa ##ctor binding and met ##hyl ##tra ##ns ##fer ##ase activity . [SEP]',\n",
       "  'existing_cui': 'C1823563',\n",
       "  'existing_cui_name': 'TYW3 gene',\n",
       "  'existing_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
       "  'our_bi_cui': 'C1823563',\n",
       "  'our_bi_cui_name': 'TYW3 gene',\n",
       "  'our_bi_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28442401.8',\n",
       "  'test_set_idx': 36180,\n",
       "  'type': 'T103',\n",
       "  'name': 'pseudokinase',\n",
       "  'context': '[CLS] T ##RI ##B ##3 down ##re ##gu ##lation enhance ##s do ##x ##or ##ubi ##cin - induced c ##yt ##oto ##xi ##city in gas ##tric cancer cells T ##RI ##B ##3 , which is a [unused1] pseudo ##kin ##ase [unused2] known to regulate multiple pro - survival pathways , appears to be a potential therapeutic target for the treatment of human tumors . However , its precise role in cancer is controversial , as T ##RI ##B ##3 protein levels have been associated with both good and poor pro ##gno ##sis in cancer patients . Here , we investigated the significance of T ##RI ##B ##3 expression in the survival of gas ##tric cancer cells exposed to anti ##can ##cer drugs . We found that the [SEP]',\n",
       "  'existing_cui': 'C3710669',\n",
       "  'existing_cui_name': 'ZED1 protein , Arabidopsis',\n",
       "  'existing_cui_desc': '[CLS] Z ##ED ##1 protein , Arab ##ido ##psis [unused3] ( Chemical : Z ##ED ##1 pseudo ##kin ##ase , Arab ##ido ##psis ) [SEP]',\n",
       "  'our_bi_cui': 'C0014442',\n",
       "  'our_bi_cui_name': 'Enzymes',\n",
       "  'our_bi_cui_desc': '[CLS] En ##zy ##mes [unused3] ( Chemical , medication , substance : enzymes ; enzyme ; En ##zy ##mes [ Chemical / In ##g ##red ##ient ] ; B ##io ##cat ##aly ##sts ; En ##zy ##me ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28389374.84',\n",
       "  'test_set_idx': 34086,\n",
       "  'type': 'T201',\n",
       "  'name': 'responsive',\n",
       "  'context': '[CLS] ( a dual p ##hos ##ph ##oi ##nos ##iti ##de 3 - kinase - ma ##mmal ##ian target of rap ##am ##y ##cin inhibitor ) , which induce ##s down ##re ##gu ##lation of BR ##CA ##1 . These observations suggest that BR ##CA ##1 associated protein ##1 does regulate DNA damage response and influences drug sensitivity . It might therefore be relevant to investigate whether patients with high expression of BR ##CA ##1 associated protein ##1 may be [unused1] re ##sp ##ons ##ive [unused2] to p ##oly ( ad ##eno ##sin ##e dip ##hos ##phate - rib ##ose ) polymer ##ase / p ##hos ##ph ##oi ##nos ##iti ##de 3 - kinase - ma ##mmal ##ian target of rap ##am ##y ##cin inhibitor ##s . [SEP]',\n",
       "  'existing_cui': 'C0237284',\n",
       "  'existing_cui_name': 'unresponsive behavior',\n",
       "  'existing_cui_desc': '[CLS] un ##res ##po ##ns ##ive behavior [unused3] ( Finding , finding : un ##res ##po ##ns ##ive ; Un ##res ##po ##ns ##ive ; Not Re ##sp ##ons ##ive ) [SEP]',\n",
       "  'our_bi_cui': 'C0683154',\n",
       "  'our_bi_cui_name': 'drug response',\n",
       "  'our_bi_cui_desc': '[CLS] drug response [unused3] ( B ##iol ##og ##ic Fun ##ction : response to drug ; drug responses ; drugs response ) [SEP]',\n",
       "  'our_cross_cui': 'C0521982',\n",
       "  'our_cross_cui_name': 'Response to treatment',\n",
       "  'our_cross_cui_desc': '[CLS] Response to treatment [unused3] ( Clinical At ##tri ##but ##e , context - dependent category , finding , function , o ##bs ##er ##vable entity , situation : response to treatment ; response treatments ; The ##rap ##eu ##tic response ; response therapeutic ; The ##rap ##eu ##tic Response ; Finding related to therapeutic response ; successful treatment ; successful treatments ; The ##rap ##eu ##tic response , function ) [SEP]'},\n",
       " {'mention_id': '27460285.31',\n",
       "  'test_set_idx': 6603,\n",
       "  'type': 'T037',\n",
       "  'name': 'injuries',\n",
       "  'context': '[CLS] ##ic injuries . Em ##pha ##sis is placed on multi ##det ##ector CT , which represents the ideal m ##oda ##lity to comprehensive ##ly visual ##ize the operated groin region and deeper in ##tra - abdominal structures . CT consistently depicts se ##roma , mesh infections , hem ##or ##r ##hage ##s , bow ##el complications and u ##rina ##ry bladder [unused1] injuries [unused2] , and thus generally provides a consistent basis for therapeutic choice . Since radio ##logists are increasingly requested to investigate suspected i ##at ##rogen ##ic complications , this paper aims to provide an increased familiar ##ity with early CT studies after In ##guin ##al her ##nia repair , including complications and normal post ##oper ##ative appearances such as focal pseudo ##les ##ions [SEP]',\n",
       "  'existing_cui': 'C0005604',\n",
       "  'existing_cui_name': 'Birth Injuries',\n",
       "  'existing_cui_desc': '[CLS] Birth In ##ju ##ries [unused3] ( In ##ju ##ry or Po ##ison ##ing , Birth , diagnosis , disorder : In ##ju ##ries , Birth ; T ##ra ##umatic birth ; injury birth ; Birth trauma , un ##sp ##ec ##ified ; Birth T ##ra ##uma ; Birth trauma of f ##etus ; injury ; birth ; traumatic birth ; birth trauma ; birth injuries ; Birth In ##ju ##ry ; trauma birth ; Neo ##nat ##al Birth In ##ju ##ry ; birth ##ing injuries ; Birth In ##ju ##ries [ Disease / Finding ] ; Un ##sp ##ec ##ified birth trauma ; birth ##ing trauma ; B ##IR ##TH IN ##J ; IN ##J B ##IR ##TH ; Birth injuries ; birth ; injury ; [SEP]',\n",
       "  'our_bi_cui': 'C3263723',\n",
       "  'our_bi_cui_name': 'Traumatic injury',\n",
       "  'our_bi_cui_desc': '[CLS] T ##ra ##umatic injury [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder : IN ##J ; In ##ju ##ry , un ##sp ##ec ##ified ; wound ; trauma ; T ##ra ##umatic In ##ju ##ry ; W ##ou ##nd ; injury from an external force ; injuries ; injury ; In ##ju ##ries ; T ##ra ##uma ; In ##ju ##ry ; In ##ju ##ry - disorder ; Un ##sp ##ec ##ified injury ) [SEP]',\n",
       "  'our_cross_cui': 'C0403677',\n",
       "  'our_cross_cui_name': 'Injury of bladder',\n",
       "  'our_cross_cui_desc': '[CLS] In ##ju ##ry of bladder [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder : bladder injuries ; Un ##sp ##ec ##ified injury of bladder ; injury ; bladder ; B ##lad ##der injury ; bladder injury ; injury bladder ; In ##ju ##ry of bladder , un ##sp ##ec ##ified ; bladder ; injury ; B ##lad ##der In ##ju ##ry ) [SEP]'},\n",
       " {'mention_id': '27882444.22',\n",
       "  'test_set_idx': 20505,\n",
       "  'type': 'T038',\n",
       "  'name': \"gene arrangement 3 ' - NP-P-M-F-HN-L-5 '\",\n",
       "  'context': \"[CLS] - 01 / CH / 15 , was isolated from a great spotted wood ##pec ##ker in the northwest region of China in 2015 . The complete genome was sequence ##d , and the results showed that the virus genome was 15 , 192 n ##t in length , in the [unused1] gene arrangement 3 ' - N ##P - P - M - F - H ##N - L - 5 ' [unused2] . Several amino acid mutations were identified in the functional domains of the F and H ##N proteins . The path ##ogenic ##ity index of the is ##olate was evaluated , and the mean death time was 72 h and the in ##tra ##cer ##eb ##ral path ##ogenic ##ity index was 0 [SEP]\",\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C1517495',\n",
       "  'our_bi_cui_name': 'Gene Feature',\n",
       "  'our_bi_cui_desc': '[CLS] Gene Feature [unused3] ( Ana ##tom ##ical Structure : Gene Organization ; Gene Structure ; Se ##q Feature ; Se ##quence Feature ; Gene Structure / Organization ) [SEP]',\n",
       "  'our_cross_cui': 'C0887940',\n",
       "  'our_cross_cui_name': 'Gene Order',\n",
       "  'our_cross_cui_desc': '[CLS] Gene Order [unused3] ( B ##iol ##og ##ic Fun ##ction : Po ##si ##tions , Gene ; A ##rra ##nge ##ments , Gene ; Po ##si ##tion , Gene ; A ##rra ##nge ##ment , Gene ; Gene A ##rra ##nge ##ment ; Gene Po ##si ##tions ; Gene Po ##si ##tion ; Gene A ##rra ##nge ##ments ; Order , Gene ) [SEP]'},\n",
       " {'mention_id': '27286118.9',\n",
       "  'test_set_idx': 1441,\n",
       "  'type': 'T033',\n",
       "  'name': 'no prostatitis',\n",
       "  'context': '[CLS] ##to ##logical pro ##sta ##titis and lower u ##rina ##ry tract symptoms and sexual function This prospective analysis assessed the effect of his ##to ##logical pro ##sta ##titis on lower u ##rina ##ry tract functions and sexual function . The patients were separated into two groups as his ##to ##logical ##ly observed pro ##sta ##titis ( Group A ) and [unused1] no pro ##sta ##titis [unused2] ( Group B ) according to the bio ##psy outcomes . International pro ##state s ##ym ##pt ##om score , international index of erect ##ile function - 5 scores , ma ##ximal and average flow rate , and residual urine volumes were compared statistical ##ly between groups . There was no significant difference ( P > 0 . 05 ) [SEP]',\n",
       "  'existing_cui': 'C0033581',\n",
       "  'existing_cui_name': 'prostatitis',\n",
       "  'existing_cui_desc': '[CLS] pro ##sta ##titis [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Pro ##sta ##titis ; pro ##state inflammation ; In ##f ##lam ##mat ##ory diseases of pro ##state ; Pro ##sta ##titis , un ##sp ##ec ##ified ; Pro ##state inflammatory diseases ; Pro ##sta ##titis [ Disease / Finding ] ; In ##f ##lam ##mation of pro ##state ; In ##f ##lam ##mation of the pro ##state ; In ##f ##lam ##mat ##ory disease of pro ##state , un ##sp ##ec ##ified ; inflammation ; pro ##state ; Pro ##static inflammatory disease ; pro ##state ; inflammation ; Pro ##sta ##ti ##tide ##s ) [SEP]',\n",
       "  'our_bi_cui': 'C0497153',\n",
       "  'our_bi_cui_name': 'No disease',\n",
       "  'our_bi_cui_desc': '[CLS] No disease [unused3] ( Finding : Disease ; none ; no disease ; A ##bs ##ence ( of ) ; disease ; absence of disease ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27826436.55',\n",
       "  'test_set_idx': 18385,\n",
       "  'type': 'T204',\n",
       "  'name': 'cultivars',\n",
       "  'context': '[CLS] The content of as ##cor ##bic acid of c ##v . To ##chi ##oto ##me was higher than the others , but there was no significant difference in cult ##iva ##rs of Ben ##ih ##op ##pe , To ##chi ##oto ##me , and Sa ##chin ##oka . Fr ##uc ##tos ##e and glucose were the major sugar ##s in all [unused1] cult ##iva ##rs [unused2] . C ##it ##ric acid was the major organic acid in c ##v . To ##chi ##oto ##me , c ##v . Sa ##chin ##oka , and c ##v . G ##ui ##mei ##ren . To ##chi ##oto ##me had higher ratios of T ##SS / T ##A and total sugar ##s / total organic acids than others , arising from [SEP]',\n",
       "  'existing_cui': 'C3385047',\n",
       "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
       "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
       "  'our_bi_cui': 'C0242775',\n",
       "  'our_bi_cui_name': 'Agricultural Crops',\n",
       "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
       "  'our_cross_cui': 'C0032098',\n",
       "  'our_cross_cui_name': 'Plants',\n",
       "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
       " {'mention_id': '28197156.20',\n",
       "  'test_set_idx': 28090,\n",
       "  'type': 'T103',\n",
       "  'name': 'OsHAP3',\n",
       "  'context': '[CLS] study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial cult ##iva ##r . Fine mapping suggested that Carbon As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( [unused1] O ##s ##HA ##P ##3 [unused2] ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting [SEP]',\n",
       "  'existing_cui': 'C1427162',\n",
       "  'existing_cui_name': 'THAP3 gene',\n",
       "  'existing_cui_desc': '[CLS] T ##HA ##P ##3 gene [unused3] ( Ana ##tom ##ical Structure : T ##HA ##P domain containing , a ##pop ##tosis associated protein 3 ; T ##HA ##P D ##OM ##A ##IN - CO ##NT ##A ##IN ##ING PR ##OT ##EI ##N 3 ) [SEP]',\n",
       "  'our_bi_cui': 'C1722024',\n",
       "  'our_bi_cui_name': 'HO3 protein , Arabidopsis',\n",
       "  'our_bi_cui_desc': '[CLS] H ##O ##3 protein , Arab ##ido ##psis [unused3] ( Chemical : hem ##e oxygen ##ase 3 , Arab ##ido ##psis ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28203549.82',\n",
       "  'test_set_idx': 28274,\n",
       "  'type': 'T170',\n",
       "  'name': 'ST',\n",
       "  'context': '[CLS] ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s with K ##1 , K ##2 , K ##5 , K ##20 , and K ##5 ##7 ( 27 . 5 % , 19 / 69 ) and was only found among K ##1 is ##olate ##s . ST ##65 was the second most prevalent [unused1] ST [unused2] ( 26 . 1 % , 18 / 69 ) and was also only found among K ##2 is ##olate ##s . ST ##23 - K ##1 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s ( 84 . 2 % , 16 / 19 ) were associated with p ##yo ##genic liver a [SEP]',\n",
       "  'existing_cui': 'C0036183',\n",
       "  'existing_cui_name': 'Sao Tome and Principe',\n",
       "  'existing_cui_desc': '[CLS] Sa ##o Tom ##e and P ##rin ##ci ##pe [unused3] ( Spa ##tial Concept , geographic location : SA ##O TO ##ME AND PR ##IN ##CI ##P ##E ; São Tom ##é and P ##r ##ín ##ci ##pe ) [SEP]',\n",
       "  'our_bi_cui': 'C0887835',\n",
       "  'our_bi_cui_name': 'Ribotype',\n",
       "  'our_bi_cui_desc': '[CLS] R ##ib ##otype [unused3] ( Finding : R ##ib ##otype ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0449943',\n",
       "  'our_cross_cui_name': 'Serotype',\n",
       "  'our_cross_cui_desc': '[CLS] Ser ##otype [unused3] ( Intel ##lect ##ual Product , attribute , o ##bs ##er ##vable entity , qualifier value : se ##rov ##ar ; se ##rov ##ars ; Ser ##ova ##rs ; se ##rot ##ype ; se ##rot ##ype ##s ; Ser ##otype ##s ; Ser ##ova ##r ) [SEP]'},\n",
       " {'mention_id': '28289065.41',\n",
       "  'test_set_idx': 31384,\n",
       "  'type': 'T058',\n",
       "  'name': 'RP',\n",
       "  'context': '[CLS] re ##cu ##rrence within G ##lea ##son Grade Groups based on either bio ##psy or pro ##state ##ct ##omy scoring . Multi ##var ##iate analysis further confirmed that a higher Grade Groups was significantly associated with risk of bio ##chemical re ##cu ##rrence . This Grade Groups system had a higher pro ##gno ##stic discrimination for both initial bio ##psy and [unused1] R ##P [unused2] than G ##lea ##son score . Our study valid ##ates the use of the revised and updated Grade Groups system in a mixed - ethnicity population of Asian men . Higher Grade Groups was significantly associated with increased risk of bio ##chemical re ##cu ##rrence . We therefore recommend its use to inform clinical management for patients with pro ##state cancer [SEP]',\n",
       "  'existing_cui': 'C1538326',\n",
       "  'existing_cui_name': 'BLOC1S3 gene',\n",
       "  'existing_cui_desc': '[CLS] B ##L ##OC ##1 ##S ##3 gene [unused3] ( Ana ##tom ##ical Structure : B ##io ##genesis of L ##ys ##oso ##me - related Organ ##elles complex - 1 Sub ##uni ##t 3 ; Herman ##sky - P ##ud ##lak syndrome 8 ; HP ##S ##8 GE ##NE ; R ##ED ##UC ##ED P ##IG ##ME ##NT ##AT ##ION , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; B ##IO ##GE ##NE ##SI ##S OF L ##Y ##SO ##SO ##ME - R ##EL ##AT ##ED OR ##GA ##NE ##LL ##ES CO ##MP ##LE ##X 1 , S ##U ##B ##UN ##IT 3 ; bio ##genesis of l ##ys ##oso ##mal organ ##elles complex 1 subunit 3 ; B ##L ##OC - 1 [SEP]',\n",
       "  'our_bi_cui': 'C0033573',\n",
       "  'our_bi_cui_name': 'Prostatectomy',\n",
       "  'our_bi_cui_desc': '[CLS] Pro ##state ##ct ##omy [unused3] ( Health Care Act ##ivity , procedure , treatment : pro ##state re ##section ; Ex ##cision Pro ##ced ##ures on the Pro ##state ; pro ##state ##ct ##omy ; g ##eni ##to - u ##rina ##ry tract surgery pro ##state ##ct ##omy ; pro ##state re ##section ##s ; Pro ##state ##ct ##omi ##es ; pro ##state ##ct ##omi ##es ; Me ##d : Pro ##state ##ct ##omy ; surgical removal of the pro ##state ; pro ##state re ##section ##ing ; Pro ##state ex ##cision ) [SEP]',\n",
       "  'our_cross_cui': 'C0194810',\n",
       "  'our_cross_cui_name': 'Radical prostatectomy',\n",
       "  'our_cross_cui_desc': '[CLS] Radical pro ##state ##ct ##omy [unused3] ( Health Care Act ##ivity , procedure , treatment : pro ##state ##ct ##omy radical ; radical pro ##state ##ct ##omy ; Total pro ##state ##ct ##omy ; Pro ##sta ##tov ##esi ##cule ##ct ##omy ; total pro ##state ##ct ##omy ; Radical pro ##state ##ct ##omy by any approach ; Radical Pro ##state ##ct ##omy ; pro ##state ##ct ##omi ##es radical ) [SEP]'},\n",
       " {'mention_id': '27812530.11',\n",
       "  'test_set_idx': 18001,\n",
       "  'type': 'T103',\n",
       "  'name': \"material 's\",\n",
       "  'context': \"[CLS] for En ##han ##cing A ##pp ##lica ##bility in V ##ert ##eb ##rop ##last ##y Pol ##yme ##thy ##lm ##eth ##ac ##ryl ##ate bone cement is a popular bone void fill ##er for ve ##rte ##bro ##p ##last ##y . However , the use of Pol ##yme ##thy ##lm ##eth ##ac ##ryl ##ate has some draw ##backs , including the [unused1] material ' s [unused2] excessive stiff ##ness , ex ##oth ##er ##mic polymer ##ization , and short handling time . This study aimed to create an ideal modified bone cement to solve the above - mentioned problems . Mo ##dified bone cement ##s were prepared by combining Pol ##yme ##thy ##lm ##eth ##ac ##ryl ##ate with three different volume fraction ##s of cast ##or oil [SEP]\",\n",
       "  'existing_cui': 'C2986060',\n",
       "  'existing_cui_name': 'Material Form Code',\n",
       "  'existing_cui_desc': '[CLS] Material Form Code [unused3] ( Intel ##lect ##ual Product : Material . form ##C ##ode ) [SEP]',\n",
       "  'our_bi_cui': 'C0032521',\n",
       "  'our_bi_cui_name': 'Polymers',\n",
       "  'our_bi_cui_desc': '[CLS] Pol ##yme ##rs [unused3] ( Chemical , substance : Pol ##yme ##ric ; Pol ##yme ##ric Mac ##rom ##ole ##cule ##s ; Pol ##yme ##r ; P ##OL ##Y ##ME ##R S ##U ##BS ##TA ##NC ##E ; Pol ##yme ##rs [ Chemical / In ##g ##red ##ient ] ; polymer ; polymer ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0005479',\n",
       "  'our_cross_cui_name': 'Biomaterials',\n",
       "  'our_cross_cui_desc': '[CLS] B ##io ##mate ##rial ##s [unused3] ( Chemical : B ##io ##mate ##rial ; bio ##com ##pa ##tible materials ; B ##io ##medical Material ; bio ##mate ##rial ##s ; B ##io ##medical materials ; B ##io ##com ##pa ##tible Materials ; bio ##medical materials ; bio ##mate ##rial ; Materials , B ##io ##com ##pa ##tible ; bio ##medical material ; B ##io ##com ##pa ##tible Materials [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '28441489.37',\n",
       "  'test_set_idx': 36159,\n",
       "  'type': 'T033',\n",
       "  'name': 'Cold - start',\n",
       "  'context': '[CLS] composition of the volatile organic compounds emissions between Port Fuel In ##jection and G ##DI ##s , including ben ##zen ##e , to ##lue ##ne , et ##hyl ##ben ##zen ##e , and x ##yle ##nes . Therefore , the secondary organic a ##ero ##sol and oz ##one formation potential of the exhaust does not depend on engine technology . [unused1] Cold - start [unused2] contributes a larger fraction of the total unified cycle emissions for vehicles meeting more - string ##ent emission standards . Organic gas emissions were the most sensitive to cold - start compared to the other poll ##uta ##nts tested here . There were no statistical ##ly significant differences in the effects of cold - start on G ##DI ##s and P [SEP]',\n",
       "  'existing_cui': 'C0452588',\n",
       "  'existing_cui_name': 'Start brand of breakfast cereal',\n",
       "  'existing_cui_desc': '[CLS] Start brand of breakfast cereal [unused3] ( Food , substance : Start ) [SEP]',\n",
       "  'our_bi_cui': 'C1455171',\n",
       "  'our_bi_cui_name': 'Cool-X-A',\n",
       "  'our_bi_cui_desc': '[CLS] Cool - X - A [unused3] ( Chemical : Cool - Cool ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27482869.9',\n",
       "  'test_set_idx': 7902,\n",
       "  'type': 'T082',\n",
       "  'name': 'Chapel Hill',\n",
       "  'context': \"[CLS] on 30 September 1946 in Columbus , OH . He studied medicine at the University of Michigan , graduated in 1973 , and after a rotating internship , he completed a master ' s degree in maternal and child health ( 1976 ) and a PhD in e ##pid ##em ##iology ( 1979 ) at the University of North Carolina in [unused1] Chapel Hill [unused2] . After graduation , he went to work at the National Institute of Environmental Health Sciences ( National Institute of Environmental Health Sciences , one of the US National Institutes of Health ) in Durham , NC , where he has spent his career . He developed a research program in reproductive and per ##ina ##tal e ##pid ##em ##iology , [SEP]\",\n",
       "  'existing_cui': 'C0313304',\n",
       "  'existing_cui_name': 'hemoglobin Chapel Hill',\n",
       "  'existing_cui_desc': '[CLS] hem ##og ##lo ##bin Chapel Hill [unused3] ( Chemical , substance : Ha ##em ##og ##lo ##bin Chapel Hill ; H ##b Chapel Hill ; He ##mo ##g ##lo ##bin Chapel Hill ; H ##b 74 ( E ##F ##3 ) , As ##p - g ##ly ) [SEP]',\n",
       "  'our_bi_cui': 'C0313304',\n",
       "  'our_bi_cui_name': 'hemoglobin Chapel Hill',\n",
       "  'our_bi_cui_desc': '[CLS] hem ##og ##lo ##bin Chapel Hill [unused3] ( Chemical , substance : Ha ##em ##og ##lo ##bin Chapel Hill ; H ##b Chapel Hill ; He ##mo ##g ##lo ##bin Chapel Hill ; H ##b 74 ( E ##F ##3 ) , As ##p - g ##ly ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '28271342.55',\n",
       "  'test_set_idx': 30732,\n",
       "  'type': 'T092',\n",
       "  'name': 'European Society for Medical Oncology',\n",
       "  'context': '[CLS] 159 cancer ##s at Ra or R ##b were located within 12 cm from the anal verge by rigid pro ##ct ##os ##copy , while only 79 . 7 % of Ra or 82 . 1 % of R ##b cancer ##s were located in the mid ( 5 . 1 - 10 cm ) or low ( ≤ 5 cm ) re ##ct ##um , respectively . Ra and R ##b cancer ##s are deemed to be re ##ct ##al cancer ##s according to National Comprehensive Cancer Network guidelines , but these classification ##s are not interchange ##able with mid - and low - re ##ct ##al cancer ##s , respectively , according to the [unused1] European Society for Medical On ##cology [unused2] guidelines . [SEP]',\n",
       "  'existing_cui': 'C0025098',\n",
       "  'existing_cui_name': 'Medical oncology specialty',\n",
       "  'existing_cui_desc': '[CLS] Medical on ##cology specialty [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line , qualifier value : ME ##D ON ##CO ##L ; medical on ##cology ; On ##cology , Medical ; on ##cology medical ; ON ##CO ##L ME ##D ; Medical On ##cology ; Medical on ##cology ) [SEP]',\n",
       "  'our_bi_cui': 'C0037459',\n",
       "  'our_bi_cui_name': 'Societies , Medical',\n",
       "  'our_bi_cui_desc': '[CLS] Societies , Medical [unused3] ( Organization : Medical Society ; medical societies ; Society , Medical ; medical society ; S ##OC ##IE ##TY ME ##D ; Medical Societies ; ME ##D S ##OC ##IE ##TI ##ES ; S ##OC ##IE ##TI ##ES ME ##D ; ME ##D S ##OC ##IE ##TY ) [SEP]',\n",
       "  'our_cross_cui': 'C1708333',\n",
       "  'our_cross_cui_name': 'Health Care Organization',\n",
       "  'our_cross_cui_desc': '[CLS] Health Care Organization [unused3] ( Organization : Healthcare Organization ) [SEP]'},\n",
       " {'mention_id': '27526663.53',\n",
       "  'test_set_idx': 9493,\n",
       "  'type': 'T204',\n",
       "  'name': 'B. cinerea',\n",
       "  'context': '[CLS] to the j ##as ##mon ##ic acid defence pathway . We found that Pro ##D ##H1 and Pro ##D ##H ##2 are both necessary to achieve maximum resistance against P ##st - A ##v ##r ##R ##pm ##1 and B . c ##iner ##ea . However , Pro ##D ##H ##2 has a major effect on early restriction of [unused1] B . c ##iner ##ea [unused2] growth . Interest ##ingly , Pro ##D ##H1 is up - regulated by sa ##lic ##yl ##ic acid and j ##as ##mon ##ic acid , whereas Pro ##D ##H ##2 is only activated by j ##as ##mon ##ic acid , and both genes display transcription ##al inter - regulation at basal and infection conditions . These studies provide the first [SEP]',\n",
       "  'existing_cui': 'C0326708',\n",
       "  'existing_cui_name': 'Callaeas cinereus',\n",
       "  'existing_cui_desc': '[CLS] Call ##ae ##as c ##iner ##eus [unused3] ( E ##uka ##ryo ##te , organism : Call ##ae ##as c ##iner ##eus ( G ##mel ##in , J ##F , 1788 ) ; G ##lau ##co ##pis c ##iner ##ea c ##iner ##ea ; Watt ##led crow ; Ko ##ka ##ko ; k ##oka ##ko ; Call ##ae ##as c ##iner ##ea ) [SEP]',\n",
       "  'our_bi_cui': 'C0317886',\n",
       "  'our_bi_cui_name': 'Neisseria cinerea',\n",
       "  'our_bi_cui_desc': '[CLS] N ##ei ##sser ##ia c ##iner ##ea [unused3] ( Ba ##cter ##ium , organism : N ##ei ##sser ##ia c ##iner ##ea ( von Ling ##els ##heim 1906 ) Murray 1939 ; Micro ##co ##cc ##us c ##iner ##eus ; NE ##IS ##SE ##RI ##A C ##IN ##ER ##EA ) [SEP]',\n",
       "  'our_cross_cui': 'C0579190',\n",
       "  'our_cross_cui_name': 'Botrytis cinerea',\n",
       "  'our_cross_cui_desc': '[CLS] Bo ##try ##tis c ##iner ##ea [unused3] ( E ##uka ##ryo ##te , organism : Sc ##ler ##ot ##inia fuck ##eli ##ana ) [SEP]'},\n",
       " {'mention_id': '27838742.32',\n",
       "  'test_set_idx': 18999,\n",
       "  'type': 'T103',\n",
       "  'name': 'delicaflavone',\n",
       "  'context': '[CLS] in male BA ##L ##B / c nude mice without o ##bs ##er ##vable adverse effect . By transmission electron micro ##sco ##py with a ##c ##rid ##ine orange and Cy ##to - ID ® Auto ##pha ##gy detection dye ##s , Western b ##lot analysis , and R ##T - PC ##R ass ##ay , we confirmed that [unused1] del ##ica ##f ##lav ##one [unused2] induce ##s auto ##pha ##gic cell death by increasing the ratio of L ##C ##3 - II to L ##C ##3 - I , which are auto ##pha ##gy - related proteins , and promoting the generation of acidic ve ##si ##cular organ ##elles and auto ##ly ##so ##some ##s in the c ##yt ##op ##las ##m of human lung [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0529351',\n",
       "  'our_bi_cui_name': 'darifenacin',\n",
       "  'our_bi_cui_desc': '[CLS] da ##ri ##fen ##ac ##in [unused3] ( Chemical , medication , product , substance : Dar ##ife ##nac ##in ##um ; ( S ) - 1 - ( 2 - ( 2 , 3 - di ##hy ##dr ##o - 5 - Benz ##of ##ura ##ny ##l ) et ##hyl ) - alpha , alpha - dip ##hen ##yl - 3 - p ##yr ##rol ##id ##ine ##ace ##tam ##ide ; Dar ##ife ##nac ##in ; ( S ) - 1 - ( 2 - ( 2 , 3 - di ##hy ##dr ##o - 5 - ben ##zo ##fu ##ran ##yl ) et ##hyl ) - alpha , alpha - dip ##hen ##yl - 3 - p ##yr ##rol ##id ##ine ##ace ##tam ##ide ; [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27475696.21',\n",
       "  'test_set_idx': 7484,\n",
       "  'type': 'T038',\n",
       "  'name': 'OSCCs',\n",
       "  'context': '[CLS] normal oral m ##uc ##osa ( n = 5 ) , oral precursor lesions ( simple h ##yper ##p ##lasia , n = 11 ; sq ##ua ##mous in ##tra ##ep ##ith ##eli ##al neo ##p ##lasia , S ##IN I - III , n = 35 ) , and oral sq ##ua ##mous cell car ##cin ##oma specimen . [unused1] OS ##CC ##s [unused2] were s ##tra ##ti ##fied in a young female ( n = 7 ) study co ##hor ##t and older patients ( n = 46 ) . In the young female study co ##hor ##t three patients ( n = 3 / 7 ) developed oral sq ##ua ##mous cell car ##cin ##oma during or shortly after pregnancy . B ##rea [SEP]',\n",
       "  'existing_cui': 'C1416926',\n",
       "  'existing_cui_name': 'LSS gene',\n",
       "  'existing_cui_desc': '[CLS] L ##SS gene [unused3] ( Ana ##tom ##ical Structure : LA ##N ##OS ##TE ##RO ##L S ##Y ##NT ##HA ##SE ; 2 , 3 - O ##X ##ID ##OS ##Q ##U ##AL ##EN ##E - LA ##N ##OS ##TE ##RO ##L C ##Y ##CL ##AS ##E ; la ##nos ##tero ##l s ##ynth ##ase ( 2 , 3 - o ##xi ##dos ##qua ##lene - la ##nos ##tero ##l c ##y ##c ##lase ) ) [SEP]',\n",
       "  'our_bi_cui': 'C0151546',\n",
       "  'our_bi_cui_name': 'Oral Cavity Carcinoma',\n",
       "  'our_bi_cui_desc': '[CLS] Oral C ##avi ##ty Car ##cin ##oma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis : Oral car ##cin ##oma ##s ; Oral car ##cin ##oma ; Mouth Car ##cin ##oma ; car ##cin ##oma oral ; Car ##cin ##oma mouth ; oral cavity cancer ; Mouth car ##cin ##oma ; car ##cin ##oma ##s oral ; car ##cin ##oma cavity oral ; Car ##cin ##oma of Oral C ##avi ##ty ; oral car ##cin ##oma ; Car ##cin ##oma of Mouth ; Car ##cin ##oma of the Oral C ##avi ##ty ; Car ##cin ##oma of mouth ; car ##cin ##oma of oral cavity ) [SEP]',\n",
       "  'our_cross_cui': 'C0585362',\n",
       "  'our_cross_cui_name': 'Squamous cell carcinoma of mouth',\n",
       "  'our_cross_cui_desc': '[CLS] S ##qua ##mous cell car ##cin ##oma of mouth [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Oral C ##avi ##ty S ##qua ##mous Cell Car ##cin ##oma ; Mouth SC ##C ; sq ##ua ##mous cell car ##cin ##oma of mouth ; sq ##ua ##mous cell car ##cin ##oma mouth ; SC ##C of Mouth ; car ##cin ##oma cell mouth sq ##ua ##mous ; S ##qua ##mous cell car ##cin ##oma of the oral cavity ; S ##qua ##mous Cell Car ##cin ##oma of the Oral C ##avi ##ty ; SC ##C of the Mouth ; Oral C ##avi ##ty SC ##C ; SC ##C of Oral C ##avi ##ty ; Mouth S ##qua ##mous Cell Car ##cin ##oma [SEP]'},\n",
       " {'mention_id': '27920749.46',\n",
       "  'test_set_idx': 21883,\n",
       "  'type': 'T170',\n",
       "  'name': 'emotionally negative film clip',\n",
       "  'context': \"[CLS] healthy young men and women participated . Part ##ici ##pants ' trait re ##ap ##pra ##isa ##l and suppression as well as state and trait anxiety were assessed . A dot - probe task was completed by all participants . Statistical tests in Study 1 revealed that participants who re ##ap ##pra ##ised to decrease negative emotions while viewing an [unused1] emotionally negative film clip [unused2] had reduced attention ##al bias to subsequently presented angry faces compared to participants who re ##ap ##pra ##ised to increase negative emotions . Multiple re ##gression analyses in Study 2 revealed that trait re ##ap ##pra ##isa ##l predicted slower or ##ient ##ing toward angry faces , whereas state anxiety predicted slower di ##sen ##ga ##gement from angry faces . [SEP]\",\n",
       "  'existing_cui': 'C0558263',\n",
       "  'existing_cui_name': 'Emotionally distant',\n",
       "  'existing_cui_desc': '[CLS] Em ##otion ##ally distant [unused3] ( Finding , finding : Em ##otion ##ally al ##oof ) [SEP]',\n",
       "  'our_bi_cui': 'C3463807',\n",
       "  'our_bi_cui_name': 'Video Media',\n",
       "  'our_bi_cui_desc': '[CLS] Video Media [unused3] ( Intel ##lect ##ual Product : Video ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27621200.3',\n",
       "  'test_set_idx': 12035,\n",
       "  'type': 'T038',\n",
       "  'name': 'kindness',\n",
       "  'context': '[CLS] A pilot study exploring the relationship between self - compassion , self - judgement , self - [unused1] kindness [unused2] , compassion , professional quality of life and well ##bei ##ng among UK community nurses Co ##mp ##ass ##ion fatigue and burn ##out can impact on performance of nurses . This paper explores the relationship between self - compassion , self - judgement , self - kindness , compassion , professional quality of life , and well ##bei ##ng among community nurses . To measure associations between self - compassion , compassion fatigue , well ##bei ##ng , and burn ##out in community nurses . Q ##uant ##itative data were collected using standard ##ised ps ##ych ##ometric question ##naire ##s : ( 1 ) Professional Quality [SEP]',\n",
       "  'existing_cui': 'C0456909',\n",
       "  'existing_cui_name': 'Blind Vision',\n",
       "  'existing_cui_desc': '[CLS] Blind Vision [unused3] ( Finding , finding : Blind ##ness ; blind vision ; Unable to see ; Blind ##ness [ Disease / Finding ] ; Can not see ; Blind ; blind ##ness ; U ##TS - Unable to see ; blind ) [SEP]',\n",
       "  'our_bi_cui': 'C0020039',\n",
       "  'our_bi_cui_name': 'Hostility',\n",
       "  'our_bi_cui_desc': '[CLS] Host ##ility [unused3] ( B ##iol ##og ##ic Fun ##ction , context - dependent category , finding , physical finding , situation , s ##ym ##pt ##om : [ D ] Host ##ility ; attitude hostile ; Host ##ile behavior ; Host ##ile behaviour ; hostile ; hostilities ; hostility ; Host ##ilities ) [SEP]',\n",
       "  'our_cross_cui': 'C0871641',\n",
       "  'our_cross_cui_name': 'affection',\n",
       "  'our_cross_cui_desc': '[CLS] affection [unused3] ( B ##iol ##og ##ic Fun ##ction : A ##ffe ##ction ; affection ##s ) [SEP]'},\n",
       " {'mention_id': '27402827.56',\n",
       "  'test_set_idx': 4900,\n",
       "  'type': 'T038',\n",
       "  'name': 'spinogenesis',\n",
       "  'context': '[CLS] G - protein in ##hibition a ##bro ##gate ##s W ##nt - 5 ##a - dependent pathway in hip ##po ##cam ##pal neurons . In particular , the activation of G ##α ##o appears to be a key factor controlling the W ##nt - 5 ##a - induced den ##dr ##itic spine density . In addition , we found that G ##β ##γ is required for the W ##nt - 5 ##a - mediated increase in c ##yt ##oso ##lic calcium levels and [unused1] spin ##ogen ##esis [unused2] . Our findings reveal that Fr ##iz ##zled ##9 and he ##tero ##tri ##mer ##ic G proteins regulate W ##nt - 5 ##a signaling and den ##dr ##itic spines in culture ##d hip ##po ##cam ##pal neurons . [SEP]',\n",
       "  'existing_cui': 'C2262776',\n",
       "  'existing_cui_name': 'retina morphogenesis in camera-type eye',\n",
       "  'existing_cui_desc': '[CLS] re ##tina m ##or ##ph ##ogen ##esis in camera - type eye [unused3] ( B ##iol ##og ##ic Fun ##ction : re ##tina m ##or ##ph ##ogen ##esis in camera - style eye ; re ##tino ##genesis ) [SEP]',\n",
       "  'our_bi_cui': 'C1155781',\n",
       "  'our_bi_cui_name': 'spindle assembly',\n",
       "  'our_bi_cui_desc': '[CLS] spin ##dle assembly [unused3] ( B ##iol ##og ##ic Fun ##ction : spin ##dle bio ##sy ##nt ##hesis ; spin ##dle formation ; bi ##pol ##ar spin ##dle bio ##sy ##nt ##hesis ; bi ##pol ##ar spin ##dle formation ) [SEP]',\n",
       "  'our_cross_cui': 'C0007613',\n",
       "  'our_cross_cui_name': 'Cell physiology',\n",
       "  'our_cross_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]'},\n",
       " {'mention_id': '27796974.8',\n",
       "  'test_set_idx': 17362,\n",
       "  'type': 'T170',\n",
       "  'name': 'Water Framework Directive',\n",
       "  'context': '[CLS] ##ive aims at reaching the good ecological status of the surface and ground water bodies ( L ##ás ##z ##l ##ó et al . Micro ##che ##m J 85 ( 1 ) : 65 - 71 , 2007 ) . The paper deals with quality evaluation of waters with special focus on the water chemistry parameters as defined in the [unused1] Water Framework Direct ##ive [unused2] and pertaining legal regulations . The purpose of this paper is to de ##vise a quantitative type of water quality assessment method which could provide rapid , accurate , and reliable information on the quality of the surface waters by using water chemistry parameters . Quality classes have been defined for every water chemistry parameter in light of the legal [SEP]',\n",
       "  'existing_cui': 'C0450152',\n",
       "  'existing_cui_name': 'Metal framework',\n",
       "  'existing_cui_desc': '[CLS] Metal framework [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
       "  'our_bi_cui': 'C1135941',\n",
       "  'our_bi_cui_name': 'Ethical Directives',\n",
       "  'our_bi_cui_desc': '[CLS] E ##thical Direct ##ives [unused3] ( Intel ##lect ##ual Product : Direct ##ive , E ##thical ; Direct ##ives , E ##thical ; E ##thical Direct ##ive ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27894020.30',\n",
       "  'test_set_idx': 21139,\n",
       "  'type': 'T033',\n",
       "  'name': 'detection',\n",
       "  'context': '[CLS] , cocaine and its main meta ##bol ##ite , ben ##zo ##yle ##c ##gon ##ine , were detected in two out of six hair samples . The concentrations for cocaine were 0 . 151 and 0 . 09 ng / mg and for ben ##zo ##yle ##c ##gon ##ine 0 . 103 and 0 . 147 ng / mg , respectively . Given that cocaine was a commonly used medicine , beginning in the mid - 19th century and per ##sist ##ing into the 20th century , it is not surprising that some patients may have ing ##ested this drug . In addition to the [unused1] detection [unused2] of cocaine , these analyses also provided evidence of ni ##cot ##ine and ca ##ffe ##ine intake . [SEP]',\n",
       "  'existing_cui': 'C0206100',\n",
       "  'existing_cui_name': 'Signal Detection',\n",
       "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
       "  'our_bi_cui': 'C1511790',\n",
       "  'our_bi_cui_name': 'Detection',\n",
       "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
       "  'our_cross_cui': 'C0442726',\n",
       "  'our_cross_cui_name': 'Detected',\n",
       "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
       " {'mention_id': '27325393.44',\n",
       "  'test_set_idx': 2493,\n",
       "  'type': 'T038',\n",
       "  'name': 'immune',\n",
       "  'context': '[CLS] ##9 , p = 0 . 03 ##5 ) , M ( β = - 0 . 01 ##7 , p = 0 . 00 ##9 ) and F ( β = - 0 . 03 ##1 , p = 0 . 02 ##4 ) were associated with the T ##has ##e and Rush staging model but not the Maud ##sley St ##aging Model . Overall , our findings suggest that proteins , which are involved in [unused1] immune [unused2] and complement activation , may represent potential bio ##mark ##ers that could be used by clinic ##ians to identify high - risk patients . Nevertheless , given that the molecular changes between the staging groups were subtle , the results need to be interpreted cautiously . [SEP]',\n",
       "  'existing_cui': 'C0073433',\n",
       "  'existing_cui_name': 'RNA , immune',\n",
       "  'existing_cui_desc': '[CLS] RNA , immune [unused3] ( Chemical : immune RNA ; I - RNA ) [SEP]',\n",
       "  'our_bi_cui': 'C0301872',\n",
       "  'our_bi_cui_name': 'Immune response',\n",
       "  'our_bi_cui_desc': '[CLS] I ##mm ##une response [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : im ##mu ##nor ##es ##po ##nse ; immune responses ; immune response ; I ##mm ##une response , un ##sp ##ec ##ified ; I ##mm ##une Response Process ; Host response ; I ##mm ##une response , function ; Host response , function ; I ##mm ##une Response ; host response ) [SEP]',\n",
       "  'our_cross_cui': 'C1155000',\n",
       "  'our_cross_cui_name': 'Immune Cell Activation Process',\n",
       "  'our_cross_cui_desc': '[CLS] I ##mm ##une Cell Act ##ivation Process [unused3] ( B ##iol ##og ##ic Fun ##ction : le ##uk ##oc ##yte activation ; immune cell activation ; I ##mm ##une Cell Act ##ivation ; le ##uc ##oc ##yte activation ) [SEP]'},\n",
       " {'mention_id': '27932585.26',\n",
       "  'test_set_idx': 22253,\n",
       "  'type': 'T103',\n",
       "  'name': 'TYW3',\n",
       "  'context': '[CLS] structure of Ta ##w ##3 , a ho ##mo ##log of T ##Y ##W ##3 from Sul ##fo ##lo ##bus so ##lf ##ata ##ric ##us , which revealed a novel α / β fold . The sequence motif ( S / T ) x ##SS ##C ##x ##GR and invariant as ##par ##tate and his ##ti ##dine , conserved in [unused1] T ##Y ##W ##3 [unused2] / Ta ##w ##3 , cluster to form the cat ##alytic center . These structural and sequence features indicate that T ##Y ##W ##3 / Ta ##w ##3 proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass [SEP]',\n",
       "  'existing_cui': 'C1823563',\n",
       "  'existing_cui_name': 'TYW3 gene',\n",
       "  'existing_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
       "  'our_bi_cui': 'C1823563',\n",
       "  'our_bi_cui_name': 'TYW3 gene',\n",
       "  'our_bi_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28243201.4',\n",
       "  'test_set_idx': 29646,\n",
       "  'type': 'T201',\n",
       "  'name': 'Response',\n",
       "  'context': '[CLS] I ##dent ##ification of Pre ##dict ##ive DNA Met ##hyl ##ation B ##io ##mark ##ers for Ch ##em ##otherapy [unused1] Response [unused2] in Color ##ec ##tal Cancer Resistance to 5 - F ##lu ##oro ##ura ##ci ##l is a major obstacle to the successful treatment of color ##ec ##tal cancer and posed an increased risk of re ##cu ##rrence . DNA met ##hyl ##ation has been suggested as one of the underlying mechanisms for re ##current disease and its contribution to the development of drug resistance remains to be clarified . This study aimed to determine the met ##hyl ##ation p ##hen ##otype in color ##ec ##tal cancer for identification of predict ##ive markers for ch ##em ##otherapy response . We performed DNA met ##hyl ##ation [SEP]',\n",
       "  'existing_cui': 'C1704632',\n",
       "  'existing_cui_name': 'Disease Response',\n",
       "  'existing_cui_desc': '[CLS] Disease Response [unused3] ( Finding : Response ; response ) [SEP]',\n",
       "  'our_bi_cui': 'C0683154',\n",
       "  'our_bi_cui_name': 'drug response',\n",
       "  'our_bi_cui_desc': '[CLS] drug response [unused3] ( B ##iol ##og ##ic Fun ##ction : response to drug ; drug responses ; drugs response ) [SEP]',\n",
       "  'our_cross_cui': 'C0521982',\n",
       "  'our_cross_cui_name': 'Response to treatment',\n",
       "  'our_cross_cui_desc': '[CLS] Response to treatment [unused3] ( Clinical At ##tri ##but ##e , context - dependent category , finding , function , o ##bs ##er ##vable entity , situation : response to treatment ; response treatments ; The ##rap ##eu ##tic response ; response therapeutic ; The ##rap ##eu ##tic Response ; Finding related to therapeutic response ; successful treatment ; successful treatments ; The ##rap ##eu ##tic response , function ) [SEP]'},\n",
       " {'mention_id': '27249559.30',\n",
       "  'test_set_idx': 788,\n",
       "  'type': 'T033',\n",
       "  'name': 'electron beam trajectory swinging',\n",
       "  'context': '[CLS] size were studied . The simulation results demonstrated that if the intensity of X - rays generated at the point - like target is greater than half of the X - ray intensity produced on the substrate , the X - ray focal spot is determined in part by the point - like target rather than by the electron beam in the conventional X - ray tube . In theory , since it is able to reduce those un ##fa ##vor ##able effects such as the [unused1] electron beam trajectory swinging [unused2] and the beam size changing for the micro ##fo ##cus X - ray tube , it could alleviate CT image artifacts caused by the X - ray focal spot shift and size change . [SEP]',\n",
       "  'existing_cui': 'C0454077',\n",
       "  'existing_cui_name': 'Teleradiotherapy using electrons',\n",
       "  'existing_cui_desc': '[CLS] Tel ##era ##dio ##ther ##ap ##y using electrons [unused3] ( Health Care Act ##ivity , procedure : Beta ##tron electron te ##let ##her ##ap ##y ; photo ##n beam radiation therapy ; Tel ##era ##dio ##ther ##ap ##y using beta particles ; Tel ##era ##dio ##ther ##ap ##y beta particles ; El ##ec ##tron Be ##am Therapy ; El ##ec ##tron te ##let ##her ##ap ##y ; El ##ec ##tron beam therapy ; El ##ec ##tron te ##ler ##adi ##oth ##era ##p ) [SEP]',\n",
       "  'our_bi_cui': 'C0600352',\n",
       "  'our_bi_cui_name': 'Electron Beam Computed Tomography',\n",
       "  'our_bi_cui_desc': '[CLS] El ##ec ##tron Be ##am Co ##mp ##uted Tom ##ography [unused3] ( Health Care Act ##ivity , also known as ultra ##fast c ##t , c ##ine c ##t : beam com ##puted electron to ##mo ##graphy ; El ##ec ##tron beam com ##puted to ##mo ##graphy ; Be ##am Tom ##ography , El ##ec ##tron ; El ##ec ##tron beam com ##puted to ##mo ##g ; Tom ##ography , El ##ec ##tron Be ##am ; El ##ec ##tron Be ##am Tom ##ography ; electron beam to ##mo ##graphy ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27760149.2',\n",
       "  'test_set_idx': 15789,\n",
       "  'type': 'T170',\n",
       "  'name': 'Biomedical Entity Search Tool',\n",
       "  'context': '[CLS] B ##ES ##T : Next - Generation [unused1] B ##io ##medical En ##ti ##ty Search Too ##l [unused2] for Knowledge Discovery from B ##io ##medical Literature As the volume of publications rapidly increases , searching for relevant information from the literature becomes more challenging . To complement standard search engines such as Pub ##M ##ed , it is desirable to have an advanced search tool that directly returns relevant bio ##medical entities such as targets , drugs , and mutations rather than a long list of articles . Some existing tools submit a que ##ry to Pub ##M ##ed and process retrieved abstract ##s to extract information at que ##ry time , resulting in a slow response time and limited coverage of only a fraction of [SEP]',\n",
       "  'existing_cui': 'C2348167',\n",
       "  'existing_cui_name': 'Search Engine',\n",
       "  'existing_cui_desc': '[CLS] Search Engine [unused3] ( Intel ##lect ##ual Product : Search Program ; Search engines ; Engine , Search ; Search Too ##l ; Search Engine ##s ) [SEP]',\n",
       "  'our_bi_cui': 'C2348167',\n",
       "  'our_bi_cui_name': 'Search Engine',\n",
       "  'our_bi_cui_desc': '[CLS] Search Engine [unused3] ( Intel ##lect ##ual Product : Search Program ; Search engines ; Engine , Search ; Search Too ##l ; Search Engine ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '27510458.36',\n",
       "  'test_set_idx': 8923,\n",
       "  'type': 'T033',\n",
       "  'name': 'double lumen sign',\n",
       "  'context': '[CLS] double l ##ume ##n sign in the participants and compared the results between high - resolution fast spin echo and the other m ##oda ##lities . high - resolution fast spin echo images clearly showed in ##ti ##mal flap ##s and double l ##ume ##n signs in all 3 patients , whereas the conventional m ##oda ##lities identified a [unused1] double l ##ume ##n sign [unused2] in only 2 of the 3 patients . The present method of op ##ti ##mized high - resolution fast spin echo imaging with a 3 ##T system improved visual ##ization of in ##ti ##mal flap ##s and should thus be considered for assessing patients with suspected in ##tra ##c ##rani ##al artery di ##sse ##ction that can not be definitive [SEP]',\n",
       "  'existing_cui': 'C0441299',\n",
       "  'existing_cui_name': 'Double lumen tube',\n",
       "  'existing_cui_desc': '[CLS] Double l ##ume ##n tube [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
       "  'our_bi_cui': 'C0233192',\n",
       "  'our_bi_cui_name': \"Ladin 's sign\",\n",
       "  'our_bi_cui_desc': \"[CLS] La ##din ' s sign [unused3] ( Finding , finding : La ##din sign ) [SEP]\",\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27488290.9',\n",
       "  'test_set_idx': 8126,\n",
       "  'type': 'T058',\n",
       "  'name': 'microendoscopic techniques',\n",
       "  'context': '[CLS] ##izing In ##tra ##oper ##ative O - Arm - Based Navigation and Micro ##end ##os ##copic Tech ##ni ##ques A retrospective analysis of the clinical outcomes of eight patients with the l ##umba ##r par ##s inter ##art ##icular ##s defects treated by direct repair with the aid of in ##tra ##oper ##ative O - arm based navigation and [unused1] micro ##end ##os ##copic techniques [unused2] . The aim of this study was to investigate the efficacy and safety of direct screw repair by using minimal ##ly invasive surgery for the l ##umba ##r par ##s inter ##art ##icular ##s defects in a pilot study . Direct repair of par ##s inter ##art ##icular ##s defects has been used to treat young adult patients . Reports [SEP]',\n",
       "  'existing_cui': 'C0441702',\n",
       "  'existing_cui_name': 'Superior pedicle technique',\n",
       "  'existing_cui_desc': '[CLS] Superior p ##edic ##le technique [unused3] ( Health Care Act ##ivity , qualifier value : March ##ac technique ) [SEP]',\n",
       "  'our_bi_cui': 'C0026035',\n",
       "  'our_bi_cui_name': 'Microsurgery',\n",
       "  'our_bi_cui_desc': '[CLS] Micro ##su ##rger ##y [unused3] ( Health Care Act ##ivity , procedure : micro ##su ##rger ##y ; micro ##su ##rger ##ies ; Micro ##su ##rg ##ical procedure ; MI ##CR ##OS ##UR ##G ) [SEP]',\n",
       "  'our_cross_cui': 'C0014245',\n",
       "  'our_cross_cui_name': 'Endoscopy',\n",
       "  'our_cross_cui_desc': '[CLS] End ##os ##copy [unused3] ( Health Care Act ##ivity , procedure , procedure : end ##os ##copy procedure ; end ##os ##copy ; end ##os ##copic examination ; procedure end ##os ##copy ; end ##os ##copic / fiber ##op ##tic examinations ; In ##spect ##ion using end ##os ##cope ; End ##os ##copic ; End ##os ##copic inspection ; End ##os ##copic Examination ; E ##ND ##OS ##CO ##P ##Y ; End ##os ##copy procedure ; end ##os ##co ##pies ; End ##os ##copic Pro ##ced ##ure ) [SEP]'},\n",
       " {'mention_id': '27602300.7',\n",
       "  'test_set_idx': 11297,\n",
       "  'type': 'T082',\n",
       "  'name': 'Eurasia',\n",
       "  'context': \"[CLS] The add ##er ( Viper ##a be ##rus ) in Southern Alt ##ay Mountains : population characteristics , distribution , morphology and phylogenetic position As the most widely distributed snake in [unused1] E ##ura ##sia [unused2] , the add ##er ( Viper ##a be ##rus ) has been extensively investigated in Europe but poorly understood in Asia . The Southern Alt ##ay Mountains represent the add ##er ' s southern distribution limit in Central Asia , whereas its population status has never been assessed . We conducted , for the first time , field surveys for the add ##er at two areas of Southern Alt ##ay Mountains using a combination of line trans ##ec ##ts and random searches . We also described the m ##or ##phological [SEP]\",\n",
       "  'existing_cui': 'C0450981',\n",
       "  'existing_cui_name': 'Addiction severity index',\n",
       "  'existing_cui_desc': '[CLS] Ad ##diction severity index [unused3] ( Intel ##lect ##ual Product , AS ##I , assessment scale : addiction severity index ) [SEP]',\n",
       "  'our_bi_cui': 'C0015176',\n",
       "  'our_bi_cui_name': 'Europe',\n",
       "  'our_bi_cui_desc': '[CLS] Europe [unused3] ( Spa ##tial Concept , geographic location ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '27782044.3',\n",
       "  'test_set_idx': 16573,\n",
       "  'type': 'T170',\n",
       "  'name': 'Comments on Beamer et al . Association',\n",
       "  'context': \"[CLS] Normal Level ##s of U ##rina ##ry CC ##16 Pro ##tein . [unused1] Co ##mme ##nts on Be ##ame ##r et al . Association [unused2] of Children ' s U ##rina ##ry CC ##16 Level ##s with A ##rsen ##ic Con ##cent ##rations in Multiple Environmental Media . In ##t . J . En ##vir ##on . Re ##s . Public Health 2016 , 13 , 52 ##1 In 1937 , Max Clara described a new type of cell in the human lung , which was later determined to be an ex ##oc ##rine secret ##ory cell type containing g ##ran ##ules composed of proteins [ 1 ] . [ . . . ] . [SEP]\",\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0282411',\n",
       "  'our_bi_cui_name': 'Published Comment',\n",
       "  'our_bi_cui_desc': '[CLS] Published Co ##mme ##nt [unused3] ( Intel ##lect ##ual Product : viewpoint ; comment ; Co ##mme ##nts ; View ##point ; commentary ; Re ##mark ; Re ##marks ; viewpoint ##s ; Co ##mme ##ntary ; comments ; Editorial Co ##mme ##nt ; Co ##mme ##nt ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28387835.66',\n",
       "  'test_set_idx': 34002,\n",
       "  'type': 'T058',\n",
       "  'name': 'MLVA',\n",
       "  'context': '[CLS] reveal differences in response between the M ##L ##VA g ##eno ##type ##s . The pro ##in ##f ##lam ##mat ##ory c ##yt ##oki ##ne response induced in human peripheral blood mon ##on ##uc ##lea ##r cells by C . burn ##eti ##i is ##olate ##s from cattle may explain the low incidence of human Q fever outbreak ##s caused by cattle . The c ##yt ##oki ##ne profile of peripheral blood mon ##on ##uc ##lea ##r cells stimulate ##d with C . burn ##eti ##i is ##olate ##s from chronic Q fever patients resembles is ##olate ##s from goats . Furthermore , c ##yt ##oki ##ne responses seem to be depending on host origin than on [unused1] M ##L ##VA [unused2] g ##eno ##type . [SEP]',\n",
       "  'existing_cui': 'C1420126',\n",
       "  'existing_cui_name': 'SLC20A2 gene',\n",
       "  'existing_cui_desc': '[CLS] SL ##C ##20 ##A ##2 gene [unused3] ( Ana ##tom ##ical Structure : S ##OL ##UT ##E CA ##R ##RI ##ER FA ##MI ##L ##Y 20 ( P ##H ##OS ##P ##HA ##TE T ##RA ##NS ##PO ##RT ##ER ) , ME ##MB ##ER 2 ; G ##IB ##BO ##N AP ##E L ##E ##U ##KE ##MI ##A R ##ET ##RO ##VI ##R ##US R ##EC ##EP ##TO ##R 2 ; G ##l ##v ##r - 2 ; P ##H ##OS ##P ##HA ##TE T ##RA ##NS ##PO ##RT ##ER , S ##OD ##I ##UM - DE ##P ##EN ##DE ##NT , 2 ; Pi ##T - 2 ; M ##UR ##IN ##E L ##E ##U ##KE ##MI ##A VI ##R ##US , AM ##P ##H [SEP]',\n",
       "  'our_bi_cui': 'C0042317',\n",
       "  'our_bi_cui_name': 'vanilmandelic acid',\n",
       "  'our_bi_cui_desc': '[CLS] van ##il ##mand ##eli ##c acid [unused3] ( Chemical , V ##MA , substance : A ##cid , Van ##il ##mand ##eli ##c ; van ##ill ##yl ##mand ##eli ##c acid ; A ##cid , Van ##ill ##yl ##mand ##eli ##c ; A ##cid , Met ##ho ##xy ##hy ##dr ##ox ##yman ##del ##ic ; Benz ##ene ##ace ##tic acid , alpha , 4 - di ##hy ##dr ##ox ##y - 3 - met ##ho ##xy - ; 4 H ##ydro ##xy 3 Met ##ho ##xy ##mand ##eli ##c A ##cid ; Van ##ill ##yl ##mand ##eli ##c acid ; Van ##il ##mand ##eli ##c A ##cid ; V ##MA ; Van ##il ##mand ##eli ##c A ##cid [ Chemical / In ##g ##red ##ient ] [SEP]',\n",
       "  'our_cross_cui': 'C1443925',\n",
       "  'our_cross_cui_name': 'Multi-locus variable-number of tandem repeat analysis',\n",
       "  'our_cross_cui_desc': '[CLS] Multi - lo ##cus variable - number of tandem repeat analysis [unused3] ( Health Care Act ##ivity , procedure : Multi - lo ##cus V ##NT ##R analysis ; M ##L ##VA - multi - lo ##cus variable - number of tandem repeat analysis ) [SEP]'},\n",
       " {'mention_id': '27488290.55',\n",
       "  'test_set_idx': 8172,\n",
       "  'type': 'T033',\n",
       "  'name': 'mild complaint',\n",
       "  'context': '[CLS] Low back pain visual analog scores decrease from pre ##oper ##ative 6 . 8 to post ##oper ##ative 1 . 4 of eight cases . Of 16 par ##s defects , healing was observed in 13 ( 81 . 3 % ) at last radio ##logical follow - up . One patient with bilateral fusion failure refused revision surgery because of [unused1] mild complaint [unused2] . No complications such as du ##ral tear , nerve root injury , and infection occurred . Mini ##mal ##ly invasive direct repair of the par ##s inter ##art ##icular ##is defects with in ##tral ##ami ##nar screw ##s by using micro ##end ##os ##copic system and navigation procedure can provide safe and effective treatment of s ##po ##ndy ##lo ##lysis [SEP]',\n",
       "  'existing_cui': 'C0277786',\n",
       "  'existing_cui_name': 'Chief complaint',\n",
       "  'existing_cui_desc': '[CLS] Chief complaint [unused3] ( Finding , finding , finding , s ##ym ##pt ##om : complaints ; chief complaint ; Co ##mp ##lain ##t ; complaints present ; Present ##ing Co ##mp ##lain ##t ; complaint ; { Chief complaint } ; Present ##ing complaint ; Chief Co ##mp ##lain ##t ; the chief complaint is : ) [SEP]',\n",
       "  'our_bi_cui': 'C0277786',\n",
       "  'our_bi_cui_name': 'Chief complaint',\n",
       "  'our_bi_cui_desc': '[CLS] Chief complaint [unused3] ( Finding , finding , finding , s ##ym ##pt ##om : complaints ; chief complaint ; Co ##mp ##lain ##t ; complaints present ; Present ##ing Co ##mp ##lain ##t ; complaint ; { Chief complaint } ; Present ##ing complaint ; Chief Co ##mp ##lain ##t ; the chief complaint is : ) [SEP]',\n",
       "  'our_cross_cui': 'C0436343',\n",
       "  'our_cross_cui_name': 'Symptom mild',\n",
       "  'our_cross_cui_desc': '[CLS] S ##ym ##pt ##om mild [unused3] ( Finding , context - dependent category , finding : mild symptoms ; s ##ym ##pt ##om mild ) [SEP]'},\n",
       " {'mention_id': '27297967.8',\n",
       "  'test_set_idx': 1713,\n",
       "  'type': 'T082',\n",
       "  'name': 'Asn19/Asn23',\n",
       "  'context': '[CLS] Tri ##g ##lut ##ath ##ione [ As ( G ##S ) 3 ] Transport by Multi ##dr ##ug Resistance Pro ##tein 1 ( MR ##P ##1 / ABC ##C ##1 ) Is Select ##ively Mo ##dified by Ph ##os ##ph ##ory ##lation of Ty ##r ##9 ##20 / Ser ##9 ##21 and G ##ly ##cos ##yla ##tion of [unused1] As ##n ##19 / As ##n ##23 [unused2] The ATP - binding cassette transport ##er multi ##dr ##ug resistance protein 1 ( MR ##P ##1 / ABC ##C ##1 ) is responsible for the cellular export of a chemical ##ly diverse array of x ##eno ##biotics and end ##ogen ##ous compounds . A ##rsen ##ic , a human car ##cin ##ogen , is a high - affinity [SEP]',\n",
       "  'existing_cui': 'C3887642',\n",
       "  'existing_cui_name': 'Hippocampus Proper',\n",
       "  'existing_cui_desc': \"[CLS] Hip ##po ##cam ##pus Pro ##per [unused3] ( Ana ##tom ##ical Structure : Hip ##po ##cam ##pus proper ; Hip ##po ##cam ##pus major ; Am ##mon ' s Horn ; CA fields ; Pro ##per , Hip ##po ##cam ##pus ; Horn , Am ##mon ; Hip ##po ##cam ##pus Pro ##pers ; Am ##mon Horn ; hip ##po ##cam ##pus ; Co ##rn ##u am ##mon ##is ; Am ##mons Horn ; Hip ##po ##cam ##pus ; corn ##u am ##mon ##is ; am ##mon ' s horn ; hip ##po ##cam ##pus proper ; Hip ##po ##cam ##pus prop ##rius ; Am ##mon ' s horn ; Co ##rn ##u Am ##mon ##is ; hip ##po ##cam ##pus major ; Horn , Am [SEP]\",\n",
       "  'our_bi_cui': 'C0003995',\n",
       "  'our_bi_cui_name': 'Asparagine',\n",
       "  'our_bi_cui_desc': '[CLS] As ##par ##agi ##ne [unused3] ( Chemical , substance : 2 - Am ##ino ##su ##cci ##nam ##ic acid ; L - as ##par ##agi ##ne ; As ##par ##tam ##ic acid ; alpha - amino ##su ##cci ##nam ##ic acid ; as ##n ; 2 - Am ##ino - 3 - car ##ba ##mo ##yl ##p ##rop ##ano ##ic acid ; as ##par ##agi ##ne ; ( S ) - As ##par ##agi ##ne ; N ; ( S ) - 2 - amino - 3 - car ##ba ##mo ##yl ##p ##rop ##ano ##ic acid ; Alpha - amino ##su ##cci ##nic acid ; As ##n ; L - as ##par ##tic acid beta - amid ##e ; ( 2 ##S ) - 2 [SEP]',\n",
       "  'our_cross_cui': 'C0002518',\n",
       "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
       "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
       " {'mention_id': '27601292.47',\n",
       "  'test_set_idx': 11222,\n",
       "  'type': 'T038',\n",
       "  'name': 'metabolic',\n",
       "  'context': '[CLS] , reflected by C - reactive protein concentrations , significantly influence d the metabolic ratio , v ##ori ##cona ##zo ##le t ##rough concentration and v ##ori ##cona ##zo ##le - N - oxide concentration ( all P < 0 . 00 ##1 ) , when corrected for other factors that could influence v ##ori ##cona ##zo ##le metabolism . The [unused1] metabolic [unused2] ratio was decreased by 0 . 99 ##22 ##9 ( N ) and the v ##ori ##cona ##zo ##le - N - oxide concentration by 0 . 99 ##7 ##75 ( N ) , while the v ##ori ##cona ##zo ##le t ##rough concentration was increased by 1 . 00 ##53 ##21 ( N ) , where N is the difference in [SEP]',\n",
       "  'existing_cui': 'C1524026',\n",
       "  'existing_cui_name': 'Metabolic Process , Cellular',\n",
       "  'existing_cui_desc': '[CLS] Met ##ab ##olic Process , Cell ##ular [unused3] ( B ##iol ##og ##ic Fun ##ction : Met ##ab ##oli ##zed ; Met ##ab ##olic Process ; cellular metabolism ; Met ##ab ##olic ; metabolism ; Met ##ab ##olis ##m ; cellular metabolic process ) [SEP]',\n",
       "  'our_bi_cui': 'C0025519',\n",
       "  'our_bi_cui_name': 'Metabolism',\n",
       "  'our_bi_cui_desc': '[CLS] Met ##ab ##olis ##m [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : Inter ##media ##ry Met ##ab ##olis ##m ; Met ##ab ##olic Process ##es ; ME ##TA ##B PR ##OC ##ES ##SE ##S ; metabolic processes ; Process ##es , Met ##ab ##olic ; General metabolic function ; Met ##ab ##olic Process ; ME ##TA ##B PR ##OC ##ES ##S ; metabolism ; PR ##OC ##ES ##SE ##S ME ##TA ##B ; General metabolic functions ; Inter ##media ##ry Met ##ab ##olic Process ; metabolic process ; metabolism ##s ; Process , Met ##ab ##olic ; PR ##OC ##ES ##S ME ##TA ##B ; Met ##ab ##olis ##m [ P ##K ] ; ME ##TA ##B [SEP]',\n",
       "  'our_cross_cui': 'C0683140',\n",
       "  'our_cross_cui_name': 'drug metabolism',\n",
       "  'our_cross_cui_desc': '[CLS] drug metabolism [unused3] ( B ##iol ##og ##ic Fun ##ction : Drug Met ##ab ##olis ##m ; drug metabolic process ; drugs metabolism ; bio ##tra ##ns ##formation drug ; bio ##tra ##ns ##formation drugs ; metabolism drug ) [SEP]'},\n",
       " {'mention_id': '27784873.10',\n",
       "  'test_set_idx': 16650,\n",
       "  'type': 'T017',\n",
       "  'name': 'urinary bladder cells',\n",
       "  'context': '[CLS] Aden ##os ##ine trip ##hos ##phate release from bladder u ##roth ##eli ##um and se ##ros ##a in a rat model of partial bladder outlet o ##bs ##truction Over ##active bladder is one of the major health problem especially in elderly people . Aden ##os ##ine trip ##hos ##phate is released from [unused1] u ##rina ##ry bladder cells [unused2] and acts as a smooth muscle contraction and sensory signal in mi ##ct ##uri ##tion but little is known about the role of Aden ##os ##ine trip ##hos ##phate release in the path ##op ##hy ##sio ##logy of over ##active bladder . To assess the relationship between Aden ##os ##ine trip ##hos ##phate and over ##active bladder , we used a partial bladder outlet o ##bs ##truction [SEP]',\n",
       "  'existing_cui': 'C0005682',\n",
       "  'existing_cui_name': 'Urinary Bladder',\n",
       "  'existing_cui_desc': '[CLS] U ##rina ##ry B ##lad ##der [unused3] ( Ana ##tom ##ical Structure , body structure : B ##lad ##der ; B ##LA ##D ##DE ##R ; bladder ; U ##rina ##ry bladder ; u ##rina ##ry bladder ; U ##rina ##ry System , B ##lad ##der ; B ##lad ##der structure ; bladder ##s ; B ##lad ##der , U ##rina ##ry ; V ##esi ##ca u ##rina ##ria ; U ##rina ##ry bladder structure ) [SEP]',\n",
       "  'our_bi_cui': 'C0427890',\n",
       "  'our_bi_cui_name': 'Urinary epithelial cell',\n",
       "  'our_bi_cui_desc': '[CLS] U ##rina ##ry e ##pit ##hel ##ial cell [unused3] ( Ana ##tom ##ical Structure , body structure , cell ) [SEP]',\n",
       "  'our_cross_cui': 'C0227599',\n",
       "  'our_cross_cui_name': 'Transitional epithelial cell of urinary bladder',\n",
       "  'our_cross_cui_desc': '[CLS] Transit ##ional e ##pit ##hel ##ial cell of u ##rina ##ry bladder [unused3] ( Ana ##tom ##ical Structure , body structure , cell : U ##rina ##ry tract transitional e ##pit ##hel ##ial cell ; U ##roth ##eli ##al cell ; B ##lad ##der transitional cell ; B ##lad ##der U ##roth ##eli ##al Cell ; B ##lad ##der Transit ##ional Cell ) [SEP]'},\n",
       " {'mention_id': '28197156.27',\n",
       "  'test_set_idx': 28097,\n",
       "  'type': 'T038',\n",
       "  'name': 'bp',\n",
       "  'context': '[CLS] ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 [unused1] b ##p [unused2] from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , Carbon As ##si ##mi ##lation Rate 8 is identical to D ##TH ##8 / G ##h ##d ##8 / L ##HD ##1 , which was reported to control rice flowering date . The increase of A is largely due to an [SEP]',\n",
       "  'existing_cui': 'C1708288',\n",
       "  'existing_cui_name': 'HP wt Allele',\n",
       "  'existing_cui_desc': '[CLS] HP w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : BP ; HP ##2 ##AL ##P ##HA ##2 ; Ha ##pt ##og ##lo ##bin w ##t All ##ele ; HP ##A ##1 ##S ) [SEP]',\n",
       "  'our_bi_cui': 'C0028630',\n",
       "  'our_bi_cui_name': 'Nucleotides',\n",
       "  'our_bi_cui_desc': '[CLS] N ##uc ##leo ##tide ##s [unused3] ( Chemical , substance : n ##uc ##leo ##tide ##s ; N ##uc ##leo ##tide ; N ##uc ##leo ##tide ##s [ Chemical / In ##g ##red ##ient ] ; n ##uc ##leo ##tide ) [SEP]',\n",
       "  'our_cross_cui': 'C0600436',\n",
       "  'our_cross_cui_name': 'Base Pairing',\n",
       "  'our_cross_cui_desc': '[CLS] Base Pa ##iring [unused3] ( B ##iol ##og ##ic Fun ##ction : base pair ; Base Pa ##iring ##s ; base pairs ; base pairing ; Base Pa ##ir ; Base Pa ##irs ) [SEP]'},\n",
       " {'mention_id': '27251800.28',\n",
       "  'test_set_idx': 823,\n",
       "  'type': 'T058',\n",
       "  'name': 'Stoppa',\n",
       "  'context': '[CLS] 3 ) post - operative complications . lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair procedure was longer than the Stop ##pa procedure ( 134 . 6 min 38 . 3 vs . 90 . 6 min 41 . 3 ; P < 0 . 05 ) . The levels of C - reactive protein were higher in the [unused1] Stop ##pa [unused2] group ( P < 0 . 05 ) but the number of le ##uc ##ocytes , ha ##ema ##to ##c ##rit , and ha ##em ##og ##lo ##bin were similar between the groups ( P > 0 . 05 ) . There was no difference in pain during the 1 s ##t and 7 th post - operative , physical functioning [SEP]',\n",
       "  'existing_cui': 'C1538901',\n",
       "  'existing_cui_name': 'ACD gene',\n",
       "  'existing_cui_desc': '[CLS] AC ##D gene [unused3] ( Ana ##tom ##ical Structure : T ##EL ##OM ##ER ##E PR ##OT ##EI ##N T ##PP ##1 ; ad ##ren ##oc ##ort ##ical d ##ys ##p ##lasia ho ##mo ##log ; AC ##D Gene ; Ad ##ren ##oc ##ort ##ical D ##ys ##p ##lasia Ho ##mo ##log ( Mouse ) Gene ; P ##OT ##1 - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N 1 ; P ##OT ##1 - AND T ##IN ##2 - OR ##GA ##NI ##Z ##ING PR ##OT ##EI ##N ; P ##OT ##1 and T ##IN ##2 organizing protein ; AC ##D , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; Tin ##t ##1 ; T ##IN ##2 interacting protein 1 [SEP]',\n",
       "  'our_bi_cui': 'C0628086',\n",
       "  'our_bi_cui_name': 'Stop-zit',\n",
       "  'our_bi_cui_desc': '[CLS] Stop - z ##it [unused3] ( Chemical ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27612561.49',\n",
       "  'test_set_idx': 11771,\n",
       "  'type': 'T170',\n",
       "  'name': 'Netherlands Trial Register',\n",
       "  'context': '[CLS] less likely to report high compliance with resistance and endurance exercises in low - to - moderate intensity exercise compared to survivors of other types of cancer . The disc ##rim ##ina ##tive ability of the multi ##var ##iable models ranged from 0 . 62 to 0 . 75 . Several demographic , clinical and ps ##ych ##oso ##cial factors were associated with participation in and ad ##herence to exercise among cancer survivors . P ##sy ##cho ##so ##cial factors were more strongly associated with ad ##herence in high intensity than low - to - moderate intensity exercise . This study was registered at the [unused1] Netherlands Trial Register [unused2] [ N ##TR ##21 ##53 ] on the 5 ( th ) of January 2010 . [SEP]',\n",
       "  'existing_cui': 'C0027778',\n",
       "  'existing_cui_name': 'Netherlands',\n",
       "  'existing_cui_desc': '[CLS] Netherlands [unused3] ( Spa ##tial Concept , geographic location : NL ; NE ##TH ##ER ##LA ##ND ##S ; net ##her ##lands ; The Netherlands ; Kingdom of the Netherlands ; NL ##D ; net ##her ##land ; ho ##lland ; Holland ) [SEP]',\n",
       "  'our_bi_cui': 'C1516642',\n",
       "  'our_bi_cui_name': 'Clinical Trials Database',\n",
       "  'our_bi_cui_desc': '[CLS] Clinical Trials Database [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
       "  'our_cross_cui': 'C0034975',\n",
       "  'our_cross_cui_name': 'Registries',\n",
       "  'our_cross_cui_desc': '[CLS] Regis ##tries [unused3] ( Intel ##lect ##ual Product : re ##gis ##tries ; registry ; Regis ##try ) [SEP]'},\n",
       " {'mention_id': '27546367.50',\n",
       "  'test_set_idx': 10061,\n",
       "  'type': 'T038',\n",
       "  'name': 'self - protective',\n",
       "  'context': '[CLS] ##ath ##ological injury score ( r = 0 . 72 ##8 ; p = 0 . 02 ##6 ) and between mean a ##rgy ##rop ##hil ##ic - NO ##R number and his ##top ##ath ##ological injury score ( r = 0 . 67 ##0 ; p = 0 . 04 ##8 ) . The detection of a ##rgy ##rop ##hil ##ic - NO ##R proteins amount may be used as an indicator to obtain information about the cellular behaviour ( [unused1] self - protective [unused2] mechanism of tub ##ular e ##pit ##hel ##ial cells ) against Is ##che ##mia / re ##per ##fusion injury and cellular damage levels ( Ta ##b . 2 , Fi ##g . 4 , Re ##f . 24 ) . [SEP]',\n",
       "  'existing_cui': 'C1875759',\n",
       "  'existing_cui_name': 'SKIN PROTECTIVE',\n",
       "  'existing_cui_desc': '[CLS] SK ##IN PR ##OT ##EC ##TI ##VE [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C0243095',\n",
       "  'our_bi_cui_name': 'Finding',\n",
       "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0524828',\n",
       "  'our_cross_cui_name': 'Cytoprotection',\n",
       "  'our_cross_cui_desc': '[CLS] Cy ##top ##rote ##ction [unused3] ( B ##iol ##og ##ic Fun ##ction : Protection , Cell ; c ##yt ##op ##rote ##ction ; Cell Protection ) [SEP]'},\n",
       " {'mention_id': '28071754.3',\n",
       "  'test_set_idx': 24708,\n",
       "  'type': 'T037',\n",
       "  'name': 'injury',\n",
       "  'context': '[CLS] Far - infrared protects vascular end ##oth ##eli ##al cells from advanced g ##ly ##cation end products - induced [unused1] injury [unused2] via Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein - mediated auto ##pha ##gy in di ##abe ##tic mice The accumulation of advanced g ##ly ##cation end products in di ##abe ##tic patients induce ##s vascular end ##oth ##eli ##al injury . Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein is a transcription factor that can be activated by low - temperature far - infrared i ##rra ##diation to ex ##ert beneficial effects on the vascular end ##oth ##eli ##um . In the present study , we investigated the influence of far - infrared - induced Pro ##my [SEP]',\n",
       "  'existing_cui': 'C0005604',\n",
       "  'existing_cui_name': 'Birth Injuries',\n",
       "  'existing_cui_desc': '[CLS] Birth In ##ju ##ries [unused3] ( In ##ju ##ry or Po ##ison ##ing , Birth , diagnosis , disorder : In ##ju ##ries , Birth ; T ##ra ##umatic birth ; injury birth ; Birth trauma , un ##sp ##ec ##ified ; Birth T ##ra ##uma ; Birth trauma of f ##etus ; injury ; birth ; traumatic birth ; birth trauma ; birth injuries ; Birth In ##ju ##ry ; trauma birth ; Neo ##nat ##al Birth In ##ju ##ry ; birth ##ing injuries ; Birth In ##ju ##ries [ Disease / Finding ] ; Un ##sp ##ec ##ified birth trauma ; birth ##ing trauma ; B ##IR ##TH IN ##J ; IN ##J B ##IR ##TH ; Birth injuries ; birth ; injury ; [SEP]',\n",
       "  'our_bi_cui': 'C0010957',\n",
       "  'our_bi_cui_name': 'Tissue damage',\n",
       "  'our_bi_cui_desc': '[CLS] T ##iss ##ue damage [unused3] ( In ##ju ##ry or Po ##ison ##ing , m ##or ##ph ##olo ##gic abnormal ##ity : damage tissues ; Dam ##age ; damages tissue ; Dam ##age , T ##iss ##ue ; tissue damage ; T ##iss ##ue Dam ##age ; damage ; damages ) [SEP]',\n",
       "  'our_cross_cui': 'C0178314',\n",
       "  'our_cross_cui_name': 'Poisoning / injury',\n",
       "  'our_cross_cui_desc': '[CLS] Po ##ison ##ing / injury [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder , finding , navigation ##al concept : In ##ju ##ry & / or poisoning ; IN ##J ##UR ##Y AND P ##O ##IS ##ON ##ING ; In ##ju ##ry and poisoning ; In ##ju ##ry / poisoning ) [SEP]'},\n",
       " {'mention_id': '27669669.10',\n",
       "  'test_set_idx': 13715,\n",
       "  'type': 'T037',\n",
       "  'name': 'subluxation',\n",
       "  'context': '[CLS] B ##ila ##teral C ##1 la ##mina ##r hooks combined with C ##2 p ##edic ##le screw fix ##ation in the treatment of at ##lant ##oa ##xial sub ##lux ##ation after G ##rise ##l syndrome Many et ##iol ##ogies can lead to at ##lant ##oa ##xial sub ##lux ##ai ##on . In G ##rise ##l syndrome , this [unused1] sub ##lux ##ation [unused2] occurs spontaneous ##ly after inflammatory processes of the head and neck . Di ##ag ##nosis is typically based on clinical history and a strong suspicion of this syndrome . Non ##su ##rg ##ical treatment most often resolve ##s the symptoms ; however , in some cases surgical treatment is necessary to repair the sub ##lux ##ation . Various surgical techniques and instrumentation systems [SEP]',\n",
       "  'existing_cui': 'C0332768',\n",
       "  'existing_cui_name': 'Joint Subluxations',\n",
       "  'existing_cui_desc': '[CLS] Joint Sub ##lux ##ations [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity , physical finding , qualifier value : sub ##lux ##ation ; Sub ##lux ##ation ; Sub ##lux ##ation , Joint ; Di ##s ##location , incomplete ; Joint sub ##lux ##ation ; Joint Sub ##lux ##ation ; Sub ##lux ##ation of joint ; sub ##lux ##ations ; Inc ##om ##ple ##te di ##s ##location ; joint sub ##lux ##ation ; Sub ##lux ##ations ; incomplete di ##s ##location ; Sub ##lux ##ations , Joint ; sub ##lux ##ation was seen ; sub ##lux ##ation of joint ; Sub ##lux ##ation - les ##ion ) [SEP]',\n",
       "  'our_bi_cui': 'C0332768',\n",
       "  'our_bi_cui_name': 'Joint Subluxations',\n",
       "  'our_bi_cui_desc': '[CLS] Joint Sub ##lux ##ations [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity , physical finding , qualifier value : sub ##lux ##ation ; Sub ##lux ##ation ; Sub ##lux ##ation , Joint ; Di ##s ##location , incomplete ; Joint sub ##lux ##ation ; Joint Sub ##lux ##ation ; Sub ##lux ##ation of joint ; sub ##lux ##ations ; Inc ##om ##ple ##te di ##s ##location ; joint sub ##lux ##ation ; Sub ##lux ##ations ; incomplete di ##s ##location ; Sub ##lux ##ations , Joint ; sub ##lux ##ation was seen ; sub ##lux ##ation of joint ; Sub ##lux ##ation - les ##ion ) [SEP]',\n",
       "  'our_cross_cui': 'C0263905',\n",
       "  'our_cross_cui_name': 'Atlantoaxial subluxation',\n",
       "  'our_cross_cui_desc': '[CLS] At ##lant ##oa ##xial sub ##lux ##ation [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder : AA ##S - At ##lant ##oa ##xial sub ##lux ##ation ; at ##lant ##oa ##xial ; sub ##lux ##ation ; di ##s ##location ; at ##lant ##oa ##xial ; At ##lant ##o - a ##xial sub ##lux ##ation ; At ##lant ##oa ##xial di ##s ##location ; at ##lant ##oa ##xial ; di ##s ##location ; Sub ##lux ##ation of at ##lant ##oa ##xial joint ; sub ##lux ##ation ; at ##lant ##oa ##xial ) [SEP]'},\n",
       " {'mention_id': '27794381.32',\n",
       "  'test_set_idx': 17172,\n",
       "  'type': 'T103',\n",
       "  'name': '[ Ca ( 2 + ) ] i',\n",
       "  'context': '[CLS] while em ##od ##in or u ##rs ##ode ##ox ##ych ##olic acid were given to the corresponding group for 7 weeks . The his ##tom ##or ##phological and ultra ##structure change of gal ##l ##bla ##dder were detected by micro ##scope and electron micro ##scope , the content of plasma ch ##ole ##cy ##sto ##kini ##n and [unused1] [ C ##a ( 2 + ) ] i [unused2] were analyzed successively by radio ##im ##mu ##no ##ass ##ay and flow c ##yt ##ome ##try . The protein and m ##RNA of G ##s ##α , G ##i ##α and Cap in ch ##ole ##cy ##st cells were determined by western b ##lot ##ting and real time polymer ##ase chain reaction . Em ##od ##in or u [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C1155431',\n",
       "  'our_bi_cui_name': 'positive regulation of cytosolic calcium ion concentration',\n",
       "  'our_bi_cui_desc': '[CLS] positive regulation of c ##yt ##oso ##lic calcium ion concentration [unused3] ( B ##iol ##og ##ic Fun ##ction : elevation of calcium ion concentration in c ##yt ##oso ##l ; c ##yt ##oso ##lic calcium ion concentration elevation ; c ##yt ##op ##las ##mic calcium ion concentration elevation ; elevation of c ##yt ##oso ##lic calcium ion concentration ; elevation of c ##yt ##op ##las ##mic calcium ion concentration ; elevation of calcium ion concentration in c ##yt ##op ##las ##m ) [SEP]',\n",
       "  'our_cross_cui': 'C0596235',\n",
       "  'our_cross_cui_name': 'Calcium ion',\n",
       "  'our_cross_cui_desc': '[CLS] Cal ##ci ##um ion [unused3] ( Chemical : Cal ##ci ##um Cat ##ion ; free calcium ; CA + 2 ; ion calcium ; Cal ##ci ##um cat ##ion ; Free Cal ##ci ##um ; calcium ions ; C ##a ##2 + ; C ##a + + ; Cal ##ci ##um Ion ##s ; C ##a 2 + ; calcium ion ; CA ##LC ##I ##UM CA ##TI ##ON ; Cal ##ci ##um Ion ; calcium cat ##ion ; Cal ##ci ##um 2 + ; Ion ##ized Cal ##ci ##um ) [SEP]'},\n",
       " {'mention_id': '28523425.48',\n",
       "  'test_set_idx': 38413,\n",
       "  'type': 'T082',\n",
       "  'name': 'M1',\n",
       "  'context': '[CLS] : see text ] of [ Formula : see text ] and [ Formula : see text ] . These findings indicate that the encoding of upper ex ##tre ##mity movement speed by M1 high - [ Formula : see text ] activity is primarily linear . Also , the fact that this activity remained elevated throughout a movement suggests that M1 does not merely generate trans ##ient instructions for a specific movement duration , but instead is responsible for the entirety of the movement . Finally , the spatial distribution of high - [ Formula : see text ] activity suggests the presence of a recruitment phenomenon in which higher speeds or increased muscle activity involve activation of larger [unused1] M1 [unused2] area s . [SEP]',\n",
       "  'existing_cui': 'C1705014',\n",
       "  'existing_cui_name': 'CHRM1 wt Allele',\n",
       "  'existing_cui_desc': '[CLS] CH ##R ##M ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : M1 ##R ; HM ##1 ; Cho ##liner ##gic Re ##ceptor , Mu ##sca ##rini ##c , 1 Gene ; Ace ##ty ##l ##cho ##line Re ##ceptor , Mu ##sca ##rini ##c 1 Gene ; Cho ##liner ##gic Re ##ceptor , Mu ##sca ##rini ##c 1 w ##t All ##ele ; Ace ##ty ##l ##cho ##line Re ##ceptor , Mu ##sca ##rini ##c , 1 Gene ) [SEP]',\n",
       "  'our_bi_cui': 'C0026607',\n",
       "  'our_bi_cui_name': 'Motor Cortex',\n",
       "  'our_bi_cui_desc': '[CLS] Motor Co ##rte ##x [unused3] ( Spa ##tial Concept , Motor , body structure : Co ##rte ##x ; Area , Motor ; Motor Area ; Areas , So ##matic Motor ; so ##mat ##omo ##tor areas ; Motor area ; Co ##rte ##x , Motor ; So ##mat ##omo ##tor Area ; Areas , Motor ; motor cortex ; Area , So ##matic Motor ; Motor Areas ; so ##matic motor areas ; So ##mat ##omo ##tor Areas ; Motor Areas , So ##matic ; motor area ; areas motor ; So ##matic Motor Area ; Area , So ##mat ##omo ##tor ; Motor Area , So ##matic ; Areas , So ##mat ##omo ##tor ; Motor cortex ; cortex motor ; So ##matic Motor [SEP]',\n",
       "  'our_cross_cui': 'C3495441',\n",
       "  'our_cross_cui_name': 'primary motor cortex',\n",
       "  'our_cross_cui_desc': '[CLS] primary motor cortex [unused3] ( Spa ##tial Concept , Carpenter , Crosby , M I : area F1 ; Motor Area , Primary ; Motor Co ##rt ##ices , Primary ; primary so ##mat ##omo ##tor area ; primary motor area ; Motor Strip ; Pre ##cent ##ral Motor Co ##rte ##x ; Pre ##cent ##ral Motor Areas ; Area , Primary Motor ; motor cortex ; Motor Co ##rt ##ices , Pre ##cent ##ral ; Primary Motor Co ##rt ##ices ; pre ##cent ##ral motor cortex ; motor strip ; Primary Motor Area ; Motor cortex ; Area , Pre ##cent ##ral Motor ; Motor Co ##rte ##x , Pre ##cent ##ral ; pre ##cent ##ral motor area ; Primary Motor Areas ; Co ##rt [SEP]'},\n",
       " {'mention_id': '27612561.28',\n",
       "  'test_set_idx': 11750,\n",
       "  'type': 'T038',\n",
       "  'name': 'identify',\n",
       "  'context': '[CLS] ##ates of exercise ad ##herence were studied separately for high intensity and low - to - moderate intensity exercise . De ##mo ##graphic , clinical , and physical factors were assessed using self - reported question ##naire ##s . Re ##lev ##ant clinical information was extracted from medical records . Multi ##var ##iable log ##istic re ##gression analyses were applied to [unused1] identify [unused2] co ##rrel ##ates that were significantly associated with participation , high session attendance , high compliance with resistance and high compliance with endurance exercises . Part ##ici ##pants were more likely to have higher education , be non - smoke ##rs , have lower psychological distress , higher outcome expectations , and perceive more exercise barriers than non - participants . In [SEP]',\n",
       "  'existing_cui': 'C0695108',\n",
       "  'existing_cui_name': 'Sperm identification from testis tissue , fresh or cryopreserved',\n",
       "  'existing_cui_desc': '[CLS] S ##per ##m identification from test ##is tissue , fresh or cry ##op ##res ##erve ##d [unused3] ( Health Care Act ##ivity : ID ##EN ##TI ##F ##Y SP ##ER ##M T ##IS ##SU ##E ; I ##dent ##ify sperm tissue ; SP ##R ##M ID F ##RO ##M T ##ST ##IS T ##IS ##S F ##RS ##H / CR ##Y ##OP ##RS ##R ##VD ) [SEP]',\n",
       "  'our_bi_cui': 'C0243095',\n",
       "  'our_bi_cui_name': 'Finding',\n",
       "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0020792',\n",
       "  'our_cross_cui_name': 'Identification',\n",
       "  'our_cross_cui_desc': '[CLS] I ##dent ##ification [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Defense Me ##chan ##ism , finding : I ##dent ##ifications ; psychological identification ; I ##dent ##ification - mental defense mechanism ; ID ##EN ##TI ##FI ##CA ##TI ##ON PS ##Y ##CH ##OL ; I ##dent ##ification - mental defence mechanism ) [SEP]'},\n",
       " {'mention_id': '27933285.46',\n",
       "  'test_set_idx': 22314,\n",
       "  'type': 'T033',\n",
       "  'name': 'signs',\n",
       "  'context': '[CLS] Re ##sp ##ons ##ive ##ness Scale , all but one of the tested patients obtained clinical scores in the clinical range for at least one area . On the AD ##OS 2 , 4 patients obtained scores indicating a moderate level of au ##tist ##ic spectrum disorder symptoms , 4 had a mild level , and 15 showed no or minimal [unused1] signs [unused2] of au ##tist ##ic spectrum disorder . Motor stereo ##ty ##pies in children with normal cognitive level represent a challenging diagnostic issue for which a finely tailored assessment is mandatory in order to define a precise developmental profile . Thus , careful and cautious use of standardized tests is warrant ##ed to avoid mi ##s ##dia ##gno ##sis . Furthermore , it [SEP]',\n",
       "  'existing_cui': 'C0311392',\n",
       "  'existing_cui_name': 'Physical findings',\n",
       "  'existing_cui_desc': '[CLS] Physical findings [unused3] ( Finding , finding , physical finding : physical finding ; physical findings ; Physical finding ; physical findings [ use for free text ] ; Physical signs ; Sign ##s - physical ; physical signs ; Physical sign ; Sign ; find physical ) [SEP]',\n",
       "  'our_bi_cui': 'C3540840',\n",
       "  'our_bi_cui_name': 'Sign or Symptom',\n",
       "  'our_bi_cui_desc': '[CLS] Sign or S ##ym ##pt ##om [unused3] ( Finding : Sign ##s or S ##ym ##pt ##oms ; Clinical Sign ##s ; C ##L ##IN ##IC ##AL F ##IN ##DI ##NG ; C ##L ##IN ##IC ##AL S ##IG ##NS ; DE ##SC ; Clinical Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0037088',\n",
       "  'our_cross_cui_name': 'Signs and Symptoms',\n",
       "  'our_cross_cui_desc': '[CLS] Sign ##s and S ##ym ##pt ##oms [unused3] ( Finding , finding : Sign ##s and S ##ym ##pt ##oms [ Disease / Finding ] ; Clinical findings ; clinical findings ; O ##bs ##er ##vable En ##ti ##ty ; sign and s ##ym ##pt ##om ; Sign and s ##ym ##pt ##om ; S ##ym ##pt ##oms and Sign ##s ; sign / s ##ym ##pt ##om ; Finding ; Clinical observation : symptoms and signs ; S ##IG ##NS S ##Y ##MP ##TO ##MS ; Clinical finding ) [SEP]'},\n",
       " {'mention_id': '27887026.29',\n",
       "  'test_set_idx': 20814,\n",
       "  'type': 'T103',\n",
       "  'name': 'CmFDH',\n",
       "  'context': '[CLS] ##O ##3 ( - ) as a substrate was evaluated by measuring the kinetic rates and conducting productivity ass ##ays . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H ) and Cha ##eto ##mium the ##rm ##op ##hil ##um showed a higher efficiency in converting HC ##O ##3 ( - ) to format ##e than [unused1] C ##m ##F ##D ##H [unused2] , whereas C ##m ##F ##D ##H was better in the oxidation of format ##e . The pH op ##ti ##mum of the reduction was at pH 7 - 8 . However , the high concentrations of HC ##O ##3 ( - ) reduced the reaction rate . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H [SEP]',\n",
       "  'existing_cui': 'C0342185',\n",
       "  'existing_cui_name': 'Hyperthyroxinemia , Familial Dysalbuminemic',\n",
       "  'existing_cui_desc': '[CLS] H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial D ##ys ##al ##bu ##mine ##mic [unused3] ( Ana ##tom ##ical Structure , disorder : H ##YP ##ER ##TH ##Y ##RO ##X ##IN ##EM ##IA , FA ##MI ##L ##IA ##L D ##Y ##SA ##L ##B ##UM ##IN ##EM ##IC ; F ##ami ##lial d ##ys ##al ##bu ##mina ##em ##ic h ##yper ##thy ##ro ##xin ##ae ##mia ; H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial D ##ys ##al ##bu ##mine ##mic [ Disease / Finding ] ; D ##ys ##al ##bu ##mine ##mic H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial ; F ##ami ##lial D ##ys ##al ##bu ##mine ##mic H ##yper ##thy ##ro ##xin ##emia ; F ##ami [SEP]',\n",
       "  'our_bi_cui': 'C0060647',\n",
       "  'our_bi_cui_name': 'Formate dehydrogenase',\n",
       "  'our_bi_cui_desc': '[CLS] Form ##ate de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , c ##yt ##och ##rome , c ##yt ##och ##rome , substance : Form ##ate de ##hy ##dr ##ogen ##ase ( c ##yt ##och ##rome ) ) [SEP]',\n",
       "  'our_cross_cui': 'C0016570',\n",
       "  'our_cross_cui_name': 'Formate dehydrogenase',\n",
       "  'our_cross_cui_desc': '[CLS] Form ##ate de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , substance : De ##hy ##dr ##ogen ##ase , N ##AD - Form ##ate ; N ##AD Form ##ate De ##hy ##dr ##ogen ##ase ; De ##hy ##dr ##ogen ##ases , Form ##ate ; N ##AD - Form ##ate De ##hy ##dr ##ogen ##ase ; Form ##ate H ##ydro ##gen ##lya ##ses ; Form ##ate De ##hy ##dr ##ogen ##ases ; Form ##ate De ##hy ##dr ##ogen ##ases [ Chemical / In ##g ##red ##ient ] ; Form ##ate : N ##AD + o ##xi ##dor ##ed ##uc ##tase ; H ##ydro ##gen ##lya ##ses , Form ##ate ) [SEP]'},\n",
       " {'mention_id': '27478553.20',\n",
       "  'test_set_idx': 7719,\n",
       "  'type': 'T098',\n",
       "  'name': 'non - night eaters',\n",
       "  'context': \"[CLS] National Health and N ##utrition Examination Survey . ' Night eating ' was defined as consuming 25 % or more of one ' s daily energy intake between 21 : 00 and 06 : 00 . Sub ##jects comply ##ing with the preceding condition were classified as ' night eat ##ers ' , whereas the rest were considered ' [unused1] non - night eat ##ers [unused2] ' . Lo ##gis ##tic re ##gression analysis examined factors related to night eating . Multiple linear re ##gression analyses were used to examine the relationship between night eating and B ##MI z - scores , whereas multi ##no ##mia ##l log ##istic re ##gression analysis was used to examine the relationship between night eating and weight status . About [SEP]\",\n",
       "  'existing_cui': 'C2350309',\n",
       "  'existing_cui_name': 'Night Vision',\n",
       "  'existing_cui_desc': '[CLS] Night Vision [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , finding , o ##bs ##er ##vable entity : Vision , Sc ##oto ##pic ; Vision , Rod ; Night vision ; Vision , Night ; s ##cot ##op ##ic vision ; Rod Vision ; Sc ##oto ##pic vision ; Sc ##oto ##pic Vision ) [SEP]',\n",
       "  'our_bi_cui': 'C0243095',\n",
       "  'our_bi_cui_name': 'Finding',\n",
       "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C1257890',\n",
       "  'our_cross_cui_name': 'Population Group',\n",
       "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
       " {'mention_id': '28295414.12',\n",
       "  'test_set_idx': 31550,\n",
       "  'type': 'T168',\n",
       "  'name': 'drinks',\n",
       "  'context': '[CLS] ##IN ##E Study Recently , the Food and Drug Administration proposed to expand the options for primary end points in the development of medications for alcohol use disorder to include either a ##bs ##tine ##nce from alcohol or a non ##ab ##st ##inen ##t outcome : no heavy drinking days ( with a heavy drinking day defined as more than 3 [unused1] drinks [unused2] per day for women and more than 4 drinks per day for men [ > 3 / > 4 cut ##off ] ) . The Food and Drug Administration also suggested that 6 months would be the most appropriate length for a clinical trial to demonstrate the stability of this non ##ab ##st ##inen ##t drinking outcome . However , few alcohol [SEP]',\n",
       "  'existing_cui': 'C0452428',\n",
       "  'existing_cui_name': 'Drink',\n",
       "  'existing_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
       "  'our_bi_cui': 'C0452428',\n",
       "  'our_bi_cui_name': 'Drink',\n",
       "  'our_bi_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
       "  'our_cross_cui': 'C0001967',\n",
       "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
       "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
       " {'mention_id': '28027760.29',\n",
       "  'test_set_idx': 23870,\n",
       "  'type': 'T058',\n",
       "  'name': '3rd generation dual - source CT',\n",
       "  'context': '[CLS] ##iac CT an ##gio ##graphy : 2 . 4 ± 0 . 9 ##m ##S ##v - 6 . 8 ± 2 . 7 m ##S ##v , all p ≤ 0 . 04 ##14 ) . In 39 patients trans ##cat ##he ##ter a ##ort ##ic valve replacement was performed and an ##nu ##lus diameter was within the recommended range in all patients . No severe cardiac or vascular complications were noted . [unused1] 3rd generation dual - source CT [unused2] provides diagnostic image quality in trans ##cat ##he ##ter a ##ort ##ic valve replacement - planning CT an ##gio ##graphy and facilitate ##s reliable assessment of trans ##cat ##he ##ter a ##ort ##ic valve replacement device and delivery option while reducing radiation dose . [SEP]',\n",
       "  'existing_cui': 'C2021220',\n",
       "  'existing_cui_name': 'third generation thyroid stimulating hormone assay',\n",
       "  'existing_cui_desc': '[CLS] third generation thy ##roid s ##ti ##mulating hormone ass ##ay [unused3] ( Health Care Act ##ivity , lab test : T ##S ##H ( 3rd generation ) ; 3rd generation T ##S ##H ass ##ay ) [SEP]',\n",
       "  'our_bi_cui': 'C4055114',\n",
       "  'our_bi_cui_name': 'Dual energy computed tomography',\n",
       "  'our_bi_cui_desc': '[CLS] Dual energy com ##puted to ##mo ##graphy [unused3] ( Health Care Act ##ivity , procedure : Dual - Energy Co ##mp ##uted Tom ##ography ; DE ##CT - dual energy com ##puted to ##mo ##graphy ) [SEP]',\n",
       "  'our_cross_cui': 'C0040405',\n",
       "  'our_cross_cui_name': 'X-Ray Computed Tomography',\n",
       "  'our_cross_cui_desc': '[CLS] X - Ray Co ##mp ##uted Tom ##ography [unused3] ( Health Care Act ##ivity , computer ##ized to ##mo ##graphy , procedure : Sc ##an , X - Ray CT ; com ##puted to ##mo ##graphy x rays ; EMI scan ; em ##i scan ; CT X ##RA ##Y ; Co ##mp ##uted X - Ray Tom ##ography ; Computer ##ised trans ##ax ##ial to ##mo ##graphy ; to ##mo ##den ##si ##tom ##et ##ry ; CA ##T scan - ; CT Sc ##an , X Ray ; Computer ##ized to ##mo ##gram ; X - Ray CA ##T Sc ##an ; Computer ##ized trans ##ax ##ial to ##mo ##graphy ; x - ray com ##puted to ##mo ##graphy ; Tom ##ography , Trans ##mission [SEP]'},\n",
       " {'mention_id': '27273231.23',\n",
       "  'test_set_idx': 1204,\n",
       "  'type': 'T204',\n",
       "  'name': 'survival model',\n",
       "  'context': '[CLS] ##l , l ##iga ##tion , and pro ##ximal l ##iga ##tion plus di ##stal En ##sea ##l ) and extracted to evaluate the pressure tolerance up to 75 mm H ##g at the sealed end . A left lower lobe ##ct ##omy was performed to evaluate chronic - phase du ##rab ##ility of the sealed s ##tum ##ps in a [unused1] survival model [unused2] . Two or three branches of the pulmonary art ##eries in each dog were allocated to each of the 3 groups . After the scheduled survival period , the pulmonary art ##eries were sampled . Press ##ure tolerance at the sealed end was evaluated in 91 pulmonary artery sections . All sealed ends showed pressure tolerance > 75 mm H ##g [SEP]',\n",
       "  'existing_cui': 'C0007620',\n",
       "  'existing_cui_name': 'Cell Survival',\n",
       "  'existing_cui_desc': '[CLS] Cell Survival [unused3] ( B ##iol ##og ##ic Fun ##ction : Via ##bilities , Cell ; cell via ##bility ; Cell Via ##bility ; Via ##bility , Cell ; cell survival ; Cell Via ##bilities ; Survival , Cell ) [SEP]',\n",
       "  'our_bi_cui': 'C0086272',\n",
       "  'our_bi_cui_name': 'Experimental Model',\n",
       "  'our_bi_cui_desc': '[CLS] Experimental Model [unused3] ( Intel ##lect ##ual Product : experimental model ; E ##X ##P ##ER M ##OD ##EL ; models experimental ; Experimental Models ; experimental ##s models ; Models , Experimental ; experimental models ; Experimental Models , Other ; Model , Experimental ; M ##OD ##EL E ##X ##P ##ER ; E ##X ##P ##ER M ##OD ##EL ##S ; M ##OD ##EL ##S E ##X ##P ##ER ) [SEP]',\n",
       "  'our_cross_cui': 'C0599779',\n",
       "  'our_cross_cui_name': 'Animal Model',\n",
       "  'our_cross_cui_desc': '[CLS] Animal Model [unused3] ( E ##uka ##ryo ##te : animal model ; Animal Models ; Models , Animal ; Animal Model , Gene ##ric ; Research Model , Animal ; animals models ; animal models ; Model , Animal ) [SEP]'},\n",
       " {'mention_id': '27986797.2',\n",
       "  'test_set_idx': 22899,\n",
       "  'type': 'T103',\n",
       "  'name': 'myomitokine',\n",
       "  'context': '[CLS] Growth differentiation factor 15 is a [unused1] my ##omi ##tok ##ine [unused2] governing systemic energy home ##ost ##asis Red ##uce ##d mitochondrial electron transport chain activity promotes long ##evity and improve ##s energy home ##ost ##asis via cell - autonomous and - non - autonomous factors in multiple model systems . This mit ##oh ##orm ##etic effect is thought to involve the mitochondrial unfolded protein response ( UP ##R ( m ##t ) ) , an adaptive stress - response pathway activated by mitochondrial pro ##te ##oto ##xi ##c stress . Using mice with skeletal muscle - specific deficiency of C ##ri ##f ##1 ( muscle - specific knockout [ M ##KO ] ) , an integral protein of the large mit ##ori ##bos ##oma ##l [SEP]',\n",
       "  'existing_cui': 'C0950133',\n",
       "  'existing_cui_name': 'Online Mendelian Inheritance In Man',\n",
       "  'existing_cui_desc': '[CLS] Online Men ##del ##ian In ##her ##ita ##nce In Man [unused3] ( Intel ##lect ##ual Product : online men ##del ##ian inheritance in man ( O ##MI ##M ) database ; Online Men ##del ##ian In ##her ##ita ##nce in Man ) [SEP]',\n",
       "  'our_bi_cui': 'C0026484',\n",
       "  'our_bi_cui_name': 'Monokines',\n",
       "  'our_bi_cui_desc': '[CLS] Mon ##oki ##nes [unused3] ( Chemical , substance : Mon ##oki ##ne ; mon ##oki ##ne ; Mon ##oki ##nes [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
       "  'our_cross_cui': 'C0574031',\n",
       "  'our_cross_cui_name': 'Biologically active substance',\n",
       "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
       " {'mention_id': '27482869.1',\n",
       "  'test_set_idx': 7894,\n",
       "  'type': 'T204',\n",
       "  'name': 'Allen J. Wilcox',\n",
       "  'context': \"[CLS] Voices : A Con ##vers ##ation with [unused1] Allen J . Wilcox [unused2] Allen James Wilcox was born on 30 September 1946 in Columbus , OH . He studied medicine at the University of Michigan , graduated in 1973 , and after a rotating internship , he completed a master ' s degree in maternal and child health ( 1976 ) and a PhD in e ##pid ##em ##iology ( 1979 ) at the University of North Carolina in Chapel Hill . After graduation , he went to work at the National Institute of Environmental Health Sciences ( National Institute of Environmental Health Sciences , one of the US National Institutes of Health ) in Durham , NC , where he has spent his career . [SEP]\",\n",
       "  'existing_cui': 'C3810728',\n",
       "  'existing_cui_name': 'Wilcox County , AL',\n",
       "  'existing_cui_desc': '[CLS] Wilcox County , AL [unused3] ( Spa ##tial Concept : Wilcox County ; AL ##13 ##1 ; Wilcox County , Alabama ) [SEP]',\n",
       "  'our_bi_cui': 'C0027361',\n",
       "  'our_bi_cui_name': 'Persons',\n",
       "  'our_bi_cui_desc': '[CLS] Persons [unused3] ( Population Group , person : Individual ; Person ; persons ; peoples ; Person [ du ##p ] ; People ; person ; people ) [SEP]',\n",
       "  'our_cross_cui': 'C0086418',\n",
       "  'our_cross_cui_name': 'Homo sapiens',\n",
       "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
       " {'mention_id': '28197156.18',\n",
       "  'test_set_idx': 28088,\n",
       "  'type': 'T017',\n",
       "  'name': 'Carbon Assimilation Rate 8',\n",
       "  'context': '[CLS] ##rs using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial cult ##iva ##r . Fine mapping suggested that [unused1] Carbon As ##si ##mi ##lation Rate 8 [unused2] en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 [SEP]',\n",
       "  'existing_cui': 'C2246620',\n",
       "  'existing_cui_name': 'iron assimilation',\n",
       "  'existing_cui_desc': '[CLS] iron ass ##im ##ilation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_bi_cui': 'C1413023',\n",
       "  'our_bi_cui_name': 'C8A gene',\n",
       "  'our_bi_cui_desc': '[CLS] C ##8 ##A gene [unused3] ( Ana ##tom ##ical Structure : complement component 8 alpha subunit ; CO ##MP ##LE ##ME ##NT CO ##MP ##ON ##EN ##T 8 , AL ##P ##HA S ##U ##B ##UN ##IT ; C ##8 AL ##P ##HA ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27372076.8',\n",
       "  'test_set_idx': 3959,\n",
       "  'type': 'T092',\n",
       "  'name': 'industrially',\n",
       "  'context': '[CLS] the St ##re ##pt ##omy ##ces ah ##y ##gro ##scopic ##us strain C ##K - 15 that acts as a re ##press ##or of m ##or ##phological development Wu ##yi ##en ##cin is produced by St ##re ##pt ##omy ##ces ah ##y ##gro ##scopic ##us var . w ##uy ##iens ##is , which has been widely used in China as an [unused1] industrial ##ly [unused2] produced bio ##pes ##tic ##ide to control various fun ##gal diseases . Although its mechanism of action , breeding , and f ##er ##mentation had been extensively characterized , less is known about the regulatory functions that affect its bio ##sy ##nt ##hesis or m ##or ##phological development . The w ##ys ##R ##3 gene of S . ah ##y ##gro [SEP]',\n",
       "  'existing_cui': 'C1552816',\n",
       "  'existing_cui_name': 'all - LocalMarkupIgnore',\n",
       "  'existing_cui_desc': '[CLS] all - Local ##M ##ark ##up ##I ##gno ##re [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
       "  'our_bi_cui': 'C0557758',\n",
       "  'our_bi_cui_name': 'Industrial environment',\n",
       "  'our_bi_cui_desc': '[CLS] Industrial environment [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
       "  'our_cross_cui': 'C0007983',\n",
       "  'our_cross_cui_name': 'Chemical Industry',\n",
       "  'our_cross_cui_desc': '[CLS] Chemical Industry [unused3] ( Organization : Chemical Industries ; IN ##D ##US ##T CH ##EM ; Industry , Chemical ; chemical industry ; chemical industries ; CH ##EM IN ##D ##US ##T ; Industries , Chemical ; Chemical industry ) [SEP]'},\n",
       " {'mention_id': '27442216.17',\n",
       "  'test_set_idx': 5813,\n",
       "  'type': 'T098',\n",
       "  'name': 'Snowmobile',\n",
       "  'context': '[CLS] ##s ( 63 % , 64 % ) than the All - terrain vehicles group ( 50 % ) ( P = 0 . 000 ##8 ) . Snow ##mobile injuries had the highest rate of spinal ( 23 % ) and lower ex ##tre ##mity fracture ##s ( 53 % ) ( P = 0 . 000 ##4 ) . [unused1] Snow ##mobile [unused2] and dirt ##bi ##ke co ##hor ##ts had higher rate of f ##em ##ur fracture ##s ( 22 % , 17 % , P = 0 . 00 ##1 ) whereas the All - terrain vehicles co ##hor ##t had higher rates of upper ex ##tre ##mity ( 18 % ) , hand ( 11 % ) , s ##cap ##ula [SEP]',\n",
       "  'existing_cui': 'C1427826',\n",
       "  'existing_cui_name': 'SBNO1 gene',\n",
       "  'existing_cui_desc': '[CLS] S ##B ##N ##O ##1 gene [unused3] ( Ana ##tom ##ical Structure , Dr ##oso ##phi ##la : FL ##J ##10 ##70 ##1 ; FL ##J ##10 ##8 ##33 ; ST ##RA ##W ##BE ##R ##R ##Y NO ##TC ##H , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 1 ; straw ##berry notch ho ##mo ##log 1 ; M ##OP ##3 ) [SEP]',\n",
       "  'our_bi_cui': 'C0597177',\n",
       "  'our_bi_cui_name': 'Particle',\n",
       "  'our_bi_cui_desc': '[CLS] Part ##icle [unused3] ( Chemical : particle ; particles ; Part ##icles ; a very small piece or part ) [SEP]',\n",
       "  'our_cross_cui': 'C0599755',\n",
       "  'our_cross_cui_name': 'Cohort',\n",
       "  'our_cross_cui_desc': '[CLS] Co ##hor ##t [unused3] ( Population Group : co ##hor ##ted ; co ##hor ##ting ; co ##hor ##t ; co ##hor ##ts ) [SEP]'},\n",
       " {'mention_id': '27299916.29',\n",
       "  'test_set_idx': 1879,\n",
       "  'type': 'T103',\n",
       "  'name': 'CQ',\n",
       "  'context': '[CLS] or synthesized . Only derivatives containing an electron def ##icient a ##romatic ring and capable of adopting flat conform ##ations , optimal for π - π interactions with Fe ( III ) PP ##IX , in ##hibit ##ed β - hem ##ati ##n formation . The two most potent analogue ##s showed na ##no ##mo ##lar parasite activity , with little [unused1] C ##Q [unused2] cross - resistance , low c ##yt ##oto ##xi ##city , and high in v ##it ##ro micro ##so ##mal stability . Selected analogue ##s in ##hibit ##ed hem ##oz ##oi ##n formation in P ##las ##mo ##dium f ##al ##ci ##par ##um causing high levels of free hem ##e . In contrast to q ##uin ##olin ##es , introduction of [SEP]',\n",
       "  'existing_cui': 'C0282245',\n",
       "  'existing_cui_name': 'Northern Mariana Islands',\n",
       "  'existing_cui_desc': '[CLS] Northern Mariana Islands [unused3] ( Spa ##tial Concept : MP ; NO ##RT ##H ##ER ##N MA ##RI ##AN ##A IS ##LA ##ND ##S ; C ##Q ; M ##NP ) [SEP]',\n",
       "  'our_bi_cui': 'C0072849',\n",
       "  'our_bi_cui_name': 'quinacillin',\n",
       "  'our_bi_cui_desc': '[CLS] q ##uin ##ac ##ill ##in [unused3] ( Chemical : 3 - car ##box ##y - 2 - q ##uin ##ox ##ali ##ny ##l ##pen ##ici ##llan ##ic acid ; Q ##uin ##ac ##ill ##in ; Q ##UI ##NA ##CI ##LL ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C0008269',\n",
       "  'our_cross_cui_name': 'Chloroquine',\n",
       "  'our_cross_cui_desc': '[CLS] Ch ##lor ##o ##quin ##e [unused3] ( Chemical , medication , product , substance : Ch ##lor ##o ##quin ##e [ Chemical / In ##g ##red ##ient ] ; Ch ##lor ##och ##in ; Ch ##lor ##o ##quin ##e [ anti - malaria ##l ] ; Ch ##lor ##o ##quin ##ium ; N ( 4 ) - ( 7 - ch ##lor ##o - 4 - Q ##uin ##olin ##yl ) - N ( 1 ) , N ( 1 ) - diet ##hyl - 1 , 4 - pen ##tan ##edia ##mine ; ch ##lor ##o ##quin ##e ; Ch ##lor ##och ##ine ; Ch ##lor ##o ##quin ##a ; CH ##L ##OR ##O ##Q ##UI ##NE ; C ##lor ##o ##quin ##a ; Ch [SEP]'},\n",
       " {'mention_id': '27623277.40',\n",
       "  'test_set_idx': 12224,\n",
       "  'type': 'T058',\n",
       "  'name': 'procedures',\n",
       "  'context': '[CLS] ( relative weight of 0 . 21 ) , risk of major complications ( relative weight of 0 . 18 ) , and distance needed to travel for treatment ( relative weight of 0 . 15 ) . Pro ##cedural and treatment preferences did not vary with demographic ##s , self - reported health status , or familiar ##ity with the [unused1] procedures [unused2] . Survey respond ##ents preferred minimal ##ly invasive operations over stereo ##ta ##ctic body radiation therapy or th ##ora ##cot ##omy for treatment of early - stage non - small cell lung cancer . Treatment m ##oda ##lity and risk of cancer re ##cu ##rrence were the most important factors associated with treatment preferences . Pro ##vide ##r experience out ##wei ##gh [SEP]',\n",
       "  'existing_cui': 'C0184661',\n",
       "  'existing_cui_name': 'Interventional procedure',\n",
       "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_bi_cui': 'C0184661',\n",
       "  'our_bi_cui_name': 'Interventional procedure',\n",
       "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27500205.1',\n",
       "  'test_set_idx': 8433,\n",
       "  'type': 'T103',\n",
       "  'name': 'Kindlins',\n",
       "  'context': '[CLS] Of [unused1] Kind ##lins [unused2] and Cancer Kind ##lins are 4 . 1 - e ##z ##rin - rid ##ix ##in - m ##oes ##in ( F ##ER ##M ) domain containing proteins . There are three kind ##lins in mammals , which share high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the [SEP]',\n",
       "  'existing_cui': 'C1720776',\n",
       "  'existing_cui_name': 'Kindling , Neurologic',\n",
       "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
       "  'our_bi_cui': 'C0010422',\n",
       "  'our_bi_cui_name': 'Crystallins',\n",
       "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28495651.5',\n",
       "  'test_set_idx': 37780,\n",
       "  'type': 'T201',\n",
       "  'name': 'cardiovascular death',\n",
       "  'context': '[CLS] Per ##cent ##ile cat ##ego ##riz ##ation of Q ##T interval as an approach for identifying adult patients at risk for [unused1] card ##iovascular death [unused2] The results from studies of the association of Q ##T pro ##long ##ation with card ##iovascular death have been inconsistent . The purpose of this study was to compare the major correction formula ##s to percent ##ile values of Q ##T for heart rate ranges as to their ability to remove the relationship of Q ##T to heart rate and to predict card ##iovascular death . Part ##ici ##pants were 16 , 53 ##1 veterans who had an initial EC ##G at the Veterans Affairs Medical Center , Pa ##lo Alto , between March 31 , 1987 , and December [SEP]',\n",
       "  'existing_cui': 'C0007226',\n",
       "  'existing_cui_name': 'Cardiovascular system',\n",
       "  'existing_cui_desc': '[CLS] Card ##iovascular system [unused3] ( Body System , body structure : Structure of card ##iovascular system , un ##sp ##ec ##ified ; CA ##RD ##IO ##VA ##SC ##U ##LA ##R S ##Y ##ST ##EM ; Card ##iovascular ; Organ System , Card ##iovascular ; CA ##RD ##IO ##VA ##SC S ##Y ##ST ##EM ; Card ##iovascular structure ; card ##iovascular system ; Card ##iovascular Organ System ; C ##ir ##cula ##tory ; Structure of card ##iovascular system ; Card ##iovascular Systems ; card ##iovascular structure ; C ##ir ##cula ##tory System ; C ##ir ##cula ##tory Systems ; { C ##ir ##cula ##tory system } ; c ##ir ##cula ##tory ; C ##ir ##cula ##tory system ; Body System , Card ##iovascular ; card ##iovascular system [SEP]',\n",
       "  'our_bi_cui': 'C0376297',\n",
       "  'our_bi_cui_name': 'Cardiac Death',\n",
       "  'our_bi_cui_desc': '[CLS] Card ##iac Death [unused3] ( B ##iol ##og ##ic Fun ##ction : death ; cardiac ; cardiac death ; cardiac deaths ; Card ##iac death ; Death , Card ##iac ; cardiac ; death ) [SEP]',\n",
       "  'our_cross_cui': 'C2926098',\n",
       "  'our_cross_cui_name': \"Mechanism of death in patient 's dying of cardiovascular causes : Type : Point in time : ^ Patient : Nominal\",\n",
       "  'our_cross_cui_desc': \"[CLS] Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : Point in time : ^ Pat ##ient : No ##mina ##l [unused3] ( Clinical At ##tri ##but ##e : Death due to C ##V causes ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : P ##t : ^ Pat ##ient : No ##m ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes ) [SEP]\"},\n",
       " {'mention_id': '27298278.22',\n",
       "  'test_set_idx': 1823,\n",
       "  'type': 'T103',\n",
       "  'name': 'E',\n",
       "  'context': '[CLS] ##one , an ant ##hra ##quin ##one , and a nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##er , together with three known q ##uin ##ones and seven other known compounds , were isolated from the aerial parts of Mo ##rin ##da par ##vi ##folia . The structures of m ##ori ##nda ##par ##vin ##s C , D , [unused1] E [unused2] , F , and G were el ##uc ##idated on the basis of s ##pect ##ros ##copic or X - ray di ##ff ##raction analysis as met ##hyl 4 - h ##ydro ##xy - 1 , 6 - dim ##eth ##ox ##y - nap ##ht ##hale ##ne - 2 - car ##box ##yla ##te , met ##hyl 4 , 8 - di [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0010207',\n",
       "  'our_bi_cui_name': 'Coumarins',\n",
       "  'our_bi_cui_desc': '[CLS] Co ##uma ##rin ##s [unused3] ( Chemical : co ##uma ##rin ##s ; Co ##uma ##rine ##s ; Der ##via ##tives , 1 , 2 - Benz ##opy ##rone ; 1 , 2 - Benz ##opy ##rone ##s ; Benz ##opy ##ran 2 ones ; 1 , 2 - Benz ##opy ##rone Der ##via ##tives ; Co ##uma ##rin ##s [ Chemical / In ##g ##red ##ient ] ; 1 , 2 Benz ##opy ##rone ##s ; Co ##uma ##rin Der ##iva ##tives ; Der ##iva ##tives , Co ##uma ##rin ; Benz ##opy ##ran - 2 - ones ; B ##EN ##Z ##OP ##Y ##RO ##NE ##S 01 02 ; 1 , 2 Benz ##o P ##yr ##ones ; 1 , 2 - Benz ##o [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28334615.30',\n",
       "  'test_set_idx': 32328,\n",
       "  'type': 'T033',\n",
       "  'name': 'molecular underpinnings',\n",
       "  'context': '[CLS] white matter property - within the force ##ps minor and the left superior temporal longitudinal f ##as ##ci ##culus . Within each of these tracts , mean fraction ##al an ##is ##ot ##rop ##y value of depression score - associated v ##ox ##els was used as a p ##hen ##otype in a subsequent Gene set en ##rich ##ment analysis . The NC ##AM ##1 Inter ##actions gene set was significantly en ##rich ##ed in these tracts . By linking the NC ##AM ##1 Inter ##actions gene set to depression scores and their structural brain co ##rrel ##ates in healthy participants , the current study contributes to the understanding of the [unused1] molecular under ##pin ##ning ##s [unused2] of de ##pressive s ##ym ##pt ##oma ##tology . [SEP]',\n",
       "  'existing_cui': 'C0019247',\n",
       "  'existing_cui_name': 'Hereditary Diseases',\n",
       "  'existing_cui_desc': '[CLS] Here ##dit ##ary Disease ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Gene ##tic disorder ; Di ##sor ##der , Gene ##tic ; genetics disease ; Gene ##tic Di ##sor ##der ; Disease , Gene ##tic ; Di ##sor ##ders , Gene ##tic ; Disease , Here ##dit ##ary ; genetic disorder ; hereditary disease ; Disease ##s , Here ##dit ##ary ; inherited disease ; Here ##dit ##ary disorder ; Here ##dit ##ary Di ##sor ##ders ; Disease ##s , Gene ##tic ; genetic disorders ; In ##her ##ited disease ; In ##her ##ited Disease ; hereditary diseases ; Molecular Disease ; H ##ER ##ED ##IT ##AR ##Y D ##IS ; Gene ##tic Disease ##s ; Gene ##tic Con ##dition ; [SEP]',\n",
       "  'our_bi_cui': 'C1148560',\n",
       "  'our_bi_cui_name': 'molecular_function',\n",
       "  'our_bi_cui_desc': '[CLS] molecular _ function [unused3] ( B ##iol ##og ##ic Fun ##ction : molecular function ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28197133.33',\n",
       "  'test_set_idx': 28049,\n",
       "  'type': 'T103',\n",
       "  'name': 'GH48',\n",
       "  'context': '[CLS] 1 % of the trans ##cripts . The CA ##Z ##yme profile was dominated by families G ##H ##9 ##4 ( cello ##bio ##se - p ##hos ##ph ##ory ##lase ) , G ##H1 ##3 ( am ##yla ##se ) , G ##H ##43 and G ##H1 ##0 ( hem ##ice ##ll ##ula ##ses ) , G ##H ##9 and [unused1] G ##H ##48 [unused2] ( cell ##ula ##ses ) , P ##L ##11 ( p ##ec ##tina ##se ) as well as G ##H ##2 and G ##H ##3 ( o ##li ##gos ##ac ##cha ##rida ##ses ) . Our data support the pivotal role of the most characterized fi ##bro ##ly ##tic bacteria ( Pre ##vo ##tel ##la , R ##umi ##no ##cc ##cus [SEP]',\n",
       "  'existing_cui': 'C1333673',\n",
       "  'existing_cui_name': 'GH1 gene',\n",
       "  'existing_cui_desc': '[CLS] G ##H1 gene [unused3] ( Ana ##tom ##ical Structure : G ##RO ##W ##TH H ##OR ##MO ##NE , NO ##R ##MA ##L ; G ##RO ##W ##TH H ##OR ##MO ##NE 1 ; G ##H1 Gene ; growth hormone 1 ; so ##mat ##ot ##rop ##in ; pit ##uit ##ary growth hormone ; G ##RO ##W ##TH H ##OR ##MO ##NE , P ##IT ##UI ##TA ##R ##Y ; h ##G ##H - N ; G ##H - N ; Growth Ho ##rmon ##e 1 Gene ) [SEP]',\n",
       "  'our_bi_cui': 'C0016799',\n",
       "  'our_bi_cui_name': 'Fumarate Hydratase',\n",
       "  'our_bi_cui_desc': '[CLS] Fu ##mara ##te H ##yd ##rata ##se [unused3] ( Chemical , substance : Fu ##mara ##te H ##yd ##rata ##se [ Chemical / In ##g ##red ##ient ] ; Fu ##mara ##te h ##yd ##rata ##se ; Fu ##mara ##se ; f ##uma ##rase ; Fu ##mara ##te h ##yd ##rata ##se ( substance ) [ Am ##bi ##guous ] ; H ##yd ##rata ##se , Fu ##mara ##te ; ( S ) - Mal ##ate h ##ydro - l ##yas ##e ; f ##uma ##rate h ##yd ##rata ##se ) [SEP]',\n",
       "  'our_cross_cui': 'C1260229',\n",
       "  'our_cross_cui_name': 'Cellulases',\n",
       "  'our_cross_cui_desc': '[CLS] Cell ##ula ##ses [unused3] ( Chemical : Cell ##ula ##ses [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '28273336.12',\n",
       "  'test_set_idx': 30879,\n",
       "  'type': 'T038',\n",
       "  'name': 'BV - allergic',\n",
       "  'context': '[CLS] ##A ##pi m 1 has been available on the I ##mm ##uno ##CA ##P system for routine diagnosis of bee venom all ##er ##gy . Now , there are five components available , and we aimed to detect the sensitivity and specific ##ity of r ##A ##pi m 1 , 2 , 3 , 5 , and 10 in [unused1] B ##V - all ##ergic [unused2] patients . We further evaluated the sensitivity of r ##A ##pi m 1 and 2 of an alternative platform and investigated possible differences in the se ##ns ##iti ##zation profile between mon ##ose ##ns ##iti ##zation and clinical ##ly relevant double se ##ns ##iti ##zation . Analysis of the whole panel of bee venom all ##er ##gens of the CA [SEP]',\n",
       "  'existing_cui': 'C0282555',\n",
       "  'existing_cui_name': 'Anti-Allergic Agents',\n",
       "  'existing_cui_desc': '[CLS] Anti - All ##ergic Agents [unused3] ( Chemical , product , substance : Anti All ##ergic Agents ; AN ##TI ##AL ##LE ##R ##GI ##C AG ##EN ##TS ; Agents , Anti ##alle ##rgy ; Anti ##alle ##rgy Agents ; anti all ##er ##gy drugs ; Agents , Anti ##alle ##rg ##ic ; anti ##alle ##rg ##ic drugs ; anti - all ##er ##gy drugs ; anti ##alle ##rg ##ic drug ; Drugs , Anti ##alle ##rg ##ic ; Anti All ##ergic ##s ; Drugs , Anti - All ##er ##gy ; all ##ergic anti ; Anti - All ##ergic ##s ; Anti ##alle ##rgen ##ic drugs ; Anti ##alle ##rg ##ics ; anti ##alle ##rg ##ic ; Agents , Anti - All ##ergic ; anti [SEP]',\n",
       "  'our_bi_cui': 'C0571832',\n",
       "  'our_bi_cui_name': 'Vitamin B group allergy',\n",
       "  'our_bi_cui_desc': '[CLS] Vita ##min B group all ##er ##gy [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder ) [SEP]',\n",
       "  'our_cross_cui': 'C1828283',\n",
       "  'our_cross_cui_name': 'Allergy to bee venom',\n",
       "  'our_cross_cui_desc': '[CLS] All ##er ##gy to bee venom [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder ) [SEP]'},\n",
       " {'mention_id': '27507702.51',\n",
       "  'test_set_idx': 8767,\n",
       "  'type': 'T103',\n",
       "  'name': 'tri -',\n",
       "  'context': '[CLS] ##ed . The most prominent protein motifs include the zinc finger , rib ##on ##uc ##lea ##se H , reverse trans ##cript ##ase , and an ##ky ##rin repeat domains . The simple sequence repeats identified from > 1 k ##b length of un ##ige ##nes show a do ##mina ##ncy of din ##uc ##leo ##tide repeat motifs followed with [unused1] t ##ri - [unused2] and te ##tra ##nu ##cle ##ot ##ide motifs . A number of un ##ige ##nes were put ##ative ##ly assessed to belong to adaptation and defense mechanisms including heat shock proteins 70 , To ##ll - like receptor 4 , AM ##P - activated protein kinase , a ##qua ##por ##in - 2 , etc . Our data provide a rich [SEP]',\n",
       "  'existing_cui': 'C0065404',\n",
       "  'existing_cui_name': 'lysyl-5-fluorotryptophyl-lysine',\n",
       "  'existing_cui_desc': '[CLS] l ##ys ##yl - 5 - flu ##oro ##try ##pt ##op ##hyl - l ##ys ##ine [unused3] ( Chemical , L : L ##ys - F - T ##rp - L ##ys ; Tri ) [SEP]',\n",
       "  'our_bi_cui': 'C0032550',\n",
       "  'our_bi_cui_name': 'Polynucleotides',\n",
       "  'our_bi_cui_desc': '[CLS] Pol ##yn ##uc ##leo ##tide ##s [unused3] ( Chemical , substance : p ##oly ##nu ##cle ##ot ##ide ; Pol ##yn ##uc ##leo ##tide ##s [ Chemical / In ##g ##red ##ient ] ; Pol ##yn ##uc ##leo ##tide ) [SEP]',\n",
       "  'our_cross_cui': 'C0282537',\n",
       "  'our_cross_cui_name': 'Trinucleotide Repeats',\n",
       "  'our_cross_cui_desc': '[CLS] Tri ##nu ##cle ##ot ##ide Rep ##eat ##s [unused3] ( Chemical : Rep ##eat ##s , Triple ##t ; triple ##t repeats ; Triple ##t Rep ##eat ##s ; t ##rin ##uc ##leo ##tide repeats ; triple ##t repeat ; Rep ##eat , Tri ##nu ##cle ##ot ##ide ; Triple ##t Rep ##eat ; Rep ##eat ##s , Tri ##nu ##cle ##ot ##ide ; Tri ##nu ##cle ##ot ##ide repeats ; Rep ##eat , Triple ##t ; t ##rin ##uc ##leo ##tide repeat ; Tri ##nu ##cle ##ot ##ide Rep ##eat ) [SEP]'},\n",
       " {'mention_id': '27669217.53',\n",
       "  'test_set_idx': 13704,\n",
       "  'type': 'T017',\n",
       "  'name': 'ermB',\n",
       "  'context': '[CLS] ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both er ##m ##B and er ##m ##T in all is ##olate ##s was er ##yt ##hr ##omy ##cin in ##du ##cible and yielded comparable mac ##rol ##ide MI ##Cs in all six is ##olate ##s . Take ##n together , in ##du ##cible expression of both er ##m ##B and er ##m ##T conferred high mac ##rol ##ide resistance in these S . gal ##lo ##ly ##ticus subsp . paste ##rian ##us is ##olate ##s . Our findings reveal new mac ##rol ##ide resistance features in S . gal ##lo ##ly ##ticus subsp . paste ##uria ##nus by both [unused1] er ##m ##B [unused2] and er ##m ##T . [SEP]',\n",
       "  'existing_cui': 'C0732611',\n",
       "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
       "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
       "  'our_bi_cui': 'C0243036',\n",
       "  'our_bi_cui_name': 'Genes , erbB',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##s , er ##b ##B [unused3] ( Ana ##tom ##ical Structure : A ##vian E ##ry ##th ##ro ##blast ##osis V ##ir ##us On ##co ##gene B ; E ##ry ##th ##ro ##blast Trans ##form ##ing Gene B ; On ##co ##gene , E ##G ##F ##R ; On ##co ##gene ER ##B B ; er ##b ##B Gene ##s ; er ##b ##B Gene ; ER ##B - B ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '28107521.38',\n",
       "  'test_set_idx': 25785,\n",
       "  'type': 'T017',\n",
       "  'name': 'SW480',\n",
       "  'context': '[CLS] the W ##nt signaling pathway still remains incomplete ##ly understood , we sought to el ##uc ##ida ##te their relative contribution in the formation of de ##grad ##as ##ome ##s , as these protein assemblies most likely represent the m ##or ##phological and functional co ##rrel ##ates of end ##ogen ##ous β - cat ##eni ##n destruction complexes . In [unused1] S ##W ##48 ##0 [unused2] color ##ec ##tal cancer cells treated with the tank ##yra ##se inhibitor G ##00 ##7 - L ##K we found that A ##X ##IN ##1 was not required for de ##grad ##as ##ome formation . In contrast , the formation of de ##grad ##as ##ome ##s as well as their capacity to de ##grade β - cat ##eni ##n were [SEP]',\n",
       "  'existing_cui': 'C3538902',\n",
       "  'existing_cui_name': 'SLC4A1 wt Allele',\n",
       "  'existing_cui_desc': '[CLS] SL ##C ##4 ##A ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : F ##R ; Sol ##ute Carrier Family 4 , An ##ion Exchange ##r , Member 1 ( E ##ry ##th ##ro ##cy ##te Me ##mb ##rane Pro ##tein Band 3 , Diego Blood Group ) w ##t All ##ele ; W ##D ; D ##I ; A ##E 1 ; W ##D ##1 ; CD ##23 ##3 ; WR ; B ##ND ##3 ; R ##TA ##1 ##A ) [SEP]',\n",
       "  'our_bi_cui': 'C3006953',\n",
       "  'our_bi_cui_name': 'Staphylococcus sp . SW48',\n",
       "  'our_bi_cui_desc': '[CLS] St ##aph ##yl ##oc ##oc ##cus s ##p . S ##W ##48 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
       "  'our_cross_cui': 'C0007634',\n",
       "  'our_cross_cui_name': 'Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
       " {'mention_id': '27621200.11',\n",
       "  'test_set_idx': 12043,\n",
       "  'type': 'T038',\n",
       "  'name': 'kindness',\n",
       "  'context': '[CLS] exploring the relationship between self - compassion , self - judgement , self - kindness , compassion , professional quality of life and well ##bei ##ng among UK community nurses Co ##mp ##ass ##ion fatigue and burn ##out can impact on performance of nurses . This paper explores the relationship between self - compassion , self - judgement , self - [unused1] kindness [unused2] , compassion , professional quality of life , and well ##bei ##ng among community nurses . To measure associations between self - compassion , compassion fatigue , well ##bei ##ng , and burn ##out in community nurses . Q ##uant ##itative data were collected using standard ##ised ps ##ych ##ometric question ##naire ##s : ( 1 ) Professional Quality of Life Scale [SEP]',\n",
       "  'existing_cui': 'C0456909',\n",
       "  'existing_cui_name': 'Blind Vision',\n",
       "  'existing_cui_desc': '[CLS] Blind Vision [unused3] ( Finding , finding : Blind ##ness ; blind vision ; Unable to see ; Blind ##ness [ Disease / Finding ] ; Can not see ; Blind ; blind ##ness ; U ##TS - Unable to see ; blind ) [SEP]',\n",
       "  'our_bi_cui': 'C0020039',\n",
       "  'our_bi_cui_name': 'Hostility',\n",
       "  'our_bi_cui_desc': '[CLS] Host ##ility [unused3] ( B ##iol ##og ##ic Fun ##ction , context - dependent category , finding , physical finding , situation , s ##ym ##pt ##om : [ D ] Host ##ility ; attitude hostile ; Host ##ile behavior ; Host ##ile behaviour ; hostile ; hostilities ; hostility ; Host ##ilities ) [SEP]',\n",
       "  'our_cross_cui': 'C0871641',\n",
       "  'our_cross_cui_name': 'affection',\n",
       "  'our_cross_cui_desc': '[CLS] affection [unused3] ( B ##iol ##og ##ic Fun ##ction : A ##ffe ##ction ; affection ##s ) [SEP]'},\n",
       " {'mention_id': '28072576.24',\n",
       "  'test_set_idx': 24800,\n",
       "  'type': 'T033',\n",
       "  'name': 'detection',\n",
       "  'context': '[CLS] ( - 1 ) Iron oxide na ##no ##par ##tic ##les ) . I ##maging based on this property has shown a substantial contrast - to - noise ratio improvement ( up to 5 fold , p < 0 . 01 ) . The speed of sound - related effect generated a well disc ##ern ##ible image contrast and allowed the [unused1] detection [unused2] of the particles existence and location , in both r ##aster - scan projection and ultra ##sonic com ##puted to ##mo ##graphy imaging . Conversely , no significant change in the acoustic at ##ten ##uation coefficient was noted . Based on these findings , it is concluded that Iron oxide na ##no ##par ##tic ##les can be used as an effective speed [SEP]',\n",
       "  'existing_cui': 'C0206100',\n",
       "  'existing_cui_name': 'Signal Detection',\n",
       "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
       "  'our_bi_cui': 'C1511790',\n",
       "  'our_bi_cui_name': 'Detection',\n",
       "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
       "  'our_cross_cui': 'C0442726',\n",
       "  'our_cross_cui_name': 'Detected',\n",
       "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
       " {'mention_id': '28424683.67',\n",
       "  'test_set_idx': 35445,\n",
       "  'type': 'T038',\n",
       "  'name': 'expand',\n",
       "  'context': '[CLS] ##city but higher secret ##ion of IF ##N - γ . Ex ##pan ##sion and functional activation of super - charged Natural killer cells by O ##Cs is dependent on inter ##le ##uki ##n ( inter ##le ##uki ##n ) - 12 and IL - 15 . Thus , in this report , we not only provide a novel strategy to [unused1] expand [unused2] super - charged Natural killer cells , but also demonstrate that rapid and sustained expansion of residual T cells within the pu ##rified Natural killer cells during expansion with den ##dr ##itic cells or O ##Cs could be a potential mechanism by which the numbers and function of Natural killer cells decline in cancer patients and in B ##LT - human ##ized [SEP]',\n",
       "  'existing_cui': 'C1263424',\n",
       "  'existing_cui_name': 'LYSP100-associated nuclear domain',\n",
       "  'existing_cui_desc': '[CLS] L ##Y ##SP ##100 - associated nuclear domain [unused3] ( Ana ##tom ##ical Structure : LA ##ND ##s ; lands ; landed ) [SEP]',\n",
       "  'our_bi_cui': 'C0205229',\n",
       "  'our_bi_cui_name': 'Expanding',\n",
       "  'our_bi_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
       "  'our_cross_cui': 'C0007595',\n",
       "  'our_cross_cui_name': 'cell growth',\n",
       "  'our_cross_cui_desc': '[CLS] cell growth [unused3] ( B ##iol ##og ##ic Fun ##ction : cell expansion ; cellular growth ; Cell ##s - - Growth ; Cell Growth ; cell growth ##s ; cells growth ; growth cell ; growth of cell ; Cell ##ular Growth ; Cell ##ular Ex ##pan ##sion ) [SEP]'},\n",
       " {'mention_id': '27921269.21',\n",
       "  'test_set_idx': 21918,\n",
       "  'type': 'T033',\n",
       "  'name': 'had sex',\n",
       "  'context': '[CLS] structure , arising from goodness of membership judgment ##s . Mode ##ration of this graded structure is also predicted , with the focus here on how sexual orientation identity affects sexual definitions . A total of 300 18 - to 30 - year - old participants completed an online survey , rating 18 behaviors for how far each constitutes having \" [unused1] had sex [unused2] \" and virgin ##ity loss . Part ##ici ##pants fell into one of four groups : he ##tero ##sexual male or female , gay male or lesbian . The predicted ratings hierarchy emerged , in which bid ##ire ##ctional g ##eni ##tal acts were rated significantly higher than un ##id ##ire ##ctional or non ##pen ##et ##rative contact , which was [SEP]',\n",
       "  'existing_cui': 'C1314687',\n",
       "  'existing_cui_name': 'Sexual intercourse - finding',\n",
       "  'existing_cui_desc': '[CLS] Sexual intercourse - finding [unused3] ( Finding , finding : Finding of sexual intercourse ; O ##bs ##er ##vation of sexual intercourse ; Making love ; Sexual intercourse ; Sexual act ; Co ##it ##us ; Finding of sexual intercourse [ du ##p ] ; Sex ; S ##I - Sexual intercourse ; V ##agi ##nal intercourse ) [SEP]',\n",
       "  'our_bi_cui': 'C3829825',\n",
       "  'our_bi_cui_name': 'Has HIV or AIDS',\n",
       "  'our_bi_cui_desc': '[CLS] Has HIV or AIDS [unused3] ( Intel ##lect ##ual Product : Does the patient have HIV or AIDS ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27905972.10',\n",
       "  'test_set_idx': 21624,\n",
       "  'type': 'T170',\n",
       "  'name': 'paper',\n",
       "  'context': '[CLS] models to describe the full age pattern of mortality are not able to capture mortality delay versus mortality compression . More recent models that assess delay versus compression mostly focused on the adult or old ages alone and did not distinguish mortality compression below and above the m ##oda ##l age at death , although they represent different mechanisms . This [unused1] paper [unused2] presents a new para ##metric model that describes the full age pattern of mortality and assess ##es compression - at different stages of life - and delay of mortality : the Co ##D ##e model . The model includes 10 parameters , of which five are constant over time . The five time - varying parameters reflect delay of mortality and compression [SEP]',\n",
       "  'existing_cui': 'C0462999',\n",
       "  'existing_cui_name': 'Litmus paper',\n",
       "  'existing_cui_desc': '[CLS] Li ##t ##mus paper [unused3] ( Medical Devi ##ce , physical object : Li ##t ##mus Paper ; lit ##mus papers ; Re ##age ##nts , Clinical Chemistry , Rapid Test , pH , Strip ; IV ##D Test Re ##age ##nt / Kit ##s , Clinical Chemistry , Rapid Test , pH , Strip ; pH Strip In ##dic ##ators ; lit ##mus paper ) [SEP]',\n",
       "  'our_bi_cui': 'C0600659',\n",
       "  'our_bi_cui_name': 'Manuscripts',\n",
       "  'our_bi_cui_desc': '[CLS] Man ##us ##cripts [unused3] ( Intel ##lect ##ual Product : manuscript ; manuscripts ; Man ##us ##cript ) [SEP]',\n",
       "  'our_cross_cui': 'C1706852',\n",
       "  'our_cross_cui_name': 'Article',\n",
       "  'our_cross_cui_desc': '[CLS] Article [unused3] ( Intel ##lect ##ual Product ) [SEP]'},\n",
       " {'mention_id': '28277189.51',\n",
       "  'test_set_idx': 31002,\n",
       "  'type': 'T017',\n",
       "  'name': 'hFoB1 .19 cells',\n",
       "  'context': '[CLS] significantly suppressed U2 ##OS cell migration and invasion . On the contrary , over ##ex ##press ##ion of C ##X ##LC ##5 remarkably promoted the migration and invasion of U2 ##OS cells . Interest ##ingly , both ex ##ogen ##ous C ##X ##CL ##5 treatment and the conditioned medium of C ##X ##CL ##5 - over ##ex ##pressing [unused1] h ##F ##o ##B ##1 . 19 cells [unused2] could also enhance the migration and invasion of U2 ##OS cells , suggesting that the promoting role of C ##X ##CL ##5 in U2 ##OS cell migration and invasion is also in a para ##c ##rine - dependent manner . According to these data , our study demonstrates that C ##X ##CL ##5 is up ##re ##gu ##lated [SEP]',\n",
       "  'existing_cui': 'C3640056',\n",
       "  'existing_cui_name': 'CD19CAR-CD3zeta-4-1BB-expressing Allogeneic T-lymphocyte Cells',\n",
       "  'existing_cui_desc': '[CLS] CD ##19 ##CA ##R - CD ##3 ##ze ##ta - 4 - 1 ##BB - expressing All ##ogen ##ei ##c T - l ##ymph ##oc ##yte Cell ##s [unused3] ( Ana ##tom ##ical Structure : CA ##RT - 19 Cell ##s ) [SEP]',\n",
       "  'our_bi_cui': 'C0007634',\n",
       "  'our_bi_cui_name': 'Cells',\n",
       "  'our_bi_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]',\n",
       "  'our_cross_cui': 'C0029418',\n",
       "  'our_cross_cui_name': 'Osteoblasts',\n",
       "  'our_cross_cui_desc': '[CLS] O ##ste ##ob ##last ##s [unused3] ( Ana ##tom ##ical Structure , cell : o ##ste ##ob ##last ##s ; o ##ste ##ob ##last ; cells o ##ste ##ob ##last ##s ; cells o ##ste ##ob ##last ; O ##ste ##ob ##last ) [SEP]'},\n",
       " {'mention_id': '28441489.18',\n",
       "  'test_set_idx': 36140,\n",
       "  'type': 'T033',\n",
       "  'name': 'cold - start',\n",
       "  'context': '[CLS] ##yna ##mo ##meter using the cold - start unified cycle . The fleet included 15 gasoline direct - injection vehicles , including 8 G ##DI ##s certified to the most - string ##ent emissions standard , super ##ult ##ra - low - emission vehicles . We q ##uant ##ified the effects of engine technology , emission certification standards , and [unused1] cold - start [unused2] on emissions . For vehicles certified to the same emissions standard , there is no statistical difference of regulated gas - phase poll ##uta ##nt emissions between P ##FI ##s and G ##DI ##s . However , G ##DI ##s had , on average , a factor of 2 higher part ##iculate matter mass emissions than P ##FI ##s due to [SEP]',\n",
       "  'existing_cui': 'C0452588',\n",
       "  'existing_cui_name': 'Start brand of breakfast cereal',\n",
       "  'existing_cui_desc': '[CLS] Start brand of breakfast cereal [unused3] ( Food , substance : Start ) [SEP]',\n",
       "  'our_bi_cui': 'C0022885',\n",
       "  'our_bi_cui_name': 'Laboratory Procedures',\n",
       "  'our_bi_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27587730.21',\n",
       "  'test_set_idx': 10760,\n",
       "  'type': 'T103',\n",
       "  'name': 'gga-miR-21',\n",
       "  'context': \"[CLS] ##ga - mi ##R - 21 in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the [unused1] g ##ga - mi ##R - 21 [unused2] inhibitor enhanced pre - ad ##ip ##oc ##yte proliferation . The subsequent investigation identified K ##rup ##pel - like factor 5 m ##RNA as a target of g ##ga - mi ##R - 21 . The g ##ga - mi ##R - 21 mimic in ##hibit ##ed K ##rup ##pel - like factor 5 3 ( ' ) U [SEP]\",\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1537719',\n",
       "  'our_bi_cui_name': 'MIR21 gene',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '27430240.52',\n",
       "  'test_set_idx': 5378,\n",
       "  'type': 'T058',\n",
       "  'name': 'dual - luciferase reporter assay',\n",
       "  'context': '[CLS] E ##2 ##F transcription factor 1 or c ##yclic ad ##eno ##sin ##e mon ##op ##hos ##phate response element - binding protein ( CR ##E ##B ) , which are predicted transcription regulatory factors of CD ##39 or CD ##7 ##3 . The regulatory relationships among these factors were then determined by western b ##lot analysis and [unused1] dual - l ##uc ##ifer ##ase reporter ass ##ay [unused2] . In addition , changes in ad ##eno ##sin ##e metabolism were measured in the treated cells . The results revealed that ad ##eno ##sin ##e and C ##GS ##21 ##6 ##80 significantly up ##re ##gu ##lated CD ##39 and CD ##7 ##3 expression ( P < 0 . 01 ) . E ##2 ##F transcription factor 1 [SEP]',\n",
       "  'existing_cui': 'C1324309',\n",
       "  'existing_cui_name': 'Latia-luciferin monooxygenase ( demethylating ) activity',\n",
       "  'existing_cui_desc': '[CLS] La ##tia - l ##uc ##ifer ##in mon ##oo ##xy ##gen ##ase ( dem ##eth ##yla ##ting ) activity [unused3] ( B ##iol ##og ##ic Fun ##ction , La ##tia l ##uc ##ifer ##in , dem ##eth ##yla ##ting : l ##uc ##ifer ##ase ; La ##tia - l ##uc ##ifer ##in , hydrogen - donor : oxygen o ##xi ##dor ##ed ##uc ##tase ; La ##tia l ##uc ##ifer ##in mon ##oo ##xy ##gen ##ase ) [SEP]',\n",
       "  'our_bi_cui': 'C0005507',\n",
       "  'our_bi_cui_name': 'Biological Assay',\n",
       "  'our_bi_cui_desc': '[CLS] Biological As ##say [unused3] ( Health Care Act ##ivity , procedure : B ##io ##ass ##ays ; B ##iol ##og ##ic As ##say ##s ; B ##IO ##L AS ##SA ##Y ; B ##IO ##L AS ##SA ##Y ##S ; As ##say ; As ##say ##s , Biological ; bio ##ass ##ay ; As ##say , Biological ; bio ##ass ##ays ; B ##io ##ass ##ay ; Biological As ##say ##s ; AS ##SA ##Y B ##IO ##L ; B ##iol ##og ##ic As ##say ; As ##say , B ##iol ##og ##ic ; AS ##SA ##Y ##S B ##IO ##L ; As ##say ##s , B ##iol ##og ##ic ; Biological ass ##ay ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '27762482.20',\n",
       "  'test_set_idx': 15898,\n",
       "  'type': 'T074',\n",
       "  'name': 'PDL',\n",
       "  'context': '[CLS] ##ura , we designed the fraction ##ation of high flu ##ence using five passes and longer pulse duration ( 6 mill ##ise ##con ##ds ) of a PD ##L in succession . A total of eight patients with er ##yt ##hem ##ato ##tel ##ang ##ie ##ct ##atic r ##osa ##cea were enrolled in this study ; all patients were treated with [unused1] PD ##L [unused2] 10 times at 2 - week intervals . E ##ry ##them ##a and te ##lang ##ie ##ct ##asi ##a scores , as well as improvement , were assessed by two physicians using the digital photographs . Mode ##rate - to - marked improvement was achieved in most of the patients , and er ##yt ##hem ##a and te ##lang ##ie ##ct [SEP]',\n",
       "  'existing_cui': 'C1414066',\n",
       "  'existing_cui_name': 'DLG5 gene',\n",
       "  'existing_cui_desc': '[CLS] DL ##G ##5 gene [unused3] ( Ana ##tom ##ical Structure : K ##IA ##A ##0 ##5 ##8 ##3 ; D ##IS ##CS LA ##R ##GE , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 5 ; P - d ##l ##g ; discs large ho ##mo ##log 5 ; P ##LA ##CE ##NT ##A AND PR ##OS ##TA ##TE DL ##G ) [SEP]',\n",
       "  'our_bi_cui': 'C0031740',\n",
       "  'our_bi_cui_name': 'Photochemotherapy',\n",
       "  'our_bi_cui_desc': '[CLS] Photo ##che ##mother ##ap ##y [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : PD ##T - Photo ##dynamic therapy ; Photo ##che ##mother ##ap ##ies ; Photo ##dynamic The ##rap ##ies ; therapy , photo ##dynamic ; Therapy , Photo ##dynamic ; THE ##R P ##H ##OT ##OD ##Y ##NA ##MI ##C ; Photo ##rad ##iation Therapy ; photo ##dynamic therapy ; photo ##che ##mother ##ap ##y ; P ##H ##OT ##OC ##H ##EM ##OT ##H ##ER ; The ##rap ##ies , Photo ##dynamic ; Photo ##dynamic Therapy Pro ##ced ##ures ; neo ##p ##las ##m / cancer photo ##rad ##iation therapy ; Photo ##che ##mother ##ap ##y [ Am ##bi ##guous ] ; Photo ##dynamic therapy ; PD [SEP]',\n",
       "  'our_cross_cui': 'C1289859',\n",
       "  'our_cross_cui_name': 'Pulsed Dye Lasers',\n",
       "  'our_cross_cui_desc': '[CLS] P ##ulse ##d D ##ye Las ##ers [unused3] ( Medical Devi ##ce , physical object : D ##ye Las ##ers , P ##ulse ##d ; P ##ulse ##d dye laser device ; Las ##er , P ##ulse ##d D ##ye ; D ##ye Las ##er , P ##ulse ##d ; Las ##ers , P ##ulse ##d D ##ye ; P ##ulse ##d D ##ye Las ##er ; pulsed dye laser ; P ##ulse ##d dye laser ) [SEP]'},\n",
       " {'mention_id': '28197156.12',\n",
       "  'test_set_idx': 28082,\n",
       "  'type': 'T017',\n",
       "  'name': 'Carbon Assimilation Rate 8',\n",
       "  'context': '[CLS] in rice ( Or ##y ##za sat ##iva ) . Ex ##p ##lo ##iting the natural variation in CO ##2 ass ##im ##ilation rate ( A ) between rice cult ##iva ##rs using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of [unused1] Carbon As ##si ##mi ##lation Rate 8 [unused2] by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial cult ##iva ##r . Fine mapping suggested that Carbon As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box [SEP]',\n",
       "  'existing_cui': 'C2246620',\n",
       "  'existing_cui_name': 'iron assimilation',\n",
       "  'existing_cui_desc': '[CLS] iron ass ##im ##ilation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
       "  'our_bi_cui': 'C1413023',\n",
       "  'our_bi_cui_name': 'C8A gene',\n",
       "  'our_bi_cui_desc': '[CLS] C ##8 ##A gene [unused3] ( Ana ##tom ##ical Structure : complement component 8 alpha subunit ; CO ##MP ##LE ##ME ##NT CO ##MP ##ON ##EN ##T 8 , AL ##P ##HA S ##U ##B ##UN ##IT ; C ##8 AL ##P ##HA ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27373772.13',\n",
       "  'test_set_idx': 4071,\n",
       "  'type': 'T038',\n",
       "  'name': 'functioning',\n",
       "  'context': '[CLS] and ne ##uron ##al commitment in the rat den ##tate g ##yr ##us Adult hip ##po ##cam ##pal ne ##uro ##genesis can be m ##od ##ulated by various physiological and path ##ological conditions , including stress , affect ##ive disorders , and several ne ##uro ##logical conditions . Given the proposed role of this form of structural plastic ##ity in the [unused1] functioning [unused2] of the hip ##po ##cam ##pus ( namely learning and memory and affect ##ive behaviors ) , it is believed that alterations in hip ##po ##cam ##pal ne ##uro ##genesis might under ##lie some of the behavioral deficit ##s associated with these psychiatric and ne ##uro ##logical conditions . Thus , the search for compounds that can reverse these deficit ##s with [SEP]',\n",
       "  'existing_cui': 'C2986655',\n",
       "  'existing_cui_name': 'Functioning Endocrine Neoplasm',\n",
       "  'existing_cui_desc': '[CLS] Fun ##ction ##ing End ##oc ##rine Neo ##p ##las ##m [unused3] ( B ##iol ##og ##ic Fun ##ction : functioning tumor ) [SEP]',\n",
       "  'our_bi_cui': 'C0007613',\n",
       "  'our_bi_cui_name': 'Cell physiology',\n",
       "  'our_bi_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]',\n",
       "  'our_cross_cui': 'C0031843',\n",
       "  'our_cross_cui_name': 'physiological aspects',\n",
       "  'our_cross_cui_desc': '[CLS] physiological aspects [unused3] ( B ##iol ##og ##ic Fun ##ction : P ##H ; physiology ; P ##H ##Y ##SI ##OL ; function ) [SEP]'},\n",
       " {'mention_id': '28125734.41',\n",
       "  'test_set_idx': 26195,\n",
       "  'type': 'T103',\n",
       "  'name': 'miR-21-5p',\n",
       "  'context': '[CLS] o ##li ##gos were employed to is ##olate mi ##RNA : : MS ##L ##N m ##RNA complexes from a normal cell line ( Met - 5 ##A ) which expresses low levels of me ##so ##the ##lin . Mi ##RNA ##s targeting the me ##so ##the ##lin m ##RNA were identified by next generation se ##quencing and [unused1] mi ##R - 21 - 5 ##p [unused2] and mi ##R - 100 - 5 ##p were selected for further valid ##ation analyses . Mi ##R - 21 - 5 ##p was shown to be able to m ##od ##ulate me ##so ##the ##lin expression in mi ##RNA mimic experiments in a panel of ma ##li ##gnant and non - ma ##li ##gnant cell lines . Further [SEP]',\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1999986',\n",
       "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '28183596.8',\n",
       "  'test_set_idx': 27754,\n",
       "  'type': 'T033',\n",
       "  'name': 'reduce/minimize',\n",
       "  'context': '[CLS] A numerical study on the application of the functional ##ly graded materials in the s ##ten ##t design Un ##des ##ira ##ble def ##orm ##ation of the s ##ten ##t can induce a significant amount of in ##jure not only to the blood vessel but also to the plaque . The objective of this study was to [unused1] reduce / minimize [unused2] these und ##esi ##rable def ##orm ##ations by the application of Fun ##ctional ##ly Grade ##d Materials . To do this , Fin ##ite El ##ement method was employed to si ##mu ##late the expansion of a s ##ten ##t and the corresponding displacement of the s ##ten ##osis plaque . Three h ##yper ##ela ##stic plaque types as well as five el ##ast [SEP]',\n",
       "  'existing_cui': 'C0340305',\n",
       "  'existing_cui_name': 'Inferior Wall Myocardial Infarction',\n",
       "  'existing_cui_desc': '[CLS] In ##fer ##ior Wall My ##oc ##ard ##ial In ##far ##ction [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Di ##aph ##rag ##matic My ##oc ##ard ##ial In ##far ##ction ; inferior my ##oc ##ard ##ial in ##far ##ction ; In ##fer ##ior MI ; My ##oc ##ard ##ial In ##far ##ction , In ##fer ##ior ; Di ##aph ##rag ##matic My ##oc ##ard ##ial In ##far ##ctions ; In ##fer ##ior my ##oc ##ard ##ial in ##far ##ction ; In ##far ##ctions , Di ##aph ##rag ##matic My ##oc ##ard ##ial ; inferior mi ; My ##oc ##ard ##ial In ##far ##ction , In ##fer ##ior Wall ; In ##fer ##ior My ##oc ##ard ##ial In ##far ##ctions ; My ##oc ##ard [SEP]',\n",
       "  'our_bi_cui': 'C0441610',\n",
       "  'our_bi_cui_name': 'Reduction - action',\n",
       "  'our_bi_cui_desc': '[CLS] Red ##uction - action [unused3] ( Health Care Act ##ivity , qualifier value : Sur ##gical reduction ; reduction ##s ; reduction ; Red ##uction ; Red ##uction p ##last ##y ; surgical reduction ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27280034.3',\n",
       "  'test_set_idx': 1332,\n",
       "  'type': 'T082',\n",
       "  'name': 'Newcastle upon Tyne',\n",
       "  'context': \"[CLS] Changes in risk factors for young male suicide in [unused1] Newcastle upon Tyne [unused2] , 1961 - 2009 Ai ##ms and method To as ##cer ##tain differences in patterns of suicide in young men over three decades ( 1960s , 1990s and 2000s ) and discuss implications for suicide prevention . Data on suicide ##s and open verdict ##s in men aged 15 - 34 were obtained from co ##roner ' s records in Newcastle upon Tyne and anal ##ys ##ed using SP ##SS software . Results An increase in suicide rates from the first to the second decade was followed by a fall in the third decade . This was associated with an increasing proportion of single men , those living alone , unemployment , [SEP]\",\n",
       "  'existing_cui': 'C0027983',\n",
       "  'existing_cui_name': 'Newcastle Disease',\n",
       "  'existing_cui_desc': \"[CLS] Newcastle Disease [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , et ##iology , manifest ##ation : Disease , Newcastle ; new ##castle disease ; Newcastle ' s disease ; A ##vian p ##ne ##um ##oe ##nce ##pha ##lit ##is ; Newcastle disease [ Am ##bi ##guous ] ; P ##se ##udo - f ##ow ##l ##pes ##t ; disease ( or disorder ) ; Newcastle ; Newcastle disease ; Newcastle ; NE ##WC ##AS ##TL ##E D ##IS ; Newcastle fever ; Newcastle Disease [ Disease / Finding ] ) [SEP]\",\n",
       "  'our_bi_cui': 'C0454880',\n",
       "  'our_bi_cui_name': 'Tyne and Wear',\n",
       "  'our_bi_cui_desc': '[CLS] Tyne and We ##ar [unused3] ( Spa ##tial Concept , geographic location : T and W - Tyne and We ##ar ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '28077286.22',\n",
       "  'test_set_idx': 25072,\n",
       "  'type': 'T103',\n",
       "  'name': 'MeHg',\n",
       "  'context': '[CLS] ##air ##ments to cognitive motor functions in ma ##mmal ##ian models . However , in birds the ne ##uro ##to ##xi ##c effects of Me ##H ##g on the developing pre - hatch ##ing brain and con ##se ##quent behavioral alterations in adult birds have not received much attention . Moreover , pass ##eri ##ne birds are poorly represented in [unused1] Me ##H ##g [unused2] ne ##uro ##to ##xi ##cology studies in comparison to other a ##vian orders . Hence in this study , we used the egg injection method to investigate the long term effects of in o ##vo Me ##H ##g exposure on brain his ##top ##ath ##ology and courts ##hip behavior in a model song ##bird species , the z ##eb ##ra fin [SEP]',\n",
       "  'existing_cui': 'C0228520',\n",
       "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
       "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
       "  'our_bi_cui': 'C0025424',\n",
       "  'our_bi_cui_name': 'Mercury',\n",
       "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
       "  'our_cross_cui': 'C0025794',\n",
       "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
       "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
       " {'mention_id': '28249376.9',\n",
       "  'test_set_idx': 29879,\n",
       "  'type': 'T168',\n",
       "  'name': 'concentrate diet',\n",
       "  'context': '[CLS] Effects of a specific blend of essential oils on apparent nut ##rient dig ##est ##ion , r ##ume ##n f ##er ##mentation and r ##ume ##n micro ##bial populations in sheep fed a 50 : 50 al ##fa ##lf ##a hay : [unused1] concentrate diet [unused2] An experiment was conducted to investigate the effects of a specific mixture of essential oils , containing thy ##me , c ##love and c ##innamon E ##O , on r ##ume ##n micro ##bial f ##er ##mentation , nut ##rient apparent dig ##est ##ibility and blood meta ##bol ##ites in fist ##ulated sheep . Six sheep fitted with r ##umi ##nal fist ##ula ##s were used in a repeated measurement design with two 24 - d periods to investigate the [SEP]',\n",
       "  'existing_cui': 'C1880165',\n",
       "  'existing_cui_name': 'Concentrate Dosage Form',\n",
       "  'existing_cui_desc': '[CLS] Con ##cent ##rate Do ##sa ##ge Form [unused3] ( Chemical : Con ##cent ##rated ; Con ##cent ##rate ; CO ##NC ; CO ##NC ##EN ##TR ##AT ##E ; Con ##c ; Con ##cent ##rated Do ##sa ##ge Form ; Con ##cent ##rated Do ##se Form ) [SEP]',\n",
       "  'our_bi_cui': 'C0003050',\n",
       "  'our_bi_cui_name': 'Animal feed',\n",
       "  'our_bi_cui_desc': '[CLS] Animal feed [unused3] ( Food , substance , substance : animal food ; animal feeds ; animal feeding ; animals food ; food animal ; Fe ##eds , Animal ; Animal Fe ##ed ; Fe ##ed , Animal ; animal feed ; Animal Fe ##eds ) [SEP]',\n",
       "  'our_cross_cui': 'C0012155',\n",
       "  'our_cross_cui_name': 'Diet',\n",
       "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
       " {'mention_id': '27886280.72',\n",
       "  'test_set_idx': 20784,\n",
       "  'type': 'T038',\n",
       "  'name': 'production',\n",
       "  'context': '[CLS] C ##ip ##ro ##f ##lo ##xa ##cin ( F ##lu ##oro ##quin ##olo ##ne ) at a low concentration resulted in killing of both cultures of P . a ##er ##ug ##ino ##sa , producing per ##sist ##ers that were in ##vu ##ln ##era ##ble to killing . Station ##ary cells appear to be somewhat more tolerant than ex ##po ##nent ##ial cells in all of these ass ##ays . We also showed that nut ##rient de ##p ##ri ##vation ( se ##rine starvation ) regulated by string ##ent and general stress response , contribute to the increased tolerance of P . a ##er ##ug ##ino ##sa ex ##po ##nent ##ial and stationary plan ##kt ##onic cells via [unused1] production [unused2] of per ##sist ##ers . [SEP]',\n",
       "  'existing_cui': 'C1548180',\n",
       "  'existing_cui_name': 'Production Processing ID',\n",
       "  'existing_cui_desc': '[CLS] Production Process ##ing ID [unused3] ( Intel ##lect ##ual Product : Production ) [SEP]',\n",
       "  'our_bi_cui': 'C0220781',\n",
       "  'our_bi_cui_name': 'Anabolism',\n",
       "  'our_bi_cui_desc': '[CLS] Ana ##bol ##ism [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : bio ##sy ##nt ##hetic process ; Ana ##bol ##ism , function ; synthesis ; bio ##sy ##nt ##hesis ; formation ; B ##ios ##ynth ##etic ; B ##ios ##ynth ##esis ; B ##io ##genesis ; B ##ios ##ynth ##etic Process ; an ##ab ##olis ##m ) [SEP]',\n",
       "  'our_cross_cui': 'C0007613',\n",
       "  'our_cross_cui_name': 'Cell physiology',\n",
       "  'our_cross_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]'},\n",
       " {'mention_id': '27669217.30',\n",
       "  'test_set_idx': 13681,\n",
       "  'type': 'T033',\n",
       "  'name': 'MIC',\n",
       "  'context': '[CLS] ##hr ##omy ##cin , and 512 mg / L for c ##lar ##ith ##rom ##y ##cin ) . E ##ff ##lux - encoding me ##f ##A and me ##f ##E genes were not detect ##able in these is ##olate ##s . The presence of 23 ##S r ##RNA mutations in specific is ##olate ##s did not significantly change mac ##rol ##ide [unused1] MI ##C [unused2] s . No n ##uc ##leo ##tide substitution ##s were found in genes encoding rib ##oso ##mal proteins L ##4 or L ##22 . The er ##m ##B and er ##m ##T genes were found in the genome ##s of all is ##olate ##s . These two genes were acquired independently in one highly v ##ir ##ulent is ##olate AL ##10 [SEP]',\n",
       "  'existing_cui': 'C2732473',\n",
       "  'existing_cui_name': 'Ductal Carcinoma In Situ with Microinvasion',\n",
       "  'existing_cui_desc': '[CLS] Du ##ct ##al Car ##cin ##oma In Sit ##u with Micro ##in ##vas ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : Micro ##in ##vasive B ##rea ##st Car ##cin ##oma ; MI ##C ; Du ##ct ##al car ##cin ##oma in sit ##u with micro ##in ##vas ##ion ) [SEP]',\n",
       "  'our_bi_cui': 'C0427978',\n",
       "  'our_bi_cui_name': 'Minimum Inhibitory Concentration measurement',\n",
       "  'our_bi_cui_desc': '[CLS] Mini ##mum In ##hibit ##ory Con ##cent ##ration measurement [unused3] ( Health Care Act ##ivity , MI ##C , procedure , qualifier value : Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test ; Con ##cent ##rations , Mini ##mum In ##hibit ##ory ; Anti ##biotic sensitivity , minimum inhibitor ##y concentration ; MI ##C su ##s ##ce ##pt ##ibility test ; Mini ##mum In ##hibit ##ory Con ##cent ##rations ; MI ##C - Mini ##mum inhibitor ##y concentration ; Con ##cent ##ration , Mini ##mum In ##hibit ##ory ; Mini ##mum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test technique ; In ##hibit ##ory Con ##cent ##rations , Mini ##mum ; Mini ##mum In ##hibit ##ory [SEP]',\n",
       "  'our_cross_cui': 'C1304747',\n",
       "  'our_cross_cui_name': 'Minimum inhibitory concentration result',\n",
       "  'our_cross_cui_desc': '[CLS] Mini ##mum inhibitor ##y concentration result [unused3] ( Finding , finding : minimum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration finding ) [SEP]'},\n",
       " {'mention_id': '27444636.25',\n",
       "  'test_set_idx': 5976,\n",
       "  'type': 'T170',\n",
       "  'name': 'Adverse Events Profile',\n",
       "  'context': '[CLS] at least 4 weeks were switched overnight to es ##lica ##rb ##az ##ep ##ine ace ##tate . Pat ##ients were switched because they experienced persistent seizure ##s with o ##x ##car ##ba ##ze ##pine but were unable to tolerate increased o ##x ##car ##ba ##ze ##pine dos ##ing due to adverse events . To ##ler ##ability was assessed using the [unused1] Ad ##verse Events Profile [unused2] , quality of life was assessed using the Quality of Life in E ##pile ##psy In ##vent ##ory 10 , and alert ##ness was assessed as reaction time using a sub ##test of the Test Battery for At ##ten ##tion Performance version 2 . 3 . Assessment ##s were performed immediately prior to and 5 days after switching from o [SEP]',\n",
       "  'existing_cui': 'C0877248',\n",
       "  'existing_cui_name': 'Adverse event',\n",
       "  'existing_cui_desc': '[CLS] Ad ##verse event [unused3] ( B ##iol ##og ##ic Fun ##ction : AD ##VE ##RS ##E E ##VE ##NT ; adverse events ; Ad ##verse Event ; adverse event ; Ad ##verse ##E ##vent ; Ad ##verse Experience ) [SEP]',\n",
       "  'our_bi_cui': 'C1521800',\n",
       "  'our_bi_cui_name': 'Adverse Drug Experience Report',\n",
       "  'our_bi_cui_desc': '[CLS] Ad ##verse Drug Experience Report [unused3] ( Intel ##lect ##ual Product : Ad ##verse Drug Report ; Ad ##verse Experience Report ; Ad ##verse Event Report ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28254329.46',\n",
       "  'test_set_idx': 30171,\n",
       "  'type': 'T033',\n",
       "  'name': 'hydroxylation degree',\n",
       "  'context': '[CLS] ##or ##ption , blood wet ##ta ##bility , bacterial and cell ad ##hesion were evaluated in order to investigate the correlation ##s between the surface p ##hy ##sio ##chemical properties and biological responses . From a method ##ological stand ##point , X ##PS and electro ##kin ##etic measurements emerged as the more suitable techniques respectively for the evaluation of [unused1] h ##ydro ##xy ##lation degree [unused2] and surface charge / is ##oe ##lect ##ric point . Moreover , determination of wet ##ta ##bility by blood appeared a specific and crucial test , the results of which are not easily predictable by using other type of tests . H ##ydro ##xy ##lation degree resulted correlated to the wet ##ta ##bility by water , but not directly to [SEP]',\n",
       "  'existing_cui': 'C1159294',\n",
       "  'existing_cui_name': 'protein hydroxylation',\n",
       "  'existing_cui_desc': '[CLS] protein h ##ydro ##xy ##lation [unused3] ( B ##iol ##og ##ic Fun ##ction : protein amino acid h ##ydro ##xy ##lation ) [SEP]',\n",
       "  'our_bi_cui': 'C0700307',\n",
       "  'our_bi_cui_name': 'hydroxyl group',\n",
       "  'our_bi_cui_desc': '[CLS] h ##ydro ##xy ##l group [unused3] ( Chemical : H ##ydro ##xy ##l group ; H ##ydro ##xy ##l Group ; h ##ydro ##xy ##l group ( OH ) - that consists of an oxygen atom joined to a hydrogen atom ; H ##ydro ##xy ; h ##ydro ##xy ##l group ( OH ) [ functional group ] - that consists of an oxygen atom joined to a hydrogen atom ; H ##ydro ##xy ##l ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28400056.14',\n",
       "  'test_set_idx': 34669,\n",
       "  'type': 'T103',\n",
       "  'name': 'EN 12791',\n",
       "  'context': '[CLS] study was to determine if me ##ce ##tron ##ium et ##ils ##ulf ##ate contributes to overall efficacy in surgical hand di ##sin ##fect ##ion . Three blinded hand rub ##s ( 45 % is ##o - prop ##ano ##l , 30 % n - prop ##ano ##l ) were applied for 1 . 5 min and compared with the [unused1] E ##N 127 ##9 ##1 [unused2] reference procedure ( crossover design ) . One commercial hand rub contained 0 . 2 % me ##ce ##tron ##ium et ##ils ##ulf ##ate , and the two other hand rub ##s were identical apart from 0 . 2 % me ##ce ##tron ##ium et ##ils ##ulf ##ate . None of the formulation ##s had a log ##10 reduction after [SEP]',\n",
       "  'existing_cui': 'C3899313',\n",
       "  'existing_cui_name': 'EN1 wt Allele',\n",
       "  'existing_cui_desc': '[CLS] E ##N ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : En - 1 ; En ##gra ##iled Home ##ob ##ox 1 w ##t All ##ele ) [SEP]',\n",
       "  'our_bi_cui': 'C0013983',\n",
       "  'our_bi_cui_name': 'Emollients',\n",
       "  'our_bi_cui_desc': '[CLS] Em ##oll ##ients [unused3] ( Chemical , product , substance : Em ##oll ##ient - Mi ##s ##c ; [ DE ##35 ##0 ] E ##MO ##LL ##IE ##NT ##S ; em ##oll ##ients ; E ##MO ##LL ##IE ##NT ##S ; em ##oll ##ient ; Em ##oll ##ient ; Em ##oll ##ient product ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28392427.22',\n",
       "  'test_set_idx': 34338,\n",
       "  'type': 'T058',\n",
       "  'name': 'CBA',\n",
       "  'context': '[CLS] s ##CD ##25 have repeatedly been reported altered in patients with mood disorders . The aim of this study was to investigate levels of these factors in serum of adolescent bi ##pol ##ar offspring , who have a heightened risk for mood disorder development and to also analyze the data combined with previously published data . Growth factors were assessed by [unused1] CB ##A [unused2] / E ##L ##IS ##A in adolescent bi ##pol ##ar offspring ( n = 96 , mean age = 16 years ) and in age - and gender - matched healthy controls ( n = 50 ) . E ##pid ##er ##mal Growth Factor belonged to a mutually co ##rrel ##ating cluster of mainly ne ##uro ##tro ##phic compounds including S [SEP]',\n",
       "  'existing_cui': 'C0025922',\n",
       "  'existing_cui_name': 'Mice , Inbred CBA',\n",
       "  'existing_cui_desc': '[CLS] Mi ##ce , In ##bred CB ##A [unused3] ( E ##uka ##ryo ##te : CB ##A ; CB ##A Mi ##ce , In ##bred ; Mi ##ce , CB ##A ; CB ##A Mouse , In ##bred ; CB ##A Mouse ; Mouse , In ##bred CB ##A ; Mouse , CB ##A ; CB ##A Mi ##ce ; In ##bred CB ##A Mouse ; In ##bred CB ##A Mi ##ce ) [SEP]',\n",
       "  'our_bi_cui': 'C0201563',\n",
       "  'our_bi_cui_name': 'Concanavalin A assay',\n",
       "  'our_bi_cui_desc': '[CLS] Con ##can ##ava ##lin A ass ##ay [unused3] ( Health Care Act ##ivity , procedure : Con A ass ##ay ) [SEP]',\n",
       "  'our_cross_cui': 'C0005507',\n",
       "  'our_cross_cui_name': 'Biological Assay',\n",
       "  'our_cross_cui_desc': '[CLS] Biological As ##say [unused3] ( Health Care Act ##ivity , procedure : B ##io ##ass ##ays ; B ##iol ##og ##ic As ##say ##s ; B ##IO ##L AS ##SA ##Y ; B ##IO ##L AS ##SA ##Y ##S ; As ##say ; As ##say ##s , Biological ; bio ##ass ##ay ; As ##say , Biological ; bio ##ass ##ays ; B ##io ##ass ##ay ; Biological As ##say ##s ; AS ##SA ##Y B ##IO ##L ; B ##iol ##og ##ic As ##say ; As ##say , B ##iol ##og ##ic ; AS ##SA ##Y ##S B ##IO ##L ; As ##say ##s , B ##iol ##og ##ic ; Biological ass ##ay ) [SEP]'},\n",
       " {'mention_id': '28436493.26',\n",
       "  'test_set_idx': 35792,\n",
       "  'type': 'T103',\n",
       "  'name': 'EsxA',\n",
       "  'context': '[CLS] , it suggested a defect in the E ##S ##X - 1 type VII secret ##ion system . Gene ##tic complement ##ation with a p ##las ##mi ##d carrying the My ##co ##ba ##cter ##ium tuberculosis H ##37 ##R ##v sequence of e ##cc ##C ##a ##1 - e ##cc ##C ##b ##1 - p ##e ##35 re - established [unused1] E ##s ##x ##A [unused2] secret ##ion , host specific E ##s ##x ##A T - cell responses , and increased strain v ##ir ##ule ##nce . The E ##S ##X - 1 secret ##ion defect prevents several v ##ir ##ule ##nce factors from being functional during infection and therefore at ##ten ##uate ##s My ##co ##ba ##cter ##ium tuberculosis . It pre ##c ##lude [SEP]',\n",
       "  'existing_cui': 'C1706322',\n",
       "  'existing_cui_name': 'ELF3 wt Allele',\n",
       "  'existing_cui_desc': '[CLS] E ##LF ##3 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : E ##SE - 1 ; ER ##T ; J ##EN ; E ##S ##X ; E ##7 ##4 - Like Factor 3 ( ET ##S Domain Trans ##cription Factor , E ##pit ##hel ##ial - S ##pecific ) w ##t All ##ele ; EP ##R - 1 ) [SEP]',\n",
       "  'our_bi_cui': 'C1822656',\n",
       "  'our_bi_cui_name': 'SCXA gene',\n",
       "  'our_bi_cui_desc': '[CLS] SC ##X ##A gene [unused3] ( Ana ##tom ##ical Structure : SC ##LE ##RA ##X ##IS , M ##O ##US ##E , H ##OM ##OL ##O ##G OF , A ; SC ##LE ##RA ##X ##IS ) [SEP]',\n",
       "  'our_cross_cui': 'C1744314',\n",
       "  'our_cross_cui_name': 'ESAT-6 protein , Mycobacterium tuberculosis',\n",
       "  'our_cross_cui_desc': '[CLS] E ##SA ##T - 6 protein , My ##co ##ba ##cter ##ium tuberculosis [unused3] ( Chemical : E ##SA ##T - 6 System 1 protein , My ##co ##ba ##cter ##ium tuberculosis ; 6 - k ##D ##a early secret ##ory anti ##genic target , My ##co ##ba ##cter ##ium tuberculosis ; E ##s ##x - 1 protein , My ##co ##ba ##cter ##ium tuberculosis ; E ##s ##x ##A protein , My ##co ##ba ##cter ##ium tuberculosis ) [SEP]'},\n",
       " {'mention_id': '27857693.31',\n",
       "  'test_set_idx': 19410,\n",
       "  'type': 'T058',\n",
       "  'name': 'IHRT',\n",
       "  'context': '[CLS] . 2 % greater change , 90 % Con ##fi ##dence Inter ##val 1 . 6 : 14 . 9 % , effect size 0 . 49 ) . Only I ##H ##RT increased counter ##mo ##ve ##ment jump peak power at Post ( 4 . 9 % , effect size 0 . 35 ) , however the difference between [unused1] I ##H ##RT [unused2] and place ##bo was unclear ( 2 . 7 , 90 % Con ##fi ##dence Inter ##val - 2 . 0 : 7 . 6 % , effect size 0 . 20 ) with no clear differences in speed or body composition throughout . Con ##c ##lusion : Heavy resistance training in h ##y ##pox ##ia is more effective than place [SEP]',\n",
       "  'existing_cui': 'C0020669',\n",
       "  'existing_cui_name': 'Hypothalamus , Middle',\n",
       "  'existing_cui_desc': '[CLS] H ##y ##pot ##hala ##mus , Middle [unused3] ( Ana ##tom ##ical Structure : Area h ##y ##pot ##hala ##mic ##a inter ##media ; Media ##l H ##y ##pot ##hala ##mus ; Intermediate h ##y ##pot ##hala ##mic area ; Intermediate H ##y ##pot ##hala ##mic Region ; Region , Intermediate H ##y ##pot ##hala ##mic ; Reg ##io h ##y ##pot ##hala ##mic ##a inter ##media ; Middle H ##y ##pot ##hala ##mus ; H ##y ##pot ##hala ##mic Region ##s , Intermediate ; H ##y ##pot ##hala ##mic Region , Intermediate ; Intermediate H ##y ##pot ##hala ##mic Region ##s ; Intermediate h ##y ##pot ##hala ##mic region ; intermediate h ##y ##pot ##hala ##mic region ; H ##y ##pot ##hala ##mus , Media [SEP]',\n",
       "  'our_bi_cui': 'C0282402',\n",
       "  'our_bi_cui_name': 'Hormone replacement therapy',\n",
       "  'our_bi_cui_desc': '[CLS] Ho ##rmon ##e replacement therapy [unused3] ( Health Care Act ##ivity , H ##RT , hormone replacement therapy , procedure : hormone replacement therapy ; Therapy , Ho ##rmon ##e Rep ##lace ##ment ; hormone replacement the ##rap ##ies ; H ##OR ##MO ##NE R ##EP ##LA ##CE THE ##R ; hormone replacement ##s ; H ##RT - Ho ##rmon ##e replacement therapy ; ER ##T ; Ho ##rmon ##e Rep ##lace ##ment Therapy ; Rep ##lace ##ment The ##rap ##ies , Ho ##rmon ##e ; hormones replacement ; men ##op ##aus ##al hormone therapy ; Rep ##lace ##ment Therapy , Ho ##rmon ##e ; R ##EP ##LA ##CE THE ##R H ##OR ##MO ##NE ; Ho ##rmon ##e Rep ##lace ##ment R ##x ; THE [SEP]',\n",
       "  'our_cross_cui': 'C0872279',\n",
       "  'our_cross_cui_name': 'Resistance Training',\n",
       "  'our_cross_cui_desc': '[CLS] Resistance Training [unused3] ( Health Care Act ##ivity : Training , Resistance ; St ##ren ##gth Training ; strength train ; strength training ; Training , St ##ren ##gth ) [SEP]'},\n",
       " {'mention_id': '27587730.26',\n",
       "  'test_set_idx': 10765,\n",
       "  'type': 'T103',\n",
       "  'name': 'gga-miR-21',\n",
       "  'context': \"[CLS] the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga - mi ##R - 21 inhibitor enhanced pre - ad ##ip ##oc ##yte proliferation . The subsequent investigation identified K ##rup ##pel - like factor 5 m ##RNA as a target of [unused1] g ##ga - mi ##R - 21 [unused2] . The g ##ga - mi ##R - 21 mimic in ##hibit ##ed K ##rup ##pel - like factor 5 3 ( ' ) U ##TR reporter activity and decreased end ##ogen ##ous K ##rup ##pel - like factor 5 expression in primary pre - ad ##ip ##ocytes . K ##rup ##pel - like factor 5 knock ##down using [SEP]\",\n",
       "  'existing_cui': 'C1537719',\n",
       "  'existing_cui_name': 'MIR21 gene',\n",
       "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_bi_cui': 'C1537719',\n",
       "  'our_bi_cui_name': 'MIR21 gene',\n",
       "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
       "  'our_cross_cui': 'C1101610',\n",
       "  'our_cross_cui_name': 'MicroRNAs',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
       " {'mention_id': '28127853.14',\n",
       "  'test_set_idx': 26308,\n",
       "  'type': 'T170',\n",
       "  'name': 'Spiritual Health Scale',\n",
       "  'context': '[CLS] attended the 12 - week program and completed the pre - test and post - test . There were 16 middle - aged and nine older adults recruited from a district of Taipei , and nine young adults recruited from the principal investigator \\' s university . The \" At ##ti ##tudes toward A ##ging Scale \" and the \" [unused1] Spiritual Health Scale [unused2] \" were two assessment instruments used in the study . The results showed that there were significant improvements in the At ##ti ##tudes toward A ##ging Scale for the young adult group ( aged 18 - 29 years ) and in the Spiritual Health Scale for the older adult group ( aged 65 - 80 years ) . The evaluation showed [SEP]',\n",
       "  'existing_cui': 'C0686997',\n",
       "  'existing_cui_name': 'Spiritual health of patient',\n",
       "  'existing_cui_desc': '[CLS] Spiritual health of patient [unused3] ( Finding , o ##bs ##er ##vable entity : Spiritual health ; Spiritual condition of patient ; spiritual health ; health spiritual ; Spiritual Health ) [SEP]',\n",
       "  'our_bi_cui': 'C1998888',\n",
       "  'our_bi_cui_name': 'Spiritual Well Being',\n",
       "  'our_bi_cui_desc': '[CLS] Spiritual Well Being [unused3] ( Intel ##lect ##ual Product : Spiritual Well - being ; spiritual well - being ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28477843.3',\n",
       "  'test_set_idx': 37379,\n",
       "  'type': 'T017',\n",
       "  'name': 'low back',\n",
       "  'context': '[CLS] Development and valid ##ation of an easy - to - use risk assessment tool for cumulative [unused1] low back [unused2] loading : The Li ##fting Fat ##ig ##ue F ##ail ##ure Too ##l ( Li ##fting Fat ##ig ##ue F ##ail ##ure Too ##l ) Recent evidence suggests that m ##us ##cu ##los ##kel ##etal disorders may be the result of a fatigue failure process in affected tissues . This paper describes a new low back exposure assessment tool ( the Li ##fting Fat ##ig ##ue F ##ail ##ure Too ##l [ Li ##FF ##T ] ) , which estimates a \" daily dose \" of cumulative loading on the low back using fatigue failure principles . Only three variables are necessary to derive the cumulative [SEP]',\n",
       "  'existing_cui': 'C0024031',\n",
       "  'existing_cui_name': 'Low Back Pain',\n",
       "  'existing_cui_desc': '[CLS] Low Back Pain [unused3] ( Finding , diagnosis , disorder , finding , s ##ym ##pt ##om : low ; back ##ache ; Back Pain ##s , Lower ; A ##ches , Low Back ; Pain ; back ; l ##umba ##r ; do ##rs ##op ##athy low back pain ; Low Back A ##che ; back ##ache ; low ; A ##che , Low Back ; lower back pain ; Lu ##mba ##r pain ; Back ##ache ##s , Low ; Back Pain ##s , Low ; Low Back Pain [ Disease / Finding ] ; l ##umba ##go ; Back A ##che , Low ; back ; pain , low ; pain ; low back ; l ##umba ##r pain ; Lu ##mba ##go [SEP]',\n",
       "  'our_bi_cui': 'C2939142',\n",
       "  'our_bi_cui_name': 'Lower back',\n",
       "  'our_bi_cui_desc': '[CLS] Lower back [unused3] ( Spa ##tial Concept , surface region , surface region , body structure : Lower back ( surface region ) ) [SEP]',\n",
       "  'our_cross_cui': 'C0230102',\n",
       "  'our_cross_cui_name': 'Lower back structure',\n",
       "  'our_cross_cui_desc': '[CLS] Lower back structure [unused3] ( Ana ##tom ##ical Structure , body structure : Lower back ; lower back ; Di ##stal back ; lower back structure ) [SEP]'},\n",
       " {'mention_id': '27842161.5',\n",
       "  'test_set_idx': 19098,\n",
       "  'type': 'T103',\n",
       "  'name': 'Netarsudil',\n",
       "  'context': '[CLS] Net ##ars ##udi ##l Inc ##rease ##s Out ##flow Facility in Human Eyes Through Multiple Me ##chan ##isms [unused1] Net ##ars ##udi ##l [unused2] is a R ##ho kinase / nor ##ep ##ine ##ph ##rine transport ##er inhibitor currently in phase 3 clinical development for g ##lau ##com ##a treatment . We investigated the effects of its active meta ##bol ##ite , net ##ars ##udi ##l - M1 , on out ##flow facility ( C ) , out ##flow h ##ydro ##dynamic ##s , and morphology of the conventional out ##flow pathway in en ##uc ##lea ##ted human eyes . Pa ##ired human eyes ( n = 5 ) were per ##fused with either 0 . 3 μ ##M net ##ars ##udi ##l - M1 or [SEP]',\n",
       "  'existing_cui': 'C0013443',\n",
       "  'existing_cui_name': 'Ear structure',\n",
       "  'existing_cui_desc': '[CLS] E ##ar structure [unused3] ( Ana ##tom ##ical Structure , Anatomy , body structure : V ##est ##ib ##ulo ##co ##ch ##lea ##r System ; System , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; ear structures ; Organ ##um vest ##ib ##ulo ##co ##ch ##lea ##re ; ear structure ; E ##ar - related structure ; au ##ris ; A ##ppa ##rat ##us , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; E ##ar and related structures ; Au ##ris ; V ##est ##ib ##ulo ##co ##ch ##lea ##r organ ; V ##est ##ib ##ulo ##co ##ch ##lea ##r A ##ppa ##rat ##us ) [SEP]',\n",
       "  'our_bi_cui': 'C0027783',\n",
       "  'our_bi_cui_name': 'Netropsin',\n",
       "  'our_bi_cui_desc': '[CLS] Net ##rops ##in [unused3] ( Chemical : Sin ##ano ##my ##cin ; Net ##rops ##in [ Chemical / In ##g ##red ##ient ] ; net ##rops ##in ; Congo ##cid ##ine ; 1 ##H - P ##yr ##rol ##e - 2 - car ##box ##ami ##de , 4 - ( ( ( ( amino ##im ##ino ##met ##hyl ) amino ) ace ##ty ##l ) amino ) - N - ( 5 - ( ( ( 3 - amino - 3 - im ##ino ##p ##rop ##yl ) amino ) carbon ##yl ) - 1 - met ##hyl - 1 ##H - p ##yr ##rol - 3 - y ##l ) - 1 - met ##hyl - ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28459124.18',\n",
       "  'test_set_idx': 36727,\n",
       "  'type': 'T038',\n",
       "  'name': 'Zebra Chip',\n",
       "  'context': '[CLS] Mexico , and Central America have experienced severe yield loss from Z ##eb ##ra Chip disease and have responded by increasing insect ##icide use to suppress populations of the insect vector , the potato ps ##yl ##lid , Ba ##cter ##ice ##ra cock ##ere ##lli ( He ##mi ##ptera : Trio ##zi ##dae ) . Despite the severe nature of [unused1] Z ##eb ##ra Chip [unused2] outbreak ##s , the causes of emergence remain unknown . We tested the h ##y ##pot ##heses that 1 ) B . cock ##ere ##lli o ##cc ##up ##ancy has increased over the last century in California and 2 ) such increases are related to climate change , specifically warmer winters . We compiled a data ##set of 87 , [SEP]',\n",
       "  'existing_cui': 'C3890232',\n",
       "  'existing_cui_name': 'Trans-Activator Protein BZLF1',\n",
       "  'existing_cui_desc': '[CLS] Trans - Act ##iva ##tor Pro ##tein B ##Z ##LF ##1 [unused3] ( Chemical : Trans - Act ##iva ##tor Pro ##tein B ##Z ##LF - 1 ; E ##ps ##tein - Barr V ##ir ##us Trans - Act ##iva ##tor Pro ##tein B ##Z ##LF ##1 ; E ##ps ##tein - Barr V ##ir ##us Trans - Act ##iva ##tor Pro ##tein B ##Z ##LF - 1 ; E ##ps ##tein - Barr V ##ir ##us B ##Z ##LF - 1 ; E ##B ##V B ##Z ##LF - 1 ; Z ##eb ##ra ; E ##B ##V B ##Z ##LF ##1 ) [SEP]',\n",
       "  'our_bi_cui': 'C0325177',\n",
       "  'our_bi_cui_name': 'Equus zebra',\n",
       "  'our_bi_cui_desc': '[CLS] E ##q ##u ##us z ##eb ##ra [unused3] ( E ##uka ##ryo ##te , organism : Mountain z ##eb ##ra ; E ##q ##u ##us z ##eb ##ra z ##eb ##ra ) [SEP]',\n",
       "  'our_cross_cui': 'C0012634',\n",
       "  'our_cross_cui_name': 'Disease',\n",
       "  'our_cross_cui_desc': '[CLS] Disease [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , or disorder : disease / disorder ; D ##IS ; Clinical disease or syndrome present ; Disease [ Disease / Finding ] ; Disease ##s ; Di ##sor ##der ; Clinical disease or syndrome ; Disease AND / OR syndrome present ; di ##ag ##nose ##s , syndrome ##s , and conditions ; Clinical disease AND / OR syndrome present ; Di ##sor ##ders ; Disease or Di ##sor ##der ; disease ; Disease ##s and Di ##sor ##ders ; condition ; Disease or syndrome present ; diseases ; disorders ; Clinical disease AND / OR syndrome ; disorder ) [SEP]'},\n",
       " {'mention_id': '27598388.17',\n",
       "  'test_set_idx': 10966,\n",
       "  'type': 'T058',\n",
       "  'name': 'elemental mapping',\n",
       "  'context': '[CLS] V ##is spectrum which showed the surface p ##las ##mon resonance band at 42 ##2 nm . Trans ##mission electron micro ##scope analysis revealed that the particles were spherical , he ##xa ##gonal , and irregular in shape and had size ranging from 30 to 80 nm . The energy di ##sper ##sive X - ray s ##pect ##ros ##copy and [unused1] elemental mapping [unused2] have displayed the purity and maximum distribution of silver in the A ##g ##NP ##s . The crystal ##line nature of A ##g ##NP ##s had been identified using X - ray di ##ff ##raction and selected area di ##ff ##raction pattern . The particle size analysis revealed that the Z - average diameter of the A ##g ##NP ##s was [SEP]',\n",
       "  'existing_cui': 'C0008630',\n",
       "  'existing_cui_name': 'Chromosome Mapping',\n",
       "  'existing_cui_desc': '[CLS] Ch ##rom ##oso ##me Map ##ping [unused3] ( Health Care Act ##ivity : Gene ##tics , Gene Map ##ping ; Map ##ping , Gene ; gene mapped ; Gene Map ##ping ##s ; Link ##age Map ##ping ; Gene Map ##ping ; Gene mapping ; chromosome mapping ; genetic mapping ; gene map ; link ##age map ; Gene ##tic Map ##ping ; Gene Map ##ping , Total Human and Non - Human ; Ch ##rom ##oso ##me Map ##ping ##s ; Map ##ping , Ch ##rom ##oso ##me ; Gene Local ##ization ; link ##age mapping ; Map ##ping , Link ##age ; Map ##ping ##s , Gene ; gene mapping ; Link ##age Map ##ping ##s ; Map ##ping ##s , Link ##age ; [SEP]',\n",
       "  'our_bi_cui': 'C3898095',\n",
       "  'our_bi_cui_name': 'Optical Mapping',\n",
       "  'our_bi_cui_desc': '[CLS] Op ##tical Map ##ping [unused3] ( Research Act ##ivity : Op ##tical Map ; O ##P ##TI ##CA ##L MA ##PP ##ING ; Op ##tical mapping ) [SEP]',\n",
       "  'our_cross_cui': 'C0022885',\n",
       "  'our_cross_cui_name': 'Laboratory Procedures',\n",
       "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
       " {'mention_id': '27611704.12',\n",
       "  'test_set_idx': 11686,\n",
       "  'type': 'T017',\n",
       "  'name': 'D',\n",
       "  'context': \"[CLS] B ##read wheat ( Tri ##tic ##um a ##est ##iv ##um , 2 ##n = 6 ##x = 42 , AA ##BB ##D ##D ) has a complex all ##oh ##ex ##ap ##lo ##id genome , which makes it difficult to differentiate between the ho ##mo ##eo ##log ##ous sequences and assign them to the chromosome A , B , or [unused1] D [unused2] sub ##gen ##ome ##s . The chromosome - based draft genome sequence of the ' Chinese Spring ' common wheat cult ##iva ##r enables the large - scale development of polymer ##ase chain reaction ( polymer ##ase chain reaction ) - based markers specific for ho ##mo ##eo ##log ##s . Based on high - confidence ' Chinese Spring ' genes with [SEP]\",\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0008645',\n",
       "  'our_bi_cui_name': 'Chromosomes , Human , 13-15',\n",
       "  'our_bi_cui_desc': '[CLS] Ch ##rom ##oso ##mes , Human , 13 - 15 [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : Ch ##rom ##oso ##mes , group D ; Ch ##rom ##oso ##mes , Group D ; Group D Ch ##rom ##oso ##me ; Ch ##rom ##oso ##me pairs 13 - 15 ; Ch ##rom ##oso ##mes D ; Ch ##rom ##oso ##me , Group D ; Group D Ch ##rom ##oso ##mes ) [SEP]',\n",
       "  'our_cross_cui': 'C0008633',\n",
       "  'our_cross_cui_name': 'Chromosomes',\n",
       "  'our_cross_cui_desc': '[CLS] Ch ##rom ##oso ##mes [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : chromosome ; Ch ##rom ##oso ##mal ; chromosome ##s ; Ch ##rom ##oso ##me ) [SEP]'},\n",
       " {'mention_id': '27892235.1',\n",
       "  'test_set_idx': 21013,\n",
       "  'type': 'T058',\n",
       "  'name': 'NHS',\n",
       "  'context': '[CLS] S ##hout louder about poor pay It seems increasingly clear to me that the [unused1] NHS [unused2] pay campaign is not making waves either in the NHS or with the public . [SEP]',\n",
       "  'existing_cui': 'C1417725',\n",
       "  'existing_cui_name': 'NHS gene',\n",
       "  'existing_cui_desc': '[CLS] NHS gene [unused3] ( Ana ##tom ##ical Structure : NHS act ##in re ##mo ##del ##ing regulator ; NHS GE ##NE ) [SEP]',\n",
       "  'our_bi_cui': 'C0018104',\n",
       "  'our_bi_cui_name': 'Government',\n",
       "  'our_bi_cui_desc': '[CLS] Government [unused3] ( Organization : governments ; Government ##s ; government ) [SEP]',\n",
       "  'our_cross_cui': 'C0027462',\n",
       "  'our_cross_cui_name': 'Health Services , National',\n",
       "  'our_cross_cui_desc': '[CLS] Health Services , National [unused3] ( Health Care Act ##ivity : National health services ; H ##EA ##LT ##H SE ##R ##V N ##AT ##ION ##AL ; SE ##R ##V N ##AT ##ION ##AL H ##EA ##LT ##H ; National Health Service ; Service , National Health ; national health services ; national health service ; Health Service , National ; N ##AT ##ION ##AL H ##EA ##LT ##H SE ##R ##V ; Services , National Health ; National Health Services ) [SEP]'},\n",
       " {'mention_id': '27802570.2',\n",
       "  'test_set_idx': 17754,\n",
       "  'type': 'T058',\n",
       "  'name': 'Treated by',\n",
       "  'context': '[CLS] Overall Quality Properties of Ki ##wi ##f ##ruit [unused1] T ##reate ##d by [unused2] C ##inn ##ama ##lde ##hy ##de and C ##it ##ral : Micro ##bial , Anti ##ox ##ida ##nt Cap ##acity during Cold St ##orage This work was undertaken to evaluate the micro ##bio ##logical characteristics and anti ##ox ##ida ##nt and physiological activities in k ##i ##wi ##f ##ruit ##s ( Act ##ini ##da del ##ici ##osa var . Qin ##mei ) with / without c ##inn ##ama ##lde ##hy ##de ( C ##1 ) and c ##it ##ral ( C ##2 ) f ##umi ##gation treatments ( 5 μ ##L / L ) during 0 , 3 , 6 , 9 , and 12 d of storage at 4 °C . [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0087111',\n",
       "  'our_bi_cui_name': 'Therapeutic procedure',\n",
       "  'our_bi_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]',\n",
       "  'our_cross_cui': 'C0332293',\n",
       "  'our_cross_cui_name': 'Treated with',\n",
       "  'our_cross_cui_desc': '[CLS] T ##reate ##d with [unused3] ( Health Care Act ##ivity , attribute : T ##reate ##d by ) [SEP]'},\n",
       " {'mention_id': '27832198.46',\n",
       "  'test_set_idx': 18668,\n",
       "  'type': 'T017',\n",
       "  'name': 'Cam734',\n",
       "  'context': '[CLS] ##al ##ci ##par ##um ch ##lor ##o ##quin ##e resistance transport ##er - specific zinc - finger n ##uc ##lea ##ses to genetically di ##sse ##ct this all ##ele in the path ##ogenic setting of as ##ex ##ual blood - stage infection . Comparative analysis of drug resistance and growth profiles of re ##comb ##ina ##nt parasite ##s that express [unused1] Cam ##7 ##34 [unused2] or variants thereof , D ##d ##2 ( the most common Southeast Asian variant ) , or wild - type P . f ##al ##ci ##par ##um ch ##lor ##o ##quin ##e resistance transport ##er , revealed previously unknown roles for P ##f ##CR ##T mutations in m ##od ##ulating parasite su ##s ##ce ##pt ##ibility to multiple anti ##mal ##aria [SEP]',\n",
       "  'existing_cui': 'C0006675',\n",
       "  'existing_cui_name': 'Calcium',\n",
       "  'existing_cui_desc': '[CLS] Cal ##ci ##um [unused3] ( Chemical , medication , substance : Co ##agu ##lation factor IV - R ##ET ##IR ##ED - ; CO ##AG FA ##CT ##OR IV ; Co ##agu ##lation Factor IV ; B ##L ##O ##OD CO ##AG FA ##CT ##OR IV ; C ##a + + element ; factor i ##v ; calcium ; Blood Co ##agu ##lation Factor IV ; Cal ##ci ##um co ##agu ##lation factor ; Co ##agu ##lation factor IV ; calcium ##s ; Cal ##ci ##um [ Chemical / In ##g ##red ##ient ] ; C ##a - Cal ##ci ##um ; CA ##LC ##I ##UM ; Factor IV ; C ##a element ; Cal ##ci ##um anal ##yte ; Factor IV , Co ##agu ##lation [SEP]',\n",
       "  'our_bi_cui': 'C1708291',\n",
       "  'our_bi_cui_name': 'CDC73 gene',\n",
       "  'our_bi_cui_desc': '[CLS] CD ##C ##7 ##3 gene [unused3] ( Ana ##tom ##ical Structure : H ##Y ##RA ##X , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; cell division cycle 73 ; para ##fi ##bro ##min ; F ##I ##HP ; PA ##RA ##FI ##BR ##OM ##IN ; CD ##C ##7 ##3 Gene ; CE ##LL D ##I ##VI ##SI ##ON C ##Y ##CL ##E PR ##OT ##EI ##N 73 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; C ##1 ##OR ##F ##28 ; Cell Division Cycle 73 , Pa ##f ##1 / RNA Pol ##yme ##rase II Complex Co ##mpo ##nent , Ho ##mo ##log ( S . c ##ere ##vis ##iae [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27671177.37',\n",
       "  'test_set_idx': 13814,\n",
       "  'type': 'T082',\n",
       "  'name': 'Quetta',\n",
       "  'context': \"[CLS] ##sis , had 4 times more chances to develop car ##ies than those who did not have flu ##oro ##sis . There was no significant association between children ' s car ##ies status and use of paste , brushing habit , mi ##s ##wa ##k , and visit to the den ##tist . The use of past ##ries and juice ##s had a direct relation with the children ' s dental car ##ies status . Dental car ##ies in children of [unused1] Que ##tta [unused2] is not so much frequent as compared to the flu ##ori ##de def ##icient countries . However , the high prevalence of moderate dental flu ##oro ##sis and consumption of past ##ries and juice ##s resulted in dental car ##ies . [SEP]\",\n",
       "  'existing_cui': 'C0262345',\n",
       "  'existing_cui_name': 'Tenia of thalamus',\n",
       "  'existing_cui_desc': '[CLS] Ten ##ia of th ##ala ##mus [unused3] ( Ana ##tom ##ical Structure : ten ##ia of th ##ala ##mi ; Ten ##ia of th ##ala ##mi ; Ta ##enia th ##ala ##mi ; T ##hala ##mus ten ##ia ; ten ##ia of the th ##ala ##mus ; Ten ##ia th ##ala ##mi ) [SEP]',\n",
       "  'our_bi_cui': 'C0337884',\n",
       "  'our_bi_cui_name': 'Quechua',\n",
       "  'our_bi_cui_desc': '[CLS] Que ##chu ##a [unused3] ( Population Group , ethnic group , ethnic group ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '27798906.12',\n",
       "  'test_set_idx': 17532,\n",
       "  'type': 'T058',\n",
       "  'name': 'measured',\n",
       "  'context': '[CLS] ##s were enrolled and 93 i ##rra ##dia ##ted P ##G ##s were analyzed . Thirty and 24 patients were treated with total doses [ relative biological effectiveness ( relative biological effectiveness ) ] of 57 . 6 G ##y and 64 . 0 G ##y , respectively , in 16 fraction ##s . par ##ot ##id g ##land volumes were [unused1] measured [unused2] using com ##puted to ##mo ##graphic images obtained before carbon ion radio ##ther ##ap ##y and every 3 - 6 months thereafter . The median follow - up period was 46 . 4 months ( range = 24 . 0 - 123 . 0 months ) . Un ##iva ##ria ##te analysis showed that par ##ot ##id g ##land volumes receiving more [SEP]',\n",
       "  'existing_cui': 'C3541902',\n",
       "  'existing_cui_name': 'Measured Tumor Identification',\n",
       "  'existing_cui_desc': '[CLS] Me ##as ##ured Tu ##mor I ##dent ##ification [unused3] ( Health Care Act ##ivity : ME ##AS ##UR ##ED ) [SEP]',\n",
       "  'our_bi_cui': 'C2734710',\n",
       "  'our_bi_cui_name': 'Measure observations',\n",
       "  'our_bi_cui_desc': '[CLS] Me ##as ##ure observations [unused3] ( Finding ) [SEP]',\n",
       "  'our_cross_cui': 'C2700258',\n",
       "  'our_cross_cui_name': 'Volume Measurement',\n",
       "  'our_cross_cui_desc': '[CLS] Volume Me ##as ##ure ##ment [unused3] ( Health Care Act ##ivity : V ##OL ##UM ##E ; Volume measurement ; Volume ) [SEP]'},\n",
       " {'mention_id': '27555898.19',\n",
       "  'test_set_idx': 10352,\n",
       "  'type': 'T103',\n",
       "  'name': 'PAA1',\n",
       "  'context': '[CLS] the specimens , 3 mm of a ##c ##ryl ##ic were grin ##ded off and separated parts were re ##att ##ache ##d by re ##si ##lient liner ##s . The specimens were divided into 2 control ( control ##1 , control ##7 ) and 4 test groups of para ##ce ##tic acid and oz ##one di ##sin ##fect ##ion ( [unused1] PA ##A ##1 [unused2] , PA ##A ##7 , oz ##one ##1 and oz ##one ##7 ; n = 10 ) . While control groups were im ##mers ##ed in di ##st ##ille ##d water for 10 min ( control ##1 ) and 7 days ( control ##7 ) , test groups were subjected to para ##ce ##tic acid ( 16 g / L ) [SEP]',\n",
       "  'existing_cui': 'C1415190',\n",
       "  'existing_cui_name': 'GPAA1 gene',\n",
       "  'existing_cui_desc': '[CLS] GP ##AA ##1 gene [unused3] ( Ana ##tom ##ical Structure : GP ##I trans ##ami ##das ##e subunit ; G ##L ##Y ##CO ##S ##Y ##LP ##H ##OS ##P ##HA ##TI ##D ##Y ##L ##IN ##OS ##IT ##OL AN ##CH ##OR AT ##TA ##CH ##ME ##NT PR ##OT ##EI ##N 1 ; g ##ly ##cos ##yl ##ph ##os ##pha ##ti ##dy ##lino ##si ##to ##l anchor attachment 1 ; h ##GA ##A ##1 ) [SEP]',\n",
       "  'our_bi_cui': 'C1528733',\n",
       "  'our_bi_cui_name': 'diphenylacetaldehyde',\n",
       "  'our_bi_cui_desc': '[CLS] dip ##hen ##yla ##ce ##tal ##de ##hy ##de [unused3] ( Chemical : D ##PA ##A c ##p ##d ) [SEP]',\n",
       "  'our_cross_cui': 'C0030968',\n",
       "  'our_cross_cui_name': 'Peracetic Acid',\n",
       "  'our_cross_cui_desc': '[CLS] Per ##ace ##tic A ##cid [unused3] ( Chemical , product , substance : A ##cid , Per ##ox ##ye ##than ##oi ##c ; per ##ace ##tic acid ; Per ##ox ##ya ##ce ##tic A ##cid ; Per ##ace ##tic A ##cid [ Chemical / In ##g ##red ##ient ] ; Ethan ##eper ##ox ##oi ##c acid ; A ##cid , Per ##ace ##tic ; Ace ##ty ##l H ##ydro ##per ##oxide ; A ##cid , Per ##ox ##ya ##ce ##tic ; Per ##ox ##ye ##than ##oi ##c A ##cid ; V ##ap ##ori ##zed Para ##ce ##tic A ##cid St ##eri ##li ##zation ; Per ##ox ##ya ##ce ##tic acid ; Per ##ace ##tic acid ; per ##ox ##ya ##ce ##tic acid ) [SEP]'},\n",
       " {'mention_id': '28477843.12',\n",
       "  'test_set_idx': 37388,\n",
       "  'type': 'T017',\n",
       "  'name': 'low back',\n",
       "  'context': '[CLS] m ##us ##cu ##los ##kel ##etal disorders may be the result of a fatigue failure process in affected tissues . This paper describes a new low back exposure assessment tool ( the Li ##fting Fat ##ig ##ue F ##ail ##ure Too ##l [ Li ##FF ##T ] ) , which estimates a \" daily dose \" of cumulative loading on the [unused1] low back [unused2] using fatigue failure principles . Only three variables are necessary to derive the cumulative load associated with a lifting task : the weight of the load , the maximum horizontal distance from the spine to the load , and the number of repetition ##s for tasks performed during the work ##day . The new tool was valid ##ated using two existing [SEP]',\n",
       "  'existing_cui': 'C0024031',\n",
       "  'existing_cui_name': 'Low Back Pain',\n",
       "  'existing_cui_desc': '[CLS] Low Back Pain [unused3] ( Finding , diagnosis , disorder , finding , s ##ym ##pt ##om : low ; back ##ache ; Back Pain ##s , Lower ; A ##ches , Low Back ; Pain ; back ; l ##umba ##r ; do ##rs ##op ##athy low back pain ; Low Back A ##che ; back ##ache ; low ; A ##che , Low Back ; lower back pain ; Lu ##mba ##r pain ; Back ##ache ##s , Low ; Back Pain ##s , Low ; Low Back Pain [ Disease / Finding ] ; l ##umba ##go ; Back A ##che , Low ; back ; pain , low ; pain ; low back ; l ##umba ##r pain ; Lu ##mba ##go [SEP]',\n",
       "  'our_bi_cui': 'C2939142',\n",
       "  'our_bi_cui_name': 'Lower back',\n",
       "  'our_bi_cui_desc': '[CLS] Lower back [unused3] ( Spa ##tial Concept , surface region , surface region , body structure : Lower back ( surface region ) ) [SEP]',\n",
       "  'our_cross_cui': 'C0230102',\n",
       "  'our_cross_cui_name': 'Lower back structure',\n",
       "  'our_cross_cui_desc': '[CLS] Lower back structure [unused3] ( Ana ##tom ##ical Structure , body structure : Lower back ; lower back ; Di ##stal back ; lower back structure ) [SEP]'},\n",
       " {'mention_id': '27388786.22',\n",
       "  'test_set_idx': 4445,\n",
       "  'type': 'T098',\n",
       "  'name': 'signers',\n",
       "  'context': \"[CLS] explained by hand movement alone , the contribution of motor movement versus ' linguistic ' processes to the strength of hem ##is ##pheric lateral ##ization during sign production remains unclear . Here we directly contrast lateral ##ization strength of covert versus over ##t signing during p ##hon ##ological and semantic flu ##ency tasks . To address the possibility that hearing native [unused1] sign ##ers [unused2] ' elevated lateral ##ization in ##dices were due to performing a task in their less dominant language , here we test deaf native sign ##ers , whose dominant language is British Sign Language . Sign ##ers were more strongly left lateral ##ized for over ##t than covert sign generation . However , the strength of lateral ##ization was not correlated with [SEP]\",\n",
       "  'existing_cui': 'C0035127',\n",
       "  'existing_cui_name': 'Cumulative Trauma Disorders',\n",
       "  'existing_cui_desc': '[CLS] C ##um ##ula ##tive T ##ra ##uma Di ##sor ##ders [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , event : Over ##use S ##yn ##drome ; Rep ##eti ##tive St ##ress In ##ju ##ries ; Di ##sor ##ders , C ##um ##ula ##tive T ##ra ##uma ; RS ##I - Rep ##eti ##tive strain injury ; R ##EP ##ET M ##OT ##ION D ##IS ; repetitive strain injury ; St ##rain In ##ju ##ry , Rep ##eti ##tive ; T ##ra ##uma Di ##sor ##ders , C ##um ##ula ##tive ; Rep ##eti ##tive Motion Di ##sor ##ders ; In ##ju ##ries , Rep ##eti ##tive St ##ress ; Motion Di ##sor ##ders , Rep ##eti ##tive ; cumulative trauma disorders [SEP]',\n",
       "  'our_bi_cui': 'C0336303',\n",
       "  'our_bi_cui_name': 'Sign-painter',\n",
       "  'our_bi_cui_desc': '[CLS] Sign - painter [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Sign ##writer ) [SEP]',\n",
       "  'our_cross_cui': 'C1257890',\n",
       "  'our_cross_cui_name': 'Population Group',\n",
       "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
       " {'mention_id': '27580908.24',\n",
       "  'test_set_idx': 10668,\n",
       "  'type': 'T098',\n",
       "  'name': \"learners '\",\n",
       "  'context': \"[CLS] to participate . Student co ##hor ##ts were alternatively given a faculty - supervised 1 ##h session playing a simple interactive digital T ##ic - ta ##c - toe q ##uiz module on p ##ediatric gas ##tro ##int ##est ##inal radio ##logy or a 1 ##h did ##actic intro ##ductory lecture on the same topic . Survey questions assessed the [unused1] learn ##ers ' [unused2] perceived ability to recall the material as well as their satisfaction with the educational experience . Results of an end - of - rotation exam were reviewed to evaluate a quantitative measure of learning between groups . Survey responses were analyzed with a ch ##i - squared test . Ex ##am results for both groups were analyzed with a paired Student [SEP]\",\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0520955',\n",
       "  'our_bi_cui_name': 'Slow learner',\n",
       "  'our_bi_cui_desc': '[CLS] Slow learn ##er [unused3] ( Finding , finding , organism : slow learn ##er ; delayed learning ; Slow Lea ##rner ##s ; slow learn ##ers ; Learning delay ) [SEP]',\n",
       "  'our_cross_cui': 'C1257890',\n",
       "  'our_cross_cui_name': 'Population Group',\n",
       "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
       " {'mention_id': '27383326.9',\n",
       "  'test_set_idx': 4277,\n",
       "  'type': 'T038',\n",
       "  'name': 'advanced',\n",
       "  'context': '[CLS] Ad ##verse events risk associated with an ##gio ##genesis inhibitor ##s addition to therapy in o ##var ##ian cancer : a meta - analysis of random ##ized controlled trials In ##hibition of an ##gio ##genesis has been regarded as an attractive treatment strategy for [unused1] advanced [unused2] or re ##current o ##var ##ian cancer . We conduct this meta - analysis to investigate the risk of adverse events of special interest related to an ##gio ##genesis inhibitor ##s in o ##var ##ian cancer . Database ##s from Pub ##M ##ed , Web of Science and Cochrane library up to December 2015 were searched to identify relevant studies . Eli ##gible studies included prospective random ##ized controlled phase II / III clinical trials evaluating therapy with or [SEP]',\n",
       "  'existing_cui': 'C0877373',\n",
       "  'existing_cui_name': 'Advanced cancer',\n",
       "  'existing_cui_desc': '[CLS] Advanced cancer [unused3] ( B ##iol ##og ##ic Fun ##ction : Advanced Mali ##gnant Neo ##p ##las ##m ; Advanced Cancer ; cancer advanced ; advanced cancer ) [SEP]',\n",
       "  'our_bi_cui': 'C0877373',\n",
       "  'our_bi_cui_name': 'Advanced cancer',\n",
       "  'our_bi_cui_desc': '[CLS] Advanced cancer [unused3] ( B ##iol ##og ##ic Fun ##ction : Advanced Mali ##gnant Neo ##p ##las ##m ; Advanced Cancer ; cancer advanced ; advanced cancer ) [SEP]',\n",
       "  'our_cross_cui': 'C0029925',\n",
       "  'our_cross_cui_name': 'Ovarian Carcinoma',\n",
       "  'our_cross_cui_desc': '[CLS] O ##var ##ian Car ##cin ##oma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis : o ##vary cancer ; o ##var ##ian car ##cin ##oma ; o ##vary car ##cin ##oma ; car ##cin ##oma o ##var ##ian ; ca o ##var ##ian ; cancer o ##var ##ian ; cancer ##s o ##var ##ian ; cancer of o ##vary ; cancer o ##vary ; o ##var ##ian cancer ; ma ##li ##gnant o ##var ##ies tumor ; o ##var ##ian cancer ##s ; o ##var ##ian car ##cin ##oma ##s ; cancer of the o ##vary ; car ##cin ##oma of o ##vary ; car ##cin ##oma o ##var ##ies ; car ##cin ##oma o ##vary ; cancer o ##var ##ies ; O ##var [SEP]'},\n",
       " {'mention_id': '27608421.15',\n",
       "  'test_set_idx': 11552,\n",
       "  'type': 'T017',\n",
       "  'name': 'woody tissue',\n",
       "  'context': '[CLS] ##cc ##um par ##vu ##m The as ##com ##y ##ce ##te Neo ##fu ##si ##co ##cc ##um par ##vu ##m , one of the ca ##usal agents of Bo ##try ##os ##pha ##eria die ##back , is a destructive wood - in ##fect ##ing fungus and a serious threat to grape production worldwide . The capability of co ##lon ##izing [unused1] wood ##y tissue [unused2] combined with the secret ##ion of p ##hy ##to ##to ##xi ##c compounds is thought to under ##lie its path ##ogenic ##ity and v ##ir ##ule ##nce . Here , we describe the repertoire of v ##ir ##ule ##nce factors and their transcription ##al dynamics as the fungus feeds on different substrates and co ##lon ##izes the wood ##y stem . [SEP]',\n",
       "  'existing_cui': 'C0040300',\n",
       "  'existing_cui_name': 'Body tissue',\n",
       "  'existing_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
       "  'our_bi_cui': 'C2699642',\n",
       "  'our_bi_cui_name': 'Stem , Woody - plant part',\n",
       "  'our_bi_cui_desc': '[CLS] St ##em , Woody - plant part [unused3] ( E ##uka ##ryo ##te : St ##em , Woody ; Li ##gn ##um ; St ##em , wood ##y ) [SEP]',\n",
       "  'our_cross_cui': 'C1514137',\n",
       "  'our_cross_cui_name': 'Plant Tissue , Cells',\n",
       "  'our_cross_cui_desc': '[CLS] Plant T ##iss ##ue , Cell ##s [unused3] ( Ana ##tom ##ical Structure : Plant cells and tissues ) [SEP]'},\n",
       " {'mention_id': '28353042.21',\n",
       "  'test_set_idx': 32949,\n",
       "  'type': 'T204',\n",
       "  'name': 'rats',\n",
       "  'context': '[CLS] - f ##ru ##ct ##ose fed male W ##ista ##r rats . high - f ##ru ##ct ##ose diet ( 66 % of f ##ru ##ct ##ose ) and PA ##A ##E ( 200 mg / kg body weight / day ) were given concurrently to the rats for a period of 60 days . Fr ##uc ##tos ##e - fed [unused1] rats [unused2] showed weight gain , h ##yper ##gly ##ce ##mia , h ##yper ##ins ##ulin ##emia , impaired glucose tolerance , impaired insulin sensitivity , d ##ys ##lip ##ide ##mia , h ##yper ##le ##pt ##ine ##mia , and h ##y ##po ##adi ##po ##nect ##ine ##mia ( P < 0 . 05 ) after 60 days . Co - administration of PA [SEP]',\n",
       "  'existing_cui': 'C2097385',\n",
       "  'existing_cui_name': 'allergy testing rat',\n",
       "  'existing_cui_desc': '[CLS] all ##er ##gy testing rat [unused3] ( Health Care Act ##ivity , lab test : rat ) [SEP]',\n",
       "  'our_bi_cui': 'C0034721',\n",
       "  'our_bi_cui_name': 'Rattus',\n",
       "  'our_bi_cui_desc': '[CLS] Rat ##tus [unused3] ( E ##uka ##ryo ##te , organism : Rat ; Genus rat ##tus ; Genus Rat ##tus ; rats ; rat ; rat ##tus ; Rat ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0034716',\n",
       "  'our_cross_cui_name': 'Rats , Wistar',\n",
       "  'our_cross_cui_desc': '[CLS] Rat ##s , W ##ista ##r [unused3] ( E ##uka ##ryo ##te , organism : W ##ista ##r rat ; W ##ista ##r Rat ##s ; w ##ista ##r rat ; w ##ista ##r rats ) [SEP]'},\n",
       " {'mention_id': '28521168.28',\n",
       "  'test_set_idx': 38297,\n",
       "  'type': 'T204',\n",
       "  'name': 'L. variegatus',\n",
       "  'context': '[CLS] of eight e ##cot ##ox ##icit ##y tests on bacteria ( V . fish ##eri , E . co ##li ) , algae ( P . sub ##cap ##ita ##ta , Ch ##lam ##yd ##omo ##nas s ##p . ) , crust ##ace ##ans ( D . ma ##gna ) , worms ( E . f ##eti ##da , [unused1] L . var ##ie ##gat ##us [unused2] ) and plants ( R . sat ##iv ##us , L . multi ##f ##lor ##um ) . The tested materials are commercially available and include Fe oxide and na ##nos ##cale zero v ##ale ##nt iron , but also hybrid products with Fe loaded into a matrix . All but one material , a ball mill ##ed na [SEP]',\n",
       "  'existing_cui': 'C3754415',\n",
       "  'existing_cui_name': 'Clania variegata',\n",
       "  'existing_cui_desc': '[CLS] Clan ##ia var ##ie ##gata [unused3] ( E ##uka ##ryo ##te : E ##ume ##ta var ##ie ##gata ; Clan ##ia var ##ie ##gata ( S ##nell ##en , 1879 ) ; O ##ike ##ticus var ##ie ##gat ##us ) [SEP]',\n",
       "  'our_bi_cui': 'C1022967',\n",
       "  'our_bi_cui_name': 'Lumbriculus variegatus',\n",
       "  'our_bi_cui_desc': '[CLS] Lu ##mb ##ric ##ulus var ##ie ##gat ##us [unused3] ( E ##uka ##ryo ##te : Lu ##mb ##ric ##ulus var ##ie ##gat ##us ( Muller , 1774 ) ) [SEP]',\n",
       "  'our_cross_cui': 'C0998692',\n",
       "  'our_cross_cui_name': 'Lytechinus variegatus',\n",
       "  'our_cross_cui_desc': '[CLS] L ##yte ##chin ##us var ##ie ##gat ##us [unused3] ( E ##uka ##ryo ##te : L ##yte ##chin ##us var ##ie ##gat ##us ( Lamar ##ck , 1816 ) ) [SEP]'},\n",
       " {'mention_id': '27252199.9',\n",
       "  'test_set_idx': 851,\n",
       "  'type': 'T017',\n",
       "  'name': 'vascular tissues',\n",
       "  'context': '[CLS] Mo ##rp ##hol ##ogical characteristics regulating p ##hall ##ic g ##lan ##s en ##gor ##gement in the American all ##iga ##tor The di ##stal part of the c ##ro ##co ##di ##lian p ##hall ##us consists of a bulb ##ous g ##lan ##s containing well - developed [unused1] vascular tissues [unused2] that can in ##f ##late before or during sexual activity , en ##lar ##ging and el ##ab ##ora ##ting the g ##lan ##s into a complex , though still functional ##ly und ##ef ##ined , cop ##ulatory structure . An enlarged g ##lan ##s put ##ative ##ly interact ##s with the female c ##lo ##aca and may change the shape of her reproductive tract to facilitate ins ##em ##ination and increase the probability of f [SEP]',\n",
       "  'existing_cui': 'C0282607',\n",
       "  'existing_cui_name': 'Vascular Neoplasms',\n",
       "  'existing_cui_desc': '[CLS] V ##as ##cular Neo ##p ##las ##ms [unused3] ( B ##iol ##og ##ic Fun ##ction : V ##as ##cular Tu ##mor ##s ; V ##as ##cular Tu ##mor ; vascular neo ##p ##las ##ms ; NE ##OP ##L VA ##SC ##U ##LA ##R ; Neo ##p ##las ##m of V ##as ##cular T ##iss ##ue ; V ##as ##cular neo ##p ##las ##m ; Neo ##p ##las ##ms , V ##as ##cular ; V ##as ##cular neo ##p ##las ##ms ; Neo ##p ##las ##m , V ##as ##cular ; VA ##SC ##U ##LA ##R NE ##OP ##L ; V ##as ##cular Neo ##p ##las ##ms [ Disease / Finding ] ; V ##as ##cular T ##iss ##ue Neo ##p ##las ##m ; V ##as ##cular [SEP]',\n",
       "  'our_bi_cui': 'C0458940',\n",
       "  'our_bi_cui_name': 'Vulval vascular structure',\n",
       "  'our_bi_cui_desc': '[CLS] V ##ul ##val vascular structure [unused3] ( Ana ##tom ##ical Structure , body structure ) [SEP]',\n",
       "  'our_cross_cui': 'C1511228',\n",
       "  'our_cross_cui_name': 'Blood Vessel Tissue',\n",
       "  'our_cross_cui_desc': '[CLS] Blood V ##ess ##el T ##iss ##ue [unused3] ( Ana ##tom ##ical Structure : V ##ES ##SE ##L , B ##L ##O ##OD ; V ##ess ##el ) [SEP]'},\n",
       " {'mention_id': '27395442.13',\n",
       "  'test_set_idx': 4644,\n",
       "  'type': 'T082',\n",
       "  'name': 'Lima',\n",
       "  'context': '[CLS] ##mo ##x are key processes for reducing the external nitrogen loads delivered to coastal ecosystems , and these processes can be affected by poll ##uta ##nts . In this study , we investigated the effect of crude oil on den ##it ##rification and an ##am ##mo ##x . Control ##led laboratory experiments were performed using sediment s ##lu ##rries from the [unused1] Lima [unused2] E ##st ##uary ( NW Portugal ) . Ana ##mm ##ox and den ##it ##rification rates were measured using ( 15 ) N - labeled NO ##3 ( - ) , and the production of ( 29 ) N ##2 and ( 30 ) N ##2 q ##uant ##ified by membrane inlet mass s ##pect ##rome ##try . Results revealed that while [SEP]',\n",
       "  'existing_cui': 'C1047251',\n",
       "  'existing_cui_name': 'Lima',\n",
       "  'existing_cui_desc': '[CLS] Lima [unused3] ( E ##uka ##ryo ##te : l ##ima ) [SEP]',\n",
       "  'our_bi_cui': 'C1047251',\n",
       "  'our_bi_cui_name': 'Lima',\n",
       "  'our_bi_cui_desc': '[CLS] Lima [unused3] ( E ##uka ##ryo ##te : l ##ima ) [SEP]',\n",
       "  'our_cross_cui': 'C0017446',\n",
       "  'our_cross_cui_name': 'Geographic Locations',\n",
       "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
       " {'mention_id': '28427655.15',\n",
       "  'test_set_idx': 35585,\n",
       "  'type': 'T033',\n",
       "  'name': 'not',\n",
       "  'context': '[CLS] ##tina ##se concentration ( 0 and 0 . 2 % ) . The responses studied were yield , v ##isco ##sity , clarity , total soluble solid ##s and pH . It was observed that p ##ec ##tina ##se was more effective in increasing the yield of juice compared to cell ##ula ##se . Ultra ##sonic pre - treatment alone did [unused1] not [unused2] significantly increase the yield of juice . When ultra ##sound was combined with pre - treatment with both the enzymes maximum yield of 89 . 40 % was obtained compared to 47 . 30 % in the control . The v ##isco ##sity of the juice decreased with addition of enzymes and with application of ultra ##sound . The clarity of the [SEP]',\n",
       "  'existing_cui': 'C1140150',\n",
       "  'existing_cui_name': 'NOC - CodeSystem',\n",
       "  'existing_cui_desc': '[CLS] NO ##C - Code ##S ##ys ##tem [unused3] ( Intel ##lect ##ual Product , NO ##C : nursing outcomes classification ) [SEP]',\n",
       "  'our_bi_cui': 'C0205160',\n",
       "  'our_bi_cui_name': 'Negative',\n",
       "  'our_bi_cui_desc': '[CLS] N ##eg ##ative [unused3] ( Finding , qualifier value : Rule ##d out ; N ##eg ##ative ( m ##od ##ifier ) [ Am ##bi ##guous ] ; N ##eg ##ative for ; N ##eg ##ative ( m ##od ##ifier ) ; ruled out ; for negative ; out ruled ; negative ; negative ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C1513916',\n",
       "  'our_cross_cui_name': 'Negative Finding',\n",
       "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
       " {'mention_id': '27876084.11',\n",
       "  'test_set_idx': 20251,\n",
       "  'type': 'T092',\n",
       "  'name': 'American College of Critical Care Medicine',\n",
       "  'context': '[CLS] determine whether se ##ptic shock - reversal is quicker in p ##ediatric patients random ##ized to an early goal - directed fluid - spa ##ring strategy versus usual care ( S ##Q ##UE ##E ##Z ##E ) : study protocol for a pilot random ##ized controlled trial Current p ##ediatric se ##ptic shock re ##sus ##citation guidelines from the [unused1] American College of Critical Care Medicine [unused2] focus on the early and goal - directed administration of in ##tra ##vas ##cular fluid followed by v ##as ##oa ##ctive medication in ##fusion ##s for persistent and fluid - re ##fra ##ctor ##y shock . However , a ##cc ##um ##ulating adult and p ##ediatric data suggest that excessive fluid administration is associated with worse patient outcomes and [SEP]',\n",
       "  'existing_cui': 'C1319411',\n",
       "  'existing_cui_name': 'Critical care medicine specialty',\n",
       "  'existing_cui_desc': '[CLS] Critical care medicine specialty [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line , qualifier value : Critical care medicine ; critical care medicine ; care critical medicine ) [SEP]',\n",
       "  'our_bi_cui': 'C1527272',\n",
       "  'our_bi_cui_name': 'American College of Physicians',\n",
       "  'our_bi_cui_desc': '[CLS] American College of Physicians [unused3] ( Professional or O ##cc ##upation ##al Group ) [SEP]',\n",
       "  'our_cross_cui': 'C1708333',\n",
       "  'our_cross_cui_name': 'Health Care Organization',\n",
       "  'our_cross_cui_desc': '[CLS] Health Care Organization [unused3] ( Organization : Healthcare Organization ) [SEP]'},\n",
       " {'mention_id': '27539945.45',\n",
       "  'test_set_idx': 9870,\n",
       "  'type': 'T103',\n",
       "  'name': 'cationic CnDMAOH ( + )',\n",
       "  'context': '[CLS] / C ##10 ##DM ##A ##O system , however , no DNA compact ##ion was observed even in Tri ##s - HC ##l buffer solution with a much lower pH and a much higher C ##10 ##DM ##A ##O concentration . The negative charges of DNA molecules can easily be neutral ##ized by positive charges of [unused1] cat ##ion ##ic C ##n ##DM ##A ##OH ( + ) [unused2] ( n = 12 and 14 ) mice ##lles . DNA was compact ##ed and then ins ##ol ##ub ##le DNA / C ##n ##DM ##A ##OH ( + ) complexes were formed . Because of the much higher critical mice ##lle concentration of the shorter chain length C ##10 ##DM ##A ##OH ( + ) , [SEP]',\n",
       "  'existing_cui': 'C1685101',\n",
       "  'existing_cui_name': 'N-deoxychoylethylenediamine',\n",
       "  'existing_cui_desc': '[CLS] N - de ##ox ##ych ##oy ##let ##hyl ##ened ##iam ##ine [unused3] ( Chemical : cat ##ion ##ic DC ##EA ) [SEP]',\n",
       "  'our_bi_cui': 'C0007447',\n",
       "  'our_bi_cui_name': 'Cations',\n",
       "  'our_bi_cui_desc': '[CLS] Cat ##ions [unused3] ( Chemical , substance : Cat ##ions [ Chemical / In ##g ##red ##ient ] ; Cat ##ion ; cat ##ions ; cat ##ion ) [SEP]',\n",
       "  'our_cross_cui': 'C0029224',\n",
       "  'our_cross_cui_name': 'Organic Chemicals',\n",
       "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
       " {'mention_id': '27334471.4',\n",
       "  'test_set_idx': 2661,\n",
       "  'type': 'T103',\n",
       "  'name': 'TSSs',\n",
       "  'context': '[CLS] CA ##GE ##d - o ##PO ##SS ##UM : motif en ##rich ##ment analysis from Cap Analysis of Gene Express ##ion - derived [unused1] T ##SS ##s [unused2] With the emergence of large - scale Cap Analysis of Gene Express ##ion data ##sets from individual labs and the FA ##NT ##OM consortium , one can now analyze the c ##is - regulatory regions associated with gene transcription at an unprecedented level of re ##fine ##ment . By coupling transcription factor binding site en ##rich ##ment analysis with Cap Analysis of Gene Express ##ion - derived g ##eno ##mic regions , CA ##GE ##d - o ##PO ##SS ##UM can identify T ##F ##s that act as key regulator ##s of genes involved in specific ma ##mmal [SEP]',\n",
       "  'existing_cui': 'C0600327',\n",
       "  'existing_cui_name': 'Toxic Shock Syndrome',\n",
       "  'existing_cui_desc': '[CLS] To ##xi ##c Shock S ##yn ##drome [unused3] ( B ##iol ##og ##ic Fun ##ction , T ##SS , diagnosis , disorder , syndrome : toxic shock syndrome ; Shock , To ##xi ##c ; toxic ; shock ; shock ; toxic ; To ##xi ##c shock syndrome ; S ##yn ##drome ##s , To ##xi ##c Shock ; S ##yn ##drome , To ##xi ##c Shock ; shock syndrome ; toxic ; toxic ; shock syndrome ; S ##yn ##drome toxic shock ; Shock S ##yn ##drome , To ##xi ##c ; T ##SS , To ##xi ##c Shock S ##yn ##drome ; To ##xi ##c Shock S ##yn ##drome ##s ; T ##SS - To ##xi ##c shock syndrome ; syndrome ; toxic shock [SEP]',\n",
       "  'our_bi_cui': 'C0017337',\n",
       "  'our_bi_cui_name': 'Genes',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]',\n",
       "  'our_cross_cui': 'C0949639',\n",
       "  'our_cross_cui_name': 'Transcription Initiation Site',\n",
       "  'our_cross_cui_desc': '[CLS] Trans ##cription In ##iti ##ation Site [unused3] ( Chemical : Start Sites , Trans ##cription ; In ##iti ##ation Site , Trans ##cription ; In ##iti ##ation Sites , Trans ##cription ; Site , Trans ##cription Start ; Start Site , Trans ##cription ; Trans ##cription Start Sites ; Site , Trans ##cription In ##iti ##ation ; Trans ##cription Start Site ; Trans ##cription In ##iti ##ation Sites ; Sites , Trans ##cription Start ; Sites , Trans ##cription In ##iti ##ation ) [SEP]'},\n",
       " {'mention_id': '28195652.2',\n",
       "  'test_set_idx': 27976,\n",
       "  'type': 'T103',\n",
       "  'name': 'piperidinol derivatives',\n",
       "  'context': '[CLS] I ##dent ##ification of the anti - my ##co ##ba ##cter ##ial functional properties of [unused1] pipe ##rid ##ino ##l derivatives [unused2] Tu ##ber ##cu ##los ##is remains a major global health threat and is now the leading cause of death from a single infectious agent worldwide . The current Tu ##ber ##cu ##los ##is drug regime ##n is inadequate , and new anti - tube ##rc ##ular agents are urgent ##ly required to be able to successfully combat the increasing prevalence of drug - resistant Tu ##ber ##cu ##los ##is . The purpose of this study was to investigate a pipe ##rid ##ino ##l compound derivative that is highly active against the My ##co ##ba ##cter ##ium tuberculosis b ##ac ##ill ##us . The anti [SEP]',\n",
       "  'existing_cui': 'C1268914',\n",
       "  'existing_cui_name': 'Piperidine derivative',\n",
       "  'existing_cui_desc': '[CLS] Piper ##id ##ine derivative [unused3] ( Chemical , product , substance ) [SEP]',\n",
       "  'our_bi_cui': 'C1268914',\n",
       "  'our_bi_cui_name': 'Piperidine derivative',\n",
       "  'our_bi_cui_desc': '[CLS] Piper ##id ##ine derivative [unused3] ( Chemical , product , substance ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '28468980.17',\n",
       "  'test_set_idx': 37011,\n",
       "  'type': 'T103',\n",
       "  'name': 'rPfSEA-1A',\n",
       "  'context': '[CLS] ##long ##s survival following P ##las ##mo ##dium be ##rg ##he ##i AN ##KA challenge . To enhance the im ##mu ##no ##genic ##ity of P ##f ##SE ##A - 1A , we identified five linear , B - cell e ##pit ##ope ##s using p ##eptide micro ##arra ##ys probe ##d with anti - se ##ra from [unused1] r ##P ##f ##SE ##A - 1A [unused2] - v ##ac ##cin ##ated non - human p ##rima ##tes . We evaluated the relationship between e ##pit ##ope - specific anti ##body levels and protection from parasite ##mia in a longitudinal treatment - re ##in ##fect ##ion co ##hor ##t in Western Kenya . Anti ##bo ##dies to three e ##pit ##ope ##s were associated with 16 [SEP]',\n",
       "  'existing_cui': 'C0120659',\n",
       "  'existing_cui_name': 'HA-1A',\n",
       "  'existing_cui_desc': '[CLS] H ##A - 1A [unused3] ( Chemical , product , substance ) [SEP]',\n",
       "  'our_bi_cui': 'C0487378',\n",
       "  'our_bi_cui_name': 'Plasmodium falciparum antigen',\n",
       "  'our_bi_cui_desc': '[CLS] P ##las ##mo ##dium f ##al ##ci ##par ##um anti ##gen [unused3] ( Chemical , substance : P ##las ##mo ##dium f ##al ##ci ##par ##um A ##g ; P ##las ##mo ##dium f ##al ##ci ##par ##um Anti ##gen ) [SEP]',\n",
       "  'our_cross_cui': 'C3849939',\n",
       "  'our_cross_cui_name': 'SEA-1 protein , Plasmodium falciparum',\n",
       "  'our_cross_cui_desc': '[CLS] SE ##A - 1 protein , P ##las ##mo ##dium f ##al ##ci ##par ##um [unused3] ( Chemical : P ##f ##SE ##A - 1 protein , P ##las ##mo ##dium f ##al ##ci ##par ##um ; s ##chi ##zon ##t e ##g ##ress anti ##gen - 1 , P ##las ##mo ##dium f ##al ##ci ##par ##um ) [SEP]'},\n",
       " {'mention_id': '28523425.26',\n",
       "  'test_set_idx': 38391,\n",
       "  'type': 'T082',\n",
       "  'name': 'M1',\n",
       "  'context': '[CLS] Specifically , subjects performed intermittent pin ##cer grasp / release , elbow fl ##ex ##ion / extension , and shoulder fl ##ex ##ion / extension at slow , moderate , and fast speeds . In all movements , bursts of power in the high - [ Formula : see text ] band ( 80 - 160 Hz ) were observed in [unused1] M1 [unused2] . In addition , the amplitude of these power bursts and the area of M1 with elevated high - [ Formula : see text ] activity were directly proportional to the movement speed . Likewise , the duration of elevated high - [ Formula : see text ] activity increased with movement duration . Based on linear re ##gression , M1 high [SEP]',\n",
       "  'existing_cui': 'C1705014',\n",
       "  'existing_cui_name': 'CHRM1 wt Allele',\n",
       "  'existing_cui_desc': '[CLS] CH ##R ##M ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : M1 ##R ; HM ##1 ; Cho ##liner ##gic Re ##ceptor , Mu ##sca ##rini ##c , 1 Gene ; Ace ##ty ##l ##cho ##line Re ##ceptor , Mu ##sca ##rini ##c 1 Gene ; Cho ##liner ##gic Re ##ceptor , Mu ##sca ##rini ##c 1 w ##t All ##ele ; Ace ##ty ##l ##cho ##line Re ##ceptor , Mu ##sca ##rini ##c , 1 Gene ) [SEP]',\n",
       "  'our_bi_cui': 'C0026607',\n",
       "  'our_bi_cui_name': 'Motor Cortex',\n",
       "  'our_bi_cui_desc': '[CLS] Motor Co ##rte ##x [unused3] ( Spa ##tial Concept , Motor , body structure : Co ##rte ##x ; Area , Motor ; Motor Area ; Areas , So ##matic Motor ; so ##mat ##omo ##tor areas ; Motor area ; Co ##rte ##x , Motor ; So ##mat ##omo ##tor Area ; Areas , Motor ; motor cortex ; Area , So ##matic Motor ; Motor Areas ; so ##matic motor areas ; So ##mat ##omo ##tor Areas ; Motor Areas , So ##matic ; motor area ; areas motor ; So ##matic Motor Area ; Area , So ##mat ##omo ##tor ; Motor Area , So ##matic ; Areas , So ##mat ##omo ##tor ; Motor cortex ; cortex motor ; So ##matic Motor [SEP]',\n",
       "  'our_cross_cui': 'C3495441',\n",
       "  'our_cross_cui_name': 'primary motor cortex',\n",
       "  'our_cross_cui_desc': '[CLS] primary motor cortex [unused3] ( Spa ##tial Concept , Carpenter , Crosby , M I : area F1 ; Motor Area , Primary ; Motor Co ##rt ##ices , Primary ; primary so ##mat ##omo ##tor area ; primary motor area ; Motor Strip ; Pre ##cent ##ral Motor Co ##rte ##x ; Pre ##cent ##ral Motor Areas ; Area , Primary Motor ; motor cortex ; Motor Co ##rt ##ices , Pre ##cent ##ral ; Primary Motor Co ##rt ##ices ; pre ##cent ##ral motor cortex ; motor strip ; Primary Motor Area ; Motor cortex ; Area , Pre ##cent ##ral Motor ; Motor Co ##rte ##x , Pre ##cent ##ral ; pre ##cent ##ral motor area ; Primary Motor Areas ; Co ##rt [SEP]'},\n",
       " {'mention_id': '28282592.40',\n",
       "  'test_set_idx': 31122,\n",
       "  'type': 'T038',\n",
       "  'name': 'activation pathway',\n",
       "  'context': '[CLS] Trans ##ient rotor ##s terminated when t ##rave ##rsing a region with differing re ##fra ##ctor ##y periods , if no obstacle to conduct ##ion was present to sufficiently delay wave ##front arrival beyond the longest re ##fra ##ctor ##y period . Other rotor ##s were an ##ni ##hil ##ated when a nearby rotor with faster spin rate gradually interrupted the [unused1] activation pathway [unused2] . Eli ##mination of anchor ##s by removal , or by simulated a ##bla ##tion over a sufficient region , prevented rotor onset at a particular location where it would otherwise form . The presence of obstacles to conduct ##ion and spatial differences in re ##fra ##ctor ##y period are important parameters for in ##iti ##ating and maintaining rotation ##al activity [SEP]',\n",
       "  'existing_cui': 'C3156336',\n",
       "  'existing_cui_name': 'protein activation cascade',\n",
       "  'existing_cui_desc': '[CLS] protein activation ca ##sca ##de [unused3] ( B ##iol ##og ##ic Fun ##ction : protein act ##iv ##itor ##y ca ##sca ##de ; protein activation pathway ) [SEP]',\n",
       "  'our_bi_cui': 'C1704259',\n",
       "  'our_bi_cui_name': 'Biochemical Pathway',\n",
       "  'our_bi_cui_desc': '[CLS] B ##io ##chemical Path ##way [unused3] ( B ##iol ##og ##ic Fun ##ction : molecular pathway ; Path ##ways ; Path ##way ) [SEP]',\n",
       "  'our_cross_cui': 'C1148560',\n",
       "  'our_cross_cui_name': 'molecular_function',\n",
       "  'our_cross_cui_desc': '[CLS] molecular _ function [unused3] ( B ##iol ##og ##ic Fun ##ction : molecular function ) [SEP]'},\n",
       " {'mention_id': '27692319.46',\n",
       "  'test_set_idx': 14317,\n",
       "  'type': 'T204',\n",
       "  'name': 'miracidia',\n",
       "  'context': '[CLS] mg / m ##L . Egg ##s in ##cu ##bate ##d with crude extract sub - fraction ##s at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μ ##g / m ##L affected em ##b ##ryo ##nic development , with n - but ##ano ##l presenting the strongest in ##hibition of [unused1] mi ##rac ##id ##ia [unused2] formation . In contrast , on the 12th day , 90 % of the mi ##rac ##id ##ia hatch ##ed in the control experiments using 0 . 03 % D ##MS ##O whereas em ##b ##ryo ##genesis was completely abolished with any concentration of al ##ben ##da ##zo ##le su ##l ##ph ##oxide AB ##Z ( S ##O ) . [SEP]',\n",
       "  'existing_cui': 'C0451085',\n",
       "  'existing_cui_name': 'Composite international diagnostic interview',\n",
       "  'existing_cui_desc': '[CLS] Co ##mpo ##site international diagnostic interview [unused3] ( Intel ##lect ##ual Product , C ##ID ##I , assessment scale : composite international diagnostic interview ; C ##ID ##I - Co ##mpo ##site international diagnostic interview ) [SEP]',\n",
       "  'our_bi_cui': 'C2807025',\n",
       "  'our_bi_cui_name': 'Focillidia',\n",
       "  'our_bi_cui_desc': '[CLS] F ##oc ##ill ##id ##ia [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
       "  'our_cross_cui': 'C0023047',\n",
       "  'our_cross_cui_name': 'Larva',\n",
       "  'our_cross_cui_desc': '[CLS] La ##rva [unused3] ( E ##uka ##ryo ##te : La ##rva ##e ; la ##rva ; larvae ) [SEP]'},\n",
       " {'mention_id': '28145492.37',\n",
       "  'test_set_idx': 26797,\n",
       "  'type': 'T103',\n",
       "  'name': 'OX2R receptor',\n",
       "  'context': '[CLS] in the presence of te ##tro ##do ##to ##xin ) , appeared to be carried by a Na ( + ) - dependent trans ##ient receptor potential - like channel ( as it was blocked by 2 - AP ##B and was diminished by removal of extra ##cellular Na ( + ) ) , and was a consequence of [unused1] O ##X ##2 ##R receptor [unused2] activation ( as it was blocked by the O ##X ##2 ##R receptor antagonist T ##CS O ##X ##2 29 , but not the O ##X ##1 ##R receptor antagonist S ##B 33 ##48 ##6 ##7 ) . Application of the hormone , me ##lat ##oni ##n , failed to alter tube ##roi ##n ##fu ##ndi ##bula ##r do ##pa [SEP]',\n",
       "  'existing_cui': 'C0913649',\n",
       "  'existing_cui_name': 'taste receptors , type 2',\n",
       "  'existing_cui_desc': '[CLS] taste receptors , type 2 [unused3] ( Chemical , taste : G protein - coupled receptor T ##R ##2 ; T ##2 ##R taste receptors ; T ##2 ##R receptor ; T ##2 ##R receptors ; taste receptor , type 2 ; T ##AS ##2 ##R ##13 protein , human ; receptor , T ##2 ##R ) [SEP]',\n",
       "  'our_bi_cui': 'C0069841',\n",
       "  'our_bi_cui_name': 'Oxytocin Receptor',\n",
       "  'our_bi_cui_desc': '[CLS] O ##xy ##to ##cin Re ##ceptor [unused3] ( Chemical : Re ##ceptor ##s , O ##xy ##to ##cin [ Chemical / In ##g ##red ##ient ] ; R ##EC ##EP ##T O ##X ##Y ##TO ##CI ##N ; Re ##ceptor ##s , O ##xy ##to ##cin ; O ##X ##Y ##TO ##CI ##N R ##EC ##EP ##T ; Re ##ceptor , O ##xy ##to ##cin ; O ##xy ##to ##cin Re ##ceptor ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0671880',\n",
       "  'our_cross_cui_name': 'orexin receptor type 2',\n",
       "  'our_cross_cui_desc': '[CLS] ore ##xin receptor type 2 [unused3] ( Chemical : Or ##ex ##in - B Re ##ceptor ##s ; H ##y ##po ##cre ##tin - 2 Re ##ceptor ; Re ##ceptor , H ##y ##po ##cre ##tin - 2 ; H ##y ##po ##cre ##tin Re ##ceptor ##s 2 ; O ##X ##2 Re ##ceptor ##s ; Or ##ex ##in B Re ##ceptor ; Re ##ceptor ##s , Or ##ex ##in - B ; Re ##ceptor ##s 2 , H ##y ##po ##cre ##tin ; Or ##ex ##in Re ##ceptor 2 ; Re ##ceptor 2 , H ##y ##po ##cre ##tin ; HC ##TR ##2 Pro ##tein ; Re ##ceptor , Or ##ex ##in - B ; Or ##ex ##in Re ##ceptor Type 2 ; Pro ##tein [SEP]'},\n",
       " {'mention_id': '27838742.73',\n",
       "  'test_set_idx': 19040,\n",
       "  'type': 'T103',\n",
       "  'name': 'Delicaflavone',\n",
       "  'context': '[CLS] m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . [unused1] Del ##ica ##f ##lav ##one [unused2] did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto [SEP]',\n",
       "  'existing_cui': 'C1870828',\n",
       "  'existing_cui_name': 'sumaflavone',\n",
       "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
       "  'our_bi_cui': 'C2828290',\n",
       "  'our_bi_cui_name': 'delafloxacin',\n",
       "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27894019.20',\n",
       "  'test_set_idx': 21081,\n",
       "  'type': 'T103',\n",
       "  'name': 'CYP315a1',\n",
       "  'context': '[CLS] ##e p ##le ##bs . X ##ant ##hur ##eni ##c acid is a known end ##ogen ##ous m ##olt regulator present in art ##hr ##op ##ods . Experimental studies have confirmed that X ##ant ##hur ##eni ##c acid in ##hibit ##s m ##olt ##ing by binding to either ( or both ) of two P ##45 ##0 enzymes ( [unused1] C ##YP ##31 ##5 ##a ##1 [unused2] or C ##YP ##31 ##4 ##a ##1 ) that are responsible for the final two h ##ydro ##xy ##lation ##s in the production of the m ##olt - in ##ducing hormone , 20 - h ##ydro ##xy ##ec ##dy ##son ##e . The lack of crystal structures and bio ##chemical ass ##ays for C ##YP ##31 ##5 ##a ##1 [SEP]',\n",
       "  'existing_cui': 'C1418799',\n",
       "  'existing_cui_name': 'PPIF gene',\n",
       "  'existing_cui_desc': '[CLS] PP ##IF gene [unused3] ( Ana ##tom ##ical Structure : C ##Y ##CL ##OP ##H ##IL ##IN 3 ; P ##EP ##TI ##D ##Y ##L - PR ##OL ##Y ##L C ##IS / T ##RA ##NS ISO ##ME ##RA ##SE , MIT ##OC ##H ##ON ##DR ##IA ##L ; P ##ept ##idy ##l ##p ##rol ##yl Is ##omer ##ase F Gene ; PP ##IF Gene ; C ##Y ##CL ##OP ##H ##IL ##IN F ; p ##ept ##idy ##l ##p ##rol ##yl is ##omer ##ase F ; Cy ##p - D ; h ##C ##y ##P ##3 ; c ##y ##c ##lop ##hil ##in D ) [SEP]',\n",
       "  'our_bi_cui': 'C0059735',\n",
       "  'our_bi_cui_name': 'Cytochrome P-450 CYP1A1',\n",
       "  'our_bi_cui_desc': '[CLS] Cy ##to ##ch ##rome P - 450 C ##YP ##1 ##A ##1 [unused3] ( Chemical , substance : Cy ##to ##ch ##rome P 450 C ##YP ##1 ##A ##1 ; Cy ##to ##ch ##rome p ##45 ##0 C ##YP ##1 ##A ##1 enzyme ; er ##od ##ing ; 7 - E ##th ##ox ##yres ##or ##uf ##in O - Dee ##thy ##lase ; C ##YP 1A ##1 ; E ##thy ##l ##res ##or ##uf ##in O - Dee ##thy ##lase ; Cy ##to ##ch ##rome P - 450 C ##YP ##1 ##A ##1 [ Chemical / In ##g ##red ##ient ] ; Cy ##to ##ch ##rome P ##45 ##0 I ##A ##1 ; C ##YP ##1 ##A ##1 ; E ##th ##ox ##yres ##or ##uf ##in [SEP]',\n",
       "  'our_cross_cui': 'C0010762',\n",
       "  'our_cross_cui_name': 'Cytochrome P450',\n",
       "  'our_cross_cui_desc': '[CLS] Cy ##to ##ch ##rome P ##45 ##0 [unused3] ( Chemical , substance : c ##yt ##och ##rome ##s p ##45 ##0 ; c ##yt ##och ##rome P ##45 ##0 ; C ##Y ##TO ##CH ##RO ##ME P 450 E ##N ##Z ##Y ##ME S ##Y ##ST ##EM ; Cy ##to ##ch ##rome p ##45 ##0 enzyme ; Super ##family , Cy ##to ##ch ##rome P ##45 ##0 ; P ##45 ##0 En ##zy ##mes ; c ##yt ##och ##rome p 450 ; En ##zy ##mes , P ##45 ##0 ; Cy ##to ##ch ##rome P 450 Families ; Cy ##to ##ch ##rome P ##45 ##0 En ##zy ##me ; P ##45 ##0 ; C ##YP ##45 ##0 ; Cy ##to ##ch ##rome p ##45 ##0 ; [SEP]'},\n",
       " {'mention_id': '27669217.40',\n",
       "  'test_set_idx': 13691,\n",
       "  'type': 'T017',\n",
       "  'name': 'ermB',\n",
       "  'context': '[CLS] . The er ##m ##B and er ##m ##T genes were found in the genome ##s of all is ##olate ##s . These two genes were acquired independently in one highly v ##ir ##ulent is ##olate AL ##10 ##100 ##2 , and cluster ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both [unused1] er ##m ##B [unused2] and er ##m ##T in all is ##olate ##s was er ##yt ##hr ##omy ##cin in ##du ##cible and yielded comparable mac ##rol ##ide MI ##Cs in all six is ##olate ##s . Take ##n together , in ##du ##cible expression of both er ##m ##B and er ##m ##T conferred high mac ##rol ##ide resistance in these S . gal [SEP]',\n",
       "  'existing_cui': 'C0732611',\n",
       "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
       "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
       "  'our_bi_cui': 'C0017339',\n",
       "  'our_bi_cui_name': 'Genes , Bacterial',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##s , Ba ##cter ##ial [unused3] ( Ana ##tom ##ical Structure , substance : Ba ##cter ##ial Gene ##s ; BA ##CT GE ##NE ##S ; GE ##NE ##S BA ##CT ; bacterial gene ; Ba ##cter ##ial genes ; Gene , Ba ##cter ##ial ; BA ##CT GE ##NE ; Ba ##cter ##ial gene ; Ba ##cter ##ial Gene ; GE ##NE BA ##CT ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '28522288.2',\n",
       "  'test_set_idx': 38314,\n",
       "  'type': 'T033',\n",
       "  'name': 'Underestimation',\n",
       "  'context': '[CLS] Grade Group [unused1] Under ##est ##imation [unused2] in Pro ##state B ##io ##psy : Pre ##dict ##ive Factor ##s and Out ##come ##s in Can ##di ##dates for Active Sur ##ve ##illa ##nce We intended to analyze the outcomes and predict ##ive factors for under ##est ##imating the pro ##state cancer grade group from pro ##state bio ##ps ##ies in a large mon ##oc ##ent ##ric co ##hor ##t of patients treated by minimal ##ly invasive radical pro ##state ##ct ##omy . Using a mon ##oc ##ent ##ric prospective ##ly maintained database , we included 306 ##2 patients who underwent minimal ##ly invasive radical pro ##state ##ct ##omy between 2006 and 2013 . We explored clinic ##op ##ath ##olo ##gic features and outcomes associated with a [SEP]',\n",
       "  'existing_cui': 'C0680844',\n",
       "  'existing_cui_name': 'estimation',\n",
       "  'existing_cui_desc': '[CLS] est ##imation [unused3] ( B ##iol ##og ##ic Fun ##ction , subjective , subjective : E ##st ##imation ; est ##imation ##s ) [SEP]',\n",
       "  'our_bi_cui': 'C0680844',\n",
       "  'our_bi_cui_name': 'estimation',\n",
       "  'our_bi_cui_desc': '[CLS] est ##imation [unused3] ( B ##iol ##og ##ic Fun ##ction , subjective , subjective : E ##st ##imation ; est ##imation ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28484550.10',\n",
       "  'test_set_idx': 37646,\n",
       "  'type': 'T038',\n",
       "  'name': 'giant',\n",
       "  'context': '[CLS] Di ##stal posterior cerebral artery re ##vas ##cular ##ization for a f ##us ##iform PC ##A an ##eur ##ys ##m : A lesson learned The need for re ##vas ##cular ##ization with pro ##ximal posterior cerebral artery o ##cc ##lusion in the treatment of [unused1] giant [unused2] and f ##us ##iform an ##eur ##ys ##ms is unclear . While early series demonstrated only about a 10 % chance of in ##far ##ction following posterior cerebral artery o ##cc ##lusion , recently several authors have advocated a bypass prior to parent vessel sacrifice in all cases . We present the case of an adult man with a f ##us ##iform an ##eur ##ys ##m of the right posterior cerebral artery at the P ##2 - P ##3 [SEP]',\n",
       "  'existing_cui': 'C0017547',\n",
       "  'existing_cui_name': 'Gigantism',\n",
       "  'existing_cui_desc': '[CLS] G ##igan ##tism [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , physical finding : G ##igan ##tism , Pit ##uit ##ary ; pit ##uit ##ary ; gig ##anti ##sm ; giants ; gig ##anti ##sm disorder ; giant ; gig ##anti ##sm ; pit ##uit ##ary ; Giant ; Normal giant ; gig ##anti ##sm was noted ; Pit ##uit ##ary G ##igan ##tism ; Giant ##ism ; gig ##anti ##sm ; P ##rim ##ord ##ial giant ; Gene ##tic giant ; genetics giant ; giant ##ism ; Pit ##uit ##ary gig ##anti ##sm ; Giant - R ##ET ##IR ##ED - ; G ##igan ##tism [ Disease / Finding ] ) [SEP]',\n",
       "  'our_bi_cui': 'C0017547',\n",
       "  'our_bi_cui_name': 'Gigantism',\n",
       "  'our_bi_cui_desc': '[CLS] G ##igan ##tism [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , physical finding : G ##igan ##tism , Pit ##uit ##ary ; pit ##uit ##ary ; gig ##anti ##sm ; giants ; gig ##anti ##sm disorder ; giant ; gig ##anti ##sm ; pit ##uit ##ary ; Giant ; Normal giant ; gig ##anti ##sm was noted ; Pit ##uit ##ary G ##igan ##tism ; Giant ##ism ; gig ##anti ##sm ; P ##rim ##ord ##ial giant ; Gene ##tic giant ; genetics giant ; giant ##ism ; Pit ##uit ##ary gig ##anti ##sm ; Giant - R ##ET ##IR ##ED - ; G ##igan ##tism [ Disease / Finding ] ) [SEP]',\n",
       "  'our_cross_cui': 'C0751004',\n",
       "  'our_cross_cui_name': 'Giant Intracranial Aneurysm',\n",
       "  'our_cross_cui_desc': '[CLS] Giant In ##tra ##c ##rani ##al An ##eur ##ys ##m [unused3] ( B ##iol ##og ##ic Fun ##ction : In ##tra ##c ##rani ##al An ##eur ##ys ##m , Giant ; An ##eur ##ys ##ms , Giant In ##tra ##c ##rani ##al ; In ##tra ##c ##rani ##al An ##eur ##ys ##ms , Giant ; Giant In ##tra ##c ##rani ##al An ##eur ##ys ##ms ; An ##eur ##ys ##m , Giant In ##tra ##c ##rani ##al ) [SEP]'},\n",
       " {'mention_id': '27887587.40',\n",
       "  'test_set_idx': 20928,\n",
       "  'type': 'T033',\n",
       "  'name': 'practical',\n",
       "  'context': \"[CLS] Community Mental Health Centre in their work towards their recovery goals were el ##icit ##ed , as follows : developing an understanding of ones ##elf and one ' s mental health problems ; learning how to change feelings and behaviour ##s ; being ' pushed ' into social arena ##s ; finding helpful medication ; and counsel ##ling in family , [unused1] practical [unused2] and financial issues . The participants ' expectations about counsel ##ling with regard to longer - term family , practical , and financial challenges were insufficient ##ly met by the Community Mental Health Centre . In the experience of the service users , recovery occurred within the context of their everyday life with or without the support of their professional help ##ers [SEP]\",\n",
       "  'existing_cui': 'C0335403',\n",
       "  'existing_cui_name': 'Practical aid',\n",
       "  'existing_cui_desc': '[CLS] P ##ractical aid [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line , pharmacy , pharmacy , occupation : P ##ractical aid ( pharmacy ) ) [SEP]',\n",
       "  'our_bi_cui': 'C4054160',\n",
       "  'our_bi_cui_name': 'Practical Domain',\n",
       "  'our_bi_cui_desc': '[CLS] P ##ractical Domain [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '28436493.28',\n",
       "  'test_set_idx': 35794,\n",
       "  'type': 'T103',\n",
       "  'name': 'EsxA',\n",
       "  'context': '[CLS] ##X - 1 type VII secret ##ion system . Gene ##tic complement ##ation with a p ##las ##mi ##d carrying the My ##co ##ba ##cter ##ium tuberculosis H ##37 ##R ##v sequence of e ##cc ##C ##a ##1 - e ##cc ##C ##b ##1 - p ##e ##35 re - established E ##s ##x ##A secret ##ion , host specific [unused1] E ##s ##x ##A [unused2] T - cell responses , and increased strain v ##ir ##ule ##nce . The E ##S ##X - 1 secret ##ion defect prevents several v ##ir ##ule ##nce factors from being functional during infection and therefore at ##ten ##uate ##s My ##co ##ba ##cter ##ium tuberculosis . It pre ##c ##lude ##s specific T - cell responses against strong anti [SEP]',\n",
       "  'existing_cui': 'C1706322',\n",
       "  'existing_cui_name': 'ELF3 wt Allele',\n",
       "  'existing_cui_desc': '[CLS] E ##LF ##3 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : E ##SE - 1 ; ER ##T ; J ##EN ; E ##S ##X ; E ##7 ##4 - Like Factor 3 ( ET ##S Domain Trans ##cription Factor , E ##pit ##hel ##ial - S ##pecific ) w ##t All ##ele ; EP ##R - 1 ) [SEP]',\n",
       "  'our_bi_cui': 'C0052654',\n",
       "  'our_bi_cui_name': 'atroxase',\n",
       "  'our_bi_cui_desc': '[CLS] at ##ro ##xa ##se [unused3] ( Chemical , substance : At ##ro ##xa ##se ) [SEP]',\n",
       "  'our_cross_cui': 'C1744314',\n",
       "  'our_cross_cui_name': 'ESAT-6 protein , Mycobacterium tuberculosis',\n",
       "  'our_cross_cui_desc': '[CLS] E ##SA ##T - 6 protein , My ##co ##ba ##cter ##ium tuberculosis [unused3] ( Chemical : E ##SA ##T - 6 System 1 protein , My ##co ##ba ##cter ##ium tuberculosis ; 6 - k ##D ##a early secret ##ory anti ##genic target , My ##co ##ba ##cter ##ium tuberculosis ; E ##s ##x - 1 protein , My ##co ##ba ##cter ##ium tuberculosis ; E ##s ##x ##A protein , My ##co ##ba ##cter ##ium tuberculosis ) [SEP]'},\n",
       " {'mention_id': '27347668.1',\n",
       "  'test_set_idx': 3121,\n",
       "  'type': 'T058',\n",
       "  'name': 'Spectral fingerprints',\n",
       "  'context': '[CLS] [unused1] S ##pect ##ral finger ##prints [unused2] of large - scale co ##rt ##ical dynamics during ambiguous motion perception Am ##bi ##guous stimuli have been widely used to study the ne ##uron ##al co ##rrel ##ates of consciousness . Recently , it has been suggested that conscious perception might arise from the dynamic inter ##play of functional ##ly specialized but widely distributed co ##rt ##ical areas . While previous research mainly focused on phase coupling as a co ##rrel ##ate of co ##rt ##ical communication , more recent findings indicated that additional coupling modes might co ##ex ##ist and possibly sub ##serve distinct co ##rt ##ical functions . Here , we studied two coupling modes , namely phase and envelope coupling , which might differ in [SEP]',\n",
       "  'existing_cui': 'C0016128',\n",
       "  'existing_cui_name': 'Fingerprints , Peptide',\n",
       "  'existing_cui_desc': '[CLS] Fin ##ger ##prints , P ##eptide [unused3] ( Health Care Act ##ivity : Fin ##ger ##print , P ##eptide ; Fin ##ger ##prints , Pro ##tein ; Pro ##tein Fin ##ger ##prints ; Pro ##tein Fin ##ger ##print ; P ##eptide Fin ##ger ##print ; P ##eptide Fin ##ger ##prints ; Fin ##ger ##print , Pro ##tein ) [SEP]',\n",
       "  'our_bi_cui': 'C0079356',\n",
       "  'our_bi_cui_name': 'DNA Fingerprints',\n",
       "  'our_bi_cui_desc': '[CLS] DNA Fin ##ger ##prints [unused3] ( Finding : Fin ##ger ##print , DNA ; Fin ##ger ##prints , DNA ; d ##na finger ##prints ; DNA Fin ##ger ##print ; d ##na finger ##print ) [SEP]',\n",
       "  'our_cross_cui': 'C0037812',\n",
       "  'our_cross_cui_name': 'Spectrum Analysis',\n",
       "  'our_cross_cui_desc': '[CLS] Spectrum Analysis [unused3] ( Health Care Act ##ivity : s ##pect ##ros ##copy ; spectrum analysis ; SP ##EC ##TR ##UM AN ##AL ; S ##pect ##ros ##copy ; Analysis , Spectrum ; AN ##AL SP ##EC ##TR ##UM ; Spectrum analysis ) [SEP]'},\n",
       " {'mention_id': '27984742.11',\n",
       "  'test_set_idx': 22893,\n",
       "  'type': 'T103',\n",
       "  'name': 'DarG',\n",
       "  'context': '[CLS] Back to the Roots : Deep View into the Evolution ##ary History of AD ##P - R ##ib ##osy ##lation Opened by the DNA - Target ##ing To ##xin - Anti ##to ##xin Mo ##du ##le Dar ##T ##G In this issue of Molecular Cell , Jan ##ke ##vic ##ius et al . ( 2016 ) character ##ize the Dar ##T ##G to ##xin - anti ##to ##xin module in which the Dar ##T to ##xin AD ##P - rib ##osy ##lates single - stranded DNA and the [unused1] Dar ##G [unused2] anti ##to ##xin counter ##acts Dar ##T by direct binding and by en ##zy ##matic re ##mo ##va l of the AD ##P - rib ##osy ##lation . [SEP]',\n",
       "  'existing_cui': 'C2767915',\n",
       "  'existing_cui_name': 'Dargida',\n",
       "  'existing_cui_desc': '[CLS] Dar ##gi ##da [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
       "  'our_bi_cui': 'C0969663',\n",
       "  'our_bi_cui_name': 'DnaG',\n",
       "  'our_bi_cui_desc': '[CLS] D ##na ##G [unused3] ( Chemical , P ##rima ##se , P ##rima ##se : D ##na ##G Pro ##tein ; D ##na ##G Gene Product ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '27442216.12',\n",
       "  'test_set_idx': 5808,\n",
       "  'type': 'T037',\n",
       "  'name': 'appendicular fractures',\n",
       "  'context': '[CLS] total of 75 ##8 patients who presented following either snow ##mobile ( n = 87 ) , AT ##V - related ( n = 308 ) or dirt ##bi ##ke ( n = 36 ##3 ) - related trauma at our institution between 1996 and 2015 were retrospective ##ly reviewed . A total of 44 ##1 a ##xial and [unused1] app ##end ##icular fracture ##s [unused2] occurred requiring 53 ##3 procedures . Snow ##mobile and dirt ##bi ##ke accidents were associated with a higher rate of fracture ##s ( 63 % , 64 % ) than the All - terrain vehicles group ( 50 % ) ( P = 0 . 000 ##8 ) . Snow ##mobile injuries had the highest rate of spinal ( 23 [SEP]',\n",
       "  'existing_cui': 'C0226745',\n",
       "  'existing_cui_name': 'Structure of appendicular vein',\n",
       "  'existing_cui_desc': '[CLS] Structure of app ##end ##icular vein [unused3] ( Ana ##tom ##ical Structure , body structure : V ##ena app ##end ##icular ##is ; A ##ppe ##ndi ##cular vein ) [SEP]',\n",
       "  'our_bi_cui': 'C0003611',\n",
       "  'our_bi_cui_name': 'Appendectomy',\n",
       "  'our_bi_cui_desc': '[CLS] A ##ppe ##nde ##ct ##omy [unused3] ( Health Care Act ##ivity , procedure , treatment : removal of app ##end ##ix ; app ##end ##ec ##tom ##ies ; A ##ppe ##nde ##ct ##omi ##es ; app ##end ##ice ##ct ##omy ; Re ##mo ##val of app ##end ##ix ; A ##ppe ##ndi ##x : Ex ##cision ; app ##end ##ec ##tom ##y procedure ; A ##ppe ##ndi ##ce ##ct ##omy ; app ##end ##ec ##tom ##y ; app ##end ##ice ##ct ##omi ##es ; Ex ##cision of app ##end ##ix ; app ##end ##ec ##tom ##y procedures ; Primary app ##end ##ec ##tom ##y ; app ##end ##ix ex ##cision ; Ex ##cision Pro ##ced ##ures on the A ##ppe ##ndi ##x ; AP ##P ##EN [SEP]',\n",
       "  'our_cross_cui': 'C0016658',\n",
       "  'our_cross_cui_name': 'Fracture',\n",
       "  'our_cross_cui_desc': '[CLS] Fr ##act ##ure [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , finding , m ##or ##ph ##olo ##gic abnormal ##ity : Broken bones ; Broken Bones ; broken bone ; Fr ##act ##ure of Bone ; bone ; fracture ; bones fractured ; Fr ##act ##ures ; fracture ; bone ; Fr ##act ##ures , Bone [ Disease / Finding ] ; fracture ##s ; fractured ; Bone , Broken ; Fr ##act ##ure of bones ; Fr ##act ##ure : [ of un ##sp ##ec ##ified bones ] or [ NO ##S ] ; Fr ##act ##ure , cause ; Fr ##act ##ure bone ; bone fracture ; bone fracture ##s ; bone fractured ; Bone Fr ##act ##ure [SEP]'},\n",
       " {'mention_id': '27722881.48',\n",
       "  'test_set_idx': 15035,\n",
       "  'type': 'T007',\n",
       "  'name': 'JPM1',\n",
       "  'context': '[CLS] strain JP ##M ##1 was proposed based on the meta ##bol ##ites and the interaction analyses . Additionally , the the ##rm ##ody ##nam ##ic analysis showed that the strain JP ##M ##1 had high tolerance for flu ##oran ##the ##ne , and the influence of flu ##oran ##the ##ne for the bacterial growth activity was ne ##gli ##gible under 100 to 400 mg L ( - 1 ) concentrations . Take ##n together , this study indicates that the strain [unused1] JP ##M ##1 [unused2] has high potential for further study in bio ##rem ##edia ##tion of p ##oly ##cy ##c ##lic a ##romatic h ##ydro ##car ##bon ( p ##oly ##cy ##c ##lic a ##romatic h ##ydro ##car ##bon ) - contaminated sites . [SEP]',\n",
       "  'existing_cui': 'C1421124',\n",
       "  'existing_cui_name': 'TRGJP gene',\n",
       "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
       "  'our_bi_cui': 'C3629619',\n",
       "  'our_bi_cui_name': 'bacterium JP1',\n",
       "  'our_bi_cui_desc': '[CLS] bacterium JP ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
       "  'our_cross_cui': 'C4153571',\n",
       "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
       "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
       " {'mention_id': '27933285.26',\n",
       "  'test_set_idx': 22294,\n",
       "  'type': 'T170',\n",
       "  'name': 'Autism Diagnostic Observation Schedule - second edition',\n",
       "  'context': \"[CLS] ##eti ##tive Be ##ha ##vior Scale - Rev ##ised , the Raven ' s Color ##ed Progressive Mat ##rice ##s , the Child Be ##ha ##vior Check ##L ##ist for ages 1 ½ - 5 or 4 - 18 ( CBC ##L ) , the Social Re ##sp ##ons ##ive ##ness Scale , and the [unused1] Au ##tism Di ##ag ##nos ##tic O ##bs ##er ##vation Schedule - second edition [unused2] ( AD ##OS 2 ) . All patients were showing motor stereo ##ty ##pies for periods of time varying from 6 to 77 months . The Motor Se ##ver ##ity St ##ere ##ot ##y ##py Scale showed that each child had a limited number of stereo ##ty ##pies ; their frequency and intensity were mild [SEP]\",\n",
       "  'existing_cui': 'C0441795',\n",
       "  'existing_cui_name': 'Second edition',\n",
       "  'existing_cui_desc': '[CLS] Second edition [unused3] ( Intel ##lect ##ual Product , qualifier value : Second Edition ) [SEP]',\n",
       "  'our_bi_cui': 'C2828257',\n",
       "  'our_bi_cui_name': 'International Classification of Diseases for Oncology , Second Edition',\n",
       "  'our_bi_cui_desc': '[CLS] International Classification of Disease ##s for On ##cology , Second Edition [unused3] ( Intel ##lect ##ual Product : I ##CD - O - 2 ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28077286.39',\n",
       "  'test_set_idx': 25089,\n",
       "  'type': 'T103',\n",
       "  'name': 'MeHg',\n",
       "  'context': '[CLS] on brain his ##top ##ath ##ology and courts ##hip behavior in a model song ##bird species , the z ##eb ##ra fin ##ch ( Ta ##eni ##opy ##gia gut ##tata ) . Egg treatment groups included : a low Me ##H ##g dose of 0 . 2 μ ##g H ##g g ( - 1 ) egg , a high [unused1] Me ##H ##g [unused2] dose of 3 . 2 μ ##g H ##g g ( - 1 ) egg , and a vehicle control ( water ) . No adverse effects of in o ##vo Me ##H ##g treatment were detected on courts ##hip song quality or on mating behavior in experimental males at sexually maturity which would suggest that o ##bs ##er ##vable ne [SEP]',\n",
       "  'existing_cui': 'C0228520',\n",
       "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
       "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
       "  'our_bi_cui': 'C0166979',\n",
       "  'our_bi_cui_name': 'dimethyl mercury',\n",
       "  'our_bi_cui_desc': '[CLS] dim ##eth ##yl mercury [unused3] ( Chemical , substance : Di ##met ##hyl ##mer ##cu ##ry ; Me ##rc ##uri ##us Met ##hyl ##en ##us ; Met ##hyl Mercury ; D ##IM ##ET ##H ##Y ##LM ##ER ##CU ##R ##Y ; Di ##met ##hyl mercury ; dim ##eth ##yl ##mer ##cu ##ry ; Mercury , Di ##met ##hyl ) [SEP]',\n",
       "  'our_cross_cui': 'C0025794',\n",
       "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
       "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
       " {'mention_id': '27503899.39',\n",
       "  'test_set_idx': 8574,\n",
       "  'type': 'T033',\n",
       "  'name': 'underlying misconceptions',\n",
       "  'context': '[CLS] time and logistics . Various forms of generic feedback can provide rapid and cost - effect feedback to large co ##hor ##ts but may be of limited benefit to students other than signaling weaknesses in knowledge . The present study describes a method that was used to provide format ##ive task - related feedback to a large co ##hor ##t of first - year physiology and anatomy students . Based on student evaluation ##s presented in this study , this method provided feedback in a manner that engaged students , uncovered [unused1] underlying mi ##sco ##nce ##ption ##s [unused2] , facilitated peer discussion , and provided opportunity for new instruction while allowing the lecturer to recognize common gaps in knowledge and inform ongoing curriculum development . [SEP]',\n",
       "  'existing_cui': 'C4313726',\n",
       "  'existing_cui_name': 'Underlying erythema',\n",
       "  'existing_cui_desc': '[CLS] Under ##lying er ##yt ##hem ##a [unused3] ( Finding , in some patients , in some patients ) [SEP]',\n",
       "  'our_bi_cui': 'C0561845',\n",
       "  'our_bi_cui_name': 'False memories',\n",
       "  'our_bi_cui_desc': '[CLS] F ##als ##e memories [unused3] ( B ##iol ##og ##ic Fun ##ction , finding : P ##se ##udo ##me ##mor ##y ; F ##als ##e Memory ; false memory ; false memories ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27259647.14',\n",
       "  'test_set_idx': 945,\n",
       "  'type': 'T103',\n",
       "  'name': '9-cis-11-trans-CLA',\n",
       "  'context': '[CLS] - surface protein belonging to the conserved family of en ##ola ##ses with a central role in g ##ly ##co ##ly ##tic metabolism , was characterized to have a side role in the intricate metabolism of bio ##hy ##dr ##ogen ##ation of l ##ino ##le ##ic acid , cat ##aly ##zing the formation of bio ##active [unused1] 9 - c ##is - 11 - trans - C ##LA [unused2] through de ##hy ##dra ##tion and is ##omer ##ization of 10 - h ##ydro ##xy - 12 - c ##is - o ##ct ##ade ##ce ##no ##ic acid . The identity of the en ##ola ##se was confirmed through mass s ##pect ##rome ##tric analysis that showed the characteristic 44 ##2 amino acid sequence with a molecular [SEP]',\n",
       "  'existing_cui': 'C0281666',\n",
       "  'existing_cui_name': 'alitretinoin',\n",
       "  'existing_cui_desc': '[CLS] al ##it ##ret ##ino ##in [unused3] ( Chemical , product , substance : 9 - CR ##A ; 9 - c ##is - T ##ret ##ino ##in ; Ali ##tre ##tino ##ín ##a ; 9 - c ##is re ##tino ##ic acid ; 9 - c ##is - Re ##tino ##ic acid ; 9 - c ##is - Re ##tino ##ic A ##cid ; Ali ##tre ##tino ##in ; Ali ##tre ##tino ##in ##um ; 3 , 7 - Di ##met ##hyl - 9 - ( 2 , 6 , 6 - trim ##eth ##yl - 1 - c ##y ##c ##lo ##he ##xen - 1 - y ##l ) 2 - trans - 4 - trans - 6 - c ##is - 8 - trans [SEP]',\n",
       "  'our_bi_cui': 'C0902483',\n",
       "  'our_bi_cui_name': 'cis-9-trans-11-octadecadienoic acid',\n",
       "  'our_bi_cui_desc': '[CLS] c ##is - 9 - trans - 11 - o ##ct ##ade ##ca ##die ##no ##ic acid [unused3] ( Chemical : 9 - c ##is - 11 - trans - o ##ct ##ade ##ca ##die ##no ##ic acid ; c ##9 ##t ##11 C ##LA ) [SEP]',\n",
       "  'our_cross_cui': 'C1609806',\n",
       "  'our_cross_cui_name': 'cis-9 , trans-11-conjugated linoleic acid',\n",
       "  'our_cross_cui_desc': '[CLS] c ##is - 9 , trans - 11 - con ##ju ##gated l ##ino ##le ##ic acid [unused3] ( Chemical : c ##9 - t ##11 - C ##LA ) [SEP]'},\n",
       " {'mention_id': '28179911.55',\n",
       "  'test_set_idx': 27649,\n",
       "  'type': 'T017',\n",
       "  'name': 'KASI',\n",
       "  'context': '[CLS] ##ido ##psis , high over - expressions of Co ##WR ##I ##1 in seven independent T ##2 lines were detected by quantitative real - time PC ##R . The relative m ##RNA accumulation of genes encoding enzymes involved in either fatty acid bio ##sy ##nt ##hesis or t ##ria ##cy ##l ##gly ##cer ##ols assembly ( BC ##CP ##2 , [unused1] K ##AS ##I [unused2] , MA ##T , E ##NR , FA ##TA , and GP ##D ##H ) were also ass ##ay ##ed in mature seeds . Furthermore , lip ##id and fatty acids C ##16 : 0 and C ##18 : 0 significantly increased . In two ho ##mo ##zy ##go ##us T ##2 trans ##genic rice lines ( G ##5 and G [SEP]',\n",
       "  'existing_cui': 'C1151968',\n",
       "  'existing_cui_name': '3-oxoacyl - [ acyl-carrier-protein ] synthase activity',\n",
       "  'existing_cui_desc': '[CLS] 3 - o ##x ##oa ##cy ##l - [ a ##cy ##l - carrier - protein ] s ##ynth ##ase activity [unused3] ( B ##iol ##og ##ic Fun ##ction , de ##car ##box ##yla ##ting : beta - k ##eto ##acy ##l - AC ##P s ##ynth ##ase I activity ; 3 - o ##x ##oa ##cy ##l : AC ##P s ##ynth ##ase I ; beta - k ##eto ##acy ##l s ##ynth ##eta ##se activity ; 3 - o ##x ##oa ##cy ##l - [ a ##cy ##l - carrier protein ] s ##ynth ##ase activity ; beta - k ##eto ##acy ##l a ##cy ##l carrier protein s ##ynth ##ase activity ; beta - k ##eto ##acy ##l - AC ##P s ##ynth [SEP]',\n",
       "  'our_bi_cui': 'C1418256',\n",
       "  'our_bi_cui_name': 'PAICS gene',\n",
       "  'our_bi_cui_desc': '[CLS] PA ##IC ##S gene [unused3] ( Ana ##tom ##ical Structure : SA ##IC ##AR S ##Y ##NT ##H ##ET ##AS ##E ; P ##H ##OS ##P ##H ##OR ##IB ##OS ##Y ##LA ##MI ##N ##O ##IM ##ID ##A ##Z ##OL ##E CA ##RB ##OX ##Y ##LA ##SE ; AI ##R CA ##RB ##OX ##Y ##LA ##SE ; AD ##E ##2 ##H1 ; p ##hos ##ph ##ori ##bos ##yla ##min ##oi ##mi ##da ##zo ##le car ##box ##yla ##se ; p ##hos ##ph ##ori ##bos ##yla ##min ##oi ##mi ##da ##zo ##les ##ucci ##no ##car ##box ##ami ##de s ##ynth ##ase ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27647760.43',\n",
       "  'test_set_idx': 12810,\n",
       "  'type': 'T170',\n",
       "  'name': 'recessive model',\n",
       "  'context': \"[CLS] ##D ##NF ##OS had a protective role for heroin addiction in the add ##itive model and dominant model ( p < 0 . 05 ) . By contrast , the all ##ele ' T ' of r ##s ##7 ##48 ##13 ##11 in B ##D ##NF ##OS significantly elevated the risk of heroin addiction in the add ##itive model , [unused1] re ##cess ##ive model [unused2] and dominant model ( p < 0 . 05 ) . We also found that all ##ele ' C ' of r ##s ##11 ##0 ##30 ##0 ##9 ##6 was associated with an increased risk of addiction in the dominant model and add ##itive model ( p < 0 . 05 ) . Additionally , we found that r ##s [SEP]\",\n",
       "  'existing_cui': 'C0017361',\n",
       "  'existing_cui_name': 'Genes , Recessive',\n",
       "  'existing_cui_desc': '[CLS] Gene ##s , Re ##cess ##ive [unused3] ( Ana ##tom ##ical Structure , function , o ##bs ##er ##vable entity , substance : Re ##cess ##ive Gene ##s ; gene re ##cess ##ive ; genes re ##cess ##ive ; Re ##cess ##ive Gene ; re ##cess ##ive genes ; re ##cess ##ive gene ; Gene , Re ##cess ##ive ; Re ##cess ##ive gene , function ; Re ##cess ##ive gene ) [SEP]',\n",
       "  'our_bi_cui': 'C0017361',\n",
       "  'our_bi_cui_name': 'Genes , Recessive',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##s , Re ##cess ##ive [unused3] ( Ana ##tom ##ical Structure , function , o ##bs ##er ##vable entity , substance : Re ##cess ##ive Gene ##s ; gene re ##cess ##ive ; genes re ##cess ##ive ; Re ##cess ##ive Gene ; re ##cess ##ive genes ; re ##cess ##ive gene ; Gene , Re ##cess ##ive ; Re ##cess ##ive gene , function ; Re ##cess ##ive gene ) [SEP]',\n",
       "  'our_cross_cui': 'C0026343',\n",
       "  'our_cross_cui_name': 'Models , Genetic',\n",
       "  'our_cross_cui_desc': '[CLS] Models , Gene ##tic [unused3] ( Intel ##lect ##ual Product : GE ##NE ##T M ##OD ##EL ##S ; genetic model ; Gene ##tic Models ; Gene ##tic Model ; Model , Gene ##tic ; M ##OD ##EL ##S GE ##NE ##T ) [SEP]'},\n",
       " {'mention_id': '27894020.12',\n",
       "  'test_set_idx': 21121,\n",
       "  'type': 'T204',\n",
       "  'name': 'Giuseppe Paravicini',\n",
       "  'context': '[CLS] Mom ##bell ##o P ##sy ##chia ##tric Hospital in Lim ##bia ##te , near Milan , replaced the old Sen ##av ##ra Hospital as the P ##sy ##chia ##tric Hospital for the Province of Milan in the 19th century . During the early 20th century , bodies of several Mom ##bell ##o patients were di ##sse ##cted and preserved by [unused1] Giuseppe Para ##vic ##ini [unused2] , an an ##ato ##mist who operated within the asylum . The aim of the present study was to examine and memorial ##ize this important ass ##em ##bla ##ge . To this end , we were allowed to sample the head hair of six such preparations for toxic ##ological analysis . By means of high performance liquid ch ##roma ##tography [SEP]',\n",
       "  'existing_cui': 'C0162568',\n",
       "  'existing_cui_name': 'Erythropoietic Protoporphyria',\n",
       "  'existing_cui_desc': '[CLS] E ##ry ##throp ##oi ##etic Proto ##por ##phy ##ria [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , er ##yt ##hr ##op ##oi ##etic pro ##top ##or ##phy ##ria p ##or ##phy ##ria : pro ##top ##or ##phy ##ria er ##yt ##hr ##op ##oi ##etic ; Proto ##por ##phy ##ria , E ##ry ##throp ##oi ##etic [ Disease / Finding ] ; E ##ry ##throp ##oi ##etic pro ##top ##or ##phy ##ria ; E ##ry ##th ##ro ##he ##pa ##tic Proto ##por ##phy ##ria ; PR ##OT ##OP ##OR ##P ##H ##Y ##RI ##A , ER ##Y ##TH ##RO ##PO ##IE ##TI ##C ; ma ##gn ##us syndrome ; Proto ##por ##phy ##ria ; er ##yt ##hr ##op ##oi ##etic ; pro [SEP]',\n",
       "  'our_bi_cui': 'C0015621',\n",
       "  'our_bi_cui_name': 'Famous Persons',\n",
       "  'our_bi_cui_desc': '[CLS] Famous Persons [unused3] ( Population Group : celebrities ; famous persons ; Ce ##le ##bri ##ties ; Person , Famous ; Persons , Famous ; famous person ; Famous Person ; Celebrity ; celebrity ) [SEP]',\n",
       "  'our_cross_cui': 'C0086418',\n",
       "  'our_cross_cui_name': 'Homo sapiens',\n",
       "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
       " {'mention_id': '27629431.19',\n",
       "  'test_set_idx': 12256,\n",
       "  'type': 'T017',\n",
       "  'name': 'initiation gene',\n",
       "  'context': '[CLS] ##tra ##cellular degradation , which is rapidly activated under starvation conditions . Recent data demonstrate a transcription ##al up ##re ##gu ##lation of several auto ##pha ##gy genes as a mechanism that controls auto ##pha ##gy in response to starvation . Here we report that despite the significant up ##re ##gu ##lation of m ##RNA of the essential auto ##pha ##gy [unused1] initiation gene [unused2] U ##L ##K ##1 , its protein level is rapidly reduced under starvation . Although both auto ##pha ##gic and pro ##te ##as ##oma ##l systems contribute to the degradation of U ##L ##K ##1 , under prolonged nitrogen de ##p ##ri ##vation , its level was still reduced in AT ##G ##7 knockout cells , and only initially stab ##ilized [SEP]',\n",
       "  'existing_cui': 'C0589507',\n",
       "  'existing_cui_name': 'Cognitive function : initiation',\n",
       "  'existing_cui_desc': '[CLS] Co ##gni ##tive function : initiation [unused3] ( B ##iol ##og ##ic Fun ##ction , o ##bs ##er ##vable entity , qualifier value : In ##iti ##ation ; initiation ) [SEP]',\n",
       "  'our_bi_cui': 'C1335755',\n",
       "  'our_bi_cui_name': 'Replication Initiation Gene',\n",
       "  'our_bi_cui_desc': '[CLS] Rep ##lication In ##iti ##ation Gene [unused3] ( Ana ##tom ##ical Structure : DNA Rep ##lication In ##iti ##ation Gene ) [SEP]',\n",
       "  'our_cross_cui': 'C0017337',\n",
       "  'our_cross_cui_name': 'Genes',\n",
       "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
       " {'mention_id': '27932585.31',\n",
       "  'test_set_idx': 22258,\n",
       "  'type': 'T103',\n",
       "  'name': 'Taw3',\n",
       "  'context': '[CLS] novel α / β fold . The sequence motif ( S / T ) x ##SS ##C ##x ##GR and invariant as ##par ##tate and his ##ti ##dine , conserved in T ##Y ##W ##3 / Ta ##w ##3 , cluster to form the cat ##alytic center . These structural and sequence features indicate that T ##Y ##W ##3 / [unused1] Ta ##w ##3 [unused2] proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass ##ays combined with mass s ##pect ##rome ##try as well as l ##igan ##d dock ##ing and co ##fa ##ctor binding ass ##ays , we have identified the active [SEP]',\n",
       "  'existing_cui': 'C3496263',\n",
       "  'existing_cui_name': 'annectant white matter',\n",
       "  'existing_cui_desc': '[CLS] an ##nect ##ant white matter [unused3] ( Ana ##tom ##ical Structure : Sub ##stant ##ia me ##du ##llar ##is an ##nect ##ens ) [SEP]',\n",
       "  'our_bi_cui': 'C0039341',\n",
       "  'our_bi_cui_name': 'tat Protein',\n",
       "  'our_bi_cui_desc': '[CLS] ta ##t Pro ##tein [unused3] ( Chemical : ta ##t Gene Product ; Gene Products , ta ##t [ Chemical / In ##g ##red ##ient ] ; Trans ##act ##ivating Reg ##ulatory Pro ##tein ; T ##AT Pro ##tein ; Trans - Act ##ivation of Trans ##cription Pro ##tein ; Trans - Act ##iva ##tor of Trans ##cription of HIV ; ta ##t Gene Products ; ta ##t protein ; Gene Product , ta ##t ; Gene Products , ta ##t ) [SEP]',\n",
       "  'our_cross_cui': 'C0033684',\n",
       "  'our_cross_cui_name': 'Proteins',\n",
       "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
       " {'mention_id': '28539192.14',\n",
       "  'test_set_idx': 38798,\n",
       "  'type': 'T033',\n",
       "  'name': 'basic level',\n",
       "  'context': '[CLS] poor literacy level of the population specifically in health . Currently , there is a fragment ##ed model of patient care , in which the systems are exclusive of each other . They do not cooperate or communicate with each other ; and if there is no vertical communication within the system , preventing refer ##ral of patients directly from the [unused1] basic level [unused2] to the complex level of care when needed . In addition , there has been no progress in the development of an em ##path ##etic , respect ##ful or person - centered clinical practice ; instead , economic , social and educational differences per ##pet ##uate a paternal ##istic clinical practice . The task of or ##ient ##ing medical training towards [SEP]',\n",
       "  'existing_cui': 'C0178499',\n",
       "  'existing_cui_name': 'Base',\n",
       "  'existing_cui_desc': '[CLS] Base [unused3] ( Chemical , chemistry , medication , substance : base ; bases ; Basic ; al ##kal ##ini ##ty ) [SEP]',\n",
       "  'our_bi_cui': 'C0871796',\n",
       "  'our_bi_cui_name': 'Knowledge level',\n",
       "  'our_bi_cui_desc': '[CLS] Knowledge level [unused3] ( B ##iol ##og ##ic Fun ##ction , o ##bs ##er ##vable entity : Knowledge Level ) [SEP]',\n",
       "  'our_cross_cui': 'C1547668',\n",
       "  'our_cross_cui_name': 'Level of Care',\n",
       "  'our_cross_cui_desc': '[CLS] Level of Care [unused3] ( Finding : Level of care ) [SEP]'},\n",
       " {'mention_id': '27400734.19',\n",
       "  'test_set_idx': 4723,\n",
       "  'type': 'T103',\n",
       "  'name': 'E',\n",
       "  'context': '[CLS] national database A random ##ized clinical trial has found that the addition of er ##lot ##ini ##b to g ##em ##ci ##ta ##bine ( GE ##M - E ) for pan ##cre ##atic cancer led to a modest increase in survival . The aim of this national population - based retrospective study was to compare the effectiveness of GE ##M - [unused1] E [unused2] to GE ##M alone for pan ##cre ##atic cancer patients in real clinical practice . Pat ##ients with pan ##cre ##atic cancer ( I ##CD - 10 : C ##25 ) with prescription claims of g ##em ##ci ##ta ##bine or er ##lot ##ini ##b between Jan 1 , 2007 and Dec 31 , 2012 were retrospective ##ly identified from the Korean [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C1142985',\n",
       "  'our_bi_cui_name': 'ezetimibe',\n",
       "  'our_bi_cui_desc': '[CLS] e ##ze ##ti ##mi ##be [unused3] ( Chemical , medication , product , substance : E ##ze ##ti ##mi ##be ; E ##ze ##ti ##mi ##bu ##m ; E ##ze ##ti ##mi ##b ; ( 1 - ( 4 - flu ##oro ##phe ##ny ##l ) - ( 3 ##R ) - ( 3 - ( 4 - flu ##oro ##phe ##ny ##l ) - ( 3 ##S ) - h ##ydro ##xy ##p ##rop ##yl ) - ( 4 ##S ) - ( 4 - h ##ydro ##xy ##phe ##ny ##l ) - 2 - a ##ze ##ti ##din ##one ) ; E ##Z ##ET ##IM ##IB ##E ; E ##ze ##ti ##mi ##be [ Chemical / In ##g ##red ##ient ] ; e ##ze [SEP]',\n",
       "  'our_cross_cui': 'C1135135',\n",
       "  'our_cross_cui_name': 'erlotinib',\n",
       "  'our_cross_cui_desc': '[CLS] er ##lot ##ini ##b [unused3] ( Chemical , medication , product , substance : N - ( 3 - et ##hy ##ny ##l ##phe ##ny ##l ) - 6 , 7 - bi ##s ( 2 - met ##ho ##xy ##eth ##ox ##y ) q ##uin ##az ##olin - 4 - am ##ine ; [ 6 , 7 - B ##is - ( 2 - met ##ho ##xy - et ##ho ##xy ) - q ##uin ##az ##olin - 4 - y ##l ] - ( 3 - et ##hy ##ny ##l - p ##hen ##yl ) - am ##ine ; ER ##L ##OT ##IN ##IB ; E ##rl ##ot ##ini ##b ) [SEP]'},\n",
       " {'mention_id': '28478603.28',\n",
       "  'test_set_idx': 37430,\n",
       "  'type': 'T170',\n",
       "  'name': 'h',\n",
       "  'context': \"[CLS] ##ei ' s gene diversity ( h = 0 . 28 ) , Shannon ' s information index ( I = 0 . 43 ) , and p ##oly ##mor ##phism information content ( P ##IC = 0 . 29 ) generated using the simple sequence repeat prime ##rs were higher than that with Inter simple sequence repeat prime ##rs ( [unused1] h [unused2] = 0 . 23 , I = 0 . 37 , P ##IC = 0 . 24 ) , thereby suggesting that the simple sequence repeat system is more efficient than the Inter simple sequence repeat system in assessing genetic diversity in various pine ##ap ##ple accession ##s . Mean genetic similarities were 0 . 74 , 0 . 61 , and [SEP]\",\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0017337',\n",
       "  'our_bi_cui_name': 'Genes',\n",
       "  'our_bi_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]',\n",
       "  'our_cross_cui': 'C0282574',\n",
       "  'our_cross_cui_name': 'Intellectual Property',\n",
       "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
       " {'mention_id': '28296885.51',\n",
       "  'test_set_idx': 31634,\n",
       "  'type': 'T103',\n",
       "  'name': 'marijuana .',\n",
       "  'context': '[CLS] - food diet had more than those living in the village consuming a mostly agricultural diet . These findings are explained by the high incidence of maize consumption in village settings , along with previously recognized variation in rate of car ##ies between men and women . The unexpected discovery of high car ##ies incidence ##s for men in the bush is likely explained by heavy reliance on honey , and perhaps differential access to tobacco and [unused1] marijuana . [unused2] These data support the notions that mechanisms of car ##io ##genesis are multi ##fa ##ctor ##ial and that the relationships between oral health and the shift from a predominantly wild - food diet to one dominated by cult ##ige ##ns are n ##uan ##ced . [SEP]',\n",
       "  'existing_cui': None,\n",
       "  'existing_cui_name': None,\n",
       "  'existing_cui_desc': None,\n",
       "  'our_bi_cui': 'C0024809',\n",
       "  'our_bi_cui_name': 'Marijuana Abuse',\n",
       "  'our_bi_cui_desc': '[CLS] Mari ##ju ##ana Abu ##se [unused3] ( B ##iol ##og ##ic Fun ##ction : abuse marijuana ; Abu ##se , Mari ##hua ##na ; Has ##h ; Abu ##se , Mari ##ju ##ana ; marijuana abuse ; marijuana drug abuse ; Mari ##ju ##ana Abu ##se [ Disease / Finding ] ; abuse ; ma ##ri ##hua ##na ; Mari ##hua ##na Abu ##se ; Mari ##ju ##ana ; Mari ##hua ##na abuse ; ma ##ri ##hua ##na ; abuse ; Mari ##ju ##ana abuse ; We ##ed ; drug abuse marijuana ; abuse drug marijuana ; Abu ##se ; drug ( s ) ; marijuana ; Po ##t ; Can ##na ##bis ) [SEP]',\n",
       "  'our_cross_cui': 'C0024808',\n",
       "  'our_cross_cui_name': 'Marihuana',\n",
       "  'our_cross_cui_desc': '[CLS] Mari ##hua ##na [unused3] ( Chemical : Mari ##ju ##ana ##s ; marijuana ; Mari ##ju ##ana ; ma ##ri ##hua ##na ; MA ##RI ##J ##U ##AN ##A [ VA Product ] ; Mari ##hua ##nas ; MA ##RI ##J ##U ##AN ##A ; cannabis ; Can ##na ##bis ) [SEP]'},\n",
       " {'mention_id': '27645371.31',\n",
       "  'test_set_idx': 12724,\n",
       "  'type': 'T033',\n",
       "  'name': 'Children abandoning treatment',\n",
       "  'context': '[CLS] the 77 ( of 41 ##8 ) children abandoning therapy , 17 ( 22 % ) refused up ##front , whereas the rest abandoned during various phases of ch ##em ##otherapy . Only 39 ( 50 . 6 % ) of these 77 families could be subsequently contacted . Financial problems , too many dependent ##s at home , and wrong perception ##s about cancer led to abandonment in majority . [unused1] Children abandoning treatment [unused2] before completion of induction had a significantly shorter survival than who abandoned post induction ( P < . 000 ##1 ) . In ##tens ##ified pre ##aba ##ndon ##ment counseling and sub ##si ##dized treatment led to significant reduction in abandonment rates ( P < . 000 ##1 ) . [SEP]',\n",
       "  'existing_cui': 'C0013806',\n",
       "  'existing_cui_name': 'Electroconvulsive Therapy',\n",
       "  'existing_cui_desc': '[CLS] El ##ec ##tro ##con ##vu ##lsive Therapy [unused3] ( Health Care Act ##ivity , EC ##T , P ##sy ##cho ##ther ##ap ##y , Therapy , electro - con ##vu ##lsive therapy , procedure , regime / therapy , treatment : electric shock treatments ; El ##ec ##tro ##sh ##ock treatment ; Therapy , Electric Shock ; Therapy , El ##ec ##tro ##sh ##ock ; Therapy , Electric Con ##vu ##lsive ; e ##cs ; electric shock therapy ; electro ##con ##vu ##lsive treatment ; Con ##vu ##lsive Therapy , Electric ; EC ##T therapy ; El ##ec ##tro ##con ##vu ##lsive treatment ; CO ##N ##V ##U ##LS ##IVE THE ##R E ##LE ##CT ##RI ##C ; The ##rap ##ies , El ##ec ##tro ##con [SEP]',\n",
       "  'our_bi_cui': 'C1298653',\n",
       "  'our_bi_cui_name': 'Patient declined anti-cancer treatment',\n",
       "  'our_bi_cui_desc': '[CLS] Pat ##ient declined anti - cancer treatment [unused3] ( Finding , finding ) [SEP]',\n",
       "  'our_cross_cui': 'C0243095',\n",
       "  'our_cross_cui_name': 'Finding',\n",
       "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
       " {'mention_id': '27842161.46',\n",
       "  'test_set_idx': 19139,\n",
       "  'type': 'T103',\n",
       "  'name': 'Netarsudil',\n",
       "  'context': '[CLS] ##age effective fi ##ltration length in e ##pis ##cle ##ral veins positively correlated with the percentage change in C ( R ##2 = 0 . 58 , P = 0 . 01 ) . A significant increase in j ##ux ##ta ##can ##ali ##cular connect ##ive tissue thickness ( P < 0 . 05 ) was found in treated eyes compared to controls . [unused1] Net ##ars ##udi ##l [unused2] acute ##ly increased C by expansion of the j ##ux ##ta ##can ##ali ##cular connect ##ive tissue and di ##lating the e ##pis ##cle ##ral veins , which led to red ##ist ##ri ##but ##ion of a ##que ##ous out ##flow through a larger area of the inner wall and e ##pis ##cle ##ral veins . [SEP]',\n",
       "  'existing_cui': 'C0013443',\n",
       "  'existing_cui_name': 'Ear structure',\n",
       "  'existing_cui_desc': '[CLS] E ##ar structure [unused3] ( Ana ##tom ##ical Structure , Anatomy , body structure : V ##est ##ib ##ulo ##co ##ch ##lea ##r System ; System , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; ear structures ; Organ ##um vest ##ib ##ulo ##co ##ch ##lea ##re ; ear structure ; E ##ar - related structure ; au ##ris ; A ##ppa ##rat ##us , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; E ##ar and related structures ; Au ##ris ; V ##est ##ib ##ulo ##co ##ch ##lea ##r organ ; V ##est ##ib ##ulo ##co ##ch ##lea ##r A ##ppa ##rat ##us ) [SEP]',\n",
       "  'our_bi_cui': 'C0701205',\n",
       "  'our_bi_cui_name': 'Rantodil',\n",
       "  'our_bi_cui_desc': '[CLS] Ra ##nto ##di ##l [unused3] ( Chemical : Bay ##er brand of ace ##met ##ac ##in ; Ra ##nt ##udi ##l ; T ##rop ##on brand of ace ##met ##ac ##in ) [SEP]',\n",
       "  'our_cross_cui': 'C1254351',\n",
       "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
       "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
       " {'mention_id': '27325547.7',\n",
       "  'test_set_idx': 2505,\n",
       "  'type': 'T103',\n",
       "  'name': 'PM2 .5',\n",
       "  'context': '[CLS] deposited in the human respiratory tract It is well - known that the health effects of PM increase as particle size decreases : particularly , great concern has risen on the role of Ultra ##F ##ine Part ##icles . Starting from the knowledge that the main fraction of atmospheric a ##ero ##sol in Rome is characterized by significant levels of [unused1] PM ##2 . 5 [unused2] ( almost 75 % of PM ##10 fraction is PM ##2 . 5 ) , the paper is focused on sub ##mic ##ron particles in such great urban area . The daytime / night ##time , work - / weekdays and cold / hot seasonal trends of sub ##mic ##ron particles will be investigated and discussed along with NO ##x [SEP]',\n",
       "  'existing_cui': 'C0665987',\n",
       "  'existing_cui_name': '1-(4-aminobutyl)-6-benzylindane',\n",
       "  'existing_cui_desc': '[CLS] 1 - ( 4 - amino ##but ##yl ) - 6 - ben ##zy ##lind ##ane [unused3] ( Chemical : PM ##2 c ##p ##d ) [SEP]',\n",
       "  'our_bi_cui': 'C0597177',\n",
       "  'our_bi_cui_name': 'Particle',\n",
       "  'our_bi_cui_desc': '[CLS] Part ##icle [unused3] ( Chemical : particle ; particles ; Part ##icles ; a very small piece or part ) [SEP]',\n",
       "  'our_cross_cui': 'C1510837',\n",
       "  'our_cross_cui_name': 'Airborne Particulate Matter',\n",
       "  'our_cross_cui_desc': '[CLS] Airborne Part ##iculate Matter [unused3] ( Chemical : Air Poll ##uta ##nts , Part ##iculate ; Am ##bie ##nt Part ##iculate Matter ; Part ##iculate Matter , Am ##bie ##nt ; Part ##iculate Matter , Airborne ; Poll ##uta ##nts , Part ##iculate Air ; Part ##iculate Air Poll ##uta ##nts ) [SEP]'},\n",
       " {'mention_id': '27251800.39',\n",
       "  'test_set_idx': 834,\n",
       "  'type': 'T058',\n",
       "  'name': 'Stoppa',\n",
       "  'context': '[CLS] during the 1 s ##t and 7 th post - operative , physical functioning , physical limitation , the impact of pain on daily activities , and the Carolina ##s Co ##m ##fort Scale during the 7 th and 15 th post - operative ( P > 0 . 05 ) . Co ##mp ##lication ##s occurred in 88 % of [unused1] Stop ##pa [unused2] group ( 22 patients ) and 64 % in lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair group ( 16 patients ) ( P < 0 . 05 ) . The comparative study between the Stop ##pa and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approaches for the bilateral ing ##uin ##al her ##nia repair demonstrated [SEP]',\n",
       "  'existing_cui': 'C1538901',\n",
       "  'existing_cui_name': 'ACD gene',\n",
       "  'existing_cui_desc': '[CLS] AC ##D gene [unused3] ( Ana ##tom ##ical Structure : T ##EL ##OM ##ER ##E PR ##OT ##EI ##N T ##PP ##1 ; ad ##ren ##oc ##ort ##ical d ##ys ##p ##lasia ho ##mo ##log ; AC ##D Gene ; Ad ##ren ##oc ##ort ##ical D ##ys ##p ##lasia Ho ##mo ##log ( Mouse ) Gene ; P ##OT ##1 - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N 1 ; P ##OT ##1 - AND T ##IN ##2 - OR ##GA ##NI ##Z ##ING PR ##OT ##EI ##N ; P ##OT ##1 and T ##IN ##2 organizing protein ; AC ##D , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; Tin ##t ##1 ; T ##IN ##2 interacting protein 1 [SEP]',\n",
       "  'our_bi_cui': 'C1080020',\n",
       "  'our_bi_cui_name': 'Lopa',\n",
       "  'our_bi_cui_desc': '[CLS] Lo ##pa [unused3] ( E ##uka ##ryo ##te : lo ##pa ) [SEP]',\n",
       "  'our_cross_cui': 'C0087111',\n",
       "  'our_cross_cui_name': 'Therapeutic procedure',\n",
       "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
       " {'mention_id': '27261783.3',\n",
       "  'test_set_idx': 1081,\n",
       "  'type': 'T082',\n",
       "  'name': 'organic - rich anaerobic sedimentary habitats',\n",
       "  'context': '[CLS] Analysis of Low - B ##io ##mass Micro ##bial Communities in the Deep B ##ios ##phere Over the past few decades , the sub ##sea ##f ##lo ##or bio ##sp ##here has been explored by scientific ocean drilling to depths of about 2 . 5 km below the sea ##f ##lo ##or . Although [unused1] organic - rich an ##ae ##ro ##bic sediment ##ary habitats [unused2] in the ocean margins harbor large numbers of micro ##bial cells , micro ##bial populations in ultra ##oli ##got ##rop ##hic a ##ero ##bic sediment ##ary habitats in the open ocean g ##yres are several orders of magnitude less abundant . Despite advances in cultivation - independent molecular ecological techniques , exploring the low - bio ##mass environment remains technological [SEP]',\n",
       "  'existing_cui': 'C0004613',\n",
       "  'existing_cui_name': 'Bacteria , Anaerobic',\n",
       "  'existing_cui_desc': '[CLS] Ba ##cter ##ia , Ana ##ero ##bic [unused3] ( Ba ##cter ##ium , organism : an ##ae ##ro ##bic bacterium ; BA ##CT AN ##A ##ER ##O ##BI ##C ; Ana ##ero ##bic bacterium ; Ana ##ero ##bic Ba ##cter ##ia ; Ana ##ero ##bic bacteria ; AN ##A ##ER ##O ##BI ##C BA ##CT ; an ##ae ##robe ; an ##ae ##ro ##bic bacteria ; Ana ##ero ##be ; an ##ae ##robe ##s ; AN ##A ##ER ##O ##BI ##C BA ##CT ##ER ##IA ) [SEP]',\n",
       "  'our_bi_cui': 'C0486320',\n",
       "  'our_bi_cui_name': 'Amorphous sediment',\n",
       "  'our_bi_cui_desc': '[CLS] Amor ##ph ##ous sediment [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
       "  'our_cross_cui': 'C0871648',\n",
       "  'our_cross_cui_name': 'Habitat',\n",
       "  'our_cross_cui_desc': '[CLS] Ha ##bit ##at [unused3] ( Spa ##tial Concept , Animal : habitats ; Animal Environment ##s ; Ha ##bit ##ats ; environment animal ; habitat ) [SEP]'},\n",
       " {'mention_id': '27427386.16',\n",
       "  'test_set_idx': 5254,\n",
       "  'type': 'T017',\n",
       "  'name': 'm. 14502T > C',\n",
       "  'context': \"[CLS] ##rial m ##od ##ifier ##s are proposed to modify the p ##hen ##otypic expression of primary Le ##ber ' s hereditary op ##tic ne ##uro ##pathy - associated mitochondrial DNA mutations . In this study , we demonstrated that the Le ##ber ' s hereditary op ##tic ne ##uro ##pathy su ##s ##ce ##pt ##ibility all ##ele ( [unused1] m . 145 ##0 ##2 ##T > C [unused2] , p . 58 ##I > V ) in the N ##D ##6 gene m ##od ##ulated the p ##hen ##otypic expression of primary Le ##ber ' s hereditary op ##tic ne ##uro ##pathy - associated m . 117 ##7 ##8 ##G > A mutation . Twenty - two Han Chinese p ##ed ##ig ##ree ##s carrying m [SEP]\",\n",
       "  'existing_cui': 'C0035609',\n",
       "  'existing_cui_name': 'Rifamycins',\n",
       "  'existing_cui_desc': '[CLS] R ##if ##am ##y ##cin ##s [unused3] ( Chemical , medication , substance : r ##if ##am ##y ##cin ; M - 14 ; R ##if ##am ##y ##cin ; R ##if ##am ##y ##cin SV ; R ##if ##omy ##cin ##s ; R ##if ##am ##y ##cin ##s [ Chemical / In ##g ##red ##ient ] ; r ##if ##am ##y ##cin ##s ; 5 , 6 , 9 , 17 , 19 , 21 - he ##xa ##hy ##dr ##ox ##y - 23 - met ##ho ##xy - 2 , 4 , 12 , 16 , 18 , 20 , 22 - he ##pta ##met ##hyl - 2 , 7 - ( e ##pox ##ype ##nta ##de ##ca ( 1 , 11 , 13 [SEP]',\n",
       "  'our_bi_cui': 'C0596611',\n",
       "  'our_bi_cui_name': 'Gene Mutation',\n",
       "  'our_bi_cui_desc': '[CLS] Gene Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction : DNA Se ##quence Alt ##eration ; Gene Alt ##eration ; DNA Alt ##eration ; gene mutation ; genes mutation ; Gene Mu ##tation Type ; M ##OL ##PA ##TH . M ##UT ; gene mutations ; Se ##quence Alt ##eration ; Gene mutation ; mutation gene ) [SEP]',\n",
       "  'our_cross_cui': 'C0002085',\n",
       "  'our_cross_cui_name': 'Alleles',\n",
       "  'our_cross_cui_desc': '[CLS] All ##ele ##s [unused3] ( Ana ##tom ##ical Structure , finding : All ##ele ; All ##elo ##mor ##ph ; Gene ##tic all ##ele ##s ; all ##ele ; All ##elo ##mor ##phs ; all ##ele ##s ; AL ##LE ##LE ) [SEP]'}]"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "d073ba4d",
   "metadata": {},
   "outputs": [],
   "source": [
    "chosen = [13478, 14309, 34150, 18011, 31580, 14732, 17537, 29659]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "27fafe6a",
   "metadata": {},
   "outputs": [],
   "source": [
    "res = [{'mention_id': '27335087.30',\n",
    "  'test_set_idx': 2759,\n",
    "  'type': 'T017',\n",
    "  'name': 'CD3 ( + ) T cells',\n",
    "  'context': '[CLS] flow c ##yt ##ometer . Cell ultra ##structure was observed under a transmission electron micro ##scope . The mitochondrial membrane potential ( Δ ##ψ ) was examined with J ##C - 1 dye . In H ##22 tumor - bearing mice , CD ##4 ( + ) T cells , CD ##8 ( + ) T cells , [unused1] CD ##3 ( + ) T cells [unused2] , and natural killer cells in peripheral blood were evaluated c ##yt ##ometric ##ally . Inter ##le ##uki ##n ( Inter ##le ##uki ##n ) - 2 and tumor ne ##c ##rosis factor ( tumor ne ##c ##rosis factor ) - α levels were measured using radio ##im ##mu ##no ##ass ##ay . The m ##RNA levels of Ba [SEP]',\n",
    "  'existing_cui': 'C1277786',\n",
    "  'existing_cui_name': 'CD3 T-cell count procedure',\n",
    "  'existing_cui_desc': '[CLS] CD ##3 T - cell count procedure [unused3] ( Health Care Act ##ivity , procedure : CD ##3 T - cell count ) [SEP]',\n",
    "  'our_bi_cui': 'C1563926',\n",
    "  'our_bi_cui_name': 'Th3 Cells',\n",
    "  'our_bi_cui_desc': '[CLS] T ##h ##3 Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell ##s , T ##h ##3 ; T ##H CE ##LL ##S 00 ##3 ; T ##h ##3 Cell ; Cell , T ##h ##3 ) [SEP]',\n",
    "  'our_cross_cui': 'C1267816',\n",
    "  'our_cross_cui_name': 'Lymphocyte positive for CD3 antigen',\n",
    "  'our_cross_cui_desc': '[CLS] L ##ymph ##oc ##yte positive for CD ##3 anti ##gen [unused3] ( Ana ##tom ##ical Structure , cell : CD ##3 + L ##ymph ##oc ##yte ) [SEP]'},\n",
    " {'mention_id': '28244917.34',\n",
    "  'test_set_idx': 29801,\n",
    "  'type': 'T033',\n",
    "  'name': 'knee bend',\n",
    "  'context': '[CLS] , and 10 treated with a P ##FC Sigma rotating platform - posterior stab ##ilized ( press - fit con ##dy ##lar Sigma rotating platform - posterior stab ##ilized ) total knee art ##hr ##op ##last ##y ( dome ##d pat ##ella ##r component ) were analyzed under flu ##oro ##scopic surveillance while the patient performed a weight - bearing deep [unused1] knee bend [unused2] from full knee extension to maximum knee fl ##ex ##ion . Re ##lev ##ant bone g ##eo ##met ##ries were segment ##ed out from com ##puted to ##mo ##graphy scan ##s , and computer - assisted - design models of the imp ##lanted components were obtained from the manufacturer . Three - dimensional pat ##ello ##fe ##mor ##al kin ##ema ##tics [SEP]',\n",
    "  'existing_cui': 'C0011119',\n",
    "  'existing_cui_name': 'Decompression Sickness',\n",
    "  'existing_cui_desc': \"[CLS] Dec ##om ##press ##ion Sick ##ness [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Dec ##om ##press ##ion Sick ##ness [ Disease / Finding ] ; Bend ##s ; Rap ##ture of the deep syndrome ; de ##com ##press ##ion ; disease ; de ##com ##press ##ion sickness ; Dec ##om ##press ##ion sickness ; Di ##vers ' p ##als ##y or para ##lysis ; disease ( or disorder ) ; de ##com ##press ##ion ; choke ##s ; Disease , C ##ais ##son ; choking ; the bends ; Di ##vers ' p ##als ##y ; ca ##iss ##on ; disease ; a ##ero ##bull ##osis ; compressed air disease ; bend ; bends ; ca ##iss ##on disease ; [SEP]\",\n",
    "  'our_bi_cui': 'C0856776',\n",
    "  'our_bi_cui_name': 'Twisted knee',\n",
    "  'our_bi_cui_desc': '[CLS] T ##wi ##sted knee [unused3] ( In ##ju ##ry or Po ##ison ##ing : twist knee ; twisted knee ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27538372.30',\n",
    "  'test_set_idx': 9811,\n",
    "  'type': 'T038',\n",
    "  'name': 'overexpression',\n",
    "  'context': '[CLS] differential ##ly expressed genes , P ##d ##p ##1 expression was significantly decreased ( 27 - fold ) on day 8 compared to D ##0 , which was accompanied by suppressed mitochondrial in ##dices , including ATP levels , membrane potential , R ##OS and mitochondrial C ##a ( 2 + ) . Not ##ably , P ##d ##p ##1 [unused1] over ##ex ##press ##ion [unused2] significantly enhanced the mitochondrial in ##dices and p ##yr ##u ##vate de ##hy ##dr ##ogen ##ase activity and reduced the expression of cardiac differentiation marker messenger RNA and the cardiac differentiation rate compared to a mock control . In confirmation of this , a knock ##down of the P ##d ##p ##1 gene promoted the expression of cardiac differentiation marker [SEP]',\n",
    "  'existing_cui': 'C1514559',\n",
    "  'existing_cui_name': 'Protein Overexpression',\n",
    "  'existing_cui_desc': '[CLS] Pro ##tein Over ##ex ##press ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction : Over ##ex ##press ##ion ; over ##ex ##press ) [SEP]',\n",
    "  'our_bi_cui': 'C1514559',\n",
    "  'our_bi_cui_name': 'Protein Overexpression',\n",
    "  'our_bi_cui_desc': '[CLS] Pro ##tein Over ##ex ##press ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction : Over ##ex ##press ##ion ; over ##ex ##press ) [SEP]',\n",
    "  'our_cross_cui': 'C0017262',\n",
    "  'our_cross_cui_name': 'Gene Expression',\n",
    "  'our_cross_cui_desc': '[CLS] Gene Express ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , finding : Express ##ions , Gene ; expression gene ; Gene expression ; Express ##ion , Gene ; Express ##ion ; Express ##ed ; gene expression ; Gene Express ##ions ) [SEP]'},\n",
    " {'mention_id': '27379139.7',\n",
    "  'test_set_idx': 4173,\n",
    "  'type': 'T017',\n",
    "  'name': 'Compound Tissue',\n",
    "  'context': '[CLS] Evaluation of Three Pro ##tein - Extra ##ction Method ##s for Pro ##te ##ome Analysis of Mai ##ze Leaf Mid ##ri ##b , a [unused1] Co ##mpo ##und T ##iss ##ue [unused2] Rich in Sc ##ler ##en ##chy ##ma Cell ##s Leaf morphology is closely related to the growth and development of maize ( Z ##ea may ##s L . ) plants and final kernel production . As an important part of the maize leaf , the mid ##ri ##b holds leaf blades in the aerial position for maximum sunlight capture . Leaf mid ##ri ##b s of adult plants contain substantial s ##cle ##rench ##ym ##a cells with heavily thick ##ened and l ##ign ##ified secondary walls and have a high amount of p ##hen [SEP]',\n",
    "  'existing_cui': 'C1706082',\n",
    "  'existing_cui_name': 'Compound',\n",
    "  'existing_cui_desc': '[CLS] Co ##mpo ##und [unused3] ( Chemical , substance , substance : compound ) [SEP]',\n",
    "  'our_bi_cui': 'C0040300',\n",
    "  'our_bi_cui_name': 'Body tissue',\n",
    "  'our_bi_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
    "  'our_cross_cui': 'C1514137',\n",
    "  'our_cross_cui_name': 'Plant Tissue , Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Plant T ##iss ##ue , Cell ##s [unused3] ( Ana ##tom ##ical Structure : Plant cells and tissues ) [SEP]'},\n",
    " {'mention_id': '28522288.42',\n",
    "  'test_set_idx': 38354,\n",
    "  'type': 'T033',\n",
    "  'name': 'percentage of positive cores',\n",
    "  'context': '[CLS] ) . In multi ##var ##iate analyses , variables predict ##ing up ##grading for G ##G ##1 pro ##state cancer were age ( P = . 00 ##14 ) , abnormal digital re ##ct ##al examination ( P < . 000 ##1 ) , pro ##state - specific anti ##gen density ( P < . 000 ##1 ) , [unused1] percentage of positive core ##s [unused2] ( P < . 000 ##1 ) , and body mass index ( P = . 03 ##7 ) . A no ##mo ##gram was generated and valid ##ated internally . B ##io ##psy g ##rading system is misleading in approximately 50 % of cases . Up ##grading grade group from bio ##psy to radical pro ##state ##ct ##omy may [SEP]',\n",
    "  'existing_cui': 'C0518026',\n",
    "  'existing_cui_name': 'body fat percentage',\n",
    "  'existing_cui_desc': '[CLS] body fat percentage [unused3] ( Finding , physical finding , physical finding : body fat percentage ##s ; Body fat percentage ; percentage body fat ; percentage of body fat ; body fat ) [SEP]',\n",
    "  'our_bi_cui': 'C1302649',\n",
    "  'our_bi_cui_name': 'Number of tissue cores positive for carcinoma',\n",
    "  'our_bi_cui_desc': '[CLS] Number of tissue core ##s positive for car ##cin ##oma [unused3] ( Clinical At ##tri ##but ##e , o ##bs ##er ##vable entity ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28084061.16',\n",
    "  'test_set_idx': 25234,\n",
    "  'type': 'T033',\n",
    "  'name': 'reason',\n",
    "  'context': '[CLS] ##dices helped explain the variation in key rehabilitation outcomes . Prospect ##ive open - co ##hor ##t study . In ##patient rehabilitation ward , Melbourne , Australia . Adults admitted for in ##patient rehabilitation ( n = 280 ) . The main outcomes were demographic ( e . g . age , gender , discharge destination ) and clinical outcomes ( [unused1] reason [unused2] for rehabilitation , length of stay , Fun ##ctional Independence Me ##as ##ure , Cha ##rls ##on Como ##rb ##id ##ity Index and C ##um ##ula ##tive Index Rat ##ing Scale ) . A series of re ##gression analyses were performed to determine the influence of com ##or ##bid ##ity on three dependent variables : L ##OS in rehabilitation ; 2 ) [SEP]',\n",
    "  'existing_cui': 'C1562480',\n",
    "  'existing_cui_name': 'Has reason',\n",
    "  'existing_cui_desc': '[CLS] Has reason [unused3] ( Intel ##lect ##ual Product , link assertion , link assertion : has reason ) [SEP]',\n",
    "  'our_bi_cui': 'C1443309',\n",
    "  'our_bi_cui_name': 'Reason for Treatment',\n",
    "  'our_bi_cui_desc': '[CLS] Reason for Treatment [unused3] ( Finding , finding : Reason ##s for treatment ) [SEP]',\n",
    "  'our_cross_cui': 'C0566251',\n",
    "  'our_cross_cui_name': 'Reason and justification',\n",
    "  'our_cross_cui_desc': '[CLS] Reason and justification [unused3] ( Finding , attribute ) [SEP]'},\n",
    " {'mention_id': '28356622.43',\n",
    "  'test_set_idx': 33083,\n",
    "  'type': 'T038',\n",
    "  'name': 'plantar moment',\n",
    "  'context': \"[CLS] ##ait parameters were calculated using the S ##pear ##man correlation analysis . [ Results ] Rate ##s of the transverse arch of the fore ##foot width and height between condition 2 and condition 3 were significantly correlated with the anterior and posterior component of ground reaction forces , the hip joint extension angle , and the ankle plant ##ar fl ##ex ##ion moment . [ Con ##c ##lusion ] Our study ' s findings indicated that increased stiff ##ness of the transverse arch of the fore ##foot was related to the increase in ankle [unused1] plant ##ar moment [unused2] , and decreased stiff ##ness of the transverse arch of the fore ##foot was related to the increase in hip joint extension angle during g ##ait . [SEP]\",\n",
    "  'existing_cui': 'C0230463',\n",
    "  'existing_cui_name': 'Sole of Foot',\n",
    "  'existing_cui_desc': '[CLS] Sol ##e of Foot [unused3] ( Spa ##tial Concept , body structure : Plant ##ar aspect of foot ; Plant ##a ; foot sole ##s ; sole ; Plant ##ar Region ; foot sole ; Reg ##io plant ##aris ; sole of foot ; Plant ##ar region ; Bottom of foot ; Sol ##e of foot ; Plant ##ar part of foot ; Sol ##e ; Structure of sole of foot ; sole ##s ; S ##OL ##E ; Plant ##ar ) [SEP]',\n",
    "  'our_bi_cui': 'C0278131',\n",
    "  'our_bi_cui_name': 'Plantar reflex',\n",
    "  'our_bi_cui_desc': '[CLS] Plant ##ar reflex [unused3] ( Finding , o ##bs ##er ##vable entity , physical finding : PR - Plant ##ar reflex ; plant ##ar reflex ) [SEP]',\n",
    "  'our_cross_cui': 'C0231784',\n",
    "  'our_cross_cui_name': 'Plantar flexion',\n",
    "  'our_cross_cui_desc': '[CLS] Plant ##ar fl ##ex ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : plant ##ar fl ##ex ##ion ; Plant ##ar fl ##ex ##ion , function ; fl ##ex ##ion plant ##ar ) [SEP]'},\n",
    " {'mention_id': '28127340.49',\n",
    "  'test_set_idx': 26275,\n",
    "  'type': 'T204',\n",
    "  'name': 'N. fasciatus',\n",
    "  'context': \"[CLS] % , No ##so ##psy ##llus f ##as ##cia ##tus = 1 . 09 % , and La ##ela ##ps nut ##tal ##li = 3 . 29 % . Among 10 genera / species of identified parasite ##s , at least 8 of them were zoo ##not ##ic with public health importance . L . nut ##tal ##li and [unused1] N . f ##as ##cia ##tus [unused2] were the only two non - zoo ##not ##ic detected parasite ##s in this survey . Harbor ##ing a wide variety of zoo ##not ##ic parasite ##s in sampled wild rode ##nts particularly when they live nearby villages , represents a potential risk to native inhabitants . Hence , controlling rode ##nts ' population in residential regions and improving [SEP]\",\n",
    "  'existing_cui': 'C1070996',\n",
    "  'existing_cui_name': 'Arion fasciatus',\n",
    "  'existing_cui_desc': '[CLS] Ari ##on f ##as ##cia ##tus [unused3] ( E ##uka ##ryo ##te : Ari ##on ( Car ##ina ##rion ) f ##as ##cia ##tus ) [SEP]',\n",
    "  'our_bi_cui': 'C2997670',\n",
    "  'our_bi_cui_name': 'Nariscus fasciatus',\n",
    "  'our_bi_cui_desc': '[CLS] Na ##ris ##cus f ##as ##cia ##tus [unused3] ( E ##uka ##ryo ##te : Na ##ris ##cus f ##as ##cia ##tus ( Di ##stant , 1918 ) ; Akbar ##atus f ##as ##cia ##tus ) [SEP]',\n",
    "  'our_cross_cui': 'C0323233',\n",
    "  'our_cross_cui_name': 'Nosopsyllus fasciatus',\n",
    "  'our_cross_cui_desc': '[CLS] No ##so ##psy ##llus f ##as ##cia ##tus [unused3] ( E ##uka ##ryo ##te , organism : Northern rat fl ##ea ; Ce ##rato ##phy ##llus f ##as ##cia ##tus ; No ##so ##psy ##llus f ##as ##cia ##tus ( Bo ##s ##c , 1800 ) ; Brown rat fl ##ea ) [SEP]'},\n",
    " {'mention_id': '27637577.41',\n",
    "  'test_set_idx': 12603,\n",
    "  'type': 'T103',\n",
    "  'name': 'bisulfite - treated DNA',\n",
    "  'context': '[CLS] ##lit ##is patients and 40 healthy individuals . Total RNA and DNA contents of le ##uk ##ocytes were extracted . Afterward , quantitative analysis was carried out by real - time PC ##R using the S ##Y ##BR Green PC ##R Master Mix . Finally , to determine the met ##hyl ##ation level , PC ##R products of [unused1] bi ##sul ##fit ##e - treated DNA [unused2] from patients and controls were sequence ##d . Compared with healthy controls , expression level of DNA met ##hyl ##tra ##ns ##fer ##ase 1 in An ##ky ##los ##ing s ##po ##ndy ##lit ##is patients was significantly down ##re ##gu ##lated . Met ##hyl ##ation of DNA met ##hyl ##tra ##ns ##fer ##ase 1 promoter was significantly higher in [SEP]',\n",
    "  'existing_cui': 'C0063088',\n",
    "  'existing_cui_name': 'hydrogen sulfite',\n",
    "  'existing_cui_desc': '[CLS] hydrogen su ##lf ##ite [unused3] ( Chemical : bi ##sul ##fit ##e ; h ##ydro ##sul ##fit ##e ) [SEP]',\n",
    "  'our_bi_cui': 'C3831347',\n",
    "  'our_bi_cui_name': 'Bisulfite Sequencing',\n",
    "  'our_bi_cui_desc': '[CLS] B ##is ##ulf ##ite Se ##quencing [unused3] ( Research Act ##ivity ) [SEP]',\n",
    "  'our_cross_cui': 'C0012854',\n",
    "  'our_cross_cui_name': 'DNA',\n",
    "  'our_cross_cui_desc': '[CLS] DNA [unused3] ( Chemical , DNA , De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid , substance : d ##na molecules ; d ##s ##D ##NA ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; d ##na / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA molecule ; DNA - De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acids ; d ##na molecule ; DNA [ Chemical / In ##g ##red ##ient ] ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; Double - [SEP]'},\n",
    " {'mention_id': '27669217.44',\n",
    "  'test_set_idx': 13695,\n",
    "  'type': 'T033',\n",
    "  'name': 'MICs',\n",
    "  'context': '[CLS] acquired independently in one highly v ##ir ##ulent is ##olate AL ##10 ##100 ##2 , and cluster ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both er ##m ##B and er ##m ##T in all is ##olate ##s was er ##yt ##hr ##omy ##cin in ##du ##cible and yielded comparable mac ##rol ##ide [unused1] MI ##Cs [unused2] in all six is ##olate ##s . Take ##n together , in ##du ##cible expression of both er ##m ##B and er ##m ##T conferred high mac ##rol ##ide resistance in these S . gal ##lo ##ly ##ticus subsp . paste ##rian ##us is ##olate ##s . Our findings reveal new mac ##rol ##ide resistance features in S . gal ##lo [SEP]',\n",
    "  'existing_cui': 'C0427978',\n",
    "  'existing_cui_name': 'Minimum Inhibitory Concentration measurement',\n",
    "  'existing_cui_desc': '[CLS] Mini ##mum In ##hibit ##ory Con ##cent ##ration measurement [unused3] ( Health Care Act ##ivity , MI ##C , procedure , qualifier value : Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test ; Con ##cent ##rations , Mini ##mum In ##hibit ##ory ; Anti ##biotic sensitivity , minimum inhibitor ##y concentration ; MI ##C su ##s ##ce ##pt ##ibility test ; Mini ##mum In ##hibit ##ory Con ##cent ##rations ; MI ##C - Mini ##mum inhibitor ##y concentration ; Con ##cent ##ration , Mini ##mum In ##hibit ##ory ; Mini ##mum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test technique ; In ##hibit ##ory Con ##cent ##rations , Mini ##mum ; Mini ##mum In ##hibit ##ory [SEP]',\n",
    "  'our_bi_cui': 'C0427978',\n",
    "  'our_bi_cui_name': 'Minimum Inhibitory Concentration measurement',\n",
    "  'our_bi_cui_desc': '[CLS] Mini ##mum In ##hibit ##ory Con ##cent ##ration measurement [unused3] ( Health Care Act ##ivity , MI ##C , procedure , qualifier value : Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test ; Con ##cent ##rations , Mini ##mum In ##hibit ##ory ; Anti ##biotic sensitivity , minimum inhibitor ##y concentration ; MI ##C su ##s ##ce ##pt ##ibility test ; Mini ##mum In ##hibit ##ory Con ##cent ##rations ; MI ##C - Mini ##mum inhibitor ##y concentration ; Con ##cent ##ration , Mini ##mum In ##hibit ##ory ; Mini ##mum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test technique ; In ##hibit ##ory Con ##cent ##rations , Mini ##mum ; Mini ##mum In ##hibit ##ory [SEP]',\n",
    "  'our_cross_cui': 'C1304747',\n",
    "  'our_cross_cui_name': 'Minimum inhibitory concentration result',\n",
    "  'our_cross_cui_desc': '[CLS] Mini ##mum inhibitor ##y concentration result [unused3] ( Finding , finding : minimum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration finding ) [SEP]'},\n",
    " {'mention_id': '27660632.56',\n",
    "  'test_set_idx': 13478,\n",
    "  'type': 'T017',\n",
    "  'name': 'regions',\n",
    "  'context': '[CLS] ) traits , mainly focused on Ch ##r ##0 ##5 , Ch ##r ##0 ##9 , Ch ##r ##10 , Ch ##r ##14 , Ch ##r ##19 , and Ch ##r ##20 . Nine ##teen pairs of e ##pis ##tat ##ic quantitative trait lo ##cus were identified , of which two pairs involved in two add ##itive quantitative trait lo ##cus . These add ##itive quantitative trait lo ##cus , e ##pis ##tat ##ic quantitative trait lo ##cus , and Q ##TL clusters were tightly linked to single n ##uc ##leo ##tide p ##oly ##mor ##phism markers , which may serve as target [unused1] regions [unused2] for map - based c ##lon ##ing , gene discovery , and marker - assisted selection in cotton breeding . [SEP]',\n",
    "  'existing_cui': 'C0017446',\n",
    "  'existing_cui_name': 'Geographic Locations',\n",
    "  'existing_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]',\n",
    "  'our_bi_cui': 'C0205146',\n",
    "  'our_bi_cui_name': 'Area',\n",
    "  'our_bi_cui_desc': '[CLS] Area [unused3] ( Spa ##tial Concept , qualifier value : area ; areas ; AR ##EA ) [SEP]',\n",
    "  'our_cross_cui': 'C1953345',\n",
    "  'our_cross_cui_name': 'Region of chromosome',\n",
    "  'our_cross_cui_desc': '[CLS] Region of chromosome [unused3] ( Ana ##tom ##ical Structure : ch ##rom ##oso ##mal region ; Ch ##rom ##oso ##mal region ; chromosome region ; Ch ##rom ##oso ##me region ) [SEP]'},\n",
    " {'mention_id': '27692319.38',\n",
    "  'test_set_idx': 14309,\n",
    "  'type': 'T204',\n",
    "  'name': 'eggs',\n",
    "  'context': '[CLS] ##roma ##tography , suspended in 1 % D ##MS ##O and used in in v ##it ##ro tests . Q ##uad ##rup ##lica ##tes of 50 F . he ##pa ##tica eggs were in ##cu ##bate ##d at 23 °C with M . ch ##aran ##tia leaf crude extract in different concentrations . After 12 days no larvae were formed in [unused1] eggs [unused2] in ##cu ##bate ##d with crude extract concentrations above 12 . 5 mg / m ##L . Egg ##s in ##cu ##bate ##d with crude extract sub - fraction ##s at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μ ##g / m ##L affected em ##b ##ryo ##nic development , with n [SEP]',\n",
    "  'existing_cui': 'C0029974',\n",
    "  'existing_cui_name': 'Ovum',\n",
    "  'existing_cui_desc': '[CLS] O ##vu ##m [unused3] ( Ana ##tom ##ical Structure , body structure , cell , cell structure , qualifier value : Human egg ; Egg ##s , Un ##fer ##til ##ized ; Fe ##rt ##ilized o ##oc ##yte ; Mat ##ure o ##vu ##m ; O ##va ; Egg ; egg cell ; o ##va ; X bearing o ##vu ##m ; female game ##tes ; O ##ocytes ; Un ##fer ##til ##ized Egg ##s ; X chromosome - bearing o ##vu ##m ; Egg , Un ##fer ##til ##ized ; O ##vu ##m structure ; Un ##fer ##til ##ized Egg ; Female game ##te ; O ##voc ##yte ; egg / o ##vu ##m ; o ##vu ##m ; female game ##te ; X - [SEP]',\n",
    "  'our_bi_cui': 'C0013710',\n",
    "  'our_bi_cui_name': 'Egg Food Product',\n",
    "  'our_bi_cui_desc': '[CLS] Egg Food Product [unused3] ( Food , Po ##ult ##ry , edible , substance : eggs ; egg food product ; egg ; Egg , Po ##ult ##ry ; Egg ; Egg ##s ; Egg ##s ( edible ) ; egg [ food ] ; E ##G ##G ) [SEP]',\n",
    "  'our_cross_cui': 'C3662687',\n",
    "  'our_cross_cui_name': 'Fasciola hepatica egg',\n",
    "  'our_cross_cui_desc': '[CLS] F ##as ##cio ##la he ##pa ##tica egg [unused3] ( E ##uka ##ryo ##te , organism : F ##as ##cio ##la he ##pa ##tica o ##va ) [SEP]'},\n",
    " {'mention_id': '28390176.60',\n",
    "  'test_set_idx': 34150,\n",
    "  'type': 'T038',\n",
    "  'name': 'inhibition',\n",
    "  'context': '[CLS] over ##ex ##press ##ion of con ##st ##it ##utive ##ly active A ##kt completely abolished the C ##uc ##ur ##bit ##ac ##in B - mediated protection of cardiac h ##yper ##tro ##phy in human card ##io ##my ##ocytes AC ##16 . Collective ##ly , our findings suggest that cu ##cu ##rb ##ita ##cin B protects against cardiac h ##yper ##tro ##phy through increasing the auto ##pha ##gy level in card ##io ##my ##ocytes , which is associated with the [unused1] in ##hibition [unused2] of A ##kt / m ##TO ##R / Fox ##O ##3 ##a signal axis . J . Cell . B ##io ##che ##m . 99 ##9 ##9 : 1 - 12 , 2017 . © 2017 Wiley Period ##ical ##s , Inc . [SEP]',\n",
    "  'existing_cui': 'C0021467',\n",
    "  'existing_cui_name': 'Psychological inhibition',\n",
    "  'existing_cui_desc': '[CLS] Psychological in ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction , Personal ##ity , Psychology : psychological in ##hibition ; in ##hibition ; in ##hibition ##s ; IN ##H ##IB ##IT ##ION ; In ##hibition ; IN ##H ##IB ##IT ##ION PS ##Y ##CH ##OL ; In ##hibition ##s ) [SEP]',\n",
    "  'our_bi_cui': 'C0021469',\n",
    "  'our_bi_cui_name': 'Metabolic Inhibition',\n",
    "  'our_bi_cui_desc': '[CLS] Met ##ab ##olic In ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : In ##hibition ; In ##hibition , function ) [SEP]',\n",
    "  'our_cross_cui': 'C1519312',\n",
    "  'our_cross_cui_name': 'Signal Transduction Inhibition',\n",
    "  'our_cross_cui_desc': '[CLS] Signal Trans ##duction In ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction : in ##hibition of signal trans ##duction ) [SEP]'},\n",
    " {'mention_id': '28084061.29',\n",
    "  'test_set_idx': 25247,\n",
    "  'type': 'T033',\n",
    "  'name': 'reason',\n",
    "  'context': '[CLS] score between rehabilitation discharge and admission ; and 3 ) the discharge destination ( home vs other ) . The mean age was 57 . 7 years , there were slightly more females ( 51 % ) , most ( 95 % ) patients previously lived at home with family or other relatives ( 63 % ) . The most common [unused1] reason [unused2] for rehabilitation was or ##th ##op ##ae ##dic or other conditions ( 52 % ) and most ( 80 % ) people were discharged home . The median L ##OS was 27 days . There were 100 ( 35 . 7 % ) patients who had no com ##or ##bid ##ity recorded using the Cha ##rls ##on Como ##rb ##id ##ity Index [SEP]',\n",
    "  'existing_cui': 'C1562480',\n",
    "  'existing_cui_name': 'Has reason',\n",
    "  'existing_cui_desc': '[CLS] Has reason [unused3] ( Intel ##lect ##ual Product , link assertion , link assertion : has reason ) [SEP]',\n",
    "  'our_bi_cui': 'C1443309',\n",
    "  'our_bi_cui_name': 'Reason for Treatment',\n",
    "  'our_bi_cui_desc': '[CLS] Reason for Treatment [unused3] ( Finding , finding : Reason ##s for treatment ) [SEP]',\n",
    "  'our_cross_cui': 'C0566251',\n",
    "  'our_cross_cui_name': 'Reason and justification',\n",
    "  'our_cross_cui_desc': '[CLS] Reason and justification [unused3] ( Finding , attribute ) [SEP]'},\n",
    " {'mention_id': '28249376.78',\n",
    "  'test_set_idx': 29948,\n",
    "  'type': 'T033',\n",
    "  'name': 'digestibility',\n",
    "  'context': '[CLS] ##ole ##ster ##ol , total protein , album ##in , blood u ##rea nitrogen and as ##par ##tate amino ##tra ##ns ##fer ##ase and al ##ani ##ne amino ##tra ##ns ##fer ##ase concentration . A ##ppa ##rent total tract dig ##est ##ibility of dry matter , crude pro ##ten , organic matter , and neutral de ##ter ##gent fiber were not influenced by mixture of essential oils supplement ##ation . The results of the present study suggested that supplement ##ation of mixture of essential oils may have limited effects on apparent nut ##rient [unused1] dig ##est ##ibility [unused2] , r ##umi ##nal f ##er ##mentation and pro ##to ##zo ##a and h ##yper am ##monia producing bacteria count , blood cells and meta ##bol ##ites . [SEP]',\n",
    "  'existing_cui': 'C0233423',\n",
    "  'existing_cui_name': 'Suggestibility',\n",
    "  'existing_cui_desc': '[CLS] Su ##gg ##est ##ibility [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : suggest ##ibility ; Su ##gg ##est ##ibility , function ) [SEP]',\n",
    "  'our_bi_cui': 'C0012238',\n",
    "  'our_bi_cui_name': 'Digestion',\n",
    "  'our_bi_cui_desc': '[CLS] Digest ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : dig ##estive system functions ; dig ##est ##ion ; Digest ##ive system functions ; dig ##est ##ions ; Digest ##ive system function ; Fun ##ctions of the dig ##estive system ; Digest ##ive ; Digest ##ive tract function ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27580908.19',\n",
    "  'test_set_idx': 10663,\n",
    "  'type': 'T058',\n",
    "  'name': 'pediatric gastrointestinal radiology',\n",
    "  'context': \"[CLS] digital game or with a traditional did ##actic lecture . Medical students participating in a fourth - year radio ##logy elect ##ive were invited to participate . Student co ##hor ##ts were alternatively given a faculty - supervised 1 ##h session playing a simple interactive digital T ##ic - ta ##c - toe q ##uiz module on [unused1] p ##ediatric gas ##tro ##int ##est ##inal radio ##logy [unused2] or a 1 ##h did ##actic intro ##ductory lecture on the same topic . Survey questions assessed the learn ##ers ' perceived ability to recall the material as well as their satisfaction with the educational experience . Results of an end - of - rotation exam were reviewed to evaluate a quantitative measure of learning between groups . [SEP]\",\n",
    "  'existing_cui': 'C1518934',\n",
    "  'existing_cui_name': 'Pediatric Radiology Specialty',\n",
    "  'existing_cui_desc': '[CLS] P ##ediatric Radio ##logy Special ##ty [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line : radio ##logy , p ##ediatric ; p ##ediatric radio ##logy ; P ##ediatric Radio ##logy ) [SEP]',\n",
    "  'our_bi_cui': 'C0947817',\n",
    "  'our_bi_cui_name': 'Gastrointestinal radiotherapies',\n",
    "  'our_bi_cui_desc': '[CLS] Gas ##tro ##int ##est ##inal radio ##ther ##ap ##ies [unused3] ( Health Care Act ##ivity ) [SEP]',\n",
    "  'our_cross_cui': 'C0203054',\n",
    "  'our_cross_cui_name': 'Radiography of gastrointestinal tract',\n",
    "  'our_cross_cui_desc': '[CLS] Radio ##graphy of gas ##tro ##int ##est ##inal tract [unused3] ( Health Care Act ##ivity , procedure : X - ray gas ##tro ##int ##est ##inal ; Radio ##graphic procedure on gas ##tro ##int ##est ##inal tract ; Gas ##tro ##int ##est ##inal tract X - ray ; G ##I tract X - ray ; Digest ##ive tract X - ray ; Radio ##log ##ic procedure on gas ##tro ##int ##est ##inal tract ; G ##I x - ray ; x - ray of gas ##tro ##int ##est ##inal tract ; X - ray ; dig ##estive tract ; X - ray gas ##tro ##int ##est ##inal tract ; X - ray of the dig ##estive tract ; Gas ##tro ##int ##est ##inal tract x - [SEP]'},\n",
    " {'mention_id': '27812530.21',\n",
    "  'test_set_idx': 18011,\n",
    "  'type': 'T103',\n",
    "  'name': 'material',\n",
    "  'context': '[CLS] °C ) . Six specimens were tested in each group of the aforementioned parameters . Inc ##rea ##sing cast ##or oil content and pre ##co ##olin ##g treatment effectively decreased the peak polymer ##ization temperatures and increased the duration to achieve the peak polymer ##ization temperature ( P < 0 . 05 ) . Furthermore , the mechanical properties of the [unused1] material [unused2] , including density , m ##od ##ulus , and maximum compression strength , decreased with increasing cast ##or oil content . However , preparation temperature ( room temperature versus pre ##co ##olin ##g ) had no significant effect ( P > 0 . 05 ) on these mechanical properties . In conclusion , the addition of cast ##or oil to Pol ##yme [SEP]',\n",
    "  'existing_cui': 'C0440470',\n",
    "  'existing_cui_name': 'Human material',\n",
    "  'existing_cui_desc': '[CLS] Human material [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
    "  'our_bi_cui': 'C0032521',\n",
    "  'our_bi_cui_name': 'Polymers',\n",
    "  'our_bi_cui_desc': '[CLS] Pol ##yme ##rs [unused3] ( Chemical , substance : Pol ##yme ##ric ; Pol ##yme ##ric Mac ##rom ##ole ##cule ##s ; Pol ##yme ##r ; P ##OL ##Y ##ME ##R S ##U ##BS ##TA ##NC ##E ; Pol ##yme ##rs [ Chemical / In ##g ##red ##ient ] ; polymer ; polymer ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0005479',\n",
    "  'our_cross_cui_name': 'Biomaterials',\n",
    "  'our_cross_cui_desc': '[CLS] B ##io ##mate ##rial ##s [unused3] ( Chemical : B ##io ##mate ##rial ; bio ##com ##pa ##tible materials ; B ##io ##medical Material ; bio ##mate ##rial ##s ; B ##io ##medical materials ; B ##io ##com ##pa ##tible Materials ; bio ##medical materials ; bio ##mate ##rial ; Materials , B ##io ##com ##pa ##tible ; bio ##medical material ; B ##io ##com ##pa ##tible Materials [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
    " {'mention_id': '28295414.42',\n",
    "  'test_set_idx': 31580,\n",
    "  'type': 'T168',\n",
    "  'name': 'drink',\n",
    "  'context': '[CLS] a 10 % probability ( or less ) of transition ##ing out of either a no heavy drinking state or a heavy drinking state . More than two - thirds of the heavy drink ##ers who exceeded the heavy drinking threshold during treatment reported , on average , a 64 % reduction in drinking frequency and a 38 % reduction in drinking intensity from pre ##tre ##at ##ment drinking levels . The results show stability of no heavy drinking as an outcome within the first 4 months of treatment and that the > 3 / > 4 [unused1] drink [unused2] cut ##off may mask substantial reduction ##s in alcohol consumption among some patients . Future studies should explore the clinical utility of reduction end points . [SEP]',\n",
    "  'existing_cui': 'C0452428',\n",
    "  'existing_cui_name': 'Drink',\n",
    "  'existing_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
    "  'our_bi_cui': 'C0452428',\n",
    "  'our_bi_cui_name': 'Drink',\n",
    "  'our_bi_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
    "  'our_cross_cui': 'C0001967',\n",
    "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
    "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
    " {'mention_id': '27617315.44',\n",
    "  'test_set_idx': 12007,\n",
    "  'type': 'T103',\n",
    "  'name': '% p2PSA',\n",
    "  'context': '[CLS] 54 . 5 % in Pro ##state Health Index > 55 ( ch ##i - square test , p < 0 . 00 ##1 ) . The area under curves of the base model including age , total pro ##state - specific anti ##gen and status of initial / repeated bio ##psy was 0 . 64 . Ad ##ding [unused1] % p ##2 ##PS ##A [unused2] and Pro ##state Health Index to the base model improved the area under curves to 0 . 79 ( p < 0 . 00 ##1 ) and 0 . 78 ( p < 0 . 00 ##1 ) , respectively , and provided net clinical benefit in decision curve analyses . The positive bio ##psy rates of G ##lea ##son [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0138741',\n",
    "  'our_bi_cui_name': 'Prostate-Specific Antigen',\n",
    "  'our_bi_cui_desc': '[CLS] Pro ##state - S ##pecific Anti ##gen [unused3] ( Chemical , PS ##A , procedure , substance : pro ##state specific anti ##gen ; gamma Semi ##no ##p ##rote ##in ; Se ##men ##ogel ##ase ; gamma semi ##no ##p ##rote ##in ; Ka ##lli ##k ##re ##in , h ##K ##3 ; Gamma - Semi ##no ##p ##rote ##in ; Pro ##state - specific anti ##gen ; HK 00 ##3 K ##AL ##L ##I ##K ##RE ##IN ; PS ##A - Pro ##state specific anti ##gen ; Ka ##lli ##k ##re ##in h ##K ##3 ; gamma - Semi ##no ##p ##rote ##in ; Pro ##state S ##pecific Anti ##gen ; EC 3 . 4 . 21 . 77 ; P - 30 anti ##gen [SEP]',\n",
    "  'our_cross_cui': 'C3710767',\n",
    "  'our_cross_cui_name': '( -2 ) pro-prostate-specific antigen , human',\n",
    "  'our_cross_cui_desc': '[CLS] ( - 2 ) pro - pro ##state - specific anti ##gen , human [unused3] ( Chemical : ( - 2 ) pro - PS ##A , human ; p ##2 ##PS ##A , human ) [SEP]'},\n",
    " {'mention_id': '27699206.11',\n",
    "  'test_set_idx': 14492,\n",
    "  'type': 'T017',\n",
    "  'name': 'lateral occipital',\n",
    "  'context': '[CLS] . However , it remains un ##res ##ol ##ved whether all objects e ##voke equivalent levels of activity in lateral o ##cci ##pit ##al , and , if not , which image features produce stronger activation . Here , we used an un ##bia ##sed para ##metric texture model to predict preferred versus non ##p ##re ##ferred stimuli in [unused1] lateral o ##cci ##pit ##al [unused2] . O ##bs ##er ##vation and ps ##ych ##op ##hy ##si ##cal results showed that predicted preferred stimuli ( both objects and non ##ob ##jects ) had smooth ( rather than texture ##d ) surfaces . These predictions were confirmed using f ##MR ##I , for objects and non ##ob ##jects . Similar preferences were also found in the f [SEP]',\n",
    "  'existing_cui': 'C0923804',\n",
    "  'existing_cui_name': 'Lateral occipital artery',\n",
    "  'existing_cui_desc': '[CLS] Later ##al o ##cci ##pit ##al artery [unused3] ( Ana ##tom ##ical Structure , Arte ##ria c ##ere ##bri posterior : P ##3 segment of posterior cerebral artery ; Arte ##ria o ##cci ##pit ##alis lateral ##is ; Se ##gment ##um P ##3 ; A . o ##cci ##pit ##alis lateral ##is ) [SEP]',\n",
    "  'our_bi_cui': 'C0228229',\n",
    "  'our_bi_cui_name': 'lateral occipital sulcus',\n",
    "  'our_bi_cui_desc': '[CLS] lateral o ##cci ##pit ##al su ##l ##cus [unused3] ( Spa ##tial Concept , human only , human only , body structure : Later ##al o ##cci ##pit ##al su ##l ##cus ; Structure of lateral o ##cci ##pit ##al su ##l ##cus ; Later ##al - O ##cci ##pit ##al Sul ##cus ; Sul ##cus o ##cci ##pit ##alis lateral ##is ) [SEP]',\n",
    "  'our_cross_cui': 'C0028785',\n",
    "  'our_cross_cui_name': 'Occipital lobe',\n",
    "  'our_cross_cui_desc': '[CLS] O ##cci ##pit ##al lobe [unused3] ( Ana ##tom ##ical Structure , body structure : o ##cci ##pit ##al region ; O ##cci ##pit ##al cortex ; lo ##bus o ##cci ##pit ##alis ; O ##cci ##pit ##al Lo ##be ; o ##cci ##pit ##al lobes ; O ##cci ##pit ##al lobes ; O ##cci ##pit ##al Region ##s ; O ##cci ##pit ##al Region ; o ##cci ##pit ##al lobe ; Lo ##be , O ##cci ##pit ##al ; lobe o ##cci ##pit ##al ; O ##cci ##pit ##al region ; Region , O ##cci ##pit ##al ; Lo ##bus o ##cci ##pit ##alis ; o ##cci ##pit ##al cortex ; Reg ##io o ##cci ##pit ##alis ; Lo ##bes , O ##cci ##pit ##al [SEP]'},\n",
    " {'mention_id': '28197156.15',\n",
    "  'test_set_idx': 28085,\n",
    "  'type': 'T082',\n",
    "  'name': 'Japanese',\n",
    "  'context': '[CLS] CO ##2 ass ##im ##ilation rate ( A ) between rice cult ##iva ##rs using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a [unused1] Japanese [unused2] commercial cult ##iva ##r . Fine mapping suggested that Carbon As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the [SEP]',\n",
    "  'existing_cui': 'C1556094',\n",
    "  'existing_cui_name': 'Japanese race',\n",
    "  'existing_cui_desc': '[CLS] Japanese race [unused3] ( Population Group , ethnic group , finding : J ##AP ##AN ##ES ##E ; Race : Japanese ; Japanese ; - - Japanese ) [SEP]',\n",
    "  'our_bi_cui': 'C1556094',\n",
    "  'our_bi_cui_name': 'Japanese race',\n",
    "  'our_bi_cui_desc': '[CLS] Japanese race [unused3] ( Population Group , ethnic group , finding : J ##AP ##AN ##ES ##E ; Race : Japanese ; Japanese ; - - Japanese ) [SEP]',\n",
    "  'our_cross_cui': 'C0022341',\n",
    "  'our_cross_cui_name': 'Japan',\n",
    "  'our_cross_cui_desc': '[CLS] Japan [unused3] ( Spa ##tial Concept , geographic location : J ##A ; JP ##N ; JP ; J ##AP ##AN ) [SEP]'},\n",
    " {'mention_id': '27882455.28',\n",
    "  'test_set_idx': 20576,\n",
    "  'type': 'T038',\n",
    "  'name': 'item integration',\n",
    "  'context': '[CLS] these memory traces into an existing body of knowledge ( item integration ) . Older adults learned 13 non ##words and were tested on their memory for the non ##words , and on whether these non ##words impacted upon processing of similar - sounding English words immediately and 24 hours later . Part ##ici ##pants accurately recognized the non ##words immediately , but showed significant decreases in delayed recognition and recall . In comparison , the non ##words impacted upon processing of similar - sounding words only in the delayed test . Together , these findings suggest that memory consolidation processes may be more evident in [unused1] item integration [unused2] than memory stab ##ilization processes for new de ##c ##lar ##ative memories in older adults . [SEP]',\n",
    "  'existing_cui': 'C1158478',\n",
    "  'existing_cui_name': 'DNA Integration',\n",
    "  'existing_cui_desc': '[CLS] DNA Integration [unused3] ( B ##iol ##og ##ic Fun ##ction : DNA integration ; Integration ) [SEP]',\n",
    "  'our_bi_cui': 'C0700301',\n",
    "  'our_bi_cui_name': 'Cognitive information processing',\n",
    "  'our_bi_cui_desc': '[CLS] Co ##gni ##tive information processing [unused3] ( B ##iol ##og ##ic Fun ##ction , o ##bs ##er ##vable entity , qualifier value : Information processing , function ; Information processing ; information process ; Process ##es information ; information processing ; Information Process ##ing ) [SEP]',\n",
    "  'our_cross_cui': 'C0025361',\n",
    "  'our_cross_cui_name': 'Mental Processes',\n",
    "  'our_cross_cui_desc': '[CLS] Mental Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction , Human , function , o ##bs ##er ##vable entity : Human Information Process ##ing ; Thought process ; cognitive processing ; processes thought ; processing thought ; Information Process ##ing , Human ; Human information processing ; Information Process ##es ; mental processing ; cognitive process ; Form of thinking , function ; mental processes ; Form of thought ; Form of thinking ; Human Information Process ##es ; Mental Process ; mental process ; thought process ) [SEP]'},\n",
    " {'mention_id': '27500205.32',\n",
    "  'test_set_idx': 8464,\n",
    "  'type': 'T103',\n",
    "  'name': 'Kindlins',\n",
    "  'context': '[CLS] play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate the capacity of in ##te ##g ##rin ##s to media ##te their functions . [unused1] Kind ##lins [unused2] are adapt ##or proteins ; their function em ##ana ##te from their interaction with binding partners , including the c ##yt ##op ##las ##mic tails of in ##te ##g ##rin ##s and components of the act ##in c ##yt ##os ##kel ##eton . The purpose of this review is to provide a brief overview of kind ##lin structure and function , [SEP]',\n",
    "  'existing_cui': 'C1720776',\n",
    "  'existing_cui_name': 'Kindling , Neurologic',\n",
    "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
    "  'our_bi_cui': 'C0010422',\n",
    "  'our_bi_cui_name': 'Crystallins',\n",
    "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27977319.24',\n",
    "  'test_set_idx': 22776,\n",
    "  'type': 'T017',\n",
    "  'name': 'THI1',\n",
    "  'context': '[CLS] ##ym ##bio ##sis , we focused on T ##H ##I ##1 , a th ##iam ##ine - bio ##sy ##nt ##hesis gene expressed in roots , nod ##ules , and seeds . The th ##i ##1 mutant had green leaves , but formed small nod ##ules and im ##mat ##ure seeds . These p ##hen ##otype ##s were rescued by [unused1] T ##H ##I ##1 [unused2] complement ##ation and by ex ##ogen ##ous th ##iam ##ine . Thus , T ##H ##I ##1 is required for nod ##ule en ##lar ##gement and seed mat ##uration . On the other hand , colonization by a ##rb ##us ##cular my ##cor ##r ##hi ##za fungus R ##hi ##zo ##pha ##gus irregular ##is was not affected in the th [SEP]',\n",
    "  'existing_cui': 'C0272238',\n",
    "  'existing_cui_name': 'Transient hypogammaglobulinemia of infancy',\n",
    "  'existing_cui_desc': '[CLS] Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of young ; trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy ; T ##H ##I - Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy ; h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia trans ##ient of infancy ; I ##mm ##uno ##g ##lo ##bul ##in mat ##uration ##al delay ; T ##H ##I - Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##inae ##mia of infancy ; Trans ##ient H ##y [SEP]',\n",
    "  'our_bi_cui': 'C1420871',\n",
    "  'our_bi_cui_name': 'TPI1 gene',\n",
    "  'our_bi_cui_desc': '[CLS] T ##PI ##1 gene [unused3] ( Ana ##tom ##ical Structure : T ##RI ##OS ##EP ##H ##OS ##P ##HA ##TE ISO ##ME ##RA ##SE 1 ; T ##PI ##1 Gene ; Trio ##se ##ph ##os ##phate Is ##omer ##ase 1 Gene ; T ##PI ; trio ##se ##ph ##os ##phate is ##omer ##ase 1 ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27999200.29',\n",
    "  'test_set_idx': 23336,\n",
    "  'type': 'T103',\n",
    "  'name': 'MepA',\n",
    "  'context': '[CLS] substrates relevant to cancer invasion . We found that Me ##p ##1 ##A was a target of Rep ##tin , a protein that is on ##co ##genic in HC ##C . We studied Me ##p ##1 ##A regulation by Rep ##tin , its role in HC ##C , and whether it media ##tes Rep ##tin on ##co ##genic effects . [unused1] Me ##p ##A [unused2] and Rep ##tin expression was measured in human HC ##C by q ##RT - PC ##R and in culture ##d cells by PC ##R , western b ##lot and en ##zy ##matic activity measurements . Cell growth was assessed by counting and M ##TS ass ##ay . Cell migration was measured in Boyd ##en chambers and wound healing ass ##ays , [SEP]',\n",
    "  'existing_cui': 'C0611930',\n",
    "  'existing_cui_name': \"adenosine 5 ' -\",\n",
    "  'existing_cui_desc': \"[CLS] ad ##eno ##sin ##e 5 ' - [unused3] ( Chemical , O - met ##hyl ##ph ##os ##phate , O - met ##hyl ##ph ##os ##phate : ME ##PA ; 5 ' - Aden ##yl ##ic acid , mon ##ome ##thy ##l est ##er ) [SEP]\",\n",
    "  'our_bi_cui': 'C1417113',\n",
    "  'our_bi_cui_name': 'MEP1A gene',\n",
    "  'our_bi_cui_desc': '[CLS] ME ##P ##1 ##A gene [unused3] ( Ana ##tom ##ical Structure : ME ##PR ##IN , AL ##P ##HA S ##U ##B ##UN ##IT ; me ##p ##rin A subunit alpha ; PA ##BA p ##eptide h ##ydro ##lase ; PP ##HA ) [SEP]',\n",
    "  'our_cross_cui': 'C1622778',\n",
    "  'our_cross_cui_name': 'MEP1A protein , human',\n",
    "  'our_cross_cui_desc': '[CLS] ME ##P ##1 ##A protein , human [unused3] ( Chemical : me ##p ##rin alpha protein , human ; me ##p ##rin A , alpha protein , human ; PA ##BA p ##eptide h ##ydro ##lase , human ) [SEP]'},\n",
    " {'mention_id': '28454015.31',\n",
    "  'test_set_idx': 36532,\n",
    "  'type': 'T170',\n",
    "  'name': 'health - risk based air quality index',\n",
    "  'context': '[CLS] weighted two - year average health - risk based air quality index data further demonstrates that all population in the studied cities in He ##nan province live with poll ##uted air - 72 % of the population is exposed to air that is un ##hea ##lt ##hy for sensitive people , while 28 % of people is exposed to air that can be harmful to healthy people ; and the health risks are much greater during winter than during other seasons . Future works should further improve the [unused1] health - risk based air quality index [unused2] algorithm , and valid ##ate the links between the clinical / e ##pid ##em ##iol ##og ##ic data and the health - risk based air quality index values . [SEP]',\n",
    "  'existing_cui': 'C1268941',\n",
    "  'existing_cui_name': 'Health risks education',\n",
    "  'existing_cui_desc': '[CLS] Health risks education [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Counsel ##ing regarding health risks ; Ad ##vice about health risks ; Counsel ##ling regarding health risks ; Education regarding health risks ) [SEP]',\n",
    "  'our_bi_cui': 'C0018761',\n",
    "  'our_bi_cui_name': 'Health Status Indicators',\n",
    "  'our_bi_cui_desc': '[CLS] Health Status In ##dic ##ators [unused3] ( Intel ##lect ##ual Product , assessment scale : Index ##es , Health Status ; In ##dic ##ators , Health Status ; health status index ; In ##dic ##ator , Health Status ; Health Status Index ; In ##dices , Health Status ; Health status indicators ; Health Status In ##dices ; Health status index ; Health Status In ##dic ##ator ; Index , Health Status ; Health Status Index ##es ; health status indicators ; health in ##dices status ) [SEP]',\n",
    "  'our_cross_cui': 'C0918012',\n",
    "  'our_cross_cui_name': 'Index',\n",
    "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
    " {'mention_id': '28000391.14',\n",
    "  'test_set_idx': 23413,\n",
    "  'type': 'T033',\n",
    "  'name': 'Family Scale administered',\n",
    "  'context': '[CLS] II . Little is known about the ps ##ych ##oso ##cial impact of inter ##sta ##ge home monitoring . Prospect ##ive mixed - method study . This study assessed the ps ##ych ##oso ##cial impact on parents during inter ##sta ##ge home monitoring . This contains for quantitative assessment the Short Form Health Survey question ##naire and the Impact of [unused1] Family Scale administered [unused2] one and five weeks following discharge before and after stage II . For q ##ual ##itative assessment , semi - structured interviews focus ##sing on the post ##dis ##cha ##rge cop ##ing strategies were conducted twice , five weeks after hospital discharge before and after stage II . Ten infants ( eight males ) with h ##y ##pop ##lastic left heart [SEP]',\n",
    "  'existing_cui': 'C3539983',\n",
    "  'existing_cui_name': 'Vaccines Administered',\n",
    "  'existing_cui_desc': '[CLS] V ##ac ##cine ##s Ad ##mini ##stered [unused3] ( Intel ##lect ##ual Product : C ##V ##X ) [SEP]',\n",
    "  'our_bi_cui': 'C0282574',\n",
    "  'our_bi_cui_name': 'Intellectual Property',\n",
    "  'our_bi_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28203067.6',\n",
    "  'test_set_idx': 28163,\n",
    "  'type': 'T033',\n",
    "  'name': 'negative impact of care',\n",
    "  'context': '[CLS] best predict ##ors of distress in family care ##rs of g ##eria ##tric patients The aim of this article was to identify the best predict ##ors of distress suffered by family care ##rs of g ##eria ##tric patients . A cross - section ##al study of 100 FC - g ##eria ##tric patient d ##ya ##ds was conducted . The [unused1] negative impact of care [unused2] sub ##sca ##le of the CO ##P ##E index was di ##cho ##tom ##ized to identify lower stress ( score of ≤ 15 on the scale ) and higher stress ( score of ≥ 16 on the scale ) ex ##ert ##ed on family care ##rs by the process of providing care . The set of ex ##p ##lana ##tory [SEP]',\n",
    "  'existing_cui': 'C0726639',\n",
    "  'existing_cui_name': 'Impact food supplement',\n",
    "  'existing_cui_desc': '[CLS] Impact food supplement [unused3] ( Food : Impact ; impact ; I ##MP ##AC ##T ) [SEP]',\n",
    "  'our_bi_cui': 'C3698401',\n",
    "  'our_bi_cui_name': 'Carers of older people in Europe index negative impact score',\n",
    "  'our_bi_cui_desc': '[CLS] Care ##rs of older people in Europe index negative impact score [unused3] ( Finding , o ##bs ##er ##vable entity ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28127853.7',\n",
    "  'test_set_idx': 26301,\n",
    "  'type': 'T058',\n",
    "  'name': 'program',\n",
    "  'context': '[CLS] Creative approach for successful aging : A pilot study of an inter ##gene ##ration ##al health promotion program To develop and evaluate the effectiveness of an inter ##gene ##ration ##al health promotion program . This was an action research project . A total of 34 participants attended the 12 - week [unused1] program [unused2] and completed the pre - test and post - test . There were 16 middle - aged and nine older adults recruited from a district of Taipei , and nine young adults recruited from the principal investigator \\' s university . The \" At ##ti ##tudes toward A ##ging Scale \" and the \" Spiritual Health Scale \" were two assessment instruments used in the study . The results showed that there [SEP]',\n",
    "  'existing_cui': 'C0237807',\n",
    "  'existing_cui_name': 'Mental health program',\n",
    "  'existing_cui_desc': '[CLS] Mental health program [unused3] ( Organization , Mental Health : health mental programs ; Programs ; Mental Health Programs ; mental health programs ; mental health program ) [SEP]',\n",
    "  'our_bi_cui': 'C0032678',\n",
    "  'our_bi_cui_name': 'Population Programs',\n",
    "  'our_bi_cui_desc': '[CLS] Population Programs [unused3] ( Health Care Act ##ivity : Program , Population ; Programs , Population ; Population Program ) [SEP]',\n",
    "  'our_cross_cui': 'C0043113',\n",
    "  'our_cross_cui_name': 'Wellness Programs',\n",
    "  'our_cross_cui_desc': '[CLS] Well ##ness Programs [unused3] ( Health Care Act ##ivity : program well ##ness ; programs well ##ness ; Programs , Well ##ness ; Well ##ness Program ; well ##ness programs ; programming well ##ness ; Program , Well ##ness ; well ##ness program ) [SEP]'},\n",
    " {'mention_id': '27580517.12',\n",
    "  'test_set_idx': 10622,\n",
    "  'type': 'T058',\n",
    "  'name': '3D spiral - based pseudo - continuous arterial spin labeling technique',\n",
    "  'context': '[CLS] patients in q ##uant ##ifying cerebral blood flow response to an ace ##ta ##zo ##lam ##ide v ##as ##od ##ila ##tor challenge . magnetic resonance imaging exams were performed on two 3 Te ##sla Philips In ##gen ##ia systems using 32 channel head coil array ##s . After local institutional review board approval , the [unused1] 3D spiral - based pseudo - continuous art ##erial spin label ##ing technique [unused2] was added to a standard brain magnetic resonance imaging exam and evaluated in 13 p ##ediatric patients ( average age : 11 . 7 ± 6 . 4 years , range : 1 . 4 - 22 . 2 years ) . All patients were administered ace ##ta ##zo ##lam ##ide for clinical ##ly indicated reasons [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0430022',\n",
    "  'our_bi_cui_name': 'diagnostic procedure',\n",
    "  'our_bi_cui_desc': '[CLS] diagnostic procedure [unused3] ( Health Care Act ##ivity , procedure : D ##IA ##G ##N ##OS ##TI ##C ; Di ##ag ##nos ##tic procedure ; Di ##ag ##nos ##tic procedures ; Di ##ag ##nos ##tic Test ; diagnostic technique ; Di ##ag ##nos ##tic ; Di ##ag ##nos ##tic Tech ##ni ##que ; Di ##ag ##nos ##tic Pro ##ced ##ure ; diagnostic procedures ; Di ##ag ##nos ##tic Method ; Pro ##ced ##ures ; diagnostic ) [SEP]',\n",
    "  'our_cross_cui': 'C3891302',\n",
    "  'our_cross_cui_name': 'Arterial Spin Labeling Magnetic Resonance Imaging',\n",
    "  'our_cross_cui_desc': '[CLS] Arte ##rial Spin Label ##ing Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity : AS ##L f ##MR ##I ; Arte ##rial Spin Label ##ing MR ##I ; AR ##TE ##RI ##AL SP ##IN LA ##BE ##L ##ING F ##UN ##CT ##ION ##AL MR ##I ) [SEP]'},\n",
    " {'mention_id': '27542380.9',\n",
    "  'test_set_idx': 9950,\n",
    "  'type': 'T017',\n",
    "  'name': 'foye-1 gene',\n",
    "  'context': '[CLS] - stability properties . The genome of the acid ##op ##hil ##ic iron - o ##xi ##di ##zing bacterium \" Fe ##rro ##vu ##m \" s ##p . J ##A ##12 was found to harbor a the ##rm ##op ##hil ##ic - like en ##e - red ##uc ##tase ( F ##O ##Y ##E - 1 ) . The [unused1] f ##oy ##e - 1 gene [unused2] was l ##igate ##d into a p ##ET ##16 ##b ##p expression vector system , and the enzyme was produced in E ##scher ##ichi ##a co ##li B ##L ##21 ( DE ##3 ; p ##L ##ys ##S ) cells in yields of 10 mg L ( - 1 ) . F ##O ##Y ##E - 1 showed remarkable [SEP]',\n",
    "  'existing_cui': 'C1332742',\n",
    "  'existing_cui_name': 'CDT1 Gene',\n",
    "  'existing_cui_desc': '[CLS] CD ##T ##1 Gene [unused3] ( Ana ##tom ##ical Structure : D ##O ##U ##BL ##E PA ##R ##KE ##D , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; ch ##roma ##tin licensing and DNA replication factor 1 ; CH ##RO ##MA ##TI ##N L ##IC ##EN ##SI ##NG AND DNA R ##EP ##L ##IC ##AT ##ION FA ##CT ##OR 1 ; DNA Rep ##lication Factor Gene ; R ##IS ##2 ) [SEP]',\n",
    "  'our_bi_cui': 'C1414643',\n",
    "  'our_bi_cui_name': 'FMO1 gene',\n",
    "  'our_bi_cui_desc': '[CLS] FM ##O ##1 gene [unused3] ( Ana ##tom ##ical Structure : fl ##avi ##n containing mon ##oo ##xy ##gen ##ase 1 ; FM ##O , F ##ET ##AL L ##IVE ##R ; FL ##AV ##IN - CO ##NT ##A ##IN ##ING M ##ON ##O ##OX ##Y ##GE ##NA ##SE 1 ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27887026.30',\n",
    "  'test_set_idx': 20815,\n",
    "  'type': 'T103',\n",
    "  'name': 'CmFDH',\n",
    "  'context': '[CLS] substrate was evaluated by measuring the kinetic rates and conducting productivity ass ##ays . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H ) and Cha ##eto ##mium the ##rm ##op ##hil ##um showed a higher efficiency in converting HC ##O ##3 ( - ) to format ##e than C ##m ##F ##D ##H , whereas [unused1] C ##m ##F ##D ##H [unused2] was better in the oxidation of format ##e . The pH op ##ti ##mum of the reduction was at pH 7 - 8 . However , the high concentrations of HC ##O ##3 ( - ) reduced the reaction rate . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H ) and Cha ##eto ##mium the ##rm [SEP]',\n",
    "  'existing_cui': 'C0342185',\n",
    "  'existing_cui_name': 'Hyperthyroxinemia , Familial Dysalbuminemic',\n",
    "  'existing_cui_desc': '[CLS] H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial D ##ys ##al ##bu ##mine ##mic [unused3] ( Ana ##tom ##ical Structure , disorder : H ##YP ##ER ##TH ##Y ##RO ##X ##IN ##EM ##IA , FA ##MI ##L ##IA ##L D ##Y ##SA ##L ##B ##UM ##IN ##EM ##IC ; F ##ami ##lial d ##ys ##al ##bu ##mina ##em ##ic h ##yper ##thy ##ro ##xin ##ae ##mia ; H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial D ##ys ##al ##bu ##mine ##mic [ Disease / Finding ] ; D ##ys ##al ##bu ##mine ##mic H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial ; F ##ami ##lial D ##ys ##al ##bu ##mine ##mic H ##yper ##thy ##ro ##xin ##emia ; F ##ami [SEP]',\n",
    "  'our_bi_cui': 'C0060672',\n",
    "  'our_bi_cui_name': 'formylmethanofuran dehydrogenase',\n",
    "  'our_bi_cui_desc': '[CLS] form ##yl ##met ##han ##of ##ura ##n de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , substance : FM ##F de ##hy ##dr ##ogen ##ase ; Form ##yl ##met ##han ##of ##ura ##n de ##hy ##dr ##ogen ##ase ) [SEP]',\n",
    "  'our_cross_cui': 'C0016570',\n",
    "  'our_cross_cui_name': 'Formate dehydrogenase',\n",
    "  'our_cross_cui_desc': '[CLS] Form ##ate de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , substance : De ##hy ##dr ##ogen ##ase , N ##AD - Form ##ate ; N ##AD Form ##ate De ##hy ##dr ##ogen ##ase ; De ##hy ##dr ##ogen ##ases , Form ##ate ; N ##AD - Form ##ate De ##hy ##dr ##ogen ##ase ; Form ##ate H ##ydro ##gen ##lya ##ses ; Form ##ate De ##hy ##dr ##ogen ##ases ; Form ##ate De ##hy ##dr ##ogen ##ases [ Chemical / In ##g ##red ##ient ] ; Form ##ate : N ##AD + o ##xi ##dor ##ed ##uc ##tase ; H ##ydro ##gen ##lya ##ses , Form ##ate ) [SEP]'},\n",
    " {'mention_id': '27325547.9',\n",
    "  'test_set_idx': 2507,\n",
    "  'type': 'T103',\n",
    "  'name': 'PM2 .5',\n",
    "  'context': '[CLS] health effects of PM increase as particle size decreases : particularly , great concern has risen on the role of Ultra ##F ##ine Part ##icles . Starting from the knowledge that the main fraction of atmospheric a ##ero ##sol in Rome is characterized by significant levels of PM ##2 . 5 ( almost 75 % of PM ##10 fraction is [unused1] PM ##2 . 5 [unused2] ) , the paper is focused on sub ##mic ##ron particles in such great urban area . The daytime / night ##time , work - / weekdays and cold / hot seasonal trends of sub ##mic ##ron particles will be investigated and discussed along with NO ##x and total PA ##H drift ##s demonstrating the primary origin of Ultra ##F [SEP]',\n",
    "  'existing_cui': 'C0665987',\n",
    "  'existing_cui_name': '1-(4-aminobutyl)-6-benzylindane',\n",
    "  'existing_cui_desc': '[CLS] 1 - ( 4 - amino ##but ##yl ) - 6 - ben ##zy ##lind ##ane [unused3] ( Chemical : PM ##2 c ##p ##d ) [SEP]',\n",
    "  'our_bi_cui': 'C0597177',\n",
    "  'our_bi_cui_name': 'Particle',\n",
    "  'our_bi_cui_desc': '[CLS] Part ##icle [unused3] ( Chemical : particle ; particles ; Part ##icles ; a very small piece or part ) [SEP]',\n",
    "  'our_cross_cui': 'C1510837',\n",
    "  'our_cross_cui_name': 'Airborne Particulate Matter',\n",
    "  'our_cross_cui_desc': '[CLS] Airborne Part ##iculate Matter [unused3] ( Chemical : Air Poll ##uta ##nts , Part ##iculate ; Am ##bie ##nt Part ##iculate Matter ; Part ##iculate Matter , Am ##bie ##nt ; Part ##iculate Matter , Airborne ; Poll ##uta ##nts , Part ##iculate Air ; Part ##iculate Air Poll ##uta ##nts ) [SEP]'},\n",
    " {'mention_id': '28540429.6',\n",
    "  'test_set_idx': 38811,\n",
    "  'type': 'T017',\n",
    "  'name': 'fibrogenic cells',\n",
    "  'context': '[CLS] I ##dent ##ification of markers for q ##ui ##es ##cent pan ##cre ##atic s ##tel ##late cells in the normal human pan ##cre ##as Pan ##cre ##atic s ##tel ##late cells play a central role as source of [unused1] fi ##bro ##genic cells [unused2] in pan ##cre ##atic cancer and chronic pan ##cre ##ati ##tis . In contrast to q ##ui ##es ##cent he ##pa ##tic s ##tel ##late cells , a specific marker for q ##ui ##es ##cent Pan ##cre ##atic s ##tel ##late cells that can be used in formal ##in - fixed and para ##ffin embedded normal human pan ##cre ##atic tissue has not been identified . The aim of this study was to identify a marker enabling the identification of q ##ui [SEP]',\n",
    "  'existing_cui': 'C0206643',\n",
    "  'existing_cui_name': 'Neoplasms , Fibrous Tissue',\n",
    "  'existing_cui_desc': '[CLS] Neo ##p ##las ##ms , Fi ##bro ##us T ##iss ##ue [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis : Fi ##bro ##us T ##iss ##ue Neo ##p ##las ##m ; F ##IB ##RO ##US T ##IS ##SU ##E NE ##OP ##L ; Fi ##bro ##cy ##tic Neo ##p ##las ##m ; Neo ##p ##las ##m , Fi ##bro ##us T ##iss ##ue ; Fi ##bro ##genic Neo ##p ##las ##m ; Fi ##bro ##blast ##ic Neo ##p ##las ##m ; Fi ##bro ##us Tu ##mor ; Fi ##bro ##us T ##iss ##ue Neo ##p ##las ##ms ; Fi ##bro ##blast ##ic Tu ##mor ; neo ##p ##las ##m of fi ##bro ##us tissue ; Fi ##bro ##genic ##T ##um ##or ; Neo ##p [SEP]',\n",
    "  'our_bi_cui': 'C0016030',\n",
    "  'our_bi_cui_name': 'Fibroblasts',\n",
    "  'our_bi_cui_desc': '[CLS] Fi ##bro ##blast ##s [unused3] ( Ana ##tom ##ical Structure , cell : Fi ##bro ##blast ##s [ Chemical / In ##g ##red ##ient ] ; fi ##bro ##blast cell ; fi ##bro ##blast ; Fi ##bro ##blast ; cells fi ##bro ##blast ; fi ##bro ##blast ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0007634',\n",
    "  'our_cross_cui_name': 'Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
    " {'mention_id': '27317610.20',\n",
    "  'test_set_idx': 2184,\n",
    "  'type': 'T038',\n",
    "  'name': 'stress',\n",
    "  'context': '[CLS] ##ology , and subsequent h ##y ##pot ##hala ##mic - pit ##uit ##ary end ##oc ##rine d ##ys ##function . These experiments were designed to test the hypothesis that a single di ##ff ##use traumatic brain injury results in chronic d ##ys ##function of co ##rt ##ico ##ster ##one , a g ##lu ##co ##cor ##tic ##oid released in response to [unused1] stress [unused2] and test ##osterone . We used a rode ##nt model of di ##ff ##use traumatic brain injury induced by mid ##line fluid percussion injury . At 2 months post ##in ##ju ##ry compared with un ##in ##jured control animals , circulating levels of co ##rt ##ico ##ster ##one were evaluated at rest , under restraint stress and in response to de ##xa [SEP]',\n",
    "  'existing_cui': 'C0038435',\n",
    "  'existing_cui_name': 'Stress',\n",
    "  'existing_cui_desc': '[CLS] St ##ress [unused3] ( Finding , finding , qualifier value : St ##ress - value ; state ; stress ; Press ##ure ; stressed ; State of stress ; stress ; stress ; state ) [SEP]',\n",
    "  'our_bi_cui': 'C0038435',\n",
    "  'our_bi_cui_name': 'Stress',\n",
    "  'our_bi_cui_desc': '[CLS] St ##ress [unused3] ( Finding , finding , qualifier value : St ##ress - value ; state ; stress ; Press ##ure ; stressed ; State of stress ; stress ; stress ; state ) [SEP]',\n",
    "  'our_cross_cui': 'C0449430',\n",
    "  'our_cross_cui_name': 'Physiological Stress',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##ys ##iol ##ogical St ##ress [unused3] ( B ##iol ##og ##ic Fun ##ction , attribute : St ##ress , Ph ##ys ##iol ##ogical ; St ##resses , Ph ##ys ##iol ##ogical ; Ph ##ys ##iol ##ogical St ##resses ; ST ##RE ##SS P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL ST ##RE ##SS ; Ph ##ys ##iol ##ogical stress ; stress physiological ; physiological stress ) [SEP]'},\n",
    " {'mention_id': '27732552.11',\n",
    "  'test_set_idx': 15248,\n",
    "  'type': 'T058',\n",
    "  'name': 'technique',\n",
    "  'context': '[CLS] tool for the monitoring of H ##b ##A ##1 ##c in diabetes patients Micro ##sa ##mp ##ling techniques have several advantages over traditional blood collection . Dr ##ied blood spot sampling and blood collection with he ##par ##ini ##zed cap ##illa ##ries are the standard techniques . Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp ##ling is a novel [unused1] technique [unused2] that collects a fixed volume of blood by applying an absorb ##ent tip to a blood drop . In the present study we explored the f ##eas ##ibility of H ##b ##A ##1 ##c monitoring with Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp ##ling sampling at home and analysis in the laboratory . Di ##abe ##tic patients were enrolled [SEP]',\n",
    "  'existing_cui': 'C0450241',\n",
    "  'existing_cui_name': 'Ffooks technique',\n",
    "  'existing_cui_desc': '[CLS] F ##fo ##ok ##s technique [unused3] ( Health Care Act ##ivity , qualifier value ) [SEP]',\n",
    "  'our_bi_cui': 'C0025663',\n",
    "  'our_bi_cui_name': 'Methods',\n",
    "  'our_bi_cui_desc': '[CLS] Method ##s [unused3] ( Intel ##lect ##ual Product , attribute : methods ; Method ; method ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '28064539.7',\n",
    "  'test_set_idx': 24490,\n",
    "  'type': 'T204',\n",
    "  'name': 'Foucauldian',\n",
    "  'context': '[CLS] T ##rea ##ting the bin ##ge or the ( fat ) body ? Rep ##res ##entation ##s of fat ##ness in a gold standard psychological treatment manual for bin ##ge eating disorder This article reports the results of a [unused1] F ##ou ##ca ##uld ##ian [unused2] - informed discourse analysis exploring representations of fat ##ness embedded within an empirical ##ly based psychological treatment manual for bin ##ge eating disorder , a condition characterized by over ##val ##uation of weight and shape . Ana ##ly ##ses indicate that the manual prior ##iti ##zes weight loss with relatively less emphasis placed on treating the diagnostic symptoms and underlying mechanisms of bin ##ge eating disorder . We raise critical concerns about these observations and link our findings to mainstream [SEP]',\n",
    "  'existing_cui': 'C1422766',\n",
    "  'existing_cui_name': 'MEG8 gene',\n",
    "  'existing_cui_desc': '[CLS] ME ##G ##8 gene [unused3] ( Ana ##tom ##ical Structure , non - protein coding : L ##IN ##C ##00 ##0 ##24 ; MA ##TE ##RNA ##LL ##Y E ##X ##PR ##ES ##SE ##D GE ##NE 8 ; maternal ##ly expressed 8 ; RNA I ##mp ##rin ##ted and A ##cc ##um ##ulated in N ##uc ##le ##us ; non - protein coding RNA 24 ; long inter ##genic non - protein coding RNA 24 ; I ##mp ##rin ##ted RNA near Meg ##3 / G ##tl ##2 ; B ##s ##r ; NC ##RNA ##00 ##0 ##24 ) [SEP]',\n",
    "  'our_bi_cui': 'C1522486',\n",
    "  'our_bi_cui_name': 'Professional Organization or Group',\n",
    "  'our_bi_cui_desc': '[CLS] Professional Organization or Group [unused3] ( Professional or O ##cc ##upation ##al Group : Other Agency or Organization ; Organization ; OR ##G ; Outside Bo ##dies ; Organization ##al ) [SEP]',\n",
    "  'our_cross_cui': 'C0086418',\n",
    "  'our_cross_cui_name': 'Homo sapiens',\n",
    "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
    " {'mention_id': '27335087.93',\n",
    "  'test_set_idx': 2822,\n",
    "  'type': 'T033',\n",
    "  'name': 'No hepatorenal toxicity',\n",
    "  'context': '[CLS] . In addition , Fu ##zhen ##g Qing ##ji ##e increased the percentage ##s of CD ##4 ( + ) T and natural killer cells cells , the ratio of CD ##4 ( + ) / CD ##8 ( + ) T cells as well as the levels of serum T ##NF - α . Fu ##zhen ##g Qing ##ji ##e also increased CD ##6 ##9 expression in tumor tissue . [unused1] No he ##pa ##tore ##nal toxicity [unused2] was observed in H ##22 tumor - bearing mice . These results indicated that Fu ##zhen ##g Qing ##ji ##e could in ##hibit the growth of he ##pa ##tom ##a cells via regulating immune function and in ##ducing mit ##och ##ond ##ria mediated a ##pop ##tosis . [SEP]',\n",
    "  'existing_cui': 'C0595916',\n",
    "  'existing_cui_name': 'Toxic nephropathy',\n",
    "  'existing_cui_desc': '[CLS] To ##xi ##c ne ##ph ##rop ##athy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : toxic ne ##ph ##rop ##athy ; toxic ; ne ##ph ##rop ##athy ; Kid ##ney To ##xi ##city ; To ##xi ##c ne ##ph ##rosis ; N ##ep ##hr ##op ##athy toxic ; ne ##ph ##rop ##athy toxic ; re ##nal toxicity ; To ##xi ##city re ##nal ; Ren ##al To ##xi ##city ; ne ##ph ##rop ##athy ; toxic ) [SEP]',\n",
    "  'our_bi_cui': 'C0857329',\n",
    "  'our_bi_cui_name': 'No toxic effect',\n",
    "  'our_bi_cui_desc': '[CLS] No toxic effect [unused3] ( Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27510458.35',\n",
    "  'test_set_idx': 8922,\n",
    "  'type': 'T033',\n",
    "  'name': 'double lumen signs',\n",
    "  'context': '[CLS] . We assessed whether these imaging methods could visual ##ize an in ##ti ##mal flap and / or double l ##ume ##n sign in the participants and compared the results between high - resolution fast spin echo and the other m ##oda ##lities . high - resolution fast spin echo images clearly showed in ##ti ##mal flap ##s and [unused1] double l ##ume ##n signs [unused2] in all 3 patients , whereas the conventional m ##oda ##lities identified a double l ##ume ##n sign in only 2 of the 3 patients . The present method of op ##ti ##mized high - resolution fast spin echo imaging with a 3 ##T system improved visual ##ization of in ##ti ##mal flap ##s and should thus be considered for [SEP]',\n",
    "  'existing_cui': 'C0441299',\n",
    "  'existing_cui_name': 'Double lumen tube',\n",
    "  'existing_cui_desc': '[CLS] Double l ##ume ##n tube [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
    "  'our_bi_cui': 'C0233192',\n",
    "  'our_bi_cui_name': \"Ladin 's sign\",\n",
    "  'our_bi_cui_desc': \"[CLS] La ##din ' s sign [unused3] ( Finding , finding : La ##din sign ) [SEP]\",\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27986797.27',\n",
    "  'test_set_idx': 22924,\n",
    "  'type': 'T103',\n",
    "  'name': 'myomitokine',\n",
    "  'context': '[CLS] with skeletal muscle - specific deficiency of C ##ri ##f ##1 ( muscle - specific knockout [ M ##KO ] ) , an integral protein of the large mit ##ori ##bos ##oma ##l subunit ( 39 ##S ) , we identified growth differentiation factor 15 as a UP ##R ( m ##t ) - associated cell - non - autonomous [unused1] my ##omi ##tok ##ine [unused2] that regulate ##s systemic energy home ##ost ##asis . muscle - specific knockout mice were protected against o ##besity and se ##ns ##iti ##zed to insulin , an effect associated with elevated growth differentiation factor 15 secret ##ion after UP ##R ( m ##t ) activation . In o ##b / o ##b mice , administration of re ##comb ##ina [SEP]',\n",
    "  'existing_cui': 'C0950133',\n",
    "  'existing_cui_name': 'Online Mendelian Inheritance In Man',\n",
    "  'existing_cui_desc': '[CLS] Online Men ##del ##ian In ##her ##ita ##nce In Man [unused3] ( Intel ##lect ##ual Product : online men ##del ##ian inheritance in man ( O ##MI ##M ) database ; Online Men ##del ##ian In ##her ##ita ##nce in Man ) [SEP]',\n",
    "  'our_bi_cui': 'C0026484',\n",
    "  'our_bi_cui_name': 'Monokines',\n",
    "  'our_bi_cui_desc': '[CLS] Mon ##oki ##nes [unused3] ( Chemical , substance : Mon ##oki ##ne ; mon ##oki ##ne ; Mon ##oki ##nes [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
    "  'our_cross_cui': 'C0574031',\n",
    "  'our_cross_cui_name': 'Biologically active substance',\n",
    "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
    " {'mention_id': '27570140.49',\n",
    "  'test_set_idx': 10512,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedure',\n",
    "  'context': \"[CLS] the 27 months of follow - up . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Over one third of high - risk patients ' requests were un ##ful ##fill ##ed , indicating that significant barriers may remain . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the [unused1] procedure [unused2] . Pro ##vide ##rs should consider these procedures urgent , especially in high - risk women , and advocate for their patients ' access to this procedure . [SEP]\",\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '28294559.26',\n",
    "  'test_set_idx': 31482,\n",
    "  'type': 'T204',\n",
    "  'name': 'chimeric mice',\n",
    "  'context': '[CLS] essential role in liver regeneration after HP ##x . Background and aim The aim of the present study was to investigate the role of C - type le ##ct ##in receptor ( C - type le ##ct ##in receptor ) - 2 in liver regeneration following partial liver re ##section in mice . Materials and methods I ##rra ##dia ##ted [unused1] ch ##ime ##ric mice [unused2] transplant ##ed with f ##etal liver cells from wild - type mice , C - type le ##ct ##in receptor - 2 - deleted ( K ##O ) mice or mice with C - type le ##ct ##in receptor - 2 deleted specifically from plate ##lets ( fl ##KO ) were generated . Mi ##ce underwent 70 % partial he [SEP]',\n",
    "  'existing_cui': 'C0676831',\n",
    "  'existing_cui_name': 'basiliximab',\n",
    "  'existing_cui_desc': '[CLS] b ##asi ##lix ##ima ##b [unused3] ( Chemical , Si ##mu ##lect , medication , product , substance : Basil ##ix ##ima ##b ; b ##asi ##lix ##ima ##b [ Chemical / In ##g ##red ##ient ] ; ch ##ime ##ric mouse - human anti ##CD ##25 ; I ##g gamma - 1 chain C region ; BA ##SI ##L ##IX ##IM ##AB ) [SEP]',\n",
    "  'our_bi_cui': 'C0025936',\n",
    "  'our_bi_cui_name': 'Mice , Transgenic',\n",
    "  'our_bi_cui_desc': '[CLS] Mi ##ce , Trans ##genic [unused3] ( E ##uka ##ryo ##te : Mouse , Trans ##genic ; mouse trans ##genic ##s ; Trans ##genic Mi ##ce ; mice trans ##genic ; Trans ##genic Mouse ; trans ##genic mice ; Trans ##genic mice ; trans ##genic mouse ) [SEP]',\n",
    "  'our_cross_cui': 'C0025929',\n",
    "  'our_cross_cui_name': 'Laboratory mice',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory mice [unused3] ( E ##uka ##ryo ##te , organism : Mouse , Laboratory ; Mouse , laboratory ; Laboratory Mi ##ce ; Mi ##ce , Laboratory ; mouse ; mice ; Laboratory Mouse ; Laboratory mouse ; laboratory mouse ) [SEP]'},\n",
    " {'mention_id': '28234635.85',\n",
    "  'test_set_idx': 29253,\n",
    "  'type': 'T017',\n",
    "  'name': 'canalicular',\n",
    "  'context': '[CLS] of L ##X ##R and ABC ##G ##5 / 8 RNA expression was suppressed in patients with portal inflammation . Current parent ##eral nutrition , increased serum levels of plant s ##tero ##ls s ##ti ##gma ##ster ##ol , a ##ven ##aster ##ol , and sit ##ost ##ero ##l along with serum c ##it ##ru ##llin ##e , a marker of enter ##oc ##yte mass , predicted portal inflammation . In p ##ediatric onset in ##test ##inal failure , current parent ##eral nutrition delivery s ##yne ##rg ##istic ##ally with in ##test ##inal compromise promote liver inflammation , which associates with progression of bio ##chemical and his ##to ##log ##ic liver injury , while reducing expression of [unused1] canal ##icular [unused2] bi ##le transport ##ers . [SEP]',\n",
    "  'existing_cui': 'C0339135',\n",
    "  'existing_cui_name': 'Canalicular laceration',\n",
    "  'existing_cui_desc': '[CLS] Canal ##icular lace ##ration [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder ) [SEP]',\n",
    "  'our_bi_cui': 'C1159621',\n",
    "  'our_bi_cui_name': 'canalicular bile acid transport',\n",
    "  'our_bi_cui_desc': '[CLS] canal ##icular bi ##le acid transport [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_cross_cui': 'C0005393',\n",
    "  'our_cross_cui_name': 'Structure of bile canaliculus',\n",
    "  'our_cross_cui_desc': '[CLS] Structure of bi ##le canal ##ic ##ulus [unused3] ( Ana ##tom ##ical Structure , body structure : Canal ##ic ##ulus , B ##ile ; B ##ile Canal ##ic ##ulus ; B ##ile canal ##ic ##ulus ; Canal ##ic ##uli , B ##ile ; B ##ile Canal ##ic ##uli ) [SEP]'},\n",
    " {'mention_id': '28125734.69',\n",
    "  'test_set_idx': 26223,\n",
    "  'type': 'T103',\n",
    "  'name': 'MiR-21-5p',\n",
    "  'context': '[CLS] ##R - 21 - 5 ##p as a true regulator of me ##so ##the ##lin . Moreover , in v ##it ##ro experiments showed that treatment with mi ##R - 21 - 5 ##p mimic reduced proliferation of ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma cell lines . Alto ##get ##her , this work shows that the mi ##R - CA ##TC ##H technique , coupled with next generation se ##quencing and in v ##it ##ro valid ##ation , represents a reliable method to identify native mi ##RNA : : m ##RNA interactions . [unused1] Mi ##R - 21 - 5 ##p [unused2] is suggested as novel regulator of me ##so ##the ##lin with a possible functional role in cellular growth . [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1999986',\n",
    "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '27473429.29',\n",
    "  'test_set_idx': 7344,\n",
    "  'type': 'T082',\n",
    "  'name': 'segments',\n",
    "  'context': '[CLS] ##8 , and 110 ##1 b ##p ) , which has demonstrated that in all cases , polymer ##ase chain reaction is successful at least on one station . In addition , three DNA fragment s with different lengths ( 32 ##3 , 110 ##1 , and 28 ##36 b ##p ) have been successfully am ##plified in a segment ##ed - flow mode without the carry - over contamination between [unused1] segments [unused2] . This result suggests that this device could serve as the polymer ##ase chain reaction module of a continuous - flow high - through ##put on - line total DNA analysis system integrating all necessary modules from cell l ##ys ##is / DNA extraction to polymer ##ase chain reaction product analysis . [SEP]',\n",
    "  'existing_cui': 'C0441635',\n",
    "  'existing_cui_name': 'Anatomical segmentation',\n",
    "  'existing_cui_desc': '[CLS] Ana ##tom ##ical segment ##ation [unused3] ( Spa ##tial Concept , qualifier value : Se ##gment ##ed ; Se ##gment ##ation ; segment ##ation ; segment ; SE ##GM ##EN ##T ; Se ##gment ) [SEP]',\n",
    "  'our_bi_cui': 'C0162326',\n",
    "  'our_bi_cui_name': 'DNA Sequence',\n",
    "  'our_bi_cui_desc': '[CLS] DNA Se ##quence [unused3] ( Spa ##tial Concept : DNA Se ##quence ##s ; Se ##quence ##s ; DNA SE ##Q ; d ##na sequences ; Se ##quence ##s , DNA ; DNA sequence ; Se ##quence ; d ##na sequence ; DNA se ##quencing ; Se ##quence , DNA ) [SEP]',\n",
    "  'our_cross_cui': 'C0442059',\n",
    "  'our_cross_cui_name': 'Segment structure',\n",
    "  'our_cross_cui_desc': '[CLS] Se ##gment structure [unused3] ( Spa ##tial Concept , qualifier value ) [SEP]'},\n",
    " {'mention_id': '27456018.8',\n",
    "  'test_set_idx': 6374,\n",
    "  'type': 'T058',\n",
    "  'name': 'SL',\n",
    "  'context': '[CLS] is a technique perceived to provide the benefits of lap ##aro ##scopic surgery while improving ta ##ct ##ile feedback and operative time . Published data are largely limited to small , single - institution studies . The 2012 - 2013 National Sur ##gical Quality Improvement Program Part ##ici ##pan ##t Data Use File was que ##ried for patients undergoing elect ##ive [unused1] SL [unused2] or H ##AL co ##lect ##omy . Pat ##ients underwent 1 : 1 prop ##ens ##ity matching and had outcomes compared . An additional subgroup analysis was performed for patients undergoing segment ##al re ##section ##s only . 13 , 94 ##9 patients were identified , of whom 60 ##8 ##4 ( 43 . 6 % ) underwent H ##AL co ##lect [SEP]',\n",
    "  'existing_cui': 'C2338991',\n",
    "  'existing_cui_name': 'Simple lobule of cerebellum',\n",
    "  'existing_cui_desc': '[CLS] Simple lo ##bul ##e of c ##ere ##bell ##um [unused3] ( Ana ##tom ##ical Structure , posterior : Post ##eri ##or c ##res ##cent ##ic lo ##bul ##e of c ##ere ##bell ##um ; Lo ##bul ##us q ##uad ##rang ##ular ##is par ##s in ##fer ##op ##ost ##eri ##or ; Lo ##bul ##us simple ##x c ##ere ##bell ##i [ H VI et VI ] ; Semi ##lu ##nar lo ##bul ##e - 1 ; Lo ##bul ##us simple ##x ; Lo ##bul ##e VI of hemisphere of c ##ere ##bell ##um ; Simple ##x ; Lo ##bul ##us q ##uad ##rang ##ular ##is par ##s ca ##uda ##lis / posterior ; Simple lo ##bul ##e of c ##ere ##bell ##um [ H VI and [SEP]',\n",
    "  'our_bi_cui': 'C0585462',\n",
    "  'our_bi_cui_name': 'Laparoscopic-assisted sigmoid colectomy',\n",
    "  'our_bi_cui_desc': '[CLS] La ##par ##os ##copic - assisted si ##g ##mo ##id co ##lect ##omy [unused3] ( Health Care Act ##ivity , procedure : La ##par ##os ##copic - assisted si ##g ##mo ##ide ##ct ##omy ; La ##par ##os ##copic si ##g ##mo ##id co ##lect ##omy ) [SEP]',\n",
    "  'our_cross_cui': 'C1517722',\n",
    "  'our_cross_cui_name': 'Laparoscopic colectomy',\n",
    "  'our_cross_cui_desc': '[CLS] La ##par ##os ##copic co ##lect ##omy [unused3] ( Health Care Act ##ivity : La ##par ##os ##copic Cole ##ct ##omy ; La ##par ##os ##copy - As ##sist ##ed Cole ##ct ##omy ; lap ##aro ##scopic - assisted co ##lect ##omy ; La ##par ##os ##copic - As ##sist ##ed Cole ##ct ##omy ) [SEP]'},\n",
    " {'mention_id': '27297967.84',\n",
    "  'test_set_idx': 1789,\n",
    "  'type': 'T082',\n",
    "  'name': 'Asn19/23Gln',\n",
    "  'context': '[CLS] ##nic kidney 29 ##3 - As ##n ##19 / 23 ##G ##ln / Ty ##r ##9 ##20 ##G ##lu / Ser ##9 ##21 ##G ##lu were similar to H ##E ##K - W ##T - MR ##P ##1 , indicating that the p ##hos ##ph ##ory ##lation - mimic ##king substitution ##s a ##bro ##gated the influence of [unused1] As ##n ##19 / 23 ##G ##ln [unused2] g ##ly ##cos ##yla ##tion . Overall , these data suggest that cross - talk between MR ##P ##1 g ##ly ##cos ##yla ##tion and p ##hos ##ph ##ory ##lation occurs and that p ##hos ##ph ##ory ##lation of Ty ##r ##9 ##20 and Ser ##9 ##21 can switch MR ##P ##1 to a lower - affinity , higher [SEP]',\n",
    "  'existing_cui': 'C1425905',\n",
    "  'existing_cui_name': 'KRTAP19-2 gene',\n",
    "  'existing_cui_desc': '[CLS] K ##RT ##AP ##19 - 2 gene [unused3] ( Ana ##tom ##ical Structure : k ##era ##tin associated protein 19 - 2 ; K ##AP ##19 . 2 ) [SEP]',\n",
    "  'our_bi_cui': 'C0002520',\n",
    "  'our_bi_cui_name': 'Amino Acids',\n",
    "  'our_bi_cui_desc': '[CLS] Am ##ino A ##cid ##s [unused3] ( Chemical , medication , product , substance : Am ##ino acid ; A ##cid ##s , Am ##ino ; amino acid preparations ; amino ##ac ##id ; Am ##ino A ##cid ; amino acids ; Am ##ino A ##cid ##s [ Chemical / In ##g ##red ##ient ] ; amino ##ac ##ids ; Am ##ino acids ; AM ##IN ##O AC ##ID PR ##EP ##AR ##AT ##ION ; amino acid ; AM ##IN ##O AC ##ID ##S ; AA - Am ##ino acid ) [SEP]',\n",
    "  'our_cross_cui': 'C0002518',\n",
    "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
    "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
    " {'mention_id': '28059412.13',\n",
    "  'test_set_idx': 24440,\n",
    "  'type': 'T103',\n",
    "  'name': 'polyketide',\n",
    "  'context': '[CLS] ##hesis J ##aws ##am ##y ##cin is a p ##oly ##ket ##ide - n ##uc ##leo ##side hybrid with a unique p ##oly ##cy ##c ##lop ##rop ##ane m ##oi ##ety on a single p ##oly ##ket ##ide chain . The unexpected isolation of c ##y ##c ##lop ##rop ##ane def ##icient jaws ##am ##y ##cin analog ##s allowed us to propose a step ##wise c ##y ##c ##lop ##rop ##ana ##tion mechanism for the en ##zy ##matic synthesis of this [unused1] p ##oly ##ket ##ide [unused2] . The con ##cise timing of the c ##y ##c ##lop ##rop ##ana ##tion could be regulated by a delicate balance between reaction rates of the con ##den ##sation and c ##y ##c ##lop ##rop ##ana ##tion reactions . [SEP]',\n",
    "  'existing_cui': 'C1157699',\n",
    "  'existing_cui_name': 'polyketide biosynthetic process',\n",
    "  'existing_cui_desc': '[CLS] p ##oly ##ket ##ide bio ##sy ##nt ##hetic process [unused3] ( B ##iol ##og ##ic Fun ##ction : p ##oly ##ket ##ide formation ; p ##oly ##ket ##ide an ##ab ##olis ##m ; p ##oly ##ket ##ide synthesis ; p ##oly ##ket ##ide bio ##sy ##nt ##hesis ) [SEP]',\n",
    "  'our_bi_cui': 'C0030956',\n",
    "  'our_bi_cui_name': 'Peptides',\n",
    "  'our_bi_cui_desc': '[CLS] P ##eptide ##s [unused3] ( Chemical , substance : p ##eptide ; p ##eptide ##s ; P ##eptide ##s [ Chemical / In ##g ##red ##ient ] ; P ##eptide ) [SEP]',\n",
    "  'our_cross_cui': 'C3179052',\n",
    "  'our_cross_cui_name': 'Polyketides',\n",
    "  'our_cross_cui_desc': '[CLS] Pol ##yke ##tide ##s [unused3] ( Chemical : Pol ##yke ##tide ##s [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
    " {'mention_id': '28457334.35',\n",
    "  'test_set_idx': 36645,\n",
    "  'type': 'T103',\n",
    "  'name': 'extracellular RNA',\n",
    "  'context': '[CLS] chain reaction . In addition , th ##rom ##boe ##last ##ography for co ##agu ##lation as well as th ##rom ##boa ##gg ##re ##go ##metry for plate ##let function was conducted . Both Cell - free DNA and extra ##cellular RNA were elevated in patients with se ##psis compared with post ##oper ##ative patients and healthy volunteers . While higher [unused1] extra ##cellular RNA [unused2] levels correlated with a faster c ##lot ##ting time and more stable c ##lot ##s , Cell - free DNA correlated with a shorter c ##lot ##ting time but also less fi ##bri ##no ##lysis . In addition , higher Cell - free DNA seems to be associated with kidney d ##ys ##function as well as with general markers of cell [SEP]',\n",
    "  'existing_cui': 'C0521119',\n",
    "  'existing_cui_name': 'Extracellular',\n",
    "  'existing_cui_desc': '[CLS] Extra ##cellular [unused3] ( Ana ##tom ##ical Structure , qualifier value : extra ##cellular ; extra ##cellular region ) [SEP]',\n",
    "  'our_bi_cui': 'C0230885',\n",
    "  'our_bi_cui_name': 'Extracellular material',\n",
    "  'our_bi_cui_desc': '[CLS] Extra ##cellular material [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0035668',\n",
    "  'our_cross_cui_name': 'RNA',\n",
    "  'our_cross_cui_desc': '[CLS] RNA [unused3] ( Chemical , RNA , R ##ib ##on ##uc ##le ##ic A ##cid , substance : rib ##on ##uc ##le ##ic acid ; R ##ib ##on ##uc ##le ##ic acids ; RNA , Non - Pol ##ya ##den ##yla ##ted ; rib ##on ##uc ##lein ##ic ##um acid ##um / rib ##on ; RNA - R ##ib ##on ##uc ##le ##ic acid ; RNA [ Chemical / In ##g ##red ##ient ] ; RNA , Non Pol ##ya ##den ##yla ##ted ; Non - Pol ##ya ##den ##yla ##ted RNA ; r ##na ; Non Pol ##ya ##den ##yla ##ted RNA ; A ##cid , R ##ib ##on ##uc ##le ##ic ; R ##ib ##on ##uc ##le ##ic acid ; Gene Products , RNA [SEP]'},\n",
    " {'mention_id': '27708411.23',\n",
    "  'test_set_idx': 14732,\n",
    "  'type': 'T103',\n",
    "  'name': 'dsDNA',\n",
    "  'context': '[CLS] ##rote ##in fi ##lam ##ent formation , is unable to media ##te ho ##mo ##log ##ous re ##comb ##ination . Mu ##tations of the C - terminal domain were evaluated using both single - and double stranded ( s ##s and d ##s ) substrates in re ##comb ##ination ass ##ays . Mu ##tations of critical amino acids affected either [unused1] d ##s ##D ##NA [unused2] re ##comb ##ination or both s ##s ##D ##NA and d ##s ##D ##NA re ##comb ##ination indicating two se ##par ##able functions , one of which is critical for d ##s ##D ##NA re ##comb ##ination and the second for re ##comb ##ination per se . As evaluated by co - im ##mu ##no ##p ##re ##ci ##pit ##ation [SEP]',\n",
    "  'existing_cui': 'C0012854',\n",
    "  'existing_cui_name': 'DNA',\n",
    "  'existing_cui_desc': '[CLS] DNA [unused3] ( Chemical , DNA , De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid , substance : d ##na molecules ; d ##s ##D ##NA ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; d ##na / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA molecule ; DNA - De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acids ; d ##na molecule ; DNA [ Chemical / In ##g ##red ##ient ] ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; Double - [SEP]',\n",
    "  'our_bi_cui': 'C0012854',\n",
    "  'our_bi_cui_name': 'DNA',\n",
    "  'our_bi_cui_desc': '[CLS] DNA [unused3] ( Chemical , DNA , De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid , substance : d ##na molecules ; d ##s ##D ##NA ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; d ##na / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA molecule ; DNA - De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acids ; d ##na molecule ; DNA [ Chemical / In ##g ##red ##ient ] ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; Double - [SEP]',\n",
    "  'our_cross_cui': 'C0311474',\n",
    "  'our_cross_cui_name': 'DNA , Double-Stranded',\n",
    "  'our_cross_cui_desc': '[CLS] DNA , Double - Strand ##ed [unused3] ( Chemical , substance : double stranded d ##na ; DNA , Double Strand ##ed ; Double - Strand ##ed DNA ; d ##s d ##na ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid double strand ; d ##s DNA ; d ##na double stranded ; d ##s - DNA ; d ##s - d ##na ; double strand d ##na ; double - stranded DNA ; DNA double strand ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid , double stranded ) [SEP]'},\n",
    " {'mention_id': '27798906.17',\n",
    "  'test_set_idx': 17537,\n",
    "  'type': 'T038',\n",
    "  'name': 'atrophy',\n",
    "  'context': '[CLS] . 4 months ( range = 24 . 0 - 123 . 0 months ) . Un ##iva ##ria ##te analysis showed that par ##ot ##id g ##land volumes receiving more than 5 , 10 , 15 , and 20 G ##y relative biological effectiveness ( V ##5 , V ##10 , V ##15 and V ##20 , respectively ) , mean dose , and maximum dose were significantly associated with par ##ot ##id g ##land at ##rop ##hy . Multi ##var ##iate analysis indicated that only V ##5 was significantly associated with [unused1] at ##rop ##hy [unused2] . Inc ##rea ##sing V ##5 was a significant risk factor for par ##ot ##id g ##land at ##rop ##hy after carbon ion radio ##ther ##ap ##y . [SEP]',\n",
    "  'existing_cui': 'C0026846',\n",
    "  'existing_cui_name': 'Muscular Atrophy',\n",
    "  'existing_cui_desc': '[CLS] Mu ##s ##cular At ##rop ##hy [unused3] ( B ##iol ##og ##ic Fun ##ction , Mu ##s ##cular , diagnosis , disorder , finding , physical finding : at ##rop ##hy ; muscle ; am ##yo ##tro ##phy ; muscle at ##rop ##hy was seen ; Was ##ting ; muscle ; At ##rop ##hi ##es , Mu ##s ##cle ; Mu ##s ##cle thin ##ning ; At ##rop ##hy - muscular ; am ##yo ##tro ##phi ##es ; muscular at ##rop ##hy ; Mu ##s ##cle wasting ; am ##yo ##tro ##phi ##a ; At ##rop ##hi ##es , Mu ##s ##cular ; muscular at ##rop ##hi ##es ; At ##rop ##hy muscle ; Mu ##s ##cle At ##rop ##hy ; Was ##ting ; muscles ; [SEP]',\n",
    "  'our_bi_cui': 'C0333641',\n",
    "  'our_bi_cui_name': 'Atrophic',\n",
    "  'our_bi_cui_desc': '[CLS] At ##rop ##hic [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : at ##rop ##hy ; At ##rop ##hy ; At ##rop ##hi ##es ; at ##rop ##hi ##es ; At ##rop ##hy [ Disease / Finding ] ; at ##rop ##hic ; at ##rop ##hy ##ing ; at ##rop ##hi ##ed ; AT ##RO ##P ##H ##Y ; At ##rop ##hy [ du ##p ] ) [SEP]',\n",
    "  'our_cross_cui': 'C0341045',\n",
    "  'our_cross_cui_name': 'Atrophy of parotid gland',\n",
    "  'our_cross_cui_desc': '[CLS] At ##rop ##hy of par ##ot ##id g ##land [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : at ##rop ##hy ; par ##ot ##id g ##land ) [SEP]'},\n",
    " {'mention_id': '28256742.21',\n",
    "  'test_set_idx': 30227,\n",
    "  'type': 'T082',\n",
    "  'name': 'Prince Edward Bay',\n",
    "  'context': '[CLS] ##s most frequently detected were pen ##ta ##ch ##lor ##o , he ##xa ##ch ##lor ##o , and he ##pta ##ch ##lor ##o con ##gene ##rs , which are structural ##ly similar to thy ##roid hormones . Pen ##ta ##ch ##lor ##op ##hen ##ol was detected at highest concentrations ( 1 . 8 ng / g ) in fish from [unused1] Prince Edward Bay [unused2] , the Bay of Q ##uin ##te Lake reference site , and Hill ##man Marsh ( the W ##heat ##ley Harbour reference site ) , suggesting local sources of contamination . El ##eva ##ted Pen ##ta ##ch ##lor ##op ##hen ##ol concentrations were also detected in the plasma of brown bull ##head from exposed sites in the Toronto and Region A [SEP]',\n",
    "  'existing_cui': 'C3828475',\n",
    "  'existing_cui_name': 'Prince Edward County , VA',\n",
    "  'existing_cui_desc': '[CLS] Prince Edward County , VA [unused3] ( Spa ##tial Concept : Prince Edward County ; Prince Edward County , Virginia ; VA ##14 ##7 ) [SEP]',\n",
    "  'our_bi_cui': 'C0033157',\n",
    "  'our_bi_cui_name': 'Prince Edward Island',\n",
    "  'our_bi_cui_desc': '[CLS] Prince Edward Island [unused3] ( Spa ##tial Concept , geographic location : Prince Edward island ; ed ##ward island prince ; prince ed ##ward island ) [SEP]',\n",
    "  'our_cross_cui': 'C3203003',\n",
    "  'our_cross_cui_name': 'Bay',\n",
    "  'our_cross_cui_desc': '[CLS] Bay [unused3] ( Spa ##tial Concept , geographic , geographic : Bay ##s ) [SEP]'},\n",
    " {'mention_id': '28249376.27',\n",
    "  'test_set_idx': 29897,\n",
    "  'type': 'T033',\n",
    "  'name': 'digestibility',\n",
    "  'context': '[CLS] in fist ##ulated sheep . Six sheep fitted with r ##umi ##nal fist ##ula ##s were used in a repeated measurement design with two 24 - d periods to investigate the effect of adding mixture of essential oils at 0 ( control ) , 0 . 8 , and 1 . 6 m ##L / d on apparent nut ##rient [unused1] dig ##est ##ibility [unused2] , r ##ume ##n f ##er ##mentation characteristics , r ##ume ##n micro ##bial population and blood chemical meta ##bol ##ites . Animals were fed with a 50 : 50 al ##fa ##lf ##a hay : concentrate diet . R ##umi ##nal pH , total volatile fatty acids concentration , m ##olar proportion of individual volatile fatty acids , ace ##tate [SEP]',\n",
    "  'existing_cui': 'C0233423',\n",
    "  'existing_cui_name': 'Suggestibility',\n",
    "  'existing_cui_desc': '[CLS] Su ##gg ##est ##ibility [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : suggest ##ibility ; Su ##gg ##est ##ibility , function ) [SEP]',\n",
    "  'our_bi_cui': 'C0012238',\n",
    "  'our_bi_cui_name': 'Digestion',\n",
    "  'our_bi_cui_desc': '[CLS] Digest ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : dig ##estive system functions ; dig ##est ##ion ; Digest ##ive system functions ; dig ##est ##ions ; Digest ##ive system function ; Fun ##ctions of the dig ##estive system ; Digest ##ive ; Digest ##ive tract function ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27977319.14',\n",
    "  'test_set_idx': 22766,\n",
    "  'type': 'T017',\n",
    "  'name': 'THI1',\n",
    "  'context': \"[CLS] is expressed in all organs , and the encoded protein cat ##aly ##zes th ##iam ##ine bio ##sy ##nt ##hesis . Loss of function produces ch ##lor ##osis , a typical th ##iam ##ine - deficiency p ##hen ##otype , and mortality . To investigate th ##iam ##ine ' s role in s ##ym ##bio ##sis , we focused on [unused1] T ##H ##I ##1 [unused2] , a th ##iam ##ine - bio ##sy ##nt ##hesis gene expressed in roots , nod ##ules , and seeds . The th ##i ##1 mutant had green leaves , but formed small nod ##ules and im ##mat ##ure seeds . These p ##hen ##otype ##s were rescued by T ##H ##I ##1 complement ##ation and by ex ##ogen ##ous [SEP]\",\n",
    "  'existing_cui': 'C0272238',\n",
    "  'existing_cui_name': 'Transient hypogammaglobulinemia of infancy',\n",
    "  'existing_cui_desc': '[CLS] Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of young ; trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy ; T ##H ##I - Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia of infancy ; h ##y ##po ##gam ##ma ##g ##lo ##bul ##ine ##mia trans ##ient of infancy ; I ##mm ##uno ##g ##lo ##bul ##in mat ##uration ##al delay ; T ##H ##I - Trans ##ient h ##y ##po ##gam ##ma ##g ##lo ##bul ##inae ##mia of infancy ; Trans ##ient H ##y [SEP]',\n",
    "  'our_bi_cui': 'C1420871',\n",
    "  'our_bi_cui_name': 'TPI1 gene',\n",
    "  'our_bi_cui_desc': '[CLS] T ##PI ##1 gene [unused3] ( Ana ##tom ##ical Structure : T ##RI ##OS ##EP ##H ##OS ##P ##HA ##TE ISO ##ME ##RA ##SE 1 ; T ##PI ##1 Gene ; Trio ##se ##ph ##os ##phate Is ##omer ##ase 1 Gene ; T ##PI ; trio ##se ##ph ##os ##phate is ##omer ##ase 1 ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '28223077.53',\n",
    "  'test_set_idx': 28937,\n",
    "  'type': 'T082',\n",
    "  'name': 'background site',\n",
    "  'context': '[CLS] that of up ##wind site , suggesting that studied land ##fill did not have obvious influence on PC ##D ##D / F ##s in ambient air from down ##wind site . ( 5 ) The 95 ##th percent ##ile car ##cin ##ogenic risk of PC ##D ##D / F ##s in ambient air from s u ##rro ##und ##ing sites , [unused1] background site [unused2] , up ##wind site and down ##wind site were 8 . 03 × 10 ( - 9 ) , 7 . 57 × 10 ( - 9 ) , 9 . 69 × 10 ( - 9 ) and 8 . 15 × 10 ( - 9 ) , respectively , which were much lower than the threshold value of car [SEP]',\n",
    "  'existing_cui': 'C0237490',\n",
    "  'existing_cui_name': 'Family Background',\n",
    "  'existing_cui_desc': '[CLS] Family Background [unused3] ( Finding , Family : Background ) [SEP]',\n",
    "  'our_bi_cui': 'C0442611',\n",
    "  'our_bi_cui_name': 'Industrial site',\n",
    "  'our_bi_cui_desc': '[CLS] Industrial site [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
    "  'our_cross_cui': 'C0205145',\n",
    "  'our_cross_cui_name': 'Site',\n",
    "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
    " {'mention_id': '27395231.31',\n",
    "  'test_set_idx': 4600,\n",
    "  'type': 'T017',\n",
    "  'name': 'shape of body',\n",
    "  'context': '[CLS] n . ( Dr ##acon ##ema ##ti ##dae ) differs from other Pro ##cha ##eto ##so ##ma species except P . long ##ica ##pit ##at ##um ( All ##gé ##n , 1935 ) in that the p ##har ##yn ##ge ##al bulb l ##ume ##n is not cut ##icular ##ised , from P . long ##ica ##pit ##at ##um by [unused1] shape of body [unused2] and r ##ost ##rum , greater number of c ##ep ##hali ##c ad ##hesive tubes , and from P . ma ##ert ##ens ##i Dec ##rae ##mer , 1989 by having a relatively longer tail , fewer anterior ad ##hesive tubes and longer s ##pic ##ules , besides lacking cut ##icular thick ##ening in the p ##har ##yn ##ge ##al bulb [SEP]',\n",
    "  'existing_cui': 'C0423805',\n",
    "  'existing_cui_name': 'Shape of nail',\n",
    "  'existing_cui_desc': '[CLS] S ##ha ##pe of nail [unused3] ( Finding , o ##bs ##er ##vable entity : nails shaped ; nails shape ; shape of nail ) [SEP]',\n",
    "  'our_bi_cui': 'C0332479',\n",
    "  'our_bi_cui_name': 'Shapes',\n",
    "  'our_bi_cui_desc': '[CLS] S ##ha ##pes [unused3] ( Spa ##tial Concept , qualifier value : shapes ; shaping ; SH ##AP ##E ; shaped ; shape ; S ##ha ##pe ; S ##ha ##pe finding ) [SEP]',\n",
    "  'our_cross_cui': 'C1268086',\n",
    "  'our_cross_cui_name': 'Body structure',\n",
    "  'our_cross_cui_desc': '[CLS] Body structure [unused3] ( Ana ##tom ##ical Structure , body structure : B ##OD ##Y ST ##R ##UC ##TU ##RE ##S ; Body structures ; B ##OD ##Y ; structure body ; body structures ; Body ; body structure ) [SEP]'},\n",
    " {'mention_id': '27400734.20',\n",
    "  'test_set_idx': 4724,\n",
    "  'type': 'T103',\n",
    "  'name': 'GEM',\n",
    "  'context': '[CLS] A random ##ized clinical trial has found that the addition of er ##lot ##ini ##b to g ##em ##ci ##ta ##bine ( GE ##M - E ) for pan ##cre ##atic cancer led to a modest increase in survival . The aim of this national population - based retrospective study was to compare the effectiveness of GE ##M - E to [unused1] GE ##M [unused2] alone for pan ##cre ##atic cancer patients in real clinical practice . Pat ##ients with pan ##cre ##atic cancer ( I ##CD - 10 : C ##25 ) with prescription claims of g ##em ##ci ##ta ##bine or er ##lot ##ini ##b between Jan 1 , 2007 and Dec 31 , 2012 were retrospective ##ly identified from the Korean Health Insurance [SEP]',\n",
    "  'existing_cui': 'C1333683',\n",
    "  'existing_cui_name': 'GMNN gene',\n",
    "  'existing_cui_desc': '[CLS] GM ##N ##N gene [unused3] ( Ana ##tom ##ical Structure : Gemini ##n , DNA Rep ##lication In ##hibit ##or Gene ; GM ##N ##N Gene ; G ##em ; GE ##MI ##NI ##N ; g ##em ##ini ##n , DNA replication inhibitor ; GE ##M ) [SEP]',\n",
    "  'our_bi_cui': 'C0017243',\n",
    "  'our_bi_cui_name': 'Gel',\n",
    "  'our_bi_cui_desc': '[CLS] G ##el [unused3] ( Chemical , Pharmacy , product , qualifier value , substance : G ##el Do ##se Form ; G ##els ; j ##elly ; j ##elli ##es ; Je ##lly ; drugs gel ; G ##el preparation ; G ##el Do ##sa ##ge Form ; GE ##L ; gel ##s ; gel preparation ; G ##el [ Do ##se Form ] ; G ##el ##D ##rug ##F ##orm ; gel ; Drug gel ) [SEP]',\n",
    "  'our_cross_cui': 'C0045093',\n",
    "  'our_cross_cui_name': 'gemcitabine',\n",
    "  'our_cross_cui_desc': \"[CLS] g ##em ##ci ##ta ##bine [unused3] ( Chemical , product , substance : g ##em ##ci ##ta ##bine [ Chemical / In ##g ##red ##ient ] ; 2 ' , 2 ' - di ##f ##lu ##oro ##de ##ox ##y ##cy ##ti ##dine ; 4 - amino - 1 - ( ( 2 ##R , 4 ##R , 5 ##R ) - 3 , 3 - Di ##f ##lu ##oro - 4 - h ##ydro ##xy - 5 - ( h ##ydro ##xy ##met ##hyl ) - te ##tra ##hy ##dr ##of ##ura ##n - 2 - y ##l ) p ##yr ##im ##id ##in - 2 ( 1 ##H ) - one ; 2 ' , 2 ' - Di ##f ##lu ##oro ##de ##ox [SEP]\"},\n",
    " {'mention_id': '27796974.2',\n",
    "  'test_set_idx': 17356,\n",
    "  'type': 'T170',\n",
    "  'name': 'Water Framework Directive',\n",
    "  'context': '[CLS] Method ##ology development on aquatic environmental assessment The [unused1] Water Framework Direct ##ive [unused2] aims at reaching the good ecological status of the surface and ground water bodies ( L ##ás ##z ##l ##ó et al . Micro ##che ##m J 85 ( 1 ) : 65 - 71 , 2007 ) . The paper deals with quality evaluation of waters with special focus on the water chemistry parameters as defined in the Water Framework Direct ##ive and pertaining legal regulations . The purpose of this paper is to de ##vise a quantitative type of water quality assessment method which could provide rapid , accurate , and reliable information on the quality of the surface waters by using water chemistry parameters . Quality classes have been [SEP]',\n",
    "  'existing_cui': 'C0450152',\n",
    "  'existing_cui_name': 'Metal framework',\n",
    "  'existing_cui_desc': '[CLS] Metal framework [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
    "  'our_bi_cui': 'C1135941',\n",
    "  'our_bi_cui_name': 'Ethical Directives',\n",
    "  'our_bi_cui_desc': '[CLS] E ##thical Direct ##ives [unused3] ( Intel ##lect ##ual Product : Direct ##ive , E ##thical ; Direct ##ives , E ##thical ; E ##thical Direct ##ive ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27539945.4',\n",
    "  'test_set_idx': 9829,\n",
    "  'type': 'T103',\n",
    "  'name': 'alkyldimethylamine oxide',\n",
    "  'context': '[CLS] The ##rm ##o - re ##versible capture and release of DNA by z ##wi ##tter ##ion ##ic surf ##act ##ants The the ##rm ##o - re ##versible capture and release of DNA were studied by the pro ##ton ##ation and de ##p ##rot ##ona ##tion of [unused1] al ##ky ##ld ##ime ##thy ##lam ##ine oxide [unused2] ( C ##n ##DM ##A ##O , n = 10 , 12 and 14 ) in Tri ##s - HC ##l buffer solution . DNA / C ##14 ##DM ##A ##OH ( + ) in Tri ##s - HC ##l buffer solution with pH = 7 . 2 is transparent at 25 °C , indicating that DNA molecules exist mainly in individuals and the binding of C ##14 ##DM ##A [SEP]',\n",
    "  'existing_cui': 'C1869399',\n",
    "  'existing_cui_name': 'hexyldimethylamine oxide',\n",
    "  'existing_cui_desc': '[CLS] he ##xy ##ld ##ime ##thy ##lam ##ine oxide [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0058638',\n",
    "  'our_bi_cui_name': 'dodecyldimethylamine oxide',\n",
    "  'our_bi_cui_desc': '[CLS] do ##de ##cy ##ld ##ime ##thy ##lam ##ine oxide [unused3] ( Chemical : DD ##A ##O ; N , N - dim ##eth ##yl ##do ##de ##cy ##c ##lam ##ine N - oxide ; do ##de ##cy ##ld ##ime ##thy ##lam ##ine N - oxide ; L ##DA ##O ; N - do ##de ##cy ##l - N , N - dim ##eth ##yla ##mine N - oxide ; la ##ury ##ld ##ime ##thy ##lam ##ine oxide ; N , N - dim ##eth ##yl ##do ##de ##cy ##lam ##ine - N - oxide ) [SEP]',\n",
    "  'our_cross_cui': 'C0029224',\n",
    "  'our_cross_cui_name': 'Organic Chemicals',\n",
    "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
    " {'mention_id': '28454015.21',\n",
    "  'test_set_idx': 36522,\n",
    "  'type': 'T170',\n",
    "  'name': 'health - risk based air quality index',\n",
    "  'context': '[CLS] , but oz ##one pollution can be significant during summer . Furthermore , as the commonly used air quality index neglect ##s the mutual health effects from multiple poll ##uta ##nts , we introduced the aggregate air quality index and health - risk based air quality index to evaluate the health risks . Results show that based on [unused1] health - risk based air quality index [unused2] , the current air quality index system likely significantly under ##est ##imate the health risks of air pollution , highlighting that the general public may need strict ##er health protection measures . The population - weighted two - year average health - risk based air quality index data further demonstrates that all population in the studied cities in He [SEP]',\n",
    "  'existing_cui': 'C1268941',\n",
    "  'existing_cui_name': 'Health risks education',\n",
    "  'existing_cui_desc': '[CLS] Health risks education [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Counsel ##ing regarding health risks ; Ad ##vice about health risks ; Counsel ##ling regarding health risks ; Education regarding health risks ) [SEP]',\n",
    "  'our_bi_cui': 'C3494320',\n",
    "  'our_bi_cui_name': 'Health Impact Assessment',\n",
    "  'our_bi_cui_desc': '[CLS] Health Impact Assessment [unused3] ( Health Care Act ##ivity : Impact Assessment ##s , Health ; Impact Assessment , Health ; Health Impact Assessment ##s ; Assessment ##s , Health Impact ; Assessment , Health Impact ) [SEP]',\n",
    "  'our_cross_cui': 'C0918012',\n",
    "  'our_cross_cui_name': 'Index',\n",
    "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
    " {'mention_id': '28385178.27',\n",
    "  'test_set_idx': 33778,\n",
    "  'type': 'T092',\n",
    "  'name': 'Kenyatta National',\n",
    "  'context': '[CLS] to describe injury e ##pid ##em ##iology and care . The objective of this study was to investigate the e ##pid ##em ##iology and outcomes of injuries at 4 refer ##ral hospitals in Kenya using hospital - based trauma re ##gis ##tries . From January 2014 to May 2015 , all injured patients presenting to the casual ##ty departments of [unused1] Kenya ##tta National [unused2] , T ##hi ##ka Level 5 , Mac ##hak ##os Level 5 , and Me ##ru Level 5 Hospital ##s were enrolled prospective ##ly . Data collected included demographic characteristics , type of pre ##hos ##pit ##al care received , pre ##hos ##pit ##al time , injury pattern , and outcomes . A total of 14 , 237 patients were enrolled [SEP]',\n",
    "  'existing_cui': 'C0015737',\n",
    "  'existing_cui_name': 'Federal Government',\n",
    "  'existing_cui_desc': '[CLS] Federal Government [unused3] ( Organization : federal government ; Government , Federal ; National Government ; Federal government ; National ) [SEP]',\n",
    "  'our_bi_cui': 'C0017446',\n",
    "  'our_bi_cui_name': 'Geographic Locations',\n",
    "  'our_bi_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]',\n",
    "  'our_cross_cui': 'C0019994',\n",
    "  'our_cross_cui_name': 'Hospitals',\n",
    "  'our_cross_cui_desc': '[CLS] Hospital ##s [unused3] ( Organization , environment : H ##OS ##P ; hospital ; Hospital ; hospital environment ; In Hospital ; H ##OS ##PI ##TA ##L ; hospitals ) [SEP]'},\n",
    " {'mention_id': '28390176.32',\n",
    "  'test_set_idx': 34122,\n",
    "  'type': 'T033',\n",
    "  'name': 'inhibitory effect',\n",
    "  'context': '[CLS] ##ora ##ted of s ##ys ##to ##lic and di ##ast ##olic abnormal ##ities , normal ##ized in gene expression of h ##yper ##tro ##phic and fi ##bro ##tic markers , reserved micro ##vas ##cular density in pressure over ##load induced h ##yper ##tro ##phic mice . C ##uc ##ur ##bit ##ac ##in B also showed significant h ##yper ##tro ##phy [unused1] inhibitor ##y effect [unused2] in p ##hen ##yle ##ph ##rine stimulate ##d card ##io ##my ##ocytes . The C ##uc ##ur ##bit ##ac ##in B - mediated mit ##igate ##d cardiac h ##yper ##tro ##phy was at ##tri ##but ##able to the increasing level of auto ##pha ##gy , which was associated with the blockade of A ##kt / m ##TO ##R / Fox ##O [SEP]',\n",
    "  'existing_cui': 'C1708997',\n",
    "  'existing_cui_name': 'Metastatic Inhibitory Effect',\n",
    "  'existing_cui_desc': '[CLS] Met ##ast ##atic In ##hibit ##ory Effect [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_bi_cui': 'C0021469',\n",
    "  'our_bi_cui_name': 'Metabolic Inhibition',\n",
    "  'our_bi_cui_desc': '[CLS] Met ##ab ##olic In ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : In ##hibition ; In ##hibition , function ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27526663.6',\n",
    "  'test_set_idx': 9446,\n",
    "  'type': 'T033',\n",
    "  'name': 'necrotrophic',\n",
    "  'context': '[CLS] Different ##ial control and function of Arab ##ido ##psis Pro ##D ##H1 and Pro ##D ##H ##2 genes on infection with bio ##tro ##phic and [unused1] ne ##c ##rot ##rop ##hic [unused2] path ##ogen ##s Arab ##ido ##psis contains two pro ##line de ##hy ##dr ##ogen ##ase genes , Pro ##D ##H1 and Pro ##D ##H ##2 , encoding for ho ##mo ##log ##ous and functional is ##oe ##nz ##yme ##s . Although Pro ##D ##H1 has been studied extensively , especially under a ##biotic stress , Pro ##D ##H ##2 has only started to be anal ##ys ##ed in recent years . These genes display distinctive expression patterns and show weak transcription ##al co - regulation , but are both activated in path ##ogen - [SEP]',\n",
    "  'existing_cui': 'C4084801',\n",
    "  'existing_cui_name': 'Prostate Health Index',\n",
    "  'existing_cui_desc': '[CLS] Pro ##state Health Index [unused3] ( Health Care Act ##ivity : p ##hi - index ) [SEP]',\n",
    "  'our_bi_cui': 'C0027540',\n",
    "  'our_bi_cui_name': 'Necrosis',\n",
    "  'our_bi_cui_desc': '[CLS] N ##ec ##rosis [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity , qualifier value : T ##iss ##ue de ##vi ##tal ##isation ; T ##iss ##ue de ##vi ##tal ##ization ; ne ##c ##rot ##ic cell death ; N ##ec ##rose ##s ; tissue death ; NE ##CR ##OS ##IS ; ne ##c ##rot ##ic ; obsolete tissue death ; Cell ##ular ne ##c ##rosis ; N ##ec ##rot ##ic Process ; cellular ne ##c ##rosis ; ne ##c ##rosis ; N ##ec ##rosis [ Disease / Finding ] ; obsolete ne ##c ##rosis ; N ##ec ##rot ##ic ; death tissue ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27689491.25',\n",
    "  'test_set_idx': 14253,\n",
    "  'type': 'T033',\n",
    "  'name': 'no',\n",
    "  'context': '[CLS] ratio = 0 . 89 ; 95 % confidence interval = 0 . 45 , 1 . 77 ) , or for sex with no effective means of birth control ( Louisiana , adjusted odds ratio = 1 . 18 ; 95 % confidence interval = 0 . 78 , 1 . 78 ; Rochester , adjusted odds ratio = 0 . 41 ; 95 % confidence interval = 0 . 13 , 1 . 27 ) after controlling for relevant co ##var ##iate ##s . We found [unused1] no [unused2] short - term effects for the offer of the intervention . Research might be needed for the long - term and intermediate impacts of youth development programs on these and other adolescent risk behaviors . [SEP]',\n",
    "  'existing_cui': 'C1140150',\n",
    "  'existing_cui_name': 'NOC - CodeSystem',\n",
    "  'existing_cui_desc': '[CLS] NO ##C - Code ##S ##ys ##tem [unused3] ( Intel ##lect ##ual Product , NO ##C : nursing outcomes classification ) [SEP]',\n",
    "  'our_bi_cui': 'C0205160',\n",
    "  'our_bi_cui_name': 'Negative',\n",
    "  'our_bi_cui_desc': '[CLS] N ##eg ##ative [unused3] ( Finding , qualifier value : Rule ##d out ; N ##eg ##ative ( m ##od ##ifier ) [ Am ##bi ##guous ] ; N ##eg ##ative for ; N ##eg ##ative ( m ##od ##ifier ) ; ruled out ; for negative ; out ruled ; negative ; negative ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C1513916',\n",
    "  'our_cross_cui_name': 'Negative Finding',\n",
    "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
    " {'mention_id': '27260627.19',\n",
    "  'test_set_idx': 989,\n",
    "  'type': 'T170',\n",
    "  'name': 'breast module BR-23',\n",
    "  'context': \"[CLS] its association with women ' s personal characteristics and cancer treatments . In this cross - section ##al study , sexual function was assessed using the Female Sexual Fun ##ction Index . The health - related quality of life was measured using the European Organization for Research and Treatment of Cancer Q ##L ##Q - C ##30 and its [unused1] breast module BR - 23 [unused2] . Of the 235 participants approached , 216 participants were included in the study . Of these , 63 patients reported no sexual activity in the last month and thus were analyzed only in relation to the sexual desire domain of Female Sexual Fun ##ction Index . A total of 154 ( 71 . 3 % ) patients were classified [SEP]\",\n",
    "  'existing_cui': 'C3542953',\n",
    "  'existing_cui_name': 'Module',\n",
    "  'existing_cui_desc': '[CLS] Mo ##du ##le [unused3] ( Intel ##lect ##ual Product , core meta ##data concept , core meta ##data concept ) [SEP]',\n",
    "  'our_bi_cui': 'C1511299',\n",
    "  'our_bi_cui_name': 'Breast Cancer Surveillance Consortium',\n",
    "  'our_bi_cui_desc': '[CLS] B ##rea ##st Cancer Sur ##ve ##illa ##nce Consortium [unused3] ( Professional or O ##cc ##upation ##al Group ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27886280.71',\n",
    "  'test_set_idx': 20783,\n",
    "  'type': 'T007',\n",
    "  'name': 'exponential and stationary planktonic cells',\n",
    "  'context': '[CLS] C ##ip ##ro ##f ##lo ##xa ##cin ( F ##lu ##oro ##quin ##olo ##ne ) at a low concentration resulted in killing of both cultures of P . a ##er ##ug ##ino ##sa , producing per ##sist ##ers that were in ##vu ##ln ##era ##ble to killing . Station ##ary cells appear to be somewhat more tolerant than ex ##po ##nent ##ial cells in all of these ass ##ays . We also showed that nut ##rient de ##p ##ri ##vation ( se ##rine starvation ) regulated by string ##ent and general stress response , contribute to the increased tolerance of P . a ##er ##ug ##ino ##sa [unused1] ex ##po ##nent ##ial and stationary plan ##kt ##onic cells [unused2] via production of per ##sist ##ers . [SEP]',\n",
    "  'existing_cui': 'C3839460',\n",
    "  'existing_cui_name': 'Nonprogressive',\n",
    "  'existing_cui_desc': '[CLS] Non ##p ##rog ##ress ##ive [unused3] ( Finding , qualifier value : Non ##p ##rog ##ress ##ive course ; Station ##ary ; Non ##p ##rog ##ress ##ive disorder ; Non - progressive ) [SEP]',\n",
    "  'our_bi_cui': 'C0007634',\n",
    "  'our_bi_cui_name': 'Cells',\n",
    "  'our_bi_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]',\n",
    "  'our_cross_cui': 'C0563199',\n",
    "  'our_cross_cui_name': 'Bacterial cell',\n",
    "  'our_cross_cui_desc': '[CLS] Ba ##cter ##ial cell [unused3] ( Ba ##cter ##ium , organism : bacterial cell ; cell bacterial ) [SEP]'},\n",
    " {'mention_id': '28077286.55',\n",
    "  'test_set_idx': 25105,\n",
    "  'type': 'T103',\n",
    "  'name': 'MeHg',\n",
    "  'context': '[CLS] Me ##H ##g dose of 3 . 2 μ ##g H ##g g ( - 1 ) egg , and a vehicle control ( water ) . No adverse effects of in o ##vo Me ##H ##g treatment were detected on courts ##hip song quality or on mating behavior in experimental males at sexually maturity which would suggest that o ##bs ##er ##vable ne ##uro ##be ##ha ##vior ##al effects of Me ##H ##g exposure may depend on the timing of exposure during offspring development . However , ne ##uro ##ana ##tom ##ical analysis indicated an increase in te ##len ##ce ##pha ##lon volume with increased [unused1] Me ##H ##g [unused2] concentrations which may suggest a prolonged inflammatory response in this region of the brain . [SEP]',\n",
    "  'existing_cui': 'C0228520',\n",
    "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
    "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
    "  'our_bi_cui': 'C0025424',\n",
    "  'our_bi_cui_name': 'Mercury',\n",
    "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
    "  'our_cross_cui': 'C0025794',\n",
    "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
    "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
    " {'mention_id': '27603112.45',\n",
    "  'test_set_idx': 11387,\n",
    "  'type': 'T103',\n",
    "  'name': 'YKoF',\n",
    "  'context': '[CLS] compounds were found to bind the EC ##F - type ABC transport ##er , but none binds stab ##ly to p ##rion protein . For the rib ##os ##witch , most compounds remained in their binding pockets during 50 n ##s of molecular dynamics simulation , indicating that RNA provides a pro ##mis ##cu ##ous binding site . In both [unused1] Y ##K ##o ##F [unused2] and th ##iam ##in p ##yr ##op ##hos ##ph ##oki ##nas ##e , most compounds remain tightly bound . However , th ##iam ##in p ##yr ##op ##hos ##ph ##oki ##nas ##e bio ##mo ##le ##cule ##s undergo poll ##uta ##nt - induced conform ##ational changes . Although most compounds are found to bind to some of these targets , [SEP]',\n",
    "  'existing_cui': 'C1424135',\n",
    "  'existing_cui_name': 'YAP1 gene',\n",
    "  'existing_cui_desc': '[CLS] Y ##AP ##1 gene [unused3] ( Ana ##tom ##ical Structure : Yes - Associated Pro ##tein 1 Gene ; Yes associated protein 1 ; Y ##AP ##65 ; Y ##OR ##K ##IE , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; Y ##AP ##1 Gene ; Y ##ES - AS ##SO ##CI ##AT ##ED PR ##OT ##EI ##N 1 , 65 - K ##D ; Y ##AP ##2 ) [SEP]',\n",
    "  'our_bi_cui': 'C0060764',\n",
    "  'our_bi_cui_name': 'FRUCTOKINASE',\n",
    "  'our_bi_cui_desc': '[CLS] F ##R ##UC ##TO ##K ##IN ##AS ##E [unused3] ( Chemical , substance : f ##ru ##ct ##oki ##nas ##e ; D - f ##ru ##ct ##oki ##nas ##e ; ATP - D - f ##ru ##ct ##ose 6 - p ##hos ##ph ##ot ##ran ##s ##fer ##ase ; s ##c ##r ##K protein ; Fr ##uc ##tok ##inas ##e ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27572277.25',\n",
    "  'test_set_idx': 10541,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedures',\n",
    "  'context': '[CLS] ; s ##ham - operated fed ad l ##ibi ##tum ; and sleeve gas ##tre ##ct ##omy . The metabolic effects and gut micro ##bio ##ta profile were analyzed 10 weeks post ##oper ##ative ##ly . Association ##s between disc ##rim ##inating genera and metabolic markers after R ##oux - en - Y gas ##tric bypass were explored . The 2 [unused1] procedures [unused2] induced similar glucose improvement and increased flora diversity after 10 weeks compared with s ##ham - operated groups . R ##oux - en - Y gas ##tric bypass induced a marked higher relative abundance of Pro ##te ##ob ##act ##eria / Gamma ##p ##rote ##ob ##act ##eria and Beta ##p ##rote ##ob ##act ##eria and increased emergence of Fu ##so ##ba ##cter [SEP]',\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '28457334.29',\n",
    "  'test_set_idx': 36639,\n",
    "  'type': 'T058',\n",
    "  'name': 'thromboaggregometry',\n",
    "  'context': '[CLS] at se ##psis onset and after surgery respectively , as well as after 24 , 72 and 168 h . Level ##s of Cell - free DNA and extra ##cellular RNA were measured by quantitative probe - based polymer ##ase chain reaction . In addition , th ##rom ##boe ##last ##ography for co ##agu ##lation as well as [unused1] th ##rom ##boa ##gg ##re ##go ##metry [unused2] for plate ##let function was conducted . Both Cell - free DNA and extra ##cellular RNA were elevated in patients with se ##psis compared with post ##oper ##ative patients and healthy volunteers . While higher extra ##cellular RNA levels correlated with a faster c ##lot ##ting time and more stable c ##lot ##s , Cell - free DNA correlated [SEP]',\n",
    "  'existing_cui': 'C0920267',\n",
    "  'existing_cui_name': 'Platelet aggregation measurement',\n",
    "  'existing_cui_desc': '[CLS] Plate ##let a ##gg ##regation measurement [unused3] ( Health Care Act ##ivity , lab test , procedure , qualifier value : P ##LA ##TA ##G ##GR ; A ##gg ##re ##go ##meter test ; Plate ##let A ##gg ##regation Me ##as ##ure ##ment ; Plate ##let a ##gg ##regation test ; Plate ##let a ##gg ##r ; Plate ##let A ##gg ##regation ; plate ##let a ##gg ##regation tests ; Plate ##let a ##gg ##regation ; Plate ##let a ##gg ##regation ass ##ay ; plate ##let a ##gg ##regation ; plate ##let a ##gg ##regation test ; Plate ##let Fun ##ction ; Plate ##let A ##gg ##regation Test ) [SEP]',\n",
    "  'our_bi_cui': 'C0920267',\n",
    "  'our_bi_cui_name': 'Platelet aggregation measurement',\n",
    "  'our_bi_cui_desc': '[CLS] Plate ##let a ##gg ##regation measurement [unused3] ( Health Care Act ##ivity , lab test , procedure , qualifier value : P ##LA ##TA ##G ##GR ; A ##gg ##re ##go ##meter test ; Plate ##let A ##gg ##regation Me ##as ##ure ##ment ; Plate ##let a ##gg ##regation test ; Plate ##let a ##gg ##r ; Plate ##let A ##gg ##regation ; plate ##let a ##gg ##regation tests ; Plate ##let a ##gg ##regation ; Plate ##let a ##gg ##regation ass ##ay ; plate ##let a ##gg ##regation ; plate ##let a ##gg ##regation test ; Plate ##let Fun ##ction ; Plate ##let A ##gg ##regation Test ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '27838742.55',\n",
    "  'test_set_idx': 19022,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] ##R , and p ##hos ##ph ##o - p ##70 ##S ##6 ##K in a time - and dose - dependent manner , suggesting that it induced auto ##pha ##gy by in ##hibit ##ing the A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K pathway in A ##5 ##4 ##9 and PC - 9 cells . [unused1] Del ##ica ##f ##lav ##one [unused2] is a potential anti ##can ##cer agent that can induce auto ##pha ##gic cell death in human non - small cell lung cancer via the A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28256742.8',\n",
    "  'test_set_idx': 30214,\n",
    "  'type': 'T082',\n",
    "  'name': 'Canadian Areas',\n",
    "  'context': '[CLS] Hal ##ogen ##ated p ##hen ##olic compounds in wild fish from Canadian Areas of Con ##cer ##n Con ##cent ##rations of ha ##log ##ena ##ted p ##hen ##olic compounds were measured in the plasma of brown bull ##head ( Am ##ei ##urus ne ##bul ##os ##us ) from 4 [unused1] Canadian Areas [unused2] of Con ##cer ##n ( A ##OC ##s ) , to assess exposure to suspected thy ##roid - disrupt ##ing chemicals . H ##ydro ##xy ##lated p ##oly ##ch ##lor ##inated bi ##phe ##ny ##ls ( OH - PC ##B ##s ) were detected in every sample collected in 3 of the A ##OC ##s ; the detection frequency was lower in samples from the Detroit River A ##OC . The OH - [SEP]',\n",
    "  'existing_cui': 'C3831211',\n",
    "  'existing_cui_name': 'Canadian County , OK',\n",
    "  'existing_cui_desc': '[CLS] Canadian County , OK [unused3] ( Spa ##tial Concept : Canadian County , Oklahoma ; OK ##01 ##7 ; Canadian County ) [SEP]',\n",
    "  'our_bi_cui': 'C0454980',\n",
    "  'our_bi_cui_name': 'Region of Canada',\n",
    "  'our_bi_cui_desc': '[CLS] Region of Canada [unused3] ( Spa ##tial Concept , geographic location : Province or Territory of Canada ; Provinces and territories of Canada ; Region ##s of Canada ) [SEP]',\n",
    "  'our_cross_cui': 'C0006823',\n",
    "  'our_cross_cui_name': 'Canada',\n",
    "  'our_cross_cui_desc': '[CLS] Canada [unused3] ( Spa ##tial Concept , geographic location : CA ##N ; CA ##NA ##DA ; CA ) [SEP]'},\n",
    " {'mention_id': '27472389.38',\n",
    "  'test_set_idx': 7179,\n",
    "  'type': 'T103',\n",
    "  'name': 'signal transducer and activator of transcription 1 inhibitor',\n",
    "  'context': '[CLS] . In contrast , ACT ##A ##2 expression was decreased by H ##ER ##2 si ##RNA . Next , we investigated the co - relation between signal trans ##du ##cer and act ##iva ##tor of transcription 1 and ACT ##A ##2 expression . Ba ##sal ACT ##A ##2 expression was significantly decreased by treatment with the [unused1] signal trans ##du ##cer and act ##iva ##tor of transcription 1 inhibitor [unused2] flu ##dar ##abi ##ne or the J ##A ##K ##2 inhibitor AG ##4 ##90 . In contrast , ACT ##A ##2 expression was increased by signal trans ##du ##cer and act ##iva ##tor of transcription 1 over ##ex ##press ##ion . Level ##s of ACT ##A ##2 , signal trans ##du ##cer and act ##iva ##tor [SEP]',\n",
    "  'existing_cui': 'C1335872',\n",
    "  'existing_cui_name': 'STAT1 gene',\n",
    "  'existing_cui_desc': '[CLS] ST ##AT ##1 gene [unused3] ( Ana ##tom ##ical Structure : Signal Trans ##du ##cer and Act ##iva ##tor of Trans ##cription 1 , 91 ##k ##D ##a Gene ; ST ##AT ##1 Gene ; transcription factor IS ##G ##F - 3 components p ##9 ##1 / p ##8 ##4 ; signal trans ##du ##cer and act ##iva ##tor of transcription 1 ; ST ##AT ##9 ##1 ; IS ##G ##F - 3 ; S ##IG ##NA ##L T ##RA ##NS ##D ##UC ##ER AND ACT ##I ##VA ##TO ##R OF T ##RA ##NS ##CR ##IP ##TI ##ON 1 ) [SEP]',\n",
    "  'our_bi_cui': 'C1519313',\n",
    "  'our_bi_cui_name': 'Signal Transduction Inhibitor',\n",
    "  'our_bi_cui_desc': '[CLS] Signal Trans ##duction In ##hibit ##or [unused3] ( Chemical : signal trans ##duction inhibitor ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27902303.1',\n",
    "  'test_set_idx': 21293,\n",
    "  'type': 'T007',\n",
    "  'name': 'Arthrobacter ginkgonis sp . nov.',\n",
    "  'context': '[CLS] [unused1] Art ##hr ##ob ##act ##er g ##ink ##gon ##is s ##p . no ##v . [unused2] , an act ##ino ##my ##ce ##te isolated from r ##hi ##zo ##sp ##here of G ##ink ##go bi ##lo ##ba L A Gram - stain - positive , a ##ero ##bic act ##ino ##ba ##cter ##ial strain ( designated S ##YP - A ##7 ##29 ##9 ##T ) , which displayed a rod - co ##cc ##us growth life ##cycle , was isolated from the r ##hi ##zo ##sp ##here of G ##ink ##go bi ##lo ##ba L . Ph ##yl ##ogen ##etic analyses based on 16 ##S r ##RNA gene sequences indicated that strain S ##YP - A ##7 ##29 ##9 ##T belongs to the genus Art [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C1197674',\n",
    "  'our_bi_cui_name': 'Arthrobacter gandavensis',\n",
    "  'our_bi_cui_desc': '[CLS] Art ##hr ##ob ##act ##er g ##anda ##ven ##sis [unused3] ( Ba ##cter ##ium , organism : Art ##hr ##ob ##act ##er g ##and ##ensis ; Art ##hr ##ob ##act ##er g ##anda ##ven ##sis Storm ##s et al . 2003 ) [SEP]',\n",
    "  'our_cross_cui': 'C0003876',\n",
    "  'our_cross_cui_name': 'Arthrobacter',\n",
    "  'our_cross_cui_desc': '[CLS] Art ##hr ##ob ##act ##er [unused3] ( Ba ##cter ##ium , organism : Art ##hr ##ob ##act ##er Con ##n and Di ##mm ##ick 1947 ( A ##pp ##roved List ##s 1980 ) em ##end . Bus ##se 2016 ; AR ##TH ##RO ##BA ##CT ##ER ; Art ##hr ##ob ##act ##er Con ##n and Di ##mm ##ick 1947 ( A ##pp ##roved List ##s 1980 ) em ##end . Koch et al . 1995 ; Genus Art ##hr ##ob ##act ##er ; Art ##hr ##ob ##act ##er species ) [SEP]'},\n",
    " {'mention_id': '27715500.7',\n",
    "  'test_set_idx': 14872,\n",
    "  'type': 'T092',\n",
    "  'name': 'meatpacking facilities',\n",
    "  'context': '[CLS] Self - reported occupational injuries among industrial beef slaughter ##house workers in the Midwest ##ern United States Although workers in [unused1] meat ##pack ##ing facilities [unused2] in the United States experience high rates of occupational injury , their injury experiences have received limited research attention . Prior research indicates under ##re ##port ##ing in injury rates in this industry as well significant variation in injury rates among facilities . To add detail to the rates and circumstances surrounding occupational injury among meat ##pack ##ing workers , we conducted a cross - section ##al study of workers employed at an industrial beef ##pack ##ing plant in Nebraska , United States ( n = 137 ) and interviewed workers about recent injury experiences . We assessed frequency , [SEP]',\n",
    "  'existing_cui': 'C2825564',\n",
    "  'existing_cui_name': 'Submitting Facility',\n",
    "  'existing_cui_desc': '[CLS] Sub ##mit ##ting Facility [unused3] ( Organization ) [SEP]',\n",
    "  'our_bi_cui': 'C0018704',\n",
    "  'our_bi_cui_name': 'Health care facility',\n",
    "  'our_bi_cui_desc': '[CLS] Health care facility [unused3] ( Organization , environment : health facilities ; health facility ; facilities medical ; medical facility ; Healthcare Facility ; Health F ##ac ##ilities ; Healthcare ##F ##ac ##ility ; Healthcare facility ; treatment facility ; facility medical ; Health care facilities ; treatment facilities ; care facilities health ; facilities treatment ; Health Facility ; health care facility ; care facility health ; Institution ; H ##EA ##LT ##H FA ##CI ##L ##IT ##Y ; Treatment F ##ac ##ilities ; Health Care Facility ; facilities health ; Health facilities ; F ##ac ##ilities , Health ; Facility , Health ) [SEP]',\n",
    "  'our_cross_cui': 'C0025019',\n",
    "  'our_cross_cui_name': 'Meat-Packing Industry',\n",
    "  'our_cross_cui_desc': '[CLS] Meat - Pack ##ing Industry [unused3] ( Organization : Industries , Meat - Pack ##ing ; Industry , Meat - Pack ##ing ; ME ##AT PA ##C ##K ##ING IN ##D ##US ##T ; Meat Pack ##ing Industry ; Meat - Pack ##ing Industries ; IN ##D ##US ##T ME ##AT PA ##C ##K ##ING ; Industry , Meat Pack ##ing ) [SEP]'},\n",
    " {'mention_id': '27583176.12',\n",
    "  'test_set_idx': 10709,\n",
    "  'type': 'T170',\n",
    "  'name': 'outcome grading scoring systems',\n",
    "  'context': '[CLS] scoring systems [ ( In ##tra ##cer ##eb ##ral hem ##or ##r ##hage score , F ##UN ##C score and in ##tra ##cer ##eb ##ral hem ##or ##r ##hage g ##rading scale ] on our population to evaluate the correlation of these scores with the 30 - day mortality in our study . We also applied three widely accepted [unused1] outcome g ##rading scoring systems [unused2] [ ( In ##tra ##cer ##eb ##ral hem ##or ##r ##hage score , F ##UN ##C score and in ##tra ##cer ##eb ##ral hem ##or ##r ##hage g ##rading scale ] on our population to evaluate the correlation of these scores with the 30 - day mortality in our study . From 34 ##2 patients ( mean age : 67 [SEP]',\n",
    "  'existing_cui': 'C1273712',\n",
    "  'existing_cui_name': 'Grading system used',\n",
    "  'existing_cui_desc': '[CLS] G ##rading system used [unused3] ( Health Care Act ##ivity , o ##bs ##er ##vable entity : g ##rading system ) [SEP]',\n",
    "  'our_bi_cui': 'C1708250',\n",
    "  'our_bi_cui_name': 'Tumor Grading System',\n",
    "  'our_bi_cui_desc': '[CLS] Tu ##mor G ##rading System [unused3] ( Intel ##lect ##ual Product : G ##rading system ; G ##rading System ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27172917.21',\n",
    "  'test_set_idx': 164,\n",
    "  'type': 'T170',\n",
    "  'name': 'biochemical predictors',\n",
    "  'context': '[CLS] predict ##ors of ma ##li ##gna ##ncy are important for the decision of appropriate management in nod ##ules with at ##y ##pia of und ##eter ##mined significance / f ##oll ##icular les ##ion of und ##eter ##mined significance ( AU ##S / FL ##US ) . Our aim was to determine the ultra ##son ##ographic ##al , clinical , and [unused1] bio ##chemical predict ##ors [unused2] of ma ##li ##gna ##ncy in these patients . A total of 42 ##7 patients with c ##yt ##ological ##ly Beth ##es ##da Category III ( AU ##S / FL ##US ) thy ##roid nod ##ules were included in this retrospective study . We divided the nod ##ules into two subgroup ##s according to the his ##top ##ath ##ology as [SEP]',\n",
    "  'existing_cui': 'C1511130',\n",
    "  'existing_cui_name': 'Biochemical Processes',\n",
    "  'existing_cui_desc': '[CLS] B ##io ##chemical Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction : B ##io ##chemical Process ; Process ##es , B ##io ##chemical ; Process , B ##io ##chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0041366',\n",
    "  'our_bi_cui_name': 'Biomarkers , Tumor',\n",
    "  'our_bi_cui_desc': '[CLS] B ##io ##mark ##ers , Tu ##mor [unused3] ( Chemical , substance : MA ##R ##KE ##R B ##IO ##CH ##EM T ##UM ##OR ; Mark ##ers , Neo ##p ##las ##m Met ##ab ##oli ##te ; Biological Tu ##mor Mark ##ers ; Tu ##mor Mark ##er , B ##iol ##og ##ic ; MA ##R ##KE ##RS B ##IO ##CH ##EM T ##UM ##OR ; Tu ##mor Mark ##ers , B ##io ##chemical ; Mark ##er , Neo ##p ##las ##m Met ##ab ##oli ##te ; Met ##ab ##oli ##te Mark ##ers , Tu ##mor ; B ##io ##chemical Tu ##mor Mark ##er ; Tu ##mor Mark ##ers , Biological ; Mark ##er , B ##io ##chemical Tu ##mor ; Mark ##ers , Car ##cin ##ogen [SEP]',\n",
    "  'our_cross_cui': 'C0683956',\n",
    "  'our_cross_cui_name': 'predictive factor',\n",
    "  'our_cross_cui_desc': '[CLS] predict ##ive factor [unused3] ( Intel ##lect ##ual Product : predict ##ive variables ; factors predict ##ive ; factor predict ##ive ; Disease Pre ##dict ##ive Factor ) [SEP]'},\n",
    " {'mention_id': '27510458.30',\n",
    "  'test_set_idx': 8917,\n",
    "  'type': 'T033',\n",
    "  'name': 'double lumen sign',\n",
    "  'context': '[CLS] slice thickness 3 mm with no inter ##s ##lice gap ) , as well as scanning with conventional m ##oda ##lities , including CT an ##gio ##graphy , magnetic resonance an ##gio ##graphy , and digital sub ##traction an ##gio ##graphy . We assessed whether these imaging methods could visual ##ize an in ##ti ##mal flap and / or [unused1] double l ##ume ##n sign [unused2] in the participants and compared the results between high - resolution fast spin echo and the other m ##oda ##lities . high - resolution fast spin echo images clearly showed in ##ti ##mal flap ##s and double l ##ume ##n signs in all 3 patients , whereas the conventional m ##oda ##lities identified a double l ##ume ##n sign in [SEP]',\n",
    "  'existing_cui': 'C0441299',\n",
    "  'existing_cui_name': 'Double lumen tube',\n",
    "  'existing_cui_desc': '[CLS] Double l ##ume ##n tube [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
    "  'our_bi_cui': 'C0233192',\n",
    "  'our_bi_cui_name': \"Ladin 's sign\",\n",
    "  'our_bi_cui_desc': \"[CLS] La ##din ' s sign [unused3] ( Finding , finding : La ##din sign ) [SEP]\",\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28127340.50',\n",
    "  'test_set_idx': 26276,\n",
    "  'type': 'T033',\n",
    "  'name': 'non - zoonotic',\n",
    "  'context': \"[CLS] = 1 . 09 % , and La ##ela ##ps nut ##tal ##li = 3 . 29 % . Among 10 genera / species of identified parasite ##s , at least 8 of them were zoo ##not ##ic with public health importance . L . nut ##tal ##li and N . f ##as ##cia ##tus were the only two [unused1] non - zoo ##not ##ic [unused2] detected parasite ##s in this survey . Harbor ##ing a wide variety of zoo ##not ##ic parasite ##s in sampled wild rode ##nts particularly when they live nearby villages , represents a potential risk to native inhabitants . Hence , controlling rode ##nts ' population in residential regions and improving awareness of local people about the risk of disease transmission [SEP]\",\n",
    "  'existing_cui': 'C0043528',\n",
    "  'existing_cui_name': 'Zoonoses',\n",
    "  'existing_cui_desc': '[CLS] Zoo ##nose ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder , navigation ##al concept : Zoo ##nosis ; Zoo ##not ##ic In ##fect ##ious Disease ; Zoo ##not ##ic infection ; Disease , Zoo ##not ##ic In ##fect ##ious ; Zoo ##nose ##s [ Disease / Finding ] ; Zoo ##not ##ic Disease ##s ; infections zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ion ; Zoo ##not ##ic Disease ; In ##fect ##ious Disease , Zoo ##not ##ic ; In ##fect ##ions , Zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ious Disease ##s ; Disease , Zoo ##not ##ic ; Disease ##s , Zoo ##not ##ic In ##fect ##ious ; zoo ##nose ; zoo ##not ##ic infection ; In [SEP]',\n",
    "  'our_bi_cui': 'C0043528',\n",
    "  'our_bi_cui_name': 'Zoonoses',\n",
    "  'our_bi_cui_desc': '[CLS] Zoo ##nose ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder , navigation ##al concept : Zoo ##nosis ; Zoo ##not ##ic In ##fect ##ious Disease ; Zoo ##not ##ic infection ; Disease , Zoo ##not ##ic In ##fect ##ious ; Zoo ##nose ##s [ Disease / Finding ] ; Zoo ##not ##ic Disease ##s ; infections zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ion ; Zoo ##not ##ic Disease ; In ##fect ##ious Disease , Zoo ##not ##ic ; In ##fect ##ions , Zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ious Disease ##s ; Disease , Zoo ##not ##ic ; Disease ##s , Zoo ##not ##ic In ##fect ##ious ; zoo ##nose ; zoo ##not ##ic infection ; In [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28197156.25',\n",
    "  'test_set_idx': 28095,\n",
    "  'type': 'T017',\n",
    "  'name': 'Carbon Assimilation Rate 8',\n",
    "  'context': '[CLS] As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of [unused1] Carbon As ##si ##mi ##lation Rate 8 [unused2] has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , Carbon As ##si ##mi ##lation Rate 8 is identical to D ##TH ##8 / G ##h ##d ##8 / L ##HD ##1 , which was reported [SEP]',\n",
    "  'existing_cui': 'C2246620',\n",
    "  'existing_cui_name': 'iron assimilation',\n",
    "  'existing_cui_desc': '[CLS] iron ass ##im ##ilation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_bi_cui': 'C1427100',\n",
    "  'our_bi_cui_name': 'SLC9A8 gene',\n",
    "  'our_bi_cui_desc': '[CLS] SL ##C ##9 ##A ##8 gene [unused3] ( Ana ##tom ##ical Structure : so ##lut ##e carrier family 9 member A ##8 ; S ##OD ##I ##UM / H ##Y ##DR ##O ##GE ##N E ##X ##CH ##AN ##GE ##R 8 ; S ##OL ##UT ##E CA ##R ##RI ##ER FA ##MI ##L ##Y 9 ( S ##OD ##I ##UM / H ##Y ##DR ##O ##GE ##N E ##X ##CH ##AN ##GE ##R ) , ME ##MB ##ER 8 ; K ##IA ##A ##0 ##9 ##39 ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27372076.29',\n",
    "  'test_set_idx': 3980,\n",
    "  'type': 'T092',\n",
    "  'name': 'industrial',\n",
    "  'context': '[CLS] Here ##in , we demonstrate for the first time that De ##o ##R family proteins derived from the same source are likely to be a single branch in a phylogenetic tree and show that w ##ys ##R ##3 acts as a re ##press ##or for its m ##or ##phological development without effect ##ing w ##uy ##ien ##cin production . We found that the Δ ##wy ##s ##R ##3 strain can grow quickly to reach a plateau stage of maximum bio ##mass at 60 h , which is ~ 12 h faster than the wild - type strain . In the [unused1] industrial [unused2] f ##er ##mentation production process , the Δ ##wy ##s ##R ##3 strain can reduce consumption and save both time and money . [SEP]',\n",
    "  'existing_cui': 'C0442611',\n",
    "  'existing_cui_name': 'Industrial site',\n",
    "  'existing_cui_desc': '[CLS] Industrial site [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
    "  'our_bi_cui': 'C0557758',\n",
    "  'our_bi_cui_name': 'Industrial environment',\n",
    "  'our_bi_cui_desc': '[CLS] Industrial environment [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
    "  'our_cross_cui': 'C0007983',\n",
    "  'our_cross_cui_name': 'Chemical Industry',\n",
    "  'our_cross_cui_desc': '[CLS] Chemical Industry [unused3] ( Organization : Chemical Industries ; IN ##D ##US ##T CH ##EM ; Industry , Chemical ; chemical industry ; chemical industries ; CH ##EM IN ##D ##US ##T ; Industries , Chemical ; Chemical industry ) [SEP]'},\n",
    " {'mention_id': '28077286.36',\n",
    "  'test_set_idx': 25086,\n",
    "  'type': 'T103',\n",
    "  'name': 'MeHg',\n",
    "  'context': '[CLS] , we used the egg injection method to investigate the long term effects of in o ##vo Me ##H ##g exposure on brain his ##top ##ath ##ology and courts ##hip behavior in a model song ##bird species , the z ##eb ##ra fin ##ch ( Ta ##eni ##opy ##gia gut ##tata ) . Egg treatment groups included : a low [unused1] Me ##H ##g [unused2] dose of 0 . 2 μ ##g H ##g g ( - 1 ) egg , a high Me ##H ##g dose of 3 . 2 μ ##g H ##g g ( - 1 ) egg , and a vehicle control ( water ) . No adverse effects of in o ##vo Me ##H ##g treatment were detected on courts ##hip [SEP]',\n",
    "  'existing_cui': 'C0228520',\n",
    "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
    "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
    "  'our_bi_cui': 'C0025424',\n",
    "  'our_bi_cui_name': 'Mercury',\n",
    "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
    "  'our_cross_cui': 'C0025794',\n",
    "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
    "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
    " {'mention_id': '28179911.98',\n",
    "  'test_set_idx': 27692,\n",
    "  'type': 'T103',\n",
    "  'name': 'C18 :1',\n",
    "  'context': '[CLS] the wild type . Ana ##ly ##ses of the seed oil content , star ##ch content , and total protein content indicated that the two T ##2 trans ##genic lines showed a significant increase ( P < 0 . 05 ) in seed oil content . The trans ##genic lines also showed a significant increase in star ##ch content , whereas total protein content decreased significantly . Further analysis of the fatty acid composition revealed that palm ##itic acid ( C ##16 : 0 ) and l ##ino ##len ##ic acid ( C ##18 : 3 ) increased significantly in the seeds of the trans ##genic rice lines , but o ##le ##ic acid ( [unused1] C ##18 : 1 [unused2] ) levels significantly declined . [SEP]',\n",
    "  'existing_cui': 'C3889128',\n",
    "  'existing_cui_name': 'BBS9 wt Allele',\n",
    "  'existing_cui_desc': '[CLS] B ##BS ##9 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : C ##18 ; PT ##H - Re ##sp ##ons ##ive B ##1 Gene ; PT ##H ##B ##1 ; Para ##thy ##roid Ho ##rmon ##e - Re ##sp ##ons ##ive B ##1 Gene ; Bar ##det - B ##ied ##l S ##yn ##drome 9 w ##t All ##ele ; B ##1 ; Para ##thy ##roid Ho ##rmon ##e Re ##sp ##ons ##ive B ##1 Gene ; D ##1 ) [SEP]',\n",
    "  'our_bi_cui': 'C0044555',\n",
    "  'our_bi_cui_name': '1-oleoyl-2-acetylglycerol',\n",
    "  'our_bi_cui_desc': '[CLS] 1 - o ##leo ##yl - 2 - ace ##ty ##l ##gly ##cer ##ol [unused3] ( Chemical : 9 - Oct ##ade ##ce ##no ##ic acid ( Z ) - , 2 - ( ace ##ty ##lo ##xy ) - 3 - h ##ydro ##xy ##p ##rop ##yl est ##er , ( S ) - ; 1 - o ##leo ##yl - 2 - ace ##ty ##l - s ##n - g ##ly ##cer ##ol ; o ##ley ##l ace ##ty ##l g ##ly ##cer ##ol ; 1 - o ##ley ##l - 2 - ace ##ty ##l ##gly ##cer ##ol ; 1 - o ##leo ##yl - 2 - ace ##ty ##l - g ##ly ##cer ##ol ; o ##leo ##yla ##ce ##ty ##l ##gly [SEP]',\n",
    "  'our_cross_cui': 'C0028928',\n",
    "  'our_cross_cui_name': 'Oleic Acid',\n",
    "  'our_cross_cui_desc': '[CLS] Ole ##ic A ##cid [unused3] ( Chemical , product , substance : Ole ##ic A ##cid [ Chemical / In ##g ##red ##ient ] ; O ##CT ##AD ##EC ##EN ##O ##IC AC ##ID 09 ; c ##is - 9 - Oct ##ade ##ce ##no ##ic A ##cid ; Oct ##ade ##c - 9 - en ##oi ##c acid ; acid o ##le ##ic ; 9 - Oct ##ade ##ce ##no ##ic acid ; 9 - Oct ##ade ##ce ##no ##ic A ##cid ; Fat ##ty A ##cid 18 : 1 n - 9 ; 9 Oct ##ade ##ce ##no ##ic A ##cid ; c ##is 9 Oct ##ade ##ce ##no ##ic A ##cid ; O ##LE ##IC AC ##ID ; o ##le ##ic acid ; [SEP]'},\n",
    " {'mention_id': '27603112.2',\n",
    "  'test_set_idx': 11344,\n",
    "  'type': 'T103',\n",
    "  'name': 'Biomolecules',\n",
    "  'context': '[CLS] Bin ##ding of Poll ##uta ##nts to [unused1] B ##io ##mo ##le ##cule ##s [unused2] : A Si ##mu ##lation Study A number of cases around the world have been reported where animals were found dead or dying with symptoms resembling a th ##iam ##ine ( vitamin B ) deficiency , and for some of these , a link to poll ##uta ##nts has been suggested . Here , we investigate whether bio ##mo ##le ##cule ##s involved in th ##iam ##in binding and transport could be blocked by a range of different poll ##uta ##nts . We used in si ##lic ##o dock ##ing of five compound classes ( 25 compounds in total ) to each of five targets ( p ##rion protein , EC [SEP]',\n",
    "  'existing_cui': 'C0104263',\n",
    "  'existing_cui_name': 'artificial lung expanding compound',\n",
    "  'existing_cui_desc': '[CLS] artificial lung expanding compound [unused3] ( Chemical , AL ##EC , product , substance : P ##uma ##ct ##ant ; pu ##ma ##ct ##ant ) [SEP]',\n",
    "  'our_bi_cui': 'C1449655',\n",
    "  'our_bi_cui_name': 'Macromolecular Substances',\n",
    "  'our_bi_cui_desc': '[CLS] Mac ##rom ##ole ##cular Sub ##stance ##s [unused3] ( Chemical : Mac ##rom ##ole ##cular Sub ##stance ##s [ Chemical / In ##g ##red ##ient ] ; Mac ##rom ##ole ##cular Co ##mpo ##unds and Complex ##es ; Sub ##stance ##s , Mac ##rom ##ole ##cular ) [SEP]',\n",
    "  'our_cross_cui': 'C0574031',\n",
    "  'our_cross_cui_name': 'Biologically active substance',\n",
    "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
    " {'mention_id': '28269352.10',\n",
    "  'test_set_idx': 30583,\n",
    "  'type': 'T170',\n",
    "  'name': 'elderly fall risk assessment model',\n",
    "  'context': '[CLS] Fall risk factors analysis based on sample en ##tropy of plant ##ar kin ##ema ##tic signal during stance phase Falls are a multi - ca ##usal phenomenon with a complex interaction . The aim of our research is to study the effect of multiple variables for potential risk of falls and construct an [unused1] elderly fall risk assessment model [unused2] based on demographic ##s data and g ##ait characteristics . A total of 101 subjects , whom belong to Mali ##an ##wa Street , aged above 50 years old and participated in question ##naire survey . Part ##ici ##pants were classified into three groups ( high , medium and low risk group ) according to the score of elderly fall risk assessment scale . In addition [SEP]',\n",
    "  'existing_cui': 'C1532976',\n",
    "  'existing_cui_name': 'Fall risk assessment',\n",
    "  'existing_cui_desc': '[CLS] Fall risk assessment [unused3] ( Health Care Act ##ivity , procedure , regime / therapy ) [SEP]',\n",
    "  'our_bi_cui': 'C2733220',\n",
    "  'our_bi_cui_name': 'Falls risk assessment score for the elderly',\n",
    "  'our_bi_cui_desc': '[CLS] Falls risk assessment score for the elderly [unused3] ( Clinical At ##tri ##but ##e , o ##bs ##er ##vable entity , o ##bs ##er ##vable entity : F ##RA ##SE - Falls risk assessment score for the elderly ) [SEP]',\n",
    "  'our_cross_cui': 'C3161035',\n",
    "  'our_cross_cui_name': 'Model',\n",
    "  'our_cross_cui_desc': '[CLS] Model [unused3] ( Intel ##lect ##ual Product : Models ; Model ##ing System ; Model System ) [SEP]'},\n",
    " {'mention_id': '28128937.20',\n",
    "  'test_set_idx': 26379,\n",
    "  'type': 'T103',\n",
    "  'name': 'CaCl2',\n",
    "  'context': '[CLS] ##ulated E ##S - Z ##n f ##ert ##ilizer ##s with and without S - o ##xi ##di ##zing micro ##or ##gan ##isms , a commercial elemental sulfur past ##ille , Z ##n ##SO ##4 , and Z ##n ##O were applied to the center of Pet ##ri dishes containing two contrasting pH soils . So ##il pH , [unused1] C ##a ##C ##l ##2 [unused2] - extract ##able sulfur and zinc , and remaining elemental sulfur were evaluated at 30 and 60 days in two soil sections ( 0 - 5 and 5 - 9 mm from the f ##ert ##ilizer application site ) . A visual ##ization test was performed to evaluate zinc diffusion over time . A significant pH decrease was observed in [SEP]',\n",
    "  'existing_cui': 'C1705551',\n",
    "  'existing_cui_name': 'ACSL1 wt Allele',\n",
    "  'existing_cui_desc': '[CLS] AC ##SL ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : LA ##CS ##2 ; A ##cy ##l - Co ##A S ##ynth ##eta ##se Long - Chain Family Member 1 w ##t All ##ele ; LA ##CS ##1 ; LA ##CS ; FA ##CL ##1 ; FA ##CL ##2 ) [SEP]',\n",
    "  'our_bi_cui': 'C0596235',\n",
    "  'our_bi_cui_name': 'Calcium ion',\n",
    "  'our_bi_cui_desc': '[CLS] Cal ##ci ##um ion [unused3] ( Chemical : Cal ##ci ##um Cat ##ion ; free calcium ; CA + 2 ; ion calcium ; Cal ##ci ##um cat ##ion ; Free Cal ##ci ##um ; calcium ions ; C ##a ##2 + ; C ##a + + ; Cal ##ci ##um Ion ##s ; C ##a 2 + ; calcium ion ; CA ##LC ##I ##UM CA ##TI ##ON ; Cal ##ci ##um Ion ; calcium cat ##ion ; Cal ##ci ##um 2 + ; Ion ##ized Cal ##ci ##um ) [SEP]',\n",
    "  'our_cross_cui': 'C0006686',\n",
    "  'our_cross_cui_name': 'Calcium Chloride',\n",
    "  'our_cross_cui_desc': '[CLS] Cal ##ci ##um Ch ##lor ##ide [unused3] ( Chemical , product , substance : calcium ( 2 + ) chloride ; CA ##LC ##I ##UM CH ##L ##OR ##ID ##E ; calcium chloride ; Cal ##ci ##um chloride ; Ch ##lor ##ide , Cal ##ci ##um ; Cal ##ci ##um Ch ##lor ##ide He ##xa ##hy ##dra ##te ; Cal ##ci ##um Ch ##lor ##ide [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
    " {'mention_id': '28263181.26',\n",
    "  'test_set_idx': 30386,\n",
    "  'type': 'T170',\n",
    "  'name': 'theorem',\n",
    "  'context': '[CLS] f ##er ##ment ##ative metabolism decreases around 10 % the production of en ##tropy per mole of glucose consumed in cancer cells . We h ##y ##pot ##hes ##ize that increased f ##er ##mentation could allow cancer cells to accomplish the P ##rig ##og ##ine theorem of the trend to minimize the rate of production of en ##tropy . According the [unused1] theorem [unused2] , open cellular systems near the steady state could evolve to minimize the rates of en ##tropy production that may be reached by modified replica ##ting cells producing en ##tropy at low rate . Re ##mark ##ably , at CO ##2 concentrations above 93 ##0 pp ##m , glucose re ##spiration produces less en ##tropy than f ##er ##mentation , which suggests [SEP]',\n",
    "  'existing_cui': 'C0034673',\n",
    "  'existing_cui_name': 'rapid eye movement',\n",
    "  'existing_cui_desc': '[CLS] rapid eye movement [unused3] ( B ##iol ##og ##ic Fun ##ction : Movement , Rapid Eye ; Rapid Eye Movement ; Rapid Eye Movement ##s ; Eye Movement ##s , Rapid ; Movement ##s , Rapid Eye ; Eye Movement , Rapid ) [SEP]',\n",
    "  'our_bi_cui': 'C1705273',\n",
    "  'our_bi_cui_name': 'Mathematical Operator',\n",
    "  'our_bi_cui_desc': '[CLS] Mathematical Opera ##tor [unused3] ( Intel ##lect ##ual Product : Opera ##tor ; Fun ##ction ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27692319.47',\n",
    "  'test_set_idx': 14318,\n",
    "  'type': 'T204',\n",
    "  'name': 'miracidia',\n",
    "  'context': '[CLS] at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μ ##g / m ##L affected em ##b ##ryo ##nic development , with n - but ##ano ##l presenting the strongest in ##hibition of mi ##rac ##id ##ia formation . In contrast , on the 12th day , 90 % of the [unused1] mi ##rac ##id ##ia [unused2] hatch ##ed in the control experiments using 0 . 03 % D ##MS ##O whereas em ##b ##ryo ##genesis was completely abolished with any concentration of al ##ben ##da ##zo ##le su ##l ##ph ##oxide AB ##Z ( S ##O ) . Chemical analysis of the crude extract and sub - fraction ##s revealed a prominent presence of fl ##av [SEP]',\n",
    "  'existing_cui': 'C0451085',\n",
    "  'existing_cui_name': 'Composite international diagnostic interview',\n",
    "  'existing_cui_desc': '[CLS] Co ##mpo ##site international diagnostic interview [unused3] ( Intel ##lect ##ual Product , C ##ID ##I , assessment scale : composite international diagnostic interview ; C ##ID ##I - Co ##mpo ##site international diagnostic interview ) [SEP]',\n",
    "  'our_bi_cui': 'C2807025',\n",
    "  'our_bi_cui_name': 'Focillidia',\n",
    "  'our_bi_cui_desc': '[CLS] F ##oc ##ill ##id ##ia [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
    "  'our_cross_cui': 'C0023047',\n",
    "  'our_cross_cui_name': 'Larva',\n",
    "  'our_cross_cui_desc': '[CLS] La ##rva [unused3] ( E ##uka ##ryo ##te : La ##rva ##e ; la ##rva ; larvae ) [SEP]'},\n",
    " {'mention_id': '28179911.66',\n",
    "  'test_set_idx': 27660,\n",
    "  'type': 'T204',\n",
    "  'name': 'T2',\n",
    "  'context': '[CLS] ##cer ##ols assembly ( BC ##CP ##2 , K ##AS ##I , MA ##T , E ##NR , FA ##TA , and GP ##D ##H ) were also ass ##ay ##ed in mature seeds . Furthermore , lip ##id and fatty acids C ##16 : 0 and C ##18 : 0 significantly increased . In two ho ##mo ##zy ##go ##us [unused1] T ##2 [unused2] trans ##genic rice lines ( G ##5 and G ##2 ) , different Co ##WR ##I ##1 expression levels were detected , but no Co ##WR ##I ##1 trans ##cripts were detected in the wild type . Ana ##ly ##ses of the seed oil content , star ##ch content , and total protein content indicated that the two T ##2 trans [SEP]',\n",
    "  'existing_cui': 'C1335834',\n",
    "  'existing_cui_name': 'SLC25A5 gene',\n",
    "  'existing_cui_desc': '[CLS] SL ##C ##25 ##A ##5 gene [unused3] ( Ana ##tom ##ical Structure : AD ##P / ATP T ##RA ##NS ##L ##OC ##AS ##E 2 ; 2 ##F ##1 ; Sol ##ute Carrier Family 25 ( Mi ##to ##cho ##nd ##rial Carrier ; Aden ##ine N ##uc ##leo ##tide Trans ##loc ##ator ) , Member 5 Gene ; AD ##EN ##IN ##E N ##UC ##LE ##OT ##ID ##E T ##RA ##NS ##L ##OC ##AT ##OR 2 ; SL ##C ##25 ##A ##5 Gene ; AD ##P / ATP CA ##R ##RI ##ER 2 ; so ##lut ##e carrier family 25 member 5 ; AD ##P / ATP T ##RA ##NS ##L ##OC ##AT ##OR OF F ##IB ##RO ##BL ##AS ##TS ; S ##OL ##UT ##E [SEP]',\n",
    "  'our_bi_cui': 'C0282641',\n",
    "  'our_bi_cui_name': 'Transgenes',\n",
    "  'our_bi_cui_desc': '[CLS] Trans ##gene ##s [unused3] ( Ana ##tom ##ical Structure : trans ##gene ; Trans ##gene ) [SEP]',\n",
    "  'our_cross_cui': 'C0085245',\n",
    "  'our_cross_cui_name': 'Plants , Transgenic',\n",
    "  'our_cross_cui_desc': '[CLS] Plants , Trans ##genic [unused3] ( E ##uka ##ryo ##te : Trans ##genic Plants ; Trans ##genic Plant ; trans ##genic plant ; trans ##genic plants ; Plant , Trans ##genic ; plant trans ##genic ; Trans ##genic plants ) [SEP]'},\n",
    " {'mention_id': '28380217.17',\n",
    "  'test_set_idx': 33737,\n",
    "  'type': 'T033',\n",
    "  'name': 'antibacterial potential',\n",
    "  'context': '[CLS] derivatives bearing 2 - fur ##oy ##l - 1 - pipe ##raz ##ine and having modest toxicity . The synthesis was completed as a multiple sequence . The structural confirmation of all the synthesized compounds was obtained by E ##I - MS , I ##R and 1 ##H - N ##MR spectral data . The enzyme in ##hibition and [unused1] anti ##ba ##cter ##ial potential [unused2] of the synthesized compounds was evaluated . To find the utility of the prepared compounds as possible therapeutic agents their c ##yt ##oto ##xi ##city was also checked . All the compounds were active against ace ##ty ##l ##cho ##lines ##tera ##se enzyme , especially 12 and 14 showed very good inhibitor ##y potential relative to E ##ser ##ine , [SEP]',\n",
    "  'existing_cui': 'C0279516',\n",
    "  'existing_cui_name': 'Anti-Bacterial Agents',\n",
    "  'existing_cui_desc': '[CLS] Anti - Ba ##cter ##ial Agents [unused3] ( Chemical , medication , product , substance : Anti ##ba ##cter ##ial agent ; Anti ##ba ##cter ##ial ##s ; anti ##ba ##cter ##ial ##s ; Anti Ba ##cter ##ial Co ##mpo ##unds ; anti - bacterial agents ; Anti ##ba ##cter ##ial Agent [ T ##C ] ; Anti ##ba ##cter ##ial Agent ; AN ##TI ##BA ##CT ##ER ##IA ##L AG ##EN ##TS ; Anti ##ba ##cter ##ial Agents ; Agents , Anti ##ba ##cter ##ial ; Anti - Ba ##cter ##ial Co ##mpo ##unds ; Anti ##ba ##cter ##ial ; Co ##mpo ##unds , Anti - Ba ##cter ##ial ; Anti Ba ##cter ##ial Agents ; anti ##ba ##cter ##ial drug ; anti ##ba ##cter [SEP]',\n",
    "  'our_bi_cui': 'C0279516',\n",
    "  'our_bi_cui_name': 'Anti-Bacterial Agents',\n",
    "  'our_bi_cui_desc': '[CLS] Anti - Ba ##cter ##ial Agents [unused3] ( Chemical , medication , product , substance : Anti ##ba ##cter ##ial agent ; Anti ##ba ##cter ##ial ##s ; anti ##ba ##cter ##ial ##s ; Anti Ba ##cter ##ial Co ##mpo ##unds ; anti - bacterial agents ; Anti ##ba ##cter ##ial Agent [ T ##C ] ; Anti ##ba ##cter ##ial Agent ; AN ##TI ##BA ##CT ##ER ##IA ##L AG ##EN ##TS ; Anti ##ba ##cter ##ial Agents ; Agents , Anti ##ba ##cter ##ial ; Anti - Ba ##cter ##ial Co ##mpo ##unds ; Anti ##ba ##cter ##ial ; Co ##mpo ##unds , Anti - Ba ##cter ##ial ; Anti Ba ##cter ##ial Agents ; anti ##ba ##cter ##ial drug ; anti ##ba ##cter [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28035661.11',\n",
    "  'test_set_idx': 23939,\n",
    "  'type': 'T082',\n",
    "  'name': 'Hortus',\n",
    "  'context': '[CLS] Evidence of tooth ##pic ##k groove formation in N ##ean ##der ##tal anterior and posterior teeth During the micro ##scopic examination of the N ##ean ##der ##tal den ##ti ##tions from El Sid ##r ##ón ( Spain ) and [unused1] Ho ##rt ##us [unused2] ( France ) , we found unusual fine parallel micro ##st ##ria ##tions on the me ##sia ##l and di ##stal sides of all tooth types , near the c ##er ##vi ##x . As its appearance was similar to tooth ##pic ##k groove ##s described in other Ho ##mo species , it could correspond to early stages on its formation . To test this hypothesis we developed an experimental replication of a groove using grass stalk ##s . Co ##mp ##aris [SEP]',\n",
    "  'existing_cui': 'C4178118',\n",
    "  'existing_cui_name': 'Tortus',\n",
    "  'existing_cui_desc': '[CLS] Tor ##tus [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
    "  'our_bi_cui': 'C0086418',\n",
    "  'our_bi_cui_name': 'Homo sapiens',\n",
    "  'our_bi_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '28125734.44',\n",
    "  'test_set_idx': 26198,\n",
    "  'type': 'T103',\n",
    "  'name': 'MiR-21-5p',\n",
    "  'context': '[CLS] ( Met - 5 ##A ) which expresses low levels of me ##so ##the ##lin . Mi ##RNA ##s targeting the me ##so ##the ##lin m ##RNA were identified by next generation se ##quencing and mi ##R - 21 - 5 ##p and mi ##R - 100 - 5 ##p were selected for further valid ##ation analyses . [unused1] Mi ##R - 21 - 5 ##p [unused2] was shown to be able to m ##od ##ulate me ##so ##the ##lin expression in mi ##RNA mimic experiments in a panel of ma ##li ##gnant and non - ma ##li ##gnant cell lines . Further mi ##RNA inhibitor experiments and l ##uc ##ifer ##ase ass ##ays in Me ##ro - 14 cells valid ##ated mi ##R - 21 [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1999986',\n",
    "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '28223077.18',\n",
    "  'test_set_idx': 28902,\n",
    "  'type': 'T082',\n",
    "  'name': 'background site',\n",
    "  'context': '[CLS] to understand the influence of Municipal solid waste land ##fill on p ##oly ##ch ##lor ##inated di ##ben ##zo - p - di ##ox ##ins and p ##oly ##ch ##lor ##inated di ##ben ##zo ##fu ##ran ##s ( PC ##D ##D / F ##s ) in surrounding atmosphere , 42 ambient air samples were collected and analyzed from surrounding sites , [unused1] background site [unused2] , up ##wind site and down ##wind site of a Municipal solid waste land ##fill in East China . The results of present study were summarized as follows . ( 1 ) The total concentrations of PC ##D ##D / F ##s ( [UNK] PC ##D ##D / F ##s ) in ambient air from surrounding sites , background site , [SEP]',\n",
    "  'existing_cui': 'C0237490',\n",
    "  'existing_cui_name': 'Family Background',\n",
    "  'existing_cui_desc': '[CLS] Family Background [unused3] ( Finding , Family : Background ) [SEP]',\n",
    "  'our_bi_cui': 'C0017446',\n",
    "  'our_bi_cui_name': 'Geographic Locations',\n",
    "  'our_bi_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]',\n",
    "  'our_cross_cui': 'C0205145',\n",
    "  'our_cross_cui_name': 'Site',\n",
    "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
    " {'mention_id': '28210319.72',\n",
    "  'test_set_idx': 28603,\n",
    "  'type': 'T033',\n",
    "  'name': 'respiratory implications',\n",
    "  'context': '[CLS] lung compliance decrease , and air ##way o ##bs ##truction makes air ##way resistance increase . The consequences of respiratory pump failure are restrict ##ive pulmonary function , h ##y ##po ##vent ##ilation , altered th ##ora ##coa ##b ##dom ##inal pattern , h ##yper ##cap ##nia , d ##ys ##p ##no ##ea , impaired regulation of breathing , in ##ef ##ficient cough and sleep disorder ##ed breathing . To understand the mechanisms leading to respiratory disturbance ##s in patients with muscular d ##ys ##tro ##phy . To understand the impact of respiratory disturbance ##s in patients with muscular d ##ys ##tro ##phy . To provide a brief description of the main forms of muscular d ##ys ##tro ##phy with their [unused1] respiratory implications [unused2] . [SEP]',\n",
    "  'existing_cui': 'C0729250',\n",
    "  'existing_cui_name': 'Respiratory complications',\n",
    "  'existing_cui_desc': '[CLS] Re ##sp ##ira ##tory complications [unused3] ( In ##ju ##ry or Po ##ison ##ing ) [SEP]',\n",
    "  'our_bi_cui': 'C0161818',\n",
    "  'our_bi_cui_name': 'Respiratory complication',\n",
    "  'our_bi_cui_desc': '[CLS] Re ##sp ##ira ##tory com ##plication [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : respiratory ; complications ; complications ; respiratory ; respiratory complications ; Re ##sp ##ira ##tory complications ; respiratory com ##plication ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28050885.57',\n",
    "  'test_set_idx': 24203,\n",
    "  'type': 'T033',\n",
    "  'name': 'No',\n",
    "  'context': '[CLS] and ankle - bra ##chia ##l index values increased by 24 % ( p = 0 . 000 ##1 ) in the treatment group but decreased in the control group . The greatest therapeutic effect was observed for stage III disease : Pain - free walking distance increased by 68 ##3 % ( p = 0 . 000 ##1 ) . [unused1] No [unused2] an ##gio ##genic therapy - related adverse events or side effects were recorded , and target limb salvage was 96 and 97 % in the treatment and control groups , respectively . The results obtained in this study are not significantly different from those observed in the phase II ##b / III registration clinical study completed in 2011 . p ##l - [SEP]',\n",
    "  'existing_cui': 'C1016143',\n",
    "  'existing_cui_name': 'Tetragenococcus halophilus',\n",
    "  'existing_cui_desc': '[CLS] Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us [unused3] ( Ba ##cter ##ium , organism : P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us Me ##es 1934 ( A ##pp ##roved List ##s 1980 ) ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us ( Me ##es 1934 ) Collins et al . 1993 ; Sa ##rc ##ina ha ##ma ##guchi ##ae ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##a ; P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us ; Te ##tra ##co ##cc ##cus No . 1 ; P ##ed ##io ##co ##cc ##us so ##ya ##e ) [SEP]',\n",
    "  'our_bi_cui': 'C0243095',\n",
    "  'our_bi_cui_name': 'Finding',\n",
    "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C1513916',\n",
    "  'our_cross_cui_name': 'Negative Finding',\n",
    "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
    " {'mention_id': '28000391.18',\n",
    "  'test_set_idx': 23417,\n",
    "  'type': 'T033',\n",
    "  'name': 'after hospital discharge',\n",
    "  'context': '[CLS] monitoring . This contains for quantitative assessment the Short Form Health Survey question ##naire and the Impact of Family Scale administered one and five weeks following discharge before and after stage II . For q ##ual ##itative assessment , semi - structured interviews focus ##sing on the post ##dis ##cha ##rge cop ##ing strategies were conducted twice , five weeks [unused1] after hospital discharge [unused2] before and after stage II . Ten infants ( eight males ) with h ##y ##pop ##lastic left heart syndrome ( n = 7 ) or other types of un ##ive ##nt ##ric ##ular heart ma ##lf ##orm ##ations ( n = 3 ) , and their parents ( nine mother / father two - parent households , one single mother [SEP]',\n",
    "  'existing_cui': 'C0586003',\n",
    "  'existing_cui_name': 'Discharge from hospital',\n",
    "  'existing_cui_desc': '[CLS] Disc ##har ##ge from hospital [unused3] ( Health Care Act ##ivity , procedure : discharge ##s hospital ; Hospital Disc ##har ##ge ; discharge from hospital ; hospital discharge ; discharge hospital ) [SEP]',\n",
    "  'our_bi_cui': 'C0586003',\n",
    "  'our_bi_cui_name': 'Discharge from hospital',\n",
    "  'our_bi_cui_desc': '[CLS] Disc ##har ##ge from hospital [unused3] ( Health Care Act ##ivity , procedure : discharge ##s hospital ; Hospital Disc ##har ##ge ; discharge from hospital ; hospital discharge ; discharge hospital ) [SEP]',\n",
    "  'our_cross_cui': 'C1320368',\n",
    "  'our_cross_cui_name': 'Post-discharge follow-up',\n",
    "  'our_cross_cui_desc': '[CLS] Post - discharge follow - up [unused3] ( Finding , finding ) [SEP]'},\n",
    " {'mention_id': '27838742.17',\n",
    "  'test_set_idx': 18984,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] developing novel ch ##em ##oth ##era ##pe ##uti ##c agents . In this study , data supporting the in v ##it ##ro and in v ##ivo anti ##can ##cer effects of del ##ica ##f ##lav ##one , a rarely occurring bi ##f ##lav ##ono ##id from Se ##lag ##ine ##lla do ##ede ##rle ##ini ##i , were reported . [unused1] Del ##ica ##f ##lav ##one [unused2] exhibited favorable anti ##can ##cer properties , as shown by the M ##TT ass ##ay and x ##eno ##gra ##ft model of human non - small cell lung cancer in male BA ##L ##B / c nude mice without o ##bs ##er ##vable adverse effect . By transmission electron micro ##sco ##py with a ##c ##rid ##ine orange and Cy [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28487667.6',\n",
    "  'test_set_idx': 37681,\n",
    "  'type': 'T170',\n",
    "  'name': 'test batteries',\n",
    "  'context': \"[CLS] When Is a Test Score Fair for the Individual Who Is Being Test ##ed ? Effects of Different Sc ##oring Pro ##ced ##ures across Multiple At ##tem ##pts When Testing a Motor Ski ##ll Task Tests or [unused1] test batteries [unused2] used for assessing motor skills , either in research studies or in clinical settings , apply a variety of procedures for scoring performances , including everything from one to ten attempts , of which the best is scored or an average is com ##puted . The rational ##e behind scoring procedures is rarely stated , and it seems that the number of attempts allowed is decided without much qualification from research . It is uncertain whether procedures fairly capture an individual ' s skill level [SEP]\",\n",
    "  'existing_cui': 'C0456724',\n",
    "  'existing_cui_name': 'Willeford test battery',\n",
    "  'existing_cui_desc': '[CLS] Will ##ef ##ord test battery [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
    "  'our_bi_cui': 'C0687197',\n",
    "  'our_bi_cui_name': 'Battery tester',\n",
    "  'our_bi_cui_desc': '[CLS] Battery test ##er [unused3] ( Medical Devi ##ce , physical object : Battery Ana ##ly ##zers ; Test ##ers , Battery ) [SEP]',\n",
    "  'our_cross_cui': 'C0392366',\n",
    "  'our_cross_cui_name': 'Tests',\n",
    "  'our_cross_cui_desc': '[CLS] Tests [unused3] ( Intel ##lect ##ual Product , qualifier value , qualifier value , procedure : tested ; testing ##s ; test ; tests ; testing ) [SEP]'},\n",
    " {'mention_id': '28356035.5',\n",
    "  'test_set_idx': 32979,\n",
    "  'type': 'T033',\n",
    "  'name': 'poor cardiovascular outcome',\n",
    "  'context': '[CLS] poor health worldwide . The most solid evidence is for air pollution , leading to increased disability - adjusted life years . Outdoor temperature and other seasonal climate changes may also influence card ##iovascular health , according to their direct m ##od ##ulation of air pollution . Moreover , an increasing body of evidence associates environmental exposure to noise with [unused1] poor card ##iovascular outcome [unused2] , and in particular with h ##yper ##tens ##ion . This review is aimed at reviewing current evidence about the role of these environmental factors in card ##iovascular disease and specifically h ##yper ##tens ##ion . In particular , the impact of air pollution , with its short - term and long - term effects , the outdoor temperature and [SEP]',\n",
    "  'existing_cui': 'C3806166',\n",
    "  'existing_cui_name': 'Poor outcome',\n",
    "  'existing_cui_desc': '[CLS] Poor outcome [unused3] ( Finding ) [SEP]',\n",
    "  'our_bi_cui': 'C3806166',\n",
    "  'our_bi_cui_name': 'Poor outcome',\n",
    "  'our_bi_cui_desc': '[CLS] Poor outcome [unused3] ( Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28441489.46',\n",
    "  'test_set_idx': 36168,\n",
    "  'type': 'T033',\n",
    "  'name': 'cold - start',\n",
    "  'context': '[CLS] depend on engine technology . Cold - start contributes a larger fraction of the total unified cycle emissions for vehicles meeting more - string ##ent emission standards . Organic gas emissions were the most sensitive to cold - start compared to the other poll ##uta ##nts tested here . There were no statistical ##ly significant differences in the effects of [unused1] cold - start [unused2] on G ##DI ##s and P ##FI ##s . For our test fleet , the measured 14 . 5 % decrease in CO ##2 emissions from G ##DI ##s was much greater than the potential climate forcing associated with higher black carbon emissions . Thus , switching from Port Fuel In ##jection to gasoline direct - injection vehicles will likely lead [SEP]',\n",
    "  'existing_cui': 'C0452588',\n",
    "  'existing_cui_name': 'Start brand of breakfast cereal',\n",
    "  'existing_cui_desc': '[CLS] Start brand of breakfast cereal [unused3] ( Food , substance : Start ) [SEP]',\n",
    "  'our_bi_cui': 'C1455171',\n",
    "  'our_bi_cui_name': 'Cool-X-A',\n",
    "  'our_bi_cui_desc': '[CLS] Cool - X - A [unused3] ( Chemical : Cool - Cool ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27570140.50',\n",
    "  'test_set_idx': 10513,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedures',\n",
    "  'context': \"[CLS] the 27 months of follow - up . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Over one third of high - risk patients ' requests were un ##ful ##fill ##ed , indicating that significant barriers may remain . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Pro ##vide ##rs should consider these [unused1] procedures [unused2] urgent , especially in high - risk women , and advocate for their patients ' access to this procedure . [SEP]\",\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '28301509.6',\n",
    "  'test_set_idx': 31703,\n",
    "  'type': 'T058',\n",
    "  'name': 'CoMPP technique',\n",
    "  'context': '[CLS] Gen ##ome - wide association mapping in winter bar ##ley for grain yield and cu ##lm cell wall polymer content using the high - through ##put [unused1] Co ##MP ##P technique [unused2] A collection of 112 winter bar ##ley varieties ( Ho ##rde ##um v ##ul ##gar ##e L . ) was grown in the field for two years ( 2008 / 09 and 2009 / 10 ) in northern Italy and grain and straw yields recorded . In the first year of the trial , a severe attack of bar ##ley yellow mosaic virus strongly influenced final performances with an average reduction of ~ 50 % for grain and straw harvested in comparison to the second year . The genetic determination for grain yield was [SEP]',\n",
    "  'existing_cui': 'C0450241',\n",
    "  'existing_cui_name': 'Ffooks technique',\n",
    "  'existing_cui_desc': '[CLS] F ##fo ##ok ##s technique [unused3] ( Health Care Act ##ivity , qualifier value ) [SEP]',\n",
    "  'our_bi_cui': 'C0430022',\n",
    "  'our_bi_cui_name': 'diagnostic procedure',\n",
    "  'our_bi_cui_desc': '[CLS] diagnostic procedure [unused3] ( Health Care Act ##ivity , procedure : D ##IA ##G ##N ##OS ##TI ##C ; Di ##ag ##nos ##tic procedure ; Di ##ag ##nos ##tic procedures ; Di ##ag ##nos ##tic Test ; diagnostic technique ; Di ##ag ##nos ##tic ; Di ##ag ##nos ##tic Tech ##ni ##que ; Di ##ag ##nos ##tic Pro ##ced ##ure ; diagnostic procedures ; Di ##ag ##nos ##tic Method ; Pro ##ced ##ures ; diagnostic ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '27887587.58',\n",
    "  'test_set_idx': 20946,\n",
    "  'type': 'T033',\n",
    "  'name': 'family',\n",
    "  'context': \"[CLS] . The participants ' expectations about counsel ##ling with regard to longer - term family , practical , and financial challenges were insufficient ##ly met by the Community Mental Health Centre . In the experience of the service users , recovery occurred within the context of their everyday life with or without the support of their professional help ##ers . To facilitate recovery , health professionals should acknowledge the service user ' s personal goals and hopes and take a more comprehensive and longer - term approach to his or her needs and desires . A ##ck ##no ##wl ##ed ##ging and f ##ac ##ilitating recovery goals by offering counsel ##ling with regard to [unused1] family [unused2] , practical and financial issues seems particularly important . [SEP]\",\n",
    "  'existing_cui': 'C1301584',\n",
    "  'existing_cui_name': 'Last Name',\n",
    "  'existing_cui_desc': '[CLS] Last Name [unused3] ( Intel ##lect ##ual Product , o ##bs ##er ##vable entity : Family Name ; family ; Last name ; Sur ##name ) [SEP]',\n",
    "  'our_bi_cui': 'C0424960',\n",
    "  'our_bi_cui_name': 'Family problems',\n",
    "  'our_bi_cui_desc': '[CLS] Family problems [unused3] ( Finding , finding , history : problem ; family ; Problem ; family ; family problems ; family ; problem ; family problem ) [SEP]',\n",
    "  'our_cross_cui': 'C0851511',\n",
    "  'our_cross_cui_name': 'Family issues',\n",
    "  'our_cross_cui_desc': '[CLS] Family issues [unused3] ( Finding : family issues ; families issues ; Family Issues ; family issue ) [SEP]'},\n",
    " {'mention_id': '28272254.30',\n",
    "  'test_set_idx': 30776,\n",
    "  'type': 'T170',\n",
    "  'name': 'papers',\n",
    "  'context': '[CLS] ##in receptor block ##ers , calcium channel block ##ers [ CC ##B ##s ] , and di ##ure ##tics ) on re ##gression of Left vent ##ric ##ular h ##yper ##tro ##phy . Re ##lative trials were identified in the Pub ##M ##ed , Web of Science , O ##VI ##D E ##BM Reviews and Cochrane databases , and the relevant [unused1] papers [unused2] were examined . We performed both traditional and Bay ##esi ##an meta - analysis of random ##ized controlled trials about the re ##gression of Left vent ##ric ##ular h ##yper ##tro ##phy . Sen ##si ##ti ##vity analysis and re ##gression analysis were performed to explore possible sources of he ##tero ##gene ##ity . Inc ##ons ##ist ##ency analysis was performed to [SEP]',\n",
    "  'existing_cui': 'C0462999',\n",
    "  'existing_cui_name': 'Litmus paper',\n",
    "  'existing_cui_desc': '[CLS] Li ##t ##mus paper [unused3] ( Medical Devi ##ce , physical object : Li ##t ##mus Paper ; lit ##mus papers ; Re ##age ##nts , Clinical Chemistry , Rapid Test , pH , Strip ; IV ##D Test Re ##age ##nt / Kit ##s , Clinical Chemistry , Rapid Test , pH , Strip ; pH Strip In ##dic ##ators ; lit ##mus paper ) [SEP]',\n",
    "  'our_bi_cui': 'C0282420',\n",
    "  'our_bi_cui_name': 'Journal Article',\n",
    "  'our_bi_cui_desc': '[CLS] Journal Article [unused3] ( Intel ##lect ##ual Product : journal article ) [SEP]',\n",
    "  'our_cross_cui': 'C1706852',\n",
    "  'our_cross_cui_name': 'Article',\n",
    "  'our_cross_cui_desc': '[CLS] Article [unused3] ( Intel ##lect ##ual Product ) [SEP]'},\n",
    " {'mention_id': '27791364.5',\n",
    "  'test_set_idx': 16973,\n",
    "  'type': 'T058',\n",
    "  'name': 'Photoacoustic / Magnetic Resonance Imaging - Guided Tumor - Targeted Photothermal Therapy',\n",
    "  'context': '[CLS] Album ##in - B ##io ##ins ##pired G ##d : C ##u ##S Nan ##oth ##eran ##ost ##ic Agent for In V ##ivo [unused1] Photo ##aco ##ustic / Ma ##gnetic Re ##son ##ance I ##maging - Guide ##d Tu ##mor - Target ##ed Photo ##thermal Therapy [unused2] Photo ##thermal therapy is attracting increasing interest and becoming more widely used for skin cancer therapy in the clinic , as a result of its non ##in ##vasive ##ness and low systemic adverse effects . However , there is an urgent need to develop bio ##com ##pa ##tible Photo ##thermal therapy agents , which enable accurate imaging , monitoring , and diagnosis . Here ##in , a bio ##com ##pa ##tible G ##d - integrated C ##u ##S na [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0031740',\n",
    "  'our_bi_cui_name': 'Photochemotherapy',\n",
    "  'our_bi_cui_desc': '[CLS] Photo ##che ##mother ##ap ##y [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : PD ##T - Photo ##dynamic therapy ; Photo ##che ##mother ##ap ##ies ; Photo ##dynamic The ##rap ##ies ; therapy , photo ##dynamic ; Therapy , Photo ##dynamic ; THE ##R P ##H ##OT ##OD ##Y ##NA ##MI ##C ; Photo ##rad ##iation Therapy ; photo ##dynamic therapy ; photo ##che ##mother ##ap ##y ; P ##H ##OT ##OC ##H ##EM ##OT ##H ##ER ; The ##rap ##ies , Photo ##dynamic ; Photo ##dynamic Therapy Pro ##ced ##ures ; neo ##p ##las ##m / cancer photo ##rad ##iation therapy ; Photo ##che ##mother ##ap ##y [ Am ##bi ##guous ] ; Photo ##dynamic therapy ; PD [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '28013256.31',\n",
    "  'test_set_idx': 23792,\n",
    "  'type': 'T033',\n",
    "  'name': 'succeeded',\n",
    "  'context': \"[CLS] with the exception of improving capacity to engage men and in ##f ##lue ##ncing practice beyond their organisation , these improvements were sustained at 5 - month post training ( P < 0 . 00 ##1 ) . The vast majority of service providers ( 93 . 4 % ) reported that E ##NG ##AG ##E had impacted their work practice up to 5 - month post training . The findings suggest that E ##NG ##AG ##E has [unused1] succeeded [unused2] in improving service providers ' capacity to engage and work with men ; improving gender compete ##ncy in the delivery of health and health related services may increase the u ##til ##isation of such services by men and thereby improve health outcomes for men . [SEP]\",\n",
    "  'existing_cui': 'C0046018',\n",
    "  'existing_cui_name': '2-chloroethyl ethyl sulfide',\n",
    "  'existing_cui_desc': '[CLS] 2 - ch ##lor ##oe ##thy ##l et ##hyl su ##lf ##ide [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C1272702',\n",
    "  'our_bi_cui_name': 'Success of action',\n",
    "  'our_bi_cui_desc': '[CLS] Success of action [unused3] ( Finding , attribute ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27636509.49',\n",
    "  'test_set_idx': 12561,\n",
    "  'type': 'T033',\n",
    "  'name': 'detection',\n",
    "  'context': '[CLS] be characterized by speech disorder and affect ##ive behavior symptoms , cluster 2 has predominantly hall ##uc ##ination symptoms and cluster 3 has mainly del ##usion symptoms . Inter ##action of five S ##NP ##s was found to have an effect on cluster 1 symptoms ; ten S ##NP ##s on cluster 2 symptoms ; and eight S ##NP ##s on cluster 3 symptoms . The interaction of specific su ##s ##ce ##pt ##ibility genes is likely to lead to specific clinical sub - p ##hen ##otype ##s of s ##chi ##zophrenia . Large ##r patient co ##hor ##ts with more extensive clinical data will improve the [unused1] detection [unused2] of gene interactions and the result ##ant s ##chi ##zophrenia clinical p ##hen ##otype ##s . [SEP]',\n",
    "  'existing_cui': 'C0206100',\n",
    "  'existing_cui_name': 'Signal Detection',\n",
    "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
    "  'our_bi_cui': 'C1511790',\n",
    "  'our_bi_cui_name': 'Detection',\n",
    "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
    "  'our_cross_cui': 'C0442726',\n",
    "  'our_cross_cui_name': 'Detected',\n",
    "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
    " {'mention_id': '27692319.41',\n",
    "  'test_set_idx': 14312,\n",
    "  'type': 'T204',\n",
    "  'name': 'Eggs',\n",
    "  'context': '[CLS] . Q ##uad ##rup ##lica ##tes of 50 F . he ##pa ##tica eggs were in ##cu ##bate ##d at 23 °C with M . ch ##aran ##tia leaf crude extract in different concentrations . After 12 days no larvae were formed in eggs in ##cu ##bate ##d with crude extract concentrations above 12 . 5 mg / m ##L . [unused1] Egg ##s [unused2] in ##cu ##bate ##d with crude extract sub - fraction ##s at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μ ##g / m ##L affected em ##b ##ryo ##nic development , with n - but ##ano ##l presenting the strongest in ##hibition of mi ##rac ##id ##ia formation . In contrast [SEP]',\n",
    "  'existing_cui': 'C0029974',\n",
    "  'existing_cui_name': 'Ovum',\n",
    "  'existing_cui_desc': '[CLS] O ##vu ##m [unused3] ( Ana ##tom ##ical Structure , body structure , cell , cell structure , qualifier value : Human egg ; Egg ##s , Un ##fer ##til ##ized ; Fe ##rt ##ilized o ##oc ##yte ; Mat ##ure o ##vu ##m ; O ##va ; Egg ; egg cell ; o ##va ; X bearing o ##vu ##m ; female game ##tes ; O ##ocytes ; Un ##fer ##til ##ized Egg ##s ; X chromosome - bearing o ##vu ##m ; Egg , Un ##fer ##til ##ized ; O ##vu ##m structure ; Un ##fer ##til ##ized Egg ; Female game ##te ; O ##voc ##yte ; egg / o ##vu ##m ; o ##vu ##m ; female game ##te ; X - [SEP]',\n",
    "  'our_bi_cui': 'C0029974',\n",
    "  'our_bi_cui_name': 'Ovum',\n",
    "  'our_bi_cui_desc': '[CLS] O ##vu ##m [unused3] ( Ana ##tom ##ical Structure , body structure , cell , cell structure , qualifier value : Human egg ; Egg ##s , Un ##fer ##til ##ized ; Fe ##rt ##ilized o ##oc ##yte ; Mat ##ure o ##vu ##m ; O ##va ; Egg ; egg cell ; o ##va ; X bearing o ##vu ##m ; female game ##tes ; O ##ocytes ; Un ##fer ##til ##ized Egg ##s ; X chromosome - bearing o ##vu ##m ; Egg , Un ##fer ##til ##ized ; O ##vu ##m structure ; Un ##fer ##til ##ized Egg ; Female game ##te ; O ##voc ##yte ; egg / o ##vu ##m ; o ##vu ##m ; female game ##te ; X - [SEP]',\n",
    "  'our_cross_cui': 'C3662687',\n",
    "  'our_cross_cui_name': 'Fasciola hepatica egg',\n",
    "  'our_cross_cui_desc': '[CLS] F ##as ##cio ##la he ##pa ##tica egg [unused3] ( E ##uka ##ryo ##te , organism : F ##as ##cio ##la he ##pa ##tica o ##va ) [SEP]'},\n",
    " {'mention_id': '28326653.24',\n",
    "  'test_set_idx': 31932,\n",
    "  'type': 'T170',\n",
    "  'name': 'Early Trauma Inventory',\n",
    "  'context': '[CLS] of P ##sy ##cho ##ther ##ap ##y or es ##ci ##tal ##op ##ram plus clinical management over the course of 8 weeks of acute and 20 weeks of extended treatment at 2 German treatment sites . Child ##hood ma ##lt ##rea ##tment was assessed using the Child ##hood T ##ra ##uma Question ##naire and the clinic ##ian rated [unused1] Early T ##ra ##uma In ##vent ##ory [unused2] . In ##ten ##tion - to - treat analyses were used to examine the impact of Child ##hood ma ##lt ##rea ##tment on depression , global functioning , and quality of life . The presence of Child ##hood ma ##lt ##rea ##tment did not result in significant differences in treatment response to Co ##gni ##tive Be ##ha ##vior ##al [SEP]',\n",
    "  'existing_cui': 'C0031213',\n",
    "  'existing_cui_name': 'Personality inventories',\n",
    "  'existing_cui_desc': '[CLS] Personal ##ity inventor ##ies [unused3] ( Health Care Act ##ivity : Personal ##ity In ##vent ##ory ; personality inventory ; inventor ##ies ; inventory ; In ##vent ##ories ; Personal ##ity In ##vent ##ories ; In ##vent ##ory , Personal ##ity ; In ##vent ##ories , Personal ##ity ) [SEP]',\n",
    "  'our_bi_cui': 'C0451546',\n",
    "  'our_bi_cui_name': 'Trauma index',\n",
    "  'our_bi_cui_desc': '[CLS] T ##ra ##uma index [unused3] ( Intel ##lect ##ual Product , assessment scale : index trauma ; trauma index ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27773614.43',\n",
    "  'test_set_idx': 16303,\n",
    "  'type': 'T058',\n",
    "  'name': 'surveillance',\n",
    "  'context': '[CLS] he ##pa ##to ##cellular car ##cin ##oma - case ##load of the hospital where patients were first admitted also had an independent influence on treatment and survival . Despite full insurance coverage for all citizens , national measures to reduce in ##e ##quities in the management of cancer patients , standard ##ised recommendations for he ##pa ##to ##cellular car ##cin ##oma [unused1] surveillance [unused2] and management , the percentage of patients undergoing cu ##rative treatment and their survival may vary four - fold depending on their post ##code . The hospital in which patients are first managed has a clear influence on access ##ibility to both good care and survival . Population - based studies have highlighted large and sometimes unexpected differences between countries in the [SEP]',\n",
    "  'existing_cui': 'C0733511',\n",
    "  'existing_cui_name': 'Medical Surveillance',\n",
    "  'existing_cui_desc': '[CLS] Medical Sur ##ve ##illa ##nce [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Sur ##ve ##illa ##nce ; medical surveillance ; surveillance ; E ##pid ##em ##iology / Sur ##ve ##illa ##nce ) [SEP]',\n",
    "  'our_bi_cui': 'C4316666',\n",
    "  'our_bi_cui_name': 'Surveillance for cancer',\n",
    "  'our_bi_cui_desc': '[CLS] Sur ##ve ##illa ##nce for cancer [unused3] ( Health Care Act ##ivity , regime / therapy ) [SEP]',\n",
    "  'our_cross_cui': 'C0038842',\n",
    "  'our_cross_cui_name': 'Supervision',\n",
    "  'our_cross_cui_desc': '[CLS] Super ##vision [unused3] ( Health Care Act ##ivity , regime / therapy , regime / therapy , procedure : supervision ) [SEP]'},\n",
    " {'mention_id': '28222192.43',\n",
    "  'test_set_idx': 28864,\n",
    "  'type': 'T204',\n",
    "  'name': 'ST1',\n",
    "  'context': '[CLS] ##ba co ##li ( 55 % ) , H ##yme ##no ##le ##pis na ##na ( 0 . 8 % ) , End ##oli ##max na ##na ( 33 . 2 % ) and Neo ##bal ##anti ##dium co ##li ( 2 . 7 % ) was detected in the B ##last ##oc ##ys ##tis - positive samples . We detected [unused1] ST ##1 [unused2] ( 21 . 4 % ) , ST ##2 ( 19 . 5 % ) , ST ##3 ( 55 . 5 % ) , ST ##4 ( 0 . 8 % ) , ST ##6 ( 2 % ) and ST ##7 ( 0 . 8 % ) ; all ##ele ##s 1 , 2 , 4 , 81 , [SEP]',\n",
    "  'existing_cui': 'C3812243',\n",
    "  'existing_cui_name': 'SDCBP wt Allele',\n",
    "  'existing_cui_desc': '[CLS] SD ##C ##B ##P w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : S ##yn ##de ##can Bin ##ding Pro ##tein ( S ##yn ##ten ##in ) w ##t All ##ele ; MD ##A - 9 ; S ##Y ##CL ; ST ##1 ; T ##AC ##IP ##18 ) [SEP]',\n",
    "  'our_bi_cui': 'C2310266',\n",
    "  'our_bi_cui_name': 'bacterium ST1',\n",
    "  'our_bi_cui_desc': '[CLS] bacterium ST ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
    "  'our_cross_cui': 'C3106801',\n",
    "  'our_cross_cui_name': 'Blastocystis sp . subtype 1',\n",
    "  'our_cross_cui_desc': '[CLS] B ##last ##oc ##ys ##tis s ##p . sub ##type 1 [unused3] ( E ##uka ##ryo ##te : B ##last ##oc ##ys ##tis s ##p . ST ##1 ; B ##last ##oc ##ys ##tis s ##p . ST - 1 ) [SEP]'},\n",
    " {'mention_id': '27669669.21',\n",
    "  'test_set_idx': 13726,\n",
    "  'type': 'T037',\n",
    "  'name': 'subluxation',\n",
    "  'context': '[CLS] ##l syndrome , this sub ##lux ##ation occurs spontaneous ##ly after inflammatory processes of the head and neck . Di ##ag ##nosis is typically based on clinical history and a strong suspicion of this syndrome . Non ##su ##rg ##ical treatment most often resolve ##s the symptoms ; however , in some cases surgical treatment is necessary to repair the [unused1] sub ##lux ##ation [unused2] . Various surgical techniques and instrumentation systems have been used to treat at ##lant ##oa ##xial sub ##lux ##ation , although there is no consensus regarding the best treatment method for the p ##ediatric population . To describe a case of at ##lant ##oa ##xial sub ##lux ##ation in a child with G ##rise ##l syndrome treated surgical ##ly with an [SEP]',\n",
    "  'existing_cui': 'C0332768',\n",
    "  'existing_cui_name': 'Joint Subluxations',\n",
    "  'existing_cui_desc': '[CLS] Joint Sub ##lux ##ations [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity , physical finding , qualifier value : sub ##lux ##ation ; Sub ##lux ##ation ; Sub ##lux ##ation , Joint ; Di ##s ##location , incomplete ; Joint sub ##lux ##ation ; Joint Sub ##lux ##ation ; Sub ##lux ##ation of joint ; sub ##lux ##ations ; Inc ##om ##ple ##te di ##s ##location ; joint sub ##lux ##ation ; Sub ##lux ##ations ; incomplete di ##s ##location ; Sub ##lux ##ations , Joint ; sub ##lux ##ation was seen ; sub ##lux ##ation of joint ; Sub ##lux ##ation - les ##ion ) [SEP]',\n",
    "  'our_bi_cui': 'C0332768',\n",
    "  'our_bi_cui_name': 'Joint Subluxations',\n",
    "  'our_bi_cui_desc': '[CLS] Joint Sub ##lux ##ations [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity , physical finding , qualifier value : sub ##lux ##ation ; Sub ##lux ##ation ; Sub ##lux ##ation , Joint ; Di ##s ##location , incomplete ; Joint sub ##lux ##ation ; Joint Sub ##lux ##ation ; Sub ##lux ##ation of joint ; sub ##lux ##ations ; Inc ##om ##ple ##te di ##s ##location ; joint sub ##lux ##ation ; Sub ##lux ##ations ; incomplete di ##s ##location ; Sub ##lux ##ations , Joint ; sub ##lux ##ation was seen ; sub ##lux ##ation of joint ; Sub ##lux ##ation - les ##ion ) [SEP]',\n",
    "  'our_cross_cui': 'C0263905',\n",
    "  'our_cross_cui_name': 'Atlantoaxial subluxation',\n",
    "  'our_cross_cui_desc': '[CLS] At ##lant ##oa ##xial sub ##lux ##ation [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder : AA ##S - At ##lant ##oa ##xial sub ##lux ##ation ; at ##lant ##oa ##xial ; sub ##lux ##ation ; di ##s ##location ; at ##lant ##oa ##xial ; At ##lant ##o - a ##xial sub ##lux ##ation ; At ##lant ##oa ##xial di ##s ##location ; at ##lant ##oa ##xial ; di ##s ##location ; Sub ##lux ##ation of at ##lant ##oa ##xial joint ; sub ##lux ##ation ; at ##lant ##oa ##xial ) [SEP]'},\n",
    " {'mention_id': '28237762.5',\n",
    "  'test_set_idx': 29307,\n",
    "  'type': 'T103',\n",
    "  'name': 'acylated phenoxyanilide',\n",
    "  'context': '[CLS] S ##ynth ##esis , SA ##R and molecular dock ##ing study of novel non - β - la ##ct ##am inhibitor ##s of T ##EM type β - la ##ct ##ama ##se The novel classes of [unused1] a ##cy ##lated p ##hen ##ox ##yan ##ili ##de [unused2] and th ##io ##ure ##a compounds were investigated for their ability to in ##hibit T ##EM type β - la ##ct ##ama ##se enzyme . Two compounds 4 ##g and 5 ##c reveal the in ##hibition pot ##ency in micro ##mo ##lar range and show their action by non - co ##valent binding in the vicinity of the T ##EM - 171 active site . The structure activity relationship around carbon chain length and different sub ##st ##it ##uen [SEP]',\n",
    "  'existing_cui': 'C0031403',\n",
    "  'existing_cui_name': 'Phenetidine',\n",
    "  'existing_cui_desc': '[CLS] Ph ##ene ##ti ##dine [unused3] ( Chemical : Ph ##ene ##ti ##dine [ Chemical / In ##g ##red ##ient ] ; Benz ##ena ##mine , 4 - et ##ho ##xy - ; Am ##ino ##phe ##net ##ole ; E ##th ##ox ##yan ##ili ##ne ) [SEP]',\n",
    "  'our_bi_cui': 'C0029224',\n",
    "  'our_bi_cui_name': 'Organic Chemicals',\n",
    "  'our_bi_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28197133.39',\n",
    "  'test_set_idx': 28055,\n",
    "  'type': 'T103',\n",
    "  'name': 'oligosaccharidases',\n",
    "  'context': '[CLS] , G ##H1 ##3 ( am ##yla ##se ) , G ##H ##43 and G ##H1 ##0 ( hem ##ice ##ll ##ula ##ses ) , G ##H ##9 and G ##H ##48 ( cell ##ula ##ses ) , P ##L ##11 ( p ##ec ##tina ##se ) as well as G ##H ##2 and G ##H ##3 ( [unused1] o ##li ##gos ##ac ##cha ##rida ##ses [unused2] ) . Our data support the pivotal role of the most characterized fi ##bro ##ly ##tic bacteria ( Pre ##vo ##tel ##la , R ##umi ##no ##cc ##cus and Fi ##bro ##ba ##cter ) , and highlight a substantial , although most probably under ##est ##imated , contribution of fungi and c ##ilia ##te pro ##to ##zo ##a to [SEP]',\n",
    "  'existing_cui': 'C0028959',\n",
    "  'existing_cui_name': 'Oligosaccharides',\n",
    "  'existing_cui_desc': '[CLS] O ##li ##gos ##ac ##cha ##ride ##s [unused3] ( Chemical , substance : o ##li ##gos ##ac ##cha ##ride ##s ; O ##li ##gos ##ac ##cha ##ride ##s [ Chemical / In ##g ##red ##ient ] ; O ##li ##gos ##ac ##cha ##ride ; o ##li ##gos ##ac ##cha ##ride ) [SEP]',\n",
    "  'our_bi_cui': 'C0012610',\n",
    "  'our_bi_cui_name': 'Disaccharidases',\n",
    "  'our_bi_cui_desc': '[CLS] Di ##sa ##cc ##hari ##das ##es [unused3] ( Chemical , substance : Di ##sa ##cc ##hari ##das ##e ; di ##sa ##cc ##hari ##das ##es ; Di ##sa ##cc ##hari ##das ##es [ Chemical / In ##g ##red ##ient ] ; di ##sa ##cc ##hari ##das ##e ) [SEP]',\n",
    "  'our_cross_cui': 'C0014442',\n",
    "  'our_cross_cui_name': 'Enzymes',\n",
    "  'our_cross_cui_desc': '[CLS] En ##zy ##mes [unused3] ( Chemical , medication , substance : enzymes ; enzyme ; En ##zy ##mes [ Chemical / In ##g ##red ##ient ] ; B ##io ##cat ##aly ##sts ; En ##zy ##me ) [SEP]'},\n",
    " {'mention_id': '28251683.22',\n",
    "  'test_set_idx': 30007,\n",
    "  'type': 'T017',\n",
    "  'name': 'occlusion',\n",
    "  'context': '[CLS] ne ##uro ##p ##rote ##ction of remote is ##cha ##em ##ic post ##con ##dition ##ing against cerebral is ##cha ##emia / re ##per ##fusion injury in rats . The middle cerebral artery o ##cc ##lusion model was established in rats and then remote is ##cha ##em ##ic post ##con ##dition ##ing was carried out by three cycles of 10 minutes [unused1] o ##cc ##lusion [unused2] / 10 minutes release of the bilateral f ##em ##oral artery at the beginning of the re ##per ##fusion . To down ##re ##gu ##late the fi ##bul ##in - 5 level , fi ##bul ##in - 5 si ##RNA was injected into the lateral vent ##ric ##le 24 hours before middle cerebral artery o ##cc ##lusion . According to our [SEP]',\n",
    "  'existing_cui': 'C0011382',\n",
    "  'existing_cui_name': 'Dental Occlusion',\n",
    "  'existing_cui_desc': '[CLS] Dental O ##cc ##lusion [unused3] ( B ##iol ##og ##ic Fun ##ction , Den ##tist ##ry , function , o ##bs ##er ##vable entity , physical finding : Dental o ##cc ##lusion ; O ##cc ##lusion ##s , Dental ; O ##CC ##L ##US ##ION DE ##NT ; Dental O ##cc ##lusion ##s ; Bit ##e ; O ##cc ##lusion ; dental o ##cc ##lusion ; tooth o ##cc ##lusion ; o ##cc ##lusion dental ; DE ##NT O ##CC ##L ##US ##ION ; Dental o ##cc ##lusion , function ; O ##cc ##lusion , Dental ) [SEP]',\n",
    "  'our_bi_cui': 'C0596298',\n",
    "  'our_bi_cui_name': 'Cerebrovascular Occlusion',\n",
    "  'our_bi_cui_desc': '[CLS] Ce ##re ##bro ##vas ##cular O ##cc ##lusion [unused3] ( B ##iol ##og ##ic Fun ##ction : c ##ere ##bro ##vas ##cular o ##cc ##lusion ; O ##cc ##lusion ; cerebral ; Ce ##re ##bro ##vas ##cular O ##cc ##lusion ##s ; o ##cc ##lusion ; c ##ere ##bro ##vas ##cular ; O ##cc ##lusion ##s , Ce ##re ##bro ##vas ##cular ; cerebral o ##cc ##lusion ; O ##cc ##lusion , Ce ##re ##bro ##vas ##cular ; c ##ere ##bro ##vas ##cular ; o ##cc ##lusion ; cerebral o ##cc ##lusion ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0740391',\n",
    "  'our_cross_cui_name': 'Middle Cerebral Artery Occlusion',\n",
    "  'our_cross_cui_desc': '[CLS] Middle Ce ##re ##bra ##l Arte ##ry O ##cc ##lusion [unused3] ( Ana ##tom ##ical Structure , diagnosis , disorder : cerebral artery o ##cc ##lusion middle ; O ##cc ##lusion , Middle Ce ##re ##bra ##l Arte ##ry ; o ##cc ##lusion ; middle cerebral artery ; a . c ##ere ##bri media ; o ##cc ##lusion ; middle cerebral artery o ##cc ##lusion ; Middle cerebral artery o ##cc ##lusion ) [SEP]'},\n",
    " {'mention_id': '27442216.26',\n",
    "  'test_set_idx': 5822,\n",
    "  'type': 'T098',\n",
    "  'name': 'All - terrain vehicles group',\n",
    "  'context': '[CLS] ex ##tre ##mity ( 18 % ) , hand ( 11 % ) , s ##cap ##ula ( 4 . 6 % ) , and open fracture ##s ( 28 . 6 % ) ( P < 0 . 01 ) . Head trauma was the most commonly associated injury in 275 patients with the highest rate in the [unused1] All - terrain vehicles group [unused2] ( 44 % ) who also had the highest rate of no helmet use ( 76 % ) . Snow ##mobile and All - terrain vehicles patients had higher In ##ju ##ry Se ##ver ##ity Score ( 11 . 3 , 9 . 6 ) than dirt ##bi ##ke patients ( 7 . 8 ) ( P = 0 . [SEP]',\n",
    "  'existing_cui': 'C2898785',\n",
    "  'existing_cui_name': 'All-terrain motor-vehicle accident',\n",
    "  'existing_cui_desc': '[CLS] All - terrain motor - vehicle accident [unused3] ( In ##ju ##ry or Po ##ison ##ing ) [SEP]',\n",
    "  'our_bi_cui': 'C2898785',\n",
    "  'our_bi_cui_name': 'All-terrain motor-vehicle accident',\n",
    "  'our_bi_cui_desc': '[CLS] All - terrain motor - vehicle accident [unused3] ( In ##ju ##ry or Po ##ison ##ing ) [SEP]',\n",
    "  'our_cross_cui': 'C1257890',\n",
    "  'our_cross_cui_name': 'Population Group',\n",
    "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
    " {'mention_id': '27826436.24',\n",
    "  'test_set_idx': 18354,\n",
    "  'type': 'T204',\n",
    "  'name': 'cultivars',\n",
    "  'context': '[CLS] and determined in c ##v . Ben ##ih ##op ##pe , To ##chi ##oto ##me , Sa ##chin ##oka , and G ##ui ##mei ##ren straw ##berry fruits extracted by head - space solid - phase micro ##ex ##traction , respectively . E ##sters significantly dominated the chemical composition of the four varieties . Fu ##rane ##ol was detected in [unused1] cult ##iva ##rs [unused2] of Sa ##chin ##oka and G ##ui ##mei ##ren , but me ##si ##fu ##ran was only found in c ##v . To ##chi ##oto ##me . To ##chi ##oto ##me and Sa ##chin ##oka showed higher content of l ##inal ##ool and ( E ) - ne ##rol ##ido ##l . Sa ##chin ##oka showed the highest content of total [SEP]',\n",
    "  'existing_cui': 'C3385047',\n",
    "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
    "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
    "  'our_bi_cui': 'C0242775',\n",
    "  'our_bi_cui_name': 'Agricultural Crops',\n",
    "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
    "  'our_cross_cui': 'C0032098',\n",
    "  'our_cross_cui_name': 'Plants',\n",
    "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
    " {'mention_id': '27587730.7',\n",
    "  'test_set_idx': 10746,\n",
    "  'type': 'T103',\n",
    "  'name': 'Gga-miR-21',\n",
    "  'context': '[CLS] G ##ga - mi ##R - 21 in ##hibit ##s chicken pre - ad ##ip ##oc ##yte proliferation in part by down - regulating K ##rup ##pel - like factor 5 [unused1] G ##ga - mi ##R - 21 [unused2] is abundant ##ly expressed in chicken pre - ad ##ip ##ocytes , but its role is unclear . The present study investigated the role of g ##ga - mi ##R - 21 in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1537719',\n",
    "  'our_bi_cui_name': 'MIR21 gene',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '27297967.72',\n",
    "  'test_set_idx': 1777,\n",
    "  'type': 'T082',\n",
    "  'name': 'Asn19/Asn23',\n",
    "  'context': '[CLS] W ##T - MR ##P ##1 , whereas individual human em ##b ##ryo ##nic kidney 29 ##3 - Ty ##r ##9 ##20 ##P ##he - and - Ser ##9 ##21 ##A ##la - MR ##P ##1 mutant ##s were similar to H ##E ##K - W ##T - MR ##P ##1 . Together , these results suggest that [unused1] As ##n ##19 / As ##n ##23 [unused2] g ##ly ##cos ##yla ##tion and Ty ##r ##9 ##20 / Ser ##9 ##21 p ##hos ##ph ##ory ##lation are responsible for altering the kinetic ##s of MR ##P ##1 - mediated As ( G ##S ) 3 transport . The kinetic ##s of As ( G ##S ) 3 transport by human em ##b ##ryo ##nic kidney 29 [SEP]',\n",
    "  'existing_cui': 'C3887642',\n",
    "  'existing_cui_name': 'Hippocampus Proper',\n",
    "  'existing_cui_desc': \"[CLS] Hip ##po ##cam ##pus Pro ##per [unused3] ( Ana ##tom ##ical Structure : Hip ##po ##cam ##pus proper ; Hip ##po ##cam ##pus major ; Am ##mon ' s Horn ; CA fields ; Pro ##per , Hip ##po ##cam ##pus ; Horn , Am ##mon ; Hip ##po ##cam ##pus Pro ##pers ; Am ##mon Horn ; hip ##po ##cam ##pus ; Co ##rn ##u am ##mon ##is ; Am ##mons Horn ; Hip ##po ##cam ##pus ; corn ##u am ##mon ##is ; am ##mon ' s horn ; hip ##po ##cam ##pus proper ; Hip ##po ##cam ##pus prop ##rius ; Am ##mon ' s horn ; Co ##rn ##u Am ##mon ##is ; hip ##po ##cam ##pus major ; Horn , Am [SEP]\",\n",
    "  'our_bi_cui': 'C0003995',\n",
    "  'our_bi_cui_name': 'Asparagine',\n",
    "  'our_bi_cui_desc': '[CLS] As ##par ##agi ##ne [unused3] ( Chemical , substance : 2 - Am ##ino ##su ##cci ##nam ##ic acid ; L - as ##par ##agi ##ne ; As ##par ##tam ##ic acid ; alpha - amino ##su ##cci ##nam ##ic acid ; as ##n ; 2 - Am ##ino - 3 - car ##ba ##mo ##yl ##p ##rop ##ano ##ic acid ; as ##par ##agi ##ne ; ( S ) - As ##par ##agi ##ne ; N ; ( S ) - 2 - amino - 3 - car ##ba ##mo ##yl ##p ##rop ##ano ##ic acid ; Alpha - amino ##su ##cci ##nic acid ; As ##n ; L - as ##par ##tic acid beta - amid ##e ; ( 2 ##S ) - 2 [SEP]',\n",
    "  'our_cross_cui': 'C0002518',\n",
    "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
    "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
    " {'mention_id': '27430240.85',\n",
    "  'test_set_idx': 5411,\n",
    "  'type': 'T103',\n",
    "  'name': 'factors',\n",
    "  'context': '[CLS] these results , it can be in ##ferred that ad ##eno ##sin ##e , the ad ##eno ##sin ##e A2 ##A receptor ago ##nist , E ##2 ##F transcription factor 1 and CR ##E ##B are the possible factors contributing to the high expression of CD ##39 and CD ##7 ##3 on the T ##re ##g cell surface during se ##psis . Aden ##os ##ine and its A2 ##A receptor ago ##nist served as the signal trans ##du ##cer [unused1] factors [unused2] of the CD ##39 / CD ##7 ##3 / ad ##eno ##sin ##e pathway , a ##cc ##ele ##rating ad ##eno ##sin ##e generation . Our study may benefit further research on ad ##eno ##sin ##e metabolism for the treatment of se ##psis . [SEP]',\n",
    "  'existing_cui': 'C0960756',\n",
    "  'existing_cui_name': 'factor A',\n",
    "  'existing_cui_desc': \"[CLS] factor A [unused3] ( Chemical : Co ( beta ) - c ##yan ##o - 7 ' ' - ( 2 - met ##hyl ) ad ##eni ##ny ##l ##co ##ba ##mi ##de ) [SEP]\",\n",
    "  'our_bi_cui': 'C0021054',\n",
    "  'our_bi_cui_name': 'Immunologic Factors',\n",
    "  'our_bi_cui_desc': '[CLS] I ##mm ##uno ##log ##ic Factor ##s [unused3] ( Chemical , substance : Factor ##s , I ##mm ##uno ##log ##ic ; I ##mm ##une Factor ##s ; Factor ##s , I ##mm ##uno ##logical ; I ##mm ##uno ##log ##ic Factor ; Factor ##s , I ##mm ##une ; I ##mm ##uno ##logical Factor ##s ; im ##mu ##no ##log ##ic substance ; FA ##CT ##OR ##S I ##MM ##UN ##OL ; im ##mu ##nological substance ; I ##MM ##UN ##OL FA ##CT ##OR ##S ; I ##mm ##uno ##log ##ic substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0005515',\n",
    "  'our_cross_cui_name': 'Biological Factors',\n",
    "  'our_cross_cui_desc': '[CLS] Biological Factor ##s [unused3] ( Chemical , product , substance : Agents , Biological ; Biological Factor ; B ##iol ##og ##ic agent ; agents biological ; B ##iol ##og ##ic Factor ##s ; B ##iol ##og ##ic Factor ; biological substance ; Factor , B ##iol ##og ##ic ; Factor ##s , Biological ; bio ##pha ##rma ##ce ##utical ##s ; Biological product ; B ##IO ##L FA ##CT ##OR ; Biological Agents ; Biological substance ; Biological Factor ##s [ Chemical / In ##g ##red ##ient ] ; Biological agent ; B ##iol ##og ##ics ; Factor , Biological ; biological drug ; B ##IO ##L FA ##CT ##OR ##S ; FA ##CT ##OR ##S B ##IO ##L ; biological substances ; bio ##pha [SEP]'},\n",
    " {'mention_id': '27932585.30',\n",
    "  'test_set_idx': 22257,\n",
    "  'type': 'T103',\n",
    "  'name': 'TYW3',\n",
    "  'context': '[CLS] ##us , which revealed a novel α / β fold . The sequence motif ( S / T ) x ##SS ##C ##x ##GR and invariant as ##par ##tate and his ##ti ##dine , conserved in T ##Y ##W ##3 / Ta ##w ##3 , cluster to form the cat ##alytic center . These structural and sequence features indicate that [unused1] T ##Y ##W ##3 [unused2] / Ta ##w ##3 proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass ##ays combined with mass s ##pect ##rome ##try as well as l ##igan ##d dock ##ing and co ##fa ##ctor binding ass ##ays , [SEP]',\n",
    "  'existing_cui': 'C1823563',\n",
    "  'existing_cui_name': 'TYW3 gene',\n",
    "  'existing_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
    "  'our_bi_cui': 'C1823563',\n",
    "  'our_bi_cui_name': 'TYW3 gene',\n",
    "  'our_bi_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27587730.11',\n",
    "  'test_set_idx': 10750,\n",
    "  'type': 'T103',\n",
    "  'name': 'gga-miR-21',\n",
    "  'context': '[CLS] - 21 in ##hibit ##s chicken pre - ad ##ip ##oc ##yte proliferation in part by down - regulating K ##rup ##pel - like factor 5 G ##ga - mi ##R - 21 is abundant ##ly expressed in chicken pre - ad ##ip ##ocytes , but its role is unclear . The present study investigated the role of [unused1] g ##ga - mi ##R - 21 [unused2] in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga - mi ##R - 21 [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C2825314',\n",
    "  'our_bi_cui_name': 'MicroRNA Gene',\n",
    "  'our_bi_cui_desc': '[CLS] Micro ##RNA Gene [unused3] ( Ana ##tom ##ical Structure : Micro RNA Gene ; Mi ##RNA Gene ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '28375743.9',\n",
    "  'test_set_idx': 33552,\n",
    "  'type': 'T103',\n",
    "  'name': 'structured RNA elements',\n",
    "  'context': '[CLS] Engineering and In V ##ivo Applications of R ##ib ##os ##witch ##es R ##ib ##os ##witch ##es are common gene regulatory units mostly found in bacteria that are capable of altering gene expression in response to a small molecule . These [unused1] structured RNA elements [unused2] consist of two modular subunit ##s : an a ##pta ##mer domain that binds with high specific ##ity and affinity to a target l ##igan ##d and an expression platform that trans ##du ##ces l ##igan ##d binding to a gene expression output . Sign ##ificant progress has been made in engineering novel a ##pta ##mer domains for new small molecule induce ##rs of gene expression . Mo ##dified expression platforms have also been op ##ti ##mized to function when [SEP]',\n",
    "  'existing_cui': 'C0003818',\n",
    "  'existing_cui_name': 'Arsenic',\n",
    "  'existing_cui_desc': '[CLS] A ##rsen ##ic [unused3] ( Chemical , As , product , substance : AR ##SE ##NI ##C ; a ##rsen ##ics ; As element ; A ##rsen ##ic [ Chemical / In ##g ##red ##ient ] ; As - A ##rsen ##ic ; A ##rsen ##ic product ; a ##rsen ##ic ) [SEP]',\n",
    "  'our_bi_cui': 'C1138413',\n",
    "  'our_bi_cui_name': 'Regulatory Sequences , Ribonucleic Acid',\n",
    "  'our_bi_cui_desc': '[CLS] Reg ##ulatory Se ##quence ##s , R ##ib ##on ##uc ##le ##ic A ##cid [unused3] ( Chemical : Reg ##ulatory RNA Region ##s ; R ##EG R ##IB ##ON ##UC ##LE ##IC AC ##ID R ##EG ##ION ; R ##EG SE ##Q R ##IB ##ON ##UC ##LE ##IC AC ##ID ; RNA Reg ##ulatory Se ##quence ; Reg ##ulatory Se ##quence ##s , R ##ib ##on ##uc ##le ##ic A ##cid [ Chemical / In ##g ##red ##ient ] ; Reg ##ulatory R ##ib ##on ##uc ##le ##ic A ##cid Region ; R ##ib ##on ##uc ##le ##ic A ##cid Reg ##ulatory Se ##quence ##s ; Reg ##ulatory Se ##quence ##s , RNA ; RNA Region ##s , Reg ##ulatory ; RNA Region , Reg ##ulatory [SEP]',\n",
    "  'our_cross_cui': 'C0035668',\n",
    "  'our_cross_cui_name': 'RNA',\n",
    "  'our_cross_cui_desc': '[CLS] RNA [unused3] ( Chemical , RNA , R ##ib ##on ##uc ##le ##ic A ##cid , substance : rib ##on ##uc ##le ##ic acid ; R ##ib ##on ##uc ##le ##ic acids ; RNA , Non - Pol ##ya ##den ##yla ##ted ; rib ##on ##uc ##lein ##ic ##um acid ##um / rib ##on ; RNA - R ##ib ##on ##uc ##le ##ic acid ; RNA [ Chemical / In ##g ##red ##ient ] ; RNA , Non Pol ##ya ##den ##yla ##ted ; Non - Pol ##ya ##den ##yla ##ted RNA ; r ##na ; Non Pol ##ya ##den ##yla ##ted RNA ; A ##cid , R ##ib ##on ##uc ##le ##ic ; R ##ib ##on ##uc ##le ##ic acid ; Gene Products , RNA [SEP]'},\n",
    " {'mention_id': '27587730.1',\n",
    "  'test_set_idx': 10740,\n",
    "  'type': 'T103',\n",
    "  'name': 'Gga-miR-21',\n",
    "  'context': '[CLS] [unused1] G ##ga - mi ##R - 21 [unused2] in ##hibit ##s chicken pre - ad ##ip ##oc ##yte proliferation in part by down - regulating K ##rup ##pel - like factor 5 G ##ga - mi ##R - 21 is abundant ##ly expressed in chicken pre - ad ##ip ##ocytes , but its role is unclear . The present study investigated the role of g ##ga - mi ##R - 21 in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1999986',\n",
    "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '27894019.21',\n",
    "  'test_set_idx': 21082,\n",
    "  'type': 'T103',\n",
    "  'name': 'CYP314a1',\n",
    "  'context': '[CLS] ##hur ##eni ##c acid is a known end ##ogen ##ous m ##olt regulator present in art ##hr ##op ##ods . Experimental studies have confirmed that X ##ant ##hur ##eni ##c acid in ##hibit ##s m ##olt ##ing by binding to either ( or both ) of two P ##45 ##0 enzymes ( C ##YP ##31 ##5 ##a ##1 or [unused1] C ##YP ##31 ##4 ##a ##1 [unused2] ) that are responsible for the final two h ##ydro ##xy ##lation ##s in the production of the m ##olt - in ##ducing hormone , 20 - h ##ydro ##xy ##ec ##dy ##son ##e . The lack of crystal structures and bio ##chemical ass ##ays for C ##YP ##31 ##5 ##a ##1 or C ##YP ##31 ##4 ##a ##1 [SEP]',\n",
    "  'existing_cui': 'C1418799',\n",
    "  'existing_cui_name': 'PPIF gene',\n",
    "  'existing_cui_desc': '[CLS] PP ##IF gene [unused3] ( Ana ##tom ##ical Structure : C ##Y ##CL ##OP ##H ##IL ##IN 3 ; P ##EP ##TI ##D ##Y ##L - PR ##OL ##Y ##L C ##IS / T ##RA ##NS ISO ##ME ##RA ##SE , MIT ##OC ##H ##ON ##DR ##IA ##L ; P ##ept ##idy ##l ##p ##rol ##yl Is ##omer ##ase F Gene ; PP ##IF Gene ; C ##Y ##CL ##OP ##H ##IL ##IN F ; p ##ept ##idy ##l ##p ##rol ##yl is ##omer ##ase F ; Cy ##p - D ; h ##C ##y ##P ##3 ; c ##y ##c ##lop ##hil ##in D ) [SEP]',\n",
    "  'our_bi_cui': 'C0051169',\n",
    "  'our_bi_cui_name': 'Alkane 1-monooxygenase',\n",
    "  'our_bi_cui_desc': '[CLS] Al ##kan ##e 1 - mon ##oo ##xy ##gen ##ase [unused3] ( Chemical , substance : P - 450 4 ##A , Cy ##to ##ch ##rome ; Al ##kan ##e 1 H ##ydro ##xy ##lase ; Cy ##to ##ch ##rome P 450 IV ##A ; A ##cid Omega - h ##ydro ##xy ##lase , Lau ##ric ; Al ##kan ##e H ##ydro ##xy ##lase ; Omega - H ##ydro ##xy ##lase , Fat ##ty A ##cid ; Lau ##ric A ##cid H ##ydro ##xy ##lase ; Al ##kan ##e 1 Mon ##oo ##xy ##gen ##ase ; Cy ##to ##ch ##rome P - 450 C ##YP ##4 ##A ; Omega - Lau ##ryl H ##ydro ##xy ##lase ; Omega - h ##ydro ##xy ##lase , Lau ##ric [SEP]',\n",
    "  'our_cross_cui': 'C0010762',\n",
    "  'our_cross_cui_name': 'Cytochrome P450',\n",
    "  'our_cross_cui_desc': '[CLS] Cy ##to ##ch ##rome P ##45 ##0 [unused3] ( Chemical , substance : c ##yt ##och ##rome ##s p ##45 ##0 ; c ##yt ##och ##rome P ##45 ##0 ; C ##Y ##TO ##CH ##RO ##ME P 450 E ##N ##Z ##Y ##ME S ##Y ##ST ##EM ; Cy ##to ##ch ##rome p ##45 ##0 enzyme ; Super ##family , Cy ##to ##ch ##rome P ##45 ##0 ; P ##45 ##0 En ##zy ##mes ; c ##yt ##och ##rome p 450 ; En ##zy ##mes , P ##45 ##0 ; Cy ##to ##ch ##rome P 450 Families ; Cy ##to ##ch ##rome P ##45 ##0 En ##zy ##me ; P ##45 ##0 ; C ##YP ##45 ##0 ; Cy ##to ##ch ##rome p ##45 ##0 ; [SEP]'},\n",
    " {'mention_id': '27506129.31',\n",
    "  'test_set_idx': 8663,\n",
    "  'type': 'T170',\n",
    "  'name': 'oversampling approaches',\n",
    "  'context': '[CLS] the SM ##OT ##E approach for both scales ( mean square error < 0 . 00 ##6 ) . Machine learning methods are able to perform an objective assessment of h ##yper ##emia g ##rading , removing both in ##tra - and inter - expert subject ##ivity while providing a gain in com ##putation time . SM ##OT ##E and [unused1] overs ##amp ##ling approaches [unused2] mini ##mise the class im ##bal ##ance problem , while feature selection reduces the number of features from 25 to 3 - 5 without worse ##ning the mean square error . As the differences between the system and a human expert are similar to the differences between experts , we can therefore conclude that the system behave ##s like an [SEP]',\n",
    "  'existing_cui': 'C0449445',\n",
    "  'existing_cui_name': 'Approach',\n",
    "  'existing_cui_desc': '[CLS] A ##pp ##roach [unused3] ( Spa ##tial Concept , attribute , qualifier value : A ##pp ##roach ##es ; approach ; approaches ; approaching ) [SEP]',\n",
    "  'our_bi_cui': 'C0430022',\n",
    "  'our_bi_cui_name': 'diagnostic procedure',\n",
    "  'our_bi_cui_desc': '[CLS] diagnostic procedure [unused3] ( Health Care Act ##ivity , procedure : D ##IA ##G ##N ##OS ##TI ##C ; Di ##ag ##nos ##tic procedure ; Di ##ag ##nos ##tic procedures ; Di ##ag ##nos ##tic Test ; diagnostic technique ; Di ##ag ##nos ##tic ; Di ##ag ##nos ##tic Tech ##ni ##que ; Di ##ag ##nos ##tic Pro ##ced ##ure ; diagnostic procedures ; Di ##ag ##nos ##tic Method ; Pro ##ced ##ures ; diagnostic ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27388786.19',\n",
    "  'test_set_idx': 4442,\n",
    "  'type': 'T038',\n",
    "  'name': 'production',\n",
    "  'context': \"[CLS] - Si ##gu ##t , Da ##ws , et al . , 2015 ) we found stronger left lateral ##ization for sign than speech . Given that this increased lateral ##ization could not be explained by hand movement alone , the contribution of motor movement versus ' linguistic ' processes to the strength of hem ##is ##pheric lateral ##ization during sign [unused1] production [unused2] remains unclear . Here we directly contrast lateral ##ization strength of covert versus over ##t signing during p ##hon ##ological and semantic flu ##ency tasks . To address the possibility that hearing native sign ##ers ' elevated lateral ##ization in ##dices were due to performing a task in their less dominant language , here we test deaf native sign ##ers , whose [SEP]\",\n",
    "  'existing_cui': 'C1548180',\n",
    "  'existing_cui_name': 'Production Processing ID',\n",
    "  'existing_cui_desc': '[CLS] Production Process ##ing ID [unused3] ( Intel ##lect ##ual Product : Production ) [SEP]',\n",
    "  'our_bi_cui': 'C0220781',\n",
    "  'our_bi_cui_name': 'Anabolism',\n",
    "  'our_bi_cui_desc': '[CLS] Ana ##bol ##ism [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : bio ##sy ##nt ##hetic process ; Ana ##bol ##ism , function ; synthesis ; bio ##sy ##nt ##hesis ; formation ; B ##ios ##ynth ##etic ; B ##ios ##ynth ##esis ; B ##io ##genesis ; B ##ios ##ynth ##etic Process ; an ##ab ##olis ##m ) [SEP]',\n",
    "  'our_cross_cui': 'C0025361',\n",
    "  'our_cross_cui_name': 'Mental Processes',\n",
    "  'our_cross_cui_desc': '[CLS] Mental Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction , Human , function , o ##bs ##er ##vable entity : Human Information Process ##ing ; Thought process ; cognitive processing ; processes thought ; processing thought ; Information Process ##ing , Human ; Human information processing ; Information Process ##es ; mental processing ; cognitive process ; Form of thinking , function ; mental processes ; Form of thought ; Form of thinking ; Human Information Process ##es ; Mental Process ; mental process ; thought process ) [SEP]'},\n",
    " {'mention_id': '27500205.3',\n",
    "  'test_set_idx': 8435,\n",
    "  'type': 'T103',\n",
    "  'name': 'Kindlins',\n",
    "  'context': '[CLS] Of Kind ##lins and Cancer [unused1] Kind ##lins [unused2] are 4 . 1 - e ##z ##rin - rid ##ix ##in - m ##oes ##in ( F ##ER ##M ) domain containing proteins . There are three kind ##lins in mammals , which share high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the [SEP]',\n",
    "  'existing_cui': 'C1720776',\n",
    "  'existing_cui_name': 'Kindling , Neurologic',\n",
    "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
    "  'our_bi_cui': 'C0010422',\n",
    "  'our_bi_cui_name': 'Crystallins',\n",
    "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27842161.1',\n",
    "  'test_set_idx': 19094,\n",
    "  'type': 'T103',\n",
    "  'name': 'Netarsudil',\n",
    "  'context': '[CLS] [unused1] Net ##ars ##udi ##l [unused2] Inc ##rease ##s Out ##flow Facility in Human Eyes Through Multiple Me ##chan ##isms Net ##ars ##udi ##l is a R ##ho kinase / nor ##ep ##ine ##ph ##rine transport ##er inhibitor currently in phase 3 clinical development for g ##lau ##com ##a treatment . We investigated the effects of its active meta ##bol ##ite , net ##ars ##udi ##l - M1 , on out ##flow facility ( C ) , out ##flow h ##ydro ##dynamic ##s , and morphology of the conventional out ##flow pathway in en ##uc ##lea ##ted human eyes . Pa ##ired human eyes ( n = 5 ) were per ##fused with either 0 . 3 μ ##M net ##ars ##udi ##l - M1 or [SEP]',\n",
    "  'existing_cui': 'C0013443',\n",
    "  'existing_cui_name': 'Ear structure',\n",
    "  'existing_cui_desc': '[CLS] E ##ar structure [unused3] ( Ana ##tom ##ical Structure , Anatomy , body structure : V ##est ##ib ##ulo ##co ##ch ##lea ##r System ; System , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; ear structures ; Organ ##um vest ##ib ##ulo ##co ##ch ##lea ##re ; ear structure ; E ##ar - related structure ; au ##ris ; A ##ppa ##rat ##us , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; E ##ar and related structures ; Au ##ris ; V ##est ##ib ##ulo ##co ##ch ##lea ##r organ ; V ##est ##ib ##ulo ##co ##ch ##lea ##r A ##ppa ##rat ##us ) [SEP]',\n",
    "  'our_bi_cui': 'C0027783',\n",
    "  'our_bi_cui_name': 'Netropsin',\n",
    "  'our_bi_cui_desc': '[CLS] Net ##rops ##in [unused3] ( Chemical : Sin ##ano ##my ##cin ; Net ##rops ##in [ Chemical / In ##g ##red ##ient ] ; net ##rops ##in ; Congo ##cid ##ine ; 1 ##H - P ##yr ##rol ##e - 2 - car ##box ##ami ##de , 4 - ( ( ( ( amino ##im ##ino ##met ##hyl ) amino ) ace ##ty ##l ) amino ) - N - ( 5 - ( ( ( 3 - amino - 3 - im ##ino ##p ##rop ##yl ) amino ) carbon ##yl ) - 1 - met ##hyl - 1 ##H - p ##yr ##rol - 3 - y ##l ) - 1 - met ##hyl - ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27457539.37',\n",
    "  'test_set_idx': 6436,\n",
    "  'type': 'T038',\n",
    "  'name': 'pregnant',\n",
    "  'context': '[CLS] in this species . In this study , the safety and efficacy ( through a neutral ##izing anti ##body response ) of the the ##rm ##ost ##able live at ##ten ##uated R ##V ##F C ##L ##13 ##T vaccine were evaluated in came ##ls in two different preliminary experiments involving 16 came ##ls , ( that 12 came ##ls and 4 [unused1] pregnant [unused2] came ##ls ) . The study revealed that the C ##L ##13 ##T vaccine was safe to use in came ##ls and no abortion ##s or te ##rato ##genic effects were observed . The single dose of the vaccine stimulate ##d a strong and long - lasting neutral ##izing anti ##body response for up to 12 months . The presence of neutral [SEP]',\n",
    "  'existing_cui': 'C0549206',\n",
    "  'existing_cui_name': 'Patient currently pregnant',\n",
    "  'existing_cui_desc': '[CLS] Pat ##ient currently pregnant [unused3] ( Finding , finding , history : Pre ##gnant ; currently pregnant ; Currently pregnant ; Pre ##gna ##ncy not delivered ; G ##ra ##vid ##ity ; G ##ra ##vid ; Pat ##ient pregnant ; pregnant patient ; PR ##EG ##NA ##NT ; pregnant ; g ##ra ##vid ) [SEP]',\n",
    "  'our_bi_cui': 'C0549206',\n",
    "  'our_bi_cui_name': 'Patient currently pregnant',\n",
    "  'our_bi_cui_desc': '[CLS] Pat ##ient currently pregnant [unused3] ( Finding , finding , history : Pre ##gnant ; currently pregnant ; Currently pregnant ; Pre ##gna ##ncy not delivered ; G ##ra ##vid ##ity ; G ##ra ##vid ; Pat ##ient pregnant ; pregnant patient ; PR ##EG ##NA ##NT ; pregnant ; g ##ra ##vid ) [SEP]',\n",
    "  'our_cross_cui': 'C0032961',\n",
    "  'our_cross_cui_name': 'Pregnancy',\n",
    "  'our_cross_cui_desc': '[CLS] Pre ##gna ##ncy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , o ##bs ##er ##vable entity , qualifier value , s ##ym ##pt ##om : G ##esta ##tion ; Pre ##gna ##ncies ; PR ##EG ##N ; g ##esta ##tion ; PR ##EG ##NA ##NC ##Y ; pre ##gna ##ncies ; female pregnancy ; Pre ##gna ##ncy , function ; pregnancy ; Pre ##gna ##ncy [ Disease / Finding ] ) [SEP]'},\n",
    " {'mention_id': '27509301.56',\n",
    "  'test_set_idx': 8838,\n",
    "  'type': 'T033',\n",
    "  'name': 'detection',\n",
    "  'context': '[CLS] 39 out of 46 est ##rogen ##ic meta ##bol ##ites were predicted as potential bio ##tra ##ns ##formation products derived from the parent chemical . The Q ##SA ##R models estimated stronger est ##rogen ##ic activity for the majority of the known est ##rogen ##ic meta ##bol ##ites compared to their parent chemicals . Finally , the three models identified a similar set of parent compounds as top ranked chemicals based on the est ##rogen ##icit ##y of put ##ative meta ##bol ##ites . This proposed in si ##lic ##o approach is an inexpensive and rapid strategy for the [unused1] detection [unused2] of chemicals with est ##rogen ##ic meta ##bol ##ites and may reduce potential false negative results from in v ##it ##ro ass ##ays . [SEP]',\n",
    "  'existing_cui': 'C0206100',\n",
    "  'existing_cui_name': 'Signal Detection',\n",
    "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
    "  'our_bi_cui': 'C1511790',\n",
    "  'our_bi_cui_name': 'Detection',\n",
    "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
    "  'our_cross_cui': 'C0442726',\n",
    "  'our_cross_cui_name': 'Detected',\n",
    "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
    " {'mention_id': '27794068.45',\n",
    "  'test_set_idx': 17122,\n",
    "  'type': 'T038',\n",
    "  'name': 'binding of',\n",
    "  'context': '[CLS] binding protein expression levels . These results reveal the important role of C ##4 ##b binding protein in negative regulation of T ##LR ##1 / 2 - dependent pro - inflammatory c ##yt ##oki ##ne production . Furthermore , using a fluorescent con ##ju ##gated Pam ##3 ##CS ##K ##4 , we show that C ##4 ##b binding protein blocks the [unused1] binding of [unused2] Pam ##3 ##CS ##K ##4 to T ##LR ##1 / 2 . Finally , we show that ex ##ogen ##ous C ##4 ##b binding protein also in ##hibit ##s Pam ##3 ##CS ##K ##4 - induced signaling leading to IL - 8 production . Our results indicate C ##4 ##b binding protein binding to T ##LR ##2 and con ##se ##quent [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0033618',\n",
    "  'our_bi_cui_name': 'Protein Binding',\n",
    "  'our_bi_cui_desc': '[CLS] Pro ##tein Bin ##ding [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : Pro ##tein binding ( biological function ) [ Am ##bi ##guous ] ; Bin ##ding , Pro ##tein ; Pro ##tein binding , function ; Pro ##tein binding ; Pro ##tein binding ( biological function ) ; protein binding ; protein amino acid binding ) [SEP]',\n",
    "  'our_cross_cui': 'C1167622',\n",
    "  'our_cross_cui_name': 'Binding',\n",
    "  'our_cross_cui_desc': '[CLS] Bin ##ding [unused3] ( B ##iol ##og ##ic Fun ##ction , Molecular Fun ##ction , Molecular Fun ##ction : binds ; Physical Inter ##action ; binding [ molecular function ] ; Molecular Inter ##action Process ; Molecular Inter ##action ; binding ; Bo ##und ; bind ) [SEP]'},\n",
    " {'mention_id': '27280034.11',\n",
    "  'test_set_idx': 1340,\n",
    "  'type': 'T082',\n",
    "  'name': 'Newcastle upon Tyne',\n",
    "  'context': \"[CLS] , 1961 - 2009 Ai ##ms and method To as ##cer ##tain differences in patterns of suicide in young men over three decades ( 1960s , 1990s and 2000s ) and discuss implications for suicide prevention . Data on suicide ##s and open verdict ##s in men aged 15 - 34 were obtained from co ##roner ' s records in [unused1] Newcastle upon Tyne [unused2] and anal ##ys ##ed using SP ##SS software . Results An increase in suicide rates from the first to the second decade was followed by a fall in the third decade . This was associated with an increasing proportion of single men , those living alone , unemployment , consumption of alcohol , use of hanging , previous suicide attempt and [SEP]\",\n",
    "  'existing_cui': 'C0027983',\n",
    "  'existing_cui_name': 'Newcastle Disease',\n",
    "  'existing_cui_desc': \"[CLS] Newcastle Disease [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , et ##iology , manifest ##ation : Disease , Newcastle ; new ##castle disease ; Newcastle ' s disease ; A ##vian p ##ne ##um ##oe ##nce ##pha ##lit ##is ; Newcastle disease [ Am ##bi ##guous ] ; P ##se ##udo - f ##ow ##l ##pes ##t ; disease ( or disorder ) ; Newcastle ; Newcastle disease ; Newcastle ; NE ##WC ##AS ##TL ##E D ##IS ; Newcastle fever ; Newcastle Disease [ Disease / Finding ] ) [SEP]\",\n",
    "  'our_bi_cui': 'C0454880',\n",
    "  'our_bi_cui_name': 'Tyne and Wear',\n",
    "  'our_bi_cui_desc': '[CLS] Tyne and We ##ar [unused3] ( Spa ##tial Concept , geographic location : T and W - Tyne and We ##ar ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '28223077.34',\n",
    "  'test_set_idx': 28918,\n",
    "  'type': 'T082',\n",
    "  'name': 'surrounding sites',\n",
    "  'context': '[CLS] 00 ##4 , 2 . 05 ##8 ± 0 . 45 ##8 , 2 . 61 ##7 ± 1 . 09 ##2 and 1 . 82 ##2 ± 0 . 56 ##6 p ##g ##N ##m ( - 3 ) , respectively . ( 2 ) The toxic equivalent concentrations of PC ##D ##D / F ##s in ambient air from [unused1] surrounding sites [unused2] , background site , up ##wind site and down ##wind site were 0 . 103 ± 0 . 01 ##7 , 0 . 09 ##6 ± 0 . 01 ##5 , 0 . 120 ± 0 . 02 ##4 and 0 . 108 ± 0 . 01 ##4 p ##g I - T ##E ##Q ##N ##m ( - 3 ) [SEP]',\n",
    "  'existing_cui': 'C1282914',\n",
    "  'existing_cui_name': 'Surrounding',\n",
    "  'existing_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
    "  'our_bi_cui': 'C1282914',\n",
    "  'our_bi_cui_name': 'Surrounding',\n",
    "  'our_bi_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
    "  'our_cross_cui': 'C0205145',\n",
    "  'our_cross_cui_name': 'Site',\n",
    "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
    " {'mention_id': '27298278.41',\n",
    "  'test_set_idx': 1842,\n",
    "  'type': 'T017',\n",
    "  'name': 'Ketr3',\n",
    "  'context': \"[CLS] ' - di ##car ##box ##yla ##te , respectively . Na ##ph ##th ##o ##quin ##ones and nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##ers were previously unknown in the genus Mo ##rin ##da . In addition , the compounds were tested for c ##yt ##oto ##xi ##city against four human cancer cell lines He ##L ##a , A2 ##7 ##80 , [unused1] Ke ##tr ##3 [unused2] and MC ##F - 7 and their effects on p ##53 - activated transcription . Three nap ##ht ##ho ##quin ##ones had moderate c ##yt ##oto ##xi ##c effects with I ##C ##50 values ranging from 1 . 51 to 9 . 56 μ ##M , through up - regulation of p ##53 transcription ##al activity . [SEP]\",\n",
    "  'existing_cui': 'C3539712',\n",
    "  'existing_cui_name': 'CELF2 wt Allele',\n",
    "  'existing_cui_desc': '[CLS] CE ##LF ##2 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : N ##AP ##OR ; ET ##R - 3 ; BR ##UN ##OL ##3 ; N ##AP ##OR - 2 ; C ##U ##GB ##P ##2 ; C ##U ##GB ##P , El ##av - Like Family Member 2 w ##t All ##ele ; ET ##R ##3 ) [SEP]',\n",
    "  'our_bi_cui': 'C0007634',\n",
    "  'our_bi_cui_name': 'Cells',\n",
    "  'our_bi_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]',\n",
    "  'our_cross_cui': 'C0085983',\n",
    "  'our_cross_cui_name': 'Cell Line , Tumor',\n",
    "  'our_cross_cui_desc': '[CLS] Cell Line , Tu ##mor [unused3] ( Ana ##tom ##ical Structure : Cell Lines , Tu ##mor ; Tu ##mor Cell Line ; Line , Tu ##mor Cell ; Lines , Tu ##mor Cell ; Tu ##mor Cell Lines ; tumor cell lines ) [SEP]'},\n",
    " {'mention_id': '27826436.48',\n",
    "  'test_set_idx': 18378,\n",
    "  'type': 'T204',\n",
    "  'name': 'cultivars',\n",
    "  'context': '[CLS] ##oka , followed by the G ##ui ##mei ##ren and To ##chi ##oto ##me varieties . Sa ##chin ##oka had the highest t ##it ##rata ##ble acid ##ity T ##A value . The content of as ##cor ##bic acid of c ##v . To ##chi ##oto ##me was higher than the others , but there was no significant difference in [unused1] cult ##iva ##rs [unused2] of Ben ##ih ##op ##pe , To ##chi ##oto ##me , and Sa ##chin ##oka . Fr ##uc ##tos ##e and glucose were the major sugar ##s in all cult ##iva ##rs . C ##it ##ric acid was the major organic acid in c ##v . To ##chi ##oto ##me , c ##v . Sa ##chin ##oka , and c ##v [SEP]',\n",
    "  'existing_cui': 'C3385047',\n",
    "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
    "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
    "  'our_bi_cui': 'C0242775',\n",
    "  'our_bi_cui_name': 'Agricultural Crops',\n",
    "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
    "  'our_cross_cui': 'C0032098',\n",
    "  'our_cross_cui_name': 'Plants',\n",
    "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
    " {'mention_id': '28421738.3',\n",
    "  'test_set_idx': 35181,\n",
    "  'type': 'T038',\n",
    "  'name': 'Amyloid - Beta Liaison',\n",
    "  'context': \"[CLS] Target ##ing the Nr ##f ##2 / [unused1] Amy ##lo ##id - Beta Lia ##ison [unused2] in Alzheimer ' s Disease : A Rat ##ional A ##pp ##roach Amy ##lo ##id is a prominent feature of Alzheimer ' s disease . Yet , a linear link ##age between am ##yl ##oid - β p ##eptide and the disease onset and progression has recently been questioned . In this context , the crucial partnership between am ##yl ##oid - β p ##eptide and Nr ##f ##2 pathways is acquiring para ##mount importance , offering prospects for de ##ci ##pher ##ing the am ##yl ##oid - β p ##eptide - centered disease network . Here , we report on a new class of anti ##ag ##g ##re ##gating [SEP]\",\n",
    "  'existing_cui': 'C2825879',\n",
    "  'existing_cui_name': 'Beta Amyloid Measurement',\n",
    "  'existing_cui_desc': '[CLS] Beta Amy ##lo ##id Me ##as ##ure ##ment [unused3] ( Health Care Act ##ivity : Beta Amy ##lo ##id ; AM ##Y ##L ##O ##ID ##B ; Amy ##lo ##id , Beta ) [SEP]',\n",
    "  'our_bi_cui': 'C1510880',\n",
    "  'our_bi_cui_name': 'Amyloid Beta-Peptide Pathway',\n",
    "  'our_bi_cui_desc': '[CLS] Amy ##lo ##id Beta - P ##eptide Path ##way [unused3] ( B ##iol ##og ##ic Fun ##ction : Generation of am ##yl ##oid b - p ##eptide by PS ##1 ) [SEP]',\n",
    "  'our_cross_cui': 'C1149161',\n",
    "  'our_cross_cui_name': 'beta-amyloid binding',\n",
    "  'our_cross_cui_desc': '[CLS] beta - am ##yl ##oid binding [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]'},\n",
    " {'mention_id': '28269453.17',\n",
    "  'test_set_idx': 30622,\n",
    "  'type': 'T170',\n",
    "  'name': 'fitness planner',\n",
    "  'context': '[CLS] End ##urance based personal ##ized fitness plan ##ner End ##urance is an important factor of card ##iovascular fitness indicating the capacity of an individual to perform exercise for a longer duration with increased intensity . Various subject specific and exercise related parameters affect endurance of an individual . In this work , we propose a statistical technique to model endurance as a function of these factors incorporating the serial dependence of observations generated by individuals over time . The proposed model provides a device to predict future endurance of a test subject following particular exercise regime . This facilitate ##s a test user with a [unused1] fitness plan ##ner [unused2] with the provision to fix exercise regime ##s to reach a set fitness goal . [SEP]',\n",
    "  'existing_cui': 'C0600623',\n",
    "  'existing_cui_name': 'Fitness Centers',\n",
    "  'existing_cui_desc': '[CLS] Fitness Centers [unused3] ( Organization : fitness center ; center fitness ; centers fitness ; Fitness Center ; Center , Fitness ; Centers , Fitness ; fitness centers ) [SEP]',\n",
    "  'our_bi_cui': 'C1690589',\n",
    "  'our_bi_cui_name': 'Verbalizes plan to support exercise',\n",
    "  'our_bi_cui_desc': '[CLS] V ##er ##bal ##izes plan to support exercise [unused3] ( Finding , finding : Des ##cribe ##s plan to support exercise ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27540584.34',\n",
    "  'test_set_idx': 9935,\n",
    "  'type': 'T097',\n",
    "  'name': 'endoscopists',\n",
    "  'context': '[CLS] course . There were no technical problems related to the novel si ##mu ##lator during the course . After s ##phi ##nc ##tero ##tom ##y , the organic p ##ap ##illa ##e could easily be exchanged within a few seconds . Overall , the novel Bill ##roth II / R ##oux - en - Y si ##mu ##lator achieved favorable results by train ##ees and expert [unused1] end ##os ##co ##pis ##ts [unused2] in all categories assessed . The new Bill ##roth II / R ##oux - en - Y mechanical si ##mu ##lator is simple and p ##rac ##tica ##ble . A first evaluation during an end ##os ##copic re ##tro ##grade ch ##ola ##ng ##io ##pan ##cre ##ato ##graphy course showed promising results . [SEP]',\n",
    "  'existing_cui': 'C0228237',\n",
    "  'existing_cui_name': 'Structure of superior temporal sulcus',\n",
    "  'existing_cui_desc': '[CLS] Structure of superior temporal su ##l ##cus [unused3] ( Spa ##tial Concept , body structure : Superior temporal fi ##ss ##ure ; Superior Te ##mpo ##ral Sul ##cus ; parallel su ##l ##cus ; Sul ##cus temporal ##is superior ; Superior temporal su ##l ##cus ; superior temporal su ##l ##cus ; Sul ##cus temporal ##is p ##rim ##us ; Sul ##cus t ##1 ; su ##l ##cus t ##1 ; superior temporal fi ##ss ##ure ; Para ##lle ##l su ##l ##cus ) [SEP]',\n",
    "  'our_bi_cui': 'C0582175',\n",
    "  'our_bi_cui_name': 'Surgeon',\n",
    "  'our_bi_cui_desc': '[CLS] Sur ##geon [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : surgeon ##s ; surgeon ; Sur ##geons ) [SEP]',\n",
    "  'our_cross_cui': 'C1522486',\n",
    "  'our_cross_cui_name': 'Professional Organization or Group',\n",
    "  'our_cross_cui_desc': '[CLS] Professional Organization or Group [unused3] ( Professional or O ##cc ##upation ##al Group : Other Agency or Organization ; Organization ; OR ##G ; Outside Bo ##dies ; Organization ##al ) [SEP]'},\n",
    " {'mention_id': '27570140.33',\n",
    "  'test_set_idx': 10496,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedure',\n",
    "  'context': '[CLS] 3 . 2 % , p < . 00 ##1 ) and those with an un ##int ##ended index pregnancy ( 13 . 8 % vs . 4 . 1 % , p < . 00 ##1 ) . Of the patients requesting post ##par ##tum tub ##al l ##iga ##tion , 118 ( 51 . 1 % ) underwent the [unused1] procedure [unused2] immediately post ##par ##tum . Co ##mple ##tion was not associated with high - risk status ( 54 . 0 % ) , or with race , insurance status or par ##ity . Among 113 women with an un ##ful ##fill ##ed post ##par ##tum tub ##al l ##iga ##tion request , there were 17 subsequent pre ##gna ##ncies ( 15 . [SEP]',\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27796974.34',\n",
    "  'test_set_idx': 17388,\n",
    "  'type': 'T082',\n",
    "  'name': 'Balatonfüred City',\n",
    "  'context': '[CLS] been defined for every water chemistry parameter in light of the legal limit values of the water parameters . In addition to this , weight in ##dices were calculated on the basis of the outcome of the paired comparison of water chemistry parameters and normal ##ized matrix . This was followed by the para ##metric level analysis of the water chemistry parameters , and finally , the aquatic environment index was calculated , which provided general information on the quality of water regarding the water chemistry parameters . The method was illustrated on Lake Ba ##lat ##on , Hungary in which case water samples taken from [unused1] Ba ##lat ##on ##f ##ü ##red City [unused2] lake area were analyzed and evaluated with the method devised . [SEP]',\n",
    "  'existing_cui': 'C0008848',\n",
    "  'existing_cui_name': 'Cities',\n",
    "  'existing_cui_desc': '[CLS] Cities [unused3] ( Spa ##tial Concept , environment : City ; city ; cities ) [SEP]',\n",
    "  'our_bi_cui': 'C0008848',\n",
    "  'our_bi_cui_name': 'Cities',\n",
    "  'our_bi_cui_desc': '[CLS] Cities [unused3] ( Spa ##tial Concept , environment : City ; city ; cities ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '28099370.14',\n",
    "  'test_set_idx': 25628,\n",
    "  'type': 'T170',\n",
    "  'name': 'written',\n",
    "  'context': '[CLS] A Course - Based A ##pp ##roach to the Doctor of Nursing Practice Project : Supporting Student Growth From Concept to Co ##mple ##tion We describe a course - based approach to the doctor of nursing practice project in which students work in groups of 8 to 12 with a faculty member to complete individual final projects that require a minimum of 360 p ##rac ##tic ##um hours in 3 - semester - long courses . Project teams include agency or community - based mentor ##s . Project findings are di ##sse ##minated through [unused1] written [unused2] and oral reports . This approach preserves faculty resources and provides students with mentor ##ing , opportunities for reflection , and time for project development . [SEP]',\n",
    "  'existing_cui': 'C4291771',\n",
    "  'existing_cui_name': 'Written Report',\n",
    "  'existing_cui_desc': '[CLS] Written Report [unused3] ( Intel ##lect ##ual Product , Radio ##logy , Radio ##logy : Written Reports ) [SEP]',\n",
    "  'our_bi_cui': 'C4291771',\n",
    "  'our_bi_cui_name': 'Written Report',\n",
    "  'our_bi_cui_desc': '[CLS] Written Report [unused3] ( Intel ##lect ##ual Product , Radio ##logy , Radio ##logy : Written Reports ) [SEP]',\n",
    "  'our_cross_cui': 'C0684224',\n",
    "  'our_cross_cui_name': 'Report',\n",
    "  'our_cross_cui_desc': '[CLS] Report [unused3] ( Intel ##lect ##ual Product , document , document , qualifier value , record artifact : document report ; reports ; Report ##ed ; Reports ; report ; report [ document ] ) [SEP]'},\n",
    " {'mention_id': '27449818.16',\n",
    "  'test_set_idx': 6211,\n",
    "  'type': 'T103',\n",
    "  'name': 'E2',\n",
    "  'context': '[CLS] to parent ##eral est ##rogen administration is characterized by reduced systemic but prominent he ##pa ##tic est ##rogen ##ic effects on lip ##ids , hem ##ost ##atic factors , G ##H - / I ##G ##F I axis , an ##gio ##tens ##ino ##gen . In order to avoid such adverse metabolic effects of oral treatment , est ##rad ##iol ( [unused1] E ##2 [unused2] ) pro ##dr ##ugs ( E ##stra ##dio ##l pro ##dr ##ugs ) were designed which bypass the liver tissue as inactive molecules . Carbon ##e ##17 - OH su ##lf ##ona ##mi ##de [ - O ##2 - NH ##2 ] substituted est ##ers of E ##2 ( EC ##50 ##8 , others ) were synthesized and tested for carbon [SEP]',\n",
    "  'existing_cui': 'C1419454',\n",
    "  'existing_cui_name': 'SNORA62 gene',\n",
    "  'existing_cui_desc': '[CLS] S ##N ##OR ##A ##6 ##2 gene [unused3] ( Ana ##tom ##ical Structure : RNA , U ##10 ##8 SM ##AL ##L N ##UC ##LE ##OL ##AR ; small n ##uc ##leo ##lar RNA , H / AC ##A box 62 ; RNA , E ##2 SM ##AL ##L N ##UC ##LE ##OL ##AR ; E ##2 ; E ##2 - 1 ; s ##no ##RNA , E ##2 ; SM ##AL ##L N ##UC ##LE ##OL ##AR RNA , H / AC ##A B ##OX , 62 ) [SEP]',\n",
    "  'our_bi_cui': 'C0014939',\n",
    "  'our_bi_cui_name': 'Estrogens',\n",
    "  'our_bi_cui_desc': '[CLS] E ##stro ##gens [unused3] ( Chemical , medication , product , substance : est ##rogen ##s ; O ##est ##rogen ##s ; est ##rogen ##ic preparation ; O ##est ##rogen product ; est ##rogen products ; E ##stro ##gen ; E ##stro ##genic drug ; E ##ST ##RO ##GE ##NS ; O ##est ##rogen ##ic drug ; O ##est ##rogen preparation ; E ##stro ##gen preparation ; O ##est ##rogen ; o ##est ##rogen products ; o ##est ##rogen ; A ##gon ##ists , E ##stro ##gen Re ##ceptor ; o ##est ##rogen ##s ; est ##rogen ; E ##stro ##gen product ; O ##est ##rogen ##ic preparation ; Co ##mpo ##unds , E ##stro ##genic ; Agents , E ##stro ##genic ; E ##stro ##gen [SEP]',\n",
    "  'our_cross_cui': 'C0014912',\n",
    "  'our_cross_cui_name': 'Estradiol',\n",
    "  'our_cross_cui_desc': '[CLS] E ##stra ##dio ##l [unused3] ( Chemical , medication , product , substance : o ##est ##rad ##iol ; Benz ##hor ##mo ##var ##ine ; O ##est ##rad ##iol - R ##ET ##IR ##ED - ; 17 beta - est ##rad ##iol ; O ##est ##rad ##iol [ g ##yna ##e ] ; 17 - Beta o ##est ##rad ##iol ; 17 beta E ##stra ##dio ##l ; E ##stra ##ld ##ine ; E ##stra ##dio ##l [ g ##yna ##e ] ; O ##est ##rad ##iol ; E ##SD ##L ; E ##2 - O ##est ##rad ##iol ; 17 beta - E ##stra ##dio ##l ; 17 beta est ##rad ##iol ; E ##stra ##dio ##l product ; O ##est ##rad ##iol preparation ; [SEP]'},\n",
    " {'mention_id': '27611704.11',\n",
    "  'test_set_idx': 11685,\n",
    "  'type': 'T017',\n",
    "  'name': 'B',\n",
    "  'context': \"[CLS] W ##heat Lines B ##read wheat ( Tri ##tic ##um a ##est ##iv ##um , 2 ##n = 6 ##x = 42 , AA ##BB ##D ##D ) has a complex all ##oh ##ex ##ap ##lo ##id genome , which makes it difficult to differentiate between the ho ##mo ##eo ##log ##ous sequences and assign them to the chromosome A , [unused1] B [unused2] , or D sub ##gen ##ome ##s . The chromosome - based draft genome sequence of the ' Chinese Spring ' common wheat cult ##iva ##r enables the large - scale development of polymer ##ase chain reaction ( polymer ##ase chain reaction ) - based markers specific for ho ##mo ##eo ##log ##s . Based on high - confidence ' Chinese Spring [SEP]\",\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0017428',\n",
    "  'our_bi_cui_name': 'Genome',\n",
    "  'our_bi_cui_desc': '[CLS] Gen ##ome [unused3] ( Ana ##tom ##ical Structure , substance : genome ; genome ##s ; Gen ##ome ##s ; Gen ##omi ##c ) [SEP]',\n",
    "  'our_cross_cui': 'C0008633',\n",
    "  'our_cross_cui_name': 'Chromosomes',\n",
    "  'our_cross_cui_desc': '[CLS] Ch ##rom ##oso ##mes [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : chromosome ; Ch ##rom ##oso ##mal ; chromosome ##s ; Ch ##rom ##oso ##me ) [SEP]'},\n",
    " {'mention_id': '27430240.21',\n",
    "  'test_set_idx': 5347,\n",
    "  'type': 'T103',\n",
    "  'name': 'factors',\n",
    "  'context': \"[CLS] trip ##hos ##phate dip ##hos ##ph ##oh ##ydro ##lase 1 ; also known as CD ##39 ) and 5 ' - e ##cton ##uc ##leo ##ti ##das ##e ( N ##T ##5 ##E ; also known as CD ##7 ##3 ) on the T ##re ##g cell surface are increased during se ##psis . In this study , to determine the [unused1] factors [unused2] leading to the high expression of CD ##39 and CD ##7 ##3 , and the regulation of the CD ##39 / CD ##7 ##3 / ad ##eno ##sin ##e pathway in The number of regulatory T cells under se ##ptic conditions , we constructed a mouse model of se ##psis and separated the The number of regulatory T cells using a flow [SEP]\",\n",
    "  'existing_cui': 'C0960756',\n",
    "  'existing_cui_name': 'factor A',\n",
    "  'existing_cui_desc': \"[CLS] factor A [unused3] ( Chemical : Co ( beta ) - c ##yan ##o - 7 ' ' - ( 2 - met ##hyl ) ad ##eni ##ny ##l ##co ##ba ##mi ##de ) [SEP]\",\n",
    "  'our_bi_cui': 'C0021054',\n",
    "  'our_bi_cui_name': 'Immunologic Factors',\n",
    "  'our_bi_cui_desc': '[CLS] I ##mm ##uno ##log ##ic Factor ##s [unused3] ( Chemical , substance : Factor ##s , I ##mm ##uno ##log ##ic ; I ##mm ##une Factor ##s ; Factor ##s , I ##mm ##uno ##logical ; I ##mm ##uno ##log ##ic Factor ; Factor ##s , I ##mm ##une ; I ##mm ##uno ##logical Factor ##s ; im ##mu ##no ##log ##ic substance ; FA ##CT ##OR ##S I ##MM ##UN ##OL ; im ##mu ##nological substance ; I ##MM ##UN ##OL FA ##CT ##OR ##S ; I ##mm ##uno ##log ##ic substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0005515',\n",
    "  'our_cross_cui_name': 'Biological Factors',\n",
    "  'our_cross_cui_desc': '[CLS] Biological Factor ##s [unused3] ( Chemical , product , substance : Agents , Biological ; Biological Factor ; B ##iol ##og ##ic agent ; agents biological ; B ##iol ##og ##ic Factor ##s ; B ##iol ##og ##ic Factor ; biological substance ; Factor , B ##iol ##og ##ic ; Factor ##s , Biological ; bio ##pha ##rma ##ce ##utical ##s ; Biological product ; B ##IO ##L FA ##CT ##OR ; Biological Agents ; Biological substance ; Biological Factor ##s [ Chemical / In ##g ##red ##ient ] ; Biological agent ; B ##iol ##og ##ics ; Factor , Biological ; biological drug ; B ##IO ##L FA ##CT ##OR ##S ; FA ##CT ##OR ##S B ##IO ##L ; biological substances ; bio ##pha [SEP]'},\n",
    " {'mention_id': '27444636.36',\n",
    "  'test_set_idx': 5987,\n",
    "  'type': 'T033',\n",
    "  'name': 'mean age 36 years',\n",
    "  'context': '[CLS] Battery for At ##ten ##tion Performance version 2 . 3 . Assessment ##s were performed immediately prior to and 5 days after switching from o ##x ##car ##ba ##ze ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate ( days 0 and 5 , respectively ) . The analysis included 21 patients ( 12 women , 9 men ; [unused1] mean age 36 years [unused2] ) . After switching from o ##x ##car ##ba ##ze ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate , there were significant improvements in mean scores for Ad ##verse Events Profile ( P < . 00 ##1 ) , Quality of Life in E ##pile ##psy In ##vent ##ory 10 ( P = . 00 ##1 ) , [SEP]',\n",
    "  'existing_cui': 'C1847486',\n",
    "  'existing_cui_name': 'Mean age of onset 56 years',\n",
    "  'existing_cui_desc': '[CLS] Mean age of onset 56 years [unused3] ( Finding ) [SEP]',\n",
    "  'our_bi_cui': 'C1834001',\n",
    "  'our_bi_cui_name': 'Mean age at onset 32 years',\n",
    "  'our_bi_cui_desc': '[CLS] Mean age at onset 32 years [unused3] ( Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27251800.42',\n",
    "  'test_set_idx': 837,\n",
    "  'type': 'T058',\n",
    "  'name': 'Stoppa',\n",
    "  'context': '[CLS] 15 th post - operative ( P > 0 . 05 ) . Co ##mp ##lication ##s occurred in 88 % of Stop ##pa group ( 22 patients ) and 64 % in lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair group ( 16 patients ) ( P < 0 . 05 ) . The comparative study between the [unused1] Stop ##pa [unused2] and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approaches for the bilateral ing ##uin ##al her ##nia repair demonstrated that : ( 1 ) The lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approach showed less surgical trauma despite the longer operation time ; ( 2 ) Quality of life during the early post - operative [SEP]',\n",
    "  'existing_cui': 'C1538901',\n",
    "  'existing_cui_name': 'ACD gene',\n",
    "  'existing_cui_desc': '[CLS] AC ##D gene [unused3] ( Ana ##tom ##ical Structure : T ##EL ##OM ##ER ##E PR ##OT ##EI ##N T ##PP ##1 ; ad ##ren ##oc ##ort ##ical d ##ys ##p ##lasia ho ##mo ##log ; AC ##D Gene ; Ad ##ren ##oc ##ort ##ical D ##ys ##p ##lasia Ho ##mo ##log ( Mouse ) Gene ; P ##OT ##1 - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N 1 ; P ##OT ##1 - AND T ##IN ##2 - OR ##GA ##NI ##Z ##ING PR ##OT ##EI ##N ; P ##OT ##1 and T ##IN ##2 organizing protein ; AC ##D , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; Tin ##t ##1 ; T ##IN ##2 interacting protein 1 [SEP]',\n",
    "  'our_bi_cui': 'C0031150',\n",
    "  'our_bi_cui_name': 'Laparoscopy',\n",
    "  'our_bi_cui_desc': '[CLS] La ##par ##os ##copy [unused3] ( Health Care Act ##ivity , G ##I only , procedure : La ##par ##os ##copic procedure ; per ##ito ##ne ##os ##copy ; Co ##eli ##os ##copy ; Ce ##lio ##sco ##pies ; Per ##ito ##ne ##os ##co ##pies ; Abd ##ome ##n end ##os ##copy ; c ##eli ##os ##copy ; lap ##aro ##scopic procedure ; Per ##ito ##ne ##os ##copy ; La ##p ; Ce ##lio ##sco ##py ; La ##par ##os ##co ##pies ; lap ##aro ##sco ##pies ; lap ##aro ##sco ##py ; lap ##aro ##scopic procedures ; diagnostic lap ##aro ##sco ##py ; End ##os ##copy of abdomen ; lap ##aro ##sco ##py procedure ; La ##par ##os ##copic ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27475696.10',\n",
    "  'test_set_idx': 7473,\n",
    "  'type': 'T038',\n",
    "  'name': 'alcohol',\n",
    "  'context': '[CLS] E ##stro ##gen and Pro ##ges ##tero ##ne hormone receptor expression in oral cavity cancer Recent studies have shown an increase in the incidence of oral sq ##ua ##mous cell car ##cin ##oma in younger patients . The hypothesis that tumors could be ho ##rmon ##ally induced during pregnancy or in young female patients without the well - known risk factors [unused1] alcohol [unused2] or tobacco abuse seems to be plausible . E ##stro ##gen Re ##ceptor alpha and Pro ##ges ##tero ##ne Re ##ceptor expression were analyzed in normal oral m ##uc ##osa ( n = 5 ) , oral precursor lesions ( simple h ##yper ##p ##lasia , n = 11 ; sq ##ua ##mous in ##tra ##ep ##ith ##eli ##al neo ##p ##lasia [SEP]',\n",
    "  'existing_cui': 'C0202304',\n",
    "  'existing_cui_name': 'Ethanol measurement',\n",
    "  'existing_cui_desc': '[CLS] Ethan ##ol measurement [unused3] ( Health Care Act ##ivity , procedure : DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TA ##LC ##OH ##OL ##S ; Ethan ##ol Me ##as ##ure ##ment ; Al ##co ##hol ##s levels ; Al ##co ##hol ##s ; Ethan ##ol ; DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TI ##TA ##TI ##VE AL ##CO ##H ##OL ##S ; Al ##co ##hol ; alcohol measurements ; Me ##as ##ure ##ment of alcohol ; E ##thy ##l Al ##co ##hol Me ##as ##ure ##ments ; Drug screen q ##uant ##al ##co ##hol ##s ; Al ##co ##hol level ; Al ##co ##hol measurement ; ET ##HA ##N ##OL ; alcohol level test ) [SEP]',\n",
    "  'our_bi_cui': 'C0001975',\n",
    "  'our_bi_cui_name': 'Alcohols',\n",
    "  'our_bi_cui_desc': '[CLS] Al ##co ##hol ##s [unused3] ( Chemical , substance : alcohol ; Al ##co ##hol [ Chemical Class ] ; Al ##co ##hol ; Al ##co ##hol ##s [ Chemical / In ##g ##red ##ient ] ; alcohol ##s ; class of chemical alcohol ##s ; alcohol substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0085762',\n",
    "  'our_cross_cui_name': 'Alcohol abuse',\n",
    "  'our_cross_cui_desc': '[CLS] Al ##co ##hol abuse [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , finding : abuses alcohol ; alcohol ; use , problem ; Ethan ##ol abuse ; problem drinking ; alcohol abuse ; problem ; alcohol use ; ethanol abuse ; Al ##co ##hol abuse , un ##sp ##ec ##ified drinking behaviour ; Al ##co ##hol abuse , un ##sp ##ec ##ified drinking behavior ; ET ##OH abuse ; abuse ; alcohol ; AA - Al ##co ##hol abuse ; alcohol abuse disorder ; drinking problems ; Al ##co ##hol abuse , un ##sp ##ec ##ified ; Problem Dr ##ink ##ing ; r ##nd ##x alcohol abuse ; alcohol abuses ; Al ##co ##hol Abu ##se ; Al ##co ##hol abuse [SEP]'},\n",
    " {'mention_id': '27920749.27',\n",
    "  'test_set_idx': 21864,\n",
    "  'type': 'T170',\n",
    "  'name': 'emotionally negative film clip',\n",
    "  'context': \"[CLS] ##al bias ##es to happy and angry faces . In Study 1 , healthy young women were recruited and randomly assigned to one of the three groups : up - , down - , and no - regulation . Part ##ici ##pants were instructed to re ##ap ##pra ##ise their emotions to increase and decrease emotional experience while viewing an [unused1] emotionally negative film clip [unused2] . At ##ten ##tional bias was assessed with a dot - probe task with pictures of angry and happy facial expressions . In Study 2 , a separate group of healthy young men and women participated . Part ##ici ##pants ' trait re ##ap ##pra ##isa ##l and suppression as well as state and trait anxiety were assessed . A [SEP]\",\n",
    "  'existing_cui': 'C0558263',\n",
    "  'existing_cui_name': 'Emotionally distant',\n",
    "  'existing_cui_desc': '[CLS] Em ##otion ##ally distant [unused3] ( Finding , finding : Em ##otion ##ally al ##oof ) [SEP]',\n",
    "  'our_bi_cui': 'C3463807',\n",
    "  'our_bi_cui_name': 'Video Media',\n",
    "  'our_bi_cui_desc': '[CLS] Video Media [unused3] ( Intel ##lect ##ual Product : Video ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28351716.3',\n",
    "  'test_set_idx': 32856,\n",
    "  'type': 'T058',\n",
    "  'name': 'digital fundus images',\n",
    "  'context': '[CLS] Di ##ag ##nosis of re ##tina ##l health in [unused1] digital fund ##us images [unused2] using continuous wave ##let transform and en ##tro ##pies Vision is para ##mount to humans to lead an active personal and professional life . The prevalence of o ##cular diseases is rising , and diseases such as g ##lau ##com ##a , Di ##abe ##tic Re ##tino ##pathy and Age - related Mac ##ular De ##gene ##ration are the leading causes of blind ##ness in developed countries . I ##dent ##ifying these diseases in mass screening programmes is time - consuming , labor - intensive and the diagnosis can be subjective . The use of an automated computer aided diagnosis system will reduce the time taken for analysis and will also [SEP]',\n",
    "  'existing_cui': 'C0017129',\n",
    "  'existing_cui_name': 'gastric fundus',\n",
    "  'existing_cui_desc': '[CLS] gas ##tric fund ##us [unused3] ( Ana ##tom ##ical Structure , body structure , vent ##ric ##ular ##is : Fund ##us ; Fund ##us gas ##tric ##us ; Fund ##us , Gas ##tric ; ST ##OM ##AC ##H , F ##UN ##D ##US ; Fund ##us of St ##oma ##ch ; fund ##us of stomach ; Gas ##tric fund ##us ; stomach fund ##us ; Gas ##tric fund ##us structure ; Fund ##us structure of stomach ; Fund ##us of the St ##oma ##ch ; F ##UN ##D ##US OF THE ST ##OM ##AC ##H ; Fund ##us of stomach ; Gas ##tric Fund ##us ) [SEP]',\n",
    "  'our_bi_cui': 'C1704254',\n",
    "  'our_bi_cui_name': 'Medical Image',\n",
    "  'our_bi_cui_desc': '[CLS] Medical Image [unused3] ( Intel ##lect ##ual Product : Image ) [SEP]',\n",
    "  'our_cross_cui': 'C0200189',\n",
    "  'our_cross_cui_name': 'Fundus photography',\n",
    "  'our_cross_cui_desc': '[CLS] Fund ##us photography [unused3] ( Health Care Act ##ivity , procedure : fund ##us photography ; O ##cular fund ##us photography ; eye fund ##us photography ) [SEP]'},\n",
    " {'mention_id': '27604152.49',\n",
    "  'test_set_idx': 11446,\n",
    "  'type': 'T007',\n",
    "  'name': 'non - aureus staphylococci',\n",
    "  'context': '[CLS] n = 3 ) . No met ##hic ##ill ##in - resistant St ##aph ##yl ##oc ##oc ##cus au ##reus were isolated from 58 ##6 culture ##d s ##wab ##s . Met ##hic ##ill ##in - susceptible S . au ##reus were detected in 9 / 257 ( 3 . 5 % ) s ##wab ##s and [unused1] non - au ##reus s ##ta ##phy ##loc ##oc ##ci [unused2] in 22 / 257 ( 8 . 5 % ) s ##wab ##s . The estimated true met ##hic ##ill ##in - resistant St ##aph ##yl ##oc ##oc ##cus au ##reus sub ##c ##lini ##cal co ##lon ##isation prevalence was 0 % , with an upper 95 % C ##I boundary of 1 . 9 % for [SEP]',\n",
    "  'existing_cui': 'C1318973',\n",
    "  'existing_cui_name': 'Staphylococcus aureus infection',\n",
    "  'existing_cui_desc': '[CLS] St ##aph ##yl ##oc ##oc ##cus au ##reus infection [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : St ##aph ##yl ##oc ##oc ##cus au ##reus infections ; St ##aph ##yl ##oc ##oc ##cus au ##reus ; In ##fect ##ion due to St ##aph ##yl ##oc ##cc ##us au ##reus ; In ##fect ##ion due to St ##aph ##yl ##oc ##oc ##cus au ##reus ; St ##aph ##yl ##oc ##oc ##cus au ##reus In ##fect ##ion ; In ##fect ##ion caused by St ##aph ##yl ##oc ##oc ##cus au ##reus ; s ##ta ##phy ##loc ##oc ##cus au ##reus infection ; s ##ta ##phy ##loc ##oc ##cus ; au ##reus ; au ##reus ; St ##aph ##yl ##oc ##oc ##cus ) [SEP]',\n",
    "  'our_bi_cui': 'C0038172',\n",
    "  'our_bi_cui_name': 'Staphylococcus aureus',\n",
    "  'our_bi_cui_desc': '[CLS] St ##aph ##yl ##oc ##oc ##cus au ##reus [unused3] ( Ba ##cter ##ium , organism : S . au ##reus ; s ##ta ##ph au ##reus ; ST ##AP ##H AU ##RE ##US ; S . AU ##RE ##US ; St ##aph . au ##reus ; St ##aph ##yl ##oc ##oc ##cus p ##yo ##gene ##s au ##reus ; s . au ##reus ; ST ##AP ##H ##Y ##L ##OC ##OC ##CU ##S AU ##RE ##US ; s ##ta ##phy ##loc ##oc ##cus au ##reus bacteria ; St ##aph ##yl ##oc ##oc ##cus au ##reus Rosen ##bach 1884 ; Micro ##co ##cc ##us au ##reus ; St ##aph ##yl ##oc ##oc ##cus Au ##reus ; St ##aph ##loc ##oc ##cus p ##yo ##gene ##s c ##it [SEP]',\n",
    "  'our_cross_cui': 'C0038170',\n",
    "  'our_cross_cui_name': 'Genus staphylococcus',\n",
    "  'our_cross_cui_desc': '[CLS] Genus s ##ta ##phy ##loc ##oc ##cus [unused3] ( Ba ##cter ##ium , organism : St ##aph ##yl ##oc ##oc ##cus species ; Genus St ##aph ##yl ##oc ##oc ##cus ; Au ##ro ##co ##cc ##us ; ST ##AP ##H ##Y ##L ##OC ##OC ##CU ##S ; St ##aph ##yl ##oc ##oc ##cus ; St ##aph ##yl ##oc ##oc ##cus Rosen ##bach 1884 ; s ##ta ##phy ##loc ##oc ##cus bacteria ; ST ##AP ##H ; s ##ta ##phy ##loc ##oc ##cus ) [SEP]'},\n",
    " {'mention_id': '27782044.8',\n",
    "  'test_set_idx': 16578,\n",
    "  'type': 'T204',\n",
    "  'name': 'Max Clara',\n",
    "  'context': \"[CLS] Normal Level ##s of U ##rina ##ry CC ##16 Pro ##tein . Co ##mme ##nts on Be ##ame ##r et al . Association of Children ' s U ##rina ##ry CC ##16 Level ##s with A ##rsen ##ic Con ##cent ##rations in Multiple Environmental Media . In ##t . J . En ##vir ##on . Re ##s . Public Health 2016 , 13 , 52 ##1 In 1937 , [unused1] Max Clara [unused2] described a new type of cell in the human lung , which was later determined to be an ex ##oc ##rine secret ##ory cell type containing g ##ran ##ules composed of proteins [ 1 ] . [ . . . ] . [SEP]\",\n",
    "  'existing_cui': 'C0225668',\n",
    "  'existing_cui_name': 'Clara cell',\n",
    "  'existing_cui_desc': '[CLS] Clara cell [unused3] ( Ana ##tom ##ical Structure , body structure , cell : Clara Cell ; Clara cell of br ##on ##chi ##ole ; c ##lar ##a cell ; cells c ##lar ##a ; B ##ron ##chi ##olar non - c ##iliated cell ; Non ##ci ##lia ##ted B ##ron ##chi ##olar E ##pit ##hel ##ial Cell ; Club Cell ) [SEP]',\n",
    "  'our_bi_cui': 'C0225668',\n",
    "  'our_bi_cui_name': 'Clara cell',\n",
    "  'our_bi_cui_desc': '[CLS] Clara cell [unused3] ( Ana ##tom ##ical Structure , body structure , cell : Clara Cell ; Clara cell of br ##on ##chi ##ole ; c ##lar ##a cell ; cells c ##lar ##a ; B ##ron ##chi ##olar non - c ##iliated cell ; Non ##ci ##lia ##ted B ##ron ##chi ##olar E ##pit ##hel ##ial Cell ; Club Cell ) [SEP]',\n",
    "  'our_cross_cui': 'C0086418',\n",
    "  'our_cross_cui_name': 'Homo sapiens',\n",
    "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
    " {'mention_id': '27905972.25',\n",
    "  'test_set_idx': 21639,\n",
    "  'type': 'T098',\n",
    "  'name': 'Danish',\n",
    "  'context': '[CLS] mixed log ##istic model with different slopes in adult , middle , and old age , and includes the m ##oda ##l age at death as a parameter to account for the delay in mortality . A ##pp ##lying the Co ##D ##e model to age - specific pro ##ba ##bilities of death for Japanese , French , American , and [unused1] Danish [unused2] men and women between 1950 and 2010 showed a very good fit of the full age pattern of mortality . Del ##ay of mortality explained about two - thirds of the increase in life expect ##ancy at birth , whereas compression of mortality due to mortality decline ##s in young age explained about one - third . No strong compression of mortality [SEP]',\n",
    "  'existing_cui': 'C0452642',\n",
    "  'existing_cui_name': 'Danish pastry',\n",
    "  'existing_cui_desc': '[CLS] Danish past ##ry [unused3] ( Food , substance ) [SEP]',\n",
    "  'our_bi_cui': 'C0011318',\n",
    "  'our_bi_cui_name': 'Denmark',\n",
    "  'our_bi_cui_desc': '[CLS] Denmark [unused3] ( Spa ##tial Concept , geographic location : D ##K ; D ##A ; den ##mark ; DE ##N ##MA ##R ##K ; D ##N ##K ) [SEP]',\n",
    "  'our_cross_cui': 'C1257890',\n",
    "  'our_cross_cui_name': 'Population Group',\n",
    "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
    " {'mention_id': '27791364.23',\n",
    "  'test_set_idx': 16991,\n",
    "  'type': 'T033',\n",
    "  'name': 'photostability',\n",
    "  'context': '[CLS] ##ic strategy , using b ##ov ##ine serum album ##in as a bio ##tem ##plate at physiological temperature . The as - prepared G ##d : C ##u ##S @ b ##ov ##ine serum album ##in na ##no ##par ##tic ##les with ultra ##sma ##ll sizes ( ca . 9 nm ) exhibited high photo ##thermal conversion efficiency and good [unused1] photos ##ta ##bility [unused2] under near - infrared laser i ##rra ##diation . With do ##ped G ##d species and strong t ##una ##ble near - infrared absorb ##ance , G ##d : C ##u ##S @ b ##ov ##ine serum album ##in na ##no ##par ##tic ##les demonstrate prominent tumor - contrasted imaging performance both on the photo ##aco ##ustic and magnetic resonance imaging [SEP]',\n",
    "  'existing_cui': 'C3272552',\n",
    "  'existing_cui_name': 'Photostability Drug Study',\n",
    "  'existing_cui_desc': '[CLS] Photo ##sta ##bility Drug Study [unused3] ( Intel ##lect ##ual Product : Photo ##sta ##bility ) [SEP]',\n",
    "  'our_bi_cui': 'C0007613',\n",
    "  'our_bi_cui_name': 'Cell physiology',\n",
    "  'our_bi_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28127863.29',\n",
    "  'test_set_idx': 26348,\n",
    "  'type': 'T033',\n",
    "  'name': 'Signs',\n",
    "  'context': '[CLS] speech re ##spiration , p ##hon ##ation , oral motor function , and ve ##lop ##har ##yn ##ge ##al function . The results of the present study suggest that a ne ##uro ##logical et ##iology could be added to the previously described structural et ##iology explaining the speech difficulties found in 22 ##q ##11 . 2 del ##eti ##on syndrome . [unused1] Sign ##s [unused2] of difficulties in both speech motor planning and speech motor programming were found . Further studies are needed to confirm the results , as are studies of the association between structural brain abnormal ##ities and ne ##uro ##logical speech symptoms . For clinical purposes , it is important that clinic ##ians have knowledge about the variable speech symptoms that may occur [SEP]',\n",
    "  'existing_cui': 'C0311392',\n",
    "  'existing_cui_name': 'Physical findings',\n",
    "  'existing_cui_desc': '[CLS] Physical findings [unused3] ( Finding , finding , physical finding : physical finding ; physical findings ; Physical finding ; physical findings [ use for free text ] ; Physical signs ; Sign ##s - physical ; physical signs ; Physical sign ; Sign ; find physical ) [SEP]',\n",
    "  'our_bi_cui': 'C1519316',\n",
    "  'our_bi_cui_name': 'Signature',\n",
    "  'our_bi_cui_desc': '[CLS] Sign ##ature [unused3] ( Intel ##lect ##ual Product : signature ##T ##ex ##t ; Sign ##ed ) [SEP]',\n",
    "  'our_cross_cui': 'C0037088',\n",
    "  'our_cross_cui_name': 'Signs and Symptoms',\n",
    "  'our_cross_cui_desc': '[CLS] Sign ##s and S ##ym ##pt ##oms [unused3] ( Finding , finding : Sign ##s and S ##ym ##pt ##oms [ Disease / Finding ] ; Clinical findings ; clinical findings ; O ##bs ##er ##vable En ##ti ##ty ; sign and s ##ym ##pt ##om ; Sign and s ##ym ##pt ##om ; S ##ym ##pt ##oms and Sign ##s ; sign / s ##ym ##pt ##om ; Finding ; Clinical observation : symptoms and signs ; S ##IG ##NS S ##Y ##MP ##TO ##MS ; Clinical finding ) [SEP]'},\n",
    " {'mention_id': '28478603.20',\n",
    "  'test_set_idx': 37422,\n",
    "  'type': 'T170',\n",
    "  'name': \"Shannon 's information index\",\n",
    "  'context': \"[CLS] am ##plified 96 bands , of which 91 ( 93 . 65 % ) were p ##oly ##morphic , whereas 20 simple sequence repeat prime ##rs am ##plified 73 bands , of which 70 ( 96 . 50 % ) were p ##oly ##morphic . N ##ei ' s gene diversity ( h = 0 . 28 ) , [unused1] Shannon ' s information index [unused2] ( I = 0 . 43 ) , and p ##oly ##mor ##phism information content ( P ##IC = 0 . 29 ) generated using the simple sequence repeat prime ##rs were higher than that with Inter simple sequence repeat prime ##rs ( h = 0 . 23 , I = 0 . 37 , P ##IC = 0 . [SEP]\",\n",
    "  'existing_cui': 'C0237669',\n",
    "  'existing_cui_name': 'Informational Messages',\n",
    "  'existing_cui_desc': '[CLS] Information ##al Message ##s [unused3] ( Intel ##lect ##ual Product , Message ##s : Information ) [SEP]',\n",
    "  'our_bi_cui': 'C1519281',\n",
    "  'our_bi_cui_name': 'Shannon Awards , Guidelines',\n",
    "  'our_bi_cui_desc': '[CLS] Shannon Awards , Guide ##lines [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
    "  'our_cross_cui': 'C0918012',\n",
    "  'our_cross_cui_name': 'Index',\n",
    "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
    " {'mention_id': '28319502.10',\n",
    "  'test_set_idx': 31866,\n",
    "  'type': 'T038',\n",
    "  'name': 'RS3PE',\n",
    "  'context': '[CLS] se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema ( RS ##3 ##P ##E ) is a rare condition in the elderly and can appear as a first presentation of various types of r ##he ##umatic and ma ##li ##gnant diseases . We presented a 62 - year - old man with the diagnosis of [unused1] RS ##3 ##P ##E [unused2] based on the clinical sign and laboratory data . Because of the possibility of associated ma ##li ##gna ##ncies in RS ##3 ##P ##E , F ##D ##G P ##ET / CT was performed to exclude o ##cc ##ult tumors . The images showed multiple , symmetrical ##ly , di ##ff ##use ##ly increased F - F ##D ##G up [SEP]',\n",
    "  'existing_cui': 'C3147672',\n",
    "  'existing_cui_name': 'IRS3P gene',\n",
    "  'existing_cui_desc': '[CLS] I ##RS ##3 ##P gene [unused3] ( Ana ##tom ##ical Structure : insulin receptor substrate 3 , pseudo ##gene ) [SEP]',\n",
    "  'our_bi_cui': 'C0035357',\n",
    "  'our_bi_cui_name': 'Retroperitoneal fibrosis',\n",
    "  'our_bi_cui_desc': \"[CLS] Re ##tro ##per ##ito ##nea ##l fi ##bro ##sis [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Or ##mond ' s disease ; or ##mond ' s disease ; Sc ##ler ##os ##ing re ##tro ##per ##ito ##ni ##tis ; I ##dio ##pathic re ##tro ##per ##ito ##nea ##l fi ##bro ##sis ; R ##P ##F - Re ##tro ##per ##ito ##nea ##l fi ##bro ##sis ; id ##io ##pathic re ##tro ##per ##ito ##nea ##l fi ##bro ##sis ; Disease , Or ##mond ' s ; re ##tro ##per ##ito ##nea ##l fi ##bro ##sis ; Or ##mond Disease ; or ##mond disease ; Fi ##bro ##ses , Re ##tro ##per ##ito ##nea ##l ; Re ##tro ##per ##ito ##nea [SEP]\",\n",
    "  'our_cross_cui': 'C2919482',\n",
    "  'our_cross_cui_name': 'Remitting seronegative symmetrical synovitis with pitting edema',\n",
    "  'our_cross_cui_desc': '[CLS] Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Re ##lap ##sing se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema ; Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; RS ##3 ##P ##E - Re ##mit ##ting se ##rone ##gat ##ive symmetric s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; Re ##lap ##sing se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; RS ##3 ##P ##E - Re ##mit ##ting se ##rone ##gat ##ive symmetric s ##yn ##ov ##itis with [SEP]'},\n",
    " {'mention_id': '27667643.25',\n",
    "  'test_set_idx': 13599,\n",
    "  'type': 'T033',\n",
    "  'name': 'health issue',\n",
    "  'context': \"[CLS] and disease . Clinical ya ##rn ##ing consists of three inter ##rel ##ated areas : the social ya ##rn , in which the practitioner aims to find common ground and develop the inter ##person ##al relationship ; the diagnostic ya ##rn , in which the practitioner facilitate ##s the patient ' s health story while interpret ##ing it through a bio ##medical or scientific lens ; and the management ya ##rn , that employs stories and metaphor ##s as tools for patients to help them understand a [unused1] health issue [unused2] so a collaborative management approach can be adopted . There is cultural and research evidence that supports this approach . Clinical ya ##rn ##ing has the potential to improve outcomes for patients and practitioners . [SEP]\",\n",
    "  'existing_cui': 'C4274868',\n",
    "  'existing_cui_name': 'Parental health issue',\n",
    "  'existing_cui_desc': '[CLS] Pa ##rent ##al health issue [unused3] ( Finding , situation : Pa ##rent has health disorder ) [SEP]',\n",
    "  'our_bi_cui': 'C0033213',\n",
    "  'our_bi_cui_name': 'Problem',\n",
    "  'our_bi_cui_desc': '[CLS] Problem [unused3] ( Finding , finding : Issue ; problem ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28481342.1',\n",
    "  'test_set_idx': 37606,\n",
    "  'type': 'T038',\n",
    "  'name': 'Recurrent noncoding regulatory mutations',\n",
    "  'context': '[CLS] [unused1] Re ##current non ##co ##ding regulatory mutations [unused2] in pan ##cre ##atic duct ##al ad ##eno ##car ##cin ##oma The contributions of coding mutations to tumor ##ige ##nes ##is are relatively well known ; however , little is known about so ##matic alterations in non ##co ##ding DNA . Here we describe Gen ##omi ##c En ##rich ##ment Co ##mp ##uta ##tional C ##luster ##ing Operation to analyze so ##matic non ##co ##ding alterations in 308 pan ##cre ##atic duct ##al ad ##eno ##car ##cin ##oma ##s and identify commonly m ##uta ##ted regulatory regions . We find re ##current non ##co ##ding mutations to be en ##rich ##ed in PD ##A pathways , including a ##xon guidance and cell ad ##hesion , and newly [SEP]',\n",
    "  'existing_cui': 'C0887909',\n",
    "  'existing_cui_name': 'RNA , Untranslated',\n",
    "  'existing_cui_desc': '[CLS] RNA , Un ##tra ##ns ##lated [unused3] ( Chemical : RNA , Non ##co ##ding ; Non - Co ##ding RNA ; Non ##co ##ding RNA ; RNA , Non ##tra ##ns ##lated ; Un ##tra ##ns ##lated RNA ; RNA , Non - Co ##ding ; RNA , Non Pro ##tein Co ##ding ; RNA , Non Co ##ding ; n ##p ##c ##RNA ; n ##c ##RNA ; RNA , Un ##tra ##ns ##lated [ Chemical / In ##g ##red ##ient ] ; Fun ##ctional RNA ; Non ##tra ##ns ##lated RNA ; Non - coding RNA ; RNA , Non - P ##eptide - Co ##ding ; Non - Pro ##tein - Co ##ding RNA ; RNA , Non - Pro ##tein - [SEP]',\n",
    "  'our_bi_cui': 'C0596611',\n",
    "  'our_bi_cui_name': 'Gene Mutation',\n",
    "  'our_bi_cui_desc': '[CLS] Gene Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction : DNA Se ##quence Alt ##eration ; Gene Alt ##eration ; DNA Alt ##eration ; gene mutation ; genes mutation ; Gene Mu ##tation Type ; M ##OL ##PA ##TH . M ##UT ; gene mutations ; Se ##quence Alt ##eration ; Gene mutation ; mutation gene ) [SEP]',\n",
    "  'our_cross_cui': 'C0026882',\n",
    "  'our_cross_cui_name': 'Mutation',\n",
    "  'our_cross_cui_desc': '[CLS] Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction , finding : genome mutation ; Gene ##tic mutation ; genetic mutation ; genetic mutations ; mutations ; Mu ##tations ; mutation ; alterations genetic ; genetic alter ##ation ) [SEP]'},\n",
    " {'mention_id': '28186384.40',\n",
    "  'test_set_idx': 27815,\n",
    "  'type': 'T033',\n",
    "  'name': 'system - related barriers',\n",
    "  'context': '[CLS] in the subsequent results . System - related factors included a lack of confidence in the rational ##e for modify ##ing the current c ##er ##vic ##al screening programme , and concerns about sample contamination and identity theft . In ##sight ##s gained from this research can be used to guide further en ##qui ##ry into the possibility of human p ##ap ##illo ##ma ##virus self - sampling and to help inform future policy and practice . Personal and [unused1] system - related barriers [unused2] including low confidence in the reasons for changing current c ##er ##vic ##al screening provision need to be addressed , should human p ##ap ##illo ##ma ##virus self - sampling be incorporated into the c ##er ##vic ##al screening programme . [SEP]',\n",
    "  'existing_cui': 'C1706912',\n",
    "  'existing_cui_name': 'BARRIER',\n",
    "  'existing_cui_desc': '[CLS] BA ##R ##RI ##ER [unused3] ( Medical Devi ##ce : Barr ##ier ; Barr ##ier Devi ##ce Co ##mpo ##nent ; barrier ) [SEP]',\n",
    "  'our_bi_cui': 'C1717601',\n",
    "  'our_bi_cui_name': 'Barriers to self management',\n",
    "  'our_bi_cui_desc': '[CLS] Barr ##iers to self management [unused3] ( Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28167893.47',\n",
    "  'test_set_idx': 27488,\n",
    "  'type': 'T033',\n",
    "  'name': 'undeveloped',\n",
    "  'context': '[CLS] be a turning moment of the m ##or ##ph ##ogen ##etic changes resisting fungi ##cid ##al toxicity . Con - G formed multi ##cellular con ##id ##ia with cell walls and se ##pta and intact dense c ##yt ##op ##las ##m . In I ##p ##r - N , fun ##gal s ##por ##ulation was in ##hibit ##ed by forming mostly [unused1] und ##eveloped [unused2] un ##ice ##ll ##ular con ##id ##ia with de ##graded and ne ##c ##rot ##ic c ##yt ##op ##las ##m . However , in I ##p ##r - I , conspicuous cellular changes occurred during s ##por ##ulation by forming multi ##cellular con ##id ##ia with double layered ( thick ##ened ) cell walls and accumulation of pro ##life ##rated lip [SEP]',\n",
    "  'existing_cui': 'C0555024',\n",
    "  'existing_cui_name': 'Eloped',\n",
    "  'existing_cui_desc': '[CLS] El ##oped [unused3] ( Finding , finding ) [SEP]',\n",
    "  'our_bi_cui': 'C0041674',\n",
    "  'our_bi_cui_name': 'Unemployment',\n",
    "  'our_bi_cui_desc': \"[CLS] Un ##em ##p ##loy ##ment [unused3] ( Finding , finding , history : unemployment ; Without employment ; out working ; U ##E - Un ##em ##p ##loy ##ed ; NO ##T E ##MP ##L ##O ##Y ##ED ; outs work ; Does Not Work ; Un ##em ##p ##loy ##ed ; U / E - Un ##em ##p ##loy ##ed ; out of work ; out work ; job ##lessness ; job ##less ; UN ##EM ##PL ##O ##Y ##ME ##NT ; unemployed ; Does n ' t Work ; Out ( of ) ; work ; Do n ' t Work ; Out of work ; work out ) [SEP]\",\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27832198.48',\n",
    "  'test_set_idx': 18670,\n",
    "  'type': 'T017',\n",
    "  'name': 'Dd2',\n",
    "  'context': '[CLS] ##quin ##e resistance transport ##er - specific zinc - finger n ##uc ##lea ##ses to genetically di ##sse ##ct this all ##ele in the path ##ogenic setting of as ##ex ##ual blood - stage infection . Comparative analysis of drug resistance and growth profiles of re ##comb ##ina ##nt parasite ##s that express Cam ##7 ##34 or variants thereof , [unused1] D ##d ##2 [unused2] ( the most common Southeast Asian variant ) , or wild - type P . f ##al ##ci ##par ##um ch ##lor ##o ##quin ##e resistance transport ##er , revealed previously unknown roles for P ##f ##CR ##T mutations in m ##od ##ulating parasite su ##s ##ce ##pt ##ibility to multiple anti ##mal ##aria ##l agents . These results were generated [SEP]',\n",
    "  'existing_cui': 'C4151768',\n",
    "  'existing_cui_name': 'bacterium DD2',\n",
    "  'existing_cui_desc': '[CLS] bacterium DD ##2 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
    "  'our_bi_cui': 'C1412089',\n",
    "  'our_bi_cui_name': 'ABCD2 gene',\n",
    "  'our_bi_cui_desc': '[CLS] ABC ##D ##2 gene [unused3] ( Ana ##tom ##ical Structure : AD ##RE ##N ##OL ##E ##U ##KO ##D ##Y ##ST ##RO ##P ##H ##Y - L ##I ##KE 1 ; AD ##RE ##N ##OL ##E ##U ##KO ##D ##Y ##ST ##RO ##P ##H ##Y - R ##EL ##AT ##ED ; AL ##DR ##P ; ATP binding cassette subfamily D member 2 ; ATP - B ##IN ##DI ##NG CA ##SS ##ET ##TE , S ##U ##BF ##AM ##IL ##Y 3 , ME ##MB ##ER 2 ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27297967.80',\n",
    "  'test_set_idx': 1785,\n",
    "  'type': 'T082',\n",
    "  'name': 'Asn19/23Gln/Tyr920Glu / Ser921Glu',\n",
    "  'context': '[CLS] ##20 / Ser ##9 ##21 p ##hos ##ph ##ory ##lation are responsible for altering the kinetic ##s of MR ##P ##1 - mediated As ( G ##S ) 3 transport . The kinetic ##s of As ( G ##S ) 3 transport by human em ##b ##ryo ##nic kidney 29 ##3 - [unused1] As ##n ##19 / 23 ##G ##ln / Ty ##r ##9 ##20 ##G ##lu / Ser ##9 ##21 ##G ##lu [unused2] were similar to H ##E ##K - W ##T - MR ##P ##1 , indicating that the p ##hos ##ph ##ory ##lation - mimic ##king substitution ##s a ##bro ##gated the influence of As ##n ##19 / 23 ##G ##ln g ##ly ##cos ##yla ##tion . Overall , these data suggest that [SEP]',\n",
    "  'existing_cui': 'C0175489',\n",
    "  'existing_cui_name': 'Nucleus Globosus',\n",
    "  'existing_cui_desc': '[CLS] N ##uc ##le ##us G ##lo ##bos ##us [unused3] ( Ana ##tom ##ical Structure , body structure : Structure of c ##ere ##bella ##r g ##lo ##bos ##e nucleus ; G ##lo ##bos ##us , N ##uc ##le ##us ; Post ##eri ##or inter ##posed nucleus ; N ##uc ##le ##us inter ##po ##si ##tus posterior ; N ##uc ##le ##us inter ##po ##si ##tus posterior c ##ere ##bell ##i ; N ##uc ##le ##us g ##lo ##bos ##us c ##ere ##bell ##i ; Post ##eri ##or inter ##po ##si ##tus nucleus ; posterior inter ##po ##si ##tus nucleus ; G ##lo ##bos ##e nucleus ; g ##lo ##bos ##e nucleus ; posterior inter ##posed nucleus ; N ##uc ##le ##i g ##lo ##bos ##i ; [SEP]',\n",
    "  'our_bi_cui': 'C0949771',\n",
    "  'our_bi_cui_name': 'Amino Acid Transporter',\n",
    "  'our_bi_cui_desc': '[CLS] Am ##ino A ##cid Transport ##er [unused3] ( Chemical : Am ##ino A ##cid Transport ##ers ; Am ##ino A ##cid Channel ; Transport ##ers , Am ##ino A ##cid ; Am ##ino A ##cid Transport Systems ; Am ##ino A ##cid Transport Systems [ Chemical / In ##g ##red ##ient ] ; Am ##ino A ##cid Transport Pro ##tein ) [SEP]',\n",
    "  'our_cross_cui': 'C0002518',\n",
    "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
    "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
    " {'mention_id': '28263181.25',\n",
    "  'test_set_idx': 30385,\n",
    "  'type': 'T170',\n",
    "  'name': 'Prigogine theorem',\n",
    "  'context': '[CLS] . 9 . Hence , calculation shows that , in respect to pure re ##spiration , the predominant f ##er ##ment ##ative metabolism decreases around 10 % the production of en ##tropy per mole of glucose consumed in cancer cells . We h ##y ##pot ##hes ##ize that increased f ##er ##mentation could allow cancer cells to accomplish the [unused1] P ##rig ##og ##ine theorem [unused2] of the trend to minimize the rate of production of en ##tropy . According the theorem , open cellular systems near the steady state could evolve to minimize the rates of en ##tropy production that may be reached by modified replica ##ting cells producing en ##tropy at low rate . Re ##mark ##ably , at CO ##2 concentrations above 93 [SEP]',\n",
    "  'existing_cui': 'C0034673',\n",
    "  'existing_cui_name': 'rapid eye movement',\n",
    "  'existing_cui_desc': '[CLS] rapid eye movement [unused3] ( B ##iol ##og ##ic Fun ##ction : Movement , Rapid Eye ; Rapid Eye Movement ; Rapid Eye Movement ##s ; Eye Movement ##s , Rapid ; Movement ##s , Rapid Eye ; Eye Movement , Rapid ) [SEP]',\n",
    "  'our_bi_cui': 'C1705273',\n",
    "  'our_bi_cui_name': 'Mathematical Operator',\n",
    "  'our_bi_cui_desc': '[CLS] Mathematical Opera ##tor [unused3] ( Intel ##lect ##ual Product : Opera ##tor ; Fun ##ction ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27760149.30',\n",
    "  'test_set_idx': 15817,\n",
    "  'type': 'T170',\n",
    "  'name': 'biomedical entity search tool',\n",
    "  'context': \"[CLS] the response time ; however , they are not constantly updated , and thus produce out ##dated results . Further , most existing tools can not process sophisticated que ##ries such as searches for mutations that co - occur with que ##ry terms in the literature . To address these problems , we introduce B ##ES ##T , a [unused1] bio ##medical entity search tool [unused2] . B ##ES ##T returns , as a result , a list of 10 different types of bio ##medical entities including genes , diseases , drugs , targets , transcription factors , mi ##RNA ##s , and mutations that are relevant to a user ' s que ##ry . To the best of our knowledge , B ##ES ##T is [SEP]\",\n",
    "  'existing_cui': 'C2348167',\n",
    "  'existing_cui_name': 'Search Engine',\n",
    "  'existing_cui_desc': '[CLS] Search Engine [unused3] ( Intel ##lect ##ual Product : Search Program ; Search engines ; Engine , Search ; Search Too ##l ; Search Engine ##s ) [SEP]',\n",
    "  'our_bi_cui': 'C0037589',\n",
    "  'our_bi_cui_name': 'Software Tools',\n",
    "  'our_bi_cui_desc': '[CLS] Software Too ##ls [unused3] ( Intel ##lect ##ual Product : Too ##l , Software ; Too ##ls , Software ; Software Too ##l ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27333847.33',\n",
    "  'test_set_idx': 2654,\n",
    "  'type': 'T170',\n",
    "  'name': 'age assessment tool',\n",
    "  'context': '[CLS] very strong at 0 . 98 ##0 ##2 ( boys 0 . 97 ##48 , girls 0 . 98 ##7 ##6 ) . The oral narrative component of the tool performed best ( R = 0 . 96 ##0 ##3 ) . Overall , 86 . 7 % of age estimates were within 1 year of the true age . The range of differences was - 1 . 43 to 3 . 92 years with a standard de ##viation of 0 . 77 years ( 9 . 24 months ) . The [unused1] age assessment tool [unused2] is a ho ##listic , simple and safe instrument that can be used to estimate age in refugee children with results comparable with radio ##logical methods currently used . [SEP]',\n",
    "  'existing_cui': 'C1518848',\n",
    "  'existing_cui_name': 'Pain Assessment Tool',\n",
    "  'existing_cui_desc': '[CLS] Pain Assessment Too ##l [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
    "  'our_bi_cui': 'C1516602',\n",
    "  'our_bi_cui_name': 'Research or Clinical Assessment Tool',\n",
    "  'our_bi_cui_desc': '[CLS] Research or Clinical Assessment Too ##l [unused3] ( Intel ##lect ##ual Product : Clinical Assessment Too ##l ; Clinical or Research Assessment Too ##l ) [SEP]',\n",
    "  'our_cross_cui': 'C0037589',\n",
    "  'our_cross_cui_name': 'Software Tools',\n",
    "  'our_cross_cui_desc': '[CLS] Software Too ##ls [unused3] ( Intel ##lect ##ual Product : Too ##l , Software ; Too ##ls , Software ; Software Too ##l ) [SEP]'},\n",
    " {'mention_id': '27297967.74',\n",
    "  'test_set_idx': 1779,\n",
    "  'type': 'T082',\n",
    "  'name': 'Tyr920/Ser921',\n",
    "  'context': '[CLS] ##nic kidney 29 ##3 - Ty ##r ##9 ##20 ##P ##he - and - Ser ##9 ##21 ##A ##la - MR ##P ##1 mutant ##s were similar to H ##E ##K - W ##T - MR ##P ##1 . Together , these results suggest that As ##n ##19 / As ##n ##23 g ##ly ##cos ##yla ##tion and [unused1] Ty ##r ##9 ##20 / Ser ##9 ##21 [unused2] p ##hos ##ph ##ory ##lation are responsible for altering the kinetic ##s of MR ##P ##1 - mediated As ( G ##S ) 3 transport . The kinetic ##s of As ( G ##S ) 3 transport by human em ##b ##ryo ##nic kidney 29 ##3 - As ##n ##19 / 23 ##G ##ln / Ty ##r ##9 [SEP]',\n",
    "  'existing_cui': 'C1414863',\n",
    "  'existing_cui_name': 'FUT2 gene',\n",
    "  'existing_cui_desc': '[CLS] F ##UT ##2 gene [unused3] ( Ana ##tom ##ical Structure : GDP - L - f ##uc ##ose : beta - D - gal ##act ##os ##ide 2 - alpha - L - f ##uc ##osy ##lt ##ran ##s ##fer ##ase 2 ; alpha ( 1 , 2 ) F ##T ##2 ; secret ##or blood group alpha - 2 - f ##uc ##osy ##lt ##ran ##s ##fer ##ase ; SEC ##2 ; SEC ##RE ##TO ##R FA ##CT ##OR ; f ##uc ##osy ##lt ##ran ##s ##fer ##ase 2 ; se ##j ; alpha ( 1 , 2 ) f ##uc ##osy ##lt ##ran ##s ##fer ##ase ; F ##UC ##OS ##Y ##LT ##RA ##NS ##F ##ER ##AS ##E 2 ; secret ##or factor ; [SEP]',\n",
    "  'our_bi_cui': 'C1519063',\n",
    "  'our_bi_cui_name': 'Phosphorylation Site',\n",
    "  'our_bi_cui_desc': '[CLS] Ph ##os ##ph ##ory ##lation Site [unused3] ( Spa ##tial Concept ) [SEP]',\n",
    "  'our_cross_cui': 'C0002518',\n",
    "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
    "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
    " {'mention_id': '27623277.16',\n",
    "  'test_set_idx': 12200,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedures',\n",
    "  'context': \"[CLS] on the patient ' s clinical condition and patient preferences . This study describes the relative importance of several considerations in lung cancer treatment from the patient ' s perspective . A con ##join ##t preference experiment began by asking respond ##ents to imagine that they had just been diagnosed with lung cancer . Re ##sp ##ond ##ents then chose among [unused1] procedures [unused2] that differed regarding treatment m ##oda ##lities , the potential for treatment - related complications , the likelihood of re ##cu ##rrence , provider case volume , and distance needed to travel for treatment . Con ##join ##t analysis derived relative weights for these attributes . A total of 225 responses were analyzed . Re ##sp ##ond ##ents were most willing to [SEP]\",\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '28125734.58',\n",
    "  'test_set_idx': 26212,\n",
    "  'type': 'T103',\n",
    "  'name': 'miR-21-5p',\n",
    "  'context': '[CLS] - 5 ##p was shown to be able to m ##od ##ulate me ##so ##the ##lin expression in mi ##RNA mimic experiments in a panel of ma ##li ##gnant and non - ma ##li ##gnant cell lines . Further mi ##RNA inhibitor experiments and l ##uc ##ifer ##ase ass ##ays in Me ##ro - 14 cells valid ##ated [unused1] mi ##R - 21 - 5 ##p [unused2] as a true regulator of me ##so ##the ##lin . Moreover , in v ##it ##ro experiments showed that treatment with mi ##R - 21 - 5 ##p mimic reduced proliferation of ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma cell lines . Alto ##get ##her , this work shows that the mi ##R - CA [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1999986',\n",
    "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '27645371.5',\n",
    "  'test_set_idx': 12698,\n",
    "  'type': 'T082',\n",
    "  'name': 'perspectives',\n",
    "  'context': '[CLS] Track ##ing children with acute l ##ymph ##ob ##lastic le ##uke ##mia who abandoned therapy : Experience , challenges , parental [unused1] perspectives [unused2] , and impact of treatment subsidies and intensified counseling Re ##fu ##sal for treatment and therapy abandonment are important reasons for un ##fa ##vor ##able outcome of childhood acute l ##ymph ##ob ##lastic le ##uke ##mia in resource - poor countries . The present study , conducted on children with acute l ##ymph ##ob ##lastic le ##uke ##mia whose treatment was abandoned , attempted to track all these children to as ##cer ##tain the causes and outcome of therapy abandonment / refusal . In order to improve outcome of acute l ##ymph ##ob ##lastic le ##uke ##mia , measures to prevent abandonment [SEP]',\n",
    "  'existing_cui': 'C0040226',\n",
    "  'existing_cui_name': 'Time Perception',\n",
    "  'existing_cui_desc': '[CLS] Time Per ##ception [unused3] ( B ##iol ##og ##ic Fun ##ction : Time perception ; perception time ; Per ##ception , Time ; Time Per ##ception ##s ; Per ##ception ##s , Time ; time perception ; Time Per ##spective ) [SEP]',\n",
    "  'our_bi_cui': 'C0030971',\n",
    "  'our_bi_cui_name': 'Perception',\n",
    "  'our_bi_cui_desc': '[CLS] Per ##ception [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : perception ##s ; perception ; Per ##ceived ; Per ##ception ##s ; perceived ; Per ##ce ##pt ##ual functions , un ##sp ##ec ##ified ; Per ##ce ##pt ##ual functions ; Per ##ception , function ; per ##ceiving ) [SEP]',\n",
    "  'our_cross_cui': 'C0449911',\n",
    "  'our_cross_cui_name': 'View',\n",
    "  'our_cross_cui_desc': '[CLS] View [unused3] ( Spa ##tial Concept , attribute : ( View ##s ; views ; view ; View ##s for ; View ##s ) [SEP]'},\n",
    " {'mention_id': '28145492.28',\n",
    "  'test_set_idx': 26788,\n",
    "  'type': 'T038',\n",
    "  'name': 'current',\n",
    "  'context': '[CLS] - A , as well as H / O - B , excited o ##s ##cilla ##ting tube ##roi ##n ##fu ##ndi ##bula ##r do ##pa ##mine neurons , in ##ducing a re ##versible de ##pol ##aris ##ing switch from p ##has ##ic to ton ##ic discharge . The H ##y ##po ##cre ##tin / Or ##ex ##in - induced inward [unused1] current [unused2] under ##pin ##ning this effect was post - s ##yna ##ptic ( as it endured in the presence of te ##tro ##do ##to ##xin ) , appeared to be carried by a Na ( + ) - dependent trans ##ient receptor potential - like channel ( as it was blocked by 2 - AP ##B and was diminished by removal of extra [SEP]',\n",
    "  'existing_cui': 'C0282444',\n",
    "  'existing_cui_name': 'Current Biog-Obit',\n",
    "  'existing_cui_desc': '[CLS] Current B ##io ##g - O ##bit [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
    "  'our_bi_cui': 'C0022023',\n",
    "  'our_bi_cui_name': 'Ions',\n",
    "  'our_bi_cui_desc': '[CLS] Ion ##s [unused3] ( Chemical , substance : ion ; Ion ##s [ Chemical / In ##g ##red ##ient ] ; Ion ; charged particles ; ions ) [SEP]',\n",
    "  'our_cross_cui': 'C0162585',\n",
    "  'our_cross_cui_name': 'Ion Transport',\n",
    "  'our_cross_cui_desc': '[CLS] Ion Transport [unused3] ( B ##iol ##og ##ic Fun ##ction : ion transport ; Transport , Ion ) [SEP]'},\n",
    " {'mention_id': '27622027.20',\n",
    "  'test_set_idx': 12093,\n",
    "  'type': 'T017',\n",
    "  'name': 'Fresh tumor - draining LN tissues',\n",
    "  'context': '[CLS] , we showed CD ##16 ##9 expression on some CD ##8 ( + ) T l ##ymph ##ocytes in regional l ##ymph nodes and investigated the function and clinical relevance of CD ##16 ##9 ( + ) CD ##8 ( + ) T cells in tumor - draining l ##ymph nodes of color ##ec ##tal cancer patients . [unused1] Fresh tumor - draining L ##N tissues [unused2] from 39 randomly enrolled patients were assessed by flow c ##yt ##ome ##try for activation and differentiation of CD ##16 ##9 ( + ) CD ##8 ( + ) T cells and T cell - mediated killing of tumor cells . In total , 114 tumor - draining L ##N para ##ffin sections from color ##ec ##tal cancer patients [SEP]',\n",
    "  'existing_cui': 'C1519521',\n",
    "  'existing_cui_name': 'Fresh Tissue',\n",
    "  'existing_cui_desc': '[CLS] Fresh T ##iss ##ue [unused3] ( Ana ##tom ##ical Structure : T ##iss ##ue , Fresh ) [SEP]',\n",
    "  'our_bi_cui': 'C0475358',\n",
    "  'our_bi_cui_name': 'Tumor tissue sample',\n",
    "  'our_bi_cui_desc': '[CLS] Tu ##mor tissue sample [unused3] ( Ana ##tom ##ical Structure , specimen : Tu ##mour tissue ; Tu ##mor Sam ##ple ; samples tissue tumor ; tissue tumor ; tissue tumors ; Tu ##mour tissue sample ; tumor tissue ; T ##UM ##OR T ##IS ##SU ##E ; Tu ##mor tissue ; tissues tumor ; Tu ##mor T ##iss ##ue ; tissue t ##umour ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0440747',\n",
    "  'our_cross_cui_name': 'Lymph Node Tissue',\n",
    "  'our_cross_cui_desc': '[CLS] L ##ymph No ##de T ##iss ##ue [unused3] ( Ana ##tom ##ical Structure , substance : L ##Y ##MP ##H NO ##DE ; L ##ymph node tissue ; L ##ymph G ##land ) [SEP]'},\n",
    " {'mention_id': '28220186.31',\n",
    "  'test_set_idx': 28686,\n",
    "  'type': 'T062',\n",
    "  'name': 'genetic tool',\n",
    "  'context': '[CLS] marker for L . stark ##ey ##i . However , gene - targeting frequencies were very low because non - ho ##mo ##log ##ous re ##comb ##ination is probably predominant in L . stark ##ey ##i . Gene ##tic engineering tools for L . stark ##ey ##i have not been sufficiently developed . In this study , we describe a new [unused1] genetic tool [unused2] and its application in L . stark ##ey ##i . To develop a highly efficient gene - targeting system for L . stark ##ey ##i , we constructed a series of mutant ##s by disrupt ##ing genes for L ##s ##K ##u ##70 ##p , L ##s ##K ##u ##80 ##p , and / or L ##s ##L ##ig ##4 ##p [SEP]',\n",
    "  'existing_cui': 'C0017296',\n",
    "  'existing_cui_name': 'gene therapy',\n",
    "  'existing_cui_desc': '[CLS] gene therapy [unused3] ( Health Care Act ##ivity , procedure , treatment : Gene the ##rap ##ies ; d ##na therapy ; Gene Transfer Pro ##ced ##ure ; Molecular Biology , Gene Therapy ; Therapy , Gene ; THE ##R GE ##NE ; gene the ##rap ##ies ; Gene therapy ; Inter ##vention , Gene ##tic ; GE ##NE THE ##R ; therapy , gene ; Gene transfer ; GE ##NE ##TI ##C ; Gene Therapy ; d ##na the ##rap ##ies ; DNA Therapy ) [SEP]',\n",
    "  'our_bi_cui': 'C0017393',\n",
    "  'our_bi_cui_name': 'Genetic Markers',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##tic Mark ##ers [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : genetic markers ; Gene ##tic marker ; MA ##R ##KE ##RS GE ##NE ##T ; GE ##NE ##T MA ##R ##KE ##R ; GE ##NE ##T MA ##R ##KE ##RS ; Mark ##ers , Gene ##tic ; Mark ##er , Gene ##tic ; MA ##R ##KE ##R GE ##NE ##T ; Gene ##tic markers ; genetic marker ; Gene ##tic Mark ##ers [ Chemical / In ##g ##red ##ient ] ; Gene ##tic marker , function ; Gene ##tic Mark ##er ) [SEP]',\n",
    "  'our_cross_cui': 'C0017387',\n",
    "  'our_cross_cui_name': 'Genetic Engineering',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##tic Engineering [unused3] ( Research Act ##ivity : GE ##NE ##T E ##NG ##IN ##EE ##RI ##NG ; B ##iot ##ech ##nology , Gene ##tic Engineering ; E ##NG ##IN ##EE ##RI ##NG GE ##NE ##T ; Gene ##tic Inter ##vention ; engineering genetic ; engineering genetics ; IN ##TE ##R ##VE ##NT ##ION GE ##NE ##T ; engineer genetic ; genetic intervention ; Gene ##tically Engineer ##ed ; genetic engineer ; genetic engineering ; Inter ##vention , Gene ##tic ; GE ##NE ##T IN ##TE ##R ##VE ##NT ##ION ; Inter ##vention ##s , Gene ##tic ; Molecular Biology , Gene ##tic Engineering ; engineered genetic ; Gene ##tic Inter ##vention ##s ; Engineering , Gene ##tic ; Re ##comb ##ina ##nt DNA Technology [SEP]'},\n",
    " {'mention_id': '28272254.12',\n",
    "  'test_set_idx': 30758,\n",
    "  'type': 'T103',\n",
    "  'name': 'therapeutic drugs',\n",
    "  'context': '[CLS] ##tens ##ion patients : Bay ##esi ##an network meta - analysis Left vent ##ric ##ular h ##yper ##tro ##phy is commonly present in patients with h ##yper ##tens ##ion . According to the expert consensus document from American , an ##gio ##tens ##in - converting enzyme inhibitor and an ##gio ##tens ##in receptor block ##ers were recommended as 1st - line [unused1] therapeutic drugs [unused2] . However , none noticed the different efficacy between fat - soluble and selective β ##1 - receptor block ##ers and other β - block ##ers on re ##gression of Left vent ##ric ##ular h ##yper ##tro ##phy before . The aim of this analysis was to compare the efficacy of fat - soluble and selective β ##1 - receptor block [SEP]',\n",
    "  'existing_cui': 'C0580398',\n",
    "  'existing_cui_name': 'Therapeutic drug level - finding',\n",
    "  'existing_cui_desc': '[CLS] The ##rap ##eu ##tic drug level - finding [unused3] ( Finding , finding , procedure : Finding of therapeutic drug level ; Drug level therapeutic ; drugs levels therapeutic ; The ##rap ##eu ##tic drug level ; therapeutic drug level ; drug levels therapeutic ; drug level therapeutic ) [SEP]',\n",
    "  'our_bi_cui': 'C1611640',\n",
    "  'our_bi_cui_name': 'Therapeutic agent',\n",
    "  'our_bi_cui_desc': '[CLS] The ##rap ##eu ##tic agent [unused3] ( Chemical , substance , substance , product : therapeutic agent ) [SEP]',\n",
    "  'our_cross_cui': 'C0013227',\n",
    "  'our_cross_cui_name': 'Pharmaceutical Preparations',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##ce ##utical Pre ##par ##ations [unused3] ( Chemical , product , substance : Drug or me ##dic ##ament ; Drug preparation ; Me ##dication ##s ; Ph ##arma ##ce ##utical / bio ##log ##ic product ; drug / agent ; medicinal products ; medications ; medicinal product ; Ph ##arma ##ce ##uti ##c Pre ##par ##ations ; Me ##dication ; Pre ##par ##ations , Ph ##arma ##ce ##uti ##c ; Drugs ; pharmaceutical preparation ; drug ; PR ##EP ##AR ##AT ##ION ##S P ##HA ##R ##M ; Ph ##arma ##ce ##utical Products ; Products , Ph ##arma ##ce ##utical ; medication ; General drug type ; Drug product ; Medicine ##s ; Drug Product ; drugs ; Medicine ; P ##HA ##R ##M [SEP]'},\n",
    " {'mention_id': '27394918.15',\n",
    "  'test_set_idx': 4520,\n",
    "  'type': 'T103',\n",
    "  'name': 'Sm',\n",
    "  'context': '[CLS] order to assess occupational exposure level of 15 rare earth elements and identify the associated influence , we used in ##duct ##ively coupled plasma mass s ##pect ##rome ##try based on closed - vessel microwave - assisted wet dig ##est ##ion procedure to de ##ter ##minate the concentration of Y , La , Ce , P ##r , N ##d , [unused1] S ##m [unused2] , E ##u , G ##d , T ##b , D ##y , Ho , E ##r , T ##m , Y ##b and Lu in u ##rina ##ry samples obtained from workers producing ultra ##fine and na ##no ##par ##tic ##les containing c ##eri ##um and la ##nt ##han ##um oxide . The results suggest that La and Ce were [SEP]',\n",
    "  'existing_cui': 'C1419249',\n",
    "  'existing_cui_name': 'RAI1 gene',\n",
    "  'existing_cui_desc': '[CLS] RA ##I ##1 gene [unused3] ( Ana ##tom ##ical Structure : Re ##tino ##ic A ##cid In ##duced 1 Gene ; R ##ET ##IN ##O ##IC AC ##ID - IN ##D ##UC ##ED GE ##NE 1 ; K ##IA ##A ##18 ##20 ; RA ##I ##1 Gene ; MG ##C ##12 ##8 ##24 ; D ##K ##F ##Z ##P ##43 ##4 ##A ##13 ##9 ; SMS ; re ##tino ##ic acid induced 1 ; R ##ET ##IN ##O ##IC AC ##ID - IN ##D ##UC ##IB ##LE 1 ) [SEP]',\n",
    "  'our_bi_cui': 'C0587072',\n",
    "  'our_bi_cui_name': 'Sm antibody',\n",
    "  'our_bi_cui_desc': '[CLS] S ##m anti ##body [unused3] ( Chemical , substance : Anti - S ##m / R ##NP Anti ##body ; Anti SM anti ##body ( substance ) [ Am ##bi ##guous ] ; s ##mith anti ##body ; Anti - Smith Anti ##body ; antibodies s ##mith ; anti s ##m antibodies ; S ##m - Smith anti ##body ; Smith anti ##body ; anti - s ##m anti ##body ; Anti - S ##m - R ##NP Anti ##body ; Anti Smith anti ##body ; Anti SM anti ##body ; Blood group anti ##body Smith ; s ##m anti ##body ; Anti - S ##m Anti ##body ; anti s ##mith anti ##body ; antibodies s ##m ) [SEP]',\n",
    "  'our_cross_cui': 'C0036147',\n",
    "  'our_cross_cui_name': 'Samarium',\n",
    "  'our_cross_cui_desc': '[CLS] Sam ##arium [unused3] ( Chemical , substance : sa ##mar ##ium ; SA ##MA ##RI ##UM ; Sam ##arium [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
    " {'mention_id': '27580517.23',\n",
    "  'test_set_idx': 10633,\n",
    "  'type': 'T058',\n",
    "  'name': 'administration of',\n",
    "  'context': '[CLS] flow measurements were com ##puted pre - and post - ace ##ta ##zo ##lam ##ide to assess c ##ere ##bro ##vas ##cular reserve . 3D spiral pseudo - continuous art ##erial spin label ##ing data were successfully reconstructed in all 13 cases . In 11 patients , cerebral blood flow increased 2 . 8 % to 93 . 2 % after [unused1] administration of [unused2] ace ##ta ##zo ##lam ##ide . In the two remaining patients , cerebral blood flow decreased by 2 . 4 to 6 . 0 % after ace ##ta ##zo ##lam ##ide . The group average change in cerebral blood flow due to ace ##ta ##zo ##lam ##ide was approximately 25 . 0 % and individual changes were statistical ##ly significant ( [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C1533734',\n",
    "  'our_bi_cui_name': 'Administration procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Administration procedure [unused3] ( Health Care Act ##ivity , Pro ##ced ##ure , procedure : administration ; Ad ##mini ##ster ##ing ; Administration ; Treatment ) [SEP]',\n",
    "  'our_cross_cui': 'C3469597',\n",
    "  'our_cross_cui_name': 'Administration of medication',\n",
    "  'our_cross_cui_desc': '[CLS] Administration of medication [unused3] ( Health Care Act ##ivity , procedure , treatment : administration drugs ; medication administration ; Me ##dication treatment ; administration of medication ; treatment medication ; medications treatments ; administration of medications ; Me ##dication Treatment ; Me ##dication administration ; drug administration ; r ##no ##x administer medication treatment ; medication management ; medication treatment ; Me ##dication administration treatments and procedures ; Drugs - - Administration ; Me ##dication Administration ; giving medications ; medications treatment ; Administration of drug or me ##dic ##ament ; giving medication ; Drug administration ; Giving medication ; medication treatments ) [SEP]'},\n",
    " {'mention_id': '27172917.20',\n",
    "  'test_set_idx': 163,\n",
    "  'type': 'T170',\n",
    "  'name': 'clinical',\n",
    "  'context': '[CLS] c ##yt ##ology The predict ##ors of ma ##li ##gna ##ncy are important for the decision of appropriate management in nod ##ules with at ##y ##pia of und ##eter ##mined significance / f ##oll ##icular les ##ion of und ##eter ##mined significance ( AU ##S / FL ##US ) . Our aim was to determine the ultra ##son ##ographic ##al , [unused1] clinical [unused2] , and bio ##chemical predict ##ors of ma ##li ##gna ##ncy in these patients . A total of 42 ##7 patients with c ##yt ##ological ##ly Beth ##es ##da Category III ( AU ##S / FL ##US ) thy ##roid nod ##ules were included in this retrospective study . We divided the nod ##ules into two subgroup ##s according to the his [SEP]',\n",
    "  'existing_cui': 'C3272565',\n",
    "  'existing_cui_name': 'Clinical Lot',\n",
    "  'existing_cui_desc': '[CLS] Clinical Lot [unused3] ( Intel ##lect ##ual Product : Clinical ) [SEP]',\n",
    "  'our_bi_cui': 'C3540840',\n",
    "  'our_bi_cui_name': 'Sign or Symptom',\n",
    "  'our_bi_cui_desc': '[CLS] Sign or S ##ym ##pt ##om [unused3] ( Finding : Sign ##s or S ##ym ##pt ##oms ; Clinical Sign ##s ; C ##L ##IN ##IC ##AL F ##IN ##DI ##NG ; C ##L ##IN ##IC ##AL S ##IG ##NS ; DE ##SC ; Clinical Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0683956',\n",
    "  'our_cross_cui_name': 'predictive factor',\n",
    "  'our_cross_cui_desc': '[CLS] predict ##ive factor [unused3] ( Intel ##lect ##ual Product : predict ##ive variables ; factors predict ##ive ; factor predict ##ive ; Disease Pre ##dict ##ive Factor ) [SEP]'},\n",
    " {'mention_id': '28338634.28',\n",
    "  'test_set_idx': 32477,\n",
    "  'type': 'T074',\n",
    "  'name': 'working',\n",
    "  'context': \"[CLS] ##ty ##l ##cho ##lines ##tera ##se and they were used for the measurement anti - Alzheimer ' s drug gal ##ant ##amine and car ##ba ##mate p ##est ##icide car ##bo ##fu ##ran with limit of detection 1 . 5 µ ##M and 20 n ##M , respectively . All measurements were carried out using screen - printed sensor with carbon [unused1] working [unused2] , silver reference , and carbon auxiliary electro ##de . Standard El ##lman ' s ass ##ay was used for valid ##ation measurement of both inhibitor ##s . Part of this work was the elimination of re ##versible inhibitor ##s represented by gal ##ant ##amine from the active site of Ace ##ty ##l ##cho ##lines ##tera ##se . For this purpose , [SEP]\",\n",
    "  'existing_cui': 'C1563350',\n",
    "  'existing_cui_name': 'Working animal',\n",
    "  'existing_cui_desc': '[CLS] Working animal [unused3] ( E ##uka ##ryo ##te : Working ) [SEP]',\n",
    "  'our_bi_cui': 'C0025080',\n",
    "  'our_bi_cui_name': 'Medical Devices',\n",
    "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
    "  'our_cross_cui': 'C0013812',\n",
    "  'our_cross_cui_name': 'electrode',\n",
    "  'our_cross_cui_desc': '[CLS] electro ##de [unused3] ( Medical Devi ##ce , physical object : El ##ec ##tro ##des ; El ##ec ##tro ##de , device ; El ##ec ##tro ##des , ( e . g . , a ##p ##nea monitor ) , per pair ; E ##LE ##CT ##RO ##DE ; electro ##des ; El ##ec ##tro ##des , pair ; El ##ec ##tro ##de ) [SEP]'},\n",
    " {'mention_id': '28208888.52',\n",
    "  'test_set_idx': 28363,\n",
    "  'type': 'T092',\n",
    "  'name': 'genetic counselling clinics',\n",
    "  'context': '[CLS] This was the first study to report the presence of H ##b ##E among the tribal ##s working in the tea gardens of Assam . Based on the present findings , sick ##le cell an ##ae ##mia and β - th ##ala ##ssa ##emia were major health problem for the tribal ##s working in the tea gardens of Assam . Pro ##per diagnostic facilities for ha ##em ##og ##lo ##bino ##pathy and th ##ala ##ssa ##emia should be established in these areas , including establishment of ha ##em ##og ##lo ##bino ##pathy and th ##ala ##ssa ##emia database collection , ha ##ema ##to ##logical analysis laboratories , [unused1] genetic counsel ##ling clinics [unused2] , pre ##nat ##al diagnosis centres and neon ##ata ##l screening centres . [SEP]',\n",
    "  'existing_cui': 'C0599986',\n",
    "  'existing_cui_name': 'Encounter due to genetic counseling',\n",
    "  'existing_cui_desc': '[CLS] En ##co ##unt ##er due to genetic counseling [unused3] ( Finding , context - dependent category , situation : here ##dit ##y ; counseling ; [ V ] Gene ##tic counseling ; advice ; genetic ; [ V ] Gene ##tic counsel ##ling ; Gene ##tic counseling ; Gene ##tic counsel ##ling ; genetic ; counseling ) [SEP]',\n",
    "  'our_bi_cui': 'C0017382',\n",
    "  'our_bi_cui_name': 'Genetic Counseling',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##tic Counsel ##ing [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : genetic counsel ##ling ; Gene ##tic counseling individual each 15 minutes ; Counsel ##ing , Gene ##tic ; Counsel ##ing ; genetic ; Gene ##tic counseling ; g ##nt ##k c ##ns ##ln ##g n ##d ##v ##dl e ##a . 15 min ; Counsel ##ling ; genetic ; genetic counseling ; Gene ##tic counsel ##ling ; GE ##NE ##T CO ##UN ##SE ##L ##ING ; CO ##UN ##SE ##L ##ING GE ##NE ##T ; Gene ##tic Counsel ##ling ) [SEP]',\n",
    "  'our_cross_cui': 'C0442592',\n",
    "  'our_cross_cui_name': 'Clinic',\n",
    "  'our_cross_cui_desc': '[CLS] Clinic [unused3] ( Organization , environment : clinic ; C ##L ##IN ##IC - WA ##L ##K IN , O ##TH ##ER ; Clinic ##s ; clinics ) [SEP]'},\n",
    " {'mention_id': '27273231.14',\n",
    "  'test_set_idx': 1195,\n",
    "  'type': 'T074',\n",
    "  'name': 'Enseal',\n",
    "  'context': '[CLS] sealing pulmonary art ##eries with the En ##sea ##l tissue - sealing device . P ##ul ##mona ##ry art ##eries from be ##ag ##le dogs ( mean body weight 13 . 1 kg , range 10 . 5 - 15 . 4 kg ) were divided into 3 groups according to the in - v ##ivo sealing method used ( [unused1] En ##sea ##l [unused2] , l ##iga ##tion , and pro ##ximal l ##iga ##tion plus di ##stal En ##sea ##l ) and extracted to evaluate the pressure tolerance up to 75 mm H ##g at the sealed end . A left lower lobe ##ct ##omy was performed to evaluate chronic - phase du ##rab ##ility of the sealed s ##tum ##ps in a survival [SEP]',\n",
    "  'existing_cui': 'C0262214',\n",
    "  'existing_cui_name': 'Claustral amygdalar area',\n",
    "  'existing_cui_desc': '[CLS] Claus ##tral am ##y ##g ##dal ##ar area [unused3] ( Ana ##tom ##ical Structure : Claus ##tr ##um di ##ff ##usa ; c ##laus ##tr ##um di ##ff ##usa ; c ##laus ##tral am ##y ##g ##dal ##oid area ; V ##ent ##ral portion of c ##laus ##tr ##um ; Area c ##laus ##tral ##is am ##y ##g ##dal ##ae ; C ##l ##A ; end ##op ##iri ##form nucleus ; ventral portion of c ##laus ##tr ##um ; Claus ##tr ##um par ##vu ##m ; c ##laus ##tral am ##y ##g ##dal ##ar area ; end ##op ##iri ##form c ##laus ##tr ##um ; V ##ent ##ral c ##laus ##tr ##um ; c ##laus ##tr ##um par ##vu ##m ; Claus ##tral am ##y ##g [SEP]',\n",
    "  'our_bi_cui': 'C0038969',\n",
    "  'our_bi_cui_name': 'Surgical sutures',\n",
    "  'our_bi_cui_desc': '[CLS] Sur ##gical su ##tures [unused3] ( Medical Devi ##ce , physical object , treatment : Su ##tures ; S ##UT ##UR ##ES ; su ##ture ; S ##UT ##UR ##E ; Su ##ture material ; Su ##ture - object ; Sur ##gical Su ##tures ; Su ##ture ; Su ##tures , Sur ##gical ; surgical su ##ture ; Su ##tur ##ing ; su ##tures ; Sur ##gical su ##ture ; Sur ##gical su ##ture , device ; Su ##ture material , device ; surgical su ##tures ) [SEP]',\n",
    "  'our_cross_cui': 'C0025080',\n",
    "  'our_cross_cui_name': 'Medical Devices',\n",
    "  'our_cross_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]'},\n",
    " {'mention_id': '28223077.17',\n",
    "  'test_set_idx': 28901,\n",
    "  'type': 'T082',\n",
    "  'name': 'surrounding sites',\n",
    "  'context': '[CLS] . In order to understand the influence of Municipal solid waste land ##fill on p ##oly ##ch ##lor ##inated di ##ben ##zo - p - di ##ox ##ins and p ##oly ##ch ##lor ##inated di ##ben ##zo ##fu ##ran ##s ( PC ##D ##D / F ##s ) in surrounding atmosphere , 42 ambient air samples were collected and analyzed from [unused1] surrounding sites [unused2] , background site , up ##wind site and down ##wind site of a Municipal solid waste land ##fill in East China . The results of present study were summarized as follows . ( 1 ) The total concentrations of PC ##D ##D / F ##s ( [UNK] PC ##D ##D / F ##s ) in ambient air from surrounding sites , [SEP]',\n",
    "  'existing_cui': 'C1282914',\n",
    "  'existing_cui_name': 'Surrounding',\n",
    "  'existing_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
    "  'our_bi_cui': 'C1282914',\n",
    "  'our_bi_cui_name': 'Surrounding',\n",
    "  'our_bi_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
    "  'our_cross_cui': 'C0205145',\n",
    "  'our_cross_cui_name': 'Site',\n",
    "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
    " {'mention_id': '27794381.97',\n",
    "  'test_set_idx': 17237,\n",
    "  'type': 'T103',\n",
    "  'name': '[ Ca ( 2 + ) ] i',\n",
    "  'context': '[CLS] ##cy ##st cells in g ##uin ##ea pig with ch ##ole ##ster ##ol calculus . The d ##ys ##function of gal ##l ##bla ##dder contraction gives rise to the disorders of mobility signal trans ##duction system in ch ##ole ##cy ##st smooth muscle cells , including low content of plasma ch ##ole ##cy ##sto ##kini ##n and [unused1] [ C ##a ( 2 + ) ] i [unused2] in ch ##ole ##cy ##st cells , abnormal protein and m ##RNA of G ##s , G ##i and Cap . Em ##od ##in can enhance the contract ##ibility of gal ##l ##bla ##dder and alleviate ch ##ole ##sta ##sis by regulating plasma ch ##ole ##cy ##sto ##kini ##n levels , [ C ##a ( 2 + ) [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C1155431',\n",
    "  'our_bi_cui_name': 'positive regulation of cytosolic calcium ion concentration',\n",
    "  'our_bi_cui_desc': '[CLS] positive regulation of c ##yt ##oso ##lic calcium ion concentration [unused3] ( B ##iol ##og ##ic Fun ##ction : elevation of calcium ion concentration in c ##yt ##oso ##l ; c ##yt ##oso ##lic calcium ion concentration elevation ; c ##yt ##op ##las ##mic calcium ion concentration elevation ; elevation of c ##yt ##oso ##lic calcium ion concentration ; elevation of c ##yt ##op ##las ##mic calcium ion concentration ; elevation of calcium ion concentration in c ##yt ##op ##las ##m ) [SEP]',\n",
    "  'our_cross_cui': 'C0596235',\n",
    "  'our_cross_cui_name': 'Calcium ion',\n",
    "  'our_cross_cui_desc': '[CLS] Cal ##ci ##um ion [unused3] ( Chemical : Cal ##ci ##um Cat ##ion ; free calcium ; CA + 2 ; ion calcium ; Cal ##ci ##um cat ##ion ; Free Cal ##ci ##um ; calcium ions ; C ##a ##2 + ; C ##a + + ; Cal ##ci ##um Ion ##s ; C ##a 2 + ; calcium ion ; CA ##LC ##I ##UM CA ##TI ##ON ; Cal ##ci ##um Ion ; calcium cat ##ion ; Cal ##ci ##um 2 + ; Ion ##ized Cal ##ci ##um ) [SEP]'},\n",
    " {'mention_id': '28433910.5',\n",
    "  'test_set_idx': 35704,\n",
    "  'type': 'T103',\n",
    "  'name': 'Spent sulphite liquor',\n",
    "  'context': '[CLS] Su ##cci ##nic acid production by im ##mo ##bil ##ized cultures using spent su ##l ##phi ##te liquor as f ##er ##mentation medium [unused1] S ##pent su ##l ##phi ##te liquor [unused2] was used as carbon source for the production of su ##cci ##nic acid using im ##mo ##bil ##ized cultures of Act ##ino ##ba ##ci ##llus su ##cci ##no ##gene ##s and Ba ##s ##fia su ##cci ##nic ##ip ##rod ##uce ##ns on two different supports , del ##ign ##ified cell ##ulos ##ic material and al ##gin ##ate beads . Fed - batch im ##mo ##bil ##ized cultures with A . su ##cci ##no ##gene ##s in al ##gin ##ates resulted in higher sugar to su ##cci ##nic acid conversion yield ( 0 . 81 [SEP]',\n",
    "  'existing_cui': 'C0038750',\n",
    "  'existing_cui_name': 'Sulfites',\n",
    "  'existing_cui_desc': '[CLS] Sul ##fit ##es [unused3] ( Chemical , substance : In ##or ##gan ##ic Sul ##fit ##es ; Sul ##fit ##e ; Sul ##fit ##es , In ##or ##gan ##ic ; Sul ##fit ##es [ Chemical / In ##g ##red ##ient ] ; su ##lf ##ites ; Sul ##phi ##te ; su ##lf ##ite ; su ##l ##phi ##tes ; Sul ##fit ##e salt ; Sul ##phi ##te salt ; S ##U ##LF ##IT ##ES IN ##OR ##G ; IN ##OR ##G S ##U ##LF ##IT ##ES ; su ##l ##phi ##te ) [SEP]',\n",
    "  'our_bi_cui': 'C0982424',\n",
    "  'our_bi_cui_name': 'Sulfurated lime solution',\n",
    "  'our_bi_cui_desc': \"[CLS] Sul ##fu ##rated lime solution [unused3] ( Chemical , substance : S ##U ##LF ##UR ##AT ##ED L ##IM ##E S ##OL ##N ; sulfur ##ated lime solution ; Lim ##e Sol ##ution , Sul ##fu ##rated ; Sul ##fu ##rated Lim ##e Sol ##ution ; V ##lem ##in ##ck ##x ' s lot ##ion ; Sul ##ph ##ura ##ted lime solution ) [SEP]\",\n",
    "  'our_cross_cui': 'C0010454',\n",
    "  'our_cross_cui_name': 'Culture Media',\n",
    "  'our_cross_cui_desc': '[CLS] Culture Media [unused3] ( Chemical , substance : Growth Medium ; growth media ; Media , Culture ; Culture media ; Culture medium ; culture medium ; culture media ; Culture Medium ; culture medium ##s ; culture media ##s ) [SEP]'},\n",
    " {'mention_id': '27430240.67',\n",
    "  'test_set_idx': 5393,\n",
    "  'type': 'T038',\n",
    "  'name': 'Adenosine triphosphate hydrolysis',\n",
    "  'context': '[CLS] significantly up ##re ##gu ##lated CD ##39 and CD ##7 ##3 expression ( P < 0 . 01 ) . E ##2 ##F transcription factor 1 and CR ##E ##B induced CD ##39 and CD ##7 ##3 expression , and were up ##re ##gu ##lated by ad ##eno ##sin ##e and C ##GS ##21 ##6 ##80 . [unused1] Aden ##os ##ine trip ##hos ##phate h ##ydro ##lysis [unused2] and ad ##eno ##sin ##e generation were in ##hibit ##ed by the knock ##down of E ##2 ##F transcription factor 1 or CR ##E ##B , and were accelerated in the presence of C ##GS ##21 ##6 ##80 . Based on these results , it can be in ##ferred that ad ##eno ##sin ##e , the ad ##eno [SEP]',\n",
    "  'existing_cui': 'C0001480',\n",
    "  'existing_cui_name': 'Adenosine Triphosphate',\n",
    "  'existing_cui_desc': \"[CLS] Aden ##os ##ine Trip ##hos ##phate [unused3] ( Chemical , ATP , Te ##tra ##hy ##dr ##ogen Trip ##hos ##phate , substance , te ##tra ##hy ##dr ##ogen trip ##hos ##phate : AD ##EN ##OS ##IN ##E T ##RI ##P ##H ##OS ##P ##HA ##TE ; ATP ; Aden ##yl ##py ##rop ##hos ##phate ; Aden ##os ##ine Trip ##hos ##phate [ Chemical / In ##g ##red ##ient ] ; Aden ##os ##ine 5 ' - trip ##hos ##phate ; Aden ##os ##ine 5 ' - ; ATP - Aden ##os ##ine trip ##hos ##phate ; Aden ##os ##ine 5 ' - Trip ##hos ##ph ##ori ##c A ##cid ; Aden ##os ##ine trip ##hos ##phate ; Aden ##os ##ine - 5 ' - trip ##hos [SEP]\",\n",
    "  'our_bi_cui': 'C0001473',\n",
    "  'our_bi_cui_name': 'Adenosine Triphosphatases',\n",
    "  'our_bi_cui_desc': '[CLS] Aden ##os ##ine Trip ##hos ##pha ##tase ##s [unused3] ( Chemical , substance : Aden ##os ##ine Trip ##hos ##pha ##tase ##s [ Chemical / In ##g ##red ##ient ] ; ATP ##ases ; ad ##eno ##sin ##et ##rip ##hos ##pha ##tase ; Aden ##os ##inet ##rip ##hos ##pha ##tase ; at ##pas ##e ; ad ##eno ##sin ##e trip ##hos ##pha ##tase ; Aden ##os ##ine Trip ##hos ##pha ##tase ; ATP p ##hos ##ph ##oh ##ydro ##lase ; Aden ##os ##ine trip ##hos ##pha ##tase ; ATP ##ase ; ATP H ##ydro ##lase ; ATP mon ##op ##hos ##pha ##tase ; Aden ##yl ##py ##rop ##hos ##pha ##tase ) [SEP]',\n",
    "  'our_cross_cui': 'C1510699',\n",
    "  'our_cross_cui_name': 'ATP Hydrolysis',\n",
    "  'our_cross_cui_desc': '[CLS] ATP H ##ydro ##lysis [unused3] ( B ##iol ##og ##ic Fun ##ction : ATP degradation ; ATP cat ##ab ##olis ##m ; obsolete ATP cat ##ab ##olic process ; ATP h ##ydro ##lysis ; ATP breakdown ) [SEP]'},\n",
    " {'mention_id': '27580517.6',\n",
    "  'test_set_idx': 10616,\n",
    "  'type': 'T058',\n",
    "  'name': 'non - Cartesian cylindrically - distributed spiral 3D pseudo - continuous arterial spin labeling magnetic resonance imaging',\n",
    "  'context': '[CLS] Assessment of cerebral blood per ##fusion reserve with ace ##ta ##zo ##lam ##ide using 3D spiral AS ##L magnetic resonance imaging : Preliminary experience in p ##ediatric patients To demonstrate the clinical f ##eas ##ibility of a new [unused1] non - Car ##tes ##ian cylindrical ##ly - distributed spiral 3D pseudo - continuous art ##erial spin label ##ing magnetic resonance imaging [unused2] pulse sequence in p ##ediatric patients in q ##uant ##ifying cerebral blood flow response to an ace ##ta ##zo ##lam ##ide v ##as ##od ##ila ##tor challenge . magnetic resonance imaging exams were performed on two 3 Te ##sla Philips In ##gen ##ia systems using 32 channel head coil array ##s . After local institutional review board approval , the 3D spiral - based [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0024485',\n",
    "  'our_bi_cui_name': 'Magnetic Resonance Imaging',\n",
    "  'our_bi_cui_desc': '[CLS] Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity , MR ##I , procedure , qualifier value : MR - Ma ##gnetic resonance ; MR TO ##MO ##GR ; Ma ##gnetic resonance technique ; magnetic resonance imaging ; N ##MR I ##maging ; Ma ##gnetic resonance imaging procedure ; St ##ead ##y - State Free Pre ##cession MR ##I ; Ma ##gnetic resonance : [ imaging ] or [ study ] ; imaging magnetic nuclear resonance ; Tom ##ography , MR ; MR ##I Sc ##an ; N ##MR - Nuclear magnetic resonance ; Z ##E ##U ##GM ##AT ##O ##GR ; TO ##MO ##GR MR ; N ##MR TO ##MO ##GR ; Nuclear magnetic resonance ; Medical I ##maging , Ma [SEP]',\n",
    "  'our_cross_cui': 'C3891302',\n",
    "  'our_cross_cui_name': 'Arterial Spin Labeling Magnetic Resonance Imaging',\n",
    "  'our_cross_cui_desc': '[CLS] Arte ##rial Spin Label ##ing Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity : AS ##L f ##MR ##I ; Arte ##rial Spin Label ##ing MR ##I ; AR ##TE ##RI ##AL SP ##IN LA ##BE ##L ##ING F ##UN ##CT ##ION ##AL MR ##I ) [SEP]'},\n",
    " {'mention_id': '27481714.73',\n",
    "  'test_set_idx': 7891,\n",
    "  'type': 'T017',\n",
    "  'name': 'principal cells',\n",
    "  'context': '[CLS] dependent ##ly suppressed by r ##uth ##eni ##um red , a put ##ative block ##er of e ##pit ##hel ##ial C ##a ( 2 + ) channels and calcium - activated chloride conduct ##ance . Finally , we discover messenger RNA for both T ##RP ##V ##6 and T ##ME ##M ##16 ##A in the rat e ##pid ##idy ##mis and show that their proteins co ##loc ##ali ##ze in the a ##pical membrane of principal cells . Collective ##ly , these data provide evidence for a coupling mechanism between T ##RP ##V ##6 and T ##ME ##M ##16 ##A in [unused1] principal cells [unused2] that may play an important role in the regulation of calcium home ##ost ##asis in the e ##pid ##idy ##mis . [SEP]',\n",
    "  'existing_cui': 'C0401925',\n",
    "  'existing_cui_name': 'Teaching principal',\n",
    "  'existing_cui_desc': '[CLS] Teaching principal [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Principal ; principal ##s ; principal ) [SEP]',\n",
    "  'our_bi_cui': 'C0017471',\n",
    "  'our_bi_cui_name': 'Germ Cells',\n",
    "  'our_bi_cui_desc': '[CLS] G ##er ##m Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell , G ##er ##m ; reproductive cells ; Rep ##rod ##uctive Cell ##s ; Ha ##p ##lo ##id g ##er ##m cell ; Game ##te ; Cell , G ##er ##m - Line ; cells g ##er ##m ; Sexual Cell ; cell sex ; Cell ##s , G ##er ##m ; cell g ##er ##m ; G ##er ##m Cell ; G ##er ##m cells ; G ##er ##m Line Cell ##s ; cells sex ; G ##er ##m - Line Cell ##s ; Ha ##p ##lo ##id n ##uc ##lea ##ted cell ; sexual cell ; Cell ##s , G ##er ##m - Line ; Game ##tes ; g ##er ##m [SEP]',\n",
    "  'our_cross_cui': 'C0007634',\n",
    "  'our_cross_cui_name': 'Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
    " {'mention_id': '28331620.12',\n",
    "  'test_set_idx': 32167,\n",
    "  'type': 'T033',\n",
    "  'name': 'unmedicated',\n",
    "  'context': '[CLS] ? The impact of stress on anger and aggression in Border ##line Personal ##ity Di ##sor ##der and At ##ten ##tion De ##fic ##it H ##yper ##act ##ivity Di ##sor ##der has not been thoroughly investigated . The goal of this study was to investigate different aspects of anger and aggression in patients with these disorders . Twenty - nine [unused1] un ##med ##ica ##ted [unused2] female Border ##line Personal ##ity Di ##sor ##der patients , 28 At ##ten ##tion De ##fic ##it H ##yper ##act ##ivity Di ##sor ##der patients and 30 healthy controls completed self - reports measuring trait anger , aggression and emotion regulation capacities . A modified version of the Point Sub ##traction A ##gg ##ression Para ##di ##g ##m and a [SEP]',\n",
    "  'existing_cui': 'C0162396',\n",
    "  'existing_cui_name': 'Unmedicated IUDs',\n",
    "  'existing_cui_desc': '[CLS] Un ##med ##ica ##ted I ##U ##Ds [unused3] ( Medical Devi ##ce : Un ##med ##ica ##ted I ##U ##D ; I ##U ##D , Un ##med ##ica ##ted ) [SEP]',\n",
    "  'our_bi_cui': 'C0332155',\n",
    "  'our_bi_cui_name': 'Did not receive therapy or drug for',\n",
    "  'our_bi_cui_desc': '[CLS] Did not receive therapy or drug for [unused3] ( Finding , context ##ual qualifier , qualifier value : N ##G - did not receive therapy or drug for ; un ##tre ##ated ; Did not receive therapy or drug for ( context ##ual qualifier ) ; Not treated for ; did not receive therapy or drug for ; N ##G ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28192171.57',\n",
    "  'test_set_idx': 27916,\n",
    "  'type': 'T062',\n",
    "  'name': 'work',\n",
    "  'context': '[CLS] art ##hr ##op ##athy , but also specific signatures of the disease , like presence of am ##yl ##oids and peculiar ca ##l ##ci ##fication ##s . Our analyses provide a unified picture of Al ##ka ##pton ##uria cart ##ila ##ge , shed ##ding a new light on the disease and opening new perspectives . O ##ch ##ron ##otic pig ##ment is a hall ##mark of Al ##ka ##pton ##uria and responsible of tissue de ##gene ##ration . Convention ##al bio - ass ##ays have not yet clarified its composition and its structural relationship with am ##yl ##oids . The present [unused1] work [unused2] proposes new strategies for filling the aforementioned gap that en ##com ##pass the integration of new analytical approaches with standardized analyses . [SEP]',\n",
    "  'existing_cui': 'C3642250',\n",
    "  'existing_cui_name': 'Work Including Work Around the House',\n",
    "  'existing_cui_desc': '[CLS] Work Including Work Around the House [unused3] ( Intel ##lect ##ual Product , includes work both outside the home and daily ch ##ores , including work around the house : Work ; Normal work ) [SEP]',\n",
    "  'our_bi_cui': 'C0242481',\n",
    "  'our_bi_cui_name': 'Research Activities',\n",
    "  'our_bi_cui_desc': '[CLS] Research Activities [unused3] ( Research Act ##ivity : research ; Research Act ##ivity ; activity research ; Research ; Activities , Research ; Act ##ivity , Research ; research activities ) [SEP]',\n",
    "  'our_cross_cui': 'C0035168',\n",
    "  'our_cross_cui_name': 'research',\n",
    "  'our_cross_cui_desc': '[CLS] research [unused3] ( Research Act ##ivity : Research ) [SEP]'},\n",
    " {'mention_id': '27832159.48',\n",
    "  'test_set_idx': 18596,\n",
    "  'type': 'T103',\n",
    "  'name': 'compound-326',\n",
    "  'context': '[CLS] D ##G ##LA profiles . In diet - induced o ##bes ##e mice , chronic treatment with compound - 32 ##6 lowered insulin resistance and caused body weight loss without significant impact on cumulative ca ##lor ##ie intake . Dec ##reased mac ##rop ##hage in ##fi ##ltration into ad ##ip ##ose tissue was expected from m ##RNA analysis . Inc ##reased daily energy expenditure was also observed following administration of compound - 32 ##6 , in line with sustained body weight loss . These data indicate that the novel Delta - 5 des ##at ##ura ##se selective inhibitor , [unused1] compound - 32 ##6 [unused2] , will be a new class of drug for the treatment of o ##bes ##e and di ##abe ##tic patients . [SEP]',\n",
    "  'existing_cui': 'C0258113',\n",
    "  'existing_cui_name': '4 - ( ( 3-bromophenyl ) amino ) -6,7 - dimethoxyquinazoline',\n",
    "  'existing_cui_desc': \"[CLS] 4 - ( ( 3 - br ##omo ##phe ##ny ##l ) amino ) - 6 , 7 - dim ##eth ##ox ##y ##quin ##az ##olin ##e [unused3] ( Chemical : Co ##mpo ##und 32 ; 4 - ( 3 ' - br ##omo ##ani ##lino ) - 6 , 7 - dim ##eth ##ox ##y ##quin ##az ##olin ##e ) [SEP]\",\n",
    "  'our_bi_cui': 'C0149246',\n",
    "  'our_bi_cui_name': 'Z 326',\n",
    "  'our_bi_cui_desc': '[CLS] Z 32 ##6 [unused3] ( Chemical ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28256742.3',\n",
    "  'test_set_idx': 30209,\n",
    "  'type': 'T082',\n",
    "  'name': 'Canadian Areas',\n",
    "  'context': '[CLS] Hal ##ogen ##ated p ##hen ##olic compounds in wild fish from [unused1] Canadian Areas [unused2] of Con ##cer ##n Con ##cent ##rations of ha ##log ##ena ##ted p ##hen ##olic compounds were measured in the plasma of brown bull ##head ( Am ##ei ##urus ne ##bul ##os ##us ) from 4 Canadian Areas of Con ##cer ##n ( A ##OC ##s ) , to assess exposure to suspected thy ##roid - disrupt ##ing chemicals . H ##ydro ##xy ##lated p ##oly ##ch ##lor ##inated bi ##phe ##ny ##ls ( OH - PC ##B ##s ) were detected in every sample collected in 3 of the A ##OC ##s ; the detection frequency was lower in samples from the Detroit River A ##OC . The OH - [SEP]',\n",
    "  'existing_cui': 'C3831211',\n",
    "  'existing_cui_name': 'Canadian County , OK',\n",
    "  'existing_cui_desc': '[CLS] Canadian County , OK [unused3] ( Spa ##tial Concept : Canadian County , Oklahoma ; OK ##01 ##7 ; Canadian County ) [SEP]',\n",
    "  'our_bi_cui': 'C0454980',\n",
    "  'our_bi_cui_name': 'Region of Canada',\n",
    "  'our_bi_cui_desc': '[CLS] Region of Canada [unused3] ( Spa ##tial Concept , geographic location : Province or Territory of Canada ; Provinces and territories of Canada ; Region ##s of Canada ) [SEP]',\n",
    "  'our_cross_cui': 'C0006823',\n",
    "  'our_cross_cui_name': 'Canada',\n",
    "  'our_cross_cui_desc': '[CLS] Canada [unused3] ( Spa ##tial Concept , geographic location : CA ##N ; CA ##NA ##DA ; CA ) [SEP]'},\n",
    " {'mention_id': '27820849.13',\n",
    "  'test_set_idx': 18195,\n",
    "  'type': 'T204',\n",
    "  'name': 'hens',\n",
    "  'context': '[CLS] p ##hen ##otypic and g ##eno ##mic evolution , with large effective population size and strong human - driven selection . In the present study , we performed Extended Ha ##p ##lot ##ype Ho ##mo ##zy ##gos ##ity tests to identify significant core regions employing 600 ##K S ##NP Chicken chip in an F ##2 population of 1 , 53 ##4 [unused1] he ##ns [unused2] , which was derived from re ##ci ##p ##ro ##cal crosses between White Le ##gh ##orn and Dong ##xia ##ng chicken . Results indicated that a total of 49 , 151 core regions with an average length of 9 . 79 K ##b were identified , which occupied approximately 52 . 15 % of genome across all auto ##some ##s , [SEP]',\n",
    "  'existing_cui': 'C0099085',\n",
    "  'existing_cui_name': '6-bromo-2-naphthyl sulfate',\n",
    "  'existing_cui_desc': '[CLS] 6 - br ##omo - 2 - nap ##ht ##hyl su ##lf ##ate [unused3] ( Chemical , B ##NS : 2 - Na ##ph ##thal ##eno ##l , 6 - br ##omo - , hydrogen su ##lf ##ate ) [SEP]',\n",
    "  'our_bi_cui': 'C0008051',\n",
    "  'our_bi_cui_name': 'Chickens',\n",
    "  'our_bi_cui_desc': '[CLS] Chicken ##s [unused3] ( E ##uka ##ryo ##te , organism : G ##all ##us gal ##lus ; Red jungle f ##ow ##l ; Chicken ; CH ##IC ##KE ##N ; ban ##tam ; G ##all ##us gal ##lus domestic ##us ; G ##all ##us domestic ##us ; Ban ##tam Chicken ; Red jungle ##fo ##wl ; Ban ##tam ; chicken ; chickens ; Domestic f ##ow ##l ancestor ) [SEP]',\n",
    "  'our_cross_cui': 'C0005595',\n",
    "  'our_cross_cui_name': 'Aves',\n",
    "  'our_cross_cui_desc': '[CLS] Ave ##s [unused3] ( E ##uka ##ryo ##te , organism : a ##vian ; bird ; a ##vian ##s ; a ##ves ; birds ; Bird ; Bird in context ; A ##vian ; Birds ; Class Ave ##s ) [SEP]'},\n",
    " {'mention_id': '28179911.59',\n",
    "  'test_set_idx': 27653,\n",
    "  'type': 'T017',\n",
    "  'name': 'GPDH',\n",
    "  'context': '[CLS] independent T ##2 lines were detected by quantitative real - time PC ##R . The relative m ##RNA accumulation of genes encoding enzymes involved in either fatty acid bio ##sy ##nt ##hesis or t ##ria ##cy ##l ##gly ##cer ##ols assembly ( BC ##CP ##2 , K ##AS ##I , MA ##T , E ##NR , FA ##TA , and [unused1] GP ##D ##H [unused2] ) were also ass ##ay ##ed in mature seeds . Furthermore , lip ##id and fatty acids C ##16 : 0 and C ##18 : 0 significantly increased . In two ho ##mo ##zy ##go ##us T ##2 trans ##genic rice lines ( G ##5 and G ##2 ) , different Co ##WR ##I ##1 expression levels were detected , but [SEP]',\n",
    "  'existing_cui': 'C1415375',\n",
    "  'existing_cui_name': 'GYPC gene',\n",
    "  'existing_cui_desc': '[CLS] G ##YP ##C gene [unused3] ( Ana ##tom ##ical Structure , G ##er ##bic ##h blood group : GP ##C ; G ##L ##Y ##CO ##P ##H ##OR ##IN C ; g ##ly ##co ##ph ##ori ##n C ; G ##L ##Y ##CO ##P ##H ##OR ##IN D ; CD ##23 ##6 ; S ##IA ##L ##O ##G ##L ##Y ##CO ##PR ##OT ##EI ##N , B ##ET ##A ; CD ##23 ##6 ##R ; G ##e ) [SEP]',\n",
    "  'our_bi_cui': 'C1418531',\n",
    "  'our_bi_cui_name': 'PHGDH gene',\n",
    "  'our_bi_cui_desc': '[CLS] P ##H ##G ##D ##H gene [unused3] ( Ana ##tom ##ical Structure : P ##H ##OS ##P ##H ##O ##G ##L ##Y ##CE ##RA ##TE DE ##H ##Y ##DR ##O ##GE ##NA ##SE ; P ##H ##G ##D ##H Gene ; Ph ##os ##ph ##og ##ly ##cer ##ate De ##hy ##dr ##ogen ##ase Gene ; SE ##RA ; p ##hos ##ph ##og ##ly ##cer ##ate de ##hy ##dr ##ogen ##ase ; 3 - P ##H ##OS ##P ##H ##O ##G ##L ##Y ##CE ##RA ##TE DE ##H ##Y ##DR ##O ##GE ##NA ##SE ; P ##G ##D ##H ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27838742.14',\n",
    "  'test_set_idx': 18981,\n",
    "  'type': 'T103',\n",
    "  'name': 'delicaflavone',\n",
    "  'context': '[CLS] / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway Search ##ing for potential anti ##can ##cer agents from natural sources is an effective strategy for developing novel ch ##em ##oth ##era ##pe ##uti ##c agents . In this study , data supporting the in v ##it ##ro and in v ##ivo anti ##can ##cer effects of [unused1] del ##ica ##f ##lav ##one [unused2] , a rarely occurring bi ##f ##lav ##ono ##id from Se ##lag ##ine ##lla do ##ede ##rle ##ini ##i , were reported . Del ##ica ##f ##lav ##one exhibited favorable anti ##can ##cer properties , as shown by the M ##TT ass ##ay and x ##eno ##gra ##ft model of human non - small cell lung cancer in male BA [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27875010.31',\n",
    "  'test_set_idx': 20236,\n",
    "  'type': 'T017',\n",
    "  'name': 'tissue',\n",
    "  'context': '[CLS] ##ified net photos ##ynth ##esis by ambient and nut ##rient - en ##rich ##ed tissues at sat ##ura ##ting i ##rra ##dian ##ce over a range of temperature conditions ( 6 - 30 °C ) . Re ##spiration was un ##af ##fected by nut ##rient treatment ; however , there was a significant increase in photos ##ynth ##etic oxygen production for nut ##rient - en ##rich ##ed [unused1] tissue [unused2] compared to ambient , but only at elevated ( ≥ 18 °C ) temperatures . This study contributes to a growing body of literature showing the complexity of responses to changes in multiple drivers , and highlights the importance of studying the impacts of global climate change within the context of more local environmental conditions . [SEP]',\n",
    "  'existing_cui': 'C0040300',\n",
    "  'existing_cui_name': 'Body tissue',\n",
    "  'existing_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
    "  'our_bi_cui': 'C0040300',\n",
    "  'our_bi_cui_name': 'Body tissue',\n",
    "  'our_bi_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
    "  'our_cross_cui': 'C1514137',\n",
    "  'our_cross_cui_name': 'Plant Tissue , Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Plant T ##iss ##ue , Cell ##s [unused3] ( Ana ##tom ##ical Structure : Plant cells and tissues ) [SEP]'},\n",
    " {'mention_id': '27384676.30',\n",
    "  'test_set_idx': 4392,\n",
    "  'type': 'T033',\n",
    "  'name': 'elongation',\n",
    "  'context': '[CLS] 3 / 4 le ##uk ##ope ##nia occurred in fourteen patients ( 58 . 33 % ) and grade 3 / 4 th ##rom ##bo ##cy ##top ##enia occurred in eleven patients ( 45 . 83 % ) . Twelve patients ( 50 . 00 % ) experienced Act ##ivated Part ##ial Ph ##rom ##bo ##p ##last ##in P ##time [unused1] el ##ong ##ation [unused2] and fourteen patients ( 58 . 33 % ) experienced h ##y ##po ##fi ##bri ##no ##gene ##mia . In conclusion , de ##xa ##met ##has ##one , g ##em ##ci ##ta ##bine and p ##eg ##as ##par ##gas ##e regime ##n is an effective and tolerate ##d treatment for newly diagnosed , advanced - stage extra ##no ##dal natural killer [SEP]',\n",
    "  'existing_cui': 'C0086206',\n",
    "  'existing_cui_name': 'Elongation Factor',\n",
    "  'existing_cui_desc': '[CLS] El ##ong ##ation Factor [unused3] ( Chemical : el ##ong ##ation factor ; Factor , El ##ong ##ation ) [SEP]',\n",
    "  'our_bi_cui': 'C0242656',\n",
    "  'our_bi_cui_name': 'Disease Progression',\n",
    "  'our_bi_cui_desc': '[CLS] Disease Progress ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , attribute : Course of illness ; Disease Progress ##ions ; Disease Course ; Course of Il ##ln ##ess ; Progress ##ion , Disease ; Course of disorder ; Disease progression ; Progress ##ion ; D ##IS PR ##O ##GR ##ES ##SI ##ON ; progression ; Di ##sor ##der Course ; Progress ##ions , Disease ; course of illness ; Disease Progress ##ion [ Disease / Finding ] ; course illness ; courses disease ; disease progression ) [SEP]',\n",
    "  'our_cross_cui': 'C0240671',\n",
    "  'our_cross_cui_name': 'Partial thromboplastin time increased',\n",
    "  'our_cross_cui_desc': '[CLS] Part ##ial th ##rom ##bo ##p ##last ##in time increased [unused3] ( Finding , finding , finding , lab test : A ##b ##nor ##mal or prolonged PT ##T ; Pro ##long ##ed partial th ##rom ##bo ##p ##last ##in time ; A ##b ##nor ##mal or prolonged partial th ##rom ##bo ##p ##last ##in time ; AP ##TT prolonged ; prolonged a ##pt ##t ; Act ##ivated partial th ##rom ##bo ##p ##last ##in time prolonged ; Pro ##long ##ed Act ##ivated Part ##ial T ##hr ##omb ##op ##last ##in Time ; Pro ##long ##ed activated partial th ##rom ##bo ##p ##last ##in time ; a ##pt ##t prolonged ; PT ##T prolonged ; AP ##TT increased ; a ##P ##TT prolonged ; elevated p [SEP]'},\n",
    " {'mention_id': '27838742.1',\n",
    "  'test_set_idx': 18968,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] [unused1] Del ##ica ##f ##lav ##one [unused2] induce ##s auto ##pha ##gic cell death in lung cancer via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway Search ##ing for potential anti ##can ##cer agents from natural sources is an effective strategy for developing novel ch ##em ##oth ##era ##pe ##uti ##c agents . In this study , data supporting the in v ##it ##ro and in v ##ivo anti ##can ##cer effects of del ##ica ##f ##lav ##one , a rarely occurring bi ##f ##lav ##ono ##id from Se ##lag ##ine ##lla do ##ede ##rle ##ini ##i , were reported . Del ##ica ##f ##lav ##one exhibited favorable anti ##can ##cer properties , as shown by the M ##TT ass [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27449818.31',\n",
    "  'test_set_idx': 6226,\n",
    "  'type': 'T058',\n",
    "  'name': 'orally treated',\n",
    "  'context': '[CLS] ) were synthesized and tested for carbon ##ic an ##hy ##dra ##se II binding . CA II in er ##yt ##hr ##ocytes is thought to oppose extraction of E ##stra ##dio ##l pro ##dr ##ugs from portal vein blood during liver passage . O ##var ##ie ##ct ##omi ##zed ( O ##V ##X , day minus 14 ) rats were [unused1] oral ##ly treated [unused2] once daily from day 1 - 3 . Sa ##c ##ri ##fic ##e day 4 . U ##ter ##i were di ##sse ##cted and weighed . Cho ##les ##tero ##l fraction ##s and an ##gio ##tens ##ino ##gen were determined in plasma . Oral E ##2 and et ##hin ##yl est ##rad ##iol generated dose related u ##ter ##ine growth and [SEP]',\n",
    "  'existing_cui': 'C0226896',\n",
    "  'existing_cui_name': 'Oral cavity',\n",
    "  'existing_cui_desc': '[CLS] Oral cavity [unused3] ( Spa ##tial Concept , Anatomy , body structure : Mouth ; B ##OD ##Y CA ##VI ##TY , OR ##AL ; Oral ##ly ; C ##avi ##tas Or ##is ; C ##avi ##ty of mouth ; Oral C ##avi ##ty ; C ##avi ##tas or ##is ; Oral ; C ##avi ##ty , Oral ; oral cavity ; an ##ato ##mie ##s mouth ; mouth anatomy ; B ##uc ##cal cavity ; mouth ; Oral cavity structure ; mouths ; anatomy mouth ; B ##uc ##cal C ##avi ##ty ; OR ##AL CA ##VI ##TY ) [SEP]',\n",
    "  'our_bi_cui': 'C1273553',\n",
    "  'our_bi_cui_name': 'Oral administration of treatment',\n",
    "  'our_bi_cui_desc': '[CLS] Oral administration of treatment [unused3] ( Health Care Act ##ivity , navigation ##al concept , procedure : Treatment administered oral ##ly ) [SEP]',\n",
    "  'our_cross_cui': 'C0001563',\n",
    "  'our_cross_cui_name': 'Administration , Oral',\n",
    "  'our_cross_cui_desc': '[CLS] Administration , Oral [unused3] ( Health Care Act ##ivity , procedure : Oral medication administration each treatment ; oral medication administration ; or ##l me ##ds ad ##min . e ##a . T ##x ; Administration , Oral Drug ; Oral Drug Administration ; AD ##MI ##N OR ##AL DR ##U ##G ; Drug Administration , Oral ; Administration ##s , Oral ; administration oral ; Administration of drug or me ##dic ##ament via oral route ; Administration ##s , Oral Drug ; Oral Drug Administration ##s ; Oral Administration ##s ; Me ##dication Administration : Oral ; OR ##AL AD ##MI ##N ; AD ##MI ##N OR ##AL ; OR ##AL DR ##U ##G AD ##MI ##N ; Me ##dication administration : oral ; oral [SEP]'},\n",
    " {'mention_id': '28027760.26',\n",
    "  'test_set_idx': 23867,\n",
    "  'type': 'T033',\n",
    "  'name': 'No',\n",
    "  'context': '[CLS] ##iac CT an ##gio ##graphy : 2 . 4 ± 0 . 9 ##m ##S ##v - 6 . 8 ± 2 . 7 m ##S ##v , all p ≤ 0 . 04 ##14 ) . In 39 patients trans ##cat ##he ##ter a ##ort ##ic valve replacement was performed and an ##nu ##lus diameter was within the recommended range in all patients . [unused1] No [unused2] severe cardiac or vascular complications were noted . 3rd generation dual - source CT provides diagnostic image quality in trans ##cat ##he ##ter a ##ort ##ic valve replacement - planning CT an ##gio ##graphy and facilitate ##s reliable assessment of trans ##cat ##he ##ter a ##ort ##ic valve replacement device and delivery option while reducing radiation dose . [SEP]',\n",
    "  'existing_cui': 'C1016143',\n",
    "  'existing_cui_name': 'Tetragenococcus halophilus',\n",
    "  'existing_cui_desc': '[CLS] Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us [unused3] ( Ba ##cter ##ium , organism : P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us Me ##es 1934 ( A ##pp ##roved List ##s 1980 ) ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us ( Me ##es 1934 ) Collins et al . 1993 ; Sa ##rc ##ina ha ##ma ##guchi ##ae ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##a ; P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us ; Te ##tra ##co ##cc ##cus No . 1 ; P ##ed ##io ##co ##cc ##us so ##ya ##e ) [SEP]',\n",
    "  'our_bi_cui': 'C0243095',\n",
    "  'our_bi_cui_name': 'Finding',\n",
    "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C1513916',\n",
    "  'our_cross_cui_name': 'Negative Finding',\n",
    "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
    " {'mention_id': '28236586.25',\n",
    "  'test_set_idx': 29279,\n",
    "  'type': 'T170',\n",
    "  'name': 'models',\n",
    "  'context': '[CLS] using a comprehensive g ##eria ##tric assessment was conducted . Di ##sa ##bility was defined as imp ##air ##ment in activities of daily living and / or instrumental activities of daily living , simplified to four items . Un ##iva ##ria ##te and multi ##var ##iate log ##istic models of disabled patients were performed . The three final multi ##var ##iate [unused1] models [unused2] were compared using the area under the receiver operating characteristic curve ( AU ##C / R ##OC ) of the log ##istic model . The mean age was 80 . 6 years , and 51 % of the patients were women with various types of cancer . The prevalence of disability was 67 . 6 % . No on ##co ##log ##ic [SEP]',\n",
    "  'existing_cui': 'C0026350',\n",
    "  'existing_cui_name': 'Theoretical model',\n",
    "  'existing_cui_desc': '[CLS] Theo ##ret ##ical model [unused3] ( Intel ##lect ##ual Product , Theo ##ret ##ical : Model , Theo ##ret ##ical ; Theo ##ret ##ical Models ; Models , Theo ##ret ##ical ; Models ; Theo ##ret ##ical Model ; theoretical model ; Models , Theo ##ret ##ic ; Model ; theoretical models ) [SEP]',\n",
    "  'our_bi_cui': 'C3161035',\n",
    "  'our_bi_cui_name': 'Model',\n",
    "  'our_bi_cui_desc': '[CLS] Model [unused3] ( Intel ##lect ##ual Product : Models ; Model ##ing System ; Model System ) [SEP]',\n",
    "  'our_cross_cui': 'C0023965',\n",
    "  'our_cross_cui_name': 'Logistic Models',\n",
    "  'our_cross_cui_desc': '[CLS] Lo ##gis ##tic Models [unused3] ( Intel ##lect ##ual Product : Model , Lo ##gis ##tic ; Models , Lo ##gis ##tic ; Lo ##gis ##tic Model ) [SEP]'},\n",
    " {'mention_id': '28145492.38',\n",
    "  'test_set_idx': 26798,\n",
    "  'type': 'T103',\n",
    "  'name': 'OX2R receptor',\n",
    "  'context': '[CLS] be carried by a Na ( + ) - dependent trans ##ient receptor potential - like channel ( as it was blocked by 2 - AP ##B and was diminished by removal of extra ##cellular Na ( + ) ) , and was a consequence of O ##X ##2 ##R receptor activation ( as it was blocked by the [unused1] O ##X ##2 ##R receptor [unused2] antagonist T ##CS O ##X ##2 29 , but not the O ##X ##1 ##R receptor antagonist S ##B 33 ##48 ##6 ##7 ) . Application of the hormone , me ##lat ##oni ##n , failed to alter tube ##roi ##n ##fu ##ndi ##bula ##r do ##pa ##mine membrane potential or o ##s ##cilla ##tory activity . This first description [SEP]',\n",
    "  'existing_cui': 'C0913649',\n",
    "  'existing_cui_name': 'taste receptors , type 2',\n",
    "  'existing_cui_desc': '[CLS] taste receptors , type 2 [unused3] ( Chemical , taste : G protein - coupled receptor T ##R ##2 ; T ##2 ##R taste receptors ; T ##2 ##R receptor ; T ##2 ##R receptors ; taste receptor , type 2 ; T ##AS ##2 ##R ##13 protein , human ; receptor , T ##2 ##R ) [SEP]',\n",
    "  'our_bi_cui': 'C0069841',\n",
    "  'our_bi_cui_name': 'Oxytocin Receptor',\n",
    "  'our_bi_cui_desc': '[CLS] O ##xy ##to ##cin Re ##ceptor [unused3] ( Chemical : Re ##ceptor ##s , O ##xy ##to ##cin [ Chemical / In ##g ##red ##ient ] ; R ##EC ##EP ##T O ##X ##Y ##TO ##CI ##N ; Re ##ceptor ##s , O ##xy ##to ##cin ; O ##X ##Y ##TO ##CI ##N R ##EC ##EP ##T ; Re ##ceptor , O ##xy ##to ##cin ; O ##xy ##to ##cin Re ##ceptor ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0671880',\n",
    "  'our_cross_cui_name': 'orexin receptor type 2',\n",
    "  'our_cross_cui_desc': '[CLS] ore ##xin receptor type 2 [unused3] ( Chemical : Or ##ex ##in - B Re ##ceptor ##s ; H ##y ##po ##cre ##tin - 2 Re ##ceptor ; Re ##ceptor , H ##y ##po ##cre ##tin - 2 ; H ##y ##po ##cre ##tin Re ##ceptor ##s 2 ; O ##X ##2 Re ##ceptor ##s ; Or ##ex ##in B Re ##ceptor ; Re ##ceptor ##s , Or ##ex ##in - B ; Re ##ceptor ##s 2 , H ##y ##po ##cre ##tin ; Or ##ex ##in Re ##ceptor 2 ; Re ##ceptor 2 , H ##y ##po ##cre ##tin ; HC ##TR ##2 Pro ##tein ; Re ##ceptor , Or ##ex ##in - B ; Or ##ex ##in Re ##ceptor Type 2 ; Pro ##tein [SEP]'},\n",
    " {'mention_id': '28203549.70',\n",
    "  'test_set_idx': 28262,\n",
    "  'type': 'T170',\n",
    "  'name': 'ST',\n",
    "  'context': '[CLS] ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e and non - HM ##K ##P is ##olate ##s were positive for r ##mp ##A . Aero ##ba ##ct ##in was found among 95 . 0 and 97 . 5 % of K ##1 and K ##2 is ##olate ##s . ST ##23 was found to be the most prevalent [unused1] ST [unused2] among 69 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s with K ##1 , K ##2 , K ##5 , K ##20 , and K ##5 ##7 ( 27 . 5 % , 19 / 69 ) and was only found among K ##1 is ##olate ##s . ST ##65 was the second [SEP]',\n",
    "  'existing_cui': 'C0036183',\n",
    "  'existing_cui_name': 'Sao Tome and Principe',\n",
    "  'existing_cui_desc': '[CLS] Sa ##o Tom ##e and P ##rin ##ci ##pe [unused3] ( Spa ##tial Concept , geographic location : SA ##O TO ##ME AND PR ##IN ##CI ##P ##E ; São Tom ##é and P ##r ##ín ##ci ##pe ) [SEP]',\n",
    "  'our_bi_cui': 'C0457537',\n",
    "  'our_bi_cui_name': 'Subtype serogroup',\n",
    "  'our_bi_cui_desc': '[CLS] Sub ##type se ##rog ##roup [unused3] ( Intel ##lect ##ual Product , qualifier value : Sub ##type se ##rog ##roup ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0449943',\n",
    "  'our_cross_cui_name': 'Serotype',\n",
    "  'our_cross_cui_desc': '[CLS] Ser ##otype [unused3] ( Intel ##lect ##ual Product , attribute , o ##bs ##er ##vable entity , qualifier value : se ##rov ##ar ; se ##rov ##ars ; Ser ##ova ##rs ; se ##rot ##ype ; se ##rot ##ype ##s ; Ser ##otype ##s ; Ser ##ova ##r ) [SEP]'},\n",
    " {'mention_id': '28445938.39',\n",
    "  'test_set_idx': 36360,\n",
    "  'type': 'T062',\n",
    "  'name': 'strategy',\n",
    "  'context': '[CLS] ##uron ##an levels and , as a result , significantly increases blood vessel functionality and per ##fusion and improve ##s the anti - tumor efficacy of do ##x ##or ##ubi ##cin . Red ##uction of extra ##cellular matrix components were mediated via T ##G ##F ##β signaling pathway in ##hibition due to down ##re ##gu ##lation of T ##G ##F ##β ##1 , CO ##L ##1 ##A ##1 , CO ##L ##3 ##A ##1 , H ##AS ##2 , H ##AS ##3 expression levels . Our findings provide evidence that re ##pur ##po ##sing Pi ##rf ##eni ##don ##e could be used as a promising [unused1] strategy [unused2] to enhance drug delivery to solid tumors by normal ##izing the tumor micro ##en ##vir ##on ##ment . [SEP]',\n",
    "  'existing_cui': 'C0589105',\n",
    "  'existing_cui_name': 'Strategy training',\n",
    "  'existing_cui_desc': '[CLS] Strategy training [unused3] ( Health Care Act ##ivity , procedure , regime / therapy ) [SEP]',\n",
    "  'our_bi_cui': 'C0085104',\n",
    "  'our_bi_cui_name': 'Drug Delivery Systems',\n",
    "  'our_bi_cui_desc': '[CLS] Drug Del ##iver ##y Systems [unused3] ( Medical Devi ##ce : drug target ##ting ; Drug Target ##ing ; delivery drug systems ; drug target ; Drug delivery systems ; Drug Target ##ings ; drug targeting ; Drug delivery system ; target drug ; drugs targets ; Del ##iver ##y System , Drug ; drugs target ; Systems , Drug Del ##iver ##y ; drug delivery systems ; drugs targeting ; drug targets ; Drug Del ##iver ##y System ; drug targeted ; System , Drug Del ##iver ##y ; Target ##ings , Drug ; Drug Del ##iver ##y ; DR ##U ##G DE ##L ##IVE ##R ##Y S ##Y ##ST ##EM ; Del ##iver ##y Systems , Drug ; drug delivery system ; delivery drugs [SEP]',\n",
    "  'our_cross_cui': 'C0035171',\n",
    "  'our_cross_cui_name': 'Research Design',\n",
    "  'our_cross_cui_desc': '[CLS] Research Design [unused3] ( Research Act ##ivity : Experiment Design ; design research ; research design ; Design ##s , Research ; Design , Research ; ST ##YP ##E ; Research Design ##s ; study design ; Study Type ; Study Design ; Experimental Design ) [SEP]'},\n",
    " {'mention_id': '27617315.66',\n",
    "  'test_set_idx': 12029,\n",
    "  'type': 'T103',\n",
    "  'name': '% p2PSA',\n",
    "  'context': '[CLS] 0 . 00 ##1 ) . By utilizing the Pro ##state Health Index cut ##off of 35 to men with pro ##state - specific anti ##gen 10 - 20 ng / m ##L and normal digital re ##ct ##al examination , 57 . 1 % ( 178 of 312 ) bio ##ps ##ies could be avoided . Both Pro ##state Health Index and % p ##2 ##PS ##A performed well in predict ##ing pro ##state cancer and high grade pro ##state cancer . The use of Pro ##state Health Index and [unused1] % p ##2 ##PS ##A [unused2] should be extended to Chinese men with pro ##state - specific anti ##gen 10 - 20 ng / m ##L and normal digital re ##ct ##al examination . [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0138741',\n",
    "  'our_bi_cui_name': 'Prostate-Specific Antigen',\n",
    "  'our_bi_cui_desc': '[CLS] Pro ##state - S ##pecific Anti ##gen [unused3] ( Chemical , PS ##A , procedure , substance : pro ##state specific anti ##gen ; gamma Semi ##no ##p ##rote ##in ; Se ##men ##ogel ##ase ; gamma semi ##no ##p ##rote ##in ; Ka ##lli ##k ##re ##in , h ##K ##3 ; Gamma - Semi ##no ##p ##rote ##in ; Pro ##state - specific anti ##gen ; HK 00 ##3 K ##AL ##L ##I ##K ##RE ##IN ; PS ##A - Pro ##state specific anti ##gen ; Ka ##lli ##k ##re ##in h ##K ##3 ; gamma - Semi ##no ##p ##rote ##in ; Pro ##state S ##pecific Anti ##gen ; EC 3 . 4 . 21 . 77 ; P - 30 anti ##gen [SEP]',\n",
    "  'our_cross_cui': 'C3710767',\n",
    "  'our_cross_cui_name': '( -2 ) pro-prostate-specific antigen , human',\n",
    "  'our_cross_cui_desc': '[CLS] ( - 2 ) pro - pro ##state - specific anti ##gen , human [unused3] ( Chemical : ( - 2 ) pro - PS ##A , human ; p ##2 ##PS ##A , human ) [SEP]'},\n",
    " {'mention_id': '28541679.21',\n",
    "  'test_set_idx': 38908,\n",
    "  'type': 'T033',\n",
    "  'name': 'pros and cons',\n",
    "  'context': '[CLS] work addresses : the range of magnetic properties reported for l ##iche ##ns , moss ##es , leaves , bark , trunk wood , insects , crust ##ace ##ans , ma ##mmal and human tissues ; their associations with atmospheric poll ##uta ##nt species ( Part ##iculate matter , NO ##x , trace elements , PA ##H ##s ) ; the [unused1] pro ##s and con ##s [unused2] of bio ##ma ##gnetic monitoring of atmospheric pollution ; current challenges for large - scale implementation of bio ##ma ##gnetic monitoring ; and future perspectives . A summary table is presented , with the aim of aid ##ing researchers and policy makers in selecting the most suitable biological sensor for their intended bio ##ma ##gnetic monitoring purpose . [SEP]',\n",
    "  'existing_cui': 'C0052649',\n",
    "  'existing_cui_name': 'gamma-Atrial Natriuretic Peptide',\n",
    "  'existing_cui_desc': '[CLS] gamma - At ##rial Nat ##ri ##ure ##tic P ##eptide [unused3] ( Chemical : Pro - AN ##F ; At ##rial Pro ##nat ##rio ##di ##lat ##in ; At ##rio ##pe ##pt ##in 126 ; AN ##P ( 1 - 126 ) ; Card ##ion ##at ##rin IV ; At ##rio ##pe ##pt ##ige ##n ; At ##rial Nat ##ri ##ure ##tic Factor ( 1 - 126 ) ; At ##rial Nat ##ri ##ure ##tic P ##eptide ( 1 - 126 ) ; At ##rial Nat ##ri ##ure ##tic Factor Pro ##hor ##mon ##e ; Pro ##at ##rial Nat ##ri ##ure ##tic Factor ; Pro ##AN ##F ; AN ##F ( 1 - 126 ) ; At ##rio ##pe ##pt ##in Pro ##hor ##mon ##e ( [SEP]',\n",
    "  'our_bi_cui': 'C0037088',\n",
    "  'our_bi_cui_name': 'Signs and Symptoms',\n",
    "  'our_bi_cui_desc': '[CLS] Sign ##s and S ##ym ##pt ##oms [unused3] ( Finding , finding : Sign ##s and S ##ym ##pt ##oms [ Disease / Finding ] ; Clinical findings ; clinical findings ; O ##bs ##er ##vable En ##ti ##ty ; sign and s ##ym ##pt ##om ; Sign and s ##ym ##pt ##om ; S ##ym ##pt ##oms and Sign ##s ; sign / s ##ym ##pt ##om ; Finding ; Clinical observation : symptoms and signs ; S ##IG ##NS S ##Y ##MP ##TO ##MS ; Clinical finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27444636.45',\n",
    "  'test_set_idx': 5996,\n",
    "  'type': 'T170',\n",
    "  'name': 'Quality of Life in Epilepsy Inventory 10',\n",
    "  'context': '[CLS] ( P < . 00 ##1 ) , Quality of Life in E ##pile ##psy In ##vent ##ory 10 ( P = . 00 ##1 ) , and alert ##ness ( P < . 05 ) . Ad ##verse Events Profile total scores improved for 21 / 21 ( 100 . 0 % ) patients , [unused1] Quality of Life in E ##pile ##psy In ##vent ##ory 10 [unused2] total scores improved for 17 / 21 ( 81 . 0 % ) patients , and alert ##ness scores improved for 16 / 21 ( 76 . 2 % ) patients . In this short - term , single - center study , an overnight switch from twice - daily o ##x ##car ##ba ##ze ##pine to [SEP]',\n",
    "  'existing_cui': 'C2698752',\n",
    "  'existing_cui_name': 'Pediatric Quality of Life Inventory',\n",
    "  'existing_cui_desc': '[CLS] P ##ediatric Quality of Life In ##vent ##ory [unused3] ( Intel ##lect ##ual Product : P ##eds ##QL ) [SEP]',\n",
    "  'our_bi_cui': 'C0085295',\n",
    "  'our_bi_cui_name': 'Interleukin-10',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##le ##uki ##n - 10 [unused3] ( Chemical , NO ##NG ##L ##Y ##CO ##S ##Y ##LA ##TE ##D , substance : C ##Y ##TO ##K ##IN ##E S ##Y ##N IN ##H ##IB FA ##CT ##OR ; Cy ##tok ##ine synthesis in ##hibit ##ing factor ; IL 01 ##0 ; Inter ##le ##uki ##n - 10 [ Chemical / In ##g ##red ##ient ] ; il ##10 ; inter ##le ##uki ##n 10 ; inter ##le ##uki ##n - 10 ; IL ##10 ; IL - 10 ; IN ##TE ##RL ##E ##U ##K ##IN 01 ##0 ; IN ##TE ##RL ##E ##U ##K ##IN - 10 ; H ##UM ##AN IN ##TE ##RL ##E ##U ##K ##IN - 10 ; Cy ##tok ##ine [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27241818.68',\n",
    "  'test_set_idx': 589,\n",
    "  'type': 'T058',\n",
    "  'name': 'output was estimated',\n",
    "  'context': '[CLS] subjects performed 5 km cycling time trials under control conditions and with l ##umba ##r in ##tra ##the ##cal f ##ent ##any ##l imp ##air ##ing lower limb muscle a ##ffer ##ent feedback ( F ##EN ##T ) . V ##ast ##us lateral ##is muscle bio ##ps ##ies were obtained before and immediately after exercise . Mo ##tone ##uron ##al [unused1] output was estimated [unused2] through vast ##us lateral ##is surface electro ##my ##ography . Ex ##er ##cise - induced changes in in ##tra ##mus ##cular meta ##bol ##ites were determine d using liquid and gas ch ##roma ##tography - mass s ##pect ##rome ##try . Q ##uad ##rice ##ps fatigue was q ##uant ##ified by pre - to post - exercise changes in potent ##iated [SEP]',\n",
    "  'existing_cui': 'C3251815',\n",
    "  'existing_cui_name': 'fluid output measurement',\n",
    "  'existing_cui_desc': '[CLS] fluid output measurement [unused3] ( Health Care Act ##ivity , procedure : Out ##put ; Me ##as ##ure ##ment of fluid output ) [SEP]',\n",
    "  'our_bi_cui': 'C0680844',\n",
    "  'our_bi_cui_name': 'estimation',\n",
    "  'our_bi_cui_desc': '[CLS] est ##imation [unused3] ( B ##iol ##og ##ic Fun ##ction , subjective , subjective : E ##st ##imation ; est ##imation ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0204709',\n",
    "  'our_cross_cui_name': 'Measuring output',\n",
    "  'our_cross_cui_desc': '[CLS] Me ##as ##uring output [unused3] ( Health Care Act ##ivity , procedure ) [SEP]'},\n",
    " {'mention_id': '28145492.7',\n",
    "  'test_set_idx': 26767,\n",
    "  'type': 'T038',\n",
    "  'name': 'Current',\n",
    "  'context': '[CLS] H ##y ##po ##cre ##tin / Or ##ex ##in P ##eptide ##s Ex ##cite Rat N ##eur ##oe ##ndo ##c ##rine Do ##pa ##mine N ##eur ##ons through Or ##ex ##in 2 Re ##ceptor - Media ##ted Act ##ivation of a Mixed Cat ##ion [unused1] Current [unused2] H ##y ##po ##cre ##tin / Or ##ex ##in neurons of the lateral h ##y ##pot ##hala ##mus are compelling m ##od ##ulator candidates for the ch ##ron ##ob ##iology of ne ##uro ##end ##oc ##rine output and , as a consequence , hormone release from the anterior pit ##uit ##ary . Here we investigate the effects of H ##y ##po ##cre ##tin / Or ##ex ##in p ##eptide ##s upon tube ##roi ##n ##fu ##ndi ##bula ##r do [SEP]',\n",
    "  'existing_cui': 'C0282444',\n",
    "  'existing_cui_name': 'Current Biog-Obit',\n",
    "  'existing_cui_desc': '[CLS] Current B ##io ##g - O ##bit [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
    "  'our_bi_cui': 'C0022023',\n",
    "  'our_bi_cui_name': 'Ions',\n",
    "  'our_bi_cui_desc': '[CLS] Ion ##s [unused3] ( Chemical , substance : ion ; Ion ##s [ Chemical / In ##g ##red ##ient ] ; Ion ; charged particles ; ions ) [SEP]',\n",
    "  'our_cross_cui': 'C0162585',\n",
    "  'our_cross_cui_name': 'Ion Transport',\n",
    "  'our_cross_cui_desc': '[CLS] Ion Transport [unused3] ( B ##iol ##og ##ic Fun ##ction : ion transport ; Transport , Ion ) [SEP]'},\n",
    " {'mention_id': '28421738.37',\n",
    "  'test_set_idx': 35215,\n",
    "  'type': 'T103',\n",
    "  'name': 'compound 12',\n",
    "  'context': \"[CLS] ##phi ##lic activation of the transcription ##al response . Moreover , 12 prevented the formation of c ##yt ##oto ##xi ##c stable o ##li ##go ##mer ##ic intermediate ##s , being significantly more effective , and per se less toxic , than prototype 1 . More importantly , as different chemical features were exploited to regulate Nr ##f ##2 and am ##yl ##oid - β p ##eptide activities , the two pathways could be tuned independently . These findings point to [unused1] compound 12 [unused2] and its derivatives as promising tools for investigating the therapeutic potential of the Nr ##f ##2 / am ##yl ##oid - β p ##eptide cellular network , laying foundation for generating new drug leads to confront Alzheimer ' s disease . [SEP]\",\n",
    "  'existing_cui': 'C3467761',\n",
    "  'existing_cui_name': 'Compound 122587',\n",
    "  'existing_cui_desc': '[CLS] Co ##mpo ##und 122 ##5 ##8 ##7 [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0620347',\n",
    "  'our_bi_cui_name': 'compound A 12',\n",
    "  'our_bi_cui_desc': \"[CLS] compound A 12 [unused3] ( Chemical : compound a 12 ; a 12 ; 5 , 9 b ( 1 ' , 2 ' ) - Benz ##eno - 9 ##b ##H - ben ##z ( g ) in ##do ##l - 3 ( 3 ##a ##H ) - one , 1 , 2 , 4 , 5 - te ##tra ##hy ##dr ##o - 1 - ( p ##hen ##yl ##met ##hyl ) - ; A - 12 ) [SEP]\",\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27298278.23',\n",
    "  'test_set_idx': 1824,\n",
    "  'type': 'T103',\n",
    "  'name': 'F',\n",
    "  'context': '[CLS] an ant ##hra ##quin ##one , and a nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##er , together with three known q ##uin ##ones and seven other known compounds , were isolated from the aerial parts of Mo ##rin ##da par ##vi ##folia . The structures of m ##ori ##nda ##par ##vin ##s C , D , E , [unused1] F [unused2] , and G were el ##uc ##idated on the basis of s ##pect ##ros ##copic or X - ray di ##ff ##raction analysis as met ##hyl 4 - h ##ydro ##xy - 1 , 6 - dim ##eth ##ox ##y - nap ##ht ##hale ##ne - 2 - car ##box ##yla ##te , met ##hyl 4 , 8 - di ##hy ##dr [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0010207',\n",
    "  'our_bi_cui_name': 'Coumarins',\n",
    "  'our_bi_cui_desc': '[CLS] Co ##uma ##rin ##s [unused3] ( Chemical : co ##uma ##rin ##s ; Co ##uma ##rine ##s ; Der ##via ##tives , 1 , 2 - Benz ##opy ##rone ; 1 , 2 - Benz ##opy ##rone ##s ; Benz ##opy ##ran 2 ones ; 1 , 2 - Benz ##opy ##rone Der ##via ##tives ; Co ##uma ##rin ##s [ Chemical / In ##g ##red ##ient ] ; 1 , 2 Benz ##opy ##rone ##s ; Co ##uma ##rin Der ##iva ##tives ; Der ##iva ##tives , Co ##uma ##rin ; Benz ##opy ##ran - 2 - ones ; B ##EN ##Z ##OP ##Y ##RO ##NE ##S 01 02 ; 1 , 2 Benz ##o P ##yr ##ones ; 1 , 2 - Benz ##o [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27570140.44',\n",
    "  'test_set_idx': 10507,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedure',\n",
    "  'context': \"[CLS] ##tum tub ##al l ##iga ##tion request , there were 17 subsequent pre ##gna ##ncies ( 15 . 0 % ) during the 27 months of follow - up . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the [unused1] procedure [unused2] . Over one third of high - risk patients ' requests were un ##ful ##fill ##ed , indicating that significant barriers may remain . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Pro ##vide ##rs should consider [SEP]\",\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27832581.28',\n",
    "  'test_set_idx': 18738,\n",
    "  'type': 'T168',\n",
    "  'name': 'SAT1',\n",
    "  'context': '[CLS] maintenance control diet ; ( 2 ) a high - star ##ch diet rich in saturated fat ; and ( 3 ) a high - star ##ch diet rich in o ##me ##ga - 3 un ##sat ##ura ##ted fat . Two feeding sequences were used to test for carry - over effects : Group A was fed control diet , [unused1] SAT ##1 [unused2] and then UN ##SA ##T ##2 , whereas Group B was fed control diet , UN ##SA ##T ##1 and then SAT ##2 . Ser ##um was collected after each diet ##ary period , anal ##ys ##ed and tested in b ##ov ##ine in v ##it ##ro em ##b ##ryo culture . In ##tro ##ducing saturated fat and un ##sat ##ura [SEP]',\n",
    "  'existing_cui': 'C1420161',\n",
    "  'existing_cui_name': 'SLC26A1 gene',\n",
    "  'existing_cui_desc': '[CLS] SL ##C ##26 ##A ##1 gene [unused3] ( Ana ##tom ##ical Structure : S ##U ##LF ##AT ##E AN ##ION T ##RA ##NS ##PO ##RT ##ER 1 ; S ##OL ##UT ##E CA ##R ##RI ##ER FA ##MI ##L ##Y 26 ( S ##U ##LF ##AT ##E T ##RA ##NS ##PO ##RT ##ER ) , ME ##MB ##ER 1 ; E ##DM ##4 ; so ##lut ##e carrier family 26 member 1 ; SAT - 1 ) [SEP]',\n",
    "  'our_bi_cui': 'C0445244',\n",
    "  'our_bi_cui_name': 'Serotype SAT1',\n",
    "  'our_bi_cui_desc': '[CLS] Ser ##otype SAT ##1 [unused3] ( Intel ##lect ##ual Product , qualifier value : SAT ##1 ) [SEP]',\n",
    "  'our_cross_cui': 'C0597423',\n",
    "  'our_cross_cui_name': 'Saturated fat',\n",
    "  'our_cross_cui_desc': '[CLS] Sa ##tura ##ted fat [unused3] ( Food , substance : saturated fatty acid ; fat ##s saturated ; saturated fatty acids ; acids fatty saturated ; Sa ##tura ##ted fatty acid ; Sa ##tura ##ted Fat ##ty A ##cid ##s ; A ##cid ##s , Sa ##tura ##ted Fat ##ty ; Fat ##ty A ##cid ##s , Sa ##tura ##ted ; saturated fat ; Sa ##tura ##ted Fat ##ty A ##cid ; Fat ##ty acids . saturated ; fat saturated ) [SEP]'},\n",
    " {'mention_id': '27913563.8',\n",
    "  'test_set_idx': 21797,\n",
    "  'type': 'T082',\n",
    "  'name': 'Yorkshire',\n",
    "  'context': '[CLS] - life balance of doctors in training - a q ##ual ##itative study In ##ves ##ti ##gate the work - life balance of doctors in training in the UK from the perspectives of trainers and train ##ees . Q ##ual ##itative semi ##structure ##d focus groups and interviews with train ##ees and trainers . Post ##graduate medical training in London , [unused1] Yorkshire [unused2] and Hu ##mber , Kent , Surrey and Sussex , and Wales during the junior doctor contract dispute at the end of 2015 . Part of a larger General Medical Council study about the fair ##ness of postgraduate medical training . 96 train ##ees and 41 trainers . Train ##ees comprised UK graduates and International Medical Graduate ##s , across all stages [SEP]',\n",
    "  'existing_cui': 'C0324292',\n",
    "  'existing_cui_name': 'Yorkshire pig',\n",
    "  'existing_cui_desc': '[CLS] Yorkshire pig [unused3] ( E ##uka ##ryo ##te , organism ) [SEP]',\n",
    "  'our_bi_cui': 'C0454874',\n",
    "  'our_bi_cui_name': 'South Yorkshire',\n",
    "  'our_bi_cui_desc': '[CLS] South Yorkshire [unused3] ( Spa ##tial Concept , geographic location : S York ##s - South Yorkshire ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '27570140.53',\n",
    "  'test_set_idx': 10516,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedure',\n",
    "  'context': \"[CLS] the 27 months of follow - up . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Over one third of high - risk patients ' requests were un ##ful ##fill ##ed , indicating that significant barriers may remain . Though women with high - risk pre ##gna ##ncies were more likely to request post ##par ##tum tub ##al l ##iga ##tion , they were not more likely to complete the procedure . Pro ##vide ##rs should consider these procedures urgent , especially in high - risk women , and advocate for their patients ' access to this [unused1] procedure [unused2] . [SEP]\",\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '28437231.11',\n",
    "  'test_set_idx': 35877,\n",
    "  'type': 'T017',\n",
    "  'name': 'blaKPC',\n",
    "  'context': '[CLS] ##s and V ##ir ##ule ##nce - Re ##lated T ##rai ##ts of E ##pid ##em ##ic K ##PC - Pro ##ducing K ##le ##bs ##iel ##la pneumonia ##e Is ##olate ##s in a Chinese University Hospital K ##le ##bs ##iel ##la pneumonia ##e is an important human path ##ogen associated with a variety of diseases and the prevalence of [unused1] b ##la ##K ##PC [unused2] carrying K . pneumonia ##e ( K ##PC - K ##p ) is rapidly increasing . Cap ##sul ##e is an important v ##ir ##ule ##nce factor in K . pneumonia ##e . In this study , we determined to first systematically character ##ize caps ##ular p ##oly ##sa ##cc ##hari ##de and v ##ir ##ule ##nce traits in K [SEP]',\n",
    "  'existing_cui': 'C1855645',\n",
    "  'existing_cui_name': 'Keratoconus posticus circumscriptus',\n",
    "  'existing_cui_desc': '[CLS] Ke ##rato ##con ##us post ##icus c ##ir ##cum ##s ##cript ##us [unused3] ( B ##iol ##og ##ic Fun ##ction : K ##ER ##AT ##OC ##ON ##US P ##OS ##TI ##CU ##S C ##IR ##CU ##MS ##CR ##IP ##TU ##S ) [SEP]',\n",
    "  'our_bi_cui': 'C1531163',\n",
    "  'our_bi_cui_name': 'beta-lactamase KPC-3 , Klebsiella pneumoniae',\n",
    "  'our_bi_cui_desc': '[CLS] beta - la ##ct ##ama ##se K ##PC - 3 , K ##le ##bs ##iel ##la pneumonia ##e [unused3] ( Chemical : b ##la ( K ##PC - 3 ) , K ##le ##bs ##iel ##la pneumonia ##e ; K ##PC - 3 beta - la ##ct ##ama ##se , K ##le ##bs ##iel ##la pneumonia ##e ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27587730.39',\n",
    "  'test_set_idx': 10778,\n",
    "  'type': 'T103',\n",
    "  'name': 'gga-miR-21',\n",
    "  'context': '[CLS] and decreased end ##ogen ##ous K ##rup ##pel - like factor 5 expression in primary pre - ad ##ip ##ocytes . K ##rup ##pel - like factor 5 knock ##down using RNA ##i had a similar effect to that of the g ##ga - mi ##R - 21 mimic on cell proliferation . The promoting effect of the [unused1] g ##ga - mi ##R - 21 [unused2] inhibitor on pre - ad ##ip ##oc ##yte proliferation was partially at ##ten ##uated by K ##rup ##pel - like factor 5 knock ##down . Take ##n together , our results demonstrated that mi ##R - 21 in ##hibit ##s chicken pre - ad ##ip ##oc ##yte proliferation , at least in part , by targeting K ##rup ##pel [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C2825314',\n",
    "  'our_bi_cui_name': 'MicroRNA Gene',\n",
    "  'our_bi_cui_desc': '[CLS] Micro ##RNA Gene [unused3] ( Ana ##tom ##ical Structure : Micro RNA Gene ; Mi ##RNA Gene ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '27859998.39',\n",
    "  'test_set_idx': 19634,\n",
    "  'type': 'T033',\n",
    "  'name': 'normative levels',\n",
    "  'context': '[CLS] for women , reduced no ##go - related the ##ta - band medial frontal cortex power and medial frontal cortex - dorsal pre ##front ##al cortex connectivity were both consistent with the potential del ##eter ##ious ca ##usal effects of alcohol exposure . These findings suggest that diminished the ##ta - band medial frontal cortex power and medial frontal cortex - dorsal pre ##front ##al cortex connectivity may be ne ##uro ##phy ##sio ##logical mechanisms underlying alcohol - related di ##sin ##hibition . Although preliminary , these results suggest that [unused1] norm ##ative levels [unused2] of alcohol use during emerging adulthood have potential sex - specific ca ##usal effects on response in ##hibition E ##EG dynamics , and thus have potentially significant public health implications . [SEP]',\n",
    "  'existing_cui': 'C1547707',\n",
    "  'existing_cui_name': 'Floor - story of building',\n",
    "  'existing_cui_desc': '[CLS] Floor - story of building [unused3] ( Spa ##tial Concept : Level ; Story ; Floor ) [SEP]',\n",
    "  'our_bi_cui': 'C1551394',\n",
    "  'our_bi_cui_name': 'normal Device Alert Level',\n",
    "  'our_bi_cui_desc': '[CLS] normal Devi ##ce Al ##ert Level [unused3] ( Finding : Normal ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28257468.26',\n",
    "  'test_set_idx': 30272,\n",
    "  'type': 'T103',\n",
    "  'name': 'non - coding regions',\n",
    "  'context': '[CLS] ##phism ##s associated with differences between lines in both their mean survival times and micro ##en ##vir ##on ##mental plastic ##ity , suggesting that lines differ in their ability to adapt to variable path ##ogen exposure ##s . The majority of p ##oly ##mor ##phism ##s increasing resistance to Ma ##5 ##4 ##9 were sex bias ##ed , located in [unused1] non - coding regions [unused2] , had moderately large effect and were rare , suggesting that there is a general cost to defense . Nevertheless , host defense was not negatively correlated with overall long ##evity and f ##ec ##und ##ity . In contrast to Ma ##5 ##4 ##9 , minor all ##ele ##s were concentrated in the most Pa ##14 - susceptible as well [SEP]',\n",
    "  'existing_cui': 'C0079941',\n",
    "  'existing_cui_name': 'Open Reading Frames',\n",
    "  'existing_cui_desc': '[CLS] Open Reading Fr ##ame ##s [unused3] ( Ana ##tom ##ical Structure , OR ##F : OR ##F ##s ; Region , Pro ##tein Co ##ding ; Pro ##tein Co ##ding Se ##quence ; Co ##ding Se ##quence ; Pro ##tein Co ##ding Region ; Fr ##ame ##s , Open Reading ; Co ##ding Region ##s , Pro ##tein ; Region ##s , Pro ##tein Co ##ding ; or ##fs ; Reading Fr ##ame , Open ; Co ##ding Region ; Open Reading Fr ##ame ; Fr ##ame , Open Reading ; Co ##ding Feature ; Co ##ding Region , Pro ##tein ; open reading frame ; Pro ##tein Co ##ding Region ##s ; Reading Fr ##ame ##s , Open ) [SEP]',\n",
    "  'our_bi_cui': 'C0079941',\n",
    "  'our_bi_cui_name': 'Open Reading Frames',\n",
    "  'our_bi_cui_desc': '[CLS] Open Reading Fr ##ame ##s [unused3] ( Ana ##tom ##ical Structure , OR ##F : OR ##F ##s ; Region , Pro ##tein Co ##ding ; Pro ##tein Co ##ding Se ##quence ; Co ##ding Se ##quence ; Pro ##tein Co ##ding Region ; Fr ##ame ##s , Open Reading ; Co ##ding Region ##s , Pro ##tein ; Region ##s , Pro ##tein Co ##ding ; or ##fs ; Reading Fr ##ame , Open ; Co ##ding Region ; Open Reading Fr ##ame ; Fr ##ame , Open Reading ; Co ##ding Feature ; Co ##ding Region , Pro ##tein ; open reading frame ; Pro ##tein Co ##ding Region ##s ; Reading Fr ##ame ##s , Open ) [SEP]',\n",
    "  'our_cross_cui': 'C0021920',\n",
    "  'our_cross_cui_name': 'Introns',\n",
    "  'our_cross_cui_desc': '[CLS] In ##tron ##s [unused3] ( Chemical , finding : In ##tron ##ic ; Inter ##vening Se ##quence ##s ; Se ##quence , Inter ##vening ; SE ##Q IN ##TE ##R ##VE ##NI ##NG ; In ##tron ; Inter ##vening Se ##quence ; intro ##ns ; intro ##n ; Non - coding DNA sequence ; Se ##quence ##s , Inter ##vening ; IN ##TE ##R ##VE ##NI ##NG SE ##Q ) [SEP]'},\n",
    " {'mention_id': '27616751.36',\n",
    "  'test_set_idx': 11894,\n",
    "  'type': 'T038',\n",
    "  'name': 'tolerant',\n",
    "  'context': '[CLS] cells in the pre - se ##ns ##iti ##zed mice . CD ##25 + T - cell de ##ple ##tion in α - CD ##45 ##RB combined with Don ##or - specific s ##ple ##en cell trans ##fusion therapy recipients could prevent skin all ##og ##raft tolerance from establishing . In addition , adopt ##ive transfer of donor - prime ##d memory T cells into the [unused1] tolerant [unused2] recipients marked ##ly broke the established tolerance . Our findings indicate that α - CD ##45 ##RB and Don ##or - specific s ##ple ##en cell trans ##fusion can s ##yne ##rg ##istic ##ally in ##hibit the accelerated rejection mediated by memory T cells and induce long - term skin all ##og ##raft acceptance in mice . [SEP]',\n",
    "  'existing_cui': 'C0344336',\n",
    "  'existing_cui_name': 'Tolerant of cold',\n",
    "  'existing_cui_desc': '[CLS] To ##ler ##ant of cold [unused3] ( Finding , finding ) [SEP]',\n",
    "  'our_bi_cui': 'C0020963',\n",
    "  'our_bi_cui_name': 'Immune Tolerance',\n",
    "  'our_bi_cui_desc': '[CLS] I ##mm ##une To ##ler ##ance [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : I ##mm ##uno ##log ##ic para ##lysis - R ##ET ##IR ##ED - ; I ##mm ##uno ##log ##ic un ##res ##po ##ns ##ive ##ness ; I ##mm ##uno ##log ##ic un ##res ##po ##ns ##ive ##ness - R ##ET ##IR ##ED - ; I ##mm ##uno ##logical To ##ler ##ance ; im ##mu ##nological para ##lysis ; I ##mm ##uno ##log ##ic To ##ler ##ance ; Self To ##ler ##ance ; To ##ler ##ance , I ##mm ##une ; I ##mm ##uno ##logical tolerance ; I ##mm ##uno ##log ##ic tolerance , function ; immune tolerance ; im ##mu ##no ##log ##ic [SEP]',\n",
    "  'our_cross_cui': 'C0887937',\n",
    "  'our_cross_cui_name': 'Allograft Tolerance',\n",
    "  'our_cross_cui_desc': '[CLS] All ##og ##raft To ##ler ##ance [unused3] ( B ##iol ##og ##ic Fun ##ction : To ##ler ##ance , All ##og ##raft ) [SEP]'},\n",
    " {'mention_id': '27506220.46',\n",
    "  'test_set_idx': 8715,\n",
    "  'type': 'T033',\n",
    "  'name': 'cerebral palsy - related issues',\n",
    "  'context': '[CLS] , e . g . participants with Gross Motor Fun ##ction Classification System level IV and V had a high level of medical input and a greater use of trunk - supporting devices , anti ##re ##f ##lux and la ##xa ##tive . Profile ##s could be established based on Gross Motor Fun ##ction Classification System levels . Adults with cerebral p ##als ##y use a large amount of drugs , mobility aids , or ##th ##otic devices , rehabilitation and medical input . Healthcare is targeted at [unused1] cerebral p ##als ##y - related issues [unused2] . Gross Motor Fun ##ction Classification System is a de ##ter ##mina ##nt of healthcare consumption and thus a useful tool for clinical practice to target care appropriately . [SEP]',\n",
    "  'existing_cui': 'C0007789',\n",
    "  'existing_cui_name': 'Cerebral Palsy',\n",
    "  'existing_cui_desc': '[CLS] Ce ##re ##bra ##l Pa ##ls ##y [unused3] ( B ##iol ##og ##ic Fun ##ction , CP , Ce ##re ##bra ##l Pa ##ls ##y , diagnosis , disorder : Pa ##ls ##y ; cerebral ; Ce ##re ##bra ##l p ##als ##y , un ##sp ##ec ##ified ; Ce ##re ##bra ##l p ##als ##y [ Am ##bi ##guous ] ; Pa ##ls ##y cerebral ; para ##lysis ; cerebral ; In ##fant ##ile cerebral p ##als ##y ; Ce ##re ##bra ##l p ##als ##y ; Ce ##re ##bra ##l para ##lysis ; cerebral para ##lysis ; Con ##gen ##ital cerebral p ##als ##y ; cerebral p ##als ##y ; CP - Ce ##re ##bra ##l p ##als ##y ; cerebral ; para ##lysis [SEP]',\n",
    "  'our_bi_cui': 'C1299636',\n",
    "  'our_bi_cui_name': 'Cognitive safety issue',\n",
    "  'our_bi_cui_desc': '[CLS] Co ##gni ##tive safety issue [unused3] ( Finding , finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0033213',\n",
    "  'our_cross_cui_name': 'Problem',\n",
    "  'our_cross_cui_desc': '[CLS] Problem [unused3] ( Finding , finding : Issue ; problem ) [SEP]'},\n",
    " {'mention_id': '27534734.29',\n",
    "  'test_set_idx': 9712,\n",
    "  'type': 'T170',\n",
    "  'name': 'Hadamard combinations',\n",
    "  'context': '[CLS] a T ##E of 80 ##ms , 20 - m ##s editing pulses are applied at 4 . 56 pp ##m ( on G ##S ##H ) , 1 . 9 pp ##m ( on GA ##BA ) , both offset ##s ( using a dual - lobe co ##sin ##e - m ##od ##ulated pulse ) or neither . [unused1] Had ##ama ##rd combinations [unused2] of the four sub - experiments yield GA ##BA and G ##S ##H difference s ##pect ##ra . It is shown that Had ##ama ##rd En ##co ##ding and Reconstruction of Mega - Edit ##ed S ##pect ##ros ##copy gives excellent separation of the edited GA ##BA and G ##S ##H signals in p ##han ##tom ##s , and resulting [SEP]',\n",
    "  'existing_cui': 'C0628845',\n",
    "  'existing_cui_name': 'chlorpromazine , dexamethasone , metoclopramide , orphenadrine drug combination',\n",
    "  'existing_cui_desc': '[CLS] ch ##lor ##p ##roma ##zine , de ##xa ##met ##has ##one , met ##oc ##lop ##ram ##ide , or ##phe ##na ##dr ##ine drug combination [unused3] ( Chemical : anti ##em ##etic combination CO ##MD ; CO ##MD combination ; ch ##lor ##p ##roma ##zine - de ##xa ##met ##has ##one - met ##oc ##lop ##ram ##ide - or ##phe ##na ##dr ##ine ) [SEP]',\n",
    "  'our_bi_cui': 'C0002045',\n",
    "  'our_bi_cui_name': 'algorithm',\n",
    "  'our_bi_cui_desc': '[CLS] algorithm [unused3] ( Intel ##lect ##ual Product : Al ##gor ##ith ##m ; Al ##gor ##ith ##ms ; algorithms ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27457539.17',\n",
    "  'test_set_idx': 6416,\n",
    "  'type': 'T038',\n",
    "  'name': 'pregnant',\n",
    "  'context': '[CLS] vaccine ( C ##L ##13 ##T ) in came ##ls R ##ift Valley fever is an emerging zoo ##not ##ic viral disease , en ##zo ##otic and endemic in Africa and the Arabian Peninsula , which poses a significant threat to both human and animal health . The disease is most severe in r ##umi ##nant ##s causing abortion ##s in [unused1] pregnant [unused2] animals , especially sheep animals and high mortality in young populations . High mortality rates and severe clinical manifest ##ation have also been reported among came ##l populations in Africa , to attend however none of the currently available live vaccine ##s against R ##V ##F have been tested for safety and efficacy in this species . In this study , the [SEP]',\n",
    "  'existing_cui': 'C0549206',\n",
    "  'existing_cui_name': 'Patient currently pregnant',\n",
    "  'existing_cui_desc': '[CLS] Pat ##ient currently pregnant [unused3] ( Finding , finding , history : Pre ##gnant ; currently pregnant ; Currently pregnant ; Pre ##gna ##ncy not delivered ; G ##ra ##vid ##ity ; G ##ra ##vid ; Pat ##ient pregnant ; pregnant patient ; PR ##EG ##NA ##NT ; pregnant ; g ##ra ##vid ) [SEP]',\n",
    "  'our_bi_cui': 'C0033011',\n",
    "  'our_bi_cui_name': 'Pregnant Women',\n",
    "  'our_bi_cui_desc': '[CLS] Pre ##gnant Women [unused3] ( Population Group , person : Woman , Pre ##gnant ; pregnant female ; W ##OM ##EN PR ##EG ##N ; Women , Pre ##gnant ; PR ##EG ##N W ##OM ##EN ; pregnant woman ; Pre ##gnant woman ; Pre ##gnant women ; Pre ##gnant Woman ; pregnant women ) [SEP]',\n",
    "  'our_cross_cui': 'C0032961',\n",
    "  'our_cross_cui_name': 'Pregnancy',\n",
    "  'our_cross_cui_desc': '[CLS] Pre ##gna ##ncy [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , o ##bs ##er ##vable entity , qualifier value , s ##ym ##pt ##om : G ##esta ##tion ; Pre ##gna ##ncies ; PR ##EG ##N ; g ##esta ##tion ; PR ##EG ##NA ##NC ##Y ; pre ##gna ##ncies ; female pregnancy ; Pre ##gna ##ncy , function ; pregnancy ; Pre ##gna ##ncy [ Disease / Finding ] ) [SEP]'},\n",
    " {'mention_id': '28071754.21',\n",
    "  'test_set_idx': 24726,\n",
    "  'type': 'T037',\n",
    "  'name': 'injury',\n",
    "  'context': '[CLS] be activated by low - temperature far - infrared i ##rra ##diation to ex ##ert beneficial effects on the vascular end ##oth ##eli ##um . In the present study , we investigated the influence of far - infrared - induced Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein activation on AG ##E - induced end ##oth ##eli ##al [unused1] injury [unused2] both in v ##it ##ro and in v ##ivo . far - infrared i ##rra ##diation in ##hibit ##ed AG ##E - induced a ##pop ##tosis in human um ##bil ##ical vein end ##oth ##eli ##al cells . Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein activation increased the expression of p ##hos ##pha ##ti ##dy ##lino ##si ##to [SEP]',\n",
    "  'existing_cui': 'C0005604',\n",
    "  'existing_cui_name': 'Birth Injuries',\n",
    "  'existing_cui_desc': '[CLS] Birth In ##ju ##ries [unused3] ( In ##ju ##ry or Po ##ison ##ing , Birth , diagnosis , disorder : In ##ju ##ries , Birth ; T ##ra ##umatic birth ; injury birth ; Birth trauma , un ##sp ##ec ##ified ; Birth T ##ra ##uma ; Birth trauma of f ##etus ; injury ; birth ; traumatic birth ; birth trauma ; birth injuries ; Birth In ##ju ##ry ; trauma birth ; Neo ##nat ##al Birth In ##ju ##ry ; birth ##ing injuries ; Birth In ##ju ##ries [ Disease / Finding ] ; Un ##sp ##ec ##ified birth trauma ; birth ##ing trauma ; B ##IR ##TH IN ##J ; IN ##J B ##IR ##TH ; Birth injuries ; birth ; injury ; [SEP]',\n",
    "  'our_bi_cui': 'C0010957',\n",
    "  'our_bi_cui_name': 'Tissue damage',\n",
    "  'our_bi_cui_desc': '[CLS] T ##iss ##ue damage [unused3] ( In ##ju ##ry or Po ##ison ##ing , m ##or ##ph ##olo ##gic abnormal ##ity : damage tissues ; Dam ##age ; damages tissue ; Dam ##age , T ##iss ##ue ; tissue damage ; T ##iss ##ue Dam ##age ; damage ; damages ) [SEP]',\n",
    "  'our_cross_cui': 'C0178314',\n",
    "  'our_cross_cui_name': 'Poisoning / injury',\n",
    "  'our_cross_cui_desc': '[CLS] Po ##ison ##ing / injury [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder , finding , navigation ##al concept : In ##ju ##ry & / or poisoning ; IN ##J ##UR ##Y AND P ##O ##IS ##ON ##ING ; In ##ju ##ry and poisoning ; In ##ju ##ry / poisoning ) [SEP]'},\n",
    " {'mention_id': '28550165.51',\n",
    "  'test_set_idx': 38995,\n",
    "  'type': 'T103',\n",
    "  'name': 'G2L1',\n",
    "  'context': '[CLS] ##formatics tool Sign ##ific ##ance Analysis of Inter ##act ##ome . We discovered that C ##LA ##SP ##2 co - im ##mu ##no ##p ##re ##ci ##pit ##ates the novel protein S ##O ##GA ##1 , the micro ##tub ##ule - associated protein kinase MA ##R ##K ##2 , and the micro ##tub ##ule / act ##in - regulating protein [unused1] G ##2 ##L ##1 [unused2] . The GT ##P ##ase - act ##ivating proteins AG ##AP ##1 and AG ##AP ##3 were also en ##rich ##ed in the C ##LA ##SP ##2 interact ##ome , although subsequent AG ##AP ##3 and C ##L ##IP ##2 interact ##ome analysis suggests a preference of AG ##AP ##3 for C ##L ##IP ##2 . Follow - up MA [SEP]',\n",
    "  'existing_cui': 'C1415613',\n",
    "  'existing_cui_name': 'HMGXB4 gene',\n",
    "  'existing_cui_desc': '[CLS] HM ##G ##X ##B ##4 gene [unused3] ( Ana ##tom ##ical Structure : T ##HC ##21 ##16 ##30 ; HM ##G B ##OX D ##OM ##A ##IN - CO ##NT ##A ##IN ##ING 4 ; HM ##G - box containing 4 ; H ##IG ##H M ##O ##BI ##L ##IT ##Y G ##RO ##UP PR ##OT ##EI ##N 2 - L ##I ##KE 1 ) [SEP]',\n",
    "  'our_bi_cui': 'C1314812',\n",
    "  'our_bi_cui_name': 'GNB2L1 protein',\n",
    "  'our_bi_cui_desc': '[CLS] G ##N ##B ##2 ##L ##1 protein [unused3] ( Chemical : RA ##C ##K - 1 ( receptor for activated C kinase ) protein ; G ##N ##B ##2 - RS ##1 protein ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28105138.37',\n",
    "  'test_set_idx': 25669,\n",
    "  'type': 'T038',\n",
    "  'name': 'diabetic',\n",
    "  'context': '[CLS] that were analyzed , the interval between s ##ym ##pt ##om onset and re ##per ##fusion therapy ( window period ) varied from 0 . 5 to 24 h . The h ##s - CR ##P value was found to be higher in non - di ##abe ##tic patients ( 0 . 61 mg / d ##l ) compared with [unused1] di ##abe ##tic [unused2] patients ( 0 . 87 mg / d ##l ) . Moreover , a significant correlation between h ##s - CR ##P and h ##s - t ##rop ##oni ##n T was also recorded ( P < 0 . 00 ##1 ) . However , there was no significant difference in the mean h ##s - CR ##P values in patients [SEP]',\n",
    "  'existing_cui': 'C0241863',\n",
    "  'existing_cui_name': 'Diabetic',\n",
    "  'existing_cui_desc': '[CLS] Di ##abe ##tic [unused3] ( Finding : di ##abe ##tics ; di ##abe ##tic ) [SEP]',\n",
    "  'our_bi_cui': 'C0241863',\n",
    "  'our_bi_cui_name': 'Diabetic',\n",
    "  'our_bi_cui_desc': '[CLS] Di ##abe ##tic [unused3] ( Finding : di ##abe ##tics ; di ##abe ##tic ) [SEP]',\n",
    "  'our_cross_cui': 'C0011847',\n",
    "  'our_cross_cui_name': 'Diabetes',\n",
    "  'our_cross_cui_desc': '[CLS] Di ##abe ##tes [unused3] ( B ##iol ##og ##ic Fun ##ction : diabetes ) [SEP]'},\n",
    " {'mention_id': '27298278.40',\n",
    "  'test_set_idx': 1841,\n",
    "  'type': 'T017',\n",
    "  'name': 'A2780',\n",
    "  'context': \"[CLS] ' - di ##car ##box ##yla ##te , respectively . Na ##ph ##th ##o ##quin ##ones and nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##ers were previously unknown in the genus Mo ##rin ##da . In addition , the compounds were tested for c ##yt ##oto ##xi ##city against four human cancer cell lines He ##L ##a , [unused1] A2 ##7 ##80 [unused2] , Ke ##tr ##3 and MC ##F - 7 and their effects on p ##53 - activated transcription . Three nap ##ht ##ho ##quin ##ones had moderate c ##yt ##oto ##xi ##c effects with I ##C ##50 values ranging from 1 . 51 to 9 . 56 μ ##M , through up - regulation of p ##53 transcription ##al activity . [SEP]\",\n",
    "  'existing_cui': 'C1504999',\n",
    "  'existing_cui_name': 'PA 2789',\n",
    "  'existing_cui_desc': '[CLS] PA 278 ##9 [unused3] ( Chemical : PA - 278 ##9 ; PA ##27 ##8 ##9 ) [SEP]',\n",
    "  'our_bi_cui': 'C4277577',\n",
    "  'our_bi_cui_name': 'A549 Cells',\n",
    "  'our_bi_cui_desc': '[CLS] A ##5 ##4 ##9 Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell , A ##5 ##4 ##9 ; Cell Lines , A ##5 ##4 ##9 ; Cell Line , A ##5 ##4 ##9 ; A ##5 ##4 ##9 Cell Lines ; A ##5 ##4 ##9 Cell ; A ##5 ##4 ##9 Cell Line ; Cell ##s , A ##5 ##4 ##9 ) [SEP]',\n",
    "  'our_cross_cui': 'C0085983',\n",
    "  'our_cross_cui_name': 'Cell Line , Tumor',\n",
    "  'our_cross_cui_desc': '[CLS] Cell Line , Tu ##mor [unused3] ( Ana ##tom ##ical Structure : Cell Lines , Tu ##mor ; Tu ##mor Cell Line ; Line , Tu ##mor Cell ; Lines , Tu ##mor Cell ; Tu ##mor Cell Lines ; tumor cell lines ) [SEP]'},\n",
    " {'mention_id': '27266283.17',\n",
    "  'test_set_idx': 1107,\n",
    "  'type': 'T103',\n",
    "  'name': 'DR-70',\n",
    "  'context': '[CLS] Pat ##ients with lung cancer are usually diagnosed at advanced or locally advanced stage , for this reason early diagnosis of lung cancer is very important . For early detection of lung cancer some methods are emphasized such as low - dose com ##puted to ##mo ##graphy or tumor bio ##mark ##ers . In this study we aimed to evaluate [unused1] DR - 70 [unused2] sensitivity and specific ##ity as a tumor marker in detection of non - small cell lung cancer ##s . Between May 2013 and April 2014 , the serum samples from 88 non lung cancer patients , 86 patients with chronic o ##bs ##truct ##ive pulmonary di ##ses ##ase were obtained . Blood samples from each participant were analyzed for DR - [SEP]',\n",
    "  'existing_cui': 'C0127021',\n",
    "  'existing_cui_name': 'MAR 70',\n",
    "  'existing_cui_desc': '[CLS] MA ##R 70 [unused3] ( Chemical : MA ##R - 70 ; MA ##R ##70 ; 5 , 12 - Na ##ph ##tha ##cene ##dio ##ne , 8 - ace ##ty ##l - 10 - ( ( 3 - amino - 2 , 3 , 6 - t ##ride ##ox ##y - 4 - O - ( 2 , 6 - did ##eo ##xy - alpha - L - a ##rab ##ino - he ##x ##opy ##rano ##sy ##l ) - alpha - L - l ##yx ##o - he ##x ##opy ##rano ##sy ##l ) o ##xy ) - 7 , 8 , 9 , 10 - te ##tra ##hy ##dr ##o - 6 , 8 , 11 - t ##ri ##hy ##dr ##ox ##y [SEP]',\n",
    "  'our_bi_cui': 'C0215991',\n",
    "  'our_bi_cui_name': 'CD70 Antigen',\n",
    "  'our_bi_cui_desc': '[CLS] CD ##70 Anti ##gen [unused3] ( Chemical , substance : Ki - 24 Anti ##gen ; T ##UM ##OR NE ##CR ##OS ##IS FA ##CT ##OR L ##IG ##AN ##D S ##UP ##ER ##FA ##MI ##L ##Y ME ##MB ##ER 00 ##7 ; CD ##27 ##L Pro ##tein ; CD ##70 Anti ##gens ; AN ##TI ##GE ##NS CD 07 ##0 ; Liga ##nd , CD ##27 ; T ##NF Super ##family , Member 7 ; CD 07 ##0 AN ##TI ##GE ##NS ; CD ##27 Liga ##nd ; Anti ##gen , CD ##70 ; Tu ##mor N ##ec ##rosis Factor Liga ##nd Super ##family Member 7 ; Anti ##gens , CD ##70 ; Anti ##gens , CD ##70 [ Chemical / In ##g ##red ##ient [SEP]',\n",
    "  'our_cross_cui': 'C0041365',\n",
    "  'our_cross_cui_name': 'Tumor Markers',\n",
    "  'our_cross_cui_desc': '[CLS] Tu ##mor Mark ##ers [unused3] ( Chemical : tumor markers ; Tu ##mor Mark ##er ; Cancer B ##io ##mark ##ers ; Tu ##mor marker ; B ##io ##mark ##ers , Cancer ; Mark ##ers , Tu ##mor ; tumor marker ; Tu ##mor markers ) [SEP]'},\n",
    " {'mention_id': '28197156.31',\n",
    "  'test_set_idx': 28101,\n",
    "  'type': 'T017',\n",
    "  'name': 'Carbon Assimilation Rate 8',\n",
    "  'context': '[CLS] ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , [unused1] Carbon As ##si ##mi ##lation Rate 8 [unused2] is identical to D ##TH ##8 / G ##h ##d ##8 / L ##HD ##1 , which was reported to control rice flowering date . The increase of A is largely due to an increase of R ##u ##B ##P regeneration rate via increased leaf nitrogen content , and partially explained by reduced s ##tom ##ata ##l limitation via [SEP]',\n",
    "  'existing_cui': 'C2246620',\n",
    "  'existing_cui_name': 'iron assimilation',\n",
    "  'existing_cui_desc': '[CLS] iron ass ##im ##ilation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_bi_cui': 'C1413023',\n",
    "  'our_bi_cui_name': 'C8A gene',\n",
    "  'our_bi_cui_desc': '[CLS] C ##8 ##A gene [unused3] ( Ana ##tom ##ical Structure : complement component 8 alpha subunit ; CO ##MP ##LE ##ME ##NT CO ##MP ##ON ##EN ##T 8 , AL ##P ##HA S ##U ##B ##UN ##IT ; C ##8 AL ##P ##HA ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '28203067.34',\n",
    "  'test_set_idx': 28191,\n",
    "  'type': 'T033',\n",
    "  'name': 'negative impact of care',\n",
    "  'context': '[CLS] self - app ##rai ##sal of cop ##ing well as a care ##gi ##ver ; lower sense of general support ; more hours of care per week ; and the motor re ##tar ##dation of the cared - for person measured with the speed of the Time ##d Up and Go test . W ##orse performance on the Time ##d Up and Go test was only the patient - related predict ##or of distress among the variables examined as contributors to the higher [unused1] negative impact of care [unused2] . En ##han ##cing the mobility of g ##eria ##tric patients through suit ##ably tailored kin ##esi ##ther ##ap ##eu ##tic methods during their hospital stay may mit ##igate the burden endured by family care ##rs . [SEP]',\n",
    "  'existing_cui': 'C0726639',\n",
    "  'existing_cui_name': 'Impact food supplement',\n",
    "  'existing_cui_desc': '[CLS] Impact food supplement [unused3] ( Food : Impact ; impact ; I ##MP ##AC ##T ) [SEP]',\n",
    "  'our_bi_cui': 'C1514593',\n",
    "  'our_bi_cui_name': 'Psychological Impact',\n",
    "  'our_bi_cui_desc': '[CLS] Psychological Impact [unused3] ( Clinical At ##tri ##but ##e ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27234220.21',\n",
    "  'test_set_idx': 277,\n",
    "  'type': 'T033',\n",
    "  'name': 'No',\n",
    "  'context': '[CLS] for complications after the procedure ( bleeding and vascular access complications ) . Pat ##ients in group A were older ( 74 ± 12 years vs . 68 ± 17 years , p < 0 . 01 ) and the main indication for anti ##coa ##gu ##lation was at ##rial fi ##bri ##lla ##tion ( 58 . 6 % ) . [unused1] No [unused2] complications occurred during the procedures . There were no acute bleeding ##s just after the bandage removal . During the first 24 ##h , only 3 ( 2 . 1 % ) radial o ##cc ##lusion ##s in group A and 2 ( 0 . 6 % ) in group B ( p = 0 . 14 ) were recorded . He [SEP]',\n",
    "  'existing_cui': 'C1016143',\n",
    "  'existing_cui_name': 'Tetragenococcus halophilus',\n",
    "  'existing_cui_desc': '[CLS] Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us [unused3] ( Ba ##cter ##ium , organism : P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us Me ##es 1934 ( A ##pp ##roved List ##s 1980 ) ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us ( Me ##es 1934 ) Collins et al . 1993 ; Sa ##rc ##ina ha ##ma ##guchi ##ae ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##a ; P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us ; Te ##tra ##co ##cc ##cus No . 1 ; P ##ed ##io ##co ##cc ##us so ##ya ##e ) [SEP]',\n",
    "  'our_bi_cui': 'C0243095',\n",
    "  'our_bi_cui_name': 'Finding',\n",
    "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C1513916',\n",
    "  'our_cross_cui_name': 'Negative Finding',\n",
    "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
    " {'mention_id': '27545500.16',\n",
    "  'test_set_idx': 9992,\n",
    "  'type': 'T103',\n",
    "  'name': '16-aldehyde tanshinone I',\n",
    "  'context': '[CLS] au ##reus are prevalent . The dramatically reduced discovery of new anti ##biotics , as well as the persistent emergence of resistant bacteria , represents a major health problem in both hospital and community settings . Using anti ##biotic enhance ##rs to rescue existing classes of anti ##biotics is an attractive strategy . In this study , [unused1] 16 - al ##de ##hy ##de tan ##shin ##one I [unused2] was synthesized and b ##act ##eri ##ost ##atic activity was explored . In addition , s ##yne ##rg ##istic or add ##itive activity between 16 - al ##de ##hy ##de tan ##shin ##one I and amino ##gly ##cos ##ide anti ##biotics or β - la ##ct ##am anti ##biotics in v ##it ##ro was identified . Moreover [SEP]',\n",
    "  'existing_cui': 'C0075810',\n",
    "  'existing_cui_name': 'tanshinone',\n",
    "  'existing_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
    "  'our_bi_cui': 'C0075810',\n",
    "  'our_bi_cui_name': 'tanshinone',\n",
    "  'our_bi_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27655308.12',\n",
    "  'test_set_idx': 13170,\n",
    "  'type': 'T092',\n",
    "  'name': 'Food banks',\n",
    "  'context': \"[CLS] is key to involve this group in determining their communication barriers and information needs . O ##bject ##ive To gain insight into how people with low literacy use and evaluate written drug information , and to identify ways in which they feel the patient leaf ##let can be improved , and in particular how images could be used . Set ##ting [unused1] Food banks [unused2] and an education institution for Dutch language training in the Netherlands . Method Semi - structured focus groups and individual interviews were held with low - liter ##ate participants ( n = 45 ) . The them ##atic framework approach was used for analysis to identify themes in the data . Main outcome measure Low - liter ##ate people ' s [SEP]\",\n",
    "  'existing_cui': 'C0005770',\n",
    "  'existing_cui_name': 'Blood Banks',\n",
    "  'existing_cui_desc': '[CLS] Blood Banks [unused3] ( Organization : blood bank ; B ##L ##O ##OD BA ##N ##K ; Blood Bank ; Blood bank ; Banks , Blood ; Blood banks ; blood banks ; B ##LD ##B ##K ; Su ##pp ##liers ; Blood Bank ; Bank , Blood ) [SEP]',\n",
    "  'our_bi_cui': 'C0016452',\n",
    "  'our_bi_cui_name': 'Food',\n",
    "  'our_bi_cui_desc': '[CLS] Food [unused3] ( Food , medication , substance : Food or Food Product ; foods ; F ##O ##OD OR F ##O ##OD PR ##OD ##UC ##T ; Food Product ; Food or Food Sub ##stance ; Food ##P ##rod ##uc ##t ; Foods ; food ) [SEP]',\n",
    "  'our_cross_cui': 'C1561598',\n",
    "  'our_cross_cui_name': 'entity - organization',\n",
    "  'our_cross_cui_desc': '[CLS] entity - organization [unused3] ( Organization : organization ) [SEP]'},\n",
    " {'mention_id': '28295414.7',\n",
    "  'test_set_idx': 31545,\n",
    "  'type': 'T168',\n",
    "  'name': 'alcohol',\n",
    "  'context': '[CLS] ##ral St ##ability of Heavy Dr ##ink ##ing Days and Dr ##ink ##ing Red ##uction ##s Among Heavy Dr ##ink ##ers in the CO ##MB ##IN ##E Study Recently , the Food and Drug Administration proposed to expand the options for primary end points in the development of medications for alcohol use disorder to include either a ##bs ##tine ##nce from [unused1] alcohol [unused2] or a non ##ab ##st ##inen ##t outcome : no heavy drinking days ( with a heavy drinking day defined as more than 3 drinks per day for women and more than 4 drinks per day for men [ > 3 / > 4 cut ##off ] ) . The Food and Drug Administration also suggested that 6 months would be the [SEP]',\n",
    "  'existing_cui': 'C0202304',\n",
    "  'existing_cui_name': 'Ethanol measurement',\n",
    "  'existing_cui_desc': '[CLS] Ethan ##ol measurement [unused3] ( Health Care Act ##ivity , procedure : DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TA ##LC ##OH ##OL ##S ; Ethan ##ol Me ##as ##ure ##ment ; Al ##co ##hol ##s levels ; Al ##co ##hol ##s ; Ethan ##ol ; DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TI ##TA ##TI ##VE AL ##CO ##H ##OL ##S ; Al ##co ##hol ; alcohol measurements ; Me ##as ##ure ##ment of alcohol ; E ##thy ##l Al ##co ##hol Me ##as ##ure ##ments ; Drug screen q ##uant ##al ##co ##hol ##s ; Al ##co ##hol level ; Al ##co ##hol measurement ; ET ##HA ##N ##OL ; alcohol level test ) [SEP]',\n",
    "  'our_bi_cui': 'C0001975',\n",
    "  'our_bi_cui_name': 'Alcohols',\n",
    "  'our_bi_cui_desc': '[CLS] Al ##co ##hol ##s [unused3] ( Chemical , substance : alcohol ; Al ##co ##hol [ Chemical Class ] ; Al ##co ##hol ; Al ##co ##hol ##s [ Chemical / In ##g ##red ##ient ] ; alcohol ##s ; class of chemical alcohol ##s ; alcohol substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0001967',\n",
    "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
    "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
    " {'mention_id': '27384489.6',\n",
    "  'test_set_idx': 4320,\n",
    "  'type': 'T082',\n",
    "  'name': 'R1628P polymorphism',\n",
    "  'context': \"[CLS] Relations ##hip between le ##uc ##ine - rich repeat kinase 2 R ##16 ##28 ##P p ##oly ##mor ##phism and Parkinson ' s disease in Asian populations Although the le ##uc ##ine - rich repeat kinase 2 [unused1] R ##16 ##28 ##P p ##oly ##mor ##phism [unused2] has been associated with the risk of Parkinson ' s disease in Taiwan , China , and Singapore , there are conflicting findings regarding this relationship . Thus , the aim of the present meta - analysis was to evaluate the associations between the le ##uc ##ine - rich repeat kinase 2 R ##16 ##28 ##P p ##oly ##mor ##phism ( r ##s ##33 ##9 ##4 ##9 ##39 ##0 ) and Parkinson ' s disease in Asian populations . [SEP]\",\n",
    "  'existing_cui': 'C0032529',\n",
    "  'existing_cui_name': 'Genetic Polymorphism',\n",
    "  'existing_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
    "  'our_bi_cui': 'C4288453',\n",
    "  'our_bi_cui_name': 'PRSS2 Gene Mutation',\n",
    "  'our_bi_cui_desc': '[CLS] PR ##SS ##2 Gene Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction : T ##R ##Y ##2 Gene Mu ##tation ; PR ##SS ##2 Mu ##tation ; Pro ##te ##ase , Ser ##ine , 2 Gene Mu ##tation ) [SEP]',\n",
    "  'our_cross_cui': 'C0752046',\n",
    "  'our_cross_cui_name': 'Single Nucleotide Polymorphism',\n",
    "  'our_cross_cui_desc': '[CLS] Single N ##uc ##leo ##tide Pol ##ym ##or ##phism [unused3] ( Spa ##tial Concept , S ##NP : Pol ##ym ##or ##phism , Single N ##uc ##leo ##tide ; Single N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s ; Pol ##ym ##or ##phism ##s , Single N ##uc ##leo ##tide ; S ##NP ##s ; N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s , Single ; N ##uc ##leo ##tide Pol ##ym ##or ##phism , Single ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s ; Pol ##ym ##or ##phism , Single Base ) [SEP]'},\n",
    " {'mention_id': '28358712.50',\n",
    "  'test_set_idx': 33201,\n",
    "  'type': 'T058',\n",
    "  'name': 'Phytochemical tests',\n",
    "  'context': '[CLS] that E . an ##gus ##ti ##folia extract significantly reduced p ##aw ed ##ema and inflammation in a dose - dependent manner . The results also showed that the measurement by digital ca ##lip ##er and mercury p ##let ##hy ##smo ##meter were both reliable and might be applied interchange ##ably ( p < 0 . 01 ) . [unused1] Ph ##yt ##och ##em ##ical tests [unused2] indicated that the h ##ydro ##al ##co ##hol ##ic fruit extract of E . an ##gus ##ti ##folia was positive for cardiac g ##ly ##cos ##ides , fl ##av ##ono ##ids , te ##rp ##eno ##ids , and sa ##po ##nin ##s . Based on our findings , the E . an ##gus ##ti ##folia fruit extract probably has [SEP]',\n",
    "  'existing_cui': 'C0577749',\n",
    "  'existing_cui_name': 'Phytochemicals',\n",
    "  'existing_cui_desc': '[CLS] Ph ##yt ##och ##em ##ical ##s [unused3] ( Chemical , substance : Ph ##yton ##ut ##rient ; Diet ##ary Ph ##yt ##och ##em ##ical ##s ; Ph ##yt ##och ##em ##ical ##s [ Chemical / In ##g ##red ##ient ] ; Plant - Der ##ive ##d Chemical ##s ; Plant - Der ##ive ##d Co ##mpo ##unds ; Co ##mpo ##unds , Plant - Der ##ive ##d ; p ##hy ##to ##chemical ; Ph ##yt ##och ##em ##ical ##s , Diet ##ary ; Ph ##yt ##och ##em ##ical ; Plant Der ##ive ##d Chemical ##s ; Chemical ##s , Plant - Der ##ive ##d ; p ##hy ##to ##chemical ##s ; Ph ##yton ##ut ##rient ##s ; Plant Der ##ive ##d Co ##mpo ##unds ) [SEP]',\n",
    "  'our_bi_cui': 'C0201682',\n",
    "  'our_bi_cui_name': 'Chemical procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Chemical procedure [unused3] ( Health Care Act ##ivity , procedure : UN ##L ##IS ##TE ##D CH ##EM ##IS ##TR ##Y PR ##OC ##ED ##UR ##E ; Chemistry Me ##as ##ure ##ment ; chemical tests ; C ##L ##IN ##IC ##AL CH ##EM ##IS ##TR ##Y T ##ES ##T ; Chemistry procedure ; Chemistry Test ; test chemical ; Chemistry procedures ; Chemical measurement ; chemical test ; Chemistry Tech ##ni ##que ; Chemistry ; Un ##listed chemistry procedure ; Chemistry Pro ##ced ##ures ; Chemical test ; chemical testing ; chemicals testing ; Clinical chemistry test ; CH ##EM ; Chemistry Pro ##ced ##ure ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '27402827.8',\n",
    "  'test_set_idx': 4852,\n",
    "  'type': 'T038',\n",
    "  'name': 'formation',\n",
    "  'context': '[CLS] W ##nt - 5 ##a / Fr ##iz ##zled ##9 receptor signaling through the G ##α ##o / G ##β ##γ complex regulate ##s den ##dr ##itic spine [unused1] formation [unused2] W ##nt l ##igan ##ds play crucial roles in the development and regulation of s ##yna ##pse structure and function . Specifically , W ##nt - 5 ##a acts as a secret ##ed growth factor that regulate ##s den ##dr ##itic spine formation in rode ##nt hip ##po ##cam ##pal neurons , resulting in posts ##yna ##ptic development that promotes the cluster ##ing of the posts ##yna ##ptic density protein - 95 . Here , we focused on the early events occurring after the interaction between W ##nt - 5 ##a and its Fr ##iz [SEP]',\n",
    "  'existing_cui': 'C0220781',\n",
    "  'existing_cui_name': 'Anabolism',\n",
    "  'existing_cui_desc': '[CLS] Ana ##bol ##ism [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : bio ##sy ##nt ##hetic process ; Ana ##bol ##ism , function ; synthesis ; bio ##sy ##nt ##hesis ; formation ; B ##ios ##ynth ##etic ; B ##ios ##ynth ##esis ; B ##io ##genesis ; B ##ios ##ynth ##etic Process ; an ##ab ##olis ##m ) [SEP]',\n",
    "  'our_bi_cui': 'C0597545',\n",
    "  'our_bi_cui_name': 'synaptogenesis',\n",
    "  'our_bi_cui_desc': '[CLS] s ##yna ##pt ##ogen ##esis [unused3] ( B ##iol ##og ##ic Fun ##ction : s ##yna ##pse bio ##genesis ; s ##yna ##pse assembly ; s ##yna ##pse formation ) [SEP]',\n",
    "  'our_cross_cui': 'C0007613',\n",
    "  'our_cross_cui_name': 'Cell physiology',\n",
    "  'our_cross_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]'},\n",
    " {'mention_id': '27671177.8',\n",
    "  'test_set_idx': 13785,\n",
    "  'type': 'T082',\n",
    "  'name': 'Quetta',\n",
    "  'context': '[CLS] Year School Children in Mode ##rate - F ##lu ##ori ##de Dr ##ink ##ing Water Community in Que ##tta , Pakistan To determine the prevalence of dental car ##ies and its relationship with dental flu ##oro ##sis , oral health behaviour and diet ##ary behaviour among 12 - year school children in moderate - flu ##ori ##de drinking water community in [unused1] Que ##tta [unused2] , Pakistan . Cross - section ##al study . Government and private schools of Que ##tta , from November 2012 to February 2013 . At ##ota ##l of 34 ##9 children aged 12 - year from 14 randomly selected schools were included . The data collection was done on question ##naire designed for children . Dental car ##ies status was examined [SEP]',\n",
    "  'existing_cui': 'C0262345',\n",
    "  'existing_cui_name': 'Tenia of thalamus',\n",
    "  'existing_cui_desc': '[CLS] Ten ##ia of th ##ala ##mus [unused3] ( Ana ##tom ##ical Structure : ten ##ia of th ##ala ##mi ; Ten ##ia of th ##ala ##mi ; Ta ##enia th ##ala ##mi ; T ##hala ##mus ten ##ia ; ten ##ia of the th ##ala ##mus ; Ten ##ia th ##ala ##mi ) [SEP]',\n",
    "  'our_bi_cui': 'C3828424',\n",
    "  'our_bi_cui_name': 'Queretaro',\n",
    "  'our_bi_cui_desc': '[CLS] Que ##reta ##ro [unused3] ( Spa ##tial Concept : Que ##reta ##ro de Arte ##aga ; Free and Sovereign State of Que ##ré ##tar ##o ; Que ##ré ##tar ##o de Arte ##aga ; Que ##ré ##tar ##o ; Free and Sovereign State of Que ##reta ##ro ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '27587730.37',\n",
    "  'test_set_idx': 10776,\n",
    "  'type': 'T103',\n",
    "  'name': 'gga-miR-21',\n",
    "  'context': \"[CLS] ##hibit ##ed K ##rup ##pel - like factor 5 3 ( ' ) U ##TR reporter activity and decreased end ##ogen ##ous K ##rup ##pel - like factor 5 expression in primary pre - ad ##ip ##ocytes . K ##rup ##pel - like factor 5 knock ##down using RNA ##i had a similar effect to that of the [unused1] g ##ga - mi ##R - 21 [unused2] mimic on cell proliferation . The promoting effect of the g ##ga - mi ##R - 21 inhibitor on pre - ad ##ip ##oc ##yte proliferation was partially at ##ten ##uated by K ##rup ##pel - like factor 5 knock ##down . Take ##n together , our results demonstrated that mi ##R - 21 in ##hibit ##s chicken pre [SEP]\",\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1537719',\n",
    "  'our_bi_cui_name': 'MIR21 gene',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '28457334.32',\n",
    "  'test_set_idx': 36642,\n",
    "  'type': 'T103',\n",
    "  'name': 'extracellular RNA',\n",
    "  'context': '[CLS] h . Level ##s of Cell - free DNA and extra ##cellular RNA were measured by quantitative probe - based polymer ##ase chain reaction . In addition , th ##rom ##boe ##last ##ography for co ##agu ##lation as well as th ##rom ##boa ##gg ##re ##go ##metry for plate ##let function was conducted . Both Cell - free DNA and [unused1] extra ##cellular RNA [unused2] were elevated in patients with se ##psis compared with post ##oper ##ative patients and healthy volunteers . While higher extra ##cellular RNA levels correlated with a faster c ##lot ##ting time and more stable c ##lot ##s , Cell - free DNA correlated with a shorter c ##lot ##ting time but also less fi ##bri ##no ##lysis . In addition , [SEP]',\n",
    "  'existing_cui': 'C0521119',\n",
    "  'existing_cui_name': 'Extracellular',\n",
    "  'existing_cui_desc': '[CLS] Extra ##cellular [unused3] ( Ana ##tom ##ical Structure , qualifier value : extra ##cellular ; extra ##cellular region ) [SEP]',\n",
    "  'our_bi_cui': 'C0230885',\n",
    "  'our_bi_cui_name': 'Extracellular material',\n",
    "  'our_bi_cui_desc': '[CLS] Extra ##cellular material [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0035668',\n",
    "  'our_cross_cui_name': 'RNA',\n",
    "  'our_cross_cui_desc': '[CLS] RNA [unused3] ( Chemical , RNA , R ##ib ##on ##uc ##le ##ic A ##cid , substance : rib ##on ##uc ##le ##ic acid ; R ##ib ##on ##uc ##le ##ic acids ; RNA , Non - Pol ##ya ##den ##yla ##ted ; rib ##on ##uc ##lein ##ic ##um acid ##um / rib ##on ; RNA - R ##ib ##on ##uc ##le ##ic acid ; RNA [ Chemical / In ##g ##red ##ient ] ; RNA , Non Pol ##ya ##den ##yla ##ted ; Non - Pol ##ya ##den ##yla ##ted RNA ; r ##na ; Non Pol ##ya ##den ##yla ##ted RNA ; A ##cid , R ##ib ##on ##uc ##le ##ic ; R ##ib ##on ##uc ##le ##ic acid ; Gene Products , RNA [SEP]'},\n",
    " {'mention_id': '28203549.81',\n",
    "  'test_set_idx': 28273,\n",
    "  'type': 'T170',\n",
    "  'name': 'ST65',\n",
    "  'context': '[CLS] the most prevalent ST among 69 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s with K ##1 , K ##2 , K ##5 , K ##20 , and K ##5 ##7 ( 27 . 5 % , 19 / 69 ) and was only found among K ##1 is ##olate ##s . [unused1] ST ##65 [unused2] was the second most prevalent ST ( 26 . 1 % , 18 / 69 ) and was also only found among K ##2 is ##olate ##s . ST ##23 - K ##1 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s ( 84 . 2 % , 16 / 19 ) were [SEP]',\n",
    "  'existing_cui': 'C0812444',\n",
    "  'existing_cui_name': 'CD82 gene',\n",
    "  'existing_cui_desc': '[CLS] CD ##8 ##2 gene [unused3] ( Ana ##tom ##ical Structure : K ##AN ##GA ##I 1 ; I ##A ##4 ; R ##2 le ##uk ##oc ##yte anti ##gen ; suppression of tumor ##ige ##nic ##ity 6 ; L ##E ##U ##KO ##C ##Y ##TE S ##UR ##FA ##CE AN ##TI ##GE ##N R ##2 ; CD ##8 ##2 Mo ##le ##cule Gene ; CD ##8 ##2 AN ##TI ##GE ##N ; R ##2 ; CD ##8 ##2 Gene ; R ##2 L ##E ##U ##KO ##C ##Y ##TE AN ##TI ##GE ##N ; PR ##OS ##TA ##TE CA ##NC ##ER AN ##TI ##ME ##TA ##ST ##AS ##IS GE ##NE K ##A ##I ##1 ; S ##UP ##PR ##ES ##SO ##R OF T ##UM ##OR ##IG [SEP]',\n",
    "  'our_bi_cui': 'C0887835',\n",
    "  'our_bi_cui_name': 'Ribotype',\n",
    "  'our_bi_cui_desc': '[CLS] R ##ib ##otype [unused3] ( Finding : R ##ib ##otype ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0449943',\n",
    "  'our_cross_cui_name': 'Serotype',\n",
    "  'our_cross_cui_desc': '[CLS] Ser ##otype [unused3] ( Intel ##lect ##ual Product , attribute , o ##bs ##er ##vable entity , qualifier value : se ##rov ##ar ; se ##rov ##ars ; Ser ##ova ##rs ; se ##rot ##ype ; se ##rot ##ype ##s ; Ser ##otype ##s ; Ser ##ova ##r ) [SEP]'},\n",
    " {'mention_id': '27545500.19',\n",
    "  'test_set_idx': 9995,\n",
    "  'type': 'T103',\n",
    "  'name': '16-aldehyde tanshinone I',\n",
    "  'context': '[CLS] settings . Using anti ##biotic enhance ##rs to rescue existing classes of anti ##biotics is an attractive strategy . In this study , 16 - al ##de ##hy ##de tan ##shin ##one I was synthesized and b ##act ##eri ##ost ##atic activity was explored . In addition , s ##yne ##rg ##istic or add ##itive activity between [unused1] 16 - al ##de ##hy ##de tan ##shin ##one I [unused2] and amino ##gly ##cos ##ide anti ##biotics or β - la ##ct ##am anti ##biotics in v ##it ##ro was identified . Moreover , 16 - al ##de ##hy ##de tan ##shin ##one I was documented to au ##gment clearance of s ##tre ##pt ##omy ##cin and am ##pic ##ill ##in against S . au ##reus in [SEP]',\n",
    "  'existing_cui': 'C0075810',\n",
    "  'existing_cui_name': 'tanshinone',\n",
    "  'existing_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
    "  'our_bi_cui': 'C0075810',\n",
    "  'our_bi_cui_name': 'tanshinone',\n",
    "  'our_bi_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28197133.25',\n",
    "  'test_set_idx': 28041,\n",
    "  'type': 'T103',\n",
    "  'name': 'GH94',\n",
    "  'context': '[CLS] ##ume ##n micro ##bio ##ta of a la ##ct ##ating dairy cow and the micro ##or ##gan ##isms forming the fiber - de ##grading community . Fun ##ctional analysis identified 12 , 237 car ##bo ##hy ##dra ##te - active enzymes , accounting for 1 % of the trans ##cripts . The CA ##Z ##yme profile was dominated by families [unused1] G ##H ##9 ##4 [unused2] ( cello ##bio ##se - p ##hos ##ph ##ory ##lase ) , G ##H1 ##3 ( am ##yla ##se ) , G ##H ##43 and G ##H1 ##0 ( hem ##ice ##ll ##ula ##ses ) , G ##H ##9 and G ##H ##48 ( cell ##ula ##ses ) , P ##L ##11 ( p ##ec ##tina ##se ) as well [SEP]',\n",
    "  'existing_cui': 'C0084342',\n",
    "  'existing_cui_name': 'RHOC Protein',\n",
    "  'existing_cui_desc': '[CLS] R ##H ##OC Pro ##tein [unused3] ( Chemical : Trans ##form ##ing Pro ##tein R ##H ##OC ; A ##p ##ly ##sia RA ##S - Re ##lated Ho ##mo ##log 9 ; RA ##S Ho ##mo ##log Gene Family , Member C ; AR ##HC ; r ##as ho ##mo ##log gene family , member C protein , human ; R ##H ##OH ##9 ; AR ##H ##9 protein , human ; R ##H ##OC protein , human ) [SEP]',\n",
    "  'our_bi_cui': 'C0014442',\n",
    "  'our_bi_cui_name': 'Enzymes',\n",
    "  'our_bi_cui_desc': '[CLS] En ##zy ##mes [unused3] ( Chemical , medication , substance : enzymes ; enzyme ; En ##zy ##mes [ Chemical / In ##g ##red ##ient ] ; B ##io ##cat ##aly ##sts ; En ##zy ##me ) [SEP]',\n",
    "  'our_cross_cui': 'C0055033',\n",
    "  'our_cross_cui_name': 'cellobiose phosphorylase',\n",
    "  'our_cross_cui_desc': '[CLS] cello ##bio ##se p ##hos ##ph ##ory ##lase [unused3] ( Chemical , substance : Cell ##ob ##ios ##e p ##hos ##ph ##ory ##lase ) [SEP]'},\n",
    " {'mention_id': '27941943.9',\n",
    "  'test_set_idx': 22594,\n",
    "  'type': 'T204',\n",
    "  'name': 'vegetable crops',\n",
    "  'context': '[CLS] Trans ##cript ##omi ##c insights into the all ##elo ##pathic effects of the garlic all ##elo ##chemical dial ##ly ##l di ##sul ##fi ##de on tomato roots G ##ar ##lic is an all ##elo ##pathic crop that can alleviate the obstacles to continuous crop ##ping of [unused1] vegetable crops [unused2] . Di ##ally ##l di ##sul ##fi ##de , one of the most important all ##elo ##chemical ##s in garlic , promotes tomato root growth . Therefore , the global trans ##cript ##ome profiles of Di ##ally ##l di ##sul ##fi ##de - treated tomato roots over time were investigated to reveal the potential growth - promoting mechanisms . We detected 1828 , 129 ##6 and 119 ##0 differential ##ly expressed genes in the 4 , [SEP]',\n",
    "  'existing_cui': 'C0042440',\n",
    "  'existing_cui_name': 'Vegetables',\n",
    "  'existing_cui_desc': '[CLS] V ##ege ##table ##s [unused3] ( Food , substance : vegetable ; vegetables ; V ##ege ##table ; diet ##ary vegetable ) [SEP]',\n",
    "  'our_bi_cui': 'C0042440',\n",
    "  'our_bi_cui_name': 'Vegetables',\n",
    "  'our_bi_cui_desc': '[CLS] V ##ege ##table ##s [unused3] ( Food , substance : vegetable ; vegetables ; V ##ege ##table ; diet ##ary vegetable ) [SEP]',\n",
    "  'our_cross_cui': 'C0242775',\n",
    "  'our_cross_cui_name': 'Agricultural Crops',\n",
    "  'our_cross_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]'},\n",
    " {'mention_id': '28125734.62',\n",
    "  'test_set_idx': 26216,\n",
    "  'type': 'T103',\n",
    "  'name': 'miR-21-5p',\n",
    "  'context': '[CLS] ##gnant and non - ma ##li ##gnant cell lines . Further mi ##RNA inhibitor experiments and l ##uc ##ifer ##ase ass ##ays in Me ##ro - 14 cells valid ##ated mi ##R - 21 - 5 ##p as a true regulator of me ##so ##the ##lin . Moreover , in v ##it ##ro experiments showed that treatment with [unused1] mi ##R - 21 - 5 ##p [unused2] mimic reduced proliferation of ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma cell lines . Alto ##get ##her , this work shows that the mi ##R - CA ##TC ##H technique , coupled with next generation se ##quencing and in v ##it ##ro valid ##ation , represents a reliable method to identify native mi ##RNA : [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1999986',\n",
    "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '28249376.71',\n",
    "  'test_set_idx': 29941,\n",
    "  'type': 'T033',\n",
    "  'name': 'total tract digestibility',\n",
    "  'context': '[CLS] hem ##og ##lo ##bin , hem ##ato ##c ##rit , glucose , beta - h ##ydro ##xy ##but ##yric acid , ch ##ole ##ster ##ol , total protein , album ##in , blood u ##rea nitrogen and as ##par ##tate amino ##tra ##ns ##fer ##ase and al ##ani ##ne amino ##tra ##ns ##fer ##ase concentration . A ##ppa ##rent [unused1] total tract dig ##est ##ibility [unused2] of dry matter , crude pro ##ten , organic matter , and neutral de ##ter ##gent fiber were not influenced by mixture of essential oils supplement ##ation . The results of the present study suggested that supplement ##ation of mixture of essential oils may have limited effects on apparent nut ##rient dig ##est ##ibility , r ##umi ##nal f ##er [SEP]',\n",
    "  'existing_cui': 'C0017178',\n",
    "  'existing_cui_name': 'Gastrointestinal Diseases',\n",
    "  'existing_cui_desc': '[CLS] Gas ##tro ##int ##est ##inal Disease ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : gas ##tro ##int ##est ##inal disease ; G ##I disorders ; disorder ; gas ##tro ##int ##est ##inal ; G ##IT disorders ; Di ##sor ##der gas ##tro ##int ##est ##inal ; G ##IT diseases ; gas ##tro ##int ##est ##inal disorders ; gas ##tro ##int ##est ##inal disorder diagnosis ; disease ( or disorder ) ; gas ##tro ##int ##est ##inal tract ; gas ##tro ##int ##est ##inal ; disorder ; Gas ##tro ##int ##est ##inal Di ##sor ##der ; disease gas ##tro ##int ##est ##inal tract ; gas ##tro ##int ##est ##inal disorder ; Gas ##tro ##int ##est ##inal Di ##sor ##ders ; Gas [SEP]',\n",
    "  'our_bi_cui': 'C0012238',\n",
    "  'our_bi_cui_name': 'Digestion',\n",
    "  'our_bi_cui_desc': '[CLS] Digest ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : dig ##estive system functions ; dig ##est ##ion ; Digest ##ive system functions ; dig ##est ##ions ; Digest ##ive system function ; Fun ##ctions of the dig ##estive system ; Digest ##ive ; Digest ##ive tract function ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28197156.17',\n",
    "  'test_set_idx': 28087,\n",
    "  'type': 'T204',\n",
    "  'name': 'cultivar',\n",
    "  'context': '[CLS] ##im ##ilation rate ( A ) between rice cult ##iva ##rs using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial [unused1] cult ##iva ##r [unused2] . Fine mapping suggested that Carbon As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a [SEP]',\n",
    "  'existing_cui': 'C3385047',\n",
    "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
    "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
    "  'our_bi_cui': 'C0242775',\n",
    "  'our_bi_cui_name': 'Agricultural Crops',\n",
    "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
    "  'our_cross_cui': 'C0032098',\n",
    "  'our_cross_cui_name': 'Plants',\n",
    "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
    " {'mention_id': '28203067.13',\n",
    "  'test_set_idx': 28170,\n",
    "  'type': 'T033',\n",
    "  'name': 'patient - related results',\n",
    "  'context': '[CLS] stress ( score of ≤ 15 on the scale ) and higher stress ( score of ≥ 16 on the scale ) ex ##ert ##ed on family care ##rs by the process of providing care . The set of ex ##p ##lana ##tory variables comprised a wide range of socio ##de ##mo ##graphic and care - related attributes , including [unused1] patient - related results [unused2] from comprehensive g ##eria ##tric assessments and disease profiles . The best combination of ex ##p ##lana ##tory variables that provided the highest predict ##ive p ##ow ##e r for distress among family care ##rs in the multiple log ##istic re ##gression model was determined according to statistical information criteria . The statistical robust ##ness of the observed relationships and [SEP]',\n",
    "  'existing_cui': 'C0420738',\n",
    "  'existing_cui_name': 'Patient informed - test result',\n",
    "  'existing_cui_desc': '[CLS] Pat ##ient informed - test result [unused3] ( Finding , context - dependent category , non - specific , situation , treatment : patient results tests ; Test result to patient ; patient results test ; patient provided with test / procedure results ; test result to patient ; Pat ##ient informed of result ) [SEP]',\n",
    "  'our_bi_cui': 'C2987124',\n",
    "  'our_bi_cui_name': 'Patient Reported Outcome',\n",
    "  'our_bi_cui_desc': '[CLS] Pat ##ient Report ##ed Out ##come [unused3] ( Intel ##lect ##ual Product : Out ##come ##s , Pat ##ient Report ##ed ; Report ##ed Out ##come , Pat ##ient ; Pat ##ient Report ##ed Out ##come ##s ; Out ##come , Pat ##ient Report ##ed ; Report ##ed Out ##come ##s , Pat ##ient ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28377051.61',\n",
    "  'test_set_idx': 33677,\n",
    "  'type': 'T103',\n",
    "  'name': 'Tyr256',\n",
    "  'context': '[CLS] ##P ##1 and N - WA ##SP were recruited to fi ##lam ##ent ##ous act ##in , and shared some common compartment ##s localized at the leading edge of lame ##lli ##po ##dia , which was impaired after the de ##ple ##tion of I ##Q ##GA ##P ##1 by using the small interference RNA . Moreover , the knock ##down of I ##Q ##GA ##P ##1 also significantly decreased N - WA ##SP p ##hos ##ph ##ory ##lation at [unused1] Ty ##r ##25 ##6 [unused2] induced by C . pneumonia ##e infection . We conclude that C . pneumonia ##e infection promotes vascular end ##oth ##eli ##al cell migration and an ##gio ##genesis presumably through the I ##Q ##GA ##P ##1 - related signaling pathway . [SEP]',\n",
    "  'existing_cui': 'C3539605',\n",
    "  'existing_cui_name': 'Complement Receptor Type 2',\n",
    "  'existing_cui_desc': '[CLS] Co ##mple ##ment Re ##ceptor Type 2 [unused3] ( Chemical : E ##B ##V Re ##ceptor ; CD ##21 ; CD ##21 Anti ##gen ; Co ##mple ##ment C ##3 ##d Re ##ceptor ; E ##ps ##tein - Barr V ##ir ##us Re ##ceptor ) [SEP]',\n",
    "  'our_bi_cui': 'C0040005',\n",
    "  'our_bi_cui_name': 'Threonine',\n",
    "  'our_bi_cui_desc': '[CLS] T ##hr ##eon ##ine [unused3] ( Chemical , T ##hr , medication , substance : L - alpha - amino - beta - h ##ydro ##xy ##but ##yric acid ; L - th ##re ##oni ##ne ; th ##re ##oni ##ne ; th ##r ; L - T ##hr ##eon ##ine ; ( 2 ##S , 3 ##R ) - 2 - Am ##ino - 3 - h ##ydro ##xy ##but ##ano ##ic acid ; T ##hr ##eon ##ine [ Chemical / In ##g ##red ##ient ] ; ( 2 ##S ) - th ##re ##oni ##ne ; T ##hr ; L T ##hr ##eon ##ine ; L - 2 - Am ##ino - 3 - h ##ydro ##xy ##but ##yric acid ; T ##H ##RE [SEP]',\n",
    "  'our_cross_cui': 'C0041485',\n",
    "  'our_cross_cui_name': 'Tyrosine',\n",
    "  'our_cross_cui_desc': '[CLS] Ty ##ros ##ine [unused3] ( Chemical , L , Ty ##r , medication , product , substance : L - Ph ##en ##yla ##lani ##ne , 4 - h ##ydro ##xy - ; L - Ty ##ros ##ine ; Ty ##r ; ( S ) - alpha - amino - 4 - H ##ydro ##xy ##ben ##zen ##ep ##rop ##ano ##ic acid ; ( S ) - 2 - Am ##ino - 3 - ( p - h ##ydro ##xy ##phe ##ny ##l ) prop ##ion ##ic acid ; ( S ) - 3 - ( p - H ##ydro ##xy ##phe ##ny ##l ) al ##ani ##ne ; ( S ) - 2 - Am ##ino - 3 - ( 4 - h ##ydro ##xy [SEP]'},\n",
    " {'mention_id': '27977439.40',\n",
    "  'test_set_idx': 22835,\n",
    "  'type': 'T033',\n",
    "  'name': 'postoperative',\n",
    "  'context': '[CLS] No effect was found between groups for the primary outcome ( P = 0 . 680 , intention to treat ) ; the median values were 42 . 4 and 37 . 7 h , respectively for the control and intervention groups ( P = 0 . 87 ##3 ) . Similar non ##sign ##ificant trends were noted for other [unused1] post ##oper ##ative [unused2] delays . Sign ##ificant effects favour ##ing the intervention were noted for dynamic pain , patient satisfaction , occurrence of nausea and vomit ##ing , occurrence of del ##iri ##um or mental confusion and occurrence of pulmonary complications . In 12 patients , although no symptoms actually occurred , the total r ##op ##iva ##ca ##ine plasma level exceeded the lowest [SEP]',\n",
    "  'existing_cui': 'C0520905',\n",
    "  'existing_cui_name': 'Vomiting , Postoperative',\n",
    "  'existing_cui_desc': '[CLS] V ##omi ##ting , Post ##oper ##ative [unused3] ( Finding , disorder : Post - op vomit ##ing ; Post ##oper ##ative V ##omi ##ting ; Em ##ese ##s , Post ##oper ##ative ; P ##OS ##TO ##P V ##OM ##IT ##ING ; V ##omi ##ting post ##oper ##ative ; E ##ME ##SI ##S P ##OS ##TO ##P ; Post ##oper ##ative Em ##ese ##s ; Em ##esis , Post ##oper ##ative ; Post pro ##cedural vomit ##ing ; Post ##oper ##ative vomit ##ing ; V ##OM ##IT ##ING P ##OS ##TO ##P ; Post ##oper ##ative Em ##esis ; P ##OS ##TO ##P E ##ME ##SI ##S ) [SEP]',\n",
    "  'our_bi_cui': 'C0032786',\n",
    "  'our_bi_cui_name': 'Postoperative Care',\n",
    "  'our_bi_cui_desc': '[CLS] Post ##oper ##ative Care [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Post ##oper ##ative care ( procedure ; CA ##RE P ##OS ##TO ##P ; care post ##oper ##ative ; P ##OS ##TO ##P CA ##RE ; Post ##oper ##ative care ; Care , Post ##oper ##ative ; post ##oper ##ative care ) [SEP]',\n",
    "  'our_cross_cui': 'C0241311',\n",
    "  'our_cross_cui_name': 'post operative',\n",
    "  'our_cross_cui_desc': '[CLS] post operative [unused3] ( Finding , finding , finding : post surgery status ; Recovery from surgery ; After Surgery ; status after surgery ; Post surgery ) [SEP]'},\n",
    " {'mention_id': '27460657.59',\n",
    "  'test_set_idx': 6673,\n",
    "  'type': 'T103',\n",
    "  'name': 'ams',\n",
    "  'context': '[CLS] ass ##ay showed that MS ##18 ##8 activated the expression of C ##YP ##70 ##3 ##A ##2 . Ye ##ast two - hybrid and electro ##ph ##ore ##tic mobility shift ass ##ays further demonstrated that MS ##18 ##8 complex ##ed with AB ##OR ##TE ##D MI ##CR ##OS ##PO ##RE ##S . The expression of C ##YP ##70 ##3 ##A ##2 could be partially restored by the elevated levels of MS ##18 ##8 in the [unused1] am ##s [unused2] mutant . Therefore , our data reveal that MS ##18 ##8 coordinates with AB ##OR ##TE ##D MI ##CR ##OS ##PO ##RE ##S to activate C ##YP ##70 ##3 ##A ##2 in s ##por ##op ##oll ##eni ##n bio ##sy ##nt ##hesis of plant tape ##tum . [SEP]',\n",
    "  'existing_cui': 'C0002699',\n",
    "  'existing_cui_name': 'Amsacrine',\n",
    "  'existing_cui_desc': \"[CLS] Am ##sa ##c ##rine [unused3] ( Chemical , product , substance : Am ##sa ##c ##rine [ Chemical / In ##g ##red ##ient ] ; AM ##SA M ; m - am ##sa ; m - AM ##SA ; AM ##SA ##CR ##IN ##E ; meta - AM ##SA ; 4 ' - ( 9 - A ##c ##rid ##in ##yla ##min ##o ) met ##hane ##sul ##fo ##n - meta - an ##isi ##di ##de ; A ##c ##rid ##in ##yl an ##isi ##di ##de ; 4 ' - ( 9 - A ##c ##rid ##in ##yla ##min ##o ) met ##hane ##sul ##phon - m - an ##isi ##di ##de ; m ##AM ##SA ; Am ##sa ##c ##rine - chemical ; a ##c [SEP]\",\n",
    "  'our_bi_cui': 'C0017337',\n",
    "  'our_bi_cui_name': 'Genes',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]',\n",
    "  'our_cross_cui': 'C1434242',\n",
    "  'our_cross_cui_name': 'AMS protein , Arabidopsis',\n",
    "  'our_cross_cui_desc': '[CLS] AM ##S protein , Arab ##ido ##psis [unused3] ( Chemical : AB ##OR ##TE ##D MI ##CR ##OS ##PO ##RE ##S protein , Arab ##ido ##psis ) [SEP]'},\n",
    " {'mention_id': '28294559.21',\n",
    "  'test_set_idx': 31477,\n",
    "  'type': 'T058',\n",
    "  'name': 'HPx',\n",
    "  'context': '[CLS] type le ##ct ##in receptor - 2 deleted from plate ##lets of ch ##ime ##ric mice ( fl ##KO ) underwent HP ##x . The liver / body weight ratio was significantly lower in the fl ##KO than in the wild - type . C - type le ##ct ##in receptor - 2 plays an essential role in liver regeneration after [unused1] HP ##x [unused2] . Background and aim The aim of the present study was to investigate the role of C - type le ##ct ##in receptor ( C - type le ##ct ##in receptor ) - 2 in liver regeneration following partial liver re ##section in mice . Materials and methods I ##rra ##dia ##ted ch ##ime ##ric mice transplant ##ed with f ##etal [SEP]',\n",
    "  'existing_cui': 'C0523688',\n",
    "  'existing_cui_name': 'Hemopexin measurement',\n",
    "  'existing_cui_desc': '[CLS] He ##mo ##pe ##xin measurement [unused3] ( Health Care Act ##ivity , procedure : He ##mo ##pe ##xin ; He ##mo ##pe ##xin Me ##as ##ure ##ment ; Beta - 1 ##B G ##ly ##co ##p ##rote ##in ; Ha ##em ##ope ##xin measurement ; Beta - 1 ##B G ##ly ##co ##p ##rote ##in Me ##as ##ure ##ment ; Beta - 1 ##B - G ##ly ##co ##p ##rote ##in Me ##as ##ure ##ment ; HP ##X ; B ##1 ##B ##G ##LP ) [SEP]',\n",
    "  'our_bi_cui': 'C0008562',\n",
    "  'our_bi_cui_name': 'High pressure liquid chromatography procedure',\n",
    "  'our_bi_cui_desc': '[CLS] High pressure liquid ch ##roma ##tography procedure [unused3] ( Health Care Act ##ivity , HP ##LC , procedure , qualifier value : HP ##LC measurement ; Ch ##roma ##tography , High Speed Li ##quid ; Ch ##roma ##tography , High Press ##ure Li ##quid ; Ch ##roma ##tography , Li ##quid , High Press ##ure ; High Performance Li ##quid Ch ##roma ##tography ; HP ##LC - High pressure liquid ch ##roma ##tography ; High performance liquid ch ##roma ##tography ; H ##SL ##C ; High performance liquid ch ##roma ##tography measurement ; High pressure liquid ch ##roma ##tography ; high pressure liquid ch ##roma ##tography ; CH ##RO ##MA ##TO ##GR H ##IG ##H P ##ER ##F ##OR ##MA ##NC ##E L ##I ##Q ##UI [SEP]',\n",
    "  'our_cross_cui': 'C0193398',\n",
    "  'our_cross_cui_name': 'Partial hepatectomy',\n",
    "  'our_cross_cui_desc': '[CLS] Part ##ial he ##pate ##ct ##omy [unused3] ( Health Care Act ##ivity , partial , procedure , treatment : He ##pate ##ct ##omy , re ##section of liver ; partial lobe ##ct ##omy ; PA ##RT ##IA ##L R ##EM ##O ##VA ##L OF L ##IVE ##R ; Sub ##to ##tal he ##pate ##ct ##omy ; partial he ##pate ##ct ##omy ; P ##H - Part ##ial he ##pate ##ct ##omy ; H ##EP ##AT ##EC ##TO ##M ##Y R ##ES ##C ##J PA ##RT ##IA ##L L ##O ##BE ##CT ##OM ##Y ; Part ##ial removal of liver ; Part ##ial He ##pate ##ct ##omy ; partial ex ##cision of liver ; He ##pate ##ct ##omy ; Part ##ial ex ##cision of liver ; sub [SEP]'},\n",
    " {'mention_id': '27820849.4',\n",
    "  'test_set_idx': 18186,\n",
    "  'type': 'T082',\n",
    "  'name': 'High Density SNPs',\n",
    "  'context': '[CLS] Gen ##ome - Wide Det ##ec ##tion of Select ##ive Sign ##ature ##s in Chicken through [unused1] High Den ##sity S ##NP ##s [unused2] Chicken is recognized as an excellent model for studies of genetic mechanism of p ##hen ##otypic and g ##eno ##mic evolution , with large effective population size and strong human - driven selection . In the present study , we performed Extended Ha ##p ##lot ##ype Ho ##mo ##zy ##gos ##ity tests to identify significant core regions employing 600 ##K S ##NP Chicken chip in an F ##2 population of 1 , 53 ##4 he ##ns , which was derived from re ##ci ##p ##ro ##cal crosses between White Le ##gh ##orn and Dong ##xia ##ng chicken . Results indicated that a [SEP]',\n",
    "  'existing_cui': 'C1268672',\n",
    "  'existing_cui_name': 'High density lesion',\n",
    "  'existing_cui_desc': '[CLS] High density les ##ion [unused3] ( Finding , finding : Les ##ion with high radio ##graphic density ) [SEP]',\n",
    "  'our_bi_cui': 'C0023821',\n",
    "  'our_bi_cui_name': 'High Density Lipoproteins',\n",
    "  'our_bi_cui_desc': '[CLS] High Den ##sity Li ##pop ##rote ##ins [unused3] ( Chemical , HD ##L , substance : alpha Li ##pop ##rote ##in ; Li ##pop ##rote ##ins , High - Den ##sity ; alpha - lip ##op ##rote ##in ; Li ##pop ##rote ##in . alpha ; alpha Li ##pop ##rote ##ins ; high density lip ##op ##rote ##in ; High density lip ##op ##rote ##ins ; High - Den ##sity Li ##pop ##rote ##ins ; high density lip ##op ##rote ##ins ; Li ##pop ##rote ##ins , HD ##L [ Chemical / In ##g ##red ##ient ] ; High den ##si ##ti ##y lip ##op ##rote ##in ; Li ##pop ##rote ##ins , Heavy ; h ##dl ##s ; alpha - Li ##pop ##rote ##ins ; [SEP]',\n",
    "  'our_cross_cui': 'C0752046',\n",
    "  'our_cross_cui_name': 'Single Nucleotide Polymorphism',\n",
    "  'our_cross_cui_desc': '[CLS] Single N ##uc ##leo ##tide Pol ##ym ##or ##phism [unused3] ( Spa ##tial Concept , S ##NP : Pol ##ym ##or ##phism , Single N ##uc ##leo ##tide ; Single N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s ; Pol ##ym ##or ##phism ##s , Single N ##uc ##leo ##tide ; S ##NP ##s ; N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s , Single ; N ##uc ##leo ##tide Pol ##ym ##or ##phism , Single ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s ; Pol ##ym ##or ##phism , Single Base ) [SEP]'},\n",
    " {'mention_id': '28390176.3',\n",
    "  'test_set_idx': 34093,\n",
    "  'type': 'T103',\n",
    "  'name': 'anti - cardiac hypertrophy drugs',\n",
    "  'context': '[CLS] C ##uc ##ur ##bit ##ac ##in B Pro ##tec ##ts Against Press ##ure Over ##load In ##duced Card ##iac H ##yper ##tro ##phy Lac ##k of effective [unused1] anti - cardiac h ##yper ##tro ##phy drugs [unused2] creates a major cause for the increasing prevalence of heart failure . In the present study , we determined the anti - h ##yper ##tro ##phy and anti - fi ##bro ##sis potential of a natural plant t ##rite ##rp ##eno ##id , C ##uc ##ur ##bit ##ac ##in B both in v ##it ##ro and in v ##ivo . A ##ort ##ic band ##ing was performed to induce cardiac h ##yper ##tro ##phy . After 1 week of surgery , mice were receive cu ##cu ##rb ##ita ##cin [SEP]',\n",
    "  'existing_cui': 'C1383860',\n",
    "  'existing_cui_name': 'Cardiac Hypertrophy',\n",
    "  'existing_cui_desc': '[CLS] Card ##iac H ##yper ##tro ##phy [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : h ##yper ##tro ##phy ; cardiac ; heart h ##yper ##tro ##phy ; Heart H ##yper ##tro ##phy ; Heart - - H ##yper ##tro ##phy ; cardiac ; h ##yper ##tro ##phy ; cardiac h ##yper ##tro ##phy ; h ##yper ##tro ##phic heart ; H ##yper ##tro ##phic ; heart ; Card ##iac h ##yper ##tro ##phy ; heart ; h ##yper ##tro ##phy ; h ##yper ##tro ##phy ; heart ) [SEP]',\n",
    "  'our_bi_cui': 'C0003195',\n",
    "  'our_bi_cui_name': 'Anti-Arrhythmia Agents',\n",
    "  'our_bi_cui_desc': '[CLS] Anti - A ##rr ##hy ##th ##mia Agents [unused3] ( Chemical , medication , product , substance : anti - a ##rr ##hy ##th ##mic ##s ; Anti A ##rr ##hy ##th ##mia Drugs ; Drugs , Anti - A ##rr ##hy ##th ##mia ; anti ##ar ##r ##hy ##th ##mic agents ; AN ##TI ##AR ##R ##H ##Y ##TH ##MI ##A AG ##EN ##TS ; Drugs , Anti ##ar ##r ##hy ##th ##mia ; anti ##ar ##r ##hy ##th ##mic drug ; anti a ##rr ##hy ##th ##mic ; Anti ##ar ##r ##hy ##th ##mic drug ; Card ##iac De ##press ##ant ; Anti ##ar ##r ##hy ##th ##mic Drugs ; Anti ##ar ##r ##hy ##th ##mic agent ; Anti - a ##rr ##hy ##th [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27838742.67',\n",
    "  'test_set_idx': 19034,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] a potential anti ##can ##cer agent that can induce auto ##pha ##gic cell death in human non - small cell lung cancer via the A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . [unused1] Del ##ica ##f ##lav ##one [unused2] induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27301681.32',\n",
    "  'test_set_idx': 1932,\n",
    "  'type': 'T103',\n",
    "  'name': '8-amino-3 ,6 - dioxaoctanoic acid',\n",
    "  'context': '[CLS] ##ao ##ct ##ano ##ic acid units facing each other in a hair ##pin form , successfully showed the expected motif and a K ##D value of 16 ##n ##M was recorded . Pol ##yam ##ide 5 , containing a β - al ##ani ##ne - β - al ##ani ##ne unit instead of the [unused1] 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid [unused2] of p ##oly ##ami ##de 2 , was synthesized for comparison . The a ##que ##ous so ##lub ##ilities and nuclear local ##ization of three of the p ##oly ##ami ##des were also examined . The results suggest the possibility of applying the 8 - amino - 3 , 6 - di ##ox ##ao ##ct [SEP]',\n",
    "  'existing_cui': 'C0623748',\n",
    "  'existing_cui_name': '2-amino-8-phosphonooctanoic acid',\n",
    "  'existing_cui_desc': '[CLS] 2 - amino - 8 - p ##hos ##phon ##oo ##ct ##ano ##ic acid [unused3] ( Chemical : 2 - AP ##8 ) [SEP]',\n",
    "  'our_bi_cui': 'C0758325',\n",
    "  'our_bi_cui_name': '5-octadecenoic acid',\n",
    "  'our_bi_cui_desc': '[CLS] 5 - o ##ct ##ade ##ce ##no ##ic acid [unused3] ( Chemical , substance : o ##ct ##ade ##ce ##no ##ic acid ; Oct ##ade ##ce ##no ##ic acid ) [SEP]',\n",
    "  'our_cross_cui': 'C0029224',\n",
    "  'our_cross_cui_name': 'Organic Chemicals',\n",
    "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
    " {'mention_id': '27506129.16',\n",
    "  'test_set_idx': 8648,\n",
    "  'type': 'T170',\n",
    "  'name': 'SMOTE approaches',\n",
    "  'context': \"[CLS] straightforward due to data issues such as class im ##bal ##ance or correlated features . In this paper , we study the specific features of h ##yper ##emia and propose various approaches to address these problems in the context of an automatic framework for h ##yper ##emia g ##rading . Over ##sa ##mp ##ling , under ##sa ##mp ##ling and [unused1] SM ##OT ##E approaches [unused2] were applied in order to tackle the problem of class im ##bal ##ance . 25 features were com ##puted for each image and re ##gression methods were then used to transform them into a value on the g ##rading scale . The values and relationships among features and experts ' values were anal ##ys ##ed , and five feature selection [SEP]\",\n",
    "  'existing_cui': 'C0449445',\n",
    "  'existing_cui_name': 'Approach',\n",
    "  'existing_cui_desc': '[CLS] A ##pp ##roach [unused3] ( Spa ##tial Concept , attribute , qualifier value : A ##pp ##roach ##es ; approach ; approaches ; approaching ) [SEP]',\n",
    "  'our_bi_cui': 'C0025663',\n",
    "  'our_bi_cui_name': 'Methods',\n",
    "  'our_bi_cui_desc': '[CLS] Method ##s [unused3] ( Intel ##lect ##ual Product , attribute : methods ; Method ; method ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27430240.76',\n",
    "  'test_set_idx': 5402,\n",
    "  'type': 'T103',\n",
    "  'name': 'factors',\n",
    "  'context': '[CLS] transcription factor 1 or CR ##E ##B , and were accelerated in the presence of C ##GS ##21 ##6 ##80 . Based on these results , it can be in ##ferred that ad ##eno ##sin ##e , the ad ##eno ##sin ##e A2 ##A receptor ago ##nist , E ##2 ##F transcription factor 1 and CR ##E ##B are the possible [unused1] factors [unused2] contributing to the high expression of CD ##39 and CD ##7 ##3 on the T ##re ##g cell surface during se ##psis . Aden ##os ##ine and its A2 ##A receptor ago ##nist served as the signal trans ##du ##cer factors of the CD ##39 / CD ##7 ##3 / ad ##eno ##sin ##e pathway , a ##cc ##ele ##rating ad ##eno [SEP]',\n",
    "  'existing_cui': 'C0960756',\n",
    "  'existing_cui_name': 'factor A',\n",
    "  'existing_cui_desc': \"[CLS] factor A [unused3] ( Chemical : Co ( beta ) - c ##yan ##o - 7 ' ' - ( 2 - met ##hyl ) ad ##eni ##ny ##l ##co ##ba ##mi ##de ) [SEP]\",\n",
    "  'our_bi_cui': 'C0021054',\n",
    "  'our_bi_cui_name': 'Immunologic Factors',\n",
    "  'our_bi_cui_desc': '[CLS] I ##mm ##uno ##log ##ic Factor ##s [unused3] ( Chemical , substance : Factor ##s , I ##mm ##uno ##log ##ic ; I ##mm ##une Factor ##s ; Factor ##s , I ##mm ##uno ##logical ; I ##mm ##uno ##log ##ic Factor ; Factor ##s , I ##mm ##une ; I ##mm ##uno ##logical Factor ##s ; im ##mu ##no ##log ##ic substance ; FA ##CT ##OR ##S I ##MM ##UN ##OL ; im ##mu ##nological substance ; I ##MM ##UN ##OL FA ##CT ##OR ##S ; I ##mm ##uno ##log ##ic substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0005515',\n",
    "  'our_cross_cui_name': 'Biological Factors',\n",
    "  'our_cross_cui_desc': '[CLS] Biological Factor ##s [unused3] ( Chemical , product , substance : Agents , Biological ; Biological Factor ; B ##iol ##og ##ic agent ; agents biological ; B ##iol ##og ##ic Factor ##s ; B ##iol ##og ##ic Factor ; biological substance ; Factor , B ##iol ##og ##ic ; Factor ##s , Biological ; bio ##pha ##rma ##ce ##utical ##s ; Biological product ; B ##IO ##L FA ##CT ##OR ; Biological Agents ; Biological substance ; Biological Factor ##s [ Chemical / In ##g ##red ##ient ] ; Biological agent ; B ##iol ##og ##ics ; Factor , Biological ; biological drug ; B ##IO ##L FA ##CT ##OR ##S ; FA ##CT ##OR ##S B ##IO ##L ; biological substances ; bio ##pha [SEP]'},\n",
    " {'mention_id': '28278150.21',\n",
    "  'test_set_idx': 31035,\n",
    "  'type': 'T062',\n",
    "  'name': 'GTEx project',\n",
    "  'context': '[CLS] distinct feature compared to the existing co ##loc ##ali ##zation analysis procedures in the literature . The proposed approach is computational ##ly efficient and requires only summary - level statistics . We evaluate and demonstrate the proposed computational approach through extensive simulation studies and analyses of blood lip ##id data and the whole blood e ##Q ##TL data from the [unused1] GT ##E ##x project [unused2] . In addition , a useful utility from our proposed method enables the com ##putation of expected co ##loc ##ali ##zation signals using simple characteristics of the association data . Using this utility , we further illustrate the importance of en ##rich ##ment analysis on the ability to discover co ##loc ##ali ##zed signals and the potential limitations of currently [SEP]',\n",
    "  'existing_cui': 'C3831542',\n",
    "  'existing_cui_name': 'Analysis Project',\n",
    "  'existing_cui_desc': '[CLS] Analysis Project [unused3] ( Research Act ##ivity : Statistical Data Group ##ing ) [SEP]',\n",
    "  'our_bi_cui': 'C0242481',\n",
    "  'our_bi_cui_name': 'Research Activities',\n",
    "  'our_bi_cui_desc': '[CLS] Research Activities [unused3] ( Research Act ##ivity : research ; Research Act ##ivity ; activity research ; Research ; Activities , Research ; Act ##ivity , Research ; research activities ) [SEP]',\n",
    "  'our_cross_cui': 'C4289040',\n",
    "  'our_cross_cui_name': 'Genotype-Tissue Expression Program',\n",
    "  'our_cross_cui_desc': '[CLS] Gen ##otype - T ##iss ##ue Express ##ion Program [unused3] ( Research Act ##ivity : GT ##E ##x ; Gen ##otype - T ##iss ##ue Express ##ion ) [SEP]'},\n",
    " {'mention_id': '28471040.20',\n",
    "  'test_set_idx': 37134,\n",
    "  'type': 'T017',\n",
    "  'name': 'rat glioma-2 cells',\n",
    "  'context': '[CLS] 1 , 2 - di ##ole ##oy ##l - 3 - trim ##eth ##yla ##mm ##onium - prop ##ane hybrid na ##no ##par ##tic ##les has been prepared and evaluated for in - v ##it ##ro characterization . Cy ##to ##to ##xi ##city of F ##TA - loaded na ##no ##par ##tic ##les along with its efficacy on [unused1] rat g ##lio ##ma - 2 cells [unused2] was also evaluated both in v ##it ##ro ( in comparison with non - ma ##li ##gnant cell line , L ##9 ##29 ) and in v ##ivo . Sc ##ann ##ing electron micro ##sco ##py studies showed that all formulation ##s prepared had smooth surface and spherical in shape . far ##nes ##yl ##thi ##osa ##lic ##yl ##ic [SEP]',\n",
    "  'existing_cui': 'C0017638',\n",
    "  'existing_cui_name': 'Glioma',\n",
    "  'existing_cui_desc': '[CLS] G ##lio ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity : G ##lial Cell Tu ##mor ##s ; g ##lio ##mas ; [ M ] G ##lio ##mas ; G ##lio ##mas ; N ##eur ##og ##lial Neo ##p ##las ##m ; Tu ##mor of the N ##eur ##og ##lia ; g ##lio ##ma ; un ##sp ##ec ##ified site ; Tu ##mor , G ##lial Cell ; Tu ##mor ##s , G ##lial Cell ; G ##lial Neo ##p ##las ##m ; Neo ##p ##las ##m of N ##eur ##og ##lia ; N ##eur ##og ##lial Tu ##mor ; G ##lial Cell Tu ##mor ; G ##lial Tu ##mor ; G ##lio [SEP]',\n",
    "  'our_bi_cui': 'C1514733',\n",
    "  'our_bi_cui_name': 'Rat Cell Line',\n",
    "  'our_bi_cui_desc': '[CLS] Rat Cell Line [unused3] ( Ana ##tom ##ical Structure ) [SEP]',\n",
    "  'our_cross_cui': 'C0007634',\n",
    "  'our_cross_cui_name': 'Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
    " {'mention_id': '27320863.24',\n",
    "  'test_set_idx': 2325,\n",
    "  'type': 'T168',\n",
    "  'name': 'methionine and choline - deficient diet',\n",
    "  'context': '[CLS] ##ine supplement ##ation in drinking water ( 1 % ) . Ph ##os ##ph ##ory ##lation of AM ##P - activated protein kinase , ace ##ty ##l - Co ##A car ##box ##yla ##se , s ##tero ##l regulatory element - binding protein 1 ##c , and liver kinase B ##1 was in ##hibit ##ed by [unused1] met ##hi ##oni ##ne and ch ##olin ##e - def ##icient diet [unused2] intake , and these changes were all in ##hibit ##ed by beta ##ine feeding . Meanwhile , beta ##ine supplement ##ation reversed the reduction of met ##hi ##oni ##ne and S - ad ##eno ##sy ##lm ##eth ##ion ##ine , and the elevation of ho ##mo ##cy ##stein ##e levels in the liver , which could [SEP]',\n",
    "  'existing_cui': 'C2928853',\n",
    "  'existing_cui_name': 'Choline / Methionine',\n",
    "  'existing_cui_desc': '[CLS] Cho ##line / Met ##hi ##oni ##ne [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0452278',\n",
    "  'our_bi_cui_name': 'Low methionine diet',\n",
    "  'our_bi_cui_desc': '[CLS] Low met ##hi ##oni ##ne diet [unused3] ( Health Care Act ##ivity , finding , regime / therapy : Dec ##rease in met ##hi ##oni ##ne content of the diet compared to the assessed base ##line intake of met ##hi ##oni ##ne for the individual . ( Source : Academy of N ##utrition and Diet ##etics N ##utrition In ##formatics Committee 2013 ) ; Dec ##reased met ##hi ##oni ##ne diet ) [SEP]',\n",
    "  'our_cross_cui': 'C0012155',\n",
    "  'our_cross_cui_name': 'Diet',\n",
    "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
    " {'mention_id': '28377738.28',\n",
    "  'test_set_idx': 33713,\n",
    "  'type': 'T204',\n",
    "  'name': 'creature',\n",
    "  'context': '[CLS] dimensional approach will help to c ##lar ##ify and justify claims about the hi ##era ##rch ##ical nature of consciousness . The approach also proves ex ##p ##lana ##tor ##ily advantage ##ous , as it enables us not only to draw attention to certain new and important differences in respect of subjective measures of awareness and to justify how a given [unused1] creature [unused2] may be ranked higher in one dimension of consciousness and lower in terms of another , but also allows for innovative explanations of a variety of well - known phenomena ( amongst these , the interpretations of blind ##sight and locked - in syndrome will be briefly outlined here ) . Moreover , a 4 ##D framework makes possible many predictions and [SEP]',\n",
    "  'existing_cui': 'C0056695',\n",
    "  'existing_cui_name': 'Cyclic AMP-Responsive DNA-Binding Protein',\n",
    "  'existing_cui_desc': '[CLS] Cy ##c ##lic AM ##P - Re ##sp ##ons ##ive DNA - Bin ##ding Pro ##tein [unused3] ( Chemical , CR ##E ##B : c ##yclic AM ##P response element binding protein ; c ##AM ##P response element binding protein ; Cy ##c ##lic AM ##P Re ##sp ##ons ##ive El ##ement Bin ##ding Pro ##tein ; c ##yclic AM ##P - re ##sp ##ons ##ive DNA - binding protein ; DNA Bin ##ding Pro ##tein , Cy ##c ##lic AM ##P Re ##sp ##ons ##ive ; c ##AM ##P Re ##sp ##ons ##ive El ##ement Bin ##ding Pro ##tein ; Cy ##c ##lic AM ##P Re ##sp ##ons ##ive DNA Bin ##ding Pro ##tein ; DNA - Bin ##ding Pro ##tein , Cy ##c ##lic [SEP]',\n",
    "  'our_bi_cui': 'C0027361',\n",
    "  'our_bi_cui_name': 'Persons',\n",
    "  'our_bi_cui_desc': '[CLS] Persons [unused3] ( Population Group , person : Individual ; Person ; persons ; peoples ; Person [ du ##p ] ; People ; person ; people ) [SEP]',\n",
    "  'our_cross_cui': 'C0003062',\n",
    "  'our_cross_cui_name': 'Animals',\n",
    "  'our_cross_cui_desc': '[CLS] Animals [unused3] ( E ##uka ##ryo ##te , organism : Animal ; animal ; multi ##cellular animals ; Animal ##ia ; Animal classified by human context ; Animal classified by role ; animal ##ia ; animal kingdom ; AN ##IM ##AL ; animals ; En ##ti ##ty ##C ##lass ##A ##ni ##mal ; Kingdom Animal ##ia ) [SEP]'},\n",
    " {'mention_id': '27460657.8',\n",
    "  'test_set_idx': 6622,\n",
    "  'type': 'T017',\n",
    "  'name': 'sexine layer',\n",
    "  'context': '[CLS] The transcription factors MS ##18 ##8 and AB ##OR ##TE ##D MI ##CR ##OS ##PO ##RE ##S form a complex to activate the expression of C ##YP ##70 ##3 ##A ##2 for s ##por ##op ##oll ##eni ##n bio ##sy ##nt ##hesis in Arab ##ido ##psis th ##alia ##na The [unused1] sex ##ine layer [unused2] of pollen grain is mainly composed of s ##por ##op ##oll ##eni ##ns . The s ##por ##op ##hy ##tic secret ##ory tape ##tum is required for the bio ##sy ##nt ##hesis of s ##por ##op ##oll ##eni ##n . Although several enzymes involved in s ##por ##op ##oll ##eni ##n bio ##sy ##nt ##hesis have been reported , the regulatory mechanism of these enzymes in tape ##tal layer remains el [SEP]',\n",
    "  'existing_cui': 'C0920995',\n",
    "  'existing_cui_name': 'Subintima',\n",
    "  'existing_cui_desc': '[CLS] Sub ##int ##ima [unused3] ( Ana ##tom ##ical Structure , organ part : la ##mina ##s ; Lay ##er ; Lam ##ina ; la ##mina ) [SEP]',\n",
    "  'our_bi_cui': 'C0017472',\n",
    "  'our_bi_cui_name': 'Germ Layers',\n",
    "  'our_bi_cui_desc': '[CLS] G ##er ##m Lay ##ers [unused3] ( Ana ##tom ##ical Structure : Lay ##er , G ##er ##m ; G ##er ##m Lay ##er ; g ##er ##m layer ; G ##er ##m layer ; Lay ##ers , G ##er ##m ) [SEP]',\n",
    "  'our_cross_cui': 'C1820011',\n",
    "  'our_cross_cui_name': 'sexine',\n",
    "  'our_cross_cui_desc': '[CLS] sex ##ine [unused3] ( Ana ##tom ##ical Structure ) [SEP]'},\n",
    " {'mention_id': '27715500.19',\n",
    "  'test_set_idx': 14884,\n",
    "  'type': 'T092',\n",
    "  'name': 'industrial beefpacking plant',\n",
    "  'context': '[CLS] have received limited research attention . Prior research indicates under ##re ##port ##ing in injury rates in this industry as well significant variation in injury rates among facilities . To add detail to the rates and circumstances surrounding occupational injury among meat ##pack ##ing workers , we conducted a cross - section ##al study of workers employed at an [unused1] industrial beef ##pack ##ing plant [unused2] in Nebraska , United States ( n = 137 ) and interviewed workers about recent injury experiences . We assessed frequency , cause and nature of self - reported injury . We estimated annual incidence rates of self - reported injuries using the OS ##HA formula and compared these rates to industry - wide data . We also evaluated psychological [SEP]',\n",
    "  'existing_cui': 'C0442611',\n",
    "  'existing_cui_name': 'Industrial site',\n",
    "  'existing_cui_desc': '[CLS] Industrial site [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
    "  'our_bi_cui': 'C0016502',\n",
    "  'our_bi_cui_name': 'Food processing industry',\n",
    "  'our_bi_cui_desc': '[CLS] Food processing industry [unused3] ( Organization : F ##O ##OD PR ##OC ##ES ##SI ##NG IN ##D ##US ##T ; IN ##D ##US ##T F ##O ##OD PR ##OC ##ES ##SI ##NG ; Food - Process ##ing Industries ; Food - Process ##ing Industry ; food industry ; Industries , Food - Process ##ing ; Industry , Food Process ##ing ; Food Process ##ing Industry ; Industry , Food - Process ##ing ) [SEP]',\n",
    "  'our_cross_cui': 'C0025019',\n",
    "  'our_cross_cui_name': 'Meat-Packing Industry',\n",
    "  'our_cross_cui_desc': '[CLS] Meat - Pack ##ing Industry [unused3] ( Organization : Industries , Meat - Pack ##ing ; Industry , Meat - Pack ##ing ; ME ##AT PA ##C ##K ##ING IN ##D ##US ##T ; Meat Pack ##ing Industry ; Meat - Pack ##ing Industries ; IN ##D ##US ##T ME ##AT PA ##C ##K ##ING ; Industry , Meat Pack ##ing ) [SEP]'},\n",
    " {'mention_id': '27301681.26',\n",
    "  'test_set_idx': 1926,\n",
    "  'type': 'T103',\n",
    "  'name': '8-amino-3 ,6 - dioxaoctanoic acid',\n",
    "  'context': '[CLS] hair ##pin motifs for tandem hair ##pin . It is demonstrated here ##in that 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid also functions as a link ##er element that can extend to 2 - b ##p in hair ##pin motifs . Not ##ably , although the [unused1] 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid [unused2] - containing unit can fail to bind the expected sequence , p ##oly ##ami ##de 4 , which has two 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid units facing each other in a hair ##pin form , successfully showed the expected motif and a K ##D value [SEP]',\n",
    "  'existing_cui': 'C0623748',\n",
    "  'existing_cui_name': '2-amino-8-phosphonooctanoic acid',\n",
    "  'existing_cui_desc': '[CLS] 2 - amino - 8 - p ##hos ##phon ##oo ##ct ##ano ##ic acid [unused3] ( Chemical : 2 - AP ##8 ) [SEP]',\n",
    "  'our_bi_cui': 'C2353403',\n",
    "  'our_bi_cui_name': 'octadecenedioic acid',\n",
    "  'our_bi_cui_desc': '[CLS] o ##ct ##ade ##cene ##dio ##ic acid [unused3] ( Chemical : O ##CT ##AD ##EC ##EN ##ED ##IO ##IC AC ##ID ; Oct ##ade ##cene ##dio ##ic A ##cid ) [SEP]',\n",
    "  'our_cross_cui': 'C0029224',\n",
    "  'our_cross_cui_name': 'Organic Chemicals',\n",
    "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
    " {'mention_id': '27894019.27',\n",
    "  'test_set_idx': 21088,\n",
    "  'type': 'T103',\n",
    "  'name': 'CYP314a1',\n",
    "  'context': \"[CLS] C ##YP ##31 ##4 ##a ##1 ) that are responsible for the final two h ##ydro ##xy ##lation ##s in the production of the m ##olt - in ##ducing hormone , 20 - h ##ydro ##xy ##ec ##dy ##son ##e . The lack of crystal structures and bio ##chemical ass ##ays for C ##YP ##31 ##5 ##a ##1 or [unused1] C ##YP ##31 ##4 ##a ##1 [unused2] , has prevented further experimental exploration of X ##ant ##hur ##eni ##c acid and E ##re ##b ' s m ##olt in ##hibition mechanisms . Here ##in , a wide array of computational techniques - ho ##mology modeling , molecular dynamics simulation ##s , binding site bio ##in ##formatics , flexible receptor - flexible l ##igan ##d dock ##ing [SEP]\",\n",
    "  'existing_cui': 'C1418799',\n",
    "  'existing_cui_name': 'PPIF gene',\n",
    "  'existing_cui_desc': '[CLS] PP ##IF gene [unused3] ( Ana ##tom ##ical Structure : C ##Y ##CL ##OP ##H ##IL ##IN 3 ; P ##EP ##TI ##D ##Y ##L - PR ##OL ##Y ##L C ##IS / T ##RA ##NS ISO ##ME ##RA ##SE , MIT ##OC ##H ##ON ##DR ##IA ##L ; P ##ept ##idy ##l ##p ##rol ##yl Is ##omer ##ase F Gene ; PP ##IF Gene ; C ##Y ##CL ##OP ##H ##IL ##IN F ; p ##ept ##idy ##l ##p ##rol ##yl is ##omer ##ase F ; Cy ##p - D ; h ##C ##y ##P ##3 ; c ##y ##c ##lop ##hil ##in D ) [SEP]',\n",
    "  'our_bi_cui': 'C0059563',\n",
    "  'our_bi_cui_name': 'cytochrome P450 3A',\n",
    "  'our_bi_cui_desc': '[CLS] c ##yt ##och ##rome P ##45 ##0 3 ##A [unused3] ( Chemical , substance : N - De ##met ##hyl ##ase , E ##ry ##th ##rom ##y ##cin ; Cy ##to ##ch ##rome p ##45 ##0 C ##YP ##3 ##A enzyme ; Cy ##to ##ch ##rome P 450 ##II ##IA ; Cy ##to ##ch ##rome P - 450 C ##YP ##3 ##A [ Chemical / In ##g ##red ##ient ] ; Cy ##to ##ch ##rome P - 450 C ##YP ##3 ##A ; Cy ##to ##ch ##rome P ##45 ##0 3 ##A ; E ##ry ##th ##rom ##y ##cin N - De ##met ##hyl ##ase ; C ##Y ##TO ##CH ##RO ##ME P 450 C ##YP 00 ##3 A ; C ##YP ##3 ##A ; P [SEP]',\n",
    "  'our_cross_cui': 'C0010762',\n",
    "  'our_cross_cui_name': 'Cytochrome P450',\n",
    "  'our_cross_cui_desc': '[CLS] Cy ##to ##ch ##rome P ##45 ##0 [unused3] ( Chemical , substance : c ##yt ##och ##rome ##s p ##45 ##0 ; c ##yt ##och ##rome P ##45 ##0 ; C ##Y ##TO ##CH ##RO ##ME P 450 E ##N ##Z ##Y ##ME S ##Y ##ST ##EM ; Cy ##to ##ch ##rome p ##45 ##0 enzyme ; Super ##family , Cy ##to ##ch ##rome P ##45 ##0 ; P ##45 ##0 En ##zy ##mes ; c ##yt ##och ##rome p 450 ; En ##zy ##mes , P ##45 ##0 ; Cy ##to ##ch ##rome P 450 Families ; Cy ##to ##ch ##rome P ##45 ##0 En ##zy ##me ; P ##45 ##0 ; C ##YP ##45 ##0 ; Cy ##to ##ch ##rome p ##45 ##0 ; [SEP]'},\n",
    " {'mention_id': '27669217.35',\n",
    "  'test_set_idx': 13686,\n",
    "  'type': 'T017',\n",
    "  'name': 'ermB',\n",
    "  'context': '[CLS] ##f ##E genes were not detect ##able in these is ##olate ##s . The presence of 23 ##S r ##RNA mutations in specific is ##olate ##s did not significantly change mac ##rol ##ide MI ##C s . No n ##uc ##leo ##tide substitution ##s were found in genes encoding rib ##oso ##mal proteins L ##4 or L ##22 . The [unused1] er ##m ##B [unused2] and er ##m ##T genes were found in the genome ##s of all is ##olate ##s . These two genes were acquired independently in one highly v ##ir ##ulent is ##olate AL ##10 ##100 ##2 , and cluster ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both er ##m ##B and er ##m [SEP]',\n",
    "  'existing_cui': 'C0732611',\n",
    "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
    "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
    "  'our_bi_cui': 'C0017339',\n",
    "  'our_bi_cui_name': 'Genes , Bacterial',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##s , Ba ##cter ##ial [unused3] ( Ana ##tom ##ical Structure , substance : Ba ##cter ##ial Gene ##s ; BA ##CT GE ##NE ##S ; GE ##NE ##S BA ##CT ; bacterial gene ; Ba ##cter ##ial genes ; Gene , Ba ##cter ##ial ; BA ##CT GE ##NE ; Ba ##cter ##ial gene ; Ba ##cter ##ial Gene ; GE ##NE BA ##CT ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27932585.12',\n",
    "  'test_set_idx': 22239,\n",
    "  'type': 'T103',\n",
    "  'name': 'TYW3',\n",
    "  'context': '[CLS] S - ad ##eno ##sy ##lm ##eth ##ion ##ine ( S - ad ##eno ##sy ##lm ##eth ##ion ##ine ) - dependent met ##hyl ##tra ##ns ##fer ##ases regulate a wide range of biological processes through the modification of proteins , nuclei ##c acids , p ##oly ##sa ##cc ##hari ##des , as well as various meta ##bol ##ites . [unused1] T ##Y ##W ##3 [unused2] / Ta ##w ##3 is a SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ase responsible for the formation of a t ##RNA modification known as w ##y ##but ##os ##ine and its derivatives that are required for accurate de ##co ##ding in protein synthesis . Here , we report the crystal structure of Ta ##w ##3 , a [SEP]',\n",
    "  'existing_cui': 'C1823563',\n",
    "  'existing_cui_name': 'TYW3 gene',\n",
    "  'existing_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
    "  'our_bi_cui': 'C1823563',\n",
    "  'our_bi_cui_name': 'TYW3 gene',\n",
    "  'our_bi_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28495651.10',\n",
    "  'test_set_idx': 37785,\n",
    "  'type': 'T201',\n",
    "  'name': 'cardiovascular death',\n",
    "  'context': '[CLS] from studies of the association of Q ##T pro ##long ##ation with card ##iovascular death have been inconsistent . The purpose of this study was to compare the major correction formula ##s to percent ##ile values of Q ##T for heart rate ranges as to their ability to remove the relationship of Q ##T to heart rate and to predict [unused1] card ##iovascular death [unused2] . Part ##ici ##pants were 16 , 53 ##1 veterans who had an initial EC ##G at the Veterans Affairs Medical Center , Pa ##lo Alto , between March 31 , 1987 , and December 20 , 1999 , and were followed for card ##iovascular death . The 4 major correction formula ##s ( Ba ##ze ##tt , Fr ##ider ##ici [SEP]',\n",
    "  'existing_cui': 'C0007226',\n",
    "  'existing_cui_name': 'Cardiovascular system',\n",
    "  'existing_cui_desc': '[CLS] Card ##iovascular system [unused3] ( Body System , body structure : Structure of card ##iovascular system , un ##sp ##ec ##ified ; CA ##RD ##IO ##VA ##SC ##U ##LA ##R S ##Y ##ST ##EM ; Card ##iovascular ; Organ System , Card ##iovascular ; CA ##RD ##IO ##VA ##SC S ##Y ##ST ##EM ; Card ##iovascular structure ; card ##iovascular system ; Card ##iovascular Organ System ; C ##ir ##cula ##tory ; Structure of card ##iovascular system ; Card ##iovascular Systems ; card ##iovascular structure ; C ##ir ##cula ##tory System ; C ##ir ##cula ##tory Systems ; { C ##ir ##cula ##tory system } ; c ##ir ##cula ##tory ; C ##ir ##cula ##tory system ; Body System , Card ##iovascular ; card ##iovascular system [SEP]',\n",
    "  'our_bi_cui': 'C0376297',\n",
    "  'our_bi_cui_name': 'Cardiac Death',\n",
    "  'our_bi_cui_desc': '[CLS] Card ##iac Death [unused3] ( B ##iol ##og ##ic Fun ##ction : death ; cardiac ; cardiac death ; cardiac deaths ; Card ##iac death ; Death , Card ##iac ; cardiac ; death ) [SEP]',\n",
    "  'our_cross_cui': 'C2926098',\n",
    "  'our_cross_cui_name': \"Mechanism of death in patient 's dying of cardiovascular causes : Type : Point in time : ^ Patient : Nominal\",\n",
    "  'our_cross_cui_desc': \"[CLS] Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : Point in time : ^ Pat ##ient : No ##mina ##l [unused3] ( Clinical At ##tri ##but ##e : Death due to C ##V causes ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : P ##t : ^ Pat ##ient : No ##m ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes ) [SEP]\"},\n",
    " {'mention_id': '27791364.33',\n",
    "  'test_set_idx': 17001,\n",
    "  'type': 'T033',\n",
    "  'name': 'near - infrared absorption',\n",
    "  'context': '[CLS] serum album ##in na ##no ##par ##tic ##les demonstrate prominent tumor - contrasted imaging performance both on the photo ##aco ##ustic and magnetic resonance imaging m ##oda ##lities . The subsequent G ##d : C ##u ##S @ b ##ov ##ine serum album ##in - mediated Photo ##thermal therapy result shows high therapy efficacy as a result of their potent [unused1] near - infrared absorption [unused2] and high photo ##thermal conversion efficiency . The immune response triggered by G ##d : C ##u ##S @ b ##ov ##ine serum album ##in - mediated Photo ##thermal therapy is pre ##lim ##ina ##rily explored . In addition , toxicity studies in v ##it ##ro and in v ##ivo verify that G ##d : C ##u ##S @ b [SEP]',\n",
    "  'existing_cui': 'C0376519',\n",
    "  'existing_cui_name': 'Spectroscopy , Near-Infrared',\n",
    "  'existing_cui_desc': '[CLS] S ##pect ##ros ##copy , Near - In ##fra ##red [unused3] ( Health Care Act ##ivity , procedure : S ##pect ##rome ##try , Near - In ##fra ##red ; N ##IR s ##pect ##ros ##copy ; Near infrared s ##pect ##ros ##copy ; Near - In ##fra ##red S ##pect ##rome ##tries ; Near - In ##fra ##red S ##pect ##rome ##try ; S ##pect ##rome ##tries , Near - In ##fra ##red ; Near - In ##fra ##red S ##pect ##ros ##copy ; S ##pect ##ros ##copy , N ##IR ; N ##IR S ##pect ##ros ##copy ; N ##IR S ##pect ##ros ##co ##pies ; S ##pect ##ros ##co ##pies , Near - In ##fra ##red ; near infrared s ##pect ##ros ##copy [SEP]',\n",
    "  'our_bi_cui': 'C0234682',\n",
    "  'our_bi_cui_name': 'Light absorption',\n",
    "  'our_bi_cui_desc': '[CLS] Light absorption [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : light absorption ; absorption of light ; Light absorption , function ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28051263.27',\n",
    "  'test_set_idx': 24246,\n",
    "  'type': 'T168',\n",
    "  'name': 'alcohol',\n",
    "  'context': '[CLS] Science ##D ##ire ##ct . Results indicated the most relevant emotional factors to be depression and anxiety . The areas of investigation for cognitive functioning concern those contents and processes related to the ability to initiate and maintain lifestyle changes . The most important behavioral factors identified are physical activity , nutrition / food intake and substance consumption : coffee , [unused1] alcohol [unused2] , cigarettes . Some of the factors identified act as protective factors , other as vulnerability factors . Non ##al ##co ##hol ##ic fatty liver disease / non ##al ##co ##hol ##ic s ##te ##ato ##he ##pa ##titis may be considered a cognitive - behavioral disease , the most effective management being lifestyle changes , with emphasis on diet and exercise . [SEP]',\n",
    "  'existing_cui': 'C0202304',\n",
    "  'existing_cui_name': 'Ethanol measurement',\n",
    "  'existing_cui_desc': '[CLS] Ethan ##ol measurement [unused3] ( Health Care Act ##ivity , procedure : DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TA ##LC ##OH ##OL ##S ; Ethan ##ol Me ##as ##ure ##ment ; Al ##co ##hol ##s levels ; Al ##co ##hol ##s ; Ethan ##ol ; DR ##U ##G SC ##RE ##EN Q ##U ##AN ##TI ##TA ##TI ##VE AL ##CO ##H ##OL ##S ; Al ##co ##hol ; alcohol measurements ; Me ##as ##ure ##ment of alcohol ; E ##thy ##l Al ##co ##hol Me ##as ##ure ##ments ; Drug screen q ##uant ##al ##co ##hol ##s ; Al ##co ##hol level ; Al ##co ##hol measurement ; ET ##HA ##N ##OL ; alcohol level test ) [SEP]',\n",
    "  'our_bi_cui': 'C0001975',\n",
    "  'our_bi_cui_name': 'Alcohols',\n",
    "  'our_bi_cui_desc': '[CLS] Al ##co ##hol ##s [unused3] ( Chemical , substance : alcohol ; Al ##co ##hol [ Chemical Class ] ; Al ##co ##hol ; Al ##co ##hol ##s [ Chemical / In ##g ##red ##ient ] ; alcohol ##s ; class of chemical alcohol ##s ; alcohol substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0001967',\n",
    "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
    "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
    " {'mention_id': '28351716.33',\n",
    "  'test_set_idx': 32886,\n",
    "  'type': 'T170',\n",
    "  'name': 'Particle Swarm Optimization',\n",
    "  'context': '[CLS] and various en ##tro ##pies namely Ya ##ger , Ren ##yi , Kapoor , Shannon , and Fu ##zzy were extracted from the de ##com ##posed images . Then , adaptive synthetic sampling approach was applied to balance the normal and abnormal data ##sets . Next , the extracted features were ranked according to the significance ##s using [unused1] Part ##icle S ##warm Op ##ti ##mi ##zation [unused2] . There ##upon , the ranked and selected features were used to train the random forest class ##ifier using s ##tra ##ti ##fied 10 - fold cross valid ##ation . Overall , the proposed system presented a performance rate of 92 . 48 % , and a sensitivity and specific ##ity of 89 . 37 % and 95 [SEP]',\n",
    "  'existing_cui': 'C4075704',\n",
    "  'existing_cui_name': 'Optimization of medication',\n",
    "  'existing_cui_desc': '[CLS] Op ##ti ##mi ##zation of medication [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
    "  'our_bi_cui': 'C0002045',\n",
    "  'our_bi_cui_name': 'algorithm',\n",
    "  'our_bi_cui_desc': '[CLS] algorithm [unused3] ( Intel ##lect ##ual Product : Al ##gor ##ith ##m ; Al ##gor ##ith ##ms ; algorithms ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27813022.13',\n",
    "  'test_set_idx': 18029,\n",
    "  'type': 'T058',\n",
    "  'name': 'On admission',\n",
    "  'context': '[CLS] ##omy : review of the literature A 63 - year - old man , who had undergone total gas ##tre ##ct ##omy and R ##oux - en - Y reconstruction for gas ##tric cancer 10 years previously , was admitted to our hospital with complaints of abdominal pain , p ##al ##pable abdominal tumor , and hem ##ate ##mes ##is . [unused1] On admission [unused2] , the abdominal tender ##ness was improving and no abdominal tumor was p ##al ##pable . Mi ##ld inflammatory changes and an ##emia were noted on blood examination . Abd ##omi ##nal com ##puted to ##mo ##graphy revealed a tumor with a layered structure in the left abdomen . The patient was diagnosed with in ##test ##inal o ##bs ##truction secondary [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0184666',\n",
    "  'our_bi_cui_name': 'Hospital admission',\n",
    "  'our_bi_cui_desc': '[CLS] Hospital admission [unused3] ( Health Care Act ##ivity , Hospital , procedure , treatment : admitted ; Ad ##mission ; hospital ; admitted hospital ; admissions ; Ad ##mit ( to ) ; hospital ; admit ; Ad ##mit ; hospital ##ization admission ; hospital admission ; admission hospital ; Ad ##mission ; admit to hospital ; Ad ##mission to hospital ; admits ; admitting ; Hospital Ad ##mission ; hospital admissions ; admission to hospital ; admissions hospital ; admission ) [SEP]',\n",
    "  'our_cross_cui': 'C0809949',\n",
    "  'our_cross_cui_name': 'Admission activity',\n",
    "  'our_cross_cui_desc': '[CLS] Ad ##mission activity [unused3] ( Health Care Act ##ivity : Ad ##mit ##ted ; Ad ##mission ) [SEP]'},\n",
    " {'mention_id': '27872234.68',\n",
    "  'test_set_idx': 20129,\n",
    "  'type': 'T103',\n",
    "  'name': 'SKCa',\n",
    "  'context': '[CLS] ##im ##id ##in - 4 - y ##l ] - am ##ine , a selective SK ##C ##a act ##iva ##tor , were marginal ##ly decreased in SH ##RS ##P art ##eries compared with W ##ista ##r - Kyoto art ##eries . The expression of end ##oth ##eli ##al trans ##ient receptor potential van ##illo ##id type 4 channel and [unused1] SK ##C ##a [unused2] protein was significantly decreased in the SH ##RS ##P me ##sent ##eric art ##eries compared with those of W ##ista ##r - Kyoto , whereas function and expression of I ##K ##C ##a were preserved in SH ##RS ##P art ##eries . These findings suggest that End ##oth ##eli ##um - dependent h ##yper ##pol ##ari ##zation - mediated responses are [SEP]',\n",
    "  'existing_cui': 'C0006675',\n",
    "  'existing_cui_name': 'Calcium',\n",
    "  'existing_cui_desc': '[CLS] Cal ##ci ##um [unused3] ( Chemical , medication , substance : Co ##agu ##lation factor IV - R ##ET ##IR ##ED - ; CO ##AG FA ##CT ##OR IV ; Co ##agu ##lation Factor IV ; B ##L ##O ##OD CO ##AG FA ##CT ##OR IV ; C ##a + + element ; factor i ##v ; calcium ; Blood Co ##agu ##lation Factor IV ; Cal ##ci ##um co ##agu ##lation factor ; Co ##agu ##lation factor IV ; calcium ##s ; Cal ##ci ##um [ Chemical / In ##g ##red ##ient ] ; C ##a - Cal ##ci ##um ; CA ##LC ##I ##UM ; Factor IV ; C ##a element ; Cal ##ci ##um anal ##yte ; Factor IV , Co ##agu ##lation [SEP]',\n",
    "  'our_bi_cui': 'C0949653',\n",
    "  'our_bi_cui_name': 'Calcium-Activated Potassium Channel',\n",
    "  'our_bi_cui_desc': '[CLS] Cal ##ci ##um - Act ##ivated Po ##tas ##sium Channel [unused3] ( Chemical : Po ##tas ##sium Channel ##s , Cal ##ci ##um De ##pen ##dent ; Po ##tas ##sium Channel ##s , Cal ##ci ##um - Act ##ivated [ Chemical / In ##g ##red ##ient ] ; Po ##tas ##sium Channel , Cal ##ci ##um Act ##ivated ; Po ##tas ##sium Channel ##s , Cal ##ci ##um - De ##pen ##dent ; K CH ##AN ##NE ##LS CA ##LC ##I ##UM ACT ##I ##VA ##TE ##D ; C ##a ##2 + - Act ##ivated K + Channel ##s ; CA ACT ##I ##VA ##TE ##D K CH ##AN ##NE ##L ; Cal ##ci ##um - Act ##ivated K + Channel ##s ; K CH ##AN [SEP]',\n",
    "  'our_cross_cui': 'C1571638',\n",
    "  'our_cross_cui_name': 'Small-Conductance Calcium-Activated Potassium Channels',\n",
    "  'our_cross_cui_desc': '[CLS] Small - Con ##duct ##ance Cal ##ci ##um - Act ##ivated Po ##tas ##sium Channel ##s [unused3] ( Chemical : SK Po ##tas ##sium Channel ##s ; Small Con ##duct ##ance Cal ##ci ##um Act ##ivated Po ##tas ##sium Channel ##s ; Small - Con ##duct ##ance Cal ##ci ##um - Act ##ivated Po ##tas ##sium Channel ##s [ Chemical / In ##g ##red ##ient ] ; Po ##tas ##sium Channel ##s , SK ) [SEP]'},\n",
    " {'mention_id': '27587730.27',\n",
    "  'test_set_idx': 10766,\n",
    "  'type': 'T103',\n",
    "  'name': 'gga-miR-21',\n",
    "  'context': \"[CLS] in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga - mi ##R - 21 inhibitor enhanced pre - ad ##ip ##oc ##yte proliferation . The subsequent investigation identified K ##rup ##pel - like factor 5 m ##RNA as a target of g ##ga - mi ##R - 21 . The [unused1] g ##ga - mi ##R - 21 [unused2] mimic in ##hibit ##ed K ##rup ##pel - like factor 5 3 ( ' ) U ##TR reporter activity and decreased end ##ogen ##ous K ##rup ##pel - like factor 5 expression in primary pre - ad ##ip ##ocytes . K ##rup ##pel - like factor 5 knock ##down using RNA ##i had a similar effect to that of [SEP]\",\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1537719',\n",
    "  'our_bi_cui_name': 'MIR21 gene',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '28127853.10',\n",
    "  'test_set_idx': 26304,\n",
    "  'type': 'T082',\n",
    "  'name': 'Taipei',\n",
    "  'context': '[CLS] program To develop and evaluate the effectiveness of an inter ##gene ##ration ##al health promotion program . This was an action research project . A total of 34 participants attended the 12 - week program and completed the pre - test and post - test . There were 16 middle - aged and nine older adults recruited from a district of [unused1] Taipei [unused2] , and nine young adults recruited from the principal investigator \\' s university . The \" At ##ti ##tudes toward A ##ging Scale \" and the \" Spiritual Health Scale \" were two assessment instruments used in the study . The results showed that there were significant improvements in the At ##ti ##tudes toward A ##ging Scale for the young adult group [SEP]',\n",
    "  'existing_cui': 'C0062316',\n",
    "  'existing_cui_name': 'hemoglobin G-Taipei',\n",
    "  'existing_cui_desc': '[CLS] hem ##og ##lo ##bin G - Taipei [unused3] ( Chemical , substance : H ##b 22 ( B ##4 ) , G ##lu - g ##ly ; hem ##og ##lo ##bin G Tai ##bei ; He ##mo ##g ##lo ##bin G - Taipei ; H ##b 22 ; H ##b G - Taipei ; H ##b G Tai ##bei ; Ha ##em ##og ##lo ##bin G - Taipei ; He ##mo ##g ##lo ##bin G Taipei ) [SEP]',\n",
    "  'our_bi_cui': 'C0039260',\n",
    "  'our_bi_cui_name': 'Taiwan',\n",
    "  'our_bi_cui_desc': '[CLS] Taiwan [unused3] ( Spa ##tial Concept , geographic location : T ##W ##N ; Form ##osa ; Republic of China ; republic of chin ##a ; T ##W ; T ##A ##I ##WA ##N ; form ##osa ; ta ##i ##wan ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '27669217.3',\n",
    "  'test_set_idx': 13654,\n",
    "  'type': 'T017',\n",
    "  'name': 'ermT',\n",
    "  'context': '[CLS] In ##du ##cible Express ##ion of both er ##m ##B and [unused1] er ##m ##T [unused2] Con ##ferred High Mac ##rol ##ide Resistance in St ##re ##pt ##oc ##oc ##cus gal ##lo ##ly ##ticus subsp . paste ##uria ##nus Is ##olate ##s in China St ##re ##pt ##oc ##oc ##cus gal ##lo ##ly ##ticus subsp . paste ##uria ##nus is an under - recognized path ##ogen and zoo ##not ##ic agent causing op ##port ##uni ##stic infections in humans . Despite increasing recognition of this subspecies as a cause for human infectious diseases , limited information is known about its anti ##biotic resistance mechanism . In this study , we aim to identify the molecular mechanism underlying the high mac ##rol ##ide resistance of six S [SEP]',\n",
    "  'existing_cui': 'C0732611',\n",
    "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
    "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
    "  'our_bi_cui': 'C1417123',\n",
    "  'our_bi_cui_name': 'MET gene',\n",
    "  'our_bi_cui_desc': '[CLS] ME ##T gene [unused3] ( Ana ##tom ##ical Structure : D ##F ##N ##B ##9 ##7 ; he ##pa ##to ##cy ##te growth factor receptor ; He ##pa ##to ##cy ##te Growth Factor Re ##ceptor Gene ; Act ##ivated He ##pa ##to ##cy ##te Growth Factor Re ##ceptor Gene ; RC ##CP ##2 ; ME ##T PR ##OT ##O ##ON ##CO ##GE ##NE ; H ##EP ##AT ##OC ##Y ##TE G ##RO ##W ##TH FA ##CT ##OR R ##EC ##EP ##TO ##R ; On ##co ##gene H ##G ##F ##R ; ME ##T Proto - On ##co ##gene , Re ##ceptor Ty ##ros ##ine Ki ##nas ##e Gene ; ME ##T pro ##to - on ##co ##gene , receptor t ##yr ##os ##ine kinase ; On [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27832198.61',\n",
    "  'test_set_idx': 18683,\n",
    "  'type': 'T017',\n",
    "  'name': 'Cam734',\n",
    "  'context': '[CLS] multiple anti ##mal ##aria ##l agents . These results were generated in the G ##C ##0 ##3 strain , used in multiple earlier P . f ##al ##ci ##par ##um ch ##lor ##o ##quin ##e resistance transport ##er studies , and might differ in natural is ##olate ##s harbor ##ing this all ##ele . Results presented here ##in show that [unused1] Cam ##7 ##34 [unused2] - mediated ch ##lor ##o ##quin ##e resistance is dependent on the rare A1 ##44 ##F mutation that has not been observed beyond Southeast Asia , and reveal distinct impacts of this and other Cam ##7 ##34 - specific mutations on ch ##lor ##o ##quin ##e resistance and parasite growth rates . B ##io ##chemical ass ##ays revealed a broad impact [SEP]',\n",
    "  'existing_cui': 'C0006675',\n",
    "  'existing_cui_name': 'Calcium',\n",
    "  'existing_cui_desc': '[CLS] Cal ##ci ##um [unused3] ( Chemical , medication , substance : Co ##agu ##lation factor IV - R ##ET ##IR ##ED - ; CO ##AG FA ##CT ##OR IV ; Co ##agu ##lation Factor IV ; B ##L ##O ##OD CO ##AG FA ##CT ##OR IV ; C ##a + + element ; factor i ##v ; calcium ; Blood Co ##agu ##lation Factor IV ; Cal ##ci ##um co ##agu ##lation factor ; Co ##agu ##lation factor IV ; calcium ##s ; Cal ##ci ##um [ Chemical / In ##g ##red ##ient ] ; C ##a - Cal ##ci ##um ; CA ##LC ##I ##UM ; Factor IV ; C ##a element ; Cal ##ci ##um anal ##yte ; Factor IV , Co ##agu ##lation [SEP]',\n",
    "  'our_bi_cui': 'C1708291',\n",
    "  'our_bi_cui_name': 'CDC73 gene',\n",
    "  'our_bi_cui_desc': '[CLS] CD ##C ##7 ##3 gene [unused3] ( Ana ##tom ##ical Structure : H ##Y ##RA ##X , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; cell division cycle 73 ; para ##fi ##bro ##min ; F ##I ##HP ; PA ##RA ##FI ##BR ##OM ##IN ; CD ##C ##7 ##3 Gene ; CE ##LL D ##I ##VI ##SI ##ON C ##Y ##CL ##E PR ##OT ##EI ##N 73 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; C ##1 ##OR ##F ##28 ; Cell Division Cycle 73 , Pa ##f ##1 / RNA Pol ##yme ##rase II Complex Co ##mpo ##nent , Ho ##mo ##log ( S . c ##ere ##vis ##iae [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '28249376.18',\n",
    "  'test_set_idx': 29888,\n",
    "  'type': 'T033',\n",
    "  'name': 'digestibility',\n",
    "  'context': '[CLS] ##n micro ##bial populations in sheep fed a 50 : 50 al ##fa ##lf ##a hay : concentrate diet An experiment was conducted to investigate the effects of a specific mixture of essential oils , containing thy ##me , c ##love and c ##innamon E ##O , on r ##ume ##n micro ##bial f ##er ##mentation , nut ##rient apparent [unused1] dig ##est ##ibility [unused2] and blood meta ##bol ##ites in fist ##ulated sheep . Six sheep fitted with r ##umi ##nal fist ##ula ##s were used in a repeated measurement design with two 24 - d periods to investigate the effect of adding mixture of essential oils at 0 ( control ) , 0 . 8 , and 1 . 6 m ##L / d [SEP]',\n",
    "  'existing_cui': 'C0233423',\n",
    "  'existing_cui_name': 'Suggestibility',\n",
    "  'existing_cui_desc': '[CLS] Su ##gg ##est ##ibility [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : suggest ##ibility ; Su ##gg ##est ##ibility , function ) [SEP]',\n",
    "  'our_bi_cui': 'C0012238',\n",
    "  'our_bi_cui_name': 'Digestion',\n",
    "  'our_bi_cui_desc': '[CLS] Digest ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : dig ##estive system functions ; dig ##est ##ion ; Digest ##ive system functions ; dig ##est ##ions ; Digest ##ive system function ; Fun ##ctions of the dig ##estive system ; Digest ##ive ; Digest ##ive tract function ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28179911.81',\n",
    "  'test_set_idx': 27675,\n",
    "  'type': 'T204',\n",
    "  'name': 'T2',\n",
    "  'context': '[CLS] ##us T ##2 trans ##genic rice lines ( G ##5 and G ##2 ) , different Co ##WR ##I ##1 expression levels were detected , but no Co ##WR ##I ##1 trans ##cripts were detected in the wild type . Ana ##ly ##ses of the seed oil content , star ##ch content , and total protein content indicated that the two [unused1] T ##2 [unused2] trans ##genic lines showed a significant increase ( P < 0 . 05 ) in seed oil content . The trans ##genic lines also showed a significant increase in star ##ch content , whereas total protein content decreased significantly . Further analysis of the fatty acid composition revealed that palm ##itic acid ( C ##16 : 0 ) and l ##ino [SEP]',\n",
    "  'existing_cui': 'C1335834',\n",
    "  'existing_cui_name': 'SLC25A5 gene',\n",
    "  'existing_cui_desc': '[CLS] SL ##C ##25 ##A ##5 gene [unused3] ( Ana ##tom ##ical Structure : AD ##P / ATP T ##RA ##NS ##L ##OC ##AS ##E 2 ; 2 ##F ##1 ; Sol ##ute Carrier Family 25 ( Mi ##to ##cho ##nd ##rial Carrier ; Aden ##ine N ##uc ##leo ##tide Trans ##loc ##ator ) , Member 5 Gene ; AD ##EN ##IN ##E N ##UC ##LE ##OT ##ID ##E T ##RA ##NS ##L ##OC ##AT ##OR 2 ; SL ##C ##25 ##A ##5 Gene ; AD ##P / ATP CA ##R ##RI ##ER 2 ; so ##lut ##e carrier family 25 member 5 ; AD ##P / ATP T ##RA ##NS ##L ##OC ##AT ##OR OF F ##IB ##RO ##BL ##AS ##TS ; S ##OL ##UT ##E [SEP]',\n",
    "  'our_bi_cui': 'C0282641',\n",
    "  'our_bi_cui_name': 'Transgenes',\n",
    "  'our_bi_cui_desc': '[CLS] Trans ##gene ##s [unused3] ( Ana ##tom ##ical Structure : trans ##gene ; Trans ##gene ) [SEP]',\n",
    "  'our_cross_cui': 'C0085245',\n",
    "  'our_cross_cui_name': 'Plants , Transgenic',\n",
    "  'our_cross_cui_desc': '[CLS] Plants , Trans ##genic [unused3] ( E ##uka ##ryo ##te : Trans ##genic Plants ; Trans ##genic Plant ; trans ##genic plant ; trans ##genic plants ; Plant , Trans ##genic ; plant trans ##genic ; Trans ##genic plants ) [SEP]'},\n",
    " {'mention_id': '28424683.56',\n",
    "  'test_set_idx': 35434,\n",
    "  'type': 'T038',\n",
    "  'name': 'expanding',\n",
    "  'context': '[CLS] ##itic cells in contrast to O ##Cs are found to promote faster expansion of residual T cells within pu ##rified Natural killer cells resulting in the decline in Natural killer cell numbers from healthy individuals . Ad ##dition of anti - CD ##3 m ##A ##b in ##hibit ##s T cell proliferation while enhancing Natural killer cell expansion ; however , [unused1] expanding [unused2] Natural killer cells have lower c ##yt ##oto ##xi ##city but higher secret ##ion of IF ##N - γ . Ex ##pan ##sion and functional activation of super - charged Natural killer cells by O ##Cs is dependent on inter ##le ##uki ##n ( inter ##le ##uki ##n ) - 12 and IL - 15 . Thus , in this report , [SEP]',\n",
    "  'existing_cui': 'C0205229',\n",
    "  'existing_cui_name': 'Expanding',\n",
    "  'existing_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
    "  'our_bi_cui': 'C0205229',\n",
    "  'our_bi_cui_name': 'Expanding',\n",
    "  'our_bi_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
    "  'our_cross_cui': 'C0007595',\n",
    "  'our_cross_cui_name': 'cell growth',\n",
    "  'our_cross_cui_desc': '[CLS] cell growth [unused3] ( B ##iol ##og ##ic Fun ##ction : cell expansion ; cellular growth ; Cell ##s - - Growth ; Cell Growth ; cell growth ##s ; cells growth ; growth cell ; growth of cell ; Cell ##ular Growth ; Cell ##ular Ex ##pan ##sion ) [SEP]'},\n",
    " {'mention_id': '27500205.30',\n",
    "  'test_set_idx': 8462,\n",
    "  'type': 'T103',\n",
    "  'name': 'kindlins',\n",
    "  'context': '[CLS] ##of ##orms and the levels of kind ##lins . Great interest in the kind ##lins has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of [unused1] kind ##lins [unused2] have clearly established that they regulate the capacity of in ##te ##g ##rin ##s to media ##te their functions . Kind ##lins are adapt ##or proteins ; their function em ##ana ##te from their interaction with binding partners , including the c ##yt ##op ##las ##mic tails of in ##te ##g ##rin ##s and components of the act ##in c ##yt [SEP]',\n",
    "  'existing_cui': 'C1720776',\n",
    "  'existing_cui_name': 'Kindling , Neurologic',\n",
    "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
    "  'our_bi_cui': 'C0010422',\n",
    "  'our_bi_cui_name': 'Crystallins',\n",
    "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27476541.71',\n",
    "  'test_set_idx': 7580,\n",
    "  'type': 'T103',\n",
    "  'name': 'NADPH oxidase inhibitor drug',\n",
    "  'context': '[CLS] 4 ) and consequently reactive oxygen species and ma ##lon ##dial ##de ##hy ##de levels were elevated in high glucose - treated PC ##12 cells . At ##or ##vas ##tat ##in could significantly decrease high glucose - induced NO ##X ##s , reactive oxygen species and ma ##lon ##dial ##de ##hy ##de elevation and improve impaired cell via ##bility . It can be concluded that high glucose could el ##eva ##te NO ##X ##s activity , reactive oxygen species and ma ##lon ##dial ##de ##hy ##de levels in neural tissues and At ##or ##vas ##tat ##in as a small molecule [unused1] N ##AD ##P ##H o ##xi ##das ##e inhibitor drug [unused2] may prevent and delay di ##abe ##tic complications , particularly ne ##uro ##pathy . [SEP]',\n",
    "  'existing_cui': 'C1151146',\n",
    "  'existing_cui_name': 'NADPH oxidase activity',\n",
    "  'existing_cui_desc': '[CLS] N ##AD ##P ##H o ##xi ##das ##e activity [unused3] ( B ##iol ##og ##ic Fun ##ction : N ##AD ( P ) H : oxygen o ##xi ##dor ##ed ##uc ##tase activity ; N ##AD ( P ) H o ##xi ##das ##e activity ; N ##AD ##P ##H o ##xi ##das ##e ) [SEP]',\n",
    "  'our_bi_cui': 'C0026457',\n",
    "  'our_bi_cui_name': 'Monoamine Oxidase Inhibitors',\n",
    "  'our_bi_cui_desc': '[CLS] Mon ##oam ##ine O ##xi ##das ##e In ##hibit ##ors [unused3] ( Chemical , MA ##O ##I , medication , product , substance : MA ##O In ##hibit ##ors ; M ##ON ##OA ##MI ##NE O ##X ##ID ##AS ##E IN ##H ##IB ; Mon ##oam ##ine o ##xi ##das ##e - - In ##hibit ##ors ; inhibitor ##s ma ##o ; am ##ine o ##xi ##das ##e inhibitor ##s ; In ##hibit ##or , Mon ##oam ##ine O ##xi ##das ##e ; Mon ##oam ##ine o ##xi ##das ##e inhibitor ##s ; In ##hibit ##ors , MA ##O ; Mon ##oam ##ine O ##xi ##das ##e In ##hibit ##or ; inhibitor mon ##oam ##ine o ##xi ##das ##e ; inhibitor ##s mon ##oam ##ine o [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27617108.15',\n",
    "  'test_set_idx': 11917,\n",
    "  'type': 'T062',\n",
    "  'name': 'RCT',\n",
    "  'context': '[CLS] adult women and can negatively influence reproductive health t ##raj ##ector ##ies . Few random ##ized controlled trials have focused on strategies to improve out ##patient ad ##herence or to reduce reproductive m ##or ##bid ##ity in this population . This paper describes the research methods and preliminary effectiveness of recruitment , retention , and intervention strategies employed in a novel [unused1] RC ##T [unused2] designed to test a technology - enhanced community - health nursing intervention among urban and young adult with P ##el ##vic inflammatory disease . and young adult women aged 13 - 25 years were recruited during acute P ##el ##vic inflammatory disease visits in out ##patient clinics and emergency departments to participate in this I ##RB - approved trial . Part [SEP]',\n",
    "  'existing_cui': 'C0281508',\n",
    "  'existing_cui_name': 'Desmoplastic Small Round Cell Tumor',\n",
    "  'existing_cui_desc': '[CLS] Des ##mo ##p ##lastic Small Round Cell Tu ##mor [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : Des ##mo ##p ##lastic small round cell t ##umour ; Des ##mo ##p ##lastic Small - Cell Tu ##mor ##s ; Des ##mo ##p ##lastic Small Cell Tu ##mor ; Des ##mo ##p ##lastic Small Round - Cell Tu ##mor ; Pol ##y ##phe ##not ##y ##pic Small Round Cell Tu ##mor ; Tu ##mor , Des ##mo ##p ##lastic Small - Cell ; des ##mo ##p ##lastic small round cell tumor ; Small - Cell Tu ##mor ##s , Des ##mo ##p ##lastic ; Des ##mo ##p ##las . small round cell tumor ; Small - Cell Tu ##mor [SEP]',\n",
    "  'our_bi_cui': 'C0206034',\n",
    "  'our_bi_cui_name': 'Clinical Trials , Randomized',\n",
    "  'our_bi_cui_desc': '[CLS] Clinical Trials , Random ##ized [unused3] ( Research Act ##ivity : random ##ized clinical trials ; Random ##ized Clinical Trials ; clinical random ##ize trials ; random ##ized clinical trial ; T ##RI ##AL ##S RA ##ND ##OM ##I ##Z ##ED C ##L ##IN ; clinical random ##ized trials ; C ##L ##IN T ##RI ##AL ##S RA ##ND ##OM ##I ##Z ##ED ; Trials , Random ##ized Clinical ; Random ##ized Clinical Trial ) [SEP]',\n",
    "  'our_cross_cui': 'C0206035',\n",
    "  'our_cross_cui_name': 'Controlled Clinical Trials , Randomized',\n",
    "  'our_cross_cui_desc': '[CLS] Control ##led Clinical Trials , Random ##ized [unused3] ( Research Act ##ivity : CO ##NT ##RO ##LL ##ED C ##L ##IN T ##RI ##AL ##S RA ##ND ##OM ##I ##Z ##ED ; Random ##ized Control ##led Clinical Trial ) [SEP]'},\n",
    " {'mention_id': '28243201.63',\n",
    "  'test_set_idx': 29705,\n",
    "  'type': 'T017',\n",
    "  'name': 'CCNEI',\n",
    "  'context': \"[CLS] h ##yper ##met ##hyl ##ated cell lines S ##W ##48 . In conclusion , we found the evidence of five potentially biological ##ly important genes in re ##current CR ##Cs that could possibly serve as a new potential therapeutic targets for patients with ch ##em ##ores ##istan ##ce . We post ##ulate that a ##ber ##rant met ##hyl ##ation of [unused1] CC ##NE ##I [unused2] , CC ##ND ##B ##P ##1 , P ##ON ##3 , DD ##X ##43 , and CH ##L ##1 in color ##ec ##tal cancer might be associated with the re ##cu ##rrence of color ##ec ##tal cancer and 5 - a ##za - 2 ' - de ##ox ##y ##cy ##ti ##dine - mediated restoration of 5 - F ##lu ##oro [SEP]\",\n",
    "  'existing_cui': 'C1332697',\n",
    "  'existing_cui_name': 'CCNE1 gene',\n",
    "  'existing_cui_desc': '[CLS] CC ##NE ##1 gene [unused3] ( Ana ##tom ##ical Structure : CC ##NE ##1 Gene ; c ##y ##c ##lin E ##1 ; C ##Y ##CL ##IN E ; c ##y ##c ##lin E ##t ; C ##Y ##CL ##IN E ##1 ; Cy ##c ##lin E ##1 Gene ; c ##y ##c ##lin E ##s ) [SEP]',\n",
    "  'our_bi_cui': 'C1413182',\n",
    "  'our_bi_cui_name': 'CCNI gene',\n",
    "  'our_bi_cui_desc': '[CLS] CC ##NI gene [unused3] ( Ana ##tom ##ical Structure : CC ##NI ##1 ; c ##y ##c ##lin I ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27583176.8',\n",
    "  'test_set_idx': 10705,\n",
    "  'type': 'T170',\n",
    "  'name': 'outcome grading scoring systems',\n",
    "  'context': '[CLS] outcome assessment is mandatory for op ##ti ##mizing therapeutic efforts . We retrospective ##ly analyzed data from 34 ##2 patients with spontaneous primary In ##tra ##cer ##eb ##ral hem ##or ##r ##hage to evaluate possible predict ##ors of 30 - day mortality considering clinical , radio ##logical , and therapeutic ##al parameters . We also applied three widely accepted [unused1] outcome g ##rading scoring systems [unused2] [ ( In ##tra ##cer ##eb ##ral hem ##or ##r ##hage score , F ##UN ##C score and in ##tra ##cer ##eb ##ral hem ##or ##r ##hage g ##rading scale ] on our population to evaluate the correlation of these scores with the 30 - day mortality in our study . We also applied three widely accepted outcome g ##rading [SEP]',\n",
    "  'existing_cui': 'C1273712',\n",
    "  'existing_cui_name': 'Grading system used',\n",
    "  'existing_cui_desc': '[CLS] G ##rading system used [unused3] ( Health Care Act ##ivity , o ##bs ##er ##vable entity : g ##rading system ) [SEP]',\n",
    "  'our_bi_cui': 'C1708250',\n",
    "  'our_bi_cui_name': 'Tumor Grading System',\n",
    "  'our_bi_cui_desc': '[CLS] Tu ##mor G ##rading System [unused3] ( Intel ##lect ##ual Product : G ##rading system ; G ##rading System ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28188533.1',\n",
    "  'test_set_idx': 27846,\n",
    "  'type': 'T170',\n",
    "  'name': 'SWATH ( ® )',\n",
    "  'context': '[CLS] Generation of High - Quality [unused1] S ##WA ##TH ( ® ) [unused2] A ##c ##quisition Data for Label - free Q ##uant ##itative Pro ##te ##omi ##cs Studies Using Triple ##TO ##F ( ® ) Mass S ##pect ##rome ##ters Data - independent acquisition is a powerful mass s ##pect ##rome ##try technique that enables comprehensive MS and MS / MS analysis of all detect ##able species , providing an information rich data file that can be mined deeply . Here , we describe how to acquire high - quality S ##WA ##TH ( ® ) A ##c ##quisition data to be used for large quantitative pro ##te ##omi ##c studies . We specifically focus on using variable sized Q ##1 windows for acquisition of [SEP]',\n",
    "  'existing_cui': 'C1416521',\n",
    "  'existing_cui_name': 'ITSN2 gene',\n",
    "  'existing_cui_desc': '[CLS] IT ##SN ##2 gene [unused3] ( Ana ##tom ##ical Structure : PR ##O ##20 ##15 ; SH ##3 domain protein 1 ##B ; inter ##sect ##in 2 ; SH ##3 ##P ##18 ; IN ##TE ##RS ##EC ##TI ##N 2 ; SH ##3 ##P ##18 - like WA ##SP associated protein ; SH ##3 D ##OM ##A ##IN PR ##OT ##EI ##N 1 ##B ; K ##IA ##A ##12 ##5 ##6 ) [SEP]',\n",
    "  'our_bi_cui': 'C0025080',\n",
    "  'our_bi_cui_name': 'Medical Devices',\n",
    "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28438542.29',\n",
    "  'test_set_idx': 36020,\n",
    "  'type': 'T103',\n",
    "  'name': 'inhibitors',\n",
    "  'context': '[CLS] showed that compounds 5 ##b and 5 ##f , with 2 - ch ##lor ##o and 4 - flu ##oro substitution ##s , showed bio ##chemical activities in micro ##mo ##lar and sub ##mic ##rom ##olar range ( I ##C ##50 1 . 34 - 5 . 03 μ ##M ) against both the targeted enzymes . The structure - activity relationship el ##uc ##idated for these novel [unused1] inhibitor ##s [unused2] against both the enzymes provide new insight into the binding mode of the inhibitor ##s to the active sites of enzymes . The positive results of the bio ##chemical ass ##ay suggest that these compounds may be further op ##ti ##mized and utilized for the treatment of di ##abe ##tic re ##tino ##pathy . [SEP]',\n",
    "  'existing_cui': 'C0243077',\n",
    "  'existing_cui_name': 'inhibitors',\n",
    "  'existing_cui_desc': '[CLS] inhibitor ##s [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0243077',\n",
    "  'our_bi_cui_name': 'inhibitors',\n",
    "  'our_bi_cui_desc': '[CLS] inhibitor ##s [unused3] ( Chemical ) [SEP]',\n",
    "  'our_cross_cui': 'C0014432',\n",
    "  'our_cross_cui_name': 'Enzyme Inhibitors',\n",
    "  'our_cross_cui_desc': '[CLS] En ##zy ##me In ##hibit ##ors [unused3] ( Chemical , product , substance : E ##N ##Z ##Y ##ME IN ##H ##IB ; enzyme inhibitor ; enzyme inhibitor ##s ; En ##zy ##me inhibitor ##s ; In ##hibit ##ors , En ##zy ##me ; enzymes inhibitor ##s ; En ##zy ##me inhibitor ) [SEP]'},\n",
    " {'mention_id': '28077286.28',\n",
    "  'test_set_idx': 25078,\n",
    "  'type': 'T103',\n",
    "  'name': 'MeHg',\n",
    "  'context': '[CLS] ##quent behavioral alterations in adult birds have not received much attention . Moreover , pass ##eri ##ne birds are poorly represented in Me ##H ##g ne ##uro ##to ##xi ##cology studies in comparison to other a ##vian orders . Hence in this study , we used the egg injection method to investigate the long term effects of in o ##vo [unused1] Me ##H ##g [unused2] exposure on brain his ##top ##ath ##ology and courts ##hip behavior in a model song ##bird species , the z ##eb ##ra fin ##ch ( Ta ##eni ##opy ##gia gut ##tata ) . Egg treatment groups included : a low Me ##H ##g dose of 0 . 2 μ ##g H ##g g ( - 1 ) egg , a high [SEP]',\n",
    "  'existing_cui': 'C0228520',\n",
    "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
    "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
    "  'our_bi_cui': 'C0025424',\n",
    "  'our_bi_cui_name': 'Mercury',\n",
    "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
    "  'our_cross_cui': 'C0025794',\n",
    "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
    "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
    " {'mention_id': '27826436.38',\n",
    "  'test_set_idx': 18368,\n",
    "  'type': 'T204',\n",
    "  'name': 'cultivars',\n",
    "  'context': '[CLS] c ##v . To ##chi ##oto ##me . To ##chi ##oto ##me and Sa ##chin ##oka showed higher content of l ##inal ##ool and ( E ) - ne ##rol ##ido ##l . Sa ##chin ##oka showed the highest content of total sugar ##s and total acids . G ##ui ##mei ##ren showed higher sweetness index than the other three [unused1] cult ##iva ##rs [unused2] . Fi ##rm ##ness of To ##chi ##oto ##me was highest among all the varieties . The highest total soluble solid ##s T ##SS value was found in c ##v . Sa ##chin ##oka , followed by the G ##ui ##mei ##ren and To ##chi ##oto ##me varieties . Sa ##chin ##oka had the highest t ##it ##rata ##ble acid ##ity [SEP]',\n",
    "  'existing_cui': 'C3385047',\n",
    "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
    "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
    "  'our_bi_cui': 'C0242775',\n",
    "  'our_bi_cui_name': 'Agricultural Crops',\n",
    "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
    "  'our_cross_cui': 'C0032098',\n",
    "  'our_cross_cui_name': 'Plants',\n",
    "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
    " {'mention_id': '28319502.3',\n",
    "  'test_set_idx': 31859,\n",
    "  'type': 'T038',\n",
    "  'name': 'RS3PE',\n",
    "  'context': '[CLS] Re ##mit ##ting Ser ##one ##gat ##ive S ##ym ##metric ##al S ##yn ##ov ##itis With Pitt ##ing Ed ##ema : Appearance on F ##D ##G P ##ET / CT Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema ( [unused1] RS ##3 ##P ##E [unused2] ) is a rare condition in the elderly and can appear as a first presentation of various types of r ##he ##umatic and ma ##li ##gnant diseases . We presented a 62 - year - old man with the diagnosis of RS ##3 ##P ##E based on the clinical sign and laboratory data . Because of the possibility of associated ma ##li ##gna ##ncies in RS ##3 ##P ##E , F ##D [SEP]',\n",
    "  'existing_cui': 'C3147672',\n",
    "  'existing_cui_name': 'IRS3P gene',\n",
    "  'existing_cui_desc': '[CLS] I ##RS ##3 ##P gene [unused3] ( Ana ##tom ##ical Structure : insulin receptor substrate 3 , pseudo ##gene ) [SEP]',\n",
    "  'our_bi_cui': 'C1696153',\n",
    "  'our_bi_cui_name': 'Remitting seronegative symmetrical synovitis with pitting oedema syndrome',\n",
    "  'our_bi_cui_desc': '[CLS] Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma syndrome [unused3] ( B ##iol ##og ##ic Fun ##ction : Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema syndrome ; RS ##3 ##P ##E syndrome ) [SEP]',\n",
    "  'our_cross_cui': 'C2919482',\n",
    "  'our_cross_cui_name': 'Remitting seronegative symmetrical synovitis with pitting edema',\n",
    "  'our_cross_cui_desc': '[CLS] Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Re ##lap ##sing se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting ed ##ema ; Re ##mit ##ting se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; RS ##3 ##P ##E - Re ##mit ##ting se ##rone ##gat ##ive symmetric s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; Re ##lap ##sing se ##rone ##gat ##ive symmetrical s ##yn ##ov ##itis with pit ##ting o ##ede ##ma ; RS ##3 ##P ##E - Re ##mit ##ting se ##rone ##gat ##ive symmetric s ##yn ##ov ##itis with [SEP]'},\n",
    " {'mention_id': '27379139.74',\n",
    "  'test_set_idx': 4240,\n",
    "  'type': 'T103',\n",
    "  'name': 'TCA',\n",
    "  'context': '[CLS] ranging from - 0 . 02 ##6 to - 0 . 48 ##7 . For all three methods , we were able to obtain high - quality protein samples and good 2D ##E maps for the maize leaf mid ##ri ##b . However , p ##hen ##ol extraction produced a better 2D ##E map with greater resolution between spots , and [unused1] T ##CA [unused2] / ace ##tone extraction produced higher protein yields . Thus , this paper includes a discussion regarding the possible reasons for differential protein extraction among the three methods . This study provides useful information that can be used to select suitable protein extraction methods for the pro ##te ##ome analysis of re ##cal ##ci ##tra ##nt plant tissues that are rich [SEP]',\n",
    "  'existing_cui': 'C0085758',\n",
    "  'existing_cui_name': 'Aganglionosis , Colonic',\n",
    "  'existing_cui_desc': '[CLS] A ##gan ##gli ##ono ##sis , Col ##onic [unused3] ( Ana ##tom ##ical Structure , disorder : A ##gan ##gli ##ono ##sis of co ##lon ; T ##CA - Total co ##lon ##ic a ##gan ##gli ##ono ##sis ; Total co ##lon ##ic a ##gan ##gli ##ono ##sis ; Col ##onic A ##gan ##gli ##ono ##sis ; Total Col ##onic A ##gan ##gli ##ono ##sis ; A ##gan ##gli ##ono ##sis , Total Col ##onic ) [SEP]',\n",
    "  'our_bi_cui': 'C0045236',\n",
    "  'our_bi_cui_name': \"2,2 ' ,2 '' - trichlorotriethylamine\",\n",
    "  'our_bi_cui_desc': \"[CLS] 2 , 2 ' , 2 ' ' - t ##rich ##lor ##ot ##rie ##thy ##lam ##ine [unused3] ( Chemical : t ##ris ( 2 - ch ##lor ##oe ##thy ##l ) am ##ine ; Tri ##mus ##tine ; Tri ##s ( beta - ch ##lor ##oe ##thy ##l ) am ##ine ; Tri ##s ( 2 - ch ##lor ##oe ##thy ##l ) am ##ine ; Tri ##ch ##lor ##met ##hine ; 2 - ch ##lor ##o - N , N - bi ##s ( 2 - ch ##lor ##oe ##thy ##l ) et ##hana ##mine ; 2 , 2 ' , 2 ' ' - t ##rich ##lor ##oe ##thy ##lam ##ine ; t ##rich ##lor ##ot ##rie ##thy ##lam ##ine ; t ##ris [SEP]\",\n",
    "  'our_cross_cui': 'C0040900',\n",
    "  'our_cross_cui_name': 'Trichloroacetic Acid',\n",
    "  'our_cross_cui_desc': '[CLS] Tri ##ch ##lor ##oa ##ce ##tic A ##cid [unused3] ( Chemical , medication , product , substance : Tri ##ch ##lor ##oa ##ce ##tic A ##cid [ Chemical / In ##g ##red ##ient ] ; T ##CA - Tri ##ch ##lor ##oa ##ce ##tic acid ; Tri ##ch ##lor ##oa ##ce ##tic acid ; A ##cid ##e t ##rich ##lora ##ce ##ti ##que ; T ##RI ##CH ##L ##OR ##OA ##CE ##TI ##C AC ##ID ; Ace ##tic acid , t ##rich ##lor ##o - ; acid t ##rich ##lor ##oa ##ce ##tic ; t ##rich ##lor ##oa ##ce ##tic acid ; T ##CA ##A - Tri ##ch ##lor ##oa ##ce ##tic acid ; A ##cid , Tri ##ch ##lor ##oa ##ce ##tic ; t ##rich [SEP]'},\n",
    " {'mention_id': '28387835.48',\n",
    "  'test_set_idx': 33984,\n",
    "  'type': 'T058',\n",
    "  'name': 'MLVA',\n",
    "  'context': '[CLS] significantly more IL - 1 ##β , T ##NF - α and IL - 22 than the is ##olate ##s from goats , sheep or chronic Q fever patients . Co ##mp ##aring the c ##yt ##oki ##ne induction of the is ##olate ##s based on their MV ##LA g ##eno ##type did not reveal differences in response between the [unused1] M ##L ##VA [unused2] g ##eno ##type ##s . The pro ##in ##f ##lam ##mat ##ory c ##yt ##oki ##ne response induced in human peripheral blood mon ##on ##uc ##lea ##r cells by C . burn ##eti ##i is ##olate ##s from cattle may explain the low incidence of human Q fever outbreak ##s caused by cattle . The c ##yt ##oki ##ne profile of [SEP]',\n",
    "  'existing_cui': 'C1420126',\n",
    "  'existing_cui_name': 'SLC20A2 gene',\n",
    "  'existing_cui_desc': '[CLS] SL ##C ##20 ##A ##2 gene [unused3] ( Ana ##tom ##ical Structure : S ##OL ##UT ##E CA ##R ##RI ##ER FA ##MI ##L ##Y 20 ( P ##H ##OS ##P ##HA ##TE T ##RA ##NS ##PO ##RT ##ER ) , ME ##MB ##ER 2 ; G ##IB ##BO ##N AP ##E L ##E ##U ##KE ##MI ##A R ##ET ##RO ##VI ##R ##US R ##EC ##EP ##TO ##R 2 ; G ##l ##v ##r - 2 ; P ##H ##OS ##P ##HA ##TE T ##RA ##NS ##PO ##RT ##ER , S ##OD ##I ##UM - DE ##P ##EN ##DE ##NT , 2 ; Pi ##T - 2 ; M ##UR ##IN ##E L ##E ##U ##KE ##MI ##A VI ##R ##US , AM ##P ##H [SEP]',\n",
    "  'our_bi_cui': 'C0023509',\n",
    "  'our_bi_cui_name': 'Lymphocyte Culture Test , Mixed',\n",
    "  'our_bi_cui_desc': '[CLS] L ##ymph ##oc ##yte Culture Test , Mixed [unused3] ( Health Care Act ##ivity , M ##LC , procedure : Mixed Le ##uk ##oc ##yte Re ##actions ; Mixed Le ##uk ##oc ##yte Re ##action ; mixed l ##ymph ##oc ##yte reaction test ; Mixed l ##ymph ##oc ##yte culture ass ##ay ; Le ##uk ##oc ##yte Re ##action , Mixed ; M ##LR test ; mixed le ##uk ##oc ##yte reaction ; Mixed L ##ymph ##oc ##yte Culture Test ; L ##ymph ##oc ##yte Re ##action , Mixed ; Mixed l ##ymph ##oc ##yte culture ; All ##ogen ##ei ##c mixed l ##ymph ##oc ##yte ass ##ay ; Le ##uk ##oc ##yte Re ##actions , Mixed ; Mixed l ##ymph ##oc ##yte reaction ; Mixed [SEP]',\n",
    "  'our_cross_cui': 'C1443925',\n",
    "  'our_cross_cui_name': 'Multi-locus variable-number of tandem repeat analysis',\n",
    "  'our_cross_cui_desc': '[CLS] Multi - lo ##cus variable - number of tandem repeat analysis [unused3] ( Health Care Act ##ivity , procedure : Multi - lo ##cus V ##NT ##R analysis ; M ##L ##VA - multi - lo ##cus variable - number of tandem repeat analysis ) [SEP]'},\n",
    " {'mention_id': '27669217.22',\n",
    "  'test_set_idx': 13673,\n",
    "  'type': 'T033',\n",
    "  'name': 'MIC',\n",
    "  'context': '[CLS] to identify the molecular mechanism underlying the high mac ##rol ##ide resistance of six S . gal ##lo ##ly ##ticus subsp . paste ##uria ##nus is ##olate ##s from dead duck ##lings collected in several natural outbreak ##s in China during 2010 - 2013 . All is ##olate ##s exhibited multi - drug resistance including high mac ##rol ##ide resistance ( [unused1] MI ##C [unused2] ≥ 102 ##4 mg / L for er ##yt ##hr ##omy ##cin , and 512 mg / L for c ##lar ##ith ##rom ##y ##cin ) . E ##ff ##lux - encoding me ##f ##A and me ##f ##E genes were not detect ##able in these is ##olate ##s . The presence of 23 ##S r ##RNA mutations in specific is [SEP]',\n",
    "  'existing_cui': 'C2732473',\n",
    "  'existing_cui_name': 'Ductal Carcinoma In Situ with Microinvasion',\n",
    "  'existing_cui_desc': '[CLS] Du ##ct ##al Car ##cin ##oma In Sit ##u with Micro ##in ##vas ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : Micro ##in ##vasive B ##rea ##st Car ##cin ##oma ; MI ##C ; Du ##ct ##al car ##cin ##oma in sit ##u with micro ##in ##vas ##ion ) [SEP]',\n",
    "  'our_bi_cui': 'C0427978',\n",
    "  'our_bi_cui_name': 'Minimum Inhibitory Concentration measurement',\n",
    "  'our_bi_cui_desc': '[CLS] Mini ##mum In ##hibit ##ory Con ##cent ##ration measurement [unused3] ( Health Care Act ##ivity , MI ##C , procedure , qualifier value : Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test ; Con ##cent ##rations , Mini ##mum In ##hibit ##ory ; Anti ##biotic sensitivity , minimum inhibitor ##y concentration ; MI ##C su ##s ##ce ##pt ##ibility test ; Mini ##mum In ##hibit ##ory Con ##cent ##rations ; MI ##C - Mini ##mum inhibitor ##y concentration ; Con ##cent ##ration , Mini ##mum In ##hibit ##ory ; Mini ##mum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test technique ; In ##hibit ##ory Con ##cent ##rations , Mini ##mum ; Mini ##mum In ##hibit ##ory [SEP]',\n",
    "  'our_cross_cui': 'C1304747',\n",
    "  'our_cross_cui_name': 'Minimum inhibitory concentration result',\n",
    "  'our_cross_cui_desc': '[CLS] Mini ##mum inhibitor ##y concentration result [unused3] ( Finding , finding : minimum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration finding ) [SEP]'},\n",
    " {'mention_id': '27563025.29',\n",
    "  'test_set_idx': 10410,\n",
    "  'type': 'T017',\n",
    "  'name': 'C2C12 cells',\n",
    "  'context': '[CLS] and inter ##connected p ##ore na ##note ##x ##tures with na ##no ##met ##re - scale na ##no ##fi ##bres . To estimate the bio ##com ##pa ##ti ##bility of the 3D p ##oly ##cap ##rol ##act ##one / p ##oly ##ani ##line composite na ##no ##fi ##bre mac ##ros ##truct ##ures , mouse my ##ob ##last ##s ( [unused1] C ##2 ##C ##12 cells [unused2] ) were culture ##d as model cells . The initial responses of C ##2 ##C ##12 cells to the 3D p ##oly ##cap ##rol ##act ##one / p ##oly ##ani ##line composite mac ##ros ##truct ##ures were significantly superior to those to pure p ##oly ##cap ##rol ##act ##one , that is , the cells exhibited typical my ##ob ##last [SEP]',\n",
    "  'existing_cui': 'C0085262',\n",
    "  'existing_cui_name': 'PC12 Cells',\n",
    "  'existing_cui_desc': '[CLS] PC ##12 Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell Line , Ph ##eo ##ch ##rom ##oc ##yt ##oma ; Ph ##eo ##ch ##rom ##oc ##yt ##oma Cell Lines ; Ph ##eo ##ch ##rom ##oc ##yt ##oma 12 Cell Line ; PC A 01 ##2 CE ##LL ##S ; p ##he ##och ##rom ##oc ##yt ##oma 12 cell line ; PC - 12 ; p ##c ##12 cell ; PC ##12 Cell ; Ph ##eo ##ch ##rom ##oc ##yt ##oma Cell Line ; Cell Lines , Ph ##eo ##ch ##rom ##oc ##yt ##oma ; PC ##12 cell ; p ##c ##12 cells ) [SEP]',\n",
    "  'our_bi_cui': 'C1135917',\n",
    "  'our_bi_cui_name': 'Myoblasts , Cardiac',\n",
    "  'our_bi_cui_desc': '[CLS] My ##ob ##last ##s , Card ##iac [unused3] ( Ana ##tom ##ical Structure : cardiac my ##ob ##last ##s ; My ##ob ##last , Card ##iac ; cardiac my ##ob ##last ; Card ##iac my ##ob ##last ; Card ##iac My ##ob ##last ##s ; Card ##iac My ##ob ##last ) [SEP]',\n",
    "  'our_cross_cui': 'C0596995',\n",
    "  'our_cross_cui_name': 'Myoblasts',\n",
    "  'our_cross_cui_desc': '[CLS] My ##ob ##last ##s [unused3] ( Ana ##tom ##ical Structure : Mu ##s ##cle Cell ##s , Em ##b ##ryo ##nic ; My ##ob ##last ; Mu ##s ##cle Cell , Em ##b ##ryo ##nic ; Pre ##cu ##rs ##or Mu ##s ##cle Cell ##s ; Mu ##s ##cle Cell , Pre ##cu ##rs ##or ; my ##ob ##last ; Em ##b ##ryo ##nic Mu ##s ##cle Cell ##s ; my ##ob ##last ##s ; Pre ##cu ##rs ##or Mu ##s ##cle Cell ; Em ##b ##ryo ##nic Mu ##s ##cle Cell ; Mu ##s ##cle Cell ##s , Pre ##cu ##rs ##or ) [SEP]'},\n",
    " {'mention_id': '27838742.76',\n",
    "  'test_set_idx': 19043,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . [unused1] Del ##ica ##f ##lav ##one [unused2] may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28197133.38',\n",
    "  'test_set_idx': 28054,\n",
    "  'type': 'T103',\n",
    "  'name': 'GH3',\n",
    "  'context': '[CLS] p ##hos ##ph ##ory ##lase ) , G ##H1 ##3 ( am ##yla ##se ) , G ##H ##43 and G ##H1 ##0 ( hem ##ice ##ll ##ula ##ses ) , G ##H ##9 and G ##H ##48 ( cell ##ula ##ses ) , P ##L ##11 ( p ##ec ##tina ##se ) as well as G ##H ##2 and [unused1] G ##H ##3 [unused2] ( o ##li ##gos ##ac ##cha ##rida ##ses ) . Our data support the pivotal role of the most characterized fi ##bro ##ly ##tic bacteria ( Pre ##vo ##tel ##la , R ##umi ##no ##cc ##cus and Fi ##bro ##ba ##cter ) , and highlight a substantial , although most probably under ##est ##imated , contribution of fungi and c ##ilia [SEP]',\n",
    "  'existing_cui': 'C1333673',\n",
    "  'existing_cui_name': 'GH1 gene',\n",
    "  'existing_cui_desc': '[CLS] G ##H1 gene [unused3] ( Ana ##tom ##ical Structure : G ##RO ##W ##TH H ##OR ##MO ##NE , NO ##R ##MA ##L ; G ##RO ##W ##TH H ##OR ##MO ##NE 1 ; G ##H1 Gene ; growth hormone 1 ; so ##mat ##ot ##rop ##in ; pit ##uit ##ary growth hormone ; G ##RO ##W ##TH H ##OR ##MO ##NE , P ##IT ##UI ##TA ##R ##Y ; h ##G ##H - N ; G ##H - N ; Growth Ho ##rmon ##e 1 Gene ) [SEP]',\n",
    "  'our_bi_cui': 'C1333877',\n",
    "  'our_bi_cui_name': 'Granzymes',\n",
    "  'our_bi_cui_desc': '[CLS] Gran ##zy ##mes [unused3] ( Chemical : Gran ##zy ##me ; g ##ran ##zy ##me ; EC 3 . 4 . 21 . - ; g ##ran ##zy ##mes ; Gran ##ule - Secret ##ed En ##zy ##me ; Gran ##zy ##mes [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
    "  'our_cross_cui': 'C0014442',\n",
    "  'our_cross_cui_name': 'Enzymes',\n",
    "  'our_cross_cui_desc': '[CLS] En ##zy ##mes [unused3] ( Chemical , medication , substance : enzymes ; enzyme ; En ##zy ##mes [ Chemical / In ##g ##red ##ient ] ; B ##io ##cat ##aly ##sts ; En ##zy ##me ) [SEP]'},\n",
    " {'mention_id': '27623277.36',\n",
    "  'test_set_idx': 12220,\n",
    "  'type': 'T058',\n",
    "  'name': 'Procedural',\n",
    "  'context': '[CLS] attributes from the con ##join ##t experiment ( each with a relative weight of 0 . 23 ) , followed by provider volume ( relative weight of 0 . 21 ) , risk of major complications ( relative weight of 0 . 18 ) , and distance needed to travel for treatment ( relative weight of 0 . 15 ) . [unused1] Pro ##cedural [unused2] and treatment preferences did not vary with demographic ##s , self - reported health status , or familiar ##ity with the procedures . Survey respond ##ents preferred minimal ##ly invasive operations over stereo ##ta ##ctic body radiation therapy or th ##ora ##cot ##omy for treatment of early - stage non - small cell lung cancer . Treatment m ##oda ##lity and [SEP]',\n",
    "  'existing_cui': 'C1619712',\n",
    "  'existing_cui_name': 'Procedural pain',\n",
    "  'existing_cui_desc': '[CLS] Pro ##cedural pain [unused3] ( Finding ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27685187.20',\n",
    "  'test_set_idx': 14117,\n",
    "  'type': 'T082',\n",
    "  'name': 'Canadian city',\n",
    "  'context': \"[CLS] determine what are considered acceptable standards for animal research methodology and translation rate to humans , a valid ##ated survey was sent to : a ) a sample of the general public , via Sam ##pling Survey International ( Sam ##pling Survey International ; Canada ) , Amazon Mechanical Tu ##rk ( Amazon Mechanical Tu ##rk ; USA ) , a [unused1] Canadian city [unused2] festival and a Canadian children ' s hospital ; b ) a sample of medical students ( two first - year classes ) ; and c ) a sample of scientists ( corresponding authors and academic p ##ae ##dia ##tric ##ians ) . There were 137 ##9 responses from the general public sample ( Sam ##pling Survey International , n = [SEP]\",\n",
    "  'existing_cui': 'C0324053',\n",
    "  'existing_cui_name': 'Canadian cattle',\n",
    "  'existing_cui_desc': '[CLS] Canadian cattle [unused3] ( E ##uka ##ryo ##te , organism : Can ##adi ##enne cow ; Canadian cow ; Can ##adi ##enne Cat ##tle ; Canadian cattle breed ; Can ##adi ##enne cattle breed ) [SEP]',\n",
    "  'our_bi_cui': 'C0008848',\n",
    "  'our_bi_cui_name': 'Cities',\n",
    "  'our_bi_cui_desc': '[CLS] Cities [unused3] ( Spa ##tial Concept , environment : City ; city ; cities ) [SEP]',\n",
    "  'our_cross_cui': 'C0006823',\n",
    "  'our_cross_cui_name': 'Canada',\n",
    "  'our_cross_cui_desc': '[CLS] Canada [unused3] ( Spa ##tial Concept , geographic location : CA ##N ; CA ##NA ##DA ; CA ) [SEP]'},\n",
    " {'mention_id': '28394935.43',\n",
    "  'test_set_idx': 34414,\n",
    "  'type': 'T103',\n",
    "  'name': 'Cys - NO',\n",
    "  'context': '[CLS] ##tric oxide s ##ynth ##ase - derived ni ##tric oxide S - ni ##tro ##sy ##lated β - act ##in on Cy ##s ##37 ##4 and impaired act ##in binding to pro ##fi ##lin - 1 , as confirmed with the trans ##ni ##tro ##sy ##lating agent S - ni ##tro ##so - L - c ##ys ##tein ##e ( [unused1] Cy ##s - NO [unused2] ) . The importance of ni ##tric oxide and the formation of P ##F ##N ##1 - act ##in complexes on the regulation of protein kinase C - θ was co ##rro ##bor ##ated by over ##ex ##press ##ion of pro ##fi ##lin - 1 - and act ##in - binding defect ##ive mutant ##s of β - act ##in [SEP]',\n",
    "  'existing_cui': 'C3252049',\n",
    "  'existing_cui_name': 'cystine-N-carboxy anhydride',\n",
    "  'existing_cui_desc': '[CLS] c ##ys ##tine - N - car ##box ##y an ##hy ##dr ##ide [unused3] ( Chemical : Cy ##s - NC ##A ) [SEP]',\n",
    "  'our_bi_cui': 'C0010654',\n",
    "  'our_bi_cui_name': 'Cysteine',\n",
    "  'our_bi_cui_desc': '[CLS] Cy ##stein ##e [unused3] ( Chemical , product , substance : ( 2 ##R ) - 2 - amino - 3 - me ##rca ##pt ##op ##rop ##ano ##ic acid ; c ##ys ##tein ##e l ; ( R ) - 2 - Am ##ino - 3 - su ##lf ##any ##l - prop ##ano ##ic acid ; Half Cy ##st ##ine ; l c ##ys ##tein ##e ; L - Cy ##stein ; Cy ##s ; C ##Y ##ST ##EI ##NE ; l - c ##ys ##tein ##e ; Half - Cy ##st ##ine ; L - Cy ##stein ##e ; ( 2 ##R ) - 2 - amino - 3 - su ##lf ##any ##l ##p ##rop ##ano ##ic acid ; L Cy ##stein [SEP]',\n",
    "  'our_cross_cui': 'C0073896',\n",
    "  'our_cross_cui_name': 'S-nitrosocysteine',\n",
    "  'our_cross_cui_desc': '[CLS] S - ni ##tro ##so ##cy ##stein ##e [unused3] ( Chemical : L - S - ni ##tro ##so ##cy ##stein ##e ; S ##NC compound ; S - ni ##tro ##so - L - c ##ys ##tein ##e ; L - S ##NC compound ) [SEP]'},\n",
    " {'mention_id': '27334669.21',\n",
    "  'test_set_idx': 2719,\n",
    "  'type': 'T033',\n",
    "  'name': 'detection',\n",
    "  'context': '[CLS] DL ##S data in a thorough manner by providing a large set of fitting parameters . This showed that DL ##S only sensed the larger ve ##si ##cles when the mice ##lles / ve ##si ##cles ratio was 80 / 20 w / w . On the other hand , as ##ym ##metric ##al flow field flow fraction ##ation allowed clear [unused1] detection [unused2] of the presence of mice ##lles when this same ratio was as low as 10 / 90 . Subsequently , the photo ##dynamic therapy efficiency of various controlled mixture ##s was assessed using multi ##cellular s ##pher ##oids when a photos ##ens ##iti ##zer , p ##he ##op ##hor ##bide a , was en ##cap ##sul ##ated in the polymer self - [SEP]',\n",
    "  'existing_cui': 'C0206100',\n",
    "  'existing_cui_name': 'Signal Detection',\n",
    "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
    "  'our_bi_cui': 'C1511790',\n",
    "  'our_bi_cui_name': 'Detection',\n",
    "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
    "  'our_cross_cui': 'C0442726',\n",
    "  'our_cross_cui_name': 'Detected',\n",
    "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
    " {'mention_id': '25847295.20',\n",
    "  'test_set_idx': 19,\n",
    "  'type': 'T017',\n",
    "  'name': 'apoptotic cells',\n",
    "  'context': '[CLS] ##late decreased DNA fragment ##ation caused by a ##pop ##tosis in PC ##12 cells . This phenomenon was confirmed after treating a ##pop ##to ##tic PC ##12 cells with non ##yl ##phe ##no ##l diet ##ho ##xy ##late , whereas the c ##yt ##och ##rome c release into the c ##yt ##oso ##l decreased as compared to that in [unused1] a ##pop ##to ##tic cells [unused2] not treated with non ##yl ##phe ##no ##l diet ##ho ##xy ##late s . Furthermore , Ba ##x contents in a ##pop ##to ##tic cells were reduced after exposure to non ##yl ##phe ##no ##l diet ##ho ##xy ##late . Thus , non ##yl ##phe ##no ##l diet ##ho ##xy ##late has the opposite effect on a ##pop ##tosis in [SEP]',\n",
    "  'existing_cui': 'C0162638',\n",
    "  'existing_cui_name': 'Apoptosis',\n",
    "  'existing_cui_desc': '[CLS] A ##pop ##tosis [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : a ##pop ##to ##tic cell death ; A ##pop ##to ##tic Process ; Programme ##d Cell Death ; programmed cell death by a ##pop ##tosis ; A ##pop ##tosis Path ##way ; a ##pop ##tos ##e ; programmed cell death ; RC ##D ; a ##pop ##tosis ; Gene - directed cell death ; a ##pop ##to ##tic programmed cell death ; Programme ##d Cell Death , Type I ; self destruction of the cell ; Me ##chan ##ism that allows cells to self - des ##truct when it is necessary ; a ##pop ##to ##tic process ; type I programmed cell death ) [SEP]',\n",
    "  'our_bi_cui': 'C1836846',\n",
    "  'our_bi_cui_name': 'Apoptotic neurons',\n",
    "  'our_bi_cui_desc': '[CLS] A ##pop ##to ##tic neurons [unused3] ( Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0007634',\n",
    "  'our_cross_cui_name': 'Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
    " {'mention_id': '27298278.20',\n",
    "  'test_set_idx': 1821,\n",
    "  'type': 'T103',\n",
    "  'name': 'morindaparvins C',\n",
    "  'context': '[CLS] ##ones , a nap ##ht ##ho ##quin ##one , an ant ##hra ##quin ##one , and a nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##er , together with three known q ##uin ##ones and seven other known compounds , were isolated from the aerial parts of Mo ##rin ##da par ##vi ##folia . The structures of [unused1] m ##ori ##nda ##par ##vin ##s C [unused2] , D , E , F , and G were el ##uc ##idated on the basis of s ##pect ##ros ##copic or X - ray di ##ff ##raction analysis as met ##hyl 4 - h ##ydro ##xy - 1 , 6 - dim ##eth ##ox ##y - nap ##ht ##hale ##ne - 2 - car ##box ##yla ##te , [SEP]',\n",
    "  'existing_cui': 'C0616488',\n",
    "  'existing_cui_name': 'morindaparvin A',\n",
    "  'existing_cui_desc': '[CLS] m ##ori ##nda ##par ##vin A [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0010206',\n",
    "  'our_bi_cui_name': 'coumarin',\n",
    "  'our_bi_cui_desc': '[CLS] co ##uma ##rin [unused3] ( Chemical , product , substance : 1 , 2 - Benz ##opy ##rone ; C ##uma ##rin ; 5 , 6 - ben ##zo - alpha - p ##yr ##one ; alpha ben ##zo ##py ##rone ; 1 , 2 - ben ##zo ##py ##rone ; ton ##ka bean camp ##hor ; To ##nka Bean Camp ##hor ; Ch ##rome ##n - 2 - one ; CO ##UM ##AR ##IN ; Co ##uma ##rin anti ##coa ##gu ##lant ; 2 ##H - 1 - Benz ##opy ##ran - 2 - one ; Co ##uma ##rini ##c an ##hy ##dr ##ide ; To ##nka bean camp ##hor ; Co ##uma ##rin ; cum ##ari ##n ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27261783.7',\n",
    "  'test_set_idx': 1085,\n",
    "  'type': 'T033',\n",
    "  'name': 'tracing',\n",
    "  'context': '[CLS] micro ##bial cells , micro ##bial populations in ultra ##oli ##got ##rop ##hic a ##ero ##bic sediment ##ary habitats in the open ocean g ##yres are several orders of magnitude less abundant . Despite advances in cultivation - independent molecular ecological techniques , exploring the low - bio ##mass environment remains technological ##ly challenging , especially in the deep sub ##sea ##f ##lo ##or bio ##sp ##here . Review ##ing the historical background of deep - bio ##sp ##here analytical methods , the importance of obtaining clean samples and [unused1] tracing [unused2] contamination , as well as methods for detect ##ing micro ##bial life , technological aspects of molecular micro ##biology , and detect ##ing sub ##sea ##f ##lo ##or metabolic activity will be discussed . [SEP]',\n",
    "  'existing_cui': 'C0079161',\n",
    "  'existing_cui_name': 'Infectious Disease Contact Tracing',\n",
    "  'existing_cui_desc': '[CLS] In ##fect ##ious Disease Contact T ##rac ##ing [unused3] ( Health Care Act ##ivity , procedure : CT - Contact tracing ; Contact T ##rac ##ing ; CO ##MM ##UN ##IC ##AB ##LE D ##IS CO ##NT ##AC ##T T ##RA ##CI ##NG ; Contact tracing ; IN ##F ##EC ##T D ##IS CO ##NT ##AC ##T T ##RA ##CI ##NG ; Co ##mm ##uni ##ca ##ble Disease Contact T ##rac ##ing ; T ##rac ##ing , Contact ) [SEP]',\n",
    "  'our_bi_cui': 'C0546881',\n",
    "  'our_bi_cui_name': 'tracking',\n",
    "  'our_bi_cui_desc': '[CLS] tracking [unused3] ( Spa ##tial Concept : Track ##ing ; tracking [ mental function ] ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27671177.13',\n",
    "  'test_set_idx': 13790,\n",
    "  'type': 'T082',\n",
    "  'name': 'Quetta',\n",
    "  'context': '[CLS] in Que ##tta , Pakistan To determine the prevalence of dental car ##ies and its relationship with dental flu ##oro ##sis , oral health behaviour and diet ##ary behaviour among 12 - year school children in moderate - flu ##ori ##de drinking water community in Que ##tta , Pakistan . Cross - section ##al study . Government and private schools of [unused1] Que ##tta [unused2] , from November 2012 to February 2013 . At ##ota ##l of 34 ##9 children aged 12 - year from 14 randomly selected schools were included . The data collection was done on question ##naire designed for children . Dental car ##ies status was examined by using WHO criteria . Dental car ##ies was found in 81 children ( 23 . [SEP]',\n",
    "  'existing_cui': 'C0262345',\n",
    "  'existing_cui_name': 'Tenia of thalamus',\n",
    "  'existing_cui_desc': '[CLS] Ten ##ia of th ##ala ##mus [unused3] ( Ana ##tom ##ical Structure : ten ##ia of th ##ala ##mi ; Ten ##ia of th ##ala ##mi ; Ta ##enia th ##ala ##mi ; T ##hala ##mus ten ##ia ; ten ##ia of the th ##ala ##mus ; Ten ##ia th ##ala ##mi ) [SEP]',\n",
    "  'our_bi_cui': 'C0337884',\n",
    "  'our_bi_cui_name': 'Quechua',\n",
    "  'our_bi_cui_desc': '[CLS] Que ##chu ##a [unused3] ( Population Group , ethnic group , ethnic group ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '27400734.18',\n",
    "  'test_set_idx': 4722,\n",
    "  'type': 'T103',\n",
    "  'name': 'GEM',\n",
    "  'context': '[CLS] analysis of Korean national database A random ##ized clinical trial has found that the addition of er ##lot ##ini ##b to g ##em ##ci ##ta ##bine ( GE ##M - E ) for pan ##cre ##atic cancer led to a modest increase in survival . The aim of this national population - based retrospective study was to compare the effectiveness of [unused1] GE ##M [unused2] - E to GE ##M alone for pan ##cre ##atic cancer patients in real clinical practice . Pat ##ients with pan ##cre ##atic cancer ( I ##CD - 10 : C ##25 ) with prescription claims of g ##em ##ci ##ta ##bine or er ##lot ##ini ##b between Jan 1 , 2007 and Dec 31 , 2012 were retrospective ##ly identified [SEP]',\n",
    "  'existing_cui': 'C1333683',\n",
    "  'existing_cui_name': 'GMNN gene',\n",
    "  'existing_cui_desc': '[CLS] GM ##N ##N gene [unused3] ( Ana ##tom ##ical Structure : Gemini ##n , DNA Rep ##lication In ##hibit ##or Gene ; GM ##N ##N Gene ; G ##em ; GE ##MI ##NI ##N ; g ##em ##ini ##n , DNA replication inhibitor ; GE ##M ) [SEP]',\n",
    "  'our_bi_cui': 'C2955445',\n",
    "  'our_bi_cui_name': 'GEL',\n",
    "  'our_bi_cui_desc': '[CLS] GE ##L [unused3] ( Chemical , G ##RA ##M , G ##RA ##M ) [SEP]',\n",
    "  'our_cross_cui': 'C0045093',\n",
    "  'our_cross_cui_name': 'gemcitabine',\n",
    "  'our_cross_cui_desc': \"[CLS] g ##em ##ci ##ta ##bine [unused3] ( Chemical , product , substance : g ##em ##ci ##ta ##bine [ Chemical / In ##g ##red ##ient ] ; 2 ' , 2 ' - di ##f ##lu ##oro ##de ##ox ##y ##cy ##ti ##dine ; 4 - amino - 1 - ( ( 2 ##R , 4 ##R , 5 ##R ) - 3 , 3 - Di ##f ##lu ##oro - 4 - h ##ydro ##xy - 5 - ( h ##ydro ##xy ##met ##hyl ) - te ##tra ##hy ##dr ##of ##ura ##n - 2 - y ##l ) p ##yr ##im ##id ##in - 2 ( 1 ##H ) - one ; 2 ' , 2 ' - Di ##f ##lu ##oro ##de ##ox [SEP]\"},\n",
    " {'mention_id': '27500205.28',\n",
    "  'test_set_idx': 8460,\n",
    "  'type': 'T103',\n",
    "  'name': 'kindlins',\n",
    "  'context': '[CLS] transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of kind ##lins . Great interest in the kind ##lins has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in [unused1] kind ##lins [unused2] , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate the capacity of in ##te ##g ##rin ##s to media ##te their functions . Kind ##lins are adapt ##or proteins ; their function em ##ana ##te from their interaction with binding partners , including the c ##yt ##op ##las ##mic tails of [SEP]',\n",
    "  'existing_cui': 'C1720776',\n",
    "  'existing_cui_name': 'Kindling , Neurologic',\n",
    "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
    "  'our_bi_cui': 'C0010422',\n",
    "  'our_bi_cui_name': 'Crystallins',\n",
    "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27545500.27',\n",
    "  'test_set_idx': 10003,\n",
    "  'type': 'T103',\n",
    "  'name': '16-aldehyde tanshinone I',\n",
    "  'context': '[CLS] I and amino ##gly ##cos ##ide anti ##biotics or β - la ##ct ##am anti ##biotics in v ##it ##ro was identified . Moreover , 16 - al ##de ##hy ##de tan ##shin ##one I was documented to au ##gment clearance of s ##tre ##pt ##omy ##cin and am ##pic ##ill ##in against S . au ##reus in a m ##uri ##ne infection model . Primary me ##chan ##istic insight indicated that [unused1] 16 - al ##de ##hy ##de tan ##shin ##one I [unused2] could damage the bacterial cell membrane , leading to accumulation of anti ##biotics inside bacterial cells . This finding might be useful for treating infections caused by S . au ##reus and expand the scope of application of tan ##shin ##ones . [SEP]',\n",
    "  'existing_cui': 'C0075810',\n",
    "  'existing_cui_name': 'tanshinone',\n",
    "  'existing_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
    "  'our_bi_cui': 'C0075810',\n",
    "  'our_bi_cui_name': 'tanshinone',\n",
    "  'our_bi_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28168514.17',\n",
    "  'test_set_idx': 27532,\n",
    "  'type': 'T058',\n",
    "  'name': 'sequential',\n",
    "  'context': '[CLS] sixty - eight consecutive patients ( age : 67 ± 10 years ; B ##MI : 27 ± 5 kg / m ² ; 61 % male ) undergoing clinical ##ly indicated CT an ##gio ##graphy with dual - source CT were included in the retrospective single - center analysis . A contrast - enhanced volume data ##set was acquired in [unused1] se ##quential [unused2] ( SS ##M ) ( n = 151 ) or he ##lica ##l scan mode ( n = 117 ) . Co ##rona ##ry segments were classified in diagnostic or non - diagnostic image quality . A subset underwent invasive an ##gio ##graphy to determine the diagnostic accuracy of CT an ##gio ##graphy . SS ##M ( 96 . 8 ± [SEP]',\n",
    "  'existing_cui': 'C1337600',\n",
    "  'existing_cui_name': 'TABLET , SEQUENTIAL',\n",
    "  'existing_cui_desc': '[CLS] T ##AB ##LE ##T , SE ##Q ##UE ##NT ##IA ##L [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0202607',\n",
    "  'our_bi_cui_name': 'Serialography , single plane',\n",
    "  'our_bi_cui_desc': '[CLS] Ser ##ial ##ography , single plane [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
    "  'our_cross_cui': 'C0441633',\n",
    "  'our_cross_cui_name': 'Scanning',\n",
    "  'our_cross_cui_desc': '[CLS] Sc ##ann ##ing [unused3] ( Health Care Act ##ivity , procedure : scan ##s ; scanned ; scan ; scanning ; Sc ##ans ; diagnostic scanning ; diagnostic scan ; Sc ##an ) [SEP]'},\n",
    " {'mention_id': '28127340.1',\n",
    "  'test_set_idx': 26227,\n",
    "  'type': 'T033',\n",
    "  'name': 'Non - zoonotic',\n",
    "  'context': '[CLS] Zoo ##not ##ic and [unused1] Non - zoo ##not ##ic [unused2] Para ##site ##s of Wild Rod ##ents in Tu ##rk ##man Sa ##hra , Northeastern Iran This study was conducted to collect inform ##ative data on the para ##sitic infection of wild rode ##nts , emphasizing on finding parasite ##s , which have medical importance to human . During 2012 - 2014 , a total number of 91 wild rode ##nts were captured from rural areas of Tu ##rk ##men Sa ##hra , Go ##les ##tan Province , using hand ##made traps . Animals were an ##est ##he ##tized , surveyed for any e ##ct ##op ##ara ##site and then their car ##cas ##ses were carefully di ##sse ##cted for examination of end ##op ##ars [SEP]',\n",
    "  'existing_cui': 'C0043528',\n",
    "  'existing_cui_name': 'Zoonoses',\n",
    "  'existing_cui_desc': '[CLS] Zoo ##nose ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder , navigation ##al concept : Zoo ##nosis ; Zoo ##not ##ic In ##fect ##ious Disease ; Zoo ##not ##ic infection ; Disease , Zoo ##not ##ic In ##fect ##ious ; Zoo ##nose ##s [ Disease / Finding ] ; Zoo ##not ##ic Disease ##s ; infections zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ion ; Zoo ##not ##ic Disease ; In ##fect ##ious Disease , Zoo ##not ##ic ; In ##fect ##ions , Zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ious Disease ##s ; Disease , Zoo ##not ##ic ; Disease ##s , Zoo ##not ##ic In ##fect ##ious ; zoo ##nose ; zoo ##not ##ic infection ; In [SEP]',\n",
    "  'our_bi_cui': 'C0043528',\n",
    "  'our_bi_cui_name': 'Zoonoses',\n",
    "  'our_bi_cui_desc': '[CLS] Zoo ##nose ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder , navigation ##al concept : Zoo ##nosis ; Zoo ##not ##ic In ##fect ##ious Disease ; Zoo ##not ##ic infection ; Disease , Zoo ##not ##ic In ##fect ##ious ; Zoo ##nose ##s [ Disease / Finding ] ; Zoo ##not ##ic Disease ##s ; infections zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ion ; Zoo ##not ##ic Disease ; In ##fect ##ious Disease , Zoo ##not ##ic ; In ##fect ##ions , Zoo ##not ##ic ; Zoo ##not ##ic In ##fect ##ious Disease ##s ; Disease , Zoo ##not ##ic ; Disease ##s , Zoo ##not ##ic In ##fect ##ious ; zoo ##nose ; zoo ##not ##ic infection ; In [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27301681.4',\n",
    "  'test_set_idx': 1904,\n",
    "  'type': 'T103',\n",
    "  'name': 'N-methylpyrrole ( Py ) - N-methylimidazole ( Im ) polyamides',\n",
    "  'context': '[CLS] p ##yr ##rol ##e - im ##ida ##zo ##le p ##oly ##ami ##des containing an 8 - amino - 3 , 6 - di ##ox ##ao ##ct ##ano ##ic acid unit With the aim of improving a ##que ##ous so ##lub ##ility , we designed and synthesized five [unused1] N - met ##hyl ##py ##rro ##le ( P ##y ) - N - met ##hyl ##im ##ida ##zo ##le ( I ##m ) p ##oly ##ami ##des [unused2] capable of recognizing 9 - b ##p sequences . Their DNA - binding a ##ffin ##ities and sequence specific ##ities were evaluated by SP ##R and Bin ##d - n - Se ##q analyses . The design of p ##oly ##ami ##de 1 was based on a conventional [SEP]',\n",
    "  'existing_cui': 'C0764095',\n",
    "  'existing_cui_name': 'N-methylimidazole-N-methylimidazole-N-methylpyrrole-aminobutyric acid - N-methylpyrrole-N-methylpyrrole-N-methylpyrrole-alanine-dimethylaminopropylamide',\n",
    "  'existing_cui_desc': '[CLS] N - met ##hyl ##im ##ida ##zo ##le - N - met ##hyl ##im ##ida ##zo ##le - N - met ##hyl ##py ##rro ##le - amino ##but ##yric acid - N - met ##hyl ##py ##rro ##le - N - met ##hyl ##py ##rro ##le - N - met ##hyl ##py ##rro ##le - al ##ani ##ne - dim ##eth ##yla ##min ##op ##rop ##yla ##mi ##de [unused3] ( Chemical : 2 ##I ##m - P ##y - ABA - 3 ##P ##y - Al ##a - D ##p ; I ##m ##I ##m ##P ##y - gamma - amino ##but ##yric acid - P ##y ##P ##y ##P ##y - beta - al ##ani ##ne - D ##p ) [SEP]',\n",
    "  'our_bi_cui': 'C1254351',\n",
    "  'our_bi_cui_name': 'Pharmacologic Substance',\n",
    "  'our_bi_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]',\n",
    "  'our_cross_cui': 'C0029224',\n",
    "  'our_cross_cui_name': 'Organic Chemicals',\n",
    "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
    " {'mention_id': '27659602.46',\n",
    "  'test_set_idx': 13391,\n",
    "  'type': 'T082',\n",
    "  'name': 'secondary root',\n",
    "  'context': '[CLS] more are at risk for re ##oper ##ation , and not until at least after 10 . 4 years have passed . Neither the valve morphology ( p = 0 . 62 ) nor con ##com ##ita ##nt a ##ort ##ic valve replacement ( p = 0 . 86 ) influenced rate of root di ##lation . In non ##sy ##nd ##rom ##ic patients , the a ##ort ##ic root is the slow ##est growing portion of the th ##ora ##ci ##c a ##ort ##a . Leaving the native root , as in root - spa ##ring ascending a ##ort ##ic replacement , is a safe approach regarding [unused1] secondary root [unused2] intervention for a ##ort ##ic root diameter ##s of 45 mm or less . [SEP]',\n",
    "  'existing_cui': 'C0027627',\n",
    "  'existing_cui_name': 'Neoplasm Metastasis',\n",
    "  'existing_cui_desc': '[CLS] Neo ##p ##las ##m Met ##ast ##asis [unused3] ( B ##iol ##og ##ic Fun ##ction , tumor : Tu ##mor Cell Mi ##gration ; meta ##sta ##si ##zed ; cancer ##s secondary ; NE ##OP ##L ME ##TA ##ST ##AS ##ES ; secondary ; meta ##static t ##umour ; meta ##static tumors ; meta ##static cancer ; meta ##static disease ; secondary cancer ; meta ##static tumor ; Met ##ast ##asis ; secondary tumors ; Neo ##p ##las ##m Met ##ast ##ases ; Neo ##p ##las ##m Met ##ast ##asis [ Disease / Finding ] ; t ##umour meta ##sta ##sis ; spreading of cancer ; tumor meta ##sta ##sis ; meta ##sta ##ses ; meta ##sta ##sis ; meta ##static t ##umour ##s ; secondary [SEP]',\n",
    "  'our_bi_cui': 'C0447373',\n",
    "  'our_bi_cui_name': 'Distal tooth root',\n",
    "  'our_bi_cui_desc': '[CLS] Di ##stal tooth root [unused3] ( Ana ##tom ##ical Structure , Den ##tis , body structure : Di ##stal root of tooth ; Di ##stal root ; Ra ##di ##x di ##stal ##is ) [SEP]',\n",
    "  'our_cross_cui': 'C0549113',\n",
    "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
    "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
    " {'mention_id': '27790175.20',\n",
    "  'test_set_idx': 16824,\n",
    "  'type': 'T038',\n",
    "  'name': 'production',\n",
    "  'context': '[CLS] sessions with two discrete toy sets were double - coded by blinded code ##rs ( code ##r assignment counter ##bal ##ance ##d ) . Key face ##ts of pre ##tens ##e development [ at ##tribution of pretend properties ( at ##tribution of pretend properties ) , object substitution , imaginary objects ] were examined . These face ##ts of pretend play [unused1] production [unused2] were then analyzed in relation to autism spectrum disorder symptoms , as well as plausible , long - the ##ori ##zed co ##rrel ##ates [ theory of mind ( theory of mind ) , verbal ability , familiar ##ity , and interest in specific toys ] . Forty children ( Ma ##ge = 6 ; 5 , SD ##age = 1 . [SEP]',\n",
    "  'existing_cui': 'C1548180',\n",
    "  'existing_cui_name': 'Production Processing ID',\n",
    "  'existing_cui_desc': '[CLS] Production Process ##ing ID [unused3] ( Intel ##lect ##ual Product : Production ) [SEP]',\n",
    "  'our_bi_cui': 'C0220781',\n",
    "  'our_bi_cui_name': 'Anabolism',\n",
    "  'our_bi_cui_desc': '[CLS] Ana ##bol ##ism [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : bio ##sy ##nt ##hetic process ; Ana ##bol ##ism , function ; synthesis ; bio ##sy ##nt ##hesis ; formation ; B ##ios ##ynth ##etic ; B ##ios ##ynth ##esis ; B ##io ##genesis ; B ##ios ##ynth ##etic Process ; an ##ab ##olis ##m ) [SEP]',\n",
    "  'our_cross_cui': 'C0025361',\n",
    "  'our_cross_cui_name': 'Mental Processes',\n",
    "  'our_cross_cui_desc': '[CLS] Mental Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction , Human , function , o ##bs ##er ##vable entity : Human Information Process ##ing ; Thought process ; cognitive processing ; processes thought ; processing thought ; Information Process ##ing , Human ; Human information processing ; Information Process ##es ; mental processing ; cognitive process ; Form of thinking , function ; mental processes ; Form of thought ; Form of thinking ; Human Information Process ##es ; Mental Process ; mental process ; thought process ) [SEP]'},\n",
    " {'mention_id': '28473083.52',\n",
    "  'test_set_idx': 37275,\n",
    "  'type': 'T170',\n",
    "  'name': 'Grading of Recommendations Assessment , Development , and Evaluation',\n",
    "  'context': '[CLS] C ##rite ##ria are evidence - based guidelines for specific clinical conditions that are reviewed annually by a multi ##disciplinary expert panel . The guide ##line development and revision include an extensive analysis of current medical literature from peer - reviewed journals and the application of well - established method ##ologies ( RA ##ND / UCLA A ##pp ##rop ##ria ##ten ##ess Method and [unused1] G ##rading of Re ##com ##men ##dation ##s Assessment , Development , and Evaluation [unused2] or G ##RA ##DE ) to rate the appropriate ##ness of imaging and treatment procedures for specific clinical scenarios . In those instances where evidence is lacking or e ##qui ##voc ##al , expert opinion may supplement the available evidence to recommend imaging or treatment . [SEP]',\n",
    "  'existing_cui': 'C1444325',\n",
    "  'existing_cui_name': 'Physical evaluation assessment',\n",
    "  'existing_cui_desc': '[CLS] Physical evaluation assessment [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : As ##ses ##s clinical measurements ; As ##ses ##s physical measurements ) [SEP]',\n",
    "  'our_bi_cui': 'C0220825',\n",
    "  'our_bi_cui_name': 'Evaluation',\n",
    "  'our_bi_cui_desc': '[CLS] Evaluation [unused3] ( Health Care Act ##ivity , qualifier value : Assessment - action ; Investigation ; Eva ##lu ##ated ; Evaluation ##s ; evaluation ##s ; evaluation ; Assessment ; Evaluation Pro ##ced ##ure ; Eva ##lu ##ate ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27442214.17',\n",
    "  'test_set_idx': 5721,\n",
    "  'type': 'T058',\n",
    "  'name': 'abdominal',\n",
    "  'context': '[CLS] of sex comparisons under ##sco ##re the need for a more comprehensive characterization of the secondary o ##ssi ##fication centers . This study evaluate ##s the ch ##ronology and sex differences for appearance and closure of p ##el ##vic and pro ##ximal f ##em ##oral secondary o ##ssi ##fication centers using com ##puted to ##mo ##graphy . Pat ##ients who underwent [unused1] abdominal [unused2] and p ##el ##vic com ##puted to ##mo ##graphy scan ##s between January 2009 and December 2014 at 2 tertiary level 1 trauma centers were retrospective ##ly reviewed . Pat ##ients between the ages of 2 and 32 years with adequate imaging of the p ##el ##vis and pro ##ximal f ##em ##urs were included . Pat ##ients with a history of [SEP]',\n",
    "  'existing_cui': 'C0000726',\n",
    "  'existing_cui_name': 'Abdomen',\n",
    "  'existing_cui_desc': '[CLS] Abd ##ome ##n [unused3] ( Spa ##tial Concept , body structure , qualifier value , volume : a ##b ##dom ##ino ##pel ##vic region ; Abd ##omi ##no ##pel ##vis ; Abd ##omi ##no ##pel ##vic region ; a ##b ##d ; Abd ##omi ##nal structure ; AB ##D ##OM ##EN ; a ##b ##dom ##ino ##pel ##vic regions ; abdominal ; Abd ##omi ##nal ; Abd ##ome ##ns ; abdomen ) [SEP]',\n",
    "  'our_bi_cui': 'C0000726',\n",
    "  'our_bi_cui_name': 'Abdomen',\n",
    "  'our_bi_cui_desc': '[CLS] Abd ##ome ##n [unused3] ( Spa ##tial Concept , body structure , qualifier value , volume : a ##b ##dom ##ino ##pel ##vic region ; Abd ##omi ##no ##pel ##vis ; Abd ##omi ##no ##pel ##vic region ; a ##b ##d ; Abd ##omi ##nal structure ; AB ##D ##OM ##EN ; a ##b ##dom ##ino ##pel ##vic regions ; abdominal ; Abd ##omi ##nal ; Abd ##ome ##ns ; abdomen ) [SEP]',\n",
    "  'our_cross_cui': 'C0412620',\n",
    "  'our_cross_cui_name': 'CT of abdomen',\n",
    "  'our_cross_cui_desc': '[CLS] CT of abdomen [unused3] ( Health Care Act ##ivity , procedure : abdomen c ##t ; abdomen c ##t scanning ; CT scan of abdomen ; com ##puted to ##mo ##graphy of abdomen ; c ##t scan abdomen ; Computer ##ized to ##mo ##graphy of abdomen ; CT scan abdomen ; c ##t abdomen scan ; C . A . T . scan of abdomen ; cat scan abdomen ; abdomen c ##t scan ##s ; CT scan ; abdomen ; Co ##mp ##uted to ##mo ##graphy , abdomen ; CT scan of the abdomen ; CT scan - abdominal ; abdomen c ##t scan ; Abd ##ome ##n CT ; c ##t of abdomen ; Co ##mp ##uted to ##mo ##graphy of abdominal organs ; [SEP]'},\n",
    " {'mention_id': '28454015.27',\n",
    "  'test_set_idx': 36528,\n",
    "  'type': 'T033',\n",
    "  'name': 'unhealthy',\n",
    "  'context': '[CLS] , highlighting that the general public may need strict ##er health protection measures . The population - weighted two - year average health - risk based air quality index data further demonstrates that all population in the studied cities in He ##nan province live with poll ##uted air - 72 % of the population is exposed to air that is [unused1] un ##hea ##lt ##hy [unused2] for sensitive people , while 28 % of people is exposed to air that can be harmful to healthy people ; and the health risks are much greater during winter than during other seasons . Future works should further improve the health - risk based air quality index algorithm , and valid ##ate the links between the clinical / e [SEP]',\n",
    "  'existing_cui': 'C0423755',\n",
    "  'existing_cui_name': 'Unhealthy skin',\n",
    "  'existing_cui_desc': '[CLS] Un ##hea ##lt ##hy skin [unused3] ( Finding , finding ) [SEP]',\n",
    "  'our_bi_cui': 'C0205161',\n",
    "  'our_bi_cui_name': 'Abnormal',\n",
    "  'our_bi_cui_desc': '[CLS] A ##b ##nor ##mal [unused3] ( Finding , qualifier value : abnormal ; A ##b ##nor ##mal ( m ##od ##ifier ) ; A ##b ##nor ##mal ( m ##od ##ifier ) [ Am ##bi ##guous ] ; AB ##N ##OR ##MA ##L ; de ##vian ##t ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27317610.39',\n",
    "  'test_set_idx': 2203,\n",
    "  'type': 'T038',\n",
    "  'name': 'activated',\n",
    "  'context': '[CLS] synthetic g ##lu ##co ##cor ##tic ##oid commonly used to test h ##y ##pot ##hala ##mic - pit ##uit ##ary end ##oc ##rine axis regulation . Test ##osterone was evaluated at rest . Further , we assessed changes in injury - induced ne ##uron morphology ( Go ##l ##gi stain ) , ne ##uro ##path ##ology ( silver stain ) and [unused1] activated [unused2] as ##tro ##cy ##tes ( G ##FA ##P ) in the para ##vent ##ric ##ular nucleus of the h ##y ##pot ##hala ##mus . Rest ##ing plasma co ##rt ##ico ##ster ##one levels were decreased at 2 months post ##in ##ju ##ry and there was a blunt ##ed co ##rt ##ico ##ster ##one increase in response to restraint induced stress . No [SEP]',\n",
    "  'existing_cui': 'C1149591',\n",
    "  'existing_cui_name': 'protein C ( activated ) activity',\n",
    "  'existing_cui_desc': '[CLS] protein C ( activated ) activity [unused3] ( B ##iol ##og ##ic Fun ##ction : auto ##p ##roth ##rom ##bin II ##A activity ; G ##SA ##PC ; activated protein C ; activated blood co ##agu ##lation factor XIV activity ; obsolete protein C ( activated ) activity ) [SEP]',\n",
    "  'our_bi_cui': 'C1326121',\n",
    "  'our_bi_cui_name': 'astrocyte activation',\n",
    "  'our_bi_cui_desc': '[CLS] as ##tro ##cy ##te activation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_cross_cui': 'C1326120',\n",
    "  'our_cross_cui_name': 'cell activation',\n",
    "  'our_cross_cui_desc': '[CLS] cell activation [unused3] ( B ##iol ##og ##ic Fun ##ction : activation cells ) [SEP]'},\n",
    " {'mention_id': '27722881.42',\n",
    "  'test_set_idx': 15029,\n",
    "  'type': 'T007',\n",
    "  'name': 'JPM1',\n",
    "  'context': '[CLS] site of di ##ox ##y ##gen ##ase was simulated and analyzed by molecular dock ##ing . Consequently , a feasible de ##grading pathway of flu ##oran ##the ##ne in the strain JP ##M ##1 was proposed based on the meta ##bol ##ites and the interaction analyses . Additionally , the the ##rm ##ody ##nam ##ic analysis showed that the strain [unused1] JP ##M ##1 [unused2] had high tolerance for flu ##oran ##the ##ne , and the influence of flu ##oran ##the ##ne for the bacterial growth activity was ne ##gli ##gible under 100 to 400 mg L ( - 1 ) concentrations . Take ##n together , this study indicates that the strain JP ##M ##1 has high potential for further study in bio ##rem ##edia [SEP]',\n",
    "  'existing_cui': 'C1421124',\n",
    "  'existing_cui_name': 'TRGJP gene',\n",
    "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
    "  'our_bi_cui': 'C3629619',\n",
    "  'our_bi_cui_name': 'bacterium JP1',\n",
    "  'our_bi_cui_desc': '[CLS] bacterium JP ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
    "  'our_cross_cui': 'C4153571',\n",
    "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
    " {'mention_id': '27580517.4',\n",
    "  'test_set_idx': 10614,\n",
    "  'type': 'T058',\n",
    "  'name': '3D spiral ASL magnetic resonance imaging',\n",
    "  'context': '[CLS] Assessment of cerebral blood per ##fusion reserve with ace ##ta ##zo ##lam ##ide using [unused1] 3D spiral AS ##L magnetic resonance imaging [unused2] : Preliminary experience in p ##ediatric patients To demonstrate the clinical f ##eas ##ibility of a new non - Car ##tes ##ian cylindrical ##ly - distributed spiral 3D pseudo - continuous art ##erial spin label ##ing magnetic resonance imaging pulse sequence in p ##ediatric patients in q ##uant ##ifying cerebral blood flow response to an ace ##ta ##zo ##lam ##ide v ##as ##od ##ila ##tor challenge . magnetic resonance imaging exams were performed on two 3 Te ##sla Philips In ##gen ##ia systems using 32 channel head coil array ##s . After local institutional review board approval , the 3D spiral - based [SEP]',\n",
    "  'existing_cui': 'C0024485',\n",
    "  'existing_cui_name': 'Magnetic Resonance Imaging',\n",
    "  'existing_cui_desc': '[CLS] Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity , MR ##I , procedure , qualifier value : MR - Ma ##gnetic resonance ; MR TO ##MO ##GR ; Ma ##gnetic resonance technique ; magnetic resonance imaging ; N ##MR I ##maging ; Ma ##gnetic resonance imaging procedure ; St ##ead ##y - State Free Pre ##cession MR ##I ; Ma ##gnetic resonance : [ imaging ] or [ study ] ; imaging magnetic nuclear resonance ; Tom ##ography , MR ; MR ##I Sc ##an ; N ##MR - Nuclear magnetic resonance ; Z ##E ##U ##GM ##AT ##O ##GR ; TO ##MO ##GR MR ; N ##MR TO ##MO ##GR ; Nuclear magnetic resonance ; Medical I ##maging , Ma [SEP]',\n",
    "  'our_bi_cui': 'C0860888',\n",
    "  'our_bi_cui_name': 'Tomography , Spiral Computed',\n",
    "  'our_bi_cui_desc': '[CLS] Tom ##ography , S ##pi ##ral Co ##mp ##uted [unused3] ( Health Care Act ##ivity , procedure : S ##pi ##ral com ##puted to ##mo ##graphy scan ; S ##pi ##ral CT ; CT ##s , S ##pi ##ral ; com ##puted to ##mo ##graphy spiral ; Sc ##ans , S ##pi ##ral CT ; He ##lica ##l CT ##s ; He ##lica ##l CT ; S ##pi ##ral CA ##T Sc ##ans ; he ##lica ##l com ##puted to ##mo ##graphy ; c ##t spiral ; S ##pi ##ral Volume ##tric CT ; S ##pi ##ral Computer ##ized Tom ##ography ; Computer - As ##sist ##ed Tom ##ography , S ##pi ##ral ; Volume ##tric CT ; He ##lica ##l Co ##mp ##uted Tom ##ography [SEP]',\n",
    "  'our_cross_cui': 'C3891302',\n",
    "  'our_cross_cui_name': 'Arterial Spin Labeling Magnetic Resonance Imaging',\n",
    "  'our_cross_cui_desc': '[CLS] Arte ##rial Spin Label ##ing Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity : AS ##L f ##MR ##I ; Arte ##rial Spin Label ##ing MR ##I ; AR ##TE ##RI ##AL SP ##IN LA ##BE ##L ##ING F ##UN ##CT ##ION ##AL MR ##I ) [SEP]'},\n",
    " {'mention_id': '28523846.34',\n",
    "  'test_set_idx': 38554,\n",
    "  'type': 'T103',\n",
    "  'name': 'proteoforms',\n",
    "  'context': '[CLS] using E ##SI - I ##MS - MS coupled with SEC - mode HP ##LC . MA ##LD ##I - IS ##D data , charge state distribution values determined using E ##SI - MS , and the collision cross - section ##al areas acquired using E ##SI - I ##MS - MS revealed the relationship between the folded and unfolded [unused1] pro ##te ##of ##orms [unused2] of forced - reduced me ##case ##rm ##in and aerial ##ly o ##xi ##dized me ##case ##rm ##in with the free - SH : protein ratio of me ##case ##rm ##in drug product . The collision cross - section ##al area , which is determined using E ##SI - I ##MS - MS , provided pro ##te ##of ##orm information [SEP]',\n",
    "  'existing_cui': 'C3496296',\n",
    "  'existing_cui_name': 'area proA of Pandya',\n",
    "  'existing_cui_desc': '[CLS] area pro ##A of Pan ##dy ##a [unused3] ( Spa ##tial Concept : pro ##kon ##io ##cor ##te ##x ; area pro ##A of Pan ##dy ##a - 1973 ) [SEP]',\n",
    "  'our_bi_cui': 'C0597298',\n",
    "  'our_bi_cui_name': 'Protein Isoforms',\n",
    "  'our_bi_cui_desc': '[CLS] Pro ##tein Is ##of ##orms [unused3] ( Chemical : protein is ##of ##orm ; Pro ##tein Is ##of ##orms [ Chemical / In ##g ##red ##ient ] ; Is ##of ##orms , Pro ##tein ; Is ##of ##orms ; is ##of ##orms ; is ##of ##orm ; Is ##of ##orm ) [SEP]',\n",
    "  'our_cross_cui': 'C1510464',\n",
    "  'our_cross_cui_name': 'Protein Structure',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein Structure [unused3] ( Chemical : protein structure ) [SEP]'},\n",
    " {'mention_id': '27975020.12',\n",
    "  'test_set_idx': 22698,\n",
    "  'type': 'T022',\n",
    "  'name': 'skin island',\n",
    "  'context': '[CLS] Di ##vide ##d and S ##lid ##ing Super ##fic ##ial Te ##mpo ##ral Arte ##ry F ##lap for Primary Don ##or - site C ##losure Super ##fic ##ial temporal artery flap ##s are often used for reconstruction of hair - bearing areas . However , primary closure of the donor site is not easy when the size of the necessary [unused1] skin island [unused2] is relatively large . In such cases , skin g ##raft ##s are needed at the donor site , resulting in bald ##ness . We have solved this issue by applying the divided and sliding flap technique , which was first reported for primary donor - site closure of a la ##tis ##si ##mus do ##rs ##i m ##us ##cu ##loc ##uta [SEP]',\n",
    "  'existing_cui': 'C0454985',\n",
    "  'existing_cui_name': 'Baffin island',\n",
    "  'existing_cui_desc': '[CLS] Ba ##ffin island [unused3] ( Spa ##tial Concept , geographic location ) [SEP]',\n",
    "  'our_bi_cui': 'C0038925',\n",
    "  'our_bi_cui_name': 'Surgical Flaps',\n",
    "  'our_bi_cui_desc': '[CLS] Sur ##gical F ##lap ##s [unused3] ( Ana ##tom ##ical Structure , attribute , qualifier value , substance : flap ; F ##lap Graf ##t ; flap created in surgery ; flap ##s ; F ##lap , Sur ##gical ; Sur ##gical F ##lap ; Re ##con ##st ##ru ##ctive F ##lap ; FL ##AP ##S S ##UR ##G ; [ Q ] F ##lap ; F ##lap ; F ##lap Trans ##p ##lant ; F ##lap ##s ; FL ##AP S ##UR ##G ; F ##lap ##s , Sur ##gical ; S ##UR ##G FL ##AP ; S ##UR ##G FL ##AP ##S ; surgical flap ) [SEP]',\n",
    "  'our_cross_cui': 'C1123023',\n",
    "  'our_cross_cui_name': 'Skin',\n",
    "  'our_cross_cui_desc': '[CLS] Skin [unused3] ( Body System , Anatomy , body structure : in ##te ##gum ##ental system ; in ##te ##gum ##ent ; skin system ; Skin of body ; skin structure ; skins ; In ##te ##gum ##ental system ; In ##te ##gum ##ent ; Pie ##l ; skinned ; Skin structure ; Cut ##is ; SK ##IN ; skin ) [SEP]'},\n",
    " {'mention_id': '28294559.30',\n",
    "  'test_set_idx': 31486,\n",
    "  'type': 'T038',\n",
    "  'name': 'deleted',\n",
    "  'context': '[CLS] type le ##ct ##in receptor ( C - type le ##ct ##in receptor ) - 2 in liver regeneration following partial liver re ##section in mice . Materials and methods I ##rra ##dia ##ted ch ##ime ##ric mice transplant ##ed with f ##etal liver cells from wild - type mice , C - type le ##ct ##in receptor - 2 - [unused1] deleted [unused2] ( K ##O ) mice or mice with C - type le ##ct ##in receptor - 2 deleted specifically from plate ##lets ( fl ##KO ) were generated . Mi ##ce underwent 70 % partial he ##pate ##ct ##omy . I ##mm ##uno ##his ##to ##chemical stain ##ing was performed to investigate the expression of the end ##ogen ##ous l ##igan ##d [SEP]',\n",
    "  'existing_cui': 'C1333210',\n",
    "  'existing_cui_name': 'INTS6 gene',\n",
    "  'existing_cui_desc': '[CLS] IN ##TS ##6 gene [unused3] ( Ana ##tom ##ical Structure : DB ##I - 1 ; IN ##TS ##6 Gene ; DE ##AD / H B ##OX 26 ; IN ##T ##6 ; DD ##X ##26 ##A ; Not ##ch ##l ##2 ; In ##te ##gra ##tor Complex Sub ##uni ##t 6 Gene ; HD ##B ; IN ##TE ##GR ##AT ##OR CO ##MP ##LE ##X S ##U ##B ##UN ##IT 6 ; DE ##LE ##TE ##D IN CA ##NC ##ER 1 ; in ##te ##gra ##tor complex subunit 6 ) [SEP]',\n",
    "  'our_bi_cui': 'C1522225',\n",
    "  'our_bi_cui_name': 'Knock-out',\n",
    "  'our_bi_cui_desc': '[CLS] K ##nock - out [unused3] ( B ##iol ##og ##ic Fun ##ction : K ##nock ##out ) [SEP]',\n",
    "  'our_cross_cui': 'C0017260',\n",
    "  'our_cross_cui_name': 'Gene Deletion',\n",
    "  'our_cross_cui_desc': '[CLS] Gene Del ##eti ##on [unused3] ( B ##iol ##og ##ic Fun ##ction , attribute : M ##OL ##PA ##TH . DE ##L ; gene del ##eti ##on ; gene del ##eti ##ons ; Del ##eti ##ons , Gene ; Gene Del ##eti ##ons ; gene del ##eti ##on mutation ; Gene del ##eti ##on ; Del ##eti ##on , Gene ) [SEP]'},\n",
    " {'mention_id': '27342978.18',\n",
    "  'test_set_idx': 2987,\n",
    "  'type': 'T017',\n",
    "  'name': 'microsatellite loci',\n",
    "  'context': '[CLS] , and its two recognised host - plant species ( Pi ##nus s ##yl ##ves ##tri ##s and P . ni ##gra ) in order to seek for any con ##cor ##dance useful to di ##sent ##ang ##le the evolutionary history of this iconic le ##pid ##op ##tera ##n . DNA variation in one mitochondrial marker and nine nuclear [unused1] micro ##sat ##elli ##te lo ##ci [unused2] revealed a strong p ##hyl ##og ##eo ##graphic pattern across 28 populations of G . is ##abe ##lla ##e studied in Spain and France comprising six groups mostly distributed along different mountain ranges . Re ##ana ##lysis of a previously published ch ##lor ##op ##last micro ##sat ##elli ##te data ##set revealed a three and two - group structure [SEP]',\n",
    "  'existing_cui': 'C1519302',\n",
    "  'existing_cui_name': 'Short Tandem Repeat',\n",
    "  'existing_cui_desc': '[CLS] Short Tan ##de ##m Rep ##eat [unused3] ( Chemical : Tan ##de ##m Rep ##eat ##s , Short ; Rep ##eat ##s , Micro ##sat ##elli ##te ; Rep ##eti ##tive Se ##quence , Simple ; Simple Rep ##eti ##tive Se ##quence ; Simple Rep ##eti ##tive Se ##quence ##s ; Simple Se ##quence Rep ##eat ; Micro ##sat ##elli ##te Rep ##eat ##s ; Rep ##eat ##s , Simple Se ##quence ; Rep ##eti ##tive Se ##quence ##s , Simple ; Micro ##sat ##elli ##te Rep ##eat ; Rep ##eat , Simple Se ##quence ; Se ##quence ##s , Simple Rep ##eti ##tive ; Se ##quence Rep ##eat , Simple ; Short Tan ##de ##m Rep ##eat ##s ; Rep ##eat ##s , Short Tan [SEP]',\n",
    "  'our_bi_cui': 'C1519302',\n",
    "  'our_bi_cui_name': 'Short Tandem Repeat',\n",
    "  'our_bi_cui_desc': '[CLS] Short Tan ##de ##m Rep ##eat [unused3] ( Chemical : Tan ##de ##m Rep ##eat ##s , Short ; Rep ##eat ##s , Micro ##sat ##elli ##te ; Rep ##eti ##tive Se ##quence , Simple ; Simple Rep ##eti ##tive Se ##quence ; Simple Rep ##eti ##tive Se ##quence ##s ; Simple Se ##quence Rep ##eat ; Micro ##sat ##elli ##te Rep ##eat ##s ; Rep ##eat ##s , Simple Se ##quence ; Rep ##eti ##tive Se ##quence ##s , Simple ; Micro ##sat ##elli ##te Rep ##eat ; Rep ##eat , Simple Se ##quence ; Se ##quence ##s , Simple Rep ##eti ##tive ; Se ##quence Rep ##eat , Simple ; Short Tan ##de ##m Rep ##eat ##s ; Rep ##eat ##s , Short Tan [SEP]',\n",
    "  'our_cross_cui': 'C0678933',\n",
    "  'our_cross_cui_name': 'Genetic Loci',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##tic Lo ##ci [unused3] ( Ana ##tom ##ical Structure : Lo ##cus , Gene ##tic ; Gene ##tic Lo ##cus ; Lo ##ci , Gene ##tic ) [SEP]'},\n",
    " {'mention_id': '28389374.19',\n",
    "  'test_set_idx': 34021,\n",
    "  'type': 'T103',\n",
    "  'name': 'of BRCA1 associated protein1',\n",
    "  'context': '[CLS] ##al regulation , ch ##roma ##tin modification by de ##ubi ##qui ##tina ##ting his ##tone 2 ##A , and DNA repair . BR ##CA ##1 associated protein ##1 mutations are frequent in ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma . Our aim was to functional ##ly character ##ize a newly identified is ##of ##orm [unused1] of BR ##CA ##1 associated protein ##1 [unused2] and investigate the effects of its expression on drug sensitivity in ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma . Express ##ion of BR ##CA ##1 associated protein ##1 is ##of ##orms was detected by quantitative polymer ##ase chain reaction in ma ##li ##gnant p ##le ##ural me ##so ##the ##lio ##ma and normal me ##so [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0259275',\n",
    "  'our_bi_cui_name': 'BRCA1 Protein',\n",
    "  'our_bi_cui_desc': '[CLS] BR ##CA ##1 Pro ##tein [unused3] ( Chemical , substance : Ring Fin ##ger Pro ##tein 53 ; BR ##CA ##1 Pro ##tein [ Chemical / In ##g ##red ##ient ] ; BR ##CA PR ##OT ##EI ##N 00 ##1 ; B ##rea ##st Cancer 1 Gene Product ; BR ##CA GE ##NE PR ##OD ##UC ##T 00 ##1 ; BR ##CA ##1 gene product ; BR ##CA ##1 Gene Product ; B ##rea ##st Cancer 1 Pro ##tein ; B ##rea ##st cancer type 1 su ##s ##ce ##pt ##ibility protein ; B ##rea ##st Cancer Type 1 Su ##s ##ce ##pt ##ibility Pro ##tein ) [SEP]',\n",
    "  'our_cross_cui': 'C1368335',\n",
    "  'our_cross_cui_name': 'BAP1 protein , human',\n",
    "  'our_cross_cui_desc': '[CLS] BA ##P ##1 protein , human [unused3] ( Chemical : BA ##P - 1 protein , human ; U ##bi ##qui ##tin Car ##box ##yl - Terminal H ##ydro ##lase BA ##P ##1 ; Ce ##re ##bra ##l Pro ##tein 6 ; BR ##CA ##1 associated protein - 1 ( u ##bi ##qui ##tin car ##box ##y - terminal h ##ydro ##lase ) , human ; EC 3 . 4 . 19 . 12 ; BR ##CA ##1 Associated Pro ##tein - 1 ; Ce ##re ##bra ##l Pro ##tein - 13 ; Ring ##2 protein , human ; BR ##CA ##1 - Associated Pro ##tein 1 ; Ce ##re ##bra ##l Pro ##tein - 6 ; BR ##CA ##1 associated protein - 1 , human [SEP]'},\n",
    " {'mention_id': '27760149.44',\n",
    "  'test_set_idx': 15831,\n",
    "  'type': 'T033',\n",
    "  'name': 'up - to - date',\n",
    "  'context': \"[CLS] problems , we introduce B ##ES ##T , a bio ##medical entity search tool . B ##ES ##T returns , as a result , a list of 10 different types of bio ##medical entities including genes , diseases , drugs , targets , transcription factors , mi ##RNA ##s , and mutations that are relevant to a user ' s que ##ry . To the best of our knowledge , B ##ES ##T is the only system that processes free text que ##ries and returns [unused1] up - to - date [unused2] results in real time including mutation information in the results . B ##ES ##T is freely accessible at http : / / best . k ##ore ##a . a ##c . k ##r . [SEP]\",\n",
    "  'existing_cui': 'C0474298',\n",
    "  'existing_cui_name': 'Up-to-date with immunizations',\n",
    "  'existing_cui_desc': '[CLS] Up - to - date with im ##mu ##ni ##zation ##s [unused3] ( Finding , finding , situation : Up - to - date with im ##mu ##nis ##ations ) [SEP]',\n",
    "  'our_bi_cui': 'C0547043',\n",
    "  'our_bi_cui_name': 'Up',\n",
    "  'our_bi_cui_desc': '[CLS] Up [unused3] ( Spa ##tial Concept , qualifier value : Up to ; Ad ; ad ; up ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27838742.87',\n",
    "  'test_set_idx': 19054,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . [unused1] Del ##ica ##f ##lav ##one [unused2] did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27887587.39',\n",
    "  'test_set_idx': 20927,\n",
    "  'type': 'T033',\n",
    "  'name': 'family',\n",
    "  'context': \"[CLS] at the Community Mental Health Centre in their work towards their recovery goals were el ##icit ##ed , as follows : developing an understanding of ones ##elf and one ' s mental health problems ; learning how to change feelings and behaviour ##s ; being ' pushed ' into social arena ##s ; finding helpful medication ; and counsel ##ling in [unused1] family [unused2] , practical and financial issues . The participants ' expectations about counsel ##ling with regard to longer - term family , practical , and financial challenges were insufficient ##ly met by the Community Mental Health Centre . In the experience of the service users , recovery occurred within the context of their everyday life with or without the support of their professional [SEP]\",\n",
    "  'existing_cui': 'C1301584',\n",
    "  'existing_cui_name': 'Last Name',\n",
    "  'existing_cui_desc': '[CLS] Last Name [unused3] ( Intel ##lect ##ual Product , o ##bs ##er ##vable entity : Family Name ; family ; Last name ; Sur ##name ) [SEP]',\n",
    "  'our_bi_cui': 'C0424960',\n",
    "  'our_bi_cui_name': 'Family problems',\n",
    "  'our_bi_cui_desc': '[CLS] Family problems [unused3] ( Finding , finding , history : problem ; family ; Problem ; family ; family problems ; family ; problem ; family problem ) [SEP]',\n",
    "  'our_cross_cui': 'C0851511',\n",
    "  'our_cross_cui_name': 'Family issues',\n",
    "  'our_cross_cui_desc': '[CLS] Family issues [unused3] ( Finding : family issues ; families issues ; Family Issues ; family issue ) [SEP]'},\n",
    " {'mention_id': '27506129.25',\n",
    "  'test_set_idx': 8657,\n",
    "  'type': 'T170',\n",
    "  'name': 'Correlation based feature selection',\n",
    "  'context': '[CLS] trained with individual features is below 0 . 1 for both scales . Multi - layer per ##ce ##pt ##ron obtain ##s the best values , but is less consistent than the random forest method . When all features are combined , the best results for both scales are achieved with Multi - layer per ##ce ##pt ##ron . [unused1] Co ##rrel ##ation based feature selection [unused2] and M ##5 provide the best results , mean square error = 0 . 108 and mean square error = 0 . 06 ##1 respectively . Finally , the class im ##bal ##ance problem is mini ##mise ##d with the SM ##OT ##E approach for both scales ( mean square error < 0 . 00 ##6 ) . Machine [SEP]',\n",
    "  'existing_cui': 'C0010101',\n",
    "  'existing_cui_name': 'Correlation Study',\n",
    "  'existing_cui_desc': '[CLS] Co ##rrel ##ation Study [unused3] ( Research Act ##ivity , Statistical : Study , Co ##rrel ##ation ; Studies , Co ##rrel ##ation ; Co ##rrel ##ation Studies ; Co ##rrel ##ation ; Statistical Co ##rrel ##ation ) [SEP]',\n",
    "  'our_bi_cui': 'C0010101',\n",
    "  'our_bi_cui_name': 'Correlation Study',\n",
    "  'our_bi_cui_desc': '[CLS] Co ##rrel ##ation Study [unused3] ( Research Act ##ivity , Statistical : Study , Co ##rrel ##ation ; Studies , Co ##rrel ##ation ; Co ##rrel ##ation Studies ; Co ##rrel ##ation ; Statistical Co ##rrel ##ation ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27779321.8',\n",
    "  'test_set_idx': 16416,\n",
    "  'type': 'T170',\n",
    "  'name': 'equilibrium partitioning approach',\n",
    "  'context': '[CLS] dose - response models for p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l - contaminated sediment using equilibrium partition ##ing The study goal was to develop a sediment p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l dose - response model based on bent ##hic in ##vert ##eb ##rate effects to PC ##B ##s . The authors used an [unused1] equilibrium partition ##ing approach [unused2] to generate predicted p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l sediment effect concentrations ( largely A ##ro ##c ##lor 125 ##4 ) associated with a gradient of toxic effects in bent ##hic organisms from effects observed in aquatic toxicity studies . The present study differs from all other equilibrium partition ##ing collective sediment investigations in that the authors [SEP]',\n",
    "  'existing_cui': 'C0014653',\n",
    "  'existing_cui_name': 'Equilibrium',\n",
    "  'existing_cui_desc': '[CLS] E ##qui ##li ##bri ##um [unused3] ( B ##iol ##og ##ic Fun ##ction , Motor Process ##es , function , o ##bs ##er ##vable entity , qualifier value : balancing ; equilibrium ; Ba ##lance ; E ##qui ##li ##bri ##um , function ; Ba ##lancing ; balance ; Ba ##lance , function ) [SEP]',\n",
    "  'our_bi_cui': 'C1295077',\n",
    "  'our_bi_cui_name': 'Chemical separation method',\n",
    "  'our_bi_cui_desc': '[CLS] Chemical separation method [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27875010.26',\n",
    "  'test_set_idx': 20231,\n",
    "  'type': 'T017',\n",
    "  'name': 'tissues',\n",
    "  'context': '[CLS] ##al mac ##roa ##l ##gal species in the North Atlantic rocky inter ##ti ##dal zone , and found that nut ##rient - en ##rich ##ed al ##gal blades showed a significant increase in tissue growth compared to individuals grown under ambient conditions . We further q ##uant ##ified net photos ##ynth ##esis by ambient and nut ##rient - en ##rich ##ed [unused1] tissues [unused2] at sat ##ura ##ting i ##rra ##dian ##ce over a range of temperature conditions ( 6 - 30 °C ) . Re ##spiration was un ##af ##fected by nut ##rient treatment ; however , there was a significant increase in photos ##ynth ##etic oxygen production for nut ##rient - en ##rich ##ed tissue compared to ambient , but only at elevated ( [SEP]',\n",
    "  'existing_cui': 'C0040300',\n",
    "  'existing_cui_name': 'Body tissue',\n",
    "  'existing_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
    "  'our_bi_cui': 'C0040300',\n",
    "  'our_bi_cui_name': 'Body tissue',\n",
    "  'our_bi_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
    "  'our_cross_cui': 'C1514137',\n",
    "  'our_cross_cui_name': 'Plant Tissue , Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Plant T ##iss ##ue , Cell ##s [unused3] ( Ana ##tom ##ical Structure : Plant cells and tissues ) [SEP]'},\n",
    " {'mention_id': '28471040.2',\n",
    "  'test_set_idx': 37116,\n",
    "  'type': 'T103',\n",
    "  'name': 'lipid - polyethylene glycol - polymer hybrid nanoparticles',\n",
    "  'context': '[CLS] Far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid - loaded [unused1] lip ##id - p ##oly ##eth ##yle ##ne g ##ly ##co ##l - polymer hybrid na ##no ##par ##tic ##les [unused2] for treatment of g ##lio ##blast ##oma We aimed to develop lip ##id - p ##oly ##eth ##yle ##ne g ##ly ##co ##l ( lip ##id - p ##oly ##eth ##yle ##ne g ##ly ##co ##l ) - polymer hybrid na ##no ##par ##tic ##les , which have high affinity to t ##umour tissue with active ingredient , a new generation anti ##ne ##op ##lastic drug , far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid for treatment of g ##lio ##blast ##oma . Far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid [SEP]',\n",
    "  'existing_cui': 'C2000189',\n",
    "  'existing_cui_name': 'polyethylene glycol-poly',\n",
    "  'existing_cui_desc': '[CLS] p ##oly ##eth ##yle ##ne g ##ly ##co ##l - p ##oly [unused3] ( Chemical , prop ##yle ##ne im ##ine , prop ##yle ##ne im ##ine : P ##EG - PP ##I ) [SEP]',\n",
    "  'our_bi_cui': 'C0005479',\n",
    "  'our_bi_cui_name': 'Biomaterials',\n",
    "  'our_bi_cui_desc': '[CLS] B ##io ##mate ##rial ##s [unused3] ( Chemical : B ##io ##mate ##rial ; bio ##com ##pa ##tible materials ; B ##io ##medical Material ; bio ##mate ##rial ##s ; B ##io ##medical materials ; B ##io ##com ##pa ##tible Materials ; bio ##medical materials ; bio ##mate ##rial ; Materials , B ##io ##com ##pa ##tible ; bio ##medical material ; B ##io ##com ##pa ##tible Materials [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28295414.14',\n",
    "  'test_set_idx': 31552,\n",
    "  'type': 'T168',\n",
    "  'name': 'drinks',\n",
    "  'context': '[CLS] Administration proposed to expand the options for primary end points in the development of medications for alcohol use disorder to include either a ##bs ##tine ##nce from alcohol or a non ##ab ##st ##inen ##t outcome : no heavy drinking days ( with a heavy drinking day defined as more than 3 drinks per day for women and more than 4 [unused1] drinks [unused2] per day for men [ > 3 / > 4 cut ##off ] ) . The Food and Drug Administration also suggested that 6 months would be the most appropriate length for a clinical trial to demonstrate the stability of this non ##ab ##st ##inen ##t drinking outcome . However , few alcohol clinical trials have examined the stability of non ##hea [SEP]',\n",
    "  'existing_cui': 'C0452428',\n",
    "  'existing_cui_name': 'Drink',\n",
    "  'existing_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
    "  'our_bi_cui': 'C0452428',\n",
    "  'our_bi_cui_name': 'Drink',\n",
    "  'our_bi_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
    "  'our_cross_cui': 'C0001967',\n",
    "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
    "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
    " {'mention_id': '28286958.6',\n",
    "  'test_set_idx': 31315,\n",
    "  'type': 'T103',\n",
    "  'name': 'dihydrofuran rings',\n",
    "  'context': '[CLS] o ##xi ##da ##tive reaction of q ##uin ##az ##olin ##ones and al ##ky ##nes has been developed for se ##quential [ 4 + 2 ] and [ 3 + 2 ] c ##y ##c ##load ##ditions to assemble a novel fused - p ##oly ##cy ##c ##lic system containing te ##tra ##hy ##dr ##opy ##rid ##ine and [unused1] di ##hy ##dr ##of ##ura ##n rings [unused2] . The reaction process involves C - H and N - H bond functional ##ization for the formation of te ##tra ##hy ##dr ##opy ##rid ##ine and an oxygen radical c ##y ##c ##li ##zation for the di ##hy ##dr ##of ##ura ##n ring . This atom - and step - economical synthesis is highly efficient and has good [SEP]',\n",
    "  'existing_cui': 'C0650776',\n",
    "  'existing_cui_name': '2,3-dihydrofuran',\n",
    "  'existing_cui_desc': '[CLS] 2 , 3 - di ##hy ##dr ##of ##ura ##n [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C4078002',\n",
    "  'our_bi_cui_name': '2,5-dihydrofuran',\n",
    "  'our_bi_cui_desc': '[CLS] 2 , 5 - di ##hy ##dr ##of ##ura ##n [unused3] ( Chemical ) [SEP]',\n",
    "  'our_cross_cui': 'C0029224',\n",
    "  'our_cross_cui_name': 'Organic Chemicals',\n",
    "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
    " {'mention_id': '28077286.16',\n",
    "  'test_set_idx': 25066,\n",
    "  'type': 'T103',\n",
    "  'name': 'MeHg',\n",
    "  'context': '[CLS] brain barrier and is a known ne ##uro - toxic ##ant . Me ##H ##g accumulation in the brain causes his ##top ##ath ##ological alterations , ne ##uro ##be ##ha ##vior ##al changes , and imp ##air ##ments to cognitive motor functions in ma ##mmal ##ian models . However , in birds the ne ##uro ##to ##xi ##c effects of [unused1] Me ##H ##g [unused2] on the developing pre - hatch ##ing brain and con ##se ##quent behavioral alterations in adult birds have not received much attention . Moreover , pass ##eri ##ne birds are poorly represented in Me ##H ##g ne ##uro ##to ##xi ##cology studies in comparison to other a ##vian orders . Hence in this study , we used the egg injection method [SEP]',\n",
    "  'existing_cui': 'C0228520',\n",
    "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
    "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
    "  'our_bi_cui': 'C0025424',\n",
    "  'our_bi_cui_name': 'Mercury',\n",
    "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
    "  'our_cross_cui': 'C0025794',\n",
    "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
    "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
    " {'mention_id': '27791169.15',\n",
    "  'test_set_idx': 16868,\n",
    "  'type': 'T017',\n",
    "  'name': 'BPH9',\n",
    "  'context': '[CLS] p ##ests of rice ( Or ##y ##za sat ##iva L . ) . Currently , 30 Brown plant ##hop ##per - resistance genes have been genetically defined , most of which are cluster ##ed on specific chromosome regions . Here , we describe molecular c ##lon ##ing and characterization of a Brown plant ##hop ##per - resistance gene , [unused1] BP ##H ##9 [unused2] , mapped on the long arm of rice chromosome 12 ( 12 ##L ) . BP ##H ##9 en ##codes a rare type of n ##uc ##leo ##tide - binding and le ##uc ##ine - rich repeat ( n ##uc ##leo ##tide - binding and le ##uc ##ine - rich repeat ) - containing protein that local ##izes to the end [SEP]',\n",
    "  'existing_cui': 'C0005001',\n",
    "  'existing_cui_name': 'Benign prostatic hypertrophy',\n",
    "  'existing_cui_desc': '[CLS] Ben ##ign pro ##static h ##yper ##tro ##phy [unused3] ( B ##iol ##og ##ic Fun ##ction , BP ##H , ben ##ign , ben ##ign pro ##static h ##yper ##tro ##phy , diagnosis : H ##yper ##tro ##phy - pro ##st . ben . ; ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static h ##yper - ben ##ign ; Ben ##ign Pro ##static H ##yper ##p ##lasia - BP ##H ; En ##lar ##ged Pro ##state ; H ##yper ##tro ##phy , Ben ##ign Pro ##static ; H ##yper ##tro ##phy ( ben ##ign ) of pro ##state ; Ben ##ign h ##yper ##tro ##phy of pro ##state ; BP ##H - ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static [SEP]',\n",
    "  'our_bi_cui': 'C1419294',\n",
    "  'our_bi_cui_name': 'RBBP9 gene',\n",
    "  'our_bi_cui_desc': '[CLS] RB ##B ##P ##9 gene [unused3] ( Ana ##tom ##ical Structure : RB ##B ##P ##10 ; B ##5 ##T O ##VE ##RE ##X ##PR ##ES ##SE ##D GE ##NE ; RB ##B ##P ##9 Gene ; R ##ET ##IN ##O ##BL ##AS ##TO ##MA - B ##IN ##DI ##NG PR ##OT ##EI ##N 9 ; Re ##tino ##blast ##oma Bin ##ding Pro ##tein 9 Gene ; re ##tino ##blast ##oma binding protein 9 ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27832159.37',\n",
    "  'test_set_idx': 18585,\n",
    "  'type': 'T103',\n",
    "  'name': 'compound-326',\n",
    "  'context': '[CLS] - molecule , in a high - fat diet - induced o ##bes ##e mouse model . In v ##ivo Delta - 5 des ##at ##ura ##se in ##hibition was confirmed by determining changes in blood a ##rac ##hi ##don ##ic acid / D ##G ##LA profiles . In diet - induced o ##bes ##e mice , chronic treatment with [unused1] compound - 32 ##6 [unused2] lowered insulin resistance and caused body weight loss without significant impact on cumulative ca ##lor ##ie intake . Dec ##reased mac ##rop ##hage in ##fi ##ltration into ad ##ip ##ose tissue was expected from m ##RNA analysis . Inc ##reased daily energy expenditure was also observed following administration of compound - 32 ##6 , in line with sustained body weight [SEP]',\n",
    "  'existing_cui': 'C0258113',\n",
    "  'existing_cui_name': '4 - ( ( 3-bromophenyl ) amino ) -6,7 - dimethoxyquinazoline',\n",
    "  'existing_cui_desc': \"[CLS] 4 - ( ( 3 - br ##omo ##phe ##ny ##l ) amino ) - 6 , 7 - dim ##eth ##ox ##y ##quin ##az ##olin ##e [unused3] ( Chemical : Co ##mpo ##und 32 ; 4 - ( 3 ' - br ##omo ##ani ##lino ) - 6 , 7 - dim ##eth ##ox ##y ##quin ##az ##olin ##e ) [SEP]\",\n",
    "  'our_bi_cui': 'C0654579',\n",
    "  'our_bi_cui_name': 'NM 326',\n",
    "  'our_bi_cui_desc': '[CLS] N ##M 32 ##6 [unused3] ( Chemical : Benz ##ene ##met ##hana ##mini ##um , N - ( 2 - ( ( ( he ##xa ##de ##cy ##lo ##xy ) h ##ydro ##xy ##ph ##os ##phi ##ny ##l ) o ##xy ) et ##hyl ) - 3 - ( i ##od ##o - 125 ##I ) - N , N - dim ##eth ##yl - , h ##ydro ##xi ##de , inner salt ; N ##M - 32 ##6 ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28373341.3',\n",
    "  'test_set_idx': 33457,\n",
    "  'type': 'T098',\n",
    "  'name': 'low spenders',\n",
    "  'context': '[CLS] Most Americans Have Good Health , Little Un ##met Need , And Few Health Care Ex ##pen ##ses The distribution of health care expenditure ##s remains highly concentrated , but most Americans use few health care resources and have low out - of - pocket spending . More than 93 percent of \" [unused1] low spend ##ers [unused2] \" ( those in the bottom half of the population ) believe they have received all needed care in a time ##ly manner . The low spending by the majority of the population has remained almost unchanged during the thirty - seven - year period examined . [SEP]',\n",
    "  'existing_cui': 'C0238421',\n",
    "  'existing_cui_name': 'Selenium deficiency',\n",
    "  'existing_cui_desc': '[CLS] Se ##len ##ium deficiency [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : deficiency se ##len ##ium ; Se + + low ; deficiency ; se ##len ##ium ; low se ##s ; se ##len ##ium ; deficiency ; Se levels low ; se ##len ##ium deficiency ) [SEP]',\n",
    "  'our_bi_cui': 'C0024045',\n",
    "  'our_bi_cui_name': 'Low-Income Population',\n",
    "  'our_bi_cui_desc': '[CLS] Low - Inc ##ome Population [unused3] ( Population Group : income low populations ; Population ##s , Low Inc ##ome ; Population , Low Inc ##ome ; Low - Inc ##ome Population ##s ; low - income population ; Population , Low - Inc ##ome ; Low Inc ##ome Population ##s ; Low Inc ##ome Population ; Population ##s , Low - Inc ##ome ) [SEP]',\n",
    "  'our_cross_cui': 'C1257890',\n",
    "  'our_cross_cui_name': 'Population Group',\n",
    "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
    " {'mention_id': '27235559.6',\n",
    "  'test_set_idx': 303,\n",
    "  'type': 'T074',\n",
    "  'name': 'vein visualization display system',\n",
    "  'context': '[CLS] Does infrared visual ##ization improve selection of ve ##ni ##pu ##nc ##ture sites for in ##d ##well ##ing needle at the forearm in second - year nursing students ? To evaluate the effectiveness of a [unused1] vein visual ##ization display system [unused2] using near - infrared light ( \" V ##ein Di ##sp ##lay \" ) for the safe and proper selection of ve ##ni ##pu ##nc ##ture sites for in ##d ##well ##ing needle placement in the forearm . Ten second year nursing students were recruited to apply an in ##d ##well ##ing needle line with and without V ##ein Di ##sp ##lay . Another ten participants were recruited from various faculty to serve as patients . The quality of the ve ##ni ##pu ##nc [SEP]',\n",
    "  'existing_cui': 'C0175631',\n",
    "  'existing_cui_name': 'Imagery',\n",
    "  'existing_cui_desc': '[CLS] Image ##ry [unused3] ( B ##iol ##og ##ic Fun ##ction : visual ##ization ; Visual ##ization ; imagery ) [SEP]',\n",
    "  'our_bi_cui': 'C0182167',\n",
    "  'our_bi_cui_name': 'Visual paging system',\n",
    "  'our_bi_cui_desc': '[CLS] Visual p ##aging system [unused3] ( Medical Devi ##ce , physical object : Pa ##ging Systems , Visual ) [SEP]',\n",
    "  'our_cross_cui': 'C0025080',\n",
    "  'our_cross_cui_name': 'Medical Devices',\n",
    "  'our_cross_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]'},\n",
    " {'mention_id': '27298278.21',\n",
    "  'test_set_idx': 1822,\n",
    "  'type': 'T103',\n",
    "  'name': 'D',\n",
    "  'context': '[CLS] ##ho ##quin ##one , an ant ##hra ##quin ##one , and a nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##er , together with three known q ##uin ##ones and seven other known compounds , were isolated from the aerial parts of Mo ##rin ##da par ##vi ##folia . The structures of m ##ori ##nda ##par ##vin ##s C , [unused1] D [unused2] , E , F , and G were el ##uc ##idated on the basis of s ##pect ##ros ##copic or X - ray di ##ff ##raction analysis as met ##hyl 4 - h ##ydro ##xy - 1 , 6 - dim ##eth ##ox ##y - nap ##ht ##hale ##ne - 2 - car ##box ##yla ##te , met ##hyl 4 , 8 [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0010207',\n",
    "  'our_bi_cui_name': 'Coumarins',\n",
    "  'our_bi_cui_desc': '[CLS] Co ##uma ##rin ##s [unused3] ( Chemical : co ##uma ##rin ##s ; Co ##uma ##rine ##s ; Der ##via ##tives , 1 , 2 - Benz ##opy ##rone ; 1 , 2 - Benz ##opy ##rone ##s ; Benz ##opy ##ran 2 ones ; 1 , 2 - Benz ##opy ##rone Der ##via ##tives ; Co ##uma ##rin ##s [ Chemical / In ##g ##red ##ient ] ; 1 , 2 Benz ##opy ##rone ##s ; Co ##uma ##rin Der ##iva ##tives ; Der ##iva ##tives , Co ##uma ##rin ; Benz ##opy ##ran - 2 - ones ; B ##EN ##Z ##OP ##Y ##RO ##NE ##S 01 02 ; 1 , 2 Benz ##o P ##yr ##ones ; 1 , 2 - Benz ##o [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28237762.14',\n",
    "  'test_set_idx': 29316,\n",
    "  'type': 'T103',\n",
    "  'name': 'acylated phenoxyanilide',\n",
    "  'context': '[CLS] ##ama ##se The novel classes of a ##cy ##lated p ##hen ##ox ##yan ##ili ##de and th ##io ##ure ##a compounds were investigated for their ability to in ##hibit T ##EM type β - la ##ct ##ama ##se enzyme . Two compounds 4 ##g and 5 ##c reveal the in ##hibition pot ##ency in micro ##mo ##lar range and show their action by non - co ##valent binding in the vicinity of the T ##EM - 171 active site . The structure activity relationship around carbon chain length and different sub ##st ##it ##uen ##ts in or ##th ##o - and para - positions of [unused1] a ##cy ##lated p ##hen ##ox ##yan ##ili ##de [unused2] as well as molecular modelling study has been performed . [SEP]',\n",
    "  'existing_cui': 'C0031403',\n",
    "  'existing_cui_name': 'Phenetidine',\n",
    "  'existing_cui_desc': '[CLS] Ph ##ene ##ti ##dine [unused3] ( Chemical : Ph ##ene ##ti ##dine [ Chemical / In ##g ##red ##ient ] ; Benz ##ena ##mine , 4 - et ##ho ##xy - ; Am ##ino ##phe ##net ##ole ; E ##th ##ox ##yan ##ili ##ne ) [SEP]',\n",
    "  'our_bi_cui': 'C0029224',\n",
    "  'our_bi_cui_name': 'Organic Chemicals',\n",
    "  'our_bi_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27894020.2',\n",
    "  'test_set_idx': 21111,\n",
    "  'type': 'T033',\n",
    "  'name': 'detection',\n",
    "  'context': '[CLS] The an ##ato ##mic ##al mum ##mie ##s of Mom ##bell ##o : [unused1] detection [unused2] of cocaine , ni ##cot ##ine , and ca ##ffe ##ine in the hair of psychiatric patients of the early 20th century The Mom ##bell ##o P ##sy ##chia ##tric Hospital in Lim ##bia ##te , near Milan , replaced the old Sen ##av ##ra Hospital as the P ##sy ##chia ##tric Hospital for the Province of Milan in the 19th century . During the early 20th century , bodies of several Mom ##bell ##o patients were di ##sse ##cted and preserved by Giuseppe Para ##vic ##ini , an an ##ato ##mist who operated within the asylum . The aim of the present study was to examine and memorial ##ize [SEP]',\n",
    "  'existing_cui': 'C0206100',\n",
    "  'existing_cui_name': 'Signal Detection',\n",
    "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
    "  'our_bi_cui': 'C1511790',\n",
    "  'our_bi_cui_name': 'Detection',\n",
    "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
    "  'our_cross_cui': 'C0442726',\n",
    "  'our_cross_cui_name': 'Detected',\n",
    "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
    " {'mention_id': '28167893.15',\n",
    "  'test_set_idx': 27456,\n",
    "  'type': 'T058',\n",
    "  'name': 'cultured',\n",
    "  'context': '[CLS] ##a imp ##ede the practical control of the Alt ##ern ##aria diseases in crop fields . This study aimed to investigate c ##yt ##ological fungi ##cid ##e resistance mechanisms of A . alter ##nat ##a against di ##car ##box ##im ##ide fungi ##cid ##e i ##p ##rod ##ione . A . alter ##nat ##a isolated from ca ##ctus brown spot was [unused1] culture ##d [unused2] on potato - de ##x ##tro ##se a ##gar with or without i ##p ##rod ##ione , and the fun ##gal cultures with different growth characteristics from no , initial and full growth were observed by light and electron micro ##sco ##py . My ##cel ##ia began to grow from one day after in ##cu ##bation and continued to be in [SEP]',\n",
    "  'existing_cui': 'C0007600',\n",
    "  'existing_cui_name': 'Cultured Cell Line',\n",
    "  'existing_cui_desc': '[CLS] Culture ##d Cell Line [unused3] ( Ana ##tom ##ical Structure : Cell lines ; cells lines ; culture ##d cell line ; Line , Cell ; Cell Line ; cells lining ; culture ##d cells ; cell line ; cell lining ; Cell Lines ; cell lines ; cells line ; Lines , Cell ) [SEP]',\n",
    "  'our_bi_cui': 'C0430400',\n",
    "  'our_bi_cui_name': 'Laboratory culture',\n",
    "  'our_bi_cui_desc': '[CLS] Laboratory culture [unused3] ( Health Care Act ##ivity , lab test , procedure : Culture ; Culture - general ; culture ; Sam ##ple culture ; laboratory culture ; sample culture ; culture from any source ; a culture from any source ) [SEP]',\n",
    "  'our_cross_cui': 'C0200954',\n",
    "  'our_cross_cui_name': 'Mycology culture',\n",
    "  'our_cross_cui_desc': '[CLS] My ##cology culture [unused3] ( Health Care Act ##ivity , lab test , procedure : culture fungus ; Culture for fungi ; fun ##gal culture ; my ##cology culture ; Fun ##gus culture ; fungus culture ; fungi culture ) [SEP]'},\n",
    " {'mention_id': '27876145.17',\n",
    "  'test_set_idx': 20326,\n",
    "  'type': 'T062',\n",
    "  'name': 'amplification strategies',\n",
    "  'context': '[CLS] ##ay let - 7 ##a micro ##RNA I ##maging of micro ##RNA in living cells could facilitate the monitoring of the expression and distribution of micro ##RNA and research on micro ##RNA - related diseases . Given the low expression levels and even down - regulation of cellular micro ##RNA that is associated with some diseases , enzyme - free [unused1] am ##p ##lification strategies [unused2] are imp ##erative for in ##tra ##cellular micro ##RNA ass ##ay . In this work , we report an en ##tropy - driven reaction for am ##p ##lification ass ##ay micro ##RNA with a detection limit of 0 . 27 p ##M . The resulting signal am ##p ##lification provides excellent recognition and signal enhance ##ment of specific micro ##RNA [SEP]',\n",
    "  'existing_cui': 'C1705759',\n",
    "  'existing_cui_name': 'Gene Amplification Abnormality',\n",
    "  'existing_cui_desc': '[CLS] Gene Am ##p ##lification A ##b ##nor ##mal ##ity [unused3] ( B ##iol ##og ##ic Fun ##ction : Am ##p ##lification ; Gene Am ##p ##lification ) [SEP]',\n",
    "  'our_bi_cui': 'C1517480',\n",
    "  'our_bi_cui_name': 'Gene Amplification Technique',\n",
    "  'our_bi_cui_desc': '[CLS] Gene Am ##p ##lification Tech ##ni ##que [unused3] ( Research Act ##ivity : Am ##p ##lification ) [SEP]',\n",
    "  'our_cross_cui': 'C0887815',\n",
    "  'our_cross_cui_name': 'RNA Amplification Techniques',\n",
    "  'our_cross_cui_desc': '[CLS] RNA Am ##p ##lification Tech ##ni ##ques [unused3] ( Research Act ##ivity : Am ##p ##lification Tech ##nics , RNA ; Am ##p ##lification Tech ##ni ##que , RNA ; RNA Am ##p ##lification Tech ##nic ; Am ##p ##lification Tech ##nic , RNA ; Tech ##nic , RNA Am ##p ##lification ; RNA Am ##p ##lification Tech ##nics ; Am ##p ##lification Tech ##ni ##ques , RNA ; Tech ##ni ##que , RNA Am ##p ##lification ; Tech ##nics , RNA Am ##p ##lification ; Tech ##ni ##ques , RNA Am ##p ##lification ; RNA Am ##p ##lification Tech ##ni ##que ) [SEP]'},\n",
    " {'mention_id': '28168514.36',\n",
    "  'test_set_idx': 27551,\n",
    "  'type': 'T058',\n",
    "  'name': 'third - generation dual - source CT',\n",
    "  'context': '[CLS] PP ##V : 86 . 0 % ; N ##P ##V : 99 . 0 % ) provided comparable diagnostic accuracy ( p = n . s . ) . SS ##M yielded significantly lower radiation doses as compared to he ##lica ##l scan mode ( 2 . 1 ± 2 . 0 vs . 5 . 1 ± 3 . 3 m ##S ##v ; p = 0 . 000 ##1 ) in age and B ##MI - matched co ##hor ##ts . SS ##M in [unused1] third - generation dual - source CT [unused2] enables significant dose savings and provides robust diagnostic image quality in patients with A ##gat ##ston score ≤ 2000 independent of heart rate , heart rhythm or o ##besity . [SEP]',\n",
    "  'existing_cui': 'C0449416',\n",
    "  'existing_cui_name': 'Source',\n",
    "  'existing_cui_desc': '[CLS] Source [unused3] ( Finding , attribute : source ; sources ) [SEP]',\n",
    "  'our_bi_cui': 'C4055114',\n",
    "  'our_bi_cui_name': 'Dual energy computed tomography',\n",
    "  'our_bi_cui_desc': '[CLS] Dual energy com ##puted to ##mo ##graphy [unused3] ( Health Care Act ##ivity , procedure : Dual - Energy Co ##mp ##uted Tom ##ography ; DE ##CT - dual energy com ##puted to ##mo ##graphy ) [SEP]',\n",
    "  'our_cross_cui': 'C0040405',\n",
    "  'our_cross_cui_name': 'X-Ray Computed Tomography',\n",
    "  'our_cross_cui_desc': '[CLS] X - Ray Co ##mp ##uted Tom ##ography [unused3] ( Health Care Act ##ivity , computer ##ized to ##mo ##graphy , procedure : Sc ##an , X - Ray CT ; com ##puted to ##mo ##graphy x rays ; EMI scan ; em ##i scan ; CT X ##RA ##Y ; Co ##mp ##uted X - Ray Tom ##ography ; Computer ##ised trans ##ax ##ial to ##mo ##graphy ; to ##mo ##den ##si ##tom ##et ##ry ; CA ##T scan - ; CT Sc ##an , X Ray ; Computer ##ized to ##mo ##gram ; X - Ray CA ##T Sc ##an ; Computer ##ized trans ##ax ##ial to ##mo ##graphy ; x - ray com ##puted to ##mo ##graphy ; Tom ##ography , Trans ##mission [SEP]'},\n",
    " {'mention_id': '27538372.8',\n",
    "  'test_set_idx': 9789,\n",
    "  'type': 'T103',\n",
    "  'name': 'mitochondrial regulators',\n",
    "  'context': '[CLS] ##hos ##pha ##tase 1 regulate ##s the early differentiation of card ##io ##my ##ocytes from mouse em ##b ##ryo ##nic stem cells Mi ##to ##cho ##nd ##ria are crucial for maintaining the properties of em ##b ##ryo ##nic stem cells and for regulating their subsequent differentiation into diverse cell lineage ##s , including card ##io ##my ##ocytes . However , [unused1] mitochondrial regulator ##s [unused2] that manage the rate of differentiation or cell fate have been rarely identified . This study aimed to determine the potential mitochondrial factor that controls the differentiation of em ##b ##ryo ##nic stem cells into cardiac my ##ocytes . We induced card ##io ##my ##oc ##yte differentiation from mouse em ##b ##ryo ##nic stem cells and performed micro ##arra ##y ass [SEP]',\n",
    "  'existing_cui': 'C0026237',\n",
    "  'existing_cui_name': 'Mitochondria',\n",
    "  'existing_cui_desc': '[CLS] Mi ##to ##cho ##nd ##ria [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : mit ##och ##ond ##ria ; Mi ##to ##cho ##nd ##rial structure ; Mi ##to ##cho ##nd ##rion ; mit ##och ##ond ##rion ; Mi ##to ##cho ##nd ##rial ; mitochondrial ) [SEP]',\n",
    "  'our_bi_cui': 'C0949610',\n",
    "  'our_bi_cui_name': 'Mitochondrial Proteins',\n",
    "  'our_bi_cui_desc': '[CLS] Mi ##to ##cho ##nd ##rial Pro ##tein ##s [unused3] ( Chemical : mitochondrial protein ; Pro ##tein , Mi ##to ##cho ##nd ##rial ; mitochondrial proteins ; Mi ##to ##cho ##nd ##rial Pro ##tein ; Mi ##to ##cho ##nd ##rial Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; Pro ##tein ##s , Mi ##to ##cho ##nd ##rial ) [SEP]',\n",
    "  'our_cross_cui': 'C0574031',\n",
    "  'our_cross_cui_name': 'Biologically active substance',\n",
    "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
    " {'mention_id': '27355340.29',\n",
    "  'test_set_idx': 3467,\n",
    "  'type': 'T082',\n",
    "  'name': 'plots',\n",
    "  'context': '[CLS] pH , and near infrared absorb ##ance , were collected in real - time in a field with two management strategies ( reduced till ##age / conventional till ##age ) and sandy to lo ##am soils . pro ##ximal soil sensing was related to observations from a long - term ( 11 years ) earth ##worm observation study conducted at 42 [unused1] plots [unused2] . Earth ##worm ##s were sampled from 0 . 5 x 0 . 5 x 0 . 2 m ³ soil blocks and identified to species level . Sen ##sor data were highly correlated with earth ##worm abundance ##s observed in reduced till ##age but less correlated with earth ##worm abundance ##s observed in conventional till ##age . This may indicate that [SEP]',\n",
    "  'existing_cui': 'C0162435',\n",
    "  'existing_cui_name': 'Olfactory tract',\n",
    "  'existing_cui_desc': '[CLS] O ##lf ##actor ##y tract [unused3] ( Ana ##tom ##ical Structure , body structure : T ##rac ##ts , O ##lf ##actor ##y ; T ##rac ##ts , Later ##al O ##lf ##actor ##y ; O ##lf ##actor ##y T ##rac ##ts ; O ##lf ##actor ##y tract structure ; St ##ria o ##lf ##actor ##ia lateral ##is ; O ##lf ##actor ##y T ##rac ##t ; T ##rac ##tus o ##lf ##actor ##ius ; Later ##al o ##lf ##actor ##y s ##tri ##ae ; T ##rac ##tus o ##lf ##actor ##ius lateral ##is ; o ##lf ##actor ##y tract ; O ##lf ##actor ##y T ##rac ##ts , Later ##al ; O ##lf ##actor ##y T ##rac ##t , Later ##al ; Later ##al O [SEP]',\n",
    "  'our_bi_cui': 'C0032098',\n",
    "  'our_bi_cui_name': 'Plants',\n",
    "  'our_bi_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]',\n",
    "  'our_cross_cui': 'C0562975',\n",
    "  'our_cross_cui_name': 'Agricultural field',\n",
    "  'our_cross_cui_desc': '[CLS] Agricultural field [unused3] ( Spa ##tial Concept , environment ) [SEP]'},\n",
    " {'mention_id': '28351424.19',\n",
    "  'test_set_idx': 32839,\n",
    "  'type': 'T170',\n",
    "  'name': '( CENTRAL )',\n",
    "  'context': '[CLS] predict ##ive of I ##CU admission . We describe the protocol for a systematic review of variables associated with I ##CU admission . ME ##D ##L ##IN ##E , E ##MB ##AS ##E , C ##IN ##A ##HL and the Cochrane Library , including Cochrane Database of System ##atic Reviews and the Cochrane Central Register of Control ##led Trials [unused1] ( CE ##NT ##RA ##L ) [unused2] will be searched for studies that assess the association of routinely recorded variables associated with subsequent un ##p ##lan ##ned I ##CU admission . Only studies involving adult patients admitted to general intensive care units will be included . We will extract data relating to the statistical association between I ##CU admission and predict ##or variables , the quality [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0242356',\n",
    "  'our_bi_cui_name': 'Databases',\n",
    "  'our_bi_cui_desc': '[CLS] Database ##s [unused3] ( Intel ##lect ##ual Product : database ; Data Bank ; Database ; data ##bank ; data base ; Database , Electronic ; databases ; data bank ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28223077.28',\n",
    "  'test_set_idx': 28912,\n",
    "  'type': 'T082',\n",
    "  'name': 'surrounding sites',\n",
    "  'context': '[CLS] from surrounding sites , background site , up ##wind site and down ##wind site of a Municipal solid waste land ##fill in East China . The results of present study were summarized as follows . ( 1 ) The total concentrations of PC ##D ##D / F ##s ( [UNK] PC ##D ##D / F ##s ) in ambient air from [unused1] surrounding sites [unused2] , background site , up ##wind site and down ##wind site were 2 . 215 ± 1 . 00 ##4 , 2 . 05 ##8 ± 0 . 45 ##8 , 2 . 61 ##7 ± 1 . 09 ##2 and 1 . 82 ##2 ± 0 . 56 ##6 p ##g ##N ##m ( - 3 ) , respectively . [SEP]',\n",
    "  'existing_cui': 'C1282914',\n",
    "  'existing_cui_name': 'Surrounding',\n",
    "  'existing_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
    "  'our_bi_cui': 'C1282914',\n",
    "  'our_bi_cui_name': 'Surrounding',\n",
    "  'our_bi_cui_desc': '[CLS] Sur ##rou ##nding [unused3] ( Spa ##tial Concept , qualifier value , qualifier value : C ##ir ##cum ##scribed ; Sur ##rou ##nd ; c ##ir ##cum ##scribed ; surrounding ; surrounded ; Sur ##rou ##nded ; surroundings ; surrounds ; surround ) [SEP]',\n",
    "  'our_cross_cui': 'C0205145',\n",
    "  'our_cross_cui_name': 'Site',\n",
    "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
    " {'mention_id': '27320863.13',\n",
    "  'test_set_idx': 2314,\n",
    "  'type': 'T168',\n",
    "  'name': 'methionine and choline - deficient diet',\n",
    "  'context': '[CLS] ##mo ##cy ##stein ##e met ##hyl ##tra ##ns ##fer ##ase ( beta ##ine - ho ##mo ##cy ##stein ##e met ##hyl ##tra ##ns ##fe ##ase ) We investigated the anti - lip ##ogenic effect of beta ##ine in rats fed met ##hi ##oni ##ne and ch ##olin ##e - def ##icient diet . In ##take of [unused1] met ##hi ##oni ##ne and ch ##olin ##e - def ##icient diet [unused2] for 3 w ##k resulted in a significant accumulation of he ##pa ##tic lip ##ids , which was prevented by beta ##ine supplement ##ation in drinking water ( 1 % ) . Ph ##os ##ph ##ory ##lation of AM ##P - activated protein kinase , ace ##ty ##l - Co ##A car ##box ##yla ##se , [SEP]',\n",
    "  'existing_cui': 'C2928853',\n",
    "  'existing_cui_name': 'Choline / Methionine',\n",
    "  'existing_cui_desc': '[CLS] Cho ##line / Met ##hi ##oni ##ne [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0452278',\n",
    "  'our_bi_cui_name': 'Low methionine diet',\n",
    "  'our_bi_cui_desc': '[CLS] Low met ##hi ##oni ##ne diet [unused3] ( Health Care Act ##ivity , finding , regime / therapy : Dec ##rease in met ##hi ##oni ##ne content of the diet compared to the assessed base ##line intake of met ##hi ##oni ##ne for the individual . ( Source : Academy of N ##utrition and Diet ##etics N ##utrition In ##formatics Committee 2013 ) ; Dec ##reased met ##hi ##oni ##ne diet ) [SEP]',\n",
    "  'our_cross_cui': 'C0012155',\n",
    "  'our_cross_cui_name': 'Diet',\n",
    "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
    " {'mention_id': '27710934.13',\n",
    "  'test_set_idx': 14824,\n",
    "  'type': 'T082',\n",
    "  'name': 'PCP',\n",
    "  'context': '[CLS] ##ing domains have been co - opted into Non ##ri ##bos ##oma ##l p ##eptide s ##ynth ##eta ##ses to introduce further variety into non ##ri ##bos ##oma ##l p ##eptide products . Line ##ar gram ##ici ##din s ##ynth ##eta ##se contains a unique form ##yla ##tion - tail ##oring domain in its initiation module ( F - A - [unused1] PC ##P [unused2] ) . The structure of the F - A di - domain has previously been determined in a crystal form which had large solvent channels and no density for the minor As ##ub sub ##dom ##ain . An attempt was made to take advantage of this packing by removing the As ##ub sub ##dom ##ain from the construct ( F - [SEP]',\n",
    "  'existing_cui': 'C1418873',\n",
    "  'existing_cui_name': 'PRCP gene',\n",
    "  'existing_cui_desc': '[CLS] PR ##CP gene [unused3] ( Ana ##tom ##ical Structure : H ##UM ##PC ##P ; AN ##GI ##OT ##EN ##SI ##NA ##SE C ; PR ##OL ##Y ##LC ##AR ##BO ##X ##YP ##EP ##TI ##DA ##SE ; an ##gio ##tens ##inas ##e C ; PC ##P ; pro ##ly ##l ##car ##box ##ype ##pt ##idas ##e ) [SEP]',\n",
    "  'our_bi_cui': 'C0030956',\n",
    "  'our_bi_cui_name': 'Peptides',\n",
    "  'our_bi_cui_desc': '[CLS] P ##eptide ##s [unused3] ( Chemical , substance : p ##eptide ; p ##eptide ##s ; P ##eptide ##s [ Chemical / In ##g ##red ##ient ] ; P ##eptide ) [SEP]',\n",
    "  'our_cross_cui': 'C1514562',\n",
    "  'our_cross_cui_name': 'Protein Domain',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein Domain [unused3] ( Spa ##tial Concept : Domain ; Mo ##ti ##f ; Region ; Domain ##s , P ##eptide ; Domain , Pro ##tein ; Domain ##s , Pro ##tein ; domain ; Pro ##tein Feature ; Pro ##tein Domain ##s ; Feature ; Pro ##tein Mo ##ti ##f ; Sign ##ature ; Domain , P ##eptide ; Pro ##tein Region ; P ##eptide Domain ; P ##eptide Domain ##s ) [SEP]'},\n",
    " {'mention_id': '27506129.11',\n",
    "  'test_set_idx': 8643,\n",
    "  'type': 'T170',\n",
    "  'name': 'automatic framework',\n",
    "  'context': '[CLS] time consuming , thus creating a need for its auto ##mat ##isation . However , the task is far from straightforward due to data issues such as class im ##bal ##ance or correlated features . In this paper , we study the specific features of h ##yper ##emia and propose various approaches to address these problems in the context of an [unused1] automatic framework [unused2] for h ##yper ##emia g ##rading . Over ##sa ##mp ##ling , under ##sa ##mp ##ling and SM ##OT ##E approaches were applied in order to tackle the problem of class im ##bal ##ance . 25 features were com ##puted for each image and re ##gression methods were then used to transform them into a value on the g ##rading scale [SEP]',\n",
    "  'existing_cui': 'C0450152',\n",
    "  'existing_cui_name': 'Metal framework',\n",
    "  'existing_cui_desc': '[CLS] Metal framework [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
    "  'our_bi_cui': 'C0002045',\n",
    "  'our_bi_cui_name': 'algorithm',\n",
    "  'our_bi_cui_desc': '[CLS] algorithm [unused3] ( Intel ##lect ##ual Product : Al ##gor ##ith ##m ; Al ##gor ##ith ##ms ; algorithms ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27474969.2',\n",
    "  'test_set_idx': 7419,\n",
    "  'type': 'T103',\n",
    "  'name': 'reduced graphene oxide',\n",
    "  'context': '[CLS] An ultra ##sen ##sitive electro ##che ##mi ##lum ##ines ##cence sensor based on [unused1] reduced graph ##ene oxide [unused2] - copper su ##lf ##ide composite coupled with cap ##illa ##ry electro ##ph ##ores ##is for determination of am ##lo ##di ##pine be ##sy ##late in mice plasma A new electro ##che ##mi ##lum ##ines ##cence sensor based on reduced graph ##ene oxide - copper su ##lf ##ide ( r ##G ##O - C ##u ##S ) composite coupled with cap ##illa ##ry electro ##ph ##ores ##is was constructed for the ultra ##sen ##sitive detection of am ##lo ##di ##pine be ##sy ##late for the first time . In this work , r ##G ##O - C ##u ##S composite was synthesized by one - pot h [SEP]',\n",
    "  'existing_cui': 'C1957670',\n",
    "  'existing_cui_name': 'oxidosqualene',\n",
    "  'existing_cui_desc': '[CLS] o ##xi ##dos ##qua ##lene [unused3] ( Chemical : sq ##us ##lene oxide ) [SEP]',\n",
    "  'our_bi_cui': 'C0060240',\n",
    "  'our_bi_cui_name': 'ferric oxide',\n",
    "  'our_bi_cui_desc': '[CLS] f ##er ##ric oxide [unused3] ( Chemical , III , iron oxide , red , substance : Map ##ico Red ; F ##ER ##RI ##C O ##X ##ID ##E , R ##ED ; Iron oxide ; Iron O ##xi ##de Red ; iron oxide ; f ##er ##ric oxide [ Chemical / In ##g ##red ##ient ] ; Natural Red O ##xi ##de ; red iron oxide ; F ##ER ##RI ##C O ##X ##ID ##E ; f ##er ##ric oxide red ; Red O ##ch ##re ; iron oxide red ; Indian Red ; Di ##iro ##n Trio ##xi ##de ; co ##l ##cot ##har ; Iron O ##xi ##de , Red ; R ##ubi ##go ; Stone Red ; Col ##cot ##har ; I [SEP]',\n",
    "  'our_cross_cui': 'C2936695',\n",
    "  'our_cross_cui_name': 'Graphene',\n",
    "  'our_cross_cui_desc': '[CLS] G ##rap ##hen ##e [unused3] ( Chemical ) [SEP]'},\n",
    " {'mention_id': '28407355.22',\n",
    "  'test_set_idx': 34806,\n",
    "  'type': 'T017',\n",
    "  'name': 'EV',\n",
    "  'context': '[CLS] ##ative im ##mu ##no ##mo ##du ##lator ##y effects in injured tissues . Recent studies have highlighted beneficial effects of extra ##cellular ve ##si ##cles from MS ##Cs ( Me ##sen ##chy ##mal stem cells - E ##V ) on tissue injury . The effects of systemic ##ally administered mouse bone ma ##rrow derived Me ##sen ##chy ##mal stem cells - [unused1] E ##V [unused2] were evaluated in an experimental m ##uri ##ne model of he ##pa ##tic is ##che ##mia - re ##per ##fusion injury induced by cross c ##lamp ##ing the he ##pa ##tic artery and portal vein for 90 minutes followed by re ##per ##fusion for periods of up ##to 6 hours . Compared with controls , in ##tra ##ven ##ous administration of [SEP]',\n",
    "  'existing_cui': 'C0014522',\n",
    "  'existing_cui_name': 'Epidermodysplasia Verruciformis',\n",
    "  'existing_cui_desc': '[CLS] E ##pid ##er ##mo ##dy ##sp ##lasia V ##er ##ru ##ci ##form ##is [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : e ##pid ##er ##mo ##dy ##sp ##lasia ve ##rr ##uc ##iform ##is ; Le ##wan ##do ##ws ##ky - Lu ##tz D ##ys ##p ##lasia ; Le ##wan ##do ##ws ##ky - Lu ##tz disease ; Lu ##tz - Le ##wan ##do ##ws ##ky Disease ; Lu ##tz Le ##wan ##do ##ws ##ky Disease ; L ##UT ##Z L ##E ##WA ##ND ##OW ##S ##K ##Y D ##IS ; E ##pid ##er ##mo ##dy ##sp ##lasia V ##er ##ru ##ci ##form ##is [ Disease / Finding ] ; Disease , Lu ##tz - Le ##wan ##do ##ws ##ky ; EP ##ID ##ER [SEP]',\n",
    "  'our_bi_cui': 'C2350307',\n",
    "  'our_bi_cui_name': 'Cell-Derived Microparticles',\n",
    "  'our_bi_cui_desc': '[CLS] Cell - Der ##ive ##d Micro ##par ##tic ##les [unused3] ( Ana ##tom ##ical Structure : Me ##mb ##rane Micro ##par ##tic ##le , Cell ; e ##ct ##oso ##me ; E ##ct ##oso ##me ; She ##dding Micro ##ves ##icles ; Micro ##ves ##icle ; Micro ##ves ##icle , She ##dding ; extra ##cellular micro ##ves ##icle ; Me ##mb ##rane Micro ##par ##tic ##les , Cell ; micro ##ves ##icle ; She ##dding Micro ##ves ##icle ; E ##ct ##oso ##mes ; Micro ##par ##tic ##le , Cell - Der ##ive ##d ; Cell Me ##mb ##rane Micro ##par ##tic ##les ; Micro ##par ##tic ##le ; Cell Der ##ive ##d Micro ##par ##tic ##les ; Micro ##par ##tic ##les , Cell Der ##ive [SEP]',\n",
    "  'our_cross_cui': 'C3894683',\n",
    "  'our_cross_cui_name': 'Extracellular Vesicles',\n",
    "  'our_cross_cui_desc': '[CLS] Extra ##cellular V ##esi ##cles [unused3] ( Ana ##tom ##ical Structure : V ##esi ##cles , Extra ##cellular ; Extra ##cellular V ##esi ##cle ; V ##esi ##cle , Extra ##cellular ; extra ##cellular ve ##si ##cle ) [SEP]'},\n",
    " {'mention_id': '27320863.51',\n",
    "  'test_set_idx': 2352,\n",
    "  'type': 'T103',\n",
    "  'name': 'inhibitor',\n",
    "  'context': '[CLS] - 1 ##c and p ##L ##K ##B ##1 in He ##p ##G ##2 cells . Met ##form ##in - induced activation of AM ##P - activated protein kinase was also in ##hibit ##ed by ho ##mo ##cy ##stein ##e . Treatment with h ##ydro ##xy ##lam ##ine , a c ##ys ##tat ##hi ##oni ##ne β - s ##ynth ##ase [unused1] inhibitor [unused2] , resulted in a reduction of p ##AM ##P ##K , p ##AC ##C and p ##SR ##E ##B ##P - 1 ##c , accompanied by an elevation of in ##tra ##cellular ho ##mo ##cy ##stein ##e . Beta ##ine treatment prevented the ho ##mo ##cy ##stein ##e - induced reduction of p ##AM ##P ##K , p ##AC ##C , p [SEP]',\n",
    "  'existing_cui': 'C0243077',\n",
    "  'existing_cui_name': 'inhibitors',\n",
    "  'existing_cui_desc': '[CLS] inhibitor ##s [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0243077',\n",
    "  'our_bi_cui_name': 'inhibitors',\n",
    "  'our_bi_cui_desc': '[CLS] inhibitor ##s [unused3] ( Chemical ) [SEP]',\n",
    "  'our_cross_cui': 'C0014432',\n",
    "  'our_cross_cui_name': 'Enzyme Inhibitors',\n",
    "  'our_cross_cui_desc': '[CLS] En ##zy ##me In ##hibit ##ors [unused3] ( Chemical , product , substance : E ##N ##Z ##Y ##ME IN ##H ##IB ; enzyme inhibitor ; enzyme inhibitor ##s ; En ##zy ##me inhibitor ##s ; In ##hibit ##ors , En ##zy ##me ; enzymes inhibitor ##s ; En ##zy ##me inhibitor ) [SEP]'},\n",
    " {'mention_id': '27791362.25',\n",
    "  'test_set_idx': 16940,\n",
    "  'type': 'T103',\n",
    "  'name': 'W',\n",
    "  'context': '[CLS] na ##no ##par ##tic ##les ( 170 ± 10 nm h ##ydro ##dynamic diameter ) produce a higher com ##puted to ##mo ##graphy contrast ( by a factor of about 2 ) than commercial i ##od ##ine - based radio ##con ##tras ##t agents ( e . g . , I ##oh ##ex ##ol ) at identical m ##olar concentrations of [unused1] W [unused2] or I atoms . P ##EG - P ##LA - coated C ##a ##W ##O ##4 na ##no ##par ##tic ##les are chemical ##ly stable and completely non ##to ##xi ##c . It was confirmed that the maximum tolerate ##d dose of this material in mice is significantly higher ( 250 ± 50 mg per kg body weight following a single in [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0441856',\n",
    "  'our_bi_cui_name': 'Group W',\n",
    "  'our_bi_cui_desc': '[CLS] Group W [unused3] ( Intel ##lect ##ual Product , qualifier value ) [SEP]',\n",
    "  'our_cross_cui': 'C0041383',\n",
    "  'our_cross_cui_name': 'tungsten',\n",
    "  'our_cross_cui_desc': '[CLS] t ##ung ##sten [unused3] ( Chemical , substance : wolf ##ram ; Wolf ##ram ; Tu ##ng ##sten [ Chemical / In ##g ##red ##ient ] ; W element ; T ##UN ##GS ##TE ##N ; Tu ##ng ##sten ) [SEP]'},\n",
    " {'mention_id': '27310615.57',\n",
    "  'test_set_idx': 2125,\n",
    "  'type': 'T103',\n",
    "  'name': 'micro',\n",
    "  'context': \"[CLS] that 56 % ( n = 31 ) of patients were over ##weight at these three different times . Weight , B ##MI and W ##ais ##t C ##ir ##cum ##ference increased significantly , indicating a worse nutrition ##al status , and there was a correlation between poor diet quality and higher values for B ##MI , W ##ais ##t - Hip Rat ##io and W ##ais ##t - to - Height Rat ##io . Ch ##em ##otherapy interfere ##s in the patients ' diet generating a negative impact on the quality and intake of [unused1] micro [unused2] and mac ##ron ##ut ##rient ##s , as well as an impact on their nutrition ##al status , with an increase in ant ##hr ##op ##ometric measurements . [SEP]\",\n",
    "  'existing_cui': 'C0085672',\n",
    "  'existing_cui_name': 'Microbiology procedure',\n",
    "  'existing_cui_desc': '[CLS] Micro ##biology procedure [unused3] ( Health Care Act ##ivity , lab test , procedure : micro ##biology test ; Micro ##biology Test ; Micro ##biology ; Micro ##biology Pro ##ced ##ure ; Laboratory Testing , Micro ##biology ; UN ##L ##IS ##TE ##D MI ##CR ##O ##BI ##OL ##O ##G ##Y ; Micro ##biology procedures ; micro ##biology tests ; Un ##listed micro ##biology procedure ; MI ##CR ##O ##BI ##OL ##O ##G ##Y PR ##OC ##ED ##UR ##E ; Test ; micro ##biology ; micro ##biology ; Micro ##biology test ; MI ##CR ##O ; Micro ##biology Tests ; Micro ##biology Pro ##ced ##ures ; diagnostic service sources micro ##biology ) [SEP]',\n",
    "  'our_bi_cui': 'C0678695',\n",
    "  'our_bi_cui_name': 'Nutrients',\n",
    "  'our_bi_cui_desc': '[CLS] N ##ut ##rient ##s [unused3] ( Food , substance : nutrients ; nut ##rient ; nutrients substances ; N ##ut ##rient ) [SEP]',\n",
    "  'our_cross_cui': 'C0282575',\n",
    "  'our_cross_cui_name': 'Micronutrients',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##nut ##rient ##s [unused3] ( Chemical : Micro ##nut ##rient ; micro ##nut ##rient ; micro ##nut ##rient ##s ) [SEP]'},\n",
    " {'mention_id': '28239461.28',\n",
    "  'test_set_idx': 29413,\n",
    "  'type': 'T170',\n",
    "  'name': 'Fluidigm platform',\n",
    "  'context': '[CLS] 6 ) , di ##stal common bi ##le duct cancer ( n = 21 ) , and gas ##tric cancer ( n = 20 ) ; chronic pan ##cre ##ati ##tis ( n = 39 ) ; and normal pan ##cre ##as ( n = 35 ) . The micro ##RNA ##s were analyzed by PC ##R using the [unused1] F ##lu ##id ##ig ##m platform [unused2] . Twenty - two micro ##RNA ##s were significantly differently expressed in patients with pan ##cre ##atic cancer when compared to healthy controls and chronic pan ##cre ##ati ##tis patients ; 17 mi ##RNA ##s were up ##re ##gu ##lated ( mi ##R - 21 - 5 ##p , - 23 ##a - 3 ##p , - 31 - [SEP]',\n",
    "  'existing_cui': 'C3896718',\n",
    "  'existing_cui_name': 'MenaCalc Platform',\n",
    "  'existing_cui_desc': '[CLS] Men ##a ##C ##al ##c Platform [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
    "  'our_bi_cui': 'C1449576',\n",
    "  'our_bi_cui_name': 'Microfluidic Analytical Techniques',\n",
    "  'our_bi_cui_desc': '[CLS] Micro ##f ##lu ##id ##ic Ana ##ly ##tical Tech ##ni ##ques [unused3] ( Health Care Act ##ivity : MI ##CR ##O ##FL ##UI ##DI ##C AN ##AL ; Ana ##ly ##ses , Micro ##f ##lu ##id ##ic ; Micro ##f ##lu ##id ##ic Ana ##ly ##tical Tech ##ni ##que ; Micro ##f ##lu ##id ##ic Ana ##ly ##ses ; Micro ##f ##lu ##id ##ic Analysis ; MI ##CR ##O ##FL ##UI ##DI ##C AN ##AL T ##EC ##H ##NI ##Q ##UE ##S ; Tech ##ni ##que , Micro ##f ##lu ##id ##ic Ana ##ly ##tical ; Tech ##ni ##ques , Micro ##f ##lu ##id ##ic Ana ##ly ##tical ; Analysis , Micro ##f ##lu ##id ##ic ; Ana ##ly ##tical Tech ##ni ##que , Micro ##f [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28493435.5',\n",
    "  'test_set_idx': 37720,\n",
    "  'type': 'T033',\n",
    "  'name': 'locating',\n",
    "  'context': '[CLS] A Fast Peak - Search ##ing Al ##gor ##ith ##m for Ultra ##sonic El ##ast ##ography T ##iss ##ue a ##xial strain est ##imation with ultra ##sound el ##ast ##ography has become a hot field in recent years . However , for key ##points tracking - based el ##ast ##ography algorithms , [unused1] lo ##cating [unused2] ex ##tre ##ma in multi ##mo ##dal ultra ##sonic radio ##f ##re ##que ##ncy signals is still a challenging problem . In this paper , a new method is proposed to locate the local ma ##xi ##ma and mini ##ma of the RF signals directly without der ##ivation operation . This algorithm can accurately locate ex ##tre ##ma even if disturbed peaks resulting from different noise exist . Furthermore , [SEP]',\n",
    "  'existing_cui': 'C3874067',\n",
    "  'existing_cui_name': 'Nerve-locating probe',\n",
    "  'existing_cui_desc': '[CLS] N ##erve - lo ##cating probe [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
    "  'our_bi_cui': 'C0392752',\n",
    "  'our_bi_cui_name': 'Localized',\n",
    "  'our_bi_cui_desc': '[CLS] Local ##ized [unused3] ( Spa ##tial Concept , qualifier value : Local ##ised ; Limited area ; local ##izing ; local ##ize ; localized ; local ##ised ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27603112.13',\n",
    "  'test_set_idx': 11355,\n",
    "  'type': 'T103',\n",
    "  'name': 'biomolecules',\n",
    "  'context': '[CLS] ##cule ##s : A Si ##mu ##lation Study A number of cases around the world have been reported where animals were found dead or dying with symptoms resembling a th ##iam ##ine ( vitamin B ) deficiency , and for some of these , a link to poll ##uta ##nts has been suggested . Here , we investigate whether [unused1] bio ##mo ##le ##cule ##s [unused2] involved in th ##iam ##in binding and transport could be blocked by a range of different poll ##uta ##nts . We used in si ##lic ##o dock ##ing of five compound classes ( 25 compounds in total ) to each of five targets ( p ##rion protein , EC ##F - type ABC transport ##er , th ##i - box [SEP]',\n",
    "  'existing_cui': 'C0104263',\n",
    "  'existing_cui_name': 'artificial lung expanding compound',\n",
    "  'existing_cui_desc': '[CLS] artificial lung expanding compound [unused3] ( Chemical , AL ##EC , product , substance : P ##uma ##ct ##ant ; pu ##ma ##ct ##ant ) [SEP]',\n",
    "  'our_bi_cui': 'C1449655',\n",
    "  'our_bi_cui_name': 'Macromolecular Substances',\n",
    "  'our_bi_cui_desc': '[CLS] Mac ##rom ##ole ##cular Sub ##stance ##s [unused3] ( Chemical : Mac ##rom ##ole ##cular Sub ##stance ##s [ Chemical / In ##g ##red ##ient ] ; Mac ##rom ##ole ##cular Co ##mpo ##unds and Complex ##es ; Sub ##stance ##s , Mac ##rom ##ole ##cular ) [SEP]',\n",
    "  'our_cross_cui': 'C0574031',\n",
    "  'our_cross_cui_name': 'Biologically active substance',\n",
    "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
    " {'mention_id': '28424240.41',\n",
    "  'test_set_idx': 35329,\n",
    "  'type': 'T038',\n",
    "  'name': 'TCR stimulation',\n",
    "  'context': '[CLS] protein 5 functions impaired T cell proliferation , IL - 2 production , and T ##h ##1 / T ##h ##17 , but not T ##h ##2 and regulatory T cell differentiation . general control non ##re ##pressed - protein 5 is recruited onto the il - 2 promoter by interacting with the N ##FA ##T in T cells upon [unused1] T ##CR stimulation [unused2] . Interest ##ingly , instead of directly ace ##ty ##lating N ##FA ##T , general control non ##re ##pressed - protein 5 cat ##aly ##zes his ##tone H ##3 l ##ys ##ine H ##9 ace ##ty ##lation to promote IL - 2 production . T cell - specific suppression of general control non ##re ##pressed - protein 5 partially protected mice [SEP]',\n",
    "  'existing_cui': 'C1292856',\n",
    "  'existing_cui_name': 'Stimulation procedure',\n",
    "  'existing_cui_desc': '[CLS] St ##im ##ulation procedure [unused3] ( Health Care Act ##ivity , procedure , qualifier value : stimulation ; stimulation ##s ; St ##im ##ulation - action ; St ##im ##ulation ) [SEP]',\n",
    "  'our_bi_cui': 'C1515144',\n",
    "  'our_bi_cui_name': 'T-Cell Receptor Activation',\n",
    "  'our_bi_cui_desc': '[CLS] T - Cell Re ##ceptor Act ##ivation [unused3] ( B ##iol ##og ##ic Fun ##ction : T ##CR Act ##ivation ; T ##CR Inter ##action ; T - Cell Re ##ceptor Inter ##action ) [SEP]',\n",
    "  'our_cross_cui': 'C2259054',\n",
    "  'our_cross_cui_name': 'stimulation of T cell receptor signaling pathway',\n",
    "  'our_cross_cui_desc': '[CLS] stimulation of T cell receptor signaling pathway [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]'},\n",
    " {'mention_id': '27482869.2',\n",
    "  'test_set_idx': 7895,\n",
    "  'type': 'T204',\n",
    "  'name': 'Allen James Wilcox',\n",
    "  'context': \"[CLS] Voices : A Con ##vers ##ation with Allen J . Wilcox [unused1] Allen James Wilcox [unused2] was born on 30 September 1946 in Columbus , OH . He studied medicine at the University of Michigan , graduated in 1973 , and after a rotating internship , he completed a master ' s degree in maternal and child health ( 1976 ) and a PhD in e ##pid ##em ##iology ( 1979 ) at the University of North Carolina in Chapel Hill . After graduation , he went to work at the National Institute of Environmental Health Sciences ( National Institute of Environmental Health Sciences , one of the US National Institutes of Health ) in Durham , NC , where he has spent his career . [SEP]\",\n",
    "  'existing_cui': 'C0237695',\n",
    "  'existing_cui_name': 'William James',\n",
    "  'existing_cui_desc': '[CLS] William James [unused3] ( E ##uka ##ryo ##te , William : James ) [SEP]',\n",
    "  'our_bi_cui': 'C0027361',\n",
    "  'our_bi_cui_name': 'Persons',\n",
    "  'our_bi_cui_desc': '[CLS] Persons [unused3] ( Population Group , person : Individual ; Person ; persons ; peoples ; Person [ du ##p ] ; People ; person ; people ) [SEP]',\n",
    "  'our_cross_cui': 'C0086418',\n",
    "  'our_cross_cui_name': 'Homo sapiens',\n",
    "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
    " {'mention_id': '28188533.10',\n",
    "  'test_set_idx': 27855,\n",
    "  'type': 'T170',\n",
    "  'name': 'SWATH ( ® )',\n",
    "  'context': '[CLS] ##c ##quisition Data for Label - free Q ##uant ##itative Pro ##te ##omi ##cs Studies Using Triple ##TO ##F ( ® ) Mass S ##pect ##rome ##ters Data - independent acquisition is a powerful mass s ##pect ##rome ##try technique that enables comprehensive MS and MS / MS analysis of all detect ##able species , providing an information rich data file that can be mined deeply . Here , we describe how to acquire high - quality [unused1] S ##WA ##TH ( ® ) [unused2] A ##c ##quisition data to be used for large quantitative pro ##te ##omi ##c studies . We specifically focus on using variable sized Q ##1 windows for acquisition of MS / MS data for generating higher specific ##ity quantitative data . [SEP]',\n",
    "  'existing_cui': 'C1416521',\n",
    "  'existing_cui_name': 'ITSN2 gene',\n",
    "  'existing_cui_desc': '[CLS] IT ##SN ##2 gene [unused3] ( Ana ##tom ##ical Structure : PR ##O ##20 ##15 ; SH ##3 domain protein 1 ##B ; inter ##sect ##in 2 ; SH ##3 ##P ##18 ; IN ##TE ##RS ##EC ##TI ##N 2 ; SH ##3 ##P ##18 - like WA ##SP associated protein ; SH ##3 D ##OM ##A ##IN PR ##OT ##EI ##N 1 ##B ; K ##IA ##A ##12 ##5 ##6 ) [SEP]',\n",
    "  'our_bi_cui': 'C0025080',\n",
    "  'our_bi_cui_name': 'Medical Devices',\n",
    "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27245335.53',\n",
    "  'test_set_idx': 758,\n",
    "  'type': 'T017',\n",
    "  'name': 'adipocytokine genes',\n",
    "  'context': '[CLS] by male offspring during the subsequent generation following paternal high - fat diet exposure diminished whereas consumption for two generations completely abolished the effect of paternal high - fat diet exposure on metabolic traits and ad ##ip ##oc ##yt ##oki ##ne promoter e ##pi ##gene ##tic changes in the offspring . The effects of paternal high - fat diet exposure on offspring were relatively weaker than those following high - fat diet exposure in u ##tero . However , paternal high - fat diet exposure had an add ##itive metabolic effect for two generations , suggesting that both paternal and maternal nutrition might affect offspring metabolism through e ##pi ##gene ##tic modifications of [unused1] ad ##ip ##oc ##yt ##oki ##ne genes [unused2] for multiple generations . [SEP]',\n",
    "  'existing_cui': 'C1955907',\n",
    "  'existing_cui_name': 'Adipokines',\n",
    "  'existing_cui_desc': '[CLS] Ad ##ip ##oki ##nes [unused3] ( Chemical : Ad ##ip ##oki ##ne ; Ad ##ip ##oki ##nes [ Chemical / In ##g ##red ##ient ] ; Ad ##ip ##oc ##yt ##oki ##nes ; Ad ##ip ##oc ##yt ##oki ##ne ) [SEP]',\n",
    "  'our_bi_cui': 'C1333196',\n",
    "  'our_bi_cui_name': 'Cytokine Gene',\n",
    "  'our_bi_cui_desc': '[CLS] Cy ##tok ##ine Gene [unused3] ( Ana ##tom ##ical Structure ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27837821.9',\n",
    "  'test_set_idx': 18842,\n",
    "  'type': 'T170',\n",
    "  'name': 'fast Fourier transform',\n",
    "  'context': '[CLS] based on the mat ##uring in barrels or the prediction of the global scores assigned by a sensory panel . To this aim , red wine samples were first anal ##ys ##ed with the vol ##tam ##metric sensor array , without performing any sample pre ##tre ##at ##ment . Afterwards , obtained responses were pre ##p ##ro ##cess ##ed employing [unused1] fast Four ##ier transform [unused2] for the compression and reduction of signal complexity , and obtained coefficients were then used as inputs to build the q ##ual ##itative and quantitative models employing either linear disc ##rim ##ina ##nt analysis or partial least squares re ##gression , respectively . Sa ##tis ##fa ##ctor ##y results were obtained overall , with a classification rate of 100 % [SEP]',\n",
    "  'existing_cui': 'C0206055',\n",
    "  'existing_cui_name': 'Spectroscopy , Fourier Transform Infrared',\n",
    "  'existing_cui_desc': '[CLS] S ##pect ##ros ##copy , Four ##ier Trans ##form In ##fra ##red [unused3] ( Research Act ##ivity : Four ##ier Trans ##form In ##fra ##red S ##pect ##ros ##copy ; F ##TI ##R ( Four ##ier transform infrared ) s ##pect ##ros ##copy ; F ##TI ##R ; F ##TI ##R s ##pect ##ros ##copy ; four ##ier transform infrared ( F ##TI ##R ) s ##pect ##ros ##copy ; Four ##ier transform infrared s ##pect ##ros ##copy ; S ##pect ##ros ##copy , In ##fra ##red , Four ##ier Trans ##form ) [SEP]',\n",
    "  'our_bi_cui': 'C3899091',\n",
    "  'our_bi_cui_name': 'Fourier Transform Ion Cyclotron Resonance Mass Spectrometry',\n",
    "  'our_bi_cui_desc': '[CLS] Four ##ier Trans ##form Ion Cy ##c ##lot ##ron Re ##son ##ance Mass S ##pect ##rome ##try [unused3] ( Research Act ##ivity ) [SEP]',\n",
    "  'our_cross_cui': 'C0002045',\n",
    "  'our_cross_cui_name': 'algorithm',\n",
    "  'our_cross_cui_desc': '[CLS] algorithm [unused3] ( Intel ##lect ##ual Product : Al ##gor ##ith ##m ; Al ##gor ##ith ##ms ; algorithms ) [SEP]'},\n",
    " {'mention_id': '27659602.24',\n",
    "  'test_set_idx': 13369,\n",
    "  'type': 'T082',\n",
    "  'name': 'root',\n",
    "  'context': '[CLS] at post ##oper ##ative base ##line and follow - up imaging by com ##puted to ##mo ##graphy or echo ##card ##io ##graphy . The annual growth rate was evaluated and also compared according to the influence of valve morphology and con ##com ##ita ##nt a ##ort ##ic valve replacement . Furthermore , the years of natural history that would require for [unused1] root [unused2] en ##lar ##gement to meet a 50 mm threshold of the root diameter were calculated . The estimated growth rate of the a ##ort ##ic root after root - spa ##ring a ##ort ##ic replacement is between 0 . 27 and 0 . 51 mm per year ( mean 0 . 41 mm , varying according to the underlying diameter ) and [SEP]',\n",
    "  'existing_cui': 'C1318154',\n",
    "  'existing_cui_name': 'Root body part',\n",
    "  'existing_cui_desc': '[CLS] Root body part [unused3] ( Ana ##tom ##ical Structure : Root ; root [ a body part ] ; root ) [SEP]',\n",
    "  'our_bi_cui': 'C0040452',\n",
    "  'our_bi_cui_name': 'Tooth root structure',\n",
    "  'our_bi_cui_desc': '[CLS] Too ##th root structure [unused3] ( Ana ##tom ##ical Structure , body structure : Ra ##di ##x co ##rona ; Root of the Too ##th ; tooth root ; Too ##th Root ; Root of Too ##th ; Root , Too ##th ; tooth roots ; root of tooth ; root tooth ; roots tooth ; Te ##eth - - Roots ; Roots , Too ##th ; of tooth root ; Too ##th Roots ; Too ##th root ; Ra ##di ##x Den ##tis ; Ra ##di ##x den ##tis ; rooted tooth ; Root of tooth ) [SEP]',\n",
    "  'our_cross_cui': 'C0549113',\n",
    "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
    "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
    " {'mention_id': '27842161.11',\n",
    "  'test_set_idx': 19104,\n",
    "  'type': 'T103',\n",
    "  'name': 'netarsudil-M1',\n",
    "  'context': '[CLS] ##ars ##udi ##l Inc ##rease ##s Out ##flow Facility in Human Eyes Through Multiple Me ##chan ##isms Net ##ars ##udi ##l is a R ##ho kinase / nor ##ep ##ine ##ph ##rine transport ##er inhibitor currently in phase 3 clinical development for g ##lau ##com ##a treatment . We investigated the effects of its active meta ##bol ##ite , [unused1] net ##ars ##udi ##l - M1 [unused2] , on out ##flow facility ( C ) , out ##flow h ##ydro ##dynamic ##s , and morphology of the conventional out ##flow pathway in en ##uc ##lea ##ted human eyes . Pa ##ired human eyes ( n = 5 ) were per ##fused with either 0 . 3 μ ##M net ##ars ##udi ##l - M1 or vehicle [SEP]',\n",
    "  'existing_cui': 'C0441971',\n",
    "  'existing_cui_name': 'Metastasis stage M1',\n",
    "  'existing_cui_desc': '[CLS] Met ##ast ##asis stage M1 [unused3] ( Finding , diagnosis , finding , tumor staging : M1 ; M1 Met ##ast ##asis Stage ; M1 Di ##stant Met ##ast ##asis Finding ; M1 T ##N ##M Finding ; M1 Cancer Stage Finding ; M1 Stage ; M1 category ; ma ##li ##g neo ##p ##las ##m t ##n ##m staging distant meta ##sta ##sis ( m ) m ##1 ; M1 Di ##stant Met ##ast ##asis Stage Finding ; M1 Met ##ast ##asis Finding ; Met ##ast ##asis Stage M1 ; M1 stage ; M1 Stage Finding ) [SEP]',\n",
    "  'our_bi_cui': 'C4307684',\n",
    "  'our_bi_cui_name': '6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid',\n",
    "  'our_bi_cui_desc': '[CLS] 6 , 7 - dim ##eth ##ox ##y - 1 , 2 , 3 , 4 - te ##tra ##hy ##dr ##ois ##o ##quin ##olin ##e - 3 - car ##box ##yl ##ic acid [unused3] ( Chemical : M1 al ##kal ##oid ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27553395.14',\n",
    "  'test_set_idx': 10264,\n",
    "  'type': 'T033',\n",
    "  'name': 'over',\n",
    "  'context': '[CLS] was 103 ##2 . 8 ( SD 252 ) k ##cal and 101 ##3 ( SD 33 ##9 . 1 ) k ##cal respectively and 105 ##7 . 2 ( SD 201 . 8 ) k ##cal and 103 ##0 . 3 ( SD 34 ##1 . 7 ) k ##cal for boys . Iron intake was low in both groups . Mean body mass index and body weight and height were similar to World Health Organization figures but significant numbers of infants and to ##ddler ##s of both sexes were [unused1] over [unused2] - or under ##weight . Although mean energy and mac ##ron ##ut ##rient intake ##s were comparable to the R ##DA , significant numbers were over - or under ##fe ##d . [SEP]',\n",
    "  'existing_cui': 'C0205136',\n",
    "  'existing_cui_name': 'Over',\n",
    "  'existing_cui_desc': '[CLS] Over [unused3] ( Spa ##tial Concept , spatial , spatial , qualifier value : over ) [SEP]',\n",
    "  'our_bi_cui': 'C0205136',\n",
    "  'our_bi_cui_name': 'Over',\n",
    "  'our_bi_cui_desc': '[CLS] Over [unused3] ( Spa ##tial Concept , spatial , spatial , qualifier value : over ) [SEP]',\n",
    "  'our_cross_cui': 'C0497406',\n",
    "  'our_cross_cui_name': 'Overweight',\n",
    "  'our_cross_cui_desc': '[CLS] Over ##weight [unused3] ( Finding , diagnosis , finding , physical finding : clinical over ##weight ; O ##VE ##R ##W ##EI ##G ##HT ; over ##weight ( B ##MI < 30 ) ; over ##weight ; Over ##weight ( B ##MI 25 - 30 ) ; Pat ##ient over ##weight ; Over ##weight [ Disease / Finding ] ) [SEP]'},\n",
    " {'mention_id': '27762482.15',\n",
    "  'test_set_idx': 15893,\n",
    "  'type': 'T074',\n",
    "  'name': 'PDL',\n",
    "  'context': '[CLS] ##nic flu ##ence proved to be superior until now . Given that pu ##rp ##ura and subsequent possible post ##in ##f ##lam ##mat ##ory h ##yper ##pi ##gment ##ation are occasionally un ##bearable in some patients , and several studies using the low non ##pur ##pura ##genic flu ##ence were reported . To deliver the sufficient high flu ##ence of a [unused1] PD ##L [unused2] without generating pu ##rp ##ura , we designed the fraction ##ation of high flu ##ence using five passes and longer pulse duration ( 6 mill ##ise ##con ##ds ) of a PD ##L in succession . A total of eight patients with er ##yt ##hem ##ato ##tel ##ang ##ie ##ct ##atic r ##osa ##cea were enrolled in this study ; all [SEP]',\n",
    "  'existing_cui': 'C1414066',\n",
    "  'existing_cui_name': 'DLG5 gene',\n",
    "  'existing_cui_desc': '[CLS] DL ##G ##5 gene [unused3] ( Ana ##tom ##ical Structure : K ##IA ##A ##0 ##5 ##8 ##3 ; D ##IS ##CS LA ##R ##GE , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 5 ; P - d ##l ##g ; discs large ho ##mo ##log 5 ; P ##LA ##CE ##NT ##A AND PR ##OS ##TA ##TE DL ##G ) [SEP]',\n",
    "  'our_bi_cui': 'C0031740',\n",
    "  'our_bi_cui_name': 'Photochemotherapy',\n",
    "  'our_bi_cui_desc': '[CLS] Photo ##che ##mother ##ap ##y [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : PD ##T - Photo ##dynamic therapy ; Photo ##che ##mother ##ap ##ies ; Photo ##dynamic The ##rap ##ies ; therapy , photo ##dynamic ; Therapy , Photo ##dynamic ; THE ##R P ##H ##OT ##OD ##Y ##NA ##MI ##C ; Photo ##rad ##iation Therapy ; photo ##dynamic therapy ; photo ##che ##mother ##ap ##y ; P ##H ##OT ##OC ##H ##EM ##OT ##H ##ER ; The ##rap ##ies , Photo ##dynamic ; Photo ##dynamic Therapy Pro ##ced ##ures ; neo ##p ##las ##m / cancer photo ##rad ##iation therapy ; Photo ##che ##mother ##ap ##y [ Am ##bi ##guous ] ; Photo ##dynamic therapy ; PD [SEP]',\n",
    "  'our_cross_cui': 'C1289859',\n",
    "  'our_cross_cui_name': 'Pulsed Dye Lasers',\n",
    "  'our_cross_cui_desc': '[CLS] P ##ulse ##d D ##ye Las ##ers [unused3] ( Medical Devi ##ce , physical object : D ##ye Las ##ers , P ##ulse ##d ; P ##ulse ##d dye laser device ; Las ##er , P ##ulse ##d D ##ye ; D ##ye Las ##er , P ##ulse ##d ; Las ##ers , P ##ulse ##d D ##ye ; P ##ulse ##d D ##ye Las ##er ; pulsed dye laser ; P ##ulse ##d dye laser ) [SEP]'},\n",
    " {'mention_id': '27298278.30',\n",
    "  'test_set_idx': 1831,\n",
    "  'type': 'T103',\n",
    "  'name': \"dimethyl 1,1 ' - dihydroxy-4 ,4 ' ,7,7 ' - tetramethoxy-2 ,2 ' - binaphthalene-3 ,3 ' - dicarboxylate\",\n",
    "  'context': \"[CLS] ##bon ##yl - 1 , 4 - nap ##ht ##ho ##quin ##one , 1 , 4 - di ##hy ##dr ##ox ##y - 7 - h ##ydro ##xy ##met ##hyl - ant ##hra ##quin ##one , and [unused1] dim ##eth ##yl 1 , 1 ' - di ##hy ##dr ##ox ##y - 4 , 4 ' , 7 , 7 ' - te ##tra ##met ##ho ##xy - 2 , 2 ' - bin ##aph ##thal ##ene - 3 , 3 ' - di ##car ##box ##yla ##te [unused2] , respectively . Na ##ph ##th ##o ##quin ##ones and nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##ers were previously unknown in the genus Mo ##rin ##da . In addition , the compounds were tested [SEP]\",\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0029224',\n",
    "  'our_bi_cui_name': 'Organic Chemicals',\n",
    "  'our_bi_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27622027.25',\n",
    "  'test_set_idx': 12098,\n",
    "  'type': 'T017',\n",
    "  'name': 'tumor - draining LN',\n",
    "  'context': '[CLS] of color ##ec ##tal cancer patients . Fresh tumor - draining L ##N tissues from 39 randomly enrolled patients were assessed by flow c ##yt ##ome ##try for activation and differentiation of CD ##16 ##9 ( + ) CD ##8 ( + ) T cells and T cell - mediated killing of tumor cells . In total , 114 [unused1] tumor - draining L ##N [unused2] para ##ffin sections from color ##ec ##tal cancer patients were analyzed by multiple - color im ##mu ##no ##f ##lu ##ores ##cence for CD ##16 ##9 ( + ) CD ##8 ( + ) T cell distribution and clinical values . The pro ##gno ##stic significance of CD ##16 ##9 ( + ) CD ##8 ( + ) T cells [SEP]',\n",
    "  'existing_cui': 'C0269800',\n",
    "  'existing_cui_name': 'Amniotic fluid leaking',\n",
    "  'existing_cui_desc': '[CLS] Am ##nio ##tic fluid leaking [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Waters leaking ; Lea ##ka ##ge of am ##nio ##tic fluid ; Am ##nio ##rr ##hea ; Li ##q ##uo ##r observed ; Dr ##ain ##age of liquor ; Flow of am ##nio ##tic liquor ; am ##nio ##tic fluid leak ; am ##nio ##tic fluid leak ##age ; am ##nio ##tic fluid ; leak ; Lea ##ka ##ge of Am ##nio ##tic F ##lu ##id ; Li ##q ##uo ##r draining ; leaking water ; water leak ; leak ##age of am ##nio ##tic fluid ; Am ##nio ##tic fluid leak ##age ; Am ##nio ##rr ##hoe ##a ; am ##nio ##tic fluid leaking ; am ##nio [SEP]',\n",
    "  'our_bi_cui': 'C0281444',\n",
    "  'our_bi_cui_name': 'tumor-draining lymph node lymphocyte therapy',\n",
    "  'our_bi_cui_desc': '[CLS] tumor - draining l ##ymph node l ##ymph ##oc ##yte therapy [unused3] ( Health Care Act ##ivity : Tu ##mor - Dr ##ain ##ing L ##ymph No ##de L ##ymph ##oc ##yte Therapy ) [SEP]',\n",
    "  'our_cross_cui': 'C0024204',\n",
    "  'our_cross_cui_name': 'lymph nodes',\n",
    "  'our_cross_cui_desc': '[CLS] l ##ymph nodes [unused3] ( Ana ##tom ##ical Structure , body structure : L ##ymph ##atic G ##land ; Structure of l ##ymph node ; nodes l ##ymph ; glands l ##ymph ##atic ; No ##de , L ##ymph ; l ##ymph ##s nodes ; L ##ymph ##atic g ##land ; l ##ymph ##atic g ##land ; L ##ymph ##ono ##dus ; node l ##ymph ; l ##ymph ##s node ; L ##ymph node structure ; l ##ymph node ; L ##ymph G ##land ; No ##dus l ##ymph ##atic ##us ; L ##ymph No ##des ; L ##ymph No ##de ; L ##Y ##MP ##H NO ##DE ; L ##ymph nodes ; No ##des , L ##ymph ; L ##ymph g ##land ; No ##dus [SEP]'},\n",
    " {'mention_id': '27500205.13',\n",
    "  'test_set_idx': 8445,\n",
    "  'type': 'T017',\n",
    "  'name': 'adherent cells',\n",
    "  'context': '[CLS] e ##z ##rin - rid ##ix ##in - m ##oes ##in ( F ##ER ##M ) domain containing proteins . There are three kind ##lins in mammals , which share high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in [unused1] ad ##here ##nt cells [unused2] , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of kind ##lins . Great interest in the kind ##lins has [SEP]',\n",
    "  'existing_cui': 'C0263567',\n",
    "  'existing_cui_name': 'Adherent scar',\n",
    "  'existing_cui_desc': '[CLS] Ad ##here ##nt scar [unused3] ( Finding , diagnosis , disorder : ad ##here ##nt scar ; ad ##here ##nt ; scar ; scar ; ad ##here ##nt ; Ad ##here ##nt skin ) [SEP]',\n",
    "  'our_bi_cui': 'C0007577',\n",
    "  'our_bi_cui_name': 'Cell Adhesion',\n",
    "  'our_bi_cui_desc': '[CLS] Cell Ad ##hesion [unused3] ( B ##iol ##og ##ic Fun ##ction : Cell Ad ##hesion ##s ; Cell ad ##hesion ; Ad ##hesion , Cell ; Cell Ad ##hesion Process ; ad ##hesion cellular ; cell ad ##hesion ; Ad ##hesion ##s , Cell ; ad ##hesion cell ; cellular ad ##hesion ; Cell ##ular Ad ##hesion ) [SEP]',\n",
    "  'our_cross_cui': 'C0007634',\n",
    "  'our_cross_cui_name': 'Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
    " {'mention_id': '28113841.10',\n",
    "  'test_set_idx': 25840,\n",
    "  'type': 'T170',\n",
    "  'name': 'reconstruction models',\n",
    "  'context': '[CLS] , we develop a structural feature based collaborative reconstruction ( St ##ructural Feature based Col ##la ##bor ##ative Reconstruction ) method for quantitative su ##s ##ce ##pt ##ibility mapping including both magnitude and su ##s ##ce ##pt ##ibility based information . The St ##ructural Feature based Col ##la ##bor ##ative Reconstruction algorithm is composed of two consecutive steps corresponding to complementary [unused1] reconstruction models [unused2] , each with a structural feature based l ##1 norm con ##stra ##int and a v ##ox ##el fi ##delity based l ##2 norm con ##stra ##int , which allows both the structure edges and tiny features to be recovered , whereas the noise and artifacts could be reduced . In the M - step , the initial su ##s ##ce [SEP]',\n",
    "  'existing_cui': 'C0237819',\n",
    "  'existing_cui_name': 'Learning Reconstruction',\n",
    "  'existing_cui_desc': '[CLS] Learning Reconstruction [unused3] ( B ##iol ##og ##ic Fun ##ction , Learning : Reconstruction ) [SEP]',\n",
    "  'our_bi_cui': 'C0449363',\n",
    "  'our_bi_cui_name': 'Method of reconstruction',\n",
    "  'our_bi_cui_desc': '[CLS] Method of reconstruction [unused3] ( Intel ##lect ##ual Product , attribute ) [SEP]',\n",
    "  'our_cross_cui': 'C3161035',\n",
    "  'our_cross_cui_name': 'Model',\n",
    "  'our_cross_cui_desc': '[CLS] Model [unused3] ( Intel ##lect ##ual Product : Models ; Model ##ing System ; Model System ) [SEP]'},\n",
    " {'mention_id': '27855073.16',\n",
    "  'test_set_idx': 19359,\n",
    "  'type': 'T103',\n",
    "  'name': 'uS4',\n",
    "  'context': \"[CLS] essential component of the small rib ##oso ##mal subunit that is involved in subunit assembly , maintenance of translation ##al fi ##delity , and the rib ##oso ##me ' s response to the anti ##biotic s ##pect ##ino ##my ##cin . While many of the characterized u ##S ##5 mutations that affect de ##co ##ding map to its interface with [unused1] u ##S ##4 [unused2] , more recent work has shown that residues distant from the u ##S ##4 - u ##S ##5 interface can also affect the de ##co ##ding process . We targeted one such interface - remote area , the loop 2 region ( residues 20 to 31 ) , for m ##uta ##genesis in E ##scher ##ichi ##a . co ##li and [SEP]\",\n",
    "  'existing_cui': 'C1419736',\n",
    "  'existing_cui_name': 'RPS4X gene',\n",
    "  'existing_cui_desc': '[CLS] R ##PS ##4 ##X gene [unused3] ( Ana ##tom ##ical Structure : S ##4 ; R ##IB ##OS ##OM ##AL PR ##OT ##EI ##N S ##4 , X - L ##IN ##KE ##D ; CE ##LL C ##Y ##CL ##E GE ##NE 2 ; rib ##oso ##mal protein S ##4 , X - linked ; S ##ING ##LE - CO ##P ##Y AB ##UN ##DA ##NT m ##RNA ; SC ##R ##10 ; R ##PS ##4 ; 40 ##S rib ##oso ##mal protein S ##4 , X is ##of ##orm ; single - copy abundant m ##RNA ; rib ##oso ##mal protein S ##4 ##X is ##of ##orm ; D ##X ##S ##30 ##6 ; FL ##J ##40 ##5 ##9 ##5 ; cell cycle gene 2 [SEP]',\n",
    "  'our_bi_cui': 'C0041528',\n",
    "  'our_bi_cui_name': 'U4 small nuclear RNA',\n",
    "  'our_bi_cui_desc': '[CLS] U ##4 small nuclear RNA [unused3] ( Chemical : U ##4 RNA ; U ##4 s ##n ##RNA ) [SEP]',\n",
    "  'our_cross_cui': 'C0073333',\n",
    "  'our_cross_cui_name': 'ribosomal protein S4',\n",
    "  'our_cross_cui_desc': '[CLS] rib ##oso ##mal protein S ##4 [unused3] ( Chemical : S ##4 rib ##oso ##mal protein ) [SEP]'},\n",
    " {'mention_id': '28223077.29',\n",
    "  'test_set_idx': 28913,\n",
    "  'type': 'T082',\n",
    "  'name': 'background site',\n",
    "  'context': '[CLS] , background site , up ##wind site and down ##wind site of a Municipal solid waste land ##fill in East China . The results of present study were summarized as follows . ( 1 ) The total concentrations of PC ##D ##D / F ##s ( [UNK] PC ##D ##D / F ##s ) in ambient air from surrounding sites , [unused1] background site [unused2] , up ##wind site and down ##wind site were 2 . 215 ± 1 . 00 ##4 , 2 . 05 ##8 ± 0 . 45 ##8 , 2 . 61 ##7 ± 1 . 09 ##2 and 1 . 82 ##2 ± 0 . 56 ##6 p ##g ##N ##m ( - 3 ) , respectively . ( 2 ) [SEP]',\n",
    "  'existing_cui': 'C0237490',\n",
    "  'existing_cui_name': 'Family Background',\n",
    "  'existing_cui_desc': '[CLS] Family Background [unused3] ( Finding , Family : Background ) [SEP]',\n",
    "  'our_bi_cui': 'C0442611',\n",
    "  'our_bi_cui_name': 'Industrial site',\n",
    "  'our_bi_cui_desc': '[CLS] Industrial site [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
    "  'our_cross_cui': 'C0205145',\n",
    "  'our_cross_cui_name': 'Site',\n",
    "  'our_cross_cui_desc': '[CLS] Site [unused3] ( Spa ##tial Concept , attribute , qualifier value : Sites ) [SEP]'},\n",
    " {'mention_id': '27371817.9',\n",
    "  'test_set_idx': 3913,\n",
    "  'type': 'T058',\n",
    "  'name': 'Non - destructive proton nuclear magnetic resonance ( ( 1 ) H NMR ) spectroscopy',\n",
    "  'context': '[CLS] of g ##ly ##cer ##op ##hos ##ph ##oli ##pid signatures of inflammation treated with non - s ##tero ##idal anti - inflammatory drugs - induced - RA ##W ##26 ##4 . 7 cells using ( 1 ) H N ##MR and U - HP ##LC / Q - TO ##F - MS [unused1] Non - destructive pro ##ton nuclear magnetic resonance ( ( 1 ) H N ##MR ) s ##pect ##ros ##copy [unused2] and highly sensitive ultra - performance liquid ch ##roma ##tography q ##uad ##rup ##ole time - of - flight mass s ##pect ##rome ##try ( U - HP ##LC / Q - TO ##F - MS ) coupled to data processing methods were applied to analyze the metabolic pro ##fi ##ling changes [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C3850002',\n",
    "  'our_bi_cui_name': 'Proton Magnetic Resonance Spectroscopy',\n",
    "  'our_bi_cui_desc': '[CLS] Proto ##n Ma ##gnetic Re ##son ##ance S ##pect ##ros ##copy [unused3] ( Health Care Act ##ivity : 1 ##H - MR ##S ) [SEP]',\n",
    "  'our_cross_cui': 'C0877853',\n",
    "  'our_cross_cui_name': 'Spectroscopy , Nuclear Magnetic Resonance',\n",
    "  'our_cross_cui_desc': '[CLS] S ##pect ##ros ##copy , Nuclear Ma ##gnetic Re ##son ##ance [unused3] ( Health Care Act ##ivity : S ##pect ##ros ##copy , N ##MR ; nuclear magnetic resonance s ##pect ##ros ##copy ; Nuclear magnetic resonance s ##pect ##ros ##copy ; N ##MR S ##pect ##ros ##copy ; S ##pect ##ros ##co ##pies , N ##MR ; N ##MR S ##pect ##ros ##co ##pies ; nm ##r s ##pect ##ros ##copy ) [SEP]'},\n",
    " {'mention_id': '28539192.15',\n",
    "  'test_set_idx': 38799,\n",
    "  'type': 'T033',\n",
    "  'name': 'complex level',\n",
    "  'context': '[CLS] the population specifically in health . Currently , there is a fragment ##ed model of patient care , in which the systems are exclusive of each other . They do not cooperate or communicate with each other ; and if there is no vertical communication within the system , preventing refer ##ral of patients directly from the basic level to the [unused1] complex level [unused2] of care when needed . In addition , there has been no progress in the development of an em ##path ##etic , respect ##ful or person - centered clinical practice ; instead , economic , social and educational differences per ##pet ##uate a paternal ##istic clinical practice . The task of or ##ient ##ing medical training towards the development of human [SEP]',\n",
    "  'existing_cui': 'C0056210',\n",
    "  'existing_cui_name': 'complex V',\n",
    "  'existing_cui_desc': '[CLS] complex V [unused3] ( Chemical , mitochondrial o ##xi ##da ##tive p ##hos ##ph ##ory ##lation system , mitochondrial o ##xi ##da ##tive p ##hos ##ph ##ory ##lation system , MA ##TS ##C , mitochondrial ad ##eno ##sin ##e trip ##hos ##phate s ##ynth ##ase complex : CO ##MP ##LE ##X ) [SEP]',\n",
    "  'our_bi_cui': 'C0456079',\n",
    "  'our_bi_cui_name': 'Disease classification level',\n",
    "  'our_bi_cui_desc': '[CLS] Disease classification level [unused3] ( Intel ##lect ##ual Product , attribute : Level ) [SEP]',\n",
    "  'our_cross_cui': 'C1547668',\n",
    "  'our_cross_cui_name': 'Level of Care',\n",
    "  'our_cross_cui_desc': '[CLS] Level of Care [unused3] ( Finding : Level of care ) [SEP]'},\n",
    " {'mention_id': '27756117.21',\n",
    "  'test_set_idx': 15618,\n",
    "  'type': 'T058',\n",
    "  'name': 'molding',\n",
    "  'context': '[CLS] ##gen are increasingly used due to their efficacy and their ease of application . In the present study , we describe a method to incorporate the co ##agu ##lant supplement ##s fi ##bri ##no ##gen and th ##rom ##bin in silk protein s ##po ##nges by mixing the co ##agu ##lants with an a ##que ##ous silk solution , followed by [unused1] mold ##ing [unused2] , freeze - drying and water an ##nea ##ling . In this combination system we demonstrate the delivery of fi ##bri ##no ##gen while maintaining its hem ##ost ##atic potential . Con ##cent ##ration ratios of silk to fi ##bri ##no ##gen of 1 . 0 % / 2 . 8 % , 2 . 3 % / 1 . 5 [SEP]',\n",
    "  'existing_cui': 'C0426103',\n",
    "  'existing_cui_name': 'Fetal head molding',\n",
    "  'existing_cui_desc': '[CLS] Fe ##tal head mold ##ing [unused3] ( Finding , finding , finding : F ##oe ##tal head m ##ou ##lding ; f ##etal head mold ##ing ; O ##bs ##er ##vation of f ##etal head mold ##ing ; Finding of f ##etal head m ##ou ##lding ; Finding of foe ##tal head m ##ou ##lding ; Mo ##lding ; O ##bs ##er ##vation of foe ##tal head m ##ou ##lding ; O ##bs ##er ##vation of f ##etal head m ##ou ##lding ; mold ##ing ; Finding of f ##etal head mold ##ing ; Fe ##tal head m ##ou ##lding ) [SEP]',\n",
    "  'our_bi_cui': 'C0947647',\n",
    "  'our_bi_cui_name': 'Manipulation procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Man ##ip ##ulation procedure [unused3] ( Health Care Act ##ivity , procedure , qualifier value , regime / therapy : manipulation ; Man ##ip ##ulation ##s ; Man ##ip ##ulation - action ; manipulation procedure ; Man ##ip ##ulate ; Man ##ip ##ula ##tive ; Man ##ip ##ulation ; Man ##ip ##ula ##tive procedure ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '27838742.64',\n",
    "  'test_set_idx': 19031,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] ##6 ##K pathway in A ##5 ##4 ##9 and PC - 9 cells . Del ##ica ##f ##lav ##one is a potential anti ##can ##cer agent that can induce auto ##pha ##gic cell death in human non - small cell lung cancer via the A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . [unused1] Del ##ica ##f ##lav ##one [unused2] showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27563025.32',\n",
    "  'test_set_idx': 10413,\n",
    "  'type': 'T017',\n",
    "  'name': 'C2C12 cells',\n",
    "  'context': '[CLS] ##no ##fi ##bres . To estimate the bio ##com ##pa ##ti ##bility of the 3D p ##oly ##cap ##rol ##act ##one / p ##oly ##ani ##line composite na ##no ##fi ##bre mac ##ros ##truct ##ures , mouse my ##ob ##last ##s ( C ##2 ##C ##12 cells ) were culture ##d as model cells . The initial responses of [unused1] C ##2 ##C ##12 cells [unused2] to the 3D p ##oly ##cap ##rol ##act ##one / p ##oly ##ani ##line composite mac ##ros ##truct ##ures were significantly superior to those to pure p ##oly ##cap ##rol ##act ##one , that is , the cells exhibited typical my ##ob ##last - like m ##or ##ph ##ologies with obvious pseudo ##po ##dia and the moderate incorporation ( less [SEP]',\n",
    "  'existing_cui': 'C0085262',\n",
    "  'existing_cui_name': 'PC12 Cells',\n",
    "  'existing_cui_desc': '[CLS] PC ##12 Cell ##s [unused3] ( Ana ##tom ##ical Structure : Cell Line , Ph ##eo ##ch ##rom ##oc ##yt ##oma ; Ph ##eo ##ch ##rom ##oc ##yt ##oma Cell Lines ; Ph ##eo ##ch ##rom ##oc ##yt ##oma 12 Cell Line ; PC A 01 ##2 CE ##LL ##S ; p ##he ##och ##rom ##oc ##yt ##oma 12 cell line ; PC - 12 ; p ##c ##12 cell ; PC ##12 Cell ; Ph ##eo ##ch ##rom ##oc ##yt ##oma Cell Line ; Cell Lines , Ph ##eo ##ch ##rom ##oc ##yt ##oma ; PC ##12 cell ; p ##c ##12 cells ) [SEP]',\n",
    "  'our_bi_cui': 'C1135917',\n",
    "  'our_bi_cui_name': 'Myoblasts , Cardiac',\n",
    "  'our_bi_cui_desc': '[CLS] My ##ob ##last ##s , Card ##iac [unused3] ( Ana ##tom ##ical Structure : cardiac my ##ob ##last ##s ; My ##ob ##last , Card ##iac ; cardiac my ##ob ##last ; Card ##iac my ##ob ##last ; Card ##iac My ##ob ##last ##s ; Card ##iac My ##ob ##last ) [SEP]',\n",
    "  'our_cross_cui': 'C0596995',\n",
    "  'our_cross_cui_name': 'Myoblasts',\n",
    "  'our_cross_cui_desc': '[CLS] My ##ob ##last ##s [unused3] ( Ana ##tom ##ical Structure : Mu ##s ##cle Cell ##s , Em ##b ##ryo ##nic ; My ##ob ##last ; Mu ##s ##cle Cell , Em ##b ##ryo ##nic ; Pre ##cu ##rs ##or Mu ##s ##cle Cell ##s ; Mu ##s ##cle Cell , Pre ##cu ##rs ##or ; my ##ob ##last ; Em ##b ##ryo ##nic Mu ##s ##cle Cell ##s ; my ##ob ##last ##s ; Pre ##cu ##rs ##or Mu ##s ##cle Cell ; Em ##b ##ryo ##nic Mu ##s ##cle Cell ; Mu ##s ##cle Cell ##s , Pre ##cu ##rs ##or ) [SEP]'},\n",
    " {'mention_id': '28460054.10',\n",
    "  'test_set_idx': 36759,\n",
    "  'type': 'T062',\n",
    "  'name': 'feasible strategy',\n",
    "  'context': '[CLS] Effect of ha ##lot ##ole ##rant r ##hi ##zo ##ba ##cter ##ia isolated from ha ##lop ##hy ##tes on the growth of sugar bee ##t ( Beta v ##ul ##gar ##is L . ) under salt stress U ##til ##ization of r ##hi ##zo ##ba ##cter ##ia that have associated with plant roots in harsh environments could be a [unused1] feasible strategy [unused2] to deal with limits to agricultural production caused by soil sa ##linity . Hal ##op ##hy ##tes occur naturally in high - salt environments , and their roots may be associated with promising micro ##bial candidates for promoting growth and salt tolerance in crops . This study aimed to is ##olate efficient ha ##lot ##ole ##rant plant - growth - promoting r ##hi [SEP]',\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0589212',\n",
    "  'our_bi_cui_name': 'Pragmatic enhancement strategies',\n",
    "  'our_bi_cui_desc': '[CLS] P ##rag ##matic enhance ##ment strategies [unused3] ( Health Care Act ##ivity , procedure , regime / therapy ) [SEP]',\n",
    "  'our_cross_cui': 'C0035171',\n",
    "  'our_cross_cui_name': 'Research Design',\n",
    "  'our_cross_cui_desc': '[CLS] Research Design [unused3] ( Research Act ##ivity : Experiment Design ; design research ; research design ; Design ##s , Research ; Design , Research ; ST ##YP ##E ; Research Design ##s ; study design ; Study Type ; Study Design ; Experimental Design ) [SEP]'},\n",
    " {'mention_id': '27371817.39',\n",
    "  'test_set_idx': 3943,\n",
    "  'type': 'T058',\n",
    "  'name': '( 1 ) H NMR spectroscopy',\n",
    "  'context': '[CLS] - MS showed higher sensitivity and specific ##ity and was more suitable for the determination of bio ##mark ##ers apart from the deficiency of time - consuming sample preparation steps and un ##am ##bi ##guous meta ##bol ##ite identification . Therefore , it is feasible to analyze the changes of g ##ly ##cer ##op ##hos ##ph ##oli ##pid ##s during inflammation by combining [unused1] ( 1 ) H N ##MR s ##pect ##ros ##copy [unused2] with U - HP ##LC / Q - TO ##F - MS . The metabolic pro ##fi ##ling of g ##ly ##cer ##op ##hos ##ph ##oli ##pid ##s provides valuable evidence for inflammation diagnosis and pro ##gno ##sis , and might un ##rave ##l the mechanisms involved in inflammation progression . [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C3850001',\n",
    "  'our_bi_cui_name': '1H NMR',\n",
    "  'our_bi_cui_desc': '[CLS] 1 ##H N ##MR [unused3] ( Health Care Act ##ivity : 1 ##H - N ##MR ) [SEP]',\n",
    "  'our_cross_cui': 'C0877853',\n",
    "  'our_cross_cui_name': 'Spectroscopy , Nuclear Magnetic Resonance',\n",
    "  'our_cross_cui_desc': '[CLS] S ##pect ##ros ##copy , Nuclear Ma ##gnetic Re ##son ##ance [unused3] ( Health Care Act ##ivity : S ##pect ##ros ##copy , N ##MR ; nuclear magnetic resonance s ##pect ##ros ##copy ; Nuclear magnetic resonance s ##pect ##ros ##copy ; N ##MR S ##pect ##ros ##copy ; S ##pect ##ros ##co ##pies , N ##MR ; N ##MR S ##pect ##ros ##co ##pies ; nm ##r s ##pect ##ros ##copy ) [SEP]'},\n",
    " {'mention_id': '27251800.7',\n",
    "  'test_set_idx': 802,\n",
    "  'type': 'T058',\n",
    "  'name': 'Stoppa technique',\n",
    "  'context': '[CLS] Early assessment of bilateral ing ##uin ##al her ##nia repair : A comparison between the lap ##aro ##scopic total extra ##per ##ito ##nea ##l and Stop ##pa approaches The present clinical trial was designed to compare the results of bilateral ing ##uin ##al her ##nia repair between patients who underwent the conventional [unused1] Stop ##pa technique [unused2] and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair with a single mesh and without staple fix ##ation . This controlled , random ##ised clinical trial was conducted at General Surgery and T ##ra ##uma of the Clinic ##s Hospital , Medical School , the University of S ##γ ##o Paulo between September 2010 and February 2011 . Total ##ly , 50 male patients , with a [SEP]',\n",
    "  'existing_cui': 'C0450241',\n",
    "  'existing_cui_name': 'Ffooks technique',\n",
    "  'existing_cui_desc': '[CLS] F ##fo ##ok ##s technique [unused3] ( Health Care Act ##ivity , qualifier value ) [SEP]',\n",
    "  'our_bi_cui': 'C0031150',\n",
    "  'our_bi_cui_name': 'Laparoscopy',\n",
    "  'our_bi_cui_desc': '[CLS] La ##par ##os ##copy [unused3] ( Health Care Act ##ivity , G ##I only , procedure : La ##par ##os ##copic procedure ; per ##ito ##ne ##os ##copy ; Co ##eli ##os ##copy ; Ce ##lio ##sco ##pies ; Per ##ito ##ne ##os ##co ##pies ; Abd ##ome ##n end ##os ##copy ; c ##eli ##os ##copy ; lap ##aro ##scopic procedure ; Per ##ito ##ne ##os ##copy ; La ##p ; Ce ##lio ##sco ##py ; La ##par ##os ##co ##pies ; lap ##aro ##sco ##pies ; lap ##aro ##sco ##py ; lap ##aro ##scopic procedures ; diagnostic lap ##aro ##sco ##py ; End ##os ##copy of abdomen ; lap ##aro ##sco ##py procedure ; La ##par ##os ##copic ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27444636.43',\n",
    "  'test_set_idx': 5994,\n",
    "  'type': 'T170',\n",
    "  'name': 'Adverse Events Profile',\n",
    "  'context': '[CLS] ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate , there were significant improvements in mean scores for Ad ##verse Events Profile ( P < . 00 ##1 ) , Quality of Life in E ##pile ##psy In ##vent ##ory 10 ( P = . 00 ##1 ) , and alert ##ness ( P < . 05 ) . [unused1] Ad ##verse Events Profile [unused2] total scores improved for 21 / 21 ( 100 . 0 % ) patients , Quality of Life in E ##pile ##psy In ##vent ##ory 10 total scores improved for 17 / 21 ( 81 . 0 % ) patients , and alert ##ness scores improved for 16 / 21 ( 76 . 2 % ) patients . In this [SEP]',\n",
    "  'existing_cui': 'C0877248',\n",
    "  'existing_cui_name': 'Adverse event',\n",
    "  'existing_cui_desc': '[CLS] Ad ##verse event [unused3] ( B ##iol ##og ##ic Fun ##ction : AD ##VE ##RS ##E E ##VE ##NT ; adverse events ; Ad ##verse Event ; adverse event ; Ad ##verse ##E ##vent ; Ad ##verse Experience ) [SEP]',\n",
    "  'our_bi_cui': 'C1521800',\n",
    "  'our_bi_cui_name': 'Adverse Drug Experience Report',\n",
    "  'our_bi_cui_desc': '[CLS] Ad ##verse Drug Experience Report [unused3] ( Intel ##lect ##ual Product : Ad ##verse Drug Report ; Ad ##verse Experience Report ; Ad ##verse Event Report ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28375449.10',\n",
    "  'test_set_idx': 33493,\n",
    "  'type': 'T058',\n",
    "  'name': 'knotting',\n",
    "  'context': '[CLS] attempt to reduce the difficulty of this surgical procedure , this study developed a modified an ##ast ##omo ##tic technique for th ##ora ##cola ##par ##os ##copic I ##vor - Lewis es ##op ##hage ##ct ##omy . During the entirety of this modified approach , neither technically challenging operations such as in ##tra ##th ##ora ##ci ##c su ##tur ##ing or [unused1] knot ##ting [unused2] , nor special instruments such as an Or ##V ##il system or a reverse - pu ##nc ##ture head are required . Between October 2015 and January 2016 , 15 consecutive patients with cancer in the di ##stal third of the es ##op ##ha ##gus or the gas ##tric card ##ia underwent this modified surgical procedure . The good short - [SEP]',\n",
    "  'existing_cui': 'C0263493',\n",
    "  'existing_cui_name': 'Trichonodosis',\n",
    "  'existing_cui_desc': '[CLS] Tri ##cho ##no ##dos ##is [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Hair knot ##ting ; t ##rich ##ono ##dos ##is ; K ##not ##ted hairs ; knot ##ting of hair ; K ##not ##ting of hair shaft ) [SEP]',\n",
    "  'our_bi_cui': 'C0023690',\n",
    "  'our_bi_cui_name': 'Ligation',\n",
    "  'our_bi_cui_desc': '[CLS] Liga ##tion [unused3] ( Health Care Act ##ivity , procedure , qualifier value : surgical binding ; l ##iga ##tion ; C ##losure by Liga ##tion ; Liga ##tion - action ; Liga ##tions ; C ##losure by l ##iga ##tion ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27273231.33',\n",
    "  'test_set_idx': 1214,\n",
    "  'type': 'T033',\n",
    "  'name': 'No',\n",
    "  'context': '[CLS] period , the pulmonary art ##eries were sampled . Press ##ure tolerance at the sealed end was evaluated in 91 pulmonary artery sections . All sealed ends showed pressure tolerance > 75 mm H ##g . A left lower lobe ##ct ##omy was performed in 13 dogs in which 35 pulmonary artery sections had been allocated into the 3 groups . [unused1] No [unused2] sealing failure was found , and path ##ological findings showed healing and persistent hem ##ost ##asis at all sealed ends of the pulmonary art ##eries after 2 and 4 weeks of the survival period . P ##ul ##mona ##ry art ##eries sealed in v ##ivo with the En ##sea ##l device showed pressure tolerance > 75 mm H ##g in the acute [SEP]',\n",
    "  'existing_cui': 'C1016143',\n",
    "  'existing_cui_name': 'Tetragenococcus halophilus',\n",
    "  'existing_cui_desc': '[CLS] Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us [unused3] ( Ba ##cter ##ium , organism : P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us Me ##es 1934 ( A ##pp ##roved List ##s 1980 ) ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##us ( Me ##es 1934 ) Collins et al . 1993 ; Sa ##rc ##ina ha ##ma ##guchi ##ae ; Te ##tra ##gen ##oc ##oc ##cus ha ##lop ##hil ##a ; P ##ed ##io ##co ##cc ##us ha ##lop ##hil ##us ; Te ##tra ##co ##cc ##cus No . 1 ; P ##ed ##io ##co ##cc ##us so ##ya ##e ) [SEP]',\n",
    "  'our_bi_cui': 'C0243095',\n",
    "  'our_bi_cui_name': 'Finding',\n",
    "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C1513916',\n",
    "  'our_cross_cui_name': 'Negative Finding',\n",
    "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
    " {'mention_id': '28495651.34',\n",
    "  'test_set_idx': 37809,\n",
    "  'type': 'T201',\n",
    "  'name': 'cardiovascular death',\n",
    "  'context': '[CLS] Hodges , and 1 . 12 ( 0 . 28 - 4 . 52 ) for Q ##T ##c Fr ##ami ##ng ##ham . The hazard ratio of Q ##T ##c Ba ##ze ##tt was significantly higher than the other formula ##s except for the 98 ##th percent ##ile method . The Fr ##ami ##ng ##ham , Hodges , and Fr ##ider ##ici ##a equations remove the effect of heart rate on Q ##T interval significantly better than the Ba ##ze ##tt equation . Using Q ##T - interval percent ##iles based on heart rate provides a consistent approach both for identifying those whose Q ##T intervals pro ##long due to drugs or other stress ##ors and for assessing [unused1] card ##iovascular death [unused2] risk . [SEP]',\n",
    "  'existing_cui': 'C0007226',\n",
    "  'existing_cui_name': 'Cardiovascular system',\n",
    "  'existing_cui_desc': '[CLS] Card ##iovascular system [unused3] ( Body System , body structure : Structure of card ##iovascular system , un ##sp ##ec ##ified ; CA ##RD ##IO ##VA ##SC ##U ##LA ##R S ##Y ##ST ##EM ; Card ##iovascular ; Organ System , Card ##iovascular ; CA ##RD ##IO ##VA ##SC S ##Y ##ST ##EM ; Card ##iovascular structure ; card ##iovascular system ; Card ##iovascular Organ System ; C ##ir ##cula ##tory ; Structure of card ##iovascular system ; Card ##iovascular Systems ; card ##iovascular structure ; C ##ir ##cula ##tory System ; C ##ir ##cula ##tory Systems ; { C ##ir ##cula ##tory system } ; c ##ir ##cula ##tory ; C ##ir ##cula ##tory system ; Body System , Card ##iovascular ; card ##iovascular system [SEP]',\n",
    "  'our_bi_cui': 'C0376297',\n",
    "  'our_bi_cui_name': 'Cardiac Death',\n",
    "  'our_bi_cui_desc': '[CLS] Card ##iac Death [unused3] ( B ##iol ##og ##ic Fun ##ction : death ; cardiac ; cardiac death ; cardiac deaths ; Card ##iac death ; Death , Card ##iac ; cardiac ; death ) [SEP]',\n",
    "  'our_cross_cui': 'C2926098',\n",
    "  'our_cross_cui_name': \"Mechanism of death in patient 's dying of cardiovascular causes : Type : Point in time : ^ Patient : Nominal\",\n",
    "  'our_cross_cui_desc': \"[CLS] Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : Point in time : ^ Pat ##ient : No ##mina ##l [unused3] ( Clinical At ##tri ##but ##e : Death due to C ##V causes ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : P ##t : ^ Pat ##ient : No ##m ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes ) [SEP]\"},\n",
    " {'mention_id': '28493435.9',\n",
    "  'test_set_idx': 37724,\n",
    "  'type': 'T033',\n",
    "  'name': 'locate',\n",
    "  'context': '[CLS] el ##ast ##ography algorithms , lo ##cating ex ##tre ##ma in multi ##mo ##dal ultra ##sonic radio ##f ##re ##que ##ncy signals is still a challenging problem . In this paper , a new method is proposed to locate the local ma ##xi ##ma and mini ##ma of the RF signals directly without der ##ivation operation . This algorithm can accurately [unused1] locate [unused2] ex ##tre ##ma even if disturbed peaks resulting from different noise exist . Furthermore , the new algorithm can speed up approximately 79 % of the implementation process as compared with the standard cross - correlation method on the same computing platform . In addition , the el ##ast ##ographic signal - to - noise ratio and the contrast - to - [SEP]',\n",
    "  'existing_cui': 'C1366498',\n",
    "  'existing_cui_name': 'Chloramphenicol Acetyl Transferase Gene',\n",
    "  'existing_cui_desc': '[CLS] Ch ##lora ##mp ##hen ##ico ##l Ace ##ty ##l Transfer ##ase Gene [unused3] ( Ana ##tom ##ical Structure : cat Gene ) [SEP]',\n",
    "  'our_bi_cui': 'C0450429',\n",
    "  'our_bi_cui_name': 'Location',\n",
    "  'our_bi_cui_desc': '[CLS] Location [unused3] ( Spa ##tial Concept , attribute : location ; Lo ##c ; L ##OC ; locations ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27444636.40',\n",
    "  'test_set_idx': 5991,\n",
    "  'type': 'T170',\n",
    "  'name': 'Adverse Events Profile',\n",
    "  'context': '[CLS] ##rb ##az ##ep ##ine ace ##tate ( days 0 and 5 , respectively ) . The analysis included 21 patients ( 12 women , 9 men ; mean age 36 years ) . After switching from o ##x ##car ##ba ##ze ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate , there were significant improvements in mean scores for [unused1] Ad ##verse Events Profile [unused2] ( P < . 00 ##1 ) , Quality of Life in E ##pile ##psy In ##vent ##ory 10 ( P = . 00 ##1 ) , and alert ##ness ( P < . 05 ) . Ad ##verse Events Profile total scores improved for 21 / 21 ( 100 . 0 % ) patients , Quality of Life in [SEP]',\n",
    "  'existing_cui': 'C0877248',\n",
    "  'existing_cui_name': 'Adverse event',\n",
    "  'existing_cui_desc': '[CLS] Ad ##verse event [unused3] ( B ##iol ##og ##ic Fun ##ction : AD ##VE ##RS ##E E ##VE ##NT ; adverse events ; Ad ##verse Event ; adverse event ; Ad ##verse ##E ##vent ; Ad ##verse Experience ) [SEP]',\n",
    "  'our_bi_cui': 'C1521800',\n",
    "  'our_bi_cui_name': 'Adverse Drug Experience Report',\n",
    "  'our_bi_cui_desc': '[CLS] Ad ##verse Drug Experience Report [unused3] ( Intel ##lect ##ual Product : Ad ##verse Drug Report ; Ad ##verse Experience Report ; Ad ##verse Event Report ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27932585.13',\n",
    "  'test_set_idx': 22240,\n",
    "  'type': 'T103',\n",
    "  'name': 'Taw3',\n",
    "  'context': '[CLS] ##lm ##eth ##ion ##ine ( S - ad ##eno ##sy ##lm ##eth ##ion ##ine ) - dependent met ##hyl ##tra ##ns ##fer ##ases regulate a wide range of biological processes through the modification of proteins , nuclei ##c acids , p ##oly ##sa ##cc ##hari ##des , as well as various meta ##bol ##ites . T ##Y ##W ##3 / [unused1] Ta ##w ##3 [unused2] is a SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ase responsible for the formation of a t ##RNA modification known as w ##y ##but ##os ##ine and its derivatives that are required for accurate de ##co ##ding in protein synthesis . Here , we report the crystal structure of Ta ##w ##3 , a ho ##mo ##log of T [SEP]',\n",
    "  'existing_cui': 'C3496263',\n",
    "  'existing_cui_name': 'annectant white matter',\n",
    "  'existing_cui_desc': '[CLS] an ##nect ##ant white matter [unused3] ( Ana ##tom ##ical Structure : Sub ##stant ##ia me ##du ##llar ##is an ##nect ##ens ) [SEP]',\n",
    "  'our_bi_cui': 'C1538017',\n",
    "  'our_bi_cui_name': 'MT-TW gene',\n",
    "  'our_bi_cui_desc': '[CLS] M ##T - T ##W gene [unused3] ( Ana ##tom ##ical Structure : t ##rn ##W ; t ##RNA - T ##RP , MIT ##OC ##H ##ON ##DR ##IA ##L ; mitochondrial ##ly encoded t ##RNA try ##pt ##op ##han ; T ##RA ##NS ##F ##ER RNA , MIT ##OC ##H ##ON ##DR ##IA ##L , T ##R ##YP ##TO ##P ##HA ##N ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27778231.78',\n",
    "  'test_set_idx': 16399,\n",
    "  'type': 'T038',\n",
    "  'name': 'resistant',\n",
    "  'context': '[CLS] pro ##gno ##stic value of these proteins in childhood acute l ##ymph ##ob ##lastic le ##uke ##mia . Furthermore , investigation of protein - protein interaction using ST ##RI ##NG database indicated that these proteins involved in the signaling pathway of N ##R ##3 ##C ##1 as de ##xa ##met ##has ##one target . In conclusion , our pro ##te ##omi ##c study in de ##xa ##met ##has ##one [unused1] resistant [unused2] le ##uke ##mic cells revealed voltage dependent an ##ion channel 1 , sorting N ##ex ##in 3 , and pre ##fold ##in subunit 6 are promising proteins that might serve as potential bio ##mark ##ers of pro ##gno ##sis and ch ##em ##otherapy in childhood acute l ##ymph ##ob ##lastic le ##uke ##mia . [SEP]',\n",
    "  'existing_cui': 'C2827757',\n",
    "  'existing_cui_name': 'Antimicrobial Resistance Result',\n",
    "  'existing_cui_desc': '[CLS] Anti ##mic ##ro ##bial Resistance Re ##sul ##t [unused3] ( Finding : Re ##sist ##ant ; R ##ES ##IS ##TA ##NT ) [SEP]',\n",
    "  'our_bi_cui': 'C1514892',\n",
    "  'our_bi_cui_name': 'Resistance Process',\n",
    "  'our_bi_cui_desc': '[CLS] Resistance Process [unused3] ( B ##iol ##og ##ic Fun ##ction : Resistance ; Re ##sist ##ant ) [SEP]',\n",
    "  'our_cross_cui': 'C0013203',\n",
    "  'our_cross_cui_name': 'Drug resistance',\n",
    "  'our_cross_cui_desc': '[CLS] Drug resistance [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : drug - related disorder resistance ; Drug Resistance Process ; Drug Resistance ; drug resistance ; Resistance , Drug ; obsolete drug resistance ; drugs resistance ; resistance drug ) [SEP]'},\n",
    " {'mention_id': '27965426.23',\n",
    "  'test_set_idx': 22660,\n",
    "  'type': 'T103',\n",
    "  'name': 'tyrosine - phosphorylated proteins',\n",
    "  'context': '[CLS] t ##yr ##os ##ine p ##hos ##ph ##ory ##lation in mit ##otic human cells including those on spin ##dle - associated proteins . ? Database mining confirmed ~ 2000 mit ##otic p ##hos ##ph ##ot ##yr ##os ##ine sites , and network analysis revealed a number of sub ##net ##works that were en ##rich ##ed in [unused1] t ##yr ##os ##ine - p ##hos ##ph ##ory ##lated proteins [unused2] , including components of the kin ##eto ##chor ##e or spin ##dle and SR ##C family kinase ##s . We identified Polo - like kinase 1 , a major signaling hub in the spin ##dle sub ##net ##work , as p ##hos ##ph ##ory ##lated at the conserved Ty ##r ( 217 ) in the kinase domain [SEP]',\n",
    "  'existing_cui': 'C0168164',\n",
    "  'existing_cui_name': 'GAP-associated protein p62',\n",
    "  'existing_cui_desc': '[CLS] GA ##P - associated protein p ##6 ##2 [unused3] ( Chemical : t ##yr ##os ##ine - p ##hos ##ph ##ory ##lated protein p ##6 ##2 ) [SEP]',\n",
    "  'our_bi_cui': 'C0031689',\n",
    "  'our_bi_cui_name': 'Phosphoproteins',\n",
    "  'our_bi_cui_desc': '[CLS] Ph ##os ##ph ##op ##rote ##ins [unused3] ( Chemical : Ph ##os ##ph ##op ##rote ##in ; Ph ##os ##ph ##op ##rote ##ins [ Chemical / In ##g ##red ##ient ] ; p ##hos ##ph ##op ##rote ##in ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27509301.9',\n",
    "  'test_set_idx': 8791,\n",
    "  'type': 'T103',\n",
    "  'name': 'environmental chemicals',\n",
    "  'context': \"[CLS] ##genic B ##io ##act ##ivity of Environmental Chemical Met ##ab ##oli ##tes The US Environmental Protection Agency ' s End ##oc ##rine Di ##s ##rup ##tor Screen ##ing Program is using in v ##it ##ro data generated from To ##x ##C ##ast / To ##x ##21 high - through ##put screening ass ##ays to assess the end ##oc ##rine activity of [unused1] environmental chemicals [unused2] . Considering that in v ##it ##ro ass ##ays may have limited metabolic capacity , inactive chemicals that are bio ##tra ##ns ##formed into meta ##bol ##ites with end ##oc ##rine bio ##act ##ivity may be missed for further screening and testing . Therefore , there is a value in developing novel approaches to account for metabolism and end ##oc ##rine [SEP]\",\n",
    "  'existing_cui': 'C0014406',\n",
    "  'existing_cui_name': 'Environment',\n",
    "  'existing_cui_desc': '[CLS] Environment [unused3] ( Spa ##tial Concept , environment , treatment : environments ; Environment ##s ; environment ; Environmental ; E ##N ##VI ##R ; en ##vir ; En ##vir ) [SEP]',\n",
    "  'our_bi_cui': 'C0014417',\n",
    "  'our_bi_cui_name': 'Environmental Pollutants',\n",
    "  'our_bi_cui_desc': '[CLS] Environmental Poll ##uta ##nts [unused3] ( Chemical : E ##N ##VI ##R P ##OL ##L ##UT ##AN ##TS ; P ##OL ##L ##UT ##AN ##TS E ##N ##VI ##R ; Poll ##uta ##nts , Environmental ) [SEP]',\n",
    "  'our_cross_cui': 'C0220806',\n",
    "  'our_cross_cui_name': 'Chemicals',\n",
    "  'our_cross_cui_desc': '[CLS] Chemical ##s [unused3] ( Chemical , medication , substance : chemical compounds ; Chemical ; chemical compound ; Chemical compound ; chemical substance ; Chemical ##ly ; Chemical product ; Chemical agent ; Chemical element AND / OR compound ; chemical ; chemicals ) [SEP]'},\n",
    " {'mention_id': '28209945.41',\n",
    "  'test_set_idx': 28530,\n",
    "  'type': 'T033',\n",
    "  'name': 'conducive',\n",
    "  'context': '[CLS] > 0 . 05 ) , and compared with group B , H ##IF - 1 ##α and P - select ##in in group C were lower ( P < 0 . 01 ) ; 60 min after the transplant ##ation , H ##IF - 1 ##α , ch ##em ##oki ##ne C ##X ##CL ##14 , P - select ##in , and S ##nail in group C were lower than that in group B ( P < 0 . 01 ) . CO ##NC ##L ##US ##ION ##S h ##y ##pot ##her ##mic machine per ##fusion can significantly reduce the levels of o ##xi ##da ##tive stress factors and inflammatory factors , which is [unused1] con ##du ##ci ##ve [unused2] for liver transplant ##ation . [SEP]',\n",
    "  'existing_cui': 'C3640666',\n",
    "  'existing_cui_name': 'Urine Conductivity',\n",
    "  'existing_cui_desc': '[CLS] U ##rine Con ##duct ##ivity [unused3] ( Health Care Act ##ivity : CO ##ND ##UC ##TU ) [SEP]',\n",
    "  'our_bi_cui': 'C0562524',\n",
    "  'our_bi_cui_name': 'Temperate environment',\n",
    "  'our_bi_cui_desc': '[CLS] Te ##mper ##ate environment [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28127853.24',\n",
    "  'test_set_idx': 26318,\n",
    "  'type': 'T058',\n",
    "  'name': 'program',\n",
    "  'context': '[CLS] The \" At ##ti ##tudes toward A ##ging Scale \" and the \" Spiritual Health Scale \" were two assessment instruments used in the study . The results showed that there were significant improvements in the At ##ti ##tudes toward A ##ging Scale for the young adult group ( aged 18 - 29 years ) and in the Spiritual Health Scale for the older adult group ( aged 65 - 80 years ) . The evaluation showed that participants were satisfied with the [unused1] program [unused2] . The results of the present study provide future directions for successful aging and inter ##gene ##ration ##al learning . G ##eria ##tr G ##eron ##to ##l In ##t 2017 ; • • : • • - • • . [SEP]',\n",
    "  'existing_cui': 'C0237807',\n",
    "  'existing_cui_name': 'Mental health program',\n",
    "  'existing_cui_desc': '[CLS] Mental health program [unused3] ( Organization , Mental Health : health mental programs ; Programs ; Mental Health Programs ; mental health programs ; mental health program ) [SEP]',\n",
    "  'our_bi_cui': 'C0376691',\n",
    "  'our_bi_cui_name': 'Programs - Publication Format',\n",
    "  'our_bi_cui_desc': '[CLS] Programs - Public ##ation Form ##at [unused3] ( Intel ##lect ##ual Product : Programs ) [SEP]',\n",
    "  'our_cross_cui': 'C0043113',\n",
    "  'our_cross_cui_name': 'Wellness Programs',\n",
    "  'our_cross_cui_desc': '[CLS] Well ##ness Programs [unused3] ( Health Care Act ##ivity : program well ##ness ; programs well ##ness ; Programs , Well ##ness ; Well ##ness Program ; well ##ness programs ; programming well ##ness ; Program , Well ##ness ; well ##ness program ) [SEP]'},\n",
    " {'mention_id': '28009593.23',\n",
    "  'test_set_idx': 23576,\n",
    "  'type': 'T098',\n",
    "  'name': 'sample',\n",
    "  'context': \"[CLS] of Nursing Scale - R ##N version ( P ##ON ##S - R ##N ) was developed to measure nurses ' perception ##s of their ability to be present to their patients . This study sum ##mar ##izes the process of re - evaluation of the ps ##ych ##ometric properties of the P ##ON ##S - R ##N instrument . A [unused1] sample [unused2] of 76 registered nurses providing direct patient care responded to the 31 - item question ##naire . The Ra ##sch rating scale model was used for assessing construct validity of P ##ON ##S - R ##N data . A principal component analysis of residual ##s supported appropriate ##ness of the sub ##sca ##les defined by a 2 - dimensional structure . The [SEP]\",\n",
    "  'existing_cui': 'C0586999',\n",
    "  'existing_cui_name': 'Vein sample',\n",
    "  'existing_cui_desc': '[CLS] V ##ein sample [unused3] ( Ana ##tom ##ical Structure , specimen ) [SEP]',\n",
    "  'our_bi_cui': 'C2348150',\n",
    "  'our_bi_cui_name': 'Sample Study Population',\n",
    "  'our_bi_cui_desc': '[CLS] Sam ##ple Study Population [unused3] ( Population Group ) [SEP]',\n",
    "  'our_cross_cui': 'C1257890',\n",
    "  'our_cross_cui_name': 'Population Group',\n",
    "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
    " {'mention_id': '27722881.39',\n",
    "  'test_set_idx': 15026,\n",
    "  'type': 'T007',\n",
    "  'name': 'JPM1',\n",
    "  'context': '[CLS] modeling method was applied to build the crystal structure of di ##ox ##y ##gen ##ase . Subsequently , the interaction mechanism between flu ##oran ##the ##ne and the active site of di ##ox ##y ##gen ##ase was simulated and analyzed by molecular dock ##ing . Consequently , a feasible de ##grading pathway of flu ##oran ##the ##ne in the strain [unused1] JP ##M ##1 [unused2] was proposed based on the meta ##bol ##ites and the interaction analyses . Additionally , the the ##rm ##ody ##nam ##ic analysis showed that the strain JP ##M ##1 had high tolerance for flu ##oran ##the ##ne , and the influence of flu ##oran ##the ##ne for the bacterial growth activity was ne ##gli ##gible under 100 to 400 mg L [SEP]',\n",
    "  'existing_cui': 'C1421124',\n",
    "  'existing_cui_name': 'TRGJP gene',\n",
    "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
    "  'our_bi_cui': 'C3629619',\n",
    "  'our_bi_cui_name': 'bacterium JP1',\n",
    "  'our_bi_cui_desc': '[CLS] bacterium JP ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
    "  'our_cross_cui': 'C4153571',\n",
    "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
    " {'mention_id': '27802570.34',\n",
    "  'test_set_idx': 17786,\n",
    "  'type': 'T103',\n",
    "  'name': 'soluble protein',\n",
    "  'context': '[CLS] ) O ##2 ( - ) ( super ##oxide an ##ion ) production were effectively decreased in the range of 27 . 27 % to 54 . 38 % . Ph ##ys ##ico ##chemical characteristics showed that k ##i ##wi ##f ##ruit ##s from treated group maintained higher levels of flesh l ##umi ##nos ##ity and firm ##ness . Essential oils also decreased the levels of reducing sugar by 45 . 97 % at day 3 , and increased the content of [unused1] soluble protein [unused2] and h ##ydro ##ly ##zed amino acid . Therefore , post ##har ##ves ##t Essential oils treatment has positive effects on delay ##ing se ##nes ##cence and enhancing anti ##ox ##ida ##nt capacities in k ##i ##wi ##f ##ruit . [SEP]',\n",
    "  'existing_cui': 'C1749467',\n",
    "  'existing_cui_name': 'soluble',\n",
    "  'existing_cui_desc': '[CLS] soluble [unused3] ( Ana ##tom ##ical Structure ) [SEP]',\n",
    "  'our_bi_cui': 'C0074926',\n",
    "  'our_bi_cui_name': 'Soy Proteins',\n",
    "  'our_bi_cui_desc': '[CLS] So ##y Pro ##tein ##s [unused3] ( Chemical , substance : So ##y proteins ; Pro ##tein ##s , So ##y ; Diet ##ary So ##y ##be ##an Pro ##tein ##s ; So ##y protein ; So ##y Pro ##tein ; Diet ##ary So ##y ##be ##an Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; so ##y proteins ; protein so ##y ; S ##O ##Y PR ##OT ##EI ##N ; so ##y protein ; So ##ya protein ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28203549.107',\n",
    "  'test_set_idx': 28299,\n",
    "  'type': 'T170',\n",
    "  'name': 'ST types',\n",
    "  'context': '[CLS] accounted for more than three is ##olate ##s . These five P ##F ##GE clusters only accounted for 35 ( 41 . 7 % , 35 / 84 ) is ##olate ##s . In conclusion , our study first found that h ##yper ##tens ##ion and male patients with 41 - 50 years old were independent risk factors . The composition of [unused1] ST types [unused2] and P ##F ##GE clusters among K . pneumonia ##e K ##2 is ##olate ##s was more diverse than K ##1 is ##olate ##s . K ##1 and K ##2 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s had respective specific profiles of v ##ir ##ule ##nce - associated genes . [SEP]',\n",
    "  'existing_cui': 'C0449570',\n",
    "  'existing_cui_name': 'Test type',\n",
    "  'existing_cui_desc': '[CLS] Test type [unused3] ( Intel ##lect ##ual Product , attribute : test types ; testing types ; tests typing ; test type ; tests types ; test typing ; type test ; tests type ) [SEP]',\n",
    "  'our_bi_cui': 'C0441756',\n",
    "  'our_bi_cui_name': 'Genotype types',\n",
    "  'our_bi_cui_desc': '[CLS] Gen ##otype types [unused3] ( Intel ##lect ##ual Product , qualifier value ) [SEP]',\n",
    "  'our_cross_cui': 'C0449943',\n",
    "  'our_cross_cui_name': 'Serotype',\n",
    "  'our_cross_cui_desc': '[CLS] Ser ##otype [unused3] ( Intel ##lect ##ual Product , attribute , o ##bs ##er ##vable entity , qualifier value : se ##rov ##ar ; se ##rov ##ars ; Ser ##ova ##rs ; se ##rot ##ype ; se ##rot ##ype ##s ; Ser ##otype ##s ; Ser ##ova ##r ) [SEP]'},\n",
    " {'mention_id': '27601292.8',\n",
    "  'test_set_idx': 11183,\n",
    "  'type': 'T038',\n",
    "  'name': 'metabolizing',\n",
    "  'context': '[CLS] V ##ori ##cona ##zo ##le metabolism is influenced by severe inflammation : a prospective study During an infection or inflammation , several drug - [unused1] meta ##bol ##izing [unused2] enzymes in the liver are down - regulated , including c ##yt ##och ##rome P ##45 ##0 is ##o - enzymes . Since v ##ori ##cona ##zo ##le is extensively meta ##bol ##ized by c ##yt ##och ##rome P ##45 ##0 is ##o - enzymes , the metabolism of v ##ori ##cona ##zo ##le can be influenced during inflammation via reduced clearance of the drug , resulting in higher v ##ori ##cona ##zo ##le t ##rough concentrations . To investigate prospective ##ly the influence of inflammation on v ##ori ##cona ##zo ##le metabolism and v ##ori ##cona [SEP]',\n",
    "  'existing_cui': 'C0085509',\n",
    "  'existing_cui_name': 'Sulfur-Reducing Bacteria',\n",
    "  'existing_cui_desc': '[CLS] Sul ##fu ##r - Red ##uc ##ing Ba ##cter ##ia [unused3] ( Ba ##cter ##ium , organism : Sul ##fu ##r Red ##uc ##ing Ba ##cter ##ia ; S ##U ##LF ##UR R ##ED ##UC ##ING BA ##CT ; Sul ##ph ##ur reducing bacteria ; Sub ##c ##lass Sul ##fu ##r Red ##uc ##ing Ba ##cter ##ia ; sulfur meta ##bol ##izing bacteria ; Sub ##c ##lass Sul ##ph ##ur Red ##uc ##ing Ba ##cter ##ia ; Sul ##fu ##r reducing bacteria ) [SEP]',\n",
    "  'our_bi_cui': 'C0870883',\n",
    "  'our_bi_cui_name': 'Metabolite',\n",
    "  'our_bi_cui_desc': '[CLS] Met ##ab ##oli ##te [unused3] ( Chemical : meta ##bol ##ites ; meta ##bol ##ite ; Met ##ab ##oli ##tes ) [SEP]',\n",
    "  'our_cross_cui': 'C0683140',\n",
    "  'our_cross_cui_name': 'drug metabolism',\n",
    "  'our_cross_cui_desc': '[CLS] drug metabolism [unused3] ( B ##iol ##og ##ic Fun ##ction : Drug Met ##ab ##olis ##m ; drug metabolic process ; drugs metabolism ; bio ##tra ##ns ##formation drug ; bio ##tra ##ns ##formation drugs ; metabolism drug ) [SEP]'},\n",
    " {'mention_id': '28234635.24',\n",
    "  'test_set_idx': 29192,\n",
    "  'type': 'T103',\n",
    "  'name': 'LXR',\n",
    "  'context': '[CLS] investigated potential molecular mechanisms of liver injury in p ##ediatric onset in ##test ##inal failure . Live ##r expression of canal ##icular p ##hos ##ph ##oli ##pid ( ABC ##B ##4 ) , bi ##le acid ( ABC ##B ##11 ) , and s ##tero ##l ( ABC ##G ##5 / 8 ) transport ##ers , their upstream regulator ##s [unused1] L ##X ##R [unused2] and FX ##R as well as pro - inflammatory c ##yt ##oki ##nes inter ##le ##uki ##n - 6 and tumor ne ##c ##rosis factor were investigated among patients with in ##test ##inal failure [ age median 3 . 8 ( I ##Q ##R 1 . 2 to 11 ) ] in relation to bio ##chemical and his ##to ##log ##ic [SEP]',\n",
    "  'existing_cui': 'C4288814',\n",
    "  'existing_cui_name': 'Liver X Receptor-Like Family',\n",
    "  'existing_cui_desc': '[CLS] Live ##r X Re ##ceptor - Like Family [unused3] ( Chemical : L ##X ##R Family ; Nuclear Re ##ceptor Sub ##family 1 Group H ) [SEP]',\n",
    "  'our_bi_cui': 'C0385463',\n",
    "  'our_bi_cui_name': 'leptin receptor',\n",
    "  'our_bi_cui_desc': '[CLS] le ##pt ##in receptor [unused3] ( Chemical : R ##EC ##EP ##T L ##EP ##TI ##N ; Re ##ceptor , O ##B ; O ##B - R ; L ##EP ##TI ##N R ##EC ##EP ##T ; O ##B Re ##ceptor ; L ##EP ##R ; CD ##29 ##5 Anti ##gens ; AN ##TI ##GE ##NS CD 295 ; Re ##ceptor ##s , Le ##pt ##in [ Chemical / In ##g ##red ##ient ] ; Le ##pt ##in Bin ##ding Pro ##tein ; Le ##pt ##in Re ##ceptor ; L ##EP ##R Pro ##tein ; Hu ##B ##21 ##9 ; Re ##ceptor , Le ##pt ##in ; Le ##pt ##in Re ##ceptor ##s ; O ##B R ##EC ##EP ##T ; Re ##ceptor ##s , Le [SEP]',\n",
    "  'our_cross_cui': 'C4277606',\n",
    "  'our_cross_cui_name': 'Liver X Receptors',\n",
    "  'our_cross_cui_desc': '[CLS] Live ##r X Re ##ceptor ##s [unused3] ( Chemical : O ##xy ##ster ##ol Re ##ceptor ##s , Nuclear ; Live ##r X Re ##ceptor ; Nuclear O ##xy ##ster ##ol Re ##ceptor ##s ; Live ##r X Re ##ceptor ##s [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
    " {'mention_id': '27791169.3',\n",
    "  'test_set_idx': 16856,\n",
    "  'type': 'T017',\n",
    "  'name': 'BPH9',\n",
    "  'context': '[CLS] All ##eli ##c diversity in an n ##uc ##leo ##tide - binding and le ##uc ##ine - rich repeat gene [unused1] BP ##H ##9 [unused2] enables rice to combat plant ##hop ##per variation Brown plant ##hop ##per , Ni ##lap ##ar ##vat ##a l ##ugen ##s St ##å ##l , is one of the most devastating insect p ##ests of rice ( Or ##y ##za sat ##iva L . ) . Currently , 30 Brown plant ##hop ##per - resistance genes have been genetically defined , most of which are cluster ##ed on specific chromosome regions . Here , we describe molecular c ##lon ##ing and characterization of a Brown plant ##hop ##per - resistance gene , BP ##H ##9 , mapped on the long arm [SEP]',\n",
    "  'existing_cui': 'C0005001',\n",
    "  'existing_cui_name': 'Benign prostatic hypertrophy',\n",
    "  'existing_cui_desc': '[CLS] Ben ##ign pro ##static h ##yper ##tro ##phy [unused3] ( B ##iol ##og ##ic Fun ##ction , BP ##H , ben ##ign , ben ##ign pro ##static h ##yper ##tro ##phy , diagnosis : H ##yper ##tro ##phy - pro ##st . ben . ; ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static h ##yper - ben ##ign ; Ben ##ign Pro ##static H ##yper ##p ##lasia - BP ##H ; En ##lar ##ged Pro ##state ; H ##yper ##tro ##phy , Ben ##ign Pro ##static ; H ##yper ##tro ##phy ( ben ##ign ) of pro ##state ; Ben ##ign h ##yper ##tro ##phy of pro ##state ; BP ##H - ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static [SEP]',\n",
    "  'our_bi_cui': 'C1419294',\n",
    "  'our_bi_cui_name': 'RBBP9 gene',\n",
    "  'our_bi_cui_desc': '[CLS] RB ##B ##P ##9 gene [unused3] ( Ana ##tom ##ical Structure : RB ##B ##P ##10 ; B ##5 ##T O ##VE ##RE ##X ##PR ##ES ##SE ##D GE ##NE ; RB ##B ##P ##9 Gene ; R ##ET ##IN ##O ##BL ##AS ##TO ##MA - B ##IN ##DI ##NG PR ##OT ##EI ##N 9 ; Re ##tino ##blast ##oma Bin ##ding Pro ##tein 9 Gene ; re ##tino ##blast ##oma binding protein 9 ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '28523846.40',\n",
    "  'test_set_idx': 38560,\n",
    "  'type': 'T103',\n",
    "  'name': 'proteoform',\n",
    "  'context': '[CLS] unfolded pro ##te ##of ##orms of forced - reduced me ##case ##rm ##in and aerial ##ly o ##xi ##dized me ##case ##rm ##in with the free - SH : protein ratio of me ##case ##rm ##in drug product . The collision cross - section ##al area , which is determined using E ##SI - I ##MS - MS , provided [unused1] pro ##te ##of ##orm [unused2] information through rapid monitoring ( < 2 min ) of in - process samples during the manufacture of me ##case ##rm ##in . E ##SI - I ##MS - MS coupled with SEC - mode HP ##LC is a rapid and robust method for analyzing the free - SH : protein ratio of me ##case ##rm ##in that allows evaluating [SEP]',\n",
    "  'existing_cui': 'C3658622',\n",
    "  'existing_cui_name': 'NeoForm',\n",
    "  'existing_cui_desc': '[CLS] Neo ##F ##orm [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0597298',\n",
    "  'our_bi_cui_name': 'Protein Isoforms',\n",
    "  'our_bi_cui_desc': '[CLS] Pro ##tein Is ##of ##orms [unused3] ( Chemical : protein is ##of ##orm ; Pro ##tein Is ##of ##orms [ Chemical / In ##g ##red ##ient ] ; Is ##of ##orms , Pro ##tein ; Is ##of ##orms ; is ##of ##orms ; is ##of ##orm ; Is ##of ##orm ) [SEP]',\n",
    "  'our_cross_cui': 'C1510464',\n",
    "  'our_cross_cui_name': 'Protein Structure',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein Structure [unused3] ( Chemical : protein structure ) [SEP]'},\n",
    " {'mention_id': '27286174.25',\n",
    "  'test_set_idx': 1488,\n",
    "  'type': 'T033',\n",
    "  'name': 'removal from the list',\n",
    "  'context': '[CLS] ##6 adults listed for kidney transplant before December 31 , 2011 . Pre ##dict ##ors were age , sex , blood type , calculated panel - reactive antibodies , donation service area , dial ##ys ##is duration , com ##or ##bid conditions , and body mass index . Out ##come ##s were deceased or living donor transplant , death or [unused1] removal from the list [unused2] due to de ##ter ##ior ##ating medical condition , or removal due to other reasons . We calculated hazards for the possible outcomes , then the cumulative incidence function for a given candidate using competing risk methodology . Disc ##rim ##ination and ca ##li ##bra ##tion were assessed through C statistics and ca ##li ##bra ##tion plots for each cause [SEP]',\n",
    "  'existing_cui': 'C4082098',\n",
    "  'existing_cui_name': 'Patient status determination , deceased and removed from state',\n",
    "  'existing_cui_desc': '[CLS] Pat ##ient status determination , deceased and removed from state [unused3] ( Finding , finding : Re ##mo ##val from state ) [SEP]',\n",
    "  'our_bi_cui': 'C0015252',\n",
    "  'our_bi_cui_name': 'removal technique',\n",
    "  'our_bi_cui_desc': '[CLS] removal technique [unused3] ( Health Care Act ##ivity , procedure , qualifier value : re ##sect ; ex ##cision procedure ; surgical removal ; procedures removal ; ex ##ti ##rp ##ation ; re ##section ##ed ; re ##section ##s ; re ##section ##ing ; surgical re ##section ; removal ; ex ##cision ##s ; Re ##mo ##val - action ; ex ##cision procedures ; surgical removal procedure ; procedure removal ; ex ##cision ; re ##sect ##ed ; Re ##mo ##val - procedure ; removal ##s ; removal procedure ; Re ##mo ##val technique ; e ##ct ##omy ; Re ##mo ##val ; re ##section ; Re ##mo ##val Pro ##ced ##ure ; Re ##mo ##val procedure ) [SEP]',\n",
    "  'our_cross_cui': 'C0420299',\n",
    "  'our_cross_cui_name': 'Removed from waiting list',\n",
    "  'our_cross_cui_desc': '[CLS] Re ##mo ##ved from waiting list [unused3] ( Finding , finding ) [SEP]'},\n",
    " {'mention_id': '28495651.19',\n",
    "  'test_set_idx': 37794,\n",
    "  'type': 'T204',\n",
    "  'name': 'Schwartz',\n",
    "  'context': '[CLS] 1987 , and December 20 , 1999 , and were followed for card ##iovascular death . The 4 major correction formula ##s ( Ba ##ze ##tt , Fr ##ider ##ici ##a , Fr ##ami ##ng ##ham , and Hodges ) were used to correct Q ##T interval . In addition , the percent ##iles for heart rate ranges as proposed by [unused1] Schwartz [unused2] were calculated . During median follow - up of 17 . 8 years , 45 ##5 card ##iovascular death events occurred . When compared to the other equations , Q ##T ##c Ba ##ze ##tt had the greatest dependence on heart rate ( R ( 2 ) = 0 . 18 ) . The hazard ratio ( 95 % confidence interval ) [SEP]',\n",
    "  'existing_cui': 'C0036391',\n",
    "  'existing_cui_name': 'Schwartz-Jampel Syndrome',\n",
    "  'existing_cui_desc': '[CLS] Schwartz - Jam ##pel S ##yn ##drome [unused3] ( B ##iol ##og ##ic Fun ##ction , Schwartz - Jam ##pel syndrome , diagnosis , disorder : O ##ste ##och ##ond ##rom ##us ##cular d ##ys ##tro ##phy ; S ##J ##A S ##Y ##ND ##RO ##ME ; s ##ch ##wart ##z jam ##pel syndrome ; My ##oto ##nic My ##op ##athy , D ##war ##fi ##sm , Cho ##nd ##rod ##ys ##tro ##phy , And O ##cular And F ##ac ##ial A ##b ##nor ##mal ##ities ; Schwartz - Jam ##pel S ##yn ##drome , Type 1 ; M ##Y ##OT ##ON ##IC M ##Y ##OP ##AT ##H ##Y , D ##WA ##R ##FI ##SM , CH ##ON ##DR ##OD ##Y ##ST ##RO ##P ##H ##Y [SEP]',\n",
    "  'our_bi_cui': 'C1261028',\n",
    "  'our_bi_cui_name': 'Schwartze operation',\n",
    "  'our_bi_cui_desc': '[CLS] Schwartz ##e operation [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
    "  'our_cross_cui': 'C0086418',\n",
    "  'our_cross_cui_name': 'Homo sapiens',\n",
    "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
    " {'mention_id': '27762482.18',\n",
    "  'test_set_idx': 15896,\n",
    "  'type': 'T074',\n",
    "  'name': 'PDL',\n",
    "  'context': '[CLS] in some patients , and several studies using the low non ##pur ##pura ##genic flu ##ence were reported . To deliver the sufficient high flu ##ence of a PD ##L without generating pu ##rp ##ura , we designed the fraction ##ation of high flu ##ence using five passes and longer pulse duration ( 6 mill ##ise ##con ##ds ) of a [unused1] PD ##L [unused2] in succession . A total of eight patients with er ##yt ##hem ##ato ##tel ##ang ##ie ##ct ##atic r ##osa ##cea were enrolled in this study ; all patients were treated with PD ##L 10 times at 2 - week intervals . E ##ry ##them ##a and te ##lang ##ie ##ct ##asi ##a scores , as well as improvement , were [SEP]',\n",
    "  'existing_cui': 'C1414066',\n",
    "  'existing_cui_name': 'DLG5 gene',\n",
    "  'existing_cui_desc': '[CLS] DL ##G ##5 gene [unused3] ( Ana ##tom ##ical Structure : K ##IA ##A ##0 ##5 ##8 ##3 ; D ##IS ##CS LA ##R ##GE , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 5 ; P - d ##l ##g ; discs large ho ##mo ##log 5 ; P ##LA ##CE ##NT ##A AND PR ##OS ##TA ##TE DL ##G ) [SEP]',\n",
    "  'our_bi_cui': 'C0031740',\n",
    "  'our_bi_cui_name': 'Photochemotherapy',\n",
    "  'our_bi_cui_desc': '[CLS] Photo ##che ##mother ##ap ##y [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : PD ##T - Photo ##dynamic therapy ; Photo ##che ##mother ##ap ##ies ; Photo ##dynamic The ##rap ##ies ; therapy , photo ##dynamic ; Therapy , Photo ##dynamic ; THE ##R P ##H ##OT ##OD ##Y ##NA ##MI ##C ; Photo ##rad ##iation Therapy ; photo ##dynamic therapy ; photo ##che ##mother ##ap ##y ; P ##H ##OT ##OC ##H ##EM ##OT ##H ##ER ; The ##rap ##ies , Photo ##dynamic ; Photo ##dynamic Therapy Pro ##ced ##ures ; neo ##p ##las ##m / cancer photo ##rad ##iation therapy ; Photo ##che ##mother ##ap ##y [ Am ##bi ##guous ] ; Photo ##dynamic therapy ; PD [SEP]',\n",
    "  'our_cross_cui': 'C1289859',\n",
    "  'our_cross_cui_name': 'Pulsed Dye Lasers',\n",
    "  'our_cross_cui_desc': '[CLS] P ##ulse ##d D ##ye Las ##ers [unused3] ( Medical Devi ##ce , physical object : D ##ye Las ##ers , P ##ulse ##d ; P ##ulse ##d dye laser device ; Las ##er , P ##ulse ##d D ##ye ; D ##ye Las ##er , P ##ulse ##d ; Las ##ers , P ##ulse ##d D ##ye ; P ##ulse ##d D ##ye Las ##er ; pulsed dye laser ; P ##ulse ##d dye laser ) [SEP]'},\n",
    " {'mention_id': '28295414.8',\n",
    "  'test_set_idx': 31546,\n",
    "  'type': 'T033',\n",
    "  'name': 'nonabstinent',\n",
    "  'context': '[CLS] Dr ##ink ##ing Days and Dr ##ink ##ing Red ##uction ##s Among Heavy Dr ##ink ##ers in the CO ##MB ##IN ##E Study Recently , the Food and Drug Administration proposed to expand the options for primary end points in the development of medications for alcohol use disorder to include either a ##bs ##tine ##nce from alcohol or a [unused1] non ##ab ##st ##inen ##t [unused2] outcome : no heavy drinking days ( with a heavy drinking day defined as more than 3 drinks per day for women and more than 4 drinks per day for men [ > 3 / > 4 cut ##off ] ) . The Food and Drug Administration also suggested that 6 months would be the most appropriate length for a [SEP]',\n",
    "  'existing_cui': 'C0457801',\n",
    "  'existing_cui_name': 'Current non-drinker of alcohol',\n",
    "  'existing_cui_desc': '[CLS] Current non - drink ##er of alcohol [unused3] ( Finding , finding , life style : alcohol does drinking ; Non - drink ##er ; Te ##eto ##tal ##ler ; non drink ##er ; A ##bs ##tain ##er ; Te ##eto ##tale ##r ; a ##bs ##tinent ; Non - Dr ##ink ##er ; Non - drink ##er alcohol ; Non ##dr ##ink ##er ; Does not drink alcohol ; Non - drink ##er ; Non - drink ##er of alcoholic beverage ; A ##bs ##tinent ; Never drinks ; Non - drink ##er alcohol ) [SEP]',\n",
    "  'our_bi_cui': 'C0457801',\n",
    "  'our_bi_cui_name': 'Current non-drinker of alcohol',\n",
    "  'our_bi_cui_desc': '[CLS] Current non - drink ##er of alcohol [unused3] ( Finding , finding , life style : alcohol does drinking ; Non - drink ##er ; Te ##eto ##tal ##ler ; non drink ##er ; A ##bs ##tain ##er ; Te ##eto ##tale ##r ; a ##bs ##tinent ; Non - Dr ##ink ##er ; Non - drink ##er alcohol ; Non ##dr ##ink ##er ; Does not drink alcohol ; Non - drink ##er ; Non - drink ##er of alcoholic beverage ; A ##bs ##tinent ; Never drinks ; Non - drink ##er alcohol ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27990563.7',\n",
    "  'test_set_idx': 23002,\n",
    "  'type': 'T168',\n",
    "  'name': 'item',\n",
    "  'context': \"[CLS] Select ##ive reaching in mac ##aque ##s : evidence for action - centred attention When a monkey select ##s a piece of food lying on the ground from among other viable objects in the near vicinity , only the desired [unused1] item [unused2] govern ##s the particular pattern and direction of the animal ' s reaching action . It would seem then that selection is an important component controlling the animal ' s action . But , we may ask , is the selection process in such cases imp ##er ##vious to the presence of other objects that could constitute potential obstacles to or constraints on movement execution ? And if it is , in fact , per ##vious to other objects , do they have [SEP]\",\n",
    "  'existing_cui': 'C0678118',\n",
    "  'existing_cui_name': 'Transmission Electron Microscopy',\n",
    "  'existing_cui_desc': '[CLS] Trans ##mission El ##ec ##tron Micro ##sco ##py [unused3] ( Health Care Act ##ivity , T ##EM : Micro ##sco ##py , El ##ec ##tron , Trans ##mission ; El ##ec ##tron Micro ##sco ##py , Trans ##mission ; Micro ##sco ##py , Trans ##mission El ##ec ##tron ; Trans ##mission electron micro ##sco ##py ; T ##RA ##NS ##MI ##SS ##ION E ##LE ##CT ##RO ##N MI ##CR ##OS ##CO ##P ##Y ; transmission electron micro ##sco ##py ) [SEP]',\n",
    "  'our_bi_cui': 'C0567415',\n",
    "  'our_bi_cui_name': 'Atom',\n",
    "  'our_bi_cui_desc': '[CLS] At ##om [unused3] ( Chemical , substance , substance : atom ; atoms ) [SEP]',\n",
    "  'our_cross_cui': 'C0016452',\n",
    "  'our_cross_cui_name': 'Food',\n",
    "  'our_cross_cui_desc': '[CLS] Food [unused3] ( Food , medication , substance : Food or Food Product ; foods ; F ##O ##OD OR F ##O ##OD PR ##OD ##UC ##T ; Food Product ; Food or Food Sub ##stance ; Food ##P ##rod ##uc ##t ; Foods ; food ) [SEP]'},\n",
    " {'mention_id': '28479312.1',\n",
    "  'test_set_idx': 37495,\n",
    "  'type': 'T058',\n",
    "  'name': 'ESBL Nordmann/Dortet/Poirel-based protocol',\n",
    "  'context': '[CLS] A modified [unused1] E ##SB ##L Nord ##mann / Do ##rte ##t / Po ##ire ##l - based protocol [unused2] to op ##ti ##mize early se ##psis management We evaluated a modification of a color ##ime ##tric test recently described by Do ##rte ##t et al . ( 2015 ) for the rapid detection of E ##SB ##L - producing En ##tero ##ba ##cter ##iac ##eae directly from positive blood cultures that requires less manipulation , materials and hands - on time . The simplified protocol showed a sensitivity and specific ##ity of 100 % and 95 . 7 % respectively . [SEP]',\n",
    "  'existing_cui': 'C1444096',\n",
    "  'existing_cui_name': 'ESBL',\n",
    "  'existing_cui_desc': '[CLS] E ##SB ##L [unused3] ( Ba ##cter ##ium , organism : Extended spectrum beta - la ##ct ##ama ##se producing bacteria ) [SEP]',\n",
    "  'our_bi_cui': 'C0282574',\n",
    "  'our_bi_cui_name': 'Intellectual Property',\n",
    "  'our_bi_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '27887578.32',\n",
    "  'test_set_idx': 20863,\n",
    "  'type': 'T170',\n",
    "  'name': 'programme materials',\n",
    "  'context': '[CLS] and Out ##come ##s Via Education programme was delivered to health professionals in mater ##nity hospitals in all seven Australian states and territories and modified for use internationally with pilot ##ing in Vietnam , Fiji , and the Netherlands ( with the assistance of the International Still ##birth Alliance , IS ##A ) . Mo ##di ##fication ##s were made to [unused1] programme materials [unused2] in consultation with local teams and included translation for the Vietnam programme . Part ##ici ##pants completed pre - and post - programme evaluation question ##naire ##s on knowledge and confidence on six key components of per ##ina ##tal death management as well as a satisfaction question ##naire . Over the period May 2012 to May 2015 , 30 I ##M [SEP]',\n",
    "  'existing_cui': 'C0033333',\n",
    "  'existing_cui_name': 'Program Development',\n",
    "  'existing_cui_desc': '[CLS] Program Development [unused3] ( Health Care Act ##ivity , procedure : development program ; Well ##ness program development community ; w ##ln ##s p ##rg ##rm de ##v ##ment cm ##unt ; Program development ; program development ; Programme development ; Development , Program ) [SEP]',\n",
    "  'our_bi_cui': 'C2936424',\n",
    "  'our_bi_cui_name': 'Electronic Supplementary Materials',\n",
    "  'our_bi_cui_desc': '[CLS] Electronic Su ##pp ##lement ##ary Materials [unused3] ( Intel ##lect ##ual Product : Su ##pp ##lement ##ary Material ; Electronic Su ##pp ##lement ##ary Material ; Supporting Information ; Su ##pp ##lement ##ary Information ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27837917.30',\n",
    "  'test_set_idx': 18943,\n",
    "  'type': 'T033',\n",
    "  'name': 'unreinforced lever pressing ensued',\n",
    "  'context': '[CLS] - administer cocaine ( n = 96 ) or were used as yo ##ked - sa ##line control animals ( n = 21 ) . After extinction , reins ##tate ##ment was initiated by 10 minutes of cue - induced drug seeking , followed by 45 minutes with contingent cocaine access , after which cocaine was discontinued and [unused1] un ##re ##in ##force ##d lever pressing ensued [unused2] . Three measures of trans ##ient s ##yna ##ptic potent ##iation were ass ##ay ##ed during reins ##tate ##ment : den ##dr ##itic spine morphology , alpha - amino - 3 - h ##ydro ##xy - 5 - met ##hyl - 4 - is ##ox ##az ##ole prop ##ion ##ic acid to N - met ##hyl - D [SEP]',\n",
    "  'existing_cui': 'C1960601',\n",
    "  'existing_cui_name': 'Head pressing',\n",
    "  'existing_cui_desc': '[CLS] Head pressing [unused3] ( Finding , finding ) [SEP]',\n",
    "  'our_bi_cui': 'C0557952',\n",
    "  'our_bi_cui_name': 'Reinforcement of behavior',\n",
    "  'our_bi_cui_desc': '[CLS] Re ##in ##force ##ment of behavior [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Re ##in ##force ##ment of behaviour ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28433448.29',\n",
    "  'test_set_idx': 35668,\n",
    "  'type': 'T062',\n",
    "  'name': 'FDS2',\n",
    "  'context': '[CLS] was determined in each sample . In F ##DS ##2 , associates of an ##emia were assessed using multiple log ##istic re ##gression and Cox proportional hazards modeling identified predict ##ors of death during 4 . 3 ± 1 . 2 years post - recruitment . The prevalence of an ##emia at base ##line was 11 . 5 % in [unused1] F ##DS ##2 [unused2] participants , 17 . 8 % in Bus ##sel ##ton Di ##abe ##tes Study type 2 patients and 5 . 4 % in Bus ##sel ##ton Di ##abe ##tes Study participants without diabetes . In F ##DS ##2 , 163 of 178 patients with an ##emia ( 91 . 6 % ) had at least one other risk factor ( serum [SEP]',\n",
    "  'existing_cui': 'C4015495',\n",
    "  'existing_cui_name': 'CEREBELLOFACIODENTAL SYNDROME',\n",
    "  'existing_cui_desc': '[CLS] CE ##RE ##BE ##LL ##O ##FA ##CI ##OD ##EN ##TA ##L S ##Y ##ND ##RO ##ME [unused3] ( B ##iol ##og ##ic Fun ##ction : CE ##RE ##BE ##LL ##AR - FA ##CI ##AL - DE ##NT ##AL S ##Y ##ND ##RO ##ME ) [SEP]',\n",
    "  'our_bi_cui': 'C0008972',\n",
    "  'our_bi_cui_name': 'Clinical Research',\n",
    "  'our_bi_cui_desc': '[CLS] Clinical Research [unused3] ( Research Act ##ivity : Clinical Studies ; Clinical Study ; C ##L ##IN ##IC ##AL ST ##U ##D ##Y ; clinical research ; clinical studies ; clinical study ; Study ) [SEP]',\n",
    "  'our_cross_cui': 'C2603343',\n",
    "  'our_cross_cui_name': 'Study',\n",
    "  'our_cross_cui_desc': '[CLS] Study [unused3] ( Research Act ##ivity ) [SEP]'},\n",
    " {'mention_id': '27722881.26',\n",
    "  'test_set_idx': 15013,\n",
    "  'type': 'T007',\n",
    "  'name': 'JPM1',\n",
    "  'context': '[CLS] ##non ##e - 1 - car ##box ##yl ##ic acid , 9 - flu ##ore ##non ##e , p ##ht ##hali ##c acid , and ben ##zoic acid were detected in the culture solution . The gene sequence encoding the a ##romatic - ring - h ##ydro ##xy ##lating di ##ox ##y ##gen ##ase was am ##plified in the strain [unused1] JP ##M ##1 [unused2] by PC ##R . Based on the translated protein sequence , a ho ##mology modeling method was applied to build the crystal structure of di ##ox ##y ##gen ##ase . Subsequently , the interaction mechanism between flu ##oran ##the ##ne and the active site of di ##ox ##y ##gen ##ase was simulated and analyzed by molecular dock ##ing . Consequently , [SEP]',\n",
    "  'existing_cui': 'C1421124',\n",
    "  'existing_cui_name': 'TRGJP gene',\n",
    "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
    "  'our_bi_cui': 'C3629619',\n",
    "  'our_bi_cui_name': 'bacterium JP1',\n",
    "  'our_bi_cui_desc': '[CLS] bacterium JP ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
    "  'our_cross_cui': 'C4153571',\n",
    "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
    " {'mention_id': '27932585.27',\n",
    "  'test_set_idx': 22254,\n",
    "  'type': 'T103',\n",
    "  'name': 'Taw3',\n",
    "  'context': '[CLS] , a ho ##mo ##log of T ##Y ##W ##3 from Sul ##fo ##lo ##bus so ##lf ##ata ##ric ##us , which revealed a novel α / β fold . The sequence motif ( S / T ) x ##SS ##C ##x ##GR and invariant as ##par ##tate and his ##ti ##dine , conserved in T ##Y ##W ##3 / [unused1] Ta ##w ##3 [unused2] , cluster to form the cat ##alytic center . These structural and sequence features indicate that T ##Y ##W ##3 / Ta ##w ##3 proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass ##ays combined with mass s [SEP]',\n",
    "  'existing_cui': 'C3496263',\n",
    "  'existing_cui_name': 'annectant white matter',\n",
    "  'existing_cui_desc': '[CLS] an ##nect ##ant white matter [unused3] ( Ana ##tom ##ical Structure : Sub ##stant ##ia me ##du ##llar ##is an ##nect ##ens ) [SEP]',\n",
    "  'our_bi_cui': 'C0039341',\n",
    "  'our_bi_cui_name': 'tat Protein',\n",
    "  'our_bi_cui_desc': '[CLS] ta ##t Pro ##tein [unused3] ( Chemical : ta ##t Gene Product ; Gene Products , ta ##t [ Chemical / In ##g ##red ##ient ] ; Trans ##act ##ivating Reg ##ulatory Pro ##tein ; T ##AT Pro ##tein ; Trans - Act ##ivation of Trans ##cription Pro ##tein ; Trans - Act ##iva ##tor of Trans ##cription of HIV ; ta ##t Gene Products ; ta ##t protein ; Gene Product , ta ##t ; Gene Products , ta ##t ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27251800.4',\n",
    "  'test_set_idx': 799,\n",
    "  'type': 'T058',\n",
    "  'name': 'Stoppa approaches',\n",
    "  'context': '[CLS] Early assessment of bilateral ing ##uin ##al her ##nia repair : A comparison between the lap ##aro ##scopic total extra ##per ##ito ##nea ##l and [unused1] Stop ##pa approaches [unused2] The present clinical trial was designed to compare the results of bilateral ing ##uin ##al her ##nia repair between patients who underwent the conventional Stop ##pa technique and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair with a single mesh and without staple fix ##ation . This controlled , random ##ised clinical trial was conducted at General Surgery and T ##ra ##uma of the Clinic ##s Hospital , Medical School , the University of S ##γ ##o Paulo between September 2010 and February 2011 . Total ##ly , 50 male patients , with a [SEP]',\n",
    "  'existing_cui': 'C0449445',\n",
    "  'existing_cui_name': 'Approach',\n",
    "  'existing_cui_desc': '[CLS] A ##pp ##roach [unused3] ( Spa ##tial Concept , attribute , qualifier value : A ##pp ##roach ##es ; approach ; approaches ; approaching ) [SEP]',\n",
    "  'our_bi_cui': 'C0205501',\n",
    "  'our_bi_cui_name': 'Transperitoneal approach',\n",
    "  'our_bi_cui_desc': '[CLS] Trans ##per ##ito ##nea ##l approach [unused3] ( Spa ##tial Concept , qualifier value : Trans ##per ##ito ##nea ##l ; Abd ##omi ##nal trans ##per ##ito ##nea ##l approach ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27580517.33',\n",
    "  'test_set_idx': 10643,\n",
    "  'type': 'T058',\n",
    "  'name': '3D cylindrically - distributed spiral pseudo - continuous arterial spin labeling magnetic resonance imaging',\n",
    "  'context': '[CLS] two remaining patients , cerebral blood flow decreased by 2 . 4 to 6 . 0 % after ace ##ta ##zo ##lam ##ide . The group average change in cerebral blood flow due to ace ##ta ##zo ##lam ##ide was approximately 25 . 0 % and individual changes were statistical ##ly significant ( p < 0 . 01 ) in all patients using a paired t - test analysis . cerebral blood flow per ##fusion data were diagnostic ##ally useful in supporting conventional MR an ##gio ##graphy and clinical findings . [unused1] 3D cylindrical ##ly - distributed spiral pseudo - continuous art ##erial spin label ##ing magnetic resonance imaging [unused2] provides a robust approach to assess cerebral blood flow and reserve in p ##ediatric patients . [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0860888',\n",
    "  'our_bi_cui_name': 'Tomography , Spiral Computed',\n",
    "  'our_bi_cui_desc': '[CLS] Tom ##ography , S ##pi ##ral Co ##mp ##uted [unused3] ( Health Care Act ##ivity , procedure : S ##pi ##ral com ##puted to ##mo ##graphy scan ; S ##pi ##ral CT ; CT ##s , S ##pi ##ral ; com ##puted to ##mo ##graphy spiral ; Sc ##ans , S ##pi ##ral CT ; He ##lica ##l CT ##s ; He ##lica ##l CT ; S ##pi ##ral CA ##T Sc ##ans ; he ##lica ##l com ##puted to ##mo ##graphy ; c ##t spiral ; S ##pi ##ral Volume ##tric CT ; S ##pi ##ral Computer ##ized Tom ##ography ; Computer - As ##sist ##ed Tom ##ography , S ##pi ##ral ; Volume ##tric CT ; He ##lica ##l Co ##mp ##uted Tom ##ography [SEP]',\n",
    "  'our_cross_cui': 'C3891302',\n",
    "  'our_cross_cui_name': 'Arterial Spin Labeling Magnetic Resonance Imaging',\n",
    "  'our_cross_cui_desc': '[CLS] Arte ##rial Spin Label ##ing Ma ##gnetic Re ##son ##ance I ##maging [unused3] ( Health Care Act ##ivity : AS ##L f ##MR ##I ; Arte ##rial Spin Label ##ing MR ##I ; AR ##TE ##RI ##AL SP ##IN LA ##BE ##L ##ING F ##UN ##CT ##ION ##AL MR ##I ) [SEP]'},\n",
    " {'mention_id': '27884439.25',\n",
    "  'test_set_idx': 20661,\n",
    "  'type': 'T017',\n",
    "  'name': 'HTLTC',\n",
    "  'context': '[CLS] ##rp ##er and SA Mu ##tton Me ##rino breeds . U ##dder s were scored subjective ##ly on a 1 - 5 scale ( 1 - u ##dder intact and 5 - u ##dder damaged severely ) and t ##icks were counted on three locations . The body sites counted were the head and th ##ora ##ci ##c limb ( [unused1] H ##TL ##TC [unused2] ) , u ##dder - p ##el ##vic limb ( UP ##LT ##C ) and per ##ine ##um - br ##ee ##ch - tail ( P ##B ##TT ##C ) . These counts were also totaled for a total t ##ick count . Rep ##rod ##uction traits were number of la ##mbs we ##ane ##d per e ##we la ##mbe ##d [SEP]',\n",
    "  'existing_cui': 'C1415797',\n",
    "  'existing_cui_name': 'HTL gene',\n",
    "  'existing_cui_desc': '[CLS] H ##TL gene [unused3] ( Ana ##tom ##ical Structure : L ##E ##UC ##IN ##E T ##RA ##NS ##PO ##RT , H ##IG ##H ; high L - le ##uc ##ine transport ; H ##IG ##H L - L ##E ##UC ##IN ##E T ##RA ##NS ##PO ##RT ) [SEP]',\n",
    "  'our_bi_cui': 'C0326478',\n",
    "  'our_bi_cui_name': 'Long-tailed tit',\n",
    "  'our_bi_cui_desc': '[CLS] Long - tailed t ##it [unused3] ( E ##uka ##ryo ##te , organism : A ##eg ##ith ##alo ##s ca ##uda ##tus ; Long - tailed T ##it ; A ##eg ##ith ##alo ##s ca ##uda ##tus ( Linnaeus , 1758 ) ; Long - tailed bush ##ti ##t ) [SEP]',\n",
    "  'our_cross_cui': 'C0229962',\n",
    "  'our_cross_cui_name': 'Body part',\n",
    "  'our_cross_cui_desc': '[CLS] Body part [unused3] ( Ana ##tom ##ical Structure , body structure : Body Parts ; Body part structure ; Pa ##rs co ##rp ##oris ; body part ; body parts ; Body region ; Ana ##tom ##ic part . * ; Body Structure ; Parts , Body ; Ana ##tom ##ic part ; body region ; Cardinal body part ; Body Part ) [SEP]'},\n",
    " {'mention_id': '28468980.13',\n",
    "  'test_set_idx': 37007,\n",
    "  'type': 'T103',\n",
    "  'name': 'PfSEA-1A',\n",
    "  'context': '[CLS] P ##f ##SE ##A - 1A are associated with protection against severe malaria in children . V ##ac ##cin ##ation of mice with P ##b ##SE ##A - 1A decreases parasite ##mia and pro ##long ##s survival following P ##las ##mo ##dium be ##rg ##he ##i AN ##KA challenge . To enhance the im ##mu ##no ##genic ##ity of [unused1] P ##f ##SE ##A - 1A [unused2] , we identified five linear , B - cell e ##pit ##ope ##s using p ##eptide micro ##arra ##ys probe ##d with anti - se ##ra from r ##P ##f ##SE ##A - 1A - v ##ac ##cin ##ated non - human p ##rima ##tes . We evaluated the relationship between e ##pit ##ope - specific anti ##body levels [SEP]',\n",
    "  'existing_cui': 'C0120659',\n",
    "  'existing_cui_name': 'HA-1A',\n",
    "  'existing_cui_desc': '[CLS] H ##A - 1A [unused3] ( Chemical , product , substance ) [SEP]',\n",
    "  'our_bi_cui': 'C4040232',\n",
    "  'our_bi_cui_name': 'Plasmodium Ag',\n",
    "  'our_bi_cui_desc': '[CLS] P ##las ##mo ##dium A ##g [unused3] ( Chemical , substance : P ##las ##mo ##dium anti ##gen ; Anti ##gen of P ##las ##mo ##dium ) [SEP]',\n",
    "  'our_cross_cui': 'C3849939',\n",
    "  'our_cross_cui_name': 'SEA-1 protein , Plasmodium falciparum',\n",
    "  'our_cross_cui_desc': '[CLS] SE ##A - 1 protein , P ##las ##mo ##dium f ##al ##ci ##par ##um [unused3] ( Chemical : P ##f ##SE ##A - 1 protein , P ##las ##mo ##dium f ##al ##ci ##par ##um ; s ##chi ##zon ##t e ##g ##ress anti ##gen - 1 , P ##las ##mo ##dium f ##al ##ci ##par ##um ) [SEP]'},\n",
    " {'mention_id': '27756117.44',\n",
    "  'test_set_idx': 15641,\n",
    "  'type': 'T103',\n",
    "  'name': 'PI',\n",
    "  'context': '[CLS] . 4 % for the 2 . 8 % , 1 . 5 % and 0 . 8 % fi ##bri ##no ##gen - containing silk s ##po ##nges , respectively . Moreover , the fi ##bri ##n formation lead to a more linear elastic behavior over longer strain ranges . In combination , the Cal ##ce ##in - AM / [unused1] P ##I [unused2] stain ##ings and M ##TT ass ##ay results indicate uniform cell ad ##hesion on the surface and c ##yt ##oc ##om ##pa ##ti ##bility of the silk / fi ##bri ##n s ##po ##nges , respectively . Moreover , the co - delivery of th ##rom ##bin with fi ##bri ##no ##gen via silk as carrier material is described , offering [SEP]',\n",
    "  'existing_cui': 'C1418544',\n",
    "  'existing_cui_name': 'SERPINA1 gene',\n",
    "  'existing_cui_desc': '[CLS] SE ##RP ##IN ##A ##1 gene [unused3] ( Ana ##tom ##ical Structure : SE ##RP ##IN ##A ##1 , ; se ##rp ##in family A member 1 ; A1 ##AT ; pro ##te ##ase inhibitor 1 ( anti - el ##ast ##ase ) , alpha - 1 - anti ##try ##ps ##in ; alpha - 1 - anti ##try ##ps ##in ; Ser ##pin P ##ept ##idas ##e In ##hibit ##or , C ##lade A ( Alpha - 1 Anti ##p ##rote ##inas ##e , Anti ##try ##ps ##in ) , Member 1 Gene ; SE ##RP ##IN P ##EP ##TI ##DA ##SE IN ##H ##IB ##IT ##OR , C ##LA ##DE A , ME ##MB ##ER 1 ; AL ##P ##HA - 1 - AN [SEP]',\n",
    "  'our_bi_cui': 'C4015812',\n",
    "  'our_bi_cui_name': 'PI I PHENOTYPE',\n",
    "  'our_bi_cui_desc': '[CLS] P ##I I P ##H ##EN ##OT ##YP ##E [unused3] ( Finding : P ##I I ) [SEP]',\n",
    "  'our_cross_cui': 'C0033470',\n",
    "  'our_cross_cui_name': 'Propidium Iodide',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##pid ##ium I ##od ##ide [unused3] ( Chemical : Pro ##pid ##ium Di ##io ##di ##de ; I ##od ##ide , Pro ##pid ##ium ; Di ##io ##di ##de , Pro ##pid ##ium ) [SEP]'},\n",
    " {'mention_id': '28421738.22',\n",
    "  'test_set_idx': 35200,\n",
    "  'type': 'T103',\n",
    "  'name': '12',\n",
    "  'context': '[CLS] designed to simultaneously activate transcription - based anti ##ox ##ida ##nt responses , whose lead 1 showed interesting properties in a preliminary investigation . Re ##lying on the requirements of am ##yl ##oid - β p ##eptide recognition , we identified the cat ##ech ##ol derivative 12 . In SH - S ##Y ##5 ##Y ne ##uro ##blast ##oma cells , [unused1] 12 [unused2] combined remarkable free radical s ##ca ##venge ##r properties to the ability to trigger the Nr ##f ##2 pathway and induce the Nr ##f ##2 - dependent defensive gene N ##Q ##O ##1 by means of electro ##phi ##lic activation of the transcription ##al response . Moreover , 12 prevented the formation of c ##yt ##oto ##xi ##c stable o ##li ##go [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0030956',\n",
    "  'our_bi_cui_name': 'Peptides',\n",
    "  'our_bi_cui_desc': '[CLS] P ##eptide ##s [unused3] ( Chemical , substance : p ##eptide ; p ##eptide ##s ; P ##eptide ##s [ Chemical / In ##g ##red ##ient ] ; P ##eptide ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27500205.24',\n",
    "  'test_set_idx': 8456,\n",
    "  'type': 'T103',\n",
    "  'name': 'kindlins',\n",
    "  'context': '[CLS] ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of kind ##lins . Great interest in the [unused1] kind ##lins [unused2] has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate the capacity of in ##te ##g ##rin [SEP]',\n",
    "  'existing_cui': 'C1720776',\n",
    "  'existing_cui_name': 'Kindling , Neurologic',\n",
    "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
    "  'our_bi_cui': 'C0010422',\n",
    "  'our_bi_cui_name': 'Crystallins',\n",
    "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27533401.2',\n",
    "  'test_set_idx': 9619,\n",
    "  'type': 'T170',\n",
    "  'name': 'tool',\n",
    "  'context': '[CLS] Help end the HIV epidemic After many delays , the public consultation on HIV prevention [unused1] tool [unused2] pre - exposure prop ##hyl ##ax ##is is finally here . Now is the time to mob ##ilis ##e - help end the HIV epidemic by responding to this NHS England consultation before 23 September . [SEP]',\n",
    "  'existing_cui': 'C1710438',\n",
    "  'existing_cui_name': 'Tool Mouse',\n",
    "  'existing_cui_desc': '[CLS] Too ##l Mouse [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
    "  'our_bi_cui': 'C0025663',\n",
    "  'our_bi_cui_name': 'Methods',\n",
    "  'our_bi_cui_desc': '[CLS] Method ##s [unused3] ( Intel ##lect ##ual Product , attribute : methods ; Method ; method ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27402480.28',\n",
    "  'test_set_idx': 4825,\n",
    "  'type': 'T033',\n",
    "  'name': 'non - genotoxic',\n",
    "  'context': '[CLS] following the principles of the O ##EC ##D test guide ##line 48 ##7 in v ##it ##ro ma ##mmal ##ian cell micro ##nu ##cle ##us test . Prof ##iciency with the ass ##ay was established by correctly identifying direct - acting g ##eno ##to ##xin ##s and g ##eno ##to ##xin ##s requiring metabolism , as well as [unused1] non - g ##eno ##to ##xi ##c [unused2] / non - car ##cin ##ogenic chemicals . We also report the analysis of our historical control data that demonstrate vehicle control and positive control values for % micro ##nu ##cle ##i in bin ##uc ##lea ##ted cells are in the ranges reported previously . Technical issues including evaluating various solvent ##s with both 48 ##h and 72 ##h [SEP]',\n",
    "  'existing_cui': 'C1257899',\n",
    "  'existing_cui_name': 'Genotoxic Stress',\n",
    "  'existing_cui_desc': '[CLS] Gen ##oto ##xi ##c St ##ress [unused3] ( B ##iol ##og ##ic Fun ##ction : Gen ##oto ##xi ##c St ##resses ; St ##resses , Gen ##oto ##xi ##c ; St ##ress , Gen ##oto ##xi ##c ) [SEP]',\n",
    "  'our_bi_cui': 'C2827065',\n",
    "  'our_bi_cui_name': 'Non-Cytotoxic Agent',\n",
    "  'our_bi_cui_desc': '[CLS] Non - Cy ##to ##to ##xi ##c Agent [unused3] ( Chemical ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27692319.52',\n",
    "  'test_set_idx': 14323,\n",
    "  'type': 'T103',\n",
    "  'name': 'ABZ ( SO )',\n",
    "  'context': '[CLS] ##hibition of mi ##rac ##id ##ia formation . In contrast , on the 12th day , 90 % of the mi ##rac ##id ##ia hatch ##ed in the control experiments using 0 . 03 % D ##MS ##O whereas em ##b ##ryo ##genesis was completely abolished with any concentration of al ##ben ##da ##zo ##le su ##l ##ph ##oxide [unused1] AB ##Z ( S ##O ) [unused2] . Chemical analysis of the crude extract and sub - fraction ##s revealed a prominent presence of fl ##av ##ono ##ids . HP ##LC - MS confirmed Que ##rc ##eti ##n to be one of the main fl ##av ##ono ##ids present in the crude extract and the n - but ##ano ##l sub ##fra ##ction . This is [SEP]',\n",
    "  'existing_cui': 'C0967870',\n",
    "  'existing_cui_name': \"N ' - ( glutathion-S-yl ) - N-acetylbenzidine S-oxide\",\n",
    "  'existing_cui_desc': \"[CLS] N ' - ( g ##lut ##ath ##ion - S - y ##l ) - N - ace ##ty ##l ##ben ##zi ##dine S - oxide [unused3] ( Chemical : AB ##Z - S ##G ) [SEP]\",\n",
    "  'our_bi_cui': 'C0069763',\n",
    "  'our_bi_cui_name': 'oxibendazole',\n",
    "  'our_bi_cui_desc': '[CLS] o ##xi ##ben ##da ##zo ##le [unused3] ( Chemical , substance : O ##xy ##ben ##da ##zo ##le ; met ##hyl 5 - [ n - prop ##ox ##y ] ben ##zi ##mi ##da ##zo ##le - 2 - car ##ba ##mate ; O ##X ##IB ##EN ##DA ##Z ##OL ##E ; Met ##hyl ( 5 - prop ##ox ##y - 1 ##H - ben ##zi ##mi ##da ##zo ##l - 2 - y ##l ) car ##ba ##mate ; O ##xi ##ben ##da ##zo ##le ; O ##B ##Z ; O ##xi ##ben ##da ##zo ##lo ; met ##hyl 5 - n - prop ##ox ##y - 2 - ben ##zi ##mi ##da ##zo ##le ##car ##ba ##mate ; Met ##hyl 5 - prop ##ox [SEP]',\n",
    "  'our_cross_cui': 'C0051091',\n",
    "  'our_cross_cui_name': 'albendazole sulfoxide',\n",
    "  'our_cross_cui_desc': '[CLS] al ##ben ##da ##zo ##le su ##lf ##oxide [unused3] ( Chemical : Rico ##ben ##da ##zo ##le ; r ##ico ##ben ##da ##zo ##le ; R ##y ##co ##ben ##da ##zo ##le ) [SEP]'},\n",
    " {'mention_id': '27702870.9',\n",
    "  'test_set_idx': 14654,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedures',\n",
    "  'context': '[CLS] ##rou ##nd Flow cat ##he ##ter from the time of its introduction in May 2015 . Pro ##ced ##ure - related data were collected prospective ##ly for the first 100 a ##bla ##tion procedures performed in our department using the Smart ##T ##ou ##ch ( ® ) Sur ##rou ##nd Flow cat ##he ##ter . From a database of 65 ##4 [unused1] procedures [unused2] performed in our unit using the Sur ##rou ##nd Flow cat ##he ##ter , we selected one to match each Smart ##T ##ou ##ch ( ® ) Sur ##rou ##nd Flow procedure , matching for procedure type , operator experience , patient age , and gender . The groups were well matched for patient age , gender , and procedure type . [SEP]',\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '28424986.28',\n",
    "  'test_set_idx': 35482,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedure',\n",
    "  'context': '[CLS] ##erial em ##bol ##ization twice in order to shrink the tumor ; however , no effect was obtained . The tumor had rapidly grown to 50 cm and caused abnormal ##ities in the hem ##ato ##logical and co ##agu ##lative systems . Pre ##oper ##ative com ##puted to ##mo ##graphy revealed that the right he ##pa ##tic vein , right he ##pa ##tic artery , and right portal vein were not involved by the hem ##ang ##io ##ma . Re ##section of the giant liver hem ##ang ##io ##ma was successfully performed after in ##tra ##oper ##ative intentional blood ##lett ##ing with concurrent blood salvage . All hem ##ato ##logical and co ##agu ##lative abnormal ##ities had returned to normal after the [unused1] procedure [unused2] . [SEP]',\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27542380.6',\n",
    "  'test_set_idx': 9947,\n",
    "  'type': 'T007',\n",
    "  'name': 'Ferrovum \" sp . JA12',\n",
    "  'context': '[CLS] ##op ##hil ##ic iron o ##xi ##di ##zer En ##e - red ##uc ##tase ##s originating from ex ##tre ##mo ##phi ##les are gaining importance in the field of bio ##cat ##aly ##sis due to higher - stability properties . The genome of the acid ##op ##hil ##ic iron - o ##xi ##di ##zing bacterium \" [unused1] Fe ##rro ##vu ##m \" s ##p . J ##A ##12 [unused2] was found to harbor a the ##rm ##op ##hil ##ic - like en ##e - red ##uc ##tase ( F ##O ##Y ##E - 1 ) . The f ##oy ##e - 1 gene was l ##igate ##d into a p ##ET ##16 ##b ##p expression vector system , and the enzyme was produced in E ##scher [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0004611',\n",
    "  'our_bi_cui_name': 'Bacteria',\n",
    "  'our_bi_cui_desc': '[CLS] Ba ##cter ##ia [unused3] ( Ba ##cter ##ium , organism : Super ##king ##dom Ba ##cter ##ia ; Domain Ba ##cter ##ia ; Ba ##cter ##ium ; BA ##CT ##ER ##IA ; bacterium ; Ba ##cter ##ia , E ##uba ##cter ##ia ; Ba ##cter ##ia . ; e ##uba ##cter ##ia ; BA ##CT ; not Ba ##cter ##ia Ha ##eck ##el 1894 ; bacteria ; E ##uba ##cter ##ia ) [SEP]',\n",
    "  'our_cross_cui': 'C3908921',\n",
    "  'our_cross_cui_name': 'Ferrovum sp . JA12',\n",
    "  'our_cross_cui_desc': '[CLS] Fe ##rro ##vu ##m s ##p . J ##A ##12 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
    " {'mention_id': '27722881.15',\n",
    "  'test_set_idx': 15002,\n",
    "  'type': 'T007',\n",
    "  'name': 'JPM1',\n",
    "  'context': '[CLS] , a gram - positive flu ##oran ##the ##ne - de ##grading bacterial strain was isolated from crude oil in Da ##gan ##g Oil ##field and identified as Micro ##ba ##cter ##ium para ##ox ##yd ##ans JP ##M ##1 by the analysis of 16 ##S r ##D ##NA sequence . After 25 days of in ##cu ##bation , the strain [unused1] JP ##M ##1 [unused2] could de ##grade 91 . 78 % of the initial amount of flu ##oran ##the ##ne . Moreover , four meta ##bol ##ites 9 - flu ##ore ##non ##e - 1 - car ##box ##yl ##ic acid , 9 - flu ##ore ##non ##e , p ##ht ##hali ##c acid , and ben ##zoic acid were detected in the culture solution [SEP]',\n",
    "  'existing_cui': 'C1421124',\n",
    "  'existing_cui_name': 'TRGJP gene',\n",
    "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
    "  'our_bi_cui': 'C3802218',\n",
    "  'our_bi_cui_name': 'Bacillus sp . JP-1',\n",
    "  'our_bi_cui_desc': '[CLS] Ba ##ci ##llus s ##p . JP - 1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
    "  'our_cross_cui': 'C4153571',\n",
    "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
    " {'mention_id': '28113841.1',\n",
    "  'test_set_idx': 25831,\n",
    "  'type': 'T058',\n",
    "  'name': 'Quantitative Susceptibility Mapping',\n",
    "  'context': '[CLS] [unused1] Q ##uant ##itative Su ##s ##ce ##pt ##ibility Map ##ping [unused2] using St ##ructural Feature based Col ##la ##bor ##ative Reconstruction in the Human Brain The reconstruction of MR quantitative su ##s ##ce ##pt ##ibility mapping from local phase measurements is an ill posed inverse problem and different regular ##ization strategies incorporating a prior ##i information extracted from magnitude and phase images have been proposed . However , the anatomy observed in magnitude and phase images does not always coincide spatial ##ly with that in su ##s ##ce ##pt ##ibility maps , which could give er ##rone ##ous est ##imation in the reconstructed su ##s ##ce ##pt ##ibility map . In this paper , we develop a structural feature based collaborative reconstruction ( St ##ructural [SEP]',\n",
    "  'existing_cui': 'C0237904',\n",
    "  'existing_cui_name': 'Hypnotic Susceptibility',\n",
    "  'existing_cui_desc': '[CLS] H ##y ##p ##not ##ic Su ##s ##ce ##pt ##ibility [unused3] ( Health Care Act ##ivity , H ##y ##p ##not ##ic : Su ##s ##ce ##pt ##ibility ) [SEP]',\n",
    "  'our_bi_cui': 'C4288325',\n",
    "  'our_bi_cui_name': 'Quantitative Ultrasound Spectroscopy',\n",
    "  'our_bi_cui_desc': '[CLS] Q ##uant ##itative Ultra ##sound S ##pect ##ros ##copy [unused3] ( Health Care Act ##ivity : Q ##uant ##itative Ultra ##sound I ##maging ) [SEP]',\n",
    "  'our_cross_cui': 'C0006117',\n",
    "  'our_cross_cui_name': 'Brain Mapping',\n",
    "  'our_cross_cui_desc': '[CLS] Brain Map ##ping [unused3] ( Health Care Act ##ivity , procedure : brain mapped ; Brain mapping ; brain map ; Map ##ping , Brain ; brain mapping ) [SEP]'},\n",
    " {'mention_id': '27837917.48',\n",
    "  'test_set_idx': 18961,\n",
    "  'type': 'T033',\n",
    "  'name': 'lever pressing',\n",
    "  'context': '[CLS] , when cocaine use was discontinued 45 minutes later , den ##dr ##itic spine morphology and alpha - amino - 3 - h ##ydro ##xy - 5 - met ##hyl - 4 - is ##ox ##az ##ole prop ##ion ##ic acid to N - met ##hyl - D - as ##par ##tate ratios were restored as animals became motivated to engage un ##rew ##arded [unused1] lever pressing [unused2] . Non ##re ##in ##force ##d drug seeking was positively correlated with changes in spine morphology , and cocaine access reversed this relationship . Using a novel modification of the reins ##tate ##ment paradigm , we show that achieving cocaine use reversed the s ##yna ##ptic plastic ##ity under ##pin ##ning the motivation to seek the drug . [SEP]',\n",
    "  'existing_cui': 'C1960601',\n",
    "  'existing_cui_name': 'Head pressing',\n",
    "  'existing_cui_desc': '[CLS] Head pressing [unused3] ( Finding , finding ) [SEP]',\n",
    "  'our_bi_cui': 'C0009651',\n",
    "  'our_bi_cui_name': 'Operant Conditioning',\n",
    "  'our_bi_cui_desc': '[CLS] Opera ##nt Con ##dition ##ing [unused3] ( B ##iol ##og ##ic Fun ##ction , Opera ##nt , procedure , regime / therapy : L ##EA ##R ##NI ##NG IN ##ST ##R ##UM ; conditioning opera ##nt ; Opera ##nt Con ##dition ##ings ; Con ##dition ##ing , Opera ##nt ; Learning , Instrumental ; Learning ##s , Instrumental ; IN ##ST ##R ##UM L ##EA ##R ##NI ##NG ; Opera ##nt conditioning ; Con ##dition ##ing ; Instrumental Con ##dition ##ing ; Instrumental Learning ; Con ##dition ##ings , Opera ##nt ; opera ##nt conditioning ; opera ##nt condition ; Instrumental Learning ##s ; instrumental conditioning ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28424683.42',\n",
    "  'test_set_idx': 35420,\n",
    "  'type': 'T038',\n",
    "  'name': 'expanding',\n",
    "  'context': '[CLS] killer cells while limiting T cell expansion for up to 60 days . Similar to patient Natural killer cells , Natural killer cells from tumor - bearing B ##LT - human ##ized mice promote faster expansion of residual T cells resulting in decreased numbers and function of Natural killer cells , whereas Natural killer cells from mice with no tumor continue [unused1] expanding [unused2] Natural killer cells and retain their c ##yt ##oto ##xi ##city . In addition , den ##dr ##itic cells in contrast to O ##Cs are found to promote faster expansion of residual T cells within pu ##rified Natural killer cells resulting in the decline in Natural killer cell numbers from healthy individuals . Ad ##dition of anti - CD ##3 m ##A [SEP]',\n",
    "  'existing_cui': 'C0205229',\n",
    "  'existing_cui_name': 'Expanding',\n",
    "  'existing_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
    "  'our_bi_cui': 'C0205229',\n",
    "  'our_bi_cui_name': 'Expanding',\n",
    "  'our_bi_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
    "  'our_cross_cui': 'C0007595',\n",
    "  'our_cross_cui_name': 'cell growth',\n",
    "  'our_cross_cui_desc': '[CLS] cell growth [unused3] ( B ##iol ##og ##ic Fun ##ction : cell expansion ; cellular growth ; Cell ##s - - Growth ; Cell Growth ; cell growth ##s ; cells growth ; growth cell ; growth of cell ; Cell ##ular Growth ; Cell ##ular Ex ##pan ##sion ) [SEP]'},\n",
    " {'mention_id': '28418943.15',\n",
    "  'test_set_idx': 35137,\n",
    "  'type': 'T204',\n",
    "  'name': 'rats',\n",
    "  'context': '[CLS] of alcohol seeking was reduced after 4 months compared with 2 months of intermittent alcohol access . The influence of individual levels of alcohol intake on loss of control over alcohol seeking was subsequently determined by assessing conditioned suppression in subgroup ##s of low and high alcohol drinking rats . Unlike the low alcohol drinking rats , the high alcohol drinking [unused1] rats [unused2] showed a ##version - resistant alcohol seeking after 2 months of intermittent alcohol access , although both groups showed comparable levels of conditioned freezing . These findings show that the development of loss of control over alcohol seeking , a key characteristic of Al ##co ##hol use disorder in humans , is dependent on both the extent of alcohol exposure and the [SEP]',\n",
    "  'existing_cui': 'C2097385',\n",
    "  'existing_cui_name': 'allergy testing rat',\n",
    "  'existing_cui_desc': '[CLS] all ##er ##gy testing rat [unused3] ( Health Care Act ##ivity , lab test : rat ) [SEP]',\n",
    "  'our_bi_cui': 'C0034721',\n",
    "  'our_bi_cui_name': 'Rattus',\n",
    "  'our_bi_cui_desc': '[CLS] Rat ##tus [unused3] ( E ##uka ##ryo ##te , organism : Rat ; Genus rat ##tus ; Genus Rat ##tus ; rats ; rat ; rat ##tus ; Rat ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0086893',\n",
    "  'our_cross_cui_name': 'Rats , Laboratory',\n",
    "  'our_cross_cui_desc': '[CLS] Rat ##s , Laboratory [unused3] ( E ##uka ##ryo ##te : laboratory rat ; Laboratory Rat ##s ; Rat , Laboratory ; Laboratory Rat ) [SEP]'},\n",
    " {'mention_id': '27838742.81',\n",
    "  'test_set_idx': 19048,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . [unused1] Del ##ica ##f ##lav ##one [unused2] induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28013256.6',\n",
    "  'test_set_idx': 23767,\n",
    "  'type': 'T097',\n",
    "  'name': 'health',\n",
    "  'context': \"[CLS] From training to practice : the impact of E ##NG ##AG ##E , Ireland ' s national men ' s health training programme Ireland ' s National Men ' s Health Policy recommended developing training programmes tailored to the needs of those working in [unused1] health [unused2] and allied health professionals and E ##NG ##AG ##E was developed to meet that recommendation . This study evaluated the impact of E ##NG ##AG ##E on front ##line service providers ' self - reported knowledge , skills , capacity and practice up to 5 - months post training . Between 2012 and 2015 , E ##NG ##AG ##E Train ##ers ( n = 57 ) delivered 62 1 - day training programmes to 81 ##0 participants . This [SEP]\",\n",
    "  'existing_cui': 'C4277525',\n",
    "  'existing_cui_name': 'One Health Initiative',\n",
    "  'existing_cui_desc': '[CLS] One Health Initiative [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line : Health , One ; One Medicine Initiative ; Health Initiative , One ; Medicine Initiative , One ; Initiative , One Medicine ; Initiative , One Health ; One Health ) [SEP]',\n",
    "  'our_bi_cui': 'C0018722',\n",
    "  'our_bi_cui_name': 'Health Occupations',\n",
    "  'our_bi_cui_desc': '[CLS] Health O ##cc ##upation ##s [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line : health occupations ; Health O ##cc ##upation ; Health Prof ##ess ##ion ; O ##cc ##upation ##s , Health ; Prof ##ess ##ions , Health ; Health Prof ##ess ##ions ; health profession ; O ##cc ##upation , Health ; health science profession ; health care field ; health occupation ; Health profession ##s ; Prof ##ess ##ion , Health ; occupation health ; Health careers ; H ##EA ##LT ##H O ##CC ##UP ; health profession ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C1704312',\n",
    "  'our_cross_cui_name': 'Health Professional',\n",
    "  'our_cross_cui_desc': '[CLS] Health Professional [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Health professionals ; Health Care Professional ##s ; H ##EA ##LT ##H CA ##RE PR ##O ##F ##ES ##SI ##ON ##AL ; Health profession ; Healthcare professional ; Healthcare worker ; Health Care Professional ; Health professional ) [SEP]'},\n",
    " {'mention_id': '27838742.43',\n",
    "  'test_set_idx': 19010,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] - I , which are auto ##pha ##gy - related proteins , and promoting the generation of acidic ve ##si ##cular organ ##elles and auto ##ly ##so ##some ##s in the c ##yt ##op ##las ##m of human lung cancer A ##5 ##4 ##9 and PC - 9 cells in a time - and dose - dependent manner . [unused1] Del ##ica ##f ##lav ##one [unused2] down ##re ##gu ##lated the expression of p ##hos ##ph ##o - A ##kt , p ##hos ##ph ##o - m ##TO ##R , and p ##hos ##ph ##o - p ##70 ##S ##6 ##K in a time - and dose - dependent manner , suggesting that it induced auto ##pha ##gy by in ##hibit ##ing the A ##kt / [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0529351',\n",
    "  'our_bi_cui_name': 'darifenacin',\n",
    "  'our_bi_cui_desc': '[CLS] da ##ri ##fen ##ac ##in [unused3] ( Chemical , medication , product , substance : Dar ##ife ##nac ##in ##um ; ( S ) - 1 - ( 2 - ( 2 , 3 - di ##hy ##dr ##o - 5 - Benz ##of ##ura ##ny ##l ) et ##hyl ) - alpha , alpha - dip ##hen ##yl - 3 - p ##yr ##rol ##id ##ine ##ace ##tam ##ide ; Dar ##ife ##nac ##in ; ( S ) - 1 - ( 2 - ( 2 , 3 - di ##hy ##dr ##o - 5 - ben ##zo ##fu ##ran ##yl ) et ##hyl ) - alpha , alpha - dip ##hen ##yl - 3 - p ##yr ##rol ##id ##ine ##ace ##tam ##ide ; [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27500205.19',\n",
    "  'test_set_idx': 8451,\n",
    "  'type': 'T103',\n",
    "  'name': 'kindlins',\n",
    "  'context': '[CLS] high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple [unused1] kind ##lins [unused2] , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of kind ##lins . Great interest in the kind ##lins has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def [SEP]',\n",
    "  'existing_cui': 'C1720776',\n",
    "  'existing_cui_name': 'Kindling , Neurologic',\n",
    "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
    "  'our_bi_cui': 'C0010422',\n",
    "  'our_bi_cui_name': 'Crystallins',\n",
    "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28144577.19',\n",
    "  'test_set_idx': 26719,\n",
    "  'type': 'T033',\n",
    "  'name': 'signs',\n",
    "  'context': '[CLS] combination with bone g ##raft ##s was used in 84 patients for the treatment of long bone non ##union ##s . All patients were evaluated radio ##graphical ##y for the development of he ##tero ##top ##ic o ##ssi ##fication during the standard assessment for the non ##union healing . In all patients ( 80 . 9 % ) with radio ##graphic [unused1] signs [unused2] of he ##tero ##top ##ic o ##ssi ##fication , a CT scan was performed . Non ##union site p ##al ##pation and ROM evaluation of the adjacent joints were also carried out . Factor ##s related to the patient ( age , gender ) , the non ##union ( location , size , chronic ##ity , number of previous procedures , infection [SEP]',\n",
    "  'existing_cui': 'C0311392',\n",
    "  'existing_cui_name': 'Physical findings',\n",
    "  'existing_cui_desc': '[CLS] Physical findings [unused3] ( Finding , finding , physical finding : physical finding ; physical findings ; Physical finding ; physical findings [ use for free text ] ; Physical signs ; Sign ##s - physical ; physical signs ; Physical sign ; Sign ; find physical ) [SEP]',\n",
    "  'our_bi_cui': 'C0311392',\n",
    "  'our_bi_cui_name': 'Physical findings',\n",
    "  'our_bi_cui_desc': '[CLS] Physical findings [unused3] ( Finding , finding , physical finding : physical finding ; physical findings ; Physical finding ; physical findings [ use for free text ] ; Physical signs ; Sign ##s - physical ; physical signs ; Physical sign ; Sign ; find physical ) [SEP]',\n",
    "  'our_cross_cui': 'C0037088',\n",
    "  'our_cross_cui_name': 'Signs and Symptoms',\n",
    "  'our_cross_cui_desc': '[CLS] Sign ##s and S ##ym ##pt ##oms [unused3] ( Finding , finding : Sign ##s and S ##ym ##pt ##oms [ Disease / Finding ] ; Clinical findings ; clinical findings ; O ##bs ##er ##vable En ##ti ##ty ; sign and s ##ym ##pt ##om ; Sign and s ##ym ##pt ##om ; S ##ym ##pt ##oms and Sign ##s ; sign / s ##ym ##pt ##om ; Finding ; Clinical observation : symptoms and signs ; S ##IG ##NS S ##Y ##MP ##TO ##MS ; Clinical finding ) [SEP]'},\n",
    " {'mention_id': '28376393.14',\n",
    "  'test_set_idx': 33592,\n",
    "  'type': 'T033',\n",
    "  'name': 'detection',\n",
    "  'context': '[CLS] ass ##ay as an approximation for the tertiary and q ##uate ##rna ##ry am ##ine load in waste ##waters and surface water samples , and this approximation was compared to N - ni ##tro ##so ##di ##met ##hyl ##amine formation potential using ch ##lora ##mine ##s . An existing color ##ime ##tric method was examined and op ##ti ##mized for the [unused1] detection [unused2] of am ##ines in environmental water samples . The method consists of liquid - liquid extraction followed by a cat ##aly ##zed reaction to form a yet - und ##ef ##ined product that is known to be both a strong ch ##rom ##op ##hore and flu ##oro ##ph ##ore . Previous work verified that this reaction was effectively cat ##aly ##zed by [SEP]',\n",
    "  'existing_cui': 'C0206100',\n",
    "  'existing_cui_name': 'Signal Detection',\n",
    "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
    "  'our_bi_cui': 'C1511790',\n",
    "  'our_bi_cui_name': 'Detection',\n",
    "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
    "  'our_cross_cui': 'C0442726',\n",
    "  'our_cross_cui_name': 'Detected',\n",
    "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
    " {'mention_id': '28377738.10',\n",
    "  'test_set_idx': 33695,\n",
    "  'type': 'T170',\n",
    "  'name': 'gradational',\n",
    "  'context': '[CLS] and the p ##oly ##se ##mous notion of consciousness continue to prove resistant to consistent measurement and un ##am ##bi ##guous definition . This is hardly surprising , given that there is no agreement even as regards the most fundamental issues they involve . One of the basic disagreements present in the continuing debate about consciousness per ##tains to its [unused1] g ##rada ##tional [unused2] nature . The general aim of this article is to show how consciousness might be graded and multi ##di ##men ##sional at the same time . We therefore focus on the question of what it is , exactly , that is or could be graded in cases of consciousness , and how we can measure it . Ultimately , four different [SEP]',\n",
    "  'existing_cui': 'C0699900',\n",
    "  'existing_cui_name': 'Catabolism',\n",
    "  'existing_cui_desc': '[CLS] Cat ##ab ##olis ##m [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : Cat ##ab ##olis ##m , function ; cat ##ab ##olis ##m ; cat ##ab ##olic process ; breakdown ; degradation ) [SEP]',\n",
    "  'our_bi_cui': 'C0445237',\n",
    "  'our_bi_cui_name': 'Rotational',\n",
    "  'our_bi_cui_desc': '[CLS] R ##ota ##tional [unused3] ( Spa ##tial Concept , qualifier value : rotation ##al ) [SEP]',\n",
    "  'our_cross_cui': 'C0441800',\n",
    "  'our_cross_cui_name': 'Grade',\n",
    "  'our_cross_cui_desc': '[CLS] Grade [unused3] ( Intel ##lect ##ual Product , attribute , qualifier value : With grade ; Has grade ; grades ; Grades ; G ##rading ; grade ) [SEP]'},\n",
    " {'mention_id': '28301509.57',\n",
    "  'test_set_idx': 31754,\n",
    "  'type': 'T017',\n",
    "  'name': '3H',\n",
    "  'context': '[CLS] . A single Q ##TL for grain yield containing three M ##TA ##s was found on chromosome 3 ##H located close to the H ##v - e ##IF ##4 ##E gene , which is known to regulate resistance to bar ##ley yellow mosaic virus . Subsequently the Q ##TL was shown to be tightly linked to r ##ym ##4 , a lo ##cus for resistance to the virus . G ##WA ##s on a ##rab ##ina ##ns q ##uant ##ified by L ##M ##6 resulted in the identification of major Q ##TL ##s closely located on [unused1] 3 ##H [unused2] and h ##y ##pot ##heses regarding put ##ative candidate genes were formulated through the study of gene expression levels based on bio ##in ##formatics tools . [SEP]',\n",
    "  'existing_cui': 'C1098079',\n",
    "  'existing_cui_name': '( 3H ) azidoneonicotinoid',\n",
    "  'existing_cui_desc': '[CLS] ( 3 ##H ) a ##zi ##don ##eon ##ico ##tino ##id [unused3] ( Chemical : ( 3 ##H ) A ##z ##N ##N ) [SEP]',\n",
    "  'our_bi_cui': 'C0008666',\n",
    "  'our_bi_cui_name': 'Chromosomes , Human , Pair 3',\n",
    "  'our_bi_cui_desc': '[CLS] Ch ##rom ##oso ##mes , Human , Pa ##ir 3 [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : Ch ##rom ##oso ##me 3 ; chromosome 3 ; Ch ##rom ##oso ##me pair 3 ; 3 chromosome ##s ; CH ##RO ##MO ##SO ##ME 03 ; CH ##RO ##MO ##SO ##ME ##S H ##UM ##AN PA ##IR 03 ; 3 chromosome ) [SEP]',\n",
    "  'our_cross_cui': 'C0008633',\n",
    "  'our_cross_cui_name': 'Chromosomes',\n",
    "  'our_cross_cui_desc': '[CLS] Ch ##rom ##oso ##mes [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : chromosome ; Ch ##rom ##oso ##mal ; chromosome ##s ; Ch ##rom ##oso ##me ) [SEP]'},\n",
    " {'mention_id': '27234220.24',\n",
    "  'test_set_idx': 280,\n",
    "  'type': 'T033',\n",
    "  'name': 'no',\n",
    "  'context': '[CLS] access complications ) . Pat ##ients in group A were older ( 74 ± 12 years vs . 68 ± 17 years , p < 0 . 01 ) and the main indication for anti ##coa ##gu ##lation was at ##rial fi ##bri ##lla ##tion ( 58 . 6 % ) . No complications occurred during the procedures . There were [unused1] no [unused2] acute bleeding ##s just after the bandage removal . During the first 24 ##h , only 3 ( 2 . 1 % ) radial o ##cc ##lusion ##s in group A and 2 ( 0 . 6 % ) in group B ( p = 0 . 14 ) were recorded . He ##mat ##oma ##s between 5 and 10 ##c ##m [SEP]',\n",
    "  'existing_cui': 'C1140150',\n",
    "  'existing_cui_name': 'NOC - CodeSystem',\n",
    "  'existing_cui_desc': '[CLS] NO ##C - Code ##S ##ys ##tem [unused3] ( Intel ##lect ##ual Product , NO ##C : nursing outcomes classification ) [SEP]',\n",
    "  'our_bi_cui': 'C0243095',\n",
    "  'our_bi_cui_name': 'Finding',\n",
    "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C1513916',\n",
    "  'our_cross_cui_name': 'Negative Finding',\n",
    "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
    " {'mention_id': '27676724.19',\n",
    "  'test_set_idx': 13878,\n",
    "  'type': 'T097',\n",
    "  'name': 'sonologist',\n",
    "  'context': '[CLS] or ##th ##oped ##ic surgeon , an occupational therapist for upper limb ma ##lf ##orm ##ation , a p ##hy ##sio ##ther ##ap ##ist for lower ma ##lf ##orm ##ation and a psychologist . This multi ##disciplinary consultation is unique because of each pregnancy story , because of each patient life story but also because of the words used by the [unused1] son ##ologist [unused2] when announcing the diagnosis . We deal with couples shocked by the pre ##nat ##al diagnosis . We help them get acceptance of the child to be born and to forget about their imaginary child . Medical information is often perceived as being \" a surf ##eit of information \" difficult to handle by the couple stunned by the overwhelming diagnosis [SEP]',\n",
    "  'existing_cui': 'C0586859',\n",
    "  'existing_cui_name': 'Pulmonologists',\n",
    "  'existing_cui_desc': '[CLS] P ##ul ##mon ##ologists [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Re ##sp ##ira ##tory disease specialist ; P ##ul ##mon ##ologist ; pulmonary specialist ; Re ##sp ##ira ##tory physician ; pu ##lm ##ono ##logist ) [SEP]',\n",
    "  'our_bi_cui': 'C1954848',\n",
    "  'our_bi_cui_name': 'Sonographer',\n",
    "  'our_bi_cui_desc': '[CLS] Son ##ographer [unused3] ( Professional or O ##cc ##upation ##al Group ) [SEP]',\n",
    "  'our_cross_cui': 'C1522486',\n",
    "  'our_cross_cui_name': 'Professional Organization or Group',\n",
    "  'our_cross_cui_desc': '[CLS] Professional Organization or Group [unused3] ( Professional or O ##cc ##upation ##al Group : Other Agency or Organization ; Organization ; OR ##G ; Outside Bo ##dies ; Organization ##al ) [SEP]'},\n",
    " {'mention_id': '27500205.23',\n",
    "  'test_set_idx': 8455,\n",
    "  'type': 'T103',\n",
    "  'name': 'kindlins',\n",
    "  'context': '[CLS] widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the levels of [unused1] kind ##lins [unused2] . Great interest in the kind ##lins has emerged from the recognition that they play major roles in controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate [SEP]',\n",
    "  'existing_cui': 'C1720776',\n",
    "  'existing_cui_name': 'Kindling , Neurologic',\n",
    "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
    "  'our_bi_cui': 'C0010422',\n",
    "  'our_bi_cui_name': 'Crystallins',\n",
    "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27659602.43',\n",
    "  'test_set_idx': 13388,\n",
    "  'type': 'T082',\n",
    "  'name': 'root',\n",
    "  'context': '[CLS] more are at risk for re ##oper ##ation , and not until at least after 10 . 4 years have passed . Neither the valve morphology ( p = 0 . 62 ) nor con ##com ##ita ##nt a ##ort ##ic valve replacement ( p = 0 . 86 ) influenced rate of root di ##lation . In non ##sy ##nd ##rom ##ic patients , the a ##ort ##ic root is the slow ##est growing portion of the th ##ora ##ci ##c a ##ort ##a . Leaving the native [unused1] root [unused2] , as in root - spa ##ring ascending a ##ort ##ic replacement , is a safe approach regarding secondary root intervention for a ##ort ##ic root diameter ##s of 45 mm or less . [SEP]',\n",
    "  'existing_cui': 'C1318154',\n",
    "  'existing_cui_name': 'Root body part',\n",
    "  'existing_cui_desc': '[CLS] Root body part [unused3] ( Ana ##tom ##ical Structure : Root ; root [ a body part ] ; root ) [SEP]',\n",
    "  'our_bi_cui': 'C0040452',\n",
    "  'our_bi_cui_name': 'Tooth root structure',\n",
    "  'our_bi_cui_desc': '[CLS] Too ##th root structure [unused3] ( Ana ##tom ##ical Structure , body structure : Ra ##di ##x co ##rona ; Root of the Too ##th ; tooth root ; Too ##th Root ; Root of Too ##th ; Root , Too ##th ; tooth roots ; root of tooth ; root tooth ; roots tooth ; Te ##eth - - Roots ; Roots , Too ##th ; of tooth root ; Too ##th Roots ; Too ##th root ; Ra ##di ##x Den ##tis ; Ra ##di ##x den ##tis ; rooted tooth ; Root of tooth ) [SEP]',\n",
    "  'our_cross_cui': 'C0549113',\n",
    "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
    "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
    " {'mention_id': '27474969.18',\n",
    "  'test_set_idx': 7435,\n",
    "  'type': 'T103',\n",
    "  'name': 'CuS',\n",
    "  'context': '[CLS] sensor based on reduced graph ##ene oxide - copper su ##lf ##ide ( r ##G ##O - C ##u ##S ) composite coupled with cap ##illa ##ry electro ##ph ##ores ##is was constructed for the ultra ##sen ##sitive detection of am ##lo ##di ##pine be ##sy ##late for the first time . In this work , r ##G ##O - [unused1] C ##u ##S [unused2] composite was synthesized by one - pot h ##ydro ##thermal method and used for electro ##de modification . The electro ##chemical and electro ##che ##mi ##lum ##ines ##cence behaviors of the sensor were investigated . More than 5 - fold enhance in electro ##che ##mi ##lum ##ines ##cence intensity was observed after modified with r ##G ##O - C ##u ##S [SEP]',\n",
    "  'existing_cui': 'C0056599',\n",
    "  'existing_cui_name': 'cupric sulfide',\n",
    "  'existing_cui_desc': '[CLS] cup ##ric su ##lf ##ide [unused3] ( Chemical , C ##u ##S : c ##p ##d with un ##sp ##ec ##ified M ##F of cup ##ric su ##lf ##ide ; co ##vel ##lite ) [SEP]',\n",
    "  'our_bi_cui': 'C0056301',\n",
    "  'our_bi_cui_name': 'Copper Sulfate',\n",
    "  'our_bi_cui_desc': '[CLS] Copper Sul ##fa ##te [unused3] ( Chemical , AS C ##UP ##RI ##C S ##U ##LF ##AT ##E , discontinued , medication , obsolete , product , substance : copper su ##l ##phate ; Copper Sul ##fa ##te [ Chemical / In ##g ##red ##ient ] ; Blue V ##it ##rio ##l ; cup ##ric su ##lf ##ate an ##hy ##dr ##ous ; CO ##PP ##ER S ##U ##LF ##AT ##E ; V ##it ##rio ##l , Blue ; BA ##SI ##C CO ##PP ##ER S ##U ##LF ##AT ##E ; Blue Vic ##king ; C ##UP ##RI ##C S ##U ##LF ##AT ##E , AN ##H ##Y ##DR ##O ##US ; Cup ##ric Sul ##fa ##te An ##hy ##dr ##ous ; Sul ##fa ##te , [SEP]',\n",
    "  'our_cross_cui': 'C0389357',\n",
    "  'our_cross_cui_name': 'cuprous sulfide',\n",
    "  'our_cross_cui_desc': '[CLS] cup ##rous su ##lf ##ide [unused3] ( Chemical : copper ( I ) su ##lf ##ide ; C ##u ##2 ##S c ##p ##d ) [SEP]'},\n",
    " {'mention_id': '28167893.31',\n",
    "  'test_set_idx': 27472,\n",
    "  'type': 'T038',\n",
    "  'name': 'Ipr-I',\n",
    "  'context': '[CLS] on potato - de ##x ##tro ##se a ##gar with i ##p ##rod ##ione , no fun ##gal growth ( i ##p ##rod ##ione - no growth , I ##p ##r - N ) occurred for the first 3 day after in ##cu ##bation , but once the initial growth ( i ##p ##rod ##ione - initial growth , [unused1] I ##p ##r - I [unused2] ) began at 4 - 5 day after in ##cu ##bation , the colonies grew and expanded continuously to be in full growth ( i ##p ##rod ##ione - growth , I ##p ##r - G ) , suggesting I ##p ##r - I may be a turning moment of the m ##or ##ph ##ogen ##etic changes resisting fungi ##cid [SEP]',\n",
    "  'existing_cui': 'C1418954',\n",
    "  'existing_cui_name': 'PRPS1 gene',\n",
    "  'existing_cui_desc': '[CLS] PR ##PS ##1 gene [unused3] ( Ana ##tom ##ical Structure : D ##F ##N ##X ##1 ; C ##MT ##X ##5 ; P ##H ##OS ##P ##H ##OR ##IB ##OS ##Y ##LP ##Y ##RO ##P ##H ##OS ##P ##HA ##TE S ##Y ##NT ##H ##ET ##AS ##E I ; PR ##S I ; rib ##ose - phosphate dip ##hos ##ph ##oki ##nas ##e 1 ; p ##hos ##ph ##ori ##bos ##yl p ##yr ##op ##hos ##phate s ##ynth ##eta ##se 1 ) [SEP]',\n",
    "  'our_bi_cui': 'C3755286',\n",
    "  'our_bi_cui_name': 'Idiophantis',\n",
    "  'our_bi_cui_desc': '[CLS] I ##dio ##pha ##nti ##s [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
    "  'our_cross_cui': 'C0018270',\n",
    "  'our_cross_cui_name': 'Growth',\n",
    "  'our_cross_cui_desc': \"[CLS] Growth [unused3] ( B ##iol ##og ##ic Fun ##ction : General ##ized Growth ; normal growth ; onto ##geny ; em ##b ##ryo ##nic growth ? ; Physical Growth ; growth ##s ; physical growth ; physical growth process ; growth ; ' growth ' ; G ##RO ##W ##TH ) [SEP]\"},\n",
    " {'mention_id': '28471040.35',\n",
    "  'test_set_idx': 37149,\n",
    "  'type': 'T038',\n",
    "  'name': 'rat glioma model',\n",
    "  'context': '[CLS] 2 g ##lio ##ma cell lines in cell culture studies , which further increases with addition of 1 , 2 - di ##ole ##oy ##l - 3 - trim ##eth ##yla ##mm ##onium - prop ##ane . Ma ##gnetic resonance imaging and his ##top ##ath ##olo ##gic evaluation on rat g ##lio ##ma - 2 t ##umour cells in [unused1] rat g ##lio ##ma model [unused2] ( 49 female W ##ista ##r rats , 250 - 300 g ) comparing in ##tra ##ven ##ous and in ##tra ##tum ##oral injection ##s of the drug have been performed and F ##TA - loaded na ##no ##par ##tic ##les reduced t ##umour size significantly in in - v ##ivo studies , with higher efficiency of in ##tra ##tum [SEP]',\n",
    "  'existing_cui': 'C0017638',\n",
    "  'existing_cui_name': 'Glioma',\n",
    "  'existing_cui_desc': '[CLS] G ##lio ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity : G ##lial Cell Tu ##mor ##s ; g ##lio ##mas ; [ M ] G ##lio ##mas ; G ##lio ##mas ; N ##eur ##og ##lial Neo ##p ##las ##m ; Tu ##mor of the N ##eur ##og ##lia ; g ##lio ##ma ; un ##sp ##ec ##ified site ; Tu ##mor , G ##lial Cell ; Tu ##mor ##s , G ##lial Cell ; G ##lial Neo ##p ##las ##m ; Neo ##p ##las ##m of N ##eur ##og ##lia ; N ##eur ##og ##lial Tu ##mor ; G ##lial Cell Tu ##mor ; G ##lial Tu ##mor ; G ##lio [SEP]',\n",
    "  'our_bi_cui': 'C1882742',\n",
    "  'our_bi_cui_name': 'Rat Malignant Glioma',\n",
    "  'our_bi_cui_desc': '[CLS] Rat Mali ##gnant G ##lio ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , R ##EN ##I : G ##lio ##ma , ma ##li ##gnant ) [SEP]',\n",
    "  'our_cross_cui': 'C0012644',\n",
    "  'our_cross_cui_name': 'Animal Disease Models',\n",
    "  'our_cross_cui_desc': '[CLS] Animal Disease Models [unused3] ( B ##iol ##og ##ic Fun ##ction : animal model ; Disease Models , Animal ; D ##IS M ##OD ##EL ##S AN ##IM ##AL ; Animal Model of Disease ; Disease Model , Animal ; Animal Disease Model ; Disease ##s - - Animal models ) [SEP]'},\n",
    " {'mention_id': '27838742.90',\n",
    "  'test_set_idx': 19057,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . [unused1] Del ##ica ##f ##lav ##one [unused2] may represent a potential therapeutic agent for lung cancer . [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27509301.2',\n",
    "  'test_set_idx': 8784,\n",
    "  'type': 'T103',\n",
    "  'name': 'Environmental Chemical',\n",
    "  'context': \"[CLS] Pre ##diction of E ##stro ##genic B ##io ##act ##ivity of [unused1] Environmental Chemical [unused2] Met ##ab ##oli ##tes The US Environmental Protection Agency ' s End ##oc ##rine Di ##s ##rup ##tor Screen ##ing Program is using in v ##it ##ro data generated from To ##x ##C ##ast / To ##x ##21 high - through ##put screening ass ##ays to assess the end ##oc ##rine activity of environmental chemicals . Considering that in v ##it ##ro ass ##ays may have limited metabolic capacity , inactive chemicals that are bio ##tra ##ns ##formed into meta ##bol ##ites with end ##oc ##rine bio ##act ##ivity may be missed for further screening and testing . Therefore , there is a value in developing novel approaches to account for [SEP]\",\n",
    "  'existing_cui': 'C0014406',\n",
    "  'existing_cui_name': 'Environment',\n",
    "  'existing_cui_desc': '[CLS] Environment [unused3] ( Spa ##tial Concept , environment , treatment : environments ; Environment ##s ; environment ; Environmental ; E ##N ##VI ##R ; en ##vir ; En ##vir ) [SEP]',\n",
    "  'our_bi_cui': 'C0014417',\n",
    "  'our_bi_cui_name': 'Environmental Pollutants',\n",
    "  'our_bi_cui_desc': '[CLS] Environmental Poll ##uta ##nts [unused3] ( Chemical : E ##N ##VI ##R P ##OL ##L ##UT ##AN ##TS ; P ##OL ##L ##UT ##AN ##TS E ##N ##VI ##R ; Poll ##uta ##nts , Environmental ) [SEP]',\n",
    "  'our_cross_cui': 'C0220806',\n",
    "  'our_cross_cui_name': 'Chemicals',\n",
    "  'our_cross_cui_desc': '[CLS] Chemical ##s [unused3] ( Chemical , medication , substance : chemical compounds ; Chemical ; chemical compound ; Chemical compound ; chemical substance ; Chemical ##ly ; Chemical product ; Chemical agent ; Chemical element AND / OR compound ; chemical ; chemicals ) [SEP]'},\n",
    " {'mention_id': '27832198.67',\n",
    "  'test_set_idx': 18689,\n",
    "  'type': 'T017',\n",
    "  'name': 'Cam734',\n",
    "  'context': '[CLS] ##er studies , and might differ in natural is ##olate ##s harbor ##ing this all ##ele . Results presented here ##in show that Cam ##7 ##34 - mediated ch ##lor ##o ##quin ##e resistance is dependent on the rare A1 ##44 ##F mutation that has not been observed beyond Southeast Asia , and reveal distinct impacts of this and other [unused1] Cam ##7 ##34 [unused2] - specific mutations on ch ##lor ##o ##quin ##e resistance and parasite growth rates . B ##io ##chemical ass ##ays revealed a broad impact of mutant P ##f ##CR ##T is ##of ##orms on parasite metabolism , including n ##uc ##leo ##side trip ##hos ##phate levels , hem ##og ##lo ##bin cat ##ab ##olis ##m and disposition of hem ##e , [SEP]',\n",
    "  'existing_cui': 'C0006675',\n",
    "  'existing_cui_name': 'Calcium',\n",
    "  'existing_cui_desc': '[CLS] Cal ##ci ##um [unused3] ( Chemical , medication , substance : Co ##agu ##lation factor IV - R ##ET ##IR ##ED - ; CO ##AG FA ##CT ##OR IV ; Co ##agu ##lation Factor IV ; B ##L ##O ##OD CO ##AG FA ##CT ##OR IV ; C ##a + + element ; factor i ##v ; calcium ; Blood Co ##agu ##lation Factor IV ; Cal ##ci ##um co ##agu ##lation factor ; Co ##agu ##lation factor IV ; calcium ##s ; Cal ##ci ##um [ Chemical / In ##g ##red ##ient ] ; C ##a - Cal ##ci ##um ; CA ##LC ##I ##UM ; Factor IV ; C ##a element ; Cal ##ci ##um anal ##yte ; Factor IV , Co ##agu ##lation [SEP]',\n",
    "  'our_bi_cui': 'C0678941',\n",
    "  'our_bi_cui_name': 'Gene Mutant',\n",
    "  'our_bi_cui_desc': '[CLS] Gene Mu ##tant [unused3] ( Ana ##tom ##ical Structure : gene mutant ##s ; Gene Mu ##tation ; gene mutant ; Gene V ##arian ##t ; mutant gene ; genes mutant ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27384489.27',\n",
    "  'test_set_idx': 4341,\n",
    "  'type': 'T082',\n",
    "  'name': 'R1628P polymorphism',\n",
    "  'context': \"[CLS] used to evaluate the strength of the association between the R ##16 ##28 ##P p ##oly ##mor ##phism and Parkinson ' s disease . This meta - analysis assessed 19 studies from 14 papers that involved a total of 9 , 92 ##7 Parkinson ' s disease patients and 8 , 60 ##2 controls and found that the [unused1] R ##16 ##28 ##P p ##oly ##mor ##phism [unused2] was significantly associated with the risk of Parkinson ' s disease in Asian populations . Moreover , s ##tra ##ti ##fication analyses indicated that the R ##16 ##28 ##P p ##oly ##mor ##phism was significantly associated with an increased risk of Parkinson ' s disease among Chinese as well as non - Chinese Asian populations and an increased [SEP]\",\n",
    "  'existing_cui': 'C0032529',\n",
    "  'existing_cui_name': 'Genetic Polymorphism',\n",
    "  'existing_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
    "  'our_bi_cui': 'C0032529',\n",
    "  'our_bi_cui_name': 'Genetic Polymorphism',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
    "  'our_cross_cui': 'C0752046',\n",
    "  'our_cross_cui_name': 'Single Nucleotide Polymorphism',\n",
    "  'our_cross_cui_desc': '[CLS] Single N ##uc ##leo ##tide Pol ##ym ##or ##phism [unused3] ( Spa ##tial Concept , S ##NP : Pol ##ym ##or ##phism , Single N ##uc ##leo ##tide ; Single N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s ; Pol ##ym ##or ##phism ##s , Single N ##uc ##leo ##tide ; S ##NP ##s ; N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s , Single ; N ##uc ##leo ##tide Pol ##ym ##or ##phism , Single ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s ; Pol ##ym ##or ##phism , Single Base ) [SEP]'},\n",
    " {'mention_id': '28353042.19',\n",
    "  'test_set_idx': 32947,\n",
    "  'type': 'T168',\n",
    "  'name': 'high - fructose diet',\n",
    "  'context': '[CLS] incidence of In ##sul ##in resistance . The present study investigate ##s the beneficial effects of a ##que ##ous extract of Ph ##yl ##lant ##hus am ##aru s ( PA ##A ##E ) on In ##sul ##in resistance and o ##xi ##da ##tive stress in high - f ##ru ##ct ##ose fed male W ##ista ##r rats . [unused1] high - f ##ru ##ct ##ose diet [unused2] ( 66 % of f ##ru ##ct ##ose ) and PA ##A ##E ( 200 mg / kg body weight / day ) were given concurrently to the rats for a period of 60 days . Fr ##uc ##tos ##e - fed rats showed weight gain , h ##yper ##gly ##ce ##mia , h ##yper ##ins ##ulin ##emia , [SEP]',\n",
    "  'existing_cui': 'C0452314',\n",
    "  'existing_cui_name': 'Low fructose diet',\n",
    "  'existing_cui_desc': '[CLS] Low f ##ru ##ct ##ose diet [unused3] ( Health Care Act ##ivity , finding ) [SEP]',\n",
    "  'our_bi_cui': 'C0301568',\n",
    "  'our_bi_cui_name': 'High residue diet',\n",
    "  'our_bi_cui_desc': '[CLS] High residue diet [unused3] ( Health Care Act ##ivity , finding , regime / therapy , treatment : High - fiber diet ; diet fiber high ; high fibre diet ; N ##SP - High non - star ##ch p ##oly ##sa ##cc ##hari ##de diet ; High rough ##age diet ; diet high fiber ; H ##F - High fibre diet ; H ##F ##D - High fiber diet ; H ##F - High fiber diet ; High fiber diet ; high residue diet ; Inc ##reased fiber diet ; diet ##s fiber high ; High non - star ##ch p ##oly ##sa ##cc ##hari ##de diet ; High fibre diet ; H ##F ##D - High fibre diet ; high fiber diet ; diet [SEP]',\n",
    "  'our_cross_cui': 'C0012155',\n",
    "  'our_cross_cui_name': 'Diet',\n",
    "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
    " {'mention_id': '27601594.44',\n",
    "  'test_set_idx': 11275,\n",
    "  'type': 'T103',\n",
    "  'name': 'IDO-1',\n",
    "  'context': '[CLS] + ) plasma cells , CD ##6 ##8 ( + ) mac ##rop ##hage ##s , and M ##HC class I on tumor cells . I ##mm ##uno ##su ##pp ##ress ##ive cell types were also unchanged , including Fox ##P ##3 ( + ) PD - 1 ( + ) cells ( put ##ative regulatory T cells ) , [unused1] ID ##O - 1 [unused2] ( + ) cells , and PD - L ##1 ( + ) cells ( both mac ##rop ##hage ##s and tumor cells ) . Hi ##era ##rch ##ical cluster ##ing revealed three response patterns : ( i ) T ##IL ( high ) tumors showed increases in multiple immune markers after ch ##em ##otherapy ; ( ii ) T [SEP]',\n",
    "  'existing_cui': 'C1427370',\n",
    "  'existing_cui_name': 'MYLIP gene',\n",
    "  'existing_cui_desc': '[CLS] M ##Y ##L ##IP gene [unused3] ( Ana ##tom ##ical Structure : IN ##D ##UC ##IB ##LE DE ##GR ##AD ##ER OF THE L ##OW DE ##NS ##IT ##Y L ##IP ##OP ##RO ##TE ##IN R ##EC ##EP ##TO ##R ; E ##3 u ##bi ##qui ##tin l ##iga ##se - in ##du ##cible de ##grade ##r of the low density lip ##op ##rote ##in receptor ; MI ##R ; M ##Y ##OS ##IN R ##EG ##U ##LA ##TO ##R ##Y L ##IG ##HT CH ##A ##IN - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N ; my ##os ##in regulatory light chain interacting protein ) [SEP]',\n",
    "  'our_bi_cui': 'C1416433',\n",
    "  'our_bi_cui_name': 'IDO1 gene',\n",
    "  'our_bi_cui_desc': '[CLS] ID ##O ##1 gene [unused3] ( Ana ##tom ##ical Structure : IN ##D ##OL ##EA ##MI ##NE 2 , 3 - D ##IO ##X ##Y ##GE ##NA ##SE ; IN ##D ##O Gene ; Indo ##leam ##ine - P ##yr ##rol ##e 2 , 3 Di ##ox ##y ##gen ##ase Gene ; ID ##O ; in ##do ##leam ##ine 2 , 3 - di ##ox ##y ##gen ##ase 1 ; IN ##D ##O ) [SEP]',\n",
    "  'our_cross_cui': 'C3529891',\n",
    "  'our_cross_cui_name': 'indoleamine 2,3-dioxygenase 1 , human',\n",
    "  'our_cross_cui_desc': '[CLS] in ##do ##leam ##ine 2 , 3 - di ##ox ##y ##gen ##ase 1 , human [unused3] ( Chemical : ID ##O ##1 protein , human ) [SEP]'},\n",
    " {'mention_id': '27898905.54',\n",
    "  'test_set_idx': 21266,\n",
    "  'type': 'T033',\n",
    "  'name': 'no',\n",
    "  'context': '[CLS] service . On p ##hen ##ot ##y ##ping all training animals for both commencement of l ##ute ##al activity and ca ##lving to first service , accuracy for ca ##lving to first service increased to 0 . 18 ; however , when valid ##ation animals were also p ##hen ##otype ##d for commencement of l ##ute ##al activity , there was [unused1] no [unused2] substantial increase in accuracy . When predict ##ing ca ##lving to first service in bi ##var ##iate analysis with proportion of samples with l ##ute ##al activity , accuracy ranged from 0 . 07 to 0 . 14 . This first study on g ##eno ##mic predictions for fertility using end ##oc ##rine traits suggests some improvement in the accuracy of prediction [SEP]',\n",
    "  'existing_cui': 'C1140150',\n",
    "  'existing_cui_name': 'NOC - CodeSystem',\n",
    "  'existing_cui_desc': '[CLS] NO ##C - Code ##S ##ys ##tem [unused3] ( Intel ##lect ##ual Product , NO ##C : nursing outcomes classification ) [SEP]',\n",
    "  'our_bi_cui': 'C0205160',\n",
    "  'our_bi_cui_name': 'Negative',\n",
    "  'our_bi_cui_desc': '[CLS] N ##eg ##ative [unused3] ( Finding , qualifier value : Rule ##d out ; N ##eg ##ative ( m ##od ##ifier ) [ Am ##bi ##guous ] ; N ##eg ##ative for ; N ##eg ##ative ( m ##od ##ifier ) ; ruled out ; for negative ; out ruled ; negative ; negative ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C1513916',\n",
    "  'our_cross_cui_name': 'Negative Finding',\n",
    "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
    " {'mention_id': '27384489.31',\n",
    "  'test_set_idx': 4345,\n",
    "  'type': 'T082',\n",
    "  'name': 'R1628P polymorphism',\n",
    "  'context': \"[CLS] papers that involved a total of 9 , 92 ##7 Parkinson ' s disease patients and 8 , 60 ##2 controls and found that the R ##16 ##28 ##P p ##oly ##mor ##phism was significantly associated with the risk of Parkinson ' s disease in Asian populations . Moreover , s ##tra ##ti ##fication analyses indicated that the [unused1] R ##16 ##28 ##P p ##oly ##mor ##phism [unused2] was significantly associated with an increased risk of Parkinson ' s disease among Chinese as well as non - Chinese Asian populations and an increased risk of Parkinson ' s disease in Chinese patients from China , Taiwan , and Singapore . In a s ##tra ##ti ##fied analysis conducted according to age , significant associations were found [SEP]\",\n",
    "  'existing_cui': 'C0032529',\n",
    "  'existing_cui_name': 'Genetic Polymorphism',\n",
    "  'existing_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
    "  'our_bi_cui': 'C0032529',\n",
    "  'our_bi_cui_name': 'Genetic Polymorphism',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##tic Pol ##ym ##or ##phism [unused3] ( B ##iol ##og ##ic Fun ##ction , Gene ##tics , finding : P ##OL ##Y ##MO ##RP ##H ##IS ##M GE ##NE ##T ; P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ; Gene ##tic p ##oly ##mor ##phism ; genetic p ##oly ##mor ##phism ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##MS ; GE ##NE ##T P ##OL ##Y ##MO ##RP ##H ##IS ##M ; Pol ##ym ##or ##phism ##s , Gene ##tic ; Gene ##tic p ##oly ##mor ##phism ##s ; p ##oly ##mor ##phism ; Pol ##ym ##or ##phism , Gene ##tic ; p ##oly ##mor ##phism ##s ; Gene ##tic Pol ##ym ##or ##phism ##s [SEP]',\n",
    "  'our_cross_cui': 'C0752046',\n",
    "  'our_cross_cui_name': 'Single Nucleotide Polymorphism',\n",
    "  'our_cross_cui_desc': '[CLS] Single N ##uc ##leo ##tide Pol ##ym ##or ##phism [unused3] ( Spa ##tial Concept , S ##NP : Pol ##ym ##or ##phism , Single N ##uc ##leo ##tide ; Single N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s ; Pol ##ym ##or ##phism ##s , Single N ##uc ##leo ##tide ; S ##NP ##s ; N ##uc ##leo ##tide Pol ##ym ##or ##phism ##s , Single ; N ##uc ##leo ##tide Pol ##ym ##or ##phism , Single ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ; single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s ; Pol ##ym ##or ##phism , Single Base ) [SEP]'},\n",
    " {'mention_id': '27259647.25',\n",
    "  'test_set_idx': 956,\n",
    "  'type': 'T103',\n",
    "  'name': '9-cis-11-trans-CLA',\n",
    "  'context': '[CLS] h ##ydro ##xy ##l derivative 10 - h ##ydro ##xi - 12 - c ##is - o ##ct ##ade ##ce ##no ##ic acid to finally form bio ##active con ##ju ##gated l ##ino ##le ##ic acid . B ##io ##chemical optimization studies were carried out to el ##uc ##ida ##te the conditions for maximum production of [unused1] 9 - c ##is - 11 - trans - C ##LA [unused2] and maximum stability of α - en ##ola ##se when cat ##aly ##zing this reaction . Furthermore , through structural analysis of the protein , we propose the binding sites of substrate and product molecules that were characterized as two h ##ydro ##phobic superficial pockets located at opposite ends of the en ##ola ##se connected through a [SEP]',\n",
    "  'existing_cui': 'C0281666',\n",
    "  'existing_cui_name': 'alitretinoin',\n",
    "  'existing_cui_desc': '[CLS] al ##it ##ret ##ino ##in [unused3] ( Chemical , product , substance : 9 - CR ##A ; 9 - c ##is - T ##ret ##ino ##in ; Ali ##tre ##tino ##ín ##a ; 9 - c ##is re ##tino ##ic acid ; 9 - c ##is - Re ##tino ##ic acid ; 9 - c ##is - Re ##tino ##ic A ##cid ; Ali ##tre ##tino ##in ; Ali ##tre ##tino ##in ##um ; 3 , 7 - Di ##met ##hyl - 9 - ( 2 , 6 , 6 - trim ##eth ##yl - 1 - c ##y ##c ##lo ##he ##xen - 1 - y ##l ) 2 - trans - 4 - trans - 6 - c ##is - 8 - trans [SEP]',\n",
    "  'our_bi_cui': 'C0902483',\n",
    "  'our_bi_cui_name': 'cis-9-trans-11-octadecadienoic acid',\n",
    "  'our_bi_cui_desc': '[CLS] c ##is - 9 - trans - 11 - o ##ct ##ade ##ca ##die ##no ##ic acid [unused3] ( Chemical : 9 - c ##is - 11 - trans - o ##ct ##ade ##ca ##die ##no ##ic acid ; c ##9 ##t ##11 C ##LA ) [SEP]',\n",
    "  'our_cross_cui': 'C1609806',\n",
    "  'our_cross_cui_name': 'cis-9 , trans-11-conjugated linoleic acid',\n",
    "  'our_cross_cui_desc': '[CLS] c ##is - 9 , trans - 11 - con ##ju ##gated l ##ino ##le ##ic acid [unused3] ( Chemical : c ##9 - t ##11 - C ##LA ) [SEP]'},\n",
    " {'mention_id': '28353042.2',\n",
    "  'test_set_idx': 32930,\n",
    "  'type': 'T168',\n",
    "  'name': 'High Fructose Diet',\n",
    "  'context': '[CLS] Ben ##ef ##ici ##al Effects of Ph ##yl ##lant ##hus am ##aru ##s Against [unused1] High Fr ##uc ##tos ##e Diet [unused2] In ##duced In ##sul ##in Resistance and He ##pa ##tic O ##xi ##da ##tive St ##ress in Male W ##ista ##r Rat ##s In ##sul ##in resistance is a characteristic feature of o ##besity , type 2 diabetes me ##lli ##tus , and card ##iovascular diseases . Em ##erging evidence suggests that the high - f ##ru ##ct ##ose consumption is a potential and important factor responsible for the rising incidence of In ##sul ##in resistance . The present study investigate ##s the beneficial effects of a ##que ##ous extract of Ph ##yl ##lant ##hus am ##aru s ( PA ##A ##E ) on [SEP]',\n",
    "  'existing_cui': 'C0452314',\n",
    "  'existing_cui_name': 'Low fructose diet',\n",
    "  'existing_cui_desc': '[CLS] Low f ##ru ##ct ##ose diet [unused3] ( Health Care Act ##ivity , finding ) [SEP]',\n",
    "  'our_bi_cui': 'C0301568',\n",
    "  'our_bi_cui_name': 'High residue diet',\n",
    "  'our_bi_cui_desc': '[CLS] High residue diet [unused3] ( Health Care Act ##ivity , finding , regime / therapy , treatment : High - fiber diet ; diet fiber high ; high fibre diet ; N ##SP - High non - star ##ch p ##oly ##sa ##cc ##hari ##de diet ; High rough ##age diet ; diet high fiber ; H ##F - High fibre diet ; H ##F ##D - High fiber diet ; H ##F - High fiber diet ; High fiber diet ; high residue diet ; Inc ##reased fiber diet ; diet ##s fiber high ; High non - star ##ch p ##oly ##sa ##cc ##hari ##de diet ; High fibre diet ; H ##F ##D - High fibre diet ; high fiber diet ; diet [SEP]',\n",
    "  'our_cross_cui': 'C0012155',\n",
    "  'our_cross_cui_name': 'Diet',\n",
    "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
    " {'mention_id': '28493435.7',\n",
    "  'test_set_idx': 37722,\n",
    "  'type': 'T033',\n",
    "  'name': 'locate',\n",
    "  'context': '[CLS] with ultra ##sound el ##ast ##ography has become a hot field in recent years . However , for key ##points tracking - based el ##ast ##ography algorithms , lo ##cating ex ##tre ##ma in multi ##mo ##dal ultra ##sonic radio ##f ##re ##que ##ncy signals is still a challenging problem . In this paper , a new method is proposed to [unused1] locate [unused2] the local ma ##xi ##ma and mini ##ma of the RF signals directly without der ##ivation operation . This algorithm can accurately locate ex ##tre ##ma even if disturbed peaks resulting from different noise exist . Furthermore , the new algorithm can speed up approximately 79 % of the implementation process as compared with the standard cross - correlation method on the [SEP]',\n",
    "  'existing_cui': 'C1366498',\n",
    "  'existing_cui_name': 'Chloramphenicol Acetyl Transferase Gene',\n",
    "  'existing_cui_desc': '[CLS] Ch ##lora ##mp ##hen ##ico ##l Ace ##ty ##l Transfer ##ase Gene [unused3] ( Ana ##tom ##ical Structure : cat Gene ) [SEP]',\n",
    "  'our_bi_cui': 'C0450429',\n",
    "  'our_bi_cui_name': 'Location',\n",
    "  'our_bi_cui_desc': '[CLS] Location [unused3] ( Spa ##tial Concept , attribute : location ; Lo ##c ; L ##OC ; locations ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27444636.41',\n",
    "  'test_set_idx': 5992,\n",
    "  'type': 'T170',\n",
    "  'name': 'Quality of Life in Epilepsy Inventory 10',\n",
    "  'context': '[CLS] analysis included 21 patients ( 12 women , 9 men ; mean age 36 years ) . After switching from o ##x ##car ##ba ##ze ##pine to es ##lica ##rb ##az ##ep ##ine ace ##tate , there were significant improvements in mean scores for Ad ##verse Events Profile ( P < . 00 ##1 ) , [unused1] Quality of Life in E ##pile ##psy In ##vent ##ory 10 [unused2] ( P = . 00 ##1 ) , and alert ##ness ( P < . 05 ) . Ad ##verse Events Profile total scores improved for 21 / 21 ( 100 . 0 % ) patients , Quality of Life in E ##pile ##psy In ##vent ##ory 10 total scores improved for 17 / 21 ( 81 [SEP]',\n",
    "  'existing_cui': 'C2698752',\n",
    "  'existing_cui_name': 'Pediatric Quality of Life Inventory',\n",
    "  'existing_cui_desc': '[CLS] P ##ediatric Quality of Life In ##vent ##ory [unused3] ( Intel ##lect ##ual Product : P ##eds ##QL ) [SEP]',\n",
    "  'our_bi_cui': 'C3897419',\n",
    "  'our_bi_cui_name': 'Symptom Interference with Life Score 10',\n",
    "  'our_bi_cui_desc': '[CLS] S ##ym ##pt ##om Inter ##ference with Life Score 10 [unused3] ( Intel ##lect ##ual Product : MD ##AS ##I S ##ym ##pt ##om Inter ##ference with Life Score 10 ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28188533.11',\n",
    "  'test_set_idx': 27856,\n",
    "  'type': 'T091',\n",
    "  'name': 'proteomic studies',\n",
    "  'context': '[CLS] ##c ##quisition Data for Label - free Q ##uant ##itative Pro ##te ##omi ##cs Studies Using Triple ##TO ##F ( ® ) Mass S ##pect ##rome ##ters Data - independent acquisition is a powerful mass s ##pect ##rome ##try technique that enables comprehensive MS and MS / MS analysis of all detect ##able species , providing an information rich data file that can be mined deeply . Here , we describe how to acquire high - quality S ##WA ##TH ( ® ) A ##c ##quisition data to be used for large quantitative [unused1] pro ##te ##omi ##c studies [unused2] . We specifically focus on using variable sized Q ##1 windows for acquisition of MS / MS data for generating higher specific ##ity quantitative data . [SEP]',\n",
    "  'existing_cui': 'C1519031',\n",
    "  'existing_cui_name': 'Pharmacoeconomic Study',\n",
    "  'existing_cui_desc': '[CLS] Ph ##arma ##coe ##con ##omi ##c Study [unused3] ( Research Act ##ivity : P ##HA ##R ##MA ##CO ##EC ##ON ##OM ##IC ) [SEP]',\n",
    "  'our_bi_cui': 'C1327760',\n",
    "  'our_bi_cui_name': 'proteomic profiling',\n",
    "  'our_bi_cui_desc': '[CLS] pro ##te ##omi ##c pro ##fi ##ling [unused3] ( Health Care Act ##ivity : Pro ##te ##omi ##c Prof ##iling ; Pro ##tein Express ##ion Prof ##iling ) [SEP]',\n",
    "  'our_cross_cui': 'C0872252',\n",
    "  'our_cross_cui_name': 'Proteomics',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##te ##omi ##cs [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line : pro ##te ##omi ##cs ; pro ##te ##omi ##c ) [SEP]'},\n",
    " {'mention_id': '28179911.58',\n",
    "  'test_set_idx': 27652,\n",
    "  'type': 'T017',\n",
    "  'name': 'FATA',\n",
    "  'context': '[CLS] ##WR ##I ##1 in seven independent T ##2 lines were detected by quantitative real - time PC ##R . The relative m ##RNA accumulation of genes encoding enzymes involved in either fatty acid bio ##sy ##nt ##hesis or t ##ria ##cy ##l ##gly ##cer ##ols assembly ( BC ##CP ##2 , K ##AS ##I , MA ##T , E ##NR , [unused1] FA ##TA [unused2] , and GP ##D ##H ) were also ass ##ay ##ed in mature seeds . Furthermore , lip ##id and fatty acids C ##16 : 0 and C ##18 : 0 significantly increased . In two ho ##mo ##zy ##go ##us T ##2 trans ##genic rice lines ( G ##5 and G ##2 ) , different Co ##WR ##I ##1 expression [SEP]',\n",
    "  'existing_cui': 'C1366645',\n",
    "  'existing_cui_name': 'CD36 gene',\n",
    "  'existing_cui_desc': '[CLS] CD ##36 gene [unused3] ( Ana ##tom ##ical Structure : SC ##AR ##B ##3 ; T ##H ##RO ##MB ##OS ##PO ##ND ##IN R ##EC ##EP ##TO ##R ; L ##E ##U ##KO ##C ##Y ##TE D ##IF ##F ##ER ##EN ##TI ##AT ##ION AN ##TI ##GE ##N CD ##36 ; GP ##I ##V ; CD ##36 Gene ; CD ##36 Mo ##le ##cule Gene ; G ##L ##Y ##CO ##PR ##OT ##EI ##N III ##b ; CD ##36 molecule ; GP III ##b ; CO ##LL ##AG ##EN R ##EC ##EP ##TO ##R , P ##LA ##TE ##LE ##T ; P ##LA ##TE ##LE ##T G ##L ##Y ##CO ##PR ##OT ##EI ##N IV ; FA ##TT ##Y AC ##ID T ##RA ##NS ##L ##OC [SEP]',\n",
    "  'our_bi_cui': 'C0812278',\n",
    "  'our_bi_cui_name': 'FAT1 gene',\n",
    "  'our_bi_cui_desc': '[CLS] FA ##T ##1 gene [unused3] ( Ana ##tom ##ical Structure : FA ##T at ##y ##pical ca ##dh ##eri ##n 1 ; CD ##HF ##7 ; FA ##T At ##y ##pical C ##ad ##her ##in 1 Gene ; ca ##dh ##eri ##n - related family member 8 ; FA ##T ; FA ##T T ##UM ##OR S ##UP ##PR ##ES ##SO ##R , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 1 ; fat gene ; FA ##T ##1 Gene ; CD ##H ##R ##8 ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '25847295.22',\n",
    "  'test_set_idx': 21,\n",
    "  'type': 'T017',\n",
    "  'name': 'apoptotic cells',\n",
    "  'context': '[CLS] PC ##12 cells with non ##yl ##phe ##no ##l diet ##ho ##xy ##late , whereas the c ##yt ##och ##rome c release into the c ##yt ##oso ##l decreased as compared to that in a ##pop ##to ##tic cells not treated with non ##yl ##phe ##no ##l diet ##ho ##xy ##late s . Furthermore , Ba ##x contents in [unused1] a ##pop ##to ##tic cells [unused2] were reduced after exposure to non ##yl ##phe ##no ##l diet ##ho ##xy ##late . Thus , non ##yl ##phe ##no ##l diet ##ho ##xy ##late has the opposite effect on a ##pop ##tosis in PC ##12 cells compared to non ##yl ##phe ##no ##l , which enhance ##s a ##pop ##tosis induced by serum de ##p ##ri ##vation . [SEP]',\n",
    "  'existing_cui': 'C0162638',\n",
    "  'existing_cui_name': 'Apoptosis',\n",
    "  'existing_cui_desc': '[CLS] A ##pop ##tosis [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : a ##pop ##to ##tic cell death ; A ##pop ##to ##tic Process ; Programme ##d Cell Death ; programmed cell death by a ##pop ##tosis ; A ##pop ##tosis Path ##way ; a ##pop ##tos ##e ; programmed cell death ; RC ##D ; a ##pop ##tosis ; Gene - directed cell death ; a ##pop ##to ##tic programmed cell death ; Programme ##d Cell Death , Type I ; self destruction of the cell ; Me ##chan ##ism that allows cells to self - des ##truct when it is necessary ; a ##pop ##to ##tic process ; type I programmed cell death ) [SEP]',\n",
    "  'our_bi_cui': 'C1836846',\n",
    "  'our_bi_cui_name': 'Apoptotic neurons',\n",
    "  'our_bi_cui_desc': '[CLS] A ##pop ##to ##tic neurons [unused3] ( Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0007634',\n",
    "  'our_cross_cui_name': 'Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
    " {'mention_id': '27965426.19',\n",
    "  'test_set_idx': 22656,\n",
    "  'type': 'T103',\n",
    "  'name': 'spindle - associated proteins',\n",
    "  'context': '[CLS] not well characterized . Although a few functional ##ly - relevant mit ##otic p ##hos ##ph ##ot ##yr ##os ##ine sites have been characterized , evidence suggests that this modification may be more prevalent than previously appreciated . Here , we examined t ##yr ##os ##ine p ##hos ##ph ##ory ##lation in mit ##otic human cells including those on [unused1] spin ##dle - associated proteins [unused2] . ? Database mining confirmed ~ 2000 mit ##otic p ##hos ##ph ##ot ##yr ##os ##ine sites , and network analysis revealed a number of sub ##net ##works that were en ##rich ##ed in t ##yr ##os ##ine - p ##hos ##ph ##ory ##lated proteins , including components of the kin ##eto ##chor ##e or spin ##dle and SR ##C [SEP]',\n",
    "  'existing_cui': 'C1425583',\n",
    "  'existing_cui_name': 'NUSAP1 gene',\n",
    "  'existing_cui_desc': '[CLS] N ##US ##AP ##1 gene [unused3] ( Ana ##tom ##ical Structure : N ##US ##AP ##1 Gene ; L ##NP ; PR ##O ##0 ##31 ##0 ##p ##1 ; N ##US ##AP ; N ##UC ##LE ##OL ##AR AND SP ##IN ##D ##LE - AS ##SO ##CI ##AT ##ED PR ##OT ##EI ##N 1 ; SA ##PL ; Q ##0 ##31 ##0 ; N ##UC ##LE ##OL ##AR PR ##OT ##EI ##N AN ##K ##T ; N ##u ##SA ##P ##1 ; FL ##J ##13 ##42 ##1 ; N ##uc ##leo ##lar and Spin ##dle Associated Pro ##tein 1 Gene ; n ##uc ##leo ##lar and spin ##dle associated protein 1 ; B ##M ##0 ##37 ) [SEP]',\n",
    "  'our_bi_cui': 'C0026045',\n",
    "  'our_bi_cui_name': 'Microtubule-Associated Proteins',\n",
    "  'our_bi_cui_desc': '[CLS] Micro ##tub ##ule - Associated Pro ##tein ##s [unused3] ( Chemical , MA ##P : Micro ##tub ##ule Associated Pro ##tein ##s ; Micro ##tub ##ule - associated protein ; MI ##CR ##OT ##U ##B ##U ##LE AS ##SO ##C PR ##OT ##EI ##NS ; micro ##tub ##ule - associated proteins ; Micro ##tub ##ule - Associated Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; Micro ##tub ##ule - Associated Pro ##tein ; Micro ##tub ##ule Associated Pro ##tein ; MA ##Ps ; micro ##tub ##ule associated protein ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28454015.24',\n",
    "  'test_set_idx': 36525,\n",
    "  'type': 'T170',\n",
    "  'name': 'health - risk based air quality index',\n",
    "  'context': '[CLS] to evaluate the health risks . Results show that based on health - risk based air quality index , the current air quality index system likely significantly under ##est ##imate the health risks of air pollution , highlighting that the general public may need strict ##er health protection measures . The population - weighted two - year average [unused1] health - risk based air quality index [unused2] data further demonstrates that all population in the studied cities in He ##nan province live with poll ##uted air - 72 % of the population is exposed to air that is un ##hea ##lt ##hy for sensitive people , while 28 % of people is exposed to air that can be harmful to healthy people ; and the health [SEP]',\n",
    "  'existing_cui': 'C1268941',\n",
    "  'existing_cui_name': 'Health risks education',\n",
    "  'existing_cui_desc': '[CLS] Health risks education [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Counsel ##ing regarding health risks ; Ad ##vice about health risks ; Counsel ##ling regarding health risks ; Education regarding health risks ) [SEP]',\n",
    "  'our_bi_cui': 'C0018761',\n",
    "  'our_bi_cui_name': 'Health Status Indicators',\n",
    "  'our_bi_cui_desc': '[CLS] Health Status In ##dic ##ators [unused3] ( Intel ##lect ##ual Product , assessment scale : Index ##es , Health Status ; In ##dic ##ators , Health Status ; health status index ; In ##dic ##ator , Health Status ; Health Status Index ; In ##dices , Health Status ; Health status indicators ; Health Status In ##dices ; Health status index ; Health Status In ##dic ##ator ; Index , Health Status ; Health Status Index ##es ; health status indicators ; health in ##dices status ) [SEP]',\n",
    "  'our_cross_cui': 'C0918012',\n",
    "  'our_cross_cui_name': 'Index',\n",
    "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
    " {'mention_id': '27500205.6',\n",
    "  'test_set_idx': 8438,\n",
    "  'type': 'T103',\n",
    "  'name': 'kindlins',\n",
    "  'context': '[CLS] Of Kind ##lins and Cancer Kind ##lins are 4 . 1 - e ##z ##rin - rid ##ix ##in - m ##oes ##in ( F ##ER ##M ) domain containing proteins . There are three [unused1] kind ##lins [unused2] in mammals , which share high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the [SEP]',\n",
    "  'existing_cui': 'C1720776',\n",
    "  'existing_cui_name': 'Kindling , Neurologic',\n",
    "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
    "  'our_bi_cui': 'C0010422',\n",
    "  'our_bi_cui_name': 'Crystallins',\n",
    "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28210319.14',\n",
    "  'test_set_idx': 28545,\n",
    "  'type': 'T038',\n",
    "  'name': 'pump failure',\n",
    "  'context': '[CLS] characterised by progressive skeletal muscle wasting , including of the respiratory muscles . Re ##sp ##ira ##tory failure , i . e . when the respiratory system fails in its gas exchange functions , is a common feature in muscular d ##ys ##tro ##phy , being the main cause of death , and it is a consequence of lung failure , [unused1] pump failure [unused2] or a combination of the two . The former is due to re ##current as ##piration , the latter to progressive weakness of respiratory muscles and an increase in the load against which they must contract . In fact , both the resist ##ive and elastic components of the work of breathing increase due to air ##way o ##bs ##truction and [SEP]',\n",
    "  'existing_cui': 'C1417212',\n",
    "  'existing_cui_name': 'MMP7 gene',\n",
    "  'existing_cui_desc': '[CLS] M ##MP ##7 gene [unused3] ( Ana ##tom ##ical Structure : M ##MP ##7 Gene ; mat ##rily ##sin ; matrix metal ##lop ##ept ##idas ##e 7 ; MA ##TR ##IX ME ##TA ##LL ##OP ##RO ##TE ##IN ##AS ##E 7 ; P ##UT ##AT ##IVE ME ##TA ##LL ##OP ##RO ##TE ##IN ##AS ##E I ; MA ##TR ##IL ##Y ##SI ##N , U ##TE ##RI ##NE ; P ##UM ##P - 1 ; Matrix Metal ##lop ##ept ##idas ##e 7 ( Mat ##rily ##sin , U ##ter ##ine ) Gene ) [SEP]',\n",
    "  'our_bi_cui': 'C0948755',\n",
    "  'our_bi_cui_name': 'Pulmonary failure',\n",
    "  'our_bi_cui_desc': '[CLS] P ##ul ##mona ##ry failure [unused3] ( B ##iol ##og ##ic Fun ##ction : pulmonary failure ; failure pulmonary ) [SEP]',\n",
    "  'our_cross_cui': 'C1145670',\n",
    "  'our_cross_cui_name': 'Respiratory Failure',\n",
    "  'our_cross_cui_desc': '[CLS] Re ##sp ##ira ##tory F ##ail ##ure [unused3] ( B ##iol ##og ##ic Fun ##ction , context - dependent category , diagnosis , disorder , situation : [ D ] Re ##sp ##ira ##tory failure ; respiratory ins ##uff ##iciency / failure ; F ##ail ##ure ; respiratory ; Re ##sp ##ira ##tory failure ; F ##ail ##ure , Re ##sp ##ira ##tory ; Re ##sp ##ira ##tory failure , un ##sp ##ec ##ified ; respiratory failure ; respiratory ins ##uff ##iciency ; F ##ail ##ure respiratory ; Re ##spiration failure ) [SEP]'},\n",
    " {'mention_id': '27882455.29',\n",
    "  'test_set_idx': 20577,\n",
    "  'type': 'T038',\n",
    "  'name': 'memory stabilization processes',\n",
    "  'context': '[CLS] these memory traces into an existing body of knowledge ( item integration ) . Older adults learned 13 non ##words and were tested on their memory for the non ##words , and on whether these non ##words impacted upon processing of similar - sounding English words immediately and 24 hours later . Part ##ici ##pants accurately recognized the non ##words immediately , but showed significant decreases in delayed recognition and recall . In comparison , the non ##words impacted upon processing of similar - sounding words only in the delayed test . Together , these findings suggest that memory consolidation processes may be more evident in item integration than [unused1] memory stab ##ilization processes [unused2] for new de ##c ##lar ##ative memories in older adults . [SEP]',\n",
    "  'existing_cui': 'C1293130',\n",
    "  'existing_cui_name': 'Stabilization',\n",
    "  'existing_cui_desc': '[CLS] St ##abi ##li ##zation [unused3] ( Health Care Act ##ivity , procedure : stab ##ilization ; St ##abi ##lis ##ation ) [SEP]',\n",
    "  'our_bi_cui': 'C1293130',\n",
    "  'our_bi_cui_name': 'Stabilization',\n",
    "  'our_bi_cui_desc': '[CLS] St ##abi ##li ##zation [unused3] ( Health Care Act ##ivity , procedure : stab ##ilization ; St ##abi ##lis ##ation ) [SEP]',\n",
    "  'our_cross_cui': 'C0025361',\n",
    "  'our_cross_cui_name': 'Mental Processes',\n",
    "  'our_cross_cui_desc': '[CLS] Mental Process ##es [unused3] ( B ##iol ##og ##ic Fun ##ction , Human , function , o ##bs ##er ##vable entity : Human Information Process ##ing ; Thought process ; cognitive processing ; processes thought ; processing thought ; Information Process ##ing , Human ; Human information processing ; Information Process ##es ; mental processing ; cognitive process ; Form of thinking , function ; mental processes ; Form of thought ; Form of thinking ; Human Information Process ##es ; Mental Process ; mental process ; thought process ) [SEP]'},\n",
    " {'mention_id': '28441489.43',\n",
    "  'test_set_idx': 36165,\n",
    "  'type': 'T033',\n",
    "  'name': 'cold - start',\n",
    "  'context': '[CLS] , and x ##yle ##nes . Therefore , the secondary organic a ##ero ##sol and oz ##one formation potential of the exhaust does not depend on engine technology . Cold - start contributes a larger fraction of the total unified cycle emissions for vehicles meeting more - string ##ent emission standards . Organic gas emissions were the most sensitive to [unused1] cold - start [unused2] compared to the other poll ##uta ##nts tested here . There were no statistical ##ly significant differences in the effects of cold - start on G ##DI ##s and P ##FI ##s . For our test fleet , the measured 14 . 5 % decrease in CO ##2 emissions from G ##DI ##s was much greater than the potential climate forcing [SEP]',\n",
    "  'existing_cui': 'C0452588',\n",
    "  'existing_cui_name': 'Start brand of breakfast cereal',\n",
    "  'existing_cui_desc': '[CLS] Start brand of breakfast cereal [unused3] ( Food , substance : Start ) [SEP]',\n",
    "  'our_bi_cui': 'C0161734',\n",
    "  'our_bi_cui_name': 'Effects of low temperature',\n",
    "  'our_bi_cui_desc': '[CLS] Effects of low temperature [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder : Effect reduced te ##mp ; cold effect ; effect of reduced temperature ; Effects of freezing or excessive cold ; A ##cci ##dent due to excessive cold of un ##sp ##ec ##ified origin ; Cold Effects ; effects of ; cold ; Effect of reduced temperature , un ##sp ##ec ##ified ; cold effects ; effects cold ; Effects of reduced temperature ; Ex ##cess ##ive cold ; effects of ; low temperature ; Effects of freezing AND / OR excessive cold ; Un ##sp ##ec ##ified effect of reduced temperature ; Ex ##cess ##ive cold of un ##sp ##ec ##ified origin ; cold ; effects of ; [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27357394.22',\n",
    "  'test_set_idx': 3609,\n",
    "  'type': 'T033',\n",
    "  'name': 'losers',\n",
    "  'context': '[CLS] establish mobility . V ##aria ##tion in the extent of patient mobility was observed across the studies . Mo ##bility was positively associated with lower waiting times , indicators of better service quality , and access to advanced technology . It was negatively associated with advanced age or lower socio ##economic backgrounds . From a policy perspective we demonstrate that a significant proportion of patients are prepared to travel beyond their nearest provider for elect ##ive services . As a consequence , some providers are likely to be \" winners \" and others \" [unused1] loser ##s [unused2] , \" which could result in overall decreased provider capacity or in ##ef ##ficient u ##til ##ization of existing services . Equity also remains a key concern . [SEP]',\n",
    "  'existing_cui': 'C0230789',\n",
    "  'existing_cui_name': 'Smooth Endoplasmic Reticulum',\n",
    "  'existing_cui_desc': '[CLS] S ##mo ##oth End ##op ##las ##mic Re ##tic ##ulum [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure , s ##ER , smooth end ##op ##las ##mic re ##tic ##ulum : End ##op ##las ##mic Re ##tic ##ulum , S ##mo ##oth ; smooth end ##op ##las ##mic re ##tic ##ulum ; A ##gra ##nu ##lar End ##op ##las ##mic Re ##tic ##ulum ; A ##gra ##nu ##lar end ##op ##las ##mic re ##tic ##ulum ; End ##op ##las ##mic Re ##tic ##ulum , A ##gra ##nu ##lar ; Re ##tic ##ulum end ##op ##las ##mic ##um non ##gra ##nu ##los ##um ; S ##mo ##oth end ##op ##las ##mic re ##tic ##ulum ; smooth ER ; S ##mo ##oth - Surface [SEP]',\n",
    "  'our_bi_cui': 'C1257890',\n",
    "  'our_bi_cui_name': 'Population Group',\n",
    "  'our_bi_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28338634.26',\n",
    "  'test_set_idx': 32475,\n",
    "  'type': 'T033',\n",
    "  'name': 'detection',\n",
    "  'context': \"[CLS] proposed for ass ##ay of the ne ##uro ##to ##xi ##c compounds . The prepared na ##no ##par ##tic ##les were modified by pure Ace ##ty ##l ##cho ##lines ##tera ##se and they were used for the measurement anti - Alzheimer ' s drug gal ##ant ##amine and car ##ba ##mate p ##est ##icide car ##bo ##fu ##ran with limit of [unused1] detection [unused2] 1 . 5 µ ##M and 20 n ##M , respectively . All measurements were carried out using screen - printed sensor with carbon working , silver reference , and carbon auxiliary electro ##de . Standard El ##lman ' s ass ##ay was used for valid ##ation measurement of both inhibitor ##s . Part of this work was the elimination of re [SEP]\",\n",
    "  'existing_cui': 'C0206100',\n",
    "  'existing_cui_name': 'Signal Detection',\n",
    "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
    "  'our_bi_cui': 'C1511790',\n",
    "  'our_bi_cui_name': 'Detection',\n",
    "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
    "  'our_cross_cui': 'C0442726',\n",
    "  'our_cross_cui_name': 'Detected',\n",
    "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
    " {'mention_id': '28158248.6',\n",
    "  'test_set_idx': 27110,\n",
    "  'type': 'T170',\n",
    "  'name': 'ordinary differential equations',\n",
    "  'context': '[CLS] Model ##ing the flux of meta ##bol ##ites in the juvenile hormone bio ##sy ##nt ##hesis pathway using generalized add ##itive models and [unused1] ordinary differential equations [unused2] Ju ##ven ##ile hormone regulate ##s development and reproductive mat ##uration in insects . The co ##rp ##ora all ##ata from female adult m ##os ##quito ##es s ##ynth ##esi ##ze flu ##ct ##uating levels of Ju ##ven ##ile hormone , which have been linked to the o ##var ##ian development and are influenced by nutrition ##al signals . The rate of Ju ##ven ##ile hormone bio ##sy ##nt ##hesis is controlled by the rate of flux of is ##op ##ren ##oids in the pathway , which is the outcome of a complex inter ##play of changes in [SEP]',\n",
    "  'existing_cui': 'C0011906',\n",
    "  'existing_cui_name': 'Differential Diagnosis',\n",
    "  'existing_cui_desc': '[CLS] Different ##ial Di ##ag ##nosis [unused3] ( Health Care Act ##ivity , context ##ual qualifier , qualifier value : D ##IA ##G D ##IF ##F ##ER ##EN ##TI ##AL ; Di ##ag ##nose ##s , Different ##ial ; D ##IF ##F ##ER ##EN ##TI ##AL D ##IA ##G ; Di ##ag ##nosis , Different ##ial ; Different ##ial d ##x ; D ##IA ##G D ##IF ##F ##ER ; differential di ##ag ##nose ##s ; differential diagnosis ; Different ##ial diagnosis ( context ##ual qualifier ) ; Different ##ial Di ##ag ##nose ##s ; differential d ##x ; Different ##ial diagnosis ; D ##IF ##F ##ER D ##IA ##G ) [SEP]',\n",
    "  'our_bi_cui': 'C1705273',\n",
    "  'our_bi_cui_name': 'Mathematical Operator',\n",
    "  'our_bi_cui_desc': '[CLS] Mathematical Opera ##tor [unused3] ( Intel ##lect ##ual Product : Opera ##tor ; Fun ##ction ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27699206.9',\n",
    "  'test_set_idx': 14490,\n",
    "  'type': 'T017',\n",
    "  'name': 'lateral occipital',\n",
    "  'context': '[CLS] - Based Category Select ##ivity in Human Visual Co ##rte ##x In f ##MR ##I studies , human lateral o ##cci ##pit ##al cortex is thought to respond selective ##ly to images of objects , compared with non ##ob ##jects . However , it remains un ##res ##ol ##ved whether all objects e ##voke equivalent levels of activity in [unused1] lateral o ##cci ##pit ##al [unused2] , and , if not , which image features produce stronger activation . Here , we used an un ##bia ##sed para ##metric texture model to predict preferred versus non ##p ##re ##ferred stimuli in lateral o ##cci ##pit ##al . O ##bs ##er ##vation and ps ##ych ##op ##hy ##si ##cal results showed that predicted preferred stimuli ( both [SEP]',\n",
    "  'existing_cui': 'C0923804',\n",
    "  'existing_cui_name': 'Lateral occipital artery',\n",
    "  'existing_cui_desc': '[CLS] Later ##al o ##cci ##pit ##al artery [unused3] ( Ana ##tom ##ical Structure , Arte ##ria c ##ere ##bri posterior : P ##3 segment of posterior cerebral artery ; Arte ##ria o ##cci ##pit ##alis lateral ##is ; Se ##gment ##um P ##3 ; A . o ##cci ##pit ##alis lateral ##is ) [SEP]',\n",
    "  'our_bi_cui': 'C0228229',\n",
    "  'our_bi_cui_name': 'lateral occipital sulcus',\n",
    "  'our_bi_cui_desc': '[CLS] lateral o ##cci ##pit ##al su ##l ##cus [unused3] ( Spa ##tial Concept , human only , human only , body structure : Later ##al o ##cci ##pit ##al su ##l ##cus ; Structure of lateral o ##cci ##pit ##al su ##l ##cus ; Later ##al - O ##cci ##pit ##al Sul ##cus ; Sul ##cus o ##cci ##pit ##alis lateral ##is ) [SEP]',\n",
    "  'our_cross_cui': 'C0028785',\n",
    "  'our_cross_cui_name': 'Occipital lobe',\n",
    "  'our_cross_cui_desc': '[CLS] O ##cci ##pit ##al lobe [unused3] ( Ana ##tom ##ical Structure , body structure : o ##cci ##pit ##al region ; O ##cci ##pit ##al cortex ; lo ##bus o ##cci ##pit ##alis ; O ##cci ##pit ##al Lo ##be ; o ##cci ##pit ##al lobes ; O ##cci ##pit ##al lobes ; O ##cci ##pit ##al Region ##s ; O ##cci ##pit ##al Region ; o ##cci ##pit ##al lobe ; Lo ##be , O ##cci ##pit ##al ; lobe o ##cci ##pit ##al ; O ##cci ##pit ##al region ; Region , O ##cci ##pit ##al ; Lo ##bus o ##cci ##pit ##alis ; o ##cci ##pit ##al cortex ; Reg ##io o ##cci ##pit ##alis ; Lo ##bes , O ##cci ##pit ##al [SEP]'},\n",
    " {'mention_id': '27781034.48',\n",
    "  'test_set_idx': 16561,\n",
    "  'type': 'T033',\n",
    "  'name': 'frequently co - occur',\n",
    "  'context': '[CLS] brain an ##oma ##lies . However , the cause of genetic generalized e ##pile ##psy remained unclear . In this study , we describe and review 28 individuals with 22 ##q ##11 . 2 del ##eti ##on syndrome and genetic generalized e ##pile ##psy ( especially juvenile my ##oc ##lon ##ic e ##pile ##psy ) , showing that both disorders [unused1] frequently co - occur [unused2] . Compared to the reported prevalence of 15 - 21 % , in our case series only 10 % of 22 ##q ##11 . 2 del ##eti ##on syndrome individuals were found to have e ##pile ##psy , often genetic generalized e ##pile ##psy . Since 22 ##q ##11 . 2 does not contain convincing genetic generalized e ##pile ##psy [SEP]',\n",
    "  'existing_cui': 'C0558131',\n",
    "  'existing_cui_name': 'Eating frequently',\n",
    "  'existing_cui_desc': '[CLS] Eat ##ing frequently [unused3] ( Finding , finding ) [SEP]',\n",
    "  'our_bi_cui': 'C0277557',\n",
    "  'our_bi_cui_name': 'Intercurrent disease',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##current disease [unused3] ( B ##iol ##og ##ic Fun ##ction , finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28011059.45',\n",
    "  'test_set_idx': 23692,\n",
    "  'type': 'T098',\n",
    "  'name': 'children',\n",
    "  'context': '[CLS] ##e se ##quencing or Il ##lum ##ina 450 ##K array ##s . Co ##rd blood mon ##on ##uc ##lea ##r cell - derived IL - 1 ##β levels were measured by means of E ##L ##IS ##A . Neo ##nat ##al immune cells harbor ##ed 58 ##9 differential ##ly met ##hyl ##ated regions that distinguished In ##fant I ##mm ##une Study [unused1] children [unused2] who did and did not have as ##th ##ma by age 9 years . In all 3 co ##hor ##ts met ##hyl ##ation in SM ##AD ##3 , the most connected node within the network of as ##th ##ma - associated , differential ##ly met ##hyl ##ated regions , was selective ##ly increased in as ##th ##matic children of as ##th ##matic [SEP]',\n",
    "  'existing_cui': 'C0682171',\n",
    "  'existing_cui_name': 'History of being abused as child',\n",
    "  'existing_cui_desc': '[CLS] History of being abused as child [unused3] ( Finding , history : child a ##bus ; abused as a child ; abused as child ; child abused ; abused child ) [SEP]',\n",
    "  'our_bi_cui': 'C0264408',\n",
    "  'our_bi_cui_name': 'Childhood asthma',\n",
    "  'our_bi_cui_desc': '[CLS] Child ##hood as ##th ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Child ##hood As ##th ##ma ; as ##th ##ma childhood ; As ##th ##ma , childhood ; As ##th ##ma in Children ; as ##th ##ma ; childhood ; As ##th ##ma in children ; childhood ; as ##th ##ma ; childhood as ##th ##ma ) [SEP]',\n",
    "  'our_cross_cui': 'C1257890',\n",
    "  'our_cross_cui_name': 'Population Group',\n",
    "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
    " {'mention_id': '28077027.24',\n",
    "  'test_set_idx': 24980,\n",
    "  'type': 'T170',\n",
    "  'name': 'EFSA',\n",
    "  'context': '[CLS] - 90 years . The p ##est ##icide residue data were obtained from the Shanghai monitoring programme during 2008 - 11 with 34 organ ##op ##hos ##phate ##s and 11 car ##ba ##mates anal ##ys ##ed in a total of 53 ##35 samples of vegetables and fruits . A pro ##ba ##bil ##istic approach was performed as recommended by the [unused1] E ##FS ##A [unused2] , using the optimistic model with non - detect ##s set as zero and with processing factors being used and the p ##ess ##im ##istic model with non - detect ##s replaced by limit of detection and without processing factors . We used the relative pot ##ency factor method to normal ##ise the various p ##est ##icides to the index compound [SEP]',\n",
    "  'existing_cui': 'C1537461',\n",
    "  'existing_cui_name': 'KIAA1109 gene',\n",
    "  'existing_cui_desc': '[CLS] K ##IA ##A ##11 ##0 ##9 gene [unused3] ( Ana ##tom ##ical Structure : T ##week ; fragile site - associated ; K ##IA ##A ##13 ##7 ##1 ; FL ##J ##21 ##40 ##4 ; T ##W ##EE ##K , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; K ##IA ##A ##11 ##0 ##9 GE ##NE ) [SEP]',\n",
    "  'our_bi_cui': 'C1708333',\n",
    "  'our_bi_cui_name': 'Health Care Organization',\n",
    "  'our_bi_cui_desc': '[CLS] Health Care Organization [unused3] ( Organization : Healthcare Organization ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28107548.15',\n",
    "  'test_set_idx': 25818,\n",
    "  'type': 'T170',\n",
    "  'name': 'multiple random forest classifiers',\n",
    "  'context': '[CLS] ##ical classification to re ##fine the detection results . High - level feature representation is first learned by a deep learning network , where multi ##par ##ame ##tric MR images are used as the input data . Then , based on the learned high - level features , a hi ##era ##rch ##ical classification method is developed , where [unused1] multiple random forest class ##ifier ##s [unused2] are it ##erative ##ly constructed to re ##fine the detection results of pro ##state cancer . The experiments were carried on 21 real patient subjects , and the proposed method achieve ##s an averaged section - based evaluation of 89 . 90 % , an averaged sensitivity of 91 . 51 % , and an averaged specific ##ity of [SEP]',\n",
    "  'existing_cui': 'C0034656',\n",
    "  'existing_cui_name': 'Randomization',\n",
    "  'existing_cui_desc': '[CLS] Random ##ization [unused3] ( Research Act ##ivity : Random ##ized ; Random All ##oc ##ation ; random ##ization ; Trial is Random ##ized ; All ##oc ##ation , Random ; random allocation ; random ##ized ; RA ##ND ##OM ) [SEP]',\n",
    "  'our_bi_cui': 'C0008902',\n",
    "  'our_bi_cui_name': 'Classification',\n",
    "  'our_bi_cui_desc': '[CLS] Classification [unused3] ( Intel ##lect ##ual Product , attribute , qualifier value : C ##LA ##SS ; class ##ifying ; Classification ##s ; class ##ify ; classification ##s ; Class ##ified ; System ##atic ##s ; Classification system ; classification system ; classified ; cat ##ego ##riz ##ation ; classified ##s ; classification systems ; systematic ##s ; Classification Systems ; classification ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27427386.17',\n",
    "  'test_set_idx': 5255,\n",
    "  'type': 'T017',\n",
    "  'name': 'p. 58I > V',\n",
    "  'context': \"[CLS] modify the p ##hen ##otypic expression of primary Le ##ber ' s hereditary op ##tic ne ##uro ##pathy - associated mitochondrial DNA mutations . In this study , we demonstrated that the Le ##ber ' s hereditary op ##tic ne ##uro ##pathy su ##s ##ce ##pt ##ibility all ##ele ( m . 145 ##0 ##2 ##T > C , [unused1] p . 58 ##I > V [unused2] ) in the N ##D ##6 gene m ##od ##ulated the p ##hen ##otypic expression of primary Le ##ber ' s hereditary op ##tic ne ##uro ##pathy - associated m . 117 ##7 ##8 ##G > A mutation . Twenty - two Han Chinese p ##ed ##ig ##ree ##s carrying m . 145 ##0 ##2 ##T > C and [SEP]\",\n",
    "  'existing_cui': 'C0614783',\n",
    "  'existing_cui_name': 'vasectrin I',\n",
    "  'existing_cui_desc': '[CLS] vase ##ct ##rin I [unused3] ( Chemical : i vs ; Secret ##in , 4 - L - al ##ani ##ne - ; V ##S I ; 4 - Al ##a - secret ##in ; secret ##in , al ##ani ##ne ( 4 ) - ; secret ##in , Al ##a ( 4 ) - ; vase ##ct ##rin i ) [SEP]',\n",
    "  'our_bi_cui': 'C0026882',\n",
    "  'our_bi_cui_name': 'Mutation',\n",
    "  'our_bi_cui_desc': '[CLS] Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction , finding : genome mutation ; Gene ##tic mutation ; genetic mutation ; genetic mutations ; mutations ; Mu ##tations ; mutation ; alterations genetic ; genetic alter ##ation ) [SEP]',\n",
    "  'our_cross_cui': 'C0002085',\n",
    "  'our_cross_cui_name': 'Alleles',\n",
    "  'our_cross_cui_desc': '[CLS] All ##ele ##s [unused3] ( Ana ##tom ##ical Structure , finding : All ##ele ; All ##elo ##mor ##ph ; Gene ##tic all ##ele ##s ; all ##ele ; All ##elo ##mor ##phs ; all ##ele ##s ; AL ##LE ##LE ) [SEP]'},\n",
    " {'mention_id': '27500205.33',\n",
    "  'test_set_idx': 8465,\n",
    "  'type': 'T103',\n",
    "  'name': 'adaptor proteins',\n",
    "  'context': '[CLS] controlling in ##te ##g ##rin function . In v ##it ##ro studies , in v ##ivo studies of mice def ##icient in kind ##lins , and studies of patients with genetic def ##ici ##encies of kind ##lins have clearly established that they regulate the capacity of in ##te ##g ##rin ##s to media ##te their functions . Kind ##lins are [unused1] adapt ##or proteins [unused2] ; their function em ##ana ##te from their interaction with binding partners , including the c ##yt ##op ##las ##mic tails of in ##te ##g ##rin ##s and components of the act ##in c ##yt ##os ##kel ##eton . The purpose of this review is to provide a brief overview of kind ##lin structure and function , a consideration of their [SEP]',\n",
    "  'existing_cui': 'C1449886',\n",
    "  'existing_cui_name': 'Adaptor Proteins , Signal Transducing',\n",
    "  'existing_cui_desc': '[CLS] Ada ##pt ##or Pro ##tein ##s , Signal Trans ##ducing [unused3] ( Chemical : adapt ##er protein ; Ada ##pt ##er Pro ##tein ; Ada ##pt ##or Signal ##ing Pro ##tein ; Signal Trans ##ducing Ada ##pt ##or Pro ##tein ##s ; Ada ##pt ##er Signal ##ing Pro ##tein ; Ada ##pt ##or Pro ##tein ; Signal Trans ##ducing Ada ##pt ##or Pro ##tein ; Ada ##pt ##or Pro ##tein ##s , Signal Trans ##ducing [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
    "  'our_bi_cui': 'C1449886',\n",
    "  'our_bi_cui_name': 'Adaptor Proteins , Signal Transducing',\n",
    "  'our_bi_cui_desc': '[CLS] Ada ##pt ##or Pro ##tein ##s , Signal Trans ##ducing [unused3] ( Chemical : adapt ##er protein ; Ada ##pt ##er Pro ##tein ; Ada ##pt ##or Signal ##ing Pro ##tein ; Signal Trans ##ducing Ada ##pt ##or Pro ##tein ##s ; Ada ##pt ##er Signal ##ing Pro ##tein ; Ada ##pt ##or Pro ##tein ; Signal Trans ##ducing Ada ##pt ##or Pro ##tein ; Ada ##pt ##or Pro ##tein ##s , Signal Trans ##ducing [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28249376.35',\n",
    "  'test_set_idx': 29905,\n",
    "  'type': 'T168',\n",
    "  'name': 'concentrate diet',\n",
    "  'context': '[CLS] at 0 ( control ) , 0 . 8 , and 1 . 6 m ##L / d on apparent nut ##rient dig ##est ##ibility , r ##ume ##n f ##er ##mentation characteristics , r ##ume ##n micro ##bial population and blood chemical meta ##bol ##ites . Animals were fed with a 50 : 50 al ##fa ##lf ##a hay : [unused1] concentrate diet [unused2] . R ##umi ##nal pH , total volatile fatty acids concentration , m ##olar proportion of individual volatile fatty acids , ace ##tate : prop ##ion ##ate ratio and met ##hane production were not affected with mixture of essential oils . Re ##lative to the control , Small p ##eptide ##s plus amino acid nitrogen and large p ##eptide ##s nitrogen [SEP]',\n",
    "  'existing_cui': 'C1880165',\n",
    "  'existing_cui_name': 'Concentrate Dosage Form',\n",
    "  'existing_cui_desc': '[CLS] Con ##cent ##rate Do ##sa ##ge Form [unused3] ( Chemical : Con ##cent ##rated ; Con ##cent ##rate ; CO ##NC ; CO ##NC ##EN ##TR ##AT ##E ; Con ##c ; Con ##cent ##rated Do ##sa ##ge Form ; Con ##cent ##rated Do ##se Form ) [SEP]',\n",
    "  'our_bi_cui': 'C0003050',\n",
    "  'our_bi_cui_name': 'Animal feed',\n",
    "  'our_bi_cui_desc': '[CLS] Animal feed [unused3] ( Food , substance , substance : animal food ; animal feeds ; animal feeding ; animals food ; food animal ; Fe ##eds , Animal ; Animal Fe ##ed ; Fe ##ed , Animal ; animal feed ; Animal Fe ##eds ) [SEP]',\n",
    "  'our_cross_cui': 'C0012155',\n",
    "  'our_cross_cui_name': 'Diet',\n",
    "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
    " {'mention_id': '27306834.45',\n",
    "  'test_set_idx': 2032,\n",
    "  'type': 'T017',\n",
    "  'name': 'naïve cell',\n",
    "  'context': '[CLS] expression patterns of memory - promoting transcription factors , T - bet and E ##ome ##s , induced in a rapid and sustainable manner . N ##T ##ef ##f cells appeared to have lower expression of Fox ##p ##1 and were re ##fra ##ctor ##y to a ##pop ##tosis upon T ##G ##F - β conditioning , implying better survival potential and resistance to tumor - induced immune suppression . Of CD ##8 ( + ) T cell pools activated to tumor - specific CT ##L ##s , [unused1] na ##ï ##ve cell [unused2] generated effect ##ors possessed the most potent c ##yt ##oto ##xi ##c activity , valid ##ating implications for use in rational design of adopt ##ive im ##mu ##not ##her ##ap ##y . [SEP]',\n",
    "  'existing_cui': 'C1179416',\n",
    "  'existing_cui_name': 'Endothelial cell of venous sinus of red pulp of spleen',\n",
    "  'existing_cui_desc': '[CLS] End ##oth ##eli ##al cell of ve ##nous sin ##us of red pulp of s ##ple ##en [unused3] ( Ana ##tom ##ical Structure : St ##ave cell ) [SEP]',\n",
    "  'our_bi_cui': 'C0007634',\n",
    "  'our_bi_cui_name': 'Cells',\n",
    "  'our_bi_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]',\n",
    "  'our_cross_cui': 'C3641721',\n",
    "  'our_cross_cui_name': 'Naive T-Lymphocyte',\n",
    "  'our_cross_cui_desc': '[CLS] Na ##ive T - L ##ymph ##oc ##yte [unused3] ( Ana ##tom ##ical Structure : T ##h ##0 ; Na ##ive T L ##ymph ##oc ##yte ; Na ##ive T - Cell ; Na ##ive T Cell ##s ; Na ##ive T Cell ) [SEP]'},\n",
    " {'mention_id': '28457334.24',\n",
    "  'test_set_idx': 36634,\n",
    "  'type': 'T103',\n",
    "  'name': 'extracellular RNA',\n",
    "  'context': '[CLS] abdominal surgery . A total of 15 patients with se ##psis , 10 post ##oper ##ative patients , and 10 healthy volunteers were included in this longitudinal study . Blood was collected at se ##psis onset and after surgery respectively , as well as after 24 , 72 and 168 h . Level ##s of Cell - free DNA and [unused1] extra ##cellular RNA [unused2] were measured by quantitative probe - based polymer ##ase chain reaction . In addition , th ##rom ##boe ##last ##ography for co ##agu ##lation as well as th ##rom ##boa ##gg ##re ##go ##metry for plate ##let function was conducted . Both Cell - free DNA and extra ##cellular RNA were elevated in patients with se ##psis compared with post ##oper [SEP]',\n",
    "  'existing_cui': 'C0521119',\n",
    "  'existing_cui_name': 'Extracellular',\n",
    "  'existing_cui_desc': '[CLS] Extra ##cellular [unused3] ( Ana ##tom ##ical Structure , qualifier value : extra ##cellular ; extra ##cellular region ) [SEP]',\n",
    "  'our_bi_cui': 'C0230885',\n",
    "  'our_bi_cui_name': 'Extracellular material',\n",
    "  'our_bi_cui_desc': '[CLS] Extra ##cellular material [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0035668',\n",
    "  'our_cross_cui_name': 'RNA',\n",
    "  'our_cross_cui_desc': '[CLS] RNA [unused3] ( Chemical , RNA , R ##ib ##on ##uc ##le ##ic A ##cid , substance : rib ##on ##uc ##le ##ic acid ; R ##ib ##on ##uc ##le ##ic acids ; RNA , Non - Pol ##ya ##den ##yla ##ted ; rib ##on ##uc ##lein ##ic ##um acid ##um / rib ##on ; RNA - R ##ib ##on ##uc ##le ##ic acid ; RNA [ Chemical / In ##g ##red ##ient ] ; RNA , Non Pol ##ya ##den ##yla ##ted ; Non - Pol ##ya ##den ##yla ##ted RNA ; r ##na ; Non Pol ##ya ##den ##yla ##ted RNA ; A ##cid , R ##ib ##on ##uc ##le ##ic ; R ##ib ##on ##uc ##le ##ic acid ; Gene Products , RNA [SEP]'},\n",
    " {'mention_id': '27732552.9',\n",
    "  'test_set_idx': 15246,\n",
    "  'type': 'T058',\n",
    "  'name': 'techniques',\n",
    "  'context': '[CLS] Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp ##ling at home as an alternative tool for the monitoring of H ##b ##A ##1 ##c in diabetes patients Micro ##sa ##mp ##ling techniques have several advantages over traditional blood collection . Dr ##ied blood spot sampling and blood collection with he ##par ##ini ##zed cap ##illa ##ries are the standard [unused1] techniques [unused2] . Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp ##ling is a novel technique that collects a fixed volume of blood by applying an absorb ##ent tip to a blood drop . In the present study we explored the f ##eas ##ibility of H ##b ##A ##1 ##c monitoring with Volume ##tric a ##bs ##or ##pt ##ive micro ##sa ##mp [SEP]',\n",
    "  'existing_cui': 'C0450241',\n",
    "  'existing_cui_name': 'Ffooks technique',\n",
    "  'existing_cui_desc': '[CLS] F ##fo ##ok ##s technique [unused3] ( Health Care Act ##ivity , qualifier value ) [SEP]',\n",
    "  'our_bi_cui': 'C0025663',\n",
    "  'our_bi_cui_name': 'Methods',\n",
    "  'our_bi_cui_desc': '[CLS] Method ##s [unused3] ( Intel ##lect ##ual Product , attribute : methods ; Method ; method ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '27647760.18',\n",
    "  'test_set_idx': 12785,\n",
    "  'type': 'T092',\n",
    "  'name': 'Sequenom',\n",
    "  'context': \"[CLS] B ##D ##NF genes and drug addiction in the Han Chinese population . We conducted a case - control study among 69 ##2 cases and 700 healthy controls from Xi ' an , China . Eight single n ##uc ##leo ##tide p ##oly ##mor ##phism ##s were selected and g ##eno ##type ##d using Mass ##AR ##RA ##Y technology ( [unused1] Se ##que ##no ##m [unused2] , San Diego , CA , USA ) . Odd ##s ratios and 95 % confidence intervals were calculated by un ##con ##ditional log ##istic re ##gression adjusting for age and sex . Using the ch ##i - squared test , we found that r ##s ##7 ##48 ##13 ##11 ( Odd ##s ratios = 1 . 275 , 95 [SEP]\",\n",
    "  'existing_cui': 'C1414863',\n",
    "  'existing_cui_name': 'FUT2 gene',\n",
    "  'existing_cui_desc': '[CLS] F ##UT ##2 gene [unused3] ( Ana ##tom ##ical Structure : GDP - L - f ##uc ##ose : beta - D - gal ##act ##os ##ide 2 - alpha - L - f ##uc ##osy ##lt ##ran ##s ##fer ##ase 2 ; alpha ( 1 , 2 ) F ##T ##2 ; secret ##or blood group alpha - 2 - f ##uc ##osy ##lt ##ran ##s ##fer ##ase ; SEC ##2 ; SEC ##RE ##TO ##R FA ##CT ##OR ; f ##uc ##osy ##lt ##ran ##s ##fer ##ase 2 ; se ##j ; alpha ( 1 , 2 ) f ##uc ##osy ##lt ##ran ##s ##fer ##ase ; F ##UC ##OS ##Y ##LT ##RA ##NS ##F ##ER ##AS ##E 2 ; secret ##or factor ; [SEP]',\n",
    "  'our_bi_cui': 'C0025080',\n",
    "  'our_bi_cui_name': 'Medical Devices',\n",
    "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
    "  'our_cross_cui': 'C0683757',\n",
    "  'our_cross_cui_name': 'Company',\n",
    "  'our_cross_cui_desc': '[CLS] Company [unused3] ( Organization , organization , organization : Business ; company ; Companies ; companies ) [SEP]'},\n",
    " {'mention_id': '28071754.10',\n",
    "  'test_set_idx': 24715,\n",
    "  'type': 'T037',\n",
    "  'name': 'injury',\n",
    "  'context': '[CLS] infrared protects vascular end ##oth ##eli ##al cells from advanced g ##ly ##cation end products - induced injury via Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein - mediated auto ##pha ##gy in di ##abe ##tic mice The accumulation of advanced g ##ly ##cation end products in di ##abe ##tic patients induce ##s vascular end ##oth ##eli ##al [unused1] injury [unused2] . Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein is a transcription factor that can be activated by low - temperature far - infrared i ##rra ##diation to ex ##ert beneficial effects on the vascular end ##oth ##eli ##um . In the present study , we investigated the influence of far - infrared - induced Pro ##my ##elo ##cy [SEP]',\n",
    "  'existing_cui': 'C0005604',\n",
    "  'existing_cui_name': 'Birth Injuries',\n",
    "  'existing_cui_desc': '[CLS] Birth In ##ju ##ries [unused3] ( In ##ju ##ry or Po ##ison ##ing , Birth , diagnosis , disorder : In ##ju ##ries , Birth ; T ##ra ##umatic birth ; injury birth ; Birth trauma , un ##sp ##ec ##ified ; Birth T ##ra ##uma ; Birth trauma of f ##etus ; injury ; birth ; traumatic birth ; birth trauma ; birth injuries ; Birth In ##ju ##ry ; trauma birth ; Neo ##nat ##al Birth In ##ju ##ry ; birth ##ing injuries ; Birth In ##ju ##ries [ Disease / Finding ] ; Un ##sp ##ec ##ified birth trauma ; birth ##ing trauma ; B ##IR ##TH IN ##J ; IN ##J B ##IR ##TH ; Birth injuries ; birth ; injury ; [SEP]',\n",
    "  'our_bi_cui': 'C0010957',\n",
    "  'our_bi_cui_name': 'Tissue damage',\n",
    "  'our_bi_cui_desc': '[CLS] T ##iss ##ue damage [unused3] ( In ##ju ##ry or Po ##ison ##ing , m ##or ##ph ##olo ##gic abnormal ##ity : damage tissues ; Dam ##age ; damages tissue ; Dam ##age , T ##iss ##ue ; tissue damage ; T ##iss ##ue Dam ##age ; damage ; damages ) [SEP]',\n",
    "  'our_cross_cui': 'C0178314',\n",
    "  'our_cross_cui_name': 'Poisoning / injury',\n",
    "  'our_cross_cui_desc': '[CLS] Po ##ison ##ing / injury [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder , finding , navigation ##al concept : In ##ju ##ry & / or poisoning ; IN ##J ##UR ##Y AND P ##O ##IS ##ON ##ING ; In ##ju ##ry and poisoning ; In ##ju ##ry / poisoning ) [SEP]'},\n",
    " {'mention_id': '27669217.46',\n",
    "  'test_set_idx': 13697,\n",
    "  'type': 'T017',\n",
    "  'name': 'ermB',\n",
    "  'context': '[CLS] ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both er ##m ##B and er ##m ##T in all is ##olate ##s was er ##yt ##hr ##omy ##cin in ##du ##cible and yielded comparable mac ##rol ##ide MI ##Cs in all six is ##olate ##s . Take ##n together , in ##du ##cible expression of both [unused1] er ##m ##B [unused2] and er ##m ##T conferred high mac ##rol ##ide resistance in these S . gal ##lo ##ly ##ticus subsp . paste ##rian ##us is ##olate ##s . Our findings reveal new mac ##rol ##ide resistance features in S . gal ##lo ##ly ##ticus subsp . paste ##uria ##nus by both er ##m ##B and er ##m ##T . [SEP]',\n",
    "  'existing_cui': 'C0732611',\n",
    "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
    "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
    "  'our_bi_cui': 'C0243036',\n",
    "  'our_bi_cui_name': 'Genes , erbB',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##s , er ##b ##B [unused3] ( Ana ##tom ##ical Structure : A ##vian E ##ry ##th ##ro ##blast ##osis V ##ir ##us On ##co ##gene B ; E ##ry ##th ##ro ##blast Trans ##form ##ing Gene B ; On ##co ##gene , E ##G ##F ##R ; On ##co ##gene ER ##B B ; er ##b ##B Gene ##s ; er ##b ##B Gene ; ER ##B - B ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27659602.7',\n",
    "  'test_set_idx': 13352,\n",
    "  'type': 'T082',\n",
    "  'name': 'root',\n",
    "  'context': '[CLS] The A ##ort ##ic Root : Natural History After Root - Spa ##ring As ##cend ##ing Rep ##lace ##ment in Non ##sy ##nd ##rom ##ic An ##eur ##ys ##mal Pat ##ients Leaving native a ##ort ##ic tissue in sit ##u in root - spa ##ring ascending a ##ort ##ic replacement raises concern regarding potential later need for [unused1] root [unused2] re ##oper ##ation or for the potential occurrence of localized di ##sse ##ctions or r ##up ##ture in the residual root . The purpose of this study was to evaluate the natural growth of the a ##ort ##ic root after root - spa ##ring a ##ort ##ic replacement . In all , 102 consecutive patients ( mean age 61 . 8 ± 12 . 5 years [SEP]',\n",
    "  'existing_cui': 'C1318154',\n",
    "  'existing_cui_name': 'Root body part',\n",
    "  'existing_cui_desc': '[CLS] Root body part [unused3] ( Ana ##tom ##ical Structure : Root ; root [ a body part ] ; root ) [SEP]',\n",
    "  'our_bi_cui': 'C0040452',\n",
    "  'our_bi_cui_name': 'Tooth root structure',\n",
    "  'our_bi_cui_desc': '[CLS] Too ##th root structure [unused3] ( Ana ##tom ##ical Structure , body structure : Ra ##di ##x co ##rona ; Root of the Too ##th ; tooth root ; Too ##th Root ; Root of Too ##th ; Root , Too ##th ; tooth roots ; root of tooth ; root tooth ; roots tooth ; Te ##eth - - Roots ; Roots , Too ##th ; of tooth root ; Too ##th Roots ; Too ##th root ; Ra ##di ##x Den ##tis ; Ra ##di ##x den ##tis ; rooted tooth ; Root of tooth ) [SEP]',\n",
    "  'our_cross_cui': 'C0549113',\n",
    "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
    "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
    " {'mention_id': '27669217.2',\n",
    "  'test_set_idx': 13653,\n",
    "  'type': 'T017',\n",
    "  'name': 'ermB',\n",
    "  'context': '[CLS] In ##du ##cible Express ##ion of both [unused1] er ##m ##B [unused2] and er ##m ##T Con ##ferred High Mac ##rol ##ide Resistance in St ##re ##pt ##oc ##oc ##cus gal ##lo ##ly ##ticus subsp . paste ##uria ##nus Is ##olate ##s in China St ##re ##pt ##oc ##oc ##cus gal ##lo ##ly ##ticus subsp . paste ##uria ##nus is an under - recognized path ##ogen and zoo ##not ##ic agent causing op ##port ##uni ##stic infections in humans . Despite increasing recognition of this subspecies as a cause for human infectious diseases , limited information is known about its anti ##biotic resistance mechanism . In this study , we aim to identify the molecular mechanism underlying the high mac ##rol ##ide resistance of six S [SEP]',\n",
    "  'existing_cui': 'C0732611',\n",
    "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
    "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
    "  'our_bi_cui': 'C0243036',\n",
    "  'our_bi_cui_name': 'Genes , erbB',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##s , er ##b ##B [unused3] ( Ana ##tom ##ical Structure : A ##vian E ##ry ##th ##ro ##blast ##osis V ##ir ##us On ##co ##gene B ; E ##ry ##th ##ro ##blast Trans ##form ##ing Gene B ; On ##co ##gene , E ##G ##F ##R ; On ##co ##gene ER ##B B ; er ##b ##B Gene ##s ; er ##b ##B Gene ; ER ##B - B ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27472389.55',\n",
    "  'test_set_idx': 7196,\n",
    "  'type': 'T017',\n",
    "  'name': 'MDA-MB231',\n",
    "  'context': '[CLS] act ##iva ##tor of transcription 1 , and H ##ER ##2 were increased and re ##lap ##se free survival was decreased in high - risk breast cancer patients . We also investigated the effect of ACT ##A ##2 on cell m ##ot ##ility , which was suppressed by ACT ##A ##2 s ##h ##RNA over ##ex ##press ##ion in [unused1] MD ##A - MB ##23 ##1 [unused2] H ##ER ##2 and 4 ##T ##1 ma ##mma ##ry car ##cin ##oma cells . The number of lung meta ##static nod ##ules was significantly decreased in ACT ##A ##2 knock ##down mice . Take ##n together , these results demonstrated that induction of ACT ##A ##2 by E ##G ##F ##R and H ##ER ##2 dim ##eri ##zation [SEP]',\n",
    "  'existing_cui': 'C1537399',\n",
    "  'existing_cui_name': 'IFIH1 gene',\n",
    "  'existing_cui_desc': '[CLS] IF ##I ##H1 gene [unused3] ( Ana ##tom ##ical Structure : IN ##TE ##R ##F ##ER ##ON - IN ##D ##UC ##ED H ##EL ##IC ##AS ##E C D ##OM ##A ##IN - CO ##NT ##A ##IN ##ING PR ##OT ##EI ##N 1 ; ID ##DM ##19 ; me ##lan ##oma differentiation - associated gene 5 ; IF ##I ##H1 Gene ; Inter ##fer ##on In ##duced With He ##lica ##se C Domain 1 Gene ; he ##lica ##rd ; inter ##fer ##on induced with he ##lica ##se C domain 1 ; H ##l ##c ##d ; MD ##A - 5 ; ME ##LA ##N ##OM ##A D ##IF ##F ##ER ##EN ##TI ##AT ##ION - AS ##SO ##CI ##AT ##ED GE ##NE 5 ) [SEP]',\n",
    "  'our_bi_cui': 'C3898556',\n",
    "  'our_bi_cui_name': 'MDA-MB-231 / ATCC',\n",
    "  'our_bi_cui_desc': '[CLS] MD ##A - MB - 231 / AT ##CC [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_cross_cui': 'C1512505',\n",
    "  'our_cross_cui_name': 'Breast Cancer Cell',\n",
    "  'our_cross_cui_desc': '[CLS] B ##rea ##st Cancer Cell [unused3] ( Ana ##tom ##ical Structure : Human B ##rea ##st Cancer Cell ; Human B ##rea ##st Cancer Cell ##s ) [SEP]'},\n",
    " {'mention_id': '27838742.78',\n",
    "  'test_set_idx': 19045,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . [unused1] Del ##ica ##f ##lav ##one [unused2] showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one did not show o ##bs ##er ##vable side effects in a x ##eno [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27799834.1',\n",
    "  'test_set_idx': 17615,\n",
    "  'type': 'T058',\n",
    "  'name': 'revision arthroscopic repair',\n",
    "  'context': '[CLS] A comparison of functional outcomes in patients undergoing [unused1] revision art ##hr ##os ##copic repair [unused2] of massive rot ##ator cu ##ff tears with and without art ##hr ##os ##copic su ##pra ##sca ##pu ##lar nerve release This study was designed to compare functional outcomes in patients undergoing revision repair of massive rot ##ator cu ##ff tears ( re ##tracted medial to the g ##len ##oid ) with Go ##uta ##llie ##r Grade 4 at ##rop ##hy and con ##com ##ita ##nt release of the su ##pra ##sca ##pu ##lar nerve to a similar group of patients with Grade 3 at ##rop ##hy undergoing revision rot ##ator cu ##ff repair without nerve release . We h ##y ##pot ##hes ##ized that patients undergoing nerve release would [SEP]',\n",
    "  'existing_cui': 'C0408075',\n",
    "  'existing_cui_name': 'Revision arthroscopic ligament repair',\n",
    "  'existing_cui_desc': '[CLS] Rev ##ision art ##hr ##os ##copic l ##iga ##ment repair [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
    "  'our_bi_cui': 'C0087111',\n",
    "  'our_bi_cui_name': 'Therapeutic procedure',\n",
    "  'our_bi_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]',\n",
    "  'our_cross_cui': 'C1997575',\n",
    "  'our_cross_cui_name': 'Revision of repair of rotator cuff',\n",
    "  'our_cross_cui_desc': '[CLS] Rev ##ision of repair of rot ##ator cu ##ff [unused3] ( Health Care Act ##ivity , procedure ) [SEP]'},\n",
    " {'mention_id': '27729085.9',\n",
    "  'test_set_idx': 15215,\n",
    "  'type': 'T038',\n",
    "  'name': 'conventional',\n",
    "  'context': '[CLS] Cho ##rdo ##ma de ##different ##iation after pro ##ton beam therapy : a case report and review of the literature Cho ##rdo ##ma is a rare invasive bone tumor that may occur anywhere along the ne ##ura ##xi ##s . A total of three primary his ##to ##logical varieties have been identified : [unused1] conventional [unused2] , ch ##ond ##roid , and de ##different ##iated . We report a case of an 8 - year - old white girl who presented with conventional chord ##oma , was treated with surgical re ##section and mixed pro ##ton and photo ##n beam therapy , and had a re ##cu ##rrence in the re ##section cavity 2 . 5 years later with de ##different ##iated morphology . The re [SEP]',\n",
    "  'existing_cui': 'C2945704',\n",
    "  'existing_cui_name': 'Conventional Treatment',\n",
    "  'existing_cui_desc': '[CLS] Convention ##al Treatment [unused3] ( Health Care Act ##ivity : conventional therapy ; Convention ##al Therapy ; conventional treatment ) [SEP]',\n",
    "  'our_bi_cui': 'C4055182',\n",
    "  'our_bi_cui_name': 'Conventional Schwannoma',\n",
    "  'our_bi_cui_desc': '[CLS] Convention ##al Sc ##hwa ##nn ##oma [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_cross_cui': 'C0008487',\n",
    "  'our_cross_cui_name': 'Chordoma',\n",
    "  'our_cross_cui_desc': '[CLS] Cho ##rdo ##ma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity : chord ##oma ; CH ##OR ##D ##OM ##A , MA ##L ##IG ##NA ##NT ; CH ##OR ##D ##OM ##A , S ##US ##CE ##P ##TI ##BI ##L ##IT ##Y TO ; chord ##oma ##s ; Cho ##rdo ##ma [ Disease / Finding ] ; Cho ##rdo ##mas ; not ##och ##ord ##oma ) [SEP]'},\n",
    " {'mention_id': '28436493.10',\n",
    "  'test_set_idx': 35776,\n",
    "  'type': 'T103',\n",
    "  'name': 'H56',\n",
    "  'context': '[CLS] in E ##S ##X - 1 secret ##ion induce ##s minimal host immune responses and path ##ology Although My ##co ##ba ##cter ##ium tuberculosis D ##K ##9 ##8 ##9 ##7 is an at ##ten ##uated strain , it was isolated from a patient with extra ##pu ##lm ##ona ##ry tuberculosis and v ##ac ##cin ##ation with a subunit vaccine ( [unused1] H ##5 ##6 [unused2] ) induced poor protection against it . Both at ##ten ##uation and lack of protection are because My ##co ##ba ##cter ##ium tuberculosis D ##K ##9 ##8 ##9 ##7 can not secret ##e the E ##s ##x ##A v ##ir ##ule ##nce factor nor induce a host response against it . Gen ##ome se ##quencing identified a frames ##hi ##ft mutation [SEP]',\n",
    "  'existing_cui': 'C3612799',\n",
    "  'existing_cui_name': 'Bacillus sp . H56',\n",
    "  'existing_cui_desc': '[CLS] Ba ##ci ##llus s ##p . H ##5 ##6 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
    "  'our_bi_cui': 'C0042210',\n",
    "  'our_bi_cui_name': 'Vaccines',\n",
    "  'our_bi_cui_desc': '[CLS] V ##ac ##cine ##s [unused3] ( Chemical , medication , product , substance : VA ##CC ##IN ##ES ; V ##ac ##cine ; vaccine product ; [ I ##M ##100 ] VA ##CC ##IN ##ES ; V ##ac ##cine ##s [ Chemical / In ##g ##red ##ient ] ; vaccine ##s ; V ##ac ##cine ##E ##nti ##ty ##T ##ype ; vaccine ) [SEP]',\n",
    "  'our_cross_cui': 'C0887892',\n",
    "  'our_cross_cui_name': 'Vaccines , Subunit',\n",
    "  'our_cross_cui_desc': '[CLS] V ##ac ##cine ##s , Sub ##uni ##t [unused3] ( Chemical : Sub ##uni ##t V ##ac ##cine ##s ; subunit vaccine ; subunit vaccine ##s ; V ##ac ##cine ##s , Sub ##uni ##t [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
    " {'mention_id': '27659602.12',\n",
    "  'test_set_idx': 13357,\n",
    "  'type': 'T082',\n",
    "  'name': 'root',\n",
    "  'context': '[CLS] ##lace ##ment in Non ##sy ##nd ##rom ##ic An ##eur ##ys ##mal Pat ##ients Leaving native a ##ort ##ic tissue in sit ##u in root - spa ##ring ascending a ##ort ##ic replacement raises concern regarding potential later need for root re ##oper ##ation or for the potential occurrence of localized di ##sse ##ctions or r ##up ##ture in the residual [unused1] root [unused2] . The purpose of this study was to evaluate the natural growth of the a ##ort ##ic root after root - spa ##ring a ##ort ##ic replacement . In all , 102 consecutive patients ( mean age 61 . 8 ± 12 . 5 years ; 60 % male ) who had undergone root - spa ##ring a ##ort ##ic replacement had [SEP]',\n",
    "  'existing_cui': 'C1318154',\n",
    "  'existing_cui_name': 'Root body part',\n",
    "  'existing_cui_desc': '[CLS] Root body part [unused3] ( Ana ##tom ##ical Structure : Root ; root [ a body part ] ; root ) [SEP]',\n",
    "  'our_bi_cui': 'C0040452',\n",
    "  'our_bi_cui_name': 'Tooth root structure',\n",
    "  'our_bi_cui_desc': '[CLS] Too ##th root structure [unused3] ( Ana ##tom ##ical Structure , body structure : Ra ##di ##x co ##rona ; Root of the Too ##th ; tooth root ; Too ##th Root ; Root of Too ##th ; Root , Too ##th ; tooth roots ; root of tooth ; root tooth ; roots tooth ; Te ##eth - - Roots ; Roots , Too ##th ; of tooth root ; Too ##th Roots ; Too ##th root ; Ra ##di ##x Den ##tis ; Ra ##di ##x den ##tis ; rooted tooth ; Root of tooth ) [SEP]',\n",
    "  'our_cross_cui': 'C0549113',\n",
    "  'our_cross_cui_name': 'Supraaortic valve area structure',\n",
    "  'our_cross_cui_desc': '[CLS] Su ##pra ##ao ##rt ##ic valve area structure [unused3] ( Spa ##tial Concept , body structure : A ##ort ##ic bulb ; AS ##CE ##ND ##ING A ##OR ##TA , A ##OR ##TI ##C R ##O ##OT ; A ##ort ##a . root ; A ##ort ##ic root ; a ##ort ##ic root ; A ##ort ##ic Root ; Root of a ##ort ##a ; B ##ul ##b of a ##ort ##a ; Su ##pra ##ao ##rt ##ic valve area ; root a ##ort ##ic ; B ##ul ##b of ascending a ##ort ##a ; B ##ul ##bus a ##ort ##ae ) [SEP]'},\n",
    " {'mention_id': '28197156.9',\n",
    "  'test_set_idx': 28079,\n",
    "  'type': 'T204',\n",
    "  'name': 'rice cultivars',\n",
    "  'context': '[CLS] , St ##oma ##tal Con ##duct ##ance and Photo ##sy ##nt ##hesis in Rice Inc ##rea ##sing the rate of leaf photos ##ynth ##esis is one important approach for increasing grain yield in rice ( Or ##y ##za sat ##iva ) . Ex ##p ##lo ##iting the natural variation in CO ##2 ass ##im ##ilation rate ( A ) between [unused1] rice cult ##iva ##rs [unused2] using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial cult ##iva ##r . Fine mapping suggested that Carbon As ##si [SEP]',\n",
    "  'existing_cui': 'C3385047',\n",
    "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
    "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
    "  'our_bi_cui': 'C0035567',\n",
    "  'our_bi_cui_name': 'Rice',\n",
    "  'our_bi_cui_desc': '[CLS] Rice [unused3] ( Food , Diet ##ary , Diet ##ary , substance : Rice ##s ; rice ) [SEP]',\n",
    "  'our_cross_cui': 'C1140671',\n",
    "  'our_cross_cui_name': 'Oryza sativa',\n",
    "  'our_cross_cui_desc': '[CLS] Or ##y ##za sat ##iva [unused3] ( E ##uka ##ryo ##te : red rice ; rice ; Or ##y ##za sat ##iva L . ; rice plant ) [SEP]'},\n",
    " {'mention_id': '27887026.36',\n",
    "  'test_set_idx': 20821,\n",
    "  'type': 'T038',\n",
    "  'name': 'hydride transfer',\n",
    "  'context': '[CLS] of HC ##O ##3 ( - ) reduced the reaction rate . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H ) and Cha ##eto ##mium the ##rm ##op ##hil ##um was modeled in the presence of HC ##O ##3 ( - ) showing that it fits to the active site . The active site setting for [unused1] h ##yd ##ride transfer [unused2] in CO ##2 reduction was modeled . The h ##yd ##ride donated by N ##AD ##H would form a favorable contact to the carbon atom of HC ##O ##3 ( - ) , resulting in a surplus of electrons within the molecule . This would cause the complex formed by hydrogen carbon ##ate and the h ##yd ##ride to break [SEP]',\n",
    "  'existing_cui': 'C0728827',\n",
    "  'existing_cui_name': 'transfers',\n",
    "  'existing_cui_desc': '[CLS] transfers [unused3] ( Finding , finding : Does transfer ; Transfer ##s ) [SEP]',\n",
    "  'our_bi_cui': 'C1159575',\n",
    "  'our_bi_cui_name': 'molecular hydrogen transport',\n",
    "  'our_bi_cui_desc': '[CLS] molecular hydrogen transport [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_cross_cui': 'C1148560',\n",
    "  'our_cross_cui_name': 'molecular_function',\n",
    "  'our_cross_cui_desc': '[CLS] molecular _ function [unused3] ( B ##iol ##og ##ic Fun ##ction : molecular function ) [SEP]'},\n",
    " {'mention_id': '27779321.3',\n",
    "  'test_set_idx': 16411,\n",
    "  'type': 'T170',\n",
    "  'name': 'equilibrium partitioning',\n",
    "  'context': '[CLS] Ben ##thi ##c injury dose - response models for p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l - contaminated sediment using [unused1] equilibrium partition ##ing [unused2] The study goal was to develop a sediment p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l dose - response model based on bent ##hic in ##vert ##eb ##rate effects to PC ##B ##s . The authors used an equilibrium partition ##ing approach to generate predicted p ##oly ##ch ##lor ##inated bi ##phe ##ny ##l sediment effect concentrations ( largely A ##ro ##c ##lor 125 ##4 ) associated with a gradient of toxic effects in bent ##hic organisms from effects observed in aquatic toxicity studies . The present study differs from all other equilibrium partition ##ing collective sediment investigations [SEP]',\n",
    "  'existing_cui': 'C0014653',\n",
    "  'existing_cui_name': 'Equilibrium',\n",
    "  'existing_cui_desc': '[CLS] E ##qui ##li ##bri ##um [unused3] ( B ##iol ##og ##ic Fun ##ction , Motor Process ##es , function , o ##bs ##er ##vable entity , qualifier value : balancing ; equilibrium ; Ba ##lance ; E ##qui ##li ##bri ##um , function ; Ba ##lancing ; balance ; Ba ##lance , function ) [SEP]',\n",
    "  'our_bi_cui': 'C0684295',\n",
    "  'our_bi_cui_name': 'Chemical extraction',\n",
    "  'our_bi_cui_desc': '[CLS] Chemical extraction [unused3] ( Health Care Act ##ivity ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28521168.15',\n",
    "  'test_set_idx': 38284,\n",
    "  'type': 'T058',\n",
    "  'name': 'test battery',\n",
    "  'context': '[CLS] ##no ##mate ##rial ##s , specifically , Nan ##o - Go ##eth ##ite , T ##rap - O ##x Fe - z ##eo ##lite ##s , Car ##bo - Iron ( ® ) and Fe ##r ##ME ##G ##12 , developed within the European F ##P ##7 project Nan ##o ##R ##em for sub - surface re ##media ##tion towards a [unused1] test battery [unused2] consisting of eight e ##cot ##ox ##icit ##y tests on bacteria ( V . fish ##eri , E . co ##li ) , algae ( P . sub ##cap ##ita ##ta , Ch ##lam ##yd ##omo ##nas s ##p . ) , crust ##ace ##ans ( D . ma ##gna ) , worms ( E . f ##eti ##da , L [SEP]',\n",
    "  'existing_cui': 'C0456724',\n",
    "  'existing_cui_name': 'Willeford test battery',\n",
    "  'existing_cui_desc': '[CLS] Will ##ef ##ord test battery [unused3] ( Health Care Act ##ivity , procedure ) [SEP]',\n",
    "  'our_bi_cui': 'C1446038',\n",
    "  'our_bi_cui_name': 'Microbiology battery test',\n",
    "  'our_bi_cui_desc': '[CLS] Micro ##biology battery test [unused3] ( Health Care Act ##ivity , procedure : Micro ##biology test battery ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '28229061.42',\n",
    "  'test_set_idx': 29008,\n",
    "  'type': 'T017',\n",
    "  'name': 'bucco - palatal',\n",
    "  'context': '[CLS] for nine ( 56 . 3 % ) cases and the ma ##xi ##lla for six ( 37 . 5 % ) cases , while a combination of the ma ##xi ##lla and the z ##y ##go ##ma were involved in one ( 6 . 3 % ) case . B ##uc ##co - l ##ing ##ual or [unused1] b ##uc ##co - p ##ala ##tal [unused2] expansion were the most common presentation ( six [ 46 . 2 % ] cases each ) . His ##to ##logical assessment of tissue specimens showed that fi ##bro ##my ##x ##oma accounted for seven ( 43 . 8 % ) cases , while the remaining nine ( 56 . 3 % ) cases were diagnosed as my ##x [SEP]',\n",
    "  'existing_cui': 'C1065206',\n",
    "  'existing_cui_name': 'Genus Bucco',\n",
    "  'existing_cui_desc': '[CLS] Genus B ##uc ##co [unused3] ( E ##uka ##ryo ##te , organism : b ##uc ##co ; B ##uc ##co ) [SEP]',\n",
    "  'our_bi_cui': 'C0565973',\n",
    "  'our_bi_cui_name': 'Buccal-incisal-palatal',\n",
    "  'our_bi_cui_desc': '[CLS] B ##uc ##cal - in ##cis ##al - p ##ala ##tal [unused3] ( Spa ##tial Concept , body structure ) [SEP]',\n",
    "  'our_cross_cui': 'C0229962',\n",
    "  'our_cross_cui_name': 'Body part',\n",
    "  'our_cross_cui_desc': '[CLS] Body part [unused3] ( Ana ##tom ##ical Structure , body structure : Body Parts ; Body part structure ; Pa ##rs co ##rp ##oris ; body part ; body parts ; Body region ; Ana ##tom ##ic part . * ; Body Structure ; Parts , Body ; Ana ##tom ##ic part ; body region ; Cardinal body part ; Body Part ) [SEP]'},\n",
    " {'mention_id': '27251800.47',\n",
    "  'test_set_idx': 842,\n",
    "  'type': 'T058',\n",
    "  'name': 'Stoppa',\n",
    "  'context': '[CLS] % of Stop ##pa group ( 22 patients ) and 64 % in lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair group ( 16 patients ) ( P < 0 . 05 ) . The comparative study between the Stop ##pa and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approaches for the bilateral ing ##uin ##al her ##nia repair demonstrated that : ( 1 ) The lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approach showed less surgical trauma despite the longer operation time ; ( 2 ) Quality of life during the early post - operative period were similar ; and ( 3 ) Co ##mp ##lication rates were higher in the [unused1] Stop ##pa [unused2] group . [SEP]',\n",
    "  'existing_cui': 'C1538901',\n",
    "  'existing_cui_name': 'ACD gene',\n",
    "  'existing_cui_desc': '[CLS] AC ##D gene [unused3] ( Ana ##tom ##ical Structure : T ##EL ##OM ##ER ##E PR ##OT ##EI ##N T ##PP ##1 ; ad ##ren ##oc ##ort ##ical d ##ys ##p ##lasia ho ##mo ##log ; AC ##D Gene ; Ad ##ren ##oc ##ort ##ical D ##ys ##p ##lasia Ho ##mo ##log ( Mouse ) Gene ; P ##OT ##1 - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N 1 ; P ##OT ##1 - AND T ##IN ##2 - OR ##GA ##NI ##Z ##ING PR ##OT ##EI ##N ; P ##OT ##1 and T ##IN ##2 organizing protein ; AC ##D , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; Tin ##t ##1 ; T ##IN ##2 interacting protein 1 [SEP]',\n",
    "  'our_bi_cui': 'C1080020',\n",
    "  'our_bi_cui_name': 'Lopa',\n",
    "  'our_bi_cui_desc': '[CLS] Lo ##pa [unused3] ( E ##uka ##ryo ##te : lo ##pa ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27791169.33',\n",
    "  'test_set_idx': 16886,\n",
    "  'type': 'T017',\n",
    "  'name': 'BPH1',\n",
    "  'context': '[CLS] sa ##lic ##yl ##ic acid - and j ##as ##mon ##ic acid - signaling pathways in rice plants and con ##fers both anti ##xen ##osis and anti ##bio ##sis to Brown plant ##hop ##per . We further demonstrated that the eight Brown plant ##hop ##per - resistance genes that are cluster ##ed on chromosome 12 ##L , including the widely used [unused1] BP ##H1 [unused2] , are all ##eli ##c with each other . To honor the priority in the literature , we thus designated this lo ##cus as BP ##H1 / 9 These eight genes can be classified into four all ##elo ##type ##s , BP ##H1 / 9 - 1 , - 2 , - 7 , and - 9 These all ##elo ##type [SEP]',\n",
    "  'existing_cui': 'C0005001',\n",
    "  'existing_cui_name': 'Benign prostatic hypertrophy',\n",
    "  'existing_cui_desc': '[CLS] Ben ##ign pro ##static h ##yper ##tro ##phy [unused3] ( B ##iol ##og ##ic Fun ##ction , BP ##H , ben ##ign , ben ##ign pro ##static h ##yper ##tro ##phy , diagnosis : H ##yper ##tro ##phy - pro ##st . ben . ; ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static h ##yper - ben ##ign ; Ben ##ign Pro ##static H ##yper ##p ##lasia - BP ##H ; En ##lar ##ged Pro ##state ; H ##yper ##tro ##phy , Ben ##ign Pro ##static ; H ##yper ##tro ##phy ( ben ##ign ) of pro ##state ; Ben ##ign h ##yper ##tro ##phy of pro ##state ; BP ##H - ben ##ign pro ##static h ##yper ##tro ##phy ; Pro ##static [SEP]',\n",
    "  'our_bi_cui': 'C2677154',\n",
    "  'our_bi_cui_name': 'BSPH1 gene',\n",
    "  'our_bi_cui_desc': '[CLS] BS ##P ##H1 gene [unused3] ( Ana ##tom ##ical Structure : bind ##er of sperm protein ho ##mo ##log 1 ; BS ##P , B ##O ##VI ##NE , H ##OM ##OL ##O ##G OF , 1 ; B ##IN ##DE ##R OF SP ##ER ##M PR ##OT ##EI ##N , B ##O ##VI ##NE , H ##OM ##OL ##O ##G OF , 1 ; E ##LS ##P ##B ##P ##2 ; b ##ov ##ine seminal plasma protein ho ##mo ##log 1 ; B ##O ##VI ##NE SE ##MI ##NA ##L P ##LA ##SM ##A PR ##OT ##EI ##N - L ##I ##KE 1 ; SE ##MI ##NA ##L P ##LA ##SM ##A PR ##OT ##EI ##N , B ##O ##VI ##NE , H ##OM ##OL [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '28243201.17',\n",
    "  'test_set_idx': 29659,\n",
    "  'type': 'T201',\n",
    "  'name': 'response',\n",
    "  'context': '[CLS] ##cu ##rrence . DNA met ##hyl ##ation has been suggested as one of the underlying mechanisms for re ##current disease and its contribution to the development of drug resistance remains to be clarified . This study aimed to determine the met ##hyl ##ation p ##hen ##otype in color ##ec ##tal cancer for identification of predict ##ive markers for ch ##em ##otherapy [unused1] response [unused2] . We performed DNA met ##hyl ##ation pro ##fi ##ling on 43 non - re ##current and five re ##current color ##ec ##tal cancer patients using the Il ##lum ##ina In ##fin ##ium Human ##M ##eth ##yla ##tion ##45 ##0 Be ##ad ##chi ##p ass ##ay . In addition , color ##ec ##tal cancer cells with different genetic backgrounds , response to [SEP]',\n",
    "  'existing_cui': 'C1704632',\n",
    "  'existing_cui_name': 'Disease Response',\n",
    "  'existing_cui_desc': '[CLS] Disease Response [unused3] ( Finding : Response ; response ) [SEP]',\n",
    "  'our_bi_cui': 'C0683154',\n",
    "  'our_bi_cui_name': 'drug response',\n",
    "  'our_bi_cui_desc': '[CLS] drug response [unused3] ( B ##iol ##og ##ic Fun ##ction : response to drug ; drug responses ; drugs response ) [SEP]',\n",
    "  'our_cross_cui': 'C0521982',\n",
    "  'our_cross_cui_name': 'Response to treatment',\n",
    "  'our_cross_cui_desc': '[CLS] Response to treatment [unused3] ( Clinical At ##tri ##but ##e , context - dependent category , finding , function , o ##bs ##er ##vable entity , situation : response to treatment ; response treatments ; The ##rap ##eu ##tic response ; response therapeutic ; The ##rap ##eu ##tic Response ; Finding related to therapeutic response ; successful treatment ; successful treatments ; The ##rap ##eu ##tic response , function ) [SEP]'},\n",
    " {'mention_id': '28273336.4',\n",
    "  'test_set_idx': 30871,\n",
    "  'type': 'T170',\n",
    "  'name': 'ImmunoCAP system',\n",
    "  'context': '[CLS] Question ##able diagnostic benefit of the commercially available panel of bee venom components For many years , only the major all ##er ##gen r ##A ##pi m 1 has been available on the [unused1] I ##mm ##uno ##CA ##P system [unused2] for routine diagnosis of bee venom all ##er ##gy . Now , there are five components available , and we aimed to detect the sensitivity and specific ##ity of r ##A ##pi m 1 , 2 , 3 , 5 , and 10 in B ##V - all ##ergic patients . We further evaluated the sensitivity of r ##A ##pi m 1 and 2 of an alternative platform and investigated possible differences in the se ##ns ##iti ##zation profile between mon ##ose ##ns ##iti ##zation [SEP]',\n",
    "  'existing_cui': 'C0026745',\n",
    "  'existing_cui_name': 'System , Multi-Hospital',\n",
    "  'existing_cui_desc': '[CLS] System , Multi - Hospital [unused3] ( Organization : Multi - Hospital Systems ; Multi Hospital Systems ; M ##U ##LT ##I H ##OS ##P S ##Y ##ST ##EM ##S ; System , Multi Hospital ; M ##U ##LT ##I ##H ##OS ##P S ##Y ##ST ##EM ##S ; Multi ##hos ##pit ##al systems ; M ##U ##LT ##I ##H ##OS ##PI ##TA ##L S ##Y ##ST ##EM ##S ; System , Multi ##hos ##pit ##al ; Multi ##hos ##pit ##al System ; Multi - Hospital System ; Systems , Multi - Hospital ; Multi ##hos ##pit ##al Systems ; S ##Y ##ST ##EM M ##U ##LT ##I H ##OS ##P ; Systems , Multi ##hos ##pit ##al ) [SEP]',\n",
    "  'our_bi_cui': 'C0025080',\n",
    "  'our_bi_cui_name': 'Medical Devices',\n",
    "  'our_bi_cui_desc': '[CLS] Medical Devi ##ces [unused3] ( Medical Devi ##ce , physical device , physical object : Clinical equipment ; B ##io ##medical device ; DE ##VI ##CE ME ##D ; ME ##D DE ##VI ##CE ##S ; ME ##D DE ##VI ##CE ; bio ##medical devices ; Devi ##ces , Medical ; Medical devices ; General bio ##medical device ; DE ##VI ##CE , GE ##NE ##RA ##L ME ##DI ##CA ##L ; B ##io ##medical equipment ; Devi ##ce , Medical ; Hospital , medical AND / OR surgical equipment ( physical device ) ; bio ##medical equipment ; medical equipment ; Medical equipment ; DE ##VI ##CE ##S ME ##D ; DE ##VI ##CE ; DE ##VI ##CE ##S ; medical device ; medical devices [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28299441.47',\n",
    "  'test_set_idx': 31686,\n",
    "  'type': 'T017',\n",
    "  'name': 'early genes',\n",
    "  'context': '[CLS] V ##v ##M ##Y ##B ##PA ##1 alter ##s the p ##hen ##yl ##p ##rop ##ano ##id pathway in tobacco floral organs , in a structure - specific fashion . We also report that a modest V ##v ##M ##Y ##B ##PA ##1 expression is sufficient to induce the expression of both pro ##ant ##ho ##cy ##ani ##din - specific and [unused1] early genes [unused2] of the p ##hen ##yl ##p ##rop ##ano ##id pathway . Consequently , pro ##ant ##ho ##cy ##ani ##din ##s and ch ##lor ##ogenic acids are induced or de no ##vo s ##ynth ##eti ##sed in floral limbs , tubes and s ##tam ##ens . Other p ##hen ##yl ##p ##rop ##ano ##id branches are con ##verse ##ly induced or depleted [SEP]',\n",
    "  'existing_cui': 'C0013458',\n",
    "  'existing_cui_name': 'Early Gene Transcription',\n",
    "  'existing_cui_desc': '[CLS] Early Gene Trans ##cription [unused3] ( B ##iol ##og ##ic Fun ##ction : Trans ##cription , Early Gene ; Gene Trans ##cription , Early ) [SEP]',\n",
    "  'our_bi_cui': 'C0013458',\n",
    "  'our_bi_cui_name': 'Early Gene Transcription',\n",
    "  'our_bi_cui_desc': '[CLS] Early Gene Trans ##cription [unused3] ( B ##iol ##og ##ic Fun ##ction : Trans ##cription , Early Gene ; Gene Trans ##cription , Early ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27786291.17',\n",
    "  'test_set_idx': 16751,\n",
    "  'type': 'T017',\n",
    "  'name': 'ctxA/B',\n",
    "  'context': '[CLS] ##s and pan ##de ##mic disease . However , a number of questions remain about long - term survival and evolution of V . ch ##ole ##rae strains within these aquatic environmental reservoirs . Through monitoring of the Haitian aquatic environment following the 2010 ch ##ole ##ra epidemic , we isolated two novel non - to ##xi ##genic ( [unused1] c ##t ##x ##A / B [unused2] - negative ) V ##ib ##rio ch ##ole ##rae O ##1 . These two is ##olate ##s underwent whole - genome se ##quencing and were investigated through comparative g ##eno ##mic ##s and Bay ##esi ##an coal ##es ##cent analysis . These is ##olate ##s cluster in the evolutionary tree with strains responsible for clinical ch ##ole ##ra , [SEP]',\n",
    "  'existing_cui': 'C0412669',\n",
    "  'existing_cui_name': 'Computerized tomography , bone density study',\n",
    "  'existing_cui_desc': '[CLS] Computer ##ized to ##mo ##graphy , bone density study [unused3] ( Health Care Act ##ivity , Q ##CT , procedure : computer ##ized to ##mo ##graphy bone den ##si ##tom ##et ##ry ; CT bone density ; quantitative com ##puted to ##mo ##graphy ; com ##puted to ##mo ##graphy bone density study ; Q ##uant ##itative com ##puted to ##mo ##graphy studies ; bone density studies com ##puted to ##mo ##graphy ; Computer ##ised to ##mo ##graphy , bone density study ; Q ##uant ##itative CT studies ) [SEP]',\n",
    "  'our_bi_cui': 'C0010868',\n",
    "  'our_bi_cui_name': 'Cytotoxin',\n",
    "  'our_bi_cui_desc': '[CLS] Cy ##to ##to ##xin [unused3] ( Chemical , substance : Cy ##to ##to ##xi ##c substance ; c ##yt ##oto ##xi ##c substances ; Cy ##to ##to ##xi ##c Agents ; c ##yt ##oto ##xi ##c substance ; c ##yt ##oto ##xin ; Cy ##to ##to ##xin ##s ; c ##yt ##oto ##xin ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '28197156.32',\n",
    "  'test_set_idx': 28102,\n",
    "  'type': 'T017',\n",
    "  'name': 'DTH8',\n",
    "  'context': '[CLS] analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , Carbon As ##si ##mi ##lation Rate 8 is identical to [unused1] D ##TH ##8 [unused2] / G ##h ##d ##8 / L ##HD ##1 , which was reported to control rice flowering date . The increase of A is largely due to an increase of R ##u ##B ##P regeneration rate via increased leaf nitrogen content , and partially explained by reduced s ##tom ##ata ##l limitation via increased s ##tom ##ata ##l conduct ##ance relative [SEP]',\n",
    "  'existing_cui': 'C0020522',\n",
    "  'existing_cui_name': 'Delayed Hypersensitivity',\n",
    "  'existing_cui_desc': '[CLS] Del ##ay ##ed H ##yper ##sen ##si ##ti ##vity [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : h ##yper ##sen ##si ##ti ##vity type i ##v ; delayed h ##yper ##sen ##si ##ti ##vity reaction ; H ##yper ##sen ##si ##ti ##vi ##ties , Tu ##ber ##cu ##lin - Type ; delayed h ##yper ##sen ##si ##ti ##vity ; Tu ##ber ##cu ##lin Type H ##yper ##sen ##si ##ti ##vity ; Cell - mediated im ##mu ##nological reaction ; Del ##ay ##ed type h ##yper ##sen ##si ##ti ##vity ; type i ##v h ##yper ##sen ##si ##ti ##vity ; Cell - mediated im ##mu ##nological react ; H ##yper ##sen ##si ##ti ##vi ##ties , Type IV ; type IV h ##yper [SEP]',\n",
    "  'our_bi_cui': 'C1413965',\n",
    "  'our_bi_cui_name': 'DHX8 gene',\n",
    "  'our_bi_cui_desc': '[CLS] D ##H ##X ##8 gene [unused3] ( Ana ##tom ##ical Structure : DE ##A ##H B ##OX P ##OL ##YP ##EP ##TI ##DE 8 ; PR ##P ##22 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; DE ##A ##H - box he ##lica ##se 8 ; PR ##P ##22 ; DE ##AD / H B ##OX 8 ; RNA H ##EL ##IC ##AS ##E 1 ; PR ##P ##F ##22 ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '28454015.20',\n",
    "  'test_set_idx': 36521,\n",
    "  'type': 'T170',\n",
    "  'name': 'health - risk based air quality index',\n",
    "  'context': '[CLS] ) at both 2014 and 2015 . PM ##2 . 5 is typically the major poll ##uta ##nt , but oz ##one pollution can be significant during summer . Furthermore , as the commonly used air quality index neglect ##s the mutual health effects from multiple poll ##uta ##nts , we introduced the aggregate air quality index and [unused1] health - risk based air quality index [unused2] to evaluate the health risks . Results show that based on health - risk based air quality index , the current air quality index system likely significantly under ##est ##imate the health risks of air pollution , highlighting that the general public may need strict ##er health protection measures . The population - weighted two - year average health [SEP]',\n",
    "  'existing_cui': 'C1268941',\n",
    "  'existing_cui_name': 'Health risks education',\n",
    "  'existing_cui_desc': '[CLS] Health risks education [unused3] ( Health Care Act ##ivity , procedure , regime / therapy : Counsel ##ing regarding health risks ; Ad ##vice about health risks ; Counsel ##ling regarding health risks ; Education regarding health risks ) [SEP]',\n",
    "  'our_bi_cui': 'C3494320',\n",
    "  'our_bi_cui_name': 'Health Impact Assessment',\n",
    "  'our_bi_cui_desc': '[CLS] Health Impact Assessment [unused3] ( Health Care Act ##ivity : Impact Assessment ##s , Health ; Impact Assessment , Health ; Health Impact Assessment ##s ; Assessment ##s , Health Impact ; Assessment , Health Impact ) [SEP]',\n",
    "  'our_cross_cui': 'C0918012',\n",
    "  'our_cross_cui_name': 'Index',\n",
    "  'our_cross_cui_desc': '[CLS] Index [unused3] ( Intel ##lect ##ual Product : index ##ed ; index ; index ##es ; Index ##es as Top ##ic ) [SEP]'},\n",
    " {'mention_id': '28077286.50',\n",
    "  'test_set_idx': 25100,\n",
    "  'type': 'T103',\n",
    "  'name': 'MeHg',\n",
    "  'context': '[CLS] Me ##H ##g dose of 3 . 2 μ ##g H ##g g ( - 1 ) egg , and a vehicle control ( water ) . No adverse effects of in o ##vo Me ##H ##g treatment were detected on courts ##hip song quality or on mating behavior in experimental males at sexually maturity which would suggest that o ##bs ##er ##vable ne ##uro ##be ##ha ##vior ##al effects of [unused1] Me ##H ##g [unused2] exposure may depend on the timing of exposure during offspring development . However , ne ##uro ##ana ##tom ##ical analysis indicated an increase in te ##len ##ce ##pha ##lon volume with increased Me ##H ##g concentrations which may suggest a prolonged inflammatory response in this region of the brain . [SEP]',\n",
    "  'existing_cui': 'C0228520',\n",
    "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
    "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
    "  'our_bi_cui': 'C0025424',\n",
    "  'our_bi_cui_name': 'Mercury',\n",
    "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
    "  'our_cross_cui': 'C0025794',\n",
    "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
    "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
    " {'mention_id': '28471040.13',\n",
    "  'test_set_idx': 37127,\n",
    "  'type': 'T103',\n",
    "  'name': 'poly ( lactic-co-glycolic acid ) -1,2 distearoyl-glycerol-3-phospho-ethanolamine-N [ methoxy ( lipid - polyethylene glycol ) -2000 ] ammonium salt',\n",
    "  'context': '[CLS] drug , far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid for treatment of g ##lio ##blast ##oma . Far ##nes ##yl ##thi ##osa ##lic ##yl ##ic acid - loaded [unused1] p ##oly ( la ##ctic - co - g ##ly ##co ##lic acid ) - 1 , 2 di ##ste ##aro ##yl - g ##ly ##cer ##ol - 3 - p ##hos ##ph ##o - ethanol ##amine - N [ met ##ho ##xy ( lip ##id - p ##oly ##eth ##yle ##ne g ##ly ##co ##l ) - 2000 ] am ##mon ##ium salt [unused2] ( P ##L ##GA - DS ##P ##E - P ##EG ) with or without 1 , 2 - di ##ole ##oy ##l - 3 - trim ##eth ##yla ##mm [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C3849743',\n",
    "  'our_bi_cui_name': 'polyethylene glycol-poly',\n",
    "  'our_bi_cui_desc': '[CLS] p ##oly ##eth ##yle ##ne g ##ly ##co ##l - p ##oly [unused3] ( Chemical , la ##ct ##ide - co - g ##ly ##co ##lide , la ##ct ##ide - co - g ##ly ##co ##lide : P ##EG - L ##G ; P ##EG - P ##L ##GA ; p ##oly ( et ##hyl ##ene g ##ly ##co ##l ) - block - la ##ct ##ide - g ##ly ##co ##lide ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28424683.50',\n",
    "  'test_set_idx': 35428,\n",
    "  'type': 'T033',\n",
    "  'name': 'decline in Natural killer cell numbers',\n",
    "  'context': '[CLS] of Natural killer cells , whereas Natural killer cells from mice with no tumor continue expanding Natural killer cells and retain their c ##yt ##oto ##xi ##city . In addition , den ##dr ##itic cells in contrast to O ##Cs are found to promote faster expansion of residual T cells within pu ##rified Natural killer cells resulting in the [unused1] decline in Natural killer cell numbers [unused2] from healthy individuals . Ad ##dition of anti - CD ##3 m ##A ##b in ##hibit ##s T cell proliferation while enhancing Natural killer cell expansion ; however , expanding Natural killer cells have lower c ##yt ##oto ##xi ##city but higher secret ##ion of IF ##N - γ . Ex ##pan ##sion and functional activation of super - [SEP]',\n",
    "  'existing_cui': 'C1855767',\n",
    "  'existing_cui_name': 'Reduced natural killer cell number',\n",
    "  'existing_cui_desc': '[CLS] Red ##uce ##d natural killer cell number [unused3] ( Finding : Red ##uce ##d number of natural killer cells ) [SEP]',\n",
    "  'our_bi_cui': 'C1855767',\n",
    "  'our_bi_cui_name': 'Reduced natural killer cell number',\n",
    "  'our_bi_cui_desc': '[CLS] Red ##uce ##d natural killer cell number [unused3] ( Finding : Red ##uce ##d number of natural killer cells ) [SEP]',\n",
    "  'our_cross_cui': 'C2363838',\n",
    "  'our_cross_cui_name': 'Natural killer cell count decreased',\n",
    "  'our_cross_cui_desc': '[CLS] Natural killer cell count decreased [unused3] ( Finding : N ##K cell count decreased ) [SEP]'},\n",
    " {'mention_id': '28234635.63',\n",
    "  'test_set_idx': 29231,\n",
    "  'type': 'T103',\n",
    "  'name': 'LXR',\n",
    "  'context': '[CLS] inter ##le ##uki ##n - 6 and tumor ne ##c ##rosis factor , repression of FX ##R and its canal ##icular bi ##le transport ##er target gene RNA expression , including ABC ##B ##4 and ABC ##B ##11 as well as decreased protein expression of ABC ##B ##11 and ABC ##B ##4 . Furthermore , up ##re ##gu ##lation of [unused1] L ##X ##R [unused2] and ABC ##G ##5 / 8 RNA expression was suppressed in patients with portal inflammation . Current parent ##eral nutrition , increased serum levels of plant s ##tero ##ls s ##ti ##gma ##ster ##ol , a ##ven ##aster ##ol , and sit ##ost ##ero ##l along with serum c ##it ##ru ##llin ##e , a marker of enter ##oc ##yte mass [SEP]',\n",
    "  'existing_cui': 'C4288814',\n",
    "  'existing_cui_name': 'Liver X Receptor-Like Family',\n",
    "  'existing_cui_desc': '[CLS] Live ##r X Re ##ceptor - Like Family [unused3] ( Chemical : L ##X ##R Family ; Nuclear Re ##ceptor Sub ##family 1 Group H ) [SEP]',\n",
    "  'our_bi_cui': 'C1366515',\n",
    "  'our_bi_cui_name': 'LEPR gene',\n",
    "  'our_bi_cui_desc': '[CLS] L ##EP ##R gene [unused3] ( Ana ##tom ##ical Structure : O ##BR ; CD ##29 ##5 ; L ##EP ##R Gene ; Le ##pt ##in Re ##ceptor Gene ; le ##pt ##in receptor ; L ##EP ##TI ##N R ##EC ##EP ##TO ##R ) [SEP]',\n",
    "  'our_cross_cui': 'C4277606',\n",
    "  'our_cross_cui_name': 'Liver X Receptors',\n",
    "  'our_cross_cui_desc': '[CLS] Live ##r X Re ##ceptor ##s [unused3] ( Chemical : O ##xy ##ster ##ol Re ##ceptor ##s , Nuclear ; Live ##r X Re ##ceptor ; Nuclear O ##xy ##ster ##ol Re ##ceptor ##s ; Live ##r X Re ##ceptor ##s [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
    " {'mention_id': '27587730.18',\n",
    "  'test_set_idx': 10757,\n",
    "  'type': 'T103',\n",
    "  'name': 'gga-miR-21',\n",
    "  'context': '[CLS] expressed in chicken pre - ad ##ip ##ocytes , but its role is unclear . The present study investigated the role of g ##ga - mi ##R - 21 in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the [unused1] g ##ga - mi ##R - 21 [unused2] mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga - mi ##R - 21 inhibitor enhanced pre - ad ##ip ##oc ##yte proliferation . The subsequent investigation identified K ##rup ##pel - like factor 5 m ##RNA as a target of g ##ga - mi ##R - 21 . The [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C2825314',\n",
    "  'our_bi_cui_name': 'MicroRNA Gene',\n",
    "  'our_bi_cui_desc': '[CLS] Micro ##RNA Gene [unused3] ( Ana ##tom ##ical Structure : Micro RNA Gene ; Mi ##RNA Gene ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '28294559.14',\n",
    "  'test_set_idx': 31470,\n",
    "  'type': 'T204',\n",
    "  'name': 'chimeric mice',\n",
    "  'context': '[CLS] role in liver regeneration after partial he ##pate ##ct ##omy in mice Essential ##s Reg ##ener ##ation role of C - type le ##ct ##in receptor - 2 after 70 % he ##pate ##ct ##omy ( HP ##x ) was investigated . Wild - type or C - type le ##ct ##in receptor - 2 deleted from plate ##lets of [unused1] ch ##ime ##ric mice [unused2] ( fl ##KO ) underwent HP ##x . The liver / body weight ratio was significantly lower in the fl ##KO than in the wild - type . C - type le ##ct ##in receptor - 2 plays an essential role in liver regeneration after HP ##x . Background and aim The aim of the present study was to investigate [SEP]',\n",
    "  'existing_cui': 'C0676831',\n",
    "  'existing_cui_name': 'basiliximab',\n",
    "  'existing_cui_desc': '[CLS] b ##asi ##lix ##ima ##b [unused3] ( Chemical , Si ##mu ##lect , medication , product , substance : Basil ##ix ##ima ##b ; b ##asi ##lix ##ima ##b [ Chemical / In ##g ##red ##ient ] ; ch ##ime ##ric mouse - human anti ##CD ##25 ; I ##g gamma - 1 chain C region ; BA ##SI ##L ##IX ##IM ##AB ) [SEP]',\n",
    "  'our_bi_cui': 'C0025936',\n",
    "  'our_bi_cui_name': 'Mice , Transgenic',\n",
    "  'our_bi_cui_desc': '[CLS] Mi ##ce , Trans ##genic [unused3] ( E ##uka ##ryo ##te : Mouse , Trans ##genic ; mouse trans ##genic ##s ; Trans ##genic Mi ##ce ; mice trans ##genic ; Trans ##genic Mouse ; trans ##genic mice ; Trans ##genic mice ; trans ##genic mouse ) [SEP]',\n",
    "  'our_cross_cui': 'C0025929',\n",
    "  'our_cross_cui_name': 'Laboratory mice',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory mice [unused3] ( E ##uka ##ryo ##te , organism : Mouse , Laboratory ; Mouse , laboratory ; Laboratory Mi ##ce ; Mi ##ce , Laboratory ; mouse ; mice ; Laboratory Mouse ; Laboratory mouse ; laboratory mouse ) [SEP]'},\n",
    " {'mention_id': '27832581.19',\n",
    "  'test_set_idx': 18729,\n",
    "  'type': 'T168',\n",
    "  'name': 'maintenance control diet',\n",
    "  'context': '[CLS] development depend on the predominant fatty acid type in the diet . In a combined in v ##ivo - in v ##it ##ro b ##ov ##ine model , two groups of cows ( n = 3 in each group ) were fed with three diet ##s consecutive ##ly ( 4 weeks feeding for each ) : ( 1 ) a [unused1] maintenance control diet [unused2] ; ( 2 ) a high - star ##ch diet rich in saturated fat ; and ( 3 ) a high - star ##ch diet rich in o ##me ##ga - 3 un ##sat ##ura ##ted fat . Two feeding sequences were used to test for carry - over effects : Group A was fed control diet , SAT ##1 and [SEP]',\n",
    "  'existing_cui': 'C2930544',\n",
    "  'existing_cui_name': 'Low-Calorie Diet',\n",
    "  'existing_cui_desc': '[CLS] Low - Cal ##ori ##e Diet [unused3] ( Finding , finding : Ki ##loc ##alo ##rie control diet ; Cal ##ori ##e controlled diet ; Diet , Low - Cal ##ori ##e ; ca ##lor ##ic restriction ; ca ##lor ##ic restrictions ; low ca ##lor ##ie diet ; Low - Cal ##ori ##e Diet ##s ; Low - ca ##lor ##ie diet ; Diet ##s , Low - Cal ##ori ##e ; ca ##lor ##ie diet ##s low ; Low ca ##lor ##ie diet ; Low energy diet ; ca ##lor ##ie restricted diet ; Low ca ##lor ##ic diet ; ca ##lor ##ie controlled diet ; Low Cal ##ori ##e Diet ; Cal ##ori ##e restricted diet ) [SEP]',\n",
    "  'our_bi_cui': 'C0452286',\n",
    "  'our_bi_cui_name': 'Fat controlled diet',\n",
    "  'our_bi_cui_desc': '[CLS] Fat controlled diet [unused3] ( Health Care Act ##ivity , finding : Mo ##dified fat diet ; fat controlled diet ) [SEP]',\n",
    "  'our_cross_cui': 'C0012155',\n",
    "  'our_cross_cui_name': 'Diet',\n",
    "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
    " {'mention_id': '27388786.23',\n",
    "  'test_set_idx': 4446,\n",
    "  'type': 'T098',\n",
    "  'name': 'signers',\n",
    "  'context': \"[CLS] during sign production remains unclear . Here we directly contrast lateral ##ization strength of covert versus over ##t signing during p ##hon ##ological and semantic flu ##ency tasks . To address the possibility that hearing native sign ##ers ' elevated lateral ##ization in ##dices were due to performing a task in their less dominant language , here we test deaf native [unused1] sign ##ers [unused2] , whose dominant language is British Sign Language . Sign ##ers were more strongly left lateral ##ized for over ##t than covert sign generation . However , the strength of lateral ##ization was not correlated with the amount of time producing movements of the right hand . Co ##mp ##aris ##ons with previous data from hearing native English speakers suggest stronger [SEP]\",\n",
    "  'existing_cui': 'C0035127',\n",
    "  'existing_cui_name': 'Cumulative Trauma Disorders',\n",
    "  'existing_cui_desc': '[CLS] C ##um ##ula ##tive T ##ra ##uma Di ##sor ##ders [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , event : Over ##use S ##yn ##drome ; Rep ##eti ##tive St ##ress In ##ju ##ries ; Di ##sor ##ders , C ##um ##ula ##tive T ##ra ##uma ; RS ##I - Rep ##eti ##tive strain injury ; R ##EP ##ET M ##OT ##ION D ##IS ; repetitive strain injury ; St ##rain In ##ju ##ry , Rep ##eti ##tive ; T ##ra ##uma Di ##sor ##ders , C ##um ##ula ##tive ; Rep ##eti ##tive Motion Di ##sor ##ders ; In ##ju ##ries , Rep ##eti ##tive St ##ress ; Motion Di ##sor ##ders , Rep ##eti ##tive ; cumulative trauma disorders [SEP]',\n",
    "  'our_bi_cui': 'C0336303',\n",
    "  'our_bi_cui_name': 'Sign-painter',\n",
    "  'our_bi_cui_desc': '[CLS] Sign - painter [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Sign ##writer ) [SEP]',\n",
    "  'our_cross_cui': 'C1257890',\n",
    "  'our_cross_cui_name': 'Population Group',\n",
    "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
    " {'mention_id': '28197156.33',\n",
    "  'test_set_idx': 28103,\n",
    "  'type': 'T017',\n",
    "  'name': 'Ghd8',\n",
    "  'context': '[CLS] in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , Carbon As ##si ##mi ##lation Rate 8 is identical to D ##TH ##8 / [unused1] G ##h ##d ##8 [unused2] / L ##HD ##1 , which was reported to control rice flowering date . The increase of A is largely due to an increase of R ##u ##B ##P regeneration rate via increased leaf nitrogen content , and partially explained by reduced s ##tom ##ata ##l limitation via increased s ##tom ##ata ##l conduct ##ance relative to A . This [SEP]',\n",
    "  'existing_cui': 'C0035439',\n",
    "  'existing_cui_name': 'Rheumatic Heart Disease',\n",
    "  'existing_cui_desc': '[CLS] R ##he ##umatic Heart Disease [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : R ##he ##umatic Heart Disease [ Disease / Finding ] ; heart disease r ##he ##umatic fever ; card ##itis r ##he ##umatic ; Heart Disease , R ##he ##umatic ; R ##he ##umatic card ##itis ; R ##he ##umatic Heart Disease ##s ; Heart Disease ##s , R ##he ##umatic ; R ##he ##umatic heart disease un ##sp ##ec ##ified ; Disease ##s , R ##he ##umatic Heart ; r ##he ##uma ##to ##id heart disease ; disease fever heart r ##he ##umatic ; R ##he ##umatic heart disease , un ##sp ##ec ##ified ; heart disease r ##he ##uma ##to ##id ; r ##he ##umatic ; [SEP]',\n",
    "  'our_bi_cui': 'C3536868',\n",
    "  'our_bi_cui_name': 'Glyceraldehyde-3-phosphate dehydrogenase',\n",
    "  'our_bi_cui_desc': '[CLS] G ##ly ##cer ##ald ##eh ##yd ##e - 3 - phosphate de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , substance : g ##ly ##cer ##ald ##eh ##yd ##e 3 phosphate de ##hy ##dr ##ogen ##ase ; A ##ging - Associated Gene 9 Pro ##tein ; P ##ept ##idy ##l - Cy ##stein ##e S - Ni ##tro ##sy ##lase GA ##PD ##H ; trio ##se ##ph ##os ##phate de ##hy ##dr ##ogen ##ase ; G ##ly ##cer ##ald ##eh ##yd ##e 3 phosphate de ##hy ##dr ##ogen ##ase ; EC 1 . 2 . 1 . 12 ; G ##ly ##cer ##ald ##eh ##yd ##e - 3 - Ph ##os ##phate De ##hy ##dr ##ogen ##ase ; Trio ##se ##ph ##os ##phate de ##hy ##dr [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27545500.22',\n",
    "  'test_set_idx': 9998,\n",
    "  'type': 'T103',\n",
    "  'name': '16-aldehyde tanshinone I',\n",
    "  'context': '[CLS] synthesized and b ##act ##eri ##ost ##atic activity was explored . In addition , s ##yne ##rg ##istic or add ##itive activity between 16 - al ##de ##hy ##de tan ##shin ##one I and amino ##gly ##cos ##ide anti ##biotics or β - la ##ct ##am anti ##biotics in v ##it ##ro was identified . Moreover , [unused1] 16 - al ##de ##hy ##de tan ##shin ##one I [unused2] was documented to au ##gment clearance of s ##tre ##pt ##omy ##cin and am ##pic ##ill ##in against S . au ##reus in a m ##uri ##ne infection model . Primary me ##chan ##istic insight indicated that 16 - al ##de ##hy ##de tan ##shin ##one I could damage the bacterial cell membrane , leading to accumulation [SEP]',\n",
    "  'existing_cui': 'C0075810',\n",
    "  'existing_cui_name': 'tanshinone',\n",
    "  'existing_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
    "  'our_bi_cui': 'C0075810',\n",
    "  'our_bi_cui_name': 'tanshinone',\n",
    "  'our_bi_cui_desc': '[CLS] tan ##shin ##one [unused3] ( Chemical : 1 , 6 - dim ##eth ##yl ##phe ##nant ##hr ##o ( 1 , 2 - b ) fur ##an - 10 , 11 - di ##one ; tan ##shin ##one I ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27445383.13',\n",
    "  'test_set_idx': 6021,\n",
    "  'type': 'T007',\n",
    "  'name': 'D7632',\n",
    "  'context': \"[CLS] Associated Legion ##ella p ##ne ##um ##op ##hil ##a Is ##olate ##s We report here the complete genome sequences of three Legion ##ella p ##ne ##um ##op ##hil ##a is ##olate ##s that are associated with a Legion ##naire ##s ' disease outbreak in New York in 2012 . Two clinical is ##olate ##s ( D ##7 ##6 ##30 and [unused1] D ##7 ##6 ##32 [unused2] ) and one environmental is ##olate ( D ##7 ##6 ##31 ) were recovered from this outbreak . A single is ##olate - specific v ##ir ##ule ##nce gene was found in D ##7 ##6 ##32 . These is ##olate ##s were included in a large study evaluating the g ##eno ##mic resolution of various bio ##in ##formatics approaches for [SEP]\",\n",
    "  'existing_cui': 'C1826211',\n",
    "  'existing_cui_name': 'MIR632 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##6 ##32 gene [unused3] ( Ana ##tom ##ical Structure : h ##sa - mi ##r - 63 ##2 ; micro ##RNA 63 ##2 ) [SEP]',\n",
    "  'our_bi_cui': 'C0038410',\n",
    "  'our_bi_cui_name': 'Streptococcus pneumoniae',\n",
    "  'our_bi_cui_desc': '[CLS] St ##re ##pt ##oc ##oc ##cus pneumonia ##e [unused3] ( Ba ##cter ##ium , organism : P ##ne ##um ##oc ##oc ##cus ; s . pneumonia ##e ; Micro ##co ##cc ##us pneumonia ##e ; ST ##RE ##P ##TO ##CO ##CC ##US P ##NE ##UM ##ON ##IA ##E ; p ##ne ##um ##oc ##oc ##cal ; s ##tre ##pt ##oc ##oc ##cus pneumonia ##e ; St ##re ##pt ##oc ##oc ##cus ( Di ##p ##loc ##oc ##cus ) pneumonia ##e ; St ##re ##pt ##oc ##oc ##cus pneumonia ##e ( Klein 1884 ) Chester 1901 ; ST ##RE ##P P ##NE ##UM ##ON ##IA ##E ; s ##tre ##pt ##oc ##oc ##cus pneumonia ##e bacteria ; p ##ne ##um ##oc ##oc ##cus ; dip ##loc ##oc [SEP]',\n",
    "  'our_cross_cui': 'C0023238',\n",
    "  'our_cross_cui_name': 'Legionella pneumophila',\n",
    "  'our_cross_cui_desc': '[CLS] Legion ##ella p ##ne ##um ##op ##hil ##a [unused3] ( Ba ##cter ##ium , organism : leg ##ione ##lla p ##ne ##um ##op ##hil ##a ; leg ##ione ##lla p ##ne ##um ##op ##hil ##ia ; P ##ne ##um ##op ##hil ##a ; L ##EG ##ION ##EL ##LA P ##NE ##UM ##OP ##H ##IL ##A ; Legion ##ella p ##ne ##um ##op ##hil ##a B ##ren ##ner et al . 1979 ) [SEP]'},\n",
    " {'mention_id': '27601292.27',\n",
    "  'test_set_idx': 11202,\n",
    "  'type': 'T082',\n",
    "  'name': 'Groningen',\n",
    "  'context': '[CLS] via reduced clearance of the drug , resulting in higher v ##ori ##cona ##zo ##le t ##rough concentrations . To investigate prospective ##ly the influence of inflammation on v ##ori ##cona ##zo ##le metabolism and v ##ori ##cona ##zo ##le t ##rough con ##cent ratio n ##s . A prospective observation ##al study was performed at the University Medical Center [unused1] G ##ron ##ingen [unused2] . Pat ##ients were eligible for inclusion if they were ≥ 18 years old and treated with v ##ori ##cona ##zo ##le . V ##ori ##cona ##zo ##le and v ##ori ##cona ##zo ##le - N - oxide concentrations were determined in discarded blood samples . To determine the degree of inflammation , C - reactive protein concentrations were used . [SEP]',\n",
    "  'existing_cui': 'C1297262',\n",
    "  'existing_cui_name': 'Groningen horse',\n",
    "  'existing_cui_desc': '[CLS] G ##ron ##ingen horse [unused3] ( E ##uka ##ryo ##te , organism : G ##ron ##ingen horse breed ) [SEP]',\n",
    "  'our_bi_cui': 'C1297262',\n",
    "  'our_bi_cui_name': 'Groningen horse',\n",
    "  'our_bi_cui_desc': '[CLS] G ##ron ##ingen horse [unused3] ( E ##uka ##ryo ##te , organism : G ##ron ##ingen horse breed ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '28125734.1',\n",
    "  'test_set_idx': 26155,\n",
    "  'type': 'T103',\n",
    "  'name': 'MiR-21-5p',\n",
    "  'context': \"[CLS] I ##dent ##ification of [unused1] Mi ##R - 21 - 5 ##p [unused2] as a Fun ##ctional Reg ##ulator of Me ##so ##the ##lin Express ##ion Using Micro ##RNA Capt ##ure A ##ffin ##ity Co ##up ##led with Next Generation Se ##quencing Micro ##RNA ##s are small non - coding RNA ##s that regulate m ##RNA expression mainly by si ##len ##cing target trans ##cripts via binding to mi ##RNA recognition elements in the 3 ' un ##tra ##ns ##lated region . The identification of b ##ona fi ##de targets is challenging for researchers working on the functional aspect of Micro ##RNA ##s . Recently , we developed a method ( mi ##R - CA ##TC ##H ) based on bio ##tin ##yla ##ted DNA anti [SEP]\",\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1999986',\n",
    "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '27695680.17',\n",
    "  'test_set_idx': 14384,\n",
    "  'type': 'T033',\n",
    "  'name': 'non-FI-DELIS',\n",
    "  'context': '[CLS] ##OT ##S Ex ##pan ##sion through Local Initiative ##s to Stop T ##B areas , then compared the difference between the case not ##ification rates of the intervention year and the previous year in the for Inn ##ova ##tive D ##OT ##S Ex ##pan ##sion through Local Initiative ##s to Stop T ##B areas with those in the [unused1] non - F ##I - DE ##L ##IS [unused2] areas within the province . Results : There was an increase in the C ##NR in the intervention year compared with the previous year for all the project sites . The differences between the C ##NR in the intervention year and the previous year ranged from 6 . 4 to 31 . 1 per 100 000 population in [SEP]',\n",
    "  'existing_cui': 'C1121292',\n",
    "  'existing_cui_name': '5-Fluoroindole-3-acetic acid',\n",
    "  'existing_cui_desc': '[CLS] 5 - F ##lu ##oro ##ind ##ole - 3 - ace ##tic acid [unused3] ( Chemical : 5 - F ##I - AA ) [SEP]',\n",
    "  'our_bi_cui': 'C0282574',\n",
    "  'our_bi_cui_name': 'Intellectual Property',\n",
    "  'our_bi_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27760149.1',\n",
    "  'test_set_idx': 15788,\n",
    "  'type': 'T170',\n",
    "  'name': 'BEST',\n",
    "  'context': '[CLS] [unused1] B ##ES ##T [unused2] : Next - Generation B ##io ##medical En ##ti ##ty Search Too ##l for Knowledge Discovery from B ##io ##medical Literature As the volume of publications rapidly increases , searching for relevant information from the literature becomes more challenging . To complement standard search engines such as Pub ##M ##ed , it is desirable to have an advanced search tool that directly returns relevant bio ##medical entities such as targets , drugs , and mutations rather than a long list of articles . Some existing tools submit a que ##ry to Pub ##M ##ed and process retrieved abstract ##s to extract information at que ##ry time , resulting in a slow response time and limited coverage of only a fraction of [SEP]',\n",
    "  'existing_cui': 'C1826421',\n",
    "  'existing_cui_name': 'BEST1 gene',\n",
    "  'existing_cui_desc': '[CLS] B ##ES ##T ##1 gene [unused3] ( Ana ##tom ##ical Structure : B ##ES ##TR ##OP ##H ##IN 1 ; B ##ES ##T ; Best disease ; R ##P ##50 ; T ##U ##15 ##B ; B ##MD ; V ##MD ##2 GE ##NE ; best ##rop ##hin 1 ) [SEP]',\n",
    "  'our_bi_cui': 'C2348167',\n",
    "  'our_bi_cui_name': 'Search Engine',\n",
    "  'our_bi_cui_desc': '[CLS] Search Engine [unused3] ( Intel ##lect ##ual Product : Search Program ; Search engines ; Engine , Search ; Search Too ##l ; Search Engine ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28158248.35',\n",
    "  'test_set_idx': 27139,\n",
    "  'type': 'T170',\n",
    "  'name': 'ordinary differential equations',\n",
    "  'context': '[CLS] 7 of the 13 metabolic steps analyzed . Ad ##dition of information on en ##zy ##matic activities almost always improved the fitness of generalized add ##itive models built solely based on substrate concentrations . generalized add ##itive models were valid ##ated using experimental data that were not included when the model was built . In addition , a system of [unused1] ordinary differential equations [unused2] was developed to describe the instant ##aneous changes in meta ##bol ##ites as a function of the levels of en ##zy ##matic cat ##alytic activities . The results demonstrated the ability of the models to predict changes in the flux of meta ##bol ##ites in the Ju ##ven ##ile hormone pathway , and can be used in the future to design [SEP]',\n",
    "  'existing_cui': 'C0011906',\n",
    "  'existing_cui_name': 'Differential Diagnosis',\n",
    "  'existing_cui_desc': '[CLS] Different ##ial Di ##ag ##nosis [unused3] ( Health Care Act ##ivity , context ##ual qualifier , qualifier value : D ##IA ##G D ##IF ##F ##ER ##EN ##TI ##AL ; Di ##ag ##nose ##s , Different ##ial ; D ##IF ##F ##ER ##EN ##TI ##AL D ##IA ##G ; Di ##ag ##nosis , Different ##ial ; Different ##ial d ##x ; D ##IA ##G D ##IF ##F ##ER ; differential di ##ag ##nose ##s ; differential diagnosis ; Different ##ial diagnosis ( context ##ual qualifier ) ; Different ##ial Di ##ag ##nose ##s ; differential d ##x ; Different ##ial diagnosis ; D ##IF ##F ##ER D ##IA ##G ) [SEP]',\n",
    "  'our_bi_cui': 'C1705273',\n",
    "  'our_bi_cui_name': 'Mathematical Operator',\n",
    "  'our_bi_cui_desc': '[CLS] Mathematical Opera ##tor [unused3] ( Intel ##lect ##ual Product : Opera ##tor ; Fun ##ction ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28344199.22',\n",
    "  'test_set_idx': 32746,\n",
    "  'type': 'T017',\n",
    "  'name': 'CD14 ( + + ) CD16 ( - )',\n",
    "  'context': '[CLS] - slice multi ##det ##ector com ##puted to ##mo ##graphy in patients with stable an ##gin ##a p ##ector ##is . Method ##s and Results : We enrolled 65 patients with stable an ##gin ##a p ##ector ##is who underwent multi ##det ##ector com ##puted to ##mo ##graphy . Three mon ##oc ##yte subset ##s ( [unused1] CD ##14 ( + + ) CD ##16 ( - ) [unused2] , CD ##14 ( + + ) CD ##16 ( + ) , and CD ##14 ( + ) CD ##16 ( + ) ) and expression of To ##ll - like receptor 4 were measured by flow c ##yt ##ome ##try . In ##tra ##cor ##ona ##ry plaque ##s were assessed by 64 - slice multi [SEP]',\n",
    "  'existing_cui': 'C1367477',\n",
    "  'existing_cui_name': 'CD14 gene',\n",
    "  'existing_cui_desc': '[CLS] CD ##14 gene [unused3] ( Ana ##tom ##ical Structure : CD ##14 Mo ##le ##cule Gene ; M ##ON ##OC ##Y ##TE D ##IF ##F ##ER ##EN ##TI ##AT ##ION AN ##TI ##GE ##N CD ##14 ; CD ##14 Gene ; CD ##14 molecule ; M ##Y ##EL ##O ##ID CE ##LL - SP ##EC ##IF ##IC L ##E ##UC ##IN ##E - R ##IC ##H G ##L ##Y ##CO ##PR ##OT ##EI ##N ) [SEP]',\n",
    "  'our_bi_cui': 'C0108768',\n",
    "  'our_bi_cui_name': 'CD14 Antigen',\n",
    "  'our_bi_cui_desc': '[CLS] CD ##14 Anti ##gen [unused3] ( Chemical , substance : CD 01 ##4 AN ##TI ##GE ##NS ; Mon ##oc ##yte 2 ; CD ##14 receptor ; My ##elo ##id Cell - S ##pecific Le ##uc ##ine - Rich G ##ly ##co ##p ##rote ##in ; Anti ##gens , CD ##14 ; CD ##14 molecule ; R ##EC ##EP ##T L ##IP ##OP ##OL ##Y ##SA ##CC ##HA ##RI ##DE ; Anti ##gens , CD ##14 [ Chemical / In ##g ##red ##ient ] ; CD ##14 - C ##luster of differentiation anti ##gen 14 ; Le ##uk ##oc ##yte M ##3 ; My ##elo ##id 4 ; Li ##pop ##oly ##sa ##cc ##hari ##de Re ##ceptor ##s ; CD ##14 ; Li ##po ##gly ##can [SEP]',\n",
    "  'our_cross_cui': 'C0026473',\n",
    "  'our_cross_cui_name': 'Monocytes',\n",
    "  'our_cross_cui_desc': '[CLS] Mon ##ocytes [unused3] ( Ana ##tom ##ical Structure , cell : blood mon ##ocytes ; Blood mon ##ocytes ; Mon ##oc ##yte ; mon ##ocytes ; mon ##oc ##yte ; M ##ON ##OC ##Y ##TE ; mon ##oc ##ytic ) [SEP]'},\n",
    " {'mention_id': '28183116.7',\n",
    "  'test_set_idx': 27733,\n",
    "  'type': 'T170',\n",
    "  'name': 'paper',\n",
    "  'context': '[CLS] On the identity of the Pa ##lea ##rc ##tic species of the wolf spider genus < i > T ##re ##ba ##cos ##a < / i > ( Ara ##nea ##e : L ##y ##cos ##idae ) In this [unused1] paper [unused2] we propose T ##re ##ba ##cos ##a br ##un ##hes ##i Ville ##po ##ux , 2007 as a junior synonym of T ##re ##ba ##cos ##a euro ##pa ##ea S ##zine ##t ##á ##r & Ka ##n - c ##sal , 2007 based on the examination of specimens from all the localities from where those species are known . Il ##lus ##tration of the type species of the genus , T ##re ##ba ##cos ##a ma ##r ##xi ( Stone , 1890 ) and [SEP]',\n",
    "  'existing_cui': 'C0462999',\n",
    "  'existing_cui_name': 'Litmus paper',\n",
    "  'existing_cui_desc': '[CLS] Li ##t ##mus paper [unused3] ( Medical Devi ##ce , physical object : Li ##t ##mus Paper ; lit ##mus papers ; Re ##age ##nts , Clinical Chemistry , Rapid Test , pH , Strip ; IV ##D Test Re ##age ##nt / Kit ##s , Clinical Chemistry , Rapid Test , pH , Strip ; pH Strip In ##dic ##ators ; lit ##mus paper ) [SEP]',\n",
    "  'our_bi_cui': 'C0600659',\n",
    "  'our_bi_cui_name': 'Manuscripts',\n",
    "  'our_bi_cui_desc': '[CLS] Man ##us ##cripts [unused3] ( Intel ##lect ##ual Product : manuscript ; manuscripts ; Man ##us ##cript ) [SEP]',\n",
    "  'our_cross_cui': 'C1706852',\n",
    "  'our_cross_cui_name': 'Article',\n",
    "  'our_cross_cui_desc': '[CLS] Article [unused3] ( Intel ##lect ##ual Product ) [SEP]'},\n",
    " {'mention_id': '27932585.39',\n",
    "  'test_set_idx': 22266,\n",
    "  'type': 'T103',\n",
    "  'name': 'TYW3',\n",
    "  'context': '[CLS] ##tate and his ##ti ##dine , conserved in T ##Y ##W ##3 / Ta ##w ##3 , cluster to form the cat ##alytic center . These structural and sequence features indicate that T ##Y ##W ##3 / Ta ##w ##3 proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass ##ays combined with mass s ##pect ##rome ##try as well as l ##igan ##d dock ##ing and co ##fa ##ctor binding ass ##ays , we have identified the active site of [unused1] T ##Y ##W ##3 [unused2] and residues essential for co ##fa ##ctor binding and met ##hyl ##tra ##ns ##fer ##ase activity . [SEP]',\n",
    "  'existing_cui': 'C1823563',\n",
    "  'existing_cui_name': 'TYW3 gene',\n",
    "  'existing_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
    "  'our_bi_cui': 'C1823563',\n",
    "  'our_bi_cui_name': 'TYW3 gene',\n",
    "  'our_bi_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28442401.8',\n",
    "  'test_set_idx': 36180,\n",
    "  'type': 'T103',\n",
    "  'name': 'pseudokinase',\n",
    "  'context': '[CLS] T ##RI ##B ##3 down ##re ##gu ##lation enhance ##s do ##x ##or ##ubi ##cin - induced c ##yt ##oto ##xi ##city in gas ##tric cancer cells T ##RI ##B ##3 , which is a [unused1] pseudo ##kin ##ase [unused2] known to regulate multiple pro - survival pathways , appears to be a potential therapeutic target for the treatment of human tumors . However , its precise role in cancer is controversial , as T ##RI ##B ##3 protein levels have been associated with both good and poor pro ##gno ##sis in cancer patients . Here , we investigated the significance of T ##RI ##B ##3 expression in the survival of gas ##tric cancer cells exposed to anti ##can ##cer drugs . We found that the [SEP]',\n",
    "  'existing_cui': 'C3710669',\n",
    "  'existing_cui_name': 'ZED1 protein , Arabidopsis',\n",
    "  'existing_cui_desc': '[CLS] Z ##ED ##1 protein , Arab ##ido ##psis [unused3] ( Chemical : Z ##ED ##1 pseudo ##kin ##ase , Arab ##ido ##psis ) [SEP]',\n",
    "  'our_bi_cui': 'C0014442',\n",
    "  'our_bi_cui_name': 'Enzymes',\n",
    "  'our_bi_cui_desc': '[CLS] En ##zy ##mes [unused3] ( Chemical , medication , substance : enzymes ; enzyme ; En ##zy ##mes [ Chemical / In ##g ##red ##ient ] ; B ##io ##cat ##aly ##sts ; En ##zy ##me ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28389374.84',\n",
    "  'test_set_idx': 34086,\n",
    "  'type': 'T201',\n",
    "  'name': 'responsive',\n",
    "  'context': '[CLS] ( a dual p ##hos ##ph ##oi ##nos ##iti ##de 3 - kinase - ma ##mmal ##ian target of rap ##am ##y ##cin inhibitor ) , which induce ##s down ##re ##gu ##lation of BR ##CA ##1 . These observations suggest that BR ##CA ##1 associated protein ##1 does regulate DNA damage response and influences drug sensitivity . It might therefore be relevant to investigate whether patients with high expression of BR ##CA ##1 associated protein ##1 may be [unused1] re ##sp ##ons ##ive [unused2] to p ##oly ( ad ##eno ##sin ##e dip ##hos ##phate - rib ##ose ) polymer ##ase / p ##hos ##ph ##oi ##nos ##iti ##de 3 - kinase - ma ##mmal ##ian target of rap ##am ##y ##cin inhibitor ##s . [SEP]',\n",
    "  'existing_cui': 'C0237284',\n",
    "  'existing_cui_name': 'unresponsive behavior',\n",
    "  'existing_cui_desc': '[CLS] un ##res ##po ##ns ##ive behavior [unused3] ( Finding , finding : un ##res ##po ##ns ##ive ; Un ##res ##po ##ns ##ive ; Not Re ##sp ##ons ##ive ) [SEP]',\n",
    "  'our_bi_cui': 'C0683154',\n",
    "  'our_bi_cui_name': 'drug response',\n",
    "  'our_bi_cui_desc': '[CLS] drug response [unused3] ( B ##iol ##og ##ic Fun ##ction : response to drug ; drug responses ; drugs response ) [SEP]',\n",
    "  'our_cross_cui': 'C0521982',\n",
    "  'our_cross_cui_name': 'Response to treatment',\n",
    "  'our_cross_cui_desc': '[CLS] Response to treatment [unused3] ( Clinical At ##tri ##but ##e , context - dependent category , finding , function , o ##bs ##er ##vable entity , situation : response to treatment ; response treatments ; The ##rap ##eu ##tic response ; response therapeutic ; The ##rap ##eu ##tic Response ; Finding related to therapeutic response ; successful treatment ; successful treatments ; The ##rap ##eu ##tic response , function ) [SEP]'},\n",
    " {'mention_id': '27460285.31',\n",
    "  'test_set_idx': 6603,\n",
    "  'type': 'T037',\n",
    "  'name': 'injuries',\n",
    "  'context': '[CLS] ##ic injuries . Em ##pha ##sis is placed on multi ##det ##ector CT , which represents the ideal m ##oda ##lity to comprehensive ##ly visual ##ize the operated groin region and deeper in ##tra - abdominal structures . CT consistently depicts se ##roma , mesh infections , hem ##or ##r ##hage ##s , bow ##el complications and u ##rina ##ry bladder [unused1] injuries [unused2] , and thus generally provides a consistent basis for therapeutic choice . Since radio ##logists are increasingly requested to investigate suspected i ##at ##rogen ##ic complications , this paper aims to provide an increased familiar ##ity with early CT studies after In ##guin ##al her ##nia repair , including complications and normal post ##oper ##ative appearances such as focal pseudo ##les ##ions [SEP]',\n",
    "  'existing_cui': 'C0005604',\n",
    "  'existing_cui_name': 'Birth Injuries',\n",
    "  'existing_cui_desc': '[CLS] Birth In ##ju ##ries [unused3] ( In ##ju ##ry or Po ##ison ##ing , Birth , diagnosis , disorder : In ##ju ##ries , Birth ; T ##ra ##umatic birth ; injury birth ; Birth trauma , un ##sp ##ec ##ified ; Birth T ##ra ##uma ; Birth trauma of f ##etus ; injury ; birth ; traumatic birth ; birth trauma ; birth injuries ; Birth In ##ju ##ry ; trauma birth ; Neo ##nat ##al Birth In ##ju ##ry ; birth ##ing injuries ; Birth In ##ju ##ries [ Disease / Finding ] ; Un ##sp ##ec ##ified birth trauma ; birth ##ing trauma ; B ##IR ##TH IN ##J ; IN ##J B ##IR ##TH ; Birth injuries ; birth ; injury ; [SEP]',\n",
    "  'our_bi_cui': 'C3263723',\n",
    "  'our_bi_cui_name': 'Traumatic injury',\n",
    "  'our_bi_cui_desc': '[CLS] T ##ra ##umatic injury [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder : IN ##J ; In ##ju ##ry , un ##sp ##ec ##ified ; wound ; trauma ; T ##ra ##umatic In ##ju ##ry ; W ##ou ##nd ; injury from an external force ; injuries ; injury ; In ##ju ##ries ; T ##ra ##uma ; In ##ju ##ry ; In ##ju ##ry - disorder ; Un ##sp ##ec ##ified injury ) [SEP]',\n",
    "  'our_cross_cui': 'C0403677',\n",
    "  'our_cross_cui_name': 'Injury of bladder',\n",
    "  'our_cross_cui_desc': '[CLS] In ##ju ##ry of bladder [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder : bladder injuries ; Un ##sp ##ec ##ified injury of bladder ; injury ; bladder ; B ##lad ##der injury ; bladder injury ; injury bladder ; In ##ju ##ry of bladder , un ##sp ##ec ##ified ; bladder ; injury ; B ##lad ##der In ##ju ##ry ) [SEP]'},\n",
    " {'mention_id': '27882444.22',\n",
    "  'test_set_idx': 20505,\n",
    "  'type': 'T038',\n",
    "  'name': \"gene arrangement 3 ' - NP-P-M-F-HN-L-5 '\",\n",
    "  'context': \"[CLS] - 01 / CH / 15 , was isolated from a great spotted wood ##pec ##ker in the northwest region of China in 2015 . The complete genome was sequence ##d , and the results showed that the virus genome was 15 , 192 n ##t in length , in the [unused1] gene arrangement 3 ' - N ##P - P - M - F - H ##N - L - 5 ' [unused2] . Several amino acid mutations were identified in the functional domains of the F and H ##N proteins . The path ##ogenic ##ity index of the is ##olate was evaluated , and the mean death time was 72 h and the in ##tra ##cer ##eb ##ral path ##ogenic ##ity index was 0 [SEP]\",\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C1517495',\n",
    "  'our_bi_cui_name': 'Gene Feature',\n",
    "  'our_bi_cui_desc': '[CLS] Gene Feature [unused3] ( Ana ##tom ##ical Structure : Gene Organization ; Gene Structure ; Se ##q Feature ; Se ##quence Feature ; Gene Structure / Organization ) [SEP]',\n",
    "  'our_cross_cui': 'C0887940',\n",
    "  'our_cross_cui_name': 'Gene Order',\n",
    "  'our_cross_cui_desc': '[CLS] Gene Order [unused3] ( B ##iol ##og ##ic Fun ##ction : Po ##si ##tions , Gene ; A ##rra ##nge ##ments , Gene ; Po ##si ##tion , Gene ; A ##rra ##nge ##ment , Gene ; Gene A ##rra ##nge ##ment ; Gene Po ##si ##tions ; Gene Po ##si ##tion ; Gene A ##rra ##nge ##ments ; Order , Gene ) [SEP]'},\n",
    " {'mention_id': '27286118.9',\n",
    "  'test_set_idx': 1441,\n",
    "  'type': 'T033',\n",
    "  'name': 'no prostatitis',\n",
    "  'context': '[CLS] ##to ##logical pro ##sta ##titis and lower u ##rina ##ry tract symptoms and sexual function This prospective analysis assessed the effect of his ##to ##logical pro ##sta ##titis on lower u ##rina ##ry tract functions and sexual function . The patients were separated into two groups as his ##to ##logical ##ly observed pro ##sta ##titis ( Group A ) and [unused1] no pro ##sta ##titis [unused2] ( Group B ) according to the bio ##psy outcomes . International pro ##state s ##ym ##pt ##om score , international index of erect ##ile function - 5 scores , ma ##ximal and average flow rate , and residual urine volumes were compared statistical ##ly between groups . There was no significant difference ( P > 0 . 05 ) [SEP]',\n",
    "  'existing_cui': 'C0033581',\n",
    "  'existing_cui_name': 'prostatitis',\n",
    "  'existing_cui_desc': '[CLS] pro ##sta ##titis [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Pro ##sta ##titis ; pro ##state inflammation ; In ##f ##lam ##mat ##ory diseases of pro ##state ; Pro ##sta ##titis , un ##sp ##ec ##ified ; Pro ##state inflammatory diseases ; Pro ##sta ##titis [ Disease / Finding ] ; In ##f ##lam ##mation of pro ##state ; In ##f ##lam ##mation of the pro ##state ; In ##f ##lam ##mat ##ory disease of pro ##state , un ##sp ##ec ##ified ; inflammation ; pro ##state ; Pro ##static inflammatory disease ; pro ##state ; inflammation ; Pro ##sta ##ti ##tide ##s ) [SEP]',\n",
    "  'our_bi_cui': 'C0497153',\n",
    "  'our_bi_cui_name': 'No disease',\n",
    "  'our_bi_cui_desc': '[CLS] No disease [unused3] ( Finding : Disease ; none ; no disease ; A ##bs ##ence ( of ) ; disease ; absence of disease ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27826436.55',\n",
    "  'test_set_idx': 18385,\n",
    "  'type': 'T204',\n",
    "  'name': 'cultivars',\n",
    "  'context': '[CLS] The content of as ##cor ##bic acid of c ##v . To ##chi ##oto ##me was higher than the others , but there was no significant difference in cult ##iva ##rs of Ben ##ih ##op ##pe , To ##chi ##oto ##me , and Sa ##chin ##oka . Fr ##uc ##tos ##e and glucose were the major sugar ##s in all [unused1] cult ##iva ##rs [unused2] . C ##it ##ric acid was the major organic acid in c ##v . To ##chi ##oto ##me , c ##v . Sa ##chin ##oka , and c ##v . G ##ui ##mei ##ren . To ##chi ##oto ##me had higher ratios of T ##SS / T ##A and total sugar ##s / total organic acids than others , arising from [SEP]',\n",
    "  'existing_cui': 'C3385047',\n",
    "  'existing_cui_name': 'Brassia hybrid cultivar',\n",
    "  'existing_cui_desc': '[CLS] Brass ##ia hybrid cult ##iva ##r [unused3] ( E ##uka ##ryo ##te : Ada hybrid cult ##iva ##r ) [SEP]',\n",
    "  'our_bi_cui': 'C0242775',\n",
    "  'our_bi_cui_name': 'Agricultural Crops',\n",
    "  'our_bi_cui_desc': '[CLS] Agricultural C ##rops [unused3] ( E ##uka ##ryo ##te : C ##rops , Agricultural ; C ##rops ; Agricultural C ##rop ) [SEP]',\n",
    "  'our_cross_cui': 'C0032098',\n",
    "  'our_cross_cui_name': 'Plants',\n",
    "  'our_cross_cui_desc': '[CLS] Plants [unused3] ( E ##uka ##ryo ##te , organism : Ch ##lor ##op ##hy ##ta / Em ##b ##ryo ##phy ##ta group ; green plants ; Ch ##lor ##ob ##ion ##ta ; Ch ##lor ##ob ##ion ##ta B ##rem ##er , 1985 ; V ##iri ##di ##p ##lant ##ae ; Plants , General ; Kingdom Plant ##ae ; V ##iri ##di ##p ##lant ##ae C ##ava ##lier - Smith , 1981 ; plants ; Kingdom V ##iri ##di ##p ##lant ##ae ; plant ; ch ##lor ##op ##hy ##te / em ##b ##ryo ##phy ##te group ; Plant ) [SEP]'},\n",
    " {'mention_id': '28197156.20',\n",
    "  'test_set_idx': 28090,\n",
    "  'type': 'T103',\n",
    "  'name': 'OsHAP3',\n",
    "  'context': '[CLS] study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial cult ##iva ##r . Fine mapping suggested that Carbon As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( [unused1] O ##s ##HA ##P ##3 [unused2] ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 b ##p from the start co ##don , resulting [SEP]',\n",
    "  'existing_cui': 'C1427162',\n",
    "  'existing_cui_name': 'THAP3 gene',\n",
    "  'existing_cui_desc': '[CLS] T ##HA ##P ##3 gene [unused3] ( Ana ##tom ##ical Structure : T ##HA ##P domain containing , a ##pop ##tosis associated protein 3 ; T ##HA ##P D ##OM ##A ##IN - CO ##NT ##A ##IN ##ING PR ##OT ##EI ##N 3 ) [SEP]',\n",
    "  'our_bi_cui': 'C1722024',\n",
    "  'our_bi_cui_name': 'HO3 protein , Arabidopsis',\n",
    "  'our_bi_cui_desc': '[CLS] H ##O ##3 protein , Arab ##ido ##psis [unused3] ( Chemical : hem ##e oxygen ##ase 3 , Arab ##ido ##psis ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28203549.82',\n",
    "  'test_set_idx': 28274,\n",
    "  'type': 'T170',\n",
    "  'name': 'ST',\n",
    "  'context': '[CLS] ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s with K ##1 , K ##2 , K ##5 , K ##20 , and K ##5 ##7 ( 27 . 5 % , 19 / 69 ) and was only found among K ##1 is ##olate ##s . ST ##65 was the second most prevalent [unused1] ST [unused2] ( 26 . 1 % , 18 / 69 ) and was also only found among K ##2 is ##olate ##s . ST ##23 - K ##1 h ##yper ##mu ##co ##vis ##co ##us K ##le ##bs ##iel ##la pneumonia ##e is ##olate ##s ( 84 . 2 % , 16 / 19 ) were associated with p ##yo ##genic liver a [SEP]',\n",
    "  'existing_cui': 'C0036183',\n",
    "  'existing_cui_name': 'Sao Tome and Principe',\n",
    "  'existing_cui_desc': '[CLS] Sa ##o Tom ##e and P ##rin ##ci ##pe [unused3] ( Spa ##tial Concept , geographic location : SA ##O TO ##ME AND PR ##IN ##CI ##P ##E ; São Tom ##é and P ##r ##ín ##ci ##pe ) [SEP]',\n",
    "  'our_bi_cui': 'C0887835',\n",
    "  'our_bi_cui_name': 'Ribotype',\n",
    "  'our_bi_cui_desc': '[CLS] R ##ib ##otype [unused3] ( Finding : R ##ib ##otype ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0449943',\n",
    "  'our_cross_cui_name': 'Serotype',\n",
    "  'our_cross_cui_desc': '[CLS] Ser ##otype [unused3] ( Intel ##lect ##ual Product , attribute , o ##bs ##er ##vable entity , qualifier value : se ##rov ##ar ; se ##rov ##ars ; Ser ##ova ##rs ; se ##rot ##ype ; se ##rot ##ype ##s ; Ser ##otype ##s ; Ser ##ova ##r ) [SEP]'},\n",
    " {'mention_id': '28289065.41',\n",
    "  'test_set_idx': 31384,\n",
    "  'type': 'T058',\n",
    "  'name': 'RP',\n",
    "  'context': '[CLS] re ##cu ##rrence within G ##lea ##son Grade Groups based on either bio ##psy or pro ##state ##ct ##omy scoring . Multi ##var ##iate analysis further confirmed that a higher Grade Groups was significantly associated with risk of bio ##chemical re ##cu ##rrence . This Grade Groups system had a higher pro ##gno ##stic discrimination for both initial bio ##psy and [unused1] R ##P [unused2] than G ##lea ##son score . Our study valid ##ates the use of the revised and updated Grade Groups system in a mixed - ethnicity population of Asian men . Higher Grade Groups was significantly associated with increased risk of bio ##chemical re ##cu ##rrence . We therefore recommend its use to inform clinical management for patients with pro ##state cancer [SEP]',\n",
    "  'existing_cui': 'C1538326',\n",
    "  'existing_cui_name': 'BLOC1S3 gene',\n",
    "  'existing_cui_desc': '[CLS] B ##L ##OC ##1 ##S ##3 gene [unused3] ( Ana ##tom ##ical Structure : B ##io ##genesis of L ##ys ##oso ##me - related Organ ##elles complex - 1 Sub ##uni ##t 3 ; Herman ##sky - P ##ud ##lak syndrome 8 ; HP ##S ##8 GE ##NE ; R ##ED ##UC ##ED P ##IG ##ME ##NT ##AT ##ION , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; B ##IO ##GE ##NE ##SI ##S OF L ##Y ##SO ##SO ##ME - R ##EL ##AT ##ED OR ##GA ##NE ##LL ##ES CO ##MP ##LE ##X 1 , S ##U ##B ##UN ##IT 3 ; bio ##genesis of l ##ys ##oso ##mal organ ##elles complex 1 subunit 3 ; B ##L ##OC - 1 [SEP]',\n",
    "  'our_bi_cui': 'C0033573',\n",
    "  'our_bi_cui_name': 'Prostatectomy',\n",
    "  'our_bi_cui_desc': '[CLS] Pro ##state ##ct ##omy [unused3] ( Health Care Act ##ivity , procedure , treatment : pro ##state re ##section ; Ex ##cision Pro ##ced ##ures on the Pro ##state ; pro ##state ##ct ##omy ; g ##eni ##to - u ##rina ##ry tract surgery pro ##state ##ct ##omy ; pro ##state re ##section ##s ; Pro ##state ##ct ##omi ##es ; pro ##state ##ct ##omi ##es ; Me ##d : Pro ##state ##ct ##omy ; surgical removal of the pro ##state ; pro ##state re ##section ##ing ; Pro ##state ex ##cision ) [SEP]',\n",
    "  'our_cross_cui': 'C0194810',\n",
    "  'our_cross_cui_name': 'Radical prostatectomy',\n",
    "  'our_cross_cui_desc': '[CLS] Radical pro ##state ##ct ##omy [unused3] ( Health Care Act ##ivity , procedure , treatment : pro ##state ##ct ##omy radical ; radical pro ##state ##ct ##omy ; Total pro ##state ##ct ##omy ; Pro ##sta ##tov ##esi ##cule ##ct ##omy ; total pro ##state ##ct ##omy ; Radical pro ##state ##ct ##omy by any approach ; Radical Pro ##state ##ct ##omy ; pro ##state ##ct ##omi ##es radical ) [SEP]'},\n",
    " {'mention_id': '27812530.11',\n",
    "  'test_set_idx': 18001,\n",
    "  'type': 'T103',\n",
    "  'name': \"material 's\",\n",
    "  'context': \"[CLS] for En ##han ##cing A ##pp ##lica ##bility in V ##ert ##eb ##rop ##last ##y Pol ##yme ##thy ##lm ##eth ##ac ##ryl ##ate bone cement is a popular bone void fill ##er for ve ##rte ##bro ##p ##last ##y . However , the use of Pol ##yme ##thy ##lm ##eth ##ac ##ryl ##ate has some draw ##backs , including the [unused1] material ' s [unused2] excessive stiff ##ness , ex ##oth ##er ##mic polymer ##ization , and short handling time . This study aimed to create an ideal modified bone cement to solve the above - mentioned problems . Mo ##dified bone cement ##s were prepared by combining Pol ##yme ##thy ##lm ##eth ##ac ##ryl ##ate with three different volume fraction ##s of cast ##or oil [SEP]\",\n",
    "  'existing_cui': 'C2986060',\n",
    "  'existing_cui_name': 'Material Form Code',\n",
    "  'existing_cui_desc': '[CLS] Material Form Code [unused3] ( Intel ##lect ##ual Product : Material . form ##C ##ode ) [SEP]',\n",
    "  'our_bi_cui': 'C0032521',\n",
    "  'our_bi_cui_name': 'Polymers',\n",
    "  'our_bi_cui_desc': '[CLS] Pol ##yme ##rs [unused3] ( Chemical , substance : Pol ##yme ##ric ; Pol ##yme ##ric Mac ##rom ##ole ##cule ##s ; Pol ##yme ##r ; P ##OL ##Y ##ME ##R S ##U ##BS ##TA ##NC ##E ; Pol ##yme ##rs [ Chemical / In ##g ##red ##ient ] ; polymer ; polymer ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0005479',\n",
    "  'our_cross_cui_name': 'Biomaterials',\n",
    "  'our_cross_cui_desc': '[CLS] B ##io ##mate ##rial ##s [unused3] ( Chemical : B ##io ##mate ##rial ; bio ##com ##pa ##tible materials ; B ##io ##medical Material ; bio ##mate ##rial ##s ; B ##io ##medical materials ; B ##io ##com ##pa ##tible Materials ; bio ##medical materials ; bio ##mate ##rial ; Materials , B ##io ##com ##pa ##tible ; bio ##medical material ; B ##io ##com ##pa ##tible Materials [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
    " {'mention_id': '28441489.37',\n",
    "  'test_set_idx': 36159,\n",
    "  'type': 'T033',\n",
    "  'name': 'Cold - start',\n",
    "  'context': '[CLS] composition of the volatile organic compounds emissions between Port Fuel In ##jection and G ##DI ##s , including ben ##zen ##e , to ##lue ##ne , et ##hyl ##ben ##zen ##e , and x ##yle ##nes . Therefore , the secondary organic a ##ero ##sol and oz ##one formation potential of the exhaust does not depend on engine technology . [unused1] Cold - start [unused2] contributes a larger fraction of the total unified cycle emissions for vehicles meeting more - string ##ent emission standards . Organic gas emissions were the most sensitive to cold - start compared to the other poll ##uta ##nts tested here . There were no statistical ##ly significant differences in the effects of cold - start on G ##DI ##s and P [SEP]',\n",
    "  'existing_cui': 'C0452588',\n",
    "  'existing_cui_name': 'Start brand of breakfast cereal',\n",
    "  'existing_cui_desc': '[CLS] Start brand of breakfast cereal [unused3] ( Food , substance : Start ) [SEP]',\n",
    "  'our_bi_cui': 'C1455171',\n",
    "  'our_bi_cui_name': 'Cool-X-A',\n",
    "  'our_bi_cui_desc': '[CLS] Cool - X - A [unused3] ( Chemical : Cool - Cool ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27482869.9',\n",
    "  'test_set_idx': 7902,\n",
    "  'type': 'T082',\n",
    "  'name': 'Chapel Hill',\n",
    "  'context': \"[CLS] on 30 September 1946 in Columbus , OH . He studied medicine at the University of Michigan , graduated in 1973 , and after a rotating internship , he completed a master ' s degree in maternal and child health ( 1976 ) and a PhD in e ##pid ##em ##iology ( 1979 ) at the University of North Carolina in [unused1] Chapel Hill [unused2] . After graduation , he went to work at the National Institute of Environmental Health Sciences ( National Institute of Environmental Health Sciences , one of the US National Institutes of Health ) in Durham , NC , where he has spent his career . He developed a research program in reproductive and per ##ina ##tal e ##pid ##em ##iology , [SEP]\",\n",
    "  'existing_cui': 'C0313304',\n",
    "  'existing_cui_name': 'hemoglobin Chapel Hill',\n",
    "  'existing_cui_desc': '[CLS] hem ##og ##lo ##bin Chapel Hill [unused3] ( Chemical , substance : Ha ##em ##og ##lo ##bin Chapel Hill ; H ##b Chapel Hill ; He ##mo ##g ##lo ##bin Chapel Hill ; H ##b 74 ( E ##F ##3 ) , As ##p - g ##ly ) [SEP]',\n",
    "  'our_bi_cui': 'C0313304',\n",
    "  'our_bi_cui_name': 'hemoglobin Chapel Hill',\n",
    "  'our_bi_cui_desc': '[CLS] hem ##og ##lo ##bin Chapel Hill [unused3] ( Chemical , substance : Ha ##em ##og ##lo ##bin Chapel Hill ; H ##b Chapel Hill ; He ##mo ##g ##lo ##bin Chapel Hill ; H ##b 74 ( E ##F ##3 ) , As ##p - g ##ly ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '28271342.55',\n",
    "  'test_set_idx': 30732,\n",
    "  'type': 'T092',\n",
    "  'name': 'European Society for Medical Oncology',\n",
    "  'context': '[CLS] 159 cancer ##s at Ra or R ##b were located within 12 cm from the anal verge by rigid pro ##ct ##os ##copy , while only 79 . 7 % of Ra or 82 . 1 % of R ##b cancer ##s were located in the mid ( 5 . 1 - 10 cm ) or low ( ≤ 5 cm ) re ##ct ##um , respectively . Ra and R ##b cancer ##s are deemed to be re ##ct ##al cancer ##s according to National Comprehensive Cancer Network guidelines , but these classification ##s are not interchange ##able with mid - and low - re ##ct ##al cancer ##s , respectively , according to the [unused1] European Society for Medical On ##cology [unused2] guidelines . [SEP]',\n",
    "  'existing_cui': 'C0025098',\n",
    "  'existing_cui_name': 'Medical oncology specialty',\n",
    "  'existing_cui_desc': '[CLS] Medical on ##cology specialty [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line , qualifier value : ME ##D ON ##CO ##L ; medical on ##cology ; On ##cology , Medical ; on ##cology medical ; ON ##CO ##L ME ##D ; Medical On ##cology ; Medical on ##cology ) [SEP]',\n",
    "  'our_bi_cui': 'C0037459',\n",
    "  'our_bi_cui_name': 'Societies , Medical',\n",
    "  'our_bi_cui_desc': '[CLS] Societies , Medical [unused3] ( Organization : Medical Society ; medical societies ; Society , Medical ; medical society ; S ##OC ##IE ##TY ME ##D ; Medical Societies ; ME ##D S ##OC ##IE ##TI ##ES ; S ##OC ##IE ##TI ##ES ME ##D ; ME ##D S ##OC ##IE ##TY ) [SEP]',\n",
    "  'our_cross_cui': 'C1708333',\n",
    "  'our_cross_cui_name': 'Health Care Organization',\n",
    "  'our_cross_cui_desc': '[CLS] Health Care Organization [unused3] ( Organization : Healthcare Organization ) [SEP]'},\n",
    " {'mention_id': '27526663.53',\n",
    "  'test_set_idx': 9493,\n",
    "  'type': 'T204',\n",
    "  'name': 'B. cinerea',\n",
    "  'context': '[CLS] to the j ##as ##mon ##ic acid defence pathway . We found that Pro ##D ##H1 and Pro ##D ##H ##2 are both necessary to achieve maximum resistance against P ##st - A ##v ##r ##R ##pm ##1 and B . c ##iner ##ea . However , Pro ##D ##H ##2 has a major effect on early restriction of [unused1] B . c ##iner ##ea [unused2] growth . Interest ##ingly , Pro ##D ##H1 is up - regulated by sa ##lic ##yl ##ic acid and j ##as ##mon ##ic acid , whereas Pro ##D ##H ##2 is only activated by j ##as ##mon ##ic acid , and both genes display transcription ##al inter - regulation at basal and infection conditions . These studies provide the first [SEP]',\n",
    "  'existing_cui': 'C0326708',\n",
    "  'existing_cui_name': 'Callaeas cinereus',\n",
    "  'existing_cui_desc': '[CLS] Call ##ae ##as c ##iner ##eus [unused3] ( E ##uka ##ryo ##te , organism : Call ##ae ##as c ##iner ##eus ( G ##mel ##in , J ##F , 1788 ) ; G ##lau ##co ##pis c ##iner ##ea c ##iner ##ea ; Watt ##led crow ; Ko ##ka ##ko ; k ##oka ##ko ; Call ##ae ##as c ##iner ##ea ) [SEP]',\n",
    "  'our_bi_cui': 'C0317886',\n",
    "  'our_bi_cui_name': 'Neisseria cinerea',\n",
    "  'our_bi_cui_desc': '[CLS] N ##ei ##sser ##ia c ##iner ##ea [unused3] ( Ba ##cter ##ium , organism : N ##ei ##sser ##ia c ##iner ##ea ( von Ling ##els ##heim 1906 ) Murray 1939 ; Micro ##co ##cc ##us c ##iner ##eus ; NE ##IS ##SE ##RI ##A C ##IN ##ER ##EA ) [SEP]',\n",
    "  'our_cross_cui': 'C0579190',\n",
    "  'our_cross_cui_name': 'Botrytis cinerea',\n",
    "  'our_cross_cui_desc': '[CLS] Bo ##try ##tis c ##iner ##ea [unused3] ( E ##uka ##ryo ##te , organism : Sc ##ler ##ot ##inia fuck ##eli ##ana ) [SEP]'},\n",
    " {'mention_id': '27838742.32',\n",
    "  'test_set_idx': 18999,\n",
    "  'type': 'T103',\n",
    "  'name': 'delicaflavone',\n",
    "  'context': '[CLS] in male BA ##L ##B / c nude mice without o ##bs ##er ##vable adverse effect . By transmission electron micro ##sco ##py with a ##c ##rid ##ine orange and Cy ##to - ID ® Auto ##pha ##gy detection dye ##s , Western b ##lot analysis , and R ##T - PC ##R ass ##ay , we confirmed that [unused1] del ##ica ##f ##lav ##one [unused2] induce ##s auto ##pha ##gic cell death by increasing the ratio of L ##C ##3 - II to L ##C ##3 - I , which are auto ##pha ##gy - related proteins , and promoting the generation of acidic ve ##si ##cular organ ##elles and auto ##ly ##so ##some ##s in the c ##yt ##op ##las ##m of human lung [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0529351',\n",
    "  'our_bi_cui_name': 'darifenacin',\n",
    "  'our_bi_cui_desc': '[CLS] da ##ri ##fen ##ac ##in [unused3] ( Chemical , medication , product , substance : Dar ##ife ##nac ##in ##um ; ( S ) - 1 - ( 2 - ( 2 , 3 - di ##hy ##dr ##o - 5 - Benz ##of ##ura ##ny ##l ) et ##hyl ) - alpha , alpha - dip ##hen ##yl - 3 - p ##yr ##rol ##id ##ine ##ace ##tam ##ide ; Dar ##ife ##nac ##in ; ( S ) - 1 - ( 2 - ( 2 , 3 - di ##hy ##dr ##o - 5 - ben ##zo ##fu ##ran ##yl ) et ##hyl ) - alpha , alpha - dip ##hen ##yl - 3 - p ##yr ##rol ##id ##ine ##ace ##tam ##ide ; [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27475696.21',\n",
    "  'test_set_idx': 7484,\n",
    "  'type': 'T038',\n",
    "  'name': 'OSCCs',\n",
    "  'context': '[CLS] normal oral m ##uc ##osa ( n = 5 ) , oral precursor lesions ( simple h ##yper ##p ##lasia , n = 11 ; sq ##ua ##mous in ##tra ##ep ##ith ##eli ##al neo ##p ##lasia , S ##IN I - III , n = 35 ) , and oral sq ##ua ##mous cell car ##cin ##oma specimen . [unused1] OS ##CC ##s [unused2] were s ##tra ##ti ##fied in a young female ( n = 7 ) study co ##hor ##t and older patients ( n = 46 ) . In the young female study co ##hor ##t three patients ( n = 3 / 7 ) developed oral sq ##ua ##mous cell car ##cin ##oma during or shortly after pregnancy . B ##rea [SEP]',\n",
    "  'existing_cui': 'C1416926',\n",
    "  'existing_cui_name': 'LSS gene',\n",
    "  'existing_cui_desc': '[CLS] L ##SS gene [unused3] ( Ana ##tom ##ical Structure : LA ##N ##OS ##TE ##RO ##L S ##Y ##NT ##HA ##SE ; 2 , 3 - O ##X ##ID ##OS ##Q ##U ##AL ##EN ##E - LA ##N ##OS ##TE ##RO ##L C ##Y ##CL ##AS ##E ; la ##nos ##tero ##l s ##ynth ##ase ( 2 , 3 - o ##xi ##dos ##qua ##lene - la ##nos ##tero ##l c ##y ##c ##lase ) ) [SEP]',\n",
    "  'our_bi_cui': 'C0151546',\n",
    "  'our_bi_cui_name': 'Oral Cavity Carcinoma',\n",
    "  'our_bi_cui_desc': '[CLS] Oral C ##avi ##ty Car ##cin ##oma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis : Oral car ##cin ##oma ##s ; Oral car ##cin ##oma ; Mouth Car ##cin ##oma ; car ##cin ##oma oral ; Car ##cin ##oma mouth ; oral cavity cancer ; Mouth car ##cin ##oma ; car ##cin ##oma ##s oral ; car ##cin ##oma cavity oral ; Car ##cin ##oma of Oral C ##avi ##ty ; oral car ##cin ##oma ; Car ##cin ##oma of Mouth ; Car ##cin ##oma of the Oral C ##avi ##ty ; Car ##cin ##oma of mouth ; car ##cin ##oma of oral cavity ) [SEP]',\n",
    "  'our_cross_cui': 'C0585362',\n",
    "  'our_cross_cui_name': 'Squamous cell carcinoma of mouth',\n",
    "  'our_cross_cui_desc': '[CLS] S ##qua ##mous cell car ##cin ##oma of mouth [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder : Oral C ##avi ##ty S ##qua ##mous Cell Car ##cin ##oma ; Mouth SC ##C ; sq ##ua ##mous cell car ##cin ##oma of mouth ; sq ##ua ##mous cell car ##cin ##oma mouth ; SC ##C of Mouth ; car ##cin ##oma cell mouth sq ##ua ##mous ; S ##qua ##mous cell car ##cin ##oma of the oral cavity ; S ##qua ##mous Cell Car ##cin ##oma of the Oral C ##avi ##ty ; SC ##C of the Mouth ; Oral C ##avi ##ty SC ##C ; SC ##C of Oral C ##avi ##ty ; Mouth S ##qua ##mous Cell Car ##cin ##oma [SEP]'},\n",
    " {'mention_id': '27920749.46',\n",
    "  'test_set_idx': 21883,\n",
    "  'type': 'T170',\n",
    "  'name': 'emotionally negative film clip',\n",
    "  'context': \"[CLS] healthy young men and women participated . Part ##ici ##pants ' trait re ##ap ##pra ##isa ##l and suppression as well as state and trait anxiety were assessed . A dot - probe task was completed by all participants . Statistical tests in Study 1 revealed that participants who re ##ap ##pra ##ised to decrease negative emotions while viewing an [unused1] emotionally negative film clip [unused2] had reduced attention ##al bias to subsequently presented angry faces compared to participants who re ##ap ##pra ##ised to increase negative emotions . Multiple re ##gression analyses in Study 2 revealed that trait re ##ap ##pra ##isa ##l predicted slower or ##ient ##ing toward angry faces , whereas state anxiety predicted slower di ##sen ##ga ##gement from angry faces . [SEP]\",\n",
    "  'existing_cui': 'C0558263',\n",
    "  'existing_cui_name': 'Emotionally distant',\n",
    "  'existing_cui_desc': '[CLS] Em ##otion ##ally distant [unused3] ( Finding , finding : Em ##otion ##ally al ##oof ) [SEP]',\n",
    "  'our_bi_cui': 'C3463807',\n",
    "  'our_bi_cui_name': 'Video Media',\n",
    "  'our_bi_cui_desc': '[CLS] Video Media [unused3] ( Intel ##lect ##ual Product : Video ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27621200.3',\n",
    "  'test_set_idx': 12035,\n",
    "  'type': 'T038',\n",
    "  'name': 'kindness',\n",
    "  'context': '[CLS] A pilot study exploring the relationship between self - compassion , self - judgement , self - [unused1] kindness [unused2] , compassion , professional quality of life and well ##bei ##ng among UK community nurses Co ##mp ##ass ##ion fatigue and burn ##out can impact on performance of nurses . This paper explores the relationship between self - compassion , self - judgement , self - kindness , compassion , professional quality of life , and well ##bei ##ng among community nurses . To measure associations between self - compassion , compassion fatigue , well ##bei ##ng , and burn ##out in community nurses . Q ##uant ##itative data were collected using standard ##ised ps ##ych ##ometric question ##naire ##s : ( 1 ) Professional Quality [SEP]',\n",
    "  'existing_cui': 'C0456909',\n",
    "  'existing_cui_name': 'Blind Vision',\n",
    "  'existing_cui_desc': '[CLS] Blind Vision [unused3] ( Finding , finding : Blind ##ness ; blind vision ; Unable to see ; Blind ##ness [ Disease / Finding ] ; Can not see ; Blind ; blind ##ness ; U ##TS - Unable to see ; blind ) [SEP]',\n",
    "  'our_bi_cui': 'C0020039',\n",
    "  'our_bi_cui_name': 'Hostility',\n",
    "  'our_bi_cui_desc': '[CLS] Host ##ility [unused3] ( B ##iol ##og ##ic Fun ##ction , context - dependent category , finding , physical finding , situation , s ##ym ##pt ##om : [ D ] Host ##ility ; attitude hostile ; Host ##ile behavior ; Host ##ile behaviour ; hostile ; hostilities ; hostility ; Host ##ilities ) [SEP]',\n",
    "  'our_cross_cui': 'C0871641',\n",
    "  'our_cross_cui_name': 'affection',\n",
    "  'our_cross_cui_desc': '[CLS] affection [unused3] ( B ##iol ##og ##ic Fun ##ction : A ##ffe ##ction ; affection ##s ) [SEP]'},\n",
    " {'mention_id': '27402827.56',\n",
    "  'test_set_idx': 4900,\n",
    "  'type': 'T038',\n",
    "  'name': 'spinogenesis',\n",
    "  'context': '[CLS] G - protein in ##hibition a ##bro ##gate ##s W ##nt - 5 ##a - dependent pathway in hip ##po ##cam ##pal neurons . In particular , the activation of G ##α ##o appears to be a key factor controlling the W ##nt - 5 ##a - induced den ##dr ##itic spine density . In addition , we found that G ##β ##γ is required for the W ##nt - 5 ##a - mediated increase in c ##yt ##oso ##lic calcium levels and [unused1] spin ##ogen ##esis [unused2] . Our findings reveal that Fr ##iz ##zled ##9 and he ##tero ##tri ##mer ##ic G proteins regulate W ##nt - 5 ##a signaling and den ##dr ##itic spines in culture ##d hip ##po ##cam ##pal neurons . [SEP]',\n",
    "  'existing_cui': 'C2262776',\n",
    "  'existing_cui_name': 'retina morphogenesis in camera-type eye',\n",
    "  'existing_cui_desc': '[CLS] re ##tina m ##or ##ph ##ogen ##esis in camera - type eye [unused3] ( B ##iol ##og ##ic Fun ##ction : re ##tina m ##or ##ph ##ogen ##esis in camera - style eye ; re ##tino ##genesis ) [SEP]',\n",
    "  'our_bi_cui': 'C1155781',\n",
    "  'our_bi_cui_name': 'spindle assembly',\n",
    "  'our_bi_cui_desc': '[CLS] spin ##dle assembly [unused3] ( B ##iol ##og ##ic Fun ##ction : spin ##dle bio ##sy ##nt ##hesis ; spin ##dle formation ; bi ##pol ##ar spin ##dle bio ##sy ##nt ##hesis ; bi ##pol ##ar spin ##dle formation ) [SEP]',\n",
    "  'our_cross_cui': 'C0007613',\n",
    "  'our_cross_cui_name': 'Cell physiology',\n",
    "  'our_cross_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]'},\n",
    " {'mention_id': '27796974.8',\n",
    "  'test_set_idx': 17362,\n",
    "  'type': 'T170',\n",
    "  'name': 'Water Framework Directive',\n",
    "  'context': '[CLS] ##ive aims at reaching the good ecological status of the surface and ground water bodies ( L ##ás ##z ##l ##ó et al . Micro ##che ##m J 85 ( 1 ) : 65 - 71 , 2007 ) . The paper deals with quality evaluation of waters with special focus on the water chemistry parameters as defined in the [unused1] Water Framework Direct ##ive [unused2] and pertaining legal regulations . The purpose of this paper is to de ##vise a quantitative type of water quality assessment method which could provide rapid , accurate , and reliable information on the quality of the surface waters by using water chemistry parameters . Quality classes have been defined for every water chemistry parameter in light of the legal [SEP]',\n",
    "  'existing_cui': 'C0450152',\n",
    "  'existing_cui_name': 'Metal framework',\n",
    "  'existing_cui_desc': '[CLS] Metal framework [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
    "  'our_bi_cui': 'C1135941',\n",
    "  'our_bi_cui_name': 'Ethical Directives',\n",
    "  'our_bi_cui_desc': '[CLS] E ##thical Direct ##ives [unused3] ( Intel ##lect ##ual Product : Direct ##ive , E ##thical ; Direct ##ives , E ##thical ; E ##thical Direct ##ive ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27894020.30',\n",
    "  'test_set_idx': 21139,\n",
    "  'type': 'T033',\n",
    "  'name': 'detection',\n",
    "  'context': '[CLS] , cocaine and its main meta ##bol ##ite , ben ##zo ##yle ##c ##gon ##ine , were detected in two out of six hair samples . The concentrations for cocaine were 0 . 151 and 0 . 09 ng / mg and for ben ##zo ##yle ##c ##gon ##ine 0 . 103 and 0 . 147 ng / mg , respectively . Given that cocaine was a commonly used medicine , beginning in the mid - 19th century and per ##sist ##ing into the 20th century , it is not surprising that some patients may have ing ##ested this drug . In addition to the [unused1] detection [unused2] of cocaine , these analyses also provided evidence of ni ##cot ##ine and ca ##ffe ##ine intake . [SEP]',\n",
    "  'existing_cui': 'C0206100',\n",
    "  'existing_cui_name': 'Signal Detection',\n",
    "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
    "  'our_bi_cui': 'C1511790',\n",
    "  'our_bi_cui_name': 'Detection',\n",
    "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
    "  'our_cross_cui': 'C0442726',\n",
    "  'our_cross_cui_name': 'Detected',\n",
    "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
    " {'mention_id': '27325393.44',\n",
    "  'test_set_idx': 2493,\n",
    "  'type': 'T038',\n",
    "  'name': 'immune',\n",
    "  'context': '[CLS] ##9 , p = 0 . 03 ##5 ) , M ( β = - 0 . 01 ##7 , p = 0 . 00 ##9 ) and F ( β = - 0 . 03 ##1 , p = 0 . 02 ##4 ) were associated with the T ##has ##e and Rush staging model but not the Maud ##sley St ##aging Model . Overall , our findings suggest that proteins , which are involved in [unused1] immune [unused2] and complement activation , may represent potential bio ##mark ##ers that could be used by clinic ##ians to identify high - risk patients . Nevertheless , given that the molecular changes between the staging groups were subtle , the results need to be interpreted cautiously . [SEP]',\n",
    "  'existing_cui': 'C0073433',\n",
    "  'existing_cui_name': 'RNA , immune',\n",
    "  'existing_cui_desc': '[CLS] RNA , immune [unused3] ( Chemical : immune RNA ; I - RNA ) [SEP]',\n",
    "  'our_bi_cui': 'C0301872',\n",
    "  'our_bi_cui_name': 'Immune response',\n",
    "  'our_bi_cui_desc': '[CLS] I ##mm ##une response [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : im ##mu ##nor ##es ##po ##nse ; immune responses ; immune response ; I ##mm ##une response , un ##sp ##ec ##ified ; I ##mm ##une Response Process ; Host response ; I ##mm ##une response , function ; Host response , function ; I ##mm ##une Response ; host response ) [SEP]',\n",
    "  'our_cross_cui': 'C1155000',\n",
    "  'our_cross_cui_name': 'Immune Cell Activation Process',\n",
    "  'our_cross_cui_desc': '[CLS] I ##mm ##une Cell Act ##ivation Process [unused3] ( B ##iol ##og ##ic Fun ##ction : le ##uk ##oc ##yte activation ; immune cell activation ; I ##mm ##une Cell Act ##ivation ; le ##uc ##oc ##yte activation ) [SEP]'},\n",
    " {'mention_id': '27932585.26',\n",
    "  'test_set_idx': 22253,\n",
    "  'type': 'T103',\n",
    "  'name': 'TYW3',\n",
    "  'context': '[CLS] structure of Ta ##w ##3 , a ho ##mo ##log of T ##Y ##W ##3 from Sul ##fo ##lo ##bus so ##lf ##ata ##ric ##us , which revealed a novel α / β fold . The sequence motif ( S / T ) x ##SS ##C ##x ##GR and invariant as ##par ##tate and his ##ti ##dine , conserved in [unused1] T ##Y ##W ##3 [unused2] / Ta ##w ##3 , cluster to form the cat ##alytic center . These structural and sequence features indicate that T ##Y ##W ##3 / Ta ##w ##3 proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass [SEP]',\n",
    "  'existing_cui': 'C1823563',\n",
    "  'existing_cui_name': 'TYW3 gene',\n",
    "  'existing_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
    "  'our_bi_cui': 'C1823563',\n",
    "  'our_bi_cui_name': 'TYW3 gene',\n",
    "  'our_bi_cui_desc': '[CLS] T ##Y ##W ##3 gene [unused3] ( Ana ##tom ##ical Structure : FL ##J ##40 ##9 ##18 ; t ##RNA - Y ##W - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; t ##RNA - y ##W s ##ynth ##esi ##zing protein 3 ho ##mo ##log ; t ##RNA - W ##Y ##B ##UT ##OS ##IN ##E - S ##Y ##NT ##H ##ES ##I ##Z ##ING PR ##OT ##EI ##N 3 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28243201.4',\n",
    "  'test_set_idx': 29646,\n",
    "  'type': 'T201',\n",
    "  'name': 'Response',\n",
    "  'context': '[CLS] I ##dent ##ification of Pre ##dict ##ive DNA Met ##hyl ##ation B ##io ##mark ##ers for Ch ##em ##otherapy [unused1] Response [unused2] in Color ##ec ##tal Cancer Resistance to 5 - F ##lu ##oro ##ura ##ci ##l is a major obstacle to the successful treatment of color ##ec ##tal cancer and posed an increased risk of re ##cu ##rrence . DNA met ##hyl ##ation has been suggested as one of the underlying mechanisms for re ##current disease and its contribution to the development of drug resistance remains to be clarified . This study aimed to determine the met ##hyl ##ation p ##hen ##otype in color ##ec ##tal cancer for identification of predict ##ive markers for ch ##em ##otherapy response . We performed DNA met ##hyl ##ation [SEP]',\n",
    "  'existing_cui': 'C1704632',\n",
    "  'existing_cui_name': 'Disease Response',\n",
    "  'existing_cui_desc': '[CLS] Disease Response [unused3] ( Finding : Response ; response ) [SEP]',\n",
    "  'our_bi_cui': 'C0683154',\n",
    "  'our_bi_cui_name': 'drug response',\n",
    "  'our_bi_cui_desc': '[CLS] drug response [unused3] ( B ##iol ##og ##ic Fun ##ction : response to drug ; drug responses ; drugs response ) [SEP]',\n",
    "  'our_cross_cui': 'C0521982',\n",
    "  'our_cross_cui_name': 'Response to treatment',\n",
    "  'our_cross_cui_desc': '[CLS] Response to treatment [unused3] ( Clinical At ##tri ##but ##e , context - dependent category , finding , function , o ##bs ##er ##vable entity , situation : response to treatment ; response treatments ; The ##rap ##eu ##tic response ; response therapeutic ; The ##rap ##eu ##tic Response ; Finding related to therapeutic response ; successful treatment ; successful treatments ; The ##rap ##eu ##tic response , function ) [SEP]'},\n",
    " {'mention_id': '27249559.30',\n",
    "  'test_set_idx': 788,\n",
    "  'type': 'T033',\n",
    "  'name': 'electron beam trajectory swinging',\n",
    "  'context': '[CLS] size were studied . The simulation results demonstrated that if the intensity of X - rays generated at the point - like target is greater than half of the X - ray intensity produced on the substrate , the X - ray focal spot is determined in part by the point - like target rather than by the electron beam in the conventional X - ray tube . In theory , since it is able to reduce those un ##fa ##vor ##able effects such as the [unused1] electron beam trajectory swinging [unused2] and the beam size changing for the micro ##fo ##cus X - ray tube , it could alleviate CT image artifacts caused by the X - ray focal spot shift and size change . [SEP]',\n",
    "  'existing_cui': 'C0454077',\n",
    "  'existing_cui_name': 'Teleradiotherapy using electrons',\n",
    "  'existing_cui_desc': '[CLS] Tel ##era ##dio ##ther ##ap ##y using electrons [unused3] ( Health Care Act ##ivity , procedure : Beta ##tron electron te ##let ##her ##ap ##y ; photo ##n beam radiation therapy ; Tel ##era ##dio ##ther ##ap ##y using beta particles ; Tel ##era ##dio ##ther ##ap ##y beta particles ; El ##ec ##tron Be ##am Therapy ; El ##ec ##tron te ##let ##her ##ap ##y ; El ##ec ##tron beam therapy ; El ##ec ##tron te ##ler ##adi ##oth ##era ##p ) [SEP]',\n",
    "  'our_bi_cui': 'C0600352',\n",
    "  'our_bi_cui_name': 'Electron Beam Computed Tomography',\n",
    "  'our_bi_cui_desc': '[CLS] El ##ec ##tron Be ##am Co ##mp ##uted Tom ##ography [unused3] ( Health Care Act ##ivity , also known as ultra ##fast c ##t , c ##ine c ##t : beam com ##puted electron to ##mo ##graphy ; El ##ec ##tron beam com ##puted to ##mo ##graphy ; Be ##am Tom ##ography , El ##ec ##tron ; El ##ec ##tron beam com ##puted to ##mo ##g ; Tom ##ography , El ##ec ##tron Be ##am ; El ##ec ##tron Be ##am Tom ##ography ; electron beam to ##mo ##graphy ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27760149.2',\n",
    "  'test_set_idx': 15789,\n",
    "  'type': 'T170',\n",
    "  'name': 'Biomedical Entity Search Tool',\n",
    "  'context': '[CLS] B ##ES ##T : Next - Generation [unused1] B ##io ##medical En ##ti ##ty Search Too ##l [unused2] for Knowledge Discovery from B ##io ##medical Literature As the volume of publications rapidly increases , searching for relevant information from the literature becomes more challenging . To complement standard search engines such as Pub ##M ##ed , it is desirable to have an advanced search tool that directly returns relevant bio ##medical entities such as targets , drugs , and mutations rather than a long list of articles . Some existing tools submit a que ##ry to Pub ##M ##ed and process retrieved abstract ##s to extract information at que ##ry time , resulting in a slow response time and limited coverage of only a fraction of [SEP]',\n",
    "  'existing_cui': 'C2348167',\n",
    "  'existing_cui_name': 'Search Engine',\n",
    "  'existing_cui_desc': '[CLS] Search Engine [unused3] ( Intel ##lect ##ual Product : Search Program ; Search engines ; Engine , Search ; Search Too ##l ; Search Engine ##s ) [SEP]',\n",
    "  'our_bi_cui': 'C2348167',\n",
    "  'our_bi_cui_name': 'Search Engine',\n",
    "  'our_bi_cui_desc': '[CLS] Search Engine [unused3] ( Intel ##lect ##ual Product : Search Program ; Search engines ; Engine , Search ; Search Too ##l ; Search Engine ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '27510458.36',\n",
    "  'test_set_idx': 8923,\n",
    "  'type': 'T033',\n",
    "  'name': 'double lumen sign',\n",
    "  'context': '[CLS] double l ##ume ##n sign in the participants and compared the results between high - resolution fast spin echo and the other m ##oda ##lities . high - resolution fast spin echo images clearly showed in ##ti ##mal flap ##s and double l ##ume ##n signs in all 3 patients , whereas the conventional m ##oda ##lities identified a [unused1] double l ##ume ##n sign [unused2] in only 2 of the 3 patients . The present method of op ##ti ##mized high - resolution fast spin echo imaging with a 3 ##T system improved visual ##ization of in ##ti ##mal flap ##s and should thus be considered for assessing patients with suspected in ##tra ##c ##rani ##al artery di ##sse ##ction that can not be definitive [SEP]',\n",
    "  'existing_cui': 'C0441299',\n",
    "  'existing_cui_name': 'Double lumen tube',\n",
    "  'existing_cui_desc': '[CLS] Double l ##ume ##n tube [unused3] ( Medical Devi ##ce , physical object ) [SEP]',\n",
    "  'our_bi_cui': 'C0233192',\n",
    "  'our_bi_cui_name': \"Ladin 's sign\",\n",
    "  'our_bi_cui_desc': \"[CLS] La ##din ' s sign [unused3] ( Finding , finding : La ##din sign ) [SEP]\",\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27488290.9',\n",
    "  'test_set_idx': 8126,\n",
    "  'type': 'T058',\n",
    "  'name': 'microendoscopic techniques',\n",
    "  'context': '[CLS] ##izing In ##tra ##oper ##ative O - Arm - Based Navigation and Micro ##end ##os ##copic Tech ##ni ##ques A retrospective analysis of the clinical outcomes of eight patients with the l ##umba ##r par ##s inter ##art ##icular ##s defects treated by direct repair with the aid of in ##tra ##oper ##ative O - arm based navigation and [unused1] micro ##end ##os ##copic techniques [unused2] . The aim of this study was to investigate the efficacy and safety of direct screw repair by using minimal ##ly invasive surgery for the l ##umba ##r par ##s inter ##art ##icular ##s defects in a pilot study . Direct repair of par ##s inter ##art ##icular ##s defects has been used to treat young adult patients . Reports [SEP]',\n",
    "  'existing_cui': 'C0441702',\n",
    "  'existing_cui_name': 'Superior pedicle technique',\n",
    "  'existing_cui_desc': '[CLS] Superior p ##edic ##le technique [unused3] ( Health Care Act ##ivity , qualifier value : March ##ac technique ) [SEP]',\n",
    "  'our_bi_cui': 'C0026035',\n",
    "  'our_bi_cui_name': 'Microsurgery',\n",
    "  'our_bi_cui_desc': '[CLS] Micro ##su ##rger ##y [unused3] ( Health Care Act ##ivity , procedure : micro ##su ##rger ##y ; micro ##su ##rger ##ies ; Micro ##su ##rg ##ical procedure ; MI ##CR ##OS ##UR ##G ) [SEP]',\n",
    "  'our_cross_cui': 'C0014245',\n",
    "  'our_cross_cui_name': 'Endoscopy',\n",
    "  'our_cross_cui_desc': '[CLS] End ##os ##copy [unused3] ( Health Care Act ##ivity , procedure , procedure : end ##os ##copy procedure ; end ##os ##copy ; end ##os ##copic examination ; procedure end ##os ##copy ; end ##os ##copic / fiber ##op ##tic examinations ; In ##spect ##ion using end ##os ##cope ; End ##os ##copic ; End ##os ##copic inspection ; End ##os ##copic Examination ; E ##ND ##OS ##CO ##P ##Y ; End ##os ##copy procedure ; end ##os ##co ##pies ; End ##os ##copic Pro ##ced ##ure ) [SEP]'},\n",
    " {'mention_id': '27602300.7',\n",
    "  'test_set_idx': 11297,\n",
    "  'type': 'T082',\n",
    "  'name': 'Eurasia',\n",
    "  'context': \"[CLS] The add ##er ( Viper ##a be ##rus ) in Southern Alt ##ay Mountains : population characteristics , distribution , morphology and phylogenetic position As the most widely distributed snake in [unused1] E ##ura ##sia [unused2] , the add ##er ( Viper ##a be ##rus ) has been extensively investigated in Europe but poorly understood in Asia . The Southern Alt ##ay Mountains represent the add ##er ' s southern distribution limit in Central Asia , whereas its population status has never been assessed . We conducted , for the first time , field surveys for the add ##er at two areas of Southern Alt ##ay Mountains using a combination of line trans ##ec ##ts and random searches . We also described the m ##or ##phological [SEP]\",\n",
    "  'existing_cui': 'C0450981',\n",
    "  'existing_cui_name': 'Addiction severity index',\n",
    "  'existing_cui_desc': '[CLS] Ad ##diction severity index [unused3] ( Intel ##lect ##ual Product , AS ##I , assessment scale : addiction severity index ) [SEP]',\n",
    "  'our_bi_cui': 'C0015176',\n",
    "  'our_bi_cui_name': 'Europe',\n",
    "  'our_bi_cui_desc': '[CLS] Europe [unused3] ( Spa ##tial Concept , geographic location ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '27782044.3',\n",
    "  'test_set_idx': 16573,\n",
    "  'type': 'T170',\n",
    "  'name': 'Comments on Beamer et al . Association',\n",
    "  'context': \"[CLS] Normal Level ##s of U ##rina ##ry CC ##16 Pro ##tein . [unused1] Co ##mme ##nts on Be ##ame ##r et al . Association [unused2] of Children ' s U ##rina ##ry CC ##16 Level ##s with A ##rsen ##ic Con ##cent ##rations in Multiple Environmental Media . In ##t . J . En ##vir ##on . Re ##s . Public Health 2016 , 13 , 52 ##1 In 1937 , Max Clara described a new type of cell in the human lung , which was later determined to be an ex ##oc ##rine secret ##ory cell type containing g ##ran ##ules composed of proteins [ 1 ] . [ . . . ] . [SEP]\",\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0282411',\n",
    "  'our_bi_cui_name': 'Published Comment',\n",
    "  'our_bi_cui_desc': '[CLS] Published Co ##mme ##nt [unused3] ( Intel ##lect ##ual Product : viewpoint ; comment ; Co ##mme ##nts ; View ##point ; commentary ; Re ##mark ; Re ##marks ; viewpoint ##s ; Co ##mme ##ntary ; comments ; Editorial Co ##mme ##nt ; Co ##mme ##nt ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28387835.66',\n",
    "  'test_set_idx': 34002,\n",
    "  'type': 'T058',\n",
    "  'name': 'MLVA',\n",
    "  'context': '[CLS] reveal differences in response between the M ##L ##VA g ##eno ##type ##s . The pro ##in ##f ##lam ##mat ##ory c ##yt ##oki ##ne response induced in human peripheral blood mon ##on ##uc ##lea ##r cells by C . burn ##eti ##i is ##olate ##s from cattle may explain the low incidence of human Q fever outbreak ##s caused by cattle . The c ##yt ##oki ##ne profile of peripheral blood mon ##on ##uc ##lea ##r cells stimulate ##d with C . burn ##eti ##i is ##olate ##s from chronic Q fever patients resembles is ##olate ##s from goats . Furthermore , c ##yt ##oki ##ne responses seem to be depending on host origin than on [unused1] M ##L ##VA [unused2] g ##eno ##type . [SEP]',\n",
    "  'existing_cui': 'C1420126',\n",
    "  'existing_cui_name': 'SLC20A2 gene',\n",
    "  'existing_cui_desc': '[CLS] SL ##C ##20 ##A ##2 gene [unused3] ( Ana ##tom ##ical Structure : S ##OL ##UT ##E CA ##R ##RI ##ER FA ##MI ##L ##Y 20 ( P ##H ##OS ##P ##HA ##TE T ##RA ##NS ##PO ##RT ##ER ) , ME ##MB ##ER 2 ; G ##IB ##BO ##N AP ##E L ##E ##U ##KE ##MI ##A R ##ET ##RO ##VI ##R ##US R ##EC ##EP ##TO ##R 2 ; G ##l ##v ##r - 2 ; P ##H ##OS ##P ##HA ##TE T ##RA ##NS ##PO ##RT ##ER , S ##OD ##I ##UM - DE ##P ##EN ##DE ##NT , 2 ; Pi ##T - 2 ; M ##UR ##IN ##E L ##E ##U ##KE ##MI ##A VI ##R ##US , AM ##P ##H [SEP]',\n",
    "  'our_bi_cui': 'C0042317',\n",
    "  'our_bi_cui_name': 'vanilmandelic acid',\n",
    "  'our_bi_cui_desc': '[CLS] van ##il ##mand ##eli ##c acid [unused3] ( Chemical , V ##MA , substance : A ##cid , Van ##il ##mand ##eli ##c ; van ##ill ##yl ##mand ##eli ##c acid ; A ##cid , Van ##ill ##yl ##mand ##eli ##c ; A ##cid , Met ##ho ##xy ##hy ##dr ##ox ##yman ##del ##ic ; Benz ##ene ##ace ##tic acid , alpha , 4 - di ##hy ##dr ##ox ##y - 3 - met ##ho ##xy - ; 4 H ##ydro ##xy 3 Met ##ho ##xy ##mand ##eli ##c A ##cid ; Van ##ill ##yl ##mand ##eli ##c acid ; Van ##il ##mand ##eli ##c A ##cid ; V ##MA ; Van ##il ##mand ##eli ##c A ##cid [ Chemical / In ##g ##red ##ient ] [SEP]',\n",
    "  'our_cross_cui': 'C1443925',\n",
    "  'our_cross_cui_name': 'Multi-locus variable-number of tandem repeat analysis',\n",
    "  'our_cross_cui_desc': '[CLS] Multi - lo ##cus variable - number of tandem repeat analysis [unused3] ( Health Care Act ##ivity , procedure : Multi - lo ##cus V ##NT ##R analysis ; M ##L ##VA - multi - lo ##cus variable - number of tandem repeat analysis ) [SEP]'},\n",
    " {'mention_id': '27488290.55',\n",
    "  'test_set_idx': 8172,\n",
    "  'type': 'T033',\n",
    "  'name': 'mild complaint',\n",
    "  'context': '[CLS] Low back pain visual analog scores decrease from pre ##oper ##ative 6 . 8 to post ##oper ##ative 1 . 4 of eight cases . Of 16 par ##s defects , healing was observed in 13 ( 81 . 3 % ) at last radio ##logical follow - up . One patient with bilateral fusion failure refused revision surgery because of [unused1] mild complaint [unused2] . No complications such as du ##ral tear , nerve root injury , and infection occurred . Mini ##mal ##ly invasive direct repair of the par ##s inter ##art ##icular ##is defects with in ##tral ##ami ##nar screw ##s by using micro ##end ##os ##copic system and navigation procedure can provide safe and effective treatment of s ##po ##ndy ##lo ##lysis [SEP]',\n",
    "  'existing_cui': 'C0277786',\n",
    "  'existing_cui_name': 'Chief complaint',\n",
    "  'existing_cui_desc': '[CLS] Chief complaint [unused3] ( Finding , finding , finding , s ##ym ##pt ##om : complaints ; chief complaint ; Co ##mp ##lain ##t ; complaints present ; Present ##ing Co ##mp ##lain ##t ; complaint ; { Chief complaint } ; Present ##ing complaint ; Chief Co ##mp ##lain ##t ; the chief complaint is : ) [SEP]',\n",
    "  'our_bi_cui': 'C0277786',\n",
    "  'our_bi_cui_name': 'Chief complaint',\n",
    "  'our_bi_cui_desc': '[CLS] Chief complaint [unused3] ( Finding , finding , finding , s ##ym ##pt ##om : complaints ; chief complaint ; Co ##mp ##lain ##t ; complaints present ; Present ##ing Co ##mp ##lain ##t ; complaint ; { Chief complaint } ; Present ##ing complaint ; Chief Co ##mp ##lain ##t ; the chief complaint is : ) [SEP]',\n",
    "  'our_cross_cui': 'C0436343',\n",
    "  'our_cross_cui_name': 'Symptom mild',\n",
    "  'our_cross_cui_desc': '[CLS] S ##ym ##pt ##om mild [unused3] ( Finding , context - dependent category , finding : mild symptoms ; s ##ym ##pt ##om mild ) [SEP]'},\n",
    " {'mention_id': '27297967.8',\n",
    "  'test_set_idx': 1713,\n",
    "  'type': 'T082',\n",
    "  'name': 'Asn19/Asn23',\n",
    "  'context': '[CLS] Tri ##g ##lut ##ath ##ione [ As ( G ##S ) 3 ] Transport by Multi ##dr ##ug Resistance Pro ##tein 1 ( MR ##P ##1 / ABC ##C ##1 ) Is Select ##ively Mo ##dified by Ph ##os ##ph ##ory ##lation of Ty ##r ##9 ##20 / Ser ##9 ##21 and G ##ly ##cos ##yla ##tion of [unused1] As ##n ##19 / As ##n ##23 [unused2] The ATP - binding cassette transport ##er multi ##dr ##ug resistance protein 1 ( MR ##P ##1 / ABC ##C ##1 ) is responsible for the cellular export of a chemical ##ly diverse array of x ##eno ##biotics and end ##ogen ##ous compounds . A ##rsen ##ic , a human car ##cin ##ogen , is a high - affinity [SEP]',\n",
    "  'existing_cui': 'C3887642',\n",
    "  'existing_cui_name': 'Hippocampus Proper',\n",
    "  'existing_cui_desc': \"[CLS] Hip ##po ##cam ##pus Pro ##per [unused3] ( Ana ##tom ##ical Structure : Hip ##po ##cam ##pus proper ; Hip ##po ##cam ##pus major ; Am ##mon ' s Horn ; CA fields ; Pro ##per , Hip ##po ##cam ##pus ; Horn , Am ##mon ; Hip ##po ##cam ##pus Pro ##pers ; Am ##mon Horn ; hip ##po ##cam ##pus ; Co ##rn ##u am ##mon ##is ; Am ##mons Horn ; Hip ##po ##cam ##pus ; corn ##u am ##mon ##is ; am ##mon ' s horn ; hip ##po ##cam ##pus proper ; Hip ##po ##cam ##pus prop ##rius ; Am ##mon ' s horn ; Co ##rn ##u Am ##mon ##is ; hip ##po ##cam ##pus major ; Horn , Am [SEP]\",\n",
    "  'our_bi_cui': 'C0003995',\n",
    "  'our_bi_cui_name': 'Asparagine',\n",
    "  'our_bi_cui_desc': '[CLS] As ##par ##agi ##ne [unused3] ( Chemical , substance : 2 - Am ##ino ##su ##cci ##nam ##ic acid ; L - as ##par ##agi ##ne ; As ##par ##tam ##ic acid ; alpha - amino ##su ##cci ##nam ##ic acid ; as ##n ; 2 - Am ##ino - 3 - car ##ba ##mo ##yl ##p ##rop ##ano ##ic acid ; as ##par ##agi ##ne ; ( S ) - As ##par ##agi ##ne ; N ; ( S ) - 2 - amino - 3 - car ##ba ##mo ##yl ##p ##rop ##ano ##ic acid ; Alpha - amino ##su ##cci ##nic acid ; As ##n ; L - as ##par ##tic acid beta - amid ##e ; ( 2 ##S ) - 2 [SEP]',\n",
    "  'our_cross_cui': 'C0002518',\n",
    "  'our_cross_cui_name': 'Amino Acid Sequence',\n",
    "  'our_cross_cui_desc': '[CLS] Am ##ino A ##cid Se ##quence [unused3] ( Spa ##tial Concept , finding : Se ##quence ##s , Am ##ino A ##cid ; Am ##ino A ##cid Se ##quence ##s ; SE ##Q AM ##IN ##O AC ##ID ; Pro ##tein Se ##quence ; amino acid sequences ; SE ##Q AA ; Structure ##s , Primary Pro ##tein ; acid amino sequences ; amino acid sequence ; Primary Pro ##tein Structure ##s ; AM ##IN ##O AC ##ID SE ##Q ; Structure , Primary Pro ##tein ; AA SE ##Q ; Am ##ino acid sequence ; protein se ##quencing ; protein sequences ; Pro ##tein Structure ##s , Primary ; Se ##quence , Am ##ino A ##cid ; protein sequence ; AM ##IN ##O AC ##ID [SEP]'},\n",
    " {'mention_id': '27601292.47',\n",
    "  'test_set_idx': 11222,\n",
    "  'type': 'T038',\n",
    "  'name': 'metabolic',\n",
    "  'context': '[CLS] , reflected by C - reactive protein concentrations , significantly influence d the metabolic ratio , v ##ori ##cona ##zo ##le t ##rough concentration and v ##ori ##cona ##zo ##le - N - oxide concentration ( all P < 0 . 00 ##1 ) , when corrected for other factors that could influence v ##ori ##cona ##zo ##le metabolism . The [unused1] metabolic [unused2] ratio was decreased by 0 . 99 ##22 ##9 ( N ) and the v ##ori ##cona ##zo ##le - N - oxide concentration by 0 . 99 ##7 ##75 ( N ) , while the v ##ori ##cona ##zo ##le t ##rough concentration was increased by 1 . 00 ##53 ##21 ( N ) , where N is the difference in [SEP]',\n",
    "  'existing_cui': 'C1524026',\n",
    "  'existing_cui_name': 'Metabolic Process , Cellular',\n",
    "  'existing_cui_desc': '[CLS] Met ##ab ##olic Process , Cell ##ular [unused3] ( B ##iol ##og ##ic Fun ##ction : Met ##ab ##oli ##zed ; Met ##ab ##olic Process ; cellular metabolism ; Met ##ab ##olic ; metabolism ; Met ##ab ##olis ##m ; cellular metabolic process ) [SEP]',\n",
    "  'our_bi_cui': 'C0025519',\n",
    "  'our_bi_cui_name': 'Metabolism',\n",
    "  'our_bi_cui_desc': '[CLS] Met ##ab ##olis ##m [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : Inter ##media ##ry Met ##ab ##olis ##m ; Met ##ab ##olic Process ##es ; ME ##TA ##B PR ##OC ##ES ##SE ##S ; metabolic processes ; Process ##es , Met ##ab ##olic ; General metabolic function ; Met ##ab ##olic Process ; ME ##TA ##B PR ##OC ##ES ##S ; metabolism ; PR ##OC ##ES ##SE ##S ME ##TA ##B ; General metabolic functions ; Inter ##media ##ry Met ##ab ##olic Process ; metabolic process ; metabolism ##s ; Process , Met ##ab ##olic ; PR ##OC ##ES ##S ME ##TA ##B ; Met ##ab ##olis ##m [ P ##K ] ; ME ##TA ##B [SEP]',\n",
    "  'our_cross_cui': 'C0683140',\n",
    "  'our_cross_cui_name': 'drug metabolism',\n",
    "  'our_cross_cui_desc': '[CLS] drug metabolism [unused3] ( B ##iol ##og ##ic Fun ##ction : Drug Met ##ab ##olis ##m ; drug metabolic process ; drugs metabolism ; bio ##tra ##ns ##formation drug ; bio ##tra ##ns ##formation drugs ; metabolism drug ) [SEP]'},\n",
    " {'mention_id': '27784873.10',\n",
    "  'test_set_idx': 16650,\n",
    "  'type': 'T017',\n",
    "  'name': 'urinary bladder cells',\n",
    "  'context': '[CLS] Aden ##os ##ine trip ##hos ##phate release from bladder u ##roth ##eli ##um and se ##ros ##a in a rat model of partial bladder outlet o ##bs ##truction Over ##active bladder is one of the major health problem especially in elderly people . Aden ##os ##ine trip ##hos ##phate is released from [unused1] u ##rina ##ry bladder cells [unused2] and acts as a smooth muscle contraction and sensory signal in mi ##ct ##uri ##tion but little is known about the role of Aden ##os ##ine trip ##hos ##phate release in the path ##op ##hy ##sio ##logy of over ##active bladder . To assess the relationship between Aden ##os ##ine trip ##hos ##phate and over ##active bladder , we used a partial bladder outlet o ##bs ##truction [SEP]',\n",
    "  'existing_cui': 'C0005682',\n",
    "  'existing_cui_name': 'Urinary Bladder',\n",
    "  'existing_cui_desc': '[CLS] U ##rina ##ry B ##lad ##der [unused3] ( Ana ##tom ##ical Structure , body structure : B ##lad ##der ; B ##LA ##D ##DE ##R ; bladder ; U ##rina ##ry bladder ; u ##rina ##ry bladder ; U ##rina ##ry System , B ##lad ##der ; B ##lad ##der structure ; bladder ##s ; B ##lad ##der , U ##rina ##ry ; V ##esi ##ca u ##rina ##ria ; U ##rina ##ry bladder structure ) [SEP]',\n",
    "  'our_bi_cui': 'C0427890',\n",
    "  'our_bi_cui_name': 'Urinary epithelial cell',\n",
    "  'our_bi_cui_desc': '[CLS] U ##rina ##ry e ##pit ##hel ##ial cell [unused3] ( Ana ##tom ##ical Structure , body structure , cell ) [SEP]',\n",
    "  'our_cross_cui': 'C0227599',\n",
    "  'our_cross_cui_name': 'Transitional epithelial cell of urinary bladder',\n",
    "  'our_cross_cui_desc': '[CLS] Transit ##ional e ##pit ##hel ##ial cell of u ##rina ##ry bladder [unused3] ( Ana ##tom ##ical Structure , body structure , cell : U ##rina ##ry tract transitional e ##pit ##hel ##ial cell ; U ##roth ##eli ##al cell ; B ##lad ##der transitional cell ; B ##lad ##der U ##roth ##eli ##al Cell ; B ##lad ##der Transit ##ional Cell ) [SEP]'},\n",
    " {'mention_id': '28197156.27',\n",
    "  'test_set_idx': 28097,\n",
    "  'type': 'T038',\n",
    "  'name': 'bp',\n",
    "  'context': '[CLS] ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 has a 1 - b ##p del ##eti ##on at 322 [unused1] b ##p [unused2] from the start co ##don , resulting in a t ##runcated protein of 125 amino acids . In addition , Carbon As ##si ##mi ##lation Rate 8 is identical to D ##TH ##8 / G ##h ##d ##8 / L ##HD ##1 , which was reported to control rice flowering date . The increase of A is largely due to an [SEP]',\n",
    "  'existing_cui': 'C1708288',\n",
    "  'existing_cui_name': 'HP wt Allele',\n",
    "  'existing_cui_desc': '[CLS] HP w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : BP ; HP ##2 ##AL ##P ##HA ##2 ; Ha ##pt ##og ##lo ##bin w ##t All ##ele ; HP ##A ##1 ##S ) [SEP]',\n",
    "  'our_bi_cui': 'C0028630',\n",
    "  'our_bi_cui_name': 'Nucleotides',\n",
    "  'our_bi_cui_desc': '[CLS] N ##uc ##leo ##tide ##s [unused3] ( Chemical , substance : n ##uc ##leo ##tide ##s ; N ##uc ##leo ##tide ; N ##uc ##leo ##tide ##s [ Chemical / In ##g ##red ##ient ] ; n ##uc ##leo ##tide ) [SEP]',\n",
    "  'our_cross_cui': 'C0600436',\n",
    "  'our_cross_cui_name': 'Base Pairing',\n",
    "  'our_cross_cui_desc': '[CLS] Base Pa ##iring [unused3] ( B ##iol ##og ##ic Fun ##ction : base pair ; Base Pa ##iring ##s ; base pairs ; base pairing ; Base Pa ##ir ; Base Pa ##irs ) [SEP]'},\n",
    " {'mention_id': '27251800.28',\n",
    "  'test_set_idx': 823,\n",
    "  'type': 'T058',\n",
    "  'name': 'Stoppa',\n",
    "  'context': '[CLS] 3 ) post - operative complications . lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair procedure was longer than the Stop ##pa procedure ( 134 . 6 min 38 . 3 vs . 90 . 6 min 41 . 3 ; P < 0 . 05 ) . The levels of C - reactive protein were higher in the [unused1] Stop ##pa [unused2] group ( P < 0 . 05 ) but the number of le ##uc ##ocytes , ha ##ema ##to ##c ##rit , and ha ##em ##og ##lo ##bin were similar between the groups ( P > 0 . 05 ) . There was no difference in pain during the 1 s ##t and 7 th post - operative , physical functioning [SEP]',\n",
    "  'existing_cui': 'C1538901',\n",
    "  'existing_cui_name': 'ACD gene',\n",
    "  'existing_cui_desc': '[CLS] AC ##D gene [unused3] ( Ana ##tom ##ical Structure : T ##EL ##OM ##ER ##E PR ##OT ##EI ##N T ##PP ##1 ; ad ##ren ##oc ##ort ##ical d ##ys ##p ##lasia ho ##mo ##log ; AC ##D Gene ; Ad ##ren ##oc ##ort ##ical D ##ys ##p ##lasia Ho ##mo ##log ( Mouse ) Gene ; P ##OT ##1 - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N 1 ; P ##OT ##1 - AND T ##IN ##2 - OR ##GA ##NI ##Z ##ING PR ##OT ##EI ##N ; P ##OT ##1 and T ##IN ##2 organizing protein ; AC ##D , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; Tin ##t ##1 ; T ##IN ##2 interacting protein 1 [SEP]',\n",
    "  'our_bi_cui': 'C0628086',\n",
    "  'our_bi_cui_name': 'Stop-zit',\n",
    "  'our_bi_cui_desc': '[CLS] Stop - z ##it [unused3] ( Chemical ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27612561.49',\n",
    "  'test_set_idx': 11771,\n",
    "  'type': 'T170',\n",
    "  'name': 'Netherlands Trial Register',\n",
    "  'context': '[CLS] less likely to report high compliance with resistance and endurance exercises in low - to - moderate intensity exercise compared to survivors of other types of cancer . The disc ##rim ##ina ##tive ability of the multi ##var ##iable models ranged from 0 . 62 to 0 . 75 . Several demographic , clinical and ps ##ych ##oso ##cial factors were associated with participation in and ad ##herence to exercise among cancer survivors . P ##sy ##cho ##so ##cial factors were more strongly associated with ad ##herence in high intensity than low - to - moderate intensity exercise . This study was registered at the [unused1] Netherlands Trial Register [unused2] [ N ##TR ##21 ##53 ] on the 5 ( th ) of January 2010 . [SEP]',\n",
    "  'existing_cui': 'C0027778',\n",
    "  'existing_cui_name': 'Netherlands',\n",
    "  'existing_cui_desc': '[CLS] Netherlands [unused3] ( Spa ##tial Concept , geographic location : NL ; NE ##TH ##ER ##LA ##ND ##S ; net ##her ##lands ; The Netherlands ; Kingdom of the Netherlands ; NL ##D ; net ##her ##land ; ho ##lland ; Holland ) [SEP]',\n",
    "  'our_bi_cui': 'C1516642',\n",
    "  'our_bi_cui_name': 'Clinical Trials Database',\n",
    "  'our_bi_cui_desc': '[CLS] Clinical Trials Database [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
    "  'our_cross_cui': 'C0034975',\n",
    "  'our_cross_cui_name': 'Registries',\n",
    "  'our_cross_cui_desc': '[CLS] Regis ##tries [unused3] ( Intel ##lect ##ual Product : re ##gis ##tries ; registry ; Regis ##try ) [SEP]'},\n",
    " {'mention_id': '27546367.50',\n",
    "  'test_set_idx': 10061,\n",
    "  'type': 'T038',\n",
    "  'name': 'self - protective',\n",
    "  'context': '[CLS] ##ath ##ological injury score ( r = 0 . 72 ##8 ; p = 0 . 02 ##6 ) and between mean a ##rgy ##rop ##hil ##ic - NO ##R number and his ##top ##ath ##ological injury score ( r = 0 . 67 ##0 ; p = 0 . 04 ##8 ) . The detection of a ##rgy ##rop ##hil ##ic - NO ##R proteins amount may be used as an indicator to obtain information about the cellular behaviour ( [unused1] self - protective [unused2] mechanism of tub ##ular e ##pit ##hel ##ial cells ) against Is ##che ##mia / re ##per ##fusion injury and cellular damage levels ( Ta ##b . 2 , Fi ##g . 4 , Re ##f . 24 ) . [SEP]',\n",
    "  'existing_cui': 'C1875759',\n",
    "  'existing_cui_name': 'SKIN PROTECTIVE',\n",
    "  'existing_cui_desc': '[CLS] SK ##IN PR ##OT ##EC ##TI ##VE [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C0243095',\n",
    "  'our_bi_cui_name': 'Finding',\n",
    "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0524828',\n",
    "  'our_cross_cui_name': 'Cytoprotection',\n",
    "  'our_cross_cui_desc': '[CLS] Cy ##top ##rote ##ction [unused3] ( B ##iol ##og ##ic Fun ##ction : Protection , Cell ; c ##yt ##op ##rote ##ction ; Cell Protection ) [SEP]'},\n",
    " {'mention_id': '28071754.3',\n",
    "  'test_set_idx': 24708,\n",
    "  'type': 'T037',\n",
    "  'name': 'injury',\n",
    "  'context': '[CLS] Far - infrared protects vascular end ##oth ##eli ##al cells from advanced g ##ly ##cation end products - induced [unused1] injury [unused2] via Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein - mediated auto ##pha ##gy in di ##abe ##tic mice The accumulation of advanced g ##ly ##cation end products in di ##abe ##tic patients induce ##s vascular end ##oth ##eli ##al injury . Pro ##my ##elo ##cy ##tic le ##uke ##mia zinc finger protein is a transcription factor that can be activated by low - temperature far - infrared i ##rra ##diation to ex ##ert beneficial effects on the vascular end ##oth ##eli ##um . In the present study , we investigated the influence of far - infrared - induced Pro ##my [SEP]',\n",
    "  'existing_cui': 'C0005604',\n",
    "  'existing_cui_name': 'Birth Injuries',\n",
    "  'existing_cui_desc': '[CLS] Birth In ##ju ##ries [unused3] ( In ##ju ##ry or Po ##ison ##ing , Birth , diagnosis , disorder : In ##ju ##ries , Birth ; T ##ra ##umatic birth ; injury birth ; Birth trauma , un ##sp ##ec ##ified ; Birth T ##ra ##uma ; Birth trauma of f ##etus ; injury ; birth ; traumatic birth ; birth trauma ; birth injuries ; Birth In ##ju ##ry ; trauma birth ; Neo ##nat ##al Birth In ##ju ##ry ; birth ##ing injuries ; Birth In ##ju ##ries [ Disease / Finding ] ; Un ##sp ##ec ##ified birth trauma ; birth ##ing trauma ; B ##IR ##TH IN ##J ; IN ##J B ##IR ##TH ; Birth injuries ; birth ; injury ; [SEP]',\n",
    "  'our_bi_cui': 'C0010957',\n",
    "  'our_bi_cui_name': 'Tissue damage',\n",
    "  'our_bi_cui_desc': '[CLS] T ##iss ##ue damage [unused3] ( In ##ju ##ry or Po ##ison ##ing , m ##or ##ph ##olo ##gic abnormal ##ity : damage tissues ; Dam ##age ; damages tissue ; Dam ##age , T ##iss ##ue ; tissue damage ; T ##iss ##ue Dam ##age ; damage ; damages ) [SEP]',\n",
    "  'our_cross_cui': 'C0178314',\n",
    "  'our_cross_cui_name': 'Poisoning / injury',\n",
    "  'our_cross_cui_desc': '[CLS] Po ##ison ##ing / injury [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder , finding , navigation ##al concept : In ##ju ##ry & / or poisoning ; IN ##J ##UR ##Y AND P ##O ##IS ##ON ##ING ; In ##ju ##ry and poisoning ; In ##ju ##ry / poisoning ) [SEP]'},\n",
    " {'mention_id': '27669669.10',\n",
    "  'test_set_idx': 13715,\n",
    "  'type': 'T037',\n",
    "  'name': 'subluxation',\n",
    "  'context': '[CLS] B ##ila ##teral C ##1 la ##mina ##r hooks combined with C ##2 p ##edic ##le screw fix ##ation in the treatment of at ##lant ##oa ##xial sub ##lux ##ation after G ##rise ##l syndrome Many et ##iol ##ogies can lead to at ##lant ##oa ##xial sub ##lux ##ai ##on . In G ##rise ##l syndrome , this [unused1] sub ##lux ##ation [unused2] occurs spontaneous ##ly after inflammatory processes of the head and neck . Di ##ag ##nosis is typically based on clinical history and a strong suspicion of this syndrome . Non ##su ##rg ##ical treatment most often resolve ##s the symptoms ; however , in some cases surgical treatment is necessary to repair the sub ##lux ##ation . Various surgical techniques and instrumentation systems [SEP]',\n",
    "  'existing_cui': 'C0332768',\n",
    "  'existing_cui_name': 'Joint Subluxations',\n",
    "  'existing_cui_desc': '[CLS] Joint Sub ##lux ##ations [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity , physical finding , qualifier value : sub ##lux ##ation ; Sub ##lux ##ation ; Sub ##lux ##ation , Joint ; Di ##s ##location , incomplete ; Joint sub ##lux ##ation ; Joint Sub ##lux ##ation ; Sub ##lux ##ation of joint ; sub ##lux ##ations ; Inc ##om ##ple ##te di ##s ##location ; joint sub ##lux ##ation ; Sub ##lux ##ations ; incomplete di ##s ##location ; Sub ##lux ##ations , Joint ; sub ##lux ##ation was seen ; sub ##lux ##ation of joint ; Sub ##lux ##ation - les ##ion ) [SEP]',\n",
    "  'our_bi_cui': 'C0332768',\n",
    "  'our_bi_cui_name': 'Joint Subluxations',\n",
    "  'our_bi_cui_desc': '[CLS] Joint Sub ##lux ##ations [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , m ##or ##ph ##olo ##gic abnormal ##ity , physical finding , qualifier value : sub ##lux ##ation ; Sub ##lux ##ation ; Sub ##lux ##ation , Joint ; Di ##s ##location , incomplete ; Joint sub ##lux ##ation ; Joint Sub ##lux ##ation ; Sub ##lux ##ation of joint ; sub ##lux ##ations ; Inc ##om ##ple ##te di ##s ##location ; joint sub ##lux ##ation ; Sub ##lux ##ations ; incomplete di ##s ##location ; Sub ##lux ##ations , Joint ; sub ##lux ##ation was seen ; sub ##lux ##ation of joint ; Sub ##lux ##ation - les ##ion ) [SEP]',\n",
    "  'our_cross_cui': 'C0263905',\n",
    "  'our_cross_cui_name': 'Atlantoaxial subluxation',\n",
    "  'our_cross_cui_desc': '[CLS] At ##lant ##oa ##xial sub ##lux ##ation [unused3] ( In ##ju ##ry or Po ##ison ##ing , disorder : AA ##S - At ##lant ##oa ##xial sub ##lux ##ation ; at ##lant ##oa ##xial ; sub ##lux ##ation ; di ##s ##location ; at ##lant ##oa ##xial ; At ##lant ##o - a ##xial sub ##lux ##ation ; At ##lant ##oa ##xial di ##s ##location ; at ##lant ##oa ##xial ; di ##s ##location ; Sub ##lux ##ation of at ##lant ##oa ##xial joint ; sub ##lux ##ation ; at ##lant ##oa ##xial ) [SEP]'},\n",
    " {'mention_id': '27794381.32',\n",
    "  'test_set_idx': 17172,\n",
    "  'type': 'T103',\n",
    "  'name': '[ Ca ( 2 + ) ] i',\n",
    "  'context': '[CLS] while em ##od ##in or u ##rs ##ode ##ox ##ych ##olic acid were given to the corresponding group for 7 weeks . The his ##tom ##or ##phological and ultra ##structure change of gal ##l ##bla ##dder were detected by micro ##scope and electron micro ##scope , the content of plasma ch ##ole ##cy ##sto ##kini ##n and [unused1] [ C ##a ( 2 + ) ] i [unused2] were analyzed successively by radio ##im ##mu ##no ##ass ##ay and flow c ##yt ##ome ##try . The protein and m ##RNA of G ##s ##α , G ##i ##α and Cap in ch ##ole ##cy ##st cells were determined by western b ##lot ##ting and real time polymer ##ase chain reaction . Em ##od ##in or u [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C1155431',\n",
    "  'our_bi_cui_name': 'positive regulation of cytosolic calcium ion concentration',\n",
    "  'our_bi_cui_desc': '[CLS] positive regulation of c ##yt ##oso ##lic calcium ion concentration [unused3] ( B ##iol ##og ##ic Fun ##ction : elevation of calcium ion concentration in c ##yt ##oso ##l ; c ##yt ##oso ##lic calcium ion concentration elevation ; c ##yt ##op ##las ##mic calcium ion concentration elevation ; elevation of c ##yt ##oso ##lic calcium ion concentration ; elevation of c ##yt ##op ##las ##mic calcium ion concentration ; elevation of calcium ion concentration in c ##yt ##op ##las ##m ) [SEP]',\n",
    "  'our_cross_cui': 'C0596235',\n",
    "  'our_cross_cui_name': 'Calcium ion',\n",
    "  'our_cross_cui_desc': '[CLS] Cal ##ci ##um ion [unused3] ( Chemical : Cal ##ci ##um Cat ##ion ; free calcium ; CA + 2 ; ion calcium ; Cal ##ci ##um cat ##ion ; Free Cal ##ci ##um ; calcium ions ; C ##a ##2 + ; C ##a + + ; Cal ##ci ##um Ion ##s ; C ##a 2 + ; calcium ion ; CA ##LC ##I ##UM CA ##TI ##ON ; Cal ##ci ##um Ion ; calcium cat ##ion ; Cal ##ci ##um 2 + ; Ion ##ized Cal ##ci ##um ) [SEP]'},\n",
    " {'mention_id': '28523425.48',\n",
    "  'test_set_idx': 38413,\n",
    "  'type': 'T082',\n",
    "  'name': 'M1',\n",
    "  'context': '[CLS] : see text ] of [ Formula : see text ] and [ Formula : see text ] . These findings indicate that the encoding of upper ex ##tre ##mity movement speed by M1 high - [ Formula : see text ] activity is primarily linear . Also , the fact that this activity remained elevated throughout a movement suggests that M1 does not merely generate trans ##ient instructions for a specific movement duration , but instead is responsible for the entirety of the movement . Finally , the spatial distribution of high - [ Formula : see text ] activity suggests the presence of a recruitment phenomenon in which higher speeds or increased muscle activity involve activation of larger [unused1] M1 [unused2] area s . [SEP]',\n",
    "  'existing_cui': 'C1705014',\n",
    "  'existing_cui_name': 'CHRM1 wt Allele',\n",
    "  'existing_cui_desc': '[CLS] CH ##R ##M ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : M1 ##R ; HM ##1 ; Cho ##liner ##gic Re ##ceptor , Mu ##sca ##rini ##c , 1 Gene ; Ace ##ty ##l ##cho ##line Re ##ceptor , Mu ##sca ##rini ##c 1 Gene ; Cho ##liner ##gic Re ##ceptor , Mu ##sca ##rini ##c 1 w ##t All ##ele ; Ace ##ty ##l ##cho ##line Re ##ceptor , Mu ##sca ##rini ##c , 1 Gene ) [SEP]',\n",
    "  'our_bi_cui': 'C0026607',\n",
    "  'our_bi_cui_name': 'Motor Cortex',\n",
    "  'our_bi_cui_desc': '[CLS] Motor Co ##rte ##x [unused3] ( Spa ##tial Concept , Motor , body structure : Co ##rte ##x ; Area , Motor ; Motor Area ; Areas , So ##matic Motor ; so ##mat ##omo ##tor areas ; Motor area ; Co ##rte ##x , Motor ; So ##mat ##omo ##tor Area ; Areas , Motor ; motor cortex ; Area , So ##matic Motor ; Motor Areas ; so ##matic motor areas ; So ##mat ##omo ##tor Areas ; Motor Areas , So ##matic ; motor area ; areas motor ; So ##matic Motor Area ; Area , So ##mat ##omo ##tor ; Motor Area , So ##matic ; Areas , So ##mat ##omo ##tor ; Motor cortex ; cortex motor ; So ##matic Motor [SEP]',\n",
    "  'our_cross_cui': 'C3495441',\n",
    "  'our_cross_cui_name': 'primary motor cortex',\n",
    "  'our_cross_cui_desc': '[CLS] primary motor cortex [unused3] ( Spa ##tial Concept , Carpenter , Crosby , M I : area F1 ; Motor Area , Primary ; Motor Co ##rt ##ices , Primary ; primary so ##mat ##omo ##tor area ; primary motor area ; Motor Strip ; Pre ##cent ##ral Motor Co ##rte ##x ; Pre ##cent ##ral Motor Areas ; Area , Primary Motor ; motor cortex ; Motor Co ##rt ##ices , Pre ##cent ##ral ; Primary Motor Co ##rt ##ices ; pre ##cent ##ral motor cortex ; motor strip ; Primary Motor Area ; Motor cortex ; Area , Pre ##cent ##ral Motor ; Motor Co ##rte ##x , Pre ##cent ##ral ; pre ##cent ##ral motor area ; Primary Motor Areas ; Co ##rt [SEP]'},\n",
    " {'mention_id': '27612561.28',\n",
    "  'test_set_idx': 11750,\n",
    "  'type': 'T038',\n",
    "  'name': 'identify',\n",
    "  'context': '[CLS] ##ates of exercise ad ##herence were studied separately for high intensity and low - to - moderate intensity exercise . De ##mo ##graphic , clinical , and physical factors were assessed using self - reported question ##naire ##s . Re ##lev ##ant clinical information was extracted from medical records . Multi ##var ##iable log ##istic re ##gression analyses were applied to [unused1] identify [unused2] co ##rrel ##ates that were significantly associated with participation , high session attendance , high compliance with resistance and high compliance with endurance exercises . Part ##ici ##pants were more likely to have higher education , be non - smoke ##rs , have lower psychological distress , higher outcome expectations , and perceive more exercise barriers than non - participants . In [SEP]',\n",
    "  'existing_cui': 'C0695108',\n",
    "  'existing_cui_name': 'Sperm identification from testis tissue , fresh or cryopreserved',\n",
    "  'existing_cui_desc': '[CLS] S ##per ##m identification from test ##is tissue , fresh or cry ##op ##res ##erve ##d [unused3] ( Health Care Act ##ivity : ID ##EN ##TI ##F ##Y SP ##ER ##M T ##IS ##SU ##E ; I ##dent ##ify sperm tissue ; SP ##R ##M ID F ##RO ##M T ##ST ##IS T ##IS ##S F ##RS ##H / CR ##Y ##OP ##RS ##R ##VD ) [SEP]',\n",
    "  'our_bi_cui': 'C0243095',\n",
    "  'our_bi_cui_name': 'Finding',\n",
    "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0020792',\n",
    "  'our_cross_cui_name': 'Identification',\n",
    "  'our_cross_cui_desc': '[CLS] I ##dent ##ification [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Defense Me ##chan ##ism , finding : I ##dent ##ifications ; psychological identification ; I ##dent ##ification - mental defense mechanism ; ID ##EN ##TI ##FI ##CA ##TI ##ON PS ##Y ##CH ##OL ; I ##dent ##ification - mental defence mechanism ) [SEP]'},\n",
    " {'mention_id': '27933285.46',\n",
    "  'test_set_idx': 22314,\n",
    "  'type': 'T033',\n",
    "  'name': 'signs',\n",
    "  'context': '[CLS] Re ##sp ##ons ##ive ##ness Scale , all but one of the tested patients obtained clinical scores in the clinical range for at least one area . On the AD ##OS 2 , 4 patients obtained scores indicating a moderate level of au ##tist ##ic spectrum disorder symptoms , 4 had a mild level , and 15 showed no or minimal [unused1] signs [unused2] of au ##tist ##ic spectrum disorder . Motor stereo ##ty ##pies in children with normal cognitive level represent a challenging diagnostic issue for which a finely tailored assessment is mandatory in order to define a precise developmental profile . Thus , careful and cautious use of standardized tests is warrant ##ed to avoid mi ##s ##dia ##gno ##sis . Furthermore , it [SEP]',\n",
    "  'existing_cui': 'C0311392',\n",
    "  'existing_cui_name': 'Physical findings',\n",
    "  'existing_cui_desc': '[CLS] Physical findings [unused3] ( Finding , finding , physical finding : physical finding ; physical findings ; Physical finding ; physical findings [ use for free text ] ; Physical signs ; Sign ##s - physical ; physical signs ; Physical sign ; Sign ; find physical ) [SEP]',\n",
    "  'our_bi_cui': 'C3540840',\n",
    "  'our_bi_cui_name': 'Sign or Symptom',\n",
    "  'our_bi_cui_desc': '[CLS] Sign or S ##ym ##pt ##om [unused3] ( Finding : Sign ##s or S ##ym ##pt ##oms ; Clinical Sign ##s ; C ##L ##IN ##IC ##AL F ##IN ##DI ##NG ; C ##L ##IN ##IC ##AL S ##IG ##NS ; DE ##SC ; Clinical Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0037088',\n",
    "  'our_cross_cui_name': 'Signs and Symptoms',\n",
    "  'our_cross_cui_desc': '[CLS] Sign ##s and S ##ym ##pt ##oms [unused3] ( Finding , finding : Sign ##s and S ##ym ##pt ##oms [ Disease / Finding ] ; Clinical findings ; clinical findings ; O ##bs ##er ##vable En ##ti ##ty ; sign and s ##ym ##pt ##om ; Sign and s ##ym ##pt ##om ; S ##ym ##pt ##oms and Sign ##s ; sign / s ##ym ##pt ##om ; Finding ; Clinical observation : symptoms and signs ; S ##IG ##NS S ##Y ##MP ##TO ##MS ; Clinical finding ) [SEP]'},\n",
    " {'mention_id': '27887026.29',\n",
    "  'test_set_idx': 20814,\n",
    "  'type': 'T103',\n",
    "  'name': 'CmFDH',\n",
    "  'context': '[CLS] ##O ##3 ( - ) as a substrate was evaluated by measuring the kinetic rates and conducting productivity ass ##ays . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H ) and Cha ##eto ##mium the ##rm ##op ##hil ##um showed a higher efficiency in converting HC ##O ##3 ( - ) to format ##e than [unused1] C ##m ##F ##D ##H [unused2] , whereas C ##m ##F ##D ##H was better in the oxidation of format ##e . The pH op ##ti ##mum of the reduction was at pH 7 - 8 . However , the high concentrations of HC ##O ##3 ( - ) reduced the reaction rate . Can ##di ##da met ##hyl ##ica ( C ##m ##F ##D ##H [SEP]',\n",
    "  'existing_cui': 'C0342185',\n",
    "  'existing_cui_name': 'Hyperthyroxinemia , Familial Dysalbuminemic',\n",
    "  'existing_cui_desc': '[CLS] H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial D ##ys ##al ##bu ##mine ##mic [unused3] ( Ana ##tom ##ical Structure , disorder : H ##YP ##ER ##TH ##Y ##RO ##X ##IN ##EM ##IA , FA ##MI ##L ##IA ##L D ##Y ##SA ##L ##B ##UM ##IN ##EM ##IC ; F ##ami ##lial d ##ys ##al ##bu ##mina ##em ##ic h ##yper ##thy ##ro ##xin ##ae ##mia ; H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial D ##ys ##al ##bu ##mine ##mic [ Disease / Finding ] ; D ##ys ##al ##bu ##mine ##mic H ##yper ##thy ##ro ##xin ##emia , F ##ami ##lial ; F ##ami ##lial D ##ys ##al ##bu ##mine ##mic H ##yper ##thy ##ro ##xin ##emia ; F ##ami [SEP]',\n",
    "  'our_bi_cui': 'C0060647',\n",
    "  'our_bi_cui_name': 'Formate dehydrogenase',\n",
    "  'our_bi_cui_desc': '[CLS] Form ##ate de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , c ##yt ##och ##rome , c ##yt ##och ##rome , substance : Form ##ate de ##hy ##dr ##ogen ##ase ( c ##yt ##och ##rome ) ) [SEP]',\n",
    "  'our_cross_cui': 'C0016570',\n",
    "  'our_cross_cui_name': 'Formate dehydrogenase',\n",
    "  'our_cross_cui_desc': '[CLS] Form ##ate de ##hy ##dr ##ogen ##ase [unused3] ( Chemical , substance : De ##hy ##dr ##ogen ##ase , N ##AD - Form ##ate ; N ##AD Form ##ate De ##hy ##dr ##ogen ##ase ; De ##hy ##dr ##ogen ##ases , Form ##ate ; N ##AD - Form ##ate De ##hy ##dr ##ogen ##ase ; Form ##ate H ##ydro ##gen ##lya ##ses ; Form ##ate De ##hy ##dr ##ogen ##ases ; Form ##ate De ##hy ##dr ##ogen ##ases [ Chemical / In ##g ##red ##ient ] ; Form ##ate : N ##AD + o ##xi ##dor ##ed ##uc ##tase ; H ##ydro ##gen ##lya ##ses , Form ##ate ) [SEP]'},\n",
    " {'mention_id': '27478553.20',\n",
    "  'test_set_idx': 7719,\n",
    "  'type': 'T098',\n",
    "  'name': 'non - night eaters',\n",
    "  'context': \"[CLS] National Health and N ##utrition Examination Survey . ' Night eating ' was defined as consuming 25 % or more of one ' s daily energy intake between 21 : 00 and 06 : 00 . Sub ##jects comply ##ing with the preceding condition were classified as ' night eat ##ers ' , whereas the rest were considered ' [unused1] non - night eat ##ers [unused2] ' . Lo ##gis ##tic re ##gression analysis examined factors related to night eating . Multiple linear re ##gression analyses were used to examine the relationship between night eating and B ##MI z - scores , whereas multi ##no ##mia ##l log ##istic re ##gression analysis was used to examine the relationship between night eating and weight status . About [SEP]\",\n",
    "  'existing_cui': 'C2350309',\n",
    "  'existing_cui_name': 'Night Vision',\n",
    "  'existing_cui_desc': '[CLS] Night Vision [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , finding , o ##bs ##er ##vable entity : Vision , Sc ##oto ##pic ; Vision , Rod ; Night vision ; Vision , Night ; s ##cot ##op ##ic vision ; Rod Vision ; Sc ##oto ##pic vision ; Sc ##oto ##pic Vision ) [SEP]',\n",
    "  'our_bi_cui': 'C0243095',\n",
    "  'our_bi_cui_name': 'Finding',\n",
    "  'our_bi_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C1257890',\n",
    "  'our_cross_cui_name': 'Population Group',\n",
    "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
    " {'mention_id': '28295414.12',\n",
    "  'test_set_idx': 31550,\n",
    "  'type': 'T168',\n",
    "  'name': 'drinks',\n",
    "  'context': '[CLS] ##IN ##E Study Recently , the Food and Drug Administration proposed to expand the options for primary end points in the development of medications for alcohol use disorder to include either a ##bs ##tine ##nce from alcohol or a non ##ab ##st ##inen ##t outcome : no heavy drinking days ( with a heavy drinking day defined as more than 3 [unused1] drinks [unused2] per day for women and more than 4 drinks per day for men [ > 3 / > 4 cut ##off ] ) . The Food and Drug Administration also suggested that 6 months would be the most appropriate length for a clinical trial to demonstrate the stability of this non ##ab ##st ##inen ##t drinking outcome . However , few alcohol [SEP]',\n",
    "  'existing_cui': 'C0452428',\n",
    "  'existing_cui_name': 'Drink',\n",
    "  'existing_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
    "  'our_bi_cui': 'C0452428',\n",
    "  'our_bi_cui_name': 'Drink',\n",
    "  'our_bi_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
    "  'our_cross_cui': 'C0001967',\n",
    "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
    "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
    " {'mention_id': '28027760.29',\n",
    "  'test_set_idx': 23870,\n",
    "  'type': 'T058',\n",
    "  'name': '3rd generation dual - source CT',\n",
    "  'context': '[CLS] ##iac CT an ##gio ##graphy : 2 . 4 ± 0 . 9 ##m ##S ##v - 6 . 8 ± 2 . 7 m ##S ##v , all p ≤ 0 . 04 ##14 ) . In 39 patients trans ##cat ##he ##ter a ##ort ##ic valve replacement was performed and an ##nu ##lus diameter was within the recommended range in all patients . No severe cardiac or vascular complications were noted . [unused1] 3rd generation dual - source CT [unused2] provides diagnostic image quality in trans ##cat ##he ##ter a ##ort ##ic valve replacement - planning CT an ##gio ##graphy and facilitate ##s reliable assessment of trans ##cat ##he ##ter a ##ort ##ic valve replacement device and delivery option while reducing radiation dose . [SEP]',\n",
    "  'existing_cui': 'C2021220',\n",
    "  'existing_cui_name': 'third generation thyroid stimulating hormone assay',\n",
    "  'existing_cui_desc': '[CLS] third generation thy ##roid s ##ti ##mulating hormone ass ##ay [unused3] ( Health Care Act ##ivity , lab test : T ##S ##H ( 3rd generation ) ; 3rd generation T ##S ##H ass ##ay ) [SEP]',\n",
    "  'our_bi_cui': 'C4055114',\n",
    "  'our_bi_cui_name': 'Dual energy computed tomography',\n",
    "  'our_bi_cui_desc': '[CLS] Dual energy com ##puted to ##mo ##graphy [unused3] ( Health Care Act ##ivity , procedure : Dual - Energy Co ##mp ##uted Tom ##ography ; DE ##CT - dual energy com ##puted to ##mo ##graphy ) [SEP]',\n",
    "  'our_cross_cui': 'C0040405',\n",
    "  'our_cross_cui_name': 'X-Ray Computed Tomography',\n",
    "  'our_cross_cui_desc': '[CLS] X - Ray Co ##mp ##uted Tom ##ography [unused3] ( Health Care Act ##ivity , computer ##ized to ##mo ##graphy , procedure : Sc ##an , X - Ray CT ; com ##puted to ##mo ##graphy x rays ; EMI scan ; em ##i scan ; CT X ##RA ##Y ; Co ##mp ##uted X - Ray Tom ##ography ; Computer ##ised trans ##ax ##ial to ##mo ##graphy ; to ##mo ##den ##si ##tom ##et ##ry ; CA ##T scan - ; CT Sc ##an , X Ray ; Computer ##ized to ##mo ##gram ; X - Ray CA ##T Sc ##an ; Computer ##ized trans ##ax ##ial to ##mo ##graphy ; x - ray com ##puted to ##mo ##graphy ; Tom ##ography , Trans ##mission [SEP]'},\n",
    " {'mention_id': '27273231.23',\n",
    "  'test_set_idx': 1204,\n",
    "  'type': 'T204',\n",
    "  'name': 'survival model',\n",
    "  'context': '[CLS] ##l , l ##iga ##tion , and pro ##ximal l ##iga ##tion plus di ##stal En ##sea ##l ) and extracted to evaluate the pressure tolerance up to 75 mm H ##g at the sealed end . A left lower lobe ##ct ##omy was performed to evaluate chronic - phase du ##rab ##ility of the sealed s ##tum ##ps in a [unused1] survival model [unused2] . Two or three branches of the pulmonary art ##eries in each dog were allocated to each of the 3 groups . After the scheduled survival period , the pulmonary art ##eries were sampled . Press ##ure tolerance at the sealed end was evaluated in 91 pulmonary artery sections . All sealed ends showed pressure tolerance > 75 mm H ##g [SEP]',\n",
    "  'existing_cui': 'C0007620',\n",
    "  'existing_cui_name': 'Cell Survival',\n",
    "  'existing_cui_desc': '[CLS] Cell Survival [unused3] ( B ##iol ##og ##ic Fun ##ction : Via ##bilities , Cell ; cell via ##bility ; Cell Via ##bility ; Via ##bility , Cell ; cell survival ; Cell Via ##bilities ; Survival , Cell ) [SEP]',\n",
    "  'our_bi_cui': 'C0086272',\n",
    "  'our_bi_cui_name': 'Experimental Model',\n",
    "  'our_bi_cui_desc': '[CLS] Experimental Model [unused3] ( Intel ##lect ##ual Product : experimental model ; E ##X ##P ##ER M ##OD ##EL ; models experimental ; Experimental Models ; experimental ##s models ; Models , Experimental ; experimental models ; Experimental Models , Other ; Model , Experimental ; M ##OD ##EL E ##X ##P ##ER ; E ##X ##P ##ER M ##OD ##EL ##S ; M ##OD ##EL ##S E ##X ##P ##ER ) [SEP]',\n",
    "  'our_cross_cui': 'C0599779',\n",
    "  'our_cross_cui_name': 'Animal Model',\n",
    "  'our_cross_cui_desc': '[CLS] Animal Model [unused3] ( E ##uka ##ryo ##te : animal model ; Animal Models ; Models , Animal ; Animal Model , Gene ##ric ; Research Model , Animal ; animals models ; animal models ; Model , Animal ) [SEP]'},\n",
    " {'mention_id': '27986797.2',\n",
    "  'test_set_idx': 22899,\n",
    "  'type': 'T103',\n",
    "  'name': 'myomitokine',\n",
    "  'context': '[CLS] Growth differentiation factor 15 is a [unused1] my ##omi ##tok ##ine [unused2] governing systemic energy home ##ost ##asis Red ##uce ##d mitochondrial electron transport chain activity promotes long ##evity and improve ##s energy home ##ost ##asis via cell - autonomous and - non - autonomous factors in multiple model systems . This mit ##oh ##orm ##etic effect is thought to involve the mitochondrial unfolded protein response ( UP ##R ( m ##t ) ) , an adaptive stress - response pathway activated by mitochondrial pro ##te ##oto ##xi ##c stress . Using mice with skeletal muscle - specific deficiency of C ##ri ##f ##1 ( muscle - specific knockout [ M ##KO ] ) , an integral protein of the large mit ##ori ##bos ##oma ##l [SEP]',\n",
    "  'existing_cui': 'C0950133',\n",
    "  'existing_cui_name': 'Online Mendelian Inheritance In Man',\n",
    "  'existing_cui_desc': '[CLS] Online Men ##del ##ian In ##her ##ita ##nce In Man [unused3] ( Intel ##lect ##ual Product : online men ##del ##ian inheritance in man ( O ##MI ##M ) database ; Online Men ##del ##ian In ##her ##ita ##nce in Man ) [SEP]',\n",
    "  'our_bi_cui': 'C0026484',\n",
    "  'our_bi_cui_name': 'Monokines',\n",
    "  'our_bi_cui_desc': '[CLS] Mon ##oki ##nes [unused3] ( Chemical , substance : Mon ##oki ##ne ; mon ##oki ##ne ; Mon ##oki ##nes [ Chemical / In ##g ##red ##ient ] ) [SEP]',\n",
    "  'our_cross_cui': 'C0574031',\n",
    "  'our_cross_cui_name': 'Biologically active substance',\n",
    "  'our_cross_cui_desc': '[CLS] Biological ##ly active substance [unused3] ( Chemical , substance : Biological ##ly Active Sub ##stance ) [SEP]'},\n",
    " {'mention_id': '27482869.1',\n",
    "  'test_set_idx': 7894,\n",
    "  'type': 'T204',\n",
    "  'name': 'Allen J. Wilcox',\n",
    "  'context': \"[CLS] Voices : A Con ##vers ##ation with [unused1] Allen J . Wilcox [unused2] Allen James Wilcox was born on 30 September 1946 in Columbus , OH . He studied medicine at the University of Michigan , graduated in 1973 , and after a rotating internship , he completed a master ' s degree in maternal and child health ( 1976 ) and a PhD in e ##pid ##em ##iology ( 1979 ) at the University of North Carolina in Chapel Hill . After graduation , he went to work at the National Institute of Environmental Health Sciences ( National Institute of Environmental Health Sciences , one of the US National Institutes of Health ) in Durham , NC , where he has spent his career . [SEP]\",\n",
    "  'existing_cui': 'C3810728',\n",
    "  'existing_cui_name': 'Wilcox County , AL',\n",
    "  'existing_cui_desc': '[CLS] Wilcox County , AL [unused3] ( Spa ##tial Concept : Wilcox County ; AL ##13 ##1 ; Wilcox County , Alabama ) [SEP]',\n",
    "  'our_bi_cui': 'C0027361',\n",
    "  'our_bi_cui_name': 'Persons',\n",
    "  'our_bi_cui_desc': '[CLS] Persons [unused3] ( Population Group , person : Individual ; Person ; persons ; peoples ; Person [ du ##p ] ; People ; person ; people ) [SEP]',\n",
    "  'our_cross_cui': 'C0086418',\n",
    "  'our_cross_cui_name': 'Homo sapiens',\n",
    "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
    " {'mention_id': '28197156.18',\n",
    "  'test_set_idx': 28088,\n",
    "  'type': 'T017',\n",
    "  'name': 'Carbon Assimilation Rate 8',\n",
    "  'context': '[CLS] ##rs using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of Carbon As ##si ##mi ##lation Rate 8 by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial cult ##iva ##r . Fine mapping suggested that [unused1] Carbon As ##si ##mi ##lation Rate 8 [unused2] en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box - binding transcription factor called O ##s ##HA ##P ##3 ##H . Se ##quencing analysis revealed that the in ##dic ##a all ##ele of Carbon As ##si ##mi ##lation Rate 8 [SEP]',\n",
    "  'existing_cui': 'C2246620',\n",
    "  'existing_cui_name': 'iron assimilation',\n",
    "  'existing_cui_desc': '[CLS] iron ass ##im ##ilation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_bi_cui': 'C1413023',\n",
    "  'our_bi_cui_name': 'C8A gene',\n",
    "  'our_bi_cui_desc': '[CLS] C ##8 ##A gene [unused3] ( Ana ##tom ##ical Structure : complement component 8 alpha subunit ; CO ##MP ##LE ##ME ##NT CO ##MP ##ON ##EN ##T 8 , AL ##P ##HA S ##U ##B ##UN ##IT ; C ##8 AL ##P ##HA ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27372076.8',\n",
    "  'test_set_idx': 3959,\n",
    "  'type': 'T092',\n",
    "  'name': 'industrially',\n",
    "  'context': '[CLS] the St ##re ##pt ##omy ##ces ah ##y ##gro ##scopic ##us strain C ##K - 15 that acts as a re ##press ##or of m ##or ##phological development Wu ##yi ##en ##cin is produced by St ##re ##pt ##omy ##ces ah ##y ##gro ##scopic ##us var . w ##uy ##iens ##is , which has been widely used in China as an [unused1] industrial ##ly [unused2] produced bio ##pes ##tic ##ide to control various fun ##gal diseases . Although its mechanism of action , breeding , and f ##er ##mentation had been extensively characterized , less is known about the regulatory functions that affect its bio ##sy ##nt ##hesis or m ##or ##phological development . The w ##ys ##R ##3 gene of S . ah ##y ##gro [SEP]',\n",
    "  'existing_cui': 'C1552816',\n",
    "  'existing_cui_name': 'all - LocalMarkupIgnore',\n",
    "  'existing_cui_desc': '[CLS] all - Local ##M ##ark ##up ##I ##gno ##re [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
    "  'our_bi_cui': 'C0557758',\n",
    "  'our_bi_cui_name': 'Industrial environment',\n",
    "  'our_bi_cui_desc': '[CLS] Industrial environment [unused3] ( Spa ##tial Concept , environment ) [SEP]',\n",
    "  'our_cross_cui': 'C0007983',\n",
    "  'our_cross_cui_name': 'Chemical Industry',\n",
    "  'our_cross_cui_desc': '[CLS] Chemical Industry [unused3] ( Organization : Chemical Industries ; IN ##D ##US ##T CH ##EM ; Industry , Chemical ; chemical industry ; chemical industries ; CH ##EM IN ##D ##US ##T ; Industries , Chemical ; Chemical industry ) [SEP]'},\n",
    " {'mention_id': '27442216.17',\n",
    "  'test_set_idx': 5813,\n",
    "  'type': 'T098',\n",
    "  'name': 'Snowmobile',\n",
    "  'context': '[CLS] ##s ( 63 % , 64 % ) than the All - terrain vehicles group ( 50 % ) ( P = 0 . 000 ##8 ) . Snow ##mobile injuries had the highest rate of spinal ( 23 % ) and lower ex ##tre ##mity fracture ##s ( 53 % ) ( P = 0 . 000 ##4 ) . [unused1] Snow ##mobile [unused2] and dirt ##bi ##ke co ##hor ##ts had higher rate of f ##em ##ur fracture ##s ( 22 % , 17 % , P = 0 . 00 ##1 ) whereas the All - terrain vehicles co ##hor ##t had higher rates of upper ex ##tre ##mity ( 18 % ) , hand ( 11 % ) , s ##cap ##ula [SEP]',\n",
    "  'existing_cui': 'C1427826',\n",
    "  'existing_cui_name': 'SBNO1 gene',\n",
    "  'existing_cui_desc': '[CLS] S ##B ##N ##O ##1 gene [unused3] ( Ana ##tom ##ical Structure , Dr ##oso ##phi ##la : FL ##J ##10 ##70 ##1 ; FL ##J ##10 ##8 ##33 ; ST ##RA ##W ##BE ##R ##R ##Y NO ##TC ##H , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 1 ; straw ##berry notch ho ##mo ##log 1 ; M ##OP ##3 ) [SEP]',\n",
    "  'our_bi_cui': 'C0597177',\n",
    "  'our_bi_cui_name': 'Particle',\n",
    "  'our_bi_cui_desc': '[CLS] Part ##icle [unused3] ( Chemical : particle ; particles ; Part ##icles ; a very small piece or part ) [SEP]',\n",
    "  'our_cross_cui': 'C0599755',\n",
    "  'our_cross_cui_name': 'Cohort',\n",
    "  'our_cross_cui_desc': '[CLS] Co ##hor ##t [unused3] ( Population Group : co ##hor ##ted ; co ##hor ##ting ; co ##hor ##t ; co ##hor ##ts ) [SEP]'},\n",
    " {'mention_id': '27299916.29',\n",
    "  'test_set_idx': 1879,\n",
    "  'type': 'T103',\n",
    "  'name': 'CQ',\n",
    "  'context': '[CLS] or synthesized . Only derivatives containing an electron def ##icient a ##romatic ring and capable of adopting flat conform ##ations , optimal for π - π interactions with Fe ( III ) PP ##IX , in ##hibit ##ed β - hem ##ati ##n formation . The two most potent analogue ##s showed na ##no ##mo ##lar parasite activity , with little [unused1] C ##Q [unused2] cross - resistance , low c ##yt ##oto ##xi ##city , and high in v ##it ##ro micro ##so ##mal stability . Selected analogue ##s in ##hibit ##ed hem ##oz ##oi ##n formation in P ##las ##mo ##dium f ##al ##ci ##par ##um causing high levels of free hem ##e . In contrast to q ##uin ##olin ##es , introduction of [SEP]',\n",
    "  'existing_cui': 'C0282245',\n",
    "  'existing_cui_name': 'Northern Mariana Islands',\n",
    "  'existing_cui_desc': '[CLS] Northern Mariana Islands [unused3] ( Spa ##tial Concept : MP ; NO ##RT ##H ##ER ##N MA ##RI ##AN ##A IS ##LA ##ND ##S ; C ##Q ; M ##NP ) [SEP]',\n",
    "  'our_bi_cui': 'C0072849',\n",
    "  'our_bi_cui_name': 'quinacillin',\n",
    "  'our_bi_cui_desc': '[CLS] q ##uin ##ac ##ill ##in [unused3] ( Chemical : 3 - car ##box ##y - 2 - q ##uin ##ox ##ali ##ny ##l ##pen ##ici ##llan ##ic acid ; Q ##uin ##ac ##ill ##in ; Q ##UI ##NA ##CI ##LL ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C0008269',\n",
    "  'our_cross_cui_name': 'Chloroquine',\n",
    "  'our_cross_cui_desc': '[CLS] Ch ##lor ##o ##quin ##e [unused3] ( Chemical , medication , product , substance : Ch ##lor ##o ##quin ##e [ Chemical / In ##g ##red ##ient ] ; Ch ##lor ##och ##in ; Ch ##lor ##o ##quin ##e [ anti - malaria ##l ] ; Ch ##lor ##o ##quin ##ium ; N ( 4 ) - ( 7 - ch ##lor ##o - 4 - Q ##uin ##olin ##yl ) - N ( 1 ) , N ( 1 ) - diet ##hyl - 1 , 4 - pen ##tan ##edia ##mine ; ch ##lor ##o ##quin ##e ; Ch ##lor ##och ##ine ; Ch ##lor ##o ##quin ##a ; CH ##L ##OR ##O ##Q ##UI ##NE ; C ##lor ##o ##quin ##a ; Ch [SEP]'},\n",
    " {'mention_id': '27623277.40',\n",
    "  'test_set_idx': 12224,\n",
    "  'type': 'T058',\n",
    "  'name': 'procedures',\n",
    "  'context': '[CLS] ( relative weight of 0 . 21 ) , risk of major complications ( relative weight of 0 . 18 ) , and distance needed to travel for treatment ( relative weight of 0 . 15 ) . Pro ##cedural and treatment preferences did not vary with demographic ##s , self - reported health status , or familiar ##ity with the [unused1] procedures [unused2] . Survey respond ##ents preferred minimal ##ly invasive operations over stereo ##ta ##ctic body radiation therapy or th ##ora ##cot ##omy for treatment of early - stage non - small cell lung cancer . Treatment m ##oda ##lity and risk of cancer re ##cu ##rrence were the most important factors associated with treatment preferences . Pro ##vide ##r experience out ##wei ##gh [SEP]',\n",
    "  'existing_cui': 'C0184661',\n",
    "  'existing_cui_name': 'Interventional procedure',\n",
    "  'existing_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_bi_cui': 'C0184661',\n",
    "  'our_bi_cui_name': 'Interventional procedure',\n",
    "  'our_bi_cui_desc': '[CLS] Inter ##vention ##al procedure [unused3] ( Health Care Act ##ivity , procedure : intervention ##al procedures ; procedure ; Inter ##vention or Pro ##ced ##ure ; intervention ##al procedure ; intervention ##D ##es ##cription ; { Pro ##ced ##ure } ; PR ##OC ##ED ##UR ##ES ; Inter ##vention ##al ; Pro ##ced ##ure ; Inter ##vention ; Pro ##ced ##ures ; intervention ; Inter ##vention St ##rate ##gies ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27500205.1',\n",
    "  'test_set_idx': 8433,\n",
    "  'type': 'T103',\n",
    "  'name': 'Kindlins',\n",
    "  'context': '[CLS] Of [unused1] Kind ##lins [unused2] and Cancer Kind ##lins are 4 . 1 - e ##z ##rin - rid ##ix ##in - m ##oes ##in ( F ##ER ##M ) domain containing proteins . There are three kind ##lins in mammals , which share high sequence identity . Kind ##lin - 1 is expressed primarily in e ##pit ##hel ##ial cells , kind ##lin - 2 is widely distributed and is particularly abundant in ad ##here ##nt cells , and kind ##lin - 3 is expressed primarily in hem ##ato ##po ##iet ##ic cells . These distributions are not exclusive ; some cells express multiple kind ##lins , and transformed cells often exhibit a ##ber ##rant expression , both in the is ##of ##orms and the [SEP]',\n",
    "  'existing_cui': 'C1720776',\n",
    "  'existing_cui_name': 'Kindling , Neurologic',\n",
    "  'existing_cui_desc': '[CLS] Kind ##ling , N ##eur ##olo ##gic [unused3] ( B ##iol ##og ##ic Fun ##ction , N ##eur ##ology : kind ##ling ; Kind ##lings , N ##eur ##olo ##gic ; Kind ##ling ; N ##eur ##olo ##gic Kind ##lings ; N ##eur ##olo ##gic Kind ##ling ) [SEP]',\n",
    "  'our_bi_cui': 'C0010422',\n",
    "  'our_bi_cui_name': 'Crystallins',\n",
    "  'our_bi_cui_desc': '[CLS] Crystal ##lins [unused3] ( Chemical , substance : Crystal ##lins [ Chemical / In ##g ##red ##ient ] ; Crystal ##lin ; Pro ##tein ##s , Len ##s ; C ##rist ##all ##in ; Len ##s Pro ##tein ##s ; crystal ##lin ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28495651.5',\n",
    "  'test_set_idx': 37780,\n",
    "  'type': 'T201',\n",
    "  'name': 'cardiovascular death',\n",
    "  'context': '[CLS] Per ##cent ##ile cat ##ego ##riz ##ation of Q ##T interval as an approach for identifying adult patients at risk for [unused1] card ##iovascular death [unused2] The results from studies of the association of Q ##T pro ##long ##ation with card ##iovascular death have been inconsistent . The purpose of this study was to compare the major correction formula ##s to percent ##ile values of Q ##T for heart rate ranges as to their ability to remove the relationship of Q ##T to heart rate and to predict card ##iovascular death . Part ##ici ##pants were 16 , 53 ##1 veterans who had an initial EC ##G at the Veterans Affairs Medical Center , Pa ##lo Alto , between March 31 , 1987 , and December [SEP]',\n",
    "  'existing_cui': 'C0007226',\n",
    "  'existing_cui_name': 'Cardiovascular system',\n",
    "  'existing_cui_desc': '[CLS] Card ##iovascular system [unused3] ( Body System , body structure : Structure of card ##iovascular system , un ##sp ##ec ##ified ; CA ##RD ##IO ##VA ##SC ##U ##LA ##R S ##Y ##ST ##EM ; Card ##iovascular ; Organ System , Card ##iovascular ; CA ##RD ##IO ##VA ##SC S ##Y ##ST ##EM ; Card ##iovascular structure ; card ##iovascular system ; Card ##iovascular Organ System ; C ##ir ##cula ##tory ; Structure of card ##iovascular system ; Card ##iovascular Systems ; card ##iovascular structure ; C ##ir ##cula ##tory System ; C ##ir ##cula ##tory Systems ; { C ##ir ##cula ##tory system } ; c ##ir ##cula ##tory ; C ##ir ##cula ##tory system ; Body System , Card ##iovascular ; card ##iovascular system [SEP]',\n",
    "  'our_bi_cui': 'C0376297',\n",
    "  'our_bi_cui_name': 'Cardiac Death',\n",
    "  'our_bi_cui_desc': '[CLS] Card ##iac Death [unused3] ( B ##iol ##og ##ic Fun ##ction : death ; cardiac ; cardiac death ; cardiac deaths ; Card ##iac death ; Death , Card ##iac ; cardiac ; death ) [SEP]',\n",
    "  'our_cross_cui': 'C2926098',\n",
    "  'our_cross_cui_name': \"Mechanism of death in patient 's dying of cardiovascular causes : Type : Point in time : ^ Patient : Nominal\",\n",
    "  'our_cross_cui_desc': \"[CLS] Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : Point in time : ^ Pat ##ient : No ##mina ##l [unused3] ( Clinical At ##tri ##but ##e : Death due to C ##V causes ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes : Type : P ##t : ^ Pat ##ient : No ##m ; Me ##chan ##ism of death in patient ' s dying of card ##iovascular causes ) [SEP]\"},\n",
    " {'mention_id': '27298278.22',\n",
    "  'test_set_idx': 1823,\n",
    "  'type': 'T103',\n",
    "  'name': 'E',\n",
    "  'context': '[CLS] ##one , an ant ##hra ##quin ##one , and a nap ##ht ##ho ##hy ##dr ##o ##quin ##one dim ##er , together with three known q ##uin ##ones and seven other known compounds , were isolated from the aerial parts of Mo ##rin ##da par ##vi ##folia . The structures of m ##ori ##nda ##par ##vin ##s C , D , [unused1] E [unused2] , F , and G were el ##uc ##idated on the basis of s ##pect ##ros ##copic or X - ray di ##ff ##raction analysis as met ##hyl 4 - h ##ydro ##xy - 1 , 6 - dim ##eth ##ox ##y - nap ##ht ##hale ##ne - 2 - car ##box ##yla ##te , met ##hyl 4 , 8 - di [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0010207',\n",
    "  'our_bi_cui_name': 'Coumarins',\n",
    "  'our_bi_cui_desc': '[CLS] Co ##uma ##rin ##s [unused3] ( Chemical : co ##uma ##rin ##s ; Co ##uma ##rine ##s ; Der ##via ##tives , 1 , 2 - Benz ##opy ##rone ; 1 , 2 - Benz ##opy ##rone ##s ; Benz ##opy ##ran 2 ones ; 1 , 2 - Benz ##opy ##rone Der ##via ##tives ; Co ##uma ##rin ##s [ Chemical / In ##g ##red ##ient ] ; 1 , 2 Benz ##opy ##rone ##s ; Co ##uma ##rin Der ##iva ##tives ; Der ##iva ##tives , Co ##uma ##rin ; Benz ##opy ##ran - 2 - ones ; B ##EN ##Z ##OP ##Y ##RO ##NE ##S 01 02 ; 1 , 2 Benz ##o P ##yr ##ones ; 1 , 2 - Benz ##o [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28334615.30',\n",
    "  'test_set_idx': 32328,\n",
    "  'type': 'T033',\n",
    "  'name': 'molecular underpinnings',\n",
    "  'context': '[CLS] white matter property - within the force ##ps minor and the left superior temporal longitudinal f ##as ##ci ##culus . Within each of these tracts , mean fraction ##al an ##is ##ot ##rop ##y value of depression score - associated v ##ox ##els was used as a p ##hen ##otype in a subsequent Gene set en ##rich ##ment analysis . The NC ##AM ##1 Inter ##actions gene set was significantly en ##rich ##ed in these tracts . By linking the NC ##AM ##1 Inter ##actions gene set to depression scores and their structural brain co ##rrel ##ates in healthy participants , the current study contributes to the understanding of the [unused1] molecular under ##pin ##ning ##s [unused2] of de ##pressive s ##ym ##pt ##oma ##tology . [SEP]',\n",
    "  'existing_cui': 'C0019247',\n",
    "  'existing_cui_name': 'Hereditary Diseases',\n",
    "  'existing_cui_desc': '[CLS] Here ##dit ##ary Disease ##s [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Gene ##tic disorder ; Di ##sor ##der , Gene ##tic ; genetics disease ; Gene ##tic Di ##sor ##der ; Disease , Gene ##tic ; Di ##sor ##ders , Gene ##tic ; Disease , Here ##dit ##ary ; genetic disorder ; hereditary disease ; Disease ##s , Here ##dit ##ary ; inherited disease ; Here ##dit ##ary disorder ; Here ##dit ##ary Di ##sor ##ders ; Disease ##s , Gene ##tic ; genetic disorders ; In ##her ##ited disease ; In ##her ##ited Disease ; hereditary diseases ; Molecular Disease ; H ##ER ##ED ##IT ##AR ##Y D ##IS ; Gene ##tic Disease ##s ; Gene ##tic Con ##dition ; [SEP]',\n",
    "  'our_bi_cui': 'C1148560',\n",
    "  'our_bi_cui_name': 'molecular_function',\n",
    "  'our_bi_cui_desc': '[CLS] molecular _ function [unused3] ( B ##iol ##og ##ic Fun ##ction : molecular function ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28197133.33',\n",
    "  'test_set_idx': 28049,\n",
    "  'type': 'T103',\n",
    "  'name': 'GH48',\n",
    "  'context': '[CLS] 1 % of the trans ##cripts . The CA ##Z ##yme profile was dominated by families G ##H ##9 ##4 ( cello ##bio ##se - p ##hos ##ph ##ory ##lase ) , G ##H1 ##3 ( am ##yla ##se ) , G ##H ##43 and G ##H1 ##0 ( hem ##ice ##ll ##ula ##ses ) , G ##H ##9 and [unused1] G ##H ##48 [unused2] ( cell ##ula ##ses ) , P ##L ##11 ( p ##ec ##tina ##se ) as well as G ##H ##2 and G ##H ##3 ( o ##li ##gos ##ac ##cha ##rida ##ses ) . Our data support the pivotal role of the most characterized fi ##bro ##ly ##tic bacteria ( Pre ##vo ##tel ##la , R ##umi ##no ##cc ##cus [SEP]',\n",
    "  'existing_cui': 'C1333673',\n",
    "  'existing_cui_name': 'GH1 gene',\n",
    "  'existing_cui_desc': '[CLS] G ##H1 gene [unused3] ( Ana ##tom ##ical Structure : G ##RO ##W ##TH H ##OR ##MO ##NE , NO ##R ##MA ##L ; G ##RO ##W ##TH H ##OR ##MO ##NE 1 ; G ##H1 Gene ; growth hormone 1 ; so ##mat ##ot ##rop ##in ; pit ##uit ##ary growth hormone ; G ##RO ##W ##TH H ##OR ##MO ##NE , P ##IT ##UI ##TA ##R ##Y ; h ##G ##H - N ; G ##H - N ; Growth Ho ##rmon ##e 1 Gene ) [SEP]',\n",
    "  'our_bi_cui': 'C0016799',\n",
    "  'our_bi_cui_name': 'Fumarate Hydratase',\n",
    "  'our_bi_cui_desc': '[CLS] Fu ##mara ##te H ##yd ##rata ##se [unused3] ( Chemical , substance : Fu ##mara ##te H ##yd ##rata ##se [ Chemical / In ##g ##red ##ient ] ; Fu ##mara ##te h ##yd ##rata ##se ; Fu ##mara ##se ; f ##uma ##rase ; Fu ##mara ##te h ##yd ##rata ##se ( substance ) [ Am ##bi ##guous ] ; H ##yd ##rata ##se , Fu ##mara ##te ; ( S ) - Mal ##ate h ##ydro - l ##yas ##e ; f ##uma ##rate h ##yd ##rata ##se ) [SEP]',\n",
    "  'our_cross_cui': 'C1260229',\n",
    "  'our_cross_cui_name': 'Cellulases',\n",
    "  'our_cross_cui_desc': '[CLS] Cell ##ula ##ses [unused3] ( Chemical : Cell ##ula ##ses [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
    " {'mention_id': '28273336.12',\n",
    "  'test_set_idx': 30879,\n",
    "  'type': 'T038',\n",
    "  'name': 'BV - allergic',\n",
    "  'context': '[CLS] ##A ##pi m 1 has been available on the I ##mm ##uno ##CA ##P system for routine diagnosis of bee venom all ##er ##gy . Now , there are five components available , and we aimed to detect the sensitivity and specific ##ity of r ##A ##pi m 1 , 2 , 3 , 5 , and 10 in [unused1] B ##V - all ##ergic [unused2] patients . We further evaluated the sensitivity of r ##A ##pi m 1 and 2 of an alternative platform and investigated possible differences in the se ##ns ##iti ##zation profile between mon ##ose ##ns ##iti ##zation and clinical ##ly relevant double se ##ns ##iti ##zation . Analysis of the whole panel of bee venom all ##er ##gens of the CA [SEP]',\n",
    "  'existing_cui': 'C0282555',\n",
    "  'existing_cui_name': 'Anti-Allergic Agents',\n",
    "  'existing_cui_desc': '[CLS] Anti - All ##ergic Agents [unused3] ( Chemical , product , substance : Anti All ##ergic Agents ; AN ##TI ##AL ##LE ##R ##GI ##C AG ##EN ##TS ; Agents , Anti ##alle ##rgy ; Anti ##alle ##rgy Agents ; anti all ##er ##gy drugs ; Agents , Anti ##alle ##rg ##ic ; anti ##alle ##rg ##ic drugs ; anti - all ##er ##gy drugs ; anti ##alle ##rg ##ic drug ; Drugs , Anti ##alle ##rg ##ic ; Anti All ##ergic ##s ; Drugs , Anti - All ##er ##gy ; all ##ergic anti ; Anti - All ##ergic ##s ; Anti ##alle ##rgen ##ic drugs ; Anti ##alle ##rg ##ics ; anti ##alle ##rg ##ic ; Agents , Anti - All ##ergic ; anti [SEP]',\n",
    "  'our_bi_cui': 'C0571832',\n",
    "  'our_bi_cui_name': 'Vitamin B group allergy',\n",
    "  'our_bi_cui_desc': '[CLS] Vita ##min B group all ##er ##gy [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder ) [SEP]',\n",
    "  'our_cross_cui': 'C1828283',\n",
    "  'our_cross_cui_name': 'Allergy to bee venom',\n",
    "  'our_cross_cui_desc': '[CLS] All ##er ##gy to bee venom [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder ) [SEP]'},\n",
    " {'mention_id': '27507702.51',\n",
    "  'test_set_idx': 8767,\n",
    "  'type': 'T103',\n",
    "  'name': 'tri -',\n",
    "  'context': '[CLS] ##ed . The most prominent protein motifs include the zinc finger , rib ##on ##uc ##lea ##se H , reverse trans ##cript ##ase , and an ##ky ##rin repeat domains . The simple sequence repeats identified from > 1 k ##b length of un ##ige ##nes show a do ##mina ##ncy of din ##uc ##leo ##tide repeat motifs followed with [unused1] t ##ri - [unused2] and te ##tra ##nu ##cle ##ot ##ide motifs . A number of un ##ige ##nes were put ##ative ##ly assessed to belong to adaptation and defense mechanisms including heat shock proteins 70 , To ##ll - like receptor 4 , AM ##P - activated protein kinase , a ##qua ##por ##in - 2 , etc . Our data provide a rich [SEP]',\n",
    "  'existing_cui': 'C0065404',\n",
    "  'existing_cui_name': 'lysyl-5-fluorotryptophyl-lysine',\n",
    "  'existing_cui_desc': '[CLS] l ##ys ##yl - 5 - flu ##oro ##try ##pt ##op ##hyl - l ##ys ##ine [unused3] ( Chemical , L : L ##ys - F - T ##rp - L ##ys ; Tri ) [SEP]',\n",
    "  'our_bi_cui': 'C0032550',\n",
    "  'our_bi_cui_name': 'Polynucleotides',\n",
    "  'our_bi_cui_desc': '[CLS] Pol ##yn ##uc ##leo ##tide ##s [unused3] ( Chemical , substance : p ##oly ##nu ##cle ##ot ##ide ; Pol ##yn ##uc ##leo ##tide ##s [ Chemical / In ##g ##red ##ient ] ; Pol ##yn ##uc ##leo ##tide ) [SEP]',\n",
    "  'our_cross_cui': 'C0282537',\n",
    "  'our_cross_cui_name': 'Trinucleotide Repeats',\n",
    "  'our_cross_cui_desc': '[CLS] Tri ##nu ##cle ##ot ##ide Rep ##eat ##s [unused3] ( Chemical : Rep ##eat ##s , Triple ##t ; triple ##t repeats ; Triple ##t Rep ##eat ##s ; t ##rin ##uc ##leo ##tide repeats ; triple ##t repeat ; Rep ##eat , Tri ##nu ##cle ##ot ##ide ; Triple ##t Rep ##eat ; Rep ##eat ##s , Tri ##nu ##cle ##ot ##ide ; Tri ##nu ##cle ##ot ##ide repeats ; Rep ##eat , Triple ##t ; t ##rin ##uc ##leo ##tide repeat ; Tri ##nu ##cle ##ot ##ide Rep ##eat ) [SEP]'},\n",
    " {'mention_id': '27669217.53',\n",
    "  'test_set_idx': 13704,\n",
    "  'type': 'T017',\n",
    "  'name': 'ermB',\n",
    "  'context': '[CLS] ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both er ##m ##B and er ##m ##T in all is ##olate ##s was er ##yt ##hr ##omy ##cin in ##du ##cible and yielded comparable mac ##rol ##ide MI ##Cs in all six is ##olate ##s . Take ##n together , in ##du ##cible expression of both er ##m ##B and er ##m ##T conferred high mac ##rol ##ide resistance in these S . gal ##lo ##ly ##ticus subsp . paste ##rian ##us is ##olate ##s . Our findings reveal new mac ##rol ##ide resistance features in S . gal ##lo ##ly ##ticus subsp . paste ##uria ##nus by both [unused1] er ##m ##B [unused2] and er ##m ##T . [SEP]',\n",
    "  'existing_cui': 'C0732611',\n",
    "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
    "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
    "  'our_bi_cui': 'C0243036',\n",
    "  'our_bi_cui_name': 'Genes , erbB',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##s , er ##b ##B [unused3] ( Ana ##tom ##ical Structure : A ##vian E ##ry ##th ##ro ##blast ##osis V ##ir ##us On ##co ##gene B ; E ##ry ##th ##ro ##blast Trans ##form ##ing Gene B ; On ##co ##gene , E ##G ##F ##R ; On ##co ##gene ER ##B B ; er ##b ##B Gene ##s ; er ##b ##B Gene ; ER ##B - B ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '28107521.38',\n",
    "  'test_set_idx': 25785,\n",
    "  'type': 'T017',\n",
    "  'name': 'SW480',\n",
    "  'context': '[CLS] the W ##nt signaling pathway still remains incomplete ##ly understood , we sought to el ##uc ##ida ##te their relative contribution in the formation of de ##grad ##as ##ome ##s , as these protein assemblies most likely represent the m ##or ##phological and functional co ##rrel ##ates of end ##ogen ##ous β - cat ##eni ##n destruction complexes . In [unused1] S ##W ##48 ##0 [unused2] color ##ec ##tal cancer cells treated with the tank ##yra ##se inhibitor G ##00 ##7 - L ##K we found that A ##X ##IN ##1 was not required for de ##grad ##as ##ome formation . In contrast , the formation of de ##grad ##as ##ome ##s as well as their capacity to de ##grade β - cat ##eni ##n were [SEP]',\n",
    "  'existing_cui': 'C3538902',\n",
    "  'existing_cui_name': 'SLC4A1 wt Allele',\n",
    "  'existing_cui_desc': '[CLS] SL ##C ##4 ##A ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : F ##R ; Sol ##ute Carrier Family 4 , An ##ion Exchange ##r , Member 1 ( E ##ry ##th ##ro ##cy ##te Me ##mb ##rane Pro ##tein Band 3 , Diego Blood Group ) w ##t All ##ele ; W ##D ; D ##I ; A ##E 1 ; W ##D ##1 ; CD ##23 ##3 ; WR ; B ##ND ##3 ; R ##TA ##1 ##A ) [SEP]',\n",
    "  'our_bi_cui': 'C3006953',\n",
    "  'our_bi_cui_name': 'Staphylococcus sp . SW48',\n",
    "  'our_bi_cui_desc': '[CLS] St ##aph ##yl ##oc ##oc ##cus s ##p . S ##W ##48 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
    "  'our_cross_cui': 'C0007634',\n",
    "  'our_cross_cui_name': 'Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]'},\n",
    " {'mention_id': '27621200.11',\n",
    "  'test_set_idx': 12043,\n",
    "  'type': 'T038',\n",
    "  'name': 'kindness',\n",
    "  'context': '[CLS] exploring the relationship between self - compassion , self - judgement , self - kindness , compassion , professional quality of life and well ##bei ##ng among UK community nurses Co ##mp ##ass ##ion fatigue and burn ##out can impact on performance of nurses . This paper explores the relationship between self - compassion , self - judgement , self - [unused1] kindness [unused2] , compassion , professional quality of life , and well ##bei ##ng among community nurses . To measure associations between self - compassion , compassion fatigue , well ##bei ##ng , and burn ##out in community nurses . Q ##uant ##itative data were collected using standard ##ised ps ##ych ##ometric question ##naire ##s : ( 1 ) Professional Quality of Life Scale [SEP]',\n",
    "  'existing_cui': 'C0456909',\n",
    "  'existing_cui_name': 'Blind Vision',\n",
    "  'existing_cui_desc': '[CLS] Blind Vision [unused3] ( Finding , finding : Blind ##ness ; blind vision ; Unable to see ; Blind ##ness [ Disease / Finding ] ; Can not see ; Blind ; blind ##ness ; U ##TS - Unable to see ; blind ) [SEP]',\n",
    "  'our_bi_cui': 'C0020039',\n",
    "  'our_bi_cui_name': 'Hostility',\n",
    "  'our_bi_cui_desc': '[CLS] Host ##ility [unused3] ( B ##iol ##og ##ic Fun ##ction , context - dependent category , finding , physical finding , situation , s ##ym ##pt ##om : [ D ] Host ##ility ; attitude hostile ; Host ##ile behavior ; Host ##ile behaviour ; hostile ; hostilities ; hostility ; Host ##ilities ) [SEP]',\n",
    "  'our_cross_cui': 'C0871641',\n",
    "  'our_cross_cui_name': 'affection',\n",
    "  'our_cross_cui_desc': '[CLS] affection [unused3] ( B ##iol ##og ##ic Fun ##ction : A ##ffe ##ction ; affection ##s ) [SEP]'},\n",
    " {'mention_id': '28072576.24',\n",
    "  'test_set_idx': 24800,\n",
    "  'type': 'T033',\n",
    "  'name': 'detection',\n",
    "  'context': '[CLS] ( - 1 ) Iron oxide na ##no ##par ##tic ##les ) . I ##maging based on this property has shown a substantial contrast - to - noise ratio improvement ( up to 5 fold , p < 0 . 01 ) . The speed of sound - related effect generated a well disc ##ern ##ible image contrast and allowed the [unused1] detection [unused2] of the particles existence and location , in both r ##aster - scan projection and ultra ##sonic com ##puted to ##mo ##graphy imaging . Conversely , no significant change in the acoustic at ##ten ##uation coefficient was noted . Based on these findings , it is concluded that Iron oxide na ##no ##par ##tic ##les can be used as an effective speed [SEP]',\n",
    "  'existing_cui': 'C0206100',\n",
    "  'existing_cui_name': 'Signal Detection',\n",
    "  'existing_cui_desc': '[CLS] Signal Det ##ec ##tion [unused3] ( B ##iol ##og ##ic Fun ##ction , Psychology , Psychology , Signal : Signal Det ##ec ##tion Theo ##ries ; Signal Det ##ec ##tions , Psychological ; Theory , Signal Det ##ec ##tion ; Signal detection ; S ##IG ##NA ##L DE ##TE ##CT ##ION AN ##AL ; Psychological Signal Det ##ec ##tions ; Det ##ec ##tion ; Signal Det ##ec ##tion Ana ##ly ##ses ; S ##IG ##NA ##L DE ##TE ##CT ##ION ; Det ##ec ##tions , Psychological Signal ; Psychological Signal Det ##ec ##tion ; Signal Det ##ec ##tion Theory ; Theo ##ries , Signal Det ##ec ##tion ; Signal Det ##ec ##tions ; Ana ##ly ##ses , Signal Det ##ec ##tion ; Det ##ec ##tion , [SEP]',\n",
    "  'our_bi_cui': 'C1511790',\n",
    "  'our_bi_cui_name': 'Detection',\n",
    "  'our_bi_cui_desc': '[CLS] Det ##ec ##tion [unused3] ( Health Care Act ##ivity : Det ##ec ##ted ) [SEP]',\n",
    "  'our_cross_cui': 'C0442726',\n",
    "  'our_cross_cui_name': 'Detected',\n",
    "  'our_cross_cui_desc': '[CLS] Det ##ec ##ted [unused3] ( Finding , finding , finding , qualifier value : detected ; detect ) [SEP]'},\n",
    " {'mention_id': '28424683.67',\n",
    "  'test_set_idx': 35445,\n",
    "  'type': 'T038',\n",
    "  'name': 'expand',\n",
    "  'context': '[CLS] ##city but higher secret ##ion of IF ##N - γ . Ex ##pan ##sion and functional activation of super - charged Natural killer cells by O ##Cs is dependent on inter ##le ##uki ##n ( inter ##le ##uki ##n ) - 12 and IL - 15 . Thus , in this report , we not only provide a novel strategy to [unused1] expand [unused2] super - charged Natural killer cells , but also demonstrate that rapid and sustained expansion of residual T cells within the pu ##rified Natural killer cells during expansion with den ##dr ##itic cells or O ##Cs could be a potential mechanism by which the numbers and function of Natural killer cells decline in cancer patients and in B ##LT - human ##ized [SEP]',\n",
    "  'existing_cui': 'C1263424',\n",
    "  'existing_cui_name': 'LYSP100-associated nuclear domain',\n",
    "  'existing_cui_desc': '[CLS] L ##Y ##SP ##100 - associated nuclear domain [unused3] ( Ana ##tom ##ical Structure : LA ##ND ##s ; lands ; landed ) [SEP]',\n",
    "  'our_bi_cui': 'C0205229',\n",
    "  'our_bi_cui_name': 'Expanding',\n",
    "  'our_bi_cui_desc': '[CLS] Ex ##pan ##ding [unused3] ( Spa ##tial Concept , qualifier value : Ex ##pan ##d ; Ex ##pan ##ded ; expanding ; expand ; expanded ) [SEP]',\n",
    "  'our_cross_cui': 'C0007595',\n",
    "  'our_cross_cui_name': 'cell growth',\n",
    "  'our_cross_cui_desc': '[CLS] cell growth [unused3] ( B ##iol ##og ##ic Fun ##ction : cell expansion ; cellular growth ; Cell ##s - - Growth ; Cell Growth ; cell growth ##s ; cells growth ; growth cell ; growth of cell ; Cell ##ular Growth ; Cell ##ular Ex ##pan ##sion ) [SEP]'},\n",
    " {'mention_id': '27921269.21',\n",
    "  'test_set_idx': 21918,\n",
    "  'type': 'T033',\n",
    "  'name': 'had sex',\n",
    "  'context': '[CLS] structure , arising from goodness of membership judgment ##s . Mode ##ration of this graded structure is also predicted , with the focus here on how sexual orientation identity affects sexual definitions . A total of 300 18 - to 30 - year - old participants completed an online survey , rating 18 behaviors for how far each constitutes having \" [unused1] had sex [unused2] \" and virgin ##ity loss . Part ##ici ##pants fell into one of four groups : he ##tero ##sexual male or female , gay male or lesbian . The predicted ratings hierarchy emerged , in which bid ##ire ##ctional g ##eni ##tal acts were rated significantly higher than un ##id ##ire ##ctional or non ##pen ##et ##rative contact , which was [SEP]',\n",
    "  'existing_cui': 'C1314687',\n",
    "  'existing_cui_name': 'Sexual intercourse - finding',\n",
    "  'existing_cui_desc': '[CLS] Sexual intercourse - finding [unused3] ( Finding , finding : Finding of sexual intercourse ; O ##bs ##er ##vation of sexual intercourse ; Making love ; Sexual intercourse ; Sexual act ; Co ##it ##us ; Finding of sexual intercourse [ du ##p ] ; Sex ; S ##I - Sexual intercourse ; V ##agi ##nal intercourse ) [SEP]',\n",
    "  'our_bi_cui': 'C3829825',\n",
    "  'our_bi_cui_name': 'Has HIV or AIDS',\n",
    "  'our_bi_cui_desc': '[CLS] Has HIV or AIDS [unused3] ( Intel ##lect ##ual Product : Does the patient have HIV or AIDS ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27905972.10',\n",
    "  'test_set_idx': 21624,\n",
    "  'type': 'T170',\n",
    "  'name': 'paper',\n",
    "  'context': '[CLS] models to describe the full age pattern of mortality are not able to capture mortality delay versus mortality compression . More recent models that assess delay versus compression mostly focused on the adult or old ages alone and did not distinguish mortality compression below and above the m ##oda ##l age at death , although they represent different mechanisms . This [unused1] paper [unused2] presents a new para ##metric model that describes the full age pattern of mortality and assess ##es compression - at different stages of life - and delay of mortality : the Co ##D ##e model . The model includes 10 parameters , of which five are constant over time . The five time - varying parameters reflect delay of mortality and compression [SEP]',\n",
    "  'existing_cui': 'C0462999',\n",
    "  'existing_cui_name': 'Litmus paper',\n",
    "  'existing_cui_desc': '[CLS] Li ##t ##mus paper [unused3] ( Medical Devi ##ce , physical object : Li ##t ##mus Paper ; lit ##mus papers ; Re ##age ##nts , Clinical Chemistry , Rapid Test , pH , Strip ; IV ##D Test Re ##age ##nt / Kit ##s , Clinical Chemistry , Rapid Test , pH , Strip ; pH Strip In ##dic ##ators ; lit ##mus paper ) [SEP]',\n",
    "  'our_bi_cui': 'C0600659',\n",
    "  'our_bi_cui_name': 'Manuscripts',\n",
    "  'our_bi_cui_desc': '[CLS] Man ##us ##cripts [unused3] ( Intel ##lect ##ual Product : manuscript ; manuscripts ; Man ##us ##cript ) [SEP]',\n",
    "  'our_cross_cui': 'C1706852',\n",
    "  'our_cross_cui_name': 'Article',\n",
    "  'our_cross_cui_desc': '[CLS] Article [unused3] ( Intel ##lect ##ual Product ) [SEP]'},\n",
    " {'mention_id': '28277189.51',\n",
    "  'test_set_idx': 31002,\n",
    "  'type': 'T017',\n",
    "  'name': 'hFoB1 .19 cells',\n",
    "  'context': '[CLS] significantly suppressed U2 ##OS cell migration and invasion . On the contrary , over ##ex ##press ##ion of C ##X ##LC ##5 remarkably promoted the migration and invasion of U2 ##OS cells . Interest ##ingly , both ex ##ogen ##ous C ##X ##CL ##5 treatment and the conditioned medium of C ##X ##CL ##5 - over ##ex ##pressing [unused1] h ##F ##o ##B ##1 . 19 cells [unused2] could also enhance the migration and invasion of U2 ##OS cells , suggesting that the promoting role of C ##X ##CL ##5 in U2 ##OS cell migration and invasion is also in a para ##c ##rine - dependent manner . According to these data , our study demonstrates that C ##X ##CL ##5 is up ##re ##gu ##lated [SEP]',\n",
    "  'existing_cui': 'C3640056',\n",
    "  'existing_cui_name': 'CD19CAR-CD3zeta-4-1BB-expressing Allogeneic T-lymphocyte Cells',\n",
    "  'existing_cui_desc': '[CLS] CD ##19 ##CA ##R - CD ##3 ##ze ##ta - 4 - 1 ##BB - expressing All ##ogen ##ei ##c T - l ##ymph ##oc ##yte Cell ##s [unused3] ( Ana ##tom ##ical Structure : CA ##RT - 19 Cell ##s ) [SEP]',\n",
    "  'our_bi_cui': 'C0007634',\n",
    "  'our_bi_cui_name': 'Cells',\n",
    "  'our_bi_cui_desc': '[CLS] Cell ##s [unused3] ( Ana ##tom ##ical Structure , Biology , body structure , cell structure : Cell ##s set ; Cell Type ; cells ; { Cell ##s } ; Normal Cell ; Set of cells ; Cell ##ular structures ; Cell structure ; Cell ; cell ; Cell ##ular structure ; the cell ; Cell ##ular ; Cell Type ##s ; Normal cell ; Cell ##ula ) [SEP]',\n",
    "  'our_cross_cui': 'C0029418',\n",
    "  'our_cross_cui_name': 'Osteoblasts',\n",
    "  'our_cross_cui_desc': '[CLS] O ##ste ##ob ##last ##s [unused3] ( Ana ##tom ##ical Structure , cell : o ##ste ##ob ##last ##s ; o ##ste ##ob ##last ; cells o ##ste ##ob ##last ##s ; cells o ##ste ##ob ##last ; O ##ste ##ob ##last ) [SEP]'},\n",
    " {'mention_id': '28441489.18',\n",
    "  'test_set_idx': 36140,\n",
    "  'type': 'T033',\n",
    "  'name': 'cold - start',\n",
    "  'context': '[CLS] ##yna ##mo ##meter using the cold - start unified cycle . The fleet included 15 gasoline direct - injection vehicles , including 8 G ##DI ##s certified to the most - string ##ent emissions standard , super ##ult ##ra - low - emission vehicles . We q ##uant ##ified the effects of engine technology , emission certification standards , and [unused1] cold - start [unused2] on emissions . For vehicles certified to the same emissions standard , there is no statistical difference of regulated gas - phase poll ##uta ##nt emissions between P ##FI ##s and G ##DI ##s . However , G ##DI ##s had , on average , a factor of 2 higher part ##iculate matter mass emissions than P ##FI ##s due to [SEP]',\n",
    "  'existing_cui': 'C0452588',\n",
    "  'existing_cui_name': 'Start brand of breakfast cereal',\n",
    "  'existing_cui_desc': '[CLS] Start brand of breakfast cereal [unused3] ( Food , substance : Start ) [SEP]',\n",
    "  'our_bi_cui': 'C0022885',\n",
    "  'our_bi_cui_name': 'Laboratory Procedures',\n",
    "  'our_bi_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27587730.21',\n",
    "  'test_set_idx': 10760,\n",
    "  'type': 'T103',\n",
    "  'name': 'gga-miR-21',\n",
    "  'context': \"[CLS] ##ga - mi ##R - 21 in chicken pre - ad ##ip ##oc ##yte proliferation . Cell proliferation ass ##ay and gene expression analysis of pro ##life ##rating cell nuclear anti ##gen showed that the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the [unused1] g ##ga - mi ##R - 21 [unused2] inhibitor enhanced pre - ad ##ip ##oc ##yte proliferation . The subsequent investigation identified K ##rup ##pel - like factor 5 m ##RNA as a target of g ##ga - mi ##R - 21 . The g ##ga - mi ##R - 21 mimic in ##hibit ##ed K ##rup ##pel - like factor 5 3 ( ' ) U [SEP]\",\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1537719',\n",
    "  'our_bi_cui_name': 'MIR21 gene',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '27430240.52',\n",
    "  'test_set_idx': 5378,\n",
    "  'type': 'T058',\n",
    "  'name': 'dual - luciferase reporter assay',\n",
    "  'context': '[CLS] E ##2 ##F transcription factor 1 or c ##yclic ad ##eno ##sin ##e mon ##op ##hos ##phate response element - binding protein ( CR ##E ##B ) , which are predicted transcription regulatory factors of CD ##39 or CD ##7 ##3 . The regulatory relationships among these factors were then determined by western b ##lot analysis and [unused1] dual - l ##uc ##ifer ##ase reporter ass ##ay [unused2] . In addition , changes in ad ##eno ##sin ##e metabolism were measured in the treated cells . The results revealed that ad ##eno ##sin ##e and C ##GS ##21 ##6 ##80 significantly up ##re ##gu ##lated CD ##39 and CD ##7 ##3 expression ( P < 0 . 01 ) . E ##2 ##F transcription factor 1 [SEP]',\n",
    "  'existing_cui': 'C1324309',\n",
    "  'existing_cui_name': 'Latia-luciferin monooxygenase ( demethylating ) activity',\n",
    "  'existing_cui_desc': '[CLS] La ##tia - l ##uc ##ifer ##in mon ##oo ##xy ##gen ##ase ( dem ##eth ##yla ##ting ) activity [unused3] ( B ##iol ##og ##ic Fun ##ction , La ##tia l ##uc ##ifer ##in , dem ##eth ##yla ##ting : l ##uc ##ifer ##ase ; La ##tia - l ##uc ##ifer ##in , hydrogen - donor : oxygen o ##xi ##dor ##ed ##uc ##tase ; La ##tia l ##uc ##ifer ##in mon ##oo ##xy ##gen ##ase ) [SEP]',\n",
    "  'our_bi_cui': 'C0005507',\n",
    "  'our_bi_cui_name': 'Biological Assay',\n",
    "  'our_bi_cui_desc': '[CLS] Biological As ##say [unused3] ( Health Care Act ##ivity , procedure : B ##io ##ass ##ays ; B ##iol ##og ##ic As ##say ##s ; B ##IO ##L AS ##SA ##Y ; B ##IO ##L AS ##SA ##Y ##S ; As ##say ; As ##say ##s , Biological ; bio ##ass ##ay ; As ##say , Biological ; bio ##ass ##ays ; B ##io ##ass ##ay ; Biological As ##say ##s ; AS ##SA ##Y B ##IO ##L ; B ##iol ##og ##ic As ##say ; As ##say , B ##iol ##og ##ic ; AS ##SA ##Y ##S B ##IO ##L ; As ##say ##s , B ##iol ##og ##ic ; Biological ass ##ay ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '27762482.20',\n",
    "  'test_set_idx': 15898,\n",
    "  'type': 'T074',\n",
    "  'name': 'PDL',\n",
    "  'context': '[CLS] ##ura , we designed the fraction ##ation of high flu ##ence using five passes and longer pulse duration ( 6 mill ##ise ##con ##ds ) of a PD ##L in succession . A total of eight patients with er ##yt ##hem ##ato ##tel ##ang ##ie ##ct ##atic r ##osa ##cea were enrolled in this study ; all patients were treated with [unused1] PD ##L [unused2] 10 times at 2 - week intervals . E ##ry ##them ##a and te ##lang ##ie ##ct ##asi ##a scores , as well as improvement , were assessed by two physicians using the digital photographs . Mode ##rate - to - marked improvement was achieved in most of the patients , and er ##yt ##hem ##a and te ##lang ##ie ##ct [SEP]',\n",
    "  'existing_cui': 'C1414066',\n",
    "  'existing_cui_name': 'DLG5 gene',\n",
    "  'existing_cui_desc': '[CLS] DL ##G ##5 gene [unused3] ( Ana ##tom ##ical Structure : K ##IA ##A ##0 ##5 ##8 ##3 ; D ##IS ##CS LA ##R ##GE , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF , 5 ; P - d ##l ##g ; discs large ho ##mo ##log 5 ; P ##LA ##CE ##NT ##A AND PR ##OS ##TA ##TE DL ##G ) [SEP]',\n",
    "  'our_bi_cui': 'C0031740',\n",
    "  'our_bi_cui_name': 'Photochemotherapy',\n",
    "  'our_bi_cui_desc': '[CLS] Photo ##che ##mother ##ap ##y [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : PD ##T - Photo ##dynamic therapy ; Photo ##che ##mother ##ap ##ies ; Photo ##dynamic The ##rap ##ies ; therapy , photo ##dynamic ; Therapy , Photo ##dynamic ; THE ##R P ##H ##OT ##OD ##Y ##NA ##MI ##C ; Photo ##rad ##iation Therapy ; photo ##dynamic therapy ; photo ##che ##mother ##ap ##y ; P ##H ##OT ##OC ##H ##EM ##OT ##H ##ER ; The ##rap ##ies , Photo ##dynamic ; Photo ##dynamic Therapy Pro ##ced ##ures ; neo ##p ##las ##m / cancer photo ##rad ##iation therapy ; Photo ##che ##mother ##ap ##y [ Am ##bi ##guous ] ; Photo ##dynamic therapy ; PD [SEP]',\n",
    "  'our_cross_cui': 'C1289859',\n",
    "  'our_cross_cui_name': 'Pulsed Dye Lasers',\n",
    "  'our_cross_cui_desc': '[CLS] P ##ulse ##d D ##ye Las ##ers [unused3] ( Medical Devi ##ce , physical object : D ##ye Las ##ers , P ##ulse ##d ; P ##ulse ##d dye laser device ; Las ##er , P ##ulse ##d D ##ye ; D ##ye Las ##er , P ##ulse ##d ; Las ##ers , P ##ulse ##d D ##ye ; P ##ulse ##d D ##ye Las ##er ; pulsed dye laser ; P ##ulse ##d dye laser ) [SEP]'},\n",
    " {'mention_id': '28197156.12',\n",
    "  'test_set_idx': 28082,\n",
    "  'type': 'T017',\n",
    "  'name': 'Carbon Assimilation Rate 8',\n",
    "  'context': '[CLS] in rice ( Or ##y ##za sat ##iva ) . Ex ##p ##lo ##iting the natural variation in CO ##2 ass ##im ##ilation rate ( A ) between rice cult ##iva ##rs using quantitative genetics is one promising means to identify genes contributing to higher photos ##ynth ##esis . In this study , we determined precise location of [unused1] Carbon As ##si ##mi ##lation Rate 8 [unused2] by crossing a high - yielding in ##dic ##a cult ##iva ##r with a Japanese commercial cult ##iva ##r . Fine mapping suggested that Carbon As ##si ##mi ##lation Rate 8 en ##codes a put ##ative He ##me Act ##iva ##tor Pro ##tein 3 ( O ##s ##HA ##P ##3 ) subunit of a CC ##AA ##T - box [SEP]',\n",
    "  'existing_cui': 'C2246620',\n",
    "  'existing_cui_name': 'iron assimilation',\n",
    "  'existing_cui_desc': '[CLS] iron ass ##im ##ilation [unused3] ( B ##iol ##og ##ic Fun ##ction ) [SEP]',\n",
    "  'our_bi_cui': 'C1413023',\n",
    "  'our_bi_cui_name': 'C8A gene',\n",
    "  'our_bi_cui_desc': '[CLS] C ##8 ##A gene [unused3] ( Ana ##tom ##ical Structure : complement component 8 alpha subunit ; CO ##MP ##LE ##ME ##NT CO ##MP ##ON ##EN ##T 8 , AL ##P ##HA S ##U ##B ##UN ##IT ; C ##8 AL ##P ##HA ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27373772.13',\n",
    "  'test_set_idx': 4071,\n",
    "  'type': 'T038',\n",
    "  'name': 'functioning',\n",
    "  'context': '[CLS] and ne ##uron ##al commitment in the rat den ##tate g ##yr ##us Adult hip ##po ##cam ##pal ne ##uro ##genesis can be m ##od ##ulated by various physiological and path ##ological conditions , including stress , affect ##ive disorders , and several ne ##uro ##logical conditions . Given the proposed role of this form of structural plastic ##ity in the [unused1] functioning [unused2] of the hip ##po ##cam ##pus ( namely learning and memory and affect ##ive behaviors ) , it is believed that alterations in hip ##po ##cam ##pal ne ##uro ##genesis might under ##lie some of the behavioral deficit ##s associated with these psychiatric and ne ##uro ##logical conditions . Thus , the search for compounds that can reverse these deficit ##s with [SEP]',\n",
    "  'existing_cui': 'C2986655',\n",
    "  'existing_cui_name': 'Functioning Endocrine Neoplasm',\n",
    "  'existing_cui_desc': '[CLS] Fun ##ction ##ing End ##oc ##rine Neo ##p ##las ##m [unused3] ( B ##iol ##og ##ic Fun ##ction : functioning tumor ) [SEP]',\n",
    "  'our_bi_cui': 'C0007613',\n",
    "  'our_bi_cui_name': 'Cell physiology',\n",
    "  'our_bi_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]',\n",
    "  'our_cross_cui': 'C0031843',\n",
    "  'our_cross_cui_name': 'physiological aspects',\n",
    "  'our_cross_cui_desc': '[CLS] physiological aspects [unused3] ( B ##iol ##og ##ic Fun ##ction : P ##H ; physiology ; P ##H ##Y ##SI ##OL ; function ) [SEP]'},\n",
    " {'mention_id': '28125734.41',\n",
    "  'test_set_idx': 26195,\n",
    "  'type': 'T103',\n",
    "  'name': 'miR-21-5p',\n",
    "  'context': '[CLS] o ##li ##gos were employed to is ##olate mi ##RNA : : MS ##L ##N m ##RNA complexes from a normal cell line ( Met - 5 ##A ) which expresses low levels of me ##so ##the ##lin . Mi ##RNA ##s targeting the me ##so ##the ##lin m ##RNA were identified by next generation se ##quencing and [unused1] mi ##R - 21 - 5 ##p [unused2] and mi ##R - 100 - 5 ##p were selected for further valid ##ation analyses . Mi ##R - 21 - 5 ##p was shown to be able to m ##od ##ulate me ##so ##the ##lin expression in mi ##RNA mimic experiments in a panel of ma ##li ##gnant and non - ma ##li ##gnant cell lines . Further [SEP]',\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1999986',\n",
    "  'our_bi_cui_name': 'MIRN21 microRNA , human',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##N ##21 micro ##RNA , human [unused3] ( Chemical : micro ##RNA - 21 , human ; mi ##RNA - 21 , human ; h ##sa - mi ##r - 21 micro ##RNA ; mi ##R - 21 , human ; mi ##R ##21 , human ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '28183596.8',\n",
    "  'test_set_idx': 27754,\n",
    "  'type': 'T033',\n",
    "  'name': 'reduce/minimize',\n",
    "  'context': '[CLS] A numerical study on the application of the functional ##ly graded materials in the s ##ten ##t design Un ##des ##ira ##ble def ##orm ##ation of the s ##ten ##t can induce a significant amount of in ##jure not only to the blood vessel but also to the plaque . The objective of this study was to [unused1] reduce / minimize [unused2] these und ##esi ##rable def ##orm ##ations by the application of Fun ##ctional ##ly Grade ##d Materials . To do this , Fin ##ite El ##ement method was employed to si ##mu ##late the expansion of a s ##ten ##t and the corresponding displacement of the s ##ten ##osis plaque . Three h ##yper ##ela ##stic plaque types as well as five el ##ast [SEP]',\n",
    "  'existing_cui': 'C0340305',\n",
    "  'existing_cui_name': 'Inferior Wall Myocardial Infarction',\n",
    "  'existing_cui_desc': '[CLS] In ##fer ##ior Wall My ##oc ##ard ##ial In ##far ##ction [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : Di ##aph ##rag ##matic My ##oc ##ard ##ial In ##far ##ction ; inferior my ##oc ##ard ##ial in ##far ##ction ; In ##fer ##ior MI ; My ##oc ##ard ##ial In ##far ##ction , In ##fer ##ior ; Di ##aph ##rag ##matic My ##oc ##ard ##ial In ##far ##ctions ; In ##fer ##ior my ##oc ##ard ##ial in ##far ##ction ; In ##far ##ctions , Di ##aph ##rag ##matic My ##oc ##ard ##ial ; inferior mi ; My ##oc ##ard ##ial In ##far ##ction , In ##fer ##ior Wall ; In ##fer ##ior My ##oc ##ard ##ial In ##far ##ctions ; My ##oc ##ard [SEP]',\n",
    "  'our_bi_cui': 'C0441610',\n",
    "  'our_bi_cui_name': 'Reduction - action',\n",
    "  'our_bi_cui_desc': '[CLS] Red ##uction - action [unused3] ( Health Care Act ##ivity , qualifier value : Sur ##gical reduction ; reduction ##s ; reduction ; Red ##uction ; Red ##uction p ##last ##y ; surgical reduction ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27280034.3',\n",
    "  'test_set_idx': 1332,\n",
    "  'type': 'T082',\n",
    "  'name': 'Newcastle upon Tyne',\n",
    "  'context': \"[CLS] Changes in risk factors for young male suicide in [unused1] Newcastle upon Tyne [unused2] , 1961 - 2009 Ai ##ms and method To as ##cer ##tain differences in patterns of suicide in young men over three decades ( 1960s , 1990s and 2000s ) and discuss implications for suicide prevention . Data on suicide ##s and open verdict ##s in men aged 15 - 34 were obtained from co ##roner ' s records in Newcastle upon Tyne and anal ##ys ##ed using SP ##SS software . Results An increase in suicide rates from the first to the second decade was followed by a fall in the third decade . This was associated with an increasing proportion of single men , those living alone , unemployment , [SEP]\",\n",
    "  'existing_cui': 'C0027983',\n",
    "  'existing_cui_name': 'Newcastle Disease',\n",
    "  'existing_cui_desc': \"[CLS] Newcastle Disease [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , et ##iology , manifest ##ation : Disease , Newcastle ; new ##castle disease ; Newcastle ' s disease ; A ##vian p ##ne ##um ##oe ##nce ##pha ##lit ##is ; Newcastle disease [ Am ##bi ##guous ] ; P ##se ##udo - f ##ow ##l ##pes ##t ; disease ( or disorder ) ; Newcastle ; Newcastle disease ; Newcastle ; NE ##WC ##AS ##TL ##E D ##IS ; Newcastle fever ; Newcastle Disease [ Disease / Finding ] ) [SEP]\",\n",
    "  'our_bi_cui': 'C0454880',\n",
    "  'our_bi_cui_name': 'Tyne and Wear',\n",
    "  'our_bi_cui_desc': '[CLS] Tyne and We ##ar [unused3] ( Spa ##tial Concept , geographic location : T and W - Tyne and We ##ar ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '28077286.22',\n",
    "  'test_set_idx': 25072,\n",
    "  'type': 'T103',\n",
    "  'name': 'MeHg',\n",
    "  'context': '[CLS] ##air ##ments to cognitive motor functions in ma ##mmal ##ian models . However , in birds the ne ##uro ##to ##xi ##c effects of Me ##H ##g on the developing pre - hatch ##ing brain and con ##se ##quent behavioral alterations in adult birds have not received much attention . Moreover , pass ##eri ##ne birds are poorly represented in [unused1] Me ##H ##g [unused2] ne ##uro ##to ##xi ##cology studies in comparison to other a ##vian orders . Hence in this study , we used the egg injection method to investigate the long term effects of in o ##vo Me ##H ##g exposure on brain his ##top ##ath ##ology and courts ##hip behavior in a model song ##bird species , the z ##eb ##ra fin [SEP]',\n",
    "  'existing_cui': 'C0228520',\n",
    "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
    "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
    "  'our_bi_cui': 'C0025424',\n",
    "  'our_bi_cui_name': 'Mercury',\n",
    "  'our_bi_cui_desc': '[CLS] Mercury [unused3] ( Chemical , H ##g , Metal , elemental , substance : mercury ; Mercury [ Chemical / In ##g ##red ##ient ] ; metal mercury ; H ##yd ##rar ##gy ##rum ; H ##g element ; Li ##quid Silver ; Quick ##si ##lve ##r ; H ##g ; H ##g - Mercury ; h ##g ; ME ##RC ##UR ##Y ) [SEP]',\n",
    "  'our_cross_cui': 'C0025794',\n",
    "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
    "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
    " {'mention_id': '28249376.9',\n",
    "  'test_set_idx': 29879,\n",
    "  'type': 'T168',\n",
    "  'name': 'concentrate diet',\n",
    "  'context': '[CLS] Effects of a specific blend of essential oils on apparent nut ##rient dig ##est ##ion , r ##ume ##n f ##er ##mentation and r ##ume ##n micro ##bial populations in sheep fed a 50 : 50 al ##fa ##lf ##a hay : [unused1] concentrate diet [unused2] An experiment was conducted to investigate the effects of a specific mixture of essential oils , containing thy ##me , c ##love and c ##innamon E ##O , on r ##ume ##n micro ##bial f ##er ##mentation , nut ##rient apparent dig ##est ##ibility and blood meta ##bol ##ites in fist ##ulated sheep . Six sheep fitted with r ##umi ##nal fist ##ula ##s were used in a repeated measurement design with two 24 - d periods to investigate the [SEP]',\n",
    "  'existing_cui': 'C1880165',\n",
    "  'existing_cui_name': 'Concentrate Dosage Form',\n",
    "  'existing_cui_desc': '[CLS] Con ##cent ##rate Do ##sa ##ge Form [unused3] ( Chemical : Con ##cent ##rated ; Con ##cent ##rate ; CO ##NC ; CO ##NC ##EN ##TR ##AT ##E ; Con ##c ; Con ##cent ##rated Do ##sa ##ge Form ; Con ##cent ##rated Do ##se Form ) [SEP]',\n",
    "  'our_bi_cui': 'C0003050',\n",
    "  'our_bi_cui_name': 'Animal feed',\n",
    "  'our_bi_cui_desc': '[CLS] Animal feed [unused3] ( Food , substance , substance : animal food ; animal feeds ; animal feeding ; animals food ; food animal ; Fe ##eds , Animal ; Animal Fe ##ed ; Fe ##ed , Animal ; animal feed ; Animal Fe ##eds ) [SEP]',\n",
    "  'our_cross_cui': 'C0012155',\n",
    "  'our_cross_cui_name': 'Diet',\n",
    "  'our_cross_cui_desc': '[CLS] Diet [unused3] ( Food , finding : Diet ##s ; regular diet ? ; Diet ##ary ; diet ; Diet ##ary finding ; diet ##s ) [SEP]'},\n",
    " {'mention_id': '27886280.72',\n",
    "  'test_set_idx': 20784,\n",
    "  'type': 'T038',\n",
    "  'name': 'production',\n",
    "  'context': '[CLS] C ##ip ##ro ##f ##lo ##xa ##cin ( F ##lu ##oro ##quin ##olo ##ne ) at a low concentration resulted in killing of both cultures of P . a ##er ##ug ##ino ##sa , producing per ##sist ##ers that were in ##vu ##ln ##era ##ble to killing . Station ##ary cells appear to be somewhat more tolerant than ex ##po ##nent ##ial cells in all of these ass ##ays . We also showed that nut ##rient de ##p ##ri ##vation ( se ##rine starvation ) regulated by string ##ent and general stress response , contribute to the increased tolerance of P . a ##er ##ug ##ino ##sa ex ##po ##nent ##ial and stationary plan ##kt ##onic cells via [unused1] production [unused2] of per ##sist ##ers . [SEP]',\n",
    "  'existing_cui': 'C1548180',\n",
    "  'existing_cui_name': 'Production Processing ID',\n",
    "  'existing_cui_desc': '[CLS] Production Process ##ing ID [unused3] ( Intel ##lect ##ual Product : Production ) [SEP]',\n",
    "  'our_bi_cui': 'C0220781',\n",
    "  'our_bi_cui_name': 'Anabolism',\n",
    "  'our_bi_cui_desc': '[CLS] Ana ##bol ##ism [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : bio ##sy ##nt ##hetic process ; Ana ##bol ##ism , function ; synthesis ; bio ##sy ##nt ##hesis ; formation ; B ##ios ##ynth ##etic ; B ##ios ##ynth ##esis ; B ##io ##genesis ; B ##ios ##ynth ##etic Process ; an ##ab ##olis ##m ) [SEP]',\n",
    "  'our_cross_cui': 'C0007613',\n",
    "  'our_cross_cui_name': 'Cell physiology',\n",
    "  'our_cross_cui_desc': '[CLS] Cell physiology [unused3] ( B ##iol ##og ##ic Fun ##ction : cell physiology ; Cell ##ular Process ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##a ; Cell ##ular Fun ##ction ; cells physiology ; Cell ##ular Ph ##ys ##iology ; Sub ##cellular Process ; cells function ; cell function ; Cell Ph ##ys ##iol ##ogical Ph ##eno ##men ##on ; Cell Ph ##ys ##iology ; Cell Process ; Cell Fun ##ction ; CE ##LL P ##H ##Y ##SI ##OL ; P ##H ##Y ##SI ##OL CE ##LL ; cell functions ; Ph ##eno ##men ##a , Cell Ph ##ys ##iol ##ogical ; Ph ##ys ##iology , Cell ; Ph ##eno ##men ##on , Cell Ph ##ys ##iol ##ogical ) [SEP]'},\n",
    " {'mention_id': '27669217.30',\n",
    "  'test_set_idx': 13681,\n",
    "  'type': 'T033',\n",
    "  'name': 'MIC',\n",
    "  'context': '[CLS] ##hr ##omy ##cin , and 512 mg / L for c ##lar ##ith ##rom ##y ##cin ) . E ##ff ##lux - encoding me ##f ##A and me ##f ##E genes were not detect ##able in these is ##olate ##s . The presence of 23 ##S r ##RNA mutations in specific is ##olate ##s did not significantly change mac ##rol ##ide [unused1] MI ##C [unused2] s . No n ##uc ##leo ##tide substitution ##s were found in genes encoding rib ##oso ##mal proteins L ##4 or L ##22 . The er ##m ##B and er ##m ##T genes were found in the genome ##s of all is ##olate ##s . These two genes were acquired independently in one highly v ##ir ##ulent is ##olate AL ##10 [SEP]',\n",
    "  'existing_cui': 'C2732473',\n",
    "  'existing_cui_name': 'Ductal Carcinoma In Situ with Microinvasion',\n",
    "  'existing_cui_desc': '[CLS] Du ##ct ##al Car ##cin ##oma In Sit ##u with Micro ##in ##vas ##ion [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : Micro ##in ##vasive B ##rea ##st Car ##cin ##oma ; MI ##C ; Du ##ct ##al car ##cin ##oma in sit ##u with micro ##in ##vas ##ion ) [SEP]',\n",
    "  'our_bi_cui': 'C0427978',\n",
    "  'our_bi_cui_name': 'Minimum Inhibitory Concentration measurement',\n",
    "  'our_bi_cui_desc': '[CLS] Mini ##mum In ##hibit ##ory Con ##cent ##ration measurement [unused3] ( Health Care Act ##ivity , MI ##C , procedure , qualifier value : Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test ; Con ##cent ##rations , Mini ##mum In ##hibit ##ory ; Anti ##biotic sensitivity , minimum inhibitor ##y concentration ; MI ##C su ##s ##ce ##pt ##ibility test ; Mini ##mum In ##hibit ##ory Con ##cent ##rations ; MI ##C - Mini ##mum inhibitor ##y concentration ; Con ##cent ##ration , Mini ##mum In ##hibit ##ory ; Mini ##mum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration su ##s ##ce ##pt ##ibility test technique ; In ##hibit ##ory Con ##cent ##rations , Mini ##mum ; Mini ##mum In ##hibit ##ory [SEP]',\n",
    "  'our_cross_cui': 'C1304747',\n",
    "  'our_cross_cui_name': 'Minimum inhibitory concentration result',\n",
    "  'our_cross_cui_desc': '[CLS] Mini ##mum inhibitor ##y concentration result [unused3] ( Finding , finding : minimum inhibitor ##y concentration ; Mini ##mum inhibitor ##y concentration finding ) [SEP]'},\n",
    " {'mention_id': '27444636.25',\n",
    "  'test_set_idx': 5976,\n",
    "  'type': 'T170',\n",
    "  'name': 'Adverse Events Profile',\n",
    "  'context': '[CLS] at least 4 weeks were switched overnight to es ##lica ##rb ##az ##ep ##ine ace ##tate . Pat ##ients were switched because they experienced persistent seizure ##s with o ##x ##car ##ba ##ze ##pine but were unable to tolerate increased o ##x ##car ##ba ##ze ##pine dos ##ing due to adverse events . To ##ler ##ability was assessed using the [unused1] Ad ##verse Events Profile [unused2] , quality of life was assessed using the Quality of Life in E ##pile ##psy In ##vent ##ory 10 , and alert ##ness was assessed as reaction time using a sub ##test of the Test Battery for At ##ten ##tion Performance version 2 . 3 . Assessment ##s were performed immediately prior to and 5 days after switching from o [SEP]',\n",
    "  'existing_cui': 'C0877248',\n",
    "  'existing_cui_name': 'Adverse event',\n",
    "  'existing_cui_desc': '[CLS] Ad ##verse event [unused3] ( B ##iol ##og ##ic Fun ##ction : AD ##VE ##RS ##E E ##VE ##NT ; adverse events ; Ad ##verse Event ; adverse event ; Ad ##verse ##E ##vent ; Ad ##verse Experience ) [SEP]',\n",
    "  'our_bi_cui': 'C1521800',\n",
    "  'our_bi_cui_name': 'Adverse Drug Experience Report',\n",
    "  'our_bi_cui_desc': '[CLS] Ad ##verse Drug Experience Report [unused3] ( Intel ##lect ##ual Product : Ad ##verse Drug Report ; Ad ##verse Experience Report ; Ad ##verse Event Report ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28254329.46',\n",
    "  'test_set_idx': 30171,\n",
    "  'type': 'T033',\n",
    "  'name': 'hydroxylation degree',\n",
    "  'context': '[CLS] ##or ##ption , blood wet ##ta ##bility , bacterial and cell ad ##hesion were evaluated in order to investigate the correlation ##s between the surface p ##hy ##sio ##chemical properties and biological responses . From a method ##ological stand ##point , X ##PS and electro ##kin ##etic measurements emerged as the more suitable techniques respectively for the evaluation of [unused1] h ##ydro ##xy ##lation degree [unused2] and surface charge / is ##oe ##lect ##ric point . Moreover , determination of wet ##ta ##bility by blood appeared a specific and crucial test , the results of which are not easily predictable by using other type of tests . H ##ydro ##xy ##lation degree resulted correlated to the wet ##ta ##bility by water , but not directly to [SEP]',\n",
    "  'existing_cui': 'C1159294',\n",
    "  'existing_cui_name': 'protein hydroxylation',\n",
    "  'existing_cui_desc': '[CLS] protein h ##ydro ##xy ##lation [unused3] ( B ##iol ##og ##ic Fun ##ction : protein amino acid h ##ydro ##xy ##lation ) [SEP]',\n",
    "  'our_bi_cui': 'C0700307',\n",
    "  'our_bi_cui_name': 'hydroxyl group',\n",
    "  'our_bi_cui_desc': '[CLS] h ##ydro ##xy ##l group [unused3] ( Chemical : H ##ydro ##xy ##l group ; H ##ydro ##xy ##l Group ; h ##ydro ##xy ##l group ( OH ) - that consists of an oxygen atom joined to a hydrogen atom ; H ##ydro ##xy ; h ##ydro ##xy ##l group ( OH ) [ functional group ] - that consists of an oxygen atom joined to a hydrogen atom ; H ##ydro ##xy ##l ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28400056.14',\n",
    "  'test_set_idx': 34669,\n",
    "  'type': 'T103',\n",
    "  'name': 'EN 12791',\n",
    "  'context': '[CLS] study was to determine if me ##ce ##tron ##ium et ##ils ##ulf ##ate contributes to overall efficacy in surgical hand di ##sin ##fect ##ion . Three blinded hand rub ##s ( 45 % is ##o - prop ##ano ##l , 30 % n - prop ##ano ##l ) were applied for 1 . 5 min and compared with the [unused1] E ##N 127 ##9 ##1 [unused2] reference procedure ( crossover design ) . One commercial hand rub contained 0 . 2 % me ##ce ##tron ##ium et ##ils ##ulf ##ate , and the two other hand rub ##s were identical apart from 0 . 2 % me ##ce ##tron ##ium et ##ils ##ulf ##ate . None of the formulation ##s had a log ##10 reduction after [SEP]',\n",
    "  'existing_cui': 'C3899313',\n",
    "  'existing_cui_name': 'EN1 wt Allele',\n",
    "  'existing_cui_desc': '[CLS] E ##N ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : En - 1 ; En ##gra ##iled Home ##ob ##ox 1 w ##t All ##ele ) [SEP]',\n",
    "  'our_bi_cui': 'C0013983',\n",
    "  'our_bi_cui_name': 'Emollients',\n",
    "  'our_bi_cui_desc': '[CLS] Em ##oll ##ients [unused3] ( Chemical , product , substance : Em ##oll ##ient - Mi ##s ##c ; [ DE ##35 ##0 ] E ##MO ##LL ##IE ##NT ##S ; em ##oll ##ients ; E ##MO ##LL ##IE ##NT ##S ; em ##oll ##ient ; Em ##oll ##ient ; Em ##oll ##ient product ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28392427.22',\n",
    "  'test_set_idx': 34338,\n",
    "  'type': 'T058',\n",
    "  'name': 'CBA',\n",
    "  'context': '[CLS] s ##CD ##25 have repeatedly been reported altered in patients with mood disorders . The aim of this study was to investigate levels of these factors in serum of adolescent bi ##pol ##ar offspring , who have a heightened risk for mood disorder development and to also analyze the data combined with previously published data . Growth factors were assessed by [unused1] CB ##A [unused2] / E ##L ##IS ##A in adolescent bi ##pol ##ar offspring ( n = 96 , mean age = 16 years ) and in age - and gender - matched healthy controls ( n = 50 ) . E ##pid ##er ##mal Growth Factor belonged to a mutually co ##rrel ##ating cluster of mainly ne ##uro ##tro ##phic compounds including S [SEP]',\n",
    "  'existing_cui': 'C0025922',\n",
    "  'existing_cui_name': 'Mice , Inbred CBA',\n",
    "  'existing_cui_desc': '[CLS] Mi ##ce , In ##bred CB ##A [unused3] ( E ##uka ##ryo ##te : CB ##A ; CB ##A Mi ##ce , In ##bred ; Mi ##ce , CB ##A ; CB ##A Mouse , In ##bred ; CB ##A Mouse ; Mouse , In ##bred CB ##A ; Mouse , CB ##A ; CB ##A Mi ##ce ; In ##bred CB ##A Mouse ; In ##bred CB ##A Mi ##ce ) [SEP]',\n",
    "  'our_bi_cui': 'C0201563',\n",
    "  'our_bi_cui_name': 'Concanavalin A assay',\n",
    "  'our_bi_cui_desc': '[CLS] Con ##can ##ava ##lin A ass ##ay [unused3] ( Health Care Act ##ivity , procedure : Con A ass ##ay ) [SEP]',\n",
    "  'our_cross_cui': 'C0005507',\n",
    "  'our_cross_cui_name': 'Biological Assay',\n",
    "  'our_cross_cui_desc': '[CLS] Biological As ##say [unused3] ( Health Care Act ##ivity , procedure : B ##io ##ass ##ays ; B ##iol ##og ##ic As ##say ##s ; B ##IO ##L AS ##SA ##Y ; B ##IO ##L AS ##SA ##Y ##S ; As ##say ; As ##say ##s , Biological ; bio ##ass ##ay ; As ##say , Biological ; bio ##ass ##ays ; B ##io ##ass ##ay ; Biological As ##say ##s ; AS ##SA ##Y B ##IO ##L ; B ##iol ##og ##ic As ##say ; As ##say , B ##iol ##og ##ic ; AS ##SA ##Y ##S B ##IO ##L ; As ##say ##s , B ##iol ##og ##ic ; Biological ass ##ay ) [SEP]'},\n",
    " {'mention_id': '28436493.26',\n",
    "  'test_set_idx': 35792,\n",
    "  'type': 'T103',\n",
    "  'name': 'EsxA',\n",
    "  'context': '[CLS] , it suggested a defect in the E ##S ##X - 1 type VII secret ##ion system . Gene ##tic complement ##ation with a p ##las ##mi ##d carrying the My ##co ##ba ##cter ##ium tuberculosis H ##37 ##R ##v sequence of e ##cc ##C ##a ##1 - e ##cc ##C ##b ##1 - p ##e ##35 re - established [unused1] E ##s ##x ##A [unused2] secret ##ion , host specific E ##s ##x ##A T - cell responses , and increased strain v ##ir ##ule ##nce . The E ##S ##X - 1 secret ##ion defect prevents several v ##ir ##ule ##nce factors from being functional during infection and therefore at ##ten ##uate ##s My ##co ##ba ##cter ##ium tuberculosis . It pre ##c ##lude [SEP]',\n",
    "  'existing_cui': 'C1706322',\n",
    "  'existing_cui_name': 'ELF3 wt Allele',\n",
    "  'existing_cui_desc': '[CLS] E ##LF ##3 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : E ##SE - 1 ; ER ##T ; J ##EN ; E ##S ##X ; E ##7 ##4 - Like Factor 3 ( ET ##S Domain Trans ##cription Factor , E ##pit ##hel ##ial - S ##pecific ) w ##t All ##ele ; EP ##R - 1 ) [SEP]',\n",
    "  'our_bi_cui': 'C1822656',\n",
    "  'our_bi_cui_name': 'SCXA gene',\n",
    "  'our_bi_cui_desc': '[CLS] SC ##X ##A gene [unused3] ( Ana ##tom ##ical Structure : SC ##LE ##RA ##X ##IS , M ##O ##US ##E , H ##OM ##OL ##O ##G OF , A ; SC ##LE ##RA ##X ##IS ) [SEP]',\n",
    "  'our_cross_cui': 'C1744314',\n",
    "  'our_cross_cui_name': 'ESAT-6 protein , Mycobacterium tuberculosis',\n",
    "  'our_cross_cui_desc': '[CLS] E ##SA ##T - 6 protein , My ##co ##ba ##cter ##ium tuberculosis [unused3] ( Chemical : E ##SA ##T - 6 System 1 protein , My ##co ##ba ##cter ##ium tuberculosis ; 6 - k ##D ##a early secret ##ory anti ##genic target , My ##co ##ba ##cter ##ium tuberculosis ; E ##s ##x - 1 protein , My ##co ##ba ##cter ##ium tuberculosis ; E ##s ##x ##A protein , My ##co ##ba ##cter ##ium tuberculosis ) [SEP]'},\n",
    " {'mention_id': '27857693.31',\n",
    "  'test_set_idx': 19410,\n",
    "  'type': 'T058',\n",
    "  'name': 'IHRT',\n",
    "  'context': '[CLS] . 2 % greater change , 90 % Con ##fi ##dence Inter ##val 1 . 6 : 14 . 9 % , effect size 0 . 49 ) . Only I ##H ##RT increased counter ##mo ##ve ##ment jump peak power at Post ( 4 . 9 % , effect size 0 . 35 ) , however the difference between [unused1] I ##H ##RT [unused2] and place ##bo was unclear ( 2 . 7 , 90 % Con ##fi ##dence Inter ##val - 2 . 0 : 7 . 6 % , effect size 0 . 20 ) with no clear differences in speed or body composition throughout . Con ##c ##lusion : Heavy resistance training in h ##y ##pox ##ia is more effective than place [SEP]',\n",
    "  'existing_cui': 'C0020669',\n",
    "  'existing_cui_name': 'Hypothalamus , Middle',\n",
    "  'existing_cui_desc': '[CLS] H ##y ##pot ##hala ##mus , Middle [unused3] ( Ana ##tom ##ical Structure : Area h ##y ##pot ##hala ##mic ##a inter ##media ; Media ##l H ##y ##pot ##hala ##mus ; Intermediate h ##y ##pot ##hala ##mic area ; Intermediate H ##y ##pot ##hala ##mic Region ; Region , Intermediate H ##y ##pot ##hala ##mic ; Reg ##io h ##y ##pot ##hala ##mic ##a inter ##media ; Middle H ##y ##pot ##hala ##mus ; H ##y ##pot ##hala ##mic Region ##s , Intermediate ; H ##y ##pot ##hala ##mic Region , Intermediate ; Intermediate H ##y ##pot ##hala ##mic Region ##s ; Intermediate h ##y ##pot ##hala ##mic region ; intermediate h ##y ##pot ##hala ##mic region ; H ##y ##pot ##hala ##mus , Media [SEP]',\n",
    "  'our_bi_cui': 'C0282402',\n",
    "  'our_bi_cui_name': 'Hormone replacement therapy',\n",
    "  'our_bi_cui_desc': '[CLS] Ho ##rmon ##e replacement therapy [unused3] ( Health Care Act ##ivity , H ##RT , hormone replacement therapy , procedure : hormone replacement therapy ; Therapy , Ho ##rmon ##e Rep ##lace ##ment ; hormone replacement the ##rap ##ies ; H ##OR ##MO ##NE R ##EP ##LA ##CE THE ##R ; hormone replacement ##s ; H ##RT - Ho ##rmon ##e replacement therapy ; ER ##T ; Ho ##rmon ##e Rep ##lace ##ment Therapy ; Rep ##lace ##ment The ##rap ##ies , Ho ##rmon ##e ; hormones replacement ; men ##op ##aus ##al hormone therapy ; Rep ##lace ##ment Therapy , Ho ##rmon ##e ; R ##EP ##LA ##CE THE ##R H ##OR ##MO ##NE ; Ho ##rmon ##e Rep ##lace ##ment R ##x ; THE [SEP]',\n",
    "  'our_cross_cui': 'C0872279',\n",
    "  'our_cross_cui_name': 'Resistance Training',\n",
    "  'our_cross_cui_desc': '[CLS] Resistance Training [unused3] ( Health Care Act ##ivity : Training , Resistance ; St ##ren ##gth Training ; strength train ; strength training ; Training , St ##ren ##gth ) [SEP]'},\n",
    " {'mention_id': '27587730.26',\n",
    "  'test_set_idx': 10765,\n",
    "  'type': 'T103',\n",
    "  'name': 'gga-miR-21',\n",
    "  'context': \"[CLS] the g ##ga - mi ##R - 21 mimic in ##hibit ##ed pre - ad ##ip ##oc ##yte proliferation . In contrast , the g ##ga - mi ##R - 21 inhibitor enhanced pre - ad ##ip ##oc ##yte proliferation . The subsequent investigation identified K ##rup ##pel - like factor 5 m ##RNA as a target of [unused1] g ##ga - mi ##R - 21 [unused2] . The g ##ga - mi ##R - 21 mimic in ##hibit ##ed K ##rup ##pel - like factor 5 3 ( ' ) U ##TR reporter activity and decreased end ##ogen ##ous K ##rup ##pel - like factor 5 expression in primary pre - ad ##ip ##ocytes . K ##rup ##pel - like factor 5 knock ##down using [SEP]\",\n",
    "  'existing_cui': 'C1537719',\n",
    "  'existing_cui_name': 'MIR21 gene',\n",
    "  'existing_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_bi_cui': 'C1537719',\n",
    "  'our_bi_cui_name': 'MIR21 gene',\n",
    "  'our_bi_cui_desc': '[CLS] MI ##R ##21 gene [unused3] ( Ana ##tom ##ical Structure : micro ##RNA 21 ; MI ##R ##N ##21 ; Micro ##RNA 21 Gene ; h ##sa - mi ##r - 21 ; MI ##R ##21 Gene ; MI ##R - 21 ; mi ##RNA ##21 ; MI ##CR ##O RNA 21 ) [SEP]',\n",
    "  'our_cross_cui': 'C1101610',\n",
    "  'our_cross_cui_name': 'MicroRNAs',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##RNA ##s [unused3] ( Chemical : micro ##rna ; Micro ##RNA ##s [ Chemical / In ##g ##red ##ient ] ; micro ##RNA ; mi ##RNA ##s ; mi ##RNA ; mi ##rna ; micro - RNA ; RNA , Micro ; Micro RNA ; MI ##R ; Micro ##RNA ) [SEP]'},\n",
    " {'mention_id': '28127853.14',\n",
    "  'test_set_idx': 26308,\n",
    "  'type': 'T170',\n",
    "  'name': 'Spiritual Health Scale',\n",
    "  'context': '[CLS] attended the 12 - week program and completed the pre - test and post - test . There were 16 middle - aged and nine older adults recruited from a district of Taipei , and nine young adults recruited from the principal investigator \\' s university . The \" At ##ti ##tudes toward A ##ging Scale \" and the \" [unused1] Spiritual Health Scale [unused2] \" were two assessment instruments used in the study . The results showed that there were significant improvements in the At ##ti ##tudes toward A ##ging Scale for the young adult group ( aged 18 - 29 years ) and in the Spiritual Health Scale for the older adult group ( aged 65 - 80 years ) . The evaluation showed [SEP]',\n",
    "  'existing_cui': 'C0686997',\n",
    "  'existing_cui_name': 'Spiritual health of patient',\n",
    "  'existing_cui_desc': '[CLS] Spiritual health of patient [unused3] ( Finding , o ##bs ##er ##vable entity : Spiritual health ; Spiritual condition of patient ; spiritual health ; health spiritual ; Spiritual Health ) [SEP]',\n",
    "  'our_bi_cui': 'C1998888',\n",
    "  'our_bi_cui_name': 'Spiritual Well Being',\n",
    "  'our_bi_cui_desc': '[CLS] Spiritual Well Being [unused3] ( Intel ##lect ##ual Product : Spiritual Well - being ; spiritual well - being ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28477843.3',\n",
    "  'test_set_idx': 37379,\n",
    "  'type': 'T017',\n",
    "  'name': 'low back',\n",
    "  'context': '[CLS] Development and valid ##ation of an easy - to - use risk assessment tool for cumulative [unused1] low back [unused2] loading : The Li ##fting Fat ##ig ##ue F ##ail ##ure Too ##l ( Li ##fting Fat ##ig ##ue F ##ail ##ure Too ##l ) Recent evidence suggests that m ##us ##cu ##los ##kel ##etal disorders may be the result of a fatigue failure process in affected tissues . This paper describes a new low back exposure assessment tool ( the Li ##fting Fat ##ig ##ue F ##ail ##ure Too ##l [ Li ##FF ##T ] ) , which estimates a \" daily dose \" of cumulative loading on the low back using fatigue failure principles . Only three variables are necessary to derive the cumulative [SEP]',\n",
    "  'existing_cui': 'C0024031',\n",
    "  'existing_cui_name': 'Low Back Pain',\n",
    "  'existing_cui_desc': '[CLS] Low Back Pain [unused3] ( Finding , diagnosis , disorder , finding , s ##ym ##pt ##om : low ; back ##ache ; Back Pain ##s , Lower ; A ##ches , Low Back ; Pain ; back ; l ##umba ##r ; do ##rs ##op ##athy low back pain ; Low Back A ##che ; back ##ache ; low ; A ##che , Low Back ; lower back pain ; Lu ##mba ##r pain ; Back ##ache ##s , Low ; Back Pain ##s , Low ; Low Back Pain [ Disease / Finding ] ; l ##umba ##go ; Back A ##che , Low ; back ; pain , low ; pain ; low back ; l ##umba ##r pain ; Lu ##mba ##go [SEP]',\n",
    "  'our_bi_cui': 'C2939142',\n",
    "  'our_bi_cui_name': 'Lower back',\n",
    "  'our_bi_cui_desc': '[CLS] Lower back [unused3] ( Spa ##tial Concept , surface region , surface region , body structure : Lower back ( surface region ) ) [SEP]',\n",
    "  'our_cross_cui': 'C0230102',\n",
    "  'our_cross_cui_name': 'Lower back structure',\n",
    "  'our_cross_cui_desc': '[CLS] Lower back structure [unused3] ( Ana ##tom ##ical Structure , body structure : Lower back ; lower back ; Di ##stal back ; lower back structure ) [SEP]'},\n",
    " {'mention_id': '27842161.5',\n",
    "  'test_set_idx': 19098,\n",
    "  'type': 'T103',\n",
    "  'name': 'Netarsudil',\n",
    "  'context': '[CLS] Net ##ars ##udi ##l Inc ##rease ##s Out ##flow Facility in Human Eyes Through Multiple Me ##chan ##isms [unused1] Net ##ars ##udi ##l [unused2] is a R ##ho kinase / nor ##ep ##ine ##ph ##rine transport ##er inhibitor currently in phase 3 clinical development for g ##lau ##com ##a treatment . We investigated the effects of its active meta ##bol ##ite , net ##ars ##udi ##l - M1 , on out ##flow facility ( C ) , out ##flow h ##ydro ##dynamic ##s , and morphology of the conventional out ##flow pathway in en ##uc ##lea ##ted human eyes . Pa ##ired human eyes ( n = 5 ) were per ##fused with either 0 . 3 μ ##M net ##ars ##udi ##l - M1 or [SEP]',\n",
    "  'existing_cui': 'C0013443',\n",
    "  'existing_cui_name': 'Ear structure',\n",
    "  'existing_cui_desc': '[CLS] E ##ar structure [unused3] ( Ana ##tom ##ical Structure , Anatomy , body structure : V ##est ##ib ##ulo ##co ##ch ##lea ##r System ; System , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; ear structures ; Organ ##um vest ##ib ##ulo ##co ##ch ##lea ##re ; ear structure ; E ##ar - related structure ; au ##ris ; A ##ppa ##rat ##us , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; E ##ar and related structures ; Au ##ris ; V ##est ##ib ##ulo ##co ##ch ##lea ##r organ ; V ##est ##ib ##ulo ##co ##ch ##lea ##r A ##ppa ##rat ##us ) [SEP]',\n",
    "  'our_bi_cui': 'C0027783',\n",
    "  'our_bi_cui_name': 'Netropsin',\n",
    "  'our_bi_cui_desc': '[CLS] Net ##rops ##in [unused3] ( Chemical : Sin ##ano ##my ##cin ; Net ##rops ##in [ Chemical / In ##g ##red ##ient ] ; net ##rops ##in ; Congo ##cid ##ine ; 1 ##H - P ##yr ##rol ##e - 2 - car ##box ##ami ##de , 4 - ( ( ( ( amino ##im ##ino ##met ##hyl ) amino ) ace ##ty ##l ) amino ) - N - ( 5 - ( ( ( 3 - amino - 3 - im ##ino ##p ##rop ##yl ) amino ) carbon ##yl ) - 1 - met ##hyl - 1 ##H - p ##yr ##rol - 3 - y ##l ) - 1 - met ##hyl - ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28459124.18',\n",
    "  'test_set_idx': 36727,\n",
    "  'type': 'T038',\n",
    "  'name': 'Zebra Chip',\n",
    "  'context': '[CLS] Mexico , and Central America have experienced severe yield loss from Z ##eb ##ra Chip disease and have responded by increasing insect ##icide use to suppress populations of the insect vector , the potato ps ##yl ##lid , Ba ##cter ##ice ##ra cock ##ere ##lli ( He ##mi ##ptera : Trio ##zi ##dae ) . Despite the severe nature of [unused1] Z ##eb ##ra Chip [unused2] outbreak ##s , the causes of emergence remain unknown . We tested the h ##y ##pot ##heses that 1 ) B . cock ##ere ##lli o ##cc ##up ##ancy has increased over the last century in California and 2 ) such increases are related to climate change , specifically warmer winters . We compiled a data ##set of 87 , [SEP]',\n",
    "  'existing_cui': 'C3890232',\n",
    "  'existing_cui_name': 'Trans-Activator Protein BZLF1',\n",
    "  'existing_cui_desc': '[CLS] Trans - Act ##iva ##tor Pro ##tein B ##Z ##LF ##1 [unused3] ( Chemical : Trans - Act ##iva ##tor Pro ##tein B ##Z ##LF - 1 ; E ##ps ##tein - Barr V ##ir ##us Trans - Act ##iva ##tor Pro ##tein B ##Z ##LF ##1 ; E ##ps ##tein - Barr V ##ir ##us Trans - Act ##iva ##tor Pro ##tein B ##Z ##LF - 1 ; E ##ps ##tein - Barr V ##ir ##us B ##Z ##LF - 1 ; E ##B ##V B ##Z ##LF - 1 ; Z ##eb ##ra ; E ##B ##V B ##Z ##LF ##1 ) [SEP]',\n",
    "  'our_bi_cui': 'C0325177',\n",
    "  'our_bi_cui_name': 'Equus zebra',\n",
    "  'our_bi_cui_desc': '[CLS] E ##q ##u ##us z ##eb ##ra [unused3] ( E ##uka ##ryo ##te , organism : Mountain z ##eb ##ra ; E ##q ##u ##us z ##eb ##ra z ##eb ##ra ) [SEP]',\n",
    "  'our_cross_cui': 'C0012634',\n",
    "  'our_cross_cui_name': 'Disease',\n",
    "  'our_cross_cui_desc': '[CLS] Disease [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , or disorder : disease / disorder ; D ##IS ; Clinical disease or syndrome present ; Disease [ Disease / Finding ] ; Disease ##s ; Di ##sor ##der ; Clinical disease or syndrome ; Disease AND / OR syndrome present ; di ##ag ##nose ##s , syndrome ##s , and conditions ; Clinical disease AND / OR syndrome present ; Di ##sor ##ders ; Disease or Di ##sor ##der ; disease ; Disease ##s and Di ##sor ##ders ; condition ; Disease or syndrome present ; diseases ; disorders ; Clinical disease AND / OR syndrome ; disorder ) [SEP]'},\n",
    " {'mention_id': '27598388.17',\n",
    "  'test_set_idx': 10966,\n",
    "  'type': 'T058',\n",
    "  'name': 'elemental mapping',\n",
    "  'context': '[CLS] V ##is spectrum which showed the surface p ##las ##mon resonance band at 42 ##2 nm . Trans ##mission electron micro ##scope analysis revealed that the particles were spherical , he ##xa ##gonal , and irregular in shape and had size ranging from 30 to 80 nm . The energy di ##sper ##sive X - ray s ##pect ##ros ##copy and [unused1] elemental mapping [unused2] have displayed the purity and maximum distribution of silver in the A ##g ##NP ##s . The crystal ##line nature of A ##g ##NP ##s had been identified using X - ray di ##ff ##raction and selected area di ##ff ##raction pattern . The particle size analysis revealed that the Z - average diameter of the A ##g ##NP ##s was [SEP]',\n",
    "  'existing_cui': 'C0008630',\n",
    "  'existing_cui_name': 'Chromosome Mapping',\n",
    "  'existing_cui_desc': '[CLS] Ch ##rom ##oso ##me Map ##ping [unused3] ( Health Care Act ##ivity : Gene ##tics , Gene Map ##ping ; Map ##ping , Gene ; gene mapped ; Gene Map ##ping ##s ; Link ##age Map ##ping ; Gene Map ##ping ; Gene mapping ; chromosome mapping ; genetic mapping ; gene map ; link ##age map ; Gene ##tic Map ##ping ; Gene Map ##ping , Total Human and Non - Human ; Ch ##rom ##oso ##me Map ##ping ##s ; Map ##ping , Ch ##rom ##oso ##me ; Gene Local ##ization ; link ##age mapping ; Map ##ping , Link ##age ; Map ##ping ##s , Gene ; gene mapping ; Link ##age Map ##ping ##s ; Map ##ping ##s , Link ##age ; [SEP]',\n",
    "  'our_bi_cui': 'C3898095',\n",
    "  'our_bi_cui_name': 'Optical Mapping',\n",
    "  'our_bi_cui_desc': '[CLS] Op ##tical Map ##ping [unused3] ( Research Act ##ivity : Op ##tical Map ; O ##P ##TI ##CA ##L MA ##PP ##ING ; Op ##tical mapping ) [SEP]',\n",
    "  'our_cross_cui': 'C0022885',\n",
    "  'our_cross_cui_name': 'Laboratory Procedures',\n",
    "  'our_cross_cui_desc': '[CLS] Laboratory Pro ##ced ##ures [unused3] ( Health Care Act ##ivity , C ##MS Te ##mpo ##rary Code ##s , context - dependent category , procedure , situation : Laboratory test panel ; Tests ; Laboratory procedure ; lab test ; laboratory tests ; Pro ##ced ##ure , lab . - general ; test ; laboratory ; Laboratory procedure - general - ; Lab . test - general ; Lab test ; Laboratory procedures - general ; laboratory procedures ; General laboratory procedure - R ##ET ##IR ##ED - ; lab testing ; General laboratory procedure ; Laboratory Test ; lab tests ; laboratory test ; Lab Test ; Test ; Laboratory Tests ; Laboratory Pro ##ced ##ure ; Investigation - lab . , general ; Test [SEP]'},\n",
    " {'mention_id': '27611704.12',\n",
    "  'test_set_idx': 11686,\n",
    "  'type': 'T017',\n",
    "  'name': 'D',\n",
    "  'context': \"[CLS] B ##read wheat ( Tri ##tic ##um a ##est ##iv ##um , 2 ##n = 6 ##x = 42 , AA ##BB ##D ##D ) has a complex all ##oh ##ex ##ap ##lo ##id genome , which makes it difficult to differentiate between the ho ##mo ##eo ##log ##ous sequences and assign them to the chromosome A , B , or [unused1] D [unused2] sub ##gen ##ome ##s . The chromosome - based draft genome sequence of the ' Chinese Spring ' common wheat cult ##iva ##r enables the large - scale development of polymer ##ase chain reaction ( polymer ##ase chain reaction ) - based markers specific for ho ##mo ##eo ##log ##s . Based on high - confidence ' Chinese Spring ' genes with [SEP]\",\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0008645',\n",
    "  'our_bi_cui_name': 'Chromosomes , Human , 13-15',\n",
    "  'our_bi_cui_desc': '[CLS] Ch ##rom ##oso ##mes , Human , 13 - 15 [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : Ch ##rom ##oso ##mes , group D ; Ch ##rom ##oso ##mes , Group D ; Group D Ch ##rom ##oso ##me ; Ch ##rom ##oso ##me pairs 13 - 15 ; Ch ##rom ##oso ##mes D ; Ch ##rom ##oso ##me , Group D ; Group D Ch ##rom ##oso ##mes ) [SEP]',\n",
    "  'our_cross_cui': 'C0008633',\n",
    "  'our_cross_cui_name': 'Chromosomes',\n",
    "  'our_cross_cui_desc': '[CLS] Ch ##rom ##oso ##mes [unused3] ( Ana ##tom ##ical Structure , body structure , cell structure : chromosome ; Ch ##rom ##oso ##mal ; chromosome ##s ; Ch ##rom ##oso ##me ) [SEP]'},\n",
    " {'mention_id': '27892235.1',\n",
    "  'test_set_idx': 21013,\n",
    "  'type': 'T058',\n",
    "  'name': 'NHS',\n",
    "  'context': '[CLS] S ##hout louder about poor pay It seems increasingly clear to me that the [unused1] NHS [unused2] pay campaign is not making waves either in the NHS or with the public . [SEP]',\n",
    "  'existing_cui': 'C1417725',\n",
    "  'existing_cui_name': 'NHS gene',\n",
    "  'existing_cui_desc': '[CLS] NHS gene [unused3] ( Ana ##tom ##ical Structure : NHS act ##in re ##mo ##del ##ing regulator ; NHS GE ##NE ) [SEP]',\n",
    "  'our_bi_cui': 'C0018104',\n",
    "  'our_bi_cui_name': 'Government',\n",
    "  'our_bi_cui_desc': '[CLS] Government [unused3] ( Organization : governments ; Government ##s ; government ) [SEP]',\n",
    "  'our_cross_cui': 'C0027462',\n",
    "  'our_cross_cui_name': 'Health Services , National',\n",
    "  'our_cross_cui_desc': '[CLS] Health Services , National [unused3] ( Health Care Act ##ivity : National health services ; H ##EA ##LT ##H SE ##R ##V N ##AT ##ION ##AL ; SE ##R ##V N ##AT ##ION ##AL H ##EA ##LT ##H ; National Health Service ; Service , National Health ; national health services ; national health service ; Health Service , National ; N ##AT ##ION ##AL H ##EA ##LT ##H SE ##R ##V ; Services , National Health ; National Health Services ) [SEP]'},\n",
    " {'mention_id': '27802570.2',\n",
    "  'test_set_idx': 17754,\n",
    "  'type': 'T058',\n",
    "  'name': 'Treated by',\n",
    "  'context': '[CLS] Overall Quality Properties of Ki ##wi ##f ##ruit [unused1] T ##reate ##d by [unused2] C ##inn ##ama ##lde ##hy ##de and C ##it ##ral : Micro ##bial , Anti ##ox ##ida ##nt Cap ##acity during Cold St ##orage This work was undertaken to evaluate the micro ##bio ##logical characteristics and anti ##ox ##ida ##nt and physiological activities in k ##i ##wi ##f ##ruit ##s ( Act ##ini ##da del ##ici ##osa var . Qin ##mei ) with / without c ##inn ##ama ##lde ##hy ##de ( C ##1 ) and c ##it ##ral ( C ##2 ) f ##umi ##gation treatments ( 5 μ ##L / L ) during 0 , 3 , 6 , 9 , and 12 d of storage at 4 °C . [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0087111',\n",
    "  'our_bi_cui_name': 'Therapeutic procedure',\n",
    "  'our_bi_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]',\n",
    "  'our_cross_cui': 'C0332293',\n",
    "  'our_cross_cui_name': 'Treated with',\n",
    "  'our_cross_cui_desc': '[CLS] T ##reate ##d with [unused3] ( Health Care Act ##ivity , attribute : T ##reate ##d by ) [SEP]'},\n",
    " {'mention_id': '27832198.46',\n",
    "  'test_set_idx': 18668,\n",
    "  'type': 'T017',\n",
    "  'name': 'Cam734',\n",
    "  'context': '[CLS] ##al ##ci ##par ##um ch ##lor ##o ##quin ##e resistance transport ##er - specific zinc - finger n ##uc ##lea ##ses to genetically di ##sse ##ct this all ##ele in the path ##ogenic setting of as ##ex ##ual blood - stage infection . Comparative analysis of drug resistance and growth profiles of re ##comb ##ina ##nt parasite ##s that express [unused1] Cam ##7 ##34 [unused2] or variants thereof , D ##d ##2 ( the most common Southeast Asian variant ) , or wild - type P . f ##al ##ci ##par ##um ch ##lor ##o ##quin ##e resistance transport ##er , revealed previously unknown roles for P ##f ##CR ##T mutations in m ##od ##ulating parasite su ##s ##ce ##pt ##ibility to multiple anti ##mal ##aria [SEP]',\n",
    "  'existing_cui': 'C0006675',\n",
    "  'existing_cui_name': 'Calcium',\n",
    "  'existing_cui_desc': '[CLS] Cal ##ci ##um [unused3] ( Chemical , medication , substance : Co ##agu ##lation factor IV - R ##ET ##IR ##ED - ; CO ##AG FA ##CT ##OR IV ; Co ##agu ##lation Factor IV ; B ##L ##O ##OD CO ##AG FA ##CT ##OR IV ; C ##a + + element ; factor i ##v ; calcium ; Blood Co ##agu ##lation Factor IV ; Cal ##ci ##um co ##agu ##lation factor ; Co ##agu ##lation factor IV ; calcium ##s ; Cal ##ci ##um [ Chemical / In ##g ##red ##ient ] ; C ##a - Cal ##ci ##um ; CA ##LC ##I ##UM ; Factor IV ; C ##a element ; Cal ##ci ##um anal ##yte ; Factor IV , Co ##agu ##lation [SEP]',\n",
    "  'our_bi_cui': 'C1708291',\n",
    "  'our_bi_cui_name': 'CDC73 gene',\n",
    "  'our_bi_cui_desc': '[CLS] CD ##C ##7 ##3 gene [unused3] ( Ana ##tom ##ical Structure : H ##Y ##RA ##X , DR ##OS ##OP ##H ##IL ##A , H ##OM ##OL ##O ##G OF ; cell division cycle 73 ; para ##fi ##bro ##min ; F ##I ##HP ; PA ##RA ##FI ##BR ##OM ##IN ; CD ##C ##7 ##3 Gene ; CE ##LL D ##I ##VI ##SI ##ON C ##Y ##CL ##E PR ##OT ##EI ##N 73 , S . CE ##RE ##VI ##SI ##A ##E , H ##OM ##OL ##O ##G OF ; C ##1 ##OR ##F ##28 ; Cell Division Cycle 73 , Pa ##f ##1 / RNA Pol ##yme ##rase II Complex Co ##mpo ##nent , Ho ##mo ##log ( S . c ##ere ##vis ##iae [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27671177.37',\n",
    "  'test_set_idx': 13814,\n",
    "  'type': 'T082',\n",
    "  'name': 'Quetta',\n",
    "  'context': \"[CLS] ##sis , had 4 times more chances to develop car ##ies than those who did not have flu ##oro ##sis . There was no significant association between children ' s car ##ies status and use of paste , brushing habit , mi ##s ##wa ##k , and visit to the den ##tist . The use of past ##ries and juice ##s had a direct relation with the children ' s dental car ##ies status . Dental car ##ies in children of [unused1] Que ##tta [unused2] is not so much frequent as compared to the flu ##ori ##de def ##icient countries . However , the high prevalence of moderate dental flu ##oro ##sis and consumption of past ##ries and juice ##s resulted in dental car ##ies . [SEP]\",\n",
    "  'existing_cui': 'C0262345',\n",
    "  'existing_cui_name': 'Tenia of thalamus',\n",
    "  'existing_cui_desc': '[CLS] Ten ##ia of th ##ala ##mus [unused3] ( Ana ##tom ##ical Structure : ten ##ia of th ##ala ##mi ; Ten ##ia of th ##ala ##mi ; Ta ##enia th ##ala ##mi ; T ##hala ##mus ten ##ia ; ten ##ia of the th ##ala ##mus ; Ten ##ia th ##ala ##mi ) [SEP]',\n",
    "  'our_bi_cui': 'C0337884',\n",
    "  'our_bi_cui_name': 'Quechua',\n",
    "  'our_bi_cui_desc': '[CLS] Que ##chu ##a [unused3] ( Population Group , ethnic group , ethnic group ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '27798906.12',\n",
    "  'test_set_idx': 17532,\n",
    "  'type': 'T058',\n",
    "  'name': 'measured',\n",
    "  'context': '[CLS] ##s were enrolled and 93 i ##rra ##dia ##ted P ##G ##s were analyzed . Thirty and 24 patients were treated with total doses [ relative biological effectiveness ( relative biological effectiveness ) ] of 57 . 6 G ##y and 64 . 0 G ##y , respectively , in 16 fraction ##s . par ##ot ##id g ##land volumes were [unused1] measured [unused2] using com ##puted to ##mo ##graphic images obtained before carbon ion radio ##ther ##ap ##y and every 3 - 6 months thereafter . The median follow - up period was 46 . 4 months ( range = 24 . 0 - 123 . 0 months ) . Un ##iva ##ria ##te analysis showed that par ##ot ##id g ##land volumes receiving more [SEP]',\n",
    "  'existing_cui': 'C3541902',\n",
    "  'existing_cui_name': 'Measured Tumor Identification',\n",
    "  'existing_cui_desc': '[CLS] Me ##as ##ured Tu ##mor I ##dent ##ification [unused3] ( Health Care Act ##ivity : ME ##AS ##UR ##ED ) [SEP]',\n",
    "  'our_bi_cui': 'C2734710',\n",
    "  'our_bi_cui_name': 'Measure observations',\n",
    "  'our_bi_cui_desc': '[CLS] Me ##as ##ure observations [unused3] ( Finding ) [SEP]',\n",
    "  'our_cross_cui': 'C2700258',\n",
    "  'our_cross_cui_name': 'Volume Measurement',\n",
    "  'our_cross_cui_desc': '[CLS] Volume Me ##as ##ure ##ment [unused3] ( Health Care Act ##ivity : V ##OL ##UM ##E ; Volume measurement ; Volume ) [SEP]'},\n",
    " {'mention_id': '27555898.19',\n",
    "  'test_set_idx': 10352,\n",
    "  'type': 'T103',\n",
    "  'name': 'PAA1',\n",
    "  'context': '[CLS] the specimens , 3 mm of a ##c ##ryl ##ic were grin ##ded off and separated parts were re ##att ##ache ##d by re ##si ##lient liner ##s . The specimens were divided into 2 control ( control ##1 , control ##7 ) and 4 test groups of para ##ce ##tic acid and oz ##one di ##sin ##fect ##ion ( [unused1] PA ##A ##1 [unused2] , PA ##A ##7 , oz ##one ##1 and oz ##one ##7 ; n = 10 ) . While control groups were im ##mers ##ed in di ##st ##ille ##d water for 10 min ( control ##1 ) and 7 days ( control ##7 ) , test groups were subjected to para ##ce ##tic acid ( 16 g / L ) [SEP]',\n",
    "  'existing_cui': 'C1415190',\n",
    "  'existing_cui_name': 'GPAA1 gene',\n",
    "  'existing_cui_desc': '[CLS] GP ##AA ##1 gene [unused3] ( Ana ##tom ##ical Structure : GP ##I trans ##ami ##das ##e subunit ; G ##L ##Y ##CO ##S ##Y ##LP ##H ##OS ##P ##HA ##TI ##D ##Y ##L ##IN ##OS ##IT ##OL AN ##CH ##OR AT ##TA ##CH ##ME ##NT PR ##OT ##EI ##N 1 ; g ##ly ##cos ##yl ##ph ##os ##pha ##ti ##dy ##lino ##si ##to ##l anchor attachment 1 ; h ##GA ##A ##1 ) [SEP]',\n",
    "  'our_bi_cui': 'C1528733',\n",
    "  'our_bi_cui_name': 'diphenylacetaldehyde',\n",
    "  'our_bi_cui_desc': '[CLS] dip ##hen ##yla ##ce ##tal ##de ##hy ##de [unused3] ( Chemical : D ##PA ##A c ##p ##d ) [SEP]',\n",
    "  'our_cross_cui': 'C0030968',\n",
    "  'our_cross_cui_name': 'Peracetic Acid',\n",
    "  'our_cross_cui_desc': '[CLS] Per ##ace ##tic A ##cid [unused3] ( Chemical , product , substance : A ##cid , Per ##ox ##ye ##than ##oi ##c ; per ##ace ##tic acid ; Per ##ox ##ya ##ce ##tic A ##cid ; Per ##ace ##tic A ##cid [ Chemical / In ##g ##red ##ient ] ; Ethan ##eper ##ox ##oi ##c acid ; A ##cid , Per ##ace ##tic ; Ace ##ty ##l H ##ydro ##per ##oxide ; A ##cid , Per ##ox ##ya ##ce ##tic ; Per ##ox ##ye ##than ##oi ##c A ##cid ; V ##ap ##ori ##zed Para ##ce ##tic A ##cid St ##eri ##li ##zation ; Per ##ox ##ya ##ce ##tic acid ; Per ##ace ##tic acid ; per ##ox ##ya ##ce ##tic acid ) [SEP]'},\n",
    " {'mention_id': '28477843.12',\n",
    "  'test_set_idx': 37388,\n",
    "  'type': 'T017',\n",
    "  'name': 'low back',\n",
    "  'context': '[CLS] m ##us ##cu ##los ##kel ##etal disorders may be the result of a fatigue failure process in affected tissues . This paper describes a new low back exposure assessment tool ( the Li ##fting Fat ##ig ##ue F ##ail ##ure Too ##l [ Li ##FF ##T ] ) , which estimates a \" daily dose \" of cumulative loading on the [unused1] low back [unused2] using fatigue failure principles . Only three variables are necessary to derive the cumulative load associated with a lifting task : the weight of the load , the maximum horizontal distance from the spine to the load , and the number of repetition ##s for tasks performed during the work ##day . The new tool was valid ##ated using two existing [SEP]',\n",
    "  'existing_cui': 'C0024031',\n",
    "  'existing_cui_name': 'Low Back Pain',\n",
    "  'existing_cui_desc': '[CLS] Low Back Pain [unused3] ( Finding , diagnosis , disorder , finding , s ##ym ##pt ##om : low ; back ##ache ; Back Pain ##s , Lower ; A ##ches , Low Back ; Pain ; back ; l ##umba ##r ; do ##rs ##op ##athy low back pain ; Low Back A ##che ; back ##ache ; low ; A ##che , Low Back ; lower back pain ; Lu ##mba ##r pain ; Back ##ache ##s , Low ; Back Pain ##s , Low ; Low Back Pain [ Disease / Finding ] ; l ##umba ##go ; Back A ##che , Low ; back ; pain , low ; pain ; low back ; l ##umba ##r pain ; Lu ##mba ##go [SEP]',\n",
    "  'our_bi_cui': 'C2939142',\n",
    "  'our_bi_cui_name': 'Lower back',\n",
    "  'our_bi_cui_desc': '[CLS] Lower back [unused3] ( Spa ##tial Concept , surface region , surface region , body structure : Lower back ( surface region ) ) [SEP]',\n",
    "  'our_cross_cui': 'C0230102',\n",
    "  'our_cross_cui_name': 'Lower back structure',\n",
    "  'our_cross_cui_desc': '[CLS] Lower back structure [unused3] ( Ana ##tom ##ical Structure , body structure : Lower back ; lower back ; Di ##stal back ; lower back structure ) [SEP]'},\n",
    " {'mention_id': '27388786.22',\n",
    "  'test_set_idx': 4445,\n",
    "  'type': 'T098',\n",
    "  'name': 'signers',\n",
    "  'context': \"[CLS] explained by hand movement alone , the contribution of motor movement versus ' linguistic ' processes to the strength of hem ##is ##pheric lateral ##ization during sign production remains unclear . Here we directly contrast lateral ##ization strength of covert versus over ##t signing during p ##hon ##ological and semantic flu ##ency tasks . To address the possibility that hearing native [unused1] sign ##ers [unused2] ' elevated lateral ##ization in ##dices were due to performing a task in their less dominant language , here we test deaf native sign ##ers , whose dominant language is British Sign Language . Sign ##ers were more strongly left lateral ##ized for over ##t than covert sign generation . However , the strength of lateral ##ization was not correlated with [SEP]\",\n",
    "  'existing_cui': 'C0035127',\n",
    "  'existing_cui_name': 'Cumulative Trauma Disorders',\n",
    "  'existing_cui_desc': '[CLS] C ##um ##ula ##tive T ##ra ##uma Di ##sor ##ders [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , event : Over ##use S ##yn ##drome ; Rep ##eti ##tive St ##ress In ##ju ##ries ; Di ##sor ##ders , C ##um ##ula ##tive T ##ra ##uma ; RS ##I - Rep ##eti ##tive strain injury ; R ##EP ##ET M ##OT ##ION D ##IS ; repetitive strain injury ; St ##rain In ##ju ##ry , Rep ##eti ##tive ; T ##ra ##uma Di ##sor ##ders , C ##um ##ula ##tive ; Rep ##eti ##tive Motion Di ##sor ##ders ; In ##ju ##ries , Rep ##eti ##tive St ##ress ; Motion Di ##sor ##ders , Rep ##eti ##tive ; cumulative trauma disorders [SEP]',\n",
    "  'our_bi_cui': 'C0336303',\n",
    "  'our_bi_cui_name': 'Sign-painter',\n",
    "  'our_bi_cui_desc': '[CLS] Sign - painter [unused3] ( Professional or O ##cc ##upation ##al Group , occupation : Sign ##writer ) [SEP]',\n",
    "  'our_cross_cui': 'C1257890',\n",
    "  'our_cross_cui_name': 'Population Group',\n",
    "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
    " {'mention_id': '27580908.24',\n",
    "  'test_set_idx': 10668,\n",
    "  'type': 'T098',\n",
    "  'name': \"learners '\",\n",
    "  'context': \"[CLS] to participate . Student co ##hor ##ts were alternatively given a faculty - supervised 1 ##h session playing a simple interactive digital T ##ic - ta ##c - toe q ##uiz module on p ##ediatric gas ##tro ##int ##est ##inal radio ##logy or a 1 ##h did ##actic intro ##ductory lecture on the same topic . Survey questions assessed the [unused1] learn ##ers ' [unused2] perceived ability to recall the material as well as their satisfaction with the educational experience . Results of an end - of - rotation exam were reviewed to evaluate a quantitative measure of learning between groups . Survey responses were analyzed with a ch ##i - squared test . Ex ##am results for both groups were analyzed with a paired Student [SEP]\",\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0520955',\n",
    "  'our_bi_cui_name': 'Slow learner',\n",
    "  'our_bi_cui_desc': '[CLS] Slow learn ##er [unused3] ( Finding , finding , organism : slow learn ##er ; delayed learning ; Slow Lea ##rner ##s ; slow learn ##ers ; Learning delay ) [SEP]',\n",
    "  'our_cross_cui': 'C1257890',\n",
    "  'our_cross_cui_name': 'Population Group',\n",
    "  'our_cross_cui_desc': '[CLS] Population Group [unused3] ( Population Group , social concept : Group ; groups population ; Group , Population ; group populations ; population ; Sub ##pop ##ulation ; Population Groups ; population group ; Groups , Population ; Population ; population groups ) [SEP]'},\n",
    " {'mention_id': '27383326.9',\n",
    "  'test_set_idx': 4277,\n",
    "  'type': 'T038',\n",
    "  'name': 'advanced',\n",
    "  'context': '[CLS] Ad ##verse events risk associated with an ##gio ##genesis inhibitor ##s addition to therapy in o ##var ##ian cancer : a meta - analysis of random ##ized controlled trials In ##hibition of an ##gio ##genesis has been regarded as an attractive treatment strategy for [unused1] advanced [unused2] or re ##current o ##var ##ian cancer . We conduct this meta - analysis to investigate the risk of adverse events of special interest related to an ##gio ##genesis inhibitor ##s in o ##var ##ian cancer . Database ##s from Pub ##M ##ed , Web of Science and Cochrane library up to December 2015 were searched to identify relevant studies . Eli ##gible studies included prospective random ##ized controlled phase II / III clinical trials evaluating therapy with or [SEP]',\n",
    "  'existing_cui': 'C0877373',\n",
    "  'existing_cui_name': 'Advanced cancer',\n",
    "  'existing_cui_desc': '[CLS] Advanced cancer [unused3] ( B ##iol ##og ##ic Fun ##ction : Advanced Mali ##gnant Neo ##p ##las ##m ; Advanced Cancer ; cancer advanced ; advanced cancer ) [SEP]',\n",
    "  'our_bi_cui': 'C0877373',\n",
    "  'our_bi_cui_name': 'Advanced cancer',\n",
    "  'our_bi_cui_desc': '[CLS] Advanced cancer [unused3] ( B ##iol ##og ##ic Fun ##ction : Advanced Mali ##gnant Neo ##p ##las ##m ; Advanced Cancer ; cancer advanced ; advanced cancer ) [SEP]',\n",
    "  'our_cross_cui': 'C0029925',\n",
    "  'our_cross_cui_name': 'Ovarian Carcinoma',\n",
    "  'our_cross_cui_desc': '[CLS] O ##var ##ian Car ##cin ##oma [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis : o ##vary cancer ; o ##var ##ian car ##cin ##oma ; o ##vary car ##cin ##oma ; car ##cin ##oma o ##var ##ian ; ca o ##var ##ian ; cancer o ##var ##ian ; cancer ##s o ##var ##ian ; cancer of o ##vary ; cancer o ##vary ; o ##var ##ian cancer ; ma ##li ##gnant o ##var ##ies tumor ; o ##var ##ian cancer ##s ; o ##var ##ian car ##cin ##oma ##s ; cancer of the o ##vary ; car ##cin ##oma of o ##vary ; car ##cin ##oma o ##var ##ies ; car ##cin ##oma o ##vary ; cancer o ##var ##ies ; O ##var [SEP]'},\n",
    " {'mention_id': '27608421.15',\n",
    "  'test_set_idx': 11552,\n",
    "  'type': 'T017',\n",
    "  'name': 'woody tissue',\n",
    "  'context': '[CLS] ##cc ##um par ##vu ##m The as ##com ##y ##ce ##te Neo ##fu ##si ##co ##cc ##um par ##vu ##m , one of the ca ##usal agents of Bo ##try ##os ##pha ##eria die ##back , is a destructive wood - in ##fect ##ing fungus and a serious threat to grape production worldwide . The capability of co ##lon ##izing [unused1] wood ##y tissue [unused2] combined with the secret ##ion of p ##hy ##to ##to ##xi ##c compounds is thought to under ##lie its path ##ogenic ##ity and v ##ir ##ule ##nce . Here , we describe the repertoire of v ##ir ##ule ##nce factors and their transcription ##al dynamics as the fungus feeds on different substrates and co ##lon ##izes the wood ##y stem . [SEP]',\n",
    "  'existing_cui': 'C0040300',\n",
    "  'existing_cui_name': 'Body tissue',\n",
    "  'existing_cui_desc': '[CLS] Body tissue [unused3] ( Ana ##tom ##ical Structure , Body , body structure : Port ##ion of tissue ; Normal T ##iss ##ue ; T ##iss ##ue ; Text ##us ; Body T ##iss ##ues ; tissues ; Body tissue structure ; body tissues ; T ##iss ; body tissue ; tissue ; T ##iss ##ues ; T ##IS ##SU ##E ) [SEP]',\n",
    "  'our_bi_cui': 'C2699642',\n",
    "  'our_bi_cui_name': 'Stem , Woody - plant part',\n",
    "  'our_bi_cui_desc': '[CLS] St ##em , Woody - plant part [unused3] ( E ##uka ##ryo ##te : St ##em , Woody ; Li ##gn ##um ; St ##em , wood ##y ) [SEP]',\n",
    "  'our_cross_cui': 'C1514137',\n",
    "  'our_cross_cui_name': 'Plant Tissue , Cells',\n",
    "  'our_cross_cui_desc': '[CLS] Plant T ##iss ##ue , Cell ##s [unused3] ( Ana ##tom ##ical Structure : Plant cells and tissues ) [SEP]'},\n",
    " {'mention_id': '28353042.21',\n",
    "  'test_set_idx': 32949,\n",
    "  'type': 'T204',\n",
    "  'name': 'rats',\n",
    "  'context': '[CLS] - f ##ru ##ct ##ose fed male W ##ista ##r rats . high - f ##ru ##ct ##ose diet ( 66 % of f ##ru ##ct ##ose ) and PA ##A ##E ( 200 mg / kg body weight / day ) were given concurrently to the rats for a period of 60 days . Fr ##uc ##tos ##e - fed [unused1] rats [unused2] showed weight gain , h ##yper ##gly ##ce ##mia , h ##yper ##ins ##ulin ##emia , impaired glucose tolerance , impaired insulin sensitivity , d ##ys ##lip ##ide ##mia , h ##yper ##le ##pt ##ine ##mia , and h ##y ##po ##adi ##po ##nect ##ine ##mia ( P < 0 . 05 ) after 60 days . Co - administration of PA [SEP]',\n",
    "  'existing_cui': 'C2097385',\n",
    "  'existing_cui_name': 'allergy testing rat',\n",
    "  'existing_cui_desc': '[CLS] all ##er ##gy testing rat [unused3] ( Health Care Act ##ivity , lab test : rat ) [SEP]',\n",
    "  'our_bi_cui': 'C0034721',\n",
    "  'our_bi_cui_name': 'Rattus',\n",
    "  'our_bi_cui_desc': '[CLS] Rat ##tus [unused3] ( E ##uka ##ryo ##te , organism : Rat ; Genus rat ##tus ; Genus Rat ##tus ; rats ; rat ; rat ##tus ; Rat ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0034716',\n",
    "  'our_cross_cui_name': 'Rats , Wistar',\n",
    "  'our_cross_cui_desc': '[CLS] Rat ##s , W ##ista ##r [unused3] ( E ##uka ##ryo ##te , organism : W ##ista ##r rat ; W ##ista ##r Rat ##s ; w ##ista ##r rat ; w ##ista ##r rats ) [SEP]'},\n",
    " {'mention_id': '28521168.28',\n",
    "  'test_set_idx': 38297,\n",
    "  'type': 'T204',\n",
    "  'name': 'L. variegatus',\n",
    "  'context': '[CLS] of eight e ##cot ##ox ##icit ##y tests on bacteria ( V . fish ##eri , E . co ##li ) , algae ( P . sub ##cap ##ita ##ta , Ch ##lam ##yd ##omo ##nas s ##p . ) , crust ##ace ##ans ( D . ma ##gna ) , worms ( E . f ##eti ##da , [unused1] L . var ##ie ##gat ##us [unused2] ) and plants ( R . sat ##iv ##us , L . multi ##f ##lor ##um ) . The tested materials are commercially available and include Fe oxide and na ##nos ##cale zero v ##ale ##nt iron , but also hybrid products with Fe loaded into a matrix . All but one material , a ball mill ##ed na [SEP]',\n",
    "  'existing_cui': 'C3754415',\n",
    "  'existing_cui_name': 'Clania variegata',\n",
    "  'existing_cui_desc': '[CLS] Clan ##ia var ##ie ##gata [unused3] ( E ##uka ##ryo ##te : E ##ume ##ta var ##ie ##gata ; Clan ##ia var ##ie ##gata ( S ##nell ##en , 1879 ) ; O ##ike ##ticus var ##ie ##gat ##us ) [SEP]',\n",
    "  'our_bi_cui': 'C1022967',\n",
    "  'our_bi_cui_name': 'Lumbriculus variegatus',\n",
    "  'our_bi_cui_desc': '[CLS] Lu ##mb ##ric ##ulus var ##ie ##gat ##us [unused3] ( E ##uka ##ryo ##te : Lu ##mb ##ric ##ulus var ##ie ##gat ##us ( Muller , 1774 ) ) [SEP]',\n",
    "  'our_cross_cui': 'C0998692',\n",
    "  'our_cross_cui_name': 'Lytechinus variegatus',\n",
    "  'our_cross_cui_desc': '[CLS] L ##yte ##chin ##us var ##ie ##gat ##us [unused3] ( E ##uka ##ryo ##te : L ##yte ##chin ##us var ##ie ##gat ##us ( Lamar ##ck , 1816 ) ) [SEP]'},\n",
    " {'mention_id': '27252199.9',\n",
    "  'test_set_idx': 851,\n",
    "  'type': 'T017',\n",
    "  'name': 'vascular tissues',\n",
    "  'context': '[CLS] Mo ##rp ##hol ##ogical characteristics regulating p ##hall ##ic g ##lan ##s en ##gor ##gement in the American all ##iga ##tor The di ##stal part of the c ##ro ##co ##di ##lian p ##hall ##us consists of a bulb ##ous g ##lan ##s containing well - developed [unused1] vascular tissues [unused2] that can in ##f ##late before or during sexual activity , en ##lar ##ging and el ##ab ##ora ##ting the g ##lan ##s into a complex , though still functional ##ly und ##ef ##ined , cop ##ulatory structure . An enlarged g ##lan ##s put ##ative ##ly interact ##s with the female c ##lo ##aca and may change the shape of her reproductive tract to facilitate ins ##em ##ination and increase the probability of f [SEP]',\n",
    "  'existing_cui': 'C0282607',\n",
    "  'existing_cui_name': 'Vascular Neoplasms',\n",
    "  'existing_cui_desc': '[CLS] V ##as ##cular Neo ##p ##las ##ms [unused3] ( B ##iol ##og ##ic Fun ##ction : V ##as ##cular Tu ##mor ##s ; V ##as ##cular Tu ##mor ; vascular neo ##p ##las ##ms ; NE ##OP ##L VA ##SC ##U ##LA ##R ; Neo ##p ##las ##m of V ##as ##cular T ##iss ##ue ; V ##as ##cular neo ##p ##las ##m ; Neo ##p ##las ##ms , V ##as ##cular ; V ##as ##cular neo ##p ##las ##ms ; Neo ##p ##las ##m , V ##as ##cular ; VA ##SC ##U ##LA ##R NE ##OP ##L ; V ##as ##cular Neo ##p ##las ##ms [ Disease / Finding ] ; V ##as ##cular T ##iss ##ue Neo ##p ##las ##m ; V ##as ##cular [SEP]',\n",
    "  'our_bi_cui': 'C0458940',\n",
    "  'our_bi_cui_name': 'Vulval vascular structure',\n",
    "  'our_bi_cui_desc': '[CLS] V ##ul ##val vascular structure [unused3] ( Ana ##tom ##ical Structure , body structure ) [SEP]',\n",
    "  'our_cross_cui': 'C1511228',\n",
    "  'our_cross_cui_name': 'Blood Vessel Tissue',\n",
    "  'our_cross_cui_desc': '[CLS] Blood V ##ess ##el T ##iss ##ue [unused3] ( Ana ##tom ##ical Structure : V ##ES ##SE ##L , B ##L ##O ##OD ; V ##ess ##el ) [SEP]'},\n",
    " {'mention_id': '27395442.13',\n",
    "  'test_set_idx': 4644,\n",
    "  'type': 'T082',\n",
    "  'name': 'Lima',\n",
    "  'context': '[CLS] ##mo ##x are key processes for reducing the external nitrogen loads delivered to coastal ecosystems , and these processes can be affected by poll ##uta ##nts . In this study , we investigated the effect of crude oil on den ##it ##rification and an ##am ##mo ##x . Control ##led laboratory experiments were performed using sediment s ##lu ##rries from the [unused1] Lima [unused2] E ##st ##uary ( NW Portugal ) . Ana ##mm ##ox and den ##it ##rification rates were measured using ( 15 ) N - labeled NO ##3 ( - ) , and the production of ( 29 ) N ##2 and ( 30 ) N ##2 q ##uant ##ified by membrane inlet mass s ##pect ##rome ##try . Results revealed that while [SEP]',\n",
    "  'existing_cui': 'C1047251',\n",
    "  'existing_cui_name': 'Lima',\n",
    "  'existing_cui_desc': '[CLS] Lima [unused3] ( E ##uka ##ryo ##te : l ##ima ) [SEP]',\n",
    "  'our_bi_cui': 'C1047251',\n",
    "  'our_bi_cui_name': 'Lima',\n",
    "  'our_bi_cui_desc': '[CLS] Lima [unused3] ( E ##uka ##ryo ##te : l ##ima ) [SEP]',\n",
    "  'our_cross_cui': 'C0017446',\n",
    "  'our_cross_cui_name': 'Geographic Locations',\n",
    "  'our_cross_cui_desc': '[CLS] Geographic Location ##s [unused3] ( Spa ##tial Concept : areas geographic ; Geographic Location ; Region ; GE ##O ##GR L ##OC ##AT ##ION ##S ; geographic region ; Geographic Region ; geographic location ; Geographic Region ##s ; Area ; geographic site ; Geographic Area ) [SEP]'},\n",
    " {'mention_id': '28427655.15',\n",
    "  'test_set_idx': 35585,\n",
    "  'type': 'T033',\n",
    "  'name': 'not',\n",
    "  'context': '[CLS] ##tina ##se concentration ( 0 and 0 . 2 % ) . The responses studied were yield , v ##isco ##sity , clarity , total soluble solid ##s and pH . It was observed that p ##ec ##tina ##se was more effective in increasing the yield of juice compared to cell ##ula ##se . Ultra ##sonic pre - treatment alone did [unused1] not [unused2] significantly increase the yield of juice . When ultra ##sound was combined with pre - treatment with both the enzymes maximum yield of 89 . 40 % was obtained compared to 47 . 30 % in the control . The v ##isco ##sity of the juice decreased with addition of enzymes and with application of ultra ##sound . The clarity of the [SEP]',\n",
    "  'existing_cui': 'C1140150',\n",
    "  'existing_cui_name': 'NOC - CodeSystem',\n",
    "  'existing_cui_desc': '[CLS] NO ##C - Code ##S ##ys ##tem [unused3] ( Intel ##lect ##ual Product , NO ##C : nursing outcomes classification ) [SEP]',\n",
    "  'our_bi_cui': 'C0205160',\n",
    "  'our_bi_cui_name': 'Negative',\n",
    "  'our_bi_cui_desc': '[CLS] N ##eg ##ative [unused3] ( Finding , qualifier value : Rule ##d out ; N ##eg ##ative ( m ##od ##ifier ) [ Am ##bi ##guous ] ; N ##eg ##ative for ; N ##eg ##ative ( m ##od ##ifier ) ; ruled out ; for negative ; out ruled ; negative ; negative ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C1513916',\n",
    "  'our_cross_cui_name': 'Negative Finding',\n",
    "  'our_cross_cui_desc': '[CLS] N ##eg ##ative Finding [unused3] ( Finding : NE ##GA ##TI ##VE ; N ##eg ##ative ) [SEP]'},\n",
    " {'mention_id': '27876084.11',\n",
    "  'test_set_idx': 20251,\n",
    "  'type': 'T092',\n",
    "  'name': 'American College of Critical Care Medicine',\n",
    "  'context': '[CLS] determine whether se ##ptic shock - reversal is quicker in p ##ediatric patients random ##ized to an early goal - directed fluid - spa ##ring strategy versus usual care ( S ##Q ##UE ##E ##Z ##E ) : study protocol for a pilot random ##ized controlled trial Current p ##ediatric se ##ptic shock re ##sus ##citation guidelines from the [unused1] American College of Critical Care Medicine [unused2] focus on the early and goal - directed administration of in ##tra ##vas ##cular fluid followed by v ##as ##oa ##ctive medication in ##fusion ##s for persistent and fluid - re ##fra ##ctor ##y shock . However , a ##cc ##um ##ulating adult and p ##ediatric data suggest that excessive fluid administration is associated with worse patient outcomes and [SEP]',\n",
    "  'existing_cui': 'C1319411',\n",
    "  'existing_cui_name': 'Critical care medicine specialty',\n",
    "  'existing_cui_desc': '[CLS] Critical care medicine specialty [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line , qualifier value : Critical care medicine ; critical care medicine ; care critical medicine ) [SEP]',\n",
    "  'our_bi_cui': 'C1527272',\n",
    "  'our_bi_cui_name': 'American College of Physicians',\n",
    "  'our_bi_cui_desc': '[CLS] American College of Physicians [unused3] ( Professional or O ##cc ##upation ##al Group ) [SEP]',\n",
    "  'our_cross_cui': 'C1708333',\n",
    "  'our_cross_cui_name': 'Health Care Organization',\n",
    "  'our_cross_cui_desc': '[CLS] Health Care Organization [unused3] ( Organization : Healthcare Organization ) [SEP]'},\n",
    " {'mention_id': '27539945.45',\n",
    "  'test_set_idx': 9870,\n",
    "  'type': 'T103',\n",
    "  'name': 'cationic CnDMAOH ( + )',\n",
    "  'context': '[CLS] / C ##10 ##DM ##A ##O system , however , no DNA compact ##ion was observed even in Tri ##s - HC ##l buffer solution with a much lower pH and a much higher C ##10 ##DM ##A ##O concentration . The negative charges of DNA molecules can easily be neutral ##ized by positive charges of [unused1] cat ##ion ##ic C ##n ##DM ##A ##OH ( + ) [unused2] ( n = 12 and 14 ) mice ##lles . DNA was compact ##ed and then ins ##ol ##ub ##le DNA / C ##n ##DM ##A ##OH ( + ) complexes were formed . Because of the much higher critical mice ##lle concentration of the shorter chain length C ##10 ##DM ##A ##OH ( + ) , [SEP]',\n",
    "  'existing_cui': 'C1685101',\n",
    "  'existing_cui_name': 'N-deoxychoylethylenediamine',\n",
    "  'existing_cui_desc': '[CLS] N - de ##ox ##ych ##oy ##let ##hyl ##ened ##iam ##ine [unused3] ( Chemical : cat ##ion ##ic DC ##EA ) [SEP]',\n",
    "  'our_bi_cui': 'C0007447',\n",
    "  'our_bi_cui_name': 'Cations',\n",
    "  'our_bi_cui_desc': '[CLS] Cat ##ions [unused3] ( Chemical , substance : Cat ##ions [ Chemical / In ##g ##red ##ient ] ; Cat ##ion ; cat ##ions ; cat ##ion ) [SEP]',\n",
    "  'our_cross_cui': 'C0029224',\n",
    "  'our_cross_cui_name': 'Organic Chemicals',\n",
    "  'our_cross_cui_desc': '[CLS] Organic Chemical ##s [unused3] ( Chemical , substance : organic chemicals ; compound organic ; Organic Chemical ##s [ Chemical / In ##g ##red ##ient ] ; organic compound ; Chemical ##s , Organic ; organic chemical ; Organic Chemical ; chemical organic ; organic compounds ; Organic compound ; Organic compounds ; Organic chemical ) [SEP]'},\n",
    " {'mention_id': '27334471.4',\n",
    "  'test_set_idx': 2661,\n",
    "  'type': 'T103',\n",
    "  'name': 'TSSs',\n",
    "  'context': '[CLS] CA ##GE ##d - o ##PO ##SS ##UM : motif en ##rich ##ment analysis from Cap Analysis of Gene Express ##ion - derived [unused1] T ##SS ##s [unused2] With the emergence of large - scale Cap Analysis of Gene Express ##ion data ##sets from individual labs and the FA ##NT ##OM consortium , one can now analyze the c ##is - regulatory regions associated with gene transcription at an unprecedented level of re ##fine ##ment . By coupling transcription factor binding site en ##rich ##ment analysis with Cap Analysis of Gene Express ##ion - derived g ##eno ##mic regions , CA ##GE ##d - o ##PO ##SS ##UM can identify T ##F ##s that act as key regulator ##s of genes involved in specific ma ##mmal [SEP]',\n",
    "  'existing_cui': 'C0600327',\n",
    "  'existing_cui_name': 'Toxic Shock Syndrome',\n",
    "  'existing_cui_desc': '[CLS] To ##xi ##c Shock S ##yn ##drome [unused3] ( B ##iol ##og ##ic Fun ##ction , T ##SS , diagnosis , disorder , syndrome : toxic shock syndrome ; Shock , To ##xi ##c ; toxic ; shock ; shock ; toxic ; To ##xi ##c shock syndrome ; S ##yn ##drome ##s , To ##xi ##c Shock ; S ##yn ##drome , To ##xi ##c Shock ; shock syndrome ; toxic ; toxic ; shock syndrome ; S ##yn ##drome toxic shock ; Shock S ##yn ##drome , To ##xi ##c ; T ##SS , To ##xi ##c Shock S ##yn ##drome ; To ##xi ##c Shock S ##yn ##drome ##s ; T ##SS - To ##xi ##c shock syndrome ; syndrome ; toxic shock [SEP]',\n",
    "  'our_bi_cui': 'C0017337',\n",
    "  'our_bi_cui_name': 'Genes',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]',\n",
    "  'our_cross_cui': 'C0949639',\n",
    "  'our_cross_cui_name': 'Transcription Initiation Site',\n",
    "  'our_cross_cui_desc': '[CLS] Trans ##cription In ##iti ##ation Site [unused3] ( Chemical : Start Sites , Trans ##cription ; In ##iti ##ation Site , Trans ##cription ; In ##iti ##ation Sites , Trans ##cription ; Site , Trans ##cription Start ; Start Site , Trans ##cription ; Trans ##cription Start Sites ; Site , Trans ##cription In ##iti ##ation ; Trans ##cription Start Site ; Trans ##cription In ##iti ##ation Sites ; Sites , Trans ##cription Start ; Sites , Trans ##cription In ##iti ##ation ) [SEP]'},\n",
    " {'mention_id': '28195652.2',\n",
    "  'test_set_idx': 27976,\n",
    "  'type': 'T103',\n",
    "  'name': 'piperidinol derivatives',\n",
    "  'context': '[CLS] I ##dent ##ification of the anti - my ##co ##ba ##cter ##ial functional properties of [unused1] pipe ##rid ##ino ##l derivatives [unused2] Tu ##ber ##cu ##los ##is remains a major global health threat and is now the leading cause of death from a single infectious agent worldwide . The current Tu ##ber ##cu ##los ##is drug regime ##n is inadequate , and new anti - tube ##rc ##ular agents are urgent ##ly required to be able to successfully combat the increasing prevalence of drug - resistant Tu ##ber ##cu ##los ##is . The purpose of this study was to investigate a pipe ##rid ##ino ##l compound derivative that is highly active against the My ##co ##ba ##cter ##ium tuberculosis b ##ac ##ill ##us . The anti [SEP]',\n",
    "  'existing_cui': 'C1268914',\n",
    "  'existing_cui_name': 'Piperidine derivative',\n",
    "  'existing_cui_desc': '[CLS] Piper ##id ##ine derivative [unused3] ( Chemical , product , substance ) [SEP]',\n",
    "  'our_bi_cui': 'C1268914',\n",
    "  'our_bi_cui_name': 'Piperidine derivative',\n",
    "  'our_bi_cui_desc': '[CLS] Piper ##id ##ine derivative [unused3] ( Chemical , product , substance ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '28468980.17',\n",
    "  'test_set_idx': 37011,\n",
    "  'type': 'T103',\n",
    "  'name': 'rPfSEA-1A',\n",
    "  'context': '[CLS] ##long ##s survival following P ##las ##mo ##dium be ##rg ##he ##i AN ##KA challenge . To enhance the im ##mu ##no ##genic ##ity of P ##f ##SE ##A - 1A , we identified five linear , B - cell e ##pit ##ope ##s using p ##eptide micro ##arra ##ys probe ##d with anti - se ##ra from [unused1] r ##P ##f ##SE ##A - 1A [unused2] - v ##ac ##cin ##ated non - human p ##rima ##tes . We evaluated the relationship between e ##pit ##ope - specific anti ##body levels and protection from parasite ##mia in a longitudinal treatment - re ##in ##fect ##ion co ##hor ##t in Western Kenya . Anti ##bo ##dies to three e ##pit ##ope ##s were associated with 16 [SEP]',\n",
    "  'existing_cui': 'C0120659',\n",
    "  'existing_cui_name': 'HA-1A',\n",
    "  'existing_cui_desc': '[CLS] H ##A - 1A [unused3] ( Chemical , product , substance ) [SEP]',\n",
    "  'our_bi_cui': 'C0487378',\n",
    "  'our_bi_cui_name': 'Plasmodium falciparum antigen',\n",
    "  'our_bi_cui_desc': '[CLS] P ##las ##mo ##dium f ##al ##ci ##par ##um anti ##gen [unused3] ( Chemical , substance : P ##las ##mo ##dium f ##al ##ci ##par ##um A ##g ; P ##las ##mo ##dium f ##al ##ci ##par ##um Anti ##gen ) [SEP]',\n",
    "  'our_cross_cui': 'C3849939',\n",
    "  'our_cross_cui_name': 'SEA-1 protein , Plasmodium falciparum',\n",
    "  'our_cross_cui_desc': '[CLS] SE ##A - 1 protein , P ##las ##mo ##dium f ##al ##ci ##par ##um [unused3] ( Chemical : P ##f ##SE ##A - 1 protein , P ##las ##mo ##dium f ##al ##ci ##par ##um ; s ##chi ##zon ##t e ##g ##ress anti ##gen - 1 , P ##las ##mo ##dium f ##al ##ci ##par ##um ) [SEP]'},\n",
    " {'mention_id': '28523425.26',\n",
    "  'test_set_idx': 38391,\n",
    "  'type': 'T082',\n",
    "  'name': 'M1',\n",
    "  'context': '[CLS] Specifically , subjects performed intermittent pin ##cer grasp / release , elbow fl ##ex ##ion / extension , and shoulder fl ##ex ##ion / extension at slow , moderate , and fast speeds . In all movements , bursts of power in the high - [ Formula : see text ] band ( 80 - 160 Hz ) were observed in [unused1] M1 [unused2] . In addition , the amplitude of these power bursts and the area of M1 with elevated high - [ Formula : see text ] activity were directly proportional to the movement speed . Likewise , the duration of elevated high - [ Formula : see text ] activity increased with movement duration . Based on linear re ##gression , M1 high [SEP]',\n",
    "  'existing_cui': 'C1705014',\n",
    "  'existing_cui_name': 'CHRM1 wt Allele',\n",
    "  'existing_cui_desc': '[CLS] CH ##R ##M ##1 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : M1 ##R ; HM ##1 ; Cho ##liner ##gic Re ##ceptor , Mu ##sca ##rini ##c , 1 Gene ; Ace ##ty ##l ##cho ##line Re ##ceptor , Mu ##sca ##rini ##c 1 Gene ; Cho ##liner ##gic Re ##ceptor , Mu ##sca ##rini ##c 1 w ##t All ##ele ; Ace ##ty ##l ##cho ##line Re ##ceptor , Mu ##sca ##rini ##c , 1 Gene ) [SEP]',\n",
    "  'our_bi_cui': 'C0026607',\n",
    "  'our_bi_cui_name': 'Motor Cortex',\n",
    "  'our_bi_cui_desc': '[CLS] Motor Co ##rte ##x [unused3] ( Spa ##tial Concept , Motor , body structure : Co ##rte ##x ; Area , Motor ; Motor Area ; Areas , So ##matic Motor ; so ##mat ##omo ##tor areas ; Motor area ; Co ##rte ##x , Motor ; So ##mat ##omo ##tor Area ; Areas , Motor ; motor cortex ; Area , So ##matic Motor ; Motor Areas ; so ##matic motor areas ; So ##mat ##omo ##tor Areas ; Motor Areas , So ##matic ; motor area ; areas motor ; So ##matic Motor Area ; Area , So ##mat ##omo ##tor ; Motor Area , So ##matic ; Areas , So ##mat ##omo ##tor ; Motor cortex ; cortex motor ; So ##matic Motor [SEP]',\n",
    "  'our_cross_cui': 'C3495441',\n",
    "  'our_cross_cui_name': 'primary motor cortex',\n",
    "  'our_cross_cui_desc': '[CLS] primary motor cortex [unused3] ( Spa ##tial Concept , Carpenter , Crosby , M I : area F1 ; Motor Area , Primary ; Motor Co ##rt ##ices , Primary ; primary so ##mat ##omo ##tor area ; primary motor area ; Motor Strip ; Pre ##cent ##ral Motor Co ##rte ##x ; Pre ##cent ##ral Motor Areas ; Area , Primary Motor ; motor cortex ; Motor Co ##rt ##ices , Pre ##cent ##ral ; Primary Motor Co ##rt ##ices ; pre ##cent ##ral motor cortex ; motor strip ; Primary Motor Area ; Motor cortex ; Area , Pre ##cent ##ral Motor ; Motor Co ##rte ##x , Pre ##cent ##ral ; pre ##cent ##ral motor area ; Primary Motor Areas ; Co ##rt [SEP]'},\n",
    " {'mention_id': '28282592.40',\n",
    "  'test_set_idx': 31122,\n",
    "  'type': 'T038',\n",
    "  'name': 'activation pathway',\n",
    "  'context': '[CLS] Trans ##ient rotor ##s terminated when t ##rave ##rsing a region with differing re ##fra ##ctor ##y periods , if no obstacle to conduct ##ion was present to sufficiently delay wave ##front arrival beyond the longest re ##fra ##ctor ##y period . Other rotor ##s were an ##ni ##hil ##ated when a nearby rotor with faster spin rate gradually interrupted the [unused1] activation pathway [unused2] . Eli ##mination of anchor ##s by removal , or by simulated a ##bla ##tion over a sufficient region , prevented rotor onset at a particular location where it would otherwise form . The presence of obstacles to conduct ##ion and spatial differences in re ##fra ##ctor ##y period are important parameters for in ##iti ##ating and maintaining rotation ##al activity [SEP]',\n",
    "  'existing_cui': 'C3156336',\n",
    "  'existing_cui_name': 'protein activation cascade',\n",
    "  'existing_cui_desc': '[CLS] protein activation ca ##sca ##de [unused3] ( B ##iol ##og ##ic Fun ##ction : protein act ##iv ##itor ##y ca ##sca ##de ; protein activation pathway ) [SEP]',\n",
    "  'our_bi_cui': 'C1704259',\n",
    "  'our_bi_cui_name': 'Biochemical Pathway',\n",
    "  'our_bi_cui_desc': '[CLS] B ##io ##chemical Path ##way [unused3] ( B ##iol ##og ##ic Fun ##ction : molecular pathway ; Path ##ways ; Path ##way ) [SEP]',\n",
    "  'our_cross_cui': 'C1148560',\n",
    "  'our_cross_cui_name': 'molecular_function',\n",
    "  'our_cross_cui_desc': '[CLS] molecular _ function [unused3] ( B ##iol ##og ##ic Fun ##ction : molecular function ) [SEP]'},\n",
    " {'mention_id': '27692319.46',\n",
    "  'test_set_idx': 14317,\n",
    "  'type': 'T204',\n",
    "  'name': 'miracidia',\n",
    "  'context': '[CLS] mg / m ##L . Egg ##s in ##cu ##bate ##d with crude extract sub - fraction ##s at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μ ##g / m ##L affected em ##b ##ryo ##nic development , with n - but ##ano ##l presenting the strongest in ##hibition of [unused1] mi ##rac ##id ##ia [unused2] formation . In contrast , on the 12th day , 90 % of the mi ##rac ##id ##ia hatch ##ed in the control experiments using 0 . 03 % D ##MS ##O whereas em ##b ##ryo ##genesis was completely abolished with any concentration of al ##ben ##da ##zo ##le su ##l ##ph ##oxide AB ##Z ( S ##O ) . [SEP]',\n",
    "  'existing_cui': 'C0451085',\n",
    "  'existing_cui_name': 'Composite international diagnostic interview',\n",
    "  'existing_cui_desc': '[CLS] Co ##mpo ##site international diagnostic interview [unused3] ( Intel ##lect ##ual Product , C ##ID ##I , assessment scale : composite international diagnostic interview ; C ##ID ##I - Co ##mpo ##site international diagnostic interview ) [SEP]',\n",
    "  'our_bi_cui': 'C2807025',\n",
    "  'our_bi_cui_name': 'Focillidia',\n",
    "  'our_bi_cui_desc': '[CLS] F ##oc ##ill ##id ##ia [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
    "  'our_cross_cui': 'C0023047',\n",
    "  'our_cross_cui_name': 'Larva',\n",
    "  'our_cross_cui_desc': '[CLS] La ##rva [unused3] ( E ##uka ##ryo ##te : La ##rva ##e ; la ##rva ; larvae ) [SEP]'},\n",
    " {'mention_id': '28145492.37',\n",
    "  'test_set_idx': 26797,\n",
    "  'type': 'T103',\n",
    "  'name': 'OX2R receptor',\n",
    "  'context': '[CLS] in the presence of te ##tro ##do ##to ##xin ) , appeared to be carried by a Na ( + ) - dependent trans ##ient receptor potential - like channel ( as it was blocked by 2 - AP ##B and was diminished by removal of extra ##cellular Na ( + ) ) , and was a consequence of [unused1] O ##X ##2 ##R receptor [unused2] activation ( as it was blocked by the O ##X ##2 ##R receptor antagonist T ##CS O ##X ##2 29 , but not the O ##X ##1 ##R receptor antagonist S ##B 33 ##48 ##6 ##7 ) . Application of the hormone , me ##lat ##oni ##n , failed to alter tube ##roi ##n ##fu ##ndi ##bula ##r do ##pa [SEP]',\n",
    "  'existing_cui': 'C0913649',\n",
    "  'existing_cui_name': 'taste receptors , type 2',\n",
    "  'existing_cui_desc': '[CLS] taste receptors , type 2 [unused3] ( Chemical , taste : G protein - coupled receptor T ##R ##2 ; T ##2 ##R taste receptors ; T ##2 ##R receptor ; T ##2 ##R receptors ; taste receptor , type 2 ; T ##AS ##2 ##R ##13 protein , human ; receptor , T ##2 ##R ) [SEP]',\n",
    "  'our_bi_cui': 'C0069841',\n",
    "  'our_bi_cui_name': 'Oxytocin Receptor',\n",
    "  'our_bi_cui_desc': '[CLS] O ##xy ##to ##cin Re ##ceptor [unused3] ( Chemical : Re ##ceptor ##s , O ##xy ##to ##cin [ Chemical / In ##g ##red ##ient ] ; R ##EC ##EP ##T O ##X ##Y ##TO ##CI ##N ; Re ##ceptor ##s , O ##xy ##to ##cin ; O ##X ##Y ##TO ##CI ##N R ##EC ##EP ##T ; Re ##ceptor , O ##xy ##to ##cin ; O ##xy ##to ##cin Re ##ceptor ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0671880',\n",
    "  'our_cross_cui_name': 'orexin receptor type 2',\n",
    "  'our_cross_cui_desc': '[CLS] ore ##xin receptor type 2 [unused3] ( Chemical : Or ##ex ##in - B Re ##ceptor ##s ; H ##y ##po ##cre ##tin - 2 Re ##ceptor ; Re ##ceptor , H ##y ##po ##cre ##tin - 2 ; H ##y ##po ##cre ##tin Re ##ceptor ##s 2 ; O ##X ##2 Re ##ceptor ##s ; Or ##ex ##in B Re ##ceptor ; Re ##ceptor ##s , Or ##ex ##in - B ; Re ##ceptor ##s 2 , H ##y ##po ##cre ##tin ; Or ##ex ##in Re ##ceptor 2 ; Re ##ceptor 2 , H ##y ##po ##cre ##tin ; HC ##TR ##2 Pro ##tein ; Re ##ceptor , Or ##ex ##in - B ; Or ##ex ##in Re ##ceptor Type 2 ; Pro ##tein [SEP]'},\n",
    " {'mention_id': '27838742.73',\n",
    "  'test_set_idx': 19040,\n",
    "  'type': 'T103',\n",
    "  'name': 'Delicaflavone',\n",
    "  'context': '[CLS] m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto ##pha ##gic cell death via A ##kt / m ##TO ##R / p ##70 ##S ##6 ##K signaling pathway . [unused1] Del ##ica ##f ##lav ##one [unused2] did not show o ##bs ##er ##vable side effects in a x ##eno ##gra ##ft mouse model . Del ##ica ##f ##lav ##one may represent a potential therapeutic agent for lung cancer . Del ##ica ##f ##lav ##one showed anti - lung cancer effects in v ##it ##ro and in v ##ivo . Del ##ica ##f ##lav ##one induced auto [SEP]',\n",
    "  'existing_cui': 'C1870828',\n",
    "  'existing_cui_name': 'sumaflavone',\n",
    "  'existing_cui_desc': '[CLS] sum ##af ##lav ##one [unused3] ( Chemical ) [SEP]',\n",
    "  'our_bi_cui': 'C2828290',\n",
    "  'our_bi_cui_name': 'delafloxacin',\n",
    "  'our_bi_cui_desc': '[CLS] del ##af ##lo ##xa ##cin [unused3] ( Chemical : 1 - ( 6 - Am ##ino - 3 , 5 - Di ##f ##lu ##oro ##py ##rid ##in - 2 - Y ##l ) - 8 - Ch ##lor ##o - 6 - F ##lu ##oro - 7 - ( 3 - H ##ydro ##xy ##az ##eti ##din - 1 - y ##l ) - 4 - O ##x ##o - 1 , 4 - Di ##hy ##dr ##o ##quin ##olin ##e - 3 - Car ##box ##yl ##ic A ##cid ; Del ##af ##lo ##xa ##cin ; DE ##LA ##FL ##OX ##AC ##IN ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27894019.20',\n",
    "  'test_set_idx': 21081,\n",
    "  'type': 'T103',\n",
    "  'name': 'CYP315a1',\n",
    "  'context': '[CLS] ##e p ##le ##bs . X ##ant ##hur ##eni ##c acid is a known end ##ogen ##ous m ##olt regulator present in art ##hr ##op ##ods . Experimental studies have confirmed that X ##ant ##hur ##eni ##c acid in ##hibit ##s m ##olt ##ing by binding to either ( or both ) of two P ##45 ##0 enzymes ( [unused1] C ##YP ##31 ##5 ##a ##1 [unused2] or C ##YP ##31 ##4 ##a ##1 ) that are responsible for the final two h ##ydro ##xy ##lation ##s in the production of the m ##olt - in ##ducing hormone , 20 - h ##ydro ##xy ##ec ##dy ##son ##e . The lack of crystal structures and bio ##chemical ass ##ays for C ##YP ##31 ##5 ##a ##1 [SEP]',\n",
    "  'existing_cui': 'C1418799',\n",
    "  'existing_cui_name': 'PPIF gene',\n",
    "  'existing_cui_desc': '[CLS] PP ##IF gene [unused3] ( Ana ##tom ##ical Structure : C ##Y ##CL ##OP ##H ##IL ##IN 3 ; P ##EP ##TI ##D ##Y ##L - PR ##OL ##Y ##L C ##IS / T ##RA ##NS ISO ##ME ##RA ##SE , MIT ##OC ##H ##ON ##DR ##IA ##L ; P ##ept ##idy ##l ##p ##rol ##yl Is ##omer ##ase F Gene ; PP ##IF Gene ; C ##Y ##CL ##OP ##H ##IL ##IN F ; p ##ept ##idy ##l ##p ##rol ##yl is ##omer ##ase F ; Cy ##p - D ; h ##C ##y ##P ##3 ; c ##y ##c ##lop ##hil ##in D ) [SEP]',\n",
    "  'our_bi_cui': 'C0059735',\n",
    "  'our_bi_cui_name': 'Cytochrome P-450 CYP1A1',\n",
    "  'our_bi_cui_desc': '[CLS] Cy ##to ##ch ##rome P - 450 C ##YP ##1 ##A ##1 [unused3] ( Chemical , substance : Cy ##to ##ch ##rome P 450 C ##YP ##1 ##A ##1 ; Cy ##to ##ch ##rome p ##45 ##0 C ##YP ##1 ##A ##1 enzyme ; er ##od ##ing ; 7 - E ##th ##ox ##yres ##or ##uf ##in O - Dee ##thy ##lase ; C ##YP 1A ##1 ; E ##thy ##l ##res ##or ##uf ##in O - Dee ##thy ##lase ; Cy ##to ##ch ##rome P - 450 C ##YP ##1 ##A ##1 [ Chemical / In ##g ##red ##ient ] ; Cy ##to ##ch ##rome P ##45 ##0 I ##A ##1 ; C ##YP ##1 ##A ##1 ; E ##th ##ox ##yres ##or ##uf ##in [SEP]',\n",
    "  'our_cross_cui': 'C0010762',\n",
    "  'our_cross_cui_name': 'Cytochrome P450',\n",
    "  'our_cross_cui_desc': '[CLS] Cy ##to ##ch ##rome P ##45 ##0 [unused3] ( Chemical , substance : c ##yt ##och ##rome ##s p ##45 ##0 ; c ##yt ##och ##rome P ##45 ##0 ; C ##Y ##TO ##CH ##RO ##ME P 450 E ##N ##Z ##Y ##ME S ##Y ##ST ##EM ; Cy ##to ##ch ##rome p ##45 ##0 enzyme ; Super ##family , Cy ##to ##ch ##rome P ##45 ##0 ; P ##45 ##0 En ##zy ##mes ; c ##yt ##och ##rome p 450 ; En ##zy ##mes , P ##45 ##0 ; Cy ##to ##ch ##rome P 450 Families ; Cy ##to ##ch ##rome P ##45 ##0 En ##zy ##me ; P ##45 ##0 ; C ##YP ##45 ##0 ; Cy ##to ##ch ##rome p ##45 ##0 ; [SEP]'},\n",
    " {'mention_id': '27669217.40',\n",
    "  'test_set_idx': 13691,\n",
    "  'type': 'T017',\n",
    "  'name': 'ermB',\n",
    "  'context': '[CLS] . The er ##m ##B and er ##m ##T genes were found in the genome ##s of all is ##olate ##s . These two genes were acquired independently in one highly v ##ir ##ulent is ##olate AL ##10 ##100 ##2 , and cluster ##ed with T ##n ##9 ##16 and IS ##12 ##16 , respectively . The expression of both [unused1] er ##m ##B [unused2] and er ##m ##T in all is ##olate ##s was er ##yt ##hr ##omy ##cin in ##du ##cible and yielded comparable mac ##rol ##ide MI ##Cs in all six is ##olate ##s . Take ##n together , in ##du ##cible expression of both er ##m ##B and er ##m ##T conferred high mac ##rol ##ide resistance in these S . gal [SEP]',\n",
    "  'existing_cui': 'C0732611',\n",
    "  'existing_cui_name': 'Selective Estrogen Receptor Modulators',\n",
    "  'existing_cui_desc': '[CLS] Select ##ive E ##stro ##gen Re ##ceptor Mo ##du ##lator ##s [unused3] ( Chemical , SE ##R ##M , medication , product , substance : E ##ST ##RO ##GE ##N R ##EC ##EP ##T M ##OD ##U ##LA ##TO ##RS SE ##LE ##CT ##IVE ; Select ##ive E ##stro ##gen Re ##ceptor Mo ##di ##fying Agents ; Select ##ive est ##rogen receptor m ##od ##ulator ##s ; Select ##ive o ##est ##rogen receptor m ##od ##ulator ; E ##stro ##gen Re ##ceptor Mo ##du ##lator , Select ##ive ; SE ##R ##M - Select ##ive est ##rogen receptor m ##od ##ulator ; SE ##R ##Ms ; SE ##R ##M - Select ##ive o ##est ##rogen receptor m ##od ##ulator ; SE ##LE ##CT ##IVE E ##ST [SEP]',\n",
    "  'our_bi_cui': 'C0017339',\n",
    "  'our_bi_cui_name': 'Genes , Bacterial',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##s , Ba ##cter ##ial [unused3] ( Ana ##tom ##ical Structure , substance : Ba ##cter ##ial Gene ##s ; BA ##CT GE ##NE ##S ; GE ##NE ##S BA ##CT ; bacterial gene ; Ba ##cter ##ial genes ; Gene , Ba ##cter ##ial ; BA ##CT GE ##NE ; Ba ##cter ##ial gene ; Ba ##cter ##ial Gene ; GE ##NE BA ##CT ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '28522288.2',\n",
    "  'test_set_idx': 38314,\n",
    "  'type': 'T033',\n",
    "  'name': 'Underestimation',\n",
    "  'context': '[CLS] Grade Group [unused1] Under ##est ##imation [unused2] in Pro ##state B ##io ##psy : Pre ##dict ##ive Factor ##s and Out ##come ##s in Can ##di ##dates for Active Sur ##ve ##illa ##nce We intended to analyze the outcomes and predict ##ive factors for under ##est ##imating the pro ##state cancer grade group from pro ##state bio ##ps ##ies in a large mon ##oc ##ent ##ric co ##hor ##t of patients treated by minimal ##ly invasive radical pro ##state ##ct ##omy . Using a mon ##oc ##ent ##ric prospective ##ly maintained database , we included 306 ##2 patients who underwent minimal ##ly invasive radical pro ##state ##ct ##omy between 2006 and 2013 . We explored clinic ##op ##ath ##olo ##gic features and outcomes associated with a [SEP]',\n",
    "  'existing_cui': 'C0680844',\n",
    "  'existing_cui_name': 'estimation',\n",
    "  'existing_cui_desc': '[CLS] est ##imation [unused3] ( B ##iol ##og ##ic Fun ##ction , subjective , subjective : E ##st ##imation ; est ##imation ##s ) [SEP]',\n",
    "  'our_bi_cui': 'C0680844',\n",
    "  'our_bi_cui_name': 'estimation',\n",
    "  'our_bi_cui_desc': '[CLS] est ##imation [unused3] ( B ##iol ##og ##ic Fun ##ction , subjective , subjective : E ##st ##imation ; est ##imation ##s ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28484550.10',\n",
    "  'test_set_idx': 37646,\n",
    "  'type': 'T038',\n",
    "  'name': 'giant',\n",
    "  'context': '[CLS] Di ##stal posterior cerebral artery re ##vas ##cular ##ization for a f ##us ##iform PC ##A an ##eur ##ys ##m : A lesson learned The need for re ##vas ##cular ##ization with pro ##ximal posterior cerebral artery o ##cc ##lusion in the treatment of [unused1] giant [unused2] and f ##us ##iform an ##eur ##ys ##ms is unclear . While early series demonstrated only about a 10 % chance of in ##far ##ction following posterior cerebral artery o ##cc ##lusion , recently several authors have advocated a bypass prior to parent vessel sacrifice in all cases . We present the case of an adult man with a f ##us ##iform an ##eur ##ys ##m of the right posterior cerebral artery at the P ##2 - P ##3 [SEP]',\n",
    "  'existing_cui': 'C0017547',\n",
    "  'existing_cui_name': 'Gigantism',\n",
    "  'existing_cui_desc': '[CLS] G ##igan ##tism [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , physical finding : G ##igan ##tism , Pit ##uit ##ary ; pit ##uit ##ary ; gig ##anti ##sm ; giants ; gig ##anti ##sm disorder ; giant ; gig ##anti ##sm ; pit ##uit ##ary ; Giant ; Normal giant ; gig ##anti ##sm was noted ; Pit ##uit ##ary G ##igan ##tism ; Giant ##ism ; gig ##anti ##sm ; P ##rim ##ord ##ial giant ; Gene ##tic giant ; genetics giant ; giant ##ism ; Pit ##uit ##ary gig ##anti ##sm ; Giant - R ##ET ##IR ##ED - ; G ##igan ##tism [ Disease / Finding ] ) [SEP]',\n",
    "  'our_bi_cui': 'C0017547',\n",
    "  'our_bi_cui_name': 'Gigantism',\n",
    "  'our_bi_cui_desc': '[CLS] G ##igan ##tism [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , physical finding : G ##igan ##tism , Pit ##uit ##ary ; pit ##uit ##ary ; gig ##anti ##sm ; giants ; gig ##anti ##sm disorder ; giant ; gig ##anti ##sm ; pit ##uit ##ary ; Giant ; Normal giant ; gig ##anti ##sm was noted ; Pit ##uit ##ary G ##igan ##tism ; Giant ##ism ; gig ##anti ##sm ; P ##rim ##ord ##ial giant ; Gene ##tic giant ; genetics giant ; giant ##ism ; Pit ##uit ##ary gig ##anti ##sm ; Giant - R ##ET ##IR ##ED - ; G ##igan ##tism [ Disease / Finding ] ) [SEP]',\n",
    "  'our_cross_cui': 'C0751004',\n",
    "  'our_cross_cui_name': 'Giant Intracranial Aneurysm',\n",
    "  'our_cross_cui_desc': '[CLS] Giant In ##tra ##c ##rani ##al An ##eur ##ys ##m [unused3] ( B ##iol ##og ##ic Fun ##ction : In ##tra ##c ##rani ##al An ##eur ##ys ##m , Giant ; An ##eur ##ys ##ms , Giant In ##tra ##c ##rani ##al ; In ##tra ##c ##rani ##al An ##eur ##ys ##ms , Giant ; Giant In ##tra ##c ##rani ##al An ##eur ##ys ##ms ; An ##eur ##ys ##m , Giant In ##tra ##c ##rani ##al ) [SEP]'},\n",
    " {'mention_id': '27887587.40',\n",
    "  'test_set_idx': 20928,\n",
    "  'type': 'T033',\n",
    "  'name': 'practical',\n",
    "  'context': \"[CLS] Community Mental Health Centre in their work towards their recovery goals were el ##icit ##ed , as follows : developing an understanding of ones ##elf and one ' s mental health problems ; learning how to change feelings and behaviour ##s ; being ' pushed ' into social arena ##s ; finding helpful medication ; and counsel ##ling in family , [unused1] practical [unused2] and financial issues . The participants ' expectations about counsel ##ling with regard to longer - term family , practical , and financial challenges were insufficient ##ly met by the Community Mental Health Centre . In the experience of the service users , recovery occurred within the context of their everyday life with or without the support of their professional help ##ers [SEP]\",\n",
    "  'existing_cui': 'C0335403',\n",
    "  'existing_cui_name': 'Practical aid',\n",
    "  'existing_cui_desc': '[CLS] P ##ractical aid [unused3] ( B ##io ##medical O ##cc ##upation or Disc ##ip ##line , pharmacy , pharmacy , occupation : P ##ractical aid ( pharmacy ) ) [SEP]',\n",
    "  'our_bi_cui': 'C4054160',\n",
    "  'our_bi_cui_name': 'Practical Domain',\n",
    "  'our_bi_cui_desc': '[CLS] P ##ractical Domain [unused3] ( Intel ##lect ##ual Product ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '28436493.28',\n",
    "  'test_set_idx': 35794,\n",
    "  'type': 'T103',\n",
    "  'name': 'EsxA',\n",
    "  'context': '[CLS] ##X - 1 type VII secret ##ion system . Gene ##tic complement ##ation with a p ##las ##mi ##d carrying the My ##co ##ba ##cter ##ium tuberculosis H ##37 ##R ##v sequence of e ##cc ##C ##a ##1 - e ##cc ##C ##b ##1 - p ##e ##35 re - established E ##s ##x ##A secret ##ion , host specific [unused1] E ##s ##x ##A [unused2] T - cell responses , and increased strain v ##ir ##ule ##nce . The E ##S ##X - 1 secret ##ion defect prevents several v ##ir ##ule ##nce factors from being functional during infection and therefore at ##ten ##uate ##s My ##co ##ba ##cter ##ium tuberculosis . It pre ##c ##lude ##s specific T - cell responses against strong anti [SEP]',\n",
    "  'existing_cui': 'C1706322',\n",
    "  'existing_cui_name': 'ELF3 wt Allele',\n",
    "  'existing_cui_desc': '[CLS] E ##LF ##3 w ##t All ##ele [unused3] ( Ana ##tom ##ical Structure : E ##SE - 1 ; ER ##T ; J ##EN ; E ##S ##X ; E ##7 ##4 - Like Factor 3 ( ET ##S Domain Trans ##cription Factor , E ##pit ##hel ##ial - S ##pecific ) w ##t All ##ele ; EP ##R - 1 ) [SEP]',\n",
    "  'our_bi_cui': 'C0052654',\n",
    "  'our_bi_cui_name': 'atroxase',\n",
    "  'our_bi_cui_desc': '[CLS] at ##ro ##xa ##se [unused3] ( Chemical , substance : At ##ro ##xa ##se ) [SEP]',\n",
    "  'our_cross_cui': 'C1744314',\n",
    "  'our_cross_cui_name': 'ESAT-6 protein , Mycobacterium tuberculosis',\n",
    "  'our_cross_cui_desc': '[CLS] E ##SA ##T - 6 protein , My ##co ##ba ##cter ##ium tuberculosis [unused3] ( Chemical : E ##SA ##T - 6 System 1 protein , My ##co ##ba ##cter ##ium tuberculosis ; 6 - k ##D ##a early secret ##ory anti ##genic target , My ##co ##ba ##cter ##ium tuberculosis ; E ##s ##x - 1 protein , My ##co ##ba ##cter ##ium tuberculosis ; E ##s ##x ##A protein , My ##co ##ba ##cter ##ium tuberculosis ) [SEP]'},\n",
    " {'mention_id': '27347668.1',\n",
    "  'test_set_idx': 3121,\n",
    "  'type': 'T058',\n",
    "  'name': 'Spectral fingerprints',\n",
    "  'context': '[CLS] [unused1] S ##pect ##ral finger ##prints [unused2] of large - scale co ##rt ##ical dynamics during ambiguous motion perception Am ##bi ##guous stimuli have been widely used to study the ne ##uron ##al co ##rrel ##ates of consciousness . Recently , it has been suggested that conscious perception might arise from the dynamic inter ##play of functional ##ly specialized but widely distributed co ##rt ##ical areas . While previous research mainly focused on phase coupling as a co ##rrel ##ate of co ##rt ##ical communication , more recent findings indicated that additional coupling modes might co ##ex ##ist and possibly sub ##serve distinct co ##rt ##ical functions . Here , we studied two coupling modes , namely phase and envelope coupling , which might differ in [SEP]',\n",
    "  'existing_cui': 'C0016128',\n",
    "  'existing_cui_name': 'Fingerprints , Peptide',\n",
    "  'existing_cui_desc': '[CLS] Fin ##ger ##prints , P ##eptide [unused3] ( Health Care Act ##ivity : Fin ##ger ##print , P ##eptide ; Fin ##ger ##prints , Pro ##tein ; Pro ##tein Fin ##ger ##prints ; Pro ##tein Fin ##ger ##print ; P ##eptide Fin ##ger ##print ; P ##eptide Fin ##ger ##prints ; Fin ##ger ##print , Pro ##tein ) [SEP]',\n",
    "  'our_bi_cui': 'C0079356',\n",
    "  'our_bi_cui_name': 'DNA Fingerprints',\n",
    "  'our_bi_cui_desc': '[CLS] DNA Fin ##ger ##prints [unused3] ( Finding : Fin ##ger ##print , DNA ; Fin ##ger ##prints , DNA ; d ##na finger ##prints ; DNA Fin ##ger ##print ; d ##na finger ##print ) [SEP]',\n",
    "  'our_cross_cui': 'C0037812',\n",
    "  'our_cross_cui_name': 'Spectrum Analysis',\n",
    "  'our_cross_cui_desc': '[CLS] Spectrum Analysis [unused3] ( Health Care Act ##ivity : s ##pect ##ros ##copy ; spectrum analysis ; SP ##EC ##TR ##UM AN ##AL ; S ##pect ##ros ##copy ; Analysis , Spectrum ; AN ##AL SP ##EC ##TR ##UM ; Spectrum analysis ) [SEP]'},\n",
    " {'mention_id': '27984742.11',\n",
    "  'test_set_idx': 22893,\n",
    "  'type': 'T103',\n",
    "  'name': 'DarG',\n",
    "  'context': '[CLS] Back to the Roots : Deep View into the Evolution ##ary History of AD ##P - R ##ib ##osy ##lation Opened by the DNA - Target ##ing To ##xin - Anti ##to ##xin Mo ##du ##le Dar ##T ##G In this issue of Molecular Cell , Jan ##ke ##vic ##ius et al . ( 2016 ) character ##ize the Dar ##T ##G to ##xin - anti ##to ##xin module in which the Dar ##T to ##xin AD ##P - rib ##osy ##lates single - stranded DNA and the [unused1] Dar ##G [unused2] anti ##to ##xin counter ##acts Dar ##T by direct binding and by en ##zy ##matic re ##mo ##va l of the AD ##P - rib ##osy ##lation . [SEP]',\n",
    "  'existing_cui': 'C2767915',\n",
    "  'existing_cui_name': 'Dargida',\n",
    "  'existing_cui_desc': '[CLS] Dar ##gi ##da [unused3] ( E ##uka ##ryo ##te ) [SEP]',\n",
    "  'our_bi_cui': 'C0969663',\n",
    "  'our_bi_cui_name': 'DnaG',\n",
    "  'our_bi_cui_desc': '[CLS] D ##na ##G [unused3] ( Chemical , P ##rima ##se , P ##rima ##se : D ##na ##G Pro ##tein ; D ##na ##G Gene Product ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '27442216.12',\n",
    "  'test_set_idx': 5808,\n",
    "  'type': 'T037',\n",
    "  'name': 'appendicular fractures',\n",
    "  'context': '[CLS] total of 75 ##8 patients who presented following either snow ##mobile ( n = 87 ) , AT ##V - related ( n = 308 ) or dirt ##bi ##ke ( n = 36 ##3 ) - related trauma at our institution between 1996 and 2015 were retrospective ##ly reviewed . A total of 44 ##1 a ##xial and [unused1] app ##end ##icular fracture ##s [unused2] occurred requiring 53 ##3 procedures . Snow ##mobile and dirt ##bi ##ke accidents were associated with a higher rate of fracture ##s ( 63 % , 64 % ) than the All - terrain vehicles group ( 50 % ) ( P = 0 . 000 ##8 ) . Snow ##mobile injuries had the highest rate of spinal ( 23 [SEP]',\n",
    "  'existing_cui': 'C0226745',\n",
    "  'existing_cui_name': 'Structure of appendicular vein',\n",
    "  'existing_cui_desc': '[CLS] Structure of app ##end ##icular vein [unused3] ( Ana ##tom ##ical Structure , body structure : V ##ena app ##end ##icular ##is ; A ##ppe ##ndi ##cular vein ) [SEP]',\n",
    "  'our_bi_cui': 'C0003611',\n",
    "  'our_bi_cui_name': 'Appendectomy',\n",
    "  'our_bi_cui_desc': '[CLS] A ##ppe ##nde ##ct ##omy [unused3] ( Health Care Act ##ivity , procedure , treatment : removal of app ##end ##ix ; app ##end ##ec ##tom ##ies ; A ##ppe ##nde ##ct ##omi ##es ; app ##end ##ice ##ct ##omy ; Re ##mo ##val of app ##end ##ix ; A ##ppe ##ndi ##x : Ex ##cision ; app ##end ##ec ##tom ##y procedure ; A ##ppe ##ndi ##ce ##ct ##omy ; app ##end ##ec ##tom ##y ; app ##end ##ice ##ct ##omi ##es ; Ex ##cision of app ##end ##ix ; app ##end ##ec ##tom ##y procedures ; Primary app ##end ##ec ##tom ##y ; app ##end ##ix ex ##cision ; Ex ##cision Pro ##ced ##ures on the A ##ppe ##ndi ##x ; AP ##P ##EN [SEP]',\n",
    "  'our_cross_cui': 'C0016658',\n",
    "  'our_cross_cui_name': 'Fracture',\n",
    "  'our_cross_cui_desc': '[CLS] Fr ##act ##ure [unused3] ( In ##ju ##ry or Po ##ison ##ing , diagnosis , disorder , finding , m ##or ##ph ##olo ##gic abnormal ##ity : Broken bones ; Broken Bones ; broken bone ; Fr ##act ##ure of Bone ; bone ; fracture ; bones fractured ; Fr ##act ##ures ; fracture ; bone ; Fr ##act ##ures , Bone [ Disease / Finding ] ; fracture ##s ; fractured ; Bone , Broken ; Fr ##act ##ure of bones ; Fr ##act ##ure : [ of un ##sp ##ec ##ified bones ] or [ NO ##S ] ; Fr ##act ##ure , cause ; Fr ##act ##ure bone ; bone fracture ; bone fracture ##s ; bone fractured ; Bone Fr ##act ##ure [SEP]'},\n",
    " {'mention_id': '27722881.48',\n",
    "  'test_set_idx': 15035,\n",
    "  'type': 'T007',\n",
    "  'name': 'JPM1',\n",
    "  'context': '[CLS] strain JP ##M ##1 was proposed based on the meta ##bol ##ites and the interaction analyses . Additionally , the the ##rm ##ody ##nam ##ic analysis showed that the strain JP ##M ##1 had high tolerance for flu ##oran ##the ##ne , and the influence of flu ##oran ##the ##ne for the bacterial growth activity was ne ##gli ##gible under 100 to 400 mg L ( - 1 ) concentrations . Take ##n together , this study indicates that the strain [unused1] JP ##M ##1 [unused2] has high potential for further study in bio ##rem ##edia ##tion of p ##oly ##cy ##c ##lic a ##romatic h ##ydro ##car ##bon ( p ##oly ##cy ##c ##lic a ##romatic h ##ydro ##car ##bon ) - contaminated sites . [SEP]',\n",
    "  'existing_cui': 'C1421124',\n",
    "  'existing_cui_name': 'TRGJP gene',\n",
    "  'existing_cui_desc': '[CLS] T ##R ##G ##JP gene [unused3] ( Ana ##tom ##ical Structure : T - cell receptor , gamma , joining segment JP ; T cell receptor gamma joining P ) [SEP]',\n",
    "  'our_bi_cui': 'C3629619',\n",
    "  'our_bi_cui_name': 'bacterium JP1',\n",
    "  'our_bi_cui_desc': '[CLS] bacterium JP ##1 [unused3] ( Ba ##cter ##ium ) [SEP]',\n",
    "  'our_cross_cui': 'C4153571',\n",
    "  'our_cross_cui_name': 'Microbacterium sp . JPM1',\n",
    "  'our_cross_cui_desc': '[CLS] Micro ##ba ##cter ##ium s ##p . JP ##M ##1 [unused3] ( Ba ##cter ##ium ) [SEP]'},\n",
    " {'mention_id': '27933285.26',\n",
    "  'test_set_idx': 22294,\n",
    "  'type': 'T170',\n",
    "  'name': 'Autism Diagnostic Observation Schedule - second edition',\n",
    "  'context': \"[CLS] ##eti ##tive Be ##ha ##vior Scale - Rev ##ised , the Raven ' s Color ##ed Progressive Mat ##rice ##s , the Child Be ##ha ##vior Check ##L ##ist for ages 1 ½ - 5 or 4 - 18 ( CBC ##L ) , the Social Re ##sp ##ons ##ive ##ness Scale , and the [unused1] Au ##tism Di ##ag ##nos ##tic O ##bs ##er ##vation Schedule - second edition [unused2] ( AD ##OS 2 ) . All patients were showing motor stereo ##ty ##pies for periods of time varying from 6 to 77 months . The Motor Se ##ver ##ity St ##ere ##ot ##y ##py Scale showed that each child had a limited number of stereo ##ty ##pies ; their frequency and intensity were mild [SEP]\",\n",
    "  'existing_cui': 'C0441795',\n",
    "  'existing_cui_name': 'Second edition',\n",
    "  'existing_cui_desc': '[CLS] Second edition [unused3] ( Intel ##lect ##ual Product , qualifier value : Second Edition ) [SEP]',\n",
    "  'our_bi_cui': 'C2828257',\n",
    "  'our_bi_cui_name': 'International Classification of Diseases for Oncology , Second Edition',\n",
    "  'our_bi_cui_desc': '[CLS] International Classification of Disease ##s for On ##cology , Second Edition [unused3] ( Intel ##lect ##ual Product : I ##CD - O - 2 ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28077286.39',\n",
    "  'test_set_idx': 25089,\n",
    "  'type': 'T103',\n",
    "  'name': 'MeHg',\n",
    "  'context': '[CLS] on brain his ##top ##ath ##ology and courts ##hip behavior in a model song ##bird species , the z ##eb ##ra fin ##ch ( Ta ##eni ##opy ##gia gut ##tata ) . Egg treatment groups included : a low Me ##H ##g dose of 0 . 2 μ ##g H ##g g ( - 1 ) egg , a high [unused1] Me ##H ##g [unused2] dose of 3 . 2 μ ##g H ##g g ( - 1 ) egg , and a vehicle control ( water ) . No adverse effects of in o ##vo Me ##H ##g treatment were detected on courts ##hip song quality or on mating behavior in experimental males at sexually maturity which would suggest that o ##bs ##er ##vable ne [SEP]',\n",
    "  'existing_cui': 'C0228520',\n",
    "  'existing_cui_name': 'Structure of reticular formation of medulla oblongata',\n",
    "  'existing_cui_desc': '[CLS] Structure of re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata [unused3] ( Ana ##tom ##ical Structure , body structure : bulb ##ar re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla ; B ##ul ##bar re ##tic ##ular formation ; Form ##ati ##o re ##tic ##ular ##is my ##ele ##nce ##pha ##li ; me ##du ##llar ##y re ##tic ##ular formation ; re ##tic ##ular formation of me ##du ##lla ; Me ##du ##llar ##y re ##tic ##ular formation ; Re ##tic ##ular formation of me ##du ##lla o ##b ##long ##ata ) [SEP]',\n",
    "  'our_bi_cui': 'C0166979',\n",
    "  'our_bi_cui_name': 'dimethyl mercury',\n",
    "  'our_bi_cui_desc': '[CLS] dim ##eth ##yl mercury [unused3] ( Chemical , substance : Di ##met ##hyl ##mer ##cu ##ry ; Me ##rc ##uri ##us Met ##hyl ##en ##us ; Met ##hyl Mercury ; D ##IM ##ET ##H ##Y ##LM ##ER ##CU ##R ##Y ; Di ##met ##hyl mercury ; dim ##eth ##yl ##mer ##cu ##ry ; Mercury , Di ##met ##hyl ) [SEP]',\n",
    "  'our_cross_cui': 'C0025794',\n",
    "  'our_cross_cui_name': 'Methylmercury Compounds',\n",
    "  'our_cross_cui_desc': '[CLS] Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [unused3] ( Chemical : Met ##hyl ##mer ##cu ##ry Co ##mpo ##unds [ Chemical / In ##g ##red ##ient ] ; Mercury Co ##mpo ##unds , Met ##hyl ; ME ##TH ##Y ##L ME ##RC ##UR ##Y CP ##DS ; Met ##hyl Mercury Co ##mpo ##unds ; ME ##TH ##Y ##LM ##ER ##CU ##R ##Y CP ##DS ; Co ##mpo ##unds , Met ##hyl ##mer ##cu ##ry ; met ##hyl ##mer ##cu ##ry ; Co ##mpo ##unds , Met ##hyl Mercury ; Met ##hyl ##mer ##cu ##ry ) [SEP]'},\n",
    " {'mention_id': '27503899.39',\n",
    "  'test_set_idx': 8574,\n",
    "  'type': 'T033',\n",
    "  'name': 'underlying misconceptions',\n",
    "  'context': '[CLS] time and logistics . Various forms of generic feedback can provide rapid and cost - effect feedback to large co ##hor ##ts but may be of limited benefit to students other than signaling weaknesses in knowledge . The present study describes a method that was used to provide format ##ive task - related feedback to a large co ##hor ##t of first - year physiology and anatomy students . Based on student evaluation ##s presented in this study , this method provided feedback in a manner that engaged students , uncovered [unused1] underlying mi ##sco ##nce ##ption ##s [unused2] , facilitated peer discussion , and provided opportunity for new instruction while allowing the lecturer to recognize common gaps in knowledge and inform ongoing curriculum development . [SEP]',\n",
    "  'existing_cui': 'C4313726',\n",
    "  'existing_cui_name': 'Underlying erythema',\n",
    "  'existing_cui_desc': '[CLS] Under ##lying er ##yt ##hem ##a [unused3] ( Finding , in some patients , in some patients ) [SEP]',\n",
    "  'our_bi_cui': 'C0561845',\n",
    "  'our_bi_cui_name': 'False memories',\n",
    "  'our_bi_cui_desc': '[CLS] F ##als ##e memories [unused3] ( B ##iol ##og ##ic Fun ##ction , finding : P ##se ##udo ##me ##mor ##y ; F ##als ##e Memory ; false memory ; false memories ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27259647.14',\n",
    "  'test_set_idx': 945,\n",
    "  'type': 'T103',\n",
    "  'name': '9-cis-11-trans-CLA',\n",
    "  'context': '[CLS] - surface protein belonging to the conserved family of en ##ola ##ses with a central role in g ##ly ##co ##ly ##tic metabolism , was characterized to have a side role in the intricate metabolism of bio ##hy ##dr ##ogen ##ation of l ##ino ##le ##ic acid , cat ##aly ##zing the formation of bio ##active [unused1] 9 - c ##is - 11 - trans - C ##LA [unused2] through de ##hy ##dra ##tion and is ##omer ##ization of 10 - h ##ydro ##xy - 12 - c ##is - o ##ct ##ade ##ce ##no ##ic acid . The identity of the en ##ola ##se was confirmed through mass s ##pect ##rome ##tric analysis that showed the characteristic 44 ##2 amino acid sequence with a molecular [SEP]',\n",
    "  'existing_cui': 'C0281666',\n",
    "  'existing_cui_name': 'alitretinoin',\n",
    "  'existing_cui_desc': '[CLS] al ##it ##ret ##ino ##in [unused3] ( Chemical , product , substance : 9 - CR ##A ; 9 - c ##is - T ##ret ##ino ##in ; Ali ##tre ##tino ##ín ##a ; 9 - c ##is re ##tino ##ic acid ; 9 - c ##is - Re ##tino ##ic acid ; 9 - c ##is - Re ##tino ##ic A ##cid ; Ali ##tre ##tino ##in ; Ali ##tre ##tino ##in ##um ; 3 , 7 - Di ##met ##hyl - 9 - ( 2 , 6 , 6 - trim ##eth ##yl - 1 - c ##y ##c ##lo ##he ##xen - 1 - y ##l ) 2 - trans - 4 - trans - 6 - c ##is - 8 - trans [SEP]',\n",
    "  'our_bi_cui': 'C0902483',\n",
    "  'our_bi_cui_name': 'cis-9-trans-11-octadecadienoic acid',\n",
    "  'our_bi_cui_desc': '[CLS] c ##is - 9 - trans - 11 - o ##ct ##ade ##ca ##die ##no ##ic acid [unused3] ( Chemical : 9 - c ##is - 11 - trans - o ##ct ##ade ##ca ##die ##no ##ic acid ; c ##9 ##t ##11 C ##LA ) [SEP]',\n",
    "  'our_cross_cui': 'C1609806',\n",
    "  'our_cross_cui_name': 'cis-9 , trans-11-conjugated linoleic acid',\n",
    "  'our_cross_cui_desc': '[CLS] c ##is - 9 , trans - 11 - con ##ju ##gated l ##ino ##le ##ic acid [unused3] ( Chemical : c ##9 - t ##11 - C ##LA ) [SEP]'},\n",
    " {'mention_id': '28179911.55',\n",
    "  'test_set_idx': 27649,\n",
    "  'type': 'T017',\n",
    "  'name': 'KASI',\n",
    "  'context': '[CLS] ##ido ##psis , high over - expressions of Co ##WR ##I ##1 in seven independent T ##2 lines were detected by quantitative real - time PC ##R . The relative m ##RNA accumulation of genes encoding enzymes involved in either fatty acid bio ##sy ##nt ##hesis or t ##ria ##cy ##l ##gly ##cer ##ols assembly ( BC ##CP ##2 , [unused1] K ##AS ##I [unused2] , MA ##T , E ##NR , FA ##TA , and GP ##D ##H ) were also ass ##ay ##ed in mature seeds . Furthermore , lip ##id and fatty acids C ##16 : 0 and C ##18 : 0 significantly increased . In two ho ##mo ##zy ##go ##us T ##2 trans ##genic rice lines ( G ##5 and G [SEP]',\n",
    "  'existing_cui': 'C1151968',\n",
    "  'existing_cui_name': '3-oxoacyl - [ acyl-carrier-protein ] synthase activity',\n",
    "  'existing_cui_desc': '[CLS] 3 - o ##x ##oa ##cy ##l - [ a ##cy ##l - carrier - protein ] s ##ynth ##ase activity [unused3] ( B ##iol ##og ##ic Fun ##ction , de ##car ##box ##yla ##ting : beta - k ##eto ##acy ##l - AC ##P s ##ynth ##ase I activity ; 3 - o ##x ##oa ##cy ##l : AC ##P s ##ynth ##ase I ; beta - k ##eto ##acy ##l s ##ynth ##eta ##se activity ; 3 - o ##x ##oa ##cy ##l - [ a ##cy ##l - carrier protein ] s ##ynth ##ase activity ; beta - k ##eto ##acy ##l a ##cy ##l carrier protein s ##ynth ##ase activity ; beta - k ##eto ##acy ##l - AC ##P s ##ynth [SEP]',\n",
    "  'our_bi_cui': 'C1418256',\n",
    "  'our_bi_cui_name': 'PAICS gene',\n",
    "  'our_bi_cui_desc': '[CLS] PA ##IC ##S gene [unused3] ( Ana ##tom ##ical Structure : SA ##IC ##AR S ##Y ##NT ##H ##ET ##AS ##E ; P ##H ##OS ##P ##H ##OR ##IB ##OS ##Y ##LA ##MI ##N ##O ##IM ##ID ##A ##Z ##OL ##E CA ##RB ##OX ##Y ##LA ##SE ; AI ##R CA ##RB ##OX ##Y ##LA ##SE ; AD ##E ##2 ##H1 ; p ##hos ##ph ##ori ##bos ##yla ##min ##oi ##mi ##da ##zo ##le car ##box ##yla ##se ; p ##hos ##ph ##ori ##bos ##yla ##min ##oi ##mi ##da ##zo ##les ##ucci ##no ##car ##box ##ami ##de s ##ynth ##ase ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27647760.43',\n",
    "  'test_set_idx': 12810,\n",
    "  'type': 'T170',\n",
    "  'name': 'recessive model',\n",
    "  'context': \"[CLS] ##D ##NF ##OS had a protective role for heroin addiction in the add ##itive model and dominant model ( p < 0 . 05 ) . By contrast , the all ##ele ' T ' of r ##s ##7 ##48 ##13 ##11 in B ##D ##NF ##OS significantly elevated the risk of heroin addiction in the add ##itive model , [unused1] re ##cess ##ive model [unused2] and dominant model ( p < 0 . 05 ) . We also found that all ##ele ' C ' of r ##s ##11 ##0 ##30 ##0 ##9 ##6 was associated with an increased risk of addiction in the dominant model and add ##itive model ( p < 0 . 05 ) . Additionally , we found that r ##s [SEP]\",\n",
    "  'existing_cui': 'C0017361',\n",
    "  'existing_cui_name': 'Genes , Recessive',\n",
    "  'existing_cui_desc': '[CLS] Gene ##s , Re ##cess ##ive [unused3] ( Ana ##tom ##ical Structure , function , o ##bs ##er ##vable entity , substance : Re ##cess ##ive Gene ##s ; gene re ##cess ##ive ; genes re ##cess ##ive ; Re ##cess ##ive Gene ; re ##cess ##ive genes ; re ##cess ##ive gene ; Gene , Re ##cess ##ive ; Re ##cess ##ive gene , function ; Re ##cess ##ive gene ) [SEP]',\n",
    "  'our_bi_cui': 'C0017361',\n",
    "  'our_bi_cui_name': 'Genes , Recessive',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##s , Re ##cess ##ive [unused3] ( Ana ##tom ##ical Structure , function , o ##bs ##er ##vable entity , substance : Re ##cess ##ive Gene ##s ; gene re ##cess ##ive ; genes re ##cess ##ive ; Re ##cess ##ive Gene ; re ##cess ##ive genes ; re ##cess ##ive gene ; Gene , Re ##cess ##ive ; Re ##cess ##ive gene , function ; Re ##cess ##ive gene ) [SEP]',\n",
    "  'our_cross_cui': 'C0026343',\n",
    "  'our_cross_cui_name': 'Models , Genetic',\n",
    "  'our_cross_cui_desc': '[CLS] Models , Gene ##tic [unused3] ( Intel ##lect ##ual Product : GE ##NE ##T M ##OD ##EL ##S ; genetic model ; Gene ##tic Models ; Gene ##tic Model ; Model , Gene ##tic ; M ##OD ##EL ##S GE ##NE ##T ) [SEP]'},\n",
    " {'mention_id': '27894020.12',\n",
    "  'test_set_idx': 21121,\n",
    "  'type': 'T204',\n",
    "  'name': 'Giuseppe Paravicini',\n",
    "  'context': '[CLS] Mom ##bell ##o P ##sy ##chia ##tric Hospital in Lim ##bia ##te , near Milan , replaced the old Sen ##av ##ra Hospital as the P ##sy ##chia ##tric Hospital for the Province of Milan in the 19th century . During the early 20th century , bodies of several Mom ##bell ##o patients were di ##sse ##cted and preserved by [unused1] Giuseppe Para ##vic ##ini [unused2] , an an ##ato ##mist who operated within the asylum . The aim of the present study was to examine and memorial ##ize this important ass ##em ##bla ##ge . To this end , we were allowed to sample the head hair of six such preparations for toxic ##ological analysis . By means of high performance liquid ch ##roma ##tography [SEP]',\n",
    "  'existing_cui': 'C0162568',\n",
    "  'existing_cui_name': 'Erythropoietic Protoporphyria',\n",
    "  'existing_cui_desc': '[CLS] E ##ry ##throp ##oi ##etic Proto ##por ##phy ##ria [unused3] ( B ##iol ##og ##ic Fun ##ction , diagnosis , disorder , er ##yt ##hr ##op ##oi ##etic pro ##top ##or ##phy ##ria p ##or ##phy ##ria : pro ##top ##or ##phy ##ria er ##yt ##hr ##op ##oi ##etic ; Proto ##por ##phy ##ria , E ##ry ##throp ##oi ##etic [ Disease / Finding ] ; E ##ry ##throp ##oi ##etic pro ##top ##or ##phy ##ria ; E ##ry ##th ##ro ##he ##pa ##tic Proto ##por ##phy ##ria ; PR ##OT ##OP ##OR ##P ##H ##Y ##RI ##A , ER ##Y ##TH ##RO ##PO ##IE ##TI ##C ; ma ##gn ##us syndrome ; Proto ##por ##phy ##ria ; er ##yt ##hr ##op ##oi ##etic ; pro [SEP]',\n",
    "  'our_bi_cui': 'C0015621',\n",
    "  'our_bi_cui_name': 'Famous Persons',\n",
    "  'our_bi_cui_desc': '[CLS] Famous Persons [unused3] ( Population Group : celebrities ; famous persons ; Ce ##le ##bri ##ties ; Person , Famous ; Persons , Famous ; famous person ; Famous Person ; Celebrity ; celebrity ) [SEP]',\n",
    "  'our_cross_cui': 'C0086418',\n",
    "  'our_cross_cui_name': 'Homo sapiens',\n",
    "  'our_cross_cui_desc': '[CLS] Ho ##mo sa ##pie ##ns [unused3] ( E ##uka ##ryo ##te , Tax ##onomy , organism , qualifier value : Humans ; Man , Modern ; humans ; man ; MA ##N ; Ho ##mo sa ##pie ##ns ( living organism ) [ Am ##bi ##guous ] ; ho ##mo sa ##pie ##ns ; Human , General ; Ho ##mo sa ##pie ##ns Linnaeus , 1758 ; Human ; Human - origin ; human ; Ho ##mo sa ##pie ##ns ( living organism ) ; Modern Man ; Man ) [SEP]'},\n",
    " {'mention_id': '27629431.19',\n",
    "  'test_set_idx': 12256,\n",
    "  'type': 'T017',\n",
    "  'name': 'initiation gene',\n",
    "  'context': '[CLS] ##tra ##cellular degradation , which is rapidly activated under starvation conditions . Recent data demonstrate a transcription ##al up ##re ##gu ##lation of several auto ##pha ##gy genes as a mechanism that controls auto ##pha ##gy in response to starvation . Here we report that despite the significant up ##re ##gu ##lation of m ##RNA of the essential auto ##pha ##gy [unused1] initiation gene [unused2] U ##L ##K ##1 , its protein level is rapidly reduced under starvation . Although both auto ##pha ##gic and pro ##te ##as ##oma ##l systems contribute to the degradation of U ##L ##K ##1 , under prolonged nitrogen de ##p ##ri ##vation , its level was still reduced in AT ##G ##7 knockout cells , and only initially stab ##ilized [SEP]',\n",
    "  'existing_cui': 'C0589507',\n",
    "  'existing_cui_name': 'Cognitive function : initiation',\n",
    "  'existing_cui_desc': '[CLS] Co ##gni ##tive function : initiation [unused3] ( B ##iol ##og ##ic Fun ##ction , o ##bs ##er ##vable entity , qualifier value : In ##iti ##ation ; initiation ) [SEP]',\n",
    "  'our_bi_cui': 'C1335755',\n",
    "  'our_bi_cui_name': 'Replication Initiation Gene',\n",
    "  'our_bi_cui_desc': '[CLS] Rep ##lication In ##iti ##ation Gene [unused3] ( Ana ##tom ##ical Structure : DNA Rep ##lication In ##iti ##ation Gene ) [SEP]',\n",
    "  'our_cross_cui': 'C0017337',\n",
    "  'our_cross_cui_name': 'Genes',\n",
    "  'our_cross_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]'},\n",
    " {'mention_id': '27932585.31',\n",
    "  'test_set_idx': 22258,\n",
    "  'type': 'T103',\n",
    "  'name': 'Taw3',\n",
    "  'context': '[CLS] novel α / β fold . The sequence motif ( S / T ) x ##SS ##C ##x ##GR and invariant as ##par ##tate and his ##ti ##dine , conserved in T ##Y ##W ##3 / Ta ##w ##3 , cluster to form the cat ##alytic center . These structural and sequence features indicate that T ##Y ##W ##3 / [unused1] Ta ##w ##3 [unused2] proteins constitute a distinct class of SA ##M - dependent met ##hyl ##tra ##ns ##fer ##ases . Using site - directed m ##uta ##genesis along with in v ##ivo complement ##ation ass ##ays combined with mass s ##pect ##rome ##try as well as l ##igan ##d dock ##ing and co ##fa ##ctor binding ass ##ays , we have identified the active [SEP]',\n",
    "  'existing_cui': 'C3496263',\n",
    "  'existing_cui_name': 'annectant white matter',\n",
    "  'existing_cui_desc': '[CLS] an ##nect ##ant white matter [unused3] ( Ana ##tom ##ical Structure : Sub ##stant ##ia me ##du ##llar ##is an ##nect ##ens ) [SEP]',\n",
    "  'our_bi_cui': 'C0039341',\n",
    "  'our_bi_cui_name': 'tat Protein',\n",
    "  'our_bi_cui_desc': '[CLS] ta ##t Pro ##tein [unused3] ( Chemical : ta ##t Gene Product ; Gene Products , ta ##t [ Chemical / In ##g ##red ##ient ] ; Trans ##act ##ivating Reg ##ulatory Pro ##tein ; T ##AT Pro ##tein ; Trans - Act ##ivation of Trans ##cription Pro ##tein ; Trans - Act ##iva ##tor of Trans ##cription of HIV ; ta ##t Gene Products ; ta ##t protein ; Gene Product , ta ##t ; Gene Products , ta ##t ) [SEP]',\n",
    "  'our_cross_cui': 'C0033684',\n",
    "  'our_cross_cui_name': 'Proteins',\n",
    "  'our_cross_cui_desc': '[CLS] Pro ##tein ##s [unused3] ( Chemical , medication , obsolete , substance : protein ; gene product ; Pro ##tein ; Pro ##tein ##s [ Chemical / In ##g ##red ##ient ] ; proteins ; protein preparations ; PR ##OT ##EI ##N ) [SEP]'},\n",
    " {'mention_id': '28539192.14',\n",
    "  'test_set_idx': 38798,\n",
    "  'type': 'T033',\n",
    "  'name': 'basic level',\n",
    "  'context': '[CLS] poor literacy level of the population specifically in health . Currently , there is a fragment ##ed model of patient care , in which the systems are exclusive of each other . They do not cooperate or communicate with each other ; and if there is no vertical communication within the system , preventing refer ##ral of patients directly from the [unused1] basic level [unused2] to the complex level of care when needed . In addition , there has been no progress in the development of an em ##path ##etic , respect ##ful or person - centered clinical practice ; instead , economic , social and educational differences per ##pet ##uate a paternal ##istic clinical practice . The task of or ##ient ##ing medical training towards [SEP]',\n",
    "  'existing_cui': 'C0178499',\n",
    "  'existing_cui_name': 'Base',\n",
    "  'existing_cui_desc': '[CLS] Base [unused3] ( Chemical , chemistry , medication , substance : base ; bases ; Basic ; al ##kal ##ini ##ty ) [SEP]',\n",
    "  'our_bi_cui': 'C0871796',\n",
    "  'our_bi_cui_name': 'Knowledge level',\n",
    "  'our_bi_cui_desc': '[CLS] Knowledge level [unused3] ( B ##iol ##og ##ic Fun ##ction , o ##bs ##er ##vable entity : Knowledge Level ) [SEP]',\n",
    "  'our_cross_cui': 'C1547668',\n",
    "  'our_cross_cui_name': 'Level of Care',\n",
    "  'our_cross_cui_desc': '[CLS] Level of Care [unused3] ( Finding : Level of care ) [SEP]'},\n",
    " {'mention_id': '27400734.19',\n",
    "  'test_set_idx': 4723,\n",
    "  'type': 'T103',\n",
    "  'name': 'E',\n",
    "  'context': '[CLS] national database A random ##ized clinical trial has found that the addition of er ##lot ##ini ##b to g ##em ##ci ##ta ##bine ( GE ##M - E ) for pan ##cre ##atic cancer led to a modest increase in survival . The aim of this national population - based retrospective study was to compare the effectiveness of GE ##M - [unused1] E [unused2] to GE ##M alone for pan ##cre ##atic cancer patients in real clinical practice . Pat ##ients with pan ##cre ##atic cancer ( I ##CD - 10 : C ##25 ) with prescription claims of g ##em ##ci ##ta ##bine or er ##lot ##ini ##b between Jan 1 , 2007 and Dec 31 , 2012 were retrospective ##ly identified from the Korean [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C1142985',\n",
    "  'our_bi_cui_name': 'ezetimibe',\n",
    "  'our_bi_cui_desc': '[CLS] e ##ze ##ti ##mi ##be [unused3] ( Chemical , medication , product , substance : E ##ze ##ti ##mi ##be ; E ##ze ##ti ##mi ##bu ##m ; E ##ze ##ti ##mi ##b ; ( 1 - ( 4 - flu ##oro ##phe ##ny ##l ) - ( 3 ##R ) - ( 3 - ( 4 - flu ##oro ##phe ##ny ##l ) - ( 3 ##S ) - h ##ydro ##xy ##p ##rop ##yl ) - ( 4 ##S ) - ( 4 - h ##ydro ##xy ##phe ##ny ##l ) - 2 - a ##ze ##ti ##din ##one ) ; E ##Z ##ET ##IM ##IB ##E ; E ##ze ##ti ##mi ##be [ Chemical / In ##g ##red ##ient ] ; e ##ze [SEP]',\n",
    "  'our_cross_cui': 'C1135135',\n",
    "  'our_cross_cui_name': 'erlotinib',\n",
    "  'our_cross_cui_desc': '[CLS] er ##lot ##ini ##b [unused3] ( Chemical , medication , product , substance : N - ( 3 - et ##hy ##ny ##l ##phe ##ny ##l ) - 6 , 7 - bi ##s ( 2 - met ##ho ##xy ##eth ##ox ##y ) q ##uin ##az ##olin - 4 - am ##ine ; [ 6 , 7 - B ##is - ( 2 - met ##ho ##xy - et ##ho ##xy ) - q ##uin ##az ##olin - 4 - y ##l ] - ( 3 - et ##hy ##ny ##l - p ##hen ##yl ) - am ##ine ; ER ##L ##OT ##IN ##IB ; E ##rl ##ot ##ini ##b ) [SEP]'},\n",
    " {'mention_id': '28478603.28',\n",
    "  'test_set_idx': 37430,\n",
    "  'type': 'T170',\n",
    "  'name': 'h',\n",
    "  'context': \"[CLS] ##ei ' s gene diversity ( h = 0 . 28 ) , Shannon ' s information index ( I = 0 . 43 ) , and p ##oly ##mor ##phism information content ( P ##IC = 0 . 29 ) generated using the simple sequence repeat prime ##rs were higher than that with Inter simple sequence repeat prime ##rs ( [unused1] h [unused2] = 0 . 23 , I = 0 . 37 , P ##IC = 0 . 24 ) , thereby suggesting that the simple sequence repeat system is more efficient than the Inter simple sequence repeat system in assessing genetic diversity in various pine ##ap ##ple accession ##s . Mean genetic similarities were 0 . 74 , 0 . 61 , and [SEP]\",\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0017337',\n",
    "  'our_bi_cui_name': 'Genes',\n",
    "  'our_bi_cui_desc': '[CLS] Gene ##s [unused3] ( Ana ##tom ##ical Structure , substance : Gene ; gene ; genes ) [SEP]',\n",
    "  'our_cross_cui': 'C0282574',\n",
    "  'our_cross_cui_name': 'Intellectual Property',\n",
    "  'our_cross_cui_desc': '[CLS] Intel ##lect ##ual Property [unused3] ( Intel ##lect ##ual Product : Intel ##lect ##ual Product ; Property , Intel ##lect ##ual ; Properties , Intel ##lect ##ual ; Intel ##lect ##ual Properties ; Intel ##lect ##ual property ; intellectual property ) [SEP]'},\n",
    " {'mention_id': '28296885.51',\n",
    "  'test_set_idx': 31634,\n",
    "  'type': 'T103',\n",
    "  'name': 'marijuana .',\n",
    "  'context': '[CLS] - food diet had more than those living in the village consuming a mostly agricultural diet . These findings are explained by the high incidence of maize consumption in village settings , along with previously recognized variation in rate of car ##ies between men and women . The unexpected discovery of high car ##ies incidence ##s for men in the bush is likely explained by heavy reliance on honey , and perhaps differential access to tobacco and [unused1] marijuana . [unused2] These data support the notions that mechanisms of car ##io ##genesis are multi ##fa ##ctor ##ial and that the relationships between oral health and the shift from a predominantly wild - food diet to one dominated by cult ##ige ##ns are n ##uan ##ced . [SEP]',\n",
    "  'existing_cui': None,\n",
    "  'existing_cui_name': None,\n",
    "  'existing_cui_desc': None,\n",
    "  'our_bi_cui': 'C0024809',\n",
    "  'our_bi_cui_name': 'Marijuana Abuse',\n",
    "  'our_bi_cui_desc': '[CLS] Mari ##ju ##ana Abu ##se [unused3] ( B ##iol ##og ##ic Fun ##ction : abuse marijuana ; Abu ##se , Mari ##hua ##na ; Has ##h ; Abu ##se , Mari ##ju ##ana ; marijuana abuse ; marijuana drug abuse ; Mari ##ju ##ana Abu ##se [ Disease / Finding ] ; abuse ; ma ##ri ##hua ##na ; Mari ##hua ##na Abu ##se ; Mari ##ju ##ana ; Mari ##hua ##na abuse ; ma ##ri ##hua ##na ; abuse ; Mari ##ju ##ana abuse ; We ##ed ; drug abuse marijuana ; abuse drug marijuana ; Abu ##se ; drug ( s ) ; marijuana ; Po ##t ; Can ##na ##bis ) [SEP]',\n",
    "  'our_cross_cui': 'C0024808',\n",
    "  'our_cross_cui_name': 'Marihuana',\n",
    "  'our_cross_cui_desc': '[CLS] Mari ##hua ##na [unused3] ( Chemical : Mari ##ju ##ana ##s ; marijuana ; Mari ##ju ##ana ; ma ##ri ##hua ##na ; MA ##RI ##J ##U ##AN ##A [ VA Product ] ; Mari ##hua ##nas ; MA ##RI ##J ##U ##AN ##A ; cannabis ; Can ##na ##bis ) [SEP]'},\n",
    " {'mention_id': '27645371.31',\n",
    "  'test_set_idx': 12724,\n",
    "  'type': 'T033',\n",
    "  'name': 'Children abandoning treatment',\n",
    "  'context': '[CLS] the 77 ( of 41 ##8 ) children abandoning therapy , 17 ( 22 % ) refused up ##front , whereas the rest abandoned during various phases of ch ##em ##otherapy . Only 39 ( 50 . 6 % ) of these 77 families could be subsequently contacted . Financial problems , too many dependent ##s at home , and wrong perception ##s about cancer led to abandonment in majority . [unused1] Children abandoning treatment [unused2] before completion of induction had a significantly shorter survival than who abandoned post induction ( P < . 000 ##1 ) . In ##tens ##ified pre ##aba ##ndon ##ment counseling and sub ##si ##dized treatment led to significant reduction in abandonment rates ( P < . 000 ##1 ) . [SEP]',\n",
    "  'existing_cui': 'C0013806',\n",
    "  'existing_cui_name': 'Electroconvulsive Therapy',\n",
    "  'existing_cui_desc': '[CLS] El ##ec ##tro ##con ##vu ##lsive Therapy [unused3] ( Health Care Act ##ivity , EC ##T , P ##sy ##cho ##ther ##ap ##y , Therapy , electro - con ##vu ##lsive therapy , procedure , regime / therapy , treatment : electric shock treatments ; El ##ec ##tro ##sh ##ock treatment ; Therapy , Electric Shock ; Therapy , El ##ec ##tro ##sh ##ock ; Therapy , Electric Con ##vu ##lsive ; e ##cs ; electric shock therapy ; electro ##con ##vu ##lsive treatment ; Con ##vu ##lsive Therapy , Electric ; EC ##T therapy ; El ##ec ##tro ##con ##vu ##lsive treatment ; CO ##N ##V ##U ##LS ##IVE THE ##R E ##LE ##CT ##RI ##C ; The ##rap ##ies , El ##ec ##tro ##con [SEP]',\n",
    "  'our_bi_cui': 'C1298653',\n",
    "  'our_bi_cui_name': 'Patient declined anti-cancer treatment',\n",
    "  'our_bi_cui_desc': '[CLS] Pat ##ient declined anti - cancer treatment [unused3] ( Finding , finding ) [SEP]',\n",
    "  'our_cross_cui': 'C0243095',\n",
    "  'our_cross_cui_name': 'Finding',\n",
    "  'our_cross_cui_desc': '[CLS] Finding [unused3] ( Finding , finding : Find ; Investigation Finding ) [SEP]'},\n",
    " {'mention_id': '27842161.46',\n",
    "  'test_set_idx': 19139,\n",
    "  'type': 'T103',\n",
    "  'name': 'Netarsudil',\n",
    "  'context': '[CLS] ##age effective fi ##ltration length in e ##pis ##cle ##ral veins positively correlated with the percentage change in C ( R ##2 = 0 . 58 , P = 0 . 01 ) . A significant increase in j ##ux ##ta ##can ##ali ##cular connect ##ive tissue thickness ( P < 0 . 05 ) was found in treated eyes compared to controls . [unused1] Net ##ars ##udi ##l [unused2] acute ##ly increased C by expansion of the j ##ux ##ta ##can ##ali ##cular connect ##ive tissue and di ##lating the e ##pis ##cle ##ral veins , which led to red ##ist ##ri ##but ##ion of a ##que ##ous out ##flow through a larger area of the inner wall and e ##pis ##cle ##ral veins . [SEP]',\n",
    "  'existing_cui': 'C0013443',\n",
    "  'existing_cui_name': 'Ear structure',\n",
    "  'existing_cui_desc': '[CLS] E ##ar structure [unused3] ( Ana ##tom ##ical Structure , Anatomy , body structure : V ##est ##ib ##ulo ##co ##ch ##lea ##r System ; System , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; ear structures ; Organ ##um vest ##ib ##ulo ##co ##ch ##lea ##re ; ear structure ; E ##ar - related structure ; au ##ris ; A ##ppa ##rat ##us , V ##est ##ib ##ulo ##co ##ch ##lea ##r ; E ##ar and related structures ; Au ##ris ; V ##est ##ib ##ulo ##co ##ch ##lea ##r organ ; V ##est ##ib ##ulo ##co ##ch ##lea ##r A ##ppa ##rat ##us ) [SEP]',\n",
    "  'our_bi_cui': 'C0701205',\n",
    "  'our_bi_cui_name': 'Rantodil',\n",
    "  'our_bi_cui_desc': '[CLS] Ra ##nto ##di ##l [unused3] ( Chemical : Bay ##er brand of ace ##met ##ac ##in ; Ra ##nt ##udi ##l ; T ##rop ##on brand of ace ##met ##ac ##in ) [SEP]',\n",
    "  'our_cross_cui': 'C1254351',\n",
    "  'our_cross_cui_name': 'Pharmacologic Substance',\n",
    "  'our_cross_cui_desc': '[CLS] Ph ##arma ##co ##log ##ic Sub ##stance [unused3] ( Chemical : Ph ##arma ##cological Sub ##stance ; Agent ; Drug Sub ##stance ; Ph ##arma ##ce ##utical agent ; Ph ##arma ##ce ##utical Agent ; DR ##U ##G ; Drug ; Ph ##arma ##co ##log ##ic Agent ; Ph ##arma ##ce ##utical ##s ; drug ) [SEP]'},\n",
    " {'mention_id': '27325547.7',\n",
    "  'test_set_idx': 2505,\n",
    "  'type': 'T103',\n",
    "  'name': 'PM2 .5',\n",
    "  'context': '[CLS] deposited in the human respiratory tract It is well - known that the health effects of PM increase as particle size decreases : particularly , great concern has risen on the role of Ultra ##F ##ine Part ##icles . Starting from the knowledge that the main fraction of atmospheric a ##ero ##sol in Rome is characterized by significant levels of [unused1] PM ##2 . 5 [unused2] ( almost 75 % of PM ##10 fraction is PM ##2 . 5 ) , the paper is focused on sub ##mic ##ron particles in such great urban area . The daytime / night ##time , work - / weekdays and cold / hot seasonal trends of sub ##mic ##ron particles will be investigated and discussed along with NO ##x [SEP]',\n",
    "  'existing_cui': 'C0665987',\n",
    "  'existing_cui_name': '1-(4-aminobutyl)-6-benzylindane',\n",
    "  'existing_cui_desc': '[CLS] 1 - ( 4 - amino ##but ##yl ) - 6 - ben ##zy ##lind ##ane [unused3] ( Chemical : PM ##2 c ##p ##d ) [SEP]',\n",
    "  'our_bi_cui': 'C0597177',\n",
    "  'our_bi_cui_name': 'Particle',\n",
    "  'our_bi_cui_desc': '[CLS] Part ##icle [unused3] ( Chemical : particle ; particles ; Part ##icles ; a very small piece or part ) [SEP]',\n",
    "  'our_cross_cui': 'C1510837',\n",
    "  'our_cross_cui_name': 'Airborne Particulate Matter',\n",
    "  'our_cross_cui_desc': '[CLS] Airborne Part ##iculate Matter [unused3] ( Chemical : Air Poll ##uta ##nts , Part ##iculate ; Am ##bie ##nt Part ##iculate Matter ; Part ##iculate Matter , Am ##bie ##nt ; Part ##iculate Matter , Airborne ; Poll ##uta ##nts , Part ##iculate Air ; Part ##iculate Air Poll ##uta ##nts ) [SEP]'},\n",
    " {'mention_id': '27251800.39',\n",
    "  'test_set_idx': 834,\n",
    "  'type': 'T058',\n",
    "  'name': 'Stoppa',\n",
    "  'context': '[CLS] during the 1 s ##t and 7 th post - operative , physical functioning , physical limitation , the impact of pain on daily activities , and the Carolina ##s Co ##m ##fort Scale during the 7 th and 15 th post - operative ( P > 0 . 05 ) . Co ##mp ##lication ##s occurred in 88 % of [unused1] Stop ##pa [unused2] group ( 22 patients ) and 64 % in lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair group ( 16 patients ) ( P < 0 . 05 ) . The comparative study between the Stop ##pa and lap ##aro ##scopic total extra ##per ##ito ##nea ##l repair approaches for the bilateral ing ##uin ##al her ##nia repair demonstrated [SEP]',\n",
    "  'existing_cui': 'C1538901',\n",
    "  'existing_cui_name': 'ACD gene',\n",
    "  'existing_cui_desc': '[CLS] AC ##D gene [unused3] ( Ana ##tom ##ical Structure : T ##EL ##OM ##ER ##E PR ##OT ##EI ##N T ##PP ##1 ; ad ##ren ##oc ##ort ##ical d ##ys ##p ##lasia ho ##mo ##log ; AC ##D Gene ; Ad ##ren ##oc ##ort ##ical D ##ys ##p ##lasia Ho ##mo ##log ( Mouse ) Gene ; P ##OT ##1 - IN ##TE ##RA ##CT ##ING PR ##OT ##EI ##N 1 ; P ##OT ##1 - AND T ##IN ##2 - OR ##GA ##NI ##Z ##ING PR ##OT ##EI ##N ; P ##OT ##1 and T ##IN ##2 organizing protein ; AC ##D , M ##O ##US ##E , H ##OM ##OL ##O ##G OF ; Tin ##t ##1 ; T ##IN ##2 interacting protein 1 [SEP]',\n",
    "  'our_bi_cui': 'C1080020',\n",
    "  'our_bi_cui_name': 'Lopa',\n",
    "  'our_bi_cui_desc': '[CLS] Lo ##pa [unused3] ( E ##uka ##ryo ##te : lo ##pa ) [SEP]',\n",
    "  'our_cross_cui': 'C0087111',\n",
    "  'our_cross_cui_name': 'Therapeutic procedure',\n",
    "  'our_cross_cui_desc': '[CLS] The ##rap ##eu ##tic procedure [unused3] ( Health Care Act ##ivity , procedure , regime / therapy , treatment : The ##rap ##eu ##tic Tech ##ni ##que ; The ##rap ##eu ##tic Method ; TX ; method treatment ; Pro ##ced ##ure - therapeutic ; T ##RE ##AT ; methods treatment ; therapeutic procedure ; The ##rap ##eu ##tic pro ##ced ; The ##rap ##eu ##tics ; Therapy ; The ##rap ##eu ##tic Pro ##ced ##ures ; Treatment ; treatment method ; The ##rap ##eu ##tic Inter ##vention ##s ; the ##rap ##ies ; therapy ; Therapy ( regime / therapy ) ; treatment ; therapeutic ##s ; Treatment ##s ; The ##rap ##eu ##tic Pro ##ced ##ure ; The ##rap ##eu ##tic ; THE ##R [SEP]'},\n",
    " {'mention_id': '27261783.3',\n",
    "  'test_set_idx': 1081,\n",
    "  'type': 'T082',\n",
    "  'name': 'organic - rich anaerobic sedimentary habitats',\n",
    "  'context': '[CLS] Analysis of Low - B ##io ##mass Micro ##bial Communities in the Deep B ##ios ##phere Over the past few decades , the sub ##sea ##f ##lo ##or bio ##sp ##here has been explored by scientific ocean drilling to depths of about 2 . 5 km below the sea ##f ##lo ##or . Although [unused1] organic - rich an ##ae ##ro ##bic sediment ##ary habitats [unused2] in the ocean margins harbor large numbers of micro ##bial cells , micro ##bial populations in ultra ##oli ##got ##rop ##hic a ##ero ##bic sediment ##ary habitats in the open ocean g ##yres are several orders of magnitude less abundant . Despite advances in cultivation - independent molecular ecological techniques , exploring the low - bio ##mass environment remains technological [SEP]',\n",
    "  'existing_cui': 'C0004613',\n",
    "  'existing_cui_name': 'Bacteria , Anaerobic',\n",
    "  'existing_cui_desc': '[CLS] Ba ##cter ##ia , Ana ##ero ##bic [unused3] ( Ba ##cter ##ium , organism : an ##ae ##ro ##bic bacterium ; BA ##CT AN ##A ##ER ##O ##BI ##C ; Ana ##ero ##bic bacterium ; Ana ##ero ##bic Ba ##cter ##ia ; Ana ##ero ##bic bacteria ; AN ##A ##ER ##O ##BI ##C BA ##CT ; an ##ae ##robe ; an ##ae ##ro ##bic bacteria ; Ana ##ero ##be ; an ##ae ##robe ##s ; AN ##A ##ER ##O ##BI ##C BA ##CT ##ER ##IA ) [SEP]',\n",
    "  'our_bi_cui': 'C0486320',\n",
    "  'our_bi_cui_name': 'Amorphous sediment',\n",
    "  'our_bi_cui_desc': '[CLS] Amor ##ph ##ous sediment [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
    "  'our_cross_cui': 'C0871648',\n",
    "  'our_cross_cui_name': 'Habitat',\n",
    "  'our_cross_cui_desc': '[CLS] Ha ##bit ##at [unused3] ( Spa ##tial Concept , Animal : habitats ; Animal Environment ##s ; Ha ##bit ##ats ; environment animal ; habitat ) [SEP]'},\n",
    " {'mention_id': '27427386.16',\n",
    "  'test_set_idx': 5254,\n",
    "  'type': 'T017',\n",
    "  'name': 'm. 14502T > C',\n",
    "  'context': \"[CLS] ##rial m ##od ##ifier ##s are proposed to modify the p ##hen ##otypic expression of primary Le ##ber ' s hereditary op ##tic ne ##uro ##pathy - associated mitochondrial DNA mutations . In this study , we demonstrated that the Le ##ber ' s hereditary op ##tic ne ##uro ##pathy su ##s ##ce ##pt ##ibility all ##ele ( [unused1] m . 145 ##0 ##2 ##T > C [unused2] , p . 58 ##I > V ) in the N ##D ##6 gene m ##od ##ulated the p ##hen ##otypic expression of primary Le ##ber ' s hereditary op ##tic ne ##uro ##pathy - associated m . 117 ##7 ##8 ##G > A mutation . Twenty - two Han Chinese p ##ed ##ig ##ree ##s carrying m [SEP]\",\n",
    "  'existing_cui': 'C0035609',\n",
    "  'existing_cui_name': 'Rifamycins',\n",
    "  'existing_cui_desc': '[CLS] R ##if ##am ##y ##cin ##s [unused3] ( Chemical , medication , substance : r ##if ##am ##y ##cin ; M - 14 ; R ##if ##am ##y ##cin ; R ##if ##am ##y ##cin SV ; R ##if ##omy ##cin ##s ; R ##if ##am ##y ##cin ##s [ Chemical / In ##g ##red ##ient ] ; r ##if ##am ##y ##cin ##s ; 5 , 6 , 9 , 17 , 19 , 21 - he ##xa ##hy ##dr ##ox ##y - 23 - met ##ho ##xy - 2 , 4 , 12 , 16 , 18 , 20 , 22 - he ##pta ##met ##hyl - 2 , 7 - ( e ##pox ##ype ##nta ##de ##ca ( 1 , 11 , 13 [SEP]',\n",
    "  'our_bi_cui': 'C0596611',\n",
    "  'our_bi_cui_name': 'Gene Mutation',\n",
    "  'our_bi_cui_desc': '[CLS] Gene Mu ##tation [unused3] ( B ##iol ##og ##ic Fun ##ction : DNA Se ##quence Alt ##eration ; Gene Alt ##eration ; DNA Alt ##eration ; gene mutation ; genes mutation ; Gene Mu ##tation Type ; M ##OL ##PA ##TH . M ##UT ; gene mutations ; Se ##quence Alt ##eration ; Gene mutation ; mutation gene ) [SEP]',\n",
    "  'our_cross_cui': 'C0002085',\n",
    "  'our_cross_cui_name': 'Alleles',\n",
    "  'our_cross_cui_desc': '[CLS] All ##ele ##s [unused3] ( Ana ##tom ##ical Structure , finding : All ##ele ; All ##elo ##mor ##ph ; Gene ##tic all ##ele ##s ; all ##ele ; All ##elo ##mor ##phs ; all ##ele ##s ; AL ##LE ##LE ) [SEP]'}]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "f3df8e55",
   "metadata": {},
   "outputs": [],
   "source": [
    "selected  = []\n",
    "for r in res:\n",
    "    if r['test_set_idx'] in chosen:\n",
    "        selected.append(r)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "c96a4c04",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'mention_id': '27660632.56',\n",
       "  'test_set_idx': 13478,\n",
       "  'type': 'T017',\n",
       "  'name': 'regions',\n",
       "  'context': ') traits , mainly focused on Chr05 , Chr09 , Chr10 , Chr14 , Chr19 , and Chr20 . Nineteen pairs of epistatic quantitative trait locus were identified , of which two pairs involved in two additive quantitative trait locus . These additive quantitative trait locus , epistatic quantitative trait locus , and QTL clusters were tightly linked to single nucleotide polymorphism markers , which may serve as target [unused1] regions [unused2] for map - based cloning , gene discovery , and marker - assisted selection in cotton breeding .',\n",
       "  'existing_cui': 'C0017446',\n",
       "  'existing_cui_name': 'Geographic Locations',\n",
       "  'existing_cui_desc': 'Geographic Locations [unused3] ( Spatial Concept : areas geographic ; Geographic Location ; Region ; GEOGR LOCATIONS ; geographic region ; Geographic Region ; geographic location ; Geographic Regions ; Area ; geographic site ; Geographic Area )',\n",
       "  'our_bi_cui': 'C0205146',\n",
       "  'our_bi_cui_name': 'Area',\n",
       "  'our_bi_cui_desc': 'Area [unused3] ( Spatial Concept , qualifier value : area ; areas ; AREA )',\n",
       "  'our_cross_cui': 'C1953345',\n",
       "  'our_cross_cui_name': 'Region of chromosome',\n",
       "  'our_cross_cui_desc': 'Region of chromosome [unused3] ( Anatomical Structure : chromosomal region ; Chromosomal region ; chromosome region ; Chromosome region )'},\n",
       " {'mention_id': '27692319.38',\n",
       "  'test_set_idx': 14309,\n",
       "  'type': 'T204',\n",
       "  'name': 'eggs',\n",
       "  'context': '[CLS] ##roma ##tography , suspended in 1 % D ##MS ##O and used in in v ##it ##ro tests . Q ##uad ##rup ##lica ##tes of 50 F . he ##pa ##tica eggs were in ##cu ##bate ##d at 23 °C with M . ch ##aran ##tia leaf crude extract in different concentrations . After 12 days no larvae were formed in [unused1] eggs [unused2] in ##cu ##bate ##d with crude extract concentrations above 12 . 5 mg / m ##L . Egg ##s in ##cu ##bate ##d with crude extract sub - fraction ##s at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μ ##g / m ##L affected em ##b ##ryo ##nic development , with n [SEP]',\n",
       "  'existing_cui': 'C0029974',\n",
       "  'existing_cui_name': 'Ovum',\n",
       "  'existing_cui_desc': '[CLS] O ##vu ##m [unused3] ( Ana ##tom ##ical Structure , body structure , cell , cell structure , qualifier value : Human egg ; Egg ##s , Un ##fer ##til ##ized ; Fe ##rt ##ilized o ##oc ##yte ; Mat ##ure o ##vu ##m ; O ##va ; Egg ; egg cell ; o ##va ; X bearing o ##vu ##m ; female game ##tes ; O ##ocytes ; Un ##fer ##til ##ized Egg ##s ; X chromosome - bearing o ##vu ##m ; Egg , Un ##fer ##til ##ized ; O ##vu ##m structure ; Un ##fer ##til ##ized Egg ; Female game ##te ; O ##voc ##yte ; egg / o ##vu ##m ; o ##vu ##m ; female game ##te ; X - [SEP]',\n",
       "  'our_bi_cui': 'C0013710',\n",
       "  'our_bi_cui_name': 'Egg Food Product',\n",
       "  'our_bi_cui_desc': '[CLS] Egg Food Product [unused3] ( Food , Po ##ult ##ry , edible , substance : eggs ; egg food product ; egg ; Egg , Po ##ult ##ry ; Egg ; Egg ##s ; Egg ##s ( edible ) ; egg [ food ] ; E ##G ##G ) [SEP]',\n",
       "  'our_cross_cui': 'C3662687',\n",
       "  'our_cross_cui_name': 'Fasciola hepatica egg',\n",
       "  'our_cross_cui_desc': '[CLS] F ##as ##cio ##la he ##pa ##tica egg [unused3] ( E ##uka ##ryo ##te , organism : F ##as ##cio ##la he ##pa ##tica o ##va ) [SEP]'},\n",
       " {'mention_id': '28390176.60',\n",
       "  'test_set_idx': 34150,\n",
       "  'type': 'T038',\n",
       "  'name': 'inhibition',\n",
       "  'context': '[CLS] over ##ex ##press ##ion of con ##st ##it ##utive ##ly active A ##kt completely abolished the C ##uc ##ur ##bit ##ac ##in B - mediated protection of cardiac h ##yper ##tro ##phy in human card ##io ##my ##ocytes AC ##16 . Collective ##ly , our findings suggest that cu ##cu ##rb ##ita ##cin B protects against cardiac h ##yper ##tro ##phy through increasing the auto ##pha ##gy level in card ##io ##my ##ocytes , which is associated with the [unused1] in ##hibition [unused2] of A ##kt / m ##TO ##R / Fox ##O ##3 ##a signal axis . J . Cell . B ##io ##che ##m . 99 ##9 ##9 : 1 - 12 , 2017 . © 2017 Wiley Period ##ical ##s , Inc . [SEP]',\n",
       "  'existing_cui': 'C0021467',\n",
       "  'existing_cui_name': 'Psychological inhibition',\n",
       "  'existing_cui_desc': '[CLS] Psychological in ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction , Personal ##ity , Psychology : psychological in ##hibition ; in ##hibition ; in ##hibition ##s ; IN ##H ##IB ##IT ##ION ; In ##hibition ; IN ##H ##IB ##IT ##ION PS ##Y ##CH ##OL ; In ##hibition ##s ) [SEP]',\n",
       "  'our_bi_cui': 'C0021469',\n",
       "  'our_bi_cui_name': 'Metabolic Inhibition',\n",
       "  'our_bi_cui_desc': '[CLS] Met ##ab ##olic In ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction , function , o ##bs ##er ##vable entity : In ##hibition ; In ##hibition , function ) [SEP]',\n",
       "  'our_cross_cui': 'C1519312',\n",
       "  'our_cross_cui_name': 'Signal Transduction Inhibition',\n",
       "  'our_cross_cui_desc': '[CLS] Signal Trans ##duction In ##hibition [unused3] ( B ##iol ##og ##ic Fun ##ction : in ##hibition of signal trans ##duction ) [SEP]'},\n",
       " {'mention_id': '27812530.21',\n",
       "  'test_set_idx': 18011,\n",
       "  'type': 'T103',\n",
       "  'name': 'material',\n",
       "  'context': '[CLS] °C ) . Six specimens were tested in each group of the aforementioned parameters . Inc ##rea ##sing cast ##or oil content and pre ##co ##olin ##g treatment effectively decreased the peak polymer ##ization temperatures and increased the duration to achieve the peak polymer ##ization temperature ( P < 0 . 05 ) . Furthermore , the mechanical properties of the [unused1] material [unused2] , including density , m ##od ##ulus , and maximum compression strength , decreased with increasing cast ##or oil content . However , preparation temperature ( room temperature versus pre ##co ##olin ##g ) had no significant effect ( P > 0 . 05 ) on these mechanical properties . In conclusion , the addition of cast ##or oil to Pol ##yme [SEP]',\n",
       "  'existing_cui': 'C0440470',\n",
       "  'existing_cui_name': 'Human material',\n",
       "  'existing_cui_desc': '[CLS] Human material [unused3] ( Body Sub ##stance , substance ) [SEP]',\n",
       "  'our_bi_cui': 'C0032521',\n",
       "  'our_bi_cui_name': 'Polymers',\n",
       "  'our_bi_cui_desc': '[CLS] Pol ##yme ##rs [unused3] ( Chemical , substance : Pol ##yme ##ric ; Pol ##yme ##ric Mac ##rom ##ole ##cule ##s ; Pol ##yme ##r ; P ##OL ##Y ##ME ##R S ##U ##BS ##TA ##NC ##E ; Pol ##yme ##rs [ Chemical / In ##g ##red ##ient ] ; polymer ; polymer ##s ) [SEP]',\n",
       "  'our_cross_cui': 'C0005479',\n",
       "  'our_cross_cui_name': 'Biomaterials',\n",
       "  'our_cross_cui_desc': '[CLS] B ##io ##mate ##rial ##s [unused3] ( Chemical : B ##io ##mate ##rial ; bio ##com ##pa ##tible materials ; B ##io ##medical Material ; bio ##mate ##rial ##s ; B ##io ##medical materials ; B ##io ##com ##pa ##tible Materials ; bio ##medical materials ; bio ##mate ##rial ; Materials , B ##io ##com ##pa ##tible ; bio ##medical material ; B ##io ##com ##pa ##tible Materials [ Chemical / In ##g ##red ##ient ] ) [SEP]'},\n",
       " {'mention_id': '28295414.42',\n",
       "  'test_set_idx': 31580,\n",
       "  'type': 'T168',\n",
       "  'name': 'drink',\n",
       "  'context': '[CLS] a 10 % probability ( or less ) of transition ##ing out of either a no heavy drinking state or a heavy drinking state . More than two - thirds of the heavy drink ##ers who exceeded the heavy drinking threshold during treatment reported , on average , a 64 % reduction in drinking frequency and a 38 % reduction in drinking intensity from pre ##tre ##at ##ment drinking levels . The results show stability of no heavy drinking as an outcome within the first 4 months of treatment and that the > 3 / > 4 [unused1] drink [unused2] cut ##off may mask substantial reduction ##s in alcohol consumption among some patients . Future studies should explore the clinical utility of reduction end points . [SEP]',\n",
       "  'existing_cui': 'C0452428',\n",
       "  'existing_cui_name': 'Drink',\n",
       "  'existing_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
       "  'our_bi_cui': 'C0452428',\n",
       "  'our_bi_cui_name': 'Drink',\n",
       "  'our_bi_cui_desc': '[CLS] Dr ##ink [unused3] ( Food , diet ##ary substance , diet ##ary substance , attribute , substance : Dr ##ink ##s ; drinks ; drink [ substance ] ; drink ) [SEP]',\n",
       "  'our_cross_cui': 'C0001967',\n",
       "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
       "  'our_cross_cui_desc': '[CLS] Al ##co ##hol ##ic Be ##ver ##ages [unused3] ( Food , Al ##co ##hol ##ic , substance : Be ##ver ##age , Al ##co ##hol ##ic ; Al ##co ##hol ##ic Be ##ver ##age ; Al ##co ##hol ##ic beverages ; alcoholic drinks ; Be ##ver ##ages ; Be ##ver ##ages , Al ##co ##hol ##ic ; alcoholic beverages ; alcoholic beverage ; alcoholic ##s beverages ; Al ##co ##hol ##ic beverage ; Al ##co ##hol ##ic drink ; alcoholic drinking ) [SEP]'},\n",
       " {'mention_id': '27708411.23',\n",
       "  'test_set_idx': 14732,\n",
       "  'type': 'T103',\n",
       "  'name': 'dsDNA',\n",
       "  'context': '[CLS] ##rote ##in fi ##lam ##ent formation , is unable to media ##te ho ##mo ##log ##ous re ##comb ##ination . Mu ##tations of the C - terminal domain were evaluated using both single - and double stranded ( s ##s and d ##s ) substrates in re ##comb ##ination ass ##ays . Mu ##tations of critical amino acids affected either [unused1] d ##s ##D ##NA [unused2] re ##comb ##ination or both s ##s ##D ##NA and d ##s ##D ##NA re ##comb ##ination indicating two se ##par ##able functions , one of which is critical for d ##s ##D ##NA re ##comb ##ination and the second for re ##comb ##ination per se . As evaluated by co - im ##mu ##no ##p ##re ##ci ##pit ##ation [SEP]',\n",
       "  'existing_cui': 'C0012854',\n",
       "  'existing_cui_name': 'DNA',\n",
       "  'existing_cui_desc': '[CLS] DNA [unused3] ( Chemical , DNA , De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid , substance : d ##na molecules ; d ##s ##D ##NA ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; d ##na / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA molecule ; DNA - De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acids ; d ##na molecule ; DNA [ Chemical / In ##g ##red ##ient ] ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; Double - [SEP]',\n",
       "  'our_bi_cui': 'C0012854',\n",
       "  'our_bi_cui_name': 'DNA',\n",
       "  'our_bi_cui_desc': '[CLS] DNA [unused3] ( Chemical , DNA , De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid , substance : d ##na molecules ; d ##s ##D ##NA ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; d ##na / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA / des ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; DNA molecule ; DNA - De ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic A ##cid ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acids ; d ##na molecule ; DNA [ Chemical / In ##g ##red ##ient ] ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid ; Double - [SEP]',\n",
       "  'our_cross_cui': 'C0311474',\n",
       "  'our_cross_cui_name': 'DNA , Double-Stranded',\n",
       "  'our_cross_cui_desc': '[CLS] DNA , Double - Strand ##ed [unused3] ( Chemical , substance : double stranded d ##na ; DNA , Double Strand ##ed ; Double - Strand ##ed DNA ; d ##s d ##na ; de ##ox ##yr ##ib ##on ##uc ##le ##ic acid double strand ; d ##s DNA ; d ##na double stranded ; d ##s - DNA ; d ##s - d ##na ; double strand d ##na ; double - stranded DNA ; DNA double strand ; De ##ox ##yr ##ib ##on ##uc ##le ##ic acid , double stranded ) [SEP]'},\n",
       " {'mention_id': '27798906.17',\n",
       "  'test_set_idx': 17537,\n",
       "  'type': 'T038',\n",
       "  'name': 'atrophy',\n",
       "  'context': '[CLS] . 4 months ( range = 24 . 0 - 123 . 0 months ) . Un ##iva ##ria ##te analysis showed that par ##ot ##id g ##land volumes receiving more than 5 , 10 , 15 , and 20 G ##y relative biological effectiveness ( V ##5 , V ##10 , V ##15 and V ##20 , respectively ) , mean dose , and maximum dose were significantly associated with par ##ot ##id g ##land at ##rop ##hy . Multi ##var ##iate analysis indicated that only V ##5 was significantly associated with [unused1] at ##rop ##hy [unused2] . Inc ##rea ##sing V ##5 was a significant risk factor for par ##ot ##id g ##land at ##rop ##hy after carbon ion radio ##ther ##ap ##y . [SEP]',\n",
       "  'existing_cui': 'C0026846',\n",
       "  'existing_cui_name': 'Muscular Atrophy',\n",
       "  'existing_cui_desc': '[CLS] Mu ##s ##cular At ##rop ##hy [unused3] ( B ##iol ##og ##ic Fun ##ction , Mu ##s ##cular , diagnosis , disorder , finding , physical finding : at ##rop ##hy ; muscle ; am ##yo ##tro ##phy ; muscle at ##rop ##hy was seen ; Was ##ting ; muscle ; At ##rop ##hi ##es , Mu ##s ##cle ; Mu ##s ##cle thin ##ning ; At ##rop ##hy - muscular ; am ##yo ##tro ##phi ##es ; muscular at ##rop ##hy ; Mu ##s ##cle wasting ; am ##yo ##tro ##phi ##a ; At ##rop ##hi ##es , Mu ##s ##cular ; muscular at ##rop ##hi ##es ; At ##rop ##hy muscle ; Mu ##s ##cle At ##rop ##hy ; Was ##ting ; muscles ; [SEP]',\n",
       "  'our_bi_cui': 'C0333641',\n",
       "  'our_bi_cui_name': 'Atrophic',\n",
       "  'our_bi_cui_desc': '[CLS] At ##rop ##hic [unused3] ( B ##iol ##og ##ic Fun ##ction , m ##or ##ph ##olo ##gic abnormal ##ity : at ##rop ##hy ; At ##rop ##hy ; At ##rop ##hi ##es ; at ##rop ##hi ##es ; At ##rop ##hy [ Disease / Finding ] ; at ##rop ##hic ; at ##rop ##hy ##ing ; at ##rop ##hi ##ed ; AT ##RO ##P ##H ##Y ; At ##rop ##hy [ du ##p ] ) [SEP]',\n",
       "  'our_cross_cui': 'C0341045',\n",
       "  'our_cross_cui_name': 'Atrophy of parotid gland',\n",
       "  'our_cross_cui_desc': '[CLS] At ##rop ##hy of par ##ot ##id g ##land [unused3] ( B ##iol ##og ##ic Fun ##ction , disorder : at ##rop ##hy ; par ##ot ##id g ##land ) [SEP]'},\n",
       " {'mention_id': '28243201.17',\n",
       "  'test_set_idx': 29659,\n",
       "  'type': 'T201',\n",
       "  'name': 'response',\n",
       "  'context': '[CLS] ##cu ##rrence . DNA met ##hyl ##ation has been suggested as one of the underlying mechanisms for re ##current disease and its contribution to the development of drug resistance remains to be clarified . This study aimed to determine the met ##hyl ##ation p ##hen ##otype in color ##ec ##tal cancer for identification of predict ##ive markers for ch ##em ##otherapy [unused1] response [unused2] . We performed DNA met ##hyl ##ation pro ##fi ##ling on 43 non - re ##current and five re ##current color ##ec ##tal cancer patients using the Il ##lum ##ina In ##fin ##ium Human ##M ##eth ##yla ##tion ##45 ##0 Be ##ad ##chi ##p ass ##ay . In addition , color ##ec ##tal cancer cells with different genetic backgrounds , response to [SEP]',\n",
       "  'existing_cui': 'C1704632',\n",
       "  'existing_cui_name': 'Disease Response',\n",
       "  'existing_cui_desc': '[CLS] Disease Response [unused3] ( Finding : Response ; response ) [SEP]',\n",
       "  'our_bi_cui': 'C0683154',\n",
       "  'our_bi_cui_name': 'drug response',\n",
       "  'our_bi_cui_desc': '[CLS] drug response [unused3] ( B ##iol ##og ##ic Fun ##ction : response to drug ; drug responses ; drugs response ) [SEP]',\n",
       "  'our_cross_cui': 'C0521982',\n",
       "  'our_cross_cui_name': 'Response to treatment',\n",
       "  'our_cross_cui_desc': '[CLS] Response to treatment [unused3] ( Clinical At ##tri ##but ##e , context - dependent category , finding , function , o ##bs ##er ##vable entity , situation : response to treatment ; response treatments ; The ##rap ##eu ##tic response ; response therapeutic ; The ##rap ##eu ##tic Response ; Finding related to therapeutic response ; successful treatment ; successful treatments ; The ##rap ##eu ##tic response , function ) [SEP]'}]"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "selected"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "8c57424d",
   "metadata": {},
   "outputs": [],
   "source": [
    "for s in selected:\n",
    "    for attr in ['context', 'existing_cui_desc', 'our_bi_cui_desc', 'our_cross_cui_desc']:\n",
    "        split = s[attr].split()\n",
    "        final = []\n",
    "        for token in split:\n",
    "            if token in ['[CLS]', '[SEP]']:\n",
    "                continue\n",
    "            if token[:2] == \"##\":\n",
    "                if len(final) == 0:\n",
    "                    final.append(token[2:])\n",
    "                else:\n",
    "                    final[-1] += token[2:]\n",
    "            else:\n",
    "                final.append(token)\n",
    "        s[attr] = ' '.join(final)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "8a488052",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'mention_id': '27660632.56',\n",
       "  'test_set_idx': 13478,\n",
       "  'type': 'T017',\n",
       "  'name': 'regions',\n",
       "  'context': ') traits , mainly focused on Chr05 , Chr09 , Chr10 , Chr14 , Chr19 , and Chr20 . Nineteen pairs of epistatic quantitative trait locus were identified , of which two pairs involved in two additive quantitative trait locus . These additive quantitative trait locus , epistatic quantitative trait locus , and QTL clusters were tightly linked to single nucleotide polymorphism markers , which may serve as target [unused1] regions [unused2] for map - based cloning , gene discovery , and marker - assisted selection in cotton breeding .',\n",
       "  'existing_cui': 'C0017446',\n",
       "  'existing_cui_name': 'Geographic Locations',\n",
       "  'existing_cui_desc': 'Geographic Locations [unused3] ( Spatial Concept : areas geographic ; Geographic Location ; Region ; GEOGR LOCATIONS ; geographic region ; Geographic Region ; geographic location ; Geographic Regions ; Area ; geographic site ; Geographic Area )',\n",
       "  'our_bi_cui': 'C0205146',\n",
       "  'our_bi_cui_name': 'Area',\n",
       "  'our_bi_cui_desc': 'Area [unused3] ( Spatial Concept , qualifier value : area ; areas ; AREA )',\n",
       "  'our_cross_cui': 'C1953345',\n",
       "  'our_cross_cui_name': 'Region of chromosome',\n",
       "  'our_cross_cui_desc': 'Region of chromosome [unused3] ( Anatomical Structure : chromosomal region ; Chromosomal region ; chromosome region ; Chromosome region )'},\n",
       " {'mention_id': '27692319.38',\n",
       "  'test_set_idx': 14309,\n",
       "  'type': 'T204',\n",
       "  'name': 'eggs',\n",
       "  'context': 'romatography , suspended in 1 % DMSO and used in in vitro tests . Quadruplicates of 50 F . hepatica eggs were incubated at 23 °C with M . charantia leaf crude extract in different concentrations . After 12 days no larvae were formed in [unused1] eggs [unused2] incubated with crude extract concentrations above 12 . 5 mg / mL . Eggs incubated with crude extract sub - fractions at concentrations of 1000 , 100 , 10 , 1 , 0 . 1 , 0 . 01 μg / mL affected embryonic development , with n',\n",
       "  'existing_cui': 'C0029974',\n",
       "  'existing_cui_name': 'Ovum',\n",
       "  'existing_cui_desc': 'Ovum [unused3] ( Anatomical Structure , body structure , cell , cell structure , qualifier value : Human egg ; Eggs , Unfertilized ; Fertilized oocyte ; Mature ovum ; Ova ; Egg ; egg cell ; ova ; X bearing ovum ; female gametes ; Oocytes ; Unfertilized Eggs ; X chromosome - bearing ovum ; Egg , Unfertilized ; Ovum structure ; Unfertilized Egg ; Female gamete ; Ovocyte ; egg / ovum ; ovum ; female gamete ; X -',\n",
       "  'our_bi_cui': 'C0013710',\n",
       "  'our_bi_cui_name': 'Egg Food Product',\n",
       "  'our_bi_cui_desc': 'Egg Food Product [unused3] ( Food , Poultry , edible , substance : eggs ; egg food product ; egg ; Egg , Poultry ; Egg ; Eggs ; Eggs ( edible ) ; egg [ food ] ; EGG )',\n",
       "  'our_cross_cui': 'C3662687',\n",
       "  'our_cross_cui_name': 'Fasciola hepatica egg',\n",
       "  'our_cross_cui_desc': 'Fasciola hepatica egg [unused3] ( Eukaryote , organism : Fasciola hepatica ova )'},\n",
       " {'mention_id': '28390176.60',\n",
       "  'test_set_idx': 34150,\n",
       "  'type': 'T038',\n",
       "  'name': 'inhibition',\n",
       "  'context': 'overexpression of constitutively active Akt completely abolished the Cucurbitacin B - mediated protection of cardiac hypertrophy in human cardiomyocytes AC16 . Collectively , our findings suggest that cucurbitacin B protects against cardiac hypertrophy through increasing the autophagy level in cardiomyocytes , which is associated with the [unused1] inhibition [unused2] of Akt / mTOR / FoxO3a signal axis . J . Cell . Biochem . 9999 : 1 - 12 , 2017 . © 2017 Wiley Periodicals , Inc .',\n",
       "  'existing_cui': 'C0021467',\n",
       "  'existing_cui_name': 'Psychological inhibition',\n",
       "  'existing_cui_desc': 'Psychological inhibition [unused3] ( Biologic Function , Personality , Psychology : psychological inhibition ; inhibition ; inhibitions ; INHIBITION ; Inhibition ; INHIBITION PSYCHOL ; Inhibitions )',\n",
       "  'our_bi_cui': 'C0021469',\n",
       "  'our_bi_cui_name': 'Metabolic Inhibition',\n",
       "  'our_bi_cui_desc': 'Metabolic Inhibition [unused3] ( Biologic Function , function , observable entity : Inhibition ; Inhibition , function )',\n",
       "  'our_cross_cui': 'C1519312',\n",
       "  'our_cross_cui_name': 'Signal Transduction Inhibition',\n",
       "  'our_cross_cui_desc': 'Signal Transduction Inhibition [unused3] ( Biologic Function : inhibition of signal transduction )'},\n",
       " {'mention_id': '27812530.21',\n",
       "  'test_set_idx': 18011,\n",
       "  'type': 'T103',\n",
       "  'name': 'material',\n",
       "  'context': '°C ) . Six specimens were tested in each group of the aforementioned parameters . Increasing castor oil content and precooling treatment effectively decreased the peak polymerization temperatures and increased the duration to achieve the peak polymerization temperature ( P < 0 . 05 ) . Furthermore , the mechanical properties of the [unused1] material [unused2] , including density , modulus , and maximum compression strength , decreased with increasing castor oil content . However , preparation temperature ( room temperature versus precooling ) had no significant effect ( P > 0 . 05 ) on these mechanical properties . In conclusion , the addition of castor oil to Polyme',\n",
       "  'existing_cui': 'C0440470',\n",
       "  'existing_cui_name': 'Human material',\n",
       "  'existing_cui_desc': 'Human material [unused3] ( Body Substance , substance )',\n",
       "  'our_bi_cui': 'C0032521',\n",
       "  'our_bi_cui_name': 'Polymers',\n",
       "  'our_bi_cui_desc': 'Polymers [unused3] ( Chemical , substance : Polymeric ; Polymeric Macromolecules ; Polymer ; POLYMER SUBSTANCE ; Polymers [ Chemical / Ingredient ] ; polymer ; polymers )',\n",
       "  'our_cross_cui': 'C0005479',\n",
       "  'our_cross_cui_name': 'Biomaterials',\n",
       "  'our_cross_cui_desc': 'Biomaterials [unused3] ( Chemical : Biomaterial ; biocompatible materials ; Biomedical Material ; biomaterials ; Biomedical materials ; Biocompatible Materials ; biomedical materials ; biomaterial ; Materials , Biocompatible ; biomedical material ; Biocompatible Materials [ Chemical / Ingredient ] )'},\n",
       " {'mention_id': '28295414.42',\n",
       "  'test_set_idx': 31580,\n",
       "  'type': 'T168',\n",
       "  'name': 'drink',\n",
       "  'context': 'a 10 % probability ( or less ) of transitioning out of either a no heavy drinking state or a heavy drinking state . More than two - thirds of the heavy drinkers who exceeded the heavy drinking threshold during treatment reported , on average , a 64 % reduction in drinking frequency and a 38 % reduction in drinking intensity from pretreatment drinking levels . The results show stability of no heavy drinking as an outcome within the first 4 months of treatment and that the > 3 / > 4 [unused1] drink [unused2] cutoff may mask substantial reductions in alcohol consumption among some patients . Future studies should explore the clinical utility of reduction end points .',\n",
       "  'existing_cui': 'C0452428',\n",
       "  'existing_cui_name': 'Drink',\n",
       "  'existing_cui_desc': 'Drink [unused3] ( Food , dietary substance , dietary substance , attribute , substance : Drinks ; drinks ; drink [ substance ] ; drink )',\n",
       "  'our_bi_cui': 'C0452428',\n",
       "  'our_bi_cui_name': 'Drink',\n",
       "  'our_bi_cui_desc': 'Drink [unused3] ( Food , dietary substance , dietary substance , attribute , substance : Drinks ; drinks ; drink [ substance ] ; drink )',\n",
       "  'our_cross_cui': 'C0001967',\n",
       "  'our_cross_cui_name': 'Alcoholic Beverages',\n",
       "  'our_cross_cui_desc': 'Alcoholic Beverages [unused3] ( Food , Alcoholic , substance : Beverage , Alcoholic ; Alcoholic Beverage ; Alcoholic beverages ; alcoholic drinks ; Beverages ; Beverages , Alcoholic ; alcoholic beverages ; alcoholic beverage ; alcoholics beverages ; Alcoholic beverage ; Alcoholic drink ; alcoholic drinking )'},\n",
       " {'mention_id': '27708411.23',\n",
       "  'test_set_idx': 14732,\n",
       "  'type': 'T103',\n",
       "  'name': 'dsDNA',\n",
       "  'context': 'rotein filament formation , is unable to mediate homologous recombination . Mutations of the C - terminal domain were evaluated using both single - and double stranded ( ss and ds ) substrates in recombination assays . Mutations of critical amino acids affected either [unused1] dsDNA [unused2] recombination or both ssDNA and dsDNA recombination indicating two separable functions , one of which is critical for dsDNA recombination and the second for recombination per se . As evaluated by co - immunoprecipitation',\n",
       "  'existing_cui': 'C0012854',\n",
       "  'existing_cui_name': 'DNA',\n",
       "  'existing_cui_desc': 'DNA [unused3] ( Chemical , DNA , Deoxyribonucleic Acid , substance : dna molecules ; dsDNA ; Deoxyribonucleic acid ; dna / desoxyribonucleic acid ; DNA / desoxyribonucleic acid ; DNA molecule ; DNA - Deoxyribonucleic acid ; Deoxyribonucleic Acid ; Deoxyribonucleic acids ; dna molecule ; DNA [ Chemical / Ingredient ] ; deoxyribonucleic acid ; Double -',\n",
       "  'our_bi_cui': 'C0012854',\n",
       "  'our_bi_cui_name': 'DNA',\n",
       "  'our_bi_cui_desc': 'DNA [unused3] ( Chemical , DNA , Deoxyribonucleic Acid , substance : dna molecules ; dsDNA ; Deoxyribonucleic acid ; dna / desoxyribonucleic acid ; DNA / desoxyribonucleic acid ; DNA molecule ; DNA - Deoxyribonucleic acid ; Deoxyribonucleic Acid ; Deoxyribonucleic acids ; dna molecule ; DNA [ Chemical / Ingredient ] ; deoxyribonucleic acid ; Double -',\n",
       "  'our_cross_cui': 'C0311474',\n",
       "  'our_cross_cui_name': 'DNA , Double-Stranded',\n",
       "  'our_cross_cui_desc': 'DNA , Double - Stranded [unused3] ( Chemical , substance : double stranded dna ; DNA , Double Stranded ; Double - Stranded DNA ; ds dna ; deoxyribonucleic acid double strand ; ds DNA ; dna double stranded ; ds - DNA ; ds - dna ; double strand dna ; double - stranded DNA ; DNA double strand ; Deoxyribonucleic acid , double stranded )'},\n",
       " {'mention_id': '27798906.17',\n",
       "  'test_set_idx': 17537,\n",
       "  'type': 'T038',\n",
       "  'name': 'atrophy',\n",
       "  'context': '. 4 months ( range = 24 . 0 - 123 . 0 months ) . Univariate analysis showed that parotid gland volumes receiving more than 5 , 10 , 15 , and 20 Gy relative biological effectiveness ( V5 , V10 , V15 and V20 , respectively ) , mean dose , and maximum dose were significantly associated with parotid gland atrophy . Multivariate analysis indicated that only V5 was significantly associated with [unused1] atrophy [unused2] . Increasing V5 was a significant risk factor for parotid gland atrophy after carbon ion radiotherapy .',\n",
       "  'existing_cui': 'C0026846',\n",
       "  'existing_cui_name': 'Muscular Atrophy',\n",
       "  'existing_cui_desc': 'Muscular Atrophy [unused3] ( Biologic Function , Muscular , diagnosis , disorder , finding , physical finding : atrophy ; muscle ; amyotrophy ; muscle atrophy was seen ; Wasting ; muscle ; Atrophies , Muscle ; Muscle thinning ; Atrophy - muscular ; amyotrophies ; muscular atrophy ; Muscle wasting ; amyotrophia ; Atrophies , Muscular ; muscular atrophies ; Atrophy muscle ; Muscle Atrophy ; Wasting ; muscles ;',\n",
       "  'our_bi_cui': 'C0333641',\n",
       "  'our_bi_cui_name': 'Atrophic',\n",
       "  'our_bi_cui_desc': 'Atrophic [unused3] ( Biologic Function , morphologic abnormality : atrophy ; Atrophy ; Atrophies ; atrophies ; Atrophy [ Disease / Finding ] ; atrophic ; atrophying ; atrophied ; ATROPHY ; Atrophy [ dup ] )',\n",
       "  'our_cross_cui': 'C0341045',\n",
       "  'our_cross_cui_name': 'Atrophy of parotid gland',\n",
       "  'our_cross_cui_desc': 'Atrophy of parotid gland [unused3] ( Biologic Function , disorder : atrophy ; parotid gland )'},\n",
       " {'mention_id': '28243201.17',\n",
       "  'test_set_idx': 29659,\n",
       "  'type': 'T201',\n",
       "  'name': 'response',\n",
       "  'context': 'currence . DNA methylation has been suggested as one of the underlying mechanisms for recurrent disease and its contribution to the development of drug resistance remains to be clarified . This study aimed to determine the methylation phenotype in colorectal cancer for identification of predictive markers for chemotherapy [unused1] response [unused2] . We performed DNA methylation profiling on 43 non - recurrent and five recurrent colorectal cancer patients using the Illumina Infinium HumanMethylation450 Beadchip assay . In addition , colorectal cancer cells with different genetic backgrounds , response to',\n",
       "  'existing_cui': 'C1704632',\n",
       "  'existing_cui_name': 'Disease Response',\n",
       "  'existing_cui_desc': 'Disease Response [unused3] ( Finding : Response ; response )',\n",
       "  'our_bi_cui': 'C0683154',\n",
       "  'our_bi_cui_name': 'drug response',\n",
       "  'our_bi_cui_desc': 'drug response [unused3] ( Biologic Function : response to drug ; drug responses ; drugs response )',\n",
       "  'our_cross_cui': 'C0521982',\n",
       "  'our_cross_cui_name': 'Response to treatment',\n",
       "  'our_cross_cui_desc': 'Response to treatment [unused3] ( Clinical Attribute , context - dependent category , finding , function , observable entity , situation : response to treatment ; response treatments ; Therapeutic response ; response therapeutic ; Therapeutic Response ; Finding related to therapeutic response ; successful treatment ; successful treatments ; Therapeutic response , function )'}]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "selected"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "782cd831",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
